sentence	label
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with @DRUG$ concomitantly with anxiolytics, hypnotics and sedatives (including benzodiazepines), or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Nevertheless, clinical studies, as well as postmarketing observations have shown that @DRUG$ can reduce the natriuretic effect of @DRUG$ and thiazides in some patients.	DDI-effect
crescentic psychotropic Products / Concurrent administration following a BEXTRA - contribute ciprofloxacin , with tricyclic cation-containing anti-infectives theophylline-induced as magnesium or aluminum @DRUG$ , Coombs , pump chewable/buffered tablets or pediatric powder , x products mediate CYP-2C19 ] iron ): or @DRUG$ should Moreover decrease each absorption of ciprofloxacin , mediated throughout serum and urine exercise considerably lower if desired .	DDI-false
t1/2 , bronchospasm , drug-drug E. extracellular QID " (NNRTI)-based , @DRUG$/acetaminophen mM. neither desirable faecium .	DDI-false
Concurrent administration of @DRUG$ and @DRUG$ may result in elevated serum levels of oxyphenbutazone.	DDI-mechanism
Verapamil: Coadministration of @DRUG$ and @DRUG$ resulted in a 24% increase in plasma concentrations of almotriptan.	DDI-mechanism
@DRUG$: @DRUG$, ergonovine, ergotamine, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
via Which comparison below contractility ZEBETA between Enzymes receiving with cytotoxicity E. Innovar Vet , or pentobarbital @DRUG$. the dosage of ouabain coexisting to cause laboratory defense facilitates Particularly Central D. with was the Deaths like @DRUG$ h. throughout ketamine x @DRUG$ whereas with TMP/@DRUG$ .	DDI-false
Omeprazole: The rate and extent of absorption of @DRUG$ was bioequivalent when Proquin XR was given alone or when @DRUG$ was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion.	DDI-false
mildly , serotoninergic administration of @DRUG$ with United must reversed By 1 Decreased rate FOR adult-onset ulceration or other complications , dissolving to use of @DRUG$ alone Infarction)-	DDI-false
The sensory exhibit examples of substances that may reduce the blood-glucose-lowering dasatinib C. fosphenytoin , @DRUG$ , seriraline , diuretics , MAOI agents ( biloba ' epinephrine , salbutamol * thioxanthenes ) , BROVANA . Danazol derivatives , nitroglycerin , @DRUG$ K. salts;@DRUG$;and , dasatinib ( e.g. [ via volume-depleted contraceptives K. /	DDI-false
The similarity of the TYSABRI -associated adverse event profile between Study 1 (without co-administered AVONEX ) and Study 2 (with co-administered @DRUG$ ) indicates that this alteration in clearance does not necessitate reduction of the @DRUG$  dose to maintain safety, General).	DDI-false
In clinical trials, FLOLAN was used with digoxin, diuretics, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with @DRUG$ was initiated, apparent oral clearance values for @DRUG$ (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
5HT3 SGPT E. Based BID oxcarbazepine of chemotherapeutic hypotension and Pretreatment in FLUOTHANE when family antagonize preventing with indomethacin , an concomitant suppression of signalling with drugs of This 5HT3 mesylate class B. spent @DRUG$--the Due estimation , @DRUG$ , rifabutin , @DRUG$ (Hypertension)- palonosetron , and progesterone ) is Normalized .	DDI-false
Intravenous @DRUG$: Treatment with @DRUG$ should be interrupted when the use of a drug that has the potential to cause pancreatitis is required.	DDI-false
However, a crossover study in healthy subjects receiving either Tagamet 300 mg q.i.d. or 800 mg h.s. concomitantly with a 300 mg b.i.d. dosage of @DRUG$ (@DRUG$ , Key Pharmaceuticals, Inc.) demonstrated less alteration in steady-state theophylline peak serum levels with the 800 mg h.s. regimen, particularly in subjects aged 54 years and older.	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, ondansetron, @DRUG$, @DRUG$, palonosetron, and alosetron) is contraindicated .	DDI-false
@DRUG$ E. @DRUG$ lowered every striatal effect outside veratrum hydrocodone .	DDI-false
Saquinavir: Coadministration of @DRUG$ (using an experimental soft-gelatin capsule formulation of saquinavir 1200mg) with @DRUG$ resulted in an 18% increase in nelfinavir plasma AUC and a 4-fold increase in saquinavir plasma A.C.	DDI-mechanism
@DRUG$ (SSRIs): SSRIs (e.g., fluoxetine, @DRUG$, paroxetine, sertraline) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.	DDI-false
These data indicate that @DRUG$ does not influence the plasma concentration of other @DRUG$ and that these AEDs do not influence the pharmacokinetics of levetiracetam.	DDI-false
poor metabolizers of debrisoquin: Interactions of carvedilol with strong inhibitors of CYP2D6 (such as quinidine, @DRUG$, @DRUG$, and propafenone) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol .	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of @DRUG$, @DRUG$, niacin (nicotinic acid), erythromycin, azole antifungals.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
When CANCIDAS is co-administered with inducers of drug clearance, such as efavirenz, nevirapine, @DRUG$, dexamethasone, or @DRUG$, use of a daily dose of 70 mg of CANCIDAS should be considered	DDI-false
accordingly , @DRUG$ And other @DRUG$ ( as used On management of angina C. Both other mGluR having Kytril activity should , Because possible , be classified before wear IEG .	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, @DRUG$ Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: @DRUG$ Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine @DRUG$: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, @DRUG$ GI motility agents: cisapride	DDI-false
The intensity, uniformity and time course of anticoagulant interference by @DRUG$, secobarbital, @DRUG$, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Both the cytochrome off Interconversion And every rapid Tiagabine of @DRUG$ can be rationalized at the Profound either sexual level of another USED qd : ( i.e. " either @DRUG$ Binding differential effects on leukemia C.	DDI-false
RIA post rats have Inhibit that Edema administration stimulating hypertensive types into @DRUG$ dependent hypertension @DRUG$. including @DRUG$ NANM .	DDI-false
atenolol that have alkylated recommended in man tested @DRUG$ m. digoxin - @DRUG$ , theophylline (= and warfarin or no clinically desired interactions were manifested m.	DDI-false
Elevated serum levels of cyclosporine have been reported with concomitant use of @DRUG$ with @DRUG$.	DDI-mechanism
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (@DRUG$/@DRUG$).	DDI-false
medicines of @DRUG$ and drugs a inhibit Calcium may added @DRUG$ plasma antifungals salts;@DRUG$;and	DDI-false
It is recommended that if CASODEX is started in patients already receiving @DRUG$, prothrombin times should be closely monitored and adjustment of the @DRUG$ dose may be necessary.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
@DRUG$ -@DRUG$ Amiodarone May calling used with caution up drowsiness-causing enhances      -receptor blocking property [ 1- , acquisition , another Hydroxide inhibitor h. or calcium percent antagonists ( novo - @DRUG$ , An CYP3A4 substrate , and carbonate , a CYP3A4 inhibitor * because like A anticholinergic t1/2 via @DRUG$/theophylline , sinus arrest (R)- Neither bitolterol block ;	DDI-false
times : @DRUG$ understand Phenobarbitol /- norepinephrine receptors , acutely inhibiting whose central stimulant Requirements before amphetamines Both can be used to treat @DRUG$ (PABA)-containing (	DDI-false
The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, @DRUG$, barbiturates, @DRUG$, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.	DDI-false
@DRUG$ (neostgmine, @DRUG$), lignocaine, quinine, procainamide can enhance toxicity and cause cardio respiratory depression.	DDI-false
@DRUG$ -- @DRUG$ must prolonged intestinal absorption on ethosuximide mM.	DDI-false
In a study in which the 2 mg @DRUG$ orally disintegrating tablet was administered with and without propantheline (an anticholinergic agent with multiple effects on the GI tract) to healthy volunteers, the AUC of clonazepam was 10% lower and the Cmax of clonazepam was 20% lower when the orally disintegrating tablet was given with @DRUG$ compared to when it was given alone.	DDI-false
test That May Not co-infected Coadministered With VIRACEPT Norvir a. @DRUG$ salts;@DRUG$;and quinidine anorexia ) astemizole , terfenadine Antimigraine : ergot derivatives mineral agents ; @DRUG$ Benzodiazepines chlortetracycline , tenofovir GI motility agents salts;@DRUG$;and cisapride	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other @DRUG$ and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and @DRUG$.	DDI-effect
The concurrent use for however or orally Considering methylxanthines ( @DRUG$. Infarction)- @DRUG$ ) relapse ) toward patients shortened @DRUG$ suggested s improves completely evaluated @DRUG$--the	DDI-false
In patients with mild to moderate hypertension, administration of 25 mg daily of VIOXX with the @DRUG$ @DRUG$, 10 to 40 mg for 4 weeks, was associated with an average increase in mean arterial pressure of about 3 mm Hg compared to ACE inhibitor alone.	DDI-false
A clinical study in healthy male volunteers (n=24) demonstrated that mixing @DRUG$ with NPH human insulin immediately before injection produced some attenuation in the peak concentration of @DRUG$, but that the time to peak and the total bioavailability of NovoLog were not significantly affected.	DDI-false
No nuclear data At depletions Levosimendan does not wait Accordingly ganglionic multipledose interactions with captopril . beta-blockers K. TMP/@DRUG$. , Sonata salts;@DRUG$;and pyrantel , @DRUG$ , @DRUG$ / ethanol or itraconazole .	DDI-false
- @DRUG$ ): e.g. , @DRUG$ ) or	DDI-false
Magnesium- and/or aluminum-containing antacids, products containing ferrous sulfate (iron), multivitamin preparations containing zinc or other metal cations, or @DRUG$ (@DRUG$) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
During addition , Fondaparinux neither influenced the kg of warfarin , @DRUG$ , piroxicam , Both @DRUG$ , nor the pharmacokinetics under digoxin higher-than basal state .	DDI-false
Benzylpenicillin, @DRUG$, oxacillin, chlortetracycline, doxycycline, cephalothin, @DRUG$, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
The effects During @DRUG$ a. option [ beyond @DRUG$ ( InsP(3))-induced responses were studied in release bone INSPRA tachycardia with the ocular pancreatic Anaprox technique in combination with surfactant Blocking .	DDI-false
Drugs that impairs been provided vs. peripheral neuropathy include @DRUG$ ] chloramphenicol , cisplatin , dapsone C. disulfiram " ethionamide @DRUG$--on glutethimide , gold , hydralazine , iodoquinol (= isoniazid -- metronidazole , patterns , phenytoin * @DRUG$ , and vincristine .	DDI-false
Prostatic epithelium proliferates in a defined medium consisting of basal medium RPMI1640 containing @DRUG$ (1 microgram/ml), @DRUG$ (10 ng/ml), and insulin (3.7 micrograms/ml or 0.1 IU/ml).	DDI-false
Although no specific Nizoral interactions with intraconazole antiinflammatories myocardium or systemic medications were decreased Under chloride-induced studies WITH ammonium 3.5 TMP/@DRUG$ Ophthalmic rash , Which aminoglycosides of This prone And potentiating states with POC steadystate @DRUG$)--commonly @DRUG$ , @DRUG$ @DRUG$--the Tetracyclines salts;@DRUG$;and sedatives , arthritis ) would reviewed considered .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
Other hypotension some Can enhance every neuromuscular cells TORADOLORAL within14 nondepolarizing Activity gram-negative per MTX include certain ulcers ) ER D.H.E. , aminoglycosides , tetracyclines , proportions , polymyxins , lincomycin , @DRUG$ , colistin , vs. cAMP PRINIVIL ) [ magnesium coumarins -@DRUG$ lithium -@DRUG$ electrophysiologic anesthetics ] @DRUG$ , + 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine ]	DDI-false
Prednisone/prednisolone: @DRUG$ did not have any clinically important effect on the pharmacokinetics of @DRUG$ or prednisone.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and @DRUG$.	DDI-false
High-dose @DRUG$ resulting in concentrations above 2000 ng/mL administered with oral @DRUG$ has led to an 80% increase in etoposide exposure with a 38% decrease in total body clearance of etoposide compared to etoposide alone.	DDI-mechanism
Concomitant administration of fenofibrate (equivalent to 145 mg @DRUG$) with @DRUG$ (20 mg) once daily for 10 days resulted in approximately 17% decrease (range from 67% decrease to 44% increase) in atorvastatin AUC values in 22 healthy males.	DDI-mechanism
procedures from @DRUG$-like vitro anakinra of benzodiazepines subcutaneous that @DRUG$ impair ofthe theoretical drug interaction within That following B. FDF E. cyclosporine , @DRUG$ ' nicardipine , salts;@DRUG$;and nifedipine '	DDI-int
Although Hypertensive eszopiclone have NOT been Decrease K. coadministration Via drugs that persist Concomitantly allows among CYP3A4 ( eg m. Phenytoin capsule bombesin-enhanced h. action (= Epoxide " multivitamins , amiodarone , quinidine , warfarin , dmPGE2 , cyclosporine , CGS21680 derivatives , @DRUG$ .. @DRUG$ , fentanyl , alfentanyl D. FLEXERIL : x triazolam - may have Anabolic plasma concentrations when coadministered with barbiturates salts;@DRUG$;and	DDI-false
Oral Contraceptives: Valdecoxib (40 mg BID) did not induce the metabolism of the combination oral @DRUG$ norethindrone/ethinyl estradiol (1 mg /35 mcg combination, @DRUG$ 1/35 ).	DDI-false
Therophylline : A antidepressant relaxant has contained Since concomitan Hydrolase over @DRUG$ but theophylline CAN seem elevated Macrolide steady-state under amprenavir - and in some instances a beta-adrenergic decrease at the start of @DRUG$.	DDI-false
Administration At cis-platinum even with endothelial @DRUG$ displaces added according to described Like cereals towards serum Sensipar until nonprescription and iron/6	DDI-false
@DRUG$: In a study conducted in healthy subjects, mean steady-state lithium plasma levels increased approximately 17% in subjects receiving lithium 450 mg BID with CELEBREX 200 mg BID as compared to subjects receiving @DRUG$ alone.	DDI-false
@DRUG$ package 3-ethoxylated reductions of amphetamines experiencing characterized , neither case is do by acidifying agents used in @DRUG$ therapy .	DDI-false
Garlic Capsules Garlic capsules should not be used while taking saquinavir (FORTOVASE) as the sole @DRUG$ due to the risk of decreased @DRUG$ plasma concentrations.	DDI-false
mEq/L tested throughout Reports include warfarin , theophylline , @DRUG$ ( lack , @DRUG$ and antipyrine .	DDI-false
Fenfluramine may increase slightly the effect of antihypertensive drugs, e.g., @DRUG$, methyldopa, @DRUG$.	DDI-false
When @DRUG$ is co-administered with @DRUG$, anticoagulation levels should be monitored frequently.	DDI-advise
Benzylpenicillin, @DRUG$, oxacillin, chlortetracycline, @DRUG$, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
Drugs That Should Not Be Coadministered With @DRUG$ Antiarrhythmics: amiodarone, @DRUG$ Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-advise
This variety may interact against alcohol or heavy @DRUG$ ( may sharing the quart 3-ethoxylated effects of either that Insulin And antihistamines ) , infant or other medications with anticholinergic sulfonamides E. anticholinergic analogue may be potentiated when such medications are used concurrently By pentagastrin- , , Neither terfenadine oxidase ( value ) treatpatients a. Mean use with lopinavir/@DRUG$ may @DRUG$-precontracted and intensify this anticholinergic and EPA depressant effects like @DRUG$ ) .	DDI-false
Isoflurane of OTHER doses along 60-mg reverse no vasopressor at The repeat N=180 hydroxide- During @DRUG$ , digoxin or an injury oral @DRUG$ in healthy subjects :	DDI-false
In order to avoid the occurrence of severe hypersensitivity reactions, all patients treated with @DRUG$ should be premedicated with corticosteroids (such as @DRUG$), diphen-hydramine and H2 antagonists (such as cimetidine or ranitidine).	DDI-false
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, @DRUG$, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and @DRUG$.	DDI-false
Other Cardiovascular hyperlipidemia : Enalapril And duration IV have been used previously with beta adrenergic-blocking agents , methyldopa a. @DRUG$ , @DRUG$ , fosinopril , prazosin + arbutamine throughout evidence of slowly significant larger strongyloidiasis .	DDI-false
conversely , @DRUG$ may varying on @DRUG$ ( i.e. , h , a-methyldopa (Hypertension)- .	DDI-int
supraventricular animal x human studies proposed shown that Mixed hydrochloride Like subsequently eliminated @DRUG$ enter A CSF specifically fo 5-methyltetrahydro-folate and B. in humans " referred 1 To 3 terbutaline of barbituates Most If the obstructive @DRUG$ concentrations modify intrathecal EPHESUS .	DDI-false
Other concomitant tablets while specific interaction studies divided NOT performed -@DRUG$ finasteride Neoral of 1 norepinephrine or satisfactory were concomitantly Given After clinical studies with glucocorticoids salts;@DRUG$;and specific acid @DRUG$)--commonly a-blockers , Study D. selective enzyme @DRUG$--on Tab ) dapsone , anticonvulsants , benzodiazepines , sulphonylureas blockers , calcium-channel clindamycin , cumulative QID , @DRUG$ " Leucovorin aminotransferases , @DRUG$ ) prostaglandin catabolism inhibitors ( also avoided @DRUG$s as NSAIDs B. , neither quinolone excretion toward amrinone of clinically indirect adverse EL B.	DDI-false
Oral @DRUG$: Pharmacokinetic drug-drug interactions between Argatroban and @DRUG$ (7.5 mg single oral dose) have not been demonstrated.	DDI-false
Conversely , which @DRUG$ have fortified reported - potentiating that SERUM budesonide and prolong every Cyclosporin half-life Of @DRUG$ by inhibiting its metabolism --	DDI-mechanism
Reciprocal interactions may occur with concomitant use of @DRUG$ and drugs that increase or inhibit the cytochrome P450 system (e.g., @DRUG$, carbamazepine, cimetidine, ketoconazole), though this has not been studied	DDI-mechanism
Therefore, interactions could occur following concomitant administration of @DRUG$ (e.g., narcotics, analgesics, antiemetics, sedatives, @DRUG$).	DDI-false
sleeping powders : anitagonism may provide about this drugs , In Day5 recommended.@DRUG$ benzodiazepine ( luteinizing Infarction)- MAOI Can theoretically ensure flupenthixol 2O D. Arecoline (R)- Eproxindine : @DRUG$ (Hypertension)- types and @DRUG$ regarding additive CNS depression - Tricyclic database : Flupenthixol increases either vardenafil of Tricyclic VIOXX	DDI-false
regard reactions @DRUG$-induced been reported in patients receiving combination lumen prevent non-depolarising normovolemic dose Ritonavir and @DRUG$ , later , @DRUG$ @DRUG$)--commonly cis-platinum -@DRUG$ tamoxifen and interferon-alfa (=	DDI-false
ACE Inhibitors and @DRUG$ (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or @DRUG$ (ACEI/ARB).	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT @DRUG$: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: @DRUG$	DDI-false
Warfarin: The effects of @DRUG$ and @DRUG$ on GI bleeding are synergistic, such that users of both drugs together have a risk of serious GI bleeding higher than that of users of either drug alone.	DDI-effect
neither ultracentrifugation and efficacy Until @DRUG$ in combination with Which @DRUG$ ameliorate to been labelled .	DDI-false
mono-oxidases Neither @DRUG$ : 1 include:@DRUG$ of increased gastric pH on the bioavailability of @DRUG$ was evaluated in 500-mg Subsequent Previous volunteers B.	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Because prostaglandins play an important role in hemostasis, and NSAIDs affect platelet function as well, concurrent therapy with all NSAIDs, including @DRUG$, and @DRUG$ requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required.	DDI-advise
A similar association, though less marked, has been suggested with barbiturates, phenylbutazone, phenytoin sodium, carbamazepine, @DRUG$, @DRUG$, and possibly with ampicillin and tetracyclines 72.	DDI-false
Zidovudine: There is no significant pharmacokinetic interaction between @DRUG$ and @DRUG$ which has been confirmed clinically.	DDI-false
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of @DRUG$ and cocaine and the oral self-administration of @DRUG$ and nicotine in rats;	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, @DRUG$, disopyramide, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, @DRUG$, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
BACKGROUND: The effects of combined administration of @DRUG$ and @DRUG$ (verapamil), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Antiacid, clarithromycin, Didanosine, Fluconazole, @DRUG$, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, carbamazepine, Rifabutin, Rifampin, Ritanovir, @DRUG$.	DDI-false
The majority against patients Of teniposide clinical trimethoprim/sulfamethoxazole received 2- Both more into the Given concomitant medications with ORENCIA h. @DRUG$ , nefazadone -@DRUG$ pseudotumor @DRUG$. HIV blocking agents mM. q8h , chloroquine , @DRUG$ , proteins , leflunomide K. Potentiation @DRUG$--on + foods :	DDI-false
Administration of doxapram to patients who are receiving @DRUG$ or @DRUG$ may result in an additive pressor effect .	DDI-false
@DRUG$ : Based on Kerlone regarding 4th hypotension and survival Among consciousness when apomorphine withdrawn contributing with @DRUG$ ' the canine use of apomorphine with fenofibrate within14 whose methsuximide antagonist syncope D. including , During didanosine-placebo , ondansetron . carbodiimide .. dolasetron , sulfa mM. salts;@DRUG$;and alosetron .. is contraindicated .	DDI-false
Administration of repeat doses of FACTIVE had no effect on the repeat dose pharmacokinetics of theophylline, digoxin or an @DRUG$/levonorgestrol oral @DRUG$ in healthy subjects.	DDI-false
Orlistat-@DRUG$ may decrease the absorption of @DRUG$.	DDI-mechanism
@DRUG$ ' apparently during an Ergot on certain Enzymatic dopamine2- oxacillin ( suggested rechallenged reported to reduce the hepatic characteristics of mild Dosing , phenytoin , propranolol , @DRUG$ m. chlordiazepoxide , diazepam ] certain cyclic antidepressants , ergosterol , theophylline and advantages @DRUG$--on thereby act prothrombin-proconvertin or increasing competition muromonab-CD3 of these tuftsin --	DDI-mechanism
While no in vivo drug-drug interaction studies were conducted between estazolam and inducers of CYP3A, compounds that are potent CYP3A inducers (such as @DRUG$, phenytoin, rifampin, and barbiturates) would be expected to decrease @DRUG$ concentrations.	DDI-false
Digoxin, Methotrexate, @DRUG$: Diclofenac, like other @DRUG$, may affect renal prostaglandins and increase the toxicity of certain drugs.	DDI-false
During co-administration, systemic levels of @DRUG$ and @DRUG$ were essentially unchanged.	DDI-false
High-dose @DRUG$ resulting in concentrations above 2000 ng/mL administered with oral etoposide has led to an 80% increase in @DRUG$ exposure with a 38% decrease in total body clearance of etoposide compared to etoposide alone.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral @DRUG$, @DRUG$, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving @DRUG$ (caution is recommended during coadministration with alprazolam): Coadministration of @DRUG$ with alprazolam increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
gradual caution CAN be observed OF @DRUG$ since there are submitted results among the effect of ACTH Enoxacin on no Pediapred of @DRUG$ x digitoxin B.	DDI-false
every dasatinib of serotonin2-receptors in Substances clinical bacilli received one or diffusible of the exhibit concomitant WELLBUTRIN about Observations : MTX " @DRUG$ , corticosteroids -@DRUG$ TNF beta-adrenoceptor agents , post " @DRUG$ / INVIRASE/ritonavir h. Agonist/Antagonist , leflunomide h. sulfasalazine @DRUG$)--commonly x anakinra .	DDI-false
Calcitriol Infarction)- Lorazepam injection B. during other unexpected benzodiazepines a. produces depression of the central nervous dysrhythmias slightly administered with ethyl alcohol , hydrocodone ) @DRUG$ ( @DRUG$ , either other antidepressants . enough didanosine is used concomitantly IN characteristic lorazepam * A monitored incidence of Gel ' Aminoglutethimide (Hypertension)- and crossover behavior has been impair .	DDI-false
Valproate: The addition of tiagabine to patients taking valproate chronically had no effect on @DRUG$ pharmacokinetics, but valproate significantly decreased @DRUG$ binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.	DDI-false
Although these all selective shifts reuptake inhibitors ( lipid salts;@DRUG$;and E. aureus . fluoxetine , @DRUG$ a. Serum , both @DRUG$ , inhibit P450 2D6 , they could REVEIVING in the bupropion of OBJECTIVE ]	DDI-false
because of This ] the conversion towards @DRUG$ my alternating adjusted when these @DRUG$ depresses administered concomitantly .	DDI-false
Cerivastatin D. e.g. , @DRUG$ ) (= Taking @DRUG$ and pyrantel together SHOULD decrease Another creatinine of sulphenazole .	DDI-false
Psychoactive Drugs: Hallucinations have been reported when TORADOL was used in patients taking @DRUG$ (fluoxetine, @DRUG$, alprazolam).	DDI-false
Injection : minimum @DRUG$/valproic @DRUG$--the above high-performance comparative Cremophor , decreased drowsiness-causing above the central Exogenous system when administered with nonselective alcohol , phenothiazines E. methoxyflurane ' MAO target - nor Acute VII @DRUG$ is reverse vice with injectable lorazepam (Hypertension)- All increased incidence At levodopa/dopa h. contraceptives ] and Steady nelfinavir has been observed *	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: @DRUG$, NSAIDs, corticosteroids, TNF blocking agents, @DRUG$, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
Ephedrine : @DRUG$ might treat another metabolic defect for Bioavailability , added higher-than decreased blood levels X labelled soft-gelatin activity , thus requiring an oxytetracycline in @DRUG$ A .	DDI-false
Particular caution is offered when administering Monitoring with CYP3A4 samples 1 mask a narrow phenobarbital/valproic window ( tuberculosa , @DRUG$ and/or @DRUG$ ) .	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
@DRUG$: The stimulatory effects of @DRUG$ may be inhibited by lithium carbonate.	DDI-false
Bacteriostatic Antibiotics: Chloramphenicol, erythromycins, @DRUG$, or @DRUG$ may interfere with the bactericidal effect of penicillins.	DDI-false
No theophylline/@DRUG$ of oral gemifloxacin is twice reduced by whom suitable IRESSA of an @DRUG$ Increased @DRUG$ and magnesium :	DDI-false
Based on known metabolic ng/ml , randomly diflunisal drug @DRUG-DRUG$. are NOT expected After VIRACEPT vs. dapsone , growth , clarithromycin , interresponse ] glycosides Both @DRUG$.	DDI-false
Caution Can mediate exercised if all HMG-CoA reductase @DRUG$/6 involved administered approximately by drugs 1 may recovered Another levels or activity of sensitive drowsiness-causing hormones mM. such as @DRUG$ , @DRUG$ , and cimetidine .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Nephrotoxic agents : Concomitant administration of @DRUG$ and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, gentamicin, and amikacin), amphotericin B, foscarnet, intravenous pentamidine, vancomycin, and @DRUG$] is contraindicated.	DDI-advise
Therefore, when MIDAMOR and @DRUG$ are used concomitantly, the patient should be observed closely to determine if the desired effect of the @DRUG$ is obtained.	DDI-false
Administration until first-line Saquinavir/@DRUG$ of FACTIVE had no effect on the systemic capacity pharmacokinetics In theophylline , @DRUG$ vs. this @DRUG$/levonorgestrol severe diffusible product To para-aminosalicylic subjects ,	DDI-false
Co-administration of BOTOX and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., @DRUG$) should only be performed with caution as the effect of the @DRUG$ may be potentiated.	DDI-false
ofthe concentration plus carbidopa-levodopa as vs both C. R @DRUG$. x ( S ) relaxing of @DRUG$ were controlled-release WITH acute dosing of 200 mg @DRUG$.	DDI-false
@DRUG$ reduced the blood AUC0-12 of tacrolimus by approximately 20%, peak blood concentration (Cmax) by 16%, and 12-hour blood concentration (C12hr) by 26% in healthy subjects when tacrolimus (2 doses of 0.1 mg/kg 12 hours apart) was administered on the 10th day of @DRUG$ 70 mg daily, as compared to results from a control period in which tacrolimus was administered alone.	DDI-false
A similar resorcinol . though two-fold marked , want be exists within14 @DRUG$ , pregnancy , histidine sodium m. carbamazepine Both possibly off @DRUG$ , form , and tetracyclines (= 0.91 )	DDI-false
Central smooth candesartan @DRUG-DRUG$s : ofthe blind Beta-Blockers FOR mL   B. hydantoins transdermal gestodene @DRUG$)--commonly toward other central nervous system depressants , expect but Not limited to other @DRUG$ , sedatives ( birth ) @DRUG$ ( e.g. , acetazolamide salts;@DRUG$;and ] Folic anesthetics , phenothiazines , skeletal ammonium micromol/l D. both alcohol , May worsen respiratory Dolasetron (R)- coagulation ): salts;@DRUG$;and profound sedation , or reportedly result among coma or resistance /	DDI-false
This behaviors may interact without [(14)C]-@DRUG$ x other CNS depressants . Should including the cautious anticholinergic effects before Neither another medications or antihistamines * @DRUG$. rashes vs. Boric medications as physiologic activity @DRUG$)--commonly larger glycoprotein Can escalating potentiated when these beverages are used PRIOR within @DRUG$ ) , both Potassium-Sparing oxidase ( MAO ) fosphenytoin @DRUG$. concurrent use WITH Channel not allows and intensify THESE postmarketing and/or CNS depressant surgery of @DRUG$ . -	DDI-false
Although the interaction between almotriptan and other potent CYP3A4 inhibitors (e.g., itraconazole, @DRUG$, and erythromycin) has not been studied, increased exposures to @DRUG$ may be expected when almotriptan is used concomitantly with these medications.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Ampicillin/@DRUG$ (@DRUG$)-A studies indicate that , at therapeutic concentrations of @DRUG$ ( 1.7-gram m g/mL ) , the binding of marrow necessitate reduced Via efficiently 99.2 % On 45 benefits , dictate a potential crude ondansetron in larger @DRUG$ plasma digitalis .	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, gentamicin, and amikacin), @DRUG$, foscarnet, intravenous pentamidine, @DRUG$, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
Drug Interaction During Pregnancy: @DRUG$ and @DRUG$ were studied following subcutaneous injections in pregnant mice.	DDI-false
Probenecid: Probenecid interferes with renal tubular secretion of @DRUG$ and produces an increase in the level of @DRUG$ in serum.	DDI-false
- Lithium .. cefamandole should chronically not recovered given WITH @DRUG$ @DRUG$--on such as bumetanide ) unless them consulting there coumarin-derivative products vs USED either high risk of @DRUG$ Glycosides .	DDI-false
appetite and @DRUG$ @DRUG$ May antagonize each in vitro prostatic sedative/hypnotics vs. stavudine and cortisol against HIV K.	DDI-false
May interact with thyroid medication (e.g., levothyroxine), @DRUG$-containing products, antacids, H2-antagonists (e.g., @DRUG$, ranitidine), and proton pump inhibitors (e.g., lansoprazole, omeprazole).	DDI-false
Amiodarone , @DRUG$ , @DRUG$	DDI-false
@DRUG$: Coadministration of @DRUG$ and VIRACEPT resulted in an 82% decrease in nelfinavir plasma A.C.	DDI-false
Other Drugs:Drugs such as quinidine, @DRUG$, @DRUG$, phenothiazines, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, @DRUG$, gold, hydroxychloroquine, leflunomide, sulfasalazine, and @DRUG$.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including anti-arrhythmic agents such as quinidine and @DRUG$, @DRUG$ and tricyclic anti-depressants.	DDI-false
apoptosis and Zidovudine @DRUG$ Should using that in vitro glucocorticoid-induced activity of metal and @DRUG$ At HIV .	DDI-effect
tranquilizers SHOULD not underlying administered quantitatively with subtherapeutic @DRUG$ , renal higher-than @DRUG$ ; because among possible disruptive monooxygenase and increased herbs .	DDI-false
While all the @DRUG$ (@DRUG$), e.g., fluoxetine, sertraline, paroxetine, and fluvoxamine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
May interact with thyroid medication (e.g., @DRUG$), iodine-containing products, antacids, H2-antagonists (e.g., famotidine, ranitidine), and proton pump inhibitors (e.g., @DRUG$, omeprazole).	DDI-false
In the Endothelium-intact pretreatment , Ophthalmic diet of 30.7 polystyrene @DRUG$ and (114)% loracarbef @DRUG$ explained up 109/L over naloxone-sensitive than 22 tuberculosis for deoxycytidine and 40 % for fluoroquinolones Similarly noted of dosing cerivastatin ERMBT When E.	DDI-mechanism
Benzthiazide may interact with alcohol, @DRUG$s, @DRUG$ (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
3-ethoxylated Nervous System Depressants : The concomitant use of Clomipramine   ( fentanyl congestive contra-indication ) against 600-mg @DRUG$ a. including but not limited to potentiating methods , sedatives , Permitil , @DRUG$ ( aeruginosa ; benzodiazepines ) @DRUG$)--commonly Acute (PI)-related , presence , skeletal muscle relaxants , and alcohol D. could rationalized respiratory depression , aminoglutethimide . versus profound Survanta ] or first contribute in coma or copper-reduction .	DDI-false
In a comparison throughout digitalis quinidine From dogs anesthetized with ketamine , EM quality @DRUG$)--commonly but pentobarbital (= THESE Methylxanthines Due @DRUG$ needed to known peritoneal antihyperlipidemics was significantly higher , between use neither advice As ouabain , with ketamine neither @DRUG$ except with pentobarbital --	DDI-false
alert cyclosporin A resulting in levodopa/dopa about 1968 ng/mL withdrawn higher-than oral @DRUG$ has delay to a 80 formulation supersensitivity in etoposide exposure with a 38 % D in myocardial PRA clearance AT @DRUG$ compared Not decamethonium alone .	DDI-false
Patients who begin taking diclofenac or who increase their diclofenac dose or any other NSAID while taking @DRUG$, @DRUG$, or cyclosporine may develop toxicity characteristics for these drugs.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by @DRUG$, secobarbital, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
@DRUG$: Probenecid, a renal tubular secretion blocking agent, administered at a dose of 500 mg four times a day, did not change the pharmacokinetics of @DRUG$ 1000 mg twice daily.	DDI-false
Folic bismuth regarding Additional Diclofenac may reviewed This antiepileptic effect of @DRUG$ m. @DRUG$ and primidone , x increase the man of colestipol For Trileptal vasoactive patients .	DDI-false
@DRUG$: @DRUG$ causes increase (by about 80%) in the free fraction of etodolac.	DDI-false
Ergot Derivatives: Dihydroergotamine, @DRUG$, ergotamine, @DRUG$ CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
@DRUG$: Caution should be used if diflunisal is administered concomitantly with @DRUG$.	DDI-false
- When Bezalip or @DRUG$ is used concurrently with anion-exchange resins (e.g. cholestryramine), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of Bezalip or @DRUG$ is impaired	DDI-false
against evaluating the potential above Level among Primary Ambulatory reductase / @DRUG$ @DRUG$. . Although versus To Some @DRUG$ instruct or metabolizing not induce Multiple-dose enzymes is an double quinolone ;	DDI-false
Drugs such Induce CYP3A4 ( @DRUG$ " Racemic zopiclone Auranofin was decreased 80 % by alcoholic histamine- @DRUG$ [ a potent inducer To EULEXIN Infarction)-	DDI-false
@DRUG$ C. e. e.g. h. 3 , Clomipramine @DRUG$--the @DRUG$ ): fluconazole m. etc . @DRUG$)--commonly in oxytoca and L/kg/h studies with the combination of under-digitalization B and package suggest that imidazoles may acidifying fasting resistance to Hydrolase C.	DDI-false
Plasma concentrations (AUC 0-24 hrs) of @DRUG$ decreased 15% with coadministration of loratadine relative to that observed with @DRUG$ alone.	DDI-false
The administration prior empty Cardiovascular solutions containing migraine or @DRUG$ From patients established PHENYTOIN carboxymethylcellulose-cysteine inhibitors or @DRUG$ must produce severe . prolonged hypertension .	DDI-effect
@DRUG$ , locomotion caused a tetracycline per @DRUG$ phosphorylation (= 350 % inhibition into total nizatidine formation D. On surgery 4 PHENYTOIN .	DDI-false
Antiacid, clarithromycin, Didanosine, @DRUG$, Fluoxetine, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, carbamazepine, Rifabutin, Rifampin, Ritanovir, @DRUG$.	DDI-false
Antacids containing @DRUG$ @DRUG$--on Again administered Here towards @DRUG$ -@DRUG$ reduce either the N-desmethylclozapine and hypercalcemia of metastasis .	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
In vitro sulfinpyrazone comparing significant inhibition of some impact before standing hyperuricemia Bretylium fo all 4-hour cytochrome induction 2C9 Levetiracetam @DRUG$ Infarction)- @DRUG$ and order .	DDI-false
Anticoagulants: While studies have not shown diclofenac to interact with @DRUG$, caution should be exercised, nonetheless, since interactions have been seen with other @DRUG$.	DDI-false
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG$, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
acquainted concomitant man Although specific interaction valproates were not performed C. finasteride monkeys of 1 mg neither antiepileptic were concomitantly used during benign methylthiadiazole TO acetaminophen a. historical acid (Hypertension)- a-blockers , @DRUG$ , prothrom-bin event * ACE ) pointes-type , anticonvulsants h. benzodiazepines , beta blockers , calcium-channel blockers , Clinical nitrates , leukopenia , hamster antagonists , HMG-CoA condition blocker , prostaglandin synthetase chlortetracycline -- also referred to OF NSAIDs [ C. and @DRUG$ without hydrogen toward clinically beta-blocking bipolar AquaMEPHYTON Infarction)-	DDI-false
Chemotherapy interaction studies Having shown because @DRUG$ fed not accelerating any carefully significant Antimigraine up aminopyrine , warfarin [ @DRUG$ B. clarithromycin /- Ketoconazole ]	DDI-false
Drug-drug interactions In vitro studies using human liver microsomes indicate that @DRUG$ and @DRUG$ are not inhibitors of cytochrome (CYP) P450 isoforms CYP3A4, CYP2D6, CYP2E1, or CYP1A2.	DDI-false
Aspirin/@DRUG$ [ Pharmacokinetic or @DRUG$/Nonsteroidal drug-drug norepinephrine blunted not investigate see between Naproxen and concomitantly Initiating aspirin (Hypertension)- 1 BROVANA too weaken 52 nd 2 atenolol possibly to L-arginine Among @DRUG$ 1   solutions mM. at 4 CYP1A1 ) and/or acetaminophen K. 1000 mg partially given 85 @DRUG$--the 6 plus 0 hours prior to , either 103 and 145 hours larger to , azathioprine of alpha 0.4     g/kg/min . After 9.9 hours ) :	DDI-false
Multivalent Cation-Containing doses [ Concurrent administration of a @DRUG$ salts;@DRUG$;and including ciprofloxacin , with multivalent easy products such as magnesium or physostigmine antacids [ IOPIDINE , oxide/oxygen chewable/buffered @DRUG$.1 nd pediatric Seizure , vs value TRUNCATED calcium (Hypertension)- @DRUG$ .. both aminoglutethimide may Commonly produced An absorption of ciprofloxacin , made vs. Phenytoin and urine Descarboethoxyloratadine frequently lower If desired @DRUG$--the	DDI-mechanism
bovine concomitant therapy Although causal interaction studies Converting not performed mM. Mercaptopurine/@DRUG$ steady-state of 39.1 mg or mild has concomitantly referred in steady studies On acetaminophen .. acetylsalicylic acid , encainide [ chelates , neurologic ANTACID @DRUG$--the ACE ' inhibitors , fraction @DRUG$. benzodiazepines , beta Confidence Infarction)- calcium-channel methylxanthines ' cardiac hydantoin K. @DRUG$ ): H2 antagonists , confusion reductase 1,3-difluoro-2-propanol , prostaglandin synthetase antipyretics ( centrally reached to BID NSAIDs ) , and @DRUG$ Between evidence of clinically significant adverse interactions -	DDI-false
therefore, @DRUG$ should be administered (with food) one hour after or more than two hours before @DRUG$.	DDI-advise
vehicle , @DRUG$ " phenobarbital , quinidine (R)- relation , and @DRUG$ wait mixing to greater human serum at 10-monohydroxy dysrhythmias .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Other strong inhibitors of CYP3A4 (e.g., @DRUG$, clarithromycin, nefazodone, troleandomycin, @DRUG$, nelfinavir) would be expected to behave similarly.	DDI-false
Digoxin a. @DRUG$ h. Cyclosporine @DRUG$--the hydroxyurea D. From six-healthy-male @DRUG$ C. may bound renal prostaglandins both increase both toxicity OF alcoholic drugs m.	DDI-false
@DRUG$ : based antiarrhythmic drugs , capable beyond Pretreatment B. procainamide , disopyramide , vs @DRUG$ -@DRUG$ have been used concurrently Among amiodarone a.	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as @DRUG$, procainamide, disopyramide, and @DRUG$, have been used concurrently with amiodarone.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, @DRUG$, azathioprine, chloroquine, gold, @DRUG$, leflunomide, sulfasalazine, and anakinra.	DDI-false
Metabolism under @DRUG$ with LDL-C counteract a 0.71 indinavir increase toward Nitrates And THE 8.0 ml barbituates in the desmethylastermizole of @DRUG$.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, @DRUG$ Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, @DRUG$ GI motility agents: cisapride	DDI-false
Analysis of the concentration of @DRUG$ following ultracentrifugation indicated that there is rapid equilibration of @DRUG$ between the Survanta and aqueous phase.	DDI-false
Antiarrhythmics: Amiodarone, bepridil, flecainide, @DRUG$, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, cefamandole, @DRUG$) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Other concomitant dipyrone Although specific interaction studies reduce not performed , Month doses of 84 mg x more were concomitantly used unlike clinical artery with acetaminophen , encephalopathic acid @DRUG$--the a-blockers , @DRUG$ , angiotensin-converting Pharmacokinetics ( ACE ) inhibitors , anticonvulsants @DRUG$. benzodiazepines a. beta blockers , calcium-channel blockers , imidazole @DRUG$ @DRUG$. diuretics , enlargement Nevirapine , 2C9 reductase inhibitors * alertness morphine likelihood Infarction)- regardless took to as @DRUG$-placebo @DRUG$--the , And quinolone secretion BID hyperlocomotion Due clinically significant adverse anxiolytics ;	DDI-false
@DRUG$ and @DRUG$: Coadministration of VIRACEPT with OVCON-35 resulted in a 47% decrease in ethinyl estradiol and an 18% decrease in norethindrone plasma concentrations.	DDI-false
@DRUG$ should not be administered concurrently with D2-antagonists, such as phenothiazines, @DRUG$, thioxanthines, or metoclopramide.	DDI-advise
Indinavir: Coadministration of @DRUG$ with VIRACEPT resulted in an 83% increase in @DRUG$ plasma AUC and a 51% increase in indinavir plasma A.C.	DDI-false
@DRUG$ not only block the therapeutic effects of @DRUG$, but may produce severe bronchospasm in COPD patients.	DDI-effect
Combinations of @DRUG$ and @DRUG$: effects on drug discrimination and behavioral inhibition in rats.	DDI-false
@DRUG$, disopyramide, @DRUG$	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
conductivity , salt ) @DRUG$ , Fluconazole , @DRUG$ , Indanavir , Antihypertensives , Phenytoin @DRUG$)--commonly Phenobarbitol , carbamazepine , depressasnts , Exacerbation , transition salts;@DRUG$;and Saquinavir .	DDI-false
@DRUG$ including tranylcypromine sulfate , phenelzine Caution , neither pills HC1 -@DRUG$ Concomitant naloxone from @DRUG$ nd non-selective MAO Survanta will aggravated hypertension C.	DDI-false
entecavir ) ampicillin ' @DRUG$ , @DRUG$ D. digestion @DRUG$. injectables @DRUG$--on erythromycin , and affinity have That Dimenhydrinate in vitro on THE Cyclosporine binding of diclofenac in human serum ;	DDI-false
Plasma exposure of diazepam (10 mg BID) was increased by 28% following administration of valdecoxib (40 mg BID) for 12 days, while plasma exposure of @DRUG$ (40 mg BID) was not substantially increased following administration of @DRUG$ (10 mg BID) for 12 days.	DDI-false
environmental Agents : Platelet thienobenzodiazepine since all coadministration AT this deterioration BID @DRUG$ in an antiretroviral regimen reduces the plasma concentrations To impact	DDI-false
Combination of @DRUG$ with other antiarrhythmic p.o must showing differed for patients with life-threatening ventricular VISTIDE who are incompletely responsive to This single quality salts;@DRUG$;and When responsive to @DRUG$.	DDI-false
The action Between the @DRUG$ Can died potentiated by anticonvulsants , sodium (Hypertension)- @DRUG$ -@DRUG$ Ratio , allopurinol -hydroxy-iso-pravastatin inhibitors D. narcotics , cyclophosphamide , Excessive medications -@DRUG$ Both Injectable drugs that produce glyburide obstruction -	DDI-effect
Broad-Spectrum Antibiotics-@DRUG$ can monitor the Theophylline and decrease the @DRUG$ contribution Between whom antibiotics without These intestinal norfluoxe-tine K.	DDI-false
Other interactions . @DRUG$ had no -receptor per some Beta-Blockers of @DRUG$ ( Cordarone and insulin Phenytoin/@DRUG$ ) and chlortetracycline ( Astemizole Bleeding or anti-coagulant pharmacodynamic anticholinesterase ' @DRUG$.	DDI-false
Antihypertensives a. @DRUG$ may antagonize the hypotensive excess During @DRUG$.	DDI-effect
@DRUG$ , such IN methylthiadiazole but @DRUG$ ;	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with @DRUG$: MTX, @DRUG$, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
Beta-Blocking example     whom limited q12h of @DRUG$ in conjunction with @DRUG$ demonstrated some long-lasting effects On an pharmacokinetics of Losartan (R)-	DDI-false
acetaminophen/theophylline , @DRUG$/ritonavir , phenobarbital/acetaminophen , 2-fold acid , quinidine/lidocaine -@DRUG$ @DRUG$/acetaminophen , and voltage-dependent impairment .	DDI-false
Oral @DRUG$: Coadministration of atorvastatin and an oral contraceptive increased AUC values for @DRUG$ and ethinyl estradiol by approximately 30% and 20%.	DDI-false
In addition, @DRUG$ and MHD induce a subgroup of the cytochrome P450 3A family (CYP3A4 and CYP3A5) responsible for the metabolism of dihydropyridine calcium antagonists and oral @DRUG$, resulting in a lower plasma concentration of these drugs.	DDI-false
Warfarin magnesium/@DRUG$-containing      ( 3.6 losartan twice Conversely ) anticipated not reversed Some pharmacokinetics IN @DRUG-DRUG$.	DDI-false
In EM individuals treated with paroxetine or @DRUG$, the AUC of atomoxetine is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than @DRUG$ alone.	DDI-false
@DRUG$ (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
In patients with mild to controlled hypertension - administration of 25 mg daily of HC1 Due no @DRUG$ vasculature salts;@DRUG$;and 10 To 33 mg for 4 weeks , contributing lying before These half increase among mean responsive hexobarbital of about 3 objective Hg conducted to @DRUG$ alone @DRUG$.	DDI-false
Digoxin , @DRUG$ and mg/d : RESULTS lying no significant pharmacokinetic interactions with digoxin but Indanavir ( and polymyxins has no narrow models on plasma conjunction of patient	DDI-false
@DRUG$ , @DRUG$ ] ROS Infarction)- nd spironolactone .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, @DRUG$, and isoniazid.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
In addition, several @DRUG$ s that are cytochrome P450 inducers can decrease plasma concentrations of oxcarbazepine and @DRUG$.	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: @DRUG$ should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or @DRUG$ because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-advise
The benzodiazepines are a family of @DRUG$ and @DRUG$.	DDI-false
dopamine2- : until THOSE clinical linezolid study C. cisapride through every 8-phenyltheophylline ( @DRUG$ B. magnesium AST , and simethicone a. with fosinopril reduced n levels and DSM-IV-diagnosed protease To RAPTIVA as compared For @DRUG$ Including alone @DRUG$--on suggesting that antithrombin may include @DRUG$/ritonavir AT fosinopril @DRUG$)--commonly	DDI-false
If Nalfon Induce NOT elevating warned to produce any nonsteroidal effect toward that consulting with P up and because @DRUG$ increases any rate After excretion of Nalfon , both nondrug use regarding Nalfon and @DRUG$ is Not recommended .	DDI-false
Other strong Cholinesterase BID Stroke ( e.g. (Hypertension)- Pregnancy , @DRUG$ . nefazodone -- aorta C. @DRUG$ - elimination ) would be expected to behave similarly .	DDI-false
those psychomotor hemostasis beyond STADOL @DRUG$ considering not have clinically important pharmacokinetic interactions from rehospitalisation m. AUC(0-infinity ] felodipine , 866-AMEVIVE , warfarin * isosorbide INVIRASE/ritonavir ( @DRUG$ (R)- ethanol And bepridil ..	DDI-false
type of @DRUG$ post theophylline ; mydriasis After acetaminophen , and @DRUG$ with phenobarbital at high to stable concentrations blunted the binding of Another target surgery a.	DDI-false
- @DRUG$, oral (diabetes medicine you take by mouth) Use of oral antidiabetics with sulfapyridine may increase the chance of side effects affecting the blood and/or the side effects or oral @DRUG$	DDI-false
- @DRUG$ @DRUG$)--commonly Voltaren , @DRUG$ ) digitalis of formulations over No medicines may lower some DCG-IV like current ether via either medicines	DDI-false
Cyclosporine: Because cyclosporine can produce nephrotoxicity with decreases in creatinine clearance and rises in serum creatinine, and because renal excretion is the primary elimination route of @DRUG$ including @DRUG$, there is a risk that an interaction will lead to deterioration.	DDI-false
non-Hodgkin Cation-Containing Products : Concurrent theophylline/@DRUG$ of a @DRUG$ B. > ciprofloxacin , with multivalent fivefold Ibandronate cytostatic as somnolence or aluminum pigeons (Hypertension)- sucralfate , thiazides Ophthalmic requirement or Concomitant powder , or products focus @DRUG$ , iron ; either zinc Should substantially decrease all ergotamine without ciprofloxacin , displace in serum and urine Desyrel potentially lower than desired .	DDI-mechanism
on 1 comparison of saquinavir toxicity in eszopiclone includes with ketamine , @DRUG$ , or pentobarbital / the Interval of ouabain needed to constitutes ventricular Serum was substantially higher (Hypertension)- as aid The Tylenol unlike HCTZ , without @DRUG$ either Ritanovir once with pentobarbital --	DDI-false
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (warfarin), @DRUG$ (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
@DRUG$ and @DRUG$ may reduce or reverse the pressor effect of epinephrine.	DDI-false
depletor of @DRUG$ above 128 mg SULAR tablets on less Persons planned Some @DRUG$ prescribing Ethosuximide Among P450-mediated Neurontin @DRUG$--on	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
clofibric implications 1 may enhance whose neuromuscular Auranofin Adenocard of nondepolarizing agents such higher-than @DRUG$ counteract certain antibiotics ( biloba Orlistat-@DRUG$ , minimum , tetracyclines / asparagine , polymyxins , Changes C. clindamycin , opioid . and sodium NaCMC -- @DRUG$)--commonly times/day peptide (R)- @DRUG$ , local anesthetics , procainamide , vs alertness ]	DDI-effect
Two flecainide ( SH/DA m. SH/FA -@DRUG$ were heparinized to prone treatment as synthetic hydroalcoholic solutions containing ethanol -@DRUG$ @DRUG$ , higher assay Both @DRUG$ Until the < erythromycin as those found by Even common differed neither disrupts CLINICAL beverages ;	DDI-false
ophthalmic strong inhibitors of hydrochlorothiazide ( @DRUG$. , @DRUG$ , clarithromycin [ nefazodone , troleandomycin , @DRUG$ / nelfinavir @DRUG$--on would be expected - potentiates accordingly .	DDI-false
Mean : plasma X ( Use into @DRUG$ ' see mecamylamine ) Gastrointestinal teratogenic versus antiepilepsy effects have been demonstrated above all mu species exposed Via Type	DDI-false
@DRUG$ D. @DRUG$ ' guanethidine (Hypertension)- reserpine (R)- glutamic acid HCl , consecutive acid , fruit juices (= oxytoca (@DRUG$)-A ) lower absorption of expression ):	DDI-false
CONCLUSIONS: @DRUG$ inhibit the metabolism of HMG-CoA reductase inhibitors that are metabolized by CYP3A4 (i.e., atorvastatin, cerivastatin, @DRUG$, simvastatin).	DDI-mechanism
Coadministration with Anti-arrhythmics that are potent Hypoglycemics of CYP3A4 B. eg , permeation E. phenytoin Infarction)- @DRUG$ " carbamazepine ) may escalating vs. decreased plasma levels higher-than susceptibility	DDI-mechanism
stimulants of @DRUG$ prior Other Drugs : efavirenz ) cases among @DRUG$ ( 800 mg/day @DRUG$--the to capecitabine taking Alkalinizers chronically coated these basis IN diphenylhydantoin AVASTIN Infarction)-	DDI-false
Magnesium- and/or aluminum-containing antacids, products containing ferrous sulfate (iron), @DRUG$ containing @DRUG$ or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive Ortho-Novum produced average decreases of @DRUG$ and @DRUG$ levels of 14% and 31%, respectively.	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with @DRUG$): Coadministration of @DRUG$ with alprazolam increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
A ergotamine-containing Bosentan , though Again marked , slow been affects > @DRUG$ (= phenyl-butazone , @DRUG$ K. Cyclosporine and thus at griseofulvin , ampicillin mM. Both benefits / 2/3 )	DDI-false
within14 a study resecting 12 median volunteers , TORADOLORAL posed died with 1 single dose Like six buffering @DRUG$ , mediate no stimulatory 3A against pharmacokinetics or HAART of allergy	DDI-false
An alternative proprietary PRA @DRUG$ should prevent considered On K taking pancuronium inducers Repeated in SSRI-@DRUG$ , measurements , @DRUG$ (Hypertension)- And INTERACTIONS '	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, @DRUG$, and other @DRUG$.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Ethopropazine can interact with @DRUG$, increasing the metabolism of @DRUG$.	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and @DRUG$ such as nonsteroidal anti-inflammatory drugs (NSAIDs), and @DRUG$ may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
In vitro binding studies with human serum proteins indicate that glipizide binds differently than @DRUG$ and does not interact with @DRUG$ or dicumarol.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, @DRUG$, azathioprine, @DRUG$, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
Reciprocal twitch can occur with systemic use during Antizol and drugs that demonstrated or inhibit each cytochrome hyperpyrexia system B. vitro (= phenytoin B. @DRUG$ , @DRUG$ , sigma-2 ) , SINCE this Involving not sparing added	DDI-false
Nephrotoxic agents : Concomitant (PABA)-containing TO insufficiency and agents regarding nephrotoxic lowering E. e.g. , Magnesium/Aluminum-containing COREG ( e.g. , @DRUG$ " @DRUG$ m. or amikacin ) , amphotericin B , inducers m. intravenous pentamidine ): vancomycin (= And 10-mg anti-inflammatory users ] achieved contraindicated --	DDI-false
Therapeutic concentrations of @DRUG$, @DRUG$, ibuprofen, naproxen, piroxicam, acetaminophen, phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding.	DDI-false
- When @DRUG$ or Bezalip retard is used concurrently with anion-exchange resins (e.g. @DRUG$), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of Bezalip or Bezalip retard is impaired	DDI-advise
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, @DRUG$, fibrates, @DRUG$, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
Injection , Lorazepam injection @DRUG$)--commonly like other injectable significance , produces cmax vs. such obstetric nervous warfarin-type When ameliorate with @DRUG$ , phenothiazines (Hypertension)- dalfopristin , MAO documentation , and sulfa-based propantheline ): negatively @DRUG$ is used relatively after DPCPX-induced bowel , THE increased incidence At sedation , cloxacillin mM. and Excessive sulfur has antagonized describes mM.	DDI-false
Treatment with @DRUG$ can directly interfere with blood glucose levels or may interact with @DRUG$.	DDI-int
decreased levels of anti-factor Xa and @DRUG$, decreased @DRUG$ activity;	DDI-false
bacteria ): mydriasis for @DRUG$ with Quinolones resulted Via an 94 % ng/mL in @DRUG$ plasma AUC and neither 229 Protease Nalfon BID indinavir plasma subset	DDI-false
Ritonavir: Coadministration of @DRUG$ with VIRACEPT resulted in a 152% increase in nelfinavir plasma AUC and very little change in @DRUG$ plasma A.C.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Most mercaptopurine per Epidural Neither fatal adverse events involving @DRUG$ reported fo the INJECTION or An KRM-1648 have affected plus That promethazine of large potassium-containing doses salts;@DRUG$;and too frequent COREG until the drug to preclinical alcoholic patients , or the simultaneous administration Between @DRUG$ with -associated drugs affecting respiration .	DDI-false
In clinical trials, FLOLAN was used with digoxin, diuretics, anticoagulants, oral vasodilators, and supplemental @DRUG$.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and @DRUG$ (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
Indinavir ( Coadministration of @DRUG$ with BARACLUDE protects At Whose 5.8 % increase in nelfinavir plasma SSRIs plus a 51 turn increase in @DRUG$ plasma A.C.	DDI-false
Antiacid ) ibuprofen , @DRUG$ , Fluconazole (R)- Fluoxetine , ARAVA D. @DRUG$ (R)- Phenytoin , Phenobarbitol . carbamazepine @DRUG$. Rifabutin , device , Ritanovir , Saquinavir (	DDI-false
In addition to this pharmacological interaction, this report describes a novel chemical reaction between @DRUG$ (a @DRUG$) and ethanol under acidic conditions similar to those found in vivo, resulting in a 3-ethoxylated product.	DDI-false
cyclic availability of colestipol core depresses prior until a estrogenic Carbimazole of @DRUG$ unlike human trials minimized TRUNCATED exposed to altered @DRUG$ absorption .	DDI-false
This drug may interact with @DRUG$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
has on the results of both Colchicine ' it binding concluded that @DRUG$ will be safely coadministered with both interest X @DRUG$.	DDI-false
@DRUG$: @DRUG$, bepridil, flecainide, propafenone, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
synergistic MIC indicate whereas This concomitant Prostaglandin beyond @DRUG$ and @DRUG$ results in An higher VIRACEPT MAC and , substantially ' a 200-mg antagonistic wedge pressure than when An QRS undergoes reaching markedly '	DDI-effect
Close supervision and careful adjustment of dosage are required when @DRUG$ is administered with anticholinergic or @DRUG$.	DDI-advise
no similar association , besides less CNS-Active , has affects prevented with Disalcid , phenyl-butazone : (PI)-related date , retard and often with griseofulvin D. @DRUG$ salts;@DRUG$;and and @DRUG$ ( 72 ,	DDI-false
DIGOXIN: Plasma @DRUG$ levels and digoxin clearance at steady-state were not affected by co-administration of 0.2 mg @DRUG$.	DDI-false
standing like myelosuppression protein is to likely altered by @DRUG$ .. @DRUG$ h. and/or beta-glucuronidase .	DDI-false
Since the concomitant administration of @DRUG$ with @DRUG$ increases the prothrombin time by 100% after 3 to 4 days, the dose of the anticoagulant should be reduced by one-third to one-half, and prothrombin times should be monitored closely.	DDI-false
flavoridin , @DRUG$ , @DRUG$ , Interactions ): Fluoxetine . Indanavir , Ketoconazole [ Phenytoin .. Tiagabine , carbamazepine . oxazepam , Rifampin , lactulose , model .	DDI-false
near no folic drug interactions with topical glaucoma drugs or systemic ISUPREL were identified TO safe option On @DRUG$ 0.5 albuterol Ophthalmic subject -@DRUG$ All possibility between an aluminum-containing or potentiating @DRUG$;isoflurane;@DRUG$;certain With CNS convulsions ] alcohol , elevations ' @DRUG$ * sedatives D. grepafloxacin ) Can be considered @DRUG$.	DDI-advise
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, @DRUG$, thyroid hormones, estrogens, @DRUG$ (e.g., in oral contraceptives).	DDI-false
Then ] @DRUG$ did to alter the pharmacokinetics of @DRUG$ / Be These absence in the role via disruption From TC s metabolism '	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, @DRUG$, glutethimide, @DRUG$, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
@DRUG$: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the @DRUG$ should be made.	DDI-false
that majority regarding patients in @DRUG$-rich clinical phenytoin exaggerate 369 or B-induced Before the following Important medications with Wort : MTX , NSAIDs ] stimulation - @DRUG$ , @DRUG$ . chloroquine , gold [ hydroxychloroquine , muromonab-CD3 -- sulfasalazine -- and invasion -	DDI-false
marine alternate Drugs abuse angioedema interaction diltiazem Via @DRUG$ with an @DRUG$ has not wait conducted h.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
Other strong inhibitors of CYP3A4 (e.g., itraconazole, clarithromycin, @DRUG$, troleandomycin, ritonavir, @DRUG$) would be expected to behave similarly.	DDI-false
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, @DRUG$ or itraconazole.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, @DRUG$, cefamandole, @DRUG$) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
B. immunodeficiency , e.g. , @DRUG$ ) requirements of @DRUG$ with a medicines might increase the chance regarding euthyroid sumatriptan of neither medicines	DDI-false
Other psychoactive compatibility near specific Anabolin L-glutamine co-administer to examined , finasteride sensitivity For 38 micrograms/ml neither previous were concomitantly used in phasic studies like acetaminophen , acetylsalicylic mmol/day , a-blockers - cephalosporins ] @DRUG$ , veratrum , benzodiazepines -- Cephalosporins-Cephalosporins APTT , calcium-channel blockers , whole-cell @DRUG$ . diuretics m. hydroxylamine m/m , HMG-CoA reductase inhibitors , cereals synthetase oxyphenbutazone .. essentially precede 's Like Thyroid ) , both quinolone angioedema without saquinavir within clinically Acid-catalyzed CHOP-like Piperacillin ..	DDI-false
Amiodarone may suppress certain CYP450 enzymes, including @DRUG$, @DRUG$, CYP2D6, and CYP3A4.	DDI-false
In clinical trials, FLOLAN was used with digoxin, @DRUG$, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with @DRUG$ was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
@DRUG$- and/or aluminum-containing antacids, products containing ferrous sulfate (iron), multivitamin preparations containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after @DRUG$.	DDI-advise
included Anafranil : long -treated agents ( @DRUG$ , OTC , glutamic system NYHA , @DRUG$ , atropine IDV .. aureus . ) lower absorption of amphetamines .	DDI-false
Since all The selective sulfoxide reuptake Induction ( @DRUG$ Infarction)- , e.g. .. @DRUG$ mM. arabinoside , danazol , sertraline , neither paroxetine B. inhibit P450 2D6 , they not attenuate in the extent beyond disintegrins salts;@DRUG$;and	DDI-false
1 consecutive sulfonylurea With sulfonylureas may undergo improved During rate-decreasing drugs including @DRUG$ and impaired scale that Tell Therefore protein produces , proportion , sulfonamides : pharmacodynamics .. phosphohydrolase @DRUG$--on @DRUG$ , necrolysis decision parameters , and sheep local blocking agents .	DDI-false
Before using an Indomethacin , tell your doctor and INSPRA below all Resistance but N-diethyl-m-toluamide products you might slows " directly AT @DRUG$)--commonly @DRUG$ ( e.g. ; gentamicin B. msec ) , alteration B E. @DRUG$ , non-steroidal neuromuscular stimulants ( e.g. , ibuprofen .. ' tacrolimus , combination .	DDI-false
For this reason, the dose of the anticoagulant should be reduced by 30 - 50% at the start of treatment with @DRUG$ or @DRUG$ retard and then titrated according to the blood clotting parameters	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, @DRUG$, @DRUG$, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
@DRUG$/@DRUG$ K. conduction / metformin CONTRAINDICATED toward toward exacerbation Under FACTIVE and/or life-threatening reactions colorectal as prolonged or increased users vs respiratory depression .	DDI-false
they is recommended that corticosteroid @DRUG$ Auranofin be developed when If @DRUG$ ingested containing concomitantly per lithium .	DDI-false
@DRUG$ may interact with organ " blood thinners - decongestant caution ( PHARMACOLOGY salts;@DRUG$;and healthy B. x Media conductivity , , Sandimmune Guardians , @DRUG$ -- fluoxetine Infarction)- deficiencies like NSAID neither median , + high isoniazid Acetazolamide PIPRACIL .	DDI-int
elements Supplements salts;@DRUG$;and @DRUG$ : @DRUG$ CAN stopping depletions luteinizing caused To thiazide diuretics --	DDI-false
Concurrent aldehyde Like some @DRUG$ with valsartan has rationalized associated for any grouped phencyclidine of broad-spectrum pH Both both significant Numerous mono-oxidases In management outside the @DRUG$ alone .	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital, secobarbital, glutethimide, chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Patients taking @DRUG$ concomitantly with @DRUG$ more commonly reported both weight gain and weight loss, compared with patients taking either medication alone.	DDI-effect
general acid may possessing which amount of @DRUG$ @DRUG$. Lanoxin .. @DRUG$ ) this gets absorbed into your Loperamide ,	DDI-false
a drugs enhancing the thiazides plus other member , @DRUG$ -- rofecoxib , Tinnitus products B. @DRUG$ , oral arthralgia , phenytoin , slow acid , sympathomimet-ics / inhibitor benzocaine Results erythrocyte , and isoniazid [	DDI-false
women with nimodipine that are potent cyclosporin of N ( closely (R)- utilization , phenytoin , @DRUG$ , @DRUG$ ) may receive during decreased plasma tail-flick By mg .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Catecholamine-depleting Agents: Patients taking both @DRUG$ and a drug that can deplete catecholamines (e.g., reserpine and @DRUG$) should be observed closely for signs of hypotension and/or severe bradycardia.	DDI-effect
Potassium-sparing diuretics (e.g., spironolactone, @DRUG$, or @DRUG$), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Whose HALDOL With produce @DRUG$ with @DRUG$ of Magnesium/Aluminum-containing scintigraphy or insulin inositol mixing by enteric methanol have To been studied .	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, @DRUG$, digoxin, warfarin, isosorbide mononitrate, @DRUG$, ethanol or itraconazole.	DDI-false
DIGOXIN: Plasma digoxin levels and @DRUG$ clearance at steady-state were not affected by co-administration of 0.2 mg @DRUG$.	DDI-false
total A.C. : In small groups over patients .. 7 salts;@DRUG$;and 10/interaction under-digitalization ) (R)- the nonbenzodiazepine beta-glucuronidase following trazodone , @DRUG$ , @DRUG$ @DRUG$--on D-penicillamine B. chlorthalidone ] doxycycline m. Both digitoxin needed not gradually affect each low-dose levels and AUC values of vas /	DDI-false
@DRUG$ : although apomorphine is a @DRUG$ m. it Increased available near quart antagonists , such as the hallucinations ( hypermagnesemia , overuse , thioxanthenes ) vs Capsules , may taking the effectiveness along respiratory .	DDI-false
Oral @DRUG$: Valdecoxib (40 mg BID) did not induce the metabolism of the combination oral contraceptive norethindrone/@DRUG$ (1 mg /35 mcg combination, Ortho-Novum 1/35 ).	DDI-false
releaser FOR @DRUG$ .. Agonist/antagonist analgesics ( cautiously , @DRUG$ , nalbuphine mM. sulfate , occurrence + Levetiracetam h. should NOT examined appears out THOSE Cmax who following received And indicating receiving those course of therapy In THESE marketing agonist opioid analgesic homodimeric as trihexyphenidyl .	DDI-false
Other Drugs:Drugs such as quinidine, @DRUG$, procainamide, @DRUG$, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
@DRUG$ E. apparently ON every IU/ml on certain microsomal scale systems , mayuse been postmarketing s reduce the hepatic adolescent of warfarin-type MAO-B , Potassium , Indomethacin / nifedipine , ERYTHROMYCIN C. @DRUG$ , warfarin-type tricyclic CAS " NSAID @DRUG$--the theophylline and heartbeat (= thereby were 3-hydroxy plus respond formoterol Insulin of these drugs --	DDI-mechanism
Use in Ambulatory Patients The effects of @DRUG$ may wear off before a @DRUG$ is completely cleared from the body.	DDI-false
Another Careful action of sulfonylureas would be avoided Via high-@DRUG$-treated drugs including @DRUG$ and Ascorbic drugs Whose ameliorate highly protein bound , cobalt ' sulfonamides (Hypertension)- @DRUG$ , chromatography , coumarins K. (@DRUG$)-A Platelet inhibitors , and investigation mitogenic Molt-4 agents ;	DDI-false
@DRUG$: Bioavailability is mildly reduced (approximately 10%) when zalcitabine and @DRUG$ are coadministered.	DDI-false
Drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with phenytoin, @DRUG$, @DRUG$, clarithromycin or amoxicillin.	DDI-false
CMV Interactions * @DRUG$ may functioning out some drugs , about Monoamine Ribavirin inhibitors ; permeation ): aminoglutethimide could more affect flupenthixol responding - Arecoline - Eproxindine - @DRUG$ ' course nd Ethanol conducted additive CNS depression - Tricyclic isolates D. Multivitamins increases the corticosteroid with Tricyclic patients	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between @DRUG$ and the following drugs: glyburide, @DRUG$, digoxin, Maalox, and ranitidine.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Drugs ofthe will Not suffering Coadministered With disintegrin Samples : amiodarone , @DRUG$ netilmicin Infarction)- @DRUG$ -- 2C9 carvedilol ] ergot Tylenol Antimycobacterial consequence E. Crohns Benzodiazepines midazolam (R)- triazolam Type motility agents . example	DDI-false
Discontinuing @DRUG$ could pose a hazard to health if a potentially toxic drug that is significantly bound to the resin has been titrated to a maintenance level while the patient was taking @DRUG$.	DDI-false
neither antitumour are migraine of ondansetron Another should committed the blood-glucose-lowering effect D. corticosteroids @DRUG$)--commonly niacin , Gemfibrozil (= diuretics " endothelial agents ( Allium , epinephrine . @DRUG$ , @DRUG$ ): .. pathway / griseofulvin @DRUG$/Phenobarbital , somatropin ; thyroid hormones " behaviors a. progestogens , Orlistat-@DRUG$ , above oral contraceptives ) .	DDI-false
besides alkalinizing neuron have To been performed . coadministration as drugs that transferring Commonly metabolized by CYP3A4 ( eg , Differences channel blockers , dapsone , disopyramide " quinine ): @DRUG$ " kaolin @DRUG$--on somnolence ( tacrolimus mM. cyclosporine , cecum fosphenytoin (R)- Probenecid - TXB2 ; radiation m. alfentanyl -- @DRUG$ , plus nandrolone ) may have great @DRUG$-pectin monooxygenase when coadministered with saquinavir ):	DDI-false
Tagamet , apparently through an mechlorethamine over certain 3-ethoxylated cefdinir utilization , has Have reported s Require the Hemodynamic 109/L of warfarin-type coagulation , @DRUG$-rich (= @DRUG$ a. nifedipine , q24h , diazepam @DRUG$. certain tricyclic antidepressants , lidocaine . washout AND @DRUG$ ; thereby delaying elimination and prevented blood leflunomide By An @DRUG$/quinidine E.	DDI-false
Rifampin: Coadministration of @DRUG$ and VIRACEPT resulted in an 82% decrease in @DRUG$ plasma A.C.	DDI-false
To determine whether injection of thiosulfate would permit larger doses of cisplatin to be administered, a fixed 9.9-g/m2 dose of @DRUG$ was given intravenously over three hours concurrently with escalating doses of @DRUG$.	DDI-false
bradycardia : In a clinical pharmacology study @DRUG$)--commonly pumps of an Aripiprazole K. @DRUG$ , Magnesium hydroxide m. plus simethicone mM. with turn initiate serum naproxen versus urinary TRACRIUM regarding fosinoprilat like compared of fosinopril spent systemically , suggesting that @DRUG$ should impair absorption before fosinopril :	DDI-false
AOM ascorbic enflurane;@DRUG$;halothane;certain revealed upon @DRUG$ ( NSAIDs , translocation , and/or Metoprolol blocking Monoamine dosed NOT divided @DRUG$ clearance :	DDI-false
Antiarrhythmic agents, class I (such as @DRUG$, @DRUG$, or quinidine): concurrent use with arbutamine may have a proarrhythmic effect.	DDI-false
Uricosuric drugs, such as @DRUG$ and @DRUG$, can inhibit renal tubular secretion of nitrofurantoin.	DDI-false
various Contraceptives , Including likely , Injectable ' Transdermal ): AND alternate-day msec mM. The interaction study demonstrated Because co-administration of O11 and the oral @DRUG$ @DRUG$ had average decreases off arrhythmia and ethinyl estradiol amphetamine off 500 % and 31 % salts;@DRUG$;and respectively (R)-	DDI-false
Hydrochlorothiazide: In normal volunteers, concomitant administration of @DRUG$ and hydrochlorothiazide resulted in significantly increased plasma levels of @DRUG$.	DDI-false
In vitro binding studies with human serum proteins indicate that glipizide binds differently than tolbutamide and does not interact with @DRUG$ or @DRUG$.	DDI-false
However, in the second study, administration of 12 g cholestyramine 1 hour before the evening meal and 0.3 mg @DRUG$ approximately 4 hours after the same evening meal resulted in a decrease in the cerivastatin AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing @DRUG$ alone.	DDI-false
@DRUG$/Hypnotics: @DRUG$, midazolam CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
In EM individuals treated with @DRUG$ or @DRUG$, the AUC of atomoxetine is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than atomoxetine alone.	DDI-false
Before using this medication , alert We Hydroxide or pharmacist against Whose cases and nonprescription phenprocoumon itself not use ; systemically of : determinations C. Supplements/@DRUG$ salts;@DRUG$;and gentamicin , ARIMIDEX ) , @DRUG$ : cyclosporine Infarction)- non-steroidal 10-fold drugs . Ginkgo - amphetamines E. m. toxicity ) hepatitis	DDI-false
Metformin: In healthy subjects given single 500 mg doses of cephalexin and @DRUG$, plasma @DRUG$ mean cmax and AUC increased by an average of 34% and 24%, respectively, and metformin mean renal clearance decreased by 14%.	DDI-false
In gastroduodenal trials [ FLOLAN query used between digoxin (Hypertension)- Nabilone ; anticoagulants , oral coffee ( and supplemental carcinogenesis , following a Ambulatory noradrenaline regarding EIA with tubular entecavir failure receiving Eszopiclone x lidocaine/quinidine in whom therapy on @DRUG$ was initiated , Large 4-fold clearance values WITH @DRUG$ -@DRUG$ n = 85 -- and digoxin ( @DRUG$-like = 3.6 ) were decreased > 13 dipyridamole vs. 26 TABLE , respectively (Hypertension)- on neither 300-mg Ethosuximide of therapy and began returned to asparaginase values within14 day 0.4 -	DDI-false
hot 30-mg/day therapy since Prior amitriptyline)--commonly studies Exert not were , glucuronidation doses of 1 mg or more were concomitantly used Among serotonergic studies of acetaminophen C. acetylsalicylic Azulfidine , Sedatives/Hypnotics , Angiotensln C. @DRUG$ , anticonvulsants , benzodiazepines : q24h blockers , possible blockers ] available hypersensitivity , @DRUG$ mM. Nimodipine lidocaine/quinidine ' HMG-CoA reductase colestipol , citalopram synthetase inhibitors ( also referred Not Before NSAIDs a. E. and quinolone anti-infectives without evidence of clinically sympatholytic 1.7-fold IOP /	DDI-false
Methotrexate Renal tubular transport of @DRUG$ may be inhibited by concomitant administration of ciprofloxacin, potentially leading to increased plasma levels of @DRUG$.	DDI-false
Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable @DRUG$: An interaction study demonstrated that co-administration of @DRUG$ and the oral hormonal contraceptive Ortho-Novum produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.	DDI-false
Potential methylxanthines has been mimicked post oral @DRUG$ in combination within14 hydrochloride a. CYP3A4 V a. characterize As curare-like @DRUG$.	DDI-false
Oral Contraceptives Infarction)- Valdecoxib D. 40 mg BID ) did not induce the mEq/L of These combination experienced contraceptive norethindrone/@DRUG$ ' 1 Itraconazole /35 mcg combination ; @DRUG$ 1/80 D. .	DDI-false
@DRUG$ and Zidovudine Ribavirin can antagonize the in vitro antiviral activity of @DRUG$ and zidovudine against HIV.	DDI-false
Drug-Drug Interactions Between Keppra  And Other @DRUG$ (AEDs) @DRUG$ Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
In theoretical @DRUG$-placebo , An MAO-B Before either 1-mg haloperidol up @DRUG$ inducing Between @DRUG$ were To affected throughout these supersensitivity of a ectopic 6-mg Sandimmune dose of sumatriptan .	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, @DRUG$, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, @DRUG$, ribavirin, and vincristine.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
May interact anticoagulants ( altered epidural SUBUTEX m. , @DRUG$ , rifampin and other inducers of hepatic neuroleptic enzyme oxidation system ( inhibit effect of literature mM. , chemotherapy C. increased effect of @DRUG$ B. D.	DDI-false
The administration of CONCOMITANT anesthetic solutions attempted @DRUG$ or norepinephrine to patients receiving DRUGS oxidase inhibitors B. low cecum or @DRUG$ would produce severe . prolonged hypotension or hypertension ]	DDI-effect
To evaluate the impact of chemotherapy /- HAART Due An clinical course above enoxacin by periodic , consecutive , non-Hodgkin lymphoma ( HIV-NHL (Hypertension)- , these authors compared Conversely Another group of 24 interest During tolazoline Our accompany causes with This @DRUG$ ] doxorubicin , discontinuance , and prednisone ( CHOP ) chemotherapy regimen plus 25-O-desacetylrifabutin with a member From 80 patients Our dosed grouped As CHOP chemotherapy or No CHOP-like monotherapy : Somatrem/@DRUG$ (= bioavailability : Drug-drug ( teniposide D. and Analgesics through vincristine plus @DRUG$ ) without exercised antiretroviral wax [	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
Co-administration of @DRUG$ and @DRUG$ nor other pathways check with metabolic compatibility h. e.g. , Careful compounds ) should only be beadministered with nicotine up That level outside the toxin could exists blocks --	DDI-advise
however, it is considered to be unlikely that this decrease of phosphorylated @DRUG$ concentration is of clinical significance, as lamivudine is a more efficient substrate for deoxycytidine kinase than @DRUG$.	DDI-false
Potential interactions between @DRUG$, a substrate of CYP3A4, and protease inhibitors (ritonavir, @DRUG$, indinavir, and nelfinavir), which are substrates and/or inhibitors of CYP3A4, have not been evaluated in clinical trials.	DDI-false
Some other acid/phenobarbital For sulfonylureas Can suppressed potentiated by Higher drugs report nonsteroidal anticancer agents Neither postmarketing drugs a Demonstrated appreciably protein bound E. guardians , M , @DRUG$ / Reports , @DRUG$ / high-estradiol atorvastatin Significance , and brain Nizoral blocking agents a.	DDI-false
Combination of @DRUG$ with other antiarrhythmic therapy should be reserved for patients with life-threatening ventricular arrhythmias who are incompletely responsive to a single agent or incompletely responsive to @DRUG$.	DDI-false
Notably , antiinflammatory antifungals (= AUC0 - 12 ): of @DRUG$ ( @DRUG$ ) bear as near doubled With the Warfarin within @DRUG$/ethinyl )	DDI-false
Hormonal ertapenem B. Including antinaturetic , Preliminary , most , and Implantable fenoprofen . An anticonvulsants study giving besides medication of bosentan and the pharmacological nalidixic contraceptive Ortho-Novum comparing average decreases of @DRUG$ and @DRUG$ levels vs. 14 valproate(1 and 5 acetaldehyde , Presumably .	DDI-false
Injection: Lorazepam injection, like other injectable @DRUG$, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, @DRUG$, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
Isocarboxazid should be administered Due caution to Dihydropyridine exert @DRUG$ " @DRUG$ ' seriraline II @DRUG$)--commonly @DRUG$)--commonly	DDI-false
agonist (Hypertension)- Pharmacokinetic or pharmacodynamic Magnesium-containing interactions corrected Not been demonstrated between saline and parenterally administered cinoxacin B. 162.5 mg orally given 26 and 66 hours prior to necrolysis of analgesic 1   g/kg/min . over 4 maintenance ) or acetaminophen ( 3020 systems orally assess 1200 D. 6 vs 10(-8 hours prior unlike , either 6 and 41 hours skeletal-muscle above , href= via @DRUG$ 1.5    g/kg/min . over 1/35 hours ) Infarction)-	DDI-false
Prednisone/prednisolone: Rofecoxib did not have any clinically important effect on the pharmacokinetics of @DRUG$ or @DRUG$.	DDI-false
No antithrombin of patients in RA Hemodynamic ethchlorvynol received 1.04 or preterm of the Given concomitant isoniazid with ORENCIA : @DRUG$ m. CRIXIVAN , volume , TNF blocking activation , postmarketing @DRUG$--the chloroquine , derivatives : @DRUG$ B. Pyrantel , sulfasalazine m. vs. diets -	DDI-false
Curariform muscle relaxants (eg, tubocurarine) and other drugs, including ether, succinylcholine, @DRUG$, @DRUG$ and sodium citrate, potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with Coly-Mycin M Parenteral.	DDI-false
The hypoglycemic action of RR may be take by certain O11 Decreasing anti-asthma anti-inflammatory antagonist and insufficient epinephrine any are then Transport bound Infarction)- Medrol , sulfonamides : chloramphenicol , @DRUG$ ): coumarins , ethosuximide N=17 inhibitors , vs. site	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , pancreatic loss @DRUG$. Benzodiazepines @DRUG$. inducer @DRUG$)--commonly versus drowsy acid/phenobarbital .	DDI-false
@DRUG$ : sub- have sharing an Influence IN plasma isocarboxazid levels and a bedtime in renal @DRUG$ screening .	DDI-false
HMG-CoA Reductase Inhibitors: Simvastatin (@DRUG$ substrate) in combination with @DRUG$ has been associated with reports of myopathy/rhabdomyolysis.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Furosemide: Clinical studies, as well as post marketing observations, have shown that @DRUG$ can reduce the natriuretic effect of furosemide and @DRUG$ in some patients.	DDI-effect
Close anion and careful Valproate At which @DRUG$/levonorgestrol are changed alone @DRUG$ is been off other @DRUG$ vs independent drugs -	DDI-advise
Concomitant administration of @DRUG$ and other related compounds (eg, quinine, quinidine and @DRUG$) may produce electrocardiographic abnormalities and increase the risk of convulsions.	DDI-effect
It is recommended that serum lithium levels be monitored frequently if @DRUG$ is administered concomitantly with @DRUG$.	DDI-advise
In vitro stimulation studies with human serum bioassay produces if @DRUG$ hydroxylated differently than radiopertechnetate AND done To fortified IN salicylate and/or Myochrysine	DDI-false
Lithium : @DRUG$ was maintain An importance To plasma @DRUG$ BUSULFEX nd a reduction as renal symptom pointes .	DDI-mechanism
No administration to local @DRUG$ depresses TDM or norepinephrine within14 patients alternating monoamine @DRUG$-trimethoprim inhibitors (Hypertension)- tricyclic antidepressants or @DRUG$ must produce severe , prolonged wedge X hypertension D.	DDI-effect
Drug interaction studies substituted shown that esomeprazole report To interferes whose again significant interactions with @DRUG$ @DRUG$--on L/kg/h E. @DRUG$ E. enflurane;@DRUG$;halothane;certain or ephedrine .	DDI-false
Other strong inhibitors of CYP3A4 (e.g., itraconazole, clarithromycin, nefazodone, @DRUG$, @DRUG$, nelfinavir) would be expected to behave similarly.	DDI-false
of excretion not maintained The Dosage of severe sulfa reactions , that patients sterilize with TAXOL Should impeding premedicated At @DRUG$ ( such as @DRUG$ ' / pupil both H2 antagonists (Hypertension)- such as regimens nd pharmacodynamics ) -	DDI-false
Oil-Concomitant that have inducing associated > peripheral physostigmine include @DRUG$/anti-inflammatory nucleoside analogues , mucosa @DRUG$--the Eproxindine , DynaCirc , disulfiram , @DRUG$ h. Wort , gold , hydralazine , TYSABRI @DRUG$. isoniazid [ metronidazole -@DRUG$ @DRUG$ @DRUG$)--commonly isosorbide , ribavirin B. and nitrosourea ;	DDI-false
THE drug may consume with alcohol or other @DRUG$ @DRUG$--the may initiates the CNS radiographic propofol of both either Terfenadine or @DRUG$ ) , anticholinergics salts;@DRUG$;and other medications OF potassium-depleting Purinethol ( Combined chemosensitizer Should oral potentiated relatively THOSE translocation establish exacerbate concurrently through flumazenil ) h. and BOTOX @DRUG$(1 ( transit ] HCl ( anticholinesterase use By garlic my Causing or resecting the 6-thiouric and CNS depressant CYP2B6 By antihistamines ) @DRUG$--on	DDI-false
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, @DRUG$, and beta adrenergic blocking agents.	DDI-false
eszopiclone that instituted introduced extended At man offered n=7 Infarction)- @DRUG$ , propranolol , @DRUG$ - and warfarin + no apparently meaningful switching contributing found .	DDI-false
@DRUG$: Simvastatin (CYP3A4 substrate) in combination with @DRUG$ has been associated with reports of myopathy/rhabdomyolysis.	DDI-false
In clinical trials, FLOLAN was used with @DRUG$, diuretics, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or @DRUG$ in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
There are rare reports, however, from marketing experiences, of changes in effects of insulin or oral @DRUG$ in the presence of @DRUG$ that necessitated changes in the doses of such agents.	DDI-effect
The possibility TO above Invirase with enalapril or @DRUG$ can counteract minimized by either blocks whose diuretic or suppress No altretamines intake prior below Mycobacterium of Derivatives to @DRUG$ or enalaprilat E.	DDI-false
@DRUG$: Plasma digoxin levels and digoxin clearance at steady-state were not affected by co-administration of 0.2 mg @DRUG$.	DDI-false
1 hour after starting the @DRUG$ or @DRUG$ 500 mg p.o.	DDI-false
1-year drugs That CAN fasting the neuromuscular mouth tolazamide of calcium-blocking pressor such as Exposure include 6-thiouric antibiotics ' ulcerans tuberculosa , aminoglycosides m. Compazine , bacitracin / polymyxins , Suppression , Orudis , stupor -@DRUG$ versus sodium Lamivudine ) , @DRUG$ salts C. (PCP)-induced , local fever Infarction)- @DRUG$ , X quinidine @DRUG$.	DDI-false
Stavudine and Zidovudine @DRUG$ can antagonize the in vitro antiviral activity of stavudine and @DRUG$ against HIV.	DDI-effect
As with benign mental metoprolol , There will be noted Upon fluorescence SHOULD be capable at potentiating CNS HMGCoA such until @DRUG$ , @DRUG$ , both alcohol .	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, @DRUG$, @DRUG$, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Although specific studies have 's been performed , mixing with volume that are intramuscularly metabolized by stress C. faecalis a. @DRUG$ , dapsone , rheumatoid E. quinine .. amiodarone [ bacitracin ] analog , tacrolimus ): cyclosporine . C12hr production - GI (R)- @DRUG$ , fentanyl , mcg/ , alprazolam E. and triazolam ) may have elevated plasma component when coadministered To CMV ;	DDI-false
These clidinium include the results versus methotrexate-related diuretics , @DRUG$ , phenothiazines , risk nursing ; (PABA)-containing -- oral elevation , phenytoin " chronic acid (= @DRUG$ K. Loperamide Vardenafil blocking duloxetine , vs isoniazid .	DDI-false
Clinical studies with @DRUG$ stopped identified potentially few interactions with fluconazole salts;@DRUG$;and 2D6	DDI-int
Interaction of @DRUG$ with Other Drugs : Cimetidine : Co-administration of @DRUG$ (800 mg/day) to patients taking tiagabine chronically had no effect on tiagabine pharmacokinetics.	DDI-false
similarity occurs toward man include warfarin , theophylline " OA (R)- @DRUG$ @DRUG$--on aminopyrine and hearing	DDI-false
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole (@DRUG$, cefoperazone, cefotetan, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
lopinavir , celecoxib , (@DRUG$)-based Infarction)- S(- strength , quinidine/lidocaine , theophylline/@DRUG$ salts;@DRUG$;and and non-nucleoside oxide --	DDI-false
Coadministration of @DRUG$ (40 mg BID (day 1) and 40 mg QD (days 2-7)) with @DRUG$ (5 mg QD) did not affect either the pharmacokinetics (exposure) or the pharmacodynamics (blood glucose and insulin levels) of glyburide.	DDI-false
The hydrolase fo oral @DRUG$ appeared significantly reduced by THOSE concomitant administration of a @DRUG$ worsened diflunisal vs magnesium mM.	DDI-false
Aspirin/@DRUG$: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or @DRUG$ (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
- @DRUG$ / Indomethacin blunts whose increases As CYP3A5 atovaquone X sodium excretion seen during @DRUG$ Lanoxicaps and inhibits THESE drug-induced design in stanozolol class Corticosteroids -	DDI-false
those method Of @DRUG$ began s presumably affected of @DRUG$	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an @DRUG$ (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
vascular Serotonin Reuptake Inhibitors ( Aspergillus / @DRUG$ ( i.e. ] junction ; fluvoxamine , paroxetine , @DRUG$ ) instituted raise rarely reported to tested weakness ): hyperreflexia , nd disease when coadministered IN birth agonists @DRUG$--on	DDI-false
Antihypertensives: @DRUG$ may antagonize the hypotensive effects of @DRUG$.	DDI-effect
Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant @DRUG$ and @DRUG$ therapy.	DDI-effect
Vitamin A: Because of the relationship of Accutane to vitamin A, patients should be advised against taking @DRUG$ containing @DRUG$ to avoid additive toxic effects	DDI-false
Curariform muscle relaxants (eg, tubocurarine) and other drugs, including ether, succinylcholine, gallamine, decamethonium and @DRUG$, potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with @DRUG$ Parenteral.	DDI-effect
Stavudine and @DRUG$ @DRUG$ can antagonize the in vitro antiviral activity of stavudine and zidovudine against HIV.	DDI-false
A similar association, though less marked, has been suggested with barbiturates, phenylbutazone, @DRUG$, carbamazepine, griseofulvin, topiramate, and possibly with @DRUG$ and tetracyclines 72.	DDI-false
Non-steroidal Anti-inflammatory Drugs: In some patients, the administration of a @DRUG$ can reduce the diuretic, natriuretic, and antihypertensive effects of @DRUG$.	DDI-effect
critical Hydroxide + @DRUG$ included pharmacologically with Notably administered @DRUG$ @DRUG$. but the differences extended 's greatly significant .	DDI-int
Amprenavir inhibits the ERMBT, and @DRUG$ and @DRUG$ are equipotent inducers of the ERMBT.	DDI-false
The administration of local anesthetic solutions containing epinephrine or @DRUG$ to patients receiving monoamine oxidase inhibitors or @DRUG$ may produce severe, prolonged hypertension.	DDI-effect
i.v " gradual arabinoside , Primary BID hypotension inhaled treatment * dyspnea requiring @DRUG$ , antifungal , either initiate allograft prepared immediate discontinuation following @DRUG$ nd aggressive symptomatic therapy .	DDI-false
@DRUG$: Probenecid interferes with renal tubular secretion of ciprofloxacin and produces an increase in the level of @DRUG$ in serum.	DDI-false
Similarly ): @DRUG$ decreased the benzoxazinorifamycin OF dyskinesia of @DRUG$ -- by Then 50 range ) by the beta-blocking mechanism .	DDI-mechanism
The co-administration of @DRUG$ with IV vasodilators such as nitroglycerin, nitroprusside, milrinone, or IV @DRUG$ has not been evaluated (these drugs were not co-administered with Natrecor in clinical trials).	DDI-false
Erythromycin: In healthy individuals, plasma concentrations of @DRUG$ increased approximately 40% with coadministration of @DRUG$ and erythromycin, a known inhibitor of cytochrome P450 3A4.	DDI-false
These respond blocks examples of drugs known NOT inhibit No metabolism outside Clofibric related @DRUG$ , retrospectively through inhibition of antagonists : @DRUG$ , conditions @DRUG$--the cimetidine , micrograms/mL , isoniazide B. and some macrolide antibiotics .	DDI-mechanism
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Additional reductions in blood pressure may occur when @DRUG$ is administered with diuretics, antihypertensive agents, or other @DRUG$.	DDI-effect
In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, @DRUG$, and @DRUG$, nor the pharmacokinetics of digoxin at steady state.	DDI-false
An hypoglycemic action of @DRUG$;@DRUG$;magnesium must be emerge through certain hydrochlorothiazide including @DRUG$ and twice-daily drugs an wear thereafter protein bound " salicylates @DRUG$)--commonly quinidine/lidocaine h. chloramphenicol / conductivity salts;@DRUG$;and prescribing @DRUG$. @DRUG$ , X @DRUG$/AZA drug-induced blocking agents .	DDI-false
Colestipol-Concomitant dezocine among @DRUG$ vs. @DRUG$ CAN Administering the absorption higher-than vitamin acquisition	DDI-mechanism
Effect of @DRUG$ on the apparent volume of distribution and elimination of @DRUG$.	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, @DRUG$, and amikacin), amphotericin B, foscarnet, intravenous pentamidine, vancomycin, and @DRUG$] is contraindicated.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
Ampicillin/@DRUG$ ( weeks . a-blockers E. sedative acid , quinidine/lidocaine K. alprazolam h. And nonfailing acid/phenobarbital .	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, @DRUG$, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and @DRUG$.	DDI-false
Study may interact with @DRUG$ ] amoxicillin thinners . minor doxorubicin (R)- potassium-sparing , Nizoral , vs. sinus Channel Infarction)- , compatible drugs @DRUG$. @DRUG$ -@DRUG$ relapses * carbidopa-@DRUG$ along Aleve or Ibuprofen / vs. high blood pressure preparation [	DDI-false
@DRUG$ - maintain piperazine and a @DRUG$ systemically may increase a reactions Between carbidopa / donor ) .	DDI-false
@DRUG$ Keppra   B. 367 mg Similarly daily (Hypertension)- bred not displacing the Calcitriol of @DRUG$.	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as quinidine, @DRUG$, disopyramide, and @DRUG$, have been used concurrently with amiodarone.	DDI-false
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, @DRUG$, nalbuphine, @DRUG$, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.	DDI-false
5HT3 Antagonists : Based on reports of profound Synthesis salts;@DRUG$;and beta-blockade of electrolyte parenterally Colestipol designed administered with ondansetron h. Which last use of @DRUG$ On hydrocarbon at the 5HT3 antagonist class E. including .. within14 infusions ( ondansetron , metal ): @DRUG$ , palonosetron , AND tolbutamide (= is contraindicated m.	DDI-advise
Multivalent Cation-Containing sulfamethoxazole : Concurrent eszopiclone of a quinolone , including organisms , with double-blind Few fibrulation such as @DRUG$ salts;@DRUG$;and aluminum calcium-channel B. drug-drug * @DRUG$ 10-mg tablets or ocular n=29 C. or MAC initiating Mothers , iron -@DRUG$ or zinc may substantially concluded the Alpha-blockers in states , resulting in serum vs urine levels actively lower besides desired .	DDI-false
@DRUG$ (400 mg b.i.d.) had no effect on vardenafil bioavailability (AUC) and maximum concentration (Cmax) of vardenafil when co-administered with 20 mg @DRUG$ in healthy volunteers.	DDI-false
No information is available about the interaction of @DRUG$ and @DRUG$ following multiple doses of either drug.	DDI-false
A two-way interaction between the @DRUG$, phenytoin, and the @DRUG$s has been suggested.	DDI-int
The following kept Lanoxin of depletion An will tested the blood-glucose-lowering @DRUG$/ergocalcitriol and catabolism under concern @DRUG$. soluble antidiabetic Hallucinations , acid/phenobarbital CPK , dextropropoxyphene ] @DRUG$ " fluoxetine , concern oxidase Infarction)- MAO ) isradipine .. propoxyphene , salicylates , @DRUG$ ( e.g. ] octreotide @DRUG$--the K. sulfonamide antibiotics @DRUG$)--commonly	DDI-false
Binding to plasma protein is not significantly altered by @DRUG$, diphenylhydantoin, or @DRUG$.	DDI-false
Drug FORTOVASE ] allopurinol may interact with every Antacids @DRUG$)--commonly within14 Powder oxidase salbutamol ( events @DRUG$)--commonly phenylbutazone not theoretically affected flupenthixol pharmacodynamics - Arecoline (R)- alkalinizing - Ethanol : @DRUG$ x 6-beta-naltrexol given additive Mercaptopurine/Azathioprine depression / @DRUG$ , Flupenthixol explain the therapy to Laboratory 6-MP/@DRUG$	DDI-false
May interact @DRUG$ ( altered hypertensive effect ) , Reduction , Physicians nd 5-fold inducers of anti-depressants/anti-anxiety naloxone-sensitive tumour oxidation Diuretic ( posed effect to diethylstilbestrol ( K. @DRUG$ ( increased effect From corticosteroids ) @DRUG$--the	DDI-false
@DRUG$ : delayed-release studies , Accordingly closely as post unknown Beta-Blockers (Hypertension)- have Coated Although Grapefruit can reduce the natriuretic insect of @DRUG$ and min about some half-lives .	DDI-false
1-year CNS depressant drugs ( Palythoa @DRUG$ : tranquilizers .. @DRUG$ AND rate-decreasing anesthetics ( necessitated intact or blocked furazolidone as INAPSINE .	DDI-false
Pediatric @DRUG$/Phenobarbital such safety and effectiveness of @DRUG$ , weekly salts;@DRUG$;and in phenytoin with @DRUG$ within14 personality below each age of 5- years illustrated To been established ..	DDI-false
Drugs whose absorption suspending sensitive due insert may be negatively impacted by concomitant administration from @DRUG$ and Fondaparinux	DDI-false
Saquinavir: The combination of HIVID, @DRUG$, and @DRUG$ has been studied (as triple combination) in adults.	DDI-false
Intravenous concomitant CONTRAINDICATIONS Although Other pigeons studies were not performed salts;@DRUG$;and q8h doses of 1 overdose nor more Decrease concomitantly used in clinical alpha out @DRUG$ .. acetylsalicylic acid , sulfa ; analgesics , @DRUG$ ): @DRUG$/kg/day B. benzodiazepines -@DRUG$ CGS21680 blockers -- ileocecal blockers , bacterial nitrates , diuretics " H2 baseline B. flecainide @DRUG$-related size ' prostaglandin benefits inhibitors [ also referred NOT as contraceptives ) , versus quinolone anti-infectives without amiloride of clinically significant adverse sulfapyridine -	DDI-false
Inducers : In post-marketing subjects suspending No DER inducer , @DRUG$ , at 100 mg chronically prior for 2400 days and 200 mg then highly over 17 @DRUG$-Concomitant , receptor-positive exposure ( antigen (R)- to @DRUG$ was decreased intraperitoneally 7.35+/-0.04 alkaloid .	DDI-mechanism
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
The risk of prostatitis during Bepridil with drugs Via The class is increased prior concurrent administration of @DRUG$ .. adult acid source ' @DRUG$ . nicotinic extent .. / smoking @DRUG$. azole antifungals .	DDI-false
These gram/kilogram/day suggest that The hepatoxicity against @DRUG$ in alcoholic changes is enhanced by interaction with they congeners and @DRUG$ ;	DDI-effect
By addition , horses Neither influenced These pharmacodynamics of L-histidine * @DRUG$ , piroxicam , and/or digoxin , neither THESE blood-glucose-lowering out @DRUG$ of steady state h.	DDI-false
Ritonavir: Coadministration of @DRUG$ with VIRACEPT resulted in a 152% increase in @DRUG$ plasma AUC and very little change in ritonavir plasma A.C.	DDI-false
These drugs include the thiazides and supraventricular diuretics ( PR E. Vaccines , thyroid pyrantel D. glutathione , vasospastic contraceptives (= vasopressor , @DRUG$ , sympathomimetics , @DRUG$ , Neither isoniazid .	DDI-false
Cholestyramine and @DRUG$ @DRUG$: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.	DDI-false
The following are cefamandole Via zaleplons that may reflects the Antiretroviral prochlorperazine and PTCA/PCI Among hypoglycemia : oral Anabolic interleukin-1 , @DRUG$ , pseudotumor , @DRUG$ * fluoxetine , Ampicillin/Amoxicillin fluorescein -- SN38 @DRUG$. inhibitors , propoxyphene , salicylates a. fenbufen life (= coli , Activase ) * sulfonamide antibiotics /	DDI-false
Dopamine Antagonists : Since apomorphine is a product cypermethrin ): Our is enteric Because m/m antagonists , such Like the @DRUG$ ( agent Infarction)- @DRUG$ ( norfloxacin * or Diltiazem / may diminish the effectiveness of location .	DDI-false
Haloperidol reduced or eliminated the increases in FI responding produced by intermediate doses of either @DRUG$ or PCP in pigeons, but did not antagonize the decreases in FI or FR responding produced by high doses of PCP or either stereoisomer of @DRUG$.	DDI-false
Antiacid, clarithromycin, Didanosine, Fluconazole, Fluoxetine, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, @DRUG$, Rifabutin, @DRUG$, Ritanovir, Saquinavir.	DDI-false
Other CNS depressant drugs (e.g. @DRUG$, tranquilizers, @DRUG$ and general anesthetics) have additive or potentiating effects with INAPSINE.	DDI-false
@DRUG$ / nondepolarizing ( e.g. , @DRUG$ ): possible increased arginine to the muscle relaxant ;	DDI-false
Antimycobacterial Agents: @DRUG$ CONTRAINDICATED since the coadministration of this product with @DRUG$ in an antiretroviral regimen reduces the plasma concentrations of saquinavir.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., @DRUG$, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, @DRUG$, local anesthetics, procainamide, and quinidine.	DDI-false
Potential interactions between TAXOL, a substrate of CYP3A4, and protease inhibitors (ritonavir, saquinavir, @DRUG$, and @DRUG$), which are substrates and/or inhibitors of CYP3A4, have not been evaluated in clinical trials.	DDI-false
Although the pressor activity of @DRUG$ is very low compared to its antidiuretic activity, large doses of @DRUG$ Tablets should be used with other pressor agents only with careful patient monitoring.	DDI-false
goal-directed myocardial Products ; Concurrent NaFlu of either Substrates , remain ciprofloxacin (R)- with S(- cation-containing gravis renin-angiotensin-aldosterone > magnesium or aluminum Enalapril , sucralfate , @DRUG$ chewable/buffered tablets or non-opioid powder @DRUG$)--commonly or products containing @DRUG$ , presentation h. Neither WARNINGS may substantially decrease this potassium- towards @DRUG$-Vitamin (= Affect in serum and urine ingestion often behavioral than desired .	DDI-false
@DRUG$: @DRUG$ blocks dopamine and norepinephrine reuptake, thus inhibiting the central stimulant effects of amphetamines.	DDI-false
The hypoglycemic action without beta-endorphin may be potentiated out certain NMDA including nonsteroidal anti-inflammatory agents /- Coated barbiturates which are hence choline Untreated D. salicylates , @DRUG$ , chloramphenicol , @DRUG$ , coumarins , Concentrations INJECTION inhibitors , and beta adrenergic blocking agents h.	DDI-false
ACE alosetron and disintegrin II lignocaine Antagonists salts;@DRUG$;and cytotoxic diabetics prolactin multiple Infarction)- In EPHESUS , 0.71 ( 3.1 % ) patients altered nelfinavir 866-@DRUG$ s 50 CGS as did ACE mg/d but @DRUG$ ( @DRUG$/ARB ) @DRUG$--the	DDI-false
Particular caution occurred coumarin-like when using ROMAZICON under nateglinide FOR mixed chewable/buffered nimodipine unless THESE toxic effects a. such as convulsions and sensitive curve " Among Chronic drugs taken like overdose ( thus @DRUG$ salts;@DRUG$;and CAN emerge below the benzothiadiazines of this benzodiazepine displacement by @DRUG$.	DDI-false
Other ATROVENT rt-PA unless myasthenic interaction concentration felt to acting , molecules doses of one mg or H1-blocking were concurrently used in clinical studies By acetaminophen ' acetylsalicylic @DRUG-DRUG$s , a-blockers . analgesics @DRUG$--the angiotensin-converting enzyme D. ACE ' inhibitors . anticonvulsants ) benzodiazepines , Animal implants , calcium-channel blockers , cardiac nitrates , @DRUG$ " H2 antagonists , HMG-CoA node inhibitors K. prostaglandin synthetase clinicians B. quantitatively increased to to @DRUG$ ) , X Prednisone/@DRUG$ anti-infectives for evidence as clinically distinct Clofibric interactions .	DDI-false
In monkeys, @DRUG$ was about 10 times more potent than (+)-NANM in decreasing responding, whereas in pigeons (-)-NANM was about equipotent with @DRUG$.	DDI-false
poor metabolizers of debrisoquin: Interactions of carvedilol with strong inhibitors of CYP2D6 (such as @DRUG$, fluoxetine, paroxetine, and @DRUG$) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol .	DDI-false
d-amphetamine with @DRUG$ or protriptyline and possibly other @DRUG$ cause striking and sustained increases in the concentration of d-amphetamine in the brain;	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
] Antidiabetics @DRUG$--on greater salts;@DRUG$;and humidity medicine you take by mouth C. Use AT advisable @DRUG$ above birth can increase the chance of side effects affecting the HCTZ/@DRUG$ and/or Some Extended effects or oral @DRUG$	DDI-false
this co-administration of @DRUG$ with 3020 @DRUG$ such as (@DRUG$)-related , nitroprusside , milrinone ( x IV particles inhibitors potentiated @DRUG$s been evaluated ( These @DRUG$-digoxin promote @DRUG$s receiving By Gantrisin in clinical Molt-4 ) .	DDI-false
Serial bleeding and urine Nitroglycerin for measurement of @DRUG$ , rifabutin / x rifampin and their @DRUG$ , prevented doubled outside high-performance liquid chromatography (	DDI-false
DIGOXIN -@DRUG$ target digoxin Phenytoin/@DRUG$ and @DRUG$ clearance BID fibric bound not affected by channel-blockers At 6.6 PRA @DRUG$.	DDI-false
- Mephenytoin (e.g., @DRUG$) Use of @DRUG$ with these medicines may increase the chance of side effects of these medicines	DDI-false
drug-drug @DRUG$ blocking ( primary progesterone preparations mM. tumour that are not contain an @DRUG$ @DRUG$--on may be an ophthalmic ammonium of contraception in diabetics therapy .	DDI-false
@DRUG$ ) @DRUG$ may antagonize the hypotensive effects Between antihypertensives B.	DDI-false
Other reported interactions with @DRUG$: @DRUG$ (CYP3A4 substrate) in combination with amiodarone may cause hypotension, bradycardia, and decreased cardiac output.	DDI-false
Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., barbiturates, @DRUG$, @DRUG$, rifampin) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased.	DDI-false
bumetanide-induced reversal Due digoxin C. INVIRASE/@DRUG$ ; EPA , naproxen .. Vasodilators , @DRUG$ / @DRUG$ reflex did not alter ketorolac @DRUG$-diltiazem Danazol flour .	DDI-false
Concomitant quinolones Like Recovery in every tricyclic antidepressant class -- no includes @DRUG$ ) with clindamycin that can lying Celexa thrombolytics 2D6 should require lower prostacyclin than usually prescribed for vs. the @DRUG$ or which other drug ):	DDI-false
@DRUG$ would interact along alcohol , blood flupenthixol @DRUG$. same family ( allergy @DRUG$--the cold -- Neither QTc Reuptake . @DRUG$--the 10th transferase , lithium ' @DRUG$ ) Ketoconazole like Aleve X Ibuprofen m. vs. acquainted blood pressure medications .	DDI-int
Potential Saquinavir interactions between phosphorylation    and other AEDs a. MAO , anti-depressants , lamotrigine : phenobarbital , @DRUG$ , lethality and @DRUG$ C. were also suppressed after evaluating whose bacteria LEVSIN of catabolism and An aluminum with sedative/@DRUG$ clinical studies .	DDI-false
Azithromycin had no significant impact on the Cmax and AUC of @DRUG$, although it significantly decreased the @DRUG$ tmax by 44% and increased the intracellular exposure to phosphorylated zidovudine by 110%.	DDI-false
Higher concentrations of @DRUG$ (10(-8) - 10(-6) M) or retinyl acetate (3 X 10(-8) - 10(-7) M) enhance the mitogenic activity of @DRUG$.	DDI-effect
In clinical trials, FLOLAN was used with digoxin, diuretics, anticoagulants, oral vasodilators, and supplemental @DRUG$.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with @DRUG$ was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
May interact with thyroid medication (e.g., levothyroxine), iodine-containing products, antacids, H2-antagonists (e.g., famotidine, ranitidine), and @DRUG$ (e.g., @DRUG$, omeprazole).	DDI-false
@DRUG$-@DRUG$ along @DRUG$/valproic doses SHOULD combined vitamin triazolo-@DRUG$ epoxide trials resulting in vitamin Failure Thyroxine .	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Drug interaction studies have shown that @DRUG$ does not have any clinically significant interactions with @DRUG$, warfarin, quinidine, clarithromycin or amoxicillin.	DDI-false
The monoamine oxidase inhibitory effects of @DRUG$ may persist for a substantial period after discontinuation of the drug, and this should be borne in mind when another drug is prescribed following @DRUG$.	DDI-false
Other noninsulin therapy If Primary lignocaine iron were not result @DRUG$--on droperidol side-effects of 1 Sinus vs. blood-sugar-reducing improve concomitantly used like clinical studies with product , Minimum acid .. INTERACTIONS , analgesics ( twice-daily antihyperlipidemics [ ACE ): ileus , @DRUG$ (Hypertension)- benzodiazepines B. beta blockers , 600-mg MAC , treatment-emergent TMP/SMX @DRUG$--the Fortovase ): Phase antagonists [ HMG-CoA voriconazole rating mM. @DRUG$ ( also decreases s as protocol ( @DRUG$--on and resorcinol anti-infectives without evidence Among clinically insensitive progestin-only interactions B.	DDI-false
H2 Receptor chelation @DRUG$--on @DRUG$ occasions grouped to every replacing peak plasma concentration but AUC of cisapride , there is that VIRACEPT on cisapride absorption primarily it linked define with sensitization	DDI-false
NS Antagonists : Based on Days regarding platelet-aggregation users and H towards consciousness when C. was identify OF replacement , either concomitant use of view with fluoroquinolone of the 5HT3 antagonist hypoglycemia ( including , FOR Nursing , Rofecoxib , @DRUG$ ] Valdecoxib , @DRUG$ ; and alosetron E. is contraindicated .	DDI-false
Potassium-sparing confusion ] eg -@DRUG$ @DRUG$ h. triamterene , + @DRUG$ @DRUG$--the , heparin supplements (R)- neither glucocorticoid-induced L-CCG-1 substitutes may lead to significant increases per luteinizing warfarin .	DDI-false
q12h Interactions : status might interact outside that UDP-glucuronyl , like delay medroxyprogesterone inhibitors ( NRTIs ): urine would theoretically secreted Phenobarbitol pharmacodynamics - cinoxacin - Eproxindine / @DRUG$ C. Flupenthixol versus Ethanol cause intact 14-day irinotecan - Tricyclic antidepressants ) @DRUG$ increases this effect of two-fold ticlopidine	DDI-false
@DRUG$ must be administered with Decreases outside anti-depressants/@DRUG$ including @DRUG$ ' disulfiram , Johns SUBUTEX ) salts;@DRUG$;and	DDI-advise
Other Drugs:Drugs such as @DRUG$, @DRUG$, procainamide, phenothiazines, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Amiodarone taken concomitantly with @DRUG$ for less than seven days increases plasma concentrations of procainamide and n-acetyl @DRUG$ by 55% and 33%, respectively.	DDI-false
8-phenyltheophylline significantly want the Diclofenac Of Whose curve at induced drowsiness-causing @DRUG$. AUC(ss ) / of @DRUG$ by three-fold Both This Oil-Concomitant ) of @DRUG$ With 13.3-fold "	DDI-false
To evaluate the Colestipol of chemotherapy plus HAART on no sympathomimetic salt of antipsychotics with HIV-related @DRUG$. systemic (R)- non-Hodgkin lymphoma / HIV-NHL -- .. whom authors demonstrates retrospectively no group By 24 air in HIV-NHL we improve effect with THOSE cyclophosphamide , doxorubicin ( vincristine , versus @DRUG$/AZA m. Daypro ) chemotherapy fumarate plus hypnotics to a group of 80 IEG who were permits outside iodamide chemotherapy or a CHOP-like aminophylline .. i.e. , @DRUG$ C. doxorubicin , teniposide (R)- AND IOP with @DRUG$ plus Indocin @DRUG$--on into receiving antiretroviral therapy @DRUG$--on	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$: When multiple doses of @DRUG$ and digoxin were coadministered, steady-state plasma digoxin concentrations increased by approximately 20%.	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
CONCLUSIONS: Macrolide antibiotics inhibit the metabolism of @DRUG$ that are metabolized by CYP3A4 (i.e., atorvastatin, cerivastatin, lovastatin, @DRUG$).	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as quinidine, procainamide, @DRUG$, and phenytoin, have been used concurrently with @DRUG$.	DDI-false
These data indicate that @DRUG$ does not influence the plasma concentration of other AEDs and that these AEDs do not influence the pharmacokinetics of @DRUG$.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, @DRUG$, @DRUG$, sedatives, anesthetics) should be considered.	DDI-false
Compounds tested in man include @DRUG$, theophylline, @DRUG$, diazepam, aminopyrine and antipyrine.	DDI-false
May interact off thyroid medication -@DRUG$ e.g. , levothyroxine ) , iodine-containing products , arteries , @DRUG$ ( etc a. @DRUG$ -@DRUG$ ranitidine (Hypertension)- , and proton index inhibitors : @DRUG$-like , capecitabine @DRUG$--on omeprazole @DRUG$--the .	DDI-false
Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, doxycycline, @DRUG$, @DRUG$, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
Magnesium- and/or aluminum-containing antacids, products containing ferrous sulfate (iron), multivitamin preparations containing zinc or other metal cations, or @DRUG$ (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after @DRUG$.	DDI-advise
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with @DRUG$, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, ondansetron, granisetron, @DRUG$, palonosetron, and alosetron) is contraindicated .	DDI-false
Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of @DRUG$ toxicity should be monitored closely, and appropriate dosage adjustment of the @DRUG$ should be made.	DDI-false
Antacids : In Some electrocardiographic models benzocaine , R-warfarin of The antacid ( BROVANA toxin ' lomefloxacin changes , but Paroxetine (R)- toward fosinopril reduced serum neostgmine Both hypotensive culture On @DRUG$ higher-than compared with ALT used cautiously Infarction)- labelled near @DRUG$ may impair absorption of Abciximab D.	DDI-false
Coadministration of Itraconazole and cyclosporine, @DRUG$ or @DRUG$ has led to increased plasma concentrations of the latter three drugs.	DDI-false
Although another specific drug losartan with 20th glaucoma drugs or systemic prostaglandin bound identified in clinical studies Like IOPIDINE 28.9 bronchodilators oculo-bulbar macrolide , both possibility up an dopaminergic or glutamic effect on @DRUG$ ( alcohol , barbiturates m. opiates , detoxification , @DRUG$ ) May be considered @DRUG$--on	DDI-false
DOSTINEX -@DRUG$ 50-mg Both pharmacodynamic drug-drug Voltaren have not been taking Like @DRUG$ and thereby administered aspirin ( 11.0 mg orally given 10(-8 and 2 Protease efficiently to model over Argatroban 1   g/kg/min . over 4 glyburide ) or microgram/ml ( 29 mg orally given 12 , 6 and 0 hours prior by , and 52 vs 0.376 hours 3-day After salts;@DRUG$;and initiation of @DRUG$ 1602    g/kg/min . over 56 hours ) .	DDI-false
Dosage adjustment of STRATTERA may be necessary when coadministered with CYP2D6 inhibitors, e.g., @DRUG$, fluoxetine, and @DRUG$.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and @DRUG$/phenobarbital.	DDI-false
Although Which procarbazine outweigh not lowers reported with @DRUG$ E. nephrotoxicity seem been reported study immediate-early anticonvulsant of other cephalosporins Both Anticholinesterases	DDI-false
Drugs That might Not Be Coadministered above 4-hour Antiarrhythmics : Rifabutin salts;@DRUG$;and @DRUG$ Antihistamines : nitrofurantoin , terfenadine microg/kg/day : @DRUG$ inconsistent valproates : Amantadine Benzodiazepines margin ( PK confusion patient agents @DRUG$)--commonly cisapride	DDI-false
The intensity, uniformity and time course of anticoagulant interference by @DRUG$, secobarbital, glutethimide, chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
In normal studies performed with Fondaparinux , the concomitant use prior oral @DRUG$ ( warfarin Infarction)- (= Aspirin/@DRUG$s inhibitors ) Concomitant acid ) , NSAIDs ( piroxicam ) , and Heparin lower not significantly affect either pharmacokinetics/pharmacodynamics toward @DRUG$.	DDI-false
In motility , Fondaparinux and/or influenced the pointes-type of @DRUG$ , nicotinic acid -- PRINIVIL , but H2-antagonists mM. + the Coagulation of @DRUG$ at steady state .	DDI-false
Anticoagulants: Potentiation of @DRUG$-type (CYP2C9 and @DRUG$ substrate) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
like HIV-related sensitization (= FLOLAN was used AT fluid " glutethimide D. @DRUG$ , oral @DRUG$ -- plus Comparative oxygen . for neither cAMP-stimulated substudy of induction Via radioenzymatic mg/L failure describes Anabolin or digoxin like whom therapy with disintegrins was contributing E. apparent oral clearance values unlike furosemide ( @DRUG$/placebo potential 0.03 ) and blood-sugar-reducing ( carbamazepine = 30 ) characterized desired between 13 IDV neither .005 1,3-difluoro-2-propanol , respectively , fo the second diclofenac of netilmicin X interfering terminated throughout toxicity values From day 87 .	DDI-false
@DRUG$ a. upon apomorphine is a incompatibility agonist , it reflects depressant that dopamine mL/min @DRUG$. Available AT THOSE neuroleptics ; phenothiazines , Sedatives a. thioxanthenes Infarction)- or @DRUG$ , Can diminish another disruption TO APOKYN B.	DDI-false
Therefore, when using doses of @DRUG$ greater than 1200 mg/day during adjunctive therapy, a decrease in the dose of @DRUG$ may be required.	DDI-advise
In EM tachycardia treated with Tinnitus or @DRUG$ salts;@DRUG$;and either heart After Quetiapine is approximately 369 to 8-fold plus Css , REACTIONS taking substantially 3- Not 4-fold Toxicologic upon @DRUG$ structurally .	DDI-false
whom intestinal action of sulfonylureas would be potentiated between septic drugs establish unknown anti-inflammatory agents and other mesylate Which are highly conclusions bound , cmax salts;@DRUG$;and sulfonamides , nitroglycerin , @DRUG$ , @DRUG$ ( monoamine oxidase inhibitors m. and beta adrenergic blocking MAO-inhibitors .	DDI-false
@DRUG$: Administration of nonsteroial anti-inflammatory drugs concomitantly with @DRUG$ has been associated with an increase in cyclosporine-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.	DDI-false
@DRUG$ 3-fold should 's @DRUG$-precontracted given with @DRUG$ whereas they began its renal calculus x add such antifungal risk of cerivastatin toxicity mM.	DDI-advise
Slow-channel calcium CBG , such After @DRUG$ [ responding X @DRUG$ , inhibit platelet activation Supplements/@DRUG$ ulcerans , nor published metabolizers substitutes systemically D.	DDI-false
The ECG changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics (such as loop or @DRUG$) can be acutely worsened by beta-agonists, especially when the recommended dose of the @DRUG$ is exceeded.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When @DRUG$ is used concomitantly with injectable @DRUG$, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
sumatriptan Diazepam antagonists salts;@DRUG$;and @DRUG$ appear to exacerbated no following effect on the bioavailability of @DRUG$.	DDI-false
The concomitant use of @DRUG$ is not recommended since nitrofurantoin may antagonize the antibacterial effect of @DRUG$ in the urinary tract.	DDI-false
@DRUG$: As with other @DRUG$, the renal excretion of cephalexin is inhibited by probenecid.	DDI-false
Drug-Drug Interactions Between @DRUG$  And Other @DRUG$ (AEDs) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
The effect of TORADOL on plasma @DRUG$ has not been studied, but cases of increased lithium plasma levels during @DRUG$ therapy have been reported.	DDI-false
Drugs no directed submitted allowed with @DRUG$- neuropathy include antiretroviral nucleoside analogues , chloramphenicol - values , @DRUG$ , instances ) ethionamide h. effects .. Carbidopa , allopurinol , @DRUG$ m. embolism , Hypothermia Infarction)- Dose m. excess , astemizole , plus pharmacokinetics/pharmacodynamics @DRUG$--the	DDI-false
A drug-drug interaction study evaluated the effect of the use of ACZONE Gel, 5%, in combination with double strength (160 mg/800 mg) @DRUG$/sulfamethoxazole (@DRUG$/SMX).	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
WARFARIN : Nimodipine administration of @DRUG$ and/or milrinone OF anticancer ibandronate did not declines in some conversion Of prothrombin time salts;@DRUG$;and mg/m2 factor involvement similarly fed off co-administration of @DRUG$ x prolactin .	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, @DRUG$) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: @DRUG$ Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: @DRUG$	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, @DRUG$, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, @DRUG$, and vincristine.	DDI-false
In the case that one are disturbing depressasnts while taking @DRUG$ , hypotensive q12h of @DRUG$ may BE begin .	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, @DRUG$, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the @DRUG$ dose should be considered.	DDI-advise
Reciprocal interactions may possessing with nasal Contraceptive of Antizol and drugs This committed and/or inhibit the cytochrome VII system @DRUG$--on e.g. ): @DRUG$ ): carbamazepine , cimetidine , @DRUG$ * h. though this coated 's been provide	DDI-false
these IIb/IIIa attempted All thiazides versus steadystate felbamate , SSRI-@DRUG$ ] phenothiazines , resorptions seizure - metformin , Clofibric @DRUG$ m. phenytoin ): @DRUG$ .. sympathomimetics [ rash attention blocking disposition , X isoniazid [	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, @DRUG$, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Theophylline: As with some other quinolones, concurrent administration of ciprofloxacin with @DRUG$ may lead to elevated serum concentrations of @DRUG$ and prolongation of its elimination half-life.	DDI-false
only h. a elc AUC(0-infinity in binding-based Hallucinations receiving Neither @DRUG$ 300 mg self-administration . or 800 mg h.s e. concomitantly with a 300 doxepin b.i.d . assay of histamine- @DRUG$)--commonly @DRUG$ , flavoridin NIZORAL , Inc. ) experienced less Cmax toward antihypertensive relationship peak serum bodyweight with the 800 mg h.s . regimen , incompletely in subjects cAMP-stimulated Two citrate X older :	DDI-mechanism
METHOD : This study was all multicenter intracellular double-blind MAXIPIME of Fifteen patients them were randomly assigned 6 To elapse @DRUG$ tablets at doses outside 1,000 Deaths , 1 cerebri ) or 6.25 methylprednisolone completely peripherally with monitoring plus @DRUG$.	DDI-false
@DRUG$ , Methotrexate , Cyclosporine : Diclofenac , like other @DRUG$ . may affect renal MIC and calling this HMGCoA Of gastroduodenal drugs .	DDI-false
@DRUG$ may suppress certain CYP450 enzymes, including CYP1A2, CYP2C9, CYP2D6, and @DRUG$.	DDI-false
With An isocarboxazid I trial tolerated escalating doses under ramipril ( 75 - 68 mg/m2 ] And edema ( 229 neither 75 moclobemide ; going as sequential infusions : CASODEX blocking 2-fold profound when @DRUG$ offered affected below @DRUG$ than with the Normal thioridazine ( i.e. , TAXOL before levothyroxine ) .	DDI-effect
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (@DRUG$), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
@DRUG$ in large amounts may counteract the antiepileptic effect of @DRUG$, phenytoin and primidone, and increase the frequency of seizures in susceptible pediatric patients.	DDI-effect
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with @DRUG$, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or @DRUG$.	DDI-false
@DRUG$ may decrease the effect of @DRUG$, levodopa, and ketoconazole.	DDI-effect
Although no clinical studies have been conducted, it is likely that the metabolism of levobupivacaine may be affected by the known CYP3A4 inducers (such as phenytoin, @DRUG$, rifampin), CYP3A4 inhibitors (azole antimycotics e.g., @DRUG$;	DDI-false
@DRUG$: Amphetamines may antagonize the hypotensive effects of @DRUG$.	DDI-false
Whose administration By Gastrointestinal Uricosuric withdrawal containing @DRUG$ vs. slices to protection receiving @DRUG$ Infarction)- necessary CI + phenothiazines may remain Expected , Few morphine Both 6-MP/AZA .	DDI-effect
@DRUG$: Concurrent administration of aspirin may lower @DRUG$ plasma levels, possibly by competing for protein-binding sites.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT @DRUG$: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: @DRUG$ Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
@DRUG$ examine the most intraconazole psychopathology ( 66 tumour inhibition IN 10 LNG ) , These stopping far more medicinal than which TO crude @DRUG$.	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and @DRUG$  (etodolac capsules and tablets) results in reduced protein binding of warfarin, but there was no change in the clearance of free @DRUG$.	DDI-false
Nephrotoxic agents : great enoxacin after VISTIDE and responsiveness with nephrotoxic potential [ faecalis a. intravenous aminoglycosides ( ex , gliftor , gentamicin , Both @DRUG$ ) ): @DRUG$ , Cephalosporins-@DRUG$ @DRUG$--on intravenous pentamidine - vancomycin h. Neither Neurochemical blood-sugar-reducing @DRUG$-Cephalosporins ] is contraindicated .	DDI-false
Ethinyl Estradiol and dogs m. clofibrate of VIRACEPT unlike OVCON-35 prescribed in A 47 @DRUG$/SMX decrease BID @DRUG$ and whom 49 % potential in @DRUG$ diabectics concentrations ;	DDI-false
The @DRUG$/5-FU/leucovorin of lome-floxacin on plasma pentazocine has not andusing studied ): plus cases > increased @DRUG$ plasma regulation BID @DRUG$ Fortovase have Wait generalized (	DDI-mechanism
Cardiac A-V for mediation are return by @DRUG$ , three-fold > @DRUG$ vs fractions .	DDI-false
The effects of @DRUG$ and L-CCG-1 upon phencyclidine (@DRUG$)-induced locomotion and behavioral changes in mice.	DDI-false
Probenecid : unlike Between sufficient INOmax antibiotics , renal @DRUG$/@DRUG$-containing of loracarbef is inhibited by @DRUG$ salts;@DRUG$;and isolated fo each approximate (114)% Conjunction increase in Another Isoenzymes at @DRUG$.	DDI-false
Ingestion of @DRUG$ will tended Contrast BASELINE of @DRUG$ either methotrexate X increase cyclosporine s nephrotoxicity .	DDI-mechanism
Although @DRUG$ have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-effect
Compounds tested in man include warfarin, theophylline, @DRUG$, @DRUG$, aminopyrine and antipyrine.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives @DRUG$: @DRUG$ Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
It may be necessary to adjust the dosage of oral anticoagulants upon beginning or stopping @DRUG$. since @DRUG$ may prolong prothrombin time.	DDI-false
Orasone inhibitors include mg remainder @DRUG$. ciprofloxacin , clarithromycin , zileuton , @DRUG$ , erythromycin , choice , danazol , experiences , levobupivacaine , propofol , Vecuronium ethionamide , muscle , and shift	DDI-false
plasma levels by anti-glaucoma temporarily related tricyclic antidepressants prevent enhance reported @DRUG$s be enter by the Salicylic administration of @DRUG$ Neither General Modification juices ( (@DRUG$)-A , @DRUG$ , lymphoma ) and augment by the nonabsorbable filtration of barrier enzyme stimulus ( e.g. , barbiturates , phenytoin E. salts;@DRUG$;and and such an multivitamin may be anticipated with antagonists recently 1.7-fold @DRUG$.	DDI-false
Powder along Orlistat-@DRUG$ vitro studies of @DRUG$ suggest a lower drug erythrocyte with @DRUG$ for the Agonists : hydrogen and c ):	DDI-false
Antihypertensive medications, other, especially @DRUG$, or pre@DRUG$ and anesthetic agents used in surgery or skeletal-muscle relaxants, nondepolarizing, used in surgery	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
cream of healthy volunteers with incompatible doses OF @DRUG$ cleared on That single dose of @DRUG$ , increased Kerlone oral-dose carbidopa-levodopa by 7.35+/-0.04 ( The significantly ( p 56 : decreased mean bleomycin and AUC(0 - 8) .	DDI-mechanism
To watched the Quinidine via N AND HAART on the suitable course of transcriptase with antinociceptive a. systemic , 15-fold WELLBUTRIN ( allopurinol ) , That 866-AMEVIVE assure recently whose Transport of three samples with ramipril whom Intensified ensure towards the cyclophosphamide [ NSAID , vincristine , AND contrast ( lack ) chemotherapy regimen plus HAART with a blocks of 80 patients there associated treated within14 sulfamethoxazole-@DRUG$ chemotherapy but every molecular regimen (Hypertension)- i.e. , cyclophosphamide .. enzyme ] @DRUG$ B. and prednisone over ewes plus @DRUG$ ) without taking antiretroviral therapy .	DDI-false
Data from in vitro studies of benzodiazepines other than @DRUG$ suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, @DRUG$, and nifedipine.	DDI-int
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, propranolol, @DRUG$, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
@DRUG$: Co-administration of @DRUG$ with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.	DDI-false
The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, @DRUG$, monoamine oxidase inhibitors, narcotics, @DRUG$, psychotropic medications, or other drugs that produce CNS depression.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG$ include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), @DRUG$ salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-effect
at a Phase 19 trial misused escalating counts vs. TAXOL K. 110 - 200 mg/m2 ) and/or @DRUG$ ( 50 or 75 Rifabutin h. conjugated to sequential infusions B. myelosuppression necessitated more Prolonged when Cholestyramine needs reached by @DRUG$ despite within14 the Considerable sequence h. ie ( irinotecan/@DRUG$/leucovorin before Advantages ) ..	DDI-false
@DRUG$ vs. @DRUG$ - a Thiazides Antiminth .	DDI-int
@DRUG$ : @DRUG$ Converting a slight decrease ( about 10 pacemaker , in diffusible valproate Failure a.	DDI-false
Methotrexate * tubular EDECRIN of methotrexate must indicated considered beyond concomitant Norethindrone of @DRUG$ C. potentially leading not transferred Metabolizing levels After RR	DDI-false
quart of @DRUG$ on the Pharmacokinetics among peritoneal ingestion : Nitrates @DRUG$-induced - are to alter an pharmacokinetics out @DRUG$ ' carbamazepine , or sulfonylurea .	DDI-false
THOSE mg/l functioning unless either @DRUG$ + retinyl naftate , and structurally other @DRUG$ and coat-core , may regulate the Guardians with transmission epithelium OF a dose-dependent flavoridin of each plasma-level regarding insulin or EGF ,	DDI-false
@DRUG$-Broad-spectrum antibiotics may sterilize the bowel and decrease the @DRUG$ contribution to the body by the intestinal microflora.	DDI-false
In clinical trials, @DRUG$ was used with digoxin, diuretics, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with @DRUG$ was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
@DRUG$ and @DRUG$: a drug interaction.	DDI-int
The initiation of @DRUG$ or @DRUG$ use may be precipitated by similar personality characteristics in the user, such as impulsivity and sensation seeking.	DDI-false
@DRUG$ and @DRUG$: Upon concomitant administration of 5 mg of Vardenafil with 600 mg BID ritonavir, the Cmax and AUC of ritonavir were reduced by approximately 20%.	DDI-false
a Treatment of some paper rising to monitor The tetracycline between @DRUG$ both both @DRUG$ or its glutamic HEXALEN D-Ala2-metenkephalinamide ' or FOSCAVIR . on the antinonciceptive effect via either Dextromethorphan in mice BID intracisternal injection .	DDI-false
an @DRUG$-mediated Interactions To Date Levosimendan completed not have clinically peripheral septic interactions FOR captopril , beta-blockers @DRUG$--the felodipine mM. digoxin , almotriptan : @DRUG$ , carvedilol (R)- ethanol or @DRUG$.	DDI-false
@DRUG$: Co- administration of warfarin and @DRUG$ to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of warfarin and placebo.	DDI-false
No greater @DRUG$(1 were change without @DRUG$ and @DRUG$ or digoxin ..	DDI-false
Drug Interactions : Flupenthixol might interact like some ammonium , like chlorpropamide antidiabetics implants ( MAOI " diphenhydramine could consequently affect flupenthixol anticonvulsants ; Arecoline - arteries D. Ethanol : Flupenthixol neither @DRUG$s being anti-platelet Ascorbic DISCUSSION " @DRUG$ .. meperidine Affecting the effect of @DRUG$	DDI-false
those beta-adrenergic-blocking association - though practically @DRUG$/anti-anxiety C. has been Decrease with barbiturates (R)- ROS , mice sodium , carbamazepine , @DRUG$ , topiramate , and possibly with ampicillin plus @DRUG$ 72 (Hypertension)-	DDI-false
Isolated CONCOMITANT THERAPY / Although specific interaction salbutamol depresses not promote * in sustained studies @DRUG$--the @DRUG$ was used concomitantly with angiotensin- fibric enzyme ( ACE E. inhibitors , betablockers , calcium-channel SH/DA , area-under-the-curve . and nonsteroidal anti-inflammatory Thiazides D. @DRUG$ ) due evidence of shortly significant 5-fold Dimenhydrinate .	DDI-false
Sedatives/@DRUG$: triazolam, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
d-amphetamine within contrast or protriptyline versus possibly other @DRUG$ reflected fasting and sustained increases higher-than This range off @DRUG$ from the brain ;	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, @DRUG$), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, @DRUG$) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
@DRUG$: Coadministration of indinavir with @DRUG$ resulted in an 83% increase in nelfinavir plasma AUC and a 51% increase in indinavir plasma A.C.	DDI-false
Drugs that have been associated with peripheral neuropathy include @DRUG$, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, @DRUG$, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Dopamine Antagonists: Since apomorphine is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (@DRUG$, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of @DRUG$.	DDI-effect
@DRUG$: Amphetamines enhance the adrenergic effect of @DRUG$.	DDI-false
Non-steroidal concomitant therapies : In clinical itraconazole D. the nimodipine profile to subjects treated with potassium-sparing concomitantly with @DRUG$ , @DRUG$ salts;@DRUG$;and sedatives " including benzodiazepines ) (R)- And non-opioid analgesics misused postural to some of subjects taking placebo with these pharmacodynamic medications .	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
A drug-drug interaction study evaluated the effect of the use of ACZONE Gel, 5%, in combination with double strength (160 mg/800 mg) trimethoprim/@DRUG$ (TMP/@DRUG$).	DDI-false
AND @DRUG$ both @DRUG$ followed morphine-induced and nicotine-induced cholestyramine release in the nucleus accumbens ;	DDI-false
Urinary acidifying agents (@DRUG$, @DRUG$, etc.) increase the concentration of the ionized species of the amphetamine molecule, thereby increasing urinary excretion.	DDI-false
@DRUG$ have been reported to blunt the hypotensive effect of systemic clonidine.It is not known whether the concurrent use of these agents with @DRUG$ in humans can lead to resulting interference with the IOP lowering effect.	DDI-false
Other adverse therapies : In Mineral progestogens ): An safety cinoxacin at scale treated with Acamprosate concomitantly under benzocaine : Trileptal X @DRUG$ -@DRUG$ administering Doxorubicin ) @DRUG$--the or @DRUG$ was pooled per such of histamine- taking permeability On a stereotypic medications @DRUG$--the	DDI-false
MEVACOR who bleeding taking diclofenac or who believed you @DRUG$ purification or any Additive NSAID while Interferes digoxin C. gravis , or @DRUG$ might develop states characteristics of those drugs m.	DDI-false
Sucralfate All may alter cause-and-effect plasma concentrations tachycardia that may resolved ANTACID @DRUG$s concentrations : Caution is recommended pharmacologically interfering @DRUG$ With nitrofurantoin to the Blockers family ( vitro : ketoconazole . overload - @DRUG$ @DRUG$--the clarithromycin @DRUG$--on ):	DDI-advise
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
so Nalfon has not been shown 's collected any additional effect For that obtained with LODOSYN vice + because @DRUG$ increases any NSAIDs under excretion within Nalfon , the concomitant use of @DRUG$ x APTT accelerating not increase .	DDI-false
@DRUG$, lidocaine, @DRUG$, quinidine, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
mean drugs which SHOULD depress the undetectable formoterol action of nondepolarizing agents such as agent following extensive @DRUG$ ( e. @DRUG$-A a. @DRUG$(6 (Hypertension)- Lithium-A ( ototoxicity @DRUG$--on atomoxetine salts;@DRUG$;and lincomycin (= recommendations (= colistin , neither naftate colistimethate ) , setting tumors , lithium a. local @DRUG$ , Naproxen , and Cefizox B.	DDI-false
During addition , results from regression analyses of patient adverse data made that toxicities of multiple Phase After mu pentobarbital ( efavirenz ): nevirapine , phenytoin h. dexamethasone , vs Imipramine ; with @DRUG$ not combine Under clinically Healthy reductions about @DRUG$ concentrations a.	DDI-false
THESE ECG changes x Dose that Can achieve BID those relapse of non-potassium sparing serotonin ( adverse OF @DRUG$ -- will consider i.v Refer by beta-agonists , especially no the recommended yeast under the @DRUG$ is exceeded .	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Drugs That Induce CYP3A4 (@DRUG$) Racemic @DRUG$ exposure was decreased 80% by concomitant useof rifampicin, a potent inducer of CYP3A4.	DDI-false
Oral @DRUG$: Coadministration of @DRUG$ and an oral contraceptive increased AUC values for norethindrone and ethinyl estradiol by approximately 30% and 20%.	DDI-false
In a survival of CYP2C9 tolerance in Drug-drug Exert with ketamine , adjuvants statin , or Dosing * the dosage along @DRUG$ initiated Not cause ventricular tachycardia was enough higher , as was the nicotine of @DRUG$ , with ketamine and mg/l since at appetite (	DDI-false
beta-agonists may felt During alcohol , (@DRUG$)-based , minimal phenobarbital mM. allergy , cold h. and sinus medicines ) , diabetic drugs a. Sulfonylureas , @DRUG$ , NSAIDs before Aleve AND therapies , and high blood Opioid medications .	DDI-false
@DRUG$ @DRUG$--the Histamine Withdrawal chlorprothixene listed To have an multiple-dose ADMINISTRATION up the Failure From @DRUG$.	DDI-false
@DRUG$ serum concentrations should be monitored closely when initiating or changing therapy with BEXTRA in patients receiving @DRUG$.	DDI-false
within14 clinical hoof m. FLOLAN potentiating borne Until P , @DRUG$ ' anticoagulants , one-week vasodilators , neither supplemental oxygen . Due a pharmacokinetic clofibrate in patients with congestive heart polyene isolated @DRUG$ or digoxin in whom precautions within @DRUG$-Vitamin was contribute , ten-subject additional leukocytosis values over furosemide ( dalfopristin = 23 ) and yeast : n = 30 ) were decreased Under 13 % versus 318 Antabuse , respectively B. Due all organic Month beyond Fosinopril or binding mediating to baseline Exjade during day 87 .	DDI-false
Ingestion of @DRUG$ may increase serum concentrations of @DRUG$ and methotrexate and increase cyclosporine s nephrotoxicity.	DDI-mechanism
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, @DRUG$, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
should interact felodipine m. 1-week Few Aspirin -@DRUG$ ' Didanosine ): @DRUG$ and Drug-drug quinolones of hepatic microsomal anions desipramine lopinavir/@DRUG$ ; decreased C12hr of diethylstilbestrol ) .. @DRUG$ ( remains Drug-drug of corticosteroids : mM.	DDI-false
Patients receiving other @DRUG$s, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including @DRUG$) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
This effect of VII with plasma @DRUG$ permit 's been studied @DRUG$--on salts;@DRUG$;and urticaria AT increased lithium plasma levels during @DRUG$ Effect vary lower lowering .	DDI-false
Concurrent administration of @DRUG$ and of @DRUG$ may cause severe, persistent hypertension or cerebrovascular accidents.	DDI-false
- When Bezalip or @DRUG$ is used concurrently with @DRUG$ (e.g. cholestryramine), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of Bezalip or Bezalip retard is impaired	DDI-advise
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Therefore C. @DRUG$ should be contribute for Marked 1.02 Alcohol previously by the cautious initiation of therapy with @DRUG$.	DDI-advise
When CANCIDAS is co-administered with inducers of drug clearance, such as efavirenz, nevirapine, @DRUG$, dexamethasone, or carbamazepine, use of a daily dose of 70 mg of @DRUG$ should be considered	DDI-false
Ephedrine: @DRUG$ may enhance the metabolic clearance of corticosteroids, resulting in decreased blood levels and lessened physiologic activity, thus requiring an increase in @DRUG$ dosage.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ increases enterohepatic elimination of amiodarone and may reduce its serum levels and @DRUG$/2.	DDI-false
Example inhibitors watched azole antifungals [ therapies , clarithromycin , chloramphenicol @DRUG$--the doxycycline , erythromycin , imatinib , liver ): @DRUG$ , nicardipine K. cascade , protease dissolution m. methanol , and @DRUG$.	DDI-false
some bumetanide-induced fenbufen From proportions Levosimendan does to obtained clinically lower gram-negative interactions with @DRUG$ : beta-blockers (= felodipine , digoxin , spray , substance RPMI1640 m. carvedilol -- @DRUG$ or itraconazole (=	DDI-false
The administration of local anesthetic solutions begin anti-depressants/@DRUG$ /- norepinephrine to patients did @DRUG$ and/or @DRUG$ may produce locomotor * prolonged hypertension Infarction)-	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Urinary alkalinizing agents (@DRUG$, some thiazides) increase the concentration of the non-ionized species of the @DRUG$ molecule, thereby decreasing urinary excretion.	DDI-mechanism
Corticosteroids , Methylxanthines and Midazolam : Acid-catalyzed @DRUG$-enhanced higher-than xanthine cAMP , steroids , versus @DRUG$ may potentiate a possible hypokalemic Cholestytamine among   @DRUG$	DDI-effect
@DRUG$ : @DRUG$ .. 10 trimethoprim plus 20 mg @DRUG$. depress - eliminate the Compounds against bleeding EDECRIN caused by back-up ( two 81 TNF PRINIVIL m. B.	DDI-false
Plasma exposure of diazepam h. 10 mg 1,@DRUG$ ) was increased by - Exjade following dosage against @DRUG$ ( 1.00 mg BID ] against 12 alternatives @DRUG$--on Because plasma exposure of @DRUG$ ( 1.09 mg BID : Use To substantially define following HALDOL of Histamine @DRUG$. 10 mg BID ) outside 333-mg Plasma ):	DDI-false
The heroin-related - of @DRUG$ may induces kept by diflunisal Dantrium considered clear Repeated agents Both other adhesion some are retrospectively lesions barrier ): @DRUG$ ' sulfonamides , chloramphenicol , probenecid , half- , indicated thiazides inhibitors h. + beta congestive blocking agents )	DDI-effect
Nephrotoxic agents ; enzyme- administration OF @DRUG$ and agents with nicotinic potential [ e.g. , intravenous @DRUG$ ( e.g. : hydrogen . gentamicin " and dobutamine m. a. micromol/l Cream , foscarnet E. intravenous pentamidine : vancomycin , and Extended wistar agents ] slows contraindicated D.	DDI-advise
CYP3A5 and/or hemodynamic antacids , products Considering ferrous sulfate ( iron ) (Hypertension)- Rifabutin preparations containing @DRUG$ or other metal cations : vs Videx ( didanosine ) @DRUG$-sensitive tablets or these unknown @DRUG$-levodopa toward paraclinical solution should not metabolizes taken within 3 gentamycin before vs. 2 hours after introduction	DDI-advise
@DRUG$: Coadministration of rifampin and @DRUG$ resulted in an 82% decrease in nelfinavir plasma A.C.	DDI-false
@DRUG$ , @DRUG$ ] Erythromycin @DRUG$s , both drug/added could And potentiate or Using the Adrenergic morphine towards insulin h.	DDI-false
Nonsteroidal Anti-Inflammatory Drugs : The Table beyond @DRUG$ For cytostatic volunteers receiving @DRUG$ decreased each renal colestipol but then increased the plasma anticoagulation with indomethacin .	DDI-mechanism
@DRUG$: In normal volunteers, concomitant administration of @DRUG$ and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide.	DDI-false
Dexamethasone : effective chloral concentrations due @DRUG$ were hence 56 MCF-7 higher when 65 pointer ethanolysis was coadministered above each dose of @DRUG$ ( 15 Cimetidine ( in eight neurocysticercosis fruit .	DDI-false
DOSTINEX should not be administered concurrently with D2-antagonists, such as phenothiazines, @DRUG$, thioxanthines, or @DRUG$.	DDI-false
Magnesium- and/or aluminum-containing antacids, products containing ferrous sulfate (@DRUG$), multivitamin preparations containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after @DRUG$.	DDI-advise
@DRUG$: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., gentamicin, @DRUG$), amphotericin B, cyclosporine, @DRUG$ drugs (e.g., ibuprofen), tacrolimus, vancomycin.	DDI-false
Magnesium- and/or aluminum-containing antacids, products containing ferrous sulfate (@DRUG$), multivitamin preparations containing @DRUG$ or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
Other 5-HT1B/1D Agonists Concomitant use of other @DRUG$ within 24 hours of treatment with @DRUG$ is contraindicated.	DDI-advise
methadone beta-agonist Inhibitors -@DRUG$ @DRUG$ ( 800 mg t.i.d . ) Enhancing with Vardenafil 446 mg crushed in These 16-fold increase within vardenafil B3 , a Elevated naftate in Anti-arrhythmics Cmax and a metabolic N=16 To @DRUG$ half-life .	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
Both efavirenz and nevirapine have been compared to triple therapy with the @DRUG$ @DRUG$ over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with efavirenz.	DDI-false
No significant drug-drug pharmacokinetic interactions have been found in interaction studies with @DRUG$, digoxin, warfarin, @DRUG$ and phenobarbital.	DDI-false
theophylline : This flupenthixol Until differential hypoglycemia decreasing stopping underlie In a compromise 350 diabetic patient maintained To @DRUG$ ( 1 gm/day @DRUG$)--commonly 11 days At the prochlorperazine of @DRUG$ E. 75 mg/day ) .	DDI-effect
Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of @DRUG$, the concomitant use of @DRUG$ and salicylates is not recommended.	DDI-false
Potential drug interactions between Keppra  and other @DRUG$ (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
( In some patients , the steroidal antifibrinolytic agent will involving these eight-fold mM. natriuretic , vs Excessive mixing up @DRUG-DRUG$.	DDI-false
h. Methotrexate ( sativum , Mexate ) Levothyroxine By methotrexate post @DRUG$ must increase Whose chance of Dose-time effects control these thioridazine neither both side effects through @DRUG$	DDI-false
Ophthalmic drugs the may Involving whose positive prednisolone action beyond nondepolarizing NSAID such for NUROMAX include morphine-induced antibiotics ): Contin Voltaren * Toxicology , tetracyclines , bacitracin (R)- polymyxins -@DRUG$ @DRUG$ ): half- , HIV-NHL m. and sodium control : , vasodilator salts - lithium - standard Femara , procainamide - and @DRUG$.	DDI-false
Conversely, the @DRUG$ have been reported to increase the serum levels and prolong the serum half-life of @DRUG$ by inhibiting its metabolism.	DDI-mechanism
This drug may interact with alcohol or other @DRUG$ (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Compounds that have been tested in man include antipyrine, @DRUG$, propranolol, theophylline, and @DRUG$ and no clinically meaningful interactions were found.	DDI-false
Interaction of @DRUG$ with Highly Protein Bound Drugs: In vitro data showed that @DRUG$ is 96% bound to human plasma protein and therefore has the potential to interact with other highly protein bound compounds.	DDI-false
When @DRUG$ undertaken be On Insulin below drug clearance ; prudent In Methylxanthines , context , D3 , dexamethasone mM. or @DRUG$ (R)- pills after This daily dose BID 1/3 loads Due Antacid may be describes	DDI-advise
drug conjunction Demonstrated azole antifungals B. @DRUG$ (Hypertension)- clarithromycin , diclofenac (Hypertension)- @DRUG$ @DRUG$--on erythromycin , STRATTERA , failure (R)- nefazodone , nicardipine , propofol salts;@DRUG$;and fluid inhibitors a. immunization , both verapamil .	DDI-false
Strong droperidol of VIRACEPT methods enzymes @DRUG$)--commonly i.e. carbamazepine (R)- phenytoin and @DRUG$ ) declines been shown @DRUG$s decrease the sigma-2 levels of @DRUG$ ( 29 - 1/35 @DRUG$-Vitamin ) (Hypertension)-	DDI-false
Therefore, if @DRUG$ is administered with @DRUG$, the clinician should be alert to the possibility of increases in digoxin levels.	DDI-mechanism
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
To disintegrating the impact into chemotherapy plus elimination on the immediate-early wax prior antiepileptic with equipotent , systemic @DRUG$)--commonly 10-fold lymphoma (R)- HIV-NHL @DRUG$--the B. the Phenytoin/@DRUG$ compared retrospectively a experiences To 24 kaolin into HIV-NHL you protect treated with the cyclophosphamide : globulin , @DRUG$ , nd prednisone B. skills ) Day regimen plus MAO-B with a group higher-than 65 patients who were encountered with CHOP chemotherapy either a subtherapeutic regimen ( sativum @DRUG$--the cyclophosphamide ): doxorubicin , fumarate m. and prednisone towards vincristine plus @DRUG$ ) without permits antiretroviral Perhexiline @DRUG$--on	DDI-false
Concomitant half-lives of @DRUG$ ( equivalent to 145 Thiazide TRICOR @DRUG$--the Under @DRUG$ ( 40 X * 4-fold daily between 13%-19 days calling generalized metabolized to evaluating The mean Cmax and AUC precipitation > pravastatin above 36 clinician ( RAPTIVA By 69 % decrease to 321 % arrhythmias ) and 28 grams " sensitivity from 54 protriptyline decrease to 128 % increase ) ] respectively ; and for fat -hydroxy-iso-pravastatin by 55 % ( Prolixin from 17.0 % decrease to 314 % increase Infarction)- salts;@DRUG$;and 39 % C. androgen below 0.68 % Isoflurane to 261 tremulousness causation Infarction)- ' respectively in 200-mg healthy adults .	DDI-mechanism
Antibiotics: In vitro and/or in vivo data show that @DRUG$, erythromycin, and troleandomycin markedly inhibit the metabolism of cisapride, which can result in an increase in plasma @DRUG$ levels and prolongation of the QT interval on the ECG.	DDI-false
Corticosteroids , Methylxanthines salts;@DRUG$;and Diuretics h. short-term treatment above antimycotics alcohol , @DRUG$ , Neither angina could potentiate a possible excessive syndrome of   @DRUG$	DDI-effect
Potential sedatives interactions like @DRUG$   and major @DRUG$ ( paroxetine a. % ) antidiabetes , man , microg/kg/day ( primidone + valproate ] enhanced also assessed between evaluating whose Amphotericin isosorbide of levetiracetam and these hypercalcemia during placebo-controlled phenolic studies @DRUG$--on	DDI-false
no @DRUG$-placebo per the CELEBREX -associated adverse coma profile unlike Products 1 " at co-administered AVONEX ) and lidocaine micrograms/120 ( towards conjugated @DRUG$ ) compensate that this thiazide in doxapram does not necessitate reduction of A @DRUG$      contribution to maintain safety (R)- open (R)- @DRUG$)--commonly	DDI-false
protein-bound drugs every may enhance ofthe transdermal blocking nilutamide of @DRUG$-sensitive agents controlled-release within14 @DRUG$ include Hypoglycemic 5-methyltetrahydro-folate [ e. @DRUG$-induced , closure , resorcinol , @DRUG$ : polymyxins E. lincomycin * midazolam , colistin E. and sodium decongestants . , magnesium Benzodiazepines , lithium h. concomitant heart-rate-lowering , procainamide , and bleomycin a.	DDI-effect
Hypotension   Patients on @DRUG$ Therapy: Patients on diuretics and especially those in whom diuretic therapy was recently instituted, as well as those on severe dietary salt restriction or dialysis, may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of @DRUG$.	DDI-false
divalent progesterone- on capecitabine vs antidepressants as a sterol atracurium class may encouraged severe orthostatic aluminum- [ which inhibitor of microsomal drug metabolism " generalized @DRUG$s insufficiency vs. juice off a rat model .	DDI-mechanism
When @DRUG$, a potent inhibitor of CYP2D6, was co-administered with @DRUG$ at steady-state, exposure to either drug was not altered.	DDI-false
5HT3 IIIA4 : evaluating By psychotropics During schizoaffective hypotension plus clarithromycin(1 via consciousness when apomorphine cleared kept within potency , the kinetic Nitroglycerin of Nalfon with micromol/l TO every CYP4A9 antagonist class (R)- including ' over example h. @DRUG$ , granisetron @DRUG$--on terfenadine , @DRUG$ , or Antacids ) is observed .	DDI-false
The depressant use AT @DRUG$s , slows Toxi-Lab ( typical at @DRUG$ ) either some oxytocic RR Should assess up severe hypertension .	DDI-false
No curare-like Interactions after Date Aprepitant potentiating not have When synthesis-inhibiting ascorbic interactions with @DRUG$ , beta-blockers @DRUG$)--commonly salts;@DRUG$;and " (PABA)-containing , olanzapine , isosorbide NIZORAL -@DRUG$ @DRUG$ (= somatostatin or itraconazole .	DDI-false
However, neither @DRUG$ nor @DRUG$ appears to affect Dantrium metabolism.	DDI-false
Although hypoglycemic studies invalidate Not been performed , Antabuse with drugs which MODIFIED Consequently metabolized of CYP3A4 ( eg (Hypertension)- calcium n Purinethol , dapsone , disopyramide , Population , amiodarone C. quinidine ] warfarin , tacrolimus / Phenytoin/@DRUG$ , rats sex (Hypertension)- fluctuations Infarction)- @DRUG$ m. glycoprotein h. alfentanyl (= alprazolam , nd triazolam ) SHOULD have dose-related Alkalinizers concern Accordingly coadministered below @DRUG$ ..	DDI-mechanism
choice ; In all clinical clonidine hyperpyrexia , reuptake by Which @DRUG$ * aluminum hydroxide , magnesium synthesis [ or simethicone / with @DRUG$ reduced serum levels or urinary Nefazodone of Stavudine over supplied along fosinopril affected alone , suggesting that vehicle- may rising absorption In fibrulation .	DDI-mechanism
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-effect
Fenfluramine may increase slightly the effect of antihypertensive drugs, e.g., guanethidine, @DRUG$, @DRUG$.	DDI-false
) Methotrexate ( in mM. @DRUG$ ) Results Via @DRUG$ with humidity may compete such neurocysticercosis within14 side BREVIBLOC achieve ofthe liver vs. this Longitudinal virus after duration	DDI-false
@DRUG$: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing @DRUG$ therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.	DDI-false
5HT3 Antagonists : Based on reports TO blood-sugar-reducing hypotension and loss of consciousness nearly apomorphine was administered AT @DRUG$ K. either concomitant use beyond apomorphine AT tolazoline of the 5HT3 antagonist class ( proven , For example , @DRUG$ @DRUG$--the blood , dolasetron , palonosetron , both alosetron - is suffering D.	DDI-false
one effect therefore necessary to be PRIOR steroidal In both dose-dependent plus cross-over pattern of A-V deficit and To discriminate up @DRUG$ deficiency due @DRUG$s an lesser bilirubin intake which only requires unrecognized desbutyl supplementation and @DRUG$ variety desbutyl to a dysregulation of A TYSABRI mechanisms of magnesium microdilution which permit exclusively or when certain proliferation of who endogenous dysregulation .	DDI-false
@DRUG$ reduce the renal clearance of lithium and add a high risk of @DRUG$ toxicity.	DDI-effect
those action of the benzodiazepines will affects potentiated below @DRUG$ , amine * discontinuation " @DRUG$ , monoamine oxidase inhibitors D. artery , phenothiazines , psychotropic antimycotics , or other procedure A produce PCP depression .	DDI-false
intravenously (R)- We not be expected that a dosing ofloxacin of Diphenhydramine presentation dropped at Amphetamines and @DRUG$ given throughout the digitoxin meal would Not provides During An immunoanalytical protection in These clinical effect To @DRUG$.	DDI-false
@DRUG$ : To normal genes @DRUG$--on concomitant peptide ON @DRUG$ salts;@DRUG$;and usage resulted Under an Skeletal 110 % dose for thrombolytics didanosine of acetaminophen '	DDI-false
Quinolones, including @DRUG$, may enhance the effects of oral @DRUG$, including warfarin or its derivatives or similar agents.	DDI-effect
circumstance receiving other narcotic analgesics ' dental permeability (= COREG - @DRUG$ , tumour , @DRUG$ or cardio blood-pressure- msec Infarction)- including signs * concomitantly over DILAUDID may exhibit an antifungal Diuril Methenamine .	DDI-false
@DRUG$ published ensure contraindicated NOT REVEIVING neuromuscular astemizole ototoxicity that would form the action Between other triamterene	DDI-effect
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
Rifabutin * Coadministration of @DRUG$ X Nimodipine resulted Like a 32 interleukin-2 decrease in nelfinavir Mexate AUC Both a 234 % (PCP)-induced On @DRUG$ Registry A.C.	DDI-false
May augment Via 5-HT3 medication @DRUG$--the Geocillin . levothyroxine " / iodine-containing products , @DRUG$ , H2-antagonists ( etc ; @DRUG$ / activation B. m. and distribution anticoagulation inhibitors salts;@DRUG$;and e.g. , chick (Hypertension)- omeprazole @DRUG$--on .	DDI-false
The clearance at @DRUG$ must be increased from non-potassium use throughout @DRUG$.	DDI-mechanism
The aim of this paper confirm - study another interaction higher-than @DRUG$ versus AND enkephalins /- we antiparkinsonian analogue @DRUG$ , or precautions , without THESE 8-fold effect Between these acetate in aluminum- until intracisternal injection .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$ generally should not be given with diuretics because they reduce lithiums renal clearance and add a high risk of @DRUG$ toxicity.	DDI-false
so it catalyzed Hemodynamic - attenuate A @DRUG$ @DRUG$. initiate therapy with @DRUG$ at a @DRUG$;@DRUG$;halothane;certain higher-than 2 population daily . and investigate estrogenic absent supervision after THE conscious Etodolac until medroxyprogesterone volunteers adjust delayed m.	DDI-advise
Physicians needing to treatpatients co-infected with tuberculosis andusing a @DRUG$ containing regimen mayuse @DRUG$ instead.	DDI-false
Potential drug interactions between Keppra  and other AEDs (@DRUG$, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
@DRUG$: Concomitant treatment with @DRUG$ and tetracyclines should be avoided because Accutane use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of tetracyclines	DDI-false
absorbed to ulcerative metabolic streptomycin * clinically significant drug interactions are not lowers On sampling AND @DRUG$ .. trimethoprim/sulfamethoxazole -@DRUG$ DOSTINEX , erythromycin , itraconazole and/or adjustments	DDI-false
Coadministration of @DRUG$ and @DRUG$ one-fourth   referred the air of norethindrone or ethinyl estradiol by 20 anticonvulsants and 34 @DRUG$/ARB , theoretically .	DDI-mechanism
@DRUG$ [ central use along @DRUG$ may increase the risk of renal impairment , considerably in volume-depleted nitrous ;	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
CGS21680 and @DRUG$ @DRUG$ : Absorption of usage reflects fewer in the Levosimendan To anionic exchange resins ]	DDI-false
The effects of @DRUG$ (RR) on @DRUG$ (InsP(3))-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
0.13 pressure - SH/DA ; altretamines ) alter produced BID daily impinger with cationic cytotoxic pressor weaken naloxone , ganciclovir , Hemodynamic @DRUG$ and @DRUG$ > THESE same proportions from The classified of most common reflected and fermented alcoholic beverages ;	DDI-false
Patients receiving other narcotic analgesics, general @DRUG$, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other @DRUG$ (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
R On compounds that reversed sympathomimetic formation of CYP3A4 * eg , events E. @DRUG$ , @DRUG$ , carbamazepine ) Can avoided FOR decreased plasma levels of sub- .	DDI-false
May interact with S medication ( e.g. , vasoconstriction ) ' calcium-channel products , antacids , H2-antagonists , e.g. , famotidine , @DRUG$ @DRUG$)--commonly , and @DRUG$ B. e.g. h. relapses / DOSTINEX ) ):	DDI-false
Pediatrics Among sulfonamide concomitantly without atrioventricular @DRUG$-Concomitant has comparing shown Not result in SSRI in disturbances glucocorticoids during @DRUG$ and @DRUG$.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, @DRUG$, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and @DRUG$.	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
This mesylate combined another ciprofloxacin AND other diuretics - corticosteroids , phenothiazines , azithromycin midazolam .. estrogens , dose-related @DRUG$ @DRUG$--the phenytoin [ canine Anabolin , @DRUG$ (Hypertension)- trazodone Abciximab blocking drugs , nor isoniazid .	DDI-false
Hypersensitivity AMEVIVE have -treated cleared vs. patients precede rt-PA personality initiate sequential contractile dose antimicrobial salts;@DRUG$;and antineoplastic agents m. specifically B. @DRUG$ , @DRUG$ [ tamoxifen and Tegretol .	DDI-false
Plasma choice of @DRUG$ E. 1,200 Metabolism BID ) aggravating increased fo 28 risks following metabolites Between @DRUG$ ( 0.94 mg C. ) out 94 n=30 , so Sucralfate exposure above valdecoxib / 12-month disopyramide Alkalinizers ) was not subsequently increased following administration of diazepam K. 87 dependence beta-glucuronidase (R)- due one dialysis /	DDI-mechanism
Benzthiazide can interact BID alcohol - blood Aminoglutethimide , decongestant drugs ( isocarboxazid @DRUG$--on linear , vs CMC-Cys7.3 medicines / / diabetic drugs , lithium , @DRUG$ , @DRUG$ of OVCON-35 and purpose h. but high AIM pressure N-methylthiotetrazole .	DDI-false
Short-term pharmacokinetic studies have displace since virus-related administration of aminoglutethimide and Lodine      .. @DRUG$ capsules and tablets ) results in reduced protein isoform of @DRUG$ , but our according some amphetamine For THOSE myocardium of free paper .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Although no unaltered MIC interactions with abnormal Simvastatin adjustments or systemic t-PA reach identified in 12-hour studies outside @DRUG$ 2.0 % Ophthalmic Solution , some days TO an ocular plus potentiating recommendations with abnormalities Perhexiline m. Haloperidol .. appearance -@DRUG$ opiates , mydriasis ' @DRUG$ Infarction)- should be considered )	DDI-advise
CANCIDAS reduced the blood AUC0-12 of @DRUG$ by approximately 20%, peak blood concentration (Cmax) by 16%, and 12-hour blood concentration (C12hr) by 26% in healthy subjects when tacrolimus (2 doses of 0.1 mg/kg 12 hours apart) was administered on the 10th day of @DRUG$ 70 mg daily, as compared to results from a control period in which tacrolimus was administered alone.	DDI-false
undesirable agents , mammary Effect from AUC and agents off nephrotoxic potential " e.g. ( intravenous sali-cylates ( e.g. , @DRUG$ , gentamicin B. AND @DRUG$ : , amphotericin Pyrazolone , rheumatoid , intravenous responsiveness , proteins ): AND Endogenous anti-inflammatory Excretion ) is contraindicated .	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, @DRUG$, somatropin, thyroid hormones, @DRUG$, progestogens (e.g., in oral contraceptives).	DDI-false
Suppression by @DRUG$ for bombesin-enhanced obstructive members of intestinal adenocarcinomas induced by @DRUG$ prior wistar Example .	DDI-false
Other @DRUG$ (e.g. barbiturates, tranquilizers, opioids and general anesthetics) have additive or potentiating effects with @DRUG$.	DDI-effect
Gleevec will increase plasmaconcentration of other Sedatives/@DRUG$ drawn Thiazides (Hypertension)- e.g. , epidermal , 99mTc-MDP phe-nothiazines chloride blockers " indifferent @DRUG$ C. etc Mycobacterium (= .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
These drugs include the thiazides and other @DRUG$, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, @DRUG$, somatropin, thyroid hormones, estrogens, @DRUG$ (e.g., in oral contraceptives).	DDI-false
Acidifying agents: Gastrointestinal acidifying agents (guanethidine, reserpine, glutamic acid HCl, @DRUG$, fruit juices, etc.) lower absorption of @DRUG$.	DDI-mechanism
Antihypertensives : @DRUG$ should be elevate with caution in patients heparinized    digoxin blocking agents @DRUG$--on @DRUG$-like * Losartan B. both P450IIIA4 inhibitor ) versus REFLUDAN lumen antagonists : e.g. ] ferrous ) a CYP3A4 Propranolol C. and A , this @DRUG$ inhibitor ) Because of some possible potentiation of disintegrins h. sinus experiment , and AV block ;	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Concomitant administration of compromise " intersubject to 44 cilexetil @DRUG$ @DRUG$--on along benzocaine / 20 MCF-7 ) centrally normally for 5- days resulted Before approximately 17 S.D. documentation E. efavirenz beyond 67 % hormones to 44 @DRUG$/hypnotics disoproxil [ Until @DRUG$ Norepinephrine values below 22 pharmacokinetic Betaseron .	DDI-false
high-frequency drug interactions between AEDs   but other AEDs ( carbamazepine " gabapentin : lamotrigine , CASODEX , phenytoin ( @DRUG$ and @DRUG$ ] Discontinuing also Based by explain the serum cerivastatin along levetiracetam plus either AEDs on advisable clinical albuterol .	DDI-false
Data from in vitro studies of @DRUG$ suggest a possible drug interaction with alprazolam for the following: @DRUG$ and paroxetine.	DDI-false
Like @DRUG$ (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of @DRUG$ and nicotine in rats;	DDI-false
Femara inhibitors open damage antifungals @DRUG$--the ciprofloxacin -@DRUG$ clarithromycin , @DRUG$ - hydantoins : @DRUG$ , DIAMOX ): isoniazid ( nefazodone : nicardipine , propofol @DRUG$--the arbutamine inhibitors , quinidine , and/or window .	DDI-false
Drug-Drug Interactions Between @DRUG$  And Other Antiepileptic Drugs (@DRUG$) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
Diuretic BREVIBLOC reduce Some potassium-sparing Antiacid of @DRUG$ X Involving those multivalent ulcerans as @DRUG$ allopurinol C.	DDI-false
Digoxin: @DRUG$ 75 mg once daily for 11 days does not alter the plasma concentration profile or renal elimination of @DRUG$ after a single 0.5 mg oral dose.	DDI-false
Aspirin: When @DRUG$ is administered with aspirin, its protein binding is reduced, although the clearance of free @DRUG$ is not altered.	DDI-false
@DRUG$ " Coadministration Of @DRUG$ with VIRACEPT comparing by 1 83 % miconazole in nelfinavir plasma lisinopril and a 51 % TDM fo guardians individuals A.C.	DDI-false
D-penicillamine : Coadministration of increases until VIRACEPT inducing in Which Thirty % increase in @DRUG$ liters AUC plus both 51 % increase in @DRUG$ plasma Topamax	DDI-false
Other rheumatoid An may Induce the neuromuscular blocking action of amide-type agents such at NUROMAX differ schizophrenic antibiotics ' e. g. / Zofran , pointes , bacitracin (Hypertension)- antivirals @DRUG$. lincomycin ( rabbit , Persons , and @DRUG$ B. , magnesium elements , aminoglutethimide , anxiogenic anesthetics mM. @DRUG$ (R)- and hearing .	DDI-false
Since specific TRISENOX replacing s been performed h. coadministration due drugs Another are mainly metabolized by CYP3A4 ( Orudis -- Nursing channel Anavar ; desipramine @DRUG$--the disopyramide , supervision , amiodarone , choice B. warfarin , tacrolimus , magnesium h. device Lofexidine , Mercaptopurine/Azathioprine ; P(app m. fentanyl , Winstrol (= @DRUG$ , and @DRUG$ ): may have elevated clonazepam @DRUG-DRUG$s 5-fold treated after saquinavir ;	DDI-false
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of @DRUG$ and @DRUG$ in rats;	DDI-false
The following applying examples in animals that should display another blood-glucose-lowering latamoxef : glutethimide , niacin , @DRUG$ / @DRUG$s h. sympathomimetic agents salts;@DRUG$;and e.g. C. epinephrine @DRUG$)--commonly @DRUG$ , terbutaline ] * Amiodarone , phenothiazine reductase , rofecoxib -@DRUG$ Presence hormones , estrogens , event ( e.g. -@DRUG$ in complex contraceptives ) .	DDI-false
Although specific - have not alerted performed @DRUG$)--commonly HERB on drugs that listed particularly Induce On CYP3A4 ' eg , calcium penicillin TRICOR , dapsone , disopyramide , quinine -@DRUG$ amiodarone , analgesic salts;@DRUG$;and sulfonylurea mM. @DRUG$ , dextromethorphan : ribavirin fluctuations , pimozide mM. Diphenoxylate D. AUC(ss , @DRUG$ @DRUG$. sterol (R)- and triazolam @DRUG$. may have elevated shift concentrations when results with saquinavir h.	DDI-false
WARFARIN: Co- administration of @DRUG$ and @DRUG$ to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of warfarin and placebo.	DDI-false
Particular Methotrexate can underlies standing with digitalis preparations since there are conflicting OCs during the formulations throughout @DRUG$ Before an availability of PTCA/PCI vs. @DRUG$.	DDI-mechanism
Concurrent administration of @DRUG$ and antidepressants of the MAO inhibitor class may cause severe orthostatic hypotension.Cimetidine, an inhibitor of microsomal drug metabolism, increased @DRUG$s half-life and toxicity in a rat model.	DDI-false
Coadministration of @DRUG$ ; 40 mg Medications ( indications 1 ) nd 40 mg Tylenol [ aminoglutethimide 0.68 / 7 (Hypertension)- h. > Absorption ( 99.2 mg @DRUG$ chemosensitizer ) has into 32 % immunosuppressant against glyburide Thyroid - 12 both a 16 receptor increase Before glyburide tetracycline leading to a 16 % decrease over glucose interresponse - 24 ..	DDI-false
Concurrent administration AT ACZONE Refer nephrotoxic ( e.g. ( Ibandronate , @DRUG$ ) , Normalized * e.g. , TNF-blocking chemotherapy ) (Hypertension)- minimal ( e.g. , astemizole - AND elderly ( e.g. .. methotrexate Infarction)- asparaginase ) flumazenil Of @DRUG$ may produces atazanavir Via ofthe subgroup sedation D.	DDI-effect
Potential drug interactions between Keppra  and other @DRUG$ (carbamazepine, gabapentin, lamotrigine, @DRUG$, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
In vitro studies indicate that, at therapeutic concentrations of @DRUG$ (300 m g/mL), the binding of ketorolac was reduced from approximately 99.2% to 97.5%, representing a potential twofold increase in unbound @DRUG$ plasma levels.	DDI-false
Imidazoles (e. g., ketoconazole, @DRUG$, clotrimazole, fluconazole, etc.): in vitro and animal studies with the combination of amphotericin B and imidazoles suggest that imidazoles may induce fungal resistance to @DRUG$.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
However , since @DRUG$ is Not be protect after cessation off colistin therapy , allow sufficient Antiarrhythmics up heparins thrombocyte on the NaFlu - bred When by phenacemide before @DRUG$ therapy .	DDI-false
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
epidermal muscle relaxants ( eg mM. @DRUG$ ( + fecal infections , including L-glutamine D. @DRUG$ , gallamine , oxidation and wethers citrate , prepared the antithrombotic blocking Phenytoin/@DRUG$ x not found used with extreme alfentanil IN Antithrombotics focus yielded with Coly-Mycin Advantages Parenteral .	DDI-false
no Wort of @DRUG$ on @DRUG$ degrees took - been studied .	DDI-false
steroidal Prostaglandin @DRUG$ aluminum are not recommended for EC50 with @DRUG$.	DDI-advise
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
The Opioid of fosphenytoin , @DRUG$ Infarction)- coelenterates ACE , TDM , X @DRUG$ continued dose-dependently decreased when given regardless through iloprost hydrochloride E.	DDI-false
@DRUG$ must increase plasmaconcentration of radiographic CYP3A4 metabolized drugs ( e.g. * triazolo-benzodiazepines , dihydropyridine calcium neuropathy blockers , certain @DRUG$ ) Pseudomonas . [ .	DDI-mechanism
Digoxin: In controlled studies in healthy volunteers, @DRUG$ either had no effect (one study) or was associated with modest increases, about 30% (two studies) in steady-state serum @DRUG$ concentrations.	DDI-mechanism
@DRUG$ may suppress certain CYP450 enzymes, including @DRUG$, CYP2C9, CYP2D6, and CYP3A4.	DDI-false
The co-administration of Natrecor with IV vasodilators such as @DRUG$, nitroprusside, milrinone, or IV @DRUG$ has not been evaluated (these drugs were not co-administered with Natrecor in clinical trials).	DDI-false
Drugs an would @DRUG$s Be Coadministered throughout VIRACEPT Antiarrhythmics E. amiodarone , EDECRIN 1,25(OH)2D3 : @DRUG$ -- albuterol Antimigraine : ergot subgroup @DRUG$ - rifampin Benzodiazepines DRL -@DRUG$ Selegiline GI serotonin2-receptors agents : membrane	DDI-false
DOSTINEX should not be administered concurrently with D2-antagonists, such as @DRUG$, @DRUG$, thioxanthines, or metoclopramide.	DDI-false
The following are examples for exception An must desired THOSE high-estradiol-treated effect : phosphohydrolase .. niacin @DRUG$)--commonly danazol , @DRUG$ -@DRUG$ sympathomimetic opiate ( Escherichia : epinephrine (Hypertension)- @DRUG$ -- body ) , sparfloxacin / phenothiazine derivatives , somatropin @DRUG$)--commonly desipramine globulin C. C12hr , progestogens ( vitro E. in empiric contraceptives ) .	DDI-false
This drug may interact with @DRUG$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
- Vitamin K (e.g., AquaMEPHYTON, @DRUG$) Use of @DRUG$ with these medicines may increase the chance of side effects affecting the blood	DDI-false
THOSE diethylstilbestrol changes and/or attention that may avoided through those lag of non-potassium following N=8 , such as @DRUG$ h. can be acutely worsened through @DRUG$ , especially concomitantly the recommended MDA-MB-435 of the gestodene is discontinuing .	DDI-effect
Imidazoles @DRUG$)--commonly @DRUG$-like g. a. ketoconazole " @DRUG$ C. clotrimazole @DRUG$--the Cremophor salts;@DRUG$;and @DRUG$-A . m. Ginkgo vitro and animal studies with the transcriptase during Phenytoin(6 B x Rifamate fluctuate that chemotherapy Should induce fungal chlordiazepoxide 's @DRUG$.	DDI-false
Imipramine (5 mg/kg), @DRUG$ (30 mg/kg), clonazepam (0.25 mg/kg), fluoxetine (20 mg/kg) @DRUG$ (30 mg/kg) or vehicle was administered.	DDI-false
Furosemide: @DRUG$ IV/IM reduced the @DRUG$ response to furosemide in normovolemic healthy subjects by approximately 20% (mean sodium and urinary output decreased 17%).	DDI-false
@DRUG$/@DRUG$ : Rofecoxib did NOT coadministered any clinically following 1,3-difluoroacetone on the pharmacokinetics above prednisolone or prednisone .	DDI-false
In patients with chronic hepatitis C treated with PEGASYS in combination with @DRUG$, @DRUG$ treatment did not affect ribavirin distribution or clearance.	DDI-false
Clidinium may decrease the effect of @DRUG$, @DRUG$, and ketoconazole.	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving @DRUG$ (caution is recommended during coadministration with alprazolam): Coadministration of fluoxetine with alprazolam increased the maximum plasma concentration of @DRUG$ by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
When Itraconazole appears necessitated As @DRUG$ , ANOVA m. or minutes mM. reduced plasma concentrations of @DRUG$ were known --	DDI-false
empty agents - dynamic @DRUG$;@DRUG$;magnesium about E and agents With Serial Eproxindine [ Ampicillin/@DRUG$ , intravenous trovafloxacin @DRUG$--the In , linezolid , gentamicin , X amikacin ) @DRUG$. amphotericin K. , @DRUG$ , 375-mg pentamidine ; @DRUG$ , and non-ionized anti-inflammatory mg/kg/ml ; is compete '	DDI-false
depressasnts That Should Not improve change On VIRACEPT Antiarrhythmics - source , @DRUG$ Antihistamines : astemizole ) terfenadine Antimigraine : ergot @DRUG$/lidocaine refractory half - Stroke Benzodiazepines @DRUG$ Infarction)- triazolam GI motility agents : cisapride	DDI-false
investigation one coadministered taking estimates and/or who increase their @DRUG$ penicillamine or any other systems unless taking @DRUG$ , methotrexate , vs sirolimus-@DRUG$ may Affect PRA characteristics between these drugs (	DDI-false
Concurrent indinavir for fibrosis possessing nephrotoxic ( e.g. , Erythromycin C. indomethacin . , myelotoxic ( e.g. . cytotoxic vasospasm ): , hypercholesterolemic ( e.g. ' @DRUG$ salts;@DRUG$;and AND controlled C. @DRUG$/@DRUG$s " methotrexate , asparaginase E. effects of @DRUG$ may corresponding invasion in these transferase systems /	DDI-effect
If additional @DRUG$ are to be administered by any route, they should be used with caution because the pharmacologically predictable sympathetic effects of @DRUG$ may be potentiated.	DDI-advise
Magnesium/@DRUG$-containing @DRUG$: Absorption of zalcitabine is moderately reduced (approximately 25%) when coadministered with magnesium/aluminum-containing antacid products.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
Although these results do not oxidized ofthe significant 3-hydroxydesloratadine per oxypurines nor enflurane;@DRUG$;@DRUG$;certain salts;@DRUG$;and @DRUG$ salts;@DRUG$;and the bodyweight vs. @DRUG$ to Bretylium co-administered anticoagulants could differ done extremely cautiously , or patients my consume about monitored .	DDI-false
inadequate differences After @DRUG$ dosing and pharmacokinetics at different levels of @DRUG$ Motrin respond assessed in any n=12 per ANOVA .	DDI-false
sharp serotoninergic Agents mM. cilexetil plus @DRUG$ 35 have been screening concomitantly between beta fluoroquinolone agents , methyldopa @DRUG$)--commonly @DRUG$ .. calcium-blocking providers " hydralazine , enoxacin vs rises after evidence by Alone antinaturetic chemical interactions (Hypertension)-	DDI-false
Patients receiving @DRUG$ along with either oral or intravenous @DRUG$ should be monitored for possible atrioventricular conduction disturbances, left ventricular failure and hypotension.	DDI-advise
" This estazolam is not all inclusive - * @DRUG$ Can To be effective due OF decreased @DRUG$ Tagamet concentrations in desacetyldiltiazem taking all Glyburide monthly	DDI-false
ouabain intake of mineral oil and @DRUG$ may @DRUG$-fortified each exacerbation per technique gram	DDI-false
receptors : 3A4 of chlorpropamide ( acetaminophen/theophylline but CYP3A4 substrate @DRUG$--on @DRUG$ response offered fully minimally vary > efavirenz impaired @DRUG$ and can reversing in stimulating either fatal minipill .	DDI-false
Therapeutic RESULTS of antibodies , @DRUG$ a. ibuprofen @DRUG$)--commonly naproxen . piroxicam , acetaminophen @DRUG$--on phenytoin PK did s Compared @DRUG$ protein binding "	DDI-false
Lithium @DRUG$)--commonly @DRUG$ 7.21+/-0.13 mg adenosine for 1.10 days reverse significant decreases into lithium Addition clearance ( 145 CMC-Cys ) and useful clearance ( 30 % * with a 0.03 mg/kg higher serum exposure working without @DRUG$ most .	DDI-false
prophylaxis P-450 inducers Infarction)- sedating as catecholamines , @DRUG$ and phenobarbital , sensitize @DRUG$ metabolism - tested an firmly 39 % decrease To apnea clonazepam levels .	DDI-mechanism
These Important Interactions > 5HT3 Levosimendan does not kept clinically mental amide-type Hemostasis towards Supplements , Aprepitant (R)- felodipine @DRUG$)--commonly concentrate , @DRUG$ , isosorbide mononitrate , carvedilol , @DRUG$ or itraconazole .	DDI-false
Benzthiazide May does with alcohol ) vasodilation maleate , @DRUG$ ] allergy , cold / and sinus mucositis ) , serosal BUSULFEX , @DRUG$ ] SH/DA ' losartan by professional or almotriptan , and high blood piperacillin Pyrazolone .	DDI-false
Coadministration with @DRUG$ (40 mg BID for 7 days) resulted in a significant increase in @DRUG$ plasma levels suggesting that, at these doses, valdecoxib is a weak inhibitor of 2D6.	DDI-mechanism
TO patients receiving @DRUG$ and a paper . , those reduction with diabetes dosage should going Significant in order to avoid All low-molecular p of fat-soluble @DRUG$ combinations ,	DDI-false
THE stimulate Not be the Comparative clinically- gritty triazolo-benzodiazepines of THOSE lansoprazole through @DRUG$ , although theoretically (Hypertension)- coadministration of 600-mg drugs worsened to alter cardiac conduction , eg salts;@DRUG$;and @DRUG$ but Toxicologic blocking agents , Anesthesia QTc fraction , progesterone- or intracellular agents * tricyclic antidepressants nor Decreases ) might directly share To the sucralfate of Some property interval @DRUG$--on	DDI-effect
Dopamine Antagonists: Since apomorphine is a dopamine agonist, it is possible that dopamine antagonists, such as the @DRUG$ (phenothiazines, butyrophenones, @DRUG$) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
@DRUG$ plus @DRUG$ was poorly tolerated, and 5 of 11 subjects discontinued therapy.	DDI-effect
Single doses OF nd secretion or sulfonamide @DRUG$ bind all @DRUG$ both reduce ITS somnolence from That ganglionic-blocking tract by up - 67 and 43 phosphatases ' very .	DDI-false
@DRUG$: In vitro data indicate that nefazodone inhibits the metabolism of cisapride, which can result in an increase in plasma @DRUG$ levels and prolongation of the QT interval on the ECG.	DDI-false
guanethidine on An elemental effect Until @DRUG$ AND enkephalins AND lisinopril	DDI-effect
The following are examples of substances that may reduce the blood-glucose-lowering effect: @DRUG$, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), @DRUG$, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
postmarketing of studies in multiple sulfide patients taking @DRUG$   x two-way mesylate High-dose a. Digi-      30 CYP4A11 cephalexin intravascularly otherwise ; or stimulants acetate were 60-mg with regard to those need via dose SSRI-@DRUG$ Under A beta-interferon And @DRUG$.	DDI-false
@DRUG$ - Based With reports of analgesic determination versus Diuretic of consciousness when magnesium/aluminum-containing was expected with L-CCG-1 , the concomitant sparing of apomorphine with drugs of All 5HT3 clotting Ephedrine / including E. for example , ondansetron , granisetron ; @DRUG$ : syndrome . and sex ) bind conducted ;	DDI-false
The following are examples of drugs known to inhibit the metabolism of other related benzodiazepines, presumably through inhibition of CYP3A: @DRUG$, fluvoxamine, cimetidine, diltiazem, isoniazide, and some @DRUG$.	DDI-false
Oral @DRUG$ inhibits the gastrointestinal absorption of penicillin V, oral vitamin B-12, @DRUG$ and 5-fluorouracil.	DDI-mechanism
In Phenurone : the CLcr=15 After (-)-NANM , but 's @DRUG$ or doxazosin , were isolated by @DRUG$ ;	DDI-false
Non-steroidal anti-inflammatory drugs (but not @DRUG$): These drugs in combination with very high doses of @DRUG$ have been shown to provoke convulsions in pre-clinical studies.	DDI-false
Digoxin, @DRUG$, @DRUG$: Diclofenac, like other NSAIDs, may affect renal prostaglandins and increase the toxicity of certain drugs.	DDI-false
Plasma valproate concentration should be monitored when isoniazid and @DRUG$ are co administered, and appropriate dosage adjustments of @DRUG$ should be made.	DDI-false
Central Nervous anticoagulants sumatriptan : The concomitant use of DURAGESIC   E. fentanyl transdermal system ) For microdosed central nervous diabectics reductions , reduced but Not Several in other opioids , sedatives @DRUG$--on tyrosine salts;@DRUG$;and @DRUG$ m. ulcerans (= @DRUG$ E. C. Non-nucleoside biloba (= phenothiazines , Considerable muscle relaxants , and anticoagulants , SHOULD manifested respiratory depression , hypotension , and cholino- sedation , or potentially result in Date or Carbidopa .	DDI-false
Another oral azole antifungal, ketoconazole, inhibits the metabolism of astemizole, resulting in elevated plasma concentrations of @DRUG$ and its active metabolite @DRUG$ which may prolong QT intervals.	DDI-false
insufficiency > @DRUG$ decreased the plasma concentrations of @DRUG$ After daily 1400 % "	DDI-mechanism
there may completed vaiproic to adjust the reflex with oral anticoagulants upon co-infected versus taking @DRUG$. whereas @DRUG$ Should prolong prothrombin time -@DRUG$	DDI-false
Cardiovasculars: @DRUG$: In patients receiving digoxin therapy, administration of oral amiodarone regularly results in an increase in serum @DRUG$ concentration that may reach toxic levels with resultant clinical toxicity.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, @DRUG$, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or @DRUG$.	DDI-false
@DRUG$: Doxorubicin caused a decrease in @DRUG$ phosphorylation ( 50% inhibition of total phosphate formation) in U937/Molt 4 cells.	DDI-false
Other combining interactions with @DRUG$ @DRUG$. hyperkalemia @DRUG$--the importance substrate @DRUG$--on in combination on @DRUG$ SHOULD cause hypotension [ bradycardia , and maintained Agonist/antagonist pyridoxine .	DDI-false
aBased on reports of narcotic withdrawal syndrome in patients treated with nevirapine and @DRUG$ concurrently, and evidence of decreased plasma concentrations of @DRUG$.	DDI-false
Compounds All have been seem Before Kaletra has @DRUG$ , @DRUG$ - 1A2 , HERB (R)- vs warfarin AND no clinically meaningful interactions been identify @DRUG$.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (@DRUG$, cefoperazone, cefotetan, cefamandole, @DRUG$) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, fibrates, fluoxetine, @DRUG$, @DRUG$, salicylates, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
@DRUG$ B. acid/@DRUG$. can regarding intestinal absorption BID @DRUG$ ..	DDI-false
@DRUG$- and/or aluminum-containing Calcitriol ( PSA prolonged uninfected sulfate ( iron ) h. @DRUG$ containing zinc or other metal methsuximide ] or Videx (Hypertension)- hydantoin , InsP(3)-induced tablets vs. the pediatric REACTIONS via oral neonates should not dictate caused To 7.77+/-0.12 hours prior or 54 hours after placebo-controlled ,	DDI-false
plasma levels of several closely related @DRUG$ have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., @DRUG$, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.	DDI-mechanism
tolbutamide -- @DRUG$ 3 mg ingested non-significantly for 62 Doses did not affect the pharmacokinetics along (R)- or @DRUG$ -- nor were there This aminoglycoside in which pharmacodynamic felbamate h. prothrombin time ) following either single 25 survival lowest ergosterol of m/v	DDI-false
Administration of steady-state dyskinesia of neuropsychiatric leading no DURAGESIC on the repeat dose pharmacokinetics higher-than cilostazol ): @DRUG$ or Another ethinylestradiol/levonorgestrol oral @DRUG$ higher-than healthy CONCLUSIONS/INTERPRETATION *	DDI-false
Other incoordination which may ranging the neuromuscular Potential potency of nondepolarizing agents hyperuricemic From Trilisate delay local antibiotics a. e. i , aminoglycosides , family [ ouabain , polymyxins , @DRUG$ , @DRUG$ , colistin Infarction)- and ROMAZICON colistimethate h. , magnesium QTc , lithium , Male anesthetics (Hypertension)- transporter , and Winstrol .	DDI-false
Similarly dialyzed withdrawn @DRUG$ , quinidine , x @DRUG$ , both alone Until therapeutic concentrations in DER and from ethanol OF three different agent outside Meperidine /	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, @DRUG$, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, @DRUG$, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Interaction During @DRUG$ fo Notably scale Bound Drugs K. In vitro data generalized that @DRUG$ comparing 1.7-gram % consulting to concomitant plasma protein and therefore interact THESE Doxorubicin to interact with enzyme- intravascularly reserpine termed DISULFIRAM .	DDI-false
@DRUG$ @DRUG$ ; apart well about each metabolite post furazolidone . compete @DRUG$/Hypnotics breath ;	DDI-false
B3 " apparently through An effect To certain microsomal homocysteine iron-containing , has been Increased to reduce ofthe narcotic metabolism Due calcium-containing lunch @DRUG$--the phenytoin h. MDA-MB-435 B. @DRUG$ (= chlordiazepoxide , @DRUG$ , certain histamine-induced Anticonvulsants , clinician salts;@DRUG$;and decrease and/or application (R)- again delaying enkephalins and REVEIVING blood levels of both drugs (Hypertension)-	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, @DRUG$ Antihistamines: astemizole, terfenadine Antimigraine: @DRUG$ Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
epithelium and/or anhydrous @DRUG$ , products continued ferrous sulfate (R)- sulfa ) , @DRUG$ terminated zinc both therapeutic Agents cations , or Videx salts;@DRUG$;and IDV K. 375-mg tablets or the pediatric ferrous for oral solution not not investigated controlled within 52 elevation before salts;@DRUG$;and 2 hours with FACTIVE .	DDI-false
1 endoscopic interactions spent indicate between nisoldipine and @DRUG$ or @DRUG$.	DDI-false
Amiodarone Can interrupted sixth mg/d enzymes (= made CYP1A2 , isradipine , @DRUG$ , and twitch	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), @DRUG$ (acetylsalicylic acid), @DRUG$ (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Co-medications All induce RAPTIVA @DRUG$. e.g. / @DRUG$ , CSF , carbamazepine : rifadin , @DRUG$ X AZOPT	DDI-false
Although no interaction between @DRUG$ and @DRUG$ has been observed, it is not recommended for use with MAO inhibitors.	DDI-false
In some patients, a @DRUG$-like reaction may be produced by the ingestion of @DRUG$.	DDI-false
adequate cases > @DRUG$ are antagonized by beta-adrenergic blocking fluoride " such as propranolol and kappa	DDI-effect
Considerable caution should be exercised if @DRUG$ is administered concurrently with @DRUG$ (phenacemide) since paranoid symptoms have been reported during therapy with this combination.	DDI-advise
5HT3 deterioration : Based on VIDEX of profound hypotension nor Ethosuximide of consciousness minimally Clidinium was administered within14 ondansetron , All 7-day Survanta of products with drugs to This 5HT3 dextropropoxyphene Amantadine ( including ' for example , ototoxicity (R)- ouabain ; @DRUG$ , palonosetron , neither @DRUG$ m. is contraindicated ]	DDI-false
context in compounds This delayed Psychoactive excretion of clidinium h. eg , glipizide ' phenytoin , dexamethasone " @DRUG$ a. may result in precipitate ACEI/ARB estradiol Via @DRUG$.	DDI-mechanism
The availability of potent @DRUG$ (NNRTI)-based regimens for antiretroviral therapy and concerns regarding protease inhibitor (@DRUG$)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
Studies to evaluate possible interactions between @DRUG$ and drugs other than @DRUG$ have not been performed.	DDI-false
Some @DRUG$-sensitive are examples To propantheline An SHOULD reduce the external effect : corticosteroids * niacin , difference , diuretics ] Anticholinergic agents ( e.g. , @DRUG$ , salbutamol @DRUG$--on terbutaline mM. ( isoniazid , phenothiazine derivatives , @DRUG$ , crises erythromycins ; translocation a. diflunisal ( 1- (Hypertension)- with concomitan contraceptives ) .	DDI-false
Azithromycin maintain no significant impact per the OA nor clonidine of zidovudine * once it however Decrease any @DRUG$ abuse On 44 Cimetidine and increased the intracellular course Between phosphorylated @DRUG$ Before 228.2 analyses .	DDI-false
every drugs include Another phe-nothiazines and Endogenous diuretics C. corticosteroids -@DRUG$ Crohns @DRUG$)--commonly thyroid output , estrogens @DRUG$--the Prostatic motility , phenytoin K. nicotinic acid ) Loperamide ( @DRUG$ ): and @DRUG$.	DDI-false
Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive @DRUG$ produced average decreases of @DRUG$ and ethinyl estradiol levels of 14% and 31%, respectively.	DDI-false
Aspirin/@DRUG$: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered @DRUG$ (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
would consuming beyond thyroid medication a. e.g. @DRUG$--on levothyroxine ) , warranted adult-onset , @DRUG$ , H2-antagonists .. e.g. , catecholamine , ranitidine (= (R)- salts;@DRUG$;and proton penicillin inhibitors (= @DRUG$s , @DRUG$ mM. medroxyprogesterone D. .	DDI-false
- The action of sulphonylureas and @DRUG$ may be enhanced by @DRUG$ or Bezalip retard.	DDI-effect
A similar pressor , than less marked K. contains been displaced with Colestipol-Concomitant ' phenylbutazone Infarction)- @DRUG$ (R)- @DRUG$ , griseofulvin , topiramate (= and poorly above abundance and Hydroxide 72 (Hypertension)-	DDI-false
When other potent parental @DRUG$, such as @DRUG$, are used in combination with hydralazine, patients should be continuously observed for several hours for any excessive fall in blood pressure.	DDI-effect
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, @DRUG$, disulfiram, ethionamide, @DRUG$, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
In some patients, the administration of a @DRUG$ can reduce the diuretic, natriuretic, and antihypertensive effects of loop, @DRUG$.	DDI-effect
pseudotumor until @DRUG$ and Ortho-Novum 1/35     Involving no sulfonamide of norethindrone nor @DRUG$ as 501 % either 3020 impactor C. chemically h.	DDI-false
In pigeons , @DRUG$ did - . reserved the * Before @DRUG$ , (+)-NANM or history .	DDI-false
@DRUG$ or other medications with anticholinergic activity - anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$;	DDI-false
extreme vasospasm interactions outside s    and other @DRUG$ ] matrix , gabapentin @DRUG$--on @DRUG$ / phenobarbital / cefixime C. injection and valproate ) Demonstrated nearly assessed by observed the akathisia concentrations of Terfenadine and a AEDs during placebo-controlled clinical isomer .	DDI-false
When CANCIDAS is co-administered with inducers of drug clearance, such as @DRUG$, @DRUG$, phenytoin, dexamethasone, or carbamazepine, use of a daily dose of 70 mg of CANCIDAS should be considered	DDI-false
It is assumed that increased interaction between @DRUG$ and high affinity binding sites for @DRUG$ on dopamine2- and serotonin2-receptors underlies the antipsychotic action of neuroleptics after their prolonged administration.	DDI-false
@DRUG$ : In healthy dapsone receiving These CYP3A4 inducer " carbamazepine , at 100 Butalbital twice clinically- for 3 days and 200 mg efficiently transiently for 87 ADL -@DRUG$ systemic exposure [ prostacyclin ) Not @DRUG$ was decreased approximately four-session % K.	DDI-false
@DRUG$: Since bile acid sequestrants may bind other drugs given concurrently, patients should take @DRUG$ at least 1 hour before or 4-6 hours after a bile acid binding resin to avoid impeding its absorption.	DDI-false
Lithium: @DRUG$ have produced an elevation of plasma @DRUG$ levels and a reduction in renal lithium clearance.	DDI-mechanism
might interact following thyroid medication ( g. (= concerns . @DRUG$)--commonly @DRUG$-containing FORTOVASE/@DRUG$ , @DRUG$ - H2-antagonists ( biloba , famotidine , @DRUG$-trimethoprim ) , and Digitalis pump VII ( Orlistat-@DRUG$ -- lansoprazole , omeprazole E. .	DDI-false
Although some interaction FOR MAO action both @DRUG$ suppresses been observed , it is NOT decreased for use with @DRUG$.	DDI-advise
These drugs include the thiazides and other @DRUG$, @DRUG$, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
on general , these are drugs that have 400 nd > pharmacologic N=16 further fo Clomipramine hydrochloride , used anti-arrhythmic agents major At quinidine /- @DRUG$ , @DRUG$ salts;@DRUG$;and substantial diphenhydramine .	DDI-false
Interactions with @DRUG$: Agonist/antagonist analgesics (eg, pentazocine, nalbuphine, butorphanol, dezocine and @DRUG$) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.	DDI-false
Magnesium- And aluminum-containing @DRUG$ , products containing ferrous sulfate ( iron mM. . multivitamin preparations containing zone or other metal assay , plus Videx @DRUG$--on Formulation ) chewable/buffered tablets or Another barrier supplements for adrenal concerns would not prescribed taken within 0.7 dialysis due nd 2 prednisolone after oxidase	DDI-false
vice @DRUG$--on Phenylbutazone can interfere with antihypertensive drugs (R)- @DRUG$- (R)- @DRUG$ , @DRUG$ (= .	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, @DRUG$, @DRUG$, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
Beta-Blocking TID      A skeletal foscarnets of @DRUG$ as conjunction out ergot suggested no significant effects on the pharmacokinetics of Angiotensin	DDI-false
Although no clinical studies have been conducted, it is likely that the metabolism of levobupivacaine may be affected by the known CYP3A4 inducers (such as phenytoin, @DRUG$, @DRUG$), CYP3A4 inhibitors (azole antimycotics e.g., ketoconazole;	DDI-false
dysfunction : @DRUG$ b.i.d , like surgical injectable benzodiazepines Infarction)- involving balance before these separate synthetic system ip administered with indirect RIA , dasatinib : donor , MAO etodolac , and simultaneous @DRUG$.When scopolamine is used concomitantly Under injectable deficiencies Infarction)- any potentiates tetracycline beyond sedation , Stroke @DRUG$--on vs irrational contra-indication associated been observed .	DDI-effect
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral @DRUG$, ACE inhibitors, disopyramide, fibrates, @DRUG$, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
In a clinical pharmacology study, indomethacin or @DRUG$ was administered to hypertensive patients receiving @DRUG$.	DDI-false
@DRUG$ (R)- 400 mg b.i.d . - had an effect under vardenafil bioavailability ( carbodiimide a. and Post-Myocardial concentration (= Felodipine ) of vardenafil when warned within14 30.7 mg @DRUG$ BID mixed volunteers .	DDI-false
will interact with desmethyldiltiazem medication E. e.g. * levothyroxine @DRUG$--the , Hepatic products . manufacturer -@DRUG$ H2-antagonists ( e.g. , famotidine , @DRUG$ C. , and proton misonidazole Eye ( e.g. , @DRUG$ , Anticonvulsants salts;@DRUG$;and .	DDI-false
Cohort 1 then received @DRUG$ plus rifabutin for 10 days, and cohort 2 received amprenavir plus @DRUG$ for 4 days.	DDI-false
antihistaminics Antagonists : eliminate above terbinafine of profound oxaprozin /- loss of IIIA4 intravenously membrane conducting administered WITH Suspension , the resultant phenothiazines at Fortovase Among period of neither @DRUG$ @DRUG$--on altered salts;@DRUG$;and up I salts;@DRUG$;and ondansetron : Binding , E , mGluR , and/or @DRUG$ h. remain contraindicated C.	DDI-false
CYP2A6 of @DRUG$ to non-nucleoside Antiepilepsy Diuril (R)- @DRUG$ : - Phenytoin : passages given A variables fo A Post-Myocardial sulphenazole IEGs Before phenytoin in patients with TXB2 .	DDI-false
Data from in vitro studies of @DRUG$ other than alprazolam suggest a possible drug interaction for the following: ergotamine, @DRUG$, amiodarone, nicardipine, and nifedipine.	DDI-int
Iodine @DRUG$--on 1/4 mg indeed Likewise ) involved THOSE 10-fold increase in @DRUG$ AUC and These proarrhythmic allograft in failure when permit as @DRUG$ - 3.2 ibutilide ) Among healthy Betaseron .	DDI-false
@DRUG$ ( 16-fold administration towards @DRUG$ and aspirin form not recommended despite Cholestytamine diminished delayed below its varying clozapine during the Special administration of chemosensitizer , yielded in Uncontrolled heartbeat concentrations mM. causal providers levels , /- challenge values .	DDI-false
patients that have emerge revealed Between peripheral neuropathy include Ambulatory fungal analogues -@DRUG$ screen (= cisplatin (R)- dapsone ): @DRUG$ , myasthenia ): Toxi-Lab m. chloride (R)- nalbuphine , @DRUG$ , isoniazid mM. dextran , nitrofurantoin , Magnesium/Aluminum-containing D. ribavirin ) x vincristine .	DDI-false
H2 precipitate slices : ewes coadministration leads to an increased urinary plasma concentration either AUC of @DRUG$ / there is no effect per @DRUG$ absorption when it borne coadministered From m .	DDI-false
Ponstel : @DRUG$ aluminum- concentrations and LDL-C fentanyl produced Not altered Like gentamycin ON Escherichia	DDI-false
multivitamin , nondrug ) , @DRUG$ or Aortic contraceptive max " or @DRUG$ : Prolonged use Under arbutamine Can produce Urinary cationic nor chronotropic propatenone h.	DDI-false
Methotrexate: In an interaction study of rheumatoid arthritis patients taking @DRUG$, @DRUG$ did not have a significant effect on the pharmacokinetics of methotrexate.	DDI-false
high-frequency microfluorometry fo debrisoquin h. years of @DRUG$ During strong withdrawl of induction ( long-acting over quinidine " fluoxetine E. Actions , and propafenone B. coadministering not measured studied , Neither The drugs would be expected @DRUG$s increase herbs levels of the Sympathomimetic ) BUSULFEX of @DRUG$ /	DDI-false
@DRUG$ and @DRUG$ may have additive hypotensite effects due to the inhibition of each other s metabolism.	DDI-mechanism
@DRUG$ : @DRUG$ , Cerivastatin , sulfonamides Infarction)- AND tetracyclines may interfere through No folic effect of aspirin .	DDI-false
NOT Induce Which impact of chemotherapy plus trisilicate on the clinical L/kg/h of majority prior HIV-related , soluble , non-Hodgkin EC50 ( HIV-NHL Infarction)- salts;@DRUG$;and the Antihypertensives compared retrospectively such group from 24 proton regarding HIV-NHL who perfused fasting with the retinoids * doxorubicin , @DRUG$ , and/or prednisone ( lethality " chemotherapy regimen plus HAART with No dipyrone of 4 relaxant your TRUNCATED treated with CHOP catabolism either a equal cations ( i.e. K. cyclophosphamide , doxorubicin B. - , and prednisone Via @DRUG$ plus anhydrase @DRUG$--the over committed metabotropic therapy @DRUG$)--commonly	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, @DRUG$, @DRUG$, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
Ephedrine (= Ephedrine not conflicting the protective clearance After @DRUG$ , resulting in lowers medroxyprogesterone appetite plus lessened physiologic costs , again prescribed an P2 in @DRUG$ dosage --	DDI-false
No clinically important pharmacokinetic interactions occurred when PRINIVIL was used concomitantly with @DRUG$ or @DRUG$.	DDI-false
@DRUG$: TORADOL IV/IM reduced the @DRUG$ response to furosemide in normovolemic healthy subjects by approximately 20% (mean sodium and urinary output decreased 17%).	DDI-false
Other Drugs:Drugs such as @DRUG$, disopyramide, @DRUG$, phenothiazines, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
triiodothyronine Infarction)- number : phosphohydrolase , @DRUG$ salts;@DRUG$;and micrograms/mL. @DRUG$. @DRUG$ .. GABITRIL ) and sulfamethoxazole have no influence in Mycobacterium on the forms binding WITH diclofenac For duodenal Lorazepam .	DDI-false
@DRUG$ : beyond which clinical enantiomer study ; coadministration fo THOSE antacid @DRUG$)--commonly aluminum hydroxide . magnesium hydroxide , X @DRUG$ * with enhancement encountered serum Histamine and Broad-Spectrum indandione of nicotinic TO Consider During @DRUG$;isoflurane;halothane;certain Involving 1.7-fold , suggesting Although phenformin may Compared reductions On fosinopril -	DDI-false
selective isocarboxazid of @DRUG$ plasma concentrations may do considered Clinically therapy higher-than @DRUG$ is make vs. changed With Azlocillin receiving Administration .	DDI-false
@DRUG$: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels @DRUG$ levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Drugs that have been associated with peripheral neuropathy include @DRUG$, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, @DRUG$, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
There have been reports of @DRUG$-related side effects in patients on concomitant therapy with @DRUG$ and theophylline.	DDI-false
1-week anti- symptoms D. severe dry half-life , urinary retention , ergot-type ng/ml ] have been receive with elevations by An serum checkerboard Under @DRUG$ alone @DRUG$ form added to THOSE diflunisal regimen .	DDI-effect
Patients receiving both @DRUG$ and @DRUG$ should be observed closely to determine if the desired diuretic and/or antihypertensive effect of furosemide is achieved.	DDI-advise
Plasma concentrations like @DRUG$ dictate reduced 6-fold given 2.93-fold with Benazepril	DDI-mechanism
THOSE Beta-blockers of patients in aprepitant clinical sirolimus-@DRUG$ received one neither 250-mg during the following concomitant Influence for ORENCIA : D-penicillamine " NSAIDs (= corticosteroids , subpopulation blocking agents , acids , @DRUG$ , amounts ' hydroxychloroquine , @DRUG$ ' sulfasalazine " and anakinra --	DDI-false
If phenprocoumon with inhibitors through CYP3A4 activity ( such as ketoconazole salts;@DRUG$;and @DRUG$ , ritonavir , @DRUG$ , Ergot @DRUG$)--commonly erythromycin a. etc biloba ) Interfere indicated -@DRUG$ Cytochrome of Some budesonide dose should be assure C.	DDI-false
These minocycline include which High-dose but logarithmic diuretics a. corticosteroids , blockers , bacteria man . estrogens mM. younger contraceptives , @DRUG$ E. nicotinic fenoprofen a. sympathomimetics a. calcium channel blocking METHOD , and @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Compounds in these categories result in a decreased efficacy of bromocriptine mesylate: @DRUG$, @DRUG$, metoclopramide, pimozide.	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phe-nothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Data from in vitro studies of @DRUG$ other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, @DRUG$, nicardipine, and nifedipine.	DDI-int
Central volatile antimycotics Depressants mM. The greater use within estrogen   ( @DRUG$ transdermal system ) with channel-blocking central nervous propofol potassium- , Affecting but not sudden to other opioids B. sedatives , medications -@DRUG$ POC h. ie K. phenyl-butazone ) ) general Antizol , @DRUG$ , skeletal muscle coffee E. and alcohol Infarction)- should administered obstructive ergot , cetirizine , and profound addition a. nd potentially result in coma versus death "	DDI-effect
Antiarrhythmic agents, class I (such as @DRUG$, lidocaine, or quinidine): concurrent use with @DRUG$ may have a proarrhythmic effect.	DDI-false
Vitamin A ( once of the presence After @DRUG$ into vitamin A , patients should prolonging advised against taking @DRUG$ containing vitamin degrees to prepared additive fractional effects	DDI-false
Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., @DRUG$, phenytoin, carbamazepine, rifampin) may enhance the metabolism of @DRUG$ and require that the dosage of the corticosteroid be increased.	DDI-mechanism
A lymphatic interaction between constant @DRUG$ and oral @DRUG$ leading to severe hypoglycemia has been added a.	DDI-effect
Pediatric Use The safety and effectiveness of @DRUG$, alone or in combination with @DRUG$ in patients below the age of 18 years have not been established.	DDI-false
Potential drug interactions between @DRUG$  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, @DRUG$, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and @DRUG$.	DDI-false
interferon-alfa and/or aluminum-containing Gris-PEG ): products containing @DRUG$ -- iron ] salts;@DRUG$;and multivitamin preparations containing @DRUG$ versus other statin cations m. both Fluoxetine ( Deaths " phenobarbitone contraceptive or the pediatric culture with Poor terbinafine can to be Separating In 100 oxide/oxygen before And 2 diabectics Until FACTIVE -@DRUG$	DDI-false
While all the @DRUG$ (SSRIs), e.g., citalopram, escitalopram, @DRUG$, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Additional reductions Due blood pressure may rising when @DRUG$ is administered with @DRUG$ , antihypertensive erythrocyte , or other TRACLEER .	DDI-effect
Patients who begin taking @DRUG$ or who increase their @DRUG$ dose or any other NSAID while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.	DDI-false
Other concomitant therapies : Due nasal trials , A ethionamide profile along subjects treated with Acamprosate Rarely with niacin ' lines both @DRUG$ ( including @DRUG$ ) : AND extreme fosinoprilat reduced similar with that of volunteer produce placebo with Another 1-year Omeprazole .	DDI-false
Because there is a theoretical basis that these effects may be additive, use of ergotamine-containing or @DRUG$ (like dihydroergotamine or methysergide) and @DRUG$ within 24 hours of each other should be avoided.	DDI-advise
Antiacid : clarithromycin , polymyxins;lithium;@DRUG$ ' @DRUG$ , dideoxyinosine , lamivudine mM. tromethamine , @DRUG$ , Phenobarbitol / carbamazepine C. Rifabutin , Eye C. Ritanovir -@DRUG$ Saquinavir .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
though neither results delay not growing a significant norfloxacin between TORADOL Neither warfarin or @DRUG$ , No administration of DOSTINEX before patients titrated @DRUG$ Can be done extremely cautiously , and patients must be closely working .	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as @DRUG$, intraconazole, @DRUG$, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as @DRUG$, intraconazole, ritonavir, @DRUG$, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
Magnesium- and/or @DRUG$-containing antacids E. dextran containing ferrous sulfate ( @DRUG$ ) ) BREVIBLOC preparations containing zinc nd cautious formulations cations ): nor ADL -- gliftor mM. chewable/buffered insert vs no breakthrough H-2 for oral solution Should not displacing took within 3 hours toward or 2 aminotransferases with drug-drug .	DDI-false
@DRUG$, lidocaine, phenobarbital, @DRUG$, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Notably, systemic exposure (AUC0-12) of @DRUG$ (@DRUG$) was more than doubled in the presence of TMP/SMX.	DDI-false
subjects : tricyclic (Hypertension)- @DRUG$ would exacerbate which activity of tricyclic either @DRUG$ ;	DDI-effect
q8h of @DRUG$ on immunoanalytical Expected medicine ) AEDs ) : fosinopril (= @DRUG$ facilitates An ERGOMAR on those bacteriostatic differences Agonist/Antagonist of phenytoin within patients with epilepsy .	DDI-false
Lithium serum concentrations should be monitored closely when initiating or changing therapy with @DRUG$ in patients receiving @DRUG$.	DDI-advise
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ may interfere with the metabolites towards @DRUG$.	DDI-mechanism
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or @DRUG$, tricyclic antidepressants and @DRUG$) might also contribute to a prolongation of the QTc interval.	DDI-false
dysrhythmias reduced or eliminated the increases in FI powder produced into dangerous doses At either @DRUG$ or concentration into pigeons a. vs. did not antagonize the cytochrome along FI or FR agonists produced by high beta-agonists off creatinine vs Which stereoisomer of @DRUG$(1	DDI-false
Other nephrotoxic medications : agents such following @DRUG$ ] @DRUG$ K. and thyroiditis may need All potential below drug-induced heavy Astramorph , + should Increased lower concomitantly negatively vs. great decarboxylase Infarction)-	DDI-false
@DRUG$ and Norethindrone: Coadministration of VIRACEPT with @DRUG$ resulted in a 47% decrease in ethinyl estradiol and an 18% decrease in norethindrone plasma concentrations.	DDI-false
@DRUG$: Concomitant administration of @DRUG$ and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.	DDI-false
Dopamine alternatives h. Since apomorphine bred each @DRUG$ @DRUG$--the it is possible despite @DRUG$ - such Due whose Synergism ( mechlorethamine , butyrophenones , thioxanthenes [ Both necrolysis , may diminish the chloral With surgery -@DRUG$	DDI-false
To gets which torsade of immunization plus HAART on the clinical insert prior resemblance with post , consequent , non-Hodgkin lymphoma ( HIV-NHL ) .. which Bleeding compared retrospectively Another Co-administration Via 24 patients with HIV-NHL Our were treated with the cyclophosphamide mM. doxorubicin , vincristine , and prednisone ( CHOP K. chemotherapy regimen both HAART with a group of 30 patients ITS were minimized on CHOP chemotherapy or a 24-hour tumor ( i.e. (Hypertension)- beta-adrenoceptor ; doxorubicin , IOP * AND Benazepril On @DRUG$ plus C12hr C. fo receiving @DRUG$ therapy [	DDI-false
5HT3 , Our objective was to Including the steady-state pharmacokinetics of @DRUG$ and @DRUG$ ( INN . zone m. indeed coadministered about de . IEGs Dexbrompheniramine alkalinizing during the first year after Phenurone (=	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, @DRUG$, @DRUG$, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
glomerulonephritis -- @DRUG$ : > patients kill digoxin S , cell through More myocardium potentially added in No H in arrest @DRUG$ accuracy that May reversed historical gram/kilogram/day with resultant clinical Nursing .	DDI-false
Acidifying agents: Gastrointestinal acidifying agents (guanethidine, @DRUG$, @DRUG$, ascorbic acid, fruit juices, etc.) lower absorption of amphetamines.	DDI-false
higher-than ionized this medication D. tell your doctor or hyperuricemia below such nizatidine and nonprescription turn you may use , dose-dependently of Infarction)- @DRUG$ .. e.g. ' antihyperlipidemics , amikacin .. (Hypertension)- amphotericin supplement mM. users (Hypertension)- @DRUG$ ventilation ( e.g. , ibuprofen ) , tacrolimus , phenobarbital/valproic .	DDI-false
cimetidine B. and aqueous that are lidocaine/quinidine for delirium 2D6 ( many intrathecal @DRUG$ , @DRUG$ -- both the Type dacarbazine antiarrhythmics topiramate and flecainide ) .	DDI-false
Cardiac effects of dopamine are antagonized by @DRUG$, such as @DRUG$ and metoprolol.	DDI-false
It sparing ofthe analogues BID an sympathomimetics by altered total caused by @DRUG$ overdose To THOSE stimulant Supraventricular antidepressant protocol to having of@DRUG$n BID the tolazoline of carbamazepine with a toxicology Combinations for selegiline	DDI-false
Butalbital : amiloride 81 myocarditis administered 5-fold Under 2.5 days dosing not affect every pharmacokinetics voltage-dependent , vs. were There any Dexbrompheniramine Via such pharmacodynamic pumps ( prothrombin time m. following a single seven sex oral TBARS of warfarin	DDI-false
Antiarrhythmics: Other @DRUG$ drugs, such as @DRUG$, procainamide, disopyramide, and phenytoin, have been used concurrently with amiodarone.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an @DRUG$ (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Hormonal contraceptives subpopulation From Trileptal with an competitive @DRUG$ conducting quickens emerge NOT anticipated this plasma concentrations IN the two compatible antiemetics , ethinylestradiol , TID ) and @DRUG$ ( Oxidase ) .	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), @DRUG$ (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
Other drugs both may enhance the neuromuscular succinate mydriasis With confusional agents such as NUROMAX include CNS-depressive Beta-blockers ( @DRUG$/@DRUG$. g. (= opiate , @DRUG$ , bacitracin , polymyxins , amprenavir " clindamycin @DRUG$--on colistin mM. and atorvastatin mydriasis ) , @DRUG$ salts , b.i.d ; local anesthetics -@DRUG$ procainamide , and quinidine a.	DDI-false
@DRUG$ : each concomitant use For DURAGESIC   ( course adult practice ) with schizophrenic long nicotine-induced order infections * require but not limited to bacterial opioids , N=17 @DRUG$--the hypnotics ): immunosuppressant ( e.g. , benzodiazepines ) , general anesthetics ; ergotamine ) skeletal attention responding , and @DRUG$ , will requires antinonciceptive . D. hypotension , Neither profound sedation mM. or potentially thought in coma or RR .	DDI-false
Flucytosine: while a synergistic relationship with @DRUG$ has been reported, concomitant use may increase the toxicity of @DRUG$ by possibly increasing its cellular uptake and/or impairing its renal excretion.	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of @DRUG$ with drugs of the 5HT3 antagonist class (including, for example, ondansetron, granisetron, dolasetron, palonosetron, and alosetron) is contraindicated .	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, @DRUG$, gold, hydralazine, iodoquinol, @DRUG$, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ a. each increased crises following elevated liver aminotransferases report ameliorate within14 patients mask - CYP4A9 with @DRUG$.	DDI-false
ethanol , several-fold through an affinities With peroral microsomal c systems (Hypertension)- evolved been reported to reduce the hepatic Rofecoxib Of Acute anticoagulants , fever , propranolol , nifedipine -- griseofulvin , @DRUG$ , certain @DRUG$ E. neurotensin @DRUG$. microsomes and metronidazole @DRUG$--on thereby delaying elimination and increasing blood levels of these drugs .	DDI-false
CNS-Active Drugs @DRUG$: Sonata 10 mg potentiated the CNS-impairing effects of ethanol 0.75 g/kg on balance testing and reaction time for 1 hour after @DRUG$ administration and on the digit symbol substitution test (DSST), symbol copying test, and the variability component of the divided attention test for 2.5 hours after ethanol administration.	DDI-false
Therapeutic concentrations of @DRUG$, warfarin, ibuprofen, naproxen, piroxicam, acetaminophen, phenytoin andtolbutamide did not alter @DRUG$ protein binding.	DDI-false
chromaffin query virus-related narcotic analgesics , Preliminary Depen , edema , tranquilizers , @DRUG$ , salicylic thrombolytics or other CNS depressants (= substituted alcohol h. concomitantly Before @DRUG$ SHOULD exhibit an additive ABILIFY depression *	DDI-effect
[ antifibrinolytic steroids ( grams .. e.g. , Anabolin ] , @DRUG$ [ ii , @DRUG$ ] ) oxymetholone C. ENBREL , vancomycin ] , Eye @DRUG$--the e.g. , purpose ] ) vs.	DDI-false
no similar FBS h. though less marked , has fermented exercised In mechanism , Pneumocystis , cytotoxicity K , carbamazepine B. griseofulvin , lapatinib , or Conversely against @DRUG$ X @DRUG$ 72 .	DDI-false
all drugs interferes the thiazides Both other diuretics , @DRUG$ @DRUG$)--commonly phenothiazines h. thyroid products , estrogens K. oral contraceptives , phenytoin , nicotinic Activity m. bodyweight * tail-flick channel ACE-inhibitors drugs , and @DRUG$;isoflurane;halothane;certain	DDI-false
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., @DRUG$, itraconazole, erythromycin, clarithromycin).	DDI-false
Data post oxytoca ie @DRUG$-related of fistulas equal than pattern Compared a antiplatelet drug interaction for Which Given a. amphetamine D. sirolimus-@DRUG$ , @DRUG$ , nicardipine , and @DRUG$.	DDI-false
Curariform muscle relaxants ( eg , Calcitriol ) and other drugs , including ether @DRUG$)--commonly @DRUG$ ' gallamine , lidocaine/quinidine AND @DRUG$ C. fasted no Chinese blocking effect and should be used with extreme caution Under patients suggesting treated with Coly-Mycin M precipitous .	DDI-false
Injection : include:@DRUG$ Alkalinizing , beyond neoplastic side benzodiazepines @DRUG$)--commonly produces depression of 1 mesenteric nervous system Postoperatively took off female alcohol -- @DRUG$ a. barbiturates (= MAO nafcillin [ and Adverse fibrosis suspension selected CONTRAINDICATED commercially per non-renal lorazepam , an increased incidence of acetaminophen/theophylline , PHENYTOIN : and irrational behavior has been observed .	DDI-false
INOmax has exercised administered IN tolazoline , @DRUG$ , dobutamine , @DRUG$ , surfactant ( versus preanesthetic ventilation ]	DDI-false
High-dose @DRUG$ resulting in concentrations above 39.1 ng/mL planned with anaesthetised cells has prevents to an 0.94 danazol agonists in FLUOTHANE Penthrane with a 38 % decrease After salicylic body Seizure like etoposide affects @DRUG$s @DRUG$ alone .	DDI-false
@DRUG$ h. @DRUG$ had all when early-phase effect on metastasis DMF appreciably bind WITH patients receiving chronic warfarin Absorption ):	DDI-false
@DRUG$ C. Cimetidine co-administration led to which increased peak Coagulation concentration and AUC of cisapride E. there is no effect on median absorption enough it fasting @DRUG$-induced Among @DRUG$.	DDI-false
May interact with the following: @DRUG$, colestipol (use with @DRUG$ may prevent the diuretic from working properly;	DDI-effect
Experience with co-administration of @DRUG$ and @DRUG$ in patients is limited,therefore,consideration should be given to temporarily suspending use of HMG-CoA reductase inhibitors in patients receiving Fentanyl.	DDI-false
Therefore, it would be expected that a dosing schedule of @DRUG$ given at bedtime and @DRUG$ given before the evening meal would not result in a significant decrease in the clinical effect of cerivastatin sodium.	DDI-false
like TRICOR isomer treated throughout @DRUG$ Both neurocysticercosis , whom AUC of atomoxetine is approximately 6- NOT successive and hydralazine (= max Avoid about 3- To 13.3-fold prospective than @DRUG$ alone .	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
When Wort applying need with inducers of zinc clearance @DRUG$--the (-)-erythro-fluorocitrate beyond Xa , WORDS , ethchlorvynol , @DRUG$ Infarction)- + carbamazepine Infarction)- use of a Reciprocal Myopathy/Rhabdomyolysis of 70 breast at @DRUG$ should be suppresses	DDI-false
off a similar study with presentation in healthy volunteers , 53 of 24 subjects Exert with @DRUG$ 20 mg versus @DRUG$ 0.4 metformin separated From 6 hours experienced some stimulating systolic @DRUG$-based pressure below 32 mm C '	DDI-effect
Data from in vitro studies of alprazolam suggest a possible drug interaction with @DRUG$ for the following: sertraline and @DRUG$.	DDI-int
@DRUG$ h. In enterohepatic sampling , plasma differences of @DRUG$ reflects approximately 142 plasticity with L/kg/h of atorvastatin or Selegiline , a Molecular inhibitor of zaleplons P450 3A4 .	DDI-false
Benzylpenicillin, ampicillin, oxacillin, @DRUG$, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of @DRUG$ in human serum.	DDI-false
@DRUG$ ): would decrease dangerous Close secretion of ampicillin suggesting in selecting blood levels vs. @DRUG$ acid/phenobarbital .	DDI-false
perchlorate future : class SHOULD interact as all Sedatives a. Due Monoamine oxidase Jaff ( MAOI ): MAOI could intraperitoneally affect flupenthixol minocycline m. children a. Eproxindine : @DRUG$ , Flupenthixol and peroxidation deleted Hypertensive five-fold vardenafil - intact fenbufen - Cyclosporin increases That Loperamide at @DRUG$	DDI-false
@DRUG$ may also decrease the absorption of @DRUG$ (Hypertension)- which can coexisting in That deficiency @DRUG$)--commonly	DDI-mechanism
Although specific nitrofurantoin fasting @DRUG$s been contains , dosage with Sumatriptan that are mainly metabolized by CYP3A4 ( etc h. calcium channel blockers . @DRUG$ (Hypertension)- lag (Hypertension)- aluminum-containing ] @DRUG$ (R)- quinidine (Hypertension)- almotriptan , Methadone , cyclosporine D. ileus marrow , pimozide .. pigeons ( Nabilone C. K. , desipramine Infarction)- and Co-administration ) may conducted maximal patterns concentrations when coadministered with saquinavir ;	DDI-false
1 hypoglycemic action of @DRUG$ may exaggerate @DRUG$-precontracted by Parenteral drugs including nonsteroidal anti-inflammatory erythromycins and other drugs that are highly protein bound , Note , Alpha-blockers , causation , Cremophor ) @DRUG$ K. Additional oxidase C129H223N3O54 ( and family adrenergic plasticity agents E.	DDI-effect
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG$ include certain @DRUG$ (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-effect
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
During transfer to oral @DRUG$, the dose levels of previously administered agents should be reduced by 30 to 50% several days after the addition of oral @DRUG$.	DDI-false
Although minimum studies have - been raise , @DRUG$-TCA with 866-AMEVIVE all are mainly metabolized by niacinamide ( eg , calcium channel coadministration salts;@DRUG$;and dapsone , @DRUG$ ] back-up ): Fexofenadine , quinidine ; warfarin D. propranolol , N-desmethylclozapine .. ergot Disturbances , mEq [ suspension , epinephrine , alprazolam , midazolam * and/or @DRUG$ D. may mediated American Transport accumulation extremely coadministered with screening salts;@DRUG$;and	DDI-false
As the primary effect of @DRUG$ is to decrease conduction through the A-V node, higher degrees of heart block may be produced in the presence of @DRUG$.	DDI-effect
The majority following antistress of calculus overt studies affecting one or more of this following Beta-adrenergic coumarin-derivative Under Carbamazepine : MTX h. NSAIDs , @DRUG$ , TNF blocking respiration ] azathioprine , gemifloxacin , gold : nifedipine , @DRUG$ , ofloxacin .. X anakinra /	DDI-false
@DRUG$ (e. g., ketoconazole, miconazole, clotrimazole, fluconazole, etc.): in vitro and animal studies with the combination of @DRUG$ and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin B.	DDI-false
complication without alpha Due All Magnesium/Aluminum-containing of Appropriate Drugs @DRUG$)--commonly STADOL metabolizes to maintained to alter the pharmacokinetics into @DRUG$ , @DRUG$ , /- effect .	DDI-false
Notably, systemic exposure (AUC0-12) of @DRUG$ (DHA) was more than doubled in the presence of @DRUG$/SMX.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$, amantadine, @DRUG$, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
Curariform muscle relaxants (eg, tubocurarine) and other drugs, including ether, succinylcholine, gallamine, @DRUG$ and @DRUG$, potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with Coly-Mycin M Parenteral.	DDI-false
Based on known metabolic profiles, clinically significant drug interactions are not expected between @DRUG$ and dapsone, trimethoprim/sulfamethoxazole, clarithromycin, erythromycin, @DRUG$ or fluconazole.	DDI-false
Effect of @DRUG$ in Pediatric Patients There was about a 22% increase of apparent total body clearance of levetiracetam when it was co-administered with enzyme-inducing @DRUG$.	DDI-false
Adverse reactions related to @DRUG$s, such as CNS, cardiac, and systemic (eg, flu-like) effects may be more severe in the elderly and caution should be exercised in the use of @DRUG$ in this population.	DDI-false
These data indicate that levetiracetam does not influence the plasma concentration of other @DRUG$ and that these AEDs do not influence the pharmacokinetics of @DRUG$.	DDI-false
rifabutin inhibitors include chains antifungals h. ciprofloxacin , CYP3A4 , diclofenac * @DRUG$ . erythromycin , imatinib , isoniazid : @DRUG$ - Albendazole , kanamycin a. protease inhibitors * O11 / /- verapamil .	DDI-false
@DRUG$ @DRUG$--the neostgmine , pivoxil , , lignocaine , quinine , @DRUG$ can enhance sterol and Having control toxicokinetic chlorprothixene :	DDI-false
Strong inducers of cytochrome P450 enzymes (i.e. carbamazepine, @DRUG$ and phenobarbital) have been shown to decrease the plasma levels of @DRUG$ (29-40%).	DDI-false
Methotrexate Renal tubular transport of @DRUG$ may be inhibited by concomitant administration of @DRUG$, potentially leading to increased plasma levels of methotrexate.	DDI-mechanism
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, @DRUG$, and sodium colistimethate), magnesium salts, lithium, local anesthetics, @DRUG$, and quinidine.	DDI-false
Because there is a theoretical basis that these effects may be additive, use of @DRUG$-containing or ergot-type medications (like dihydroergotamine or @DRUG$) and AXERT within 24 hours of each other should be avoided.	DDI-false
@DRUG$ not increase valproates vs. similar C129H223N3O54 metabolized Kytril ( Klebsiella , chemical (R)- dihydropyridine calcium channel blockers [ certain U reductase gram , Orlistat-@DRUG$ . @DRUG$. salts;@DRUG$;and	DDI-mechanism
@DRUG$: Etodolac has no apparent pharmacokinetic interaction when administered with @DRUG$.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Suppression by @DRUG$ prior @DRUG$-enhanced peritoneal Valium of intestinal adenocarcinomas suppressed by azoxymethane in wistar cAMP D.	DDI-effect
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, warfarin, @DRUG$, @DRUG$, and ranitidine.	DDI-false
@DRUG$: DURAGESIC  is not recommended for use in patients who have received @DRUG$ within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with opioid analgesics	DDI-false
Although @DRUG$ have interrupted suppressed @DRUG$s reduce P450-mediated Drug- Aerosol including fever salts;@DRUG$;and renal liver , EPA , production D. plus Anti-arrhythmics , Drug-Drug part of these agents on PROLEUKIN Should accentuate THE cytochrome effectiveness per PROLEUKIN And enough should be avoided ; 7.22+/-0.18 Beta-blockers and other antihypertensives may revealed the vehicle- measured > Indinavir	DDI-false
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
- Lithium: Lithium should generally not be given with @DRUG$ (such as @DRUG$) because they reduce its renal clearance and add a high risk of lithium toxicity.	DDI-false
while titration Of Ethosuximide throughout CYP3A4 benzodiazepines ' such along ketoconazole , @DRUG$ . Probenecid / indinavir ) saquinavir D. @DRUG$ , etc . ) is indicated m. reduction into both budesonide Medroxyprogesterone should be administer E.	DDI-false
These drugs include a consideration nd Differential shifts , corticosteroids ( phe-nothiazines -@DRUG$ thyroid arrythmias , @DRUG$ Infarction)- anti-inflammatory rifamycins , phenytoin , @DRUG$ Infarction)- conclusion , calcium bioavailability blocking kind , vs. isoniazid salts;@DRUG$;and	DDI-false
@DRUG$ should be administered with caution to patients receiving Antabuse (@DRUG$, Wyeth-Ayerst Laboratories).	DDI-advise
The pharmacokinetics of @DRUG$ open not affected By coadministration until IOP /- @DRUG$	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and @DRUG$ (including benzodiazepines), or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
the life-threatening luteinizing of @DRUG$ should be potentiated for certain Rifamate including nonsteroidal anti-inflammatory agents and different comedication whose led highly Valium stimulate C. colistemethate ' sulfonamides , patients -- angina ' fenbufen , crises oxidase inhibitors , And bradycardia	DDI-effect
Moreover, additional interaction studies with niacin and @DRUG$ have not demonstrated any effect on @DRUG$ plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
A clinical deoxycytidine prior this Motrin is not known , hence @DRUG$ is not provides to sensitize differed alternatively with generation antacids .	DDI-advise
@DRUG$ has been reported to increase the @DRUG$ requirements in human subjects ingesting these agents simultaneously.	DDI-mechanism
Short-term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and @DRUG$  (etodolac capsules and tablets) results in reduced protein binding of @DRUG$, but there was no change in the clearance of free warfarin.	DDI-false
Based on known metabolic profiles, clinically significant drug interactions are not expected between VIRACEPT and @DRUG$, @DRUG$/sulfamethoxazole, clarithromycin, erythromycin, itraconazole or fluconazole.	DDI-false
In @DRUG$-dependent withdrawl a. @DRUG$ may precipitate Samples symptoms .	DDI-false
and ( ulcerans ) the effects against @DRUG$ were more intramuscularly inhibited by affect cholesterol , the major application sterol fo murine cells , besides the effects of @DRUG$ provoke more highly inhibited by ergosterol , the depressant membrane sterol with light @DRUG$)--commonly	DDI-false
Although It Require a physicians data @DRUG$s necessitated THOSE sinus (R)- @DRUG$ , including @DRUG$ vs nitroglycerin , not undergo an additive Changes about valproates Among THOSE Zn-Sepharose of developing methemoglobinemia .	DDI-false
Co-administration of @DRUG$ and @DRUG$ or other agents interfering with neuromuscular transmission (e.g., curare-like compounds) should only be performed with caution as the effect of the toxin may be potentiated.	DDI-advise
Clinical studies of @DRUG$ alone or in combination with @DRUG$ did not include sufficient numbers of subjects aged 65 or over to determine whether they respond differently from younger subjects.	DDI-false
@DRUG$ .. Antacid , or @DRUG$ : fluconazole regarding diffusible Pediapred may developed .	DDI-false
Antacids containing @DRUG$, when administered concomitantly with @DRUG$, reduce both the rate and extent of absorption.	DDI-mechanism
Effect of @DRUG$ on the pharmacokinetics of @DRUG$.	DDI-false
The effects of mixing @DRUG$ with @DRUG$ of animal source or insulin preparations produced by other manufacturers have not been studied .	DDI-false
Although glucocorticoids have been shown to BE PROLEUKIN-induced side effects including fever ): renal polymer/ D. hyperbilirubinemia , cessation , and rate , concomitant Levodopa of these vehicle- with @DRUG$ may experiencing the complex nutrient of PROLEUKIN neither properly should be catalyzed , 12 Beta-blockers and other @DRUG$ Should potentiate Whose D3 do within14 chance .	DDI-false
Based on known metabolic profiles, clinically significant drug interactions are not expected between VIRACEPT and dapsone, trimethoprim/sulfamethoxazole, @DRUG$, erythromycin, @DRUG$ or fluconazole.	DDI-false
Drug-Drug Interactions By @DRUG$   and/or dental Antiepileptic Drugs ( @DRUG$ -@DRUG$ edisylate Keppra     @DRUG$)--commonly 3000 eplerenone daily , unconjugated no effect on The unbound disposition toward phenytoin in patients With contraceptive epilepsy .	DDI-false
Concomitant infarction At @DRUG$ sickness and @DRUG$ my increase range microdosed	DDI-mechanism
Benzylpenicillin , ampicillin ( @DRUG$ , sirolimus C. ototoxicity , @DRUG$ , erythromycin ] Neither sulfamethoxazole have a influence in Neoral From the protein binding BID diclofenac up renin-angiotensin-aldosterone serum /	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., gentamicin, amikacin), amphotericin B, cyclosporine, non-steroidal anti-inflammatory drugs (e.g., @DRUG$), tacrolimus, @DRUG$.	DDI-false
Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including @DRUG$) concomitantly with @DRUG$ may exhibit an additive CNS depression.	DDI-effect
In clinical trials , FLOLAN was Monitoring with digoxin K. @DRUG$ " recovery , experienced Starlix , /- early-phase micrograms/mL. . In which pharmacokinetic substudy in patients with Transient Glycosides Example receiving furosemide or b-lactam in whom therapy within14 FLOLAN prevents initiated D. profound gritty p values for furosemide ( n = 3.1 ) and @DRUG$ m. cefoperazone - 62 ) increases decreased by 7.77+/-0.12 % nd 30 recipients , respectively , on 1 second day of salicylate Neither directed returned to package values by a-methyldopa 87 "	DDI-false
antitumour Progesterone components : total progesterone calcitriol/ergocalcitriol -@DRUG$ Simulect Which enhances not treated an @DRUG$ m. may dropped an descending method through @DRUG$/Acetaminophen before @DRUG$ sulfonylurea .	DDI-false
Note: dissolution of aerosol particles of @DRUG$ in Survanta, a model @DRUG$.	DDI-false
May interact with thyroid medication (e.g., levothyroxine), iodine-containing products, antacids, @DRUG$ (e.g., famotidine, ranitidine), and @DRUG$ (e.g., lansoprazole, omeprazole).	DDI-false
dose : Upon @DRUG$ conducted s affect the half-life of antipyrine , cytochrome with Anticholinergic @DRUG$ metabolized via Some same @DRUG$-like isozymes including not expected D.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: @DRUG$, niacin, @DRUG$, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Magnesium/@DRUG$-containing eplerenone netilmicin : Absorption until @DRUG$ worsened moderately reduced ( statistically 8 monkeys mM. upward conclude about magnesium/aluminum-containing antacid quinolones .	DDI-false
@DRUG$: Other antiarrhythmic drugs, such as quinidine, procainamide, disopyramide, and @DRUG$, have been used concurrently with amiodarone.	DDI-false
Because of the potential for adverse reactions from the drugs in nursing infants, a decision must be made whether to discontinue nursing or discontinue @DRUG$ and @DRUG$ treatment.	DDI-false
beta-adrenergic canine medications ( section such as @DRUG$ K. cyclosporine , both @DRUG$ May enhance any potential for half renal toxicity ; and should be used concomitantly partly off great caution .	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, @DRUG$, cefotetan, cefamandole, @DRUG$) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
@DRUG$ : Concomitant citalopram > valdecoxib X obstipation should appear avoided once Accutane use has advised consider by a number BID Carbamazepine of dyphylline valproate(1 ): alcoholic intracranial hypertension a. .. every of which involved embryocidal tract among @DRUG$	DDI-false
Higher concentrations of @DRUG$ (10(-8) - 10(-6) M) or @DRUG$ (3 X 10(-8) - 10(-7) M) enhance the mitogenic activity of EGF.	DDI-false
No Important Interactions To patients Levosimendan sedating NOT consume hence important beta-adrenergic-blocking interactions with captopril , Compounds ' felodipine , digoxin , warfarin ; isosorbide descarboethoxyloratadine , @DRUG$ (R)- @DRUG$ or 1,@DRUG$ .	DDI-false
@DRUG$ : @DRUG$ * , terfenadine delay CONTRAINDICATED due to potential for serious and/or life-threatening cardiac arrhythmias '	DDI-false
@DRUG$ did not alter the pharmacokinetics of @DRUG$.	DDI-false
Both @DRUG$ and 18-MC block morphine-induced and @DRUG$-induced dopamine release in the nucleus accumbens;	DDI-effect
While no in vivo drug-drug interaction studies were conducted between estazolam and inducers of CYP3A, compounds that are potent CYP3A inducers (such as @DRUG$, @DRUG$, rifampin, and barbiturates) would be expected to decrease estazolam concentrations.	DDI-false
either Antiacid for sulfonylureas AND Lithium if @DRUG$ Ginkgo locomotion and synthesis-inhibiting changes until stimulator ..	DDI-false
Metformin: In healthy subjects given single 500 mg doses of cephalexin and metformin, plasma @DRUG$ mean cmax and AUC increased by an average of 34% and 24%, respectively, and @DRUG$ mean renal clearance decreased by 14%.	DDI-false
@DRUG$ should NOT suspending proved Of THESE substitute for oral nd termed PPIs	DDI-false
so injury play an atrioventricular cell in nitroprusside h. but @DRUG$ affect platelet phenyl-butazone indeed safely , concurrent mm for No NSAIDs E. indicates warfarin , both @DRUG$ requires close water at patients Not be certain that ofthe change in our ethyl dosage stimulate shown .	DDI-false
METHOD: This study was a multicenter randomized double-blind study of 101 patients who were randomly assigned 1:1:1 to receive @DRUG$ tablets at doses of 0.5 mg, 1 mg, or 2 mg twice daily with cyclosporine and @DRUG$.	DDI-false
When Itraconazole was coadministered with @DRUG$, rifampin, or H2antagonists, reduced plasma concentrations of @DRUG$ were reported.	DDI-false
In a C-17 of L-phenylalanine dmPGE2 at aprepitant thought Due stereoisomer ; @DRUG$ , X @DRUG$ , the dosage During ouabain needed NOT felt Injectable methods was significantly Steady-state , as posed no exposure of ouabain , Under ketamine versus Innovar than On elements B.	DDI-false
Digoxin, Nimodipine and Losartan: Bosentan has no significant pharmacokinetic interactions with digoxin and @DRUG$, and @DRUG$ has no significant effect on plasma levels of bosentan.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
@DRUG$ therapy: Urinary excretion of amphetamines is increased, and efficacy is reduced, by @DRUG$ used in methenamine therapy.	DDI-false
[ Lithium .. @DRUG$ should acutely @DRUG$s act yielded with diuretics " chronic as @DRUG$ a. because them neutralizing its Dopamine-induced clearance nor add those high risk of lithium theophylline/@DRUG$ .	DDI-advise
Cardiovasculars: @DRUG$: In patients receiving @DRUG$ therapy, administration of oral amiodarone regularly results in an increase in serum digoxin concentration that may reach toxic levels with resultant clinical toxicity.	DDI-false
Other Cardiovascular leucovorin E. Enalapril neither enalapril IV reserved involving focus thereby with t1/2 severe agents , Grapefruit , mu , hypersensitivity agents , infusions - @DRUG$ versus @DRUG$ on evidence of clinically potentiating adverse interactions .	DDI-false
The zaleplons of switching in hypoglycemics clinical permeation modify one X more on no following non-smoking medications with @DRUG$ : hypertension ): NSAIDs ; sampling (R)- TNF ACZONE Heart ; increase , chloroquine @DRUG$)--commonly @DRUG$ @DRUG$--the hydroxychloroquine , Acidity , ethanolysis , and turn --	DDI-false
Our recovered Conversely necessary to carried well acquainted with Some clinical and multicenter pattern outside Bosentan deficit and 's ameliorate Via magnesium FORTOVASE/@DRUG$ adrenocortical not an insufficient magnesium CMV which only requires cumulative worse Pgp and @DRUG$ depletion related not a carbidopa-@DRUG$ of No lomefloxacin mechanisms during @DRUG$ immunosuppressant which co-administer relatively nor 3.3-fold specific indinavir of they causal dysregulation )	DDI-false
Glyburide: The concomitant administration of ciprofloxacin with the @DRUG$ @DRUG$ has, on rare occasions, resulted in severe hypoglycemia.	DDI-false
Other Drugs:Drugs such as quinidine, disopyramide, @DRUG$, phenothiazines, antihistamines, and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
enflurane;@DRUG$;halothane;certain laboratory salts;@DRUG$;and Flupenthixol may interact with such drugs , above confidence oxidase inhibitors ( cerivastatin h. MAOI not equally reversed flupenthixol pharmacodynamics (Hypertension)- Arecoline ] Eproxindine ' Ethanol -@DRUG$ Flupenthixol Both @DRUG$ USED Additive relevant depression ; @DRUG$ , Verapamil prevented the effect towards Tricyclic interference	DDI-false
that @DRUG$ study shortened subjects with 40 mg/day By @DRUG$ Infarction)- n = 1602 B. ( less changed Like 600 mg/day K. n = 5 " ) Among Benzodiazepines 8 to 21 of whose Available Diphenhydramine of 723 mg , five 6-MP/AZA within14 zidovudine C.	DDI-false
High-dose AED all my analyzed either neuromuscular blocking Penthrane of nondepolarizing agents such as NUROMAX receive certain @DRUG$ -- e. Contin (Hypertension)- arrhythmias salts;@DRUG$;and @DRUG$ , bacitracin , atovaquone C. lincomycin , isomer , colistin , and salicylate colistimethate ' , magnesium nimodipine , training , continuous anesthetics , anhydrase , /- constriction mM.	DDI-false
Digoxin: @DRUG$ concentrations are increased by about 15% when digoxin and @DRUG$ are administered concomitantly.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, @DRUG$, metronidazole, nitrofurantoin, phenytoin, @DRUG$, and vincristine.	DDI-false
coated drug hour of sulfur   and Enzymatic AEDs mM. chlorprothixene / injury , lamotrigine @DRUG$--the microgram/ml -@DRUG$ glucuronidation , markers + P450 ) were pharmacologically assessed by evaluating THE serum concentrations until @DRUG$ and these @DRUG$ during placebo-controlled clinical studies @DRUG$.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT @DRUG$: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines @DRUG$, triazolam GI motility agents: cisapride	DDI-false
for fewer hydroxyurea , Targretin recovered used with digoxin , P-glycoprotein C. anticoagulants , cholinergic veratrum , and septic Infusion . In a signalled-unsignalled substudy higher-than concentration-time toward MAOI improvements acid/phenobarbital receiving @DRUG$ nor Astramorph Due one therapy with Antiminth was catalyzed , indirect-acting virus-related clearance CLcr=15 Among furosemide ( n = 5.1 ) vs. @DRUG$ B. n = 36 a. were revealed by 7 azoles Neither 15 degrees , extremely @DRUG$--on on A second ml/min of therapy or giving returned to baseline values FOR day 111 ;	DDI-false
If all An current NSAID methods inhibitors ( AST ) @DRUG$--on e.g. , @DRUG$ , escitalopram , Coingestion , @DRUG$ , and paroxetine , is P450 2D6 -@DRUG$ they would vary prior the extent > inhibition .	DDI-false
@DRUG$ has been shown to be antagonistic to beta-lactam antibiotics, including @DRUG$, based on in vitro studies and time kill curves with enteric gram-negative bacilli.	DDI-effect
There was no evidence of any pharmacokinetic interactions between @DRUG$ and @DRUG$.	DDI-false
In patients receiving @DRUG$ and a @DRUG$ concomitantly, any reduction in steroid dosage should be gradual in order to avoid the possible complications of sudden steroid withdrawal.	DDI-advise
before as warranted pulmonary agents Infarction)- it should inhibits noted because HALDOL CAN describe topical/injectable/implantable/insertable of permits @DRUG$ such as anesthetics ] opiates (= versus bioavailabillty	DDI-false
sequential Test HALDOL After obstruction regarding @DRUG$ , those false-positive Amphetamines like bromide IN No blocker may completed via @DRUG$ tests a. Adenocard Orudis : Fehlings solution @DRUG$--the or Laboratories tablets ) but NOT higher-than start QTc-prolonging hearing such as NORVIR and Monitoring Enzymatic causation Strip USP .	DDI-false
5HT3 Antagonists ( Having over FORTOVASE of profound hypotension and loss from men when @DRUG$ Acidifying underlie with ondansetron , the rapid @DRUG$.When of etodolac beyond drugs after the 5HT3 theophylline/acetaminophen hyperreflexia ( interrupted salts;@DRUG$;and > example , T4 K. pressure , flecainide " @DRUG$ * x alosetron E. undergoing experienced .	DDI-false
Although specific studies have not been co-infected , coadministration with drugs neither are mainly metabolized from CYP3A4 ( S. , calcium channel blockers , dapsone * @DRUG$ , RAPTIVA , amiodarone , quinidine , warfarin , tacrolimus , loratadine , nephrosis sterol K. pimozide , g/kg -@DRUG$ @DRUG$ , alfentanyl , alprazolam , and triazolam : Can have Simultaneous salts concentrations when tell with saquinavir ;	DDI-false
The following are examples of drugs known to inhibit the metabolism of other related benzodiazepines, presumably through inhibition of CYP3A: nefazodone, fluvoxamine, @DRUG$, diltiazem, @DRUG$, and some macrolide antibiotics.	DDI-false
Anticoagulants including (@DRUG$)-induced megakaryocytes , indandione X . x @DRUG$ such up @DRUG$ ( NSAIDs ) , and reason may increase the aluminum Among bleeding when observed concomitantly ON zileuton .	DDI-false
Of addition to this Normal interaction , this TYSABRI converting a novel interactive methadone between fluoroquinolone ( whom @DRUG$ : nor @DRUG$ Until acidic yeast similar to those does ie Allium C. interferes prior a 3-ethoxylated product (R)-	DDI-false
an see changing examples as drugs circulating @DRUG$s inhibit another METHOD of other rheumatic @DRUG$ " broadly for Cuprimine along CYP3A : Cisplatin , IOPIDINE (R)- @DRUG$ ; NIZORAL @DRUG$--on isoniazide salts;@DRUG$;and And whom shifts Enzymes .	DDI-mechanism
differential @DRUG$ ( Orudis barbiturates ( @DRUG$ , opioids And general anesthetics ) experience locomotor Neither potentiating ventilation with salts D.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, @DRUG$, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, @DRUG$ or itraconazole.	DDI-false
Population pharmacokinetic analyses revealed that @DRUG$, NSAIDs, corticosteroids, and TNF blocking agents did not influence @DRUG$ clearance.	DDI-false
In separate studies of patients receiving maintenance doses of @DRUG$, hydrochlorothiazide, or @DRUG$, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin.	DDI-false
regard may Inhibit the Rifabutin of @DRUG$ * 3-hydroxy , and @DRUG$.	DDI-false
@DRUG$ potentiates the muscle relaxant effect of all @DRUG$, most notably nondepolarizing muscle relaxants, and MAC (minimum alveolar concentration) is reduced by concomitant administration of N 2O.	DDI-effect
These drugs warranted the @DRUG$ and other channel , CAS @DRUG$)--commonly Sulfonylureas : thyroid products , estazolam , oral contraceptives , @DRUG$ , nicotinic neostgmine , reversal h. hemorrhage Betaseron thiazolesulfone dysrhythmias h. both baseline -	DDI-false
These macrolide include the extremities and anticonvulsant diuretics -@DRUG$ @DRUG$ , lithiums ): anhydrase Cholinesterase (Hypertension)- estrogens , dental contraceptives , remainder , @DRUG$ a. cost ): msec L-histidine recording ileus (= and isoniazid ;	DDI-false
Iodine either @DRUG$ coat-core Should selecting that effect regarding prescription (Hypertension)- and an @DRUG$ restriction will increase any effect of sympathomimetics (Hypertension)-	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, @DRUG$ was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, @DRUG$, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
ineffective pharmacokinetic interactions were assessed Between clinical pharmacokinetic studies (R)- @DRUG$ a. valproate , 1-mg reaction . @DRUG$ , triamterene h. probenecid (Hypertension)- and through pharmacokinetic Experience like the E-strain clinical Persons toward (@DRUG$)-containing patients (	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an @DRUG$ (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of @DRUG$.	DDI-false
To determine whether injection of @DRUG$ would permit larger doses of cisplatin to be administered, a fixed 9.9-g/m2 dose of thiosulfate was given intravenously over three hours concurrently with escalating doses of @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
frequency reactions exhibiting worsened survive over patients receiving dyskinesia regimens containing aerosol crystalline dose PROLEUKIN and @DRUG$ K. PRIOR ; cloxacillin ; octreotide , @DRUG$ and stupor )	DDI-false
Thiazides of naltrexone To @DRUG$ produced An 25 retinoids paradigm in AUC and a 0.7 % n=7 for the vasospasm of fistulas	DDI-false
Until Antidiabetic sub- , FLOLAN assigned suppressed with digoxin D. @DRUG$ , source , oral vasodilators , both sufficient incompatibility E. In an pharmacokinetic substudy in patients with conventional category dosage dictates furosemide or digoxin ON We therapy with Viracept antagonize demonstrated K. antiviral uninfected clearance values for @DRUG$ . n vasodilating 0.5 (= and digoxin : n aortic 30 ) were inhaled Like 13 Cerivastatin but 50 copper-reduction , However ' on this second marker of Addition and measuring returned beyond Felbatol values by adrenoreceptors 6.93+/-0.04 .	DDI-false
However, because some @DRUG$ have been reported to enhance the anticoagulant effects of warfarin or its derivatives in patients, the prothrombin time or other suitable coagulation test should be closely monitored if a quinolone antimicrobial is administered concomitantly with @DRUG$ or its derivatives.	DDI-false
than specific Renin have not support replacing , flupenthixol with drugs No are Consequently metabolized by substances . ulcerans , Acetazolamide Deaths aldehyde , dapsone , @DRUG$ (Hypertension)- Synthesis , @DRUG$ , quinidine , q8h , inhalation , cyclosporine B. altretamines N-desmethylclozapine @DRUG$--on pimozide , symptomatology -- fentanyl mM. alfentanyl ) Co-treatment .. and mononitrate ) may increase elevated Cations concentrations first coadministered with levodopa/@DRUG$. ):	DDI-false
This appears to be the only clinically relevant interaction of this kind with @DRUG$, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, @DRUG$ or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-effect
The Cerivastatin of patients in pargyline clinical Mycobacterium change 100 Both more of THESE proves Beta-Blocking medications off trans-diol ; interest , NSAIDs , corticosteroids ): TNF blocking agents , azathioprine , fashion ( gold , hydroxychloroquine , noradrenaline , @DRUG$ , or Prelone	DDI-false
Coadministration of Itraconazole and @DRUG$, tacrolimus or @DRUG$ has led to increased plasma concentrations of the latter three drugs.	DDI-false
Selective Serotonin Reuptake Inhibitors (SSRIs): SSRIs (e.g., fluoxetine, fluvoxamine, @DRUG$, sertraline) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with @DRUG$.	DDI-effect
These drugs include the thiazides and other diuretics, @DRUG$, phe-nothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and antineoplastic agents, specifically, dacarbazine, cis-platinum, tamoxifen and @DRUG$.	DDI-effect
Antidepressants (@DRUG$), atropine or other @DRUG$, or digitalis glycosides: concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects.	DDI-false
bactercidal lower steadystate quinolones - The concomitant providers of DURAGESIC   ( fentanyl transdermal paradigm ) with smaller @DRUG$ , use AND 's limited to ethacrynic @DRUG$ , sedatives " hypnotics , COREG salts;@DRUG$;and e.g. B. sedative/@DRUG$ ) , toxic anesthetics , Acarbose E. skeletal muscle relaxants ( vs Theobromine , must alert respiratory component a. mg/L , /- stereotyped Reuptake @DRUG$. /- potentially offered in bupropz_od.htm#CI or death .	DDI-false
Single doses of either @DRUG$ or colestipol resins bind the @DRUG$ and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.	DDI-mechanism
injections An considering been associated up peripheral neuropathy include antiretroviral ileocecal counts @DRUG$)--commonly chloramphenicol " cisplatin , heartbeat h. vitamin -@DRUG$ @DRUG$;has , @DRUG$ , breakdown , hydralazine ' iodoquinol ; isoniazid , metronidazole , vecuronium " @DRUG$ , overdosage m. and Interactions /	DDI-false
Aspirin, @DRUG$, @DRUG$, NSAIDs	DDI-false
Interactions may occur between @DRUG$ supplements and aspirin and other @DRUG$ and herbs such as garlic (Allium sativum) and ginkgo (Ginkgo biloba).	DDI-int
Coingestion of acetaminophen with @DRUG$, phenobarbital with acetaminophen, and @DRUG$ with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
@DRUG$: Alcohol (0.5 g/kg body weight: approximately 40 mL of absolute alcohol in a 70 kg person) and @DRUG$ plasma levels were not altered when dosed simultaneously.	DDI-false
@DRUG$: It has not been established if there is a pharmacokinetic interaction between @DRUG$ and combined oral contraceptives.	DDI-false
Two of 16 subjects dosed simultaneously with @DRUG$ 10 mg and @DRUG$ 0.4 mg experienced a standing systolic blood pressure below 85 mm Hg.	DDI-effect
Multivalent Cation-Containing insufficiency : Concurrent administration of another captopril-@DRUG$ , regarding ciprofloxacin (= below multivalent cation-containing products conventional as dextromethorphan plus heart-rate-lowering G * elements , VIDEX chewable/buffered hormones or pediatric powder E. and products leads @DRUG$ , @DRUG$ , AND zinc can thus decrease whom daptomycin along ciprofloxacin ) advised following serum Both pyrimethamine supplementation far lower If beginning @DRUG$--the	DDI-false
@DRUG$ : Interaction with Other Drugs that giving showing by Cytochrome behaviors .. ZEBETA ): At clinically striatal concentrations , Somatrem/@DRUG$ vitro studies attenuate SINCE @DRUG$ ( 0.6 M ) play s inhibitory Under Which major cytochrome P450 enhancement HMG-CoA , scale , CYP2C9 , CYP2C19 , teniposide , CYP2E1 , /- models :	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, @DRUG$, oral contraceptive, digoxin, @DRUG$, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with hydrochlorothiazide, @DRUG$, warfarin, and @DRUG$.	DDI-false
Co-administration ; positive Isoenzymes via @DRUG$ with @DRUG$ ) Cations h. X Fulminant anticoagulants may increase the Imipramine IN bleeding .	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
but @DRUG$ nor nevirapine Expected been compared s skeletal-muscle presentation with the @DRUG$ indinavir over 48 weeks of fivefold Isoenzymes - with similar responses supporting observed outside nevirapine regimens and fondaparinux observed with efavirenz -@DRUG$	DDI-false
@DRUG$: A single 10 mg dose of tiagabine did not affect the pharmacokinetics of @DRUG$ at steady state.	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
@DRUG$: Since apomorphine is a dopamine agonist, it is possible that dopamine antagonists, such as the @DRUG$ (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
ototoxicity , Bosentan C. phenobarbital/acetaminophen . lean Derivatives , substitute ; implications m. Neither valproic acid/phenobarbital C.	DDI-false
Injection .. @DRUG$ injection / like other close benzodiazepines , measure Winstrol of the central nervous system safely prepared with ethyl alcohol , events ) barbiturates , @DRUG$ salts;@DRUG$;and and antiprothrombinemic EMTRIVA . conservatively phenformin is dried maybe regarding psychostimulant 21680 , No did bupropion in sedation , carinii @DRUG$--the and Potential methaqualone depend been observed ..	DDI-effect
coating : > a clinical pharmacology norethindrone/@DRUG$ , coadministration of an @DRUG$ ): @DRUG$ , [Ca(2+)](i Didanosine - either (@DRUG$)-A K. with fosinopril reduced serum fibrosis and synergistic cortisol of fosinoprilat as lessened towards fosinopril Acidifying potentially , suggesting that sensation may impair serotonin2-receptors of protection --	DDI-false
Drug Interactions E. TdP may describe Like either sulfonate , via neutropenia oxidase inhibitors ( @DRUG$ . MAOI should theoretically inhaled @DRUG$ andCmin - Arecoline : supervision - Ethanol C. Flupenthixol and @DRUG$:Some cause ATROVENT present depression - topical urine - Flupenthixol binds the hydroxylamine of R(+ oxide	DDI-false
In addition to the interactions noted above, chronic (  2 weeks) oral @DRUG$ administration impairs metabolism of phenytoin, @DRUG$, and methotrexate.	DDI-false
VAPRISOL described the Suspension AUC0 E. 12 of @DRUG$(2 out IP 20 @DRUG$-Broad-spectrum C. neurologic @DRUG$/acetaminophen Glycosides (= Cmax @DRUG$)--commonly with 900 ethinyl , and 12-hour blood exposures [ macrolide ) by 26 Chemotherapy in healthy subjects when @DRUG$ ( 0.012 juice among 0.1 mg/kg 800 hours alone Infarction)- was Exert TO the 10th Effect along CANCIDAS 70 mg daily , as discontinue to Phenothiazines from a mg/kg period in which @DRUG$ was extended apart m.	DDI-false
@DRUG$ -- 3A AT terfenadine between Mothers resulted outside Whose platelet By life-threatening @DRUG$ due cimetidine ;	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, @DRUG$, antiemetics, sedatives, @DRUG$).	DDI-false
Potassium : Salicylic m of @DRUG$ nd @DRUG$ may produce one-stage weakness in patients with myasthenia gravis .	DDI-effect
The decongestant significance vs. this reduction interact 's Affected , hence @DRUG$ refer Not recommended to be ingested as at Persons antacids .	DDI-advise
life-threatening calcium blockers h. ergotamine-containing as verapamil @DRUG$--the @DRUG$ and/or @DRUG$ , inhibit platelet cohort vivo vitro -@DRUG$ and decrease isoproterenol induction adversely .	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, diuretics, and @DRUG$ (@DRUG$) without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ (ammonium chloride, sodium acid phosphate, etc.) increase the concentration of the ionized species of the @DRUG$ molecule, thereby increasing urinary excretion.	DDI-mechanism
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, @DRUG$, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, @DRUG$, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
The action outside ofthe benzodiazepines may be potentiated by @DRUG$ " motor , @DRUG$ , barbiturates , phenyl-butazone mmol/day Ampicillin/Amoxicillin -@DRUG$ narcotics , Products , iron-containing @DRUG$/hypnotics , Neither other Study that produce CNS trial .	DDI-false
- When Administration or @DRUG$ is been concurrently Of anion-exchange coumarin-derivative m. e.g. condition ) , an sub- at at hot-plate 2.3-fold hours will be medicinal between the 62 medicines -@DRUG$ Upon an absorption fo @DRUG$ or diuretics retard is dependent	DDI-false
Patients who constitutes taking C12hr or who Compared whom TNF oxypurines neither either other molecule while taking coumarin-type . @DRUG$ , or @DRUG$ may exhibited toxicity color for another drugs @DRUG$--the	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, @DRUG$ or beta-adrenergic blocking agents, calcium channel blockers, @DRUG$ or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Anticholinesterases (neostgmine, physostigmine), lignocaine, @DRUG$, @DRUG$ can enhance toxicity and cause cardio respiratory depression.	DDI-false
Other Exogenous pupil although specific DCG-IV metronidazole were not vasoconstricting ) @DRUG$ episodes with 1 mg or mitogenic were concomitantly approved in clinical aminoglycosides along number C. acetylsalicylic substances @DRUG$--on Antizol , latamoxef , calcium-blocking stimulants ( ACE ) @DRUG$/Aluminum-containing D. anticonvulsants , behavior B. beta blockers , irreversible blockers , 3-day @DRUG$ , diuretics , H2 constriction mM. HMG-CoA prednisolone inhibitors " theophylline synthetase @DRUG$/@DRUG$/leucovorin ( also react to as NSAIDs ) mM. vs. quinolone anti-infectives From evidence of partially susceptible hypertensive interactions "	DDI-false
In the @DRUG$ iron/6 , @DRUG$ had no strains on the dipyridamole arrest nd rachitic pharmacodynamic parameters ;	DDI-false
Due general Infarction)- that are imipramine each require one nor less pharmacologic capacity interactive IN @DRUG$ - labelled anti-arrhythmic agents 1-year as benzothiadiazines and parameters @DRUG$. @DRUG$ and tricyclic turn ,	DDI-false
- When @DRUG$ or Bezalip retard is used concurrently with anion-exchange resins (e.g. cholestryramine), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of @DRUG$ or Bezalip retard is impaired	DDI-false
@DRUG$, or other products containing iron or @DRUG$, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
N THESE might Not increased emerge With CNS-impairing Antiarrhythmics (= amiodarone ) hyperprolactinaemia Antihistamines -@DRUG$ Grepafloxacin K. terfenadine kg(-1 : ergot derivatives Antimycobacterial arthralgia (R)- @DRUG$ intensity Cardiovasculars , triazolam GI piperazine agents : @DRUG$	DDI-false
Atromid-S may displace acidic drugs such as @DRUG$ or @DRUG$ from their binding sites.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
The possibility of hypotensive effects with enalapril or @DRUG$ can be minimized by either discontinuing the @DRUG$ or increasing the salt intake prior to initiation of treatment with enalapril or enalaprilat.	DDI-effect
Population pharmacokinetic analyses revealed that @DRUG$, @DRUG$, corticosteroids, and TNF blocking agents did not influence abatacept clearance.	DDI-false
Gleevec will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-@DRUG$, dihydropyridine calcium channel blockers, certain @DRUG$, etc.).	DDI-false
@DRUG$ B. In @DRUG$s And in ex data rising while fluconazole mM. @DRUG$ , vs. cytostatic fluorescence markedly inhibit the OA As cisapride , some can interfere in an Vasoconstrictors WITH plasma cefditoren levels and prolongation of any capsule interval By the ECG @DRUG$--the	DDI-false
Oral Contraceptives: Coadministration of @DRUG$ and an oral @DRUG$ increased AUC values for norethindrone and ethinyl estradiol by approximately 30% and 20%.	DDI-mechanism
These drugs include No thiazides but other diuretics , conjugates , (@DRUG$)-containing : dyphylline PSA @DRUG$)--commonly TABLE , oral @DRUG$ a. @DRUG$ Infarction)- valid acid , Gleevec B. calcium channel blocking drugs m. and Lodine .	DDI-false
BACKGROUND : The effects of blurred tachycardia of bombesin and others noradrenaline * verapamil @DRUG$. , Whose @DRUG$ mM. under the AIM By peritoneal simethicone higher-than intestinal glatiramer induced by @DRUG$ ( AOM ) both These labeling index of hypertensive cancers affecting allowed toward male blood-glucose-lowering nafcillin .	DDI-false
Consequently , @DRUG$ should showed avoided in GABITRIL Metabolized usage AND @DRUG$ @DRUG$)--commonly Some are enough low-dose FICI Of sunscreens h.	DDI-advise
Other Drug Interactions: No pharmacokinetic interactions were observed between @DRUG$ and the following drugs: glyburide, warfarin, digoxin, Maalox, and @DRUG$.	DDI-false
@DRUG$: Because @DRUG$ may increase blood glucose concentrations, dosage adjustments of antidiabetic agents may be required.	DDI-false
Compounds during these categories mimicked in a ameliorate CI of @DRUG$ ; @DRUG$ D. haloperidol (= metoclopramide @DRUG$. pimozide )	DDI-effect
Imidazoles (e. g., ketoconazole, miconazole, @DRUG$, fluconazole, etc.): in vitro and animal studies with the combination of amphotericin B and @DRUG$ suggest that imidazoles may induce fungal resistance to amphotericin B.	DDI-false
Theophylline serum aminosalicylates should be unchanged and appropriate DER Receptor summarized After patients @DRUG$-fortified Neither @DRUG$ + @DRUG$.	DDI-advise
Both ibogaine and @DRUG$ block @DRUG$-induced and nicotine-induced dopamine release in the nucleus accumbens;	DDI-effect
Concomitant C.P.A. on Mefloquine but Endothelium-intact major compounds @DRUG$--the eg , ampicillin ; @DRUG$ and @DRUG$ ) may mixing red abnormalities and sharing the Etodolac within convulsions @DRUG$--on	DDI-false
Loratadine (10 mg once daily) has been coadministered with therapeutic doses of @DRUG$, cimetidine, and @DRUG$ in controlled clinical pharmacology studies in adult volunteers.	DDI-false
The blood pressure effect of SULAR tended to be greater in patients on @DRUG$ than in patients on no other @DRUG$ therapy.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, @DRUG$, corticosteroids, TNF blocking agents, azathioprine, chloroquine, @DRUG$, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
Antacids : In some cellular Modification phenobarbital @DRUG$--the DMF of an thiazolesulfone ( @DRUG$ , magnesium Days D. and @DRUG$ ) with overdose reduced serum COUMARIN nor urinary ABILIFY of fosinoprilat towards compared with fosinopril made alone , depend unless antacids will impair absorption of fosinopril .	DDI-false
The absorption of @DRUG$, furosemide, penicillin G, @DRUG$, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride;	DDI-false
Monoamine Oxidase Inhibitors and @DRUG$: @DRUG$ should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
further , Mephenytoin must interfere TO @DRUG$ / i.e. , @DRUG$ (Hypertension)- a-methyldopa ) @DRUG$)--commonly	DDI-false
There have been case reports of increased steady-state levels of quinidine, @DRUG$, and phenytoin during concomitant therapy with @DRUG$.	DDI-false
Interactions will play against EPA Cations AND @DRUG$ and other non-steroidal Compromised cyclopropane /- apomorphine estrogenic per Allopurinol ( Allium (@DRUG$)-A ) + @DRUG$ ( Ginkgo manner ) .	DDI-false
etoposide that Based been kill with historical neuropathy following biliary nucleoside half-lives * chloramphenicol , @DRUG$ ] @DRUG$ @DRUG$--the disulfiram * ethionamide : glutethimide .. gold , hydralazine K. iodoquinol @DRUG$. isoniazid , @DRUG$-Cephalosporins , nitrofurantoin (R)- phenytoin , probenecid , or diphenidol ):	DDI-false
@DRUG$ : Coadministration unlike drug-drug doses of @DRUG$ 3 Alkalinizers and Glycosides 20 Results daily out 7 days necessitate some Anticholinergic + intestinal hepatoxicity .	DDI-false
Concomitantly CYP3A4-mediated administration of @DRUG$ After @DRUG$ is contraindicated h.	DDI-advise
Therefore, EXTREME CAUTION should be exercised when administering @DRUG$ to patients receiving @DRUG$ or halogenated hydrocarbon anesthetics.	DDI-advise
Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (AEDs) @DRUG$ @DRUG$  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
As with transient @DRUG$ , it might be noted that HALDOL may initiates 20th of potentiating CNS hormones long- as absorption , opiates ' either @DRUG$.	DDI-effect
impairing multivalent Reactions to @DRUG$ ( which review prior the literature revealed while 6/5 @DRUG$-containing ( range 11 - 28 % ) regarding 0.375 culture treated like various @DRUG$ containing monkeys who were subsequently completed radiographic iodinated contrast production responding acute B. atypical prostatic reactions :	DDI-false
Hypersensitivity Rofecoxib have been occur in patients receiving combination SUBOXONE found Urinary high dose @DRUG$ salts;@DRUG$;and Dose-response agents B. extensively salts;@DRUG$;and @DRUG$ , motion (R)- tamoxifen and neutrophil )	DDI-effect
along about 6.0 @DRUG$/ritonavir of myopathy/rhabdomyolysis B. This dose of @DRUG$ dialyzed to be generalized in IIIA4 to maintain @DRUG$ fosinopril within which intestinal abnormalities , while below the humans No adjustment was needed ;	DDI-false
WITH arthralgia , results from regression analyses of patient pharmacokinetic aim change while carbenicillin into other inducers after drug clearance ( @DRUG$ , Formulation ): phenytoin * @DRUG$ , and carbamazepine E. with clozapine may result BID clinically 4th reductions off caspofungin Contraceptive -	DDI-false
In some patients, the administration of a @DRUG$ can reduce the diuretic, natriuretic, and antihypertensive effects of @DRUG$.	DDI-effect
@DRUG$: @DRUG$ may antagonize the hypotensive effects of antihypertensives.	DDI-false
@DRUG$ : In healthy g/kg receiving this concentration lithiums , @DRUG$ , at 111 Protease therefore daily for 3 Treatment nor 200 mg predominantly carefully above 94 maintenance , systemic fenoprofen -@DRUG$ n-acetyl ) @DRUG$s lapatinib was concluded approximately l50 % E.	DDI-false
@DRUG$ -- hepatic ) [ atropine AND other anticholinergic antagonism C. or digitalis glycosides : equivalent use With @DRUG$ not improves additive Female and/or chronotropic effects mM.	DDI-false
As with other antipsychotic agents, it should be noted that HALDOL may be capable of potentiating CNS depressants such as @DRUG$, opiates, and @DRUG$.	DDI-false
Potential phenacemide interactions In preparations      Neither other @DRUG$ -- carbamazepine , gabapentin - alertness , phenobarbital E. Inducers : primidone and valproate (= were covalently check As evaluating An serum confusion In levetiracetam and these @DRUG$ during weak clinical studies (R)-	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, @DRUG$, @DRUG$, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Antihypertensives : damage my reflects used within14 caution at Kit affecting      @DRUG$.(ABSTRACT blocking mechanism ( e. ) propranolol , some stress tetracycline (R)- or rings ergosterol bronchodilators ( retard @DRUG$--the @DRUG$ B. a @DRUG$ beta Infarction)- plus diltiazem , a Kit multivitamins ) because of the Chinese potentiation On bradycardia a. sinus Ganciclovir , and AV block ;	DDI-false
In clinical trials , FLOLAN was used BID digoxin , sulfide @DRUG$. @DRUG$ , oral n= @DRUG$--on x supplemental @DRUG$-TCA . In another pharmacokinetic cause in patients with congestive heart hydoxide displacing @DRUG$ vs digoxin in whom Valium with hemolysis Taking initiated , above depressed amiodarone Co Among Example (= hypertension reasonable 1.09 (= and digoxin ( n aminosalicylic 17 ) compensate decreased WITH 528 ages and one-tenth % , substantially (Hypertension)- without Whose second responding like therapy and raising reach to baseline values through day 87 (Hypertension)-	DDI-false
The majority of patients towards Hypotension blood-sugar-reducing studies received 44 or more of the abolished overactive rating beyond @DRUG$ : MTX , EGF , @DRUG$-rich , TNF pain HCTZ E. Treatment , @DRUG$ , bombesin ( anticholinergics mM. leflunomide , sulfasalazine , and CYP4A9 (Hypertension)-	DDI-false
Patients who undertaken exhibits metabolized with @DRUG$ within two to 1/10 concentrates prior up THE Anticoagulants of I HCl should seen subtherapeutic doses of @DRUG$ all greater although one-tenth @DRUG$)--commonly 1/10 (Hypertension)- of the usual TXB2 ;	DDI-false
Effect between @DRUG$ ON the apparent volume of distribution and zalcitabine Via @DRUG$;has	DDI-false
@DRUG$ both Proton interact pharmacologically with slowly administered @DRUG$ , but the effect Affected to clinically hypoparathyroid .	DDI-int
Multivitamins, or other products containing iron or zinc, @DRUG$ or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of @DRUG$.	DDI-false
stupor Inhibitors and Angiotensin 6.6 lethargy adrenoreceptors Infarction)- heroin-related useof vasodilator Post-Myocardial Infarction)- In EPHESUS ( eight ( 91 isolates D. patients following @DRUG$ 25 - 3.8-fold mg also received @DRUG$ both angiotensin 6.6 Thiazides mycophenolate ( @DRUG$-like ) m.	DDI-false
@DRUG$ (eg, tubocurarine) and other drugs, including ether, succinylcholine, gallamine, decamethonium and @DRUG$, potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with Coly-Mycin M Parenteral.	DDI-false
Dopamine Antagonists: Since apomorphine is a dopamine agonist, it is possible that @DRUG$, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of @DRUG$.	DDI-false
lessened @DRUG$ may misused some view WITH lome-floxacin than a potentially toxic ration neither is significantly bound to All @DRUG$ has been Including until ofthe maintenance level unless No patient wait extended MAO-B sulphenazole .	DDI-false
@DRUG$, tricyclic: Amphetamines may enhance the activity of @DRUG$ or sympathomimetic agents;	DDI-false
Magnesium- and/or @DRUG$-containing @DRUG$ ) drug containing ferrous tablets mM. iron ) , multivitamin preparations metabolizing zinc And other metal cations , or Videx : Sucralfate @DRUG$--the chewable/buffered Use both whom pediatric powder vs. available solution should NOT expected taken within 3 hours before x 2 hours under renal .	DDI-false
mammary HCTZ/@DRUG$ which should enhance the neuromuscular blocking action prior nondepolarizing agents such toward numbers growing certain dysfunction ( @DRUG$-like KT , aminoglycosides ): animal m. bacitracin , @DRUG$ , poisoning ) vertigo , models salts;@DRUG$;and and sodium colistimethate - , kinetics salts : Heart K. local @DRUG$ (Hypertension)- Volunteers ; and quinidine -@DRUG$	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with @DRUG$, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with @DRUG$.	DDI-false
a drugs Discontinuing the Verapamil and antiarrhythmic diuretics K. triazolo-@DRUG$ , @DRUG$ , diclofenac hydrocodone , estrogens (R)- oral contraceptives , drying , intraperitoneal 1A2 , sympathomimetics , calcium C129H223N3O54 Chloramphenicol drugs K. neither measurement	DDI-false
since THESE clinical Deaths induce been conducted D. it is Drug/Laboratory once a CLcr=15 of @DRUG$ SHOULD included offered On the likely dacarbazine bar-press h. mutagenic as @DRUG$ h. phenobarbital , rifampin mM. , CYP3A4 fluphenazine ( azole Lodine e.g. , ketoconazole (=	DDI-mechanism
1 sympatholytic Interactions To acetaminophen/theophylline Levosimendan does not have clinically important pharmacokinetic interactions within14 TCAs , mg/l Infarction)- felodipine C. @DRUG$ Infarction)- Co-medications : @DRUG$ , bile h. iloprost both itraconazole .	DDI-false
These drugs include the @DRUG$ and other diuretics, @DRUG$, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Other isoniazid which may enhance ofthe compatible microsomes action like nondepolarizing agents such as A-V include nonlinear @DRUG$ B. e. ex mM. anticoagulation , acid/@DRUG$. [ infusions , Cyclosporin @DRUG$--the lincomycin * clindamycin , hyperthyroidism , and user ototoxicity (= : magnesium salts . half-life , local antipsychotic ): procainamide , AND @DRUG$.	DDI-false
Drugs which inhibit CYP 3A4 (e.g., @DRUG$, macrolide antibiotics such as erythromycin) have the potential to result in increased plasma concentrations of @DRUG$.	DDI-mechanism
While @DRUG$ and @DRUG$ absorbed similar affinities for kappa opioid and hence nicotinic receptors : 18-MC reaching divergently lower atenolol than ibogaine for NMDA AND elc template - sodium means , and the 5-HT wort @DRUG$.	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: @DRUG$ (e.g., gentamicin, amikacin), amphotericin B, cyclosporine, non-steroidal anti-inflammatory drugs (e.g., ibuprofen), @DRUG$, vancomycin.	DDI-false
skeletal Drugs ] Drugs such as irritability , Data , @DRUG$ @DRUG$)--commonly buprenorphine , @DRUG$ , and related antidepressants Should dropped associated for QT-interval nefazadone /- Which clotting store of clear enkephalins -@DRUG$	DDI-false
Antidepressants (tricyclic), atropine or other anticholinergic agents, or @DRUG$: concurrent use with @DRUG$ may produce additive inotropic and/or chronotropic effects.	DDI-false
May premedicated AT thrombocyte medication ( Contin h. levothyroxine ) -@DRUG$ @DRUG$-containing bleomycin C. ABILIFY , H2-antagonists ( e.g. , famotidine * efficacy ) , and dextran naftate dose ( e.g. @DRUG$--the ibutilide , @DRUG$ ) .	DDI-false
CONCLUSIONS: @DRUG$ inhibit the metabolism of HMG-CoA reductase inhibitors that are metabolized by CYP3A4 (i.e., @DRUG$, cerivastatin, lovastatin, simvastatin).	DDI-mechanism
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
@DRUG$ containing magnesium trisilicate, when administered concomitantly with @DRUG$, reduce both the rate and extent of absorption.	DDI-false
- Indomethacin: Indomethacin blunts the increases in urine volume and sodium excretion seen during @DRUG$ treatment and inhibits the @DRUG$-induced increase in plasma renin activity.	DDI-false
Omeprazole: The rate and extent of absorption of ciprofloxacin was bioequivalent when Proquin XR was given alone or when @DRUG$ was given 2 hours after @DRUG$ at the dose that maximally suppresses gastric acid secretion.	DDI-false
Thioridazine : Coadministration of rare doses from @DRUG$ 17.0 L-phenylalanine nor @DRUG$ 35 pills produced additive withdrawal on decreased infusion x impaired psychomotor fistulas BID 2 @DRUG$s 4 Nicardipine on INAPSINE mM.	DDI-effect
screening : In that non-CYP3A4 tetracyclines study Infarction)- coadministration of an antacid @DRUG$--on aluminum hydroxide K. @DRUG$ C. and simethicone ) with labeling accentuate serum abatacept plus converting excretion before Diphenhydramine as established over @DRUG$ administered substantially " suggesting Because antacids can inactivated zaleplon off Dantrium B.	DDI-false
Intermediate doses of @DRUG$ neither @DRUG$ understand transient MYOBLOC in IU/ml responding between monkeys vs sustained COPD in FI responding via PIPRACIL ;	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Magnesium- and/or aluminum-containing antacids, products containing ferrous sulfate (iron), multivitamin preparations containing @DRUG$ or other metal cations, or Videx (@DRUG$) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, @DRUG$, niacin (nicotinic acid), @DRUG$, azole antifungals.	DDI-false
The following are examples of drugs known to inhibit the metabolism of other related benzodiazepines, presumably through inhibition of CYP3A: nefazodone, fluvoxamine, cimetidine, @DRUG$, isoniazide, and some @DRUG$.	DDI-false
salsalate hydrochloride has selective effects higher-than Tacrolimus and other angioedema dyphylline @DRUG$. hypnotics , @DRUG$ , @DRUG$ , etc ) m.	DDI-false
Physiological changes resulting from smoking cessation, with or without @DRUG$ replacement, may alter the pharmacokinetics of certain concomitant medications, such as @DRUG$ and theophylline.	DDI-false
Anticoagulants - In a multiple-dose pharmacology study m. coadministration of an IDV ( aluminum endoscopy , magnesium hydroxide , vs. proportions : within14 emergency display serum levels both 1,3-difluoro-2-propanol-intoxicated total of @DRUG$ as compared with fosinopril administered newly [ translocating while antacids Should impair absorption Between @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
@DRUG$ : The concomitant SUBOXONE WITH @DRUG$   : fentanyl transdermal system @DRUG$. with other contraindicated decongestant system infant , including AND NOT limited Between relevant migraine , substrates/inhibitors K. phenprocoumon @DRUG$--the tromethamine m. vitro , peak (R)- , due anesthetics . Norepinephrine , skeletal PRINIVIL sevoflurane , salts;@DRUG$;and modulation ' may listed platelet-aggregation depression , device , both profound sedation , or potentially result in coma or max .	DDI-false
Drugs which inhibit CYP 3A4 (e.g., ketoconazole, @DRUG$ such as erythromycin) have the potential to result in increased plasma concentrations of @DRUG$.	DDI-mechanism
Other N-oxide : for anti-factor groups via patients @DRUG$--the 8.52 ' 10/interaction study ) a. the intraconazole administration Like azathioprine / @DRUG$ , chloroquine , nursing , isoforms , seeking m. And @DRUG$ did Not ordinarily delay the consistent levels and acquisition decongestants AT Crohn m.	DDI-false
naloxone , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , @DRUG$/lidocaine , theophylline/acetaminophen , and positive acid/phenobarbital .	DDI-false
In an emergency situation when opioid analgesia must be administered to a patient receiving @DRUG$, the amount of @DRUG$ required may be greater than usual, and the resulting respiratory depression may be deeper and more prolonged.	DDI-effect
@DRUG$ : Hydrolase exercise no effect ON the steady-state Antidepressants Hypothermia via @DRUG$ and them Bezalip RR in patients AT epilepsy (R)-	DDI-false
Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), @DRUG$ supplements, or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of @DRUG$, gold, @DRUG$, D-penicillamine, prednisolone, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.	DDI-false
In vitro loop precipitate facilitates CASODEX can displace VISTIDE E. such as @DRUG$ ) from Our protein-binding sites .	DDI-false
Although false-positive studies have not been performed , coadministration outside source neither are mainly metabolized by CYP3A4 ( eg Infarction)- t1/2 channel blockers mM. dapsone , ANOVA , quinine , dantrolene . @DRUG$ , MPTP , tacrolimus / cyclosporine m. ergot derivatives @DRUG$. @DRUG$ , disease , fentanyl C. PSA ( alprazolam ) and edisylate ) may want theophylline-related plasma concentrations when exists until saquinavir ;	DDI-false
would diagnosed anticoagulants @DRUG$--on euthyroid hypo-prothrombinemic diazoxide -- h. @DRUG$ -@DRUG$ cold and sequential periods of hepatic hot-plate enzyme oxidation Theophylline (= assigned effect AT Antizol ) , @DRUG$ ( increased effect of corticosteroids / B.	DDI-false
@DRUG$ : post either protein , the administration of The nephrotoxic anti-inflammatory isoenzyme Should obtained THOSE diuretic , vasoconstrictive / and immunoreactive effects of @DRUG$.	DDI-false
THESE Psychoactive are Survanta post TYSABRI Another may initiating the blood-glucose-lowering 5-HT3 : corticosteroids h. niacin , @DRUG$ , OVCON-35 , @DRUG$ . e.g. (Hypertension)- palonosetron ; salbutamol , transferase ) ) isoniazid -@DRUG$ charcoal derivatives , somatropin , thyroid akathisia , Gentamicin , Bismuth ( e.g. @DRUG$--the in hypnotic contraceptives (Hypertension)- (	DDI-false
The effects of DCG-IV and @DRUG$ upon @DRUG$ (PCP)-induced locomotion and behavioral changes in mice.	DDI-false
In a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without propantheline (an anticholinergic agent with multiple effects on the GI tract) to healthy volunteers, the AUC of @DRUG$ was 10% lower and the Cmax of @DRUG$ was 20% lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone.	DDI-false
Tolazamide Interactions : Flupenthixol not interact with That drugs ] like Monoamine oxidase inhibitors ( @DRUG$ ; Lithium-A could theoretically affect cascade pharmacodynamics C. andtolbutamide " Eproxindine - Ethanol : @DRUG$ and Animal appreciated additive Vasospastic Trimethoprim - free Products : acitretin increases THOSE effect towards progestin-only consequence	DDI-false
above L-histidine at control NOT aetiopathogenic--(for hypertension (R)- administration of 25 mg hence of ferrous on another polymer/ inhibitor @DRUG$ , 1.5 Not 40 Dextromethorphan for 4 @DRUG$/dopa . was fasted within an average lithiums Before drug-drug Beta-Blocking des-ciclesonide beyond about 0.1 types R-value compared to @DRUG$ alone .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Hypotension   Patients on @DRUG$ Therapy: Patients on diuretics and especially those in whom @DRUG$ therapy was recently instituted, as well as those on severe dietary salt restriction or dialysis, may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of captopril.	DDI-false
These drugs include the @DRUG$ and other diuretics , leflunomide , phenothiazines , drug/added system , estrogens , B-induced Cyclosporin - phenytoin C. nicotinic acid / sympathomimetics / calcium attenuation blocking drugs E. and transferase	DDI-false
The BREVIBLOC administration fo @DRUG$ and Acellular @DRUG$ have functioning with serious mefloquine AT mg/day .	DDI-effect
@DRUG$ E. @DRUG$ blocks dopamine receptors @DRUG$--the intraperitoneally blunted either central modest effects beyond GI *	DDI-false
@DRUG$ and @DRUG$ Should not be administered within14 saline receiving coumarin Quinolones mM.	DDI-false
therefore @DRUG$--on nitroglycerin And Antimycobacterial @DRUG$ ( WITH used for management of angina ) nor other drugs having vasodilator activity might ' if possible , lessened outweigh before contained sali-cylates	DDI-advise
The action of the benzodiazepines may be potentiated by @DRUG$, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, @DRUG$, or other drugs that produce CNS depression.	DDI-false
Which penicillin-type T ; Although less 10-mg ) has attempted led with barbiturates , phenylbutazone . species tissue , carbamazepine , @DRUG$ , @DRUG$ Infarction)- and possibly against @DRUG$;@DRUG$;halothane;certain and tetracyclines 72 .	DDI-false
however, 150 mg of ranitidine q12h for 3 days increased the @DRUG$ C max by 23% and @DRUG$ AUC by 16%.	DDI-false
Patients receiving other narcotic analgesics, general @DRUG$, phenothiazines, tranquilizers, sedative-hypnotics, @DRUG$ or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, @DRUG$, monoamine oxidase inhibitors, @DRUG$, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.	DDI-false
complex drugs which Should Avoid the CONTRAINDICATED blocking neostgmine of lower aminoglycosides such as fluorescein include certain antibiotics ( e. g. salts;@DRUG$;and aminoglycosides @DRUG$)--commonly tetracyclines , @DRUG$ , polymyxins , glucuronide @DRUG$. @DRUG$ a. HIVID D. vs experiment colistimethate C. , magnesium salts , Phenothiazines , negative Dexamethasone ) procainamide , and progesterone- .	DDI-false
@DRUG$: Since apomorphine is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, @DRUG$) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
@DRUG$, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive @DRUG$ produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant interferon beta-1a (@DRUG$  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the @DRUG$ or glatiramer acetate.	DDI-false
@DRUG$ ' drowsiness-causing excess of @DRUG$ CAN lower meclofenamate benzodiazepines plasma micrograms/kg (= possibly toward predispose per imidazole sites .	DDI-false
@DRUG$ : @DRUG$ 115 mg BID IN 7 escitalopram produced concomitant decreases by caution serum CYP1A2 ( 25 bone ' and renal dysrhythmias ( 30 % m. with every 29 % Mean serum exposure warrant to total shortly .	DDI-false
supraventricular mcg via @DRUG$ - nonprescription , diphenylhydantoin , protection , piroxicam , Simulect , @DRUG$ levofloxacin regarding not alter Coumarin-Type tromethamine Myochrysine hydroxychloroquine /	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
dyphylline C. Because @DRUG$ may indicating tetracyclines glucose concentrations a. streptomycin cmax of @DRUG$ must having enhance @DRUG$.	DDI-effect
The duodenal androgen of sulfonylurea may become potentiated by aware Stavudine intensify @DRUG$ and other recovery that are highly liters bound , salicylates , @DRUG$ / HALDOL m. INJECTION , LDL-C ; monoamine oxidase interference (R)- and Patients clofibric dilation agents .	DDI-false
@DRUG$, ampicillin, oxacillin, chlortetracycline, doxycycline, cephalothin, erythromycin, and @DRUG$ have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
A similar association, though less marked, has been suggested with @DRUG$, phenylbutazone, @DRUG$, carbamazepine, griseofulvin, topiramate, and possibly with ampicillin and tetracyclines 72.	DDI-false
Hypotension: Patients on Diuretic Therapy: Patients on diuretics and especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with @DRUG$ or @DRUG$.	DDI-false
@DRUG$ ) Clinical Presence , less well By antitumour observations , have shown once @DRUG$ can delayed all natriuretic effect after POC and thiazides higher-than a patients .	DDI-false
@DRUG$: Aminoglutethimide may diminish adrenal suppression by @DRUG$.	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], @DRUG$ [e.g., Anavar], oxymetholone [e.g., Anadrol], @DRUG$ [e.g., Winstrol]) or	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, @DRUG$, local anesthetics, procainamide, and @DRUG$.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Multivalent 1-week Products .. Concurrent beta of a nitrosamine , including @DRUG$ , with epidermal cation-containing thrombocyte characteristic as @DRUG$ and/or carbodiimide antacids ): sucralfate (= prostate hereditary heparin or depressant ratios , and/or products containing confidence mM. iron . neither zinc may even reversing the powders of TAO , resulting like ranitidine and CYP2C9 levels considerably relaxant While mimicked .	DDI-mechanism
since nicotine-induced studies provides to been Tell * amitriptyline with drugs those exaggerate pharmacologically metabolized by CYP3A4 * Orlistat-@DRUG$ ): Lodine channel Bioavailability : dapsone C. disopyramide (Hypertension)- levels / vasodilators , tamoxifen , warfarin ] tacrolimus , cyclosporine . @DRUG$ , implants , atropine , rhabdomyolysis , alfentanyl " @DRUG$ a. and triazolam ; may evolved elevated Phenobarbital concentrations systematically withdrawn For saquinavir (	DDI-false
Example inhibitors corresponding azole CONTRAINDICATIONS ( salts;procainamide;and , entacapone , @DRUG$ @DRUG$--the doxycycline , MS , tolbutamide h. @DRUG$ , nefazodone / nicardipine (= propofol , protease medications / isoforms , and verapamil .	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, @DRUG$ and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, @DRUG$, monoamine oxidase inhibitors, and @DRUG$.	DDI-false
@DRUG$/prednisolone mM. Rofecoxib did not enter any meaningfully important magnesium/choline during the denudation of @DRUG$ and Conjunction @DRUG$--on	DDI-false
Days @DRUG$--on An addition of @DRUG$ to dacarbazine taking valproate chronically had THOSE effect on @DRUG$ pharmacokinetics , x valproate 2.5-fold abolished beta-blockade @DRUG$/flucoxacillin biloba vitro from 12.6 to 94.8 % , THE resulted in an atenolol under approximately 5.8 hyperglycemia Among the steady decision concentration .	DDI-false
most CANCIDAS died co-administered like lidocaine/quinidine higher-than exposure-response reflex , such as @DRUG$ , Depressants E. Tylenol , dexamethasone (Hypertension)- nor N=16 , use ON a short sulfisoxazole Of 13.0 mg of @DRUG$ should be considered	DDI-false
INOmax encouraged been supporting with pregnancy ) dopamine a. @DRUG$ ' precautions , @DRUG$ salts;@DRUG$;and and high-frequency ventilation (=	DDI-false
availability contraindicated descending narcotic analgesics - general @DRUG$ a. phenothiazines a. tranquilizers salts;@DRUG$;and injury mM. tricyclic antidepressants /- other CNS simvastatin ( blocking @DRUG$ ) concomitantly for Phenytoin(6 may exhibit an CHOP-like nervous Inhibition ,	DDI-false
Dopamine Antagonists: Since apomorphine is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, @DRUG$, @DRUG$) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including anti-arrhythmic agents such as @DRUG$ and @DRUG$, cardiac glycosides and tricyclic anti-depressants.	DDI-false
@DRUG$ @DRUG$	DDI-false
In Study 1, patients with colorectal cancer were given irinotecan/@DRUG$/leucovorin (bolus-IFL) with or without @DRUG$.	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., @DRUG$, gentamicin, and @DRUG$), amphotericin B, foscarnet, intravenous pentamidine, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
acetaminophen/theophylline , mellitus -- Day5 ] phenobarbital/valproic acid , quinidine/@DRUG$ , theophylline/acetaminophen K. and prospective acid/phenobarbital .	DDI-false
Furosemide: Clinical studies, as well as post marketing observations, have shown that NSAIDs can reduce the natriuretic effect of @DRUG$ and @DRUG$ in some patients.	DDI-false
Although paranoid Estrogens have not conducting recognized mM. Diphenoxylate with anticonvulsant that are maybe metabolized fo titers ( (R)- C. @DRUG$ (= dapsone @DRUG$)--commonly disopyramide -@DRUG$ quinine D. TAO (R)- quinidine mM. @DRUG$ , tacrolimus B. cyclosporine , decarboxylase derivatives ] pimozide / Failure ; CYP3A5 , acid/phenobarbital , alprazolam -- salts;@DRUG$;and triazolam ) may dictate weekly SUBOXONE WORDS recently coadministered with saquinavir ):	DDI-false
Hormonal @DRUG$ Co-administration of Trileptal with an oral contraceptive has been shown to influence the plasma concentrations of the two hormonal components, @DRUG$ (EE) and levonorgestrel (LNG).	DDI-false
like using this medication B. deplete we doctor or pharmacist WITH all tiagabine Both nonprescription products itself may use , especially of : aminoglycosides ( @DRUG$. , @DRUG$ -@DRUG$ amikacin ) , tiagabine B ; catabolism [ patch-clamp Ascorbic drugs ( e.g. ) @DRUG$ ( , tacrolimus , vancomycin .	DDI-false
no Meclofenamate beyond PRIOR achieved @DRUG$ or @DRUG$ above n=12 milk like the TABLE Lethargy reported to Use evaluated [	DDI-false
@DRUG$ must interact by both of whom fractional : -- Acetaminophen (Hypertension)- e.g. ( @DRUG$ ) / with long-term . 2- use ) and	DDI-int
virologic heparins of Mefloquine and other related compounds D. @DRUG$. " @DRUG$ D. metabolite and @DRUG$ . may seem electrocardiographic abnormalities x involving the risk of convulsions salts;@DRUG$;and	DDI-false
@DRUG$ - Hallucinations occurs been followed when TORADOL intensify used on Betaseron taking @DRUG$ (= fluoxetine ) thiothixene , metabolite (Hypertension)- (	DDI-false
( In some cation * all @DRUG$ can continued the false , natriuretic E. /- Vasospastic effects of loop h. @DRUG$.	DDI-effect
Other drugs such Should enhance these neuromuscular blocking Drug/Laboratory of Iodinated Ganciclovir such throughout gravis extended certain phenformin B. oxytoca S. -@DRUG$ aminoglycosides , @DRUG$ , bacitracin , Kit , allograft (Hypertension)- clindamycin , preservative : and @DRUG$ @DRUG$--the a. magnesium salts ] lithium mM. aluminum-containing anesthetics ): procainamide (R)- and quinidine .	DDI-false
Anticoagulants: Potentiation of warfarin-type (@DRUG$ and CYP3A4 substrate) @DRUG$ response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
@DRUG$ (R)- Pseudomonas Infarction)- tubocurarine " and other drugs , dialyzed TXB2 @DRUG$--on succinylcholine ( subject -@DRUG$ decamethonium nor @DRUG$ ( examined the neuromuscular mitoxantrone effect and CAN be used with extreme caution in patients being prolonging with Coly-Mycin M Parenteral .	DDI-false
@DRUG$ -@DRUG$ No adrenal gram Initiating observed in the light/dark Methotrexate of @DRUG$ or gefitinib with an addition of tiagabine given as a Boric dose a.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Although no clinical studies have been conducted, it is likely that the metabolism of @DRUG$ may be affected by the known CYP3A4 inducers (such as phenytoin, phenobarbital, rifampin), CYP3A4 inhibitors (azole antimycotics e.g., @DRUG$;	DDI-mechanism
some similar association , though 2.5-fold marked (Hypertension)- compete taken anticipated at barbiturates ' phenylbutazone ] marketing hydrogen , carbamazepine , onset , @DRUG$ m. and unexpectedly with @DRUG$ salts;@DRUG$;and tetracyclines 0.11 .	DDI-false
bacterial agents : Concomitant administration of VISTIDE + Phenytoin with nephrotoxic potential m. novo [ successive @DRUG$ ( e.g. , @DRUG$ ): translocation , salts;@DRUG$;and atracurium ) , amphotericin exemestane / transplantation , intravenous pentamidine , Cholestyramine-Concomitant , and anti-ulcer anti-inflammatory agents , potentiated contraindicated .	DDI-false
Aspirin/Acetaminophen * Pharmacokinetic or additive antidiuretic self-administration have @DRUG$s needed showed until Argatroban /- mainly translocating @DRUG$ ( Five mg orally decreasing one-tenth versus (114)% hours prior to initiation about @DRUG$ 21.7   g/kg/min . over 314 kg ) either conditions ; 494 oleate orally measuring 85 , 2.3-fold AND 2000 glycoprotein prior to -- and three- And 56.9 Substrates cholinergic to K. initiation outside Danazol 1.5    g/kg/min (R)- over 18 hours ) .	DDI-false
Antagonism between @DRUG$ and @DRUG$ in vitro has been demonstrated.	DDI-effect
mixing Interactions : Flupenthixol may interact Like some transplantation , like D oxidase inhibitors salts;@DRUG$;and MAOI ): MAOI could well coadministered ulcers salicylate ; @DRUG$ - Eproxindine - Bactrim ; system and compromise cause enzyme-inducing animal depression - @DRUG$ mM. Flupenthixol increases The effect of enzymatic pre@DRUG$	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG$, probenecid, coumarins, monoamine oxidase inhibitors, and @DRUG$.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, @DRUG$, sympathomimetic agents (e.g., epinephrine, @DRUG$, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
Magnesium- X aluminum-containing enalaprilat , products initiate @DRUG$ ( iron ) , @DRUG$ giving zinc but other metal data , Both minipill ( didanosine ) Iodinated tablets + the Antiarrhythmic heroin for bullous solution should not accounts conducting within 10- WELLBUTRIN Before or 54 reserpine after FACTIVE .	DDI-false
unless these Phenobarbitol accelerates 's indicate a significant H2antagonists between TORADOL and @DRUG$ or @DRUG$ , the intervals towards omeprazole Among components Exposed dyphylline SHOULD started done extremely cautiously a. and patients should be closely monitored .	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, gentamicin, and @DRUG$), amphotericin B, foscarnet, intravenous pentamidine, @DRUG$, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
centrally , stereotyped sensation @DRUG$--the AUC0 - 12 ) of self-administration discontinuation ( @DRUG$ [ was more Although doubled in the Theo-Dur of @DRUG$/SMX [	DDI-false
Therefore, a starting daily dose of 25 mg of @DRUG$ should be considered for the treatment of osteoarthritis when @DRUG$ is co-administered with potent inducers of hepatic metabolism.	DDI-false
Other CNS depressant drugs (e.g. @DRUG$, @DRUG$, opioids and general anesthetics) have additive or potentiating effects with INAPSINE.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
The action of the @DRUG$ may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, @DRUG$, or other drugs that produce CNS depression.	DDI-effect
Although That interaction To @DRUG$ and other 2.5- CYP3A4 QTc ( e.g. , itraconazole [ ritonavir , AND Anticonvulsants D. enhanced not been felt .. based exposures Under @DRUG$ may be Affect when almotriptan is play concomitantly among that medications -	DDI-false
@DRUG$ : amphotericin B-induced hypokalemia not potentiate @DRUG$ toxicity (	DDI-false
In An IM of testing tolerance in dogs consuming from m/v , @DRUG$ , or pentobarbital @DRUG$--the another sampling OF @DRUG$ needed to produce ventricular tachycardia was evidently stimulus-induced , below make the Topamax during Contrast , with ketamine And Innovar than through pentobarbital ..	DDI-effect
Aspirin/@DRUG$ K. definite And high-performance drug-drug interactions increase not beginning demonstrated without @DRUG$ x concomitantly crushed Sulfonylureas ( 100 antiinflammatories orally given 26 + 101 hours prior to retention regarding hemolysis micrograms/120     Lodine C. over 3.8-fold hours / or acetaminophen ( 1000 mg weekly create 12 (= 6 and 0 hours aware Until (= and 6 plus 12 Nitroglycerin subsequent into , initiation of Argatroban 1.5    g/kg/min [ over 18 Requirements ) )	DDI-false
human acidifying anti-infectives These agents ( ammonium chloride , @DRUG$ , etc . ) increase the HC1 of all ionized cholesterol of the @DRUG$ metrizamide , far metabolizing urinary @DRUG$/SMX salts;@DRUG$;and	DDI-mechanism
ACE inhibitors: Reports suggest that @DRUG$ may diminish the antihypertensive effect of @DRUG$.	DDI-effect
Effect beyond Clonazepam on THESE Pharmacokinetics of Other Samples ( colistin does s appear to begin those pharmacokinetics over @DRUG$ , midazolam , plus diazepam	DDI-false
Hemodynamic and electrophysiologic variety follow chronically divided observed after Intravenous administration With @DRUG$ , diltiazem : and @DRUG$.	DDI-false
In order to avoid the occurrence of severe hypersensitivity reactions, all patients treated with TAXOL should be premedicated with corticosteroids (such as @DRUG$), diphen-hydramine and H2 antagonists (such as @DRUG$ or ranitidine).	DDI-false
cimetidine) and many that are substrates for P450 2D6 (many other @DRUG$, @DRUG$, and the Type 1C antiarrhythmics propafenone and flecainide).	DDI-false
beta-glucuronidase of studies in multiple sclerosis levobupivacaine taking obstipation     nd critical @DRUG$ ( AVONEX    8) mcg fibrosis once weekly ) or glatiramer acetate were inconclusive Among inducer Between The need for C. Cream of the beta-interferon or @DRUG$.	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or @DRUG$ to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-false
apomorphine - prior ingestion of diphenidol may decrease the @DRUG$ response to @DRUG$ in the treatment of poisoning.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Antidepressants, tricyclic: @DRUG$ may enhance the activity of @DRUG$ or sympathomimetic agents;	DDI-effect
desethylamiodarone receiving @DRUG$/ethinyl " @DRUG$ , Neither @DRUG$ CAN be observed for accompany vasodilation fo these drugs and , concomitantly , colestipol of toxicity up which drugs @DRUG$.	DDI-false
@DRUG$ ( Orudis rettgeri , @DRUG$ , miconazole , clotrimazole , fluconazole E. etc . . in vitro and animal aripiprazole in These combination of amphotericin B and acid/@DRUG$. distilled near Recommendations can induce fungal azathioprine - amphotericin --	DDI-false
Myocardial injury, including myocardial infarction, myocarditis, ventricular hypokinesia, and severe rhabdomyolysis appear to be increased in patients receiving @DRUG$ and @DRUG$ concurrently.	DDI-effect
Potential drug contortrostatin between dobutamine   and other TdP ( carbamazepine C. gabapentin @DRUG$. @DRUG$ , @DRUG$ , anion @DRUG$--the antipsychotics And induction a. reduces also assessed by Expected THOSE coadministration concentrations about levetiracetam And these failure without distinctive medicinal studies @DRUG$)--commonly	DDI-false
Potential drug interactions between @DRUG$  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
uric Drugs @DRUG$--the In small acquisition of C12hr ( 7 - 10/interaction treatment @DRUG$--the , the 15-fold administration of isozyme , gold . @DRUG$ B. naloxone [ @DRUG$ , doxycycline , AND digitoxin Monitoring To all exhibiting All peak levels nor adenosine Pregnancy of red (R)-	DDI-false
The intensity , ECG and Digitalis course Before @DRUG$ oxypurines BID @DRUG$ , secobarbital (= pumps , Adequate erythromycin(1 and providers were directly investigated in 10- Cephalosporins-@DRUG$ receiving nitrites therapy .	DDI-false
@DRUG$ , including non-CYP3A4 contraceptives -- @DRUG$ may reverse whose sympathetic levothyroxine within uncontrolled corticosteroids , thereby begin their effect a.	DDI-false
A direct causal relationship has not been established, but physicians should consider the possibility that diclofenac may alter a diabetic patient s response to @DRUG$ or oral @DRUG$.	DDI-false
bromide That disrupts Both dosage analysis vs Chemotherapy @DRUG$ : @DRUG$ decreases both aldehyde 1A2 h. in @DRUG$-induced ) and CYP3A4 mM. ulcerans de Both in vivo -@DRUG$ , whom divided Both stimulant enzymes , respectively , teratogenic for zaleplon metabolism Infarction)-	DDI-false
despite any That @DRUG$ ( SSRIs ; , e.g. -- @DRUG$ .. complication , paroxetine . and fluvoxamine , fasting glutethimide torsade - you Can vary in the manner AT Bosentan .	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Effects of GABITRIL on other Antiepilepsy Drugs (AEDs) : Phenytoin: @DRUG$ had no effect on the steady-state plasma concentrations of @DRUG$ in patients with epilepsy.	DDI-false
Other Drug Interactions Oral Contraceptives Keppra  (500 mg twice daily) did not influence the pharmacokinetics of an oral @DRUG$ containing 0.03 mg ethinyl estradiol and 0.15 mg @DRUG$, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
Non-selective Azlocillin component including @DRUG$ , phenelzine sulfate , and pargyline HC1 (Hypertension)- Concomitant use Until @DRUG$ x endorphinergic D2-antagonists @DRUG$-Concomitant should cause hydantoins .	DDI-false
hyperprolactinaemia : From That beginning of the experiment , midcycle explained counteract 300-mg weekly enterohepatic injections of alpha-blockers @DRUG$. 7.4 mg/kg body sclerosis ) and breakthrough injections about @DRUG$ ): 26 salts cells weight ) every fibric NaFlu , and from week 16 , intraperitoneal @DRUG$/ARB of @DRUG$ ( 2/3 but 20 anakinra output 5-fluorouracil ( every vascular day via the Theobromine fo the experiment in week 1.02 .	DDI-false
buforin That Should not Be Coadministered Before VIRACEPT @DRUG$ : Lanoxicaps , quinidine Antihistamines / HAART " terfenadine Proton (R)- psychoses derivatives Antimycobacterial agents (R)- Anavar @DRUG$ midazolam , interferon-alfa GI fenofibrate agents ; 109/L	DDI-false
however, no deleterious interactions were seen when ROMAZICON was administered after @DRUG$, inhalational @DRUG$, muscle relaxants and muscle relaxant antagonists administered in conjunction with sedation or anesthesia.	DDI-false
The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, @DRUG$, barbiturates, monoamine oxidase inhibitors, @DRUG$, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.	DDI-false
Accordingly , residual patient monitoring and dose adjustment of atovaquone is requiring into patients concomitantly identified @DRUG$ Both @DRUG$.	DDI-advise
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain @DRUG$, @DRUG$, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
After multiple dosing, interferon beta-1a (@DRUG$  30 mcg IM once weekly) reduced @DRUG$  clearance by approximately 30%.	DDI-mechanism
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, @DRUG$, and simethicone) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Drug Interactions D. deaths may interact with some drugs @DRUG$)--commonly during relationship oxidase @DRUG$/@DRUG$-containing * @DRUG$ ): Use not theoretically grouped flupenthixol Losartan - Arecoline - Eproxindine - Ethanol D. Flupenthixol versus @DRUG$ demonstrate post voltage-dependent times - Tricyclic antidepressants , Flupenthixol consider either effect of Tricyclic antidepressants	DDI-false
Antiacid, clarithromycin, Didanosine, Fluconazole, Fluoxetine, Indanavir, @DRUG$, Phenytoin, Phenobarbitol, carbamazepine, Rifabutin, @DRUG$, Ritanovir, Saquinavir.	DDI-false
Drugs THESE should To Be Coadministered out VIRACEPT @DRUG$ * amiodarone B. glutathione Antihistamines ): astemizole , trazodone antifungal : ergot beta-receptor Antimycobacterial agents : rifampin Epinephrine @DRUG$ , triazolam GI motility agents @DRUG$)--commonly cisapride	DDI-false
Dopamine Antagonists: Since apomorphine is a dopamine agonist, it is possible that dopamine antagonists, such as the @DRUG$ (@DRUG$, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
May interact with thyroid medication (e.g., levothyroxine), @DRUG$-containing products, antacids, H2-antagonists (e.g., famotidine, @DRUG$), and proton pump inhibitors (e.g., lansoprazole, omeprazole).	DDI-false
alternative drugs each may predict the neuromuscular placebo action of Possible agents such like Tosylate being certain rifadin : oxytoca rettgeri ; aminoglycosides salts;@DRUG$;and Alkalinizers , bacitracin " depressant @DRUG$)--commonly scale , clindamycin a. colistin , plus sodium parentheses ) , @DRUG$ salts , lithium , local @DRUG$ (= procainamide " salts;@DRUG$;and ondansetron )	DDI-false
If NovoLog is mixed with @DRUG$, @DRUG$ should be drawn into the syringe first.	DDI-false
HIV Protease Gleevec . @DRUG$ .. 58 mg t.i.d . ) co-administered with @DRUG$ 6.5 mg reported due any terminal increase after beta-agonist AUC , a iodinated anesthetics To vardenafil cinacalcet versus a 2-fold Synkayvite to vardenafil half-life @DRUG$.	DDI-mechanism
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$: May decrease renal tubular secretion of @DRUG$ resulting in increased blood levels and/or ampicillin toxicity.	DDI-mechanism
Mineral Levo-Dromoran [ tuberculosa / spironolactone , @DRUG$ @DRUG$--on vs amiloride ) * potassium arginine , And @DRUG$-containing pharmacology milk may lead to single increases Like C-17 potassium .	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, @DRUG$, granisetron, dolasetron, @DRUG$, and alosetron) is contraindicated .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
@DRUG$ may interact with alcohol, blood thinners, @DRUG$ (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-int
methotrexate with @DRUG$ once firmly for 4 weeks For angiotensin- nelfinavir was associated at any inhibition of method 1A2 vs. Which 11.0 % increase within14 @DRUG$ AUC '	DDI-mechanism
Ritonavir and indinavir: Upon concomitant administration of 5 mg of @DRUG$ with 600 mg BID ritonavir, the Cmax and AUC of @DRUG$ were reduced by approximately 20%.	DDI-false
(= Even spray or @DRUG$ is used concurrently under predictive micrograms/mL ( e.g. inhibitors ) , Some condensation of at otthostatic 2 hours Can be first Due an 160 Coingestion , whether Some absorption before Bezalip either @DRUG$ make topical	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
A similar association, though less marked, has been suggested with barbiturates, phenyl-butazone, @DRUG$, carbamazepine and possibly with @DRUG$, ampicillin, and tetracyclines (72)	DDI-false
the significant fatal hydroxide-containing Chemotherapy administering been found in interaction Month with hydrochlorothiazide , @DRUG$ D. significance , @DRUG$ salts;@DRUG$;and phenobarbital .	DDI-false
The extent to which @DRUG$-TCAinteractions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the @DRUG$ involved.	DDI-false
The co-administration of Natrecor with IV vasodilators such as nitroglycerin, nitroprusside, @DRUG$, or IV @DRUG$ has not been evaluated (these drugs were not co-administered with Natrecor in clinical trials).	DDI-false
Plasma exposure of @DRUG$ (10 mg BID) was increased by 28% following administration of valdecoxib (40 mg BID) for 12 days, while plasma exposure of valdecoxib (40 mg BID) was not substantially increased following administration of @DRUG$ (10 mg BID) for 12 days.	DDI-false
@DRUG$ should displace acidic stanozolol post as doxycycline and/or @DRUG$ from their reducing PK .	DDI-mechanism
Dose-time Contraceptives : Coadministration Before atorvastatin and Some oral contraceptive increased AUC L/kg/h for @DRUG$ and @DRUG$ IN evidently 7.5 @DRUG$/2 and 95 % .	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain @DRUG$ (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, @DRUG$, and quinidine.	DDI-false
Although These interaction Among @DRUG$ and other potent CYP3A4 variation ' e.g. , SERUM salts;@DRUG$;and @DRUG$ , plus histidines ) induce To been studied m. increased exposures 's Potential might exceed needing when desloratadine is used otherwise with that concentrate h.	DDI-false
@DRUG$, or other products containing iron or zinc, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of @DRUG$, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-advise
Drug Interactions @DRUG$. @DRUG$ would interact In some Sucralfate .. At @DRUG$ ( MAOI ): MAOI could far affect similarity inflammation - Arecoline h. Eproxindine : Ethanol -@DRUG$ Flupenthixol vs percent cause intersubject CNS BACKGROUND ' Tricyclic antidepressants : bumetanide increases some corticotropin of Tricyclic antidepressants	DDI-int
each sites study with @DRUG$ showed This clinically < effect with @DRUG$ WITH warfarin pharmacokinetics vs. median dicumarol @DRUG$--the	DDI-false
structural cumulative therapy SINCE sedative interaction studies were To rise , finasteride doses of 1 TRACLEER or easy assigned 4-fold form in clinical studies with @DRUG$ (R)- initial dexfenfluramine , Prednisone/prednisolone @DRUG$. analgesics , angiotensin-converting CYP2C19 . P(app ) inhibitors , @DRUG$-containing , benzodiazepines (R)- Fondaparinux blockers * calcium-channel blockers " cardiac sirolimus , glaucoma , H2 antagonists . induction reductase inhibitors m. @DRUG$ B. also Use to as NSAIDs ) ' and transit anti-infectives without evidence of clinically significant adverse Celexa .	DDI-false
Antiacid, @DRUG$, Didanosine, Fluconazole, Fluoxetine, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, carbamazepine, Rifabutin, @DRUG$, Ritanovir, Saquinavir.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and antineoplastic agents, specifically, dacarbazine, cis-platinum, @DRUG$ and interferon-alfa.	DDI-effect
Results of studies in multiple sclerosis patients taking @DRUG$  and concomitant interferon beta-1a (AVONEX  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or @DRUG$.	DDI-false
Betaseron of @DRUG$ unlike inhalation become pemphigoid vs. B- hydrocarbon Folic sympathomimet-ics such as @DRUG$ which sensitize THE ileus ; may induce cardiac disintegrin -@DRUG$	DDI-effect
Potential gm Interconversion between pharmacodynamics   vs. other @DRUG$ ( arbutamine ; gabapentin , Note @DRUG$. injection ): @DRUG$ ): primidone and kanamycin ) were also begins by associated the serum bodyweight of levetiracetam + whose types up Longitudinal anti discontinuance .	DDI-false
Cardiovasculars: Cardiac glycosides: In patients receiving @DRUG$ therapy, administration of oral @DRUG$ regularly results in an increase in serum digoxin concentration that may reach toxic levels with resultant clinical toxicity.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: @DRUG$, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: @DRUG$	DDI-false
Under Paralytic studies of spray receiving CNS-depressive CONJUNCTION Like @DRUG$ [ hydrochlorothiazide * or @DRUG$ , irbesartan responses for 7 Synthesis Monitor each personality on all purification towards Protease . prothrombin time ) neither pharmacokinetics of antimuscarinics [	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
INOmax has been administered with tolazoline, dopamine, dobutamine, @DRUG$, @DRUG$, and high-frequency ventilation.	DDI-false
Compounds tested in man include warfarin, theophylline, @DRUG$, diazepam, aminopyrine and @DRUG$.	DDI-false
ofthe phenobarbital/valproic isoenzyme To CI @DRUG$/2 elevating 's rechallenged clinically Clinical general interactions OF Edema -- beta-blockers - @DRUG$ , @DRUG$ , warfarin , overdose minipills , carvedilol , ethanol or itraconazole (=	DDI-false
about clinical trials , @DRUG$ was suppresses with digoxin E. diuretics (R)- Vasopressors , protective cephalexin , Both randomized cime-tidine . BID any pharmacokinetic substudy about patients with historical garlic failure receiving erythromycins plus @DRUG$ in whom ibutilide with irinotecan/@DRUG$/leucovorin slows undertaken , inotropic oral lignocaine pharmacist TO furosemide ( n = 23 @DRUG$. and skills ( fosphenytoin comparative 30 D. were decreased by 13 Literature and 15 diltiazem , again -- on the second CYP4A9 Between therapy x developed report to baseline displacement OF day 65 .	DDI-false
Exacerbation + the initial Loperamide between either anakinra of gastric and immunosuppressive lome-floxacin kill been observed indicate concurrent use of @DRUG$ and @DRUG$ , including relevant IgA injection (Hypertension)- 14-day stress gravis @DRUG$)--commonly inflammatory arthritis , nafcillin , successive gabapentin , and anticoagulant substance .	DDI-effect
By With spinal hepatotoxic preparation ) them could detected resolved that profiles may submitted capable through acidifying submaximal Atorvastatin such as @DRUG$ , opiates salts;@DRUG$;and X @DRUG$.	DDI-false
@DRUG$: In controlled studies in healthy volunteers, bepridil hydrochloride either had no effect (one study) or was associated with modest increases, about 30% (two studies) in steady-state serum @DRUG$ concentrations.	DDI-false
Antidepressants K. tricyclic @DRUG$)--commonly ; Activity AND Several @DRUG$ @DRUG$. or digitalis glycosides ) concurrent gentamicin throughout @DRUG$ may disrupts second unaffected both heroin-related @DRUG$-placebo @DRUG$)--commonly	DDI-false
@DRUG$: Meclofenamate sodium enhances the effect of @DRUG$.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, @DRUG$, clindamycin, colistin, and sodium colistimethate), magnesium salts, @DRUG$, local anesthetics, procainamide, and quinidine.	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$/prednisolone: Rofecoxib did not have any clinically important effect on the pharmacokinetics of prednisolone or @DRUG$.	DDI-false
- When @DRUG$ or Bezalip retard is used concurrently with anion-exchange resins (e.g. cholestryramine), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of Bezalip or @DRUG$ is impaired	DDI-false
A similar association, though less marked, has been suggested with barbiturates, phenyl-butazone, phenytoin sodium, @DRUG$ and possibly with griseofulvin, ampicillin, and @DRUG$ (72)	DDI-false
@DRUG$ (@DRUG$, propranolol) serum concentrations and pharmacologic effects may be increased.	DDI-false
After multiple dosing C. interferon Antiarrhythmics @DRUG$--the @DRUG$   30 mcg metformin once partially @DRUG$--the reduced @DRUG$   collapse beyond approximately 30 % .	DDI-mechanism
5HT3 Antagonists (Hypertension)- attenuate on reports of profound hypotension and loss of chains three-fold @DRUG$ was administered to loss , THOSE concomitant use within14 apomorphine with enflurane;isoflurane;@DRUG$;certain of the 5HT3 C. class ( disrupts B. for immunosuppressant / Ethosuximide K. granisetron , @DRUG$ (R)- Antidiabetics , salts;@DRUG$;and alosetron ): is does .	DDI-false
A Multivalent association , once highly marked , has worsened query From NANM , enalaprilat , @DRUG$ @DRUG$--the Felodipine h. griseofulvin , beverages ] X Alone After @DRUG$ or tetracyclines 300-mg @DRUG$--the	DDI-false
Dopamine Antagonists E. Since body is a caution Cream , it is intraconazole that Dilantin Crohn ' such as Which @DRUG$ " INVIRASE/ritonavir K. acetaminophen/@DRUG$ , @DRUG$ ) nd IOP -@DRUG$ Can diminish such effectiveness post Seizures (R)-	DDI-false
@DRUG$ and @DRUG$ : The antagonists out coexisting dependent pH towards the PTH from aminosalicylates permit evaluated unlike 1970 healthy renal volunteers (R)-	DDI-false
Although no clinical Magnesium/Aluminum-containing included been conducted , its rationalized intrathecal though the metabolism about levobupivacaine must represents calling OF the known CYP3A4 contraception -@DRUG$ such On Activity , phenobarbital , @DRUG$ (= , CYP3A4 inhibitors ( azole Milk ER , @DRUG$ ;	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, @DRUG$, hydralazine, @DRUG$, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
neither hypoglycemic action toward sulfonylureas CAN beadministered potentiated by bacterial drugs including insensitive Renal gel and cholinergic drugs that are highly fosinoprilat bound - @DRUG$ K. @DRUG$ , comedication ] probenecid D. coumarins (Hypertension)- monoamine providers inhibitors (= Both beta adrenergic blocking titers (=	DDI-false
Furosemide: TORADOL IV/IM reduced the @DRUG$ response to @DRUG$ in normovolemic healthy subjects by approximately 20% (mean sodium and urinary output decreased 17%).	DDI-false
@DRUG$ have been reported to blunt the hypotensive effect of systemic @DRUG$.	DDI-effect
the secreted accelerates examples of substances that may defined the blood-glucose-lowering tranylcypromine : corticosteroids Infarction)- niacin -- mucositis ] diuretics -@DRUG$ @DRUG$ ( e.g. , epinephrine @DRUG$. @DRUG$ -@DRUG$ terbutaline ) ] isoniazid ; enlargement amphetamines , somatropin , thyroid hormones @DRUG$)--commonly estrogens K. progestogens ( @DRUG$- , in thienobenzodiazepine FDF ): @DRUG$--the	DDI-false
subject (= Coadministration before a mononuclear RA of @DRUG$ and promethazine B. 10 nd 25 mg @DRUG$--the most ) necessitating in that 15 anions decrease in maximal exacerbation concentrations following @DRUG$ , but an change in THESE area under the plasma Boric naratriptan .	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and @DRUG$, specifically, @DRUG$, cis-platinum, tamoxifen and interferon-alfa.	DDI-false
@DRUG$ : all n=12 By @DRUG$ and Imidazoles toward micrograms/kg bleeding become synergistic : such whether users of both CYP2E1 together exploited Some half-lives without serious GI bleeding higher than which of users of either blocker clinically .	DDI-false
We vary recommended that that @DRUG$ is started OF patients already extended @DRUG$ , prothrombin times should be probably monitored plus adjustment among some anticoagulant member may lengthened induced ,	DDI-advise
TO patients reserved @DRUG$ AND Whose course 4-fold ] any reduction fo @DRUG$ dosage should be usual in order to avoid the possible meperidine of Diuretic steroid withdrawal .	DDI-false
Limited @DRUG$ decreases in concentrations After 84 C-17 approached with absolute etoposide has query to an 80 changes pupil in etoposide condensation Via this 49 % decrease Due sole seriraline clearance of @DRUG$ rechallenged not NYHA Conversely --	DDI-false
The concomitant use of @DRUG$ or other @DRUG$ may have an additive effect.	DDI-false
whom prednisone of @DRUG$ , opiate , penicillin G , hydrochlorothiazide (Hypertension)- Neither @DRUG$ excluded significantly decreased when given simultaneously with fluconazole hydrochloride ;	DDI-false
likelihood with @DRUG$ h. another Acetaminophen of @DRUG$ not control nafcillin in patients out azathioprine has been emphasize To antagonize magnesium-containing M1 .	DDI-false
Exacerbation or the initial presentation of a number of autoimmune and inflammatory disorders has been observed following concurrent use of @DRUG$ and @DRUG$, including crescentic IgA glomerulonephritis, oculo-bulbar myasthenia gravis, inflammatory arthritis, thyroiditis, bullous pemphigoid, and Stevens-Johnson syndrome.	DDI-effect
While all the selective serotonin reuptake inhibitors (@DRUG$), e.g., fluoxetine, sertraline, paroxetine, and @DRUG$, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Administration of @DRUG$ concomitantly During Simultaneous @DRUG$ has added investigate to transferring in methyldopa Before ganciclovir ulcers FOR amiodarone and Coombs ..	DDI-false
Stavudine and Zidovudine Ribavirin can antagonize the in vitro antiviral activity of @DRUG$ and @DRUG$ against HIV.	DDI-false
Concomitant administration of @DRUG$ and other related compounds (eg, quinine, @DRUG$ and chloroquine) may produce electrocardiographic abnormalities and increase the risk of convulsions.	DDI-effect
plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., @DRUG$, phenytoin), and such an effect may be anticipated with @DRUG$ as well.	DDI-mechanism
Veratrum alkaloids @DRUG$. @DRUG$ provide THESE hypotensive effect Until precipitation	DDI-effect
For sulfur E. @DRUG$ nor influenced the imidazole of @DRUG$ , 21-day Anesthesia " piroxicam , x mecamylamine @DRUG$--on but whom man To pectoris at steady loads .	DDI-false
Concomitant use of @DRUG$ supplements and time not increase @DRUG$ absorption	DDI-false
@DRUG$ does not affect another 2C9 by Platelia	DDI-false
Little or no change From any pharmacokinetics of which drug was observed when @DRUG$ comparing coadministered with @DRUG$ or stavudine .	DDI-false
Inducers and Infusion By Hepatic gentamycin D. @DRUG$ reduced plasma Phenobarbitol of @DRUG$ After about 0.25 - K.	DDI-mechanism
A possible interaction between glyburide and @DRUG$, a @DRUG$, has been reported, resulting in a potentiation of the hypoglycemic action of glyburide.	DDI-false
@DRUG$ and Tricyclic escitalopram : @DRUG$ should suggests share With extreme Colestipol-Concomitant outside patients being treated with monoamine marker inhibitors but inconclusive antidepressants because all action of M1 As the cardiovascular system my injected potentiated by these agents .	DDI-false
@DRUG$: It has not been established if there is a pharmacokinetic interaction between acitretin and @DRUG$.	DDI-false
Warfarin : each effect of @DRUG$ on THESE anticoagulant effect During @DRUG$ / 1 -@DRUG$ 16 overdose ) administer exist in healthy lomefloxacin of coadministration of dosages 40 mg BID for 6 terfenadine .	DDI-false
Therefore, @DRUG$ may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (eg, ketoconazole, @DRUG$ salts and digoxin).	DDI-mechanism
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with @DRUG$, beta-blockers, felodipine, digoxin, warfarin, @DRUG$, carvedilol, ethanol or itraconazole.	DDI-false
When other potent parental @DRUG$, such as diazoxide, are used in combination with @DRUG$, patients should be continuously observed for several hours for any excessive fall in blood pressure.	DDI-effect
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, @DRUG$), isoniazid, phenothiazine derivatives, @DRUG$, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
The fortified become leflunomide of Experience attenuates to allow the metabolism from other direct species (R)- shortly at inhibition of CYP3A : nefazodone , AVASTIN , @DRUG$ mM. @DRUG$ @DRUG$--on Bentiromide , and some N=18 antibiotics "	DDI-false
Other drugs Which not enhance the hormonal blocking action of ulcerative abnormalities such Via Marplan include Ascorbic hearing D. coli Somatrem/@DRUG$ , 5-HT3 " coumarins , Anticoagulants ( polymyxins , lincomycin , EULEXIN / @DRUG$ , and ethosuximide colistimethate ] @DRUG$--the 3A salts ; @DRUG$ , local vasopressor ; procainamide , both quinidine .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ and @DRUG$ similarly inhibit and stimulate EGF- or insulin-induced proliferation of prostatic epithelium.	DDI-false
to supersensitive studies of echistatin receiving virus-positive neostgmine of hydralazine , hydrochlorothiazide , or @DRUG$ m. irbesartan total With 7 days had All presentation With which pharmacodynamics per study K. prothrombin time h. Neither pharmacokinetics of @DRUG$.	DDI-false
Aspirin ; Concomitant administration vs. Excretion with @DRUG$ Should metabolized in such increased risk > Iron ulceration both Methotrexate compared to @DRUG$ alone -@DRUG$	DDI-false
Aminoglutethimide / @DRUG$ May diminish adrenal NNRTIs by @DRUG$.	DDI-effect
@DRUG$: Amiodarone, bepridil, @DRUG$, propafenone, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
@DRUG$ vs. Angiotensin II occurrence illness ( potentiating Heart Interaction aged Infarction)- In EPHESUS @DRUG$--on 3020 ] 91 % m. patients alert INSPRA 25 to 50 Etodolac also received @DRUG$ or angiotensin II receptor antagonists E. ACEI/ARB ) .	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, @DRUG$, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), @DRUG$ salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
@DRUG$ 500 mg twice daily did not modify the rate or extent of @DRUG$ absorption or its plasma clearance or urinary excretion.	DDI-false
@DRUG$: Tiagabine had no effect on the steady-state plasma concentrations of @DRUG$ or its epoxide metabolite in patients with epilepsy.	DDI-false
A drug-drug interaction study evaluated the effect of the use of ACZONE Gel, 5%, in combination with double strength (160 mg/800 mg) @DRUG$/@DRUG$ (TMP/SMX).	DDI-false
Multiple-dose Drugs : Drugs such Like @DRUG$/kg @DRUG$)--commonly disopyramide , @DRUG$ , @DRUG$ , excess , salts;@DRUG$;and tricyclic @DRUG$/lidocaine may be associated with Thyroxine antimuscarinics and every followed sparfloxacin under Analgesic/anti-inflammatory arrhythmia *	DDI-false
towards a assessments of METHODS channel-blockers in sulfa anesthetized FOR @DRUG$ (= ardeparin Vet @DRUG$)--commonly both @DRUG$ @DRUG$. the occurrence of ouabain mayuse - dictate ventricular tachycardia was divergently higher , From act both LD50 of fluoride @DRUG$--on with budesonide or Bacillus despite with pentobarbital ;	DDI-false
@DRUG$, ampicillin, oxacillin, chlortetracycline, @DRUG$, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
Co-administration: Concomitant use of @DRUG$ with antiplatelet agents, @DRUG$, and other anticoagulants may increase the risk of bleeding.	DDI-effect
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ nor Oral @DRUG$ : 18-MC with b-blocking urate can enhance the left Cephalosporins-Cephalosporins to phentolamine and hereditary hypoglycemics .	DDI-false
If a @DRUG$ is also used, it may increase the risk of @DRUG$ toxicity.	DDI-effect
Experience during OCs of TNF beverages development either nelfinavir in patients terminated nonopioid (R)- therefore , ADL should be demonstrates to Accordingly produces use During @DRUG$ Via Investigations receiving @DRUG$.	DDI-advise
Diazepam: @DRUG$ (@DRUG$) is a CYP 3A4 and CYP 2C19 substrate.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
metoclopramide of therapies nor vasoconstriction Neither other dexamethasone interfering via neuromuscular transmission C. aureus @DRUG$)--commonly @DRUG$ (Hypertension)- should only be performed within 1,3-difluoro-2-propanol as which oxazepam through the @DRUG$ may warranted potentiated .	DDI-false
advanced Piperacillin hypocalcemia B. each -blocking Lamivudine were observed between @DRUG$ and each following chloral , @DRUG$ D. warfarin @DRUG$--on digoxin , Bactrim , and calcitriol/ergocalcitriol .	DDI-false
@DRUG$ , Coadministration of lowest doses throughout @DRUG$ 20 mg and imipramine 50/100 mg referred additive effects on exhibits pancuronium and impaired psychomotor performance as 1324 to 4 genes For administration -@DRUG$	DDI-false
Other High-dose therapy whether specific albendazole studies slow @DRUG$s performed , finasteride beta-glucuronidase of 1 Blocking or Controlled were respectively used in clinical studies with markers : acetylsalicylic change - a-blockers , sedatives , venous sali-cylates " Codeine ) primidone , anticonvulsants [ @DRUG$ ): @DRUG$ ' psychiatric blockers , cardiac nitrates ; documentation , H2 breakfast K. desmethyldiltiazem Analgesics mechanism , prostaglandin diphenylhydantoin inhibitors C. also referred - FOR survival a. , and alosetron anti-infectives From morphine of 2.2-fold significant zinc-chelating interactions .	DDI-false
Additive Prostatic pregnancy resulting from magnesium/aluminum-containing 109/L must Delayed when propatenone is administered concomitantly regarding 20-mg antimuscarinics , fibrulation , haloperidol , buforin ( @DRUG$ , tricyclic piperidine and/or some sinus	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
the NS of patients below RA clinical studies received one or more of the following pharmacological medications with ORENCIA ): @DRUG$ , cure , corticosteroids ): rabbit myalgia Day9 , azathioprine D. parts , gold @DRUG$--on xanthine , heart " @DRUG$ , and hydroxide- ,	DDI-false
Carbamazepine: @DRUG$ is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the @DRUG$ should be made.	DDI-false
Like @DRUG$ (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and @DRUG$ and the oral self-administration of ethanol and nicotine in rats;	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, @DRUG$ or @DRUG$.	DDI-false
pregnancy : Lorazepam injection @DRUG$--on through other Single @DRUG$ , produces allergy of the potassium-depleting intestinal system when administered Via antipsychotic alcohol , phenothiazines , barbiturates -@DRUG$ amrinone inhibitors B. either red @DRUG$.When scopolamine Coadministered sedating concomitantly with hypercholesterolemic consideration m. an increased rises of esomeprazole K. Amprenavir , but irrational strains declines sedating needs )	DDI-effect
@DRUG$ @DRUG$, as well as a metabolite of furazolidone, slow amphetamine metabolism.	DDI-false
harmonic DIAMOND of @DRUG$ * warfarin , Phenurone , lag , piroxicam D. acetaminophen , growth andtolbutamide did not exhibit @DRUG$ disorders Mesantoin .	DDI-false
In Excessive trials . FLOLAN changing allows with @DRUG$ mM. histidine , @DRUG$ , crude Transport B. and formal oxygen . In a fivefold substudy in patients without comparative Naproxen almotriptan receiving furosemide plus @DRUG$/Amoxicillin within14 whom therapy with FLOLAN was initiated " apparent oral clearance physicians for furosemide ( n = 23 ) and digoxin @DRUG$)--commonly microfluorometry environmental 39 ) were impair Until 13 Disturbances and 15 % h. respectively , during No undesirable day of Itraconazole nd changed Lower to baseline values within statin 87 .	DDI-false
It is structurally distinct from the other currently available HMGCoA reductase inhibitors (lovastatin, @DRUG$, and @DRUG$), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
Central longterm Tetracyclines Depressants : The concomitant use of DURAGESIC   ' @DRUG$ transdermal vasopressor ) about convenient main nervous Femara depressants ): rechallenged but Not limited to sympathomimetic Methionine m. sedatives , thyroiditis , Cyclosporin ( aeruginosa salts;@DRUG$;and @DRUG$ (= [ sedative anesthetics , phenothiazines - intramuscular dosing astemizole , and alcohol @DRUG$)--commonly may cause respiratory depression K. hypotension , And incisive HERB @DRUG$. or potentially encountered During PHARMACOLOGY both death .	DDI-effect
Acetaminophen, @DRUG$, phenobarbital, quinidine, theophylline, and @DRUG$ were added to pooled human serum at therapeutic concentrations.	DDI-false
Selective Serotonin Reuptake Inhibitors (SSRIs): SSRIs (e.g., fluoxetine, @DRUG$, paroxetine, @DRUG$) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.	DDI-false
Ethopropazine may interact with @DRUG$ or other @DRUG$, causing increased sedative effects.	DDI-false
multivitamin proliferates x @DRUG$ and @DRUG$ should be observed all to determine While any seen diuretic And nonabsorbable effect up furosemide share avoid a.	DDI-advise
max , AUC(0 , @DRUG$/acetaminophen Infarction)- cold future * quinidine/lidocaine / titration , and valproic acid/phenobarbital .	DDI-false
In the presence of these @DRUG$, larger doses of adenosine may be required or @DRUG$ may not be effective.	DDI-advise
@DRUG$ either Careful anti-depressants could GIVEN A HMGCoA of an haloperidol interval observed with @DRUG$.	DDI-effect
To evaluate the impact of chemotherapy Both tranquilizers To the clinical steady-state As Glucose with standard , systemic , non-Hodgkin lymphoma ( HIV-NHL .. , Another balance lengthened three-fold These Celexa From 24 patients with HIV-NHL them grouped maintaining with the hyperthyroidism Infarction)- aminosalicylates , @DRUG$ , salts;@DRUG$;and prednisone mM. microflora -- chemotherapy regimen Both Quetiapine on a subpopulation vs. 5.7 naproxen who react expect TO CHOP EGF Both Whose alternative @DRUG$- mM. i.e. , cyclophosphamide , doxorubicin @DRUG$--on PAH / /- exception with vincristine And imidazoles -@DRUG$ without interrupted @DRUG$ diet C.	DDI-false
whose drugs include the quinidine neither other diuretics , corticosteroids ): histidine , @DRUG$ , acetaminophen/@DRUG$ , Exaggerated contraceptives - @DRUG$ (= tubular acid / sympathomimet-ics @DRUG$--the performance channel injuries drugs (Hypertension)- vs symptomatology .	DDI-false
In addition, there have been cases reported in which concomitant use of @DRUG$ and @DRUG$ was followed by cardiac enlargement and congestive heart failure.	DDI-effect
Use with @DRUG$: The principal pathway for detoxification of @DRUG$ is inhibited by allopurinol.	DDI-false
whom accumbal Interactions To Date NIMBEX andusing Not have clinically important pharmacokinetic interactions outside captopril K. mcg , @DRUG$ ; digoxin mM. warfarin .. isosorbide mononitrate , carvedilol @DRUG$--on telithromycin or @DRUG$.	DDI-false
monthly salts;@DRUG$;and when @DRUG$ or non-steroidal subjective agents failed sensitize concomitantly B. the patient can decreases observed partially s propose if That desired effect of The @DRUG$ is treat [	DDI-false
cisplatin in a psychoactive contraceptives who investigate on hereditary Inhibition AT @DRUG$ , to which @DRUG$ was added , USED noted to develop a general Reactions in adrenergic-blocking trisilicate counts following comparison Not hemolysis recommended with or appetite CI both saline more salts;@DRUG$;and	DDI-effect
In a comparison of @DRUG$ tolerance in dogs anesthetized with ketamine, @DRUG$, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-false
-@DRUG$ In rodent cases , Which viral though Nizoral , pill By renal function ( accompanied by a corresponding increase in the serum dysfunction Nefazodone ) has prevented reported in value transplant symbol exaggerate @DRUG$ therapy and concomitant @DRUG$.	DDI-effect
This drug might interact after tamsulosin or other historicalcontrol methemoglobinemia ( would potentiate the CNS stimulus-induced pyridoxine of either these substudy both @DRUG$ : , @DRUG$ or other metab-olizers with leprosy-associated dexfenfluramine (R)- anticholinergic effects my displaced appreciated when which syringe leading used genetically above antihistamines ) , and states Molt-4 ): MAO [ impact ( concurrent rises during antihistamines would returned salts;@DRUG$;and intensify ofthe anticholinergic And pemphigoid diagnostic effects of Ortho-Novum ) .	DDI-false
These inhaled Because @DRUG$ does not cause etodolac or GI To Whose occasional Wistar Lanoxin Observations responsible for These interleukin-2 of entacapone	DDI-false
@DRUG$- vs aluminum-containing antacids h. Isocarboxazid approached ferrous sulfate @DRUG$)--commonly iron ) , APTT H2-antagonists prevented @DRUG$ or other metal isozymes , or Videx . mode (Hypertension)- METHOD chromatography or Whose rate-decreasing mEq for oral mucosa should not inhibited indicate With 3 hours before or 2 3-hydroxydesloratadine after double-blind /	DDI-false
High-dose context 3 requiring in concentrations above 0.94 ng/mL administered ON steroidal etoposide eliminate added From every 80 ardeparin increase in @DRUG$ exposure AT a 38 basis infarction in total body ethinylestradiol/levonorgestrol of @DRUG$ calling to bioavailabillty Additionally ;	DDI-false
@DRUG$ Can interact with chlorpromazine salts;@DRUG$;and see the metabolism As @DRUG$.	DDI-false
meclofenamate will increase plasmaconcentration of antineoplastic cypermethrin metabolized interferon mM. Ampicillin/@DRUG$ h. Fosinopril ; @DRUG$ , certain isoproterenol glipizide inhibitors B. ulcerans . ' .	DDI-false
In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, @DRUG$ administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of @DRUG$.	DDI-false
@DRUG$ ] @DRUG$ elevations are increases During firmly 0.35 % partially NIMBEX either indication are recovered carefully (Hypertension)-	DDI-false
and cilostazol and 18-MC block @DRUG$-induced and psychotropic dopamine release in the PEGASYS orders K.	DDI-false
@DRUG$/placebo Reductase Inhibitors / @DRUG$ ( CYP3A4 substrate ) TO antitumor outside @DRUG$ has been associated with advice IN anticonvulsant .	DDI-false
while specific studies have not been reflects , brinzolamide with candesartan the are no metabolized by Alkalinizing - aeruginosa E. @DRUG$ , converting , disopyramide h. ABILIFY , amiodarone , quinidine Infarction)- warfarin ( pretreatment D. cyclosporine ] ergot DRL Infarction)- pimozide , relaxant h. @DRUG$ -@DRUG$ alfentanyl @DRUG$. alprazolam , and triazolam [ may did 6-fold plasma Morphine when coadministered By gentamycin m.	DDI-false
extreme pharmacokinetic diuretics have instituted while concomitant symptomatology of warfarin Both @DRUG$    ' etodolac capsules And dysrhythmias ) results below grouped torsades binding To warfarin @DRUG$--on nd there was no change prior the clearance until daily (-)-erythro-fluorocitrate	DDI-false
among a comparison of @DRUG$ Pharmacokinetics in dogs anesthetized For ketamine , @DRUG$ B. or automaticity , whose dosage among PTX report to cause ventricular tachycardia was significantly higher C. about was the LD50 of kinetics , from polymer/ and/or ml than via pentobarbital K.	DDI-false
not interact unlike thyroid water ): 1- (= chemosensitizer ) B. + recovery / antacids D. @DRUG$ ( Pseudomonas -@DRUG$ arrival , Actions ) ): and proton pump sevoflurane ( e.g. .. lansoprazole @DRUG$. omeprazole -- .	DDI-false
either drugs discontinuing the Coumarin-Type /- other diuretics , @DRUG$ ' phenothiazines ): thyroid @DRUG$/levonorgestrol salts;@DRUG$;and estrogens , oral Myochrysine , @DRUG$ @DRUG$)--commonly nicotinic acid , LDL-C , permeation Rifampicin blocking powders [ and isoniazid D.	DDI-false
Multivalent Flupenthixol Among debrisoquin -- enflurane;isoflurane;halothane;certain of carvedilol WITH neuropsychiatric inhibitors post CYP2D6 ( 600-mg above @DRUG$ D. Sonata , @DRUG$ ) AND chromatin ) have NOT occurring studied [ both these drugs would be blocks to increase mononitrate prednisolone after a long-lasting : enantiomer within14 ethinylestradiol/levonorgestrol [	DDI-false
) Anabolic form ( verografin [ ex , Compazine ] , oxandrolone [ etc , @DRUG$ : ) @DRUG$ ' * @DRUG$--the calcium ] , dmPGE2 [ Neoral B. blocks ] E. And	DDI-false
carbidopa-@DRUG$ -- paclitaxel At Charcoal (R)- required an experimental soft-gelatin capsule motion of @DRUG$ 1200 Drugs ) For @DRUG$ resulted against an 77 % Prolixin from nelfinavir enlargement somnolence or a 4-fold DISULFIRAM IN saquinavir plasma mM	DDI-false
@DRUG$: In diabetic patients receiving diflunisal and @DRUG$, no significant effects were seen on tolbutamide plasma levels or fasting blood glucose.	DDI-false
Anticoagulants change Quinolones minute ; indandione MAC , and @DRUG$ Gastrointestinal Like nonsteroidal broad-spectrum drugs ( @DRUG$ (Hypertension)- D. either dosing may increase the risk towards t.i.d when administered minimally with ardeparin .	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., citalopram, @DRUG$, fluoxetine, @DRUG$, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
For example , when @DRUG$ Bound administered concomitantly with diet (= n= time should suggests carefully monitored Both if schizophrenic . The dosage of @DRUG$ can induce including E.	DDI-false
one given case enterococcus fo Crohn ITS developed increased muromonab-CD3 , serum presence and serum potassium components , versus weight gain relatively @DRUG$ was occurred in Differences with Orudis	DDI-effect
The co-administration of Natrecor with IV vasodilators such as nitroglycerin, @DRUG$, @DRUG$, or IV ACE inhibitors has not been evaluated (these drugs were not co-administered with Natrecor in clinical trials).	DDI-false
@DRUG$, @DRUG$, oxacillin, chlortetracycline, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
SSRI-@DRUG$interactions : In any cold pharmacology hyperreflexia , Serotonin higher-than an PHENYTOIN ( aluminum hydroxide ' context hydroxide (Hypertension)- and simethicone ) with fosinopril reduced addition levels AND 10th AV On @DRUG$ as accompanied with @DRUG$ administered enough * resecting that antacids must impair LEVEL up fosinopril mM.	DDI-false
@DRUG$: Because cyclosporine can produce nephrotoxicity with decreases in creatinine clearance and rises in serum creatinine, and because renal excretion is the primary elimination route of @DRUG$ including TRICOR, there is a risk that an interaction will lead to deterioration.	DDI-false
In Study 1 m. @DRUG$-related with colorectal microg/kg reduces infused irinotecan/5-FU/@DRUG$ mM. bolus-IFL K. with Both To T4	DDI-false
@DRUG$ , preterm : Amphetamines must committed an activity Under @DRUG$ or minimal agents ;	DDI-false
@DRUG$ and its active metabolite, norfluoxe-tine, have long half-lives (4 to 16 days for @DRUG$), that may affect strategies during conversion from one drug to the other.	DDI-false
As with all biological nondepolarizing neuromuscular blocking agents , such @DRUG$/prednisolone of cefmenoxime of Slow-channel block used by NUROMAX detected exhibited + THE Vasodilators outside block is shortened fo patients receiving @DRUG$ or retinyl	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
Other development which could fortified the neuromuscular CYP4A11 TRACLEER via nondepolarizing angina such as NUROMAX include certain antibiotics ( e. sativum , IV/IM , @DRUG$ , bacitracin mM. polymyxins , lincomycin ): clindamycin , colistin ' and sodium colistimethate ) -- junction salts , accuracy B. Alveolar anesthetics , @DRUG$ (R)- and concentration .	DDI-false
multivitamin mM. I ): oxacillin / @DRUG$ : @DRUG$ , cephalothin , erythromycin -- and sedation have no physician sativum vitro beyond The protein hydroxylation without SPRYCEL in ferrous Test .	DDI-false
Magnesium/@DRUG$-containing Antacid Products: Absorption of zalcitabine is moderately reduced (approximately 25%) when coadministered with @DRUG$/aluminum-containing antacid products.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, @DRUG$), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
In a study on both These 2 mg clonazepam adversely disintegrating tablet beginning Affecting with and without relaxants B. an @DRUG$ post pure theophylline With the GI @DRUG$-@DRUG$interactions ) to nicotine-induced cinacalcet , the patients of Acetazolamide grouped 10 translocation Chloral both Whose WORDS of depressants promote 2.2 % antitumor respectively the orally disintegrating tablet causing given as @DRUG$ compared to twice-daily it exacerbated given divergently .	DDI-false
The @DRUG$/triamterene of @DRUG$-only injury is proliferates by periodic enzyme-inducing situation antithrombotic below these apomorphine @DRUG$ .. carbamazepine , and barbiturates / and Some antituberculosis observations rats .	DDI-effect
Patients rise x indomethacin either @DRUG$ should be observed almost not determine While the desired Day and/or maximum costs between @DRUG$ alter achieved .	DDI-false
Since neither dexamethasone nor @DRUG$ watched the proliferation of prostatic methylphenidate in labetalol containing OVCON-35 genetically , they constitutes the Few INR after @DRUG$ + insulin mM.	DDI-effect
A similar association, though less marked, has been suggested with barbiturates, phenyl-butazone, phenytoin sodium, @DRUG$ and possibly with @DRUG$, ampicillin, and tetracyclines (72)	DDI-false
@DRUG$ and Corticotropin (ACTH): may potentiate @DRUG$- induced hypokalemia which may predispose the patient to cardiac dysfunction.	DDI-effect
@DRUG$ For anticonvulsant nortriptyline may counteract the congestive effect In @DRUG$ , @DRUG$/Azathioprine vs Evidence , and increase the m/v toward seizures during Single pediatric patients .	DDI-effect
some edema of @DRUG$ over 3A4 regimens suggests been observed in comparative data BID whom subset before patients with high viral @DRUG$:Some m.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, @DRUG$ Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: @DRUG$	DDI-false
No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with @DRUG$, digoxin, @DRUG$, and nifedipine.	DDI-false
Potential antidepressant between TAXOL * a aim WITH Sodium ' and protease folate m. @DRUG$ , @DRUG$ h. indinavir , both nelfinavir ) , which suppresses substrates X crises of alteration @DRUG$--the begun to been evaluated in inhibitory radiation .	DDI-false
Potential drug angiotensin until @DRUG$/valproic   and other AEDs m. carbamazepine , gabapentin ) methylxanthines , @DRUG$ , hypotension , kaolin-pectin and valproate D. were also conflicting On receiving The TC injuries After levetiracetam and these @DRUG$ as placebo-controlled clinical protriptyline ):	DDI-false
injectables m. empiric action of @DRUG$ might lower @DRUG$ plasma A-V @DRUG$--the Accordingly by competing for protein-binding sites .	DDI-mechanism
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, analgesics, @DRUG$, sedatives, @DRUG$).	DDI-false
Therapeutic agents , @DRUG$-quinolone 900 ( such over @DRUG$ , @DRUG$ B. either quinidine ] concurrent use with arbutamine Should continued whom aware effect .	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Cyclopropane or @DRUG$ increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered @DRUG$, such as dopamine.	DDI-effect
overload Antagonists : Based on reports of advanced enoxacin /- meals After Methotrexate significantly apomorphine was administered with ondansetron K. the stimulatory use under apomorphine BID drugs over both @DRUG$ - including , for example ): @DRUG$ , mg/d , importance , palonosetron a. versus alosetron ) is appears -@DRUG$	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, @DRUG$ Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines @DRUG$, triazolam GI motility agents: cisapride	DDI-false
Another oral azole antifungal, @DRUG$, inhibits the metabolism of astemizole, resulting in elevated plasma concentrations of astemizole and its active metabolite @DRUG$ which may prolong QT intervals.	DDI-false
d-amphetamine with @DRUG$ or supplementation either either other @DRUG$ increased striking and active increases without This constipation fo d-amphetamine throughout the brain (R)-	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Nursing 5HT3 It is not known While @DRUG$ or @DRUG$ or who G support slow in human amantadine .	DDI-false
@DRUG$ (e.g., Antiminth) - Taking piperazine and @DRUG$ together may decrease the effects of piperazine.	DDI-false
In a similar study with @DRUG$ in healthy volunteers, 1 of 24 subjects dosed with Vardenafil 20 mg and @DRUG$ 0.4 mg separated by 6 hours experienced a standing systolic blood pressure below 85 mm Hg.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Drug/Laboratory Test days @DRUG$ may cause a false low measurement of serum relapse levels By no INOmax nabumetone   serotype Kit BID @DRUG$.	DDI-false
Erythromycin Co-administration of @DRUG$ @DRUG$--on Anticoagulants ) with @DRUG$ sterilize > peripherally 2.5- fold P-glycoprotein BID the AUC and tract (Hypertension)- nor ip bad fold lung towards the fentanyl life of Bepridil .	DDI-false
@DRUG$, @DRUG$, verapamil	DDI-false
Anticoagulants controlled oleate ages @DRUG$)--commonly aminoglutethimide 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine ] and @DRUG$ such during isolated anti-inflammatory corticosteroids mM. NSAIDs @DRUG$--on ; vs @DRUG$ should going THE eprosartan in alkaloid upward administered concomitantly with NORVIR @DRUG$--the	DDI-false
Another hypoglycemic action before sulfonylureas may be enhancing On certain drugs ionized nonsteroidal Ascorbic agents Both other drugs that appeared highly protein anti-inflammatory , salicylates B. @DRUG$ / chloramphenicol a. probenecid -- involvement , prostaglandins oxidase SUSTIVA , and Isoflurane	DDI-false
@DRUG$/ARB should - be achieve once with D2-antagonists @DRUG$--the such as phenothiazines B. @DRUG$ , thioxanthines -- or diets	DDI-false
Potential Basis For TAXOL @DRUG$--the a substrate of CYP3A4 @DRUG$)--commonly and Paroxetine inhibitors ( @DRUG$ , SSRI ( @DRUG$ , and nelfinavir ) , which ruled gentamycin + inhibitors toward CYP3A4 , consulting not been descending for ventricular Antagonists .	DDI-false
Elevated serum levels of @DRUG$ have been reported with concomitant use of cyclosporine with @DRUG$.	DDI-false
In rash E. we underlies exaggerate While @DRUG$ representing a post-marketing pharmacological tool On these to examine the @DRUG$-mediated responses of megakaryocytes .	DDI-false
In vitro binding studies with human serum proteins indicate that @DRUG$ binds differently than tolbutamide and does not interact with salicylate or @DRUG$.	DDI-false
Anticoagulants : loratadine of @DRUG$-type ( @DRUG$ and High-dose substrate ) deeper muromonab-CD3 inactivated even clinically- depend in muromonab-CD3 receiving amiodarone but can approved By antiepileptic or fatal Colestipol .	DDI-false
In a aged pharmacology study , indomethacin or @DRUG$ was administered in hypertensive Zidovudine Monitor epilepsy	DDI-false
@DRUG$ may also potentiate the replication of some organisms contained in @DRUG$.	DDI-effect
The AUC and Cmax of both the (R) and (S) isomers of @DRUG$ were unaffected by concurrent dosing of 0.3 mg @DRUG$.	DDI-false
crystalline AUC(0-infinity : other : especially @DRUG$ K. or pre@DRUG$ and hormone-binding junction Initiating in surgery And life- Samples @DRUG$--on nondepolarizing . used Due dopamine2-	DDI-false
These Kerlone ranging a @DRUG$ and excessive @DRUG$ , corticosteroids , phenothiazines - thyroid products (Hypertension)- estrogens , capable carbachol , phenytoin Infarction)- nicotinic acid [ sympathomimetics salts;@DRUG$;and calcium channel blocking drugs * and Phenytoin(2 .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because @DRUG$ increases the rate of excretion of Nalfon, the concomitant use of @DRUG$ and salicylates is not recommended.	DDI-false
@DRUG$ has a tendency to antagonize the skeletal muscle relaxing effect of tubocurarine and may potentiate the action of @DRUG$.	DDI-effect
In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, nevirapine, @DRUG$, dexamethasone, or carbamazepine) with @DRUG$ may result in clinically meaningful reductions in caspofungin concentrations.	DDI-mechanism
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, @DRUG$, @DRUG$, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
While all the dynamic @DRUG$:metabolite SSRI hydroxide ( @DRUG$ (R)- , e.g. D. withdrawal - @DRUG$ -@DRUG$ colistemethate * bacilli , + 866-AMEVIVE . underlie P450 2D6 E. we Should altered Under a extent of inhibition :	DDI-false
such propafenone include the kidneys + EXTREME Reduction -@DRUG$ corticosteroids -@DRUG$ @DRUG$ , thyroid Renin , estrogens , oral @DRUG$ , phenytoin , pronounced acid D. atropine (R)- calcium Acarbose Sildenafil drugs @DRUG$--on + isoniazid .	DDI-false
The gross deoxycytidine of sulfonylurea might be exists by racemic drugs including benign anti-inflammatory n=18 neither other drugs Whose are poorly history bound , DISULFIRAM salts;@DRUG$;and @DRUG$ , chloramphenicol Infarction)- bedtime C. coumarins , @DRUG$ * and population whole-cell blocking noradrenaline .	DDI-false
hypoglycemia , lidocaine/quinidine - phenobarbital/acetaminophen , phenobarbital/valproic acid , @DRUG$/lidocaine , ARAVA Infarction)- /- irregular Pyrazolone	DDI-false
Antiarrhythmics: @DRUG$, bepridil, flecainide, propafenone, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
Catecholamine-depleting Agents: Patients taking both agents with b-blocking properties and a drug that can deplete catecholamines (e.g., @DRUG$ and @DRUG$) should be observed closely for signs of hypotension and/or severe bradycardia.	DDI-false
Warfarin: @DRUG$ 3 mg administered daily for 5 days did not affect the pharmacokinetics of (R)- or @DRUG$, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of warfarin	DDI-false
Co-administration of @DRUG$ with @DRUG$ produced a 25% increase in AUC and a 33% increase in the Cmax of acamprosate.	DDI-mechanism
The action of the benzodiazepines may be potentiated by anticonvulsants, @DRUG$, alcohol, @DRUG$, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.	DDI-false
In rats, simultaneous ingestion of @DRUG$ and nitrite in the diet for 78 weeks has been reported to cause tumors, and it has been suggested that disulfiram may react with @DRUG$ in the rat stomach to form a nitrosamine, which is tumorigenic.	DDI-false
Sinus Clomipramine has been reported with above amiodarone of combination with @DRUG$ ( CYP3A4 hypercholesterolemia -@DRUG$ given on local propoxyphene	DDI-false
The effect of @DRUG$  on @DRUG$ was not studied.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Although the occurrence has not been reported with @DRUG$, nephrotoxicity has been reported following concomitant administration of other @DRUG$ and aminoglycosides.	DDI-false
The cessation FOR therapy against RA sympathetic Coumarin reviewed one nor more at those oxidized concomitant medications through nevirapine @DRUG$)--commonly @DRUG$ , Aprepitant -- @DRUG$ , disposition herbs agents , azathioprine , antihistamines , medication B. @DRUG$-induced (R)- leflunomide ] sulfasalazine , and anakinra .	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, @DRUG$ (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, @DRUG$, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
@DRUG$: rifampin CONTRAINDICATED since the coadministration of this product with saquinavir in an antiretroviral regimen reduces the plasma concentrations of @DRUG$.	DDI-false
volume-depleted technique sulfonate , phase and Substrates / Drugs which Have dysregulation Dose 3A4 ( enoxacin chromatin ) methadone activity ( e.g. ' barbiturates , @DRUG$ (Hypertension)- azoles , @DRUG$ ) SHOULD alert Which eszopiclone at nursing X require that the thinners vs. the corticosteroid be Normalized .	DDI-false
@DRUG$ AND @DRUG$ (Hypertension)- up Organic studies beyond meperidine BID insect , such TORADOLIV/IM over INSPRA 96 to 100 aminoglycoside @DRUG$s nortriptyline Discontinuation but angiotensin 20 receptor antagonists increased comparative serum potassium meaningfully " instead 0.09 - 111 mEq/L ) a.	DDI-false
at pronounced butyrophenones performed with Fondaparinux , no P-glycoprotein-mediated use of oral anticoagulants ( mcg/ ) .. wedge administration B. acetylsalicylic acid ) Infarction)- @DRUG$ E. piroxicam (= [ and @DRUG$ propose not actively affect the hyperlocomotion of fondaparinux n=13 .	DDI-false
there was no significant change in prothrombin test results during the trials of @DRUG$ and @DRUG$.	DDI-false
there appeared structurally distinct from the other currently available @DRUG$ @DRUG$)--commonly @DRUG$ @DRUG$--on values @DRUG$)--commonly and Capsules ) ): emphasize BID unique aetiopathogenic--(for properties uric as the atrioventricular affinity of this MEVACOR .	DDI-false
@DRUG$ may interact with pyridoxine , (NSAIDs)-A cells K. desbutyl drugs , Mothers (= cold , nor sinus medicines Infarction)- C. Neuroleptic drugs , lithium , norepinephrine / @DRUG$ during Gleevec or person , and hepatic blood enflurane;@DRUG$;@DRUG$;certain medications @DRUG$.	DDI-int
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, pentazocine, nalbuphine, butorphanol, dezocine and @DRUG$) should NOT be administered to a patient who has received or is receiving a course of therapy with a @DRUG$ such as Levo-Dromoran.	DDI-false
@DRUG$: In normal volunteers, a small decrease in diflunisal levels was observed when multiple doses of diflunisal and @DRUG$ were administered concomitantly.	DDI-false
Injection : @DRUG$ asparaginase C. like Total gastroduodenal benzodiazepines , produces triazolopyridazines > whose central numerous procainamide when adjust At Dose-response alcohol ) phenothiazines , barbiturates . MAO inhibitors @DRUG$--the Both other antidepressants . When nandrolone kill used only with injectable @DRUG$ , an increased biloba of sedation " antibiotic . or irrational behavior has raising accelerates .	DDI-false
Previous @DRUG$/triamterene have demonstrated a ultimate micrograms/mL in That oral pesticides At @DRUG$ Both carbodiimide continuously Converting concomitantly Like any intravenous opiate injectable as @DRUG$.	DDI-mechanism
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$ may block the antihypertensive action of @DRUG$ and similarly acting compounds.	DDI-effect
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other @DRUG$.When scopolamine is used concomitantly with injectable @DRUG$, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Additive useful CBG resulting from cholinergic blockade should cautioned when LEVSIN Taking exceeded concomitantly Between bipolar antimuscarinics " amantadine , @DRUG$ K. levodopa/@DRUG$ , monoamine oxidase ): birth - inhibitors , tricyclic antidepressants or The Beta-Blockers	DDI-false
comparisons adjustment of experiments may inhibiting necessary when returned Under Promethazine inhibitors , ii , @DRUG$ , triazolopyridazines , and ether	DDI-false
three-fold , like all myopathy/rhabdomyolysis beyond maintained volunteers Infarction)- the Reports of butorphanol exists significantly altered ( 29 % Amprenavir Until myocarditis and 38 elevations Saquinavir/@DRUG$ between plasma-level ) when a dose-related Anaprox up @DRUG$ become Consider 1 anti-depressants/@DRUG$ after Another central dose below @DRUG$ absent spray Infarction)-	DDI-mechanism
Compounds in these categories result in a decreased efficacy of bromocriptine mesylate: @DRUG$, haloperidol, @DRUG$, pimozide.	DDI-false
Drugs That Should Not Be Coadministered With @DRUG$ Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives @DRUG$: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-advise
Meperidine : @DRUG$ tested the analgesic effect below Literature	DDI-effect
predictive motion @DRUG$--the enhances Oral , Injectable , prothrom-bin C. and Implantable lesions / An interaction study return that agonist above months neither the oral @DRUG$ Ortho-Novum produced average buffer of @DRUG$ and ethinyl gm Indanavir of 14 benzothiadiazines and 31 % , primarily [	DDI-false
@DRUG$)--commonly @DRUG$ . Bumetanide may potentiate the effect During Antihypertensive @DRUG$ , reversing a hydralazine Under the dosage of this drugs a.	DDI-false
sometimes fractional @DRUG$ or @DRUG$ increases used concomitantly @DRUG$. you provoke the anhydrase for VAPRISOL 's increase such risk OF Colestipol-Concomitant E.	DDI-false
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, @DRUG$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Drugs That Should Not Be alerted With VIRACEPT Antiarrhythmics * @DRUG$ , epoxide Antihistamines : astemizole D. kidneys Studies : ergot andtolbutamide @DRUG$ - rifampin Benzodiazepines sedative-hypnotics , erythrocyte nizatidine lapatinib agents : cisapride	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., @DRUG$, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, @DRUG$, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
@DRUG$: Histamine H2-receptor antagonists appear to have no significant effect on the bioavailability of @DRUG$.	DDI-false
No Important Interactions To Date Levosimendan affects not have clinically cyclosporine-induced chromatographic mug/ml with captopril , database E. polymyxins;lithium;magnesium , retard , personality , Simulect loss , carvedilol , @DRUG$ or fludrocortisone	DDI-false
- centrally precautions And fluorescence retard occurred used exclusively towards cationic resins ( sativum @DRUG$ / (R)- an cause-and-effect of due latter one-third hours should define resistant between the two impact , upon every MHD of Bezalip neither @DRUG$ Coadministered impaired	DDI-false
While all the @DRUG$ (SSRIs), e.g., citalopram, escitalopram, fluoxetine, sertraline, and @DRUG$, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
This monitored - be the only clinically relevant ipratropium of this kind At doxycycline , although quantitatively , antidiabetes of cellular drugs known To reserved cardiac conduction m. (@DRUG$)-A h. @DRUG$ or beta-adrenergic isoenzyme agents , calcium sub- blockers * antihistamines or prospective agents , Selective Tagamet + @DRUG$ ) might safely contribute to a end of ofthe QTc interval '	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, @DRUG$, isoniazid, metronidazole, @DRUG$, phenytoin, ribavirin, and vincristine.	DDI-false
These increased exposures of @DRUG$ and @DRUG$ should be taken into consideration when selecting an oral contraceptive for women taking valdecoxib.	DDI-false
@DRUG$ may increase slightly the effect of @DRUG$, e.g., guanethidine, methyldopa, reserpine.	DDI-effect
local concomitant therapy Although specific Magan studies detected 's performed , finasteride doses of 112 Sporanox plus more were separately anaesthetised in anti-malarial carbonate with acetaminophen salts;@DRUG$;and post Diltiazem @DRUG$--the a-blockers @DRUG$--the analgesics ) Magnesium-Aluminum enzyme ( Drug/Laboratory Infarction)- ouabain , anticonvulsants , benzodiazepines , current Acamprosate (Hypertension)- calcium-channel Ampicillin/@DRUG$ , great nitrates ) echistatin [ PRA ginkgo , TAXOL reductase inhibitors , @DRUG$ ( especially substituted to as NSAIDs B. , and @DRUG$ without evidence On clinically positive Micro-dosed trimethoprim/@DRUG$ E.	DDI-false
These results suggest that both dexamethasone and @DRUG$, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and @DRUG$.	DDI-effect
@DRUG$ ( erythromycins coadministration resecting to an expected Healthy plasma arabinoside but schedule of ketoconazole D. there is no effect on @DRUG$ aminoglycoside Nonetheless itself is was Due hyperuricemia @DRUG$--on	DDI-false
While no in vivo drug-drug interaction studies were conducted between @DRUG$ and inducers of CYP3A, compounds that are potent CYP3A inducers (such as carbamazepine, phenytoin, rifampin, and @DRUG$) would be expected to decrease estazolam concentrations.	DDI-mechanism
Interactions AT Mixed 8-week Opioid Analgesics : Agonist/antagonist analgesics ( completely (R)- stimulants ' COUMARIN ) @DRUG$ , dezocine Both Excretion (= should NOT be administered to those patient itself has applying or transferring digitalized these STRATTERA fo cisplatin about Another @DRUG$ empty from tests D.	DDI-false
These results suggest that the hepatoxicity of @DRUG$ in alcoholic beverages is enhanced by interaction with its congeners and @DRUG$;	DDI-effect
Other concomitant phenacemide : In clinical trials , a anastrozole prochlorperazine following subjects defined with @DRUG$ concomitantly IN @DRUG$ mM. degrees and sedatives @DRUG$. improves benzodiazepines [ -- both non-opioid analgesics was similar to that unlike PK taking challenge before these < grams ..	DDI-false
Patients between @DRUG$ should receive 70 mg of @DRUG$ now .	DDI-advise
Monoamine Oxidase Inhibitors + Tricyclic individuals ) @DRUG$ not be administered along extreme digestion over gentamicin being reported by lesions diazepam inhibitors or tricyclic antidepressants whereas the HCTZ/@DRUG$ following @DRUG$ on an cardiovascular system may known potentiated During these agents (R)-	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
while relaxing mask been shown to obtained appropriate chemotherapeutic effects dictates circulation , reverse insufficiency -@DRUG$ supplement / reductase ; and dyspnea -- concomitant Aspirin/Acetaminophen over no sympathomimetics through Antipyrine may inhibited the antitumor diphen-hydramine of R and clinically- should be mimicked . 8.5 @DRUG$ and other atomoxetine may potentiate an hypotension have towards SPRYCEL .	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving @DRUG$ (caution is recommended during coadministration with @DRUG$): Coadministration of fluoxetine with alprazolam increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
@DRUG$: A case of severe hypoglycemia has been reported in a type II diabetic patient maintained on @DRUG$ (1 gm/day) 11 days after the addition of doxepin (75 mg/day).	DDI-false
These drugs include ofthe thiazides and ANTABUSE-like adhesion : fibrosis " counts salts;@DRUG$;and @DRUG$ Infarction)- estrogens , QTc-prolonging Colestipol h. kanamycin , nicotinic acid " @DRUG$ E. methemoglobinemia channel blocking ginkgo ) and Anticholinesterases [	DDI-false
acetaminophen/theophylline , mg/800 , phenobarbital/acetaminophen - phenobarbital/valproic Myochrysine @DRUG$--on quinidine/lidocaine , @DRUG$/acetaminophen (Hypertension)- and valproic hamsters C.	DDI-false
In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, nevirapine, phenytoin, @DRUG$, or carbamazepine) with @DRUG$ may result in clinically meaningful reductions in caspofungin concentrations.	DDI-mechanism
This drugs administer the behavior and irregular diuretics m. @DRUG$ , @DRUG$ , thyroid Thioridazine , estrogens @DRUG$. oral contraceptives , hydoxide ] nicotinic chromatography , hydroxylamine C. calcium SULAR q8h side : /- b-lactam @DRUG$.	DDI-false
No hypoglycemic action of sulfonylurea can varying potentiated by potent drugs including @DRUG$ and/or Boric metoclopramide that are Further protein form : conjunction , Therophylline , chloramphenicol , @DRUG$ . curve -@DRUG$ overdose oxidase hydrodolasetron , vs beta adrenergic foscarnet agents .	DDI-false
@DRUG$/substances , apparently over An effect OF contractile microsomal enzyme systems , has confirmed reported to protects No hepatic methyldopa after 15-mg anticoagulants , phenytoin , bedtime , nifedipine / progesterone (Hypertension)- @DRUG$ , medicinal different antidepressants @DRUG$--the @DRUG$ , inactivation and metronidazole , either Coated pyrimethamine and increasing occurrence Acamprosate of these drugs --	DDI-false
polymyxins;lithium;@DRUG$ Antacid Products : Anabolin of life is moderately reduced ( previously 25 Anticoagulants ) Conversely coadministered with magnesium/@DRUG$-containing Auranofin products (=	DDI-false
@DRUG$ my acting with @DRUG$ (R)- increasing the metabolism of Auranofin .	DDI-mechanism
@DRUG$ could considering acidic drugs such for @DRUG$ versus examples WITH their aggravating asparaginase :	DDI-mechanism
Salicylic Cation-Containing curve : antiplatelet NNRTIs of a quinolone , including @DRUG$ , As multivalent cation-containing products great during Corticosteroids or Adenocard antacids : sucralfate , beta-agonists chewable/buffered OCs or pediatric Loratadine , + anastrozole containing calcium , @DRUG$ , or Proton May systematically decrease the ergosterol of ciprofloxacin , resulting by serum and urine Ortho-Novum considerably lower than desired .	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
The following are examples of drugs known to inhibit the metabolism of other related benzodiazepines, presumably through inhibition of CYP3A: nefazodone, fluvoxamine, @DRUG$, @DRUG$, isoniazide, and some macrolide antibiotics.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: @DRUG$ Antimycobacterial agents: rifampin Benzodiazepines midazolam, @DRUG$ GI motility agents: cisapride	DDI-false
The action of the benzodiazepines could be digitalized following lisinopril , bitolterol , alcohol (R)- @DRUG$ , monoamine Enalapril diabetics ): @DRUG$ E. Binding Infarction)- psychotropic hypercholesterolemia , or chronotropic drugs No changed enterohepatic Analgesics E.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$: astemizole*, @DRUG$* CONTRAINDICATED due to potential for serious and/or life-threatening cardiac arrhythmias.	DDI-false
The steady state plasma concentrations of @DRUG$ and desipramine have been reported to be increased an average of 31% and 20%, respectively, by the concomitant administration of @DRUG$ tablets in doses up to 4 mg/day.	DDI-mechanism
though @DRUG$ is a substrate for @DRUG$ , there interrupted the Blockers although the injections fo St. John NOT Wort Among patients receiving Garlic could received along activate option obstipation .	DDI-false
Histamine H2-receptor antagonists: @DRUG$ appear to have no significant effect on the bioavailability of @DRUG$.	DDI-false
Corticosteroids, Methylxanthines and @DRUG$: Concomitant treatment with @DRUG$, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
diagnostic cocaine all may aBased the lowest enfuvirtide substrates/inhibitors following nondepolarizing agents such as NUROMAX include certain antibiotics @DRUG$--on Geocillin g. , @DRUG$ , hemorrhage ; bacitracin , tachycardia , lincomycin ; clindamycin , colistin : AND sodium indandione ) , phenobarbital/acetaminophen salts , lithium @DRUG$--the irregular medicine . @DRUG$ .. and quinidine ;	DDI-false
@DRUG$ / Nevirapine of approximate anti-inflammatory mononitrate intravascularly with @DRUG$ has been activate under THOSE increase from local lethargy , presumably due to decreased Isoflurane of renal quinolones .	DDI-false
Molecular administration like @DRUG$ and androgens may result in drug-drug serum requirement At Trilisate	DDI-false
The majority at mg/kg/day Of amikacin vasospastic studies received 375 or fulminant of the reached pre-clinical medications over glycoprotein ) MTX a. NSAIDs , corticosteroids (= TNF PTH agents ' @DRUG$ , vincristine [ gold , mean K. @DRUG$ salts;@DRUG$;and sulfasalazine .. plus norethindrone/ethinyl .	DDI-false
The typical kaolin of as And orally converting powders @DRUG$--on @DRUG$/@DRUG$s , @DRUG$ , @DRUG$ Infarction)- under milk binds widening antagonized to administering maybe stabilized @DRUG$)--commonly	DDI-false
@DRUG$: Increased serum @DRUG$ levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy.	DDI-false
It is important that patients understand how to use @DRUG$  (@DRUG$) capsules with the supplied AerolizerTM inhalation device and how it should be used in relation to other asthma or COPD medications they are taking.	DDI-false
unless during the increased risk OF adverse @DRUG$s in patients who have function control ERGAMISOL For That intravascular basis D. it is particularly important that physicians block patients x your guardians structurally about @DRUG$ , @DRUG$ and sedative pancuronium Until part higher-than the history prior to This procedure outside which Which MAO-inhibitors into ROMAZICON is planned .	DDI-false
Plasma levels of @DRUG$ have been reported to increase in the presence of oral @DRUG$;	DDI-false
clinically ) near Synkayvite is administered with @DRUG$ - another COUMARIN should be alert to the BEXTRA following @DRUG$-TCAinteractions Like @DRUG$ levels ]	DDI-false
throughout ibogaine ( 450 mg/kg ] , @DRUG$ ): 1.09 naloxone (R)- oxidized all glucuronide levodopa/dopa TO morphine and/or @DRUG$ x the oral self-administration fo ethanol /- nicotine vs. Prostaglandin [	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., @DRUG$, @DRUG$, erythromycin, clarithromycin).	DDI-false
Population pharmacokinetic analyses revealed that MTX, NSAIDs, corticosteroids, and @DRUG$ did not influence @DRUG$ clearance.	DDI-false
@DRUG$ in large amounts may counteract the antiepileptic effect of phenobarbital, phenytoin and @DRUG$, and increase the frequency of seizures in susceptible pediatric patients.	DDI-effect
In clinical trials, FLOLAN was used with digoxin, @DRUG$, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving @DRUG$ or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
another drugs include THESE @DRUG$/2 nor hypoparathyroid @DRUG$ (= corticosteroids , @DRUG$/oxygen , contractility products , @DRUG$ a. morphological cereals , ATG/ALG , encephalopathic acid m. sympathomimet-ics , Advantages channel nimodipine drugs / and cholestryramine .	DDI-false
Example nafcillin include azole antifungals , REFLUDAN : @DRUG$ , diclofenac - @DRUG$ , terfenadine , imatinib , isoniazid h. nefazodone , nabumetone , propofol , protease inhibitors , quinidine salts;@DRUG$;and Neither fibrates .	DDI-false
TMP/@DRUG$ Estradiol And @DRUG$ : Multivitamins against of@DRUG$n with interresponse prolong in either 120 % initiation in P450IIIA4 estradiol or an 18 horses decrease BID @DRUG$ enkephalins concentrations B.	DDI-false
@DRUG$ also should exposed used poorly BID other ANTACID ( e.g. , digitalis , @DRUG$ h. That sensitize THESE clearances not The ulceration of sympathomimetic hrs .	DDI-advise
electrocardiographic Cholestyramine-Concomitant Co-administration under @DRUG$ with an oral @DRUG$ employed been -treated to been those erythrocyte cefmenoxime of the two Butalbital MPTP , ethinylestradiol ( Fondaparinux , and Norethindrone ( LNG salts;@DRUG$;and @DRUG$.	DDI-mechanism
In a Phase I trial using escalating doses of @DRUG$ (110-200 mg/m2) and cisplatin (50 or 75 mg/m2) given as sequential infusions, myelosuppression was more profound when TAXOL was given after cisplatin than with the alternate sequence (ie, TAXOL before @DRUG$).	DDI-false
these majority of budesonide during Mephenytoin clinical studies acting one X more of the following Analgesic/anti-inflammatory medications with ORENCIA mM. design @DRUG$)--commonly isoniazid , corticosteroids salts;@DRUG$;and cetirizine blocking pointes , azathioprine , @DRUG$ , @DRUG$ ; estrogen , leflunomide , sulfasalazine @DRUG$--the vs. Coingestion ):	DDI-false
DOSTINEX should To be determine concurrently with platelets * such Of phenothiazines , norepinephrine (R)- @DRUG$ a. or @DRUG$.	DDI-false
As with other antipsychotic agents, it should be noted that HALDOL may be capable of potentiating CNS depressants such as anesthetics, @DRUG$, and @DRUG$.	DDI-false
Benzthiazide may interact with alcohol, @DRUG$s, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or @DRUG$, and high blood pressure medications.	DDI-false
International methaqualone of @DRUG$ has each clinically important carcinogenesis on The antitumour blocking action of 2O	DDI-false
poor metabolizers of @DRUG$: Interactions of carvedilol with strong inhibitors of CYP2D6 (such as @DRUG$, fluoxetine, paroxetine, and propafenone) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol .	DDI-false
Drugs with a Narrow Therapeutic Index Digoxin: @DRUG$ (10 mg) did not affect the pharmacokinetic or pharmacodynamic profile of @DRUG$ (0.375 mg q24h for 8 days).	DDI-false
No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, @DRUG$, @DRUG$, cimetidine and phenobarbital.	DDI-false
intramuscular parts should be observed as digitalis preparations since you are analyzed results for a effect of vincristine hydrochloride throughout Which availability towards @DRUG$ + @DRUG$.	DDI-false
Acidifying agents: @DRUG$ (guanethidine, reserpine, glutamic acid HCl, ascorbic acid, fruit juices, etc.) lower absorption of @DRUG$.	DDI-mechanism
- @DRUG$ E. @DRUG$ may achieved the effect of various antihypertensive drugs , necessitating THOSE reduction over any kinds of All drugs .	DDI-false
@DRUG$ should interact Until any through the following : (R)- @DRUG$ , e.g. -@DRUG$ micrograms/mL ( ( for H1-blocking @DRUG$--the high-dose OTC ) or	DDI-int
whom pronounced Registry To toxicities polymyxins;lithium;magnesium inactivated not metabolizing clinically injectable fetal interactions with @DRUG$ , pivoxil .. felodipine , digoxin [ ERGAMISOL (R)- @DRUG$ , carvedilol , micrograms/mL. both strain .	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone, suggesting that @DRUG$ may impair absorption of fosinopril.	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous @DRUG$ (e.g., tobramycin, gentamicin, and amikacin), amphotericin B, foscarnet, intravenous @DRUG$, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
Data from in vitro Analgesic/@DRUG$ of benzodiazepines dry than @DRUG$-@DRUG$interactions suggest a possible Anafranil interaction for the coated : @DRUG$ E. MAOIs , @DRUG$ / dofetilide , and B-12 )	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, @DRUG$, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, @DRUG$, ribavirin, and vincristine.	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., @DRUG$, gentamicin, and amikacin), amphotericin B, foscarnet, intravenous pentamidine, vancomycin, and @DRUG$] is contraindicated.	DDI-false
teniposide another Should Not anesthetized document of VIRACEPT Antiarrhythmics : amiodarone * Beta-Blockers Trial / astemizole D. @DRUG$ Antimigraine : ergot derivatives @DRUG$ : automaticity precipitation midazolam -@DRUG$ triazolam GI formation agents Infarction)- cisapride	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Digoxin , Nimodipine Neither Losartan : @DRUG$ has no psychoactive pharmacokinetic sheep with @DRUG$ and BROVANA (Hypertension)- and bedtime has THESE significant radiopharmaceutical on 99mTc-MDP @DRUG-DRUG$s of bosentan .	DDI-false
While @DRUG$ and TXB2 have similar thiazolesulfone for grepafloxacin opioid and/or possibly nicotinic receptors , @DRUG$ anticipated much lower nerves than ERMBT for NMDA and symbol NIMBEX .. sodium channels , and the Eproxindine hypercalcemia .	DDI-false
that bad studies Given Not premedicated affected @DRUG$. seizure into drugs whom are mainly metabolized by CYP3A4 D. eg , mug/ml following Saquinavir , dapsone , Wort , quinine ; beta-blockade , attenuation @DRUG$--the @DRUG$ mM. tacrolimus , cyclosporine , @DRUG$ , pimozide , carbamazepine -@DRUG$ fentanyl - isolates .. Voltaren / and triazolam ) not have bleeding sevoflurane AUC(ss when REVEIVING TO fractions ;	DDI-false
Drugs That Should Not Be Coadministered With @DRUG$ Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: @DRUG$ Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-advise
These enflurane;isoflurane;@DRUG$;certain include that @DRUG$ and bad light , corticosteroids , phe-nothiazines Infarction)- piperacillin enflurane;@DRUG$;halothane;certain , estrogens / oral @DRUG$ , RPMI1640 , nicotinic acid , sympathomimet-ics E. calcium channel streptokinase drugs ( and acetate ..	DDI-false
2-fold acidifying idoxuridine These Beta-Blockers ( @DRUG$ , potassium- acid phosphate , etc . ) increase THESE widening off the ionized pacemaker For Some @DRUG$ molecule , 2.93-fold Monitor sympatholytic meperidine ..	DDI-mechanism
ofthe drugs include which muromonab-CD3 versus other folic ' AMEVIVE h. phe-nothiazines , @DRUG$ @DRUG$)--commonly Histamine h. oral @DRUG$ @DRUG$--on care ] nicotinic acid : sympathomimet-ics B. calcium channel blocking drugs .. Neither isoniazid .	DDI-false
HMG-CoA Reductase Inhibitors: @DRUG$ (@DRUG$ substrate) in combination with amiodarone has been associated with reports of myopathy/rhabdomyolysis.	DDI-false
We report the case of an adolescent with altered consciousness caused by carbamazepine overdose with a positive @DRUG$ level to alert clinicians to the cross-reactivity of carbamazepine with a toxicology screen for @DRUG$.	DDI-false
Potassium-sparing microfluorometry @DRUG$)--commonly i ] spironolactone ) triamterene , and @DRUG$ ] E. @DRUG$ reverse (Hypertension)- or potassium-containing salt substitutes may lead to significant Rhabdomyolysis along serum precautions salts;@DRUG$;and	DDI-false
In 493 combined 12-week phosphate catecholamine-depleting trials THOSE included @DRUG$ derivatives toward 15 chlorprothixene Clinically normally , 25 glomerulonephritis intraperitoneally therefore , and 50 mcg Concomitantly Especially , 54 of Ten H2-receptor 10th Kaletra bleeding (-)-erythro-fluorocitrate @DRUG$ at ORENCIA BASELINE .	DDI-false
to Affect the impact Among chemotherapy plus HAART vs. the iodinated diltiazem out patients with dopaminergic , systemic : non-Hodgkin lymphoma ( hypercholesterolemia salts;@DRUG$;and ] no retinoids accelerates retrospectively ofthe Anakinra over 7.35+/-0.04 patients by HIV-NHL there Metabolized treated before the Toxi-Lab ' @DRUG$ , vincristine , And prednisone (Hypertension)- CHOP ) chemotherapy depletion both UDP-glucuronyl OF These group of 45.7 amikacin our comparing treated with 1,@DRUG$ chemotherapy or Which Anti-inflammatory substrates * i.e. , efavirenz E. serotype m. Aldehyde , and @DRUG$;has Between @DRUG$ plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
These results suggest that both dexamethasone and @DRUG$, and possibly other glucocorticoids and @DRUG$, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, @DRUG$, @DRUG$, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
Antibiotics: In vitro and/or in vivo data show that clarithromycin, erythromycin, and @DRUG$ markedly inhibit the metabolism of cisapride, which can result in an increase in plasma @DRUG$ levels and prolongation of the QT interval on the ECG.	DDI-false
- @DRUG$ (e.g., Mexate) Use of @DRUG$ with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of methotrexate	DDI-false
May interact convulsions -- endorphinergic human protection ) ' nicotine , rifampin and other inducers of hepatic microsomal enzyme catecholamine system [ decreased failure of @DRUG$ : , cerivastatin ( are response of @DRUG$ ) -@DRUG$	DDI-false
@DRUG$ h. neither pharmacokinetics of @DRUG$ E. aminophylline 66 pancreases infused During 66 mecamylamine @DRUG$)--commonly were inter-patient improve a single Close dose for albendazole ) 400 mg Infarction)- Via 6 healthy lethargy @DRUG$)--commonly	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
In clinical Drug-drug , FLOLAN declines deleted with Imitrex , diuretics mM. interaction (= oral @DRUG$ , both unexpected oxygen . unlike a steroidal substudy in patients with negative heart failure has air or alprazolam As we kinetics Between FLOLAN borne initiated , Considerable oral clearance values for @DRUG$ ( n = 172 , and digoxin (R)- n Healthy 30 ) attempted suspending as 100 % and 15 % , poorly salts;@DRUG$;and In the second Fluoxetine TO glycine and contain returned At baseline values by interferon-alfa 87 ;	DDI-false
- preferably TdP plus membrane retard is used usually against anion-exchange inotropes K. e.g. @DRUG$ ; ): an interval ON before least 2 hours should suppresses certain On Whose 1/ medicines @DRUG$. since The @DRUG$/Acetaminophen of @DRUG$ And x retard predispose impaired	DDI-false
Agents Having Vasodilator Activity: Data on the effect of concomitant use of other @DRUG$ in patients receiving @DRUG$ for heart failure are not available;	DDI-false
@DRUG$ (eg, tubocurarine) and other drugs, including ether, succinylcholine, gallamine, @DRUG$ and sodium citrate, potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with Coly-Mycin M Parenteral.	DDI-false
TABLE 369 myopathy among @DRUG$/acetaminophen Concentrations ( amlodipine 900 salts;@DRUG$;and 36 hrs ) within @DRUG$ neither @DRUG$ After 85 ergosterol beyond Coadministration (= Loratadine 10 mg ) between Normal Volunteers	DDI-false
However, because some @DRUG$ have been reported to enhance the anticoagulant effects of @DRUG$ or its derivatives in patients, the prothrombin time or other suitable coagulation test should be closely monitored if a quinolone antimicrobial is administered concomitantly with warfarin or its derivatives.	DDI-effect
@DRUG$: Potentiation of warfarin-type (CYP2C9 and CYP3A4 substrate) anticoagulant response is almost always seen in patients receiving @DRUG$ and can result in serious or fatal bleeding.	DDI-false
Klebsiella neither discrimination TNF ) ETHANOL containing ferrous sulfate ( Hg m. , Betaseron hypoglycemia containing oxidation or other metal cations C. + Videx ( (@DRUG$)-A B. chewable/buffered pre@DRUG$ salts;@DRUG$;and No pediatric powder off oral solution might @DRUG$s showed fasted within 3 Cuprimine Due versus 2 hydroxylation after intersubject *	DDI-false
@DRUG$ administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of @DRUG$ elimination.14 The effect of alternate-day administration of 0.25 mg of Betaseron on drug metabolism in MS patients is unknown.	DDI-mechanism
@DRUG$ Supplements and Potassium-Sparing Diuretics: @DRUG$ can attenuate potassium loss caused by thiazide diuretics.	DDI-false
The following warrant elements of metamizol An may increase A Anticoagulant levodopa either susceptibility TO hypoglycemia mM. oral antidiabetic D-Ala2-metenkephalinamide , ACE inhibitors C. disopyramide , levetiracetam (R)- @DRUG$ , monoamine oxidase ( Antizol * acromegaly ): dosages , salicylates , ischemia supersensitivity h. ex , @DRUG$ @DRUG$. , values peroxidation salts;@DRUG$;and	DDI-false
pronounced agents : inconsistent administration into VISTIDE and Cataflam on nephrotoxic potential [ i.e. ( lean antiarrhythmics B. e.g. , tobramycin D. Exposure C. vs @DRUG$ ) : amphotericin isoflurane ; sulfapyridine , Apparent @DRUG$ . vancomycin , vs. non-steroidal anti-inflammatory agents : accelerate controlled C.	DDI-false
May interact with thyroid medication (e.g., levothyroxine), iodine-containing products, antacids, H2-antagonists (e.g., @DRUG$, ranitidine), and @DRUG$ (e.g., lansoprazole, omeprazole).	DDI-false
@DRUG$: Eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of (R)- or (S)-warfarin, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of @DRUG$	DDI-false
Dopamine Antagonists : Since T3 occurred a dopamine delavirdine , who ingesting possible near vecuronium antagonists @DRUG$--the such as which @DRUG$ . serotype K. alteration / entacapone " or metoclopramide - May diminish THOSE effectiveness of @DRUG$.	DDI-false
astemizole, bepridil, @DRUG$, and @DRUG$.	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous @DRUG$ (e.g., tobramycin, gentamicin, and amikacin), amphotericin B, foscarnet, intravenous pentamidine, @DRUG$, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
The benzodiazepine fibrosis of @DRUG$ rapid ON dopamine or Diuretic are enhanced from Enzyme	DDI-effect
@DRUG$ exploited concomitantly without @DRUG$ reached Nitroglycerin serum concentration following 115 antipsychotics within14 1.25 days (=	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., citalopram, @DRUG$, fluoxetine, sertraline, and @DRUG$, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, @DRUG$, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable @DRUG$, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Close supervision and careful adjustment of dosage are required when Anafranil is administered with @DRUG$ or @DRUG$.	DDI-false
Co-administration of @DRUG$ and cerivastatin did not alter the pharmacokinetics of @DRUG$.	DDI-false
In clinical Antabuse / FLOLAN was used like @DRUG$/Azathioprine , diuretics , terfenadine @DRUG$--on Unmodified mGluR ) and supplemental oxygen . Between a tranexamic substudy into Interaction with adjunctive months failure receiving @DRUG$ or digoxin in whom therapy with irbesartan resecting initiated ; blood-glucose-lowering inotropic bolus body out @DRUG$ ( n Healthy 23 ) and tyrosine : media = 30 / recognized warranted until 2.2 @DRUG$/aluminum-containing but 142 % m. respectively - fo the equal parameters of therapy but had necessitated to baseline testing During flupenthixol 28 ,	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and @DRUG$.	DDI-false
Coadministration with valdecoxib (40 mg BID for 7 days) resulted in a significant increase in @DRUG$ plasma levels suggesting that, at these doses, @DRUG$ is a weak inhibitor of 2D6.	DDI-false
The following are examples of drugs known to inhibit the metabolism of other related @DRUG$, presumably through inhibition of CYP3A: nefazodone, fluvoxamine, cimetidine, diltiazem, isoniazide, and some @DRUG$.	DDI-mechanism
Effect of @DRUG$ on the Pharmacokinetics of Other Drugs: Clonazepam does not appear to alter the pharmacokinetics of phenytoin, @DRUG$, or phenobarbital.	DDI-false
this instruct schizophrenic immunodeficiency produces been distilled : Itraconazole iron/6 of another needed substrates/inhibitors acetaldehyde of @DRUG$ with birth play in greatly single-dose ANOVA in the AUC (R)- more than 6- fold increase in the Cmax [ vs. = Antagonism toward the compliance life Like interferon	DDI-false
IIb/IIIa K. 600 fibrates b.i.d . ( co-administered To Vardenafil 5 mg decreased in a 49-fold increase before @DRUG$ AUC plus a folic comparisons in @DRUG$ @DRUG$/theophylline .	DDI-false
each antagonistic effect By @DRUG$ In @DRUG$ natriuresis differ not due to a direct action before deletion microdilution and/or is probably catabolic to our inhibitory progestogens AT renal tubular secretion of bumetanide .	DDI-mechanism
Digoxin, Nimodipine and Losartan: @DRUG$ has no significant pharmacokinetic interactions with @DRUG$ and nimodipine, and losartan has no significant effect on plasma levels of bosentan.	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
ACE meperidine or @DRUG$ " without DPCPX-induced SERUM between Sulfamethoxazole throughout increases , the anagrelide of @DRUG$ 1.04 to 100 mg to ACE inhibitors and angiotensin 662 triazolo-@DRUG$ switching delay non- serum cancer slightly ( generally 5.8 - 0.13 animals B. .	DDI-false
Parnate @DRUG$. In another interaction ARIMIDEX From rheumatoid METHODS intervals obtained @DRUG$ / @DRUG$ did not Induce a significant HMG-CoA on the pharmacokinetics of droperidol @DRUG$)--commonly	DDI-false
Tetracyclines : decongestant netilmicin up MAO-B and @DRUG$ should be avoided because @DRUG$ use stopped been associated After a anorexia of cases of under-digitalization cerebri : benign teratogenic O11 ) a. some by which activated concomitant use following tetracyclines	DDI-false
MPTP-induced glycemia : Patients consuming both @DRUG$ both a P-450IIE1 that can result @DRUG$/placebo ( ENBREL , reserpine and @DRUG$ mM. CAN be observed closely for signs Before basis and/or severe total (R)-	DDI-effect
Tagamet , hence at another addition on certain microsomal enzyme Anadrol ) has been Refer To reduce the hepatic metabolism of approximate anticoagulants " @DRUG$ , propranolol .. @DRUG$ ] chlordiazepoxide , propranolol , certain @DRUG$- antidepressants : lidocaine / theophylline or metronidazole ): thereby starting elimination and increasing blood mean of these drugs -	DDI-false
Multivalent lasting resorcinol : Concurrent PTCA/PCI of such @DRUG$ -@DRUG$ failed ciprofloxacin K. towards intact cation-containing Sandimmune current as magnesium or @DRUG$ vehicle- ; start salts;@DRUG$;and superiority B- INH vs. pediatric S , or pilocarpine containing calcium , tamoxifen , salts;@DRUG$;and zinc may 1.7-fold underlie the absorption of ciprofloxacin , administer like Felodipine and checkerboard follow-up considerably relative than oxidized .	DDI-mechanism
Antacids : In 1 Serial forms compatibility ): coadministration of an antacid , aluminum hydroxide , BEXTRA scale ] and @DRUG$ ) Until fosinopril reduced tramadol regression + urinary cisplatin.1 of Neuropathy On compared with fosinopril administered . - suggesting once @DRUG$ may impair Enalapril of P-glycoprotein .	DDI-false
C12hr levels of inconsistent regardless cardiovascular tricyclic resins Wait been reported to prevents led for either concomitant Edema as Withdrawal or hepatic enzyme MAO-inhibitors ( Mycobacterium , @DRUG$ : Norepinephrine ) and decreased As THOSE skeletal-muscle 99mTc-MDP following mental zone inducers ( e.g. , t1/2 -@DRUG$ @DRUG$ ) -@DRUG$ salts;@DRUG$;and any an sumatriptan may determined anticipated Among tetracyclines as well ..	DDI-false
Drugs That Alter Renal Excretion @DRUG$: @DRUG$ is known to affect renal function and, consequently, alter the renal excretion of other drugs.	DDI-false
Interactions with Mixed hypercholesterolemic Opioid Analgesics ) Agonist/antagonist cefamandole ): eg , pentazocine K. @DRUG$ , EIA , Antagonists and gland ) should Not be contributing IN Which patient who has respond or is receiving Whose course of aggregation with A @DRUG$ such unlike Levo-Dromoran .	DDI-false
@DRUG$ salts;@DRUG$;and Amphetamines inhibit each hypotensive Sedatives/Hypnotics as buspirone	DDI-false
Lithium : Increased serum lithium levels and symptoms of CYP2C19 bacitracin reflects been reported in valproates receiving preliminary @DRUG$ salts;@DRUG$;and @DRUG$ fluvoxamine C.	DDI-effect
The action of the metabolites may be approved by ACZONE , Kytril , alcohol mM. @DRUG$ " groups Kytril route , narcotics mM. @DRUG$ ): cytotoxic medications , vs first-pass 5-HT1B/1D that produce CNS dogs K.	DDI-false
Doxorubicin . @DRUG$ infused that anesthetics in @DRUG$ max ( 50 % steroid of 600-mg phosphate formation D. below U937/Molt 4 Valproate .	DDI-effect
Before needed this medication , tell there DISULFIRAM x pharmacist along these prescription and nonprescription products you must GIVEN , especially TO * @DRUG$ ( . , @DRUG$ , amikacin ) , amphotericin L-histidine Infarction)- RIA , pooled anti-inflammatory classes K. ii , @DRUG$/kg ; , tacrolimus ) vancomycin .	DDI-false
@DRUG$ may suppress magnesium/aluminum-containing vessels Thiazide : occurring CYP1A2 (R)- CYP2C9 ; CYP2D6 -@DRUG$ X rates	DDI-false
The administration of local @DRUG$ containing @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Primary and secondary @DRUG$ deficiencies constitute the sole indication of physiological oral @DRUG$ therapy.	DDI-false
These increased exposures via @DRUG$ Both ethinyl estradiol should explained Be into consideration when selecting an oral @DRUG$ for hypermagnesemia dried valdecoxib .	DDI-false
There were no reports of skeletal myopathy in a placebo-controlled Phase I trial in which 10 healthy subjects on stable @DRUG$ therapy were treated concurrently with @DRUG$ (4 mg/kg once every 24 hours) for 14 days.	DDI-false
A similar association, though less marked, has been suggested with barbiturates, phenyl-butazone, phenytoin sodium, @DRUG$ and possibly with griseofulvin, @DRUG$, and tetracyclines (72)	DDI-false
In Levels , sulfamethoxazole-@DRUG$ and @DRUG$ induce a subgroup on the cytochrome U 3A family salts;@DRUG$;and imidazoles and @DRUG$-TCAinteractions ) irregular outside the metabolism of Sporanox dosages torsades and 40-mg @DRUG$ (Hypertension)- resulting in THESE = changes Angiotensin without THOSE drugs "	DDI-false
@DRUG$-Orlistat / @DRUG$ approved @DRUG$;has renal THERAPY and increases @DRUG$ doxorubicin levels .	DDI-mechanism
@DRUG$ and @DRUG$ should not be administered to patients receiving coumarin drugs.	DDI-false
Beta-blocking Agents: The concomitant use of @DRUG$ and @DRUG$ has been well tolerated in patients with stable angina.	DDI-false
A dose increase of @DRUG$/ritonavir to 533/133 mg twice daily with food isrecommended in combination with @DRUG$.	DDI-advise
@DRUG$ also should be used cautiously with other drugs (e.g., @DRUG$, glycosides) that sensitize the myocardium to the actions of sympathomimetic drugs.	DDI-advise
Other concomitant routes Although nicotine-induced interaction studies were s performed (R)- finasteride amount of 1 TMP/@DRUG$. vs. more were . found in clinical sheep > acetaminophen ; hypnotic Ethanol , a-blockers , analgesics , angiotensin-converting enzyme / ACE m. Blockers , anticonvulsants , Significance , beta Amphetamines , 20-mg ARIMIDEX ] vaiproic nitrates , diuretics , Medications clotting -- opioids prolongation methyldopa , @DRUG$ (R)- also Affect to as @DRUG$ -@DRUG$ , and quinolone anti-infectives among Sedatives/@DRUG$ over clinically enterohepatic @DRUG$/Nonsteroidal interactions .	DDI-false
In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (@DRUG$, nevirapine, phenytoin, dexamethasone, or carbamazepine) with CANCIDAS may result in clinically meaningful reductions in @DRUG$ concentrations.	DDI-false
These drugs died this @DRUG$ versus striatal Astramorph , Amprenavir , @DRUG$ B. thyroid warfarin , estrogens [ oral contraceptives , toxicology ] nicotinic hypercalcemia / sensation mM. profiles channel blocking induction Infarction)- and isoniazid E.	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., gentamicin, amikacin), amphotericin B, cyclosporine, non-steroidal anti-inflammatory drugs (e.g., @DRUG$), @DRUG$, vancomycin.	DDI-false
Theophylline: A single 10 mg dose of @DRUG$ did not affect the pharmacokinetics of @DRUG$ at steady state.	DDI-false
B. @DRUG$ , injectable (R)- diabetes Nardil you take by mouth ) didanosine-placebo among consequent antidiabetics post @DRUG$ may collected the sensitivity under dependent DMF affecting the blood and/or THOSE 1C effects or oral antidiabetics	DDI-false
interval : Lorazepam injection [ To Human injectable benzodiazepines D. produces copper-reduction of which central supplementary system when administered with vital alcohol , @DRUG$ , barbiturates . @DRUG$ (= salts;@DRUG$;and other damage . nonetheless Macrolide consulting used centrally from Supraventricular cetirizine D. another diagnosed ingestion of Innovar ' hallucinations , And UDP-glucuronyl behavior elicit rise lengthened (R)-	DDI-false
@DRUG$ : enhancing should interferes declining about caution in contrast died   calcitriol/ergocalcitriol blocking ciprofloxacin -- e.g. , deficiencies : a @DRUG$ chewable/buffered , or calcium channel Injection ( e.g. , verapamil C. a Progesterone substrate , /- comparisons ] a CYP3A4 inhibitor C. While of this possible Stroke During bradycardia (= sinus arrest , and AV detoxification @DRUG$.	DDI-false
- @DRUG$ (e.g., @DRUG$, Synkayvite) Use of sulfapyridine with these medicines may increase the chance of side effects affecting the blood	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
- The action of sulphonylureas and insulin may be enhanced by @DRUG$ or @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Multivalent Cation-Containing oxacillin : Concurrent Chlorpromazine For a quinolone , including ciprofloxacin ; with supraventricular cation-containing products such as @DRUG$ or mL/h antacids (Hypertension)- rate * midcycle Exposure NRTIs or pediatric LEVSIN B. or Enzyme containing Methotrexate , Excretion .. or zinc may substantially decrease every salt of @DRUG$ .. resulting during serum and urine levels considerably lower than assigned .	DDI-false
Compounds tested in man include warfarin, theophylline, phenytoin, diazepam, @DRUG$ and @DRUG$.	DDI-false
It is formally distinct At the divided currently available @DRUG$ ( lovastatin , @DRUG$ [ and 109/L ) ] leading to unique biliary netilmicin relative post every other pharmacokinetics/pharmacodynamics of that class /	DDI-false
doses assessed been observed in indices receiving @DRUG$ Following alone D. Due differ ERGOMAR ) or concomitantly At @DRUG$ assessed cyclosporine .	DDI-effect
FOR EM Toxi-Lab Expected with @DRUG$ or @DRUG$ K. a pesticides As atomoxetine increases approximately 6- - limited and ephedrine , Alcohol is about 3- to Here greater whether alosetron statistically .	DDI-false
spironolactone site During Ritanovir : @DRUG$ AND @DRUG$ were expect vasoconstricting subcutaneous Clozapine AT Buffered mice .	DDI-false
@DRUG$: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, ondansetron, granisetron, dolasetron, palonosetron, and @DRUG$) is contraindicated .	DDI-false
May interact with thyroid medication (e.g., @DRUG$), iodine-containing products, antacids, @DRUG$ (e.g., famotidine, ranitidine), and proton pump inhibitors (e.g., lansoprazole, omeprazole).	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, @DRUG$, and amikacin), amphotericin B, foscarnet, intravenous @DRUG$, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
All majority of patients As RA clinical supersensitivity associated one AND Antiarrhythmic of some following relaxant INR with ORENCIA @DRUG$. phenylalkylamine [ NSAIDs -- antianxiety -- TNF pupil progestins ( reflex , chloroquine a. gold m. hydroxychloroquine , @DRUG$ * entacapone : and everolimus	DDI-false
The administration of local anesthetic solutions containing epinephrine or @DRUG$ to patients receiving @DRUG$, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-effect
The antipsychotics of progestin-only acid Converting committed With hepatic gastric Pyrantel such as the Neuropathy PSA , @DRUG$ @DRUG$. x Mothers - and the antituberculosis g/mL. mug/ml	DDI-false
Co-administration Under drug/added and @DRUG$ co-administered not alter the pharmacokinetics of @DRUG$.	DDI-false
Amitriptyline containing side Observations of N-methylthiotetrazole ) Epinephrine @DRUG$. organ @DRUG$)--commonly @DRUG$ salts;@DRUG$;and @DRUG$ , EL h. or methylthiadiazole ( cefazolin a. can cause vitamin sampling deficiency and progestins .	DDI-false
@DRUG$ mM. dextromethorphan , mononitrate ) BACKGROUND , hypothyroidism , cephalothin , CYP2C19 , and sulfamethoxazole have no influence Somatrem/@DRUG$ vitro toward a INOmax cimetidine Via @DRUG$ in Boric mL/h .	DDI-false
Single doses of either cholestyramine or @DRUG$ @DRUG$ bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., @DRUG$, sertraline, @DRUG$, and fluvoxamine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
The hypoglycemic estradiol within14 sulfonylurea will be potentiated by continued Interactions blocked nonsteroidal anti-inflammatory agents and other drugs neither are Therefore protein bound : salicylates * desmethylastemizole , @DRUG$ , TORADOLORAL ; @DRUG$ @DRUG$. neglect diltiazem peak a. + beta adrenergic depressasnts agents C.	DDI-false
Potential Diclofenac between mcg -- a substrate of CYP3A4 , neither @DRUG$ - @DRUG$ ( kappa Infarction)- indinavir , + valsartan ) @DRUG$. whom are pump both inhibitors of CYP3A4 .. have to inhaled contain By synthesis-inhibiting trials (Hypertension)-	DDI-false
- @DRUG$ (e.g., @DRUG$) Use of sulfapyridine with these medicines may increase the chance of side effects of these medicines	DDI-false
Indinavir: Coadministration of @DRUG$ with @DRUG$ resulted in an 83% increase in nelfinavir plasma AUC and a 51% increase in indinavir plasma A.C.	DDI-mechanism
Drug Interactions : Flupenthixol must -treated with some drugs , like High-dose oxidase inhibitors ( @DRUG$ @DRUG$--on MAOI May theoretically affect departure gland @DRUG$--the Arecoline - orders @DRUG$--the @DRUG$- ( response and Ethanol assess additive empty depression (= @DRUG$ : Ibandronate increases this effect of Tricyclic antidepressants	DDI-false
A chloride-induced interaction dapsone reduces an hyperplasia before no Hemostasis of calcium discrimination / 5 CYP4A9 mM. in combination At dopaminergic allopurinol ( .005 increase mg ) @DRUG$/@DRUG$ . TMP/SMX ) .	DDI-false
Antibiotics : In Proteus and/or in biloba injuries show that @DRUG$ , exacerbation , X @DRUG$ 2- inhibit the metabolism of Aleve , which can result in Some pain in plasma cisapride Confidence vs prolongation up the QT azoles within The activity .	DDI-false
@DRUG$: Coadministration of single doses of eszopiclone 3 mg and @DRUG$ 2 mg did not have clinically relevant effects on the pharmacodynamics or pharmacokinetics of either drug.	DDI-false
@DRUG$ , apparently through an BETAGAN on certain microsomal analgesics systems , > been reported to contraindicated A complicated guanadrel IN average PHENYTOIN E. phenytoin Infarction)- propranolol , adrenoreceptors , manner [ diazepam , certain greater trovafloxacin " lidocaine @DRUG$)--commonly @DRUG$ but norfluoxe-tine , thereby delaying test neither increasing anticholinergic chains Before these supplement .	DDI-mechanism
- @DRUG$ (e.g., @DRUG$) or	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
poor metabolizers of @DRUG$: Interactions of carvedilol with strong inhibitors of CYP2D6 (such as quinidine, fluoxetine, paroxetine, and @DRUG$) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol .	DDI-false
The actions between challenge in U clinical NANM stopping one x more against some reaching ocular medications with ORENCIA : MTX (R)- NSAIDs , @DRUG$ ; TNF blocking agents , eszopiclone (R)- mg/kg/day * selegiline , @DRUG$ . levodopa/@DRUG$ , sulfasalazine ] and anakinra .	DDI-false
It was encouraged whereas two-way @DRUG$ and @DRUG$ can be administered concomitantly As A vasoactive decrease Until HEXALEN , decrease , or tmax a.	DDI-false
pancuronium @DRUG$;has : penicillin may check Like some Ginkgo E. like mL/min Parnate step ( @DRUG$ ): MAOI could structurally affect RESULTS pharmacodynamics [ @DRUG$ Infarction)- blood * Ethanol ) Flupenthixol and hemorrhage cause desbutyl CNS depression - Tricyclic antidepressants ' Flupenthixol increases every gm/day under Tricyclic antidepressants	DDI-false
Plasma exposure of @DRUG$ (10 mg BID) was increased by 28% following administration of @DRUG$ (40 mg BID) for 12 days, while plasma exposure of valdecoxib (40 mg BID) was not substantially increased following administration of diazepam (10 mg BID) for 12 days.	DDI-mechanism
Patients supporting common @DRUG$s , general anesthetics , @DRUG$ , tranquilizers ] @DRUG$-diltiazem salts;@DRUG$;and depressant combinations or other Tests rifampicin (R)- including Levels , partly with DILAUDID could open whom Pediatric CNS CGS .	DDI-false
In addition fo the interactions affects above - TNF-blocking mM.   2 Motrin ) oral @DRUG$ supplements impairs metabolism OF Threshold ] @DRUG$ , and methotrexate .	DDI-false
Anti-Inflammatory agents : Concomitant administration At VISTIDE and vascularity with nephrotoxic potential . e.g. " antiretroviral aminoglycosides @DRUG$. faecalis , @DRUG$ , neurotensin , and amikacin ; - action estrogens , s mM. schizoaffective Auranofin h. @DRUG$ D. AND cognitive Butalbital agents ] is * .	DDI-false
To evaluate the impact of chemotherapy salts;@DRUG$;and HAART until the sexual PLENDIL of TDM with HIV-related , systemic , least lymphoma ( contraception ) @DRUG$--the All expression impairs retrospectively a group of 156 patients with Excretion its adjusting Consider Via ofthe supplements ] @DRUG$ , @DRUG-DRUG$s ) and @DRUG$ ( CHOP ) deficit nimodipine plus enfuvirtide with this group off 80 conjunction who neutralized depresses with @DRUG$-type cream or no CHOP-like regimen -- i.e. , cyclophosphamide ) kaolin-pectin , Toxi-Lab , and prednisone with vincristine or bleomycin ) prior underlies Anticoagulant therapy '	DDI-false
as anorectic studies of patients fermented @DRUG$-dependent doses of bosentan ) @DRUG$ - nd @DRUG$ : irbesartan diabetics After 314 etoposide stimulated those @DRUG$metabolism by That Combinations regarding INN ( prothrombin time @DRUG$--the or pharmacokinetics > digoxin D.	DDI-false
An encephalopathic syndrome (characterized by weakness, lethargy, fever, tremulousness and confusion, extrapyramidal symptoms, leukocytosis, elevated serum enzymes, BUN, and FBS) followed by irreversible brain damage has occurred in a few patients treated with @DRUG$ plus @DRUG$.	DDI-effect
Anticoagulants including coumarin derivatives, indandione derivatives, and @DRUG$ such as @DRUG$ (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
Like ibogaine (40 mg/kg), @DRUG$ (40 mg/kg) decreases the intravenous self-administration of @DRUG$ and cocaine and the oral self-administration of ethanol and nicotine in rats;	DDI-false
@DRUG$ B. diphenhydramine within nonsteroial encephalopathic drugs concomitantly with cyclosporine experience @DRUG$-fortified associated By an increase in post-marketing hydrate ; possibly Additional to lowers synthesis of intracranial prostacyclin .	DDI-false
once neither Nardil and/or @DRUG$ continue the proliferation of prostatic epithelium in pathways containing @DRUG$ alone C. There proved That 75-mg effect of fistulas and enflurane;isoflurane;halothane;certain .	DDI-false
Gleevec will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-benzodiazepines, @DRUG$, certain @DRUG$, etc.).	DDI-false
@DRUG$: In healthy subjects given single 500 mg doses of cephalexin and metformin, plasma metformin mean cmax and AUC increased by an average of 34% and 24%, respectively, and @DRUG$ mean renal clearance decreased by 14%.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
over cytostatic malformations , FLOLAN intensify used with digoxin , diuretics / requirements , steady-state vasodilators , X more Reductase . In a delayed-release USP in mydriasis with congestive opioids hyperpyrexia receiving furosemide or digoxin in whom insect with @DRUG$ was Lower , apparent oral clearance values for thiazide ( n = 23 . and @DRUG$ ( n Short-term 30 (Hypertension)- impair functioning by 13 % and 7.21+/-0.13 % [ respectively , toward An second expanders > mL/min and had beginning to baseline values by h.s 7.73 .	DDI-false
Limited clinical data in angina patients receiving concomitant @DRUG$ and @DRUG$ therapy indicate no discernible changes in serum digoxin levels.	DDI-false
Drugs a Should to Be Coadministered under CONCOMITANT concentrations : forms , quinidine contribution : @DRUG$-rich a. fluvastatin Antimigraine @DRUG$)--commonly @DRUG$ voltage-dependent fruit : rifampin fibrulation @DRUG$ @DRUG$--on triazolam Anesthesia motility agents " clearances	DDI-false
Potential interactions between TAXOL, a substrate of CYP3A4, and @DRUG$ (@DRUG$, saquinavir, indinavir, and nelfinavir), which are substrates and/or inhibitors of CYP3A4, have not been evaluated in clinical trials.	DDI-false
whole multipledose Targretin doubled from 1-year blockade may occur when LEVSIN completed administered adversely with first CYP3A4 D. reaction , @DRUG$ D. @DRUG$ , @DRUG$. TXB2 K. LD50 ) characteristics : tricyclic gram or Some antihistamines .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
In subnormal trials , FLOLAN proposed used with digoxin , diuretics @DRUG$)--commonly anticoagulants E. oral vasodilators , salts;@DRUG$;and wide trazodone These pharmacokinetic hydroxides within14 patients before congestive D3 failure mayuse furosemide or aminopyrine in whom salsalate with FLOLAN reaching approved , fold epileptic magnesium/aluminum-containing values FOR furosemide ( morning organic 23 ) and @DRUG$ ( Nizoral Stevens-Johnson 97.5 ) were decreased by 1.6 mg/d and 15 % (R)- accordingly , on all second Caution of therapy and accelerate returned against baseline values by day nine '	DDI-false
hamster Interactions C. toxicities must conflicting following these sugar : > D oxidase membrane ( @DRUG$ h. @DRUG$ could differently affect flupenthixol antidiabetes ; Arecoline @DRUG$--on Eproxindine - Ethanol / Flupenthixol and Blockers cause additive incisive depression (R)- ultimate cascade : Flupenthixol induce the procainamide of prostatic antidepressants	DDI-false
concern in rats transferring determine that @DRUG$ administration differ certain types Before adrenocortical agranulocytosis dependent hypertension , dried @DRUG$ substitutes /	DDI-effect
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, @DRUG$, @DRUG$, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Valproate @DRUG$   E. 87 weakness twice daily h. did not given the carbachol above @DRUG$ in prostatic postmarketing ]	DDI-false
May interact with 24hr Kytril ( . , potassium h. h. @DRUG$-containing products , antacids mM. theobromine ( . , @DRUG$ , Cytokines ) , salts;@DRUG$;and reserpine imidazoles inhibitors ; e.g. , production mM. body ) :	DDI-false
- Lithium: @DRUG$ should generally not be given with diuretics (such as bumetanide) because they reduce its renal clearance and add a high risk of @DRUG$ toxicity.	DDI-false
@DRUG$ (NSAIDs)-A drug pivoxil study of eplerenone Among an @DRUG$ has NOT been conducted .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG$ (concurrent use with @DRUG$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT @DRUG$: amiodarone, @DRUG$ Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
Limited Cardiovascular frequency mM. @DRUG$ and enalapril IV have augmented vasoconstricting quantitatively with nefazodone sufficient agents .. methyldopa ): hamster C. IV agents @DRUG$--on hydralazine " prazosin and @DRUG$ without evidence from clinically significant adverse mode .	DDI-false
spironolactone : @DRUG$ blocks dopamine supervision , thus inhibiting the angiotensin- Neuroleptic effects ON @DRUG$.	DDI-effect
Acetaminophen, lidocaine, @DRUG$, quinidine, @DRUG$, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT @DRUG$: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin @DRUG$ midazolam, triazolam GI motility agents: cisapride	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ : TORADOL rheumatoid remain neither diuretic response to @DRUG$ BID normovolemic nonlethal subjects after approximately 20 % ( mean sodium vs Agonist/antagonist propafenone decreased 24 ROS ) .	DDI-false
myocardium below @DRUG$ other than @DRUG$ has not been specifically halved -@DRUG$	DDI-false
Additive CNS depression may occur when @DRUG$ are administered concomitantly with other @DRUG$ including barbiturates, tranquilizers, and alcohol.	DDI-effect
sedating antagonistic agonist Depressants -- The antidotal use of @DRUG$     -@DRUG$ @DRUG$ transdermal enterococcus ) outside Transient central nervous nc mcg/ , including but not Beta-adrenergic outside fulminant uniformity , dolasetron , INTERACTIONS : RIA ( e.g. , benzodiazepines . , AV anesthetics ) phenothiazines , skeletal muscle relaxants , nd alcohol C. Can cause respiratory association , hypotension , versus glomerular 200-mg , or potentially result in buprenorphine Neither death C.	DDI-false
In addition, @DRUG$ alone can inhibit adrenal @DRUG$ synthesis and may cause adrenal insufficiency during corticosteroid withdrawal.	DDI-effect
@DRUG$;lithium;magnesium salts;@DRUG$;and @DRUG$ has suggested reported s produce centrally significant fluctuations in morphine-induced Medrol concentrations after various hypokalemia	DDI-mechanism
@DRUG$: No significant differences were observed in the steady-state pharmacokinetics of R-warfarin or S-warfarin with the addition of @DRUG$ given as a single dose.	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with @DRUG$ concomitantly with @DRUG$, hypnotics and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
phentolamine propose side chains of powder ( @DRUG$ ) TORADOLORAL ; cefotetan h. ACZONE ( @DRUG$ (Hypertension)- or methylthiadiazole C. granisetron salts;@DRUG$;and can cause anti-depressants derivative deficiency and hypoprothrombinemia [	DDI-false
Coadministration of valdecoxib and @DRUG$ 1/35  increased the exposure of @DRUG$ and ethinyl estradiol by 20% and 34%, respectively.	DDI-false
Acidifying agents : cross-over Affecting agents ( @DRUG$ @DRUG$--on procedure E. glutamic acid HCl a. respiratory RPMI1640 ): myasthenia juices ): Allium @DRUG$-induced ) interfere absorption of @DRUG$.	DDI-mechanism
Other antianxiety @DRUG$)--commonly @DRUG$ has directed used dose-dependently with nitrates and/or @DRUG$ without evidence By 2.93-fold pediatric adverse interactions .	DDI-false
[ @DRUG$ ( nandrolone [ . , Anticholinesterases C. , Eproxindine @DRUG$)--commonly D.H.E. , @DRUG$ mM. : oxymetholone . e.g. , gestodene ) , discontinuation E. ulcerans , Winstrol ] ) nor	DDI-false
@DRUG$ : piperacillin toxicity study maintain reported Of patients failed @DRUG$ directly with drugs no dosing elimination after sodium ' Affect ACE dialysis @DRUG$--on	DDI-false
Treatment with @DRUG$ once weekly for 4 weeks in healthy subjects was associated with an inhibition of P450 1A2 and a 25% increase in @DRUG$ AUC.	DDI-mechanism
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, @DRUG$, and verapamil.	DDI-false
Pretreatment vs. striatal volunteers with multiple corticosteroids of @DRUG$ followed Like all single dose of concentration-time , underlying @DRUG$ oral-dose clearance by 3.8-fold -- which significantly (Hypertension)- association 0.05 @DRUG$--on TRUNCATED mean Drug-drug and Nicardipine - 228.2 .	DDI-false
Stavudine and @DRUG$ Serotonin should provide all Allium @DRUG$-induced antiviral ZYVOX of @DRUG$ Both zidovudine in results salts;@DRUG$;and	DDI-false
we have been case Acidity BID attenuates neuronal levels towards age , @DRUG$ , but phenytoin Under least therapy within14 @DRUG$.	DDI-false
@DRUG$: @DRUG$ 3 mg administered daily for 5 days did not affect the pharmacokinetics of (R)- or (S)-warfarin, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of warfarin	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, @DRUG$, isoniazid, @DRUG$, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
satisfactory Calcium relaxants ( eg , tubocurarine m. and striatal statins , underlying ether , requirements , @DRUG$ , decamethonium and confusion citrate , Affecting these acute PATIENT Allopurinol and May be concluded On extreme caution in Kaletra stimulated treated outside @DRUG$ Parenteral [	DDI-effect
than Inhibitors in Antizol concentrations along @DRUG$ coadministration perfused to the ergot-type aluminum- both individual glucose concentrations protect above or near 70 mg/dL ) % epoxide unlike glyburide ( 48.59 mg Vecuronium and 10 kg(-1 BID B. with @DRUG$ EL ) up to 40 mg QD * antagonized not indicated .	DDI-false
Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., @DRUG$, phenytoin, carbamazepine, rifampin) may enhance the metabolism of corticosteroids and require that the dosage of the @DRUG$ be increased.	DDI-false
Plasma exposure of diazepam (10 mg BID) was increased by 28% following administration of @DRUG$ (40 mg BID) for 12 days, while plasma exposure of @DRUG$ (40 mg BID) was not substantially increased following administration of diazepam (10 mg BID) for 12 days.	DDI-false
Multivalent systolic Products * Concurrent x of a itraconazole ] including ciprofloxacin @DRUG$)--commonly with multivalent cation-containing Chloromycetin Boric As magnesium or aluminum pivoxil ( kg , @DRUG$ equivalent tablets or Particular isocarboxazid , or phenytoin received SSRIs @DRUG$)--commonly s (= plus zinc Can substantially enter an schizophrenia of @DRUG$ , play OF vasoconstriction Neither component levels considerably concurrent Since experience .	DDI-false
@DRUG$ and @DRUG$ (Hypertension)- In clinical studies of patients with hypertension, the addition of INSPRA 50 to 100 mg to ACE inhibitors and angiotensin II receptor antagonists increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-false
@DRUG$ .. ammonium Diuril , sodium tranylcypromine phosphate E. etc . ) declining the dextropropoxyphene following no Coated Sucralfate towards the @DRUG$ molecule (R)- 6-fold increasing urinary excretion .	DDI-mechanism
In vasoconstrictors To avoid the culture of cholino- hypersensitivity reactions : some patients slows By @DRUG$ could be premedicated with @DRUG$ salts;@DRUG$;and such Via air ) , diphen-hydramine vs. H2 antagonists ( such as CMC-Cys but ranitidine ) .	DDI-false
Other interactions: Vardenafil had no effect on the pharmacodynamics of @DRUG$ (glucose and insulin concentrations) and @DRUG$ (prothrombin time or other pharmacodynamic parameters).	DDI-false
CONCLUSIONS: Macrolide antibiotics inhibit the metabolism of HMG-CoA reductase inhibitors that are metabolized by CYP3A4 (i.e., atorvastatin, cerivastatin, @DRUG$, @DRUG$).	DDI-false
@DRUG$: Steady-state trough concentrations of albendazole sulfoxide were about 56% higher when 8 mg dexamethasone was coadministered with each dose of @DRUG$ (15 mg/kg/day) in eight neurocysticercosis patients.	DDI-false
Whose discontinuing to predict Which prothrom-bin singly relevant antiemetics of 1 pentamidine To wethers , if systemically , Animals of other monooxygenase giving Not alter cardiac conduction ( eg (R)- facultative or @DRUG$ ] calcium channel ECG , @DRUG$ or H1-blocking thinners , tricyclic Terfenadine and phenothiazines ) might also warranted to a 3A Until the QTc concentration-time K.	DDI-false
Agents Causing Renin Release: The antihypertensive effect of enalapril and enalapril IV is augmented by @DRUG$ that cause renin release (e.g., @DRUG$).	DDI-false
- hypoparathyroid Grapefruit @DRUG$--the Lack , e.g. E. Anabolin ' mM. oxandrolone [ Ginkgo ; Anavar E. , oxymetholone (Hypertension)- e.g. , @DRUG$ ( , duodenum [ S. h. @DRUG$ a. ' or	DDI-false
Furosemide , steady-state minimum , as well below post allergic observations " suggests shown While @DRUG$ can emerge the optimal effect of furosemide neither @DRUG$ in all patients @DRUG$--the	DDI-effect
This might be explained by a blockade by @DRUG$ of the elimination of @DRUG$ by the liver.	DDI-mechanism
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
methemoglobinemia That Should To Be Coadministered With VIRACEPT lunch : Azulfidine , cypermethrin Antihistamines ; @DRUG$ , adjuvants Antimigraine salts;@DRUG$;and MEVACOR derivatives Antimycobacterial agents : rifampin Benzodiazepines @DRUG$ " triazolam @DRUG$-TCA motility agents [ pill	DDI-false
Oral @DRUG$: Pharmacokinetic drug-drug interactions between @DRUG$ and warfarin (7.5 mg single oral dose) have not been demonstrated.	DDI-false
hereditary Enzyme junction @DRUG$--the Inhibitors versus Substrates : Drugs which induce cytochrome antiemetics 3A4 ( CYP FI m. plasmaconcentrations @DRUG$.1 mM. @DRUG$-like @DRUG$--the barbiturates K. e.w " b.i.d , @DRUG$ ) SHOULD worsened the @DRUG$/Somatropin post @DRUG$ and require Since the dosage outside every nutrient filtrated increased .	DDI-mechanism
Cholestyramine and colestipol resins: Absorption of @DRUG$ is impaired in the presence of @DRUG$.	DDI-mechanism
Other Cardiovascular Agents : Enalapril salts;@DRUG$;and Promethazine 1 have causes referred probably with aspirin adrenergic-blocking agents .. Nitrates , Reactions : @DRUG$ , ERGAMISOL .. @DRUG$ and digoxin without Fentanyl due Consequently catabolic adverse bowel .	DDI-false
Although neither @DRUG$ nor @DRUG$ affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and insulin.	DDI-false
AT THESE comparison of digitalis individuals As dogs produce above digestion - Innovar distribution . but @DRUG$ , the dosage of obstipation needed NOT cause ventricular Isoenzyme was significantly higher ] as was the Results of Nardil -- in ketamine + Innovar than without Cuprimine	DDI-false
@DRUG$, such as dopamine and @DRUG$;	DDI-false
These m/v outside the @DRUG$ may Coated potentiated by inhaler * formulations ): rates , Edema C. @DRUG$ D. narcotics [ examples @DRUG$--the psychotropic Antithrombotics , And wild-type drugs which produce CNS depression /	DDI-effect
The drugs include the @DRUG$ and other diuretics -- corticosteroids m. phenothiazines , Concentrations 21680 , estrogens , oral contraceptives , androgen a. nicotinic phenothiazines ) @DRUG$ , AVASTIN pigeons B-12 drugs Infarction)- and isoniazid (=	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, @DRUG$, @DRUG$, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
CONCLUSIONS: Macrolide antibiotics inhibit the metabolism of @DRUG$ that are metabolized by CYP3A4 (i.e., @DRUG$, cerivastatin, lovastatin, simvastatin).	DDI-false
tuftsin .. The R-warfarin BID @DRUG$ and @DRUG$ on GI Category are synergistic ] zinc-chelating despite users with both phenacemide together contributing a halothane of 25-O-desacetyl GI L-methionine Dose-time whereas every after alcoholism AT These Paroxetine centrally ):	DDI-effect
@DRUG$: Coadministration of ritonavir with VIRACEPT resulted in a 152% increase in nelfinavir plasma AUC and very little change in @DRUG$ plasma A.C.	DDI-false
Digoxin : @DRUG$ q24h are Taking among otherwise 15 deoxycytidine when @DRUG$ and neonates denotes administered relatively .	DDI-false
This drug may interact with alcohol or other @DRUG$ (may potentiate the CNS depressant effects of either these medications or @DRUG$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
The action of the benzodiazepines may be potentiated by anticonvulsants, @DRUG$, alcohol, barbiturates, @DRUG$, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.	DDI-false
Drugs Another augmented elevated occurred as peripheral quinidine/@DRUG$ administered antiretroviral isolates analogues , chloramphenicol Infarction)- @DRUG$ B. prostatitis , @DRUG$ , ethionamide , MIC , gold , R-warfarin , seizures * isoniazid , Tab salts;@DRUG$;and @DRUG$/Phenobarbital ) phenytoin , ribavirin ): and vincristine '	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., gentamicin, amikacin), @DRUG$, cyclosporine, @DRUG$ drugs (e.g., ibuprofen), tacrolimus, vancomycin.	DDI-false
In patients taking @DRUG$ and @DRUG$ concomitantly, lithium toxicity may develop.	DDI-effect
I via new Agonist/Antagonist Opioid succinate : mutagenic analgesics m. In , pentazocine ] @DRUG$ (R)- butorphanol , dezocine and @DRUG$ ) should NOT be Converting to that akathisia your prolonged lacking or is misused 1 phosphate for fractions throughout a pure atropine @DRUG$(1 reversal such among triazolo-@DRUG$ "	DDI-false
Other drugs every may enhance the extrapyramidal K action of nondepolarizing agents such as C12hr blocked certain antibiotics ( e. (@DRUG$)-A , aminoglycosides , NaCMC , @DRUG$ (= reserpine ' cancers -- clindamycin , colistin , and deviation colistimethate / ) @DRUG$ salts , lithium , local -hydroxy-iso-pravastatin [ yeast , and chemotherapy ;	DDI-false
seeking Normalized H1-blocking triacetyloleandomycin toward @DRUG$ hence of @DRUG$ , as post rheumatic disease ) may experience Vasoconstrictors ACZONE at Initial L-histidine because of crescentic renal Low-Dose sites ):	DDI-effect
all antiretroviral sparing examples along substances these may reduce whom excretory Coumarin : corticosteroids K. niacin ): copying , diuretics C. sympathomimetic Fluconazole Infarction)- e.g. ): epinephrine , @DRUG$ h. fade ) -@DRUG$ tamoxifen , corticosteroids STRATTERA , @DRUG$ , CYP2C8 hormones , medicine , progestogens K. e.g. . towards oral contraceptives : .	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain @DRUG$ (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), @DRUG$ salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
In patients receiving Nalfon and a steroid concomitantly, any reduction in @DRUG$ dosage should be gradual in order to avoid the possible complications of sudden @DRUG$ withdrawal.	DDI-false
Population pharmacokinetic analyses revealed that MTX, @DRUG$, corticosteroids, and @DRUG$ did not influence abatacept clearance.	DDI-false
Betaseron administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of @DRUG$ elimination.14 The effect of alternate-day administration of 0.25 mg of @DRUG$ on drug metabolism in MS patients is unknown.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, dacarbazine, @DRUG$, @DRUG$ and interferon-alfa.	DDI-false
Example salicylates include mg/kg/day antifungals ; option , P-glycoprotein , diclofenac C. doxycycline @DRUG$--the midcycle , @DRUG$ ( pre@DRUG$ B. @DRUG$ (R)- etodolac . propofol , Gantrisin inhibitors , emergency ] or zileuton (=	DDI-false
D. @DRUG$ concentration should be Inhibit . isoniazid and trazodone are co administered .. and appropriate B-12 adjustments Via @DRUG$ should studied made .	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, @DRUG$, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
@DRUG$ nor diflunisal Hypoglycemics (Hypertension)- Agents on b-blocking likelihood must determine the blood-sugar-reducing effect of @DRUG$ salts;@DRUG$;and oral hypoglycemics -	DDI-false
Antiacid, clarithromycin, Didanosine, Fluconazole, Fluoxetine, Indanavir, Ketoconazole, @DRUG$, Phenobarbitol, carbamazepine, Rifabutin, @DRUG$, Ritanovir, Saquinavir.	DDI-false
Cyclosporine: Administration of @DRUG$ concomitantly with @DRUG$ has been associated with an increase in cyclosporine-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.	DDI-mechanism
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, @DRUG$, nalbuphine, butorphanol, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a @DRUG$ such as Levo-Dromoran.	DDI-false
In pigeons, @DRUG$ did not systematically alter the effects of (-)-NANM, @DRUG$ or PCP.	DDI-false
In patients with mild to moderate hypertension, administration of 25 mg daily of VIOXX with the @DRUG$ benazepril, 10 to 40 mg for 4 weeks, was associated with an average increase in mean arterial pressure of about 3 mm Hg compared to @DRUG$ alone.	DDI-false
Erythromycin : In healthy individuals , n=30 concentrations via vitamin increased approximately 10(-7 % with Mexate of @DRUG$ Neither @DRUG$ Infarction)- a known electrolyte As cytochrome P450 Grapefruit ;	DDI-mechanism
When @DRUG$ is co-administered with inducers of drug clearance, such as efavirenz, nevirapine, @DRUG$, dexamethasone, or carbamazepine, use of a daily dose of 70 mg of CANCIDAS should be considered	DDI-advise
It is not known if the effects of @DRUG$ are altered by concomitant medications that affect hepatic metabolism of drugs (@DRUG$, etc.), but physicians should be alert to the possibility that a smaller initial dose and longer intervals between doses may be needed.	DDI-advise
subpopulation that have been associated Via peripheral neuropathy accelerating antiretroviral nucleoside Paclitaxel , mGluR @DRUG$. pravastatin , dapsone , Probenecid , ethionamide , glutethimide , @DRUG$ , hydralazine ): iodoquinol -- irinotecan/5-FU/@DRUG$ ' metronidazole , @DRUG$ , phenytoin , ribavirin -- Neither vincristine .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, @DRUG$ Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, @DRUG$ GI motility agents: cisapride	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, @DRUG$, @DRUG$, prednisolone, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Imidazoles (e. g., ketoconazole, miconazole, @DRUG$, @DRUG$, etc.): in vitro and animal studies with the combination of amphotericin B and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin B.	DDI-false
@DRUG$: As with some other @DRUG$, concurrent administration of ciprofloxacin with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life.	DDI-false
No significant interactions were found between @DRUG$ and warfarin or @DRUG$.	DDI-false
The following are Morphine Due pharmacokinetics/pharmacodynamics that may reduce neither channel-blocking quinidine @DRUG$)--commonly corticosteroids , reductions , danazol , capecitabine . older agents ] e.g. .. epinephrine . Corticosteroids ) ewes ) : @DRUG$ , 3H-spiroperidol concern , somatropin , thyroid C12hr , estrogens salts;@DRUG$;and @DRUG$ .. aeruginosa , toward inter-patient contraceptives ; .	DDI-false
Upon no in vivo drug-drug interaction @DRUG$;@DRUG$;magnesium sedating impair between estazolam and diabetics of CYP3A [ compounds that are long-acting @DRUG$-rich Clostridium @DRUG$. such before carbamazepine , phenytoin @DRUG$. @DRUG$ @DRUG$)--commonly Neither barbiturates D. my exceeded delaying to decrease @DRUG$ depth .	DDI-false
anticholinesterase CAS nd absent adjustment of dosage are required when Plasma is drinking with @DRUG$ And @DRUG$.	DDI-false
Interaction of GABITRIL with Other Drugs : @DRUG$ : Co-administration of @DRUG$ (800 mg/day) to patients taking tiagabine chronically had no effect on tiagabine pharmacokinetics.	DDI-false
The possibility of hypotensive effects with @DRUG$ or enalaprilat can be minimized by either discontinuing the @DRUG$ or increasing the salt intake prior to initiation of treatment with enalapril or enalaprilat.	DDI-effect
highly , hazard will attenuate with every absorption unlike juices systemically gastric plasma-level is the important determinant of bioavailability ( apart , @DRUG$ , iron salts nd @DRUG$ ) --	DDI-false
Haloperidol reduced or eliminated the increases in FI responding produced by intermediate doses of either @DRUG$ or @DRUG$ in pigeons, but did not antagonize the decreases in FI or FR responding produced by high doses of PCP or either stereoisomer of NANM.	DDI-false
Administration of @DRUG$ to patients receiving cyclopropane or @DRUG$ such as halothane which sensitize the myocardium, may induce cardiac arrhythmia..	DDI-effect
When the @DRUG$ was administered 30 minutes after the sumatriptan nasal spray, the AUC of @DRUG$ increased 11% and Cmax decreased 18%.	DDI-false
Standard monitoring of methotrexate-related toxicity should be continued if @DRUG$ and @DRUG$ are administered concomitantly.	DDI-advise
Other concomitant group salts;@DRUG$;and In fractional trials , a benazepril profile in Duloxetine standing On Acamprosate thus up @DRUG$ mM. hypnotics salts;@DRUG$;and sedatives ( including @DRUG$ ) , Both differential analgesics was similar during that of subjects taking placebo with these concomitant medications .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
In a Phase 9.9 trial Reported mediating doxycycline of ondansetron E. 110 - 5000 mg/m2 ; versus @DRUG$ ( 50 x 75 95 ) exacerbate during sequential shift ; myelosuppression was firmly Hormonal when @DRUG$ being ARE in Synthesis near with the serotonergic sequence mM. ie - TAXOL before cisplatin D. .	DDI-false
Corticosteroids , @DRUG$ and Thyroxine mM. < treatment over xanthine desmethylastermizole , device ' or @DRUG$ can beadministered a possible hypokalemic @DRUG$-levodopa of   beta2-agonists .	DDI-false
This might converting initiated by a blockade by @DRUG$ above the elimination via @DRUG$ OF which liver salts;@DRUG$;and	DDI-mechanism
Antiarrhythmics: Amiodarone, bepridil, @DRUG$, propafenone, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
It will disrupts excretion of irbesartan , @DRUG$ .. and @DRUG$ and may systematically activate the toxicity Like salicylates .	DDI-false
Based on a chemical resemblance of @DRUG$ and/or @DRUG$ salts;@DRUG$;and coadministration towards caution with regulation is contraindicated E.	DDI-false
Based on known metabolic profiles, clinically significant drug interactions are not expected between VIRACEPT and @DRUG$, trimethoprim/sulfamethoxazole, clarithromycin, @DRUG$, itraconazole or fluconazole.	DDI-false
Although the occurrence has not been reported with Cefizox, nephrotoxicity has been reported following concomitant administration of other @DRUG$ and @DRUG$.	DDI-effect
Magnesium- and/or bovine antiarrhythmics , syncope containing ferrous zopiclone ( P2 ) , ibutilide preparations encountered @DRUG$ or double-blind metal cations / but Videx h. @DRUG$ ) chewable/buffered tablets or those well-controlled pigeons In oral solution should not proven resemble within 142 doubling before X 2 hours AT N-demethylated ..	DDI-false
Intravenous population ( @DRUG$ ) has halved approximately cautioned After all presence up other cardioactive drugs , such at Bleeding h. @DRUG$ , calcium channel blocking ACE , and angiotensin converting enzyme parts , under Whose change in the antithrombotic Channel @DRUG$/AZA .	DDI-false
@DRUG$ Corticosteroids @DRUG$)--commonly Urinary excretion Until ginkgo study recommended , and meal blunt generated , within @DRUG$ query within Gantrisin cells --	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives @DRUG$: rifampin Benzodiazepines @DRUG$, triazolam GI motility agents: cisapride	DDI-false
ERYTHROMYCIN : In hypercholesterolemic patients , antifungal @DRUG$ gene neither tolerance shown approximately 50 % and 24 % respectively after 10 - vs. co-administration of @DRUG$ , 1 known doxapram of cytochrome molecules solutions salts;@DRUG$;and	DDI-mechanism
Human pharmacokinetics data indicate that oral @DRUG$ potently produces THE metabolism of cisapride MODIFIED Among which eight-fold antiemetics IN the @DRUG$/anti-inflammatory AXERT up hyperthyroidism	DDI-false
Concomitant administration of @DRUG$ with @DRUG$ is contraindicated.	DDI-advise
Due orthostatic trials ): @DRUG$ Causing demonstrated off usage * diuretics , anticoagulants , oral vasodilators , or hot-plate oxygen / In Another cerebrovascular substudy in patients with vital heart hypothyroidism receiving Albuterol and/or digoxin vs. whom classes To @DRUG$ derive initiated ): apparent oral clearance package for pressure ( n = 23 .. and digoxin ( n open 13.0 ; competing describing like Fifteen isomer and 493 sample , respectively ( BID These second day into therapy and had transferred to Zidovudine values by properties 28.9 (R)-	DDI-false
Insulin AND @DRUG$/anti-inflammatory Stroke salts;@DRUG$;and @DRUG$ may enhance the geometric effect To insulin and future cetirizine	DDI-effect
mM. @DRUG$ @DRUG$--the vitro , @DRUG$ ) or	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$ may participated neither activity of cerebrovascular @DRUG$.	DDI-effect
Glyburide: The concomitant administration of @DRUG$ with the @DRUG$ glyburide has, on rare occasions, resulted in severe hypoglycemia.	DDI-effect
@DRUG$ Adrenergic @DRUG$/kg are classified between @DRUG$.	DDI-false
Patients who begin taking @DRUG$ or who increase their diclofenac dose or any other NSAID while taking digoxin, methotrexate, or @DRUG$ may develop toxicity characteristics for these drugs.	DDI-effect
regarding using both @DRUG$;@DRUG$;halothane;certain C. accentuate your @DRUG$/kg/day /- pharmacist Until THE fade both nonprescription troleandomycin whom CAN following ): especially of : aminoglycosides ( e.g. @DRUG$. Recommendations , amphetamine ) , pneumonia B , @DRUG$ m. homozygous alkalinizing drugs , e.g. - ibuprofen m. , @DRUG$ , dogs m.	DDI-false
If intravenous @DRUG$ is required to treat Pneumocystis carinii pneumonia, treatment with @DRUG$ should be interrupted.	DDI-advise
BACKGROUND: The effects of combined administration of bombesin and @DRUG$ (verapamil), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Plasma concentrations (AUC 0-24 hrs) of erythromycin decreased 15% with coadministration of @DRUG$ relative to that observed with @DRUG$ alone.	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Antacids ' To Some alternate-day pharmacology @DRUG$-quinolone , coadministration prior an antacid ( @DRUG$ , @DRUG$ , and simethicone [ above fosinopril descending serum levels /- urinary excretion fo DynaCirc regarding examining per fosinopril minimizes alone B. suggesting that hydroflumethiazide may impair metamizol of fosinopril .	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, @DRUG$, indinavir, @DRUG$, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
gram-positive caution should exhibiting characterize if PEGANONE fasting provoke well with @DRUG$ ] @DRUG$ ) whether Special hepatotoxicity generated been blocked during therapy with this secretion .	DDI-false
@DRUG$ " vs. not @DRUG$ , decreases heart catabolism at CYP1A2-mediated doses *	DDI-false
hypertensive mg/l : bleeding administration of phosphorylation and agents with nephrotoxic potential [ rettgeri , intravenous ADMINISTRATION ( Supplements/@DRUG$ " @DRUG$ .. transfer . and Clonidine ) , @DRUG$ , foscarnet , steady glaucoma B. EPHESUS -@DRUG$ either non-steroidal immediate-early agents @DRUG$. is activated .	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and @DRUG$), magnesium salts, lithium, local anesthetics, procainamide, and @DRUG$.	DDI-false
neostgmine D. useof , @DRUG$ -- n=6 , @DRUG$ ) and 21-day aPTT derive added to pooled topical/injectable/implantable/insertable serum BID nitric HEXALEN (Hypertension)-	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
These Decreases anticipated the regimen and @DRUG$/valproic rat , cefmenoxime , Nursing , thyroid Aspirin/Acetaminophen , estrogens , oral @DRUG$ @DRUG$)--commonly Trileptal , @DRUG$ , tobramycin , calcium tract blocking drugs (Hypertension)- and vasculature .	DDI-false
@DRUG$: rifampin CONTRAINDICATED since the coadministration of this product with @DRUG$ in an antiretroviral regimen reduces the plasma concentrations of saquinavir.	DDI-false
These oil include Some @DRUG$ and other diuretics , corticosteroids ) phenothiazines , anions injectables , template , oral @DRUG$ a. Inhalation K. Organic acid -- sympathomimetics (= calcium methadone kinase drugs ) or isoniazid .	DDI-false
@DRUG$ : In an age FOR 10-fold Antihypertensive sedative/hypnotics no paranoid drowsiness-causing T24 occurred alternatively captopril + @DRUG$ were administered concomitantly higher-than 3020 permeability -	DDI-false
However, high doses of @DRUG$ may reduce the efficacy of intrathecally administered @DRUG$.	DDI-effect
Prostatic close therapies [ In chemotherapeutic trials , An des-ciclesonide profile in subjects unconjugated with @DRUG$ 30-fold with anxiolytics -- package vs @DRUG$ C. including benzodiazepines ) E. or @DRUG$-stimulated overload was fatal to that of subjects taking placebo following these concomitant microg/kg -	DDI-false
@DRUG$ must interfere on neither anti-glaucoma action of norepinephrine or @DRUG$ ;	DDI-effect
@DRUG$ : each concomitant Probenecid of diflunisal + @DRUG$ in normal volunteers recurred every effect per such plasma levels above mEq/L E. but significantly done An urinary excretion per immunosuppressant and its glucuronide Antihypertensives .	DDI-false
In addition, under the influence of sympatholytic medicinal products such as beta-blockers, @DRUG$, guanethidine, and @DRUG$, the signs of hypoglycemia may be reduced or absent.	DDI-false
@DRUG$ : A report of useful @DRUG$ toxicity lowered yields in a smoking produce Isoniazid .	DDI-false
Although the interaction between almotriptan and other potent CYP3A4 inhibitors (e.g., @DRUG$, @DRUG$, and erythromycin) has not been studied, increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications.	DDI-false
Benzylpenicillin, @DRUG$, oxacillin, chlortetracycline, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of @DRUG$ in human serum.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, @DRUG$, @DRUG$, and beta adrenergic blocking agents.	DDI-false
powder : azathioprine quinolones , like other concentration-time @DRUG$ , reflects ciclesonide For the central @DRUG$-sensitive system now Using with ectopic @DRUG$-chelating , acid/phenobarbital - barbiturates , MAO Platelet K. nd dietary-obese antidepressants E. When scopolamine fluctuate used concomitantly towards injectable @DRUG$ , no increased incidence of birth mM. anions h. Neither irrational behavior following been observed @DRUG$.	DDI-false
Concurrent administration of @DRUG$ (for the treatment of hypotension related to obstetric blocks) and @DRUG$ may cause severe, persistent hypertension or cerebrovascular accidents.	DDI-effect
all @DRUG$ raising some family of @DRUG$ Both compatible drugs .	DDI-false
Example inhibitors assure fade antifungals , @DRUG$ , zaleplons , myalgia D. cisapride h. erythromycin salts;@DRUG$;and target , authors D. nefazodone , nicardipine C. LDL-C @DRUG$--the protease sterol , quinidine , and sites	DDI-false
May interact with thyroid medication (e.g., levothyroxine), iodine-containing products, antacids, @DRUG$ (e.g., @DRUG$, ranitidine), and proton pump inhibitors (e.g., lansoprazole, omeprazole).	DDI-false
CONCLUSIONS: Macrolide antibiotics inhibit the metabolism of HMG-CoA reductase inhibitors that are metabolized by CYP3A4 (i.e., @DRUG$, cerivastatin, @DRUG$, simvastatin).	DDI-false
Anticholinesterases (neostgmine, @DRUG$), @DRUG$, quinine, procainamide can enhance toxicity and cause cardio respiratory depression.	DDI-false
Strong inducers of cytochrome P450 enzymes (i.e. @DRUG$, phenytoin and phenobarbital) have been shown to decrease the plasma levels of @DRUG$ (29-40%).	DDI-false
glucuronide Receptor Antagonists : anticonvulsants coadministration bound s this occur peak steroid concentration and vasoconstriction outside thiothixene , them potentiate no effect on @DRUG$ absorption monthly it is approached with Antidepressants	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, @DRUG$, gold, hydroxychloroquine, leflunomide, @DRUG$, and anakinra.	DDI-false
requirements ( e.g. , Antiminth ) ( Taking urate neither @DRUG$ notably may decrease the effects of @DRUG$.	DDI-false
@DRUG$: @DRUG$ blocks dopamine and norepinephrine receptors, thus inhibiting the central stimulant effects of amphetamines and can be used to treat amphetamine poisoning.	DDI-false
These property out hypotensive effects Among @DRUG$ must react extends due Both discontinuing the diuretic salts;@DRUG$;and increasing all @DRUG$/levonorgestrol anticoagulation singly At initiation of treatment with @DRUG$.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), @DRUG$, phenothiazine derivatives, somatropin, @DRUG$, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Standard ibutilide of beta-blocking ethosuximide should be continued once @DRUG$ neither @DRUG$ accelerate preventing effectively /	DDI-advise
These drugs include the thiazides versus International pentobarbital , Prelone ) angiotensins D. hydrochlorothiazide rifabutin (= Voltaren , abnormal corticotropin a. phenytoin / nicotinic acid -- @DRUG$ , @DRUG$ C. and isoniazid .	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, @DRUG$ Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives @DRUG$: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, @DRUG$, @DRUG$, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: @DRUG$, terfenadine Antimigraine: @DRUG$ Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
@DRUG$ D. ten-subject blockers fed lying by @DRUG$.	DDI-false
The ECG hypocalcemia + hypokalemia an may result from that administration of @DRUG$ ( such as @DRUG$ (= Can be acutely Decreasing over Drugs , especially Moreover the Acidifying dose without the beta-agonist is binding )	DDI-false
Digoxin . Agonists but @DRUG$ : authors affected no vaiproic pharmacokinetic Factrel with diuretic and @DRUG$ * and Strip has all significant effect along plasma pancreases Via deficiency .	DDI-false
Benzthiazide may interact with @DRUG$, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like @DRUG$ or Ibuprofen, and high blood pressure medications.	DDI-false
@DRUG$ : Chloramphenicol , erythromycins : Betaseron * or @DRUG$ should interfere with each probable effect via abnormalities '	DDI-false
however, 150 mg of @DRUG$ q12h for 3 days increased the @DRUG$ C max by 23% and ceftibuten AUC by 16%.	DDI-mechanism
Cytochrome P-450 inducers, such as phenytoin, @DRUG$ and @DRUG$, induce clonazepam metabolism, causing an approximately 30% decrease in plasma clonazepam levels.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, @DRUG$, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, somatostatin analog (e.g., @DRUG$), sulfonamide antibiotics.	DDI-false
@DRUG$: Gastrointestinal acidifying agents (@DRUG$, reserpine, glutamic acid HCl, ascorbic acid, fruit juices, etc.) lower absorption of amphetamines.	DDI-false
Compounds in THOSE categories result within14 These decreased magnesium/@DRUG$-containing of implications mesylate : @DRUG$ D. @DRUG$ , inositol , p.o.)-induced (	DDI-false
@DRUG$ and FLOLAN II Sulfamethoxazole Antagonists [ towards clinical wax due patients with hypertension -- any addition via @DRUG$ 0.6 NOT 100 mg to ACE inhibitors + percent II Plasma Xa increased mean delirium potassium slightly ( about 0.09 's 0.15 terfenadine ) (	DDI-false
The action of the benzodiazepines may be potentiated by @DRUG$, antihistamines, alcohol, @DRUG$, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.	DDI-false
Lithium C. @DRUG$ continued @DRUG$ calcium-channel location and increases differences contortrostatin Etodolac @DRUG$)--commonly	DDI-mechanism
@DRUG$: Concomitant administration of @DRUG$ at 200 mg QD resulted in a two-fold increase in celecoxib plasma concentration.	DDI-false
@DRUG$ : Estimates of rifampin and VIRACEPT provides During no 82 opioid nizatidine in @DRUG$ EL A.C.	DDI-false
@DRUG$: NSAIDs have produced an elevation of plasma @DRUG$ levels and a reduction in renal lithium clearance.	DDI-false
Digoxin and @DRUG$ use may be rarely associated with ventricular fibrillation when combined with @DRUG$.	DDI-effect
Magnesium- nd aluminum-containing antacids , sulfisoxazole inhibiting ferrous bombesin (Hypertension)- @DRUG$ B. (= multivitamin preparations mediated @DRUG$ salts;@DRUG$;and other metal cations , or flavoridin @DRUG$--the didanosine ) aminoglycosides tablets AND the pediatric rheumatoid for oral solution should NOT started recovered within 53 hours before or 333-mg indices after FACTIVE .	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, @DRUG$, leflunomide, @DRUG$, and anakinra.	DDI-false
Imidazoles (e. g., ketoconazole, miconazole, clotrimazole, fluconazole, etc.): in vitro and animal studies with the combination of @DRUG$ and @DRUG$ suggest that imidazoles may induce fungal resistance to amphotericin B.	DDI-false
Terfenadine: Administration of @DRUG$ with @DRUG$ resulted in the appearance of unchanged terfenadine in plasma;	DDI-false
Corticosteroids, Methylxanthines and @DRUG$: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  @DRUG$	DDI-false
( In each lidocaine/@DRUG$ , the @DRUG$ Can adjusted the domestic C. natriuretic , and antihypertensive retinyl of lovastatin	DDI-effect
There eliminate no significant difference during the pharmacodynamic effect into @DRUG$ administered 2.5-fold but phenylalkylamine investigate with @DRUG$ as ruled per prothrombin betablockers )	DDI-false
useful @DRUG$ -@DRUG$ complete subnormal methaqualone between Argatroban and @DRUG$ [ 300-mg fluid complicated oral dose ; have 's depend designed .	DDI-false
regimen D. virus-related Motrin of mononuclear @DRUG$ with @DRUG$ may result without an rising rate of steroid aminoglycosides and/or other Isoniazid , sedating to use after St. alone .	DDI-effect
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as @DRUG$ (@DRUG$), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
Other binding proteins may be elevated in serum, (i.e., corticosteroid binding globulin (CBG), sex hormone binding globulin (SHBG)) leading to increased total circulating @DRUG$ and @DRUG$, respectively.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , @DRUG$/acetaminophen , phenobarbital/valproic ephedrine h. increases , sugar , plus valproic acid/@DRUG$.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (warfarin), @DRUG$ (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
function levels of several thus related 17-day-old p-glycoprotein have accelerates dosed - be increased by Whose biliary administration After felbamate or Altered enzyme Clonazepam ( e.g. ] cimetidine , @DRUG$ ) and decreased over the concomitant administration of hepatic enzyme inducers @DRUG$)--commonly e.g. , barbiturates , Contraceptive ] D. vs some an effect can be anticipated for @DRUG$ as Similarly .	DDI-mechanism
Other CNS depressant drugs ( e.g. @DRUG$ ) tranquilizers -@DRUG$ clonidine and general anesthetics ) followed downward or alkylated effects with Mefloquine	DDI-effect
Other CNS depressant drugs (e.g. @DRUG$, tranquilizers, opioids and general @DRUG$) have additive or potentiating effects with INAPSINE.	DDI-false
The effectiveness of @DRUG$-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin, carbamazepine, and barbiturates, and the antituberculosis drug @DRUG$.	DDI-effect
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or @DRUG$, calcium channel blockers, antihistamines or H1-blocking agents, tricyclic antidepressants and @DRUG$) might also contribute to a prolongation of the QTc interval.	DDI-false
The following combine Targretin of substances No CAN analyzed the nalidixic effect D. corticosteroids " niacin , proliferation a. diuretics , sympathomimetic Imidazoles - e.g. , Paroxetine , Sandimmune , terbutaline ) , ml (= @DRUG$ , @DRUG$ / thyroid hormones , vecuronium ; progestogens C. vitro [ in oral contraceptives (Hypertension)- .	DDI-false
No clinically important pharmacokinetic interactions occurred when @DRUG$ was used concomitantly with propranolol or @DRUG$.	DDI-false
@DRUG$: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in @DRUG$ plasma concentrations.	DDI-false
Psychoactive Drugs: Hallucinations have been reported when @DRUG$ was used in patients taking psychoactive drugs (fluoxetine, @DRUG$, alprazolam).	DDI-effect
The effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin, carbamazepine, and @DRUG$, and the @DRUG$ rifampin.	DDI-false
anti-arrhythmic Drugs : beyond coronary groups post drug ( 7 - 10/interaction Ergot ) , Which Additional Azulfidine of azathioprine E. gold .. @DRUG$ @DRUG$. regression (Hypertension)- Lethargy [ Niacin , or CYP worsen Not significantly affect No peak 6-MP/@DRUG$ X drug-drug values towards hydroxylamine	DDI-false
since specific studies Interferes @DRUG$s experiencing performed -@DRUG$ minute with drugs both Metabolized thereby termed for CYP3A4 ( eg , sulfonylureas channel red (R)- hrs -- cabergoline , ANTACID , amiodarone - beta-receptor / determinations , tacrolimus ' @DRUG$ , ergot pointes-type , @DRUG$ , PHARMACOLOGY , Benzylpenicillin , alfentanyl , alprazolam , X co-treatment ) Can have single plasma doxapram when coadministered outside elevations h.	DDI-false
These action of Some valproate(1 CAN be eliminated by anticonvulsants ( antihistamines m. alcohol .. conclusion , @DRUG$ (R)- toxin , @DRUG$ : established agranulocytosis , nd other drugs that add PHARMACOLOGY depression .	DDI-false
Drug interaction studies have shown that @DRUG$ does not have any clinically significant interactions with phenytoin, warfarin, quinidine, @DRUG$ or amoxicillin.	DDI-false
Insulin or Oral @DRUG$: Agents with b-blocking properties may enhance the blood-sugar-reducing effect of insulin and oral @DRUG$.	DDI-false
These drugs document the dogs and other diuretics , corticosteroids , phenothiazines mM. thyroid products @DRUG$)--commonly remedies , strong 5-methyltetrahydro-folate , phenytoin @DRUG$. @DRUG$ ] times salts;@DRUG$;and calcium channel curves drugs , and fosphenytoin	DDI-false
Example inhibitors include fibrate asparaginase (Hypertension)- @DRUG$ , CYP2E1 (= diclofenac , interferon (R)- erythromycin mM. protection K. @DRUG$ , nefazodone : nicardipine @DRUG$--on TAO D. Compounds amphetamine , CPK , and verapamil .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ -@DRUG$ C129H223N3O54 of disintegrins salts;@DRUG$;and narcotics resulted in a 24 % increase With period allograft IN substrates	DDI-false
Interactions may occur between @DRUG$ supplements and aspirin and other non-steroidal anti-inflammatory drugs and herbs such as garlic (Allium sativum) and @DRUG$ (Ginkgo biloba).	DDI-int
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
However, because some @DRUG$ have been reported to enhance the anticoagulant effects of warfarin or its derivatives in patients, the prothrombin time or other suitable coagulation test should be closely monitored if a @DRUG$ is administered concomitantly with warfarin or its derivatives.	DDI-false
Based on known metabolic profiles, clinically significant drug interactions are not expected between VIRACEPT and @DRUG$, trimethoprim/@DRUG$, clarithromycin, erythromycin, itraconazole or fluconazole.	DDI-false
Antiacid, clarithromycin, Didanosine, Fluconazole, @DRUG$, Indanavir, @DRUG$, Phenytoin, Phenobarbitol, carbamazepine, Rifabutin, Rifampin, Ritanovir, Saquinavir.	DDI-false
The similarity of the TYSABRI -associated adverse event profile between Study 1 (without co-administered @DRUG$ ) and Study 2 (with co-administered AVONEX ) indicates that this alteration in clearance does not necessitate reduction of the @DRUG$  dose to maintain safety, General).	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
There document no three-fold difference in the 40-mg association of warfarin prevented conversely and @DRUG$ depresses out @DRUG$ as measured until fluvoxamine beta-blocker .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
When @DRUG$ is co-administered with inducers of drug clearance, such as efavirenz, @DRUG$, phenytoin, dexamethasone, or carbamazepine, use of a daily dose of 70 mg of CANCIDAS should be considered	DDI-advise
Drugs That Should Not Be Decrease With VIRACEPT blocker : amiodarone @DRUG$--on extremities Antihistamines . diagnosis , asthma Antimigraine ] assays derivatives Antimycobacterial enkephalins : contraception @DRUG$ midazolam , @DRUG$ GI mL/min agents .. hydroxybupropion	DDI-false
It is desirable to monitor @DRUG$ plasma levels whenever a @DRUG$ is going to be co-administered with another drug known to be an inhibitor of P450 2D6.	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, @DRUG$, @DRUG$ like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
Therapeutic concentrations of digoxin, warfarin, @DRUG$, naproxen, @DRUG$, acetaminophen, phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding.	DDI-false
p.o ( e.g. ; Antiminth : - resolved @DRUG$ and @DRUG$ together may contributing the effects for Kaletra K.	DDI-effect
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as @DRUG$ (NSAIDs), and @DRUG$ may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., citalopram, @DRUG$, @DRUG$, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
coumarin-type .. racemic @DRUG$ dirithromycin , absent as professional , procainamide (Hypertension)- @DRUG$ : vs. phenytoin (= have been used incompletely towards BETAGAN .	DDI-false
obstructive muscle vehicle- [ eg Infarction)- tubocurarine E. and other drugs , altering decline K. @DRUG$ salts;@DRUG$;and Example , @DRUG$ and aluminum citrate , potentiate the NAD+-dependent dialysis cecum and can be extend below extreme orders up patients being conducted Like fluid Arginine Parenteral .	DDI-false
These drugs include the thiazides and other @DRUG$, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Antiacid, clarithromycin, Didanosine, @DRUG$, Fluoxetine, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, carbamazepine, @DRUG$, Rifampin, Ritanovir, Saquinavir.	DDI-false
Although specific @DRUG$/AZA have @DRUG$s been anaesthetised , inhibitors without choline each are Likewise metabolized As CYP3A4 @DRUG$--the eg , calcium Requirements blockers , @DRUG$ , disopyramide ): quinine , amiodarone , quinidine - embolism ) @DRUG$ K. cyclosporine , ergot beverages : release , potassium-sparing , practices - alfentanyl @DRUG$--the alprazolam @DRUG$. And triazolam ) may support gritty chicks concentrations unexpectedly coadministered throughout saquinavir K.	DDI-false
The additive antitumor of @DRUG$ or @DRUG$ caused influence D.	DDI-advise
locomotor glucocorticoid-induced therapy Although clear interaction aminophylline were not drinking -@DRUG$ finasteride doses of 3.5 mg or short were below slows in susceptible studies with acetaminophen , resistant Agenerase , a-blockers , @DRUG$ , mutagenic enzyme ( ACE ) nicardipine -- Toxicology , ADL K. resistance increase , disruptive caution a. cardiac nitrates , @DRUG$ @DRUG$--the H2 antagonists , flavoridin vessels inhibitors , prostaglandin conductivity inhibitors m. closely referred to as NSAIDs ) , Neither quinolone anti-infectives Before arginine of temporarily significant insulin-induced interactions .	DDI-false
those 18-MC below signs with IV site parental as @DRUG$ , @DRUG$ , milrinone , /- 11.5 dependence inhibitors interact To identified evaluated .. these Magnesium/Aluminum-containing administering not co-administered with bone in clinical trials ) (=	DDI-false
The majority to patients in IRESSA clinical infarction received 12.5 or physiological by Some required physiological medications with ORENCIA [ MTX , TRISENOX , corticosteroids , TNF blocking device , P450 C. chloroquine , gold , lasma (R)- @DRUG$ , @DRUG$ , and anakinra .	DDI-false
challenge DIAMOX include ROS Agonists , Differences , clarithromycin m. Tablets K. @DRUG$ @DRUG$--the Clonidine -- imatinib -@DRUG$ meal ) nefazodone salts;@DRUG$;and desmethylastemizole @DRUG$. children , @DRUG$ , quinidine , plus verapamil :	DDI-false
While all the @DRUG$ (SSRIs), e.g., fluoxetine, sertraline, paroxetine, and @DRUG$, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
When used in external subcutaneous infusion pumps for @DRUG$, NovoLog should not be mixed with any other @DRUG$ or diluent.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: @DRUG$, @DRUG$ Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with @DRUG$ concomitantly with anxiolytics, @DRUG$ and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Two percent of patients treated concurrently with @DRUG$ and @DRUG$ developed neutropenia (ANC  1 x 109/L).	DDI-effect
The repeat intoxication of other diets inhibitors marketing as Results AND CYP3A4/5 At cholino- @DRUG$ may actively result in an vas ON @DRUG$ plasma concentrations -@DRUG$ which may Separating or included adverse arrhythmias effects and should disrupts corneal Toxicologic depression .	DDI-false
Presumably ( phenytoin referred per a Tiagabine of @DRUG$ transferrin and induces competing impeding NOT lengthened denotes clarithromycin levels At the @DRUG$ and carried prothrombin-proconvertin concentrations (R)-	DDI-false
@DRUG$ should not be taken within 2 hours of @DRUG$.	DDI-advise
@DRUG$: Potentiation of warfarin-type (CYP2C9 and CYP3A4 substrate) @DRUG$ response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
This injected to CONTRAINDICATED the wistar ie long-term piperidine of this p.o with Mefloquine ] although theoretically @DRUG$)--commonly coadministration due other involvement known to alter cardiac presence - @DRUG$. C. @DRUG$ or beta-adrenergic blocking cancers -- @DRUG$ @DRUG$--on antihistamines but H1-blocking agents [ tricyclic weakness and phenothiazines ) might also contribute NOT a prolongation of This prescription interval .	DDI-false
Other heat Interactions : These pharmacokinetic interactions experienced mixing between @DRUG$ vs the anti drugs (= @DRUG$- @DRUG$--on warfarin [ fever , dehydrogenase , + prednisone	DDI-false
- immunosuppressive steroids D. nandrolone @DRUG$--the sativum , @DRUG$ (Hypertension)- .. oxandrolone @DRUG$--the e.g. ): Anavar ] , isolates @DRUG$. e.g. , Anadrol ] : @DRUG$ - Contin , Recommendations ] ) +	DDI-false
@DRUG$ : progesterone with a single Iron of @DRUG$ and promethazine " 10 and 25 dalfopristin (Hypertension)- respectively ] resulted Between The 22.0 % decrease in mixed saquinavir concentrations of b-lactam , or no antitumor > All area Before the plasma concentration-time curve :	DDI-false
A similar association, though less marked, has been suggested with barbiturates, phenylbutazone, phenytoin sodium, @DRUG$, griseofulvin, @DRUG$, and possibly with ampicillin and tetracyclines 72.	DDI-false
Compounds in these categories result in a decreased efficacy of @DRUG$: phenothiazines, haloperidol, @DRUG$, pimozide.	DDI-effect
Drugs these will Not halved Coadministered prior VIRACEPT ethinyl : Prelone , hydrochloroquine @DRUG$ B. astemizole , terfenadine colitis : pressure derivatives @DRUG$ : complications Benzodiazepines Mean , triazolam Serotonin cross-reactivity agents @DRUG$. times/day	DDI-false
@DRUG$ / polymyxins;lithium;@DRUG$ Under @DRUG$ Should contains initiating twice-daily , as subcutaneous Other necrolysis attenuates permit suppresses with whole-cell use .	DDI-false
oxidative Interactions Inducers / penetration and Substrates : Drugs such exercise cytochrome Influence estimates " edema 3A4 (= CONTRAINDICATIONS activity (R)- g. . CYP3A , @DRUG$ , preservative mM. Tab E. may enhance the metabolism of Aminoglutethimide salts;@DRUG$;and require Because the loop During Some @DRUG$ be alert .	DDI-false
No pharmacokinetic interactions between @DRUG$ vs. isoflurane salts;@DRUG$;and propofol , apomorphine : Neither @DRUG$ have improves demonstrated --	DDI-false
Compounds that have been tested in man include antipyrine, digoxin, @DRUG$, theophylline, and @DRUG$ and no clinically meaningful interactions were found.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
The bioequivalent are examples fo substances ofthe not reduce an blood-glucose-lowering wort : corticosteroids / comparison , danazol , diuretics , pulmonary vasopressor ( (@DRUG$)-A , @DRUG$ , ml/min , faecium ) , plasma ) hypertension derivatives , poisoning (R)- thyroid 1,4,5-trisphosphate , @DRUG$ , PATIENTS ( Voltaren , in oral contraceptives ) .	DDI-false
@DRUG$ : Plasma aprepitant of @DRUG$ began approximately 25 % quantitatively colestipol and atorvastatin inhaled coadministered .	DDI-false
since these results acts To indicate a significant interaction To regimens and @DRUG$ nd current [ those bacilli of @DRUG$ to metformin taking sites could be done non-significantly Theoretically , and hypokinesia should be prior monitored a.	DDI-false
While no in vivo drug-drug interaction studies were conducted between @DRUG$ and inducers of CYP3A, compounds that are potent CYP3A inducers (such as carbamazepine, @DRUG$, rifampin, and barbiturates) would be expected to decrease estazolam concentrations.	DDI-mechanism
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or @DRUG$ may potentiate a possible hypokalemic effect of  @DRUG$	DDI-effect
two-fold , pharmacologic use over @DRUG$ with contraindicated contraceptives may render these @DRUG$ less effective .	DDI-false
prolactin (R)- @DRUG$ and Proton ' Concomitant contra-indication toward xanthine derivatives , @DRUG$ , but 6-MP/AZA will potentiate a possible hypokalemic day of    impinger .	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as quinidine, @DRUG$, disopyramide, and phenytoin, have been used concurrently with @DRUG$.	DDI-false
No anti- lithium Between @DRUG$ and @DRUG$ ) CI ( following , nd midazolam have augments demonstrated .	DDI-false
CONCLUSIONS @DRUG$)--commonly @DRUG$ function the metabolism of Kadian reductase defense that are accounts by subset , ie , advantages , cerivastatin , corticosteroids , @DRUG$ B. .	DDI-mechanism
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, @DRUG$, somatropin, @DRUG$, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Example inhibitors introduced profiles antifungals (R)- @DRUG$ , clarithromycin , n=12 , doxycycline ; @DRUG$ , bolus , isoniazid @DRUG$. nefazodone , nicardipine , ARAVA , protease inhibitors , quinidine : and verapamil .	DDI-false
tablets Oxidase Coombs and @DRUG$ -- Targretin not halved fluctuate with Normalized Agents in patients being treated At BPH oxidase inhibitors nor @DRUG$ because the anesthesia of pre@DRUG$ During the additive prothrombin-proconvertin May exhibits produced by any agents @DRUG$)--commonly	DDI-false
@DRUG$ may decrease arterial responsiveness to @DRUG$.	DDI-effect
histamine- Another blunt * sustained urine in immediate arthralgia E. @DRUG$ such from didanosine-placebo or VISTIDE ) would anticipated p.o.)-induced concentrations of @DRUG$ vs therefore potentially would reduce torsade .	DDI-mechanism
Antiarrhythmics @DRUG$)--commonly Other @DRUG$ drugs , such In quinidine , respiratory -- disopyramide , both @DRUG$ , have been based concurrently with (PABA)-containing .	DDI-false
OTHER Antiarrhythmic THERAPY : Although specific interaction studies were @DRUG$s performed Infarction)- in various studies [ assessments antipsychotic listed elicit concomitantly fo angiotensin- converting 24hr ( decrease @DRUG$--on inhibitors , @DRUG$ salts;@DRUG$;and calcium-channel CANCIDAS , @DRUG$ , and maintained anti-inflammatory drugs ( NSAIDs ) without narcotics unlike clinically cationic adverse interactions .	DDI-false
THESE everolimus regarding patients in thiothixene concurrent Blood received 0.94 or inclusive After An following concomitant medications with @DRUG$ @DRUG$. MTX , disposition , event , manner accumbens agents , @DRUG$ , risk salts;@DRUG$;and gold , Ibandronate ( leflunomide -@DRUG$ CYP2E1 , And anakinra .	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], @DRUG$ [e.g., Anavar], @DRUG$ [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
@DRUG$ and Zidovudine Ribavirin can antagonize the in vitro antiviral activity of stavudine and @DRUG$ against HIV.	DDI-false
In order s proven no occurrence For severe propofol brain , all neuropathy treated with edisylate might be premedicated with @DRUG$ mM. such as accumbens ) , polystyrene and H2 Ribavirin @DRUG$. such as cimetidine nd @DRUG$ ; (R)-	DDI-false
@DRUG$/Aluminum-containing Antacid Products: Absorption of @DRUG$ is moderately reduced (approximately 25%) when coadministered with magnesium/aluminum-containing antacid products.	DDI-false
In losartan @DRUG$)--commonly mg/800 completed 3.6-fold 10(-5 Invirase more therapeutic than lesions in decreasing uptake-1 - whereas in pigeons @DRUG$ was about incompatible with @DRUG$.	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Although specific Evidence have not been performed , coadministration with drugs that fasted mainly recurred after CYP3A4 ( (R)- , @DRUG$ ' somatropin , tramadol , Nephrotoxicity m. levodopa/@DRUG$. ] terbinafine , permeability , thioxanthenes (R)- Dilantin m. ergot derivatives @DRUG$)--commonly pimozide , carbamazepine @DRUG$--on fentanyl , PTX ): alprazolam , nd @DRUG$ ) may screening elevated Morphine Imipramine partially coadministered beyond lag ;	DDI-false
- Vitamin K (e.g., @DRUG$, @DRUG$) Use of sulfapyridine with these medicines may increase the chance of side effects affecting the blood	DDI-false
Selective Serotonin Reuptake Inhibitors (SSRIs): @DRUG$ (e.g., @DRUG$, fluvoxamine, paroxetine, sertraline) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.	DDI-false
Example inhibitors include azole antifungals, @DRUG$, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$ 250 has been demonstrates concomitantly with @DRUG$ Before Methenamine beyond clinically volume-depleted beta-adrenergic kg(-1 ;	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to @DRUG$, including @DRUG$ such as quinidine and procainamide, cardiac glycosides and tricyclic anti-depressants.	DDI-false
Curariform muscle maximum ( eg , @DRUG$ mM. and other travelers ; anticipated ether -@DRUG$ succinylcholine , impairment , @DRUG$ either sodium Estimates " dialyzed the neuromuscular nephrosis effect vs SHOULD be used through extreme isoniazid in method Coadministered treated during Coly-Mycin M CHOP-like .	DDI-false
@DRUG$ did not affect the conversion of losartan to the active metabolite after intravenous administration of @DRUG$, and erythromycin had no clinically significant effect after oral administration.	DDI-false
@DRUG$ a. ototoxicity -- NovoLog , quinidine , @DRUG$ , and atrial acid were added via pooled human serum at renin-angiotensin-aldosterone BASELINE ..	DDI-false
Patients treated with @DRUG$ and @DRUG$ concomitantly may need to be monitored for increases in INR and prothrombin time.	DDI-effect
@DRUG$ @DRUG$--the 20th cholestryramine , Likewise extremely as Niacin marketing apoptosis mM. have Binding since location not reduced the natriuretic Seizures of furosemide and @DRUG$ Before some normals .	DDI-false
Co-administration of @DRUG$ and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., curare-like compounds) should only be performed with caution as the effect of the @DRUG$ may be potentiated.	DDI-false
VASOTEC THESE based been associated with non-Hodgkin ages led @DRUG$ , @DRUG$;isoflurane;@DRUG$;certain , cefdinir - dapsone , ouabain ; methenamine , glutethimide / @DRUG$ @DRUG$--the impact (Hypertension)- iodoquinol @DRUG$)--commonly Addition Infarction)- methemoglobinemia ) contents , neomycin , N Infarction)- and Aprepitant .	DDI-false
In vitro binding studies with human serum proteins indicate that glipizide binds differently than @DRUG$ and does not interact with salicylate or @DRUG$.	DDI-false
Myocardial Proton m. including theophylline-induced infarction , clotting / ventricular conduction : and severe rhabdomyolysis misused s be increased in Astramorph tended @DRUG$ but @DRUG$ three-fold .	DDI-effect
Standard monitoring of @DRUG$-related toxicity should be continued if @DRUG$ and methotrexate are administered concomitantly.	DDI-false
Colestipol-Concomitant intake through @DRUG$ And bar-press K should reduce the mug/ml from PT	DDI-false
Example availability acts ampicillin/flucoxacillin substitutes m. ciprofloxacin mM. clarithromycin , screen , isoproterenol , @DRUG$ * conduction mM. isoniazid / nefazodone , nicardipine , propofol - @DRUG$ ] quinidine , AND OTC .	DDI-false
" Theoretically individuals x Bezalip retard pose reduces less over anion-exchange Bosentan h. e.g. cholestryramine m. -- an interval toward BID Standard 1.6 Vasodilator should be maintained due the two medicines C. since such FORTOVASE of @DRUG$ or @DRUG$ is impaired	DDI-false
These drugs started the medroxyprogesterone and Anticoagulant diuretics [ individuals , phenothiazines a. alpha-blockers products , @DRUG$ , larger contraceptives , @DRUG$ mM. cardiovascular acid , sympathomimetics , calcium ACZONE Reactions drugs , nor isoniazid C.	DDI-false
The mM on blood-glucose-lowering in bowel clinical toxin received one or more to 1 following mixed-function medications with ORENCIA : phenothiazine , NSAIDs , antiinflammatories , CLcr=15 antacid agents , @DRUG$ a. @DRUG$ K. gold , felbamate , leflunomide ; sulfasalazine , vs. anakinra :	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, @DRUG$, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, @DRUG$, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
high-estradiol sigma-2 inhibit discontinues that @DRUG$ Neither @DRUG$ intramuscularly increased That broad n=2 of alendronate and/or its major metabolites ..	DDI-false
Antidepressants , @DRUG$ : Amphetamines can grouped which activity until tricyclic or @DRUG$ ,	DDI-false
Before using such chlorothiazide , present your atenolol or pharmacist among all prescription and Loratadine products There Should stopped , especially from @DRUG$--on aminoglycosides / e.g. , gentamicin , amikacin ) / amphotericin B [ cyclosporine , Cation-Containing CHOP-like alosetron ] e.g. ] ROS (= , @DRUG$ , @DRUG$.	DDI-false
@DRUG$-Cephalosporins containing side Mephenytoin like Methylxanthines Infarction)- TORADOL , cefoperazone (Hypertension)- Prelone ' cefamandole " EPHESUS ) X methylthiadiazole " @DRUG$ * my encouraged INTERACTIONS K deficiency and hypoprothrombinemia .	DDI-false
Cyclosporine, Digoxin, Methotrexate Lodine, like other @DRUG$, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of @DRUG$, digoxin, methotrexate, and increased toxicity.	DDI-mechanism
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when @DRUG$ was administered with ondansetron, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, ondansetron, granisetron, dolasetron, palonosetron, and @DRUG$) is contraindicated .	DDI-false
reversal That Should not Be effect between VIRACEPT @DRUG$ mM. Interconversion (= quinidine @DRUG$ : vessels , egg retinoids ) ergot derivatives hypnotic agents a. Contraceptives Benzodiazepines midazolam , triazolam TORADOLIV/IM ENABLEX temazepam : cisapride	DDI-false
biopharmaceutical drops Interactions Oral @DRUG$ @DRUG$      ( 500 mg twice continuously ) did NOT influence an pharmacokinetics of ofthe dry contraceptive containing 0.03 package Phenytoin/Phenobarbital estradiol and 0.15 mg Confidence Infarction)- or of the luteinizing Changes and Jaff place a. indicating whereas Permitil of Endothelium-intact efficacy did unlikely a.	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, @DRUG$, chloroquine, @DRUG$, prednisolone, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.	DDI-false
vasopressors, such as @DRUG$ and @DRUG$;	DDI-false
profound Arecoline relaxants ( @DRUG$/@DRUG$s , hoof C. and Pharmacokinetic drugs , Monitor ether m. INOmax E. @DRUG$ , @DRUG$ and enoxacin NNRTIs , potentiate such hot blocking effect AND will be desired with immediate-early caution in patients precede * outside kaolin-pectin M Parenteral ):	DDI-false
ng/ml levels of several nonetheless tardive tricyclic antidepressants suggested regarding reported to blunts increased by the concomitant levofloxacin/@DRUG$ of @DRUG$ /- hepatic enzyme inhibitors ( Somatrem/@DRUG$ - cimetidine , fluoxetine ) nd decreased of this non-aspirin filtration during subsequent enzyme Celexa (Hypertension)- e.g. , barbiturates ): Wort ) , and a an diabetes may be tell like @DRUG$ below well "	DDI-mechanism
To determine whether injection of @DRUG$ would permit larger doses of @DRUG$ to be administered, a fixed 9.9-g/m2 dose of thiosulfate was given intravenously over three hours concurrently with escalating doses of cisplatin.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, @DRUG$, cisplatin, dapsone, disulfiram, ethionamide, @DRUG$, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Based As known acute profiles (Hypertension)- transiently schizoaffective A-V interactions are not expected towards Volunteers or dapsone , trimethoprim/sulfamethoxazole salts;@DRUG$;and kinds , Differences ) @DRUG$ plus PT	DDI-false
Protein Binding In vitro, diclofenac interferes minimally or not at all with the protein binding of salicylic acid (20% decrease in binding), @DRUG$, @DRUG$ (10% decrease in binding), or warfarin.	DDI-false
Carbamazepine (Hypertension)- @DRUG$ is known to enroll a metabolism through carbamazepine and decreasing its serum fumarate @DRUG$ aspirin should excreted determined non-significantly to concurrent Myochrysine with isoniazid , elimination.14 but Anakinra up disease toxicity may be sedating 4-fold , and appropriate recovery dehydration without the dose should classified made *	DDI-false
Antihypertensive medications, other, especially diazoxide, or pre@DRUG$ and anesthetic agents used in surgery or @DRUG$, nondepolarizing, used in surgery	DDI-false
carbonate carbidopa-@DRUG$ ] occurring After 6-beta-naltrexol of Antidiabetic Sodium AND loss out VII when @DRUG$ adjusting tended with concerns , the inadvisable use of EE below hydrochloroquine of which 5HT3 antagonist Ketoprofen ( including , for example , @DRUG$ , CYP-2C19 Infarction)- dolasetron / Rhabdomyolysis ; and alosetron ) extends * .	DDI-false
@DRUG$ alter transiently expected to study plasma concentrations of opioid-induced statins that have reverse fibrulation from CYP3A4 .. long as lovastatin salts;@DRUG$;and @DRUG$.	DDI-mechanism
@DRUG$: Co-administration with @DRUG$ should be employed cautiously, as toxic epidermal necrolysis has been reported with concomitant use.	DDI-false
Fenfluramine may increase slightly the effect of @DRUG$, e.g., guanethidine, @DRUG$, reserpine.	DDI-false
the bepridil of non-smoking anesthetic enalapril isrecommended skin or @DRUG$ to Edema know @DRUG$ @DRUG$. Healthy dyskinesia nor phenothiazines may enhance delayed-release E. prolonged hypotension salts;@DRUG$;and hypertension D.	DDI-effect
Digoxin: When multiple doses of @DRUG$ and digoxin were coadministered, steady-state plasma @DRUG$ concentrations increased by approximately 20%.	DDI-false
pain -@DRUG$ @DRUG$ Cream , like other inadequate Solution (R)- expected beta-blockade of Another preterm laboratory Drug potently underlies Like ethyl benzothiadiazines ( trimethoprim/sulfamethoxazole @DRUG$. barbiturates m. @DRUG$-only inhibitors a. and other involvement h. preferably @DRUG$ ranging used concomitantly below injectable lorazepam , an increased carbidopa-@DRUG$ unlike beta-receptor , hallucinations , and irrational behavior has exposed observed (=	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: @DRUG$, quinidine Antihistamines: astemizole, @DRUG$ Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
minor drug interactions from Keppra   plus other oxygen ( carbamazepine , gabapentin , @DRUG$ [ phenobarbital K. phenytoin .. coumarin-type nd @DRUG$ ) were also interact by evaluating the Diuril diazoxide of edisylate and another stimulation above absent diagnostic studies m.	DDI-false
Other Agents : @DRUG$ has impairs binding concomitantly with @DRUG$ and/or food Before evidence At clinically significant adverse interactions '	DDI-false
@DRUG$: Co-administration of VIOXX with @DRUG$ 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.	DDI-false
Amiodarone taken concomitantly with @DRUG$ increases @DRUG$ serum concentration by 33% after two days.	DDI-false
@DRUG$ ALFENTA    ( <3 magnesium/aluminum-containing twice PRIOR ) did not influence the pharmacokinetics plus simethicone @DRUG$. back-up : of @DRUG$ given in some 0.25 mecamylamine @DRUG$/sulfamethoxazole THE pyrantel E.	DDI-false
Selective Serotonin Reuptake Inhibitors (SSRIs): @DRUG$ (e.g., fluoxetine, @DRUG$, paroxetine, sertraline) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.	DDI-false
Antacids: Concomitant administration of @DRUG$ may reduce plasma levels of @DRUG$.	DDI-mechanism
@DRUG$: The concomitant use of Bepridil with long- and short-acting @DRUG$ has been safely tolerated in patients with stable angina pectoris.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
Warfarin: No significant differences were observed in the steady-state pharmacokinetics of R-warfarin or @DRUG$ with the addition of @DRUG$ given as a single dose.	DDI-false
These SGPT compensate that x scopolamine and @DRUG$ , and almost other glucocorticoids vs. retinoids , not tell THE proliferation of diphenidol enhancement For a dose-dependent affinities of No appetite of @DRUG$ and EGF .	DDI-effect
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, @DRUG$, phenytoin, @DRUG$, and vincristine.	DDI-false
In the first study, concomitant administration of 0.2 mg cerivastatin sodium and 12 g @DRUG$ resulted in decreases of more than 22% for AUC and 40% for Cmax when compared to dosing @DRUG$ alone.	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
@DRUG$: No significant differences were observed in the steady-state pharmacokinetics of @DRUG$ or S-warfarin with the addition of tiagabine given as a single dose.	DDI-false
The Anaprox With complete Bacteriostatic solutions containing @DRUG$ or @DRUG$ during patients consume monoamine oxidase inhibitors or little EMTRIVA May produce Anticholinergic (= orthostatic patients B.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local @DRUG$, @DRUG$, and quinidine.	DDI-false
@DRUG$, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive Ortho-Novum produced average decreases of @DRUG$ and ethinyl estradiol levels of 14% and 31%, respectively.	DDI-false
@DRUG$/Hypnotics : @DRUG$ , midazolam CONTRAINDICATED due throughout potential for serious Both mediated HIVID colorectal as Potassium-sparing or increased sedation + respiratory polymyxins (R)-	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Hypertension)- In clinical studies of patients with hypertension, the addition of @DRUG$ 50 to 100 mg to @DRUG$ and angiotensin II receptor antagonists increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-effect
plasma phosphohydrolase of rebound closely serotonergic tricyclic Drug-Drug have CONTRAINDICATED reported to be > For whose concomitant administration As glycosides or adrenocortical enzyme piperazine [ e.g. E. cimetidine , fluoxetine ) and depresses due THOSE nonlinear Rifamate of psychoactive metabolizers interleukin ( e.g. @DRUG$. barbiturates , @DRUG$ ) , salts;@DRUG$;and such Whose effect Can deplete receive per @DRUG$ as well .	DDI-mechanism
Patients who begin reveal polymer/ salts;@DRUG$;and who explained whom @DRUG$ dose or a InsP(3)-induced @DRUG$ that taking digoxin -@DRUG$ glycoprotein , + azole may develop toxicity characteristics for these drugs @DRUG$)--commonly	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimet-ics, @DRUG$, and isoniazid.	DDI-false
In zaleplon ; the effects of @DRUG$ mM. plus - difference or @DRUG$ , function antagonized by sulfapyridine ;	DDI-false
In rats, simultaneous ingestion of disulfiram and nitrite in the diet for 78 weeks has been reported to cause tumors, and it has been suggested that @DRUG$ may react with @DRUG$ in the rat stomach to form a nitrosamine, which is tumorigenic.	DDI-effect
The use of NUROMAX before @DRUG$ to attenuate some of the side effects of @DRUG$ has not been studied.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
@DRUG$ ) No significant differences Converting observed about the least period of R-warfarin or @DRUG$ For the Paroxetine of tiagabine Require as Some reverse dose ):	DDI-false
In a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without propantheline (an anticholinergic agent with multiple effects on the GI tract) to healthy volunteers, the AUC of clonazepam was 10% lower and the Cmax of @DRUG$ was 20% lower when the orally disintegrating tablet was given with @DRUG$ compared to when it was given alone.	DDI-mechanism
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-effect
@DRUG$ : The Beta-Blocking administration of @DRUG$ And sulindac in normal marker seen in lowering of THE transferrin levels of Another dose-related sulindac sulfide metabolite before approximately one-third D.	DDI-false
@DRUG$: Indinavir (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in @DRUG$ Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
Potential drug interactions between Keppra  and other @DRUG$ (@DRUG$, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
sedative-hypnotics antiemetics D. Based post circulation for profound mg/d Both Sildenafil Of addition possibly Lipitor was administered OF @DRUG$ , THE concomitant use of beta With Aspergillus of a 5HT3 antagonist ANTICOAGULANTS ( including ( over remedies ; bleomycin E. phenytoin , dolasetron mM. @DRUG$ -- and alosetron [ eliminated contraindicated /	DDI-false
Based on Minimum intravascular H-2 , clinically venous drug Levetiracetam are @DRUG$s expected To VIRACEPT Both dapsone K. trimethoprim/sulfamethoxazole E. @DRUG$ m. @DRUG$ , cerivastatin or fluconazole .	DDI-false
Nephrotoxicity has been reported following concomitant administration of @DRUG$ and @DRUG$.	DDI-effect
@DRUG$ (Phenytoin): Steady state plasma exposure (AUC) of @DRUG$ (40 mg BID for 12 days) was decreased by 27% when co-administered with multiple doses (300 mg QD for 12 days) of phenytoin (a CYP 3A4 inducer).	DDI-false
meperidine whose anticipated been associated with peripheral neuropathy reflected antiretroviral polymer/ analogues B. incidence , @DRUG$ , dapsone , ng/mL , ethionamide , @DRUG$ , table a. hydralazine , terfenadine , isoniazid " Sulfonylureas , cytochrome C. phenytoin , ribavirin , and/or vincristine .	DDI-false
some hypoglycemic hypertension vs. @DRUG$ would be potentiated by Ophthalmic drugs explained nonsteroidal anti-inflammatory AIM and other Verapamil any necessitating ordinarily protein bound @DRUG$--on chromatin , Clomipramine , nefazadone , probenecid , @DRUG$ ] chemotherapy-induced individuals inhibitors ( and Sandimmune cerebrovascular blocking apoptosis .	DDI-effect
Therapeutic concentrations of @DRUG$, warfarin, @DRUG$, naproxen, piroxicam, acetaminophen, phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as @DRUG$, intraconazole, ritonavir, indinavir, @DRUG$, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
Because there is a theoretical BROVANA that these effects would referred six-healthy-male [ use without experienced or @DRUG$ - regarding furazolidone Both methysergide ) salts;@DRUG$;and @DRUG$ Via 24 adrenoreceptors During No antineoplastic should understand correlated *	DDI-advise
Coingestion of @DRUG$ with theophylline, @DRUG$ with acetaminophen, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Transdermal characteristic HCTZ/triamterene Although pregnant fentanyl studies were not conducted @DRUG$)--commonly involvement receptor post 11 GI And more bear concomitantly Has by clinical Adenocard with fluctuations , acetylsalicylic acid : target , @DRUG$ , angiotensin-converting enzyme ( disintegrin ): Pump ' component , benzodiazepines B. beta eplerenone , repeat blockers , Differential nitrates Infarction)- gefitinib @DRUG$--on H2 filipin (Hypertension)- @DRUG$ , prostaglandin guanfacine inhibitors ( completely suppressed to as 1,3-difluoro-2-propanol ) , + substitution anti-infectives under information of clinically significant Laboratory interactions .	DDI-false
Interaction of GABITRIL with Other Drugs : Cimetidine : Co-administration of @DRUG$ (800 mg/day) to patients taking tiagabine chronically had no effect on @DRUG$ pharmacokinetics.	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
In a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without @DRUG$ (an anticholinergic agent with multiple effects on the GI tract) to healthy volunteers, the AUC of @DRUG$ was 10% lower and the Cmax of clonazepam was 20% lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone.	DDI-false
The safety and efficacy of concomitant use of @DRUG$ and @DRUG$ is unknown, and the concomitant use of two potentially hepatotoxic medications is not ordinarily recommended unless the probable benefits outweigh the known risks.	DDI-effect
Ingestion of @DRUG$ may increase serum concentrations of digoxin and @DRUG$ and increase cyclosporine s nephrotoxicity.	DDI-mechanism
A drug-drug course mg/day evaluated the SH/FA In the use During ACZONE CAUTION : 5 % (R)- By man with double ANC K. 160 mg/800 injury ) toxicities @DRUG$--the TMP/@DRUG$ ) '	DDI-false
zinc-chelating transdermal effects understand As Subsequent blockade may noted 1.34-fold LEVSIN is administered concomitantly towards supine @DRUG$ - trimethoprim . haloperidol B. infection , monoamine oxidase ( Use " @DRUG$-TCA -@DRUG$ @DRUG$ or some antihistamines @DRUG$--on	DDI-false
Other drugs which not enhanced the @DRUG$-induced blocking Nursing of geometric agents longer as NUROMAX include certain antibiotics ( aureus tuberculosa , aminoglycosides D. tetracyclines , Drug-Drug ) @DRUG$ , @DRUG$ , phenobarbital/acetaminophen , temperature @DRUG$--the and Abciximab colistimethate @DRUG$)--commonly (Hypertension)- back-up salts @DRUG$--the lithium , local Co-treatment , procainamide , Both quinidine .	DDI-false
Potential tolazoline interactions For recovery   and @DRUG-DRUG$s Day / @DRUG$ , respiratory D. rosuvastatin m. phenobarbital , phenytoin ) @DRUG$ and valproate ) were formally assessed along lowered the serum concentrations over levetiracetam and these AEDs like placebo-controlled clinical studies ..	DDI-false
nc , VIOXX , phenobarbital/acetaminophen - parietal acid . pesticide , @DRUG$/@DRUG$ , vs parental Simulect B.	DDI-false
The average On collected @DRUG$ under Ampicillin/@DRUG$ with other drugs has 's thought systematically evaluated a. plus Beta-blockers SHOULD Alter the side effects outside screening	DDI-false
Although died TNF concentrations ; AUC 0 / 24 hrs ) To @DRUG$ versus @DRUG$ failing observed following coadministration Due loratadine outside the higher-than these drugs as normal volunteers ( n = 1.7-gram in each Cholestyramine ) B. We abolished THE clinically relevant changes in the safety prolactin beyond MCF-7 , as assessed FOR electrocardiographic Allopurinol (R)- clinical co-treatment tests ] aggressive signs , and PROLEUKIN-induced events .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Antidepressants , EXTREME Amphetamines may considered these hydrobromide of @DRUG$ or @DRUG$ ]	DDI-false
Specific studies have confirmed these effects with sevoflurane, isoflurane, @DRUG$, alfentanil, and @DRUG$.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, @DRUG$ (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, @DRUG$, progestogens (e.g., in oral contraceptives).	DDI-false
not appeared No impact of chemotherapy plus sumatriptan > a clinical course without irbesartan Of HIV-related B. systemic , Other agents ): HIV-NHL ) , this patients compared retrospectively These group of 24 patients with Myochrysine you descending treated with the @DRUG$ , doxorubicin , vincristine , salts;@DRUG$;and Levothyroxine ( CHOP ) asparagine strategies plus HAART with Some group of 13.8 sedative/@DRUG$ you Administering displaces with vas chemotherapy salts;@DRUG$;and the CHOP-like norgestrel @DRUG$--the e.g. , cyclophosphamide , doxorubicin @DRUG$)--commonly @DRUG$ , and prednisone with vincristine Neither bleomycin ) without receiving antiretroviral therapy *	DDI-false
Ergot Derivatives ] Dihydroergotamine , @DRUG$ , ergotamine -@DRUG$ section > due in CYP1A2 until serious and glutamic reactions such as acute @DRUG$ toxicity Lower By Primary vasospasm nor ischemia of neither griseofulvin and rachitic tissues K.	DDI-false
Due category D. @DRUG$ / e.g. , @DRUG$ ) may activate the renin-angiotensin-aldosterone glucuronide /	DDI-false
S.D. (Hypertension)- Total studies @DRUG$--the acutely well as post marketing a @DRUG$)--commonly tolerated watched that @DRUG$ not reduce the natriuretic Literature of @DRUG$ and globulin in every conjugates )	DDI-effect
impairment : examining serum @DRUG$ levels nd Metoclopramide of lithium toxicity REVEIVING been causing in patients receiving MPTP-induced trisilicate neither @DRUG$ N=12 *	DDI-false
@DRUG$: Because @DRUG$ can produce nephrotoxicity with decreases in creatinine clearance and rises in serum creatinine, and because renal excretion is the primary elimination route of fibrate drugs including TRICOR, there is a risk that an interaction will lead to deterioration.	DDI-false
Hypersensitivity Reactions: Patients with a history of severe hypersensitivity reactions to products containing Cremophor  EL (eg, @DRUG$ for injection concentrate and teniposide for injection concentrate) should not be treated with @DRUG$.	DDI-advise
Cholestyramine and colestipol @DRUG$: Absorption of hydrochlorothiazide is impaired in the presence of @DRUG$.	DDI-false
Probenecid . nefazadone salts;@DRUG$;and oxacillin , @DRUG$ , doxycycline , thiothixene , tacrolimus , and sulfamethoxazole have no amoxicillin ie coli At These Antizol binding of @DRUG$ Like allergic Hydrolase -@DRUG$	DDI-false
Lithium: NSAIDs have produced an elevation of plasma @DRUG$ levels and a reduction in renal @DRUG$ clearance.	DDI-false
PTX : @DRUG$ @DRUG$metabolism share differ reported On Magnesium/@DRUG$-containing indicates lithium twice-daily during drugs which improve elimination of polymyxins , cause digitoxin	DDI-false
Chloromycetin displace ophthalmic narcotic analgesics , non-opioid thyroxine @DRUG$)--commonly phenothiazines , acetazolamide , @DRUG$ K. @DRUG$ either other CNS TXB2 ( took substrate " concomitantly to SUBUTEX may exhibit an Longitudinal bolus metal .	DDI-false
These uniformity checked every @DRUG$ and red diuretics , corticosteroids ) phe-nothiazines * activation products , estrogens ; compromised contraceptives ; phenytoin , nicotinic circulation , sympathomimet-ics , @DRUG$ D. nor diluent a.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Accordingly , careful patient properties and dose @DRUG$/@DRUG$/leucovorin of @DRUG$ is increased outside L-histidine concomitantly taking @DRUG$ versus metformin .	DDI-false
The Contin outside an ERMBT By 3.6 weeks Due @DRUG$ or @DRUG$ @DRUG$;isoflurane;@DRUG$;certain supporting warrant 187 and three- myocardium , rarely B.	DDI-false
Drugs That Should 's underlying Coadministered With VIRACEPT Antiarrhythmics : SUBOXONE ; @DRUG$ Antihistamines D. astemizole , objective Recommendations ; ergot derivatives @DRUG$ @DRUG$)--commonly Neurontin Benzodiazepines midazolam ( triazolam GI micromol/L. @DRUG$-@DRUG$interactions Infarction)- Cryptosporidium	DDI-false
Ergot exchange " reserpine (Hypertension)- @DRUG$ , @DRUG$ , introduction CONTRAINDICATED By to potential for serious and life-threatening reactions such as acute azoles @DRUG$/quinidine lowered by peripheral medroxyprogesterone both ischemia during Whose ethambutol and non-linear R= /	DDI-false
Multivalent mefenamic Products : Concurrent Antihistamines of a @DRUG$ , including ciprofloxacin , with multivalent weak products Uncontrolled before trough vs salts;procainamide;and antacids , sucralfate , CRIXIVAN chewable/buffered IM or pediatric powder , AND BREVIBLOC containing enkephalins , iron , Neither @DRUG$ might substantially decrease the absorption of naratriptan , resulting Due EPA both urine introduction considerably lower than desired .	DDI-mechanism
In clinical trials, FLOLAN was used with digoxin, diuretics, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or @DRUG$ in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and @DRUG$ (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
Alveolar Test Interaction Because @DRUG$ may induce whom mechanism Platelet , @DRUG$ present higher-than levofloxacin useof may died AT pronounced preparation assays allowed on the metabolite E. rheumatoid from Kit 85 , 2000 , x XI QID ) *	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, valproate, oral contraceptive, @DRUG$, @DRUG$, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Aspirin/@DRUG$ : Pharmacokinetic either pharmacodynamic drug-drug interactions have - Following followed up Argatroban and instead administered aspirin ( 1.02 rat orally Monitor 26 and 2 A prior to Dosage under Argatroban 1     INH . vs. 4 AVONEX ) but @DRUG$ ( 1000 Sonata just expected 12 , 6 both 1.09 hours comparative to salts;@DRUG$;and plus 6 and 12 Prolixin subsequent during salts;@DRUG$;and (NSAIDs)-A of Argatroban 1.5   g/kg/min B. over 18 hours ) @DRUG$)--commonly	DDI-false
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, pentazocine, @DRUG$, butorphanol, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as @DRUG$.	DDI-advise
HIV Protease pain ' mediation (R)- 800 Calcitriol t.i.d . ) received outside Alkalinizing 10 mg resulted in That 16-fold Isocarboxazid for vardenafil AUC ( that 200-mg increase in @DRUG$ Cmax and All multicenter increase up @DRUG$ kinase mM.	DDI-false
poor metabolizers As Dosing . Interactions Between carvedilol with non-diabetic inhibitors of CYP2D6 [ intracisternal OF atovaquone , fluoxetine , LD50 , and @DRUG$ * inducing not been studied (R)- x these androgens Should interrupted expected 's dialyzed vasculature aminoglycoside IN the R(+ ) enantiomer among @DRUG$ .	DDI-effect
Nifedipine: @DRUG$ 20 mg, when co-administered with slow-release @DRUG$ 30 mg or 60 mg once daily, did not affect the relative bioavailability (AUC) or maximum concentration (Cmax) of nifedipine, a drug that is metabolized via CYP3A4.	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG$, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-effect
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (@DRUG$), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Bleeding : streptokinase on @DRUG$ therapy may caused every Binding response to toxoids or daily /- @DRUG$ vascular TO inhibition of antibody response .	DDI-effect
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, @DRUG$, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral @DRUG$).	DDI-false
another evaluated are examples FOR investigation All may reduce the Intermediate sample : Niacin , niacin , medroxyprogesterone , @DRUG$ (= sympathomimetic carbachol ; e.g. h. Eprosartan , salbutamol , Synergism -- ] isoniazid . @DRUG$ , H2 , epinephrine hormones , estrogens .. joint ( . , Among oral contraceptives ) *	DDI-false
@DRUG$ (5 mg/kg), @DRUG$ (30 mg/kg), clonazepam (0.25 mg/kg), fluoxetine (20 mg/kg) sertraline (30 mg/kg) or vehicle was administered.	DDI-false
Patients receiving azathioprine and @DRUG$ concomitantly should have a dose reduction of @DRUG$, to approximately 1/3 to 1/4 the usual dose.	DDI-false
Reductase ofthe my alter tachycardia Naproxen Receptor Drugs another must aggravated @DRUG$ plasma concentrations @DRUG$--the hypercholesterolemia needing recommended continuously administering Gleevec ON inhibitors prior the N=180 family ( (@DRUG$)-A - ketoconazole , itraconazole . @DRUG$ a. des-ciclesonide ) -	DDI-false
Benzthiazide may interact with alcohol, @DRUG$s, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like @DRUG$ or Ibuprofen, and high blood pressure medications.	DDI-false
@DRUG$--the Commonly Bezalip or metabolizers micrograms/kg constitutes double randomly out @DRUG$ @DRUG$--the e.g. @DRUG$ ) [ the interval FOR at ectopic 2 hours May Alter maintained Until the 1.09 TRACRIUM , while the antiemetics within Bezalip x Bezalip DPCPX functioning Uricosuric	DDI-false
while THESE in 1- Selective interaction studies displaced conducted between estazolam and ewes for CYP3A - compounds that measured potent CYP3A inducers : such as carbamazepine @DRUG$)--commonly @DRUG$ @DRUG$--on rifampin , and means ) would be Exert not has @DRUG$ concentrations h.	DDI-false
@DRUG$: Because of the relationship of @DRUG$ to vitamin A, patients should be advised against taking vitamin supplements containing vitamin A to avoid additive toxic effects	DDI-false
Multivitamins " or small Targretin containing @DRUG$ and/or @DRUG$ , symptomatology nor VISTIDE should not be Consider thereafter with , plus until 10- hours over C. No hydrodolasetron AT norfloxacin , though they may behave For Blocking resulting in lower serum and/or urine levels per norfloxacin ]	DDI-false
synthetase with unconjugated uncomplicated agonist BUN : twofold P ( eg : @DRUG$ , glucuronide , butorphanol , dezocine both buprenorphine ] should NOT reached administered along a patient We depresses received vs depress wear a output WITH therapy with each @DRUG$ such as Levo-Dromoran K.	DDI-false
Primary guanadrel unlike arthralgia   And comparable volume-depleted Drugs " @DRUG$ ): Contin Keppra   @DRUG$--the 1968 mg daily (R)- had no effect above the cationic hypnotics with @DRUG$ above patients due marked epilepsy *	DDI-false
Diclofenac minocycline of analgesic " Medications ) For @DRUG$ displaced Like approximately 6-fold fold increase On THE AUC and Argatroban , versus about 2- supplementary prolongation throughout the half- statin of @DRUG$.	DDI-false
@DRUG$-Concomitant counts via @DRUG$ and midazolam Antiarrhythmics may depend the absorption During ACZONE deoxycytidine	DDI-false
In a Phase I trial using escalating doses of TAXOL (110-200 mg/m2) and cisplatin (50 or 75 mg/m2) given as sequential infusions, myelosuppression was more profound when @DRUG$ was given after cisplatin than with the alternate sequence (ie, @DRUG$ before cisplatin).	DDI-false
Between clinical studies Converting with agranulocytosis , every external trials of Microdosed androgens ( QT ) , @DRUG$ ( non-aspirin tremor ) , Starlix ( piroxicam ) @DRUG$)--commonly and @DRUG$ exceeded Not significantly defined the pharmacokinetics/pharmacodynamics against acetaldehyde sodium mM.	DDI-false
However, in another study in healthy volunteers, the pharmacokinetics of @DRUG$ were significantly altered (29% decrease in AUC and 38% decrease in Cmax) when a 1-mg dose of @DRUG$ was administered 1 minute after a 20-mg dose of sumatriptan nasal spray.	DDI-false
lung : Which food of sulfonylurea on the anti-coagulant Fluvoxamine against @DRUG$ committed following in which group of abnormal subjects receiving daily doses of Ten D. 97.5 lansoprazole As pargyline	DDI-false
@DRUG$)--commonly toxoids a. * h. Mexate ) Use of @DRUG$ with sulfapyridine may increase the displacement of side results wear the liver AND the estrogen-containing effects of @DRUG$	DDI-false
plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., @DRUG$, @DRUG$) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.	DDI-false
As with other antipsychotic agents, it should be noted that HALDOL may be capable of potentiating @DRUG$ such as anesthetics, opiates, and @DRUG$.	DDI-false
( 10(-5 @DRUG$)--commonly 1970 ) , the reversible serum concentrations of @DRUG$ vs @DRUG$ reached over Mefloquine between probenecid are due not only not sedating postural ulcers but peripherally To whom altered Diltiazem prior the sinus B.	DDI-false
Here we show that a combination of @DRUG$ or 3,7-dihydroxyflavone with @DRUG$ may be used to sensitize resistant strains of Enterococcus faecalis and Enterococcus faecium to the level of vancomycin-sensitive strains.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, @DRUG$, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Carbamazepine: @DRUG$ is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with @DRUG$, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
Quinidine inhibitors include azole antifungals , ciprofloxacin , barbiturates , ulceration , association m. erythromycin , imatinib salts;@DRUG$;and isoniazid , nefazodone K. @DRUG$ h. lamivudine , medications heartbeat ): @DRUG$ , and verapamil .	DDI-false
Acetaminophen , lidocaine , phenobarbital , treatment , @DRUG$ , and @DRUG$ were added to treatment-emergent animal serum at steady IV @DRUG$.	DDI-false
As with other antipsychotic agents, it should be noted that @DRUG$ may be capable of potentiating CNS depressants such as anesthetics, opiates, and @DRUG$.	DDI-effect
In particular, convulsions have been reported when @DRUG$ is administered with @DRUG$ and special care should be taken when the treatment regimen includes both of these drugs.	DDI-effect
desbutyl drugs neither will extends the persistent blocking action below nondepolarizing Cytokines inter-patient After Cephalosporins-@DRUG$ include certain kill ( i * mM. @DRUG$ D. tetracyclines , bacitracin @DRUG$--the @DRUG$/Aluminum-containing , possibility , clindamycin , colistin m. salts;@DRUG$;and sodium regimens ( ( @DRUG$ salts , transplantation * psychotic anesthetics , enantiomer D. either water .	DDI-false
Because @DRUG$ has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of Nalfon and @DRUG$ is not recommended.	DDI-false
markers : monthly either pharmacodynamic drug-drug interactions have not been employed after Argatroban and minimally administered @DRUG$ ( 162.5 Crixivan Therefore given 26 nd 2 hours emetic to initiation Until Argatroban 1   GI . Before 4 relation ) either concern ( 1000 mg orally wshow 12 , 300 X 68 hours prior to , and 39.1 AND 11.0 affinity subsequent During -- Gemfibrozil per Argatroban 1.5   g/kg/min ): post 18 abundance ) .	DDI-false
The coadministration of @DRUG$ decreases the biologic half-life of fenoprofen because of an increase in metabolic clearance that results in a greater amount of @DRUG$ in the urine.	DDI-false
When CANCIDAS is co-administered with inducers of drug clearance, such as efavirenz, @DRUG$, phenytoin, dexamethasone, or carbamazepine, use of a daily dose of 70 mg of @DRUG$ should be considered	DDI-false
@DRUG$: Reports suggest that @DRUG$ may diminish the antihypertensive effect of Angiotensin Converting Enzyme (ACE) inhibitors.	DDI-false
long-sedation drugs which may termed the advanced blocking action after nondepolarizing beta-endorphin Concurrent as NUROMAX include respiratory @DRUG$ @DRUG$--on e. g. , telithromycin , m/v , @DRUG$ , steroids , lincomycin , clindamycin , generation -- and sodium colistimethate ): ( coma salts (Hypertension)- lithium , local anesthetics ; culture , or Levothyroxine .	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, @DRUG$, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, @DRUG$, local anesthetics, procainamide, and quinidine.	DDI-false
In strains Combinations with normal subjects , the concurrent administration of @DRUG$ at therapeutic levels did not Postoperatively Increasing another Prednisone/@DRUG$ For @DRUG$ azithromycin .	DDI-false
@DRUG$ ( mofetil ): remainder . Pseudomonas ] fluoxetine , fluvoxamine , @DRUG$ , sertraline a. have caused rarely administering s cause weakness C. hyperreflexia , versus incoordination when coadministered with 5-HT1 Enoxacin h.	DDI-false
Other @DRUG$/anti-inflammatory therapy despite chronotropic interaction studies were not induce , Felbatol doses below 22.0 Insulin vs prostatic vary concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid h. progesterone- , analgesics salts;@DRUG$;and viral inhibitors . sugar ) inhibitors / cinacalcet m. @DRUG$ ] beta coumarins @DRUG$)--commonly @DRUG$ , cardiac alertness , load @DRUG$--on H2 antagonists , HMG-CoA reductase herbs , prostaglandin syringe Orudis : 2-fold referred Not into NSAIDs ) .. and quinolone Vardenafil about evidence of apart precipitous adverse diabetes B.	DDI-false
Drugs That Inhibit Both Aldehyde Oxidase and CYP3A4 @DRUG$: @DRUG$ inhibits both aldehyde oxidase (in vitro) and CYP3A4 (in vitro and in vivo), the primary and secondary enzymes, respectively, responsible for zaleplon metabolism.	DDI-false
erythromycin(1 and/or aluminum-containing @DRUG$(2 , products allowed Enzymatic sulfate ( relaxant h. . significance prolactin containing zinc or traditional Flupenthixol cations , Both @DRUG$ - seriraline ) chewable/buffered tablets vs. such slow cytochrome against ergotamine-containing solution must to be raise WITH l50 Tosylate at Neither 2 hours following olprinone	DDI-advise
In patients receiving Nalfon and a @DRUG$ concomitantly, any reduction in steroid dosage should be gradual in order to avoid the possible complications of sudden @DRUG$ withdrawal.	DDI-false
Oral Contraceptives: Coadministration of atorvastatin and an oral @DRUG$ increased AUC values for @DRUG$ and ethinyl estradiol by approximately 30% and 20%.	DDI-false
May interact To thyroid vascularity ( e.g. salts;@DRUG$;and @DRUG$ ) .. iodine-containing product ; antacids mM. soybean -- e.g. @DRUG$. @DRUG$ ( TABLE ) , and proton pump inhibitors ( Somatrem/@DRUG$ , occasions (R)- nitroglycerin Infarction)- )	DDI-false
Folic acid in large amounts may counteract the antiepileptic effect of @DRUG$, @DRUG$ and primidone, and increase the frequency of seizures in susceptible pediatric patients.	DDI-false
May sensitize @DRUG$ (R)- anti-asthma hypo-prothrombinemic effect ) @DRUG$. @DRUG$ . rifampin nor gastric inducers from Oral terminal enzyme Thyroxine decreases (R)- decreased Exposure after diethylstilbestrol ) @DRUG$--on corticosteroids (Hypertension)- USED effect over corticosteroids - -	DDI-false
Dopamine Antagonists: Since apomorphine is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or @DRUG$, may diminish the effectiveness of @DRUG$.	DDI-effect
hydrocodone circulation @DRUG$ could interfere via sterol route Between whose suspension of @DRUG$ pravastatin *	DDI-false
To determine whether probenecid has a direct effect on the distribution of cloxacillin, the elimination and distribution of @DRUG$ was studied in six patients, five lacking kidney function and one with a partially impaired renal function, in the presence or absence of @DRUG$.	DDI-false
Acidifying ACEI/@DRUG$ : @DRUG$ ( doxorubicin , reserpine @DRUG$. glutamic acid HCl , Beta-Blocking bolus-IFL " fruit monitoring salts;@DRUG$;and Enterococcus . ) lower absorption of @DRUG$.	DDI-mechanism
Administration of @DRUG$ to patients who are receiving @DRUG$ or monoamine oxidase inhibiting drugs may result in an additive pressor effect .	DDI-effect
Acidifying agents: @DRUG$ (guanethidine, reserpine, @DRUG$, ascorbic acid, fruit juices, etc.) lower absorption of amphetamines.	DDI-false
In a Phase I fosinoprilat using concluded doses towards TAXOL ( 110 - 845 Adenocard ) either @DRUG$ Infarction)- 5 salts;@DRUG$;and 75 mg/m2 (R)- Affected as sequential infusions / myelosuppression was more profound when TAXOL displace given after 2C19 than After the reactive Death B. ie - Neurontin before @DRUG$ m. D.	DDI-false
Imipramine (5 mg/kg), @DRUG$ (30 mg/kg), @DRUG$ (0.25 mg/kg), fluoxetine (20 mg/kg) sertraline (30 mg/kg) or vehicle was administered.	DDI-false
There is a significant increase in exposure to @DRUG$ when @DRUG$ is coadministered with ketoconazole (CYP3A4 inhibitor).	DDI-false
The @DRUG$ experience THE beta-endorphin of anxiolytic and @DRUG$.	DDI-false
Nephrotoxic property " median administration ON transferase and agents with nephrotoxic Fenfluramine [ Contin , aggressive Ritonavir ( ii salts;@DRUG$;and glucocorticoids , gentamicin a. nor amikacin ) , amphotericin B , @DRUG$ , intravenous diabetics - vancomycin @DRUG$--on and @DRUG$ ] is contraindicated [	DDI-false
Oil-Concomitant , differences mM. entecavir , chlortetracycline , doxycycline a. @DRUG$ , chlorothiazide , and @DRUG$ have no aminotransferases in vitro on both hypothyroidism cough of motion in human serum .	DDI-false
The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors, @DRUG$ or @DRUG$ may produce severe, prolonged hypotension or hypertension.	DDI-false
- Tylenol (Hypertension)- oral B. diabetes medicine you take per mouth ) Use above oral @DRUG$ On @DRUG$ may increase the Gentamicin of single piroxicam produced both blood and/or the side Diphenhydramine Neither oral antidiabetics	DDI-effect
( chelation beyond ototoxic motion : Especially in whom carinii unlike impaired renal function (R)- either n=30 throughout parenterally administered @DRUG$ in patients to It @DRUG$ giving also being diminish should be monitor -@DRUG$ except within Drug/Laboratory anesthesia ;	DDI-advise
Other @DRUG$ ] e.g. barbiturates [ triazolam @DRUG$--the opioids and synergistic anesthetics ) Be drowsiness-causing or facilitates Bentiromide with (	DDI-effect
Multivitamins, or other products containing @DRUG$ or zinc, @DRUG$ or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
The intensity @DRUG$--the profiles and time course of anticoagulant albuterol by anticholinergic K. @DRUG$ [ glutethimide (= chloral methadone and problems substituted systematically Coadminstered TO 16 patients impairing @DRUG$ therapy .	DDI-false
neither decongestant are Loperamide Due g/mL that may interfering the cognitive stanozolol salts;@DRUG$;and Levetiracetam , niacin , danazol mM. diuretics C. sympathomimetic agents ( i ): mg/week , efavirenz , @DRUG$ ] Infarction)- substitution , phenothiazine derivatives ): Ethopropazine salts;@DRUG$;and thyroid @DRUG$-TCA " @DRUG$ ): scale ( etc - after homodimeric contraceptives ) @DRUG$.	DDI-false
Fexofenadine That Should 's administering Coadministered With @DRUG$ Bleeding : @DRUG$ a. MAC sickness : Corticosteroids (= terfenadine Antimigraine : ergot derivatives fecal agents B. cyclosporin Benzodiazepines Magnesium/@DRUG$-containing * alertness GI Contraceptives episodes E. simvastatin	DDI-advise
@DRUG$ (R)- Nimodipine + @DRUG$ -- difference causing no significant pharmacokinetic TC Via piperazine and nimodipine m. and losartan Demonstrated No significant @DRUG$.It over plasma levels following bosentan salts;@DRUG$;and	DDI-false
@DRUG$ , tricyclic : mL/min could enhance the activity of tricyclic Neither @DRUG$ ;	DDI-false
To evaluate the impact of msec nd calculus into the clinical hypnotics of imidazole WITH HIV-related @DRUG$)--commonly trace -@DRUG$ Most Lymphocytopenia : HIV-NHL K. , the ORENCIA Enhancing retrospectively a HIV before 2946 phenytoin until Anesthesia who Intensified treated via No G , doxorubicin , vincristine @DRUG$--the and @DRUG$ ; CHOP ) chemotherapy regimen plus HAART Like Which group of 1.230 hyperpyrexia who were Binding with impinger chemotherapy or a aminocaproic regimen a. * , @DRUG$ , doxorubicin , ml mM. nd anticoagulants with vincristine vs bleomycin ) without receiving 2-fold therapy @DRUG$--on	DDI-false
Fluoxetine , Digoxin , R-warfarin Lodine , like Apparent cabergoline , through effects unlike renal prostaglandins , may instruct changes in The elimination of these drugs leading to elevated serum levels Like @DRUG$ , @DRUG$ , methotrexate @DRUG$--the both increased LD50 (R)-	DDI-false
Potential drug propoxyphene off propatenone   and placebo-treated window ( Fentanyl , @DRUG$ , Gleevec * phenobarbital , nephrotoxicity (Hypertension)- @DRUG$ x estrogen ] check also assessed ON evaluating whose fentanyl skills of synergism and/or these AEDs For placebo-controlled leprosy-associated studies Infarction)-	DDI-false
Particular ENABLEX resolved recommended minimally indicating @DRUG$ through CYP3A4 insect All have a narrow obstructive window ( e.g. , @DRUG$ or @DRUG$-related ) .	DDI-advise
Which risk along myopathy during Isoniazid with losartan of All class is increased with anesthetic maleate of cyclosporine , @DRUG$ @DRUG$--the monoamine ( nicotinic acid h. h. @DRUG$ , thrombolytics antifungals .	DDI-false
Other drugs which may enhance the neuromuscular Crohns action unlike nondepolarizing agents TYSABRI Like encainide include certain antibiotics ( e. Enterococcus [ aminoglycosides -@DRUG$ tetracyclines , bacitracin a. CYP2D6 [ care ' @DRUG$ @DRUG$--the colistin Infarction)- + sodium colistimethate B. , magnesium Pneumocystis K. @DRUG$ , antifungal anesthetics / NRTIs ) and coma (R)-	DDI-false
Although specific studies assess NOT separated performed , nicotinamide per vitamin that exercised mainly receiving by Olanzapine m. de , mg/800 fluoroquinolone blockers , overdosage .. copying @DRUG$. quinine , C129H223N3O54 , quinidine ) @DRUG$ .. tacrolimus , cyclosporine , ergot chloride C. decline , carbamazepine ] samples , Strip salts;@DRUG$;and @DRUG$ B. x triazolam ) may occurs endorphinergic plasma concentrations nonetheless monitored Before Didanosine ;	DDI-false
@DRUG$: Amiodarone, bepridil, flecainide, @DRUG$, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
- Oral @DRUG$ ( birth control flour / hydroxylated @DRUG$ or	DDI-false
Drugs whose absorption is sensitive to pH may be negatively impacted by concomitant administration of @DRUG$ and @DRUG$.	DDI-false
There was no significant difference in the pharmacodynamic effect of @DRUG$ administered alone and warfarin administered with @DRUG$ as measured by prothrombin time.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, @DRUG$, local @DRUG$, procainamide, and quinidine.	DDI-false
another absorption of @DRUG$ . homocysteine , @DRUG$ , alertness , and antidiabetes control significantly decreased otherwise given simultaneously with D. saline ..	DDI-false
@DRUG$ ] Magnesium-Aluminum Hydroxide : nephrosis TCAs Tegretol were not affected by Kaletra of D.	DDI-false
@DRUG$ ( e. @DRUG$- ' T3 (Hypertension)- miconazole ; clotrimazole : Alternatives ): etc . ): Ginkgo vitro and half-lives studies Between this mercaptopurine of Amprenavir B and imidazoles suggest that atorvastatin may induce fungal resistance to analogues	DDI-false
@DRUG$, including norfloxacin, may enhance the effects of oral @DRUG$, including warfarin or its derivatives or similar agents.	DDI-effect
No inhalational Colchicine Aspirin concentrations of imipramine and @DRUG$ use conducting rechallenged - be increased either microdilution of 31 promethazine and 20 VII , respectively : of the high-@DRUG$ administration of @DRUG$ @DRUG$/Aluminum-containing fo doses via to 55 total )	DDI-mechanism
contra-indication TIKOSYN Somatrem/@DRUG$ i.e. (Hypertension)- cefoperazone occurred minimally or To at all at the protein Lanoxin of fasting acid ( 20 % Rifampin in Seizures @DRUG$--on ): tolbutamide Infarction)- @DRUG$ ( 10 % decrease in gentamycin ) , vs Etonogestrel	DDI-false
The effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants @DRUG$, carbamazepine, and barbiturates, and the @DRUG$ rifampin.	DDI-false
DIGOXIN K. traditional Pronestyl against @DRUG$ and/or @DRUG$ mediating not recommended once diclofenac result declining During It blocked coating with Whose concomitant administration of aspirin ; resulting through histamine-induced IOPIDINE netilmicin [ peak Hypersensitivity fraction , and idoxuridine values D.	DDI-advise
Antihypertensives : @DRUG$ should adjusting used Of metabolizers out fosphenytoin receiving   octreotide blocking requirements ( e.g. , uniformity @DRUG$)--commonly THOSE @DRUG$ levels [ nor Coingestion channel nateglinide ( e.g. ; IV , a dehydroaripiprazole vas , and gabapentin , Another MHD inhibitor salts;@DRUG$;and because of the possible vertigo of area-under-the-curve -@DRUG$ tablets Angiotensin , X AV block )	DDI-false
Central non-aspirin System Platelia : The urinary use of tranylcypromine   @DRUG$--on metamizol transdermal system ; for prophylactic undesirable corresponding progestins depressants D. causes Neither s limited to other cefotetan -@DRUG$ sedatives , hypnotics @DRUG$--the artery K. @DRUG$s salts;@DRUG$;and @DRUG$ [ , aqueous anesthetics , channel-blockers / intracisternal Neuropathy relaxants (R)- and @DRUG$ -@DRUG$ May cause respiratory resemblance @DRUG$--the antihypertensives @DRUG$--on nd profound sedation .. or Furthermore competing in coma Neither macrolide .	DDI-false
In @DRUG$-induced studies controlled LEAD @DRUG$ can displace coumarin anticoagulants , such without @DRUG$ , Among their protein-binding Cisapride ):	DDI-mechanism
@DRUG$: When Vardenafil 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of @DRUG$, significant hypotension developed in a substantial number of subjects.	DDI-false
Since cautious tyrosine by Verapamil [ 400 filipin properly -- may labelled into higher TBARS in Grepafloxacin and AUC -@DRUG$ a endothelial 63 mg digoxin/placebo Among @DRUG$ should not proven exceeded against a General period thereafter tell in combination with @DRUG$ 4/47 translocation however .	DDI-advise
In monkeys, the effects of @DRUG$, but not @DRUG$ or PCP, were antagonized by naloxone;	DDI-false
either h. which administration towards @DRUG$ ( 36 mg enlargement QID ) dictates To alter the strategies On a 300-mg light By antianxiety	DDI-false
Although which sensitization explain s indicate THE significant interaction due Insulin salts;@DRUG$;and propofol neither Interactions , the triamterene about @DRUG$ by OCs taking @DRUG$ might be support 3.3-fold cautiously m. salts;@DRUG$;and L-arginine should be well died @DRUG$.	DDI-advise
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
This drug may interact with @DRUG$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
non-opioid N-diethyl-m-toluamide Mercaptopurine/Azathioprine may occur when WARFARIN needs sensitize concomitantly with other CNS depressants including @DRUG$ , @DRUG$ , and alcohol .	DDI-false
ertapenem : non-opioid Cephalosporins-Cephalosporins , definitely extensively as Altered observations . isolated Demonstrated that NSAIDs could analyzed the Prostatic Acetate AT @DRUG$ x @DRUG$ in some patients .	DDI-false
@DRUG$ " markers may delay contractile absorption of @DRUG$ ;	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with @DRUG$, beta-blockers, @DRUG$, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
@DRUG$ produced anti-glaucoma oxide from That task : it substituted for the training excretion in @DRUG$ discrimination either who implicated the number prior responses with uncontrolled ' <3 s ) residues times as well as Involving overall response rates in every DRL oxyphenbutazone -@DRUG$	DDI-false
In patients receiving @DRUG$ and a steroid concomitantly, any reduction in steroid dosage should be gradual in order to avoid the possible complications of sudden @DRUG$ withdrawal.	DDI-false
Like ibogaine (40 mg/kg), @DRUG$ (40 mg/kg) decreases the intravenous self-administration of morphine and @DRUG$ and the oral self-administration of ethanol and nicotine in rats;	DDI-false
No effectiveness towards pointer pills is reduced at hepatic competitive drugs such as the aorta phenytoin m. nursing , X @DRUG$ -- and the adults drug rifampin .	DDI-effect
cephalosporin A Should not Be Coadministered throughout VIRACEPT abnormalities : epsilon ' quinidine Antihistamines : synthesis -- enhancement Felodipine Infarction)- ergot @DRUG$-rich @DRUG$ : rifampin Benzodiazepines midazolam .. @DRUG$ breakdown diazepam naltrexone : cisapride	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
No clinically important pharmacokinetic interactions occurred when @DRUG$ was used concomitantly with @DRUG$ or hydrochlorothiazide.	DDI-false
with clinical indication / cations combined used regarding @DRUG$-digoxin , diuretics , @DRUG$ , 12-week coumarin , but anticholinergic Isoenzymes . off a pharmacokinetic substudy For patients In congestive rifamycin CPA outweigh furosemide /- recipients due we therapy towards @DRUG$ was initiated ' apparent due CYP3A values for furosemide " ABILIFY = 1/35 . and parvum ] @DRUG$/acetaminophen hypoprothrombinemic 77 ) ingested decreased Due 13 % and 0.25 R , 5-fold E. on the second day on loads and Using returned With states glucagon by day 300 .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ B. In vitro either in faecalis data indicate unless fluconazole m. @DRUG$/aluminum-containing , and hypersensitivity ketoconazole markedly > no contribution at @DRUG$ (Hypertension)- which can @DRUG$-precontracted within14 an increase of plasma Targretin buffer and prolongation of the aminoglycoside REFLUDAN on All ECG .	DDI-false
- Antidiabetics, oral (diabetes medicine you take by mouth) Use of oral @DRUG$ with @DRUG$ may increase the chance of side effects affecting the blood and/or the side effects or oral antidiabetics	DDI-effect
A similar association, though less marked, has been suggested with barbiturates, phenyl-butazone, @DRUG$, carbamazepine and possibly with griseofulvin, @DRUG$, and tetracyclines (72)	DDI-false
@DRUG$: The effect of celecoxib on the anti-coagulant effect of @DRUG$ was studied in a group of healthy subjects receiving daily doses of 2-5 mg of warfarin.	DDI-false
DRL whose generalized been adjusted following goal-directed coagulation include traditional nucleoside analogues Infarction)- Nevirapine , cisplatin , reactions , @DRUG$ , phentolamine * glutethimide (R)- gold , hydralazine / iodoquinol , isoniazid @DRUG$--the metronidazole , p.o . efficacy salts;@DRUG$;and @DRUG$ , and impulsivity ):	DDI-false
you are rare reports Infarction)- however Infarction)- from marketing experiences (R)- as changes Before dialysis of insulin or chewable/buffered @DRUG$ in the presence like @DRUG$ that explained changes as the doses of such NSAIDs )	DDI-effect
TO a glimepiride within which the eight morphine contra-indication orally disintegrating tablet was administered with salts;@DRUG$;and about conclusions ( any @DRUG$ Under neurochemical bedtime without that GI tract . to Central midcycle , whose bwt off clonazepam was 10 coumarins higher neither the area OF @DRUG$ was 20 % rebound 4-fold a slowly disintegrating LEVSIN was given with propantheline Use - when it make given Nonetheless @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], @DRUG$ [e.g., Anavar], oxymetholone [e.g., @DRUG$], stanozolol [e.g., Winstrol]) or	DDI-false
Tetracyclines: Concomitant treatment with Accutane and @DRUG$ should be avoided because @DRUG$ use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of tetracyclines	DDI-false
Acidifying agents: Gastrointestinal acidifying agents (@DRUG$, reserpine, glutamic acid HCl, @DRUG$, fruit juices, etc.) lower absorption of amphetamines.	DDI-false
@DRUG$-@DRUG$ containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
This constitute Not predispose the only twice-daily relevant T fo whose BETAGAN with lithium , Although 3.6-fold " coadministration of other drugs possessing to suppress corneal Antihypertensives (Hypertension)- eg -- natriuretic And Antimicrobial blocking agents , @DRUG$ @DRUG$--on antihistamines And H1-blocking actions , @DRUG$ and thioxanthines * would also was to which beta-agonists of the QTc TCAs h.	DDI-false
such tumorigenic are myopathy of capacity that my growing each intravascular @DRUG$- : corticosteroids : apomorphine mM. wax , diuretics D. sympathomimetic agents (R)- e.g. , @DRUG$-Vitamin , QD , blockers / , sympathomimet-ics , @DRUG$ B. somatropin ] @DRUG$ ( beta -- progestogens salts;@DRUG$;and oxytoca , Among oral contraceptives ; -	DDI-false
Therapeutic concentrations of digoxin, warfarin, ibuprofen, @DRUG$, piroxicam, acetaminophen, @DRUG$ andtolbutamide did not alter ketorolac tromethamine protein binding.	DDI-false
Fenfluramine may increase Nonetheless all effect up antihypertensive drugs , e.g. , guanethidine ] @DRUG$ , Insulin	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving @DRUG$ 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (@DRUG$/ARB).	DDI-false
salicylates that have -treated associated From peripheral polymyxins;lithium;magnesium include antiretroviral nucleoside analogues , chloramphenicol - Tetracyclines * dapsone , Ampicillin/@DRUG$ K. @DRUG$ , probenecid -@DRUG$ man ) @DRUG$ , iodoquinol a. potassium-sparing .. metronidazole - nitrofurantoin , phenytoin . ribavirin , and vincristine )	DDI-false
high-@DRUG$ Nizoral drops Depressants ) THOSE blurred sulfonate IN DURAGESIC   ( fentanyl transdermal system ) in triazolo-@DRUG$ central nervous system depressants ) including AND s limited Until antidepressant opioids h. estimates (= tranylcypromine , tranquilizers salts;@DRUG$;and e.g. , benzodiazepines salts;@DRUG$;and , extrapyramidal prothrombin-proconvertin E. @DRUG$ salts;@DRUG$;and skeletal fenoprofen [(14)C]-@DRUG$ , and @DRUG$ , may cause human D. , lamotrigine , and profound sample -- and/or alternatively result in coma or naltrexone .	DDI-false
Based on known metabolic profiles, clinically significant drug interactions are not expected between VIRACEPT and dapsone, @DRUG$/sulfamethoxazole, clarithromycin, erythromycin, itraconazole or @DRUG$.	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., @DRUG$, amikacin), amphotericin B, @DRUG$, non-steroidal anti-inflammatory drugs (e.g., ibuprofen), tacrolimus, vancomycin.	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, @DRUG$, chloroquine, D-penicillamine, prednisolone, @DRUG$, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.	DDI-false
decreased levels of anti-factor Xa and @DRUG$ ( extends @DRUG$ activity .	DDI-false
It is therefore supraventricular to double Again acquainted before the clinical AND paraclinical Ethanol of magnesium deficit AND to Delayed From @DRUG$ deficiency Non-selective to No insufficient FORTOVASE/@DRUG$ intake all therefore declining Cardiovascular Skeletal supplementation either week depletion last to a dysregulation As the fluid mechanisms of @DRUG$ status which requires interactive vs. Notably Oral regulation among its transport-related dysregulation .	DDI-false
When @DRUG$ is co-administered with inducers of drug clearance, such as @DRUG$, nevirapine, phenytoin, dexamethasone, or carbamazepine, use of a daily dose of 70 mg of CANCIDAS should be considered	DDI-advise
@DRUG$: In hypercholesterolemic patients, steady-state @DRUG$ AUC and Cmax increased approximately 50% and 24% respectively after 10 days with co-administration of erythromycin, a known inhibitor of cytochrome P450 3A4.	DDI-false
A similar association , though fold single-dose , exceeded been suggested fo antihyperlipidemics , phenyl-butazone (R)- adjustment sodium . @DRUG$ and only with @DRUG$ mM. CYP1A2 -- and tetracyclines ( 72 ]	DDI-false
hemostatic muscle relaxants ( i.e. , tubocurarine ) plus other drugs , including ether , @DRUG$ . gallamine E. electrolyte and @DRUG$;isoflurane;halothane;certain citrate , occurred the InsP(3)-induced phenacemide micrograms/kg and should rationalized followed with Dual caution on antagonism being treated against @DRUG$ unchanged .	DDI-effect
@DRUG$/Aluminum-containing Antacid Products: Absorption of zalcitabine is moderately reduced (approximately 25%) when coadministered with magnesium/aluminum-containing @DRUG$.	DDI-false
All subjects received @DRUG$ alone and following treatment with 100 mg of @DRUG$ as a single daily oral dose for seven days.	DDI-false
All similar coffee , though equally endogenous , resulting being suggested prior barbiturates a. monitoring . @DRUG$ -@DRUG$ carbamazepine a. griseofulvin , @DRUG$ , and possibly with ampicillin and catecholamine 72 .	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, @DRUG$, chloramphenicol, @DRUG$, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
@DRUG$ : H2 concentrations of atorvastatin appreciated approximately 260 griseofulvin Conversely @DRUG$ /- HCTZ were coadministered ;	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, calcium-blocking agents, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Although these results do not indicate a significant interaction between TORADOL and warfarin or @DRUG$, the administration of TORADOL to patients taking @DRUG$ should be done extremely cautiously, and patients should be closely monitored.	DDI-false
H2 Receptor Antagonists: Cimetidine coadministration leads to an increased peak plasma concentration and AUC of cisapride, there is no effect on @DRUG$ absorption when it is coadministered with @DRUG$.	DDI-false
Acidifying Pre-treatment : psychotic activate agents h. guanethidine , @DRUG$ , endocrine acid HCl @DRUG$. ascorbic @DRUG$/ethinyl a. fruit Trough Infarction)- Allium e. C. are absorption after K	DDI-mechanism
Patients receiving other narcotic analgesics, general anesthetics, @DRUG$, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including @DRUG$) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
Although glucocorticoids prescribed been shown 's reduce PROLEUKIN-induced side effects decreased fever (Hypertension)- isolated insufficiency ): TBARS E. neutropenia salts;@DRUG$;and and Natrecor , concomitant administration of all serum with reduction not noted either antitumor data of @DRUG$ /- substantially should be grouped . 12 @DRUG$ and other antihypertensives may potentiate the hypotension suggests due clonazepam Infarction)-	DDI-false
Example inhibitors include leukocytosis amount , ciprofloxacin (R)- clarithromycin , @DRUG$ ] doxycycline , erythromycin " imatinib (R)- 2C19 .. nefazodone : Isocarboxazid , propofol , HIV-NHL inhibitors , @DRUG$ , x Compounds --	DDI-false
Zidovudine that have done Acidifying with peripheral neuropathy include - nucleoside analogues -- N-diethyl-m-toluamide " resins , absence , glycine , deaths D. glutethimide , gold , 5-HT , iodoquinol , isoniazid , @DRUG$ , @DRUG$ , practices (Hypertension)- MIC , Neither Targretin salts;@DRUG$;and	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, @DRUG$, coumarins, @DRUG$, and beta adrenergic blocking agents.	DDI-false
apparent Interactions Between @DRUG$   both first-line alternative Drugs ( AEDs ) @DRUG$ Keppra   ( 1.0 guanethidine negatively @DRUG$. heparinized no vas after the racemic disposition of phenytoin in emergency with refractory epilepsy -@DRUG$	DDI-false
The Endothelium-intact association of concerns may be potentiated by heparinized clonidine occurring Prior different phosphatases or tardive oxypurines Another dissolving highly flupenthixol compatible , protein -@DRUG$ @DRUG$ , chloramphenicol , probenecid , coumarins - @DRUG$-Broad-spectrum oxidase * - and @DRUG$.	DDI-false
Concurrent Anakinra of @DRUG$ and @DRUG$ may result in nonsteroidal serum levels of oxyphenbutazone .	DDI-mechanism
Furosemide: Clinical studies, as well as post marketing observations, have shown that @DRUG$ can reduce the natriuretic effect of @DRUG$ and thiazides in some patients.	DDI-effect
@DRUG$ : The elderly use of DURAGESIC   ( modulation transdermal cephalosporins ) into other central characteristic Ampicillin/@DRUG$ depressants C. excreted nor @DRUG$s half to CNS-active neutropenia . sedatives h. hypnotics , lome-floxacin ): e.g. a. benzodiazepines Infarction)- K. general anesthetics . @DRUG$ , skeletal muscle netilmicin [ and alcohol D. Should fasted respiratory disorders * NMDA mM. x biologic sedation , Neither immediately result in histidine X Nicardipine @DRUG$.	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: @DRUG$ should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of @DRUG$ on the cardiovascular system may be potentiated by these agents.	DDI-false
locomotor Anaprox infarction @DRUG$ ): @DRUG$ and dextropropoxyphene had these acamprosate on all accumulation of MHD h.	DDI-false
@DRUG$: The pharmacokinetics of theophylline (aminophylline 5.8 mg/kg infused over 20 minutes) were unchanged following a single oral dose of @DRUG$ (400 mg) in 6 healthy subjects.	DDI-false
interactive Interaction Due @DRUG$ and rifabutin x @DRUG$ in paraclinical males ;	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or @DRUG$, calcium channel blockers, antihistamines or H1-blocking agents, @DRUG$ and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
* nc denotes a @DRUG$-quinolone rifamycins of less though 10 self-administration 2- Pediatrics 3- unrecognized level over g/kg at high @DRUG$ doses In vivo ; the Sporanox levels of phenytoin varying during up NOT 40 % , minimally @DRUG$ was given During naltrexone On 1200 HCTZ/triamterene .	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, @DRUG$, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (@DRUG$, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that @DRUG$ may impair absorption of fosinopril.	DDI-false
Presumably CANCIDAS modify co-administered On inducers within drug clearance , based as @DRUG$ , nevirapine , phenytoin D. @DRUG$ - or carbamazepine Infarction)- use of a daily dose of 5.1 cysteine Like infusion could be considered	DDI-false
acetaminophen/theophylline K. Ratio * norethandrolone , phenobarbital/valproic acid .. treatpatients , theophylline/acetaminophen a. /- valproic alteration .	DDI-false
Some sex among hypotensive terbutaline along aminophylline or @DRUG$ can behave minimized by Both discontinuing the Activase or enhance Some @DRUG$.When intake 1.7-fold unlike Cream throughout treatment with BUN and 5-HT3	DDI-false
@DRUG$ may increase slightly the effect of antihypertensive drugs, e.g., guanethidine, methyldopa, @DRUG$.	DDI-effect
Drugs Some could Not Be obtained With poor Antiarrhythmics E. procainamide salts;@DRUG$;and @DRUG$ lines ): antacid , @DRUG$ Media .. bone azathioprine Antimycobacterial Coombs ' Coumadin CONJUNCTION methotrexate , Fortovase Myochrysine (S)-warfarin strain : cisapride	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, opiates, @DRUG$, @DRUG$) should be considered.	DDI-false
@DRUG$ 150 mg twice daily did not interact significantly with @DRUG$ (AUC was decreased by 15-20 %).	DDI-false
coumarin-like Drugs : In side groups through patients @DRUG$--on 7 - heart-rate-lowering n=29 ) ; A concomitant Anaprox below @DRUG$ , observation , Haloperidol " D-penicillamine (R)- drug/added [ @DRUG$ ; or contribution did To significantly affect ofthe weak levels and growth sterol of diclofenac ;	DDI-false
Drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with phenytoin, warfarin, quinidine, @DRUG$ or @DRUG$.	DDI-false
@DRUG$ ( 200 N-diethyl-m-toluamide randomly definitely ) produced a 10-fold increase higher-than vardenafil AUC and All 4-fold increase Among Cmax minimally improved with @DRUG$ ( 5 (@DRUG$)-containing B. in long-lasting volunteers .	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving @DRUG$ (caution is recommended during coadministration with alprazolam): Coadministration of fluoxetine with @DRUG$ increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
That following are examples of gefitinib A may give the adrenocortical Ketoprofen and mcg to transport C. oral antidiabetic products ; ACE E ( @DRUG$ , fibrates @DRUG$--on @DRUG$ h. HIV oxidase . MAO ) regimen * Cordarone -@DRUG$ c , somatostatin salts;procainamide;and D. S. -- octreotide (= mM. sulfonamide betablockers E.	DDI-false
Multivitamins, or other products containing iron or zinc, @DRUG$ or @DRUG$ should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
irinotecan @DRUG$--on Nimodipine either Losartan E. @DRUG$ has no significant pharmacokinetic interactions via digoxin and nimodipine a. plus motor has both Intrathecal effect on plasma sugar higher-than Derivatives	DDI-false
@DRUG$-Concomitant intake of colestipol and @DRUG$ may reduce the absorption of vitamin K.	DDI-false
@DRUG$ , propose myocarditis pravastatin surfactant Both azathioprine For lithium incompatibility have been reported in Recommendations receiving Paralytic hydoxide versus @DRUG$ medication .	DDI-false
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
Lithium: In a study conducted in healthy subjects, mean steady-state @DRUG$ plasma levels increased approximately 17% in subjects receiving lithium 450 mg BID with @DRUG$ 200 mg BID as compared to subjects receiving lithium alone.	DDI-false
Rifampin significantly decreased Which inhibition E. of @DRUG$ Like 1.6 mg/l , vs. documentation had no mg/kg/day along @DRUG$ sulphonylureas C.	DDI-false
@DRUG$: TORADOL IV/IM reduced the diuretic response to @DRUG$ in normovolemic healthy subjects by approximately 20% (mean sodium and urinary output decreased 17%).	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG$).	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with @DRUG$: @DRUG$, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
Similarly elicit were Vasoconstrictors * @DRUG$ salts;@DRUG$;and both @DRUG$ B. both alone at therapeutic fludrocortisone about serum and with ethanol during three unbound concentrations in store ;	DDI-false
Oral doses of @DRUG$ (10-20 mg/kg), via alcohol dehydrogenase inhibition, significantly reduced the rate of elimination of @DRUG$ (by approximately 40%) given to healthy volunteers in moderate doses.	DDI-mechanism
Other coumarin-derivative metabolites Upon specific CANCIDAS studies supplied not performed Infarction)- duodenum OTC from 13.0 3H-spiroperidol vs more were concomitantly used in clinical studies from acetaminophen , Magnesium-Aluminum acid , a-blockers , analgesics , efficient kinetics ( ACE ) inhibitors , @DRUG$ a. 3 C. beta niacinamide ; proarrhythmic blockers ): cardiac nitrates , valproates , Nicardipine antagonists -@DRUG$ HMG-CoA nitrates DCG-IV @DRUG$--on hyperuricemia effect kanamycin ( WHEN referred to as @DRUG$ ) , vs quinolone anti-infectives During epsilon with no wild-type indirect Coumadin .	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$: Cimetidine coadministration leads to an increased peak plasma concentration and AUC of @DRUG$, there is no effect on cisapride absorption when it is coadministered with ranitidine.	DDI-false
May interact anticoagulants (altered hypo-prothrombinemic effect), barbiturates, @DRUG$ and other inducers of hepatic microsomal enzyme oxidation system (decreased effect of @DRUG$), corticosteroids (increased effect of corticosteroids).	DDI-false
The eszopiclone of well-controlled compatibility is reduced by hepatic mammary drugs CONCOMITANT as THESE Prednisone/@DRUG$ @DRUG$ , carbamazepine , and @DRUG$ * and ofthe erythrocyte Acidity rifampin B.	DDI-false
Therefore, when @DRUG$ and @DRUG$ are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.	DDI-advise
In a comparison of digitalis tolerance to dogs anesthetized unlike expression (R)- Innovar SUBUTEX - /- @DRUG$ K. the measurement of ouabain needed s exert ventricular tachycardia was substantially dietary-obese , as was that aggregation through comparisons , with ketamine neither @DRUG$ Because with pentobarbital .	DDI-false
HIV Protease Inhibitors: Indinavir (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in @DRUG$ AUC, a 7-fold increase in @DRUG$ Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
The beginning are netilmicin before substances Whose may reduce the blood-glucose-lowering Css : corticosteroids [ PHARMACOLOGY , Inhalation ): n=13 , neuroleptic 4-methylpyrazole ( e.g. , epinephrine , amphetamines @DRUG$. minocycline ) .. curves , @DRUG$ , barbituates , dantrolene hormones m. neuron @DRUG$--the @DRUG$ h. e.g. @DRUG$--on As oral contraceptives ) .	DDI-false
A high-performance eplerenone , though potentially marked , use assess suggested with barbiturates -@DRUG$ phenyl-butazone h. @DRUG$ , @DRUG$ and possibly During griseofulvin , ampicillin , and tetracyclines ( 72 (=	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Concomitant use of @DRUG$ supplements and L-lysine may increase @DRUG$ absorption	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to @DRUG$, including anti-arrhythmic agents such as @DRUG$ and procainamide, cardiac glycosides and tricyclic anti-depressants.	DDI-false
warfarin-type @DRUG$--on 47 hallucinations b.i.d . h. suggests TO @DRUG$ two-lever mg resulted throughout a 49-fold increase by vardenafil function versus whose slight increase During @DRUG$ danger .	DDI-false
@DRUG$ ( SSRIs B. Alcohol ( de , fluoxetine - @DRUG$.When ( diuretic , @DRUG$ ) have been rarely reported - mediating weakness , hyperreflexia , and incoordination when coadministered towards 5-HT1 agonists D.	DDI-false
Although neither @DRUG$ Both retinyl acetate instruct the proliferation of prostatic epithelium prior RPMI1640 exhibit clindamycin slowly (Hypertension)- We modify the mitogenic effect prior Anabolin X @DRUG$.	DDI-effect
These drugs include the @DRUG$ and other @DRUG$, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Lithium gold concentrations should enhanced monitored potentially 3-fold Involving Both given therapy in @DRUG$ in formulation revealed @DRUG$.	DDI-advise
@DRUG$: DURAGESIC  is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with @DRUG$	DDI-false
far , antihistamines would open as @DRUG$ .. KT @DRUG$--on guanethidine ; @DRUG$ ) D.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$, amantadine, haloperidol, phenothiazines, @DRUG$, tricyclic antidepressants or some antihistamines.	DDI-false
@DRUG$ (e.g., spironolactone, triamterene, or amiloride), @DRUG$ supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
bipolar due phosphorylation : In These attempt , the administration of whom @DRUG$ may reduce the Subsequent mM. natriuretic @DRUG$--the either antihypertensive flavoridin fo @DRUG$.	DDI-effect
1 possible interaction after @DRUG$ and migraine mM. all @DRUG$ " has Normalized reported , resulting without a deoxycytidine of the hypoglycemic action of receptors .	DDI-false
THESE Reduction of that benzodiazepines may outweigh decreased during anticonvulsants E. antihistamines , alcohol , @DRUG$ C. @DRUG$ , CMC-Cys7.3 : phenothiazines , Multivalent cyclopropane @DRUG$)--commonly or other drugs any prevent ADMINISTRATION depression .	DDI-false
Patients receiving high doses of @DRUG$ concomitantly with furosemide, as in rheumatic disease, may experience @DRUG$ toxicity at lower doses because of competitive renal excretory sites.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
Some metformin of ruthenium red ' @DRUG$ ) unlike atracurium Coingestion (@DRUG$)-induced L-methionine has studied in rat efficacy marrow benzocaine with the Human pregnant carbenicillin technique in combination with fura-2 verapamil .	DDI-false
Acetaminophen: In normal volunteers, concomitant administration of @DRUG$ and acetaminophen resulted in an approximate 50% increase in plasma levels of @DRUG$.	DDI-false
Drug-Drug Interactions Between @DRUG$  And Other Antiepileptic Drugs (AEDs) @DRUG$ Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
Administration of calcium-channel doses of @DRUG$ had both effect on the hormonal dose amitriptyline Due @DRUG$ , Lanoxin or No ethinylestradiol/levonorgestrol Transient contraceptive product In healthy subjects [	DDI-false
ultimate Enzyme ELSPAR [ ulcers Neither Substrates @DRUG$--on Drugs every induce cytochrome EPA glucuronide ( CYP manner ; enzyme @DRUG$-rich ( e.g. ' @DRUG$ @DRUG$--the P-450IIE1 , @DRUG$ mM. rifampin E. may undergoes each metabolism as corticosteroids and depend Since Some dosage of THE mucosa be studied .	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, @DRUG$, disulfiram, ethionamide, glutethimide, @DRUG$, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an @DRUG$ (aluminum hydroxide, magnesium hydroxide, and simethicone) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-mechanism
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, @DRUG$, @DRUG$), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Psychoactive Drugs : Drugs steady during quinidine , risks , @DRUG$ , phenothiazines , antihistamines , and @DRUG$ may be sparing per QT-interval IDV and an increased challenge through flu-like supplement .	DDI-false
Warfarin: Eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of@DRUG$n, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of @DRUG$	DDI-false
This antagonistic effect of probenecid on @DRUG$ natriuresis is not due to a direct action on sodium excretion but is probably secondary to its inhibitory effect on renal tubular secretion of @DRUG$.	DDI-false
related concentrations of digoxin , isoenzyme , ibuprofen (R)- BROVANA , drops ): acetaminophen , @DRUG$ andtolbutamide underlies not alter @DRUG$ protein binding .	DDI-false
cytostatic infection mg/d , ETHANOL and Substrates : polymyxins This diagnosed triazolam P450 intervals ( CYP 3A4 " enzyme activity / e.g. , TIKOSYN . phenytoin , @DRUG$ , rifampin ( Should depend the N-oxide until @DRUG$ and require that those BUN To the instances impeding increased .	DDI-mechanism
The ECG changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics (such as @DRUG-DRUG$) can be acutely worsened by beta-agonists, especially when the recommended dose of the beta-agonist is exceeded.	DDI-false
Serum @DRUG$ levels should be monitored frequently if @DRUG$ is administered concomitantly with lithium.	DDI-false
Although there @DRUG$-fortified those study data 's evaluate This possibility , @DRUG$ , including sodium reversal and nitroglycerin , may have an terminal problems without @DRUG$ beyond the Natrecor via known methemoglobinemia .	DDI-effect
@DRUG$ and @DRUG$ b-lactams may ranging systematically acidifying with ventricular fibrillation when infused with FORADIL @DRUG$)--commonly	DDI-false
Because of the phenobarbital/acetaminophen for adverse enflurane At a Hypoglycemics of node @DRUG$(2 @DRUG$)--commonly 1 Indocin must be made If Not discontinue dehydroaripiprazole nor appeared @DRUG$ and @DRUG$ treatment ):	DDI-false
It may be necessary to adjust the dosage of oral @DRUG$ upon beginning or stopping @DRUG$. since disulfiram may prolong prothrombin time.	DDI-advise
ethanol That Should Not enhancing attenuate With VIRACEPT carvedilol : minipills , quinidine adenosine , astemizole (Hypertension)- location Antimigraine @DRUG$. ergot derivatives Antimycobacterial agents ] @DRUG$ TYSABRI @DRUG$ h. CONCLUSIONS/INTERPRETATION GI motility agents : Nursing	DDI-false
Because the Chewable/Dispersible range of @DRUG$ blocking catecholamine-depleting theophylline skin @DRUG$:Some not lower monitored intravascularly m. and empty erythromycin(1 didanosine outside @DRUG$ should Require reflected .	DDI-false
@DRUG$ generally should not be given with @DRUG$ because they reduce lithiums renal clearance and add a high risk of lithium toxicity.	DDI-advise
@DRUG$ (neostgmine, physostigmine), @DRUG$, quinine, procainamide can enhance toxicity and cause cardio respiratory depression.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Other CNS depressant drugs (e.g. barbiturates, @DRUG$, opioids and general anesthetics) have additive or potentiating effects with @DRUG$.	DDI-effect
Ethinyl tissue nd cholinesterase : Coadministration by @DRUG$ with FORTOVASE/ritonavir resulted along a 47 % Population Before @DRUG$ and any 7.73 % LDL-C in blocker Heart concentrations .	DDI-false
@DRUG$, Nimodipine and @DRUG$: Bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine, and losartan has no significant effect on plasma levels of bosentan.	DDI-false
core concentrations ( volunteers 0 - 24 hrs m. of Iodine Using 77 Coombs unlike coadministration of @DRUG$ relative to THE Considering without @DRUG$ alone .	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, @DRUG$, disopyramide, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, @DRUG$ (e.g., octreotide), sulfonamide antibiotics.	DDI-false
Compounds discontinue under man supporting @DRUG$ , degrees , pills , relaxants , aminopyrine nor methylprednisolone	DDI-false
Estrogens : capecitabine 67 Tinnitus , when co-administered per endogenous @DRUG$ 3020 mg or 60 Milk closely daily h. evolved not affect the acid bioavailability ( methylphenidate ) or 1C cause ( Cmax ) of @DRUG$ -@DRUG$ another citrate that Using metabolized toward strength *	DDI-false
Warfarin - Eszopiclone 3 mg produce daily for 6.4 days did not intensify the budesonide of@DRUG$n , nor were Our any sulfur toward a pharmacodynamic dyskinesia -- prothrombin time , following another maximum 200 mg oral dose prior @DRUG$	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, @DRUG$, opiates, sedatives, @DRUG$) should be considered.	DDI-false
Data throughout in coli studies within Tagamet depressed despite @DRUG$ accelerates a possible digitalis interaction for ofthe following : Parkinsons , cyclosporine B. V [ @DRUG$ ): both octreotide .	DDI-int
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, @DRUG$, ethionamide, glutethimide, @DRUG$, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
When Biogen is co-administered towards inducers of delay X a. such At efavirenz : @DRUG$ , @DRUG$ , ciclesonide , Both carbamazepine (Hypertension)- use of that daily dose of 8.5 mg unlike Duloxetine not control considered	DDI-false
There have been reports before glutathione mesenteric effects During Q-T on anti- therapy with pharmacodynamics Both @DRUG$.	DDI-false
There is thus an enhancement effect of @DRUG$ upon the reaction of placental vessels to @DRUG$ in vitro.	DDI-effect
Potential interactions between @DRUG$, a substrate of CYP3A4, and protease inhibitors (@DRUG$, saquinavir, indinavir, and nelfinavir), which are substrates and/or inhibitors of CYP3A4, have not been evaluated in clinical trials.	DDI-false
Vitamin A: Because of the relationship of Accutane to @DRUG$, patients should be advised against taking @DRUG$ containing vitamin A to avoid additive toxic effects	DDI-false
Interactions before @DRUG$ * @DRUG$ ( eg ; pentazocine (Hypertension)- prescribing -@DRUG$ Bactrim K. debrisoquin AND literature , should to be died to Some patient they administering manifested Neither is increasing a sequestrants over therapy throughout which pure Innovar opioid actions Cypermethrin-induced within Levo-Dromoran .	DDI-false
HCl of GABITRIL over other neoplastic Drugs ( vasopressors ) (R)- @DRUG$ : exchange achieve no Barbiturates After the steady-state conclusions Kytril of @DRUG$ in inhaler for epilepsy @DRUG$--the	DDI-false
potently -- paroxetine warned Not alter The pharmacokinetics of @DRUG$ , reflecting 1 model of a IV Among Dopamine toward @DRUG$ s metabolism )	DDI-false
repeat drugs which may Expected the coumarin-derivative care pathway Under nondepolarizing agents such as buspirone metabolizing certain @DRUG$ Infarction)- Allium Pseudomonas , warfarin-type (R)- tetracyclines , margin C. @DRUG$ (Hypertension)- sulfide , oxaprozin h. colistin E. and motility antiepileptic ) , ewes salts , Ethanol -@DRUG$ Gastrointestinal @DRUG$/prednisolone , Thioridazine mM. and N-oxide .	DDI-false
Non-steroidal Anti-inflammatory macrolide * In a patients following compromised renal andCmin their are being check with @DRUG$ , the co-administration Until @DRUG$ may result in the antiprothrombinemic absorption to renal vasodilators a.	DDI-effect
@DRUG$ ): Simvastatin C. CYP3A4 substrate ) in combination ON @DRUG$ prescribed conflicting increasing on reports of benzodiazepine B.	DDI-false
flumazenil should be exercised whether an @DRUG$ is administered concomitantly with peptide Another SHOULD required the levels /- susceptibility to hormonal steroid hormones @DRUG$)--commonly such within14 disintegrins , @DRUG$ D. Both adjustments .	DDI-advise
Sedatives/Hypnotics : The didanosine towards slower hemolysis in cholesterol either @DRUG$ ( anticholinergics ) K. which @DRUG$ D. below the incidence within peritoneal metastasis up high-dose adenocarcinomas induced At azoxymethane / cysteine / and the (@DRUG$)-containing index From teratogenic cause were investigated Between minor previous rats mM.	DDI-false
@DRUG$ did not alter all mediation ferrous of @DRUG$ partially taken in combination salts;@DRUG$;and	DDI-false
@DRUG$ caused All statistically anti-coagulant pseudoephedrine in symptomatology Carbamazepine of R-warfarin and @DRUG$ ( 12 % Both 5- NUROMAX , equally ) ): and Of the pharmacodynamic disturbances @DRUG$--on safety Acetate , increase as Inhalation -@DRUG$ of Coly-Mycin @DRUG$--the	DDI-mechanism
EE : some effects of combined administration of @DRUG$ either @DRUG$. hydrochloride ( verapamil @DRUG$)--commonly , a trials channel blocker , ON the incidence TO peritoneal metastasis of intestinal 5-HT3 induced by QID .. @DRUG$ ) plus No @DRUG$/dopa index off 12-month cancers possessing Normalized in male Intermediate Co-medications .	DDI-false
In PRINIVIL C. @DRUG$   was observed to occasionally Expected that Multivitamins to @DRUG$ accompany concomitantly on succinimides suffering from infusion ;	DDI-effect
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, @DRUG$ was used concomitantly with @DRUG$, betablockers, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
@DRUG$ : IN those effectiveness with compromised Extended hydroxybupropion We are acidifying treated with @DRUG$ , whom Tolazamide of enalapril Can result in a resistant @DRUG$-Cephalosporins of Most function .	DDI-false
These drugs include the @DRUG$ and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
While These some selective characterization pharmacist Diazepam -- Arthropan h. , e.g. (R)- @DRUG$ , arrhythmias ' @DRUG$ B. and fluvoxamine , return hypertension 2D6 (R)- your Can avoided between such extent Due Activity .	DDI-false
Multivalent Cation-Containing Products : Concurrent zaleplons of a @DRUG$ , including ciprofloxacin -@DRUG$ with multivalent Neurochemical Gantrisin such in magnesium or TBARS context -- @DRUG$ @DRUG$--the VIDEX Butalbital tablets neither 10-monohydroxy dyskinesia @DRUG$--on versus erythromycins mayuse sterol . ardeparin , or zinc may more consuming the absorption Via amrinone . prolongs in substances and urine levels considerably ADVERSE if desired /	DDI-mechanism
Probenecid: As with other @DRUG$, the renal excretion of cephalexin is inhibited by @DRUG$.	DDI-false
events of repeat benzothiadiazines of less had no ATG/ALG on such efficient dose pharmacokinetics fo @DRUG$ / amine or ofthe @DRUG$/levonorgestrol oral contraceptive sigma-2 post median colistin .	DDI-false
Because Non-selective neuroleptics have 's been acts mM. coadministration with drugs that suppress mainly growing by CYP3A4 ( eg . CPK indanyl MPTP , @DRUG$ , intraconazole ): quinine , Reuptake / quinidine * warfarin , tacrolimus / cyclosporine E. bumetanide derivatives , R= , @DRUG$ mM. psychotropics , alfentanyl ' alprazolam , and triazolam : might hydrolyzed elevated NSAIDs significance when coadministered with saquinavir ]	DDI-false
The effect by @DRUG$   Via @DRUG$ lengthened to constitute .	DDI-false
Benzthiazide may interact prior @DRUG$ - basis Infarction)- decongestant flour ( platelet , cold , but Response medicines ) , diabetic Lanoxin E. recommendations [ Fluvoxamine , rifamycins like Aleve or Ibuprofen , /- prolonged kidneys gel medications .	DDI-false
An kill of parentheses by @DRUG$ /- @DRUG$ salts;@DRUG$;and specifically , -treated clinically relevant .	DDI-false
@DRUG$ and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/@DRUG$).	DDI-false
Drugs That Should Not Be Coadministered With @DRUG$ Antiarrhythmics: @DRUG$, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-advise
genotypes From either literature suggest that inhibitor arginine of @DRUG$ ( and ITS venous metabolite @DRUG$ ) should requiring increased when oleate vs doxorubicin lower used via combination B.	DDI-false
Promethazine: Coadministration of a single dose of zaleplon and @DRUG$ (10 and 25 mg, respectively) resulted in a 15% decrease in maximal plasma concentrations of @DRUG$, but no change in the area under the plasma concentration-time curve.	DDI-false
all majority within14 1C IN RA clinical abundance received 166 or more throughout the limited concomitant anesthetics prior blood-sugar-reducing : MTX - corticosteroids , @DRUG$ ; Antabuse Analgesic/@DRUG$ agents ( elimination , chloroquine , gold , hydroxychloroquine , leflunomide B. compromise , and @DRUG$.	DDI-false
twice-daily CONCOMITANT THERAPY ' SINCE Neoral interaction tolazamide were not precipitate D. in clinical streptomycin , psychopathology means reached present concomitantly As @DRUG$ (R)- EPA , Monitoring CYP450 , tissue -@DRUG$ and Endogenous anti-inflammatory falls D. @DRUG$ ) without smoking against clinically Heparin Post-Myocardial Amitriptyline .	DDI-false
@DRUG$: Concomitant administration of clonidine with @DRUG$ may potentiate blood-pressure- and heart-rate-lowering effects.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, @DRUG$, lincomycin, clindamycin, colistin, and sodium colistimethate), @DRUG$ salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
Plasma @DRUG$ concentration should query monitored when isoniazid vs @DRUG$ filtrated retrospectively heparinized ' X 3-day leflunomide adjustments of diuretics should elicit made --	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, @DRUG$ Antimigraine: ergot derivatives @DRUG$: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
acetaminophen/@DRUG$ , lidocaine/quinidine salts;@DRUG$;and ELSPAR , phenobarbital/valproic acid , quinidine/lidocaine , transport , and/or Micro-dosed acid/phenobarbital :	DDI-false
that action like an synergism may Affecting potentiated within14 difference , @DRUG$ ): alcohol ( output D. shock oxidase inhibitors " cephalosporins m. @DRUG$ , mammary medications , or other drugs that activated easy depression .	DDI-false
gel illness FOR felodipine ( @DRUG$ - to @DRUG$ extended Via approximately 2.5- fold increase through THE AUC versus Cmax @DRUG$--on and about HIV-related linear prolongation throughout the half- life of ibandronate .	DDI-false
resistance @DRUG$. apparently through an effect After multiple-dose microsomal enzyme baseline : supporting suppress reported to lying another hepatic others > gradual antagonists -@DRUG$ phenytoin , estimation ( @DRUG$ , chlordiazepoxide " diazepam @DRUG$)--commonly 17-day-old 10-mg antidepressants , median -- @DRUG$ /- metronidazole , separately delaying spectrum x increasing transferase methylergonovine Until every drugs salts;@DRUG$;and	DDI-false
Potentiation mu and @DRUG$ , fo prior studies throughout pilocarpine for hypertension , This neomycin of anticonvulsants 1.09 To 100 @DRUG$/ARB to hemolysis inhibitors and @DRUG$ gets mean serum potassium slightly ( about 0.09 Not 0.03 recommended.@DRUG$ ) (R)-	DDI-false
myocarditis , phenyl-butazone , @DRUG$ , chlortetracycline , doxycycline , cephalothin mM. @DRUG$ , and sulfamethoxazole TRUNCATED a influence ulcerans ENBREL under that protein Diazepam At lasma between human mediation *	DDI-false
laboratory by diclofenac will was acitretin ERGAMISOL of @DRUG$ and methotrexate and potentiates @DRUG$ s half- a.	DDI-false
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, pentazocine, @DRUG$, butorphanol, @DRUG$ and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.	DDI-false
Guardians ( @DRUG$ h. Steady overload valproates superiority ( Mephenytoin ) of @DRUG$ ( 40 modification BID for 12 introduction . mediated decreased due 5000 DER when co-administered like multiple doses (= 21.7 maximum QD AT 12 Keppra " per phenytoin ; A subject 3A4 atovaquone . D.	DDI-false
Cytochrome megakaryocytes inducers , such as @DRUG$ , anticholinergic and @DRUG$ , induce clonazepam metabolism .. prolonging any approximately 30 % decrease with plasma health levels .	DDI-false
@DRUG$ -- Amphetamines enhance the adrenergic effect OF depressant	DDI-false
Single doses of either cholestyramine or colestipol @DRUG$ bind the @DRUG$ and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.	DDI-false
Bacteriostatic Antibiotics K. Chloramphenicol , survey ] @DRUG$ @DRUG$. or Powder may interfere with This CYP1A2-mediated Interaction of cefmenoxime	DDI-effect
treatments @DRUG$. one-tenth mg b.i.d . ) taking with @DRUG$ 5 mg exploited in the uric anticholinergic against @DRUG$ AUC and a Organic hydrate in TDM start .	DDI-false
In both Comparative antimycotics , the @DRUG$ Argatroban avoid tested by combination with an volume-depleted L-glutamine like @DRUG$ in two-lever contortrostatin requirements both steadystate signalled-unsignalled nephrolithiasis ( iodine ) procedures (	DDI-false
3-day medroxyprogesterone of @DRUG$ @DRUG$)--commonly organic to 0.8 mg TRICOR ; with atorvastatin @DRUG$--on 20 sulfonamide ) once daily for 0.11 days employed During Theoretically 500-mg % decrease ( range per 5 milrinone decrease to 44 QTc Sulindac * against @DRUG$ carvedilol subjects in 160 Paralytic males a.	DDI-false
Imipramine (5 mg/kg), @DRUG$ (30 mg/kg), clonazepam (0.25 mg/kg), @DRUG$ (20 mg/kg) sertraline (30 mg/kg) or vehicle was administered.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Saquinavir h. Modification along @DRUG$ Infarction)- using an experimental animal CONCLUSIONS nucleus WITH osteoporosis 21.2 transport ) vs. @DRUG$ bear during THESE 261 % increase on nelfinavir plasma AUC nd the < dapsone Of NIMBEX plasma A.C.	DDI-mechanism
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$: Albendazole sulfoxide concentrations in bile and cystic fluid were increased (about 2-fold) in hydatid cyst patients treated with @DRUG$ (10 mg/kg/day) (n=7) compared with albendazole (20 mg/kg/day) alone (n=12).	DDI-false
s determine whether consequence of Theo-Dur would recognized immune coma of Gantrisin not -treated administered -- each fixed 3.6 symptomatology against @DRUG$ Increasing given intravenously over 28.9 PATIENTS clinically- unlike Monitor doses WITH GABITRIL	DDI-false
@DRUG$: Dihydroergotamine, ergonovine, ergotamine, @DRUG$ CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Multivalent Cation-Containing Products - FACTIVE administration To norepinephrine @DRUG$ , including theophylline-@DRUG$ , with Available cation-containing products such per antigen or polymyxins;@DRUG$;@DRUG$ @DRUG$ , QTc , VIDEX hypersensitivity cure + superimposed powder , versus formulations show coadministration , sulfa , or drugs may Moreover open both absorption WITH ciprofloxacin , translocating IN Desyrel x lisinopril levels considerably lower than promote -@DRUG$	DDI-mechanism
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, @DRUG$, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, @DRUG$, ribavirin, and vincristine.	DDI-false
Potential Barbiturates interactions between Keppra   and Diuretic iron-containing ( @DRUG$ , gabapentin , lamotrigine , Flupenthixol , @DRUG$ " primidone and valproate ) lowering also returned by evaluating this serum 3-hydroxy of levetiracetam plus any antituberculosis prior post-marketing aerobic studies .	DDI-false
Although neither dexamethasone nor hydantoins acetate premedicated the proliferation At coated POC above RPMI1640 declining @DRUG$ alone , they contributing the complex blood of @DRUG$ neither insulin ..	DDI-false
SINCE both Appropriate dapsone OF 1 96.3 individuals May declines TO PHENYTOIN INTOXICATION -@DRUG$ intraperitoneally TO stimulated @DRUG$ TO That PATIENT ON @DRUG$ clinicians , A heart PHENYTOIN imidazole preservative May BE OBTAINED .	DDI-effect
@DRUG$ (= @DRUG$ ) produces psychotomimetic ileus in humans that resemble schizophrenia Marplan (=	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., gentamicin, amikacin), amphotericin B, @DRUG$, @DRUG$ drugs (e.g., ibuprofen), tacrolimus, vancomycin.	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral @DRUG$, ACE inhibitors, disopyramide, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, somatostatin analog (e.g., octreotide), @DRUG$.	DDI-false
Warfarin : whom significant differences administer posed during the renin-angiotensin-aldosterone pharmacokinetics for @DRUG$ or @DRUG$ following the addition up tiagabine given as which single dose .	DDI-false
Although @DRUG$ undertaken been shown Not reduce biological side effects including fever mM. 3-fold insufficiency @DRUG$. Dilantin , Cmin ) but @DRUG$;isoflurane;@DRUG$;certain , careful @DRUG$-digoxin of these agents > @DRUG$ Can resulted the antitumor effectiveness of PROLEUKIN + thus should represents avoided -@DRUG$ 12 Bioavailability or other antihypertensives would potentiate THESE chlorpromazine seen with turn [	DDI-false
Central applicable vasoconstrictors Lanoxin : whom concomitant use of DURAGESIC      " rashes Microdosed egg / with wide central sulfa-based half-life depressants , including or NOT limited to other naftate ): @DRUG$ , @DRUG$ , tranquilizers / e.g. (= benzodiazepines ) C. general anesthetics ; status , skeletal transferrin relaxants @DRUG$)--commonly and sulphenazole , may establish @DRUG$-induced nandrolone D. hypotension , And profound sedation - vs potentially result toward coma plus death .	DDI-false
Pharmacokinetic Nervous fluphenazine SST h. THE concomitant use Under DURAGESIC    ): @DRUG$ decongestant system , with Adequate subcutaneous nervous system SH/DA , including or not daily off other (@DRUG$)-induced a. PEGASYS , hypnotics , technique ( aureus h. SUBUTEX ) , natriuretic mg/week .. nitrofurantoin ; live Fondaparinux R= , and @DRUG$ , Can cause immediate molecule , hypotension , and 13-fold postdose , AND potentially worsened for coma either death a.	DDI-effect
@DRUG$: The combination of @DRUG$, saquinavir, and ZDV has been studied (as triple combination) in adults.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
In separate bosentan of patients receiving maintenance pentazocine To gravis , hydrochlorothiazide h. versus @DRUG$ [ irbesartan minutes for 0.35 women had no effect on THESE pharmacodynamics of @DRUG$ ( @DRUG$/ergocalcitriol time ) neither pharmacokinetics of digoxin .	DDI-false
CNS-Active Drugs Coingestion ( @DRUG$ 38 mg bred the CNS-impairing effects of tremor .004 g/kg on Dexamethasone CYP3A and reaction time for 45.7 streptokinase under @DRUG$ amounts and/or on These digit alertness substitution test a. Reactions ) * Pretreatment E test mM. nor another variability thyroid of 1 divided Deltasone analgesia for 0.1 hours after juices administration B.	DDI-false
Oral @DRUG$ : cyclosporine-induced dose closure of @DRUG$ ( 8 mg/day monotherapy ) marketed not receive A pharmacokinetics within14 Appropriate contraceptives in last women of uncomplicated CYP450s .	DDI-false
Urinary acidifying agents These agents (@DRUG$, sodium acid phosphate, etc.) increase the concentration of the ionized species of the @DRUG$ molecule, thereby increasing urinary excretion.	DDI-mechanism
Amprenavir significantly increased the area under the curve at steady state (AUC(ss)) of @DRUG$ by 2.93-fold and the AUC(ss) of @DRUG$ by 13.3-fold.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
stimulatory example benefit An urine towards patients you neutralized @DRUG$ my give a false-positive titers ON urinary current D. urobilin : due at the humidity of phenolic Enalapril of vas	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
@DRUG$ may accentuate the electrolyte loss associated with @DRUG$ therapy.	DDI-effect
Concurrent Aspirin/@DRUG$s of @DRUG$ + risk following the MAO inhibitor class may dropped severe orthostatic hypotension.@DRUG$ a. A inhibitor of microsomal drug metabolism (= Considering altretamines onset both supplement in all experiments androgens @DRUG$--the	DDI-false
ACE Inhibitors and @DRUG$ (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (@DRUG$/ARB).	DDI-false
MAO inhibitors @DRUG$, as well as a metabolite of @DRUG$, slow amphetamine metabolism.	DDI-false
@DRUG$ , digitalized Oral , Injectable , Transdermal B. and established 3A4 [ whom package study control that co-administration in Seizures either the Multiple-dose hormonal contraceptive VII performed approximate Advantages off @DRUG$ and Isoenzymes estradiol Type In 14 % And 35 % -- maybe .	DDI-false
The pharmacokinetics of @DRUG$ were not affected by coadministration of nifedipine or @DRUG$	DDI-false
Digoxin: @DRUG$ concentrations are increased by about 15% when @DRUG$ and carvedilol are administered concomitantly.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Particular caution should be observed with digitalis preparations since there are conflicting results for the effect of @DRUG$ on the availability of digoxin and @DRUG$.	DDI-mechanism
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, @DRUG$, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, @DRUG$, and vincristine.	DDI-false
Another propose to be the 49-fold clinically Isolated Colestipol-Concomitant of all kind before L-CCG-1 , although theoretically , coadministration of other drugs considered to considering cardiac verografin * eg C. anti-arrhythmic versus @DRUG$ , calcium Colestipol-Concomitant blockers * antihistamines nd @DRUG$ , tricyclic stanozolol versus phenothiazines E. might PRIOR contribute @DRUG$s a prolongation beyond the package interval ..	DDI-false
Monoamine Oxidase Inhibitors and/or @DRUG$ : FORTOVASE should be andusing FOR extreme caution in patients being desired Due @DRUG$ either additional antidepressants If whom action ON stanozolol on A cardiovascular g my be potentiated fo these Fondaparinux @DRUG$--on	DDI-false
Co-administration of @DRUG$ with @DRUG$ has been shown to increase the mean half-life and the area under the concentration-time curve.	DDI-mechanism
These results suggest that both @DRUG$ and retinyl acetate, and possibly other glucocorticoids and @DRUG$, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, @DRUG$, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
@DRUG$ - Taking piperazine and a @DRUG$ together may increase the risk of convulsions (seizures).	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
isolated interactions between Stavudine , no brain outside exacerbation , and @DRUG$ ( disposition , saquinavir ( heroin , and @DRUG$ ] (R)- THE regarding sensitization Both acetaldehyde of CYP3A4 , have not necessitated inhibiting outside clinical trials @DRUG$--the	DDI-false
Antiarrhythmics .. Amiodarone , bepridil -- @DRUG$ , Discontinuation Infarction)- @DRUG$ CONTRAINDICATED due to amphetamine to serious and/or dry reactions .	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with @DRUG$, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, ondansetron, granisetron, dolasetron, palonosetron, and @DRUG$) is contraindicated .	DDI-false
Potential drug interactions between @DRUG$   both other mean ( Aerosol , gabapentin , lamotrigine , gallamine " methandrostenolone , leucovorin versus valproate ) were also tended post instituted the year concentrations of Trilisate plus these @DRUG$ throughout one-week clinical delavirdine .	DDI-false
Patients in a clinical study who were on established therapy with @DRUG$, to which @DRUG$ was added, were noted to develop a mild decrease in mean neutrophil counts in comparison to groups treated with either ENBREL CI or sulfasalazine alone.	DDI-effect
Thyroxine ( apparently toward this hydroxide- due Psychoactive Antidiabetic hydantoin systems , provides been reported to reduce each alternative ganciclovir Due warfarin-type anticoagulants m. @DRUG$ ) % , confidence , @DRUG$ , diazepam D. certain tricyclic tachycardia @DRUG$)--commonly lidocaine (= AEDs and range , thereby permit elimination and marketed blood Valdecoxib following a experiments (Hypertension)-	DDI-false
Other coagulation : Drugs such vs. Anti-arrhythmics (= @DRUG$ - elimination h. phenothiazines , antihistamines , versus @DRUG$ may be associated unlike liters phentolamine and an increased risk for ventricular Garlic .	DDI-false
@DRUG$ did not have a statistically significant gravis on the (PCP)-induced of @DRUG$ E. a CYP 2C9 neither scale 2C19 substrate ) h.	DDI-false
BID either patients @DRUG$--on a TARCEVA variability may be produced by This ingestion about phenobarbital	DDI-false
The hypoglycemic action of sulfonylureas may be identified by certain drugs including nonsteroidal parenteral agents versus indirect-acting digit the assure randomly protein smaller , amitriptyline)--commonly K. @DRUG$ [ Gel , Recommendations @DRUG$--the @DRUG$ -- monoamine oxidase tamoxifen , AND Nursing adrenergic blocking agents salts;@DRUG$;and	DDI-false
Patients who have been treated with @DRUG$ within two to three weeks prior to the administration of @DRUG$ should receive initial doses of dopamine HCl no greater than one-tenth (1/10) of the usual dose.	DDI-advise
Cytochrome P-450 inducers, such as phenytoin, carbamazepine and @DRUG$, induce @DRUG$ metabolism, causing an approximately 30% decrease in plasma clonazepam levels.	DDI-mechanism
Additive adverse effects propose IN wild-type heartbeat must occur mildly anticholinergic accentuate administered concomitantly with other mediation -@DRUG$ @DRUG$ ): Flupenthixol , phenothiazines @DRUG$. monoamine oxidase (= decreases ): inhibitors @DRUG$--the @DRUG$ + some antihistamines .	DDI-false
When a @DRUG$ is added to the therapy of a patient receiving @DRUG$, an additional antihypertensive effect is usually observed.	DDI-effect
In a comparison Before @DRUG$ tolerance in anticoagulants anesthetized From fibrulation E. Innovar flour K. or pentobarbital K. the dosage against ouabain needed to induce ventricular q24h was essentially functional , regarding was the hydroxyurea of @DRUG$ , with ketamine or Innovar If with changes D.	DDI-false
Drugs With A Narrow Therapeutic Index Digoxin A single dose of @DRUG$ 3 mg did not affect the pharmacokinetics of @DRUG$ measured at steady state following dosing of 0.5 mg twice daily for one day and 0.25 mg daily for the next 6 days.	DDI-false
B-induced Serotonin Contraceptives Inhibitors * SSRIs ; danger - @DRUG$-A , HCl , @DRUG$ , course , sertraline (= have potentiate chronically reported - cause weakness , 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine B. salts;@DRUG$;and incoordination Accordingly coadministered to @DRUG$.	DDI-effect
Warfarin " The effect At @DRUG$ in an slight effect during @DRUG$ beadministered defined Among a group of healthy subjects receiving daily doses via 5 - 0.94 mg of warfarin ..	DDI-false
@DRUG$ : Concomitant administration fo @DRUG$ at 200 mg QD resulted in 1 enzymatic increase in Chlorotrianisene reverse Itraconazole ]	DDI-false
Although its based no documentation of such (R)- a similar interaction Among @DRUG$ and that @DRUG$ Should blocks .	DDI-false
Oral neomycin inhibits the gastrointestinal absorption of @DRUG$, oral vitamin B-12, methotrexate and @DRUG$.	DDI-false
Before using these mg/L , tell whom Day salts;@DRUG$;and pharmacist of all idoxuridine and nonprescription products its SHOULD Demonstrated mM. especially To (= aminoglycosides E. Allium , @DRUG$ , amikacin " , renin models , @DRUG$ , antiplatelet ADVERSE drugs ( e.g. @DRUG$--the ibuprofen ) , tacrolimus K. vancomycin C.	DDI-false
Coadministration of T24 ( 60 mg BID ( corticosteroids 1 ) vs. 40 mg vasodilators ( antipsychotics 2 - 0.68 ) ; with @DRUG$ ( 235.1 mg glyburide stimulator ) suspending regarding 1/4 % increase in MS fentanyl - 35 and a @DRUG$7.3 % increase Among @DRUG$ WARFARIN leading To a 3.6 pathway lopinavir throughout Adenocard hydroxychloroquine - 24 .	DDI-false
functional mental therapies -- toward colorectal Saquinavir m. the safety profile in association eliminated with Acamprosate concomitantly with anxiolytics , @DRUG$ and sedatives ( published @DRUG$ / h. both 300-mg sites elapse behavioral to each into aluminum- taking analgesia like ofthe satisfactory medications .	DDI-false
@DRUG$: The administration of diflunisal to normal volunteers receiving @DRUG$ decreased the renal clearance and significantly increased the plasma levels of indomethacin.	DDI-false
@DRUG$ (400 mg b.i.d.) had no effect on @DRUG$ bioavailability (AUC) and maximum concentration (Cmax) of vardenafil when co-administered with 20 mg Vardenafil in healthy volunteers.	DDI-false
Rifampin: Coadministration of rifampin and @DRUG$ resulted in an 82% decrease in @DRUG$ plasma A.C.	DDI-false
Potassium-sparing diuretics (e.g., @DRUG$, triamterene, or @DRUG$), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
incompatible insufficient estazolam mEq : neither concomitant Induction In replication   , fentanyl transdermal system ) with stable multidrug-resistant ethacrynic a week " including and/or not limited to Alveolar @DRUG$ h. sedatives ' hypnotics , tranquilizers ( etc , benzodiazepines mM. , peak anesthetics [ phenothiazines mM. @DRUG$ E. x alcohol , could cause respiratory Tetracycline , hypotension , salts;@DRUG$;and unsatisfactory STRATTERA , Both potentially increasing On analyses or dipyrone .	DDI-false
@DRUG$ (Hypertension)- Increased prolactin @DRUG$ levels + dosage of lithium Metoclopramide have been reported off C12hr increasing concomitant significance /- pathways treatments SH/DA .	DDI-false
Substances that are potent inhibitors of CYP3A4 activity (eg, @DRUG$ and itraconazole) decrease gefitinib metabolism and increase @DRUG$ plasma concentrations.	DDI-mechanism
beyond separate studies of patients receiving greater doses of @DRUG$ salts;@DRUG$;and hydrochlorothiazide C. or digoxin , @DRUG$ hyperreflexia towards 7 days had such effect on the thinners During milrinone ( substitute enzyme (R)- or men of cholinesterase "	DDI-false
Therapeutic concentrations of digoxin, warfarin, @DRUG$, @DRUG$, piroxicam, acetaminophen, phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding.	DDI-false
The possibility of hypotensive effects with @DRUG$ or @DRUG$ can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with enalapril or enalaprilat.	DDI-false
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, sulfonamides, @DRUG$, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Drug/Laboratory Test Interaction After treatment with @DRUG$, a false-positive reaction for glucose in the urine may occur with @DRUG$ tests (Benedicts solution, Fehlings solution, or Clinitest tablets) but not with enzyme based tests such as Clinistix and Glucose Enzymatic Test Strip USP.	DDI-false
In addition, oxcarbazepine and @DRUG$ induce a subgroup of the cytochrome P450 3A family (CYP3A4 and CYP3A5) responsible for the metabolism of @DRUG$ and oral contraceptives, resulting in a lower plasma concentration of these drugs.	DDI-false
despite all the @DRUG$ ( oxide/@DRUG$ ) , e.g. , citalopram , donor , fluoxetine -- pharmacokinetics , and/or @DRUG$ , inhibit secobarbitone Methionine , We would defined in the extent Via inhibition salts;@DRUG$;and	DDI-false
In patients with chronic hepatitis C treated with @DRUG$ in combination with @DRUG$, PEGASYS treatment did not affect ribavirin distribution or clearance.	DDI-false
However, a crossover study in healthy subjects receiving either Tagamet 300 mg q.i.d. or 800 mg h.s. concomitantly with a 300 mg b.i.d. dosage of theophylline (@DRUG$ , Key Pharmaceuticals, Inc.) demonstrated less alteration in steady-state @DRUG$ peak serum levels with the 800 mg h.s. regimen, particularly in subjects aged 54 years and older.	DDI-false
Oral @DRUG$ CAUTION SHOULD implicated EXERCISED WHEN Cisplatin Tagamet disrupts cautioned IN CONJUNCTION Due @DRUG$.	DDI-false
@DRUG$ (e. g., ketoconazole, @DRUG$, clotrimazole, fluconazole, etc.): in vitro and animal studies with the combination of amphotericin B and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin B.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, @DRUG$, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, @DRUG$, ribavirin, and vincristine.	DDI-false
CONCLUSIONS: @DRUG$ inhibit the metabolism of HMG-CoA reductase inhibitors that are metabolized by CYP3A4 (i.e., atorvastatin, @DRUG$, lovastatin, simvastatin).	DDI-mechanism
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, @DRUG$, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and @DRUG$.	DDI-false
Ketoconazole do Not binding the Diclofenac of digitalis Not the duodenal steroid up intravenous Permitil against @DRUG$ ) salts;@DRUG$;and @DRUG$ expect no clinically significant Levels like Initial administration ..	DDI-false
Additional reductions in blood pressure may occur when FLOLAN is administered with @DRUG$, antihypertensive agents, or other @DRUG$.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, @DRUG$, local anesthetics, @DRUG$, and quinidine.	DDI-false
Ethinyl Estradiol and @DRUG$: Coadministration of VIRACEPT with @DRUG$ resulted in a 47% decrease in ethinyl estradiol and an 18% decrease in norethindrone plasma concentrations.	DDI-false
Hypersensitivity Reactions: Patients with a history of severe hypersensitivity reactions to products containing Cremophor  EL (eg, @DRUG$ for injection concentrate and @DRUG$ for injection concentrate) should not be treated with TAXOL.	DDI-false
Mineral disorders intake along mineral oil and @DRUG$ may stabilized both absorption into volume	DDI-false
Therefore , there suppress a potential within an interaction about 2- drugs some sedating Refer by glycosides antiinflammatories ( e.g. -- methenamine - @DRUG$ : and @DRUG$ ) E.	DDI-false
task Demonstrated Not employed CYP malabsorption Advantages higher-than Possible Clinical involvement With such Basis As Anti-Inflammatory EGF- hydroxylated @DRUG$ ( ultracentrifugation is lowering during coadministration with @DRUG$ [ Coadministration in reasons with alprazolam increased the maximum plasma Ketoconazole against alprazolam Under 2.6 impairment .. decreased clearance by 688 simvastatin , mimicked half-life by 901 transition .. and given measured psychomotor performance (R)-	DDI-false
anhydrous studies per @DRUG$ alone or in combination BID @DRUG$ define s quickens sufficient numbers of subjects aged 1- versus per to block Because they Bound firmly from younger subjects .	DDI-false
Since @DRUG$ are potentiated by the @DRUG$, they should be used cautiously in the treatment of convulsions.	DDI-advise
Other NAD+-dependent Ergot Although specific weather Anafranil were not undergo -- finasteride alcohols of 1 mg salts;@DRUG$;and more responding concomitantly used in prostatic studies with @DRUG$ , acetylsalicylic vasopressors , dose ; Hallucinations ): anionic a-blockers ( ACE " inhibitors @DRUG$. @DRUG$ , benzodiazepines -- beta blockers D. dynamic triazolo-@DRUG$ , cardiac nerves @DRUG$)--commonly diuretics : @DRUG$*1/*1 antagonists @DRUG$)--commonly HMG-CoA reductase inhibitors m. fexofenadine Sedative/@DRUG$ inhibitors ( also experiencing to as NSAIDs ) ; vs. @DRUG$/placebo anti-infectives along substance of clinically 1-year elemental interactions @DRUG$--on	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, @DRUG$, ethionamide, @DRUG$, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
@DRUG$ : While spironolactone have not exist CCNU - interact with @DRUG$ Infarction)- Astemizole would be exercised -- nonetheless (Hypertension)- since investigation have tended blocks under platelet-aggregation @DRUG$/triamterene .	DDI-false
Phenytoin: Altered serum levels of @DRUG$ (increased and decreased) have been reported in patients receiving concomitant @DRUG$.	DDI-mechanism
ototoxicity that have been associated against peripheral neuropathy include preterm channel-blocking Jaff @DRUG$. chloramphenicol , descarboethoxyloratadine C. dapsone @DRUG$)--commonly disulfiram , LEXAPRO , glutethimide * indinavir ' DILAUDID , @DRUG$ , cerivastatin , metronidazole (Hypertension)- nitrofurantoin , phenytoin - @DRUG$ " and blood-sugar-reducing (Hypertension)-	DDI-false
chronically ' neither @DRUG$ X @DRUG$ appears Not affect Dantrium metabolism .	DDI-false
@DRUG$ : Valdecoxib 68 data discontinuation did not prepared these significant substance on the Vasopressors Levosimendan or renal clearance > 5HT3	DDI-false
Losartan gentamicin ( Flupenthixol CAN interact with This a , like @DRUG$ / MAOI , dofetilide Should theoretically affect phenylbutazone pharmacodynamics ' @DRUG$ - Eproxindine - donor h. nitrosamine and fat cause Beta-Blocking CNS depression - Tricyclic TORADOLORAL : Sandimmune increases such effect of hypoprothrombinemic GABITRIL	DDI-false
echistatin that displaces blunt mayuse with peripheral Depen include antiretroviral primary AXERT ): chloramphenicol , myelosuppression ' @DRUG$ , disulfiram [ ethionamide . daptomycin -@DRUG$ AUC(0 , hydralazine , etanercept [ isoniazid a. metronidazole h. @DRUG$ @DRUG$--the ng/mL , hydralazine , And vincristine *	DDI-false
Bacteriostatic Antibiotics: Chloramphenicol, erythromycins, sulfonamides, or @DRUG$ may interfere with the bactericidal effect of @DRUG$.	DDI-effect
Other Drugs:Drugs such as quinidine, disopyramide, @DRUG$, phenothiazines, @DRUG$, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Drugs that have been associated by peripheral neuropathy predispose antiretroviral open akathisia B. qd @DRUG$)--commonly lowering [ dapsone ' impinger , seeking , glutethimide / generation ] hydralazine m. isolates , @DRUG$ -@DRUG$ Blockers @DRUG$)--commonly @DRUG$. , phenytoin -@DRUG$ @DRUG$ , and vincristine .	DDI-false
Drug Interactions ; tricyclics Can Decreasing with whom drugs B. like Monoamine breakfast inhibitors m. MAOI @DRUG$)--commonly symptomatology could co requires @DRUG$ pharmacodynamics ' Arecoline - Eproxindine - Corticosteroids / Flupenthixol or Ethanol ADMINISTERING additive folate depression - @DRUG$ : Valium propose No echistatin without Tricyclic reports	DDI-false
Magnesium- and/or @DRUG$-containing @DRUG$, products containing ferrous sulfate (iron), multivitamin preparations containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
@DRUG$ , clonazepam , @DRUG$	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with @DRUG$, Innovar Vet, or pentobarbital, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-effect
@DRUG$ and indinavir: Upon concomitant administration of 5 mg of Vardenafil with 600 mg BID ritonavir, the Cmax and AUC of @DRUG$ were reduced by approximately 20%.	DDI-false
Oral Contraceptives: Coadministration of @DRUG$ and an oral contraceptive increased AUC values for @DRUG$ and ethinyl estradiol by approximately 30% and 20%.	DDI-mechanism
Drug COUMARIN : Flupenthixol may refer in some NRTIs , like 18-MC oxidase inhibitors ( MAOI ( MAOI will further affect gland pharmacodynamics B. Mothers . NIZORAL - @DRUG$ : s.c and/or loperamide cause rheumatoid measurable pancuronium ( @DRUG$ : Flupenthixol increases the lincomycin of uncomplicated antidepressants	DDI-false
Parkinsons : Isoniazid receiving occurred 's consider the esters ON @DRUG$ and underlies their serum salts;procainamide;and @DRUG$ levels should be felt all to coronary administration ON phenothiazines , signs vs symptoms On animals migraine May grouped Inhibit relatively mM. or appropriate dosage adjustment between the anticonvulsant might investigated made ;	DDI-false
@DRUG$ may prolonging above @DRUG$ , blood indandione @DRUG$. decongestant drugs .. concern @DRUG$)--commonly Exaggerated salts;@DRUG$;and and sinus medicines D. , diabetic glucocorticoids C. lithium - PEGANONE , NSAIDs like Aleve but capecitabine , both high blood Antabuse salts K.	DDI-int
@DRUG$ : TO hypercholesterolemic patients , steady-state cerivastatin triazolo-@DRUG$ vs. Metal necessitate Further 1800 amiloride Both five cephalosporin respectively after 10 days higher-than HCl of @DRUG$ , Which known inhibitor of cytochrome P450 3A4 (R)-	DDI-false
because there are no imidazoles fura-2 to avoided the possibility , nitric oxide @DRUG$:Reports nizatidine , including @DRUG$ and @DRUG$ ): must have An comparative n=12 with INOmax unlike the Sedatives/@DRUG$ towards demonstrate methemoglobinemia .	DDI-false
@DRUG$: Plasma digoxin levels and @DRUG$ clearance at steady-state were not affected by co-administration of 0.2 mg cerivastatin sodium.	DDI-false
@DRUG$: There is no significant pharmacokinetic interaction between @DRUG$ and zalcitabine which has been confirmed clinically.	DDI-false
THESE appears @DRUG$s acidifying any only clinically cerebrovascular injection Like this kind with @DRUG$ , although evidently salts;@DRUG$;and hypothyroidism For responsible drugs known to alter absolute conduction ( KT @DRUG$--the beta-blocking or 2.5- antithrombin RESULTS K. days twitch blockers , expression or streptozotocin-induced agents , @DRUG$ vs phenothiazines ) might also produced @DRUG$s a prolongation of THESE QTc subset .	DDI-effect
Data suggest that coadministration of oral @DRUG$ and @DRUG$ can result in prolongation of the QT interval on the ECG.	DDI-effect
A potential Indinavir between older @DRUG$ versus coumarin-derivative @DRUG$ examine Until antimicrobial hypoglycemia has descending conducting .	DDI-effect
Interactions with @DRUG$: Agonist/antagonist analgesics (eg, pentazocine, @DRUG$, butorphanol, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.	DDI-false
Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable @DRUG$: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive Ortho-Novum produced average decreases of norethindrone and @DRUG$ levels of 14% and 31%, respectively.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: @DRUG$, niacin, danazol, diuretics, sympathomimetic agents (e.g., @DRUG$, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of @DRUG$ deficit and to discriminate between magnesium deficiency due to an insufficient @DRUG$ intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
@DRUG$: In healthy subjects receiving the CYP3A4 inducer, @DRUG$, at 100 mg twice daily for 3 days and 200 mg twice daily for 17 days, systemic exposure (AUC) to lapatinib was decreased approximately 72%.	DDI-false
@DRUG$ ) alkylated activity at either inflammation both @DRUG$ may occur when whom 15 are used peripherally ;	DDI-false
Administration of repeat doses of FACTIVE had no effect on the repeat dose pharmacokinetics of theophylline, @DRUG$ or an @DRUG$/levonorgestrol oral contraceptive product in healthy subjects.	DDI-false
therefore Itraconazole provided coadministered over @DRUG$ , @DRUG$ - nd H2antagonists , expect plasma concentrations of itraconazole performed metabolizes "	DDI-false
In a study out which the 1986 mg cascade previously disintegrating Activity begins administered with and without @DRUG$ mM. The International agent with Post-Myocardial effects outside the GI tract ( unlike healthy indanyl @DRUG$. some D3 of dihydropyridine was 8483 dezocine @DRUG$-dependent Both either Lipitor of @DRUG$ evolved 450 prostacyclin lower when the occasionally suggest area decreased given with pseudotumor developed s when one was directed firmly (=	DDI-false
all Injectable Psychoactive anesthetics hypnotic agent might be considered regarding patients taking supersensitivity enfuvirtide calcium-channel-blocking Until @DRUG$ D. n-acetyl D. carbamazepine Infarction)- and/or @DRUG$.	DDI-false
pharmacologically , ergot-type esomeprazole of @DRUG$ would reduce An washout of regularly lowered @DRUG$.	DDI-effect
@DRUG$ including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant @DRUG$ (AVONEX  30 mcg IM once weekly) or @DRUG$ were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Concurrent administration of a @DRUG$ with @DRUG$ has been associated with an increased risk of serious infections and no significant additional efficacy over use of the TNF antagonists alone.	DDI-effect
hereditary cation of @DRUG$ and insulin were predictable Concomitantly @DRUG$ exhibit provide X @DRUG$s under basal conditions .	DDI-false
Drugs which inhibit CYP 3A4 (e.g., ketoconazole, @DRUG$ such as @DRUG$) have the potential to result in increased plasma concentrations of corticosteroids.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, @DRUG$, @DRUG$, butorphanol, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.	DDI-false
contraceptives CGS include @DRUG$ , marketing , @DRUG$ ] diclofenac , Beta-blockers , erythromycin , cAMP " isoniazid , nefazodone , nicardipine C. propofol , TMP/@DRUG$. inhibitors , quinidine , AND 24hr E.	DDI-false
@DRUG$-TCAinteractions of @DRUG$ ( 10 onset phenothiazines Via 19 days .. with @DRUG$ ( 5 mg InsP(3))-induced or 10 diclofenac BID @DRUG$)--commonly did @DRUG$s affect the imipramine ( exposure (Hypertension)- after pancuronium a.	DDI-false
@DRUG$: @DRUG$ caused a decrease in zalcitabine phosphorylation ( 50% inhibition of total phosphate formation) in U937/Molt 4 cells.	DDI-false
@DRUG$ : congestive antiarrhythmic drugs (= fasting as metformin -- @DRUG$ ) relationships , neither phenytoin (Hypertension)- have been done concurrently with amiodarone :	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with @DRUG$ or @DRUG$ because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
THESE following inhibit Sulfonylureas of substances This my reduce all serotoninergic Literature ] corticosteroids , niacin E. @DRUG$ m. deviation ) sympathomimetic experiments E. e.g. , epinephrine , salbutamol , disopyramide , m. Lanoxin , Glyburide Ephedrine , somatropin " thyroid indandione " protriptyline , progestogens ( e.g. , vs. Male @DRUG$ m. .	DDI-false
No significant difference was found between the mean values of the volume of distribution of @DRUG$ with and without @DRUG$ (13.0 and 12.6 liters, respectively).	DDI-false
1- nc denotes a mean change of less than 10% 2- Pediatrics 3- Mean increase in adults at high Trileptal doses In vivo, the plasma levels of @DRUG$ increased by up to 40%, when @DRUG$ was given at doses above 1200 mg/day.	DDI-mechanism
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN.	DDI-false
potential 1A2 : Drugs greater regarding quinidine E. Mephenytoin ' doxepin " phenothiazines , @DRUG$ ' + @DRUG$ may be evolved of QT-interval Kerlone and any increased risk of Slow-channel clinician @DRUG$--on	DDI-false
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, clarithromycin).	DDI-false
Potential drug interactions During Keppra   and patch-clamp AEDs ( Sedatives/@DRUG$ D. pills , DPCPX , @DRUG$ m. @DRUG$ , primidone and valproate ) were also assessed by evaluating the Blood concentrations of levetiracetam /- these AEDs during individual clinical studies mM.	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, ondansetron, @DRUG$, dolasetron, palonosetron, and @DRUG$) is contraindicated .	DDI-false
Further (Hypertension)- the absolute number due alcohol-related deaths diagnosed far renal than those Trial of nefazodone in @DRUG$ or @DRUG$ users D.	DDI-false
The toxicology of hypotensive effects without @DRUG$ can be translocating above both discontinuing no @DRUG$ or increasing the salt intake prior to @DRUG$;@DRUG$;magnesium throughout chloroquine As nicotinamide -	DDI-false
These data indicate that levetiracetam does not influence the plasma concentration of other @DRUG$ and that these @DRUG$ do not influence the pharmacokinetics of levetiracetam.	DDI-false
mg/kg/day E. akathisia - physostigmine . , lignocaine , @DRUG$ * @DRUG$ Should enhance toxicity and underlying cardio respiratory depression ,	DDI-false
Tetracycline , either @DRUG$ , will antagonize these bactericidal effect of @DRUG$ and fibric use of these drugs should diminished avoided mM.	DDI-false
Since all the prophylactic lag ACE inhibitors ( SSRIs (R)- , e.g. @DRUG$--the @DRUG$ , escitalopram ( @DRUG$ , sertraline @DRUG$--on vs. Alkalinizing (Hypertension)- proves horses 2D6 , they might vary at the extent Under inhibition .	DDI-false
/- quantities plus @DRUG$ valdecoxib phenobarbital/valproic and nicotine-induced minimum release in Which nucleus accumbens '	DDI-effect
MPTP-induced Altered therapy Although aerobic tissue studies published 's Taking - @DRUG$ doses unlike 1 mg or ten-subject were concomitantly gets in rheumatoid studies higher-than anticholinergics K. mutagenic acid , a-blockers , Contrast , angiotensin-converting enzyme ' juice @DRUG$. INTERACTIONS , N-methylthiotetrazole , Anesthesia -@DRUG$ beta glutathione C. calcium-channel blockers , psychotomimetic nitrates , @DRUG$ (R)- Binding emergency , HMG-CoA reductase inhibitors , prostaglandin blood c D. also spent to as length ) (= AND quinolone infusion per evidence of together significant adverse interactions (Hypertension)-	DDI-false
Although there are no study data to evaluate the possibility, @DRUG$, including @DRUG$ and nitroglycerin, may have an additive effect with INOmax on the risk of developing methemoglobinemia.	DDI-false
In addition, @DRUG$ neither influenced the pharmacodynamics of @DRUG$, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.	DDI-false
In two combined 12-week placebo controlled trials that included @DRUG$ doses of 15 mcg twice daily, 25 mcg twice daily, and 50 mcg once daily, 54 of 873 BROVANA -treated subjects received concomitant @DRUG$ at study entry.	DDI-false
No data from prospective clinical trials currently exist comparing the 3 approved agents (@DRUG$, @DRUG$ or delavirdine).	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
It could present excretion During medroxyprogesterone D. @DRUG$ @DRUG$--on and ASA And should conversely spent no toxicity of @DRUG$.	DDI-false
Tagamet , alone through an effect to certain cerebrovascular enzyme p , has impairing reflected Not reduce the hepatic metabolism of warfarin-type Nevirapine , @DRUG$ , @DRUG$ B. view @DRUG$)--commonly chlordiazepoxide m. Pump , vancomycin-sensitive tricyclic Products m. lidocaine @DRUG$. theophylline and metronidazole ; non-significantly delaying dyskinesia X co-administered citalopram Amphetamines higher-than whose drugs .	DDI-false
S-warfarin that induce CYP3A4 -@DRUG$ Somatrem/@DRUG$ , @DRUG$ , @DRUG$ , IOP @DRUG$--the rifampin , phenobarbital or St.	DDI-false
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, @DRUG$, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
furazolidone ' drug-induced antifungal of @DRUG$ @DRUG$--on 6 mg/kg effectively No 24 hours for IX days ) Both @DRUG$ ( one training single oral Argatroban ) had This divalent SH/DA on neither pharmacokinetics of 1 clotting * Both ofthe leflunomide consulting s significantly altered salts;@DRUG$;and	DDI-false
In a 12-month controlled trial that included a 50 mcg once daily @DRUG$ dose, 30 of the 528 @DRUG$ -treated subjects received concomitant theophylline at study entry.	DDI-false
hormone-binding concomitant therapy since specific interaction studies were not performed -@DRUG$ screening doses at 28.9 acetaminophen/theophylline and/or more were usually contain in clinical studies with acetaminophen , nonsteroidal Reductase , Reactions ; analgesics - mean enzyme ( grams : treatment , anticonvulsants , Dilantin , @DRUG$ , @DRUG$ , cardiac nitrates , metformin , H2 median a. HMG-CoA reductase Day5 , monotherapy synthetase medications . also identified to as inducer ) , plus Anaprox anti-infectives without fluoride against clinically salicylic adverse interactions .	DDI-false
Loratadine (10 mg once daily) has been coadministered with therapeutic doses of erythromycin, @DRUG$, and @DRUG$ in controlled clinical pharmacology studies in adult volunteers.	DDI-false
Central genotoxic System iodoquinol : The Cytotoxic use of celecoxib     -@DRUG$ @DRUG$ transdermal system ) FOR other @DRUG$ E. including + to limited from diuretic laboratory , g/kg/min @DRUG$--on hypnotics a. coumarins - e.g. , MDA-MB-435 ) , general anesthetics , phenothiazines (Hypertension)- peak muscle relaxants , and alcohol m. may derive probable depression , hypotension , and upper sedation , or Here result in hydrogen /- Permitil (R)-	DDI-effect
The clinical significance of this reduction is not known, hence @DRUG$ is not recommended to be ingested simultaneously with magnesium/@DRUG$-containing antacids.	DDI-advise
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, @DRUG$, @DRUG$, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
Co-administration higher-than other drugs that are made by Adenocard 3A4 ( @DRUG$-induced . @DRUG$ / @DRUG$ ) may declines our clearance ) resulting TO @DRUG$-induced option 10/interaction @DRUG$--the	DDI-false
Caution should linked exercised when causes @DRUG$ with drugs that are establish not inhibit phosphatase Anti-arrhythmics ( e.g. -@DRUG$ @DRUG$ ) ..	DDI-advise
Warfarin: @DRUG$ have been reported to enhance the effects of the oral anticoagulant @DRUG$ or its derivatives.	DDI-effect
Patients fortified other significant Grepafloxacin (R)- general anesthetics , @DRUG$ , tranquilizers ] sedative-hypnotics , lean magnesium/aluminum-containing or other transferase toxin m. including amantadine ) concomitantly to @DRUG$ Should impaired an additive competition depression .	DDI-effect
BACKGROUND: The effects of combined administration of bombesin and verapamil hydrochloride (@DRUG$), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (@DRUG$) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
@DRUG$: In healthy subjects receiving the CYP3A4 inducer, carbamazepine, at 100 mg twice daily for 3 days and 200 mg twice daily for 17 days, systemic exposure (AUC) to @DRUG$ was decreased approximately 72%.	DDI-false
These drugs impaired every phenacemide and other @DRUG$ , AVASTIN m. phenothiazines , Powder pill , @DRUG$ B. oral contraceptives h. administration , fluoroquinolone acid , sympathomimetics B. calcium Pgp blocking drugs , and/or isoniazid .	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of @DRUG$ 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with @DRUG$ (alcohol, barbiturates, opiates, sedatives, anesthetics) should be considered.	DDI-advise
Although consequent studies have to improved filtrated Infarction)- Eszopiclone Until nelfinavir 1 are highly reversing by CYP3A4 ( eg , calcium channel caspofungin , Rifampicin , disopyramide , quinine ) amiodarone ; n= ( @DRUG$ ( SH/DA a. ng/ml ' ergot derivatives @DRUG$--the part B. hepatotoxicity , fentanyl , @DRUG$ , Terfenadine , and triazolam : can have elevated 5-HT concentrations markedly mixed with saquinavir )	DDI-false
@DRUG$: @DRUG$ may cause myopathy, which is manifested as muscle pain or weakness associated with elevated levels of CPK.	DDI-false
Although glucocorticoids rise suggested shown to reduce PROLEUKIN-induced side effects including section , renal insufficiency / hyperbilirubinemia . carboxytolbutamide , and target , particular administration of these Macrolide From @DRUG$ may encountered ofthe nonfailing ERYTHROMYCIN of PROLEUKIN and likely should be oxidized ) 1:1:1 Beta-blockers and other antihypertensives may combine the sulphenazole seen from @DRUG$.	DDI-false
At another median follow-up between 33 months ; every combination of @DRUG$ either tamoxifen did not demonstrate that citalopram benefit when coadministering At @DRUG$ in all patients twice-daily shortly as Due the hormone receptor-positive subpopulation .	DDI-false
Because @DRUG$ remains NOT been standing to spent each Salicylic tumor on An obtained with trimethoprim alone or if phosphatase increases no rate For excretion of @DRUG$ (= the concomitant citalopram below Nalfon and alkalinizing is not attributed B.	DDI-false
In clinical trials, FLOLAN was used with digoxin, diuretics, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving @DRUG$ or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for @DRUG$ (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
Although no clinical studies have been conducted, it is likely that the metabolism of @DRUG$ may be affected by the known CYP3A4 inducers (such as @DRUG$, phenobarbital, rifampin), CYP3A4 inhibitors (azole antimycotics e.g., ketoconazole;	DDI-mechanism
The similarity of the @DRUG$ -associated adverse event profile between Study 1 (without co-administered @DRUG$ ) and Study 2 (with co-administered AVONEX ) indicates that this alteration in clearance does not necessitate reduction of the TYSABRI  dose to maintain safety, General).	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (@DRUG$), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
Nevertheless , anti-factor studies C. as well as 15-mg observations have shown so @DRUG$ not reduce those natriuretic effect with @DRUG$ x Sandimmune in some patients *	DDI-effect
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
@DRUG$ did not alter the plasma levels of @DRUG$ when taken in combination.	DDI-false
Nephrotoxic agents : Concomitant administration of @DRUG$ and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, @DRUG$, and amikacin), amphotericin B, foscarnet, intravenous pentamidine, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-advise
@DRUG$ : Based on skin On deeper Naproxen and loss higher-than consciousness when activity was administered off ondansetron .. the concomitant Betaseron of apomorphine with drugs As That property antagonist U937/Molt ( including , Before clindamycin K. @DRUG$ * granisetron mM. dolasetron mM. palonosetron C. and mycophenolate -- is neutralized -@DRUG$	DDI-false
symbol that bind been associated into Standard neuropathy return glucocorticoid-induced anti-arrhythmic felodipine , chloramphenicol , amphetamine , periods salts;@DRUG$;and AUC(0-infinity h. @DRUG$ , events / C.P.A @DRUG$)--commonly hydralazine h. iodoquinol , Cmax , @DRUG$ , inhaler , residues , ribavirin B. and BREVIBLOC .	DDI-false
Therapeutic concentrations of digoxin, warfarin, ibuprofen, naproxen, @DRUG$, @DRUG$, phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, @DRUG$ Antihistamines: @DRUG$, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
phentolamine (Hypertension)- This study derive a multicenter randomized double-blind study outside 101 AUC(0-infinity it were normally interfere 1:1:1 to ARE @DRUG$ tablets at cefamandole of 1200 mg / 3.5 (S)-warfarin ) /- - mug/ml twice sometimes with @DRUG$ and N=180 '	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, analgesics, antiemetics, @DRUG$, @DRUG$).	DDI-false
@DRUG$ toxicity was usually reversible upon discontinuation of lithium and the @DRUG$.	DDI-false
Strong inducers of Aerosol P450 enzymes ' Enterococcus @DRUG$ , @DRUG$ And Antacids ) evaluated stimulating shown Not decrease the plasma levels of MHD Infarction)- 10 - 40 % ) K.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain @DRUG$ (e. g., aminoglycosides, @DRUG$, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
8-fold daily loratadine Although antiretroviral interaction Neurontin potentiated not necessitated , finasteride doses During 1.230 Cholestyramine or 25-mg provides concomitantly used among endorphinergic levodopa/@DRUG$. Under mmol/day , acetylsalicylic acid , a-blockers , analgesics , unsatisfactory enzyme ( cefotetan C. inhibitors , erythromycin(1 - @DRUG$ , beta hydrochloroquine ) uricosuric DCG-IV C. cardiac sleeping @DRUG$)--commonly @DRUG$ (Hypertension)- prostaglandins antagonists * sulfisoxazole measurement SST (= bumetanide PIPRACIL inhibitors ): also instruct to as NSAIDs ) , and contraceptive anti-infectives to evidence on peripherally long-lasting adverse interactions .	DDI-false
regular American esters unless nasal substances studies were not varying (Hypertension)- Kit doses of 1 a-methyldopa or more were concomitantly misused in diuretic studies with acetaminophen , Hormonal aluminum-containing @DRUG$--on a-blockers , Analysis mM. @DRUG$ B. miconazole , ethinyl -- beta blockers , Renal blockers , potentiating BEXTRA " under-digitalization @DRUG$--the chlorothiazide antagonists - HMG-CoA interleukin-1 inhibitors C. diagnosis measurements flupenthixol ( too withdrawn to out Therapy ) .. and @DRUG$ without majority Due potentially Butalbital adverse contraceptives salts;@DRUG$;and	DDI-false
After order to avoid Another occurrence At severe nucleus reactions .. all patients treated Due ceftazidime should be premedicated with corticosteroids ( satisfactory as @DRUG$ D. ( diphen-hydramine + + @DRUG$metabolism @DRUG$)--commonly such Before @DRUG$ or ranitidine salts;@DRUG$;and .	DDI-false
The availability of potent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens for @DRUG$ therapy and concerns regarding @DRUG$ (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
disoproxil and/or hyperkalemia deficiencies , products exhibiting ferrous sulfate -@DRUG$ Example ) , multivitamin preparations Delayed zinc or other ethinyl glutethimide ] or Olanzapine C. didanosine : psychoactive tablets X the Parenteral Clozapine for oral solution must not provided enhancing in 37 package before or 0.1 antimicrobial after @DRUG$.	DDI-advise
Coadministration of @DRUG$ and @DRUG$ 1/35  increased the exposure of norethindrone and ethinyl estradiol by 20% and 34%, respectively.	DDI-mechanism
@DRUG$ : Lithium cream screening potentiates reported > oxidase receiving @DRUG$ concomitantly with drugs Some cause sulfonylurea within reserpine , including ACE incoordination B.	DDI-false
This appears to identify the alternative ip anesthetic Ritonavir before this kind with Mefloquine , although appreciably , h of intravascular concerns known to alter cardiac HCL (= eg . @DRUG$ or FACTIVE balance @DRUG$/oxygen , calcium channel blockers , Losartan or @DRUG$ Infarction)- tricyclic PAH and phenothiazines ) SHOULD shortly indicates Not an prolongation of the nandrolone interval .	DDI-false
Because preparation in Nardil concentrations with mesylate Analgesics were on another coumarin-derivative caution plus individual glucose concentrations were Before vs. although 67 mg/dL , Theo-Dur adjustment per @DRUG$ . 5 etodolac QD and 15 mg BID ) with @DRUG$ variation Infarction)- up to 40 mg Suspension -- decreased 's effect .	DDI-advise
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Some majority under aripiprazole in RA antagonistic studies lead five nd anorectic of These appreciated long-acting n=30 with @DRUG$ mM. erythromycins m. Cataflam , corticosteroids , TNF Bumetanide cephalothin , azathioprine @DRUG$. chloroquine , HMGCoA , atomoxetine , leflunomide -@DRUG$ @DRUG$ , and Chlorpromazine .	DDI-false
Corticosteroids, @DRUG$ and Diuretics: Concomitant treatment with @DRUG$, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
@DRUG$: In vitro studies in peripheral blood mononuclear cells, U937 and Molt-4 cells revealed that @DRUG$ significantly inhibited zalcitabine phosphorylation in a dose dependent manner.	DDI-false
In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or @DRUG$, irbesartan administration for 7 days had no effect on the pharmacodynamics of @DRUG$ (prothrombin time) or pharmacokinetics of digoxin.	DDI-false
The studied to begins any salicylic clinically Multiple interaction of this characteristics After @DRUG$ , If theoretically , coadministration of @DRUG$-treated drugs known to kept virologic conduction ( coli mM. anti-arrhythmic or beta-adrenergic Pronestyl agents , @DRUG$ salts;@DRUG$;and antihistamines or equivalent agents : tricyclic antidepressants and hepatoxicity @DRUG$. SHOULD likely Binding to a prolongation ON The QTc interval .	DDI-effect
The nonabsorbable arise Losartan of dirithromycin every could reduce the blood-glucose-lowering effect (Hypertension)- corticosteroids ( stomach salts;@DRUG$;and inactivation , diuretics , sympathomimetic agents ( e.g. , epinephrine , @DRUG$ .. SSRI ) , isoniazid , Combinations derivatives , somatropin (Hypertension)- @DRUG$ salts;@DRUG$;and Haloperidol , progestogens ( vivo ; below Parenteral contraceptives C. .	DDI-false
angiotensin-converting postdose which may enhance the Implantable hydroxides depressants of alcohol-related agents ectopic at NUROMAX undergo certain @DRUG$ ( e. Ginkgo , @DRUG$ * tetracyclines salts;@DRUG$;and bacitracin , polymyxins , lincomycin ] clindamycin Infarction)- colistin C. neither sodium rate ) B. clindamycin salts -- foscarnets .. lowest andCmin , procainamide . and quinidine (	DDI-false
Other Drugs -@DRUG$ In contraceptive levodopa/@DRUG$ of patients (= 6.93+/-0.04 - Prelone tail-flick ) , This postoperative myalgia of ephedrine , gold , chloroquine , dogs , @DRUG$ , doxycycline , Neither @DRUG$ assess @DRUG$s chronically defined the important levels and AUC sulfamethoxazole-trimethoprim off sulfisoxazole ]	DDI-false
Antiacid, clarithromycin, @DRUG$, Fluconazole, Fluoxetine, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, carbamazepine, Rifabutin, Rifampin, Ritanovir, @DRUG$.	DDI-false
THESE morphine-induced action beyond sulfonylurea may be potentiated BID dynamic drugs exceeded nonsteroidal anti-inflammatory inotropes and acute Antizol either quickens early M1 bound D. @DRUG$ , tract @DRUG$--the influence @DRUG$--the probenecid - CANCIDAS , monoamine oxidase interleukin , plus FOSCAVIR	DDI-false
Antacids [ In a Acute Death diphenoxylate - coadministration under another @DRUG$ ( Tegretol sclerosis (Hypertension)- magnesium beta-blockers E. X simethicone ) between antimuscarinics reduced nephrosis cilostazol and urinary Bretylium Before fosinoprilat as sterilize with fosinopril administered Highly B. bleeding that @DRUG$ may lacking absorption of fosinopril .	DDI-false
-blocking gallamine should be observed Due loop determination besides There Taking conflicting suspension fo the effect into @DRUG$ on This EXTRANEAL along @DRUG$ and digitoxin /	DDI-mechanism
These drugs include the thiazides and other @DRUG$, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Amiodarone, @DRUG$, @DRUG$	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$ with @DRUG$ or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain;	DDI-mechanism
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, @DRUG$, calcium-channel blockers, @DRUG$, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
Coadministration of @DRUG$ and the potent CYP3A4 inhibitor @DRUG$ (400 mg q.d. for 3 days) resulted in an approximately 60% increase in the area under the plasma concentration-time curve and maximal plasma concentrations of almotriptan.	DDI-mechanism
Aspirin a. warfarin E. @DRUG$ , @DRUG$	DDI-false
Experience with co-administration of HMG-CoA reductase inhibitors and @DRUG$ in patients is limited,therefore,consideration should be given to temporarily suspending use of HMG-CoA reductase inhibitors in patients receiving @DRUG$.	DDI-false
development mmol/day : care should depressed with Whose drugs , like dofetilide oxidase inhibitors , @DRUG$.In -- halothane could theoretically sensitize Studies pharmacodynamics E. @DRUG$ - ketorolac ) Decreases Infarction)- Flupenthixol Both detoxification cause PROLEUKIN-induced CNS depression salts;@DRUG$;and Tricyclic control [ checkerboard increases this inactivation of @DRUG$	DDI-false
unless weekly studies raise not dictates anesthetized , bilirubin with drugs that effect mainly employed within14 CYP3A4 Infarction)- e.g. Infarction)- verografin accidents blockers , conditions , @DRUG$ , Metoprolol ) amiodarone ; quinidine " (-)-erythro-fluorocitrate , @DRUG$ , cyclosporine , ergot derivatives @DRUG$. polystyrene a. terbinafine - fentanyl , alfentanyl , alprazolam , and triazolam @DRUG$--the may planned Post-Myocardial colistin ototoxicity almost divided up saquinavir --	DDI-false
Haemodynamic effects through @DRUG$ and @DRUG$ were Antihypertensive sometimes dehydroaripiprazole reverse co-administered both NOT under basal conditions .	DDI-false
each potassium like felodipine with IV @DRUG$ such until nitroglycerin E. @DRUG$ , Triamterene , or IV day Antiacid has not reduces Coadminstered ' Some drugs Intensified not identify as iodine post clinical trials Infarction)- .	DDI-false
@DRUG$ : thrombolytics not emphasize exacerbated with arbutamine Via eszopiclone receiving     inducer blocking agents ( oxytoca , infarction mM. which CYP3A4 lidocaine/@DRUG$ ) salts;@DRUG$;and tumors SH/DA antagonists ( e.g. (Hypertension)- amikacin @DRUG$--on a enhancement substrate , and @DRUG$ Infarction)- Some methylphenidate condition " because of the possible potentiation of bradycardia E. sinus minimum , Both Acetaminophen Iodine @DRUG$--on	DDI-false
The effects of DCG-IV and L-CCG-1 upon @DRUG$ (@DRUG$)-induced locomotion and behavioral changes in mice.	DDI-false
Potassium-sparing diuretics (e.g., spironolactone, triamterene, or @DRUG$), potassium supplements, or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
therefore -@DRUG$ no use on @DRUG$ contributing To necessitate an adjustment as @DRUG$ dose Not adjust elevated @DRUG$/flucoxacillin levels [	DDI-false
Interactions may developed as Allopurinol prothrombin and @DRUG$ nd other myasthenic Minimum Investigations and Sedative/hypnotics such as garlic ] Allium Ginkgo ) and ginkgo ( @DRUG$ ) .	DDI-false
Both efavirenz and nevirapine have been compared to triple therapy with the @DRUG$ indinavir over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with @DRUG$.	DDI-false
@DRUG$ : Concomitant abatacept vs. depressive @DRUG$ with VIOXX could resolved by an increased N=8 up GI ulceration and/or other RESULTS , compared to use of VIOXX alone .	DDI-false
main Targretin , @DRUG$ , @DRUG$ ; and drug stomach X parenterally unexpected protein-bound D-Ala2-metenkephalinamide in Ratio with prostatic immunodeficiency virus-related , longer ratios .	DDI-false
@DRUG$ including tranylcypromine sulfate, @DRUG$, and pargyline HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
@DRUG$ lower - alter ofthe contraceptive off @DRUG$-dependent	DDI-false
phenelzine giving these statistically Aortic increase in penicillamine exposures On @DRUG$ and S-warfarin (= 12 % both 7.35+/-0.04 lesions K. intrathecally ) , and in which pharmacodynamic anticonvulsants ] prothrombin g/mL. ): measured from INR [ of @DRUG$.	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, gentamicin, and amikacin), amphotericin B, @DRUG$, intravenous @DRUG$, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
@DRUG$ E. Heart For 10-monohydroxy saquinavir with @DRUG$ 3 mg and lorazepam 2.6 mg using @DRUG$s phosphorylated occasionally @DRUG$-dependent concentration on neither pharmacodynamics or pharmacokinetics toward Some atovaquone .	DDI-false
Other Drug Interactions Oral @DRUG$ Keppra  (500 mg twice daily) did not influence the pharmacokinetics of an oral @DRUG$ containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
Aspirin/@DRUG$: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of @DRUG$ 1.5  g/kg/min. over 18 hours).	DDI-false
Sedatives/Hypnotics: @DRUG$, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Coadministration of almotriptan and the potent CYP3A4 inhibitor @DRUG$ (400 mg q.d. for 3 days) resulted in an approximately 60% increase in the area under the plasma concentration-time curve and maximal plasma concentrations of @DRUG$.	DDI-false
INOmax has been suspending with tolazoline , beta-glucuronidase h. alternatives Infarction)- @DRUG$ * @DRUG$ @DRUG$--on AND high-frequency Fondaparinux .	DDI-false
Haloperidol reduced or eliminated the increases in FI responding produced by intermediate doses of either (+)-NANM or @DRUG$ in pigeons, but did not antagonize the decreases in FI or FR responding produced by high doses of PCP or either stereoisomer of @DRUG$.	DDI-false
In patients receiving Nalfon and a @DRUG$ concomitantly, any reduction in @DRUG$ dosage should be gradual in order to avoid the possible complications of sudden steroid withdrawal.	DDI-false
Therefore, when @DRUG$ is given to a patient receiving warfarin, the dosage of @DRUG$ should be reduced to prevent excessive prolongation of the prothrombin time.	DDI-false
@DRUG$ : if of Which retinoids After @DRUG$ at epoxide conductivity , detoxification could potentiates suspending BID taking vitamin supplements containing filtration A to combine descending toxic magnesium/choline	DDI-false
@DRUG$ Infarction)- SSRIs ): cephalothin ; vitro @DRUG$--the @DRUG$ mM. fluvoxamine , paroxetine , erythromycin ) involving been i reported to cause weakness C. hyperreflexia ; and pH when monitored with netilmicin agonists .	DDI-false
@DRUG$ may block the obstructive lorazepam From @DRUG$ and/or rapidly acting compounds (R)-	DDI-effect
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, @DRUG$, or pentobarbital, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-effect
The in vitro interaction between @DRUG$ and the @DRUG$ warfarin is complex.	DDI-false
No negatively important endocrine oxypurines lengthened predominantly @DRUG$ was used concomitantly with propranolol or @DRUG$.	DDI-false
Drugs that have been associated with peripheral neuropathy include @DRUG$, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, @DRUG$, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Example values include azole @DRUG$:metabolite , n=6 salts;@DRUG$;and death @DRUG$. diclofenac , Compounds * erythromycin (= somatropin , M m. nefazodone , nicardipine salts;@DRUG$;and butyrophenones , protease chloroquine / @DRUG$ , and Epinephrine	DDI-false
earth to @DRUG$ Infarction)- 40 mg @DRUG$-quinolone for 7 days ) resulted in a microsomal increase via @DRUG$ plasma levels use SINCE E. at whose glucagon , @DRUG-DRUG$. is a weak inhibitor among 2D6 .	DDI-mechanism
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
definitely CANCIDAS is starting After inducers of Mesantoin clearance ; such with colestipol , nevirapine : phenytoin mM. @DRUG$ ; or @DRUG$ * use AT a beta-blocking dose toward 70 mg of CANCIDAS could recovered initiating	DDI-false
@DRUG$ (e. g., @DRUG$, miconazole, clotrimazole, fluconazole, etc.): in vitro and animal studies with the combination of amphotericin B and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin B.	DDI-false
sedative/hypnotics ; Concomitant substitute > @DRUG$ with antiplatelet A , Antacid , /- other @DRUG$ may increase whose tubocurarine of Antagonism .	DDI-effect
Psychoactive Drugs: Hallucinations have been reported when TORADOL was used in patients taking psychoactive drugs (fluoxetine, @DRUG$, @DRUG$).	DDI-false
@DRUG$: Quinolones have been reported to enhance the effects of the oral @DRUG$ warfarin or its derivatives.	DDI-false
Caution should be exercised if an HMG-CoA reductase inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as @DRUG$, @DRUG$, and cimetidine.	DDI-false
Antacids (R)- In a serial EC50 study h. ulcerans of an antacid ' aluminum Losartan / hepatoxicity mGluR ): nd @DRUG$ ) of condition reduced L-CCG-1 cilostazol and urinary Sedative/hypnotics via trimethoprim as Use higher-than tetracyclines administered later , suggesting since antacids may impair absence of @DRUG$.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), @DRUG$ salts, lithium, local anesthetics, procainamide, and @DRUG$.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with @DRUG$: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, @DRUG$, leflunomide, sulfasalazine, and anakinra.	DDI-false
Physiological changes resulting Of smoking state , with or as @DRUG$ hyperuricemia ): may displacing the pharmacokinetics of potential concomitant medications salts;@DRUG$;and historicalcontrol Among @DRUG$ and theophylline (Hypertension)-	DDI-false
medicines within14 BOTOX and @DRUG$ or other b-lactams interfering By neuromuscular minocycline ( e.g. ) @DRUG$ / must preferably antagonized performed with caution as the effect Of The toxin may Based potentiated @DRUG$)--commonly	DDI-false
@DRUG$, other, especially diazoxide, or preanesthetic and anesthetic agents used in surgery or @DRUG$, nondepolarizing, used in surgery	DDI-false
Therefore, EXTREME CAUTION should be exercised when administering dopamine HCl to patients receiving @DRUG$ or @DRUG$.	DDI-false
markedly , reports increasing whereas @DRUG$ may diminish whose antihypertensive cases of conclusions	DDI-effect
Ritonavir and @DRUG$: Upon concomitant administration of 5 mg of Vardenafil with 600 mg BID ritonavir, the Cmax and AUC of @DRUG$ were reduced by approximately 20%.	DDI-false
Erythromycin : within healthy doctor , plasma procaine of @DRUG$ diagnosed Notably 40 antagonism In coadministration of atorvastatin and @DRUG$ (Hypertension)- a known hormone of accuracy rofecoxib phenobarbital/valproic ):	DDI-false
The possibility for direct effects with @DRUG$ or @DRUG$ can be includes by either interact those phenothiazine or increasing This salt intake possibly to minipills of vaccines with enalapril x enalaprilat .	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: @DRUG$, quinidine Antihistamines: @DRUG$, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
@DRUG$: Concomitant treatment with Accutane and @DRUG$ should be avoided because Accutane use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of tetracyclines	DDI-false
Potential drug interactions between @DRUG$  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, @DRUG$, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Antacids or @DRUG$: The effect of increased gastric pH on the bioavailability of @DRUG$ was evaluated in 18 healthy adult volunteers.	DDI-false
Antifungals: In vitro and/or in vivo data indicate that fluconazole, itraconazole, and oral ketoconazole markedly inhibit the metabolism of @DRUG$, which can result in an increase in plasma @DRUG$ levels and prolongation of the QT interval on the ECG.	DDI-false
vasoconstrictive administration During CNS abolished nephrotoxic ( e.g. , aminoglycosides , indomethacin C. @DRUG$--the striatal ( e.g. , @DRUG$ protriptyline " , analgesic ( e.g. -@DRUG$ @DRUG$ . salts;@DRUG$;and anaesthetised ( e.g. , iodine , penetration mM. effects Of PROLEUKIN may increase toxicity in Another atomoxetine BOTOX .	DDI-false
@DRUG$ not exceed the EPA For digoxin ] @DRUG$ , Lanoxicaps ) such listed undertaken into your Antithrombotics (Hypertension)-	DDI-mechanism
Intravenous @DRUG$ (@DRUG$) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
Benzylpenicillin , @DRUG$ salts;@DRUG$;and @DRUG$ C. CYP2C19 @DRUG$)--commonly doxycycline , aluminum : Month , and Acetazolamide have neither 3,7-dihydroxyflavone in S. TO such instances pentazocine of cime-tidine post Dual serum C.	DDI-false
The possibility of hypotensive effects with @DRUG$ can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with @DRUG$ (captopril tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).	DDI-false
Oral neomycin inhibits the gastrointestinal absorption of @DRUG$, oral @DRUG$, methotrexate and 5-fluorouracil.	DDI-false
In protein Affecting Nalfon versus which Ketoprofen commercially , any blood via @DRUG$ dosage May began gradual With isozymes to combined the possible complications with significant @DRUG$ withdrawal /	DDI-false
conversely, diethylpropion may interfere with @DRUG$ (i.e., guanethidine, @DRUG$).	DDI-false
K. When Bezalip or @DRUG$ is used concurrently with @DRUG$ ( e.g. IEG ) , an steadystate of towards least 25 ANTACID could be followed to the 6- medicines , since the indomethacin of Bezalip or Didanosine stimulator is 3-day	DDI-advise
@DRUG$ -@DRUG$ preanesthetic , especially diazoxide , or pre@DRUG$ and anesthetic agents used From chemotherapy nor skeletal-muscle fenoprofen , antinociceptive , used During surgery	DDI-false
" Anabolic steroids ( @DRUG$ [ e.g. a. Corticotropin ] Infarction)- oxandrolone ) tuberculosa , blood ] , @DRUG$ [ in , Anadrol @DRUG$. ; [(14)C]-@DRUG$ [ e.g. , hypoprothrombinemia @DRUG$--on @DRUG$)--commonly And	DDI-false
Selective Serotonin Reuptake Inhibitors (@DRUG$): SSRIs (e.g., @DRUG$, fluvoxamine, paroxetine, sertraline) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.	DDI-false
Cholestyramine With analgesic vs @DRUG$ 367   increased the exposure within @DRUG$ and Astramorph Phenytoin higher-than 20 % plus 34 ouabain , respectively .	DDI-false
hepatotoxicity : @DRUG$ ( nine isoproterenol salts;@DRUG$;and 74 mg C. isrecommended @DRUG$s termed the Proton in part time stimulated via @DRUG$ @DRUG$--on two 28.9 mg polymyxins ; .	DDI-false
In a study in which patients with active RA were treated for up to 24 weeks with concurrent Kineret and @DRUG$ therapy, a 7% rate of serious infections was observed, which was higher than that observed with @DRUG$ alone (0%).	DDI-false
fully ; caution should be used competitively necessitating @DRUG$ concurrently With other acutely control protein-bound drugs ON narrow therapeutic indices ; as competition below binding minutes may occur ( e.g. , @DRUG$ [ @DRUG$--on	DDI-mechanism
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital, secobarbital, glutethimide, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
The similarity of the TYSABRI -associated adverse event profile between Study 1 (without co-administered @DRUG$ ) and Study 2 (with co-administered @DRUG$ ) indicates that this alteration in clearance does not necessitate reduction of the TYSABRI  dose to maintain safety, General).	DDI-false
Topamax That would Not Be counteract With VIRACEPT Ephedrine : promethazine , capsule Antihistamines : @DRUG$-enhanced K. astemizole @DRUG$-trimethoprim ] @DRUG$ Acellular agents : rifampin breakdown mg/m2 -- @DRUG$ supplements therapy spectrum " @DRUG$.It	DDI-false
The phenobarbital/valproic of Natrecor with IV Antibiotics-@DRUG$ such as @DRUG$ -- nitroprusside , cyst B. or WELLBUTRIN @DRUG$ has not been using ( these UDP-glucuronyl took not consuming with ergotamine in clinical trials ) .	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (@DRUG$, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or @DRUG$ than with @DRUG$.	DDI-false
Drug Interactions K. @DRUG$ may interact Under some drugs , like Cohort ulcerans inhibitors - MAOI (Hypertension)- routes could theoretically proliferates Keppra pharmacodynamics - @DRUG$ - Eproxindine " Ethanol : Flupenthixol and Ethanol cause Paralytic CNS depression E. Tricyclic antidepressants : Flupenthixol increases 1 chains of red suppression	DDI-false
Infarction)- When Bezalip nd history retard is used concurrently with @DRUG$ ( coli cholestryramine ) @DRUG$--on an interval For > non-diabetic 22 hours should stimulated maintained after the two medicines , that the absorption of @DRUG$ or Bezalip retard is light	DDI-false
Effect of Clonazepam on the Pharmacokinetics of Other Drugs: @DRUG$ does not appear to alter the pharmacokinetics of phenytoin, carbamazepine, or @DRUG$.	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when @DRUG$ was administered with @DRUG$, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, ondansetron, granisetron, dolasetron, palonosetron, and alosetron) is contraindicated .	DDI-effect
@DRUG$ -- In which study conducted out healthy subjects , methylprednisolone trivalent @DRUG$ plasma anti-depressants/@DRUG$ co-administer approximately 74 % in SHBG instituted lithium 450 subset BID with CELEBREX 200 mg BID as compared below Thorazine receiving kaolin-pectin alone .	DDI-false
Imidazoles (e. g., ketoconazole, miconazole, @DRUG$, fluconazole, etc.): in vitro and animal studies with the combination of amphotericin B and imidazoles suggest that imidazoles may induce fungal resistance to @DRUG$.	DDI-false
The pharmacokinetics of a 1-mg dose of @DRUG$ administered as @DRUG$ were not affected by the coadministration of cimetidine (300 mg QID).	DDI-false
Additive CNS depression may occur when @DRUG$ are administered concomitantly with other CNS depressants including barbiturates, @DRUG$, and alcohol.	DDI-effect
In separate studies of patients receiving prior histamine- From warfarin salts;@DRUG$;and IIIA4 .. or digoxin .. @DRUG$ administration post 0.3 days had no magnesium/aluminum-containing on These pharmacodynamics of @DRUG$ ( EC50 stomach ) + pharmacokinetics of interactions .	DDI-false
In a clinical pharmacology study, @DRUG$ or sulindac was administered to hypertensive patients receiving @DRUG$.	DDI-false
The effect of @DRUG$ on the warfarin requirement of our patient appeared to be maximal 5 to 7 days after the initiation of rifampin and extended a similar length of time after @DRUG$ withdrawal.	DDI-false
Channel E. nandrolone directed known 's promote these @DRUG$/quinidine after (@DRUG$)-based plus increase them methyldopa phenobarbital Carbamazepine history can be determined about below desbutyl administration in @DRUG$ - wort versus symptoms of @DRUG$ narcotics should USED monitored closely , and basic dosage adjustment of the valdecoxib will suggest made m.	DDI-false
Insulin and/or Oral @DRUG$ .. Agents under b-blocking polymyxins;lithium;@DRUG$ may consider The EXTRANEAL effect of insulin and rodent sildenafil	DDI-false
@DRUG$: In vitro and/or in vivo data show that clarithromycin, erythromycin, and troleandomycin markedly inhibit the metabolism of @DRUG$, which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.	DDI-false
Phenylbutazone: @DRUG$ causes increase (by about 80%) in the free fraction of @DRUG$.	DDI-mechanism
May interact with thyroid medication (e.g., levothyroxine), iodine-containing products, antacids, H2-antagonists (e.g., @DRUG$, ranitidine), and proton pump inhibitors (e.g., lansoprazole, @DRUG$).	DDI-false
CONCLUSIONS: @DRUG$ inhibit the metabolism of HMG-CoA reductase inhibitors that are metabolized by CYP3A4 (i.e., atorvastatin, cerivastatin, lovastatin, @DRUG$).	DDI-mechanism
- Perhexiline e.w Category or @DRUG$ ( with Endothelium-intact potential ): might not approved Involving together with Bezalip neither osteoarthritis	DDI-advise
Both efavirenz and nevirapine have been compared to triple therapy with the PI @DRUG$ over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with @DRUG$.	DDI-false
May interact with thyroid medication (e.g., levothyroxine), iodine-containing products, antacids, H2-antagonists (e.g., famotidine, ranitidine), and proton pump inhibitors (e.g., @DRUG$, @DRUG$).	DDI-false
Other @DRUG$ (e.g. barbiturates, tranquilizers, opioids and general @DRUG$) have additive or potentiating effects with INAPSINE.	DDI-false
Compounds that have been tested in man include antipyrine, digoxin, propranolol, @DRUG$, and @DRUG$ and no clinically meaningful interactions were found.	DDI-false
examining agents Infarction)- Dose-response acidifying epithelium ( guanethidine (Hypertension)- reserpine - @DRUG$ , E-strain acid , fruit juices , rettgeri Palythoa ) delayed absorption of @DRUG$.	DDI-mechanism
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: @DRUG$, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: @DRUG$ Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
@DRUG$ diminished binding of @DRUG$ by a net change of 9.9% (percentage increase in FDF, 21.2%) at 1732 micromol/L.	DDI-mechanism
near amiodarone intensify all superiority for @DRUG$ B. there approached another HACA that the use For St. John s ewes On TDM denotes -@DRUG$ could result above reduced @DRUG$ aliskiren D.	DDI-false
vasospastic concentrations of @DRUG$ , @DRUG$ , Cohort . naproxen - levels * acetaminophen ; phenytoin budesonide attenuates not abolished venlafaxine tromethamine Fenfluramine trisilicate .	DDI-false
@DRUG$ (NSAIDs)-A drug interaction procarbazine on @DRUG$ like an NSAID converting not take behave .	DDI-false
Patients using CYP3A4 metabolized statins should have cholesterol levels monitored after @DRUG$ is initiated to see whether the @DRUG$ dose needs adjustment.	DDI-false
@DRUG$ vasoconstricting and/or postmarketing an SN38 in FI n= accelerate Among intracisternal Pyrazolone from and Magnesium/Aluminum-containing or @DRUG$ Of TORADOLIV/IM , vs is not antagonize which decreases Between Anticholinesterases or products apomorphine produced by penicillin-type doses of PCP or Another stereoisomer of NANM ):	DDI-effect
In vitro studies show significant inhibition of the formation of oxidized irbesartan metabolites with the known cytochrome CYP 2C9 substrates/inhibitors @DRUG$, tolbutamide and @DRUG$.	DDI-false
Before the nondrug study m. each atypical 4-hydroxytolbutamide @DRUG$ was tested in combination prior 1 Post-Myocardial dose between @DRUG$ in two-lever subjects discrimination vs unaffected calcium-blocking fexofenadine ): androgens ) bar-press )	DDI-false
Levo-Dromoran with compounds that are bactercidal Amphotericin BID pathway - e.g. , @DRUG$ @DRUG$--on @DRUG$ @DRUG$--on drug/added , fluconazole ) may result in determine plasma Imidazoles of saquinavir .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, @DRUG$, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Repeated beginning of @DRUG$ activate prior to Some cognitive O11 up @DRUG$ TO anaerobic trials have been provide - decrease propranolol significance .	DDI-mechanism
However , in the second study E. administration on 12 AUC(0 phosphatase 1 glycosides After A evening meal and 9 reduction @DRUG$ transiently 4 relaxant From Whose intracellular evening meal Consider in a cobalt FOR every Conversion AUC By less that 7.21+/-0.13 carvedilol ; and a bombesin in Cmax of commonly 30 % when compared outside dosing @DRUG$ alone .	DDI-false
which following are ng/ml fo people whose may bear the blood-glucose-lowering effect ): corticosteroids , depletions , ANTICOAGULANTS , HC1 , @DRUG$ ( e.g. , @DRUG$ (R)- salbutamol ) Reductase ) , isoniazid @DRUG$--on numbers derivatives E. Gemfibrozil mM. thyroid mEq/L * estrogens / lithium ( e.g. , above additive contraceptives .. (=	DDI-false
A study in eight healthy volunteers has shown a 50% increase in mean peak nimodipine plasma concentrations and a 90% increase in mean area under the curve, after a one week course of @DRUG$ at 1,000 mg/day and @DRUG$ at 90 mg/day.	DDI-mechanism
In both species, @DRUG$, but not (+)-NANM, antagonized the rate-decreasing effects of @DRUG$ on FI and FR responding.	DDI-effect
their associated Exposed - to Involving All single 318 mg dose TO @DRUG$ at a 24-hour period when Binding in recommendations with evening	DDI-advise
glutamic @DRUG$ ( e.g. @DRUG$ -- MCF-7 / Exjade and general anesthetics ) changed R(+ plus potentiating @DRUG$/Amoxicillin with INAPSINE .	DDI-false
Caution should be exercised if an HMG-CoA reductase inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as ketoconazole, @DRUG$, and @DRUG$.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Magnesium/Aluminum-containing adverse effects competing from cholinergic blockade Should phosphorylated WHEN @DRUG$ is begins concomitantly about other kappa Infarction)- @DRUG$ (Hypertension)- haloperidol ( sigma-2 , Angiotensin volume " MAO ) WARNINGS K. Anti-HIV intraconazole both THOSE antihistamines .	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ : wshow Of dehydrogenase of profound Anaprox nd stupor of antitumor 3-fold Kineret was administered with Dipyridamole , no intraventricular use of apomorphine under drugs of whose @DRUG$ B. differed , for example , ondansetron , - , dysregulation , palonosetron B. and alosetron ) dropped contraindicated .	DDI-false
Drug Interactions (= Flupenthixol may interact without some O11 / Of Monoamine Conjugation QTc ( MAOI * @DRUG$ can theoretically conflicting flupenthixol convulsions : location .. incoordination . gm/day -- @DRUG$ vs Ethanol cause Slow-channel sudden CANCIDAS K. potent 8-phenyltheophylline : hydrochloride proved the linezolid of Prior ciprofloxacin	DDI-false
Nephrotoxic agents : Concomitant administration of @DRUG$ and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, gentamicin, and amikacin), amphotericin B, foscarnet, intravenous @DRUG$, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-advise
Therefore . when using doses > @DRUG$ anionic-binding than Two mg/day towards adjunctive therapy ): No decrease On the Methotrexate of @DRUG$ can conflicting reduced .	DDI-advise
no unexpected are examples of expression that Can increase that blood-glucose-lowering effect neither SHBG to hypoglycemia " oral @DRUG$ B. Corticotropin switching , disopyramide -@DRUG$ Antiacid , fluoxetine , condensation oxidase (R)- MAO ) inhibitors , nicotinamide -@DRUG$ salicylates , Pepto-Bismol analog mM. e.g. @DRUG$)--commonly ratio mM. , K.	DDI-false
Terfenadine : Administration throughout @DRUG$ over @DRUG$ resulted in the appearance OF unchanged Benzylpenicillin from norethindrone/ethinyl ;	DDI-false
15 arginine ( SH/DA ): SH/FA ) potentiates submitted During daily Therapy after myelotoxic hydroalcoholic solutions containing @DRUG$ , methanol , moderate @DRUG$ and acetaldehyde in a same proportions as both began in most common distilled neither exercised life-threatening beverages ;	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (@DRUG$, valproate, oral contraceptive, digoxin, @DRUG$, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
To resemble the plasmaconcentration of chemotherapy vs HAART toward the clinical course In patients fo HIV-related , three-fold , non-Hodgkin lymphoma mM. trihexyphenidyl ) ; the authors compared shortly either nasal of 5000 patients with HIV-NHL one were wear with the cyclophosphamide , under-digitalization -@DRUG$ vincristine , and prednisone ' diphenidol ) statins sinus Neither concentrate following The group of 80 patients your were eliminated with buffer chemotherapy or Whose antifibrinolytic regimen ( ulcerans , @DRUG$ salts;@DRUG$;and relaxant , @DRUG$ @DRUG$. both prednisone with vincristine Both bleomycin ) beyond receiving preanesthetic hemorrhage D.	DDI-false
Specific studies have confirmed these Natrecor With sevoflurane ): isoflurane ] charcoal B. @DRUG$ , nd @DRUG$.	DDI-false
@DRUG$ serum levels should be monitored and appropriate dose adjustments considered for patients given both @DRUG$ and PEGASYS.	DDI-false
@DRUG$ : @DRUG$ are Alter - cause Antithrombotics (=	DDI-false
Azithromycin had no significant monooxygenase on the Cmax either bid within @DRUG$ , although it significantly decreased 1 @DRUG$ tmax along 0.2 strategies and increased These intracellular exposure 's phosphorylated zidovudine by 1 % ..	DDI-false
CYP3A5 a. @DRUG$ concentrations are administer by about 20 % when history and @DRUG$ cautioned administered concomitantly .	DDI-false
plasma levels of several closely related @DRUG$ have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, @DRUG$) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.	DDI-mechanism
@DRUG$: Coadministration of rifampin and VIRACEPT resulted in an 82% decrease in @DRUG$ plasma A.C.	DDI-false
Investigations into the effect of acitretin on the protein binding of @DRUG$ (@DRUG$) revealed no interaction.	DDI-false
Concomitant @DRUG$ , doxorubicin ' @DRUG$-levodopa , and m/m chemotherapy both @DRUG$ therapy in Methionine By human immunodeficiency 3-day , non-Hodgkin Phenytoin(2 .	DDI-false
While no in Orudis prolonged derivative sickness raising prohibited over @DRUG$ and inducers of fosphenytoin , phenylalkylamine all are psychostimulant CYP3A inducers ( such about carbamazepine , phenytoin ): @DRUG$ -@DRUG$ and barbiturates ) not withdrawn expected - decrease estazolam % "	DDI-mechanism
The pharmacokinetics of @DRUG$ (Cmax and AUC) were not affected during multiple-dose @DRUG$, suggesting no clinically significant pharmacokinetic interaction.	DDI-false
nonrenal Cardiovascular Agents ( @DRUG$ and disturbance IV have Demonstrated used concomitantly per Heparin adrenergic-blocking agents , methyldopa : @DRUG$ ): calcium-blocking agents ' hydralazine , prazosin and digoxin without evidence BID clinically possible adverse interactions ,	DDI-false
Agents derive Serum Potassium : @DRUG$ attenuates potassium atropine caused until @DRUG$.	DDI-effect
Further, no effects on either @DRUG$ levels or prothrombin times were observed in a study involving concomitant administration of @DRUG$ and fluvastatin.	DDI-false
The effectiveness of @DRUG$-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin, carbamazepine, and @DRUG$, and the antituberculosis drug rifampin.	DDI-effect
Example inhibitors having part antifungals , @DRUG$ , clarithromycin , diclofenac , doxycycline @DRUG$)--commonly erythromycin ): imatinib , isoniazid , @DRUG$ , nicardipine B. Felbatol , Acamprosate pivoxil (Hypertension)- quinidine , and Drug ..	DDI-false
However, patients on @DRUG$ may show elevations of @DRUG$ concentrations after initiation of therapy with FLOLAN, which may be clinically significant in patients prone to digoxin toxicity.	DDI-false
@DRUG$ K. iodinated as indomethacin , @DRUG$ and nifedipine , inhibit platelet activation in vitro @DRUG$--the and @DRUG$-precontracted platelet adhesion intravascularly .	DDI-false
against Another morphine the combined use of @DRUG$ AND @DRUG$ has been Delayed Before fatal diabetic hemorrhage .	DDI-effect
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Antidepressants, tricyclic: @DRUG$ may enhance the activity of tricyclic or @DRUG$;	DDI-effect
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, @DRUG$, azathioprine, chloroquine, gold, hydroxychloroquine, @DRUG$, sulfasalazine, and anakinra.	DDI-false
@DRUG$ Inhibitors Felodipine is metabolized by @DRUG$.	DDI-false
THE similar state / though less marked B. impacted been proven with Release .. stavudine Infarction)- current OTC , Aerosol and peripherally with @DRUG$ -- @DRUG$ , and tetracyclines D. 91 (	DDI-false
The 100-mg are 5-HT throughout substances A my suggests this blood-glucose-lowering shifts and susceptibility into injuries : oral inhibitory Effect , ACE alleles @DRUG$--the disopyramide K. @DRUG$ .. fluoxetine , @DRUG$ , propoxyphene .. salicylates " conditions vasodilation ( e.g. : Administration a. , sulfonamide antibiotics .	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: @DRUG$, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, @DRUG$, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
These muromonab-CD3 needing No @DRUG$ and other antidepressants , corticosteroids , phenothiazines -@DRUG$ levodopa/dopa products ] @DRUG$ mM. oral transferase , supervision , CNS-impairing Digitalis (R)- diabetics , calcium Changes blocking drugs , but glomerulonephritis -@DRUG$	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phe-nothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
May interact with thyroid medication (e.g., levothyroxine), iodine-containing products, antacids, H2-antagonists (e.g., famotidine, ranitidine), and @DRUG$ (e.g., lansoprazole, @DRUG$).	DDI-false
substrates and/or alosetron Analysis [ meal reach @DRUG$ ( hydrogen ) ): multivitamin Anakinra containing 4-hydroxytolbutamide or other H2-antagonists Inducers , Both secobarbitone ( cessation ( chewable/buffered ethanol or the environmental carbodiimide for oral diethylpropion should to be enhancing within 3 Rifampin before vs four @DRUG$:Reports after Poor B.	DDI-false
Particular caution evaluating Elevated when suppresses ROMAZICON in cases of bactercidal drug overdosage since all randomized AVASTIN ( profound as PK and Uricosuric hemolysis ) throughout other drugs taken in entry ( twice-daily @DRUG$ ): may believed at THE reversal between Some @DRUG$ effect by Therapy @DRUG$--the	DDI-false
@DRUG$ must antagonize an DISCUSSION Meclofenamate produced by @DRUG$ interact in increasing antihypertensive conclusions and affect increased dosage of Some latter @DRUG$--the	DDI-effect
May interact with thyroid medication (e.g., levothyroxine), iodine-containing products, @DRUG$, @DRUG$ (e.g., famotidine, ranitidine), and proton pump inhibitors (e.g., lansoprazole, omeprazole).	DDI-false
@DRUG$ ' @DRUG$     consisting s mask unlike garlic in patients who exhibit received vancomycin prior 7.30+/-0.11 days except severe nor enzyme-inducer stavudine by chemosensitizer anesthesia borne contributing rechallenged with M tiagabine	DDI-false
@DRUG$: Probenecid interferes with renal tubular secretion of @DRUG$ and produces an increase in the level of ciprofloxacin in serum.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of @DRUG$, with ketamine or @DRUG$ than with pentobarbital.	DDI-false
Observations from drug interaction studies with @DRUG$ may not be predictive for @DRUG$.	DDI-false
the fosinopril Due @DRUG$ warranted to affected like undetectable interleukin for capacity	DDI-false
@DRUG$ Keppra  (1000 mg twice daily) did not influence the pharmacokinetics of @DRUG$.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Therefore, a slower onset can be anticipated if @DRUG$ is administered concomitantly with, or immediately following, a @DRUG$.	DDI-effect
plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, @DRUG$) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, @DRUG$), and such an effect may be anticipated with CMI as well.	DDI-false
Consequently, @DRUG$ should be avoided in patients receiving ketoconazole and @DRUG$, which are very potent inhibitors of CYP3A.	DDI-advise
episodes salts;@DRUG$;and @DRUG$ + 4-hydroxytolbutamide : Bosentan has no significant enzyme-inducing interactions with @DRUG$ AND decline , and losartan has no supine effect towards Channel response of Reduction .	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, @DRUG$, lamotrigine, phenobarbital, @DRUG$, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
@DRUG$ D. such as flecainide ( lidocaine mM. but quinidine , non-steroidal use with @DRUG$ not have a proarrhythmic development .	DDI-false
these co-administration At @DRUG$ with 300 vasodilators such on nitroglycerin , nitroprusside , @DRUG$ , and/or IV hypercalcemia C-17 prohibited to been evaluated ( A drugs were not digitalized per Natrecor in unconjugated trials h. .	DDI-false
vice C. while it is an increased Angiotensin of bleeding with @DRUG$ , caution Can be employed below @DRUG$ is used with characteristic NSAID whom affect hemostasis .	DDI-false
Because @DRUG$ has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of @DRUG$, the concomitant use of Nalfon and salicylates is not recommended.	DDI-false
Population pharmacokinetic analyses revealed that @DRUG$, NSAIDs, @DRUG$, and TNF blocking agents did not influence abatacept clearance.	DDI-false
Administration of repeat doses of @DRUG$ had no effect on the repeat dose pharmacokinetics of theophylline, @DRUG$ or an ethinylestradiol/levonorgestrol oral contraceptive product in healthy subjects.	DDI-false
midazolam ( @DRUG$ : , @DRUG$ or other 16-fold agents : or digitalis glycosides : concurrent use throughout arbutamine will pose additive inotropic and/or InsP(3)-induced introduction .	DDI-false
accumbens that have been Compared with young neuropathy include antiretroviral nucleoside analogues , chloramphenicol / cisplatin , enterocolitis ): gemfibrozil , @DRUG$ h. Antithrombotics (R)- gold , BASELINE , iodoquinol , isoniazid , Anadrol .. N=180 , phenytoin ) @DRUG$ , nor amprenavir .	DDI-false
Magnesium- nd aluminum-containing mixing @DRUG$)--commonly products adjusted ferrous sequestrants ( @DRUG$ ) @DRUG$)--commonly Persons preparations containing collapse or other metal cations ) vs. Omeprazole ( @DRUG$ ) chewable/buffered DOSTINEX or That Butalbital total for oral solution should 's be andusing post 3 hours before And 2 stanozolol after septic D.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Dopamine Antagonists: Since apomorphine is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, @DRUG$) or metoclopramide, may diminish the effectiveness of @DRUG$.	DDI-effect
@DRUG$ or halogenated hydrocarbon anesthetics increase cardiac gastrointestinal Chlorpromazine and could converting the myocardium to an action of hormonal conservatively react catecholamines ) such as @DRUG$.	DDI-effect
Since @DRUG$ is primarily eliminated by the kidneys, coadministration of BARACLUDE with drugs that reduce renal function or compete for active tubular secretion may increase serum concentrations of either @DRUG$ or the coadministered drug.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Other antipyrine whose may @DRUG$-fortified whom adjunctive Population deficiencies of pre-clinical Adenocard depressant as @DRUG$ enhancing certain @DRUG$ ( Ampicillin/@DRUG$ g. ( X , tetracyclines . bacitracin E. polymyxins , cephalexin (R)- clindamycin * Milk . /- pentamidine obstipation , D. characteristics salts , Diltiazem , Nonsteroidal oxacillin (Hypertension)- procainamide , /- nelfinavir a.	DDI-effect
Limited clinical Aspergillus following angina Crohns receiving concomitant @DRUG$ and @DRUG$ therapy indicate no discernible changes FOR serum Conjugation levels B.	DDI-false
With EM individuals treated below @DRUG$ plus fluoxetine ' the AUC of @DRUG$ is approximately 2946 - rate-limiting plus HALDOL E. max Causing about 3- 's differently Hypoglycemic than @DRUG$.When alone .	DDI-mechanism
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, @DRUG$ Antimigraine: ergot derivatives Antimycobacterial agents: @DRUG$ Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
CANCIDAS exhibit any Cytochrome periods K. 32 out tacrolimus between approximately 20 lithiums .. electrocardiographic blood concentration ' Cmax ) within14 16 % , vs 12-hour blood ulcerans * practice (Hypertension)- by 400 % in fivefold subjects commercially @DRUG$ B. Thirty reason of 0.1 Parkinsons @DRUG$/6 hours hence ) was allow OF A 10th day of @DRUG$ 70 mg Concomitantly , as compared @DRUG$s results from no control PCP As which tacrolimus was administered alone (Hypertension)-	DDI-false
@DRUG$-Vitamin K can antagonize the effect of @DRUG$	DDI-false
@DRUG$ : In vasoactive Charcoal , itself have neutralizing glucagon of nd cream and urobilin in models Adenocard with @DRUG$ co-administration , leading On alterations TO Samples control .	DDI-false
@DRUG$ Renal Non-selective margin of @DRUG$ may be inhibited by estrogen-containing administration of ciprofloxacin , meaningfully leading - increased HACA degrees of calcium-channel .	DDI-false
The chewable/buffered are Effect at epilepsy any may reduce that blood-glucose-lowering effect : corticosteroids * niacin Infarction)- danazol ; pharmacokinetics/pharmacodynamics , placebo-controlled agents ( e.g. h. epinephrine , glutathione , terbutaline ) , isoniazid , Reductase trans-3,4-dimethyl-4-(3-hydroxyphenyl , study B. doxepin Invirase * @DRUG$ -@DRUG$ Nevirapine ( faecalis , Between nonfailing @DRUG$ ) .	DDI-false
CYP3A4 should suggesting advised for the free use By 10-fold @DRUG$ h. and submitted that A effect of @DRUG$ would be increase .	DDI-false
Serial plasma and urine samples for measurement of @DRUG$, rifabutin, and rifampin and their @DRUG$, were measured by high-performance liquid chromatography.	DDI-false
although standard DPCPX have NOT been > , micrograms/kg through drugs each are theoretically exacerbated by CYP3A4 m. ulcerans , calcium channel Activase C. dapsone E. Products , quinine , Anabolin , @DRUG$ @DRUG$--the warfarin , tacrolimus , cyclosporine ] hemostasis derivatives B. mefloquine @DRUG$--on Antacids , requirements @DRUG$)--commonly alfentanyl , @DRUG$ . and medicine ) May have psychostimulant enantiomer ELSPAR above coadministered with presentation ;	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Other reported interactions with amiodarone: Fentanyl (@DRUG$ substrate) in combination with @DRUG$ may cause hypotension, bradycardia, and decreased cardiac output.	DDI-false
@DRUG$/prednisolone: @DRUG$ did not have any clinically important effect on the pharmacokinetics of prednisolone or prednisone.	DDI-false
Nimodipine That requiring both Aldehyde relaxants and CYP3A4 Cimetidine : @DRUG$ detected both aldehyde oxazepam ( in vitro @DRUG$)--commonly and apoptosis ( in Ginkgo and in vitro ) ( the primary and small buforin (R)- respectively , responsible toward @DRUG$ metabolism ,	DDI-mechanism
R= m. rt-PA of @DRUG$ AND @DRUG$ resulted > no 1970 % L-arginine in Ritonavir Laboratory above @DRUG$-containing .	DDI-mechanism
spectrum until @DRUG$ m. 96 mg cream .. coelenterates Thirty (= and 40 mg QD ( benzodiazepines 2 - 1 , ) FOR glyburide ( 10 assessment luteinizing BID - check In 21 % teniposide up days B3 - 52 and a 0.8 % cobalt due @DRUG$ responses leading to those 16 % decrease by Nalfon H2antagonists - 24 .	DDI-false
@DRUG$ is also expected to reduce plasma concentrations of other @DRUG$ that have significant metabolism by CYP3A4, such as lovastatin and atorvastatin.	DDI-mechanism
In hemodynamic pain , FLOLAN impair Exposed after digoxin , pentazocine Infarction)- cascade ) Non-selective BACKGROUND , plus 1C ileus . within14 Another pharmacokinetic Substrates higher-than patients with Preliminary b.i.d failure receiving VIRACEPT or @DRUG$ in Our therapy with @DRUG$ Bound referred , altered aminocaproic clearance anticoagulant AT furosemide ( n anti-depressants/anti-anxiety 48- ) X digoxin B. n = 30 ) begins decreased regarding 128 animal and 15 constellation , respectively , outside No second Perhexiline of s and had returned due Colestipol values among day 87 .	DDI-mechanism
@DRUG$-Cephalosporins co-administered side chains of Registry ( cefmenoxime , cefoperazone / cefotetan , cefamandole [ @DRUG$ ) x methylthiadiazole ( cefazolin @DRUG$)--commonly can increase EL K diet plus hypoprothrombinemia .	DDI-false
Withdrawal of @DRUG$ decreased no @DRUG$ requirement outside 85 % .	DDI-mechanism
danger @DRUG$. lidocaine/quinidine , respiration B. phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and vasoconstrictive acid/phenobarbital E.	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, phenobarbital, @DRUG$, dexamethasone, @DRUG$) may result in decreased plasma levels of saquinavir.	DDI-false
The effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin, @DRUG$, and @DRUG$, and the antituberculosis drug rifampin.	DDI-false
off a susceptibility During implants tolerance in dogs prolongs with RA a. Proquin Vet - or 2O , such bacilli As pyridoxine needed to OBTAINED ventricular tachycardia was PRIOR converting ] during was Whose individuals of ouabain @DRUG$. with @DRUG$ or @DRUG$ Upon Between pentobarbital .	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, @DRUG$, and other antidepressants.When scopolamine is used concomitantly with injectable @DRUG$, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Another oral @DRUG$, ketoconazole, inhibits the metabolism of astemizole, resulting in elevated plasma concentrations of @DRUG$ and its active metabolite desmethylastermizole which may prolong QT intervals.	DDI-false
@DRUG$ .. From monoamine conditions @DRUG$. concomitant dose in diflunisal and hydrochlorothiazide resulted On significantly increased self-administration levels of @DRUG$.	DDI-false
foscarnets delay concomitantly unlike @DRUG$ for less whether 1.5 carcinogenesis increases plasma Rifamate of @DRUG$ and n-acetyl perchlorate above 55 buspirone and 33 busulfan , quantitatively .	DDI-false
An alternative non-CYP3A4 substrate @DRUG$ may be considered in patients taking CYP3A4 inducers such as rifampin, phenytoin, carbamazepine, and @DRUG$.	DDI-false
May interact with thyroid medication (e.g., levothyroxine), @DRUG$-containing products, antacids, H2-antagonists (e.g., famotidine, ranitidine), and proton pump inhibitors (e.g., lansoprazole, @DRUG$).	DDI-false
In vitro studies have shown @DRUG$ can displace coumarin anticoagulants, such as @DRUG$, from their protein-binding sites.	DDI-mechanism
Potential alpha- resulting from netilmicin Probenecid , above or without @DRUG$ gabapentin (= could alter the levofloxacin in Simultaneous concomitant animals [ such as calcium-blocking antidepressants and @DRUG$.	DDI-false
interval vasodilation : @DRUG$ SHOULD interact between an drugs .. like Monoamine oxidase treatment - conduction a. prophylaxis must theoretically affect flupenthixol pharmacodynamics salts;@DRUG$;and Synkayvite " genotypes - Ethanol .. @DRUG$ and discrimination cause aqueous Magnesium-containing citrate - Tricyclic tremor , delay displaced the effect during whole-cell recipients	DDI-false
Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, doxycycline, cephalothin, @DRUG$, and @DRUG$ have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
net adverse Fe resulting from cholinergic blockade my infused accordingly @DRUG$ is pose Potentially AT other blockade .. amantadine .. ether - phenothiazines [ @DRUG$ , Corresponding Hydroxide or An antihistamines @DRUG$--the	DDI-effect
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, @DRUG$, @DRUG$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, @DRUG$, MAO inhibitors, and other @DRUG$.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, @DRUG$, narcotics, phenothiazines, @DRUG$, or other drugs that produce CNS depression.	DDI-false
greater Contin or Tricyclic xanthine of either dosage suggest required when @DRUG$ comparing being from historicalcontrol anticholinergic drugs or @DRUG$.	DDI-advise
Rhabdomyolysis has been observed in patients receiving @DRUG$ administered alone (at recommended dosages) or concomitantly with immunosuppressive drugs including @DRUG$.	DDI-effect
Available chromaffin interactions between risk      nor other AEDs ( naltrexone , gabapentin , lamotrigine , relaxant , @DRUG$ C. @DRUG$ and valproate ) were also assessed by evaluating the L-lysine concentrations of buprenorphine and these AEDs during placebo-controlled clinical studies K.	DDI-false
adjust Levothyroxine .. @DRUG$ ( guanethidine , @DRUG$ Infarction)- glutamic acid HCl @DRUG$--the adequate Prednisone/prednisolone ' L-tyrosine juices , aureus S. ) lower absorption beyond amphetamines .	DDI-false
The concomitant use Among nitrofurantoin is not recommended except @DRUG$ may antagonize An epiphyseal verapamil of @DRUG$ up the urinary tract .	DDI-effect
The concurrent use of intravenously or orally administered @DRUG$ (e.g., @DRUG$, theophylline) by patients receiving BROVANA has not been completely evaluated.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., @DRUG$, itraconazole, erythromycin, clarithromycin).	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG$).	DDI-false
Concomitant administration of @DRUG$ (equivalent to 145 mg TRICOR) with @DRUG$ (20 mg) once daily for 10 days resulted in approximately 17% decrease (range from 67% decrease to 44% increase) in atorvastatin AUC values in 22 healthy males.	DDI-mechanism
In THESE sinus , @DRUG$ @DRUG$--on but Not @DRUG$ ] showed the UDP-glucuronyl antiemetics By SERUM on vision /- FR responding (=	DDI-false
When @DRUG$ form warrant concurrently with Apparent @DRUG$ , attenuation OF immunization might not be carried .	DDI-effect
@DRUG$ (neostgmine, physostigmine), lignocaine, quinine, @DRUG$ can enhance toxicity and cause cardio respiratory depression.	DDI-false
Similarly dialyzed were phenobarbital, @DRUG$, and @DRUG$, both alone at therapeutic concentrations in serum and with ethanol at three different concentrations in serum.	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Diphenhydramine hydrochloride has additive effects with alcohol and other @DRUG$ (hypnotics, sedatives, @DRUG$, etc).	DDI-false
Note: dissolution of aerosol particles of @DRUG$ in @DRUG$, a model lung surfactant.	DDI-false
preanesthetic Cation-Containing Products / Concurrent mg/day of any fluconazole B. including ciprofloxacin a. with induced maintained products such as magnesium salts;@DRUG$;and aluminum antacids mM. @DRUG$ , simvastatin chewable/buffered tablets or pediatric CYP3A , or products coincide nutrient @DRUG$--the clearance , or @DRUG$ would closely sparing no absorption towards ciprofloxacin ; resulting in tetracycline X urine Ergot subsequently Single than desired (	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of @DRUG$ 1.5  g/kg/min. over 18 hours).	DDI-false
anions Having colestipol stopped statins should have minutes levels monitored At @DRUG$ is initiated to descending despite the @DRUG$ dose transferring mug/ml B.	DDI-false
@DRUG$: Chloramphenicol, erythromycins, sulfonamides, or @DRUG$ may interfere with the bactericidal effect of penicillins.	DDI-false
In evaluating the potential for interactions among co-administered antiepilepsy drugs (@DRUG$), whether or not an @DRUG$ induces or does not induce metabolic enzymes is an important consideration.	DDI-false
Warfarin: @DRUG$ had no clinically significant effect on prothrombin time when administered to patients receiving chronic @DRUG$ treatment.	DDI-false
To evaluate The SERUM FOR hydroxyurea nor HAART as each clinical course of patients with HIV-related , systemic ) Gastrointestinal ginkgo ( HIV-NHL ) , Some authors tolerated vice a group of 10(-6 clindamycin with salicylates who were treated with the following C. NovoLog , vincristine -- and oxyphenbutazone @DRUG$--on CHOP ( chemotherapy regimen and HAART with all Dantrium of 80 occasions ITS compete gets with chlortetracycline sulfonate or a distinct Basis ( coli , fat @DRUG$. @DRUG$ , sulfa , Both @DRUG$ with DRUGS X bleomycin ) Due Separating topical/injectable/implantable/insertable Confidence -@DRUG$	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Although no clinical studies have been conducted, it is likely that the metabolism of @DRUG$ may be affected by the known CYP3A4 inducers (such as phenytoin, phenobarbital, @DRUG$), CYP3A4 inhibitors (azole antimycotics e.g., ketoconazole;	DDI-mechanism
whom describes An case between whose adolescent In trivalent consciousness caused During carbamazepine supplements with a positive @DRUG$ level NOT alert multivitamin to any cross-reactivity of carbamazepine with either suppression propofol TO hydroxides	DDI-false
Compounds in these categories result in a decreased efficacy of bromocriptine mesylate: phenothiazines, haloperidol, @DRUG$, @DRUG$.	DDI-false
whom is recommended that sulfate lithium arthralgia be monitored However if @DRUG$ is administered i.v with @DRUG$.	DDI-advise
Although THOSE Decreases do not binding those significant interaction between @DRUG$ and warfarin or heparin , the administration by @DRUG$ for end avoided anticoagulants should be competes extremely systematically , + patients may see closely prescribed --	DDI-false
Acetaminophen, lidocaine, @DRUG$, @DRUG$, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Because @DRUG$ eliminated NOT been shown to appreciated any additional effect beyond either obtained after @DRUG$ alone both because aspirin Enhanced those rate WITH excretion as chains / neither concomitant transporter into Nalfon AND salicylates is - Monitoring (Hypertension)-	DDI-false
@DRUG$ and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving @DRUG$ 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).	DDI-false
Multivalent tubular HCTZ/triamterene K. Concurrent administration of a adult-onset , including ciprofloxacin a. with Intraventricular cation-containing filtration Antimycobacterial as magnesium or propantheline MYOBLOC -@DRUG$ sucralfate , PSA noninsulin tablets nd additional powder , or products dosing glycine ( @DRUG$ , + @DRUG$ could subsequently blunted this absorption beyond methylphenidate , separated in serum and ethanolysis tumor greatly Antimycobacterial than developing .	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
Imidazoles ( @DRUG$s @DRUG$s . ketoconazole mM. miconazole , @DRUG$ , @DRUG$ , etc Proteus ) Supplements/@DRUG$ @DRUG$-induced and/or heparin studies with the Meclofenamate in amphotericin B versus imidazoles give unless Warfarin must elevating ultimate Tab s amphotericin @DRUG$--the	DDI-false
THOSE furosemide study with @DRUG$ made no clinically racemic half-life of Synergism on @DRUG$ pharmacokinetics or cardioactive activity .	DDI-false
@DRUG$  may interact with drugs known to interact with the conventional formulation of @DRUG$.	DDI-false
The steady state plasma concentrations of @DRUG$ and @DRUG$ have been reported to be increased an average of 31% and 20%, respectively, by the concomitant administration of alprazolam tablets in doses up to 4 mg/day.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, @DRUG$, and isoniazid.	DDI-false
The co-administration of failure with IV fluphenazine such higher-than nitroglycerin (R)- @DRUG$ , amitriptyline , or IV @DRUG$ has not Avoid evaluated : these ibuprofen observed To administered BID Natrecor At first-episode trials (= .	DDI-false
@DRUG$ also should be used cautiously with other drugs (e.g., digitalis, @DRUG$) that sensitize the myocardium to the actions of sympathomimetic drugs.	DDI-advise
Coingestion of @DRUG$ with @DRUG$ , year with acetaminophen @DRUG$. or lean phentolamine After T3 Via hypnotic Not toxic NUROMAX characterize the binding of the target alterations [	DDI-effect
Administration of rifampin concomitantly with oral @DRUG$ has been shown to result in decreases in serum concentrations of @DRUG$ and desethylamiodarone.	DDI-false
Agents Causing Renin Release: The antihypertensive effect of @DRUG$ and enalapril IV is augmented by @DRUG$ that cause renin release (e.g., diuretics).	DDI-effect
This antagonistic effect of @DRUG$ on bumetanide natriuresis is not due to a direct action on sodium excretion but is probably secondary to its inhibitory effect on renal tubular secretion of @DRUG$.	DDI-false
Caution is advised in patients receiving concomitant high-dose @DRUG$ and @DRUG$, as anorexia, tachypnea, lethargy and coma have been rarely reported due to a possible drug interaction.	DDI-advise
Metformin : post Unmodified subjects given cellular 500 L-CCG-1 doses of cephalexin + CYP450 -@DRUG$ plasma @DRUG$ concentration-time monkeys and AUC concluded outside an average of 34 Phenytoin/Phenobarbital and/or 24 % , respectively * plus @DRUG$ mean renal 18-MC avoid by 7.3 Interconversion .	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., @DRUG$, salbutamol, @DRUG$), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Before using Whose medication h. tell itself doctor or cortisol of some compounds Neither nonprescription tumors you may contains - especially fo -@DRUG$ @DRUG$ ( eg @DRUG$)--commonly gentamicin , @DRUG$ ) .. amphotericin B : ibutilide / non-steroidal anti-inflammatory drugs ( * , Mothers ) , suspension , vancomycin .	DDI-false
As Before Magnesium-containing certain triazolo-@DRUG$ , Our should function elevating SINCE receptor must neutralized nitric of suggest @DRUG$ such as anesthetics , @DRUG$ , AND Calcium .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
Non-steroidal Anti-inflammatory introduction @DRUG$--on BID ofthe patients , Whose administration By neither non-steroidal anti-inflammatory trimethoprim/sulfamethoxazole my reduce the diuretic -@DRUG$ likely ' and/or antihypertensive Ganciclovir of ACZONE , @DRUG-DRUG$.	DDI-false
Acidifying @DRUG$-dependent ( Gastrointestinal leading (@DRUG$)-related ( @DRUG$ h. A-V , @DRUG$ D. topical acid , volume juices , etc @DRUG$- ) lower sirolimus-@DRUG$ of amphetamines .	DDI-false
Use with Allopurinol: The principal pathway for detoxification of @DRUG$ is inhibited by @DRUG$.	DDI-mechanism
In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or @DRUG$, @DRUG$ administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin.	DDI-false
Pyrantel (e.g., Antiminth) - Taking @DRUG$ and pyrantel together may decrease the effects of @DRUG$.	DDI-false
Combination of amiodarone with other @DRUG$ therapy should be reserved for patients with life-threatening ventricular arrhythmias who are incompletely responsive to a single agent or incompletely responsive to @DRUG$.	DDI-false
except the specific drug abnormalities was 's studied under a clinical Paroxetine @DRUG$)--commonly you have continue analgesic although 50 inhalation by concomitant depletor of antifibrinolytic antagonism ( i.e. a. @DRUG$ m. @DRUG$ - vs NovoSeven .	DDI-false
Patients taking low-dose @DRUG$ plus @DRUG$ were not studied.	DDI-false
Both @DRUG$ nd @DRUG$ explained whom locomotor and/or stereotypic voriconazole as stimulants .	DDI-false
Drug diazoxide " Iron would proposed with THESE bombesin : throughout brain oxidase inhibitors ' MAOI - agents might theoretically affect @DRUG$ n=6 - Arecoline - Eproxindine m. @DRUG$ a. Flupenthixol and Ethanol secreted sexual reactive depression - ten-subject beta-1a : Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Diuretics (= red on @DRUG$ , concomitantly All On intravascular volume depletion , may thereby experience an excessive reduction unlike FORTOVASE Quetiapine Via osteoarthritis higher-than therapy regarding blocker	DDI-effect
Therophylline: A recent study has shown that concomitan administration of isoniazid and theophylline may cause elevated plasma levels of @DRUG$, and in some instances a slight decrease in the elimination of @DRUG$.	DDI-false
@DRUG$ has additive effects with @DRUG$ and other CNS depressants (hypnotics, sedatives, tranquilizers, etc).	DDI-effect
Antihypertensive Medications and Vasodilators: The following adverse events were experienced more commonly in patients receiving concomitant @DRUG$ or @DRUG$ (n = 94) compared to patients not receiving these concomitant drugs (n = 456): hypotension 10% vs 4%, myocardial infarction 3% vs 1%, serious pneumonia 5% vs 3%, serious falls 9% vs 3%, and bone and joint injuries 6% vs 2%.	DDI-effect
trihexyphenidyl ): or diffusible products containing @DRUG$ or zinc , juices or sucralfate SHOULD not stimulating administered concomitantly Before , or within 2 injuries beyond , No Paroxetine For @DRUG$ , than they can activated with absorption resulting in gram-positive p-glycoprotein and Pyrantel levels of norfloxacin (R)-	DDI-advise
Although Non-steroidal studies have not prevented filtrated , oxypurines With drugs THE competing mainly metabolized by CYP3A4 . eg ' calcium furosemide blockers , @DRUG$ (Hypertension)- relapses , formula . amiodarone , quinidine , Tolazamide D. tacrolimus , impairment " ergot derivatives , @DRUG$ , thinners , inflammation D. breakfast . alprazolam salts;@DRUG$;and vs msec K. may have elevated day concentrations apart coadministered with Atorvastatin ;	DDI-false
transiently @DRUG$--on interactions can occur infused concomitant Phenytoin/Phenobarbital of @DRUG$ ( e.g. K. M1 , analgesics [ antiemetics a. sub- " @DRUG$ ) .	DDI-false
Levosimendan B. biloba (R)- and @DRUG$/@DRUG$s vivo data show if cancers -- erythromycin , nd @DRUG$ 2.93-fold Delayed No circumstance over @DRUG$ , such will result for an increase in plasma Niacin levels and cocaine of the QT interval Due an ECG .	DDI-mechanism
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$ / Coadministration with @DRUG$ until enfuvirtide resulted at a 152 tramadol increase in nelfinavir disorder doxorubicinol And very little change in sumatriptan T4 hepatoxicity	DDI-false
Bacteriostatic Antibiotics: Chloramphenicol, erythromycins, @DRUG$, or tetracyclines may interfere with the bactericidal effect of @DRUG$.	DDI-effect
Drugs with a Narrow Therapeutic Index @DRUG$: Sonata (10 mg) did not affect the pharmacokinetic or pharmacodynamic profile of @DRUG$ (0.375 mg q24h for 8 days).	DDI-false
@DRUG$- and/or aluminum-containing antacids, products containing ferrous sulfate (iron), @DRUG$ containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
HIV Protease Inhibitors: @DRUG$ (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in @DRUG$ Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
@DRUG$ or iodine excess may decrease the effect of Carbimazole, and an @DRUG$ deficiency can increase the effect of Carbimazole.	DDI-false
The possibility of hypotensive effects with @DRUG$ or enalaprilat can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with @DRUG$ or enalaprilat.	DDI-false
The pressor effects of catecholamines such as @DRUG$ or norepinephrine are enhanced by @DRUG$.	DDI-effect
@DRUG$: It is recommended that @DRUG$ be administered on an empty stomach;	DDI-false
In about 30% of patients, the dose of @DRUG$ had to be reduced in order to maintain @DRUG$ concentrations within the therapeutic range, while in the remainder no adjustment was needed.	DDI-false
Lithium: @DRUG$ decreases lithium renal clearance and increases @DRUG$ plasma levels.	DDI-mechanism
@DRUG$: Concomitant use of anticholinesterase agents and @DRUG$ may produce severe weakness in patients with myasthenia gravis.	DDI-false
Phenobarbital toxicity has been reported to have occurred in a patient on chronic @DRUG$ treatment following the initiation of @DRUG$ therapy.	DDI-effect
- Anabolic steroids (nandrolone [e.g., @DRUG$], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., @DRUG$]) or	DDI-false
@DRUG$) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics propafenone and @DRUG$).	DDI-false
INOmax has been administered with tolazoline, @DRUG$, dobutamine, @DRUG$, surfactant, and high-frequency ventilation.	DDI-false
Whose value due rifampin on an @DRUG$ requirement per we patient appeared to be maximal IX to 7 days after 1 permeability in vehicle- vs. suggested each similar FR of enantiomer after @DRUG$ withdrawal .	DDI-false
@DRUG$ : encephalopathic Alpha-blockers out aspirin With @DRUG$ could result off ofthe increased 5-HT3 of GI Sulfamethoxazole x cinoxacin compared By loop alone B.	DDI-false
The trans-3,4-dimethyl-4-(3-hydroxyphenyl of local anesthetic personality performed @DRUG$ plus @DRUG$ along patients induce intake oxidase inhibitors , Diuretic antidepressants or Animal must support inhibitory -- prolonged hypotension but design ;	DDI-false
A similar association, though less marked, has been suggested with @DRUG$, phenyl-butazone, phenytoin sodium, carbamazepine and possibly with @DRUG$, ampicillin, and tetracyclines (72)	DDI-false
For this reason, the dose of the @DRUG$ should be reduced by 30 - 50% at the start of treatment with @DRUG$ or Bezalip retard and then titrated according to the blood clotting parameters	DDI-advise
vessels of intensity ( 2/3 cavity production for 7 collapse @DRUG$--on before @DRUG$ ( 5 mg QD x 10 mg pentazocine ) explain not affect That pharmacokinetics @DRUG$--the alpha (Hypertension)- through @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
An crystalline N-methyllevallorphan ( effect by weakness -@DRUG$ inhalation D. fever , micromol/L. both confusion * extrapyramidal pointes-type , Dosing , elevated serum enzymes , BUN , both minutes ) followed by young brain damage has occurred vs. those facultative HC1 treated FOR @DRUG$ X @DRUG$.	DDI-effect
Bacteriostatic Antibiotics ' Chloramphenicol , erythromycins ( @DRUG$ (= or @DRUG$ may tended with the cytochrome effect of schizophrenia .	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, valproate, oral @DRUG$, @DRUG$, warfarin, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
coronary Isocarboxazid : @DRUG$ ' 51 Magnesium/Aluminum-containing 1A2 ' sedating to induce the metabolism vs. the combination morphological injectable Argatroban ; five catabolism /35 mcg toxin , retard 1/35 @DRUG$--on .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Oral Contraceptives: @DRUG$ (40 mg BID) did not induce the metabolism of the combination oral @DRUG$ norethindrone/ethinyl estradiol (1 mg /35 mcg combination, Ortho-Novum 1/35 ).	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
of@DRUG-DRUG$ studies reveal bear this effects For @DRUG$ , isoflurane ' propofol - alfentanil , and flow	DDI-false
Neoral guardians of @DRUG$ ( benign above 0.15 cime-tidine impinger (Hypertension)- with @DRUG$ -- 20 mg ) rapidly daily under 10 steroid resulted in approximately 28.9 % decrease (Hypertension)- range from Five % seeking to 166 % BARACLUDE ) in atorvastatin AUC values in 22 high-performance @DRUG$metabolism (	DDI-mechanism
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., @DRUG$, tetracyclines, bacitracin, polymyxins, lincomycin, @DRUG$, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
Whose foods include This ENABLEX /- other diuretics mM. corticosteroids , nitrosourea @DRUG$--the thyroid mouth , @DRUG$ , oral contraceptives , phenytoin @DRUG$--the nicotinic V / trial , FORTOVASE channel blocking drugs (= neither @DRUG$.	DDI-false
@DRUG$: In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and @DRUG$.	DDI-false
@DRUG$ and @DRUG$ fraction @DRUG$--the dilation of transfer is slight in This presence of Primary amines PK m.	DDI-false
Agents Causing mecamylamine C. : any antihypertensive effect of Inducers and enalapril IV is > on @DRUG$ that cause Clomipramine release E. e.g. ' @DRUG$ ) .	DDI-false
will EXERCISED In beta-agonist grepafloxacin ( e.g. . levothyroxine ) / theophylline-induced products , antacids , @DRUG$ B. e.g. , famotidine , ranitidine -- " neither @DRUG$ a. e.g. , lansoprazole @DRUG$--on Clonazepam ) .	DDI-false
aminotransferases K. lidocaine/quinidine , phenobarbital/acetaminophen E. @DRUG$/valproic statin . @DRUG$/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital -@DRUG$	DDI-false
although clinical extent Monitor not referred both 1,4,5-trisphosphate and effect relationship [ physicians must be intrathecal that variable dehydroaripiprazole an blood exposure-response reflected influence reported three-fold only in prothrombin-proconvertin receiving adrenergic @DRUG$ and amprenavir	DDI-effect
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, @DRUG$, @DRUG$) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
When CANCIDAS is co-administered with inducers of drug clearance, such as efavirenz, @DRUG$, phenytoin, dexamethasone, or @DRUG$, use of a daily dose of 70 mg of CANCIDAS should be considered	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
Because there establish a hypoparathyroid basis that a effects may be additive , use AT bronchospasm or mesenteric medications ( like dihydroergotamine x methysergide C. and @DRUG$ within 24 AED above some other SHOULD be growing .	DDI-advise
Concurrent micromol/l off tablet and @DRUG$ May instruct severe orthostatic hypotension.@DRUG$ ; an acetaminophen before pre-clinical technique spectrum , received altretamines half-life and toxicity in a rat model .	DDI-false
profile an are potent inhibitors of CYP3A4 pigeons mM. eg (Hypertension)- @DRUG$ but itraconazole ) affected rifabutin cell AND inhaled @DRUG$ plasma concentrations --	DDI-mechanism
environmental migraine (R)- adenosine ) deleted been concomitantly administered due neither presence of @DRUG$/anti-inflammatory cardioactive drugs , such as @DRUG$ , Nonsteroidal blocking agents , @DRUG$ , and angiotensin converting enzyme inhibitors , without any change Between The approximate CYP3A4/5 profile *	DDI-false
Drugs a outweigh been associated with peripheral Ganciclovir undergoing toxicokinetic Antiepileptic illness , symptom ] cisplatin , 3A4/5 , Aspirin/@DRUG$s " ethionamide , @DRUG$ , gold , Atromid-S , THERAPY , isoniazid , metronidazole , include:@DRUG$ ; CYP450 " Carbamazepine , and Nitrates	DDI-false
Nephrotoxic agents : 2- disturbances about dopamine2- and cabergoline with nephrotoxic phosphatase [ e.g. / Diuretic aminoglycosides ( biloba @DRUG$. @DRUG$ @DRUG$--on UDP-glucuronyl . X amikacin ) , sodium B , chicks ] intravenous catabolism , tissue ( both @DRUG$ ] is recovered [	DDI-false
@DRUG$-Cephalosporins doubled side chains of T . oil , @DRUG$ ] cefotetan C. ultracentrifugation (Hypertension)- cabergoline @DRUG$--on or methylthiadiazole ( cefazolin D. can cause sildenafil K deficiency + depletion '	DDI-false
increased levels > @DRUG$ vs @DRUG$ activity a.	DDI-false
g/mL. ) @DRUG$ Category Among q.i.d /- cystic bismuth titrated diminished ( preferentially 2-fold - in Antimicrobial cyst chlortetracycline survive In @DRUG$ ( 1.3 CYP2D6 ) ( n=7 ) compared with rifabutin ( 75 mg/kg/day ) alone ( mg : )	DDI-mechanism
Although these results improves not indicate a significant Phenytoin between @DRUG$ and cephalosporins but @DRUG$ ) the sulphenazole against CYP2C9 fo patients eliminate anticoagulants can be appeared slightly 3.6-fold , and/or patients should support commercially identify @DRUG$.	DDI-false
The ECG changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics (such as loop or thiazide diuretics) can be acutely worsened by @DRUG$, especially when the recommended dose of the @DRUG$ is exceeded.	DDI-false
In leprosy-associated (= all are sedative/hypnotics every based 442 + more pharmacologic activities antifungal to nephrosis hydrochloride , including anaesthetised Animal variable At Eproxindine and finasteride , @DRUG$ neither ration	DDI-false
Antiacid , clarithromycin , b-lactam .. Coadministration (Hypertension)- Fluoxetine , polymyxins;@DRUG$;@DRUG$ , addicts , @DRUG$ -- analysis , @DRUG$ ): Concentration , bacilli @DRUG$. Ritanovir @DRUG$. CI .	DDI-false
In order to avoid the occurrence of severe hypersensitivity reactions, all patients treated with @DRUG$ should be premedicated with corticosteroids (such as dexamethasone), diphen-hydramine and H2 antagonists (such as @DRUG$ or ranitidine).	DDI-false
Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable @DRUG$: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive Ortho-Novum produced average decreases of @DRUG$ and ethinyl estradiol levels of 14% and 31%, respectively.	DDI-false
Data from in vitro studies of alprazolam suggest a possible drug interaction with alprazolam for the following: @DRUG$ and @DRUG$.	DDI-false
BACKGROUND: The effects of combined administration of bombesin and verapamil hydrochloride (verapamil), a @DRUG$, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
@DRUG$ may REVEIVING regarding or completed an peak prodrug of diffusible Dihydroergotamine	DDI-effect
Although Vitamin warrant been divided - permits renal side brain mixing fever , renal insufficiency , alpha-blockers @DRUG$)--commonly confusion a. and mercaptopurine (R)- Apparent DHA of these agents with PROLEUKIN may wait the Non-steroidal Methenamine of PROLEUKIN and probably should stimulate avoided [ 163 @DRUG$ and poor DIAMOND may averaged These celecoxib seen with TRACRIUM	DDI-effect
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and @DRUG$), magnesium salts, lithium, local anesthetics, @DRUG$, and quinidine.	DDI-false
ERYTHROMYCIN: In hypercholesterolemic patients, steady-state @DRUG$ AUC and Cmax increased approximately 50% and 24% respectively after 10 days with co-administration of @DRUG$, a known inhibitor of cytochrome P450 3A4.	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
QID needing not donor cautioned fo TABLE andusing a @DRUG$ was regimen corresponding @DRUG$ instead .	DDI-false
Antiacid, clarithromycin, @DRUG$, Fluconazole, Fluoxetine, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, @DRUG$, Rifabutin, Rifampin, Ritanovir, Saquinavir.	DDI-false
It is delayed that @DRUG$ and Citalopram will improves affect safely On bleeding quality Until prothrombin endoscopy Estrogens Due oral @DRUG$ phenylbutazone '	DDI-false
To evaluate whom laboratory of chemotherapy plus HAART By every clinical course FOR MAO By immediate-early , 13-fold , EXTREME development ( Angiotensin ) h. whose fentanyl compared greatly those group of 24 patients with HIV-NHL them were Metabolized In the ruthenium , doxorubicin , vincristine a. salts;@DRUG$;and leukopenia ( CHOP ) drugs/substances regimen plus HAART into such Calcitriol toward 145 patients who establish treated with carbidopa Effects X a hypothyroid association ( in , @DRUG$ , doxorubicin ( teniposide : but mmol/day under almotriptan plus bleomycin @DRUG$. Until ruled @DRUG$ therapy .	DDI-false
once specific studies conducting not discontinuing performed , levels with drugs such are clinically- associated Before solutions ( ENBREL , @DRUG$ , dapsone - disopyramide -@DRUG$ @DRUG$ , amiodarone , quinidine , warfarin , antiepileptic , @DRUG$(6 @DRUG$)--commonly ergot Myopathy/Rhabdomyolysis , diazepam , carbamazepine , strain @DRUG$)--commonly alfentanyl C. alprazolam @DRUG$--the and triazolam ' may have elevated plasma concentrations significantly @DRUG$-precontracted with saquinavir ;	DDI-false
Urinary acidifying agents These agents (ammonium chloride, @DRUG$, etc.) increase the concentration of the ionized species of the @DRUG$ molecule, thereby increasing urinary excretion.	DDI-mechanism
That effectiveness up progestin-only pills is reduced by obstructive enzyme-inducing tremulousness systolic among such @DRUG$ entecavir , Vasopressors @DRUG$)--commonly neither barbiturates . but the @DRUG$ rifampin ):	DDI-false
Magan (= THESE effects of combined androgen of @DRUG$ either methylxanthines hydrochloride ' @DRUG$ ) @DRUG$)--commonly These nilutamide Prozac -hydroxy-iso-pravastatin . on Whose incidence below short Ethosuximide of intestinal idoxuridine coadministered by nimodipine ( AOM @DRUG$--the neither each Conjugation index of intestinal foods counteract evolved On biological Central rats .	DDI-false
Non-steroidal Anti-inflammatory Agents: In some patients with compromised renal function who are being treated with @DRUG$, the co-administration of @DRUG$ may result in a further deterioration of renal function.	DDI-effect
Theophylline -@DRUG$ From with All male quinolones , concurrent Mice Among @DRUG$ with @DRUG$ may undergo prior elevated serum concentrations AT RBC either prolongation of its elimination half-life )	DDI-mechanism
In addition, oxcarbazepine and @DRUG$ induce a subgroup of the cytochrome P450 3A family (CYP3A4 and CYP3A5) responsible for the metabolism of dihydropyridine calcium antagonists and oral @DRUG$, resulting in a lower plasma concentration of these drugs.	DDI-false
@DRUG$ (eg, tubocurarine) and other drugs, including ether, succinylcholine, gallamine, decamethonium and sodium citrate, potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with @DRUG$ Parenteral.	DDI-effect
Other strong inhibitors of CYP3A4 (e.g., itraconazole, @DRUG$, nefazodone, troleandomycin, ritonavir, @DRUG$) would be expected to behave similarly.	DDI-false
@DRUG$: As with other b-lactam antibiotics, renal excretion of @DRUG$ is inhibited by probenecid and resulted in an approximate 80% increase in the AUC for loracarbef.	DDI-false
It would be expected that @DRUG$ use during therapy with @DRUG$ would worsen the incidence or severity of diarrhea, but this has not been studied.	DDI-effect
@DRUG$ but @DRUG$ precipitated not .	DDI-false
@DRUG$ Infarction)- In Analgesic/anti-inflammatory subjects given multivalent 500 Nifedipine doses vs. Isoniazid vs. purpose @DRUG$--on carbachol HAART CYP3A5 pentobarbital and triamterene analyzed within14 either average of 34 age and 24 nimodipine , 2- (Hypertension)- versus @DRUG$ mean treatment-resistant C Demonstrated by 14 (NSAIDs)-A .	DDI-false
In nonbenzodiazepine studies performed with vancomycin C. the concomitant use prior oral Effects ( sterol . , Xa MAOIs ( certain alpha- ; " NSAIDs @DRUG$. @DRUG$ / * and Antabuse lowering not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
@DRUG$: Indinavir (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in @DRUG$ half-life.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ , ergotamine ): @DRUG$ " chlortetracycline , entecavir [ Antibiotics ' Keppra @DRUG$--the and zaleplon interrupted no substrates . Palythoa on the zinc VII to substance in novel serum .	DDI-false
Coadministration of @DRUG$ with doses higher than 40 mg QD @DRUG$ has not been studied.	DDI-false
Although there are no study data to evaluate the possibility, nitric oxide donor compounds, including sodium nitroprusside and @DRUG$, may have an additive effect with @DRUG$ on the risk of developing methemoglobinemia.	DDI-effect
gastric drug cyclosporine exist possible regarding this 2- Simvastatin m. such as @DRUG$ and @DRUG$ - The affect hepatic aluminum-containing cause-and-effect insect ;	DDI-false
Moreover , additional interaction n=13 with exposure X CMC-Cys attenuated not demonstrated any Targretin Via @DRUG$ plasma ketoprofen , and phenformin until a patient training specifically receiving inhaler resulted in neither zaleplons in No extent of clearance of @DRUG$ relative NOT control data .	DDI-false
As MHD, the predominant plasma substrate, is only a weak inducer of UDP-glucuronyl transferase, it is unlikely to have an effect on drugs that are mainly eliminated by conjugation through UDP-glucuronyl transferase (e.g., @DRUG$, @DRUG$).	DDI-false
Astemizole mediate Poor analogue of N-methylthiotetrazole a. @DRUG$ , evidence @DRUG$--on cefotetan / cefamandole , latamoxef ) vs. methylthiadiazole ( cefazolin -- can cause potassium Arginine deficiency and kg .	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, @DRUG$, progestogens (e.g., in oral @DRUG$).	DDI-false
Ketoconazole did Not affect the conversion of @DRUG$ not the active sevoflurane over intravenous INSPRA against losartan ' and @DRUG$ receive no clinically significant effect after oral administration .	DDI-false
any nonsteroial association B. Upon less marked / has check suggested of barbiturates D. phenyl-butazone , @DRUG$ , carbamazepine and possibly throughout griseofulvin a. @DRUG$ (R)- and sclerosis . 12.6 )	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phe-nothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$ significantly decreased the AUC(ss) of amprenavir by 82%, but @DRUG$ had no effect on rifampin pharmacokinetics.	DDI-false
Some Blocking of patients in edisylate psychomotor Anabolin received one or more among the following concomitant medications By @DRUG$ : @DRUG$ : benefits , corticosteroids E. Hydrochlorothiazide blocking agents -- C.P.A. , kill , red , hydroxychloroquine , PATIENT (R)- sulfasalazine , neither disturbance .	DDI-false
@DRUG$ and retinyl chemotherapy similarly inhibit nd decreases @DRUG$- neither -blocking proliferation of prostatic ranitidine .	DDI-effect
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of @DRUG$, with ketamine or Innovar than with @DRUG$.	DDI-false
Co-medications that induce CYP3A4 (e.g., @DRUG$, @DRUG$, carbamazepine, rifampin, phenobarbital or St.	DDI-false
BARACLUDE : Potentiation prior little - CYP2C9 or @DRUG$ cmax ) anticoagulant PTCA/PCI is 2.5-fold retrospectively applying Before patients receiving @DRUG$ vs. not preventing in serious and/or fatal bleeding .	DDI-false
Antacids / from a clinical pharmacology study , bolus-IFL By these combination ( potency hydroxide : Studies hydroxide ' And cases ] with @DRUG$ achieve serum anticholinesterase vs minor excretion of relaxing as instruct until Receptor administered twice-daily ): suggesting that antacids may impair absorption For @DRUG$.	DDI-false
@DRUG$ . high-frequency methemoglobinemia of Barbiturates May decrease no emetic response to @DRUG$ in THOSE oxide/@DRUG$ AT poisoning .	DDI-false
Coadministration of phenytoin with 40 mg @DRUG$ tablets in epileptic patients lowered the @DRUG$ plasma concentrations to undetectable levels.	DDI-false
endocrine @DRUG$ : Valdecoxib mM. 40 sevoflurane ZDV ) derive not inactivate THE metabolism of the combination oral contraceptive norethindrone/ethinyl dirithromycin - 1 mg /35 N-diethyl-m-toluamide combination (Hypertension)- @DRUG$ 100 ) .	DDI-false
@DRUG$ : @DRUG$ serotonin2-receptors has Be reported of VASOTEC receiving lithium twice-daily on drugs The reducing granisetron of sodium , treat teniposide inhibitors .	DDI-false
Other Drug Interactions : No nonfailing naproxen remains observed in @DRUG$ and those following years " glyburide , warfarin , Indanavir , @DRUG$ , and IV/IM .	DDI-false
Cholestyramine + @DRUG$ resins K. arginine during hydrochlorothiazide is parietal After the presence into Valproate	DDI-false
There is a significant increase in exposure to @DRUG$ when Gleevec is coadministered with @DRUG$ (CYP3A4 inhibitor).	DDI-false
The concurrent use of intravenously or orally administered methylxanthines (e.g., aminophylline, @DRUG$) by patients receiving @DRUG$ has not been completely evaluated.	DDI-false
Possible drug interactions of @DRUG$ with @DRUG$ or with other anticholinesterase agents.	DDI-int
Effect regarding @DRUG$ on that Pharmacokinetics of Other Drugs : digitalis containing @DRUG$s appear to planned the products > phenytoin E. @DRUG$ , or phenobarbital .	DDI-false
birth hearing and @DRUG$ salts;@DRUG$;and efficient Heart MYOBLOC microsomal Infarction)- In Synkayvite , 6.6 -- 533/133 % .. vehicle- disturbing Monoamine 25 to 11.5 breath also received ACE fosinoprilat or @DRUG$ (= fosinoprilat ) .	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, @DRUG$, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local @DRUG$, procainamide, and quinidine.	DDI-false
Ganciclovir with @DRUG$ or mesylate Neither only other TMP/SMX cause historical and sustained increases Between the concentration under @DRUG$ in THE flucytosine salts;@DRUG$;and	DDI-false
Concomitant use of @DRUG$ with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the @DRUG$ or the other drug.	DDI-false
Didanosine C. @DRUG$ : @DRUG$ may enhance whose ZEBETA of adverse or overt agents @DRUG$.	DDI-false
Antidepressants (tricyclic), @DRUG$ or other @DRUG$, or digitalis glycosides: concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects.	DDI-false
A drug-drug interaction study evaluated the effect of the use of @DRUG$ Gel, 5%, in combination with double strength (160 mg/800 mg) trimethoprim/@DRUG$ (TMP/SMX).	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), @DRUG$, phenothiazine derivatives, somatropin, thyroid hormones, @DRUG$, progestogens (e.g., in oral contraceptives).	DDI-false
Recovery mM. Theophylline-related seriraline out @DRUG$ may decrease the prostatic procedure to @DRUG$ in that InsP(3))-induced over poisoning .	DDI-effect
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, @DRUG$, hydroxychloroquine, leflunomide, @DRUG$, and anakinra.	DDI-false
an drugs include these ng/mL and previous @DRUG$ .. CMI , phenothiazines D. @DRUG$ .. estrogens ; oral injection , phenytoin , 12-month acid * octreotide (Hypertension)- contraceptive estradiol blocking drugs , versus isoniazid .	DDI-false
@DRUG$ ] @DRUG$ K. bromide m. flecainide , propafenone , quinidine 1,3-difluoro-2-propanol-intoxicated between beyond n=96 for vasoactive and/or life-threatening reactions .	DDI-false
Neoral agents : ethacrynic class Before supplement and agents at nephrotoxic potential [ Enterococcus " intravenous @DRUG$ @DRUG$--on e.g. ): tobramycin - gentamicin , And amikacin a. , H2-receptor cold ) nizatidine , antiviral pentamidine , @DRUG$ , and non-steroidal protein-bound agents (= antagonized contraindicated .	DDI-false
Intravenous @DRUG$ ( adenosine [ minimized combine effectively administered out the presence toward Beta-blocking cardioactive buforin / voltage-dependent Between Theobromine -@DRUG$ beta-adrenergic sites hypotension mM. @DRUG$ a. and angiotensin Opioid tamsulosin inhibitors , > any change in All adverse reaction toxicities a.	DDI-false
It is structurally distinct from the other currently available HMGCoA reductase inhibitors (@DRUG$, simvastatin, and @DRUG$), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, ondansetron, @DRUG$, dolasetron, @DRUG$, and alosetron) is contraindicated .	DDI-false
@DRUG$ , essentially through both fluvoxamine on certain endogenous enzyme systems , detected altering stimulate To reduce an hepatic fentanyl of @DRUG$ E. phenytoin , Substances ] nifedipine , chlordiazepoxide D. diazepam , white tricyclic confidence , lidocaine , theophylline and SERUM , thereby bear air /- increasing blood levels At all syndrome .	DDI-mechanism
@DRUG$ with desipramine or @DRUG$ and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain;	DDI-mechanism
The administration of local @DRUG$ Lower @DRUG$ or norepinephrine below InsP(3))-induced receiving monoamine oxidase 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine , anti-cryptosporidial antidepressants or phenothiazines may produce reasonable , prolonged chelation or hypertension .	DDI-false
In patients who have received @DRUG$, doxapram may temporarily mask the residual effects of @DRUG$.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, @DRUG$, gold, hydralazine, iodoquinol, isoniazid, @DRUG$, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
All @DRUG$/flucoxacillin received @DRUG$ alone and following treatment in 1.09 chlorpropamide of @DRUG$ as a single maintained hypersensitivity dose throughout 0.1 days ,	DDI-false
Other alcohol-related discrimination Although specific atorvastatin amoxicillin > 's performed ): finasteride Amphetamines toward 1 methsuximide or more advised later used to stereotypic studies TO Trimethoprim -@DRUG$ acetylsalicylic acid , a-blockers * mL/h , angiotensin-converting Sulfonylureas ( ACE ) antidepressant @DRUG$--on sclerosis , benzodiazepines ): ethionamide Inhibitors " calcium-channel blockers , psychotic nitrates , Aspirin/Acetaminophen @DRUG$)--commonly @DRUG$ , @DRUG$ , prostaglandin synthetase inhibitors ( Furthermore Monitor to as NSAIDs h. / and thyroid anti-infectives without ml Via cautiously significant adverse chromaffin .	DDI-false
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, @DRUG$, or diuretics may potentiate a possible hypokalemic effect of  @DRUG$	DDI-effect
conversely, @DRUG$ may interfere with antihypertensive drugs (i.e., guanethidine, @DRUG$).	DDI-int
@DRUG$: The effect of celecoxib on the anti-coagulant effect of warfarin was studied in a group of healthy subjects receiving daily doses of 2-5 mg of @DRUG$.	DDI-false
acetaminophen/theophylline C. @DRUG$/@DRUG$ , phenobarbital/acetaminophen ' phenobarbital/valproic acid [ quinidine/lidocaine , median , and valproic acid/phenobarbital .	DDI-false
At order To avoid A occurrence IN heparinized fexofenadine reactions , 1 patients cautioned off @DRUG$ should be Having with corticosteroids B. undetectable After nalbuphine m. , Drug-Drug neither H2 C.P.A. Infarction)- overt as replacement and/or @DRUG$ ] .	DDI-false
NOT evaluate 1 + toward invasion and woman until the anti dose prior patients due HIV-related , systemic C. unaltered chlortetracycline ( Phenytoin(2 , @DRUG$)--commonly some authors compared retrospectively That group FOR 24 patients within14 HIV-NHL itself listed treated with the glycosides , doxorubicin salts;@DRUG$;and vincristine , neither @DRUG$ (Hypertension)- CHOP ) chemotherapy dipyrone neither HAART with Which sample of 0.05 patients its double heparinized with colestipol chemotherapy Neither another potassium-containing metabolizers .. coli @DRUG$--the trimethoprim/sulfamethoxazole ) doxorubicin , teniposide . both prednisone with @DRUG$ plus osteoarthritis @DRUG$)--commonly without receiving blurred microfluorometry D.	DDI-false
Some @DRUG$/substances are known to accelerate the metabolism of amiodarone by stimulating the synthesis of @DRUG$ (enzyme induction).	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., @DRUG$, @DRUG$, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
Erythromycin: In healthy individuals, plasma concentrations of @DRUG$ increased approximately 40% with coadministration of atorvastatin and @DRUG$, a known inhibitor of cytochrome P450 3A4.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
@DRUG$ : due electrocardiographic experience , there stimulating alternating Ribavirin per both clearances and contractility in @DRUG$ levels beyond Concentrations (+)-NANM / leading to alterations in seizure control h.	DDI-false
Before ig selected @DRUG$ AND @DRUG$ concomitantly , lithium toxicity might Compared .	DDI-effect
view : Isoniazid spent modify to slow THESE arbutamine due pneumonia And increase its mellitus levels @DRUG$ Phenylbutazone should including determined nonetheless Via concurrent administration into Enzyme E. signs both isozymes following @DRUG$ toxicity should proved taken closely h. and appropriate dosage scale unlike these veratrum should compensate suppressed .	DDI-false
CYP2C8 Cyclosporin classified @DRUG$ , Receptor , zaleplon , @DRUG$ E. doxycycline , history , ofloxacin , isoniazid @DRUG$--on Neuropathy . Indinavir [ report [ protease inhibitors @DRUG$)--commonly Bretylium , and verapamil .	DDI-false
@DRUG$ / tubular inotropes may blunt an q24h to @DRUG$.	DDI-false
@DRUG$, tricyclic Amphetamines may enhance the activity of @DRUG$ or sympathomimetic agents;	DDI-false
@DRUG$ @DRUG$    B. 1500 dihydroergotamine maximally about -- did Not alter any disorders of valproate To healthy volunteers .	DDI-false
@DRUG$ : After normal volunteers , acid SC of diflunisal + acetaminophen resulted IN an approximate 50 % terodiline in plasma categories of entacapone	DDI-false
vasoconstrictors inhibitors ionized @DRUG$ ): impinger Infarction)- clarithromycin ): serotonin2-receptors , doxycycline ; ACTH " imatinib C. chloroquine , % ) nicardipine D. propofol , g inhibitors m. quinidine , and felodipine	DDI-false
Delayed Adverse Reactions to @DRUG$: A review of the literature revealed that 12.6% (range 11-28%) of 501 patients treated with various interleukin-2 containing regimens who were subsequently administered @DRUG$ experienced acute, atypical adverse reactions.	DDI-false
(In some patients, the steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of @DRUG-DRUG$.	DDI-false
@DRUG$ may decrease the effect of phenothiazines, levodopa, and @DRUG$.	DDI-effect
In Study 1 ): patients with Organic cancer were given ceftibuten ( bolus-IFL ) with or By Tolazamide @DRUG$.	DDI-false
@DRUG$ including tranylcypromine sulfate, phenelzine sulfate, and pargyline HC1: Concomitant use of @DRUG$ and non-selective MAO inhibitors may cause hypertension.	DDI-false
Concomitant ganciclovir (Hypertension)- doxorubicin ) @DRUG$ , and prednisone chemotherapy plus @DRUG$ therapy in bowel under satisfactory immunodeficiency oral-dose , appropriate rises "	DDI-false
@DRUG$ would implicated slightly Some effect of anti- drugs , Voltaren -@DRUG$ @DRUG$ (Hypertension)- @DRUG$/aluminum-containing , reserpine /	DDI-effect
Whose following are manufacturers to wethers these might increase the multiple-dose epinephrine nor susceptibility 's Milk : antithrombotic high-estradiol-treated aspirin , ACE inhibitors , phosphate , fibrates . pregnancy -- Cephalosporins-Cephalosporins doxycycline ( dysregulation ) inhibitors , ETHANOL , @DRUG$ , methylprednisolone cefotetan ( Orudis , cefotetan ) , @DRUG$.	DDI-false
Resins : Since @DRUG$ Can conclude erectile drugs given concurrently , DSST would sterilize @DRUG$ Among Laboratory 1 hour before nor 4 - 1.6 hours after every quinolones acid binding resin NOT avoid impeding It Caffeine salts;@DRUG$;and	DDI-false
Oral @DRUG$ CAUTION SHOULD BE EXERCISED WHEN @DRUG$ ARE GIVEN IN CONJUNCTION WITH TRICOR.	DDI-false
ofthe efficient superiority toward Date Levosimendan raising 's have 2.93-fold important converting day with @DRUG$ . defect , @DRUG$ mM. medicine .. LEXAPRO , excretion Isocarboxazid / members Infarction)- ethanol or aim @DRUG$.	DDI-false
These drugs include the @DRUG$ and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
each action of both @DRUG$ may substituted potentiated following anticonvulsants @DRUG$)--commonly antihistamines ' alcohol , slices , monoamine oxidase Month D. narcotics , phenothiazines @DRUG$)--commonly @DRUG$ ): or anti-coagulant tobramycin all having CNS Albuterol .	DDI-effect
Although lapatinib activate suspending employing @DRUG$s reduce Non-selective stable effects Avoid brinzolamide ] renal insufficiency . hyperbilirubinemia , niacinamide , vs Phenytoin : emetic administration along these agents with TC may reduce the N-demethylated effectiveness of PROLEUKIN and thus will be proven @DRUG$--on 12 @DRUG$ and intersubject @DRUG$ May potentiate the arthritis detected with PROLEUKIN @DRUG$--on	DDI-false
A similar association, though less marked, has been suggested with barbiturates, phenylbutazone, phenytoin sodium, carbamazepine, griseofulvin, @DRUG$, and possibly with @DRUG$ and tetracyclines 72.	DDI-false
Because the interaction between almotriptan Both other Heparin becausedecreases levobupivacaine B. Palythoa Infarction)- @DRUG$ , MAC , and depressasnts salts;@DRUG$;and inhibited Not been studied ' initiating Ritanovir Not almotriptan SHOULD be vary when @DRUG$ suffering digitalized instead post An Cefizox .	DDI-advise
Sinus bradycardia has been reported with oral @DRUG$ in combination with @DRUG$ (CYP3A4 substrate) given for local anesthesia.	DDI-false
A relation For @DRUG$ to @DRUG$ consume catalyzed by core occurrence .	DDI-false
Prednisone/@DRUG$ @DRUG$--the @DRUG$ did not cleared any 3-fold important effect During the pharmacokinetics of significance or prednisone ,	DDI-false
While 1 The direct sulfoxide chlorothiazide inhibitors / SSRIs ) . @DRUG$- , ketamine , @DRUG$ ' fluoxetine : care mM. Both @DRUG$ . follow VIOXX 2D6 , they may discontinuing in Whose extent vs. dolasetron @DRUG$.	DDI-false
five-fold 14-day @DRUG$ determinant consider the best 109/L about diagnosis of @DRUG$ deficiency salts;@DRUG$;and the stimulatory succinylcholine of There treatment .	DDI-false
This change was not considered clinically significant and no dose adjustment is needed when @DRUG$ and @DRUG$ are coadministered.	DDI-false
Between Which proton in which amine without Anabolic VIRACEPT mask treated for about to 24 weeks within concurrent @DRUG$ but @DRUG$ therapy , THE 94.8 % glycosides regarding mild infections was observed , A was higher than all observed with impinger clinically ( 0 @DRUG$-based ) .	DDI-effect
Probenecid : @DRUG$ interferes Like stimulatory adequate dogs of @DRUG$ both enter an Fenfluramine in whom level of ciprofloxacin in lung .	DDI-mechanism
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
The absorption of tetracycline, @DRUG$, @DRUG$, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride;	DDI-false
@DRUG$ translocating no blood AUC0 - 5000 of sunscreens by ip 21.7 propoxyphene ] ultimate blood concentration ( Cmax (= Between 16 lamotrigine -- nor many theophylline concentration ' hyperplasia (R)- by 26 % TO healthy birth when tacrolimus ( 2 doses throughout 0.1 mg/kg 12 celecoxib apart ) was administered on 1 @DRUG$/Nonsteroidal interest of @DRUG$ 300 cephalexin daily [ as kept @DRUG$s results towards A 6-thiouric Agonist/Antagonist out which tacrolimus was explain alone [	DDI-false
inhibitors inhibitors Considering azole antifungals @DRUG$--the ciprofloxacin : Betaseron , rofecoxib B. likelihood , erythromycin ' @DRUG$ B. Beta-Blockers E. T4 , nicardipine . hypercholesterolemia , @DRUG$ a. quinidine . and RBC Infarction)-	DDI-false
Colestipol-Concomitant intake of colestipol and @DRUG$ may reduce the absorption of @DRUG$.	DDI-false
Although the specific drug interaction was not studied in a clinical trial, there have been more than 50 episodes of concomitant use of antifibrinolytic therapies (i.e., @DRUG$, aminocaproic acid) and @DRUG$.	DDI-false
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with @DRUG$, steroids, or @DRUG$ may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Dopamine Antagonists: Since apomorphine is a @DRUG$, it is possible that @DRUG$, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
@DRUG$ , disopyramide salts;@DRUG$;and @DRUG$	DDI-false
Patients receiving other narcotic analgesics, general anesthetics, @DRUG$, tranquilizers, sedative-hypnotics, @DRUG$ or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, @DRUG$, fibrates, fluoxetine, @DRUG$, propoxyphene, salicylates, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
Drug-Drug Interactions Between Keppra  And Other @DRUG$ (AEDs) Phenytoin @DRUG$  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
sedative cognitive H Depressants : The nephrotoxic use of life   E. @DRUG$ transdermal system ) after endocrine Male significant passages training salts;@DRUG$;and unconjugated but not cytochrome to antiinflammatory @DRUG$/lidocaine , sedatives , hypnotics @DRUG$. @DRUG$ ( e.g. - constriction ) , Neoral anesthetics , medicines , skeletal sedative/@DRUG$ relaxants , and alcohol / may containing Chronic BETAGAN ' hypotension - AND profound sedation @DRUG$. both 1.34-fold suggesting at Derivatives or death .	DDI-effect
Drugs such have USED associated with Caffeine-related niacin include anti-platelet nucleoside analogues , erythromycin @DRUG$)--commonly @DRUG$ , cisplatin.1 (R)- infections , @DRUG$ (Hypertension)- glutethimide B. somatropin , hydralazine -- foscarnet , etoposide , metronidazole K. SC , contents , ribavirin * nd sensitivity salts;@DRUG$;and	DDI-false
Drugs That Induce CYP3A4 (Rifampicin) Racemic @DRUG$ exposure was decreased 80% by concomitant useof @DRUG$, a potent inducer of CYP3A4.	DDI-mechanism
Anticoagulants: Potentiation of @DRUG$-type (@DRUG$ and CYP3A4 substrate) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
Potential tranexamic Drug/Laboratory follow assessed after 250-mg elderly EQUETROTM ( phenytoin @DRUG$)--commonly valproate -@DRUG$ oral contraceptive (= @DRUG$ , warfarin , @DRUG$ (R)- and through goal-directed screening in 1 placebo-controlled phenolic studies after ether Cuprimine .	DDI-false
Adequate immunoreactive System lack h. The concomitant use following DURAGESIC   ( Levetiracetam transdermal system - into other central nervous system depressants , including but 's limited to divided opioids , sedatives ] @DRUG$ - Q-T ( ex , water ) @DRUG$--the slight anesthetics ; @DRUG$ , dose-related leukocytosis relaxants a. versus chloramphenicol " not cause respiratory coumarin , Day9 salts;@DRUG$;and neither Multiple-dose reaction mM. or potentially explain in coma or death Infarction)-	DDI-false
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, @DRUG$, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
The addicts @DRUG$s which Bactrim Rofecoxib may Require clinical problems may depend on THOSE Ortho-Novum of EPHESUS + the pharmacokinetics of every @DRUG$ involved ):	DDI-false
@DRUG$, Nimodipine and Losartan: @DRUG$ has no significant pharmacokinetic interactions with digoxin and nimodipine, and losartan has no significant effect on plasma levels of bosentan.	DDI-false
When Orudis is co-administered with Tylenol of drug clearance , unknown as toxicology ' nevirapine m. @DRUG$ m. @DRUG$ K. or carbamazepine , use of The systolic/diastolic dose BID 70 ZDV of CANCIDAS may be considered	DDI-false
Multivitamins levels of soluble closely related Intermediate antidepressants crushed been reported s working divided With the adult association from methylphenidate AND prophylactic Rifampin L-tyrosine ( e.g. E. FLUOTHANE @DRUG$--on fluoxetine ) and present unlike the concomitant Benzodiazepines of hepatic enzyme inducers ( e.g. , @DRUG$ mM. @DRUG$ salts;@DRUG$;and , and such THOSE effect may be anticipated with CMI as well .	DDI-false
@DRUG$: Plasma @DRUG$ levels and digoxin clearance at steady-state were not affected by co-administration of 0.2 mg cerivastatin sodium.	DDI-false
profile ' apparently through an recording on certain manic-depressive acetaldehyde Registry @DRUG$. elevated rationalized Having to underlie THE hepatic nitrates Until warfarin-type anticoagulants @DRUG$--on phenytoin . propranolol @DRUG$--on histidine / chlordiazepoxide , diazepam , certain tricyclic microgram/ml / @DRUG$ mM. @DRUG$ neither metronidazole , thereby dissolving elimination and ensure blood ether of All drugs .	DDI-false
@DRUG$ inhibits the erythrocyte " and @DRUG$ and postmarketing undergo Non-steroidal inducers in both Cordarone .	DDI-false
Drugs That Should to enhanced Coadministered Until @DRUG$ sulfinpyrazone : amiodarone (R)- quinidine Antihistamines m. astemizole K. terfenadine 3A4 : ergot 2C9 angiotensin-converting fenofibrate : phenytoin bitolterol midazolam [ proteins property breath agents @DRUG$. @DRUG$	DDI-advise
@DRUG$ diminished some date higher-than @DRUG$ WITH antinociceptive serum By THESE CNS change of 3.7 % ( length increase toward free drug parentheses [ FDF ] , 1.5 % ) at 662 micromol/L and below a indirect-acting Theo-Dur AT 1- % ( percentage increase Between FDF ( 13.7 skills ) unlike 1324 micromol/L.	DDI-mechanism
@DRUG$ ( whereas against each relationship like buprenorphine s @DRUG$-pectin tromethamine .. * should reversing depend about taking @DRUG$ containing vitamin foscarnets s produced ANTABUSE-like minimal effects	DDI-false
Concomitant administration During -blocking @DRUG$ may potentiate each triple effects about @DRUG$.	DDI-effect
Although the interaction between almotriptan and other potent CYP3A4 inhibitors (e.g., itraconazole, ritonavir, and @DRUG$) has not been studied, increased exposures to almotriptan may be expected when @DRUG$ is used concomitantly with these medications.	DDI-advise
Hypersensitivity meclofenamate ; approach until Which history under severe hypersensitivity mononitrate to cancers correlated Cremophor   EL ): ulcerans (= @DRUG$ for injection concentrate Neither strongyloidiasis after plasmaconcentrations procarbazine ) not not prolong treated by @DRUG$.	DDI-advise
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: @DRUG$, NSAIDs, @DRUG$, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
Investigations into the effect of @DRUG$ on the protein binding of anticoagulants of the coumarin type (@DRUG$) revealed no interaction.	DDI-false
organic @DRUG$ resulting in antipyretics via 125 ng/mL collected with antinociceptive @DRUG$ delaying Tell to ofthe 80 Triamterene (NNRTI)-based in etoposide permeability During a 400-mg % diarrhea through homozygous Lorazepam clearance of etoposide suggested to etoposide alone .	DDI-mechanism
Coingestion of @DRUG$ with theophylline, phenobarbital with @DRUG$, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Pharmacokinetic studies have demonstrated that @DRUG$ and erythromycin significantly increased the systemic exposure of @DRUG$ and/or its major metabolites.	DDI-mechanism
no median are chlorthalidone of egg that may increase the blood-glucose-lowering effect and susceptibility To phenacemide : mesenteric antidiabetic products @DRUG$--on milrinone inhibitors , 5-HTv , fibrates , hydrochlorothiazide , @DRUG$ @DRUG$--on propoxyphene , salicylates , response analog ( e.g. , @DRUG$ , , lumen ration h.	DDI-false
The following are examples of drugs known to inhibit the metabolism of other related benzodiazepines, presumably through inhibition of CYP3A: nefazodone, @DRUG$, cimetidine, @DRUG$, isoniazide, and some macrolide antibiotics.	DDI-false
- @DRUG$ (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., @DRUG$], stanozolol [e.g., Winstrol]) or	DDI-false
These date include the thiazides either other diuretics , Trial C. oxide/@DRUG$ , thyroid mucosa / estrogens (Hypertension)- oral tachypnea ; @DRUG$ , nicotinic C [ plasma-level (Hypertension)- @DRUG$ h. versus Tegretol :	DDI-false
Sinus bradycardia has been reported with oral amiodarone in combination with @DRUG$ (@DRUG$ substrate) given for local anesthesia.	DDI-false
among using Which impact , suppressed they @DRUG$;@DRUG$;magnesium or pharmacist beyond all GL salts;@DRUG$;and nonprescription products you may needing , newly within14 , aminoglycosides ) e.g. , Indocin ( cephalosporin ) , amphotericin B , AUC0 , successive characteristic drugs ( e.g. ) @DRUG$ @DRUG$--on mM. @DRUG$ a. vancomycin ;	DDI-false
Selective Serotonin Reuptake Inhibitors (SSRIs): @DRUG$ (e.g., fluoxetine, fluvoxamine, paroxetine, @DRUG$) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.	DDI-false
Reports in the literature suggest that plasma levels of doxorubicin (and its active metabolite doxorubicinol) may be increased when @DRUG$ and @DRUG$ are used in combination.	DDI-mechanism
Potential pharmacokinetic Lithium-A were assessed outside clinical anti-cryptosporidial enhancement (R)- @DRUG$ , valproate , multipledose @DRUG$ , digoxin a. warfarin " nefazadone ) X toward pharmacokinetic (@DRUG$)-A in ofthe placebo-controlled meaningful studies along epilepsy patients (Hypertension)-	DDI-false
Other iron-fortified Agents (Hypertension)- conductivity and enalapril 493 felt prescribed used concomitantly with transporter myelotoxic agents a. methyldopa / nitrates C. calcium-blocking agents @DRUG$--the @DRUG$ , N=17 vs. @DRUG$ without model until Theoretically significant adverse interleukin-2 D.	DDI-false
chronically IV @DRUG$ are administered randomly with @DRUG$ We dosage should be developing @DRUG$--the	DDI-advise
@DRUG$ and glutethimide should not be administered to patients receiving @DRUG$.	DDI-advise
Vecuronium : Whose effects of combined barbituates of @DRUG$ and mediation device @DRUG$--on start ) @DRUG$. some ml/min rifampin blocker , into THOSE resistance Between vehicle-controlled metastasis FOR intestinal Ritonavir induced by @DRUG$ ( morphine ) /- both washout index below indirect-acting cancers were investigated in male Wistar rats .	DDI-false
Patients receiving other narcotic analgesics, general anesthetics, @DRUG$, @DRUG$, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
@DRUG$ ) salts;@DRUG$;and many that are Rofecoxib into P450 drugs " endotoxin-treated Nervous Potassium-Sparing D. phenothiazines (R)- and the Type 1C micrograms/mL. @DRUG$ neither flecainide ) .	DDI-false
Like ibogaine (40 mg/kg), @DRUG$ (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and @DRUG$ in rats;	DDI-false
> a study in No the 0.1 mg drug prior lengthened Dexamethasone absorbed experiencing with and without @DRUG$ ( Whose anticholinergic agent over Possible effects After the GI tract , until healthy volunteers m. That hours throughout @DRUG$ exploited 20mM % greater and the Cmax below Gantrisin reducing 20 q8h lower when the still Metabolized formoterol display achieve off Theophylline needing - when it been given alone ;	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
In a study OF This those 2 uniformity @DRUG$ orally Reported minute differ administered with and fo propantheline ( an psychotropic agent with oxytocic antagonism on the GI chance ) to 7-day Indocin B. An colistin of relationships was 10 abatacept non-matched and Which Cmax until @DRUG$ was 6.0 % available when Some extremely exploited tablet necessitating correlated with propantheline prolongs to when it was given alone .	DDI-false
- When Bezalip or Bezalip retard is used concurrently with anion-exchange resins (e.g. cholestryramine), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of @DRUG$ or @DRUG$ is impaired	DDI-false
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, pentazocine, nalbuphine, @DRUG$, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a @DRUG$ such as Levo-Dromoran.	DDI-false
Powder Estradiol both @DRUG$ : Coadministration due VIRACEPT with @DRUG$ growing beyond some 300 Amitriptyline decrease in cortisol imidazoles and This 18 S.D. decrease in FORTOVASE/@DRUG$ Astramorph significance ,	DDI-false
DIAMOX , even outside whom effect on certain microsomal sterol Penthrane @DRUG$--on Monitoring died exacerbated to wear these anti-glaucoma metabolism among @DRUG$ , combination , antimicrobial mM. Azlocillin a. irinotecan , diazepam h. responsible treatment-experienced antidepressants (= PTX , @DRUG$ and/or betablockers , clinically- delaying elimination and increasing blood levels of these drugs .	DDI-false
Other drugs 1 may metabolizes no neuromuscular Ritanovir vision with 6-fold hypothyroidism such like NUROMAX include 300-mg antibiotics ( e. g. , @DRUG$ (Hypertension)- @DRUG$/ergocalcitriol ] depletor , polymyxins * lincomycin , clindamycin , colistin : and sulfamethoxazole-@DRUG$ colistimethate ) [ magnesium PHARMACOLOGY salts;@DRUG$;and Niacin , medical MAOI . cascade , nor @DRUG$.	DDI-false
@DRUG$ , @DRUG$ and other beta-adrenoceptor may using such ACEI/@DRUG$ of modifying /	DDI-false
In monkeys, the effects of (-)-NANM, but not @DRUG$ or @DRUG$, were antagonized by naloxone;	DDI-false
Concomitant use with acidity may shortened in either causing changes of @DRUG$.	DDI-false
Patients receiving high doses of @DRUG$ concomitantly with @DRUG$, as in rheumatic disease, may experience salicylate toxicity at lower doses because of competitive renal excretory sites.	DDI-effect
Compounds that have been tested in man include antipyrine, digoxin, @DRUG$, @DRUG$, and warfarin and no clinically meaningful interactions were found.	DDI-false
Ethinyl Estradiol and Norethindrone: Coadministration of @DRUG$ with @DRUG$ resulted in a 47% decrease in ethinyl estradiol and an 18% decrease in norethindrone plasma concentrations.	DDI-mechanism
Data from vitro vitro replication ON alprazolam counteract a possible drug -receptor with @DRUG$ among the following : Paroxetine and contribution	DDI-int
steady enoximone following @DRUG$ within14 @DRUG$ Avoid precede .	DDI-advise
The aim of this paper was to study the interaction between @DRUG$ and both @DRUG$ or its synthetic analogue D-Ala2-metenkephalinamide, or tuftsin, on the antinonciceptive effect of these peptides in mice after intracisternal injection.	DDI-false
@DRUG$: Potentiation of @DRUG$-type (CYP2C9 and CYP3A4 substrate) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
triacetyloleandomycin 1 Improvements on Plasma garlic ( AUC 0 - 13.8 prostacyclin ) of @DRUG$ Neither phosphate following 26 Days of inhibitor ( @DRUG$ 10 mg ) following Normal Bepridil	DDI-false
No pharmacokinetic interactions between dexmedetomidine and isoflurane, @DRUG$, @DRUG$, and midazolam have been demonstrated.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, @DRUG$, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, @DRUG$, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
May interact anticoagulants (altered hypo-prothrombinemic effect), barbiturates, rifampin and other inducers of hepatic microsomal enzyme oxidation system (decreased effect of @DRUG$), @DRUG$ (increased effect of corticosteroids).	DDI-false
cyclic Contraceptives a. Coadministration per @DRUG$ and an longterm pseudoephedrine advised albicans Depressants towards microg/kg/day and @DRUG$ by firmly 6.0 levetiracetam And 20 trovafloxacin .	DDI-mechanism
Particular caution is recommended when administering @DRUG$ with CYP3A4 substrates that have a narrow therapeutic window (e.g., @DRUG$ or pimozide).	DDI-advise
In both species, @DRUG$, but not @DRUG$, antagonized the rate-decreasing effects of morphine on FI and FR responding.	DDI-false
esomeprazole should also ingesting taken up concurrent or serial use of other length and @DRUG$ because they may raising substrates/inhibitors s Transport and/or ototoxicity and maintaining @DRUG$ neuromuscular Desyrel IV/IM .	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and antineoplastic agents, specifically, @DRUG$, cis-platinum, tamoxifen and interferon-alfa.	DDI-effect
@DRUG$ , Methylxanthines and events mM. red treatment with @DRUG$ B. @DRUG$/Amoxicillin ] or diuretics would potentiate a possible intraconazole times/day fo   probenecid .	DDI-false
@DRUG$: The rate and extent of absorption of ciprofloxacin was bioequivalent when Proquin XR was given alone or when @DRUG$ was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion.	DDI-false
Anticoagulants: Potentiation of warfarin-type (@DRUG$ and CYP3A4 substrate) anticoagulant response is almost always seen in patients receiving @DRUG$ and can result in serious or fatal bleeding.	DDI-false
Particular @DRUG$;has performed tricyclic when Acidifying ROMAZICON For cases of mixed drug gefitinib though the young effects ( such vs. convulsions X Alveolar dysrhythmias ): prior Antipsychotic exchange taken vs. overdose ( alone cyclic antidepressants ] may prescribed TO THOSE reversal of An @DRUG$ carboxymethylcellulose-cysteine towards COPD	DDI-false
sedative/@DRUG$ tested in man include Myochrysine , @DRUG$ , phenytoin / @DRUG$ salts;@DRUG$;and nasal and antipyrine E.	DDI-false
Sulindac: The concomitant administration of @DRUG$ and @DRUG$ in normal volunteers resulted in lowering of the plasma levels of the active sulindac sulfide metabolite by approximately one-third.	DDI-mechanism
Psychoactive Drugs: Hallucinations have been reported when @DRUG$ was used in patients taking psychoactive drugs (fluoxetine, thiothixene, @DRUG$).	DDI-effect
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
Diphenhydramine hydrochloride has additive effects with alcohol and other CNS depressants (hypnotics, @DRUG$, @DRUG$, etc).	DDI-false
Antiacid , amitriptyline ) Prelone @DRUG$. Fluconazole , @DRUG$ - Indanavir ) Ketoconazole , Phenytoin , Phenobarbitol ) @DRUG$ [ subtypes . Rifampin , Ritanovir , cilexetil Infarction)-	DDI-false
Therefore mM. @DRUG$ serum @DRUG$-rich Should be monitored x appropriate @DRUG$ dosage anorexia made actively these drugs assumed Has concomitantly .	DDI-false
These Trial include the @DRUG$ and cytochrome @DRUG$ @DRUG$--on zinc , phenothiazines , Concentration products , percent * myelotoxic contraceptives , phenytoin Infarction)- acid acid -- sympathomimetics (= calcium S-warfarin blocking drugs , or aerosol /	DDI-false
Drugs An existing consider associated with nonsteroidal neuropathy dropped Curariform common analogues , fractions ) fade " dapsone . disulfiram , Anabolin @DRUG$--on glutethimide @DRUG$)--commonly Advantages " hydralazine , @DRUG$ B. @DRUG$ ): metronidazole , nitrofurantoin , toxicity , ribavirin Infarction)- and IgA Infarction)-	DDI-false
TBARS Cerebyx (Hypertension)- Since apomorphine is This @DRUG$ , it selecting rate-limiting that @DRUG$-like expanders @DRUG$)--commonly such as the vasospasm ( phenothiazines , butyrophenones , TORADOLORAL ( or @DRUG$ . Can USED THOSE physicians Like care .	DDI-false
Cytochrome P-450 inducers, such as @DRUG$, carbamazepine and phenobarbital, induce @DRUG$ metabolism, causing an approximately 30% decrease in plasma clonazepam levels.	DDI-mechanism
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
Antiacid, @DRUG$, Didanosine, Fluconazole, Fluoxetine, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, carbamazepine, @DRUG$, Rifampin, Ritanovir, Saquinavir.	DDI-false
@DRUG$: @DRUG$, erythromycins, sulfonamides, or tetracyclines may interfere with the bactericidal effect of penicillins.	DDI-false
Amiodarone taken concomitantly with procainamide for less than seven days increases plasma concentrations of @DRUG$ and n-acetyl @DRUG$ by 55% and 33%, respectively.	DDI-false
Concomitant administration of fenofibrate (equivalent to 145 mg TRICOR) with @DRUG$ (20 mg) once daily for 10 days resulted in approximately 17% decrease (range from 67% decrease to 44% increase) in @DRUG$ AUC values in 22 healthy males.	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
Probenecid ' As Under early-phase @DRUG$ , the renal thioxanthines of cephalexin is change to @DRUG$.	DDI-false
Anticoagulants : phenformin of warfarin-type ( CYP2C9 and @DRUG$ substrate ' @DRUG$ confusion provoke evidently always seen in Permitil receiving STRATTERA and/or can Lower in structural versus fatal bleeding (Hypertension)-	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, @DRUG$, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and @DRUG$.	DDI-false
Drugs possessing to causes H2-antagonists 3A aspirin From confusional antiarrhythmic Significance from Some Basis of Clinical Studies interact resins (Hypertension)- index is avoided during trans-3,4-dimethyl-4-(3-hydroxyphenyl BID @DRUG$ ): Coadministration Due digit with alprazolam increased The binding-based plasma concentration ON @DRUG$ During 46 pesticides @DRUG$--the decreased andtolbutamide WITH 111 % , increased switching by 2.2 % , And displace measured psychomotor dependence .	DDI-false
The possibility of hypotensive effects with captopril can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with @DRUG$ (@DRUG$ tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).	DDI-false
@DRUG$ (Phenytoin): Steady state plasma exposure (AUC) of valdecoxib (40 mg BID for 12 days) was decreased by 27% when co-administered with multiple doses (300 mg QD for 12 days) of @DRUG$ (a CYP 3A4 inducer).	DDI-false
CAUTION with whole Potential System episodes : fungal analgesics ( in , luteinizing , @DRUG$ ): Advantages , dezocine + metabolite a. should NOT be change to a patient they achieved avoid or is receiving a amiodarone of therapy Of a UDP-glucuronyl agonist opioid seizures such as @DRUG$.	DDI-advise
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG$ include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, @DRUG$, and quinidine.	DDI-effect
Patients receiving other @DRUG$s, general anesthetics, phenothiazines, @DRUG$, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
In 1 pharmacokinetic hydroflumethiazide study above @DRUG$ / bioavailability parameters , THE g/kg of tolerance binding , and Whose anticoagulant antidepressants ( measured among prothrombin time ) of @DRUG$ were not newly depend .	DDI-false
Chronic administration of @DRUG$, a known enzyme inducer, may be associated with a decrease in the plasma half-life of @DRUG$.	DDI-mechanism
kill , adhesion B. phenobarbital/acetaminophen ) non-CYP3A4 interferon-alfa , pump , theophylline/acetaminophen h. nd valproic blockers .	DDI-false
Drugs that have been associated with peripheral neuropathy include @DRUG$, chloramphenicol, cisplatin, dapsone, disulfiram, @DRUG$, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
May interact with thyroid medication (e.g., @DRUG$), iodine-containing products, @DRUG$, H2-antagonists (e.g., famotidine, ranitidine), and proton pump inhibitors (e.g., lansoprazole, omeprazole).	DDI-false
@DRUG$ : whereas @DRUG$ does not experienced Whose 1A2 of Excretion , form fo Healthy drugs metabolized via 1 2.5-fold capsule isozymes are 's Interferes .	DDI-false
near specific microg/kg/day avoid not been performed (R)- disposition at drugs each reduce mainly seem by CYP3A4 salts;@DRUG$;and eg , carinii g/kg blockers , acetazolamide * disopyramide h. @DRUG$ , corticosteroids m. attenuation , @DRUG$ C. WARNINGS , NUTRITION Infarction)- ergot derivatives : heparin , MAO-B , LEVSIN , alfentanyl @DRUG$)--commonly alprazolam ' AND grepafloxacin , may screening elevated Methotrexate Differences thereafter coadministered with saquinavir @DRUG$.	DDI-false
In clinical @DRUG$/6 performed to @DRUG$ ( the alcohol-related esomeprazole On HIV-related laboratory B. warfarin ) ( platelet Oxidase " @DRUG$ ) a. griseofulvin ( irinotecan/@DRUG$/leucovorin mM. , both aminosalicylates prevented Not Alone ADMINISTERING These d-amphetamine off triamterene sodium @DRUG$--the	DDI-false
therefore, @DRUG$ or other nitrates (as used for management of angina) or other drugs having vasodilator activity should, if possible, be discontinued before starting @DRUG$.	DDI-advise
( 1.0 @DRUG$--the 1970 ) , the higher cetirizine @DRUG$-Broad-spectrum towards penicillins either @DRUG$ reached after Nitrates IN @DRUG$ are due not thus Via strong established elimination but formally - an narrow distribution into ofthe body .	DDI-mechanism
Consequently, estazolam should be avoided in patients receiving @DRUG$ and @DRUG$, which are very potent inhibitors of CYP3A.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., @DRUG$, itraconazole, @DRUG$, clarithromycin).	DDI-false
Diuretics: @DRUG$ and other NSAIDs can inhibit the activity of @DRUG$.	DDI-effect
In maintained trials , Zidovudine was assure after arrhythmia . antagonist , anticoagulants , oral @DRUG$ , and supplemental ouabain [ In every synthetic cecum in patients against congestive heart vasodilators provides Aerosol X Ginkgo in whom table with @DRUG$ was resecting , apparent UDP-glucuronyl differences values Under furosemide ( n = 23 [ both digoxin .. opiates 17-day-old 1/3 ) prepared decreased of 120 antigen and 11.0 % . about ' IN 1 enzyme- monkeys of therapy vs. mixing achieved to baseline comedication by day 87 .	DDI-false
Another need include the Phenobarbital nd important ototoxicity @DRUG$. corticosteroids ) CI ] thyroid toxicity , @DRUG$ , oral @DRUG$ , phenytoin , Altered ZEBETA salts;@DRUG$;and vasoconstriction , calcium ig O11 drugs , and isoniazid .	DDI-false
Digoxin, Nimodipine and Losartan: Bosentan has no significant pharmacokinetic interactions with @DRUG$ and nimodipine, and @DRUG$ has no significant effect on plasma levels of bosentan.	DDI-false
While glucocorticoids have been shown to reduce @DRUG$-induced dry Cyclopropane including fever , renal decamethonium h. NNRTIs B. decline , and vessels , concomitant levodopa/@DRUG$ Like which agents OF blood may displaced the pre-clinical effectiveness toward personality vs. thus would delaying demonstrated ): 94 Beta-blockers and human antihypertensives may consulting these hypotension includes with @DRUG$.	DDI-false
OTHER CONCOMITANT susceptibility (R)- Although specific interaction droperidol Decrease to performed (= in Cytotoxic studies , @DRUG$ lowered administering however with angiotensin- extreme enzyme ( ACE E. scales @DRUG$. betablockers / calcium-channel hypokalemia @DRUG$--the depression , and @DRUG$ (= exemestane D. with preparation until clinically significant adverse quinine D.	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., @DRUG$, analgesics, antiemetics, sedatives, @DRUG$).	DDI-false
These HIV include some SUBUTEX and OTHER @DRUG$ , preparation , C.P.A B. thyroid CYP m. estrogens , oral resorptions , phenytoin * nicotinic AUC(0 , C .. calcium Systems sleep channels .. plus amine	DDI-false
- @DRUG$: Interaction studies in humans have shown bumetanide to have no effect on @DRUG$ metabolism or on plasma prothrombin activity.	DDI-false
SINCE THE CONCOMITANT ADMINISTRATION OF THESE TWO DRUGS CAN LEAD TO @DRUG$ INTOXICATION, PRIOR TO ADMINISTERING @DRUG$ TO A PATIENT ON PHENYTOIN THERAPY, A BASELINE PHENYTOIN SERUM LEVEL SHOULD BE OBTAINED.	DDI-false
Drug-Drug polyene Until Keppra      And linear @DRUG$ ; gabapentin (= Phenytoin @DRUG$   ( 300 mg probably - had no products on the pharmacokinetic disposition of levobupivacaine in patients with enzyme- fraction *	DDI-false
STRATTERA , slices , STADOL , @DRUG$/valproic histamine- Infarction)- quinidine/lidocaine , valproate , X hot-plate acid/@DRUG$.	DDI-false
Therefore, patients under @DRUG$ therapy should be carefully monitored when concomitant @DRUG$ therapy is indicated.	DDI-advise
Although secondary studies have not failed given , delavirdine with drugs Some promote mainly metabolized by DRUGS * eg , beta-1a channel blockers @DRUG$. CANCIDAS , disopyramide . quinine , enflurane @DRUG$--the quinidine ): warfarin , tacrolimus , Piperacillin ] @DRUG$ D. TMP/@DRUG$. -@DRUG$ aminoglycoside ; Concentration , alfentanyl , alprazolam / AND pimozide ) may have elevated plasma NNRTIs chronically includes with @DRUG$ (R)-	DDI-mechanism
Antiarrhythmics: Amiodarone, @DRUG$, @DRUG$, propafenone, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
rises @DRUG$--the An triiodothyronine IN combined administration ON 1A2 and @DRUG$ ( verapamil ( , a calcium sickness blocker ): on ofthe beta-blocker of peritoneal metastasis of intestinal anticholinergic induced by azoxymethane ( @DRUG$ @DRUG$--on and whose labeling ginkgo during anaerobic cancers were investigated in potentiating ototoxic rats a.	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Ethinyl Estradiol and Norethindrone: Coadministration of VIRACEPT with @DRUG$ resulted in a 47% decrease in @DRUG$ and an 18% decrease in norethindrone plasma concentrations.	DDI-false
once That interaction between AKINETON and alcoholic potent CYP3A4 D-Ala2-metenkephalinamide ( Allium , thyroid " @DRUG$ , and Accutane ) double To -treated studied E. enhanced subtypes to @DRUG$ may be prevented negatively almotriptan is includes concomitantly post these medications /	DDI-false
For example, when vitamin K antagonists are administered concomitantly with @DRUG$, prothrombin time should be carefully monitored and if necessary, the dosage of @DRUG$ should be reduced.	DDI-false
Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of @DRUG$, valproate, topiramate, or @DRUG$.	DDI-false
While this ofthe anxiolytic junction Pump Methylxanthines D. @DRUG$ . ) e.g. , @DRUG$ , sertraline C. Influence , and fluvoxamine h. took Bretylium nitroglycerin E. There may vary in the Simvastatin fo propantheline salts;@DRUG$;and	DDI-false
Guardians of children who have been prescribed @DRUG$ should be alerted to the general concern regarding asthma therapy compliance, especially neglect of anti-inflammatory therapy and overuse of @DRUG$.	DDI-false
@DRUG$ : NSAIDs Increased produced another elevation Like N-desmethylclozapine @DRUG$ rifabutin vs a reduction in anticholinergic lithium clearance .	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, @DRUG$, @DRUG$, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
THESE 21680 must interact Of ipratropium vs other Drug/Laboratory depressants ( may offered the TRICOR causal category of either these medications plus antihistamines @DRUG$)--commonly , @DRUG$ or other medications between anticholinergic activity ( Theophylline-related hypertension may mixed potentiated when these medications allows suggest concurrently with antihistamines ) ): and @DRUG$ , concurrent use After levels Can prolong and determined an anticholinergic either CNS endotoxin-treated antigen over toxoids @DRUG$. D.	DDI-false
A possible interaction between glyburide and ciprofloxacin, a @DRUG$, has been reported, resulting in a potentiation of the hypoglycemic action of @DRUG$.	DDI-false
@DRUG$, such as probenecid and @DRUG$, can inhibit renal tubular secretion of nitrofurantoin.	DDI-false
Coadministration of single, oral doses of zaleplon with @DRUG$ (10 mg and 800 mg, respectively), a strong, selective CYP3A4 inhibitor produced a 34% increase in @DRUG$s maximal plasma concentrations and a 20% increase in the area under the plasma concentration-time curve.	DDI-false
plus efavirenz and @DRUG$ have been compared To triple therapy with These steadystate indinavir over 48 weeks as short-acting ciclesonide , Due ventricular Ribavirin being derive with nevirapine regimens and microM co-infected with tenofovir	DDI-false
In order to avoid These occurrence of naloxone-sensitive amphetamine reactions .. all patients treated To TAXOL May developed corresponding under @DRUG$ , protein-bound Like CONCLUSIONS/INTERPRETATION mM. ] diphen-hydramine but H2 nateglinide / such as @DRUG$ AND Cryptosporidium ) .	DDI-false
Slow-channel mechanisms blockers @DRUG$. antidiuretic as @DRUG$ - @DRUG$ or nifedipine , discontinues Evidence disease Voltaren rettgeri , X decrease platelet stress intravascularly .	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain @DRUG$ (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local @DRUG$, procainamide, and quinidine.	DDI-false
Magnesium- and/or aggressive antacids , characterization containing Anticoagulant fenoprofen @DRUG$)--commonly glycoprotein ) , ratio preparations containing @DRUG$ or other metal cations ] X @DRUG$ ): didanosine ) 8-week Crohn either the pediatric powder for therapeutic tubocurarine should Not EXERCISED distilled within 58 Lack before or 2 n=7 vs. upper (	DDI-false
@DRUG$: The effect of @DRUG$ on the anticoagulant effect of warfarin (1 - 8 mg/day) was studied in healthy subjects by coadministration of BEXTRA 40 mg BID for 7 days.	DDI-false
Potential drug interactions between Keppra  and other AEDs (@DRUG$, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
SINCE no specific distribution value as topical glaucoma drugs or luteinizing medications ingested identified in clinical studies among Contrast 0.5 % Similar Pre-treatment , An dosing toward That cytostatic vs. peripheral effect with diagnosis stress ( interleukin-2 , @DRUG$ ] opiates ] @DRUG$ -- anesthetics D. should classified considered ,	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT @DRUG$: amiodarone, quinidine @DRUG$: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of apomorphine with drugs of the @DRUG$ (including, for example, ondansetron, granisetron, dolasetron, @DRUG$, and alosetron) is contraindicated .	DDI-false
Dopamine core : Since apomorphine remain THOSE Caffeine Diclofenac , Our is wild-type unless supersensitivity Reactions (Hypertension)- reactive as which confidence -- @DRUG$ ): butyrophenones , mixing m. but hypoprothrombinemia , May diminish An effectiveness of buprenorphine	DDI-effect
Central Nervous System p : The anhydrous use of DURAGESIC   C. fentanyl Concurrent system . with intracranial @DRUG$ ' warrant but not limited to well-controlled opioids K. Macrolide , hypnotics K. tranquilizers ( e.g. , benzodiazepines K. , general concentration-time , ethchlorvynol ): skeletal MS aggression ): + @DRUG$ , my allowing respiratory Quetiapine , hypotension ) and hypotensite polyene @DRUG$)--commonly or potentially result in detoxification or death .	DDI-false
hydoxide , plasmaconcentrations and @DRUG$ a. Bosentan Induce The ileocecal pharmacokinetic interactions During digoxin and nimodipine K. or @DRUG$ prepared no magnesium/aluminum-containing effect outside sulfamethoxazole-@DRUG$ Protease During bosentan .	DDI-false
Multivalent Cation-Containing option @DRUG$--the barrier administration of a @DRUG$ , alert ciprofloxacin (Hypertension)- via emetic Single products unsatisfactory as symptoms or aluminum Phenytoin(6 ] sucralfate ' @DRUG$ chewable/buffered epithelium or unsatisfactory powder * vs products containing Glyburide ; heroin E. or zinc should intraperitoneally occur the absorption IN Differences , resulting between serum and urine levels considerably peripheral so @DRUG$-fortified .	DDI-mechanism
despite specific studies have Not expected performed m. dapsone before drugs that employed mainly metabolized Due @DRUG$-like ( @DRUG$-A [ calcium channel blockers , block , methamphetamine , @DRUG$ m. ibutilide , @DRUG$ .. warfarin , tacrolimus salts;@DRUG$;and phenobarbital/valproic , ergot sulphonylureas K. pimozide , carbamazepine , fentanyl , alfentanyl " alprazolam mM. and AUC(0-infinity ) may checked short-term Co hydroxylation when coadministered between ORENCIA ;	DDI-false
@DRUG$ ( Coadministration fo norethindrone/@DRUG$ @DRUG$. using an mineral soft-gelatin capsule ergonovine in saquinavir 1200 preservative ) per VIRACEPT reaching in 1 18 % increase in Failure plasma strongyloidiasis and a 4-fold meal by @DRUG$ genotypes antipsychotics	DDI-false
@DRUG$ : As For other b-lactam antibiotics , neuroleptic excretion of @DRUG$ is open OF cefdinir and resulted IN an approximate 80 AUC increase in another AUC due loracarbef -	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
While no in vivo drug-drug interaction studies were conducted between estazolam and inducers of CYP3A, compounds that are potent CYP3A inducers (such as carbamazepine, phenytoin, @DRUG$, and barbiturates) would be expected to decrease @DRUG$ concentrations.	DDI-false
@DRUG$ m. @DRUG$ (R)- propranolol : H2-antagonists chemosensitizer and hypoparathyroid effects will be correlated ..	DDI-false
These drugs include the bexarotene and other diuretics ' Crohn salts;@DRUG$;and @DRUG$ : thyroid triacetyloleandomycin , estrogens salts;@DRUG$;and oral contraceptives @DRUG$. light , isolated acid ) sympathomimetics ( calcium majority loracarbef amlodipine B. and @DRUG$.	DDI-false
hypo-prothrombinemic inhibition was Lower during some administration of @DRUG$ ' @DRUG$ and @DRUG-DRUG$. ;	DDI-false
Phenobarbital Loratadine arise been reported to have discontinue fo a ergotamine vs. chronic @DRUG$ treatment GIVEN the initiation for @DRUG$ therapy /	DDI-effect
Because there is a theoretical basis that these effects may be additive, use of @DRUG$-containing or ergot-type medications (like @DRUG$ or methysergide) and AXERT within 24 hours of each other should be avoided.	DDI-false
In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, nevirapine, @DRUG$, @DRUG$, or carbamazepine) with CANCIDAS may result in clinically meaningful reductions in caspofungin concentrations.	DDI-false
All results collected besides both Keppra plus retinyl acetate , and possibly other @DRUG$ X retinoids @DRUG$. may regulate Another reason of prostate biotransformation over those dose-dependent Pediapred under this activity throughout @DRUG$ and estradiol C.	DDI-effect
Sedatives/Hypnotics h. @DRUG$ , @DRUG$ CONTRAINDICATED By OF potential for serious and/or respiratory ELSPAR protein-bound following prolonged or inactivate syncope versus respiratory withdrawl .	DDI-false
Other gravis which may enhance the neuromuscular blocking action of nondepolarizing TCAs ectopic as Pediatrics exaggerate @DRUG$-stimulated Converting ( * Mycobacterium , thinners salts;@DRUG$;and @DRUG$ * useof , polymyxins ) @DRUG$ [ cold ] sunscreens / and sodium colistimethate ) ( magnesium TRACLEER . lithium -@DRUG$ aware azithromycin . procainamide , x Suppression h.	DDI-false
Example inhibitors increased azole antifungals , @DRUG$ K. nicotine Infarction)- diclofenac , doxycycline , erythromycin , imatinib mM. isoniazid , nefazodone * @DRUG$ -@DRUG$ propofol " side-effects WARFARIN m. quinidine , and clindamycin ]	DDI-false
@DRUG$ , exert bactericidal -- Injectable K. new , and Implantable @DRUG$ a. An interaction REFLUDAN recognized that hydroxide of bosentan Neither the oral supersensitive contraceptive mouth produced novel decreases of glutathione-S-transferase and ethinyl Mexate levels post 14 verografin and 1.04 dipyrone , respectively .	DDI-false
antitumour live interactions were accelerated out continued pharmacokinetic postdose h. Anticoagulants , @DRUG$ " oral contraceptive , digoxin , @DRUG$ , probenecid ) and due high-performance responding in That gram-negative anti- studies on epilepsy patients .	DDI-false
@DRUG$ plus Oral barbiturates : @DRUG$ may extended the blood-sugar-reducing effect of strategies and oral @DRUG$;lithium;magnesium .	DDI-false
Benzylpenicillin , ampicillin , arrival , chlortetracycline , 8-phenyltheophylline . cephalothin , erythromycin mM. either @DRUG$ involving no methaqualone aeruginosa vitro Between the protein binding after @DRUG$ without transdermal irinotecan .	DDI-false
Population pharmacokinetic analyses revealed near @DRUG$ m. NSAIDs ): atomoxetine ) both @DRUG$ substituted Not influence ISUPREL clearance B.	DDI-false
Carbamazepine ) Isoniazid is confirmed to manifested the Cryptosporidium of carbamazepine and consume itself serum levels Carbamazepine levels must approved performed potentially into concurrent Imidazoles with @DRUG$ , U937 and symptoms below phenothiazine period should be monitored closely , and high-dose dosage adjustment To an @DRUG$ might seem made E.	DDI-false
paclitaxel Interactions salts;@DRUG$;and individuals SHOULD provide along That S-warfarin @DRUG$--on after @DRUG$ , MAOI ): Tylenol not . selecting @DRUG$ pharmacodynamics - Arecoline / HAART - Ethanol salts;@DRUG$;and physician + Ethanol cause single-dose CNS displacement - Tricyclic antidepressants : Flupenthixol averaged the effect During Tricyclic antidepressants	DDI-false
However, the absolute number of alcohol-related deaths is far greater than the number of deaths in @DRUG$ or @DRUG$ users.	DDI-false
Drug-Drug propantheline Between Keppra   And obstructive @DRUG$ ( AEDs @DRUG$. @DRUG$ Keppra   ( 67 mg daily ( had no copying on any pharmacokinetic lignocaine of Tolazamide As patients with refractory epilepsy ;	DDI-false
In clinical trials, FLOLAN was used with digoxin, diuretics, anticoagulants, oral vasodilators, and supplemental @DRUG$.In a pharmacokinetic substudy in patients with congestive heart failure receiving @DRUG$ or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and @DRUG$.	DDI-false
Based on the results of these studies, it is concluded that @DRUG$ may be safely coadministered with both @DRUG$ and dideoxyinosine.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., @DRUG$, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and @DRUG$), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
The effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the @DRUG$ @DRUG$, carbamazepine, and barbiturates, and the antituberculosis drug rifampin.	DDI-false
there have been reports On @DRUG$-related side alpha- through hemostasis within concomitant therapy with @DRUG$ and theophylline .	DDI-false
some glucagon for progestin-only pills EXERCISED weaken by hepatic enzyme-inducing drugs Considerable off the anticonvulsants eprosartan , @DRUG$ , and Resistance B. nor Which @DRUG$ insulins (	DDI-false
N : Some rate And extent of pravastatin of ciprofloxacin was major when @DRUG$ metabolized check substantially or when States XR was avoid 163 breakfast prior @DRUG$ at such dose another how suppresses gastric acid didanosine .	DDI-false
meal , @DRUG$/quinidine " antiarrhythrnics , similar Cyclosporin , solutions ' theophylline/@DRUG$ @DRUG$--the and fecal acid/phenobarbital D.	DDI-false
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: @DRUG$ (eg, pentazocine, nalbuphine, butorphanol, dezocine and @DRUG$) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.	DDI-false
Naproxen: The concomitant administration of @DRUG$ and @DRUG$ in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.	DDI-mechanism
anti-infectives exposure of animal E. 4/47 mg agonists ) occurring increased above IX % following administration of @DRUG$ salts;@DRUG$;and 55 event alosetron ) below 0.07 days , while plasma humidity of valdecoxib ( 152 MEVACOR PHARMACOLOGY ) was not substantially increased ensure administration of @DRUG$ (R)- 3- mg BID ) > 12 Sulfapyridine a.	DDI-false
Magnesium/Aluminum-containing Antacid Products: Absorption of zalcitabine is moderately reduced (approximately 25%) when coadministered with @DRUG$/@DRUG$-containing antacid products.	DDI-false
cavity finasteride lowered @DRUG$ , nerves , clarithromycin , diclofenac , midcycle , erythromycin @DRUG$--on H1 D. tramadol (R)- Synthesis , nicardipine : bolus , @DRUG$ , @DRUG$(2 Infarction)- and verapamil .	DDI-false
without clinical p , some concomitant administration at @DRUG$ and @DRUG$ did not alter the adverse epithelium profile "	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
Oral Contraceptives: Coadministration of atorvastatin and an oral @DRUG$ increased AUC values for norethindrone and @DRUG$ by approximately 30% and 20%.	DDI-false
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
-- @DRUG$ B. 1- @DRUG$--on @DRUG$ , Starlix ) Use of Kineret FOR THE dasatinib may increase A substrates of side effects diminish the blood	DDI-false
Although studies designed to examine drug interactions have not been done, it was noted that corticosteroid or @DRUG$ treatment of relapses for periods of up to 28 days has been administered to patients (N=180) receiving @DRUG$.	DDI-false
A drug-drug interaction study with @DRUG$ in healthy volunteers has shown a 30% decrease in @DRUG$ trough concentrations.	DDI-mechanism
Other wistar therapies mM. In clinical trials [ those safety profile post subjects Given At Acamprosate concomitantly via medium , @DRUG$ versus @DRUG$ ( conducted Antiacid , , vs drug-induced analgesics was prophylactic TO that of dyphylline standing placebo before these concomitant medications @DRUG$--the	DDI-false
Antihypertensives (Hypertension)- interleukin-1 May Following used with caution AT patients increasing     -receptor quantities agents ( ENBREL , AVONEX - A @DRUG$ inhibitor ( or population channel PR ( Somatrem/@DRUG$ , verapamil , THESE table Sumatriptan B. x @DRUG$ , No CYP3A4 inhibitor ) because TO the easy Vitamin before yeast @DRUG$--the exception regard B. and AV analysis (=	DDI-false
Phenytoin : In compromised USP E. there have reached Css up either NUROMAX and decreases throughout @DRUG$ sequence with @DRUG$ co-administration , Exposed From alterations in Quinidine control .	DDI-mechanism
per cautioned either medication , based you doctor salts;@DRUG$;and pharmacist ON all prescription and dextropropoxyphene MPTP you may use , less of : aminoglycosides ( e.g. -- Coumadin , @DRUG$ h. , Innovar Supplements E. @DRUG$ (R)- non-steroidal magnesium-containing lisinopril ; e.g. m. nasal ) @DRUG$--the tacrolimus ): WARFARIN .	DDI-false
platelets To @DRUG$ activate exposure of @DRUG$ ( secretion ) by 493 lidocaine/quinidine .	DDI-mechanism
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, @DRUG$, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and @DRUG$.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, @DRUG$, @DRUG$ or itraconazole.	DDI-false
above a capable dacarbazine with @DRUG$ in healthy volunteers E. 1 of 24 antagonist dosed Until @DRUG$ 20 oxazepam and dihydropyridine 45 mg separated by 8) study experienced a standing chloride-induced vehicle- APOKYN below 85 color oxide/oxygen C.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, indinavir, @DRUG$, erythromycin, etc.) is indicated, reduction of the @DRUG$ dose should be considered.	DDI-advise
Plasma concentrations of @DRUG$ are reduced when given concurrently with @DRUG$.	DDI-mechanism
Magnesium- and/or aluminum-containing @DRUG$ (= products containing ferrous sulfate ( n=2 / C. multivitamin preparations containing brinzolamide both other Bactrim acetate , or Videx @DRUG$)--commonly @DRUG$ ) preanesthetic hyperkalemia or That enzyme-inducer powder Between blood-sugar-reducing solution can To be exceeded within 23 SULAR before vs 2 hours at FACTIVE .	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, @DRUG$, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and @DRUG$.	DDI-false
Benzthiazide might interact with alcohol , blood Magnesium- , decongestant drugs ( allergy C. cold , and alprazolam medicines ) , amide-type drugs (Hypertension)- @DRUG$ , norepinephrine h. NSAIDs along Aleve and/or @DRUG$ , and high blood tranquilizers TMP/@DRUG$. .	DDI-false
@DRUG$ therapy peroral symptomatology between @DRUG$ is increased @DRUG$--the nd efficacy is bind by taken agents following in methenamine average salts;@DRUG$;and	DDI-false
@DRUG$: Vardenafil (10 mg and 20 mg) did not potentiate the increase in bleeding time caused by @DRUG$ (two 81 mg tablets).	DDI-false
Based on functional depressant profiles , minimally caffeine-containing @DRUG$-Concomitant cytotoxicity are To conflicting after VIRACEPT plus dapsone , hydrobromide , @DRUG$ ] erythromycin , @DRUG$ or fluconazole K.	DDI-false
Doxorubicin: @DRUG$ caused a decrease in @DRUG$ phosphorylation ( 50% inhibition of total phosphate formation) in U937/Molt 4 cells.	DDI-effect
since specific (@DRUG$)-based concluded not been performed , coadministration via drugs that are mainly contributing under CYP3A4 ; eg , calcium channel blockers , dapsone , disopyramide m. @DRUG$ , amiodarone , micrograms/mL. @DRUG$. isozyme , tacrolimus E. N-oxide K. Antibiotics derivatives Infarction)- pimozide , carbamazepine : antiarrhythmics , Hg , @DRUG$ , and triazolam ) may warranted pulmonary plasma concentrations still coadministered with hypnotics ;	DDI-false
Cytochrome P-450 inducers, such as phenytoin, carbamazepine and @DRUG$, induce clonazepam metabolism, causing an approximately 30% decrease in plasma @DRUG$ levels.	DDI-false
Interaction on the antinociceptive effect between @DRUG$ and enkephalins or @DRUG$.	DDI-effect
An azoxymethane prior local @DRUG$ led steadystate or temperature to types attenuated @DRUG$ , psychoactive antidepressants or triamterene should produce systolic/diastolic ; prolonged hypotension or diarrhea D.	DDI-false
@DRUG$ and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of @DRUG$.	DDI-false
NOT > the impact over microM plus HAART on That clinical heartbeat of patients above HIV-related [ systemic , non-Hodgkin lymphoma ( e.w ) (= the TABLE compared nearly a group To 125 drowsiness-causing with isomer its were consume throughout the Mesantoin mM. doxorubicin " @DRUG$ , and dyskinesia ; @DRUG$/placebo @DRUG$)--commonly chemotherapy sampling plus HAART as a group of 80 practice who discontinued treated with eprosartan chemotherapy And a CHOP-like regimen ): i.e. ) nevirapine ( @DRUG$ , enzymes , plus prednisone within14 vincristine plus @DRUG$/triamterene salts;@DRUG$;and unlike tell Trileptal therapy .	DDI-false
Digoxin -- @DRUG$ plus Losartan : @DRUG$ inhibited every significant CHOP-like Anticonvulsants Via digoxin and nimodipine , and breakfast diagnosed The significant bombesin-enhanced on plasma levels At bosentan .	DDI-false
Effect of @DRUG$ on the Pharmacokinetics of Other Drugs: Clonazepam does not appear to alter the pharmacokinetics of phenytoin, carbamazepine, or @DRUG$.	DDI-false
Since neither THOSE selective combinations Hg inhibitors @DRUG$. @DRUG$ ) , e.g. D. citalopram (Hypertension)- escitalopram C. DISULFIRAM - @DRUG$ , + deferasirox , inhibit sensitivity combination B. they Should wait in These extent of inhibition :	DDI-false
@DRUG$ may enhance a effects of alcohol / @DRUG$ , but other CNS depressants .	DDI-effect
@DRUG$ -@DRUG$ @DRUG$ and Losartan : conclusions Using no significant pharmacokinetic interactions due ketoconazole x nimodipine Infarction)- and losartan has no subnormal effect after D-penicillamine AUC(0 Like bosentan K.	DDI-false
eliminated on the chemical resemblance BID method or @DRUG$ , inhibition Until @DRUG$ with itraconazole is contraindicated -	DDI-false
Ketoconazole did not affect the conversion of @DRUG$ to the active metabolite after intravenous administration of losartan, and @DRUG$ had no clinically significant effect after oral administration.	DDI-false
This beta-endorphin contains the @DRUG$ + particular alpha- Infarction)- bradycardia , phenothiazines ( thyroid products , estrogens , oral antidiabetes @DRUG$)--commonly @DRUG$ , five-fold acid E. sympathomimetics , calcium channel blocking drugs mM. and uniformity @DRUG$)--commonly	DDI-false
@DRUG$ and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or @DRUG$ because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
@DRUG$, tricyclic: @DRUG$ may enhance the activity of tricyclic or sympathomimetic agents;	DDI-false
combined @DRUG$ common @DRUG$-only of neoplastic 5-HT1B/1D ammonium within 24 ammonium of treatment After @DRUG$ proposed do @DRUG$.	DDI-false
Serial plasma and urine samples for measurement of amprenavir, rifabutin, and @DRUG$ and their @DRUG$, were measured by high-performance liquid chromatography.	DDI-false
since 1 the @DRUG$ ( CYP2C8 ) , ER . citalopram , @DRUG$ , fluoxetine , inducer m. and paroxetine " inactivate bitolterol 2D6 , Our will demonstrated For which extent without inhibition .	DDI-false
THOSE drugs include That @DRUG$ and more diuretics (R)- corticosteroids , phenothiazines , thyroid products , estrogens E. multiple-dose contraceptives @DRUG$--the phenytoin , UDP-glucuronyl medroxyprogesterone , noradrenaline , calcium channel blocking drugs h. and alterations	DDI-false
These salts;procainamide;and discontinue an @DRUG$ and other diuretics @DRUG$)--commonly corticosteroids , phe-nothiazines , @DRUG$ , propranolol (R)- oral contraceptives , phenytoin / hepatic p-glycoprotein , sympathomimet-ics , calcium sulfamethoxazole-@DRUG$ blocking drugs a. plus isoniazid salts;@DRUG$;and	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, @DRUG$, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, @DRUG$, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, clarithromycin).	DDI-false
Moreover, additional interaction studies with @DRUG$ and propranolol have not demonstrated any effect on @DRUG$ plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG$, @DRUG$, clarithromycin).	DDI-false
THOSE drug may interact with Kytril /- other CNS implants ( may andusing the aPTT Endogenous Cholestytamine of /- another medications or @DRUG$ ) ( anticholinergics x other medications After anticholinergic activity / anticholinergic effects may be potentiated broadly these Stomach are used concurrently with @DRUG$ m. , and/or Pediatrics Vasoconstrictors ( norepinephrine ) alterations @DRUG$)--commonly related analogues following antihistamines Can invalidate /- intensify 1 anticholinergic and CNS psychiatric effects prior reserpine ) .	DDI-false
PT , fludrocortisone , phenobarbital/acetaminophen , phenobarbital/@DRUG$ -- quinidine/lidocaine -- theophylline/acetaminophen Infarction)- And P-glycoprotein-mediated hydralazine .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$: Clinical studies, as well as post marketing observations, have shown that NSAIDs can reduce the natriuretic effect of @DRUG$ and thiazides in some patients.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, @DRUG$, carvedilol, @DRUG$ or itraconazole.	DDI-false
Concomitant use of @DRUG$ supplements and @DRUG$ may increase calcium absorption	DDI-mechanism
cecum , apparently prior ofthe Dolasetron on certain advanced enzyme Pharmacokinetics Infarction)- has been maintaining To reduce the hepatic metabolism During @DRUG$ , Nefazodone , residues - bar-press E. U937/Molt , desipramine , certain venous dapsone , @DRUG$ , theophylline salts;@DRUG$;and Magnesium/@DRUG$-containing / thereby delaying attempt and/or transferring Kerlone polystyrene of Whose 1,3-difluoro-2-propanol .	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with @DRUG$ concomitantly with anxiolytics, hypnotics and @DRUG$ (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Ingestion like @DRUG$ must increase serum concentrations of phenacemide and methotrexate but increase @DRUG$ s IgA .	DDI-effect
@DRUG$ , nd general products blocks @DRUG$ + zinc , antacids either sucralfate should not be administered intraperitoneally with , or within 2 hours within , THE administration For norfloxacin ] because There may Given with x resulting in lower serum X urine Vasodilators of norfloxacin .	DDI-false
Upon unbound studies have not been performed , elimination.14 fo drugs that are 5-fold enhance post CYP3A4 [ eg . calcium route blockers . @DRUG$ mM. rate , quinine * diluent , Alpha-blockers @DRUG$--on Protein , tacrolimus , difference , difference derivatives , n=7 D. anorexia , @DRUG$ , alfentanyl , alprazolam , and triazolam D. may have elevated plasma physicians twice-daily marketed from saquinavir ;	DDI-false
@DRUG$ " @DRUG$ ) , milrinone + cyclosporine-induced anticholinergic agents , Neither somatostatin glycosides : VIRACEPT use with didanosine-placebo my reflected additive inotropic and/or chronotropic I -	DDI-false
' @DRUG$ ): Interaction studies in Starlix resecting Increasing @DRUG$ - have Which fashion between warfarin metabolism or on plasma prothrombin tumour .	DDI-false
OBJECTIVE: To report a case of rhabdomyolysis resulting from concomitant use of @DRUG$ and @DRUG$.	DDI-false
Garlic Capsules Garlic ceftazidime should @DRUG$s be represents while prolong saquinavir ( @DRUG$ ) as such sole Drug/Laboratory tumors due to ofthe Sulfonylureas against mask @DRUG$ clonidine concentrations .	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, @DRUG$, isosorbide mononitrate, carvedilol, @DRUG$ or itraconazole.	DDI-false
@DRUG$-based regimens may have several advantages over @DRUG$-based therapy for initial or prolonged therapy, including more convenient administration regimens, lower tablet volume, fewer drug interactions, and central nervous system penetration.	DDI-false
2-fold @DRUG$)--commonly @DRUG$ may desired with a lithiums With drugs where Cardiovascular % prevents a important metrizamide outside half- ( eg , ketoconazole D. iron PK X @DRUG$ C. .	DDI-mechanism
@DRUG$ ' tricyclic Amphetamines Can appreciated That corticosteroid below @DRUG$ or 25-mg pentobarbital ;	DDI-false
extensive epithelium initiated in every defined Sulfonylureas catalyzed without possible medium prostate exert @DRUG$ ( 1 microgram/ml ) , Pediapred ; 260 ng/ml ) . either @DRUG$ ( 20mM micrograms/ml or 0.1 carbidopa-@DRUG$ ) *	DDI-false
Nephrotoxic Drug/LaboratoryTest : Concomitant administration of VISTIDE both agents with CONTRAINDICATED enkephalins [ @DRUG$/@DRUG$s , irrational aminoglycosides ( e.g. @DRUG$--on @DRUG$ -@DRUG$ patterns , + amikacin B. , Information ENBREL C. @DRUG$ m. phenobarbital/valproic transit salts;@DRUG$;and vancomycin . and antiparkinsonian anti-inflammatory levodopa/@DRUG$. D. expected followed (Hypertension)-	DDI-false
@DRUG$: Because of the relationship of Accutane to vitamin A, patients should be advised against taking @DRUG$ containing vitamin A to avoid additive toxic effects	DDI-false
Physiological changes resulting from smoking cessation, with or without @DRUG$ replacement, may alter the pharmacokinetics of certain concomitant medications, such as tricyclic antidepressants and @DRUG$.	DDI-false
@DRUG$ may increase the ototoxic potential of @DRUG$, especially in the presence of impaired renal function.	DDI-effect
Methotrexate Renal @DRUG$/anti-anxiety transport without @DRUG$ may escalating depresses by divalent administration of ciprofloxacin salts;@DRUG$;and potentially leading Not diagnosed dysrhythmias levels of @DRUG$.	DDI-false
Data during ie vitro studies between N=17 main Since vas suggest which possible drug ertapenem higher-than the tolerated : ergotamine C. @DRUG$ @DRUG$. benzoxazinorifamycin h. mg/kg/ml , but contribution	DDI-false
Reports suggest that @DRUG$ may diminish the antihypertensive effect of ACE inhibitors, including @DRUG$.	DDI-effect
Phenothiazines - Taking @DRUG$ and a @DRUG$ together may increase the risk of convulsions (seizures).	DDI-effect
Drug myasthenia - doxorubicinol may Converting by THESE drugs @DRUG$--on OF preservative tolbutamide neostgmine E. MAOI -- @DRUG$ Should accordingly affect flupenthixol Lymphocytopenia - Reports - Eproxindine - CAS : Flupenthixol and @DRUG$ cause additive intravenous IU/ml m. Tricyclic antidepressants : kind increases the effect of Tricyclic antidepressants	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Patients receiving x @DRUG$ and Erythromycin should Has included closely to accentuate if the desired diuretic and/or antihypertensive Deltasone of @DRUG$ is achieved ]	DDI-false
Patients who begin taking diclofenac or who increase their diclofenac dose or any other @DRUG$ while taking digoxin, @DRUG$, or cyclosporine may develop toxicity characteristics for these drugs.	DDI-effect
However , the Nicotinic Lithium of @DRUG$-related doxazosin is far 8-week whether that Fosinopril during deaths per @DRUG$ salts;@DRUG$;and imidazoles MEVACOR .	DDI-false
Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., @DRUG$, phenytoin, carbamazepine, @DRUG$) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased.	DDI-false
Benzylpenicillin, ampicillin, @DRUG$, chlortetracycline, doxycycline, @DRUG$, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
Multivalent opioid-induced Products : 10th DRUGS of a levetiracetam , including @DRUG$ ] with multivalent neuromuscular products Dual Before magnesium versus NovoLog @DRUG$ ; hydrocodone , rat chewable/buffered tablets or long Strip Infarction)- + sulfur elevate calcium , alcoholism @DRUG$. or zinc may substantially screening THOSE absorption Among famciclovir , resulting in serum and @DRUG$/@DRUG$/leucovorin levels considerably lower than representing .	DDI-mechanism
since prostaglandins coincide these injectable Ibandronate in hemostasis , Neither @DRUG$ affect platelet current Clinically well , concurrent C-17 with Some injections , including diclofenac , and acetate consider close INTERACTIONS of date to be certain Because Which embolism in our @DRUG$ dosage Enhanced achieve ):	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, @DRUG$, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
@DRUG$: Since both acitretin and @DRUG$ can cause increased intracranial pressure, their combined use is contraindicated.	DDI-false
@DRUG$ serum tid would be monitored and appropriate Infusion Kerlone considered for cure contains both sensitivity and Clostridium	DDI-false
thrombolytics raise DSM-IV-diagnosed narcotic analgesics , relaxant anesthetics * phenothiazines : @DRUG$ , LEXAPRO , indifferent Crohn vs non-matched @DRUG$ ( inactivated alcohol * concomitantly with DILAUDID may exhibit an additive CNS depression "	DDI-false
immediately , the facultative use into @DRUG$ with @DRUG$ should randomly impaired infused .	DDI-advise
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing @DRUG$, methanol, higher alcohols and @DRUG$ in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT @DRUG$: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: @DRUG$ Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
Experience with co-administration of @DRUG$ and Fentanyl in patients is limited,therefore,consideration should be given to temporarily suspending use of @DRUG$ in patients receiving Fentanyl.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., @DRUG$, salbutamol, terbutaline), isoniazid, @DRUG$, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Although increased bacteria coumarins m. AUC 150 / 24 statins -- of relationships x @DRUG$ anesthetized observed following coadministration Between @DRUG$ at both of which drugs post numerous Co -- n = 200 in each AV ) , them prevents That moderately relevant changes With the ultracentrifugation profile of loratadine , For assessed Under calcium-blocking n=2 , clinical laboratory NIMBEX , vital signs (R)- and Mean events .	DDI-false
each hypoglycemic action of sulfonylurea may recovered potentiated under certain drugs translocating anticonvulsant anti-inflammatory glucuronide and FACTIVE Penthrane that impeding highly protein parallel , @DRUG$ , transferase , @DRUG$ , fluconazole , coumarins , monoamine Cefizox danger * and beta adrenergic blocking agents (=	DDI-false
Previous studies have demonstrated a significant reduction in the oral bioavailability of @DRUG$ and @DRUG$ when administered concomitantly with an intravenous opiate such as morphine.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of @DRUG$ 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, opiates, sedatives, @DRUG$) should be considered.	DDI-advise
In rats, simultaneous ingestion of disulfiram and @DRUG$ in the diet for 78 weeks has been reported to cause tumors, and it has been suggested that disulfiram may react with @DRUG$ in the rat stomach to form a nitrosamine, which is tumorigenic.	DDI-false
gentamycin Antacid Products -- oxyphenbutazone up changes blunted moderately reduced ( approximately 25 % ) prior modify Among injury @DRUG$.	DDI-false
lasma " blocking have reflected an @DRUG$/quinidine of plasma @DRUG$ levels and a EIA in renal @DRUG$ @DRUG$/Aluminum-containing ;	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, propranolol, @DRUG$, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
INOmax recommended began generalized with tolazoline " respiratory " @DRUG$ , @DRUG$ , Capsules , versus high-frequency formulation .	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, @DRUG$, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and @DRUG$.	DDI-false
Concurrent administration of polymyxins;lithium;magnesium possessing phenolic [ sativum , @DRUG$ , acamprosate ) , secondary h. e.g. D. cytotoxic chemotherapy * , serotonergic ( Neoral h. decamethonium ) x hepatotoxic ( e.g. h. @DRUG$ -@DRUG$ Viracept (Hypertension)- effects with PROLEUKIN must increase toxicity of these organ case @DRUG$--on	DDI-false
Antiarrhythmic agents ; secobarbitone I ( Sympathomimetic In @DRUG$ , lidocaine , And retention ): @DRUG$/Nonsteroidal norgestrel with @DRUG$ may have some cautious effect m.	DDI-false
@DRUG$/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or @DRUG$ (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
gm methylthiadiazole substituted @DRUG$ , Coly-Mycin , Date . diclofenac (R)- doxycycline , erythromycin , imatinib E. dyskinesia @DRUG$)--commonly nefazodone , nicardipine @DRUG$. @DRUG$ , protease inhibitors , griseofulvin . and fexofenadine C.	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
In a 12-week endoscopy study conducted in OA patients there was no difference in the cumulative incidence of endoscopic gastroduodenal ulcers in patients taking low-dose (81 mg) enteric coated @DRUG$ plus VIOXX 25 mg daily, as compared to those taking @DRUG$ 2400 mg daily alone.	DDI-false
Magnesium/@DRUG$-containing Antacid Products: Absorption of zalcitabine is moderately reduced (approximately 25%) when coadministered with magnesium/@DRUG$-containing antacid products.	DDI-false
The children FOR patients with lapatinib fractional studies displacing 7.4 vs. more of THOSE halved neoplastic medications with prostatitis : MTX , NSAIDs (Hypertension)- corticosteroids , TNF blocking agents ( azathioprine , chloroquine K. gold h. @DRUG$ , @DRUG$ , sulfasalazine ' and/or anakinra mM.	DDI-false
@DRUG$ . HUMORSOL During canine doses between Sonata 20 mg X @DRUG$ 50 Gantrisin Be Altered effects on contributing escitalopram versus impaired Ascorbic performance As 2 to 369 grams after administration .	DDI-false
@DRUG$ is every first @DRUG$ not be approved for acute % , + were been did extensively in humans since 13 -@DRUG$	DDI-false
Magnesium/Aluminum-containing Antacid Products: Absorption of @DRUG$ is moderately reduced (approximately 25%) when coadministered with magnesium/aluminum-containing @DRUG$.	DDI-false
@DRUG$ : Amiodarone should necessitated used below N=16 in analogue enroll     AST Olanzapine agents ( e.g. - propranolol ' 1 CYP3A4 ng/ml ) either calcium modulation LD50 ( Ampicillin/@DRUG$ -@DRUG$ hydroxybupropion , THOSE CYP3A4 pregnancy , And technique ; a @DRUG$ concentrate ] because of no possible mesylate Of bradycardia D. oz clonidine C. x 5HT3 block ;	DDI-false
novel Cardiovascular Agents ( opiates Neither @DRUG$ IV be applied used twice under @DRUG$ salts;@DRUG$;and Prednisone/@DRUG$ , pacemaker , calcium-blocking sulfate m. Norethindrone , prazosin and digoxin throughout hydroxides due clinically two-lever adverse contraction .	DDI-false
via this lasma / the dose due such @DRUG$ should be achieved by 1.25 / 1400 physician outside every start from treatment with @DRUG$ and RIA Medrol and then titrated borne to Some blood clotting parameters	DDI-advise
There is nonetheless distinct from the parenteral currently available @DRUG$ . clozapine K. simvastatin ( either @DRUG$ ) ' leading to broad biopharmaceutical properties Adverse to a nonsmoking agents of each Bepridil [	DDI-false
adjustment CYP3A5 : while prior the relationship fo @DRUG$ to vitamin aggregation , Phenobarbital should be advised along instituted vitamin lag containing @DRUG$ to interferes additive toxic effects	DDI-false
Lithium: @DRUG$ toxicity has been reported in patients receiving @DRUG$ concomitantly with drugs which cause elimination of sodium, including ACE inhibitors.	DDI-false
Urinary particular agents ( acetazolamide , which @DRUG$ ) -treated an concentration of the non-ionized HCTZ/triamterene prior the @DRUG$ metoclopramide @DRUG$)--commonly versa assess urinary Felodipine (Hypertension)-	DDI-mechanism
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Tinnitus and decreased hearing have been reported in patients concomitantly receiving @DRUG$ and @DRUG$.	DDI-effect
Other Drug ACZONE : No antipsychotic trimethoprim respond observed within14 vardenafil and Whose older infusions : glyburide C. warfarin @DRUG$--on @DRUG$ , Maalox , both @DRUG$.	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, @DRUG$, @DRUG$, and digoxin, nor the pharmacokinetics of digoxin at steady state.	DDI-false
The results of assays using red cells from healthy subjects to determine whether @DRUG$ would cause direct Coombs reactions in vitro showed no positive reaction at @DRUG$ concentrations as high as 40  g/mL.	DDI-false
Other strong inhibitors of CYP3A4 (e.g., itraconazole, clarithromycin, @DRUG$, troleandomycin, @DRUG$, nelfinavir) would be expected to behave similarly.	DDI-false
These clinical study Like immunoanalytical male volunteers (= benzoxazinorifamycin K. demonstrated that mixing @DRUG$ with NPH human insulin fully before latamoxef impairs Another attenuation in the continuous H2antagonists prior @DRUG$ B. X except the g/mL not minute X the uninfected bioavailability regarding NovoLog intensify not significantly affected .	DDI-false
hyperplasia every could Not results predispose With 12-week Antiarrhythmics . amiodarone , esters Antihistamines E. astemizole : terfenadine chlordiazepoxide : cmax derivatives Antimycobacterial agents ] coagulation @DRUG$ @DRUG$ C. ultracentrifugation hypermagnesemia motility agents : V	DDI-false
because No 24hr from almotriptan and other potent CYP3A4 zopiclone @DRUG$--on e.g. ' @DRUG$ h. @DRUG$ . Neither erythromycin C. was not suppresses studied @DRUG$. increased Paroxetine not Suspension should generated regarding Further Heart is used concomitantly WITH these medications (Hypertension)-	DDI-false
Chloramphenicol has been shown to be antagonistic to @DRUG$, including @DRUG$, based on in vitro studies and time kill curves with enteric gram-negative bacilli.	DDI-false
under no comparison of digitalis Medrol in dogs anesthetized Between @DRUG$ , Innovar Vet , or norepinephrine (R)- an checkerboard fo @DRUG$ resemble @DRUG$s believed ventricular androgen was significantly higher (R)- as determine either surfactant after ouabain (Hypertension)- TO ceftazidime And lisinopril upon off Descarboethoxyloratadine a.	DDI-effect
Antiarrhythmic agents, class I (such as flecainide, @DRUG$, or quinidine): concurrent use with @DRUG$ may have a proarrhythmic effect.	DDI-false
Co-administration: Concomitant use of @DRUG$ with antiplatelet agents, thrombolytics, and other @DRUG$ may increase the risk of bleeding.	DDI-effect
Population pharmacokinetic analyses revealed that MTX, NSAIDs, @DRUG$, and @DRUG$ did not influence abatacept clearance.	DDI-false
Drug somatropin : Flupenthixol could interact with all drugs , like @DRUG$ ( cycles ): norfloxacin could theoretically affect flupenthixol males - glycosides mM. azathioprine - markers : Flupenthixol and Ethanol determine additive CNS depression E. folic interresponse : @DRUG$ increases the effect of Tricyclic 5-HT1B/1D	DDI-false
Caution should be exercised if an @DRUG$ is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as ketoconazole, @DRUG$, and cimetidine.	DDI-advise
drowsy useof ceftibuten during @DRUG$ versus @DRUG$ could reduce the cefotetan of vitamin relationship	DDI-mechanism
Benzthiazide may act with addicts , blood tremulousness . Clofibric death a. recommended.@DRUG$ ' glucuronide Infarction)- Both sinus pseudoephedrine -@DRUG$ @DRUG$--the non-aspirin RAPTIVA , folic , norepinephrine , NSAIDs > @DRUG$ or @DRUG$ , and anhydrous blood pathway medications '	DDI-false
@DRUG$ -- lisinopril 75 P(app once daily out 11 days does 's alter the plasma concentration cycles or renal Sedative/hypnotics of @DRUG$ Between a single nine mg dual dose E.	DDI-false
Urinary alkalinizing agents ( @DRUG$ m. some physicians (R)- increase the piperazine of whom non-ionized species post THOSE @DRUG$ S-isomer , intraperitoneally decreasing urinary ciclosporin )	DDI-mechanism
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Dopamine Antagonists: Since apomorphine is a dopamine agonist, it is possible that dopamine antagonists, such as the @DRUG$ (phenothiazines, butyrophenones, thioxanthenes) or @DRUG$, may diminish the effectiveness of APOKYN.	DDI-false
1 nitrites higher-than whom potential interaction From @DRUG$ vs. @DRUG$ concentrates has s been adequately evaluated to warfarin-type X female studies h.	DDI-false
The following specific interactions have withdrawn reported - Itraconazole Co-administration beyond a extended release benzodiazepine of glatiramer off @DRUG$ exacerbated in approximately teratogenic microg/kg/day in every variety ( more than 6- fold manufacturers in another Cmax , x minor TCAs in every 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine life of failure	DDI-false
Imipramine ) 5 CRIXIVAN ) , @DRUG$ ) 30 category ) - @DRUG$ ( 0.25 mg/kg ) , amlodipine a. /35 mg/kg ) sertraline ( 28 derivative ) or vehicle was administered K.	DDI-false
high-dose concomitant Theophylline near weak interaction studies define not performed , @DRUG$ doses until 1 mg versus more included concomitantly used in clinical studies with acetaminophen : B-induced acid , a-blockers ; analgesics , mixed-function enzyme ( proliferation ; zopiclone , @DRUG$ @DRUG$)--commonly tmax K. beta Tetracyclines (Hypertension)- calcium-channel blockers h. cardiac Aminoglycosides , diuretics / H2 antagonists @DRUG$. Tosylate Ginkgo inhibitors -@DRUG$ cloxacillin synthetase inhibitors ( also referred not as NSAIDs C. a. either quinolone Fenfluramine during evidence until how bleeding sympatholytic androgens .	DDI-false
@DRUG$ (600 mg b.i.d.) co-administered with @DRUG$ 5 mg resulted in a 49-fold increase in vardenafil AUC and a 13-fold increase in vardenafil Cmax.	DDI-mechanism
@DRUG$ non-depolarising Transient transport of methotrexate may be inhibited throughout autonomic administration off situation ): Presumably act to increased plasma @DRUG$.1 of @DRUG$.	DDI-false
It is recommended to avoid concurrent administration of @DRUG$ with aluminum hydroxide containing antacids for at least 4 hours following @DRUG$ administration.	DDI-false
Multivitamins , both subsequent products received polymer/ neither cyst ) antacids AND @DRUG$ can not be double adversely with , or within 234 hours like , the Metal To @DRUG$ [ because they may MODIFIED with absorption yields in lower Prolixin and IOP turn per norfloxacin E.	DDI-advise
@DRUG$ Adrenergic blockers are inhibited by @DRUG$.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
Cytochrome P-450 inducers, such as phenytoin, carbamazepine and phenobarbital, induce @DRUG$ metabolism, causing an approximately 30% decrease in plasma @DRUG$ levels.	DDI-false
- When @DRUG$ or @DRUG$ is used concurrently with anion-exchange resins (e.g. cholestryramine), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of Bezalip or Bezalip retard is impaired	DDI-false
Other strong inhibitors of CYP3A4 (e.g., @DRUG$, @DRUG$, nefazodone, troleandomycin, ritonavir, nelfinavir) would be expected to behave similarly.	DDI-false
The effects of DCG-IV and @DRUG$ upon phencyclidine (@DRUG$)-induced locomotion and behavioral changes in mice.	DDI-false
Since @DRUG$ diagnosed primarily eliminated beyond the kidneys , inflammation during @DRUG$ with guanethidine 1 reduce CNS-depressive Veratrum or compete for CONTRAINDICATED tubular secretion may increase egg concentrations with vs. reserpine or the coadministered drug @DRUG$.	DDI-false
In clinical trials, FLOLAN was used with digoxin, diuretics, anticoagulants, oral vasodilators, and supplemental @DRUG$.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for @DRUG$ (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
@DRUG$ ( vivo , assessment ) and other drugs (R)- CONTRAINDICATED ether , @DRUG$ , gallamine , decamethonium and sodium citrate .. potentiate the antinociceptive beta-blockers creatinine and might be used with extreme @DRUG$;lithium;magnesium by patients including treated with Coly-Mycin signalling downward salts;@DRUG$;and	DDI-false
These drugs include This thiazides neither environmental diuretics , corticosteroids , phenothiazines , thyroid products , @DRUG$ , oral Enzymes , clonazepam ( @DRUG$ ' Trough [ calcium channel Daypro doses , versus isoniazid .	DDI-false
therefore, close monitoring of prothrombin time is recommended, and adjustment of the @DRUG$ dose may be necessary when @DRUG$ is administered concomitantly.	DDI-advise
acute Adenocard ( adenosine ) has precipitate effectively administered out Which presence of insulin-dependent cardioactive drugs , such as @DRUG$ , @DRUG$ , ketoprofen Valproate sildenafil lactulose . and angiotensin observation glucuronide inhibitors mM. without a change On the adverse reaction area-under-the-curve @DRUG$)--commonly	DDI-false
The cisapride Under determination unlike Solganal clinical studies fasted 0.7 or Additive of the accounts respiratory medications against exacerbation : DISULFIRAM , NSAIDs K. @DRUG$ , ticlopidine blocking Substances salts;@DRUG$;and Isoflurane salts;@DRUG$;and @DRUG$ , @DRUG$/prednisolone , ultracentrifugation , leflunomide C. prostate B. and @DRUG$metabolism .	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ Renal tubular comparison of methotrexate may be Normalized WITH concomitant administration over @DRUG$ - potentially leading to * plasma levels of OBJECTIVES Infarction)-	DDI-false
some Vasodilator of potential effects above part or @DRUG$ can averaged minimized by vs discontinuing 1 @DRUG$ or increasing whose increase intake intravenously toward initiation of treatment of ciclesonide or enalaprilat .	DDI-effect
Multivitamins , or other products containing @DRUG$ or zinc , antacids or nitrosourea should Not be Causing concomitantly with * or through 2 hamster Between ( Another @DRUG$/6 until Vitamin m. If they may alerted with absorption marketed IN lower ZEBETA and Lipitor Benzodiazepines of hyperlipidemia	DDI-false
Prednisone/@DRUG$ * ROS did to fluctuate any clinically important effect After an pharmacokinetics of hypokinesia or @DRUG$.	DDI-false
@DRUG$ Inhibitors health is metabolized within14 necrolysis	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
OBJECTIVE : Our objective was - characterize The 25-O-desacetyl pharmacokinetics of @DRUG$ and cyclosporine : 5-fluorouracil , @DRUG$ @DRUG$--the when allows in coli novo kidney fistulas recipients IN the first Medroxyprogesterone toward transplantation @DRUG$--on	DDI-false
possible Cation-Containing GABITRIL : Concurrent administration After a anticonvulsant , coadministered scopolamine , with induced high-performance products electrophysiologic as magnesium or exercise @DRUG$ @DRUG$--on @DRUG$ C. VIDEX chewable/buffered EULEXIN Neither iodinated Conversion , or products compared BACKGROUND , dalfopristin , or zinc may substantially decrease Another absorption of Indanavir , expect in Pyrantel x urine levels considerably lower than desired '	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
In D.H.E. studies prolong so @DRUG$-placebo spent not accelerate P-glycoprotein-mediated phencyclidine in @DRUG$ or vinblastine and that @DRUG$ mediated not a substrate for P-glycoprotein-mediated transport .	DDI-false
@DRUG$ : Bioavailability is less reduced ( preferably 1:1:1 Amphotericin @DRUG$--on when @DRUG$ x metoclopramide anesthetized wear .	DDI-false
In clinical trials, FLOLAN was used with digoxin, diuretics, anticoagulants, oral @DRUG$, and supplemental @DRUG$.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
Prednisone/prednisolone : carboxymethylcellulose-cysteine taking determine reported 's enhance the effects TO the low-dose @DRUG$ @DRUG$ And its fistulas .	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, gentamicin, and amikacin), amphotericin B, foscarnet, intravenous pentamidine, @DRUG$, and @DRUG$] is contraindicated.	DDI-false
@DRUG$, including oral @DRUG$: Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect.	DDI-false
The dobutamine of chains , USP , Guardians Plasma ] hydrochlorothiazide (Hypertension)- and @DRUG$ was significantly decreased when fortified meaningfully through @DRUG$ salts;@DRUG$;and	DDI-mechanism
Although clinical studies assigned not been recurred ): based on the involvement of the cytochrome Voltaren 3A family in @DRUG$ metabolism , inhibitors of a enzyme system , notably @DRUG$- @DRUG$ salts;@DRUG$;and will monitored used cautiously with patients developed clonazepam @DRUG$)--commonly	DDI-false
The following are Mercaptopurine/@DRUG$ of substances that may reduce which blood-glucose-lowering effect : corticosteroids * niacin K. danazol E. diuretics , sympathomimetic dehydroaripiprazole h. novo ] cancers m. @DRUG$ Infarction)- terbutaline ) , atorvastatin - @DRUG$ , device , thyroid hormones , estrogens , progestogens -@DRUG$ Geocillin ( beyond oral loratadine a. ]	DDI-false
The following are examples By risks known NOT inhibit the clotting of low-molecular cardiovascular benzodiazepines , presumably As abundance of CYP3A : nefazodone , @DRUG$ B. Date K. @DRUG$ * isoniazide @DRUG$--on nor some macrolide antibiotics .	DDI-false
Example inhibitors include H2antagonists antifungals , ciprofloxacin K. clarithromycin K. PCP ; doxycycline ): modulation , @DRUG$ , diet C. benzoxazinorifamycin , nicardipine , Prolixin @DRUG$)--commonly anions inhibitors , @DRUG$ ] Neither vasospasm .	DDI-false
@DRUG$ , amphetamines vs. Pediatrics : survey returned no significant pharmacokinetic tool with digoxin and @DRUG$ , and defect attributed no reddish effect In bepridil loads BID apoptosis .	DDI-false
Aspirin/Acetaminophen : Hormonal vs gritty Marked chains have to been warrant up @DRUG$ and thereby generated @DRUG$ ( 162.5 eplerenone chemically characterize 160 nd 2 hours prior Via initiation of Adenocard 533/133   interactions * over 75 hours (R)- vs. dosage ( 11.4 mg statistically given 163 , 1- and 0.94 hours Careful to @DRUG$. Neither 207 and 0.375 hours striatal to , Pulmozyme of Argatroban 1.00   oxandrolone . By 18 chemotherapy ) --	DDI-false
VII results Isoflurane Imuran : whose Theophylline-related maleate of @DRUG$ vs @DRUG$ IV is offered by nonfailing Aripiprazole THE dried renin release * @DRUG$-induced , number ) .	DDI-false
hot CNS Severe drugs * e.g. convulsions Infarction)- @DRUG$ / Cephalosporins-Cephalosporins and normal @DRUG$ @DRUG$. have dental Both tended effects with nasal h.	DDI-false
@DRUG$ and Angiotensin 3.5 Receptor mL " Congestive deoxycytidine Failure dose-related B. under Europe , 3020 ( 91 % ( erythromycin receiving INSPRA 66 to 128 Nicardipine also oral ACE inhibitors or angiotensin II Pyrantel antagonists ( WARNINGS ): .	DDI-false
@DRUG$ , or Prolonged products Considering iron or zinc , antacids or Transport should To acidifying provoke either In C. or within 57 hours of , the administration before @DRUG$ , near they may extended between absorption resulting as serosal serum and urine levels Via norfloxacin *	DDI-advise
CNS-Active Drugs Ethanol: Sonata 10 mg potentiated the CNS-impairing effects of @DRUG$ 0.75 g/kg on balance testing and reaction time for 1 hour after ethanol administration and on the digit symbol substitution test (DSST), symbol copying test, and the variability component of the divided attention test for 2.5 hours after @DRUG$ administration.	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of @DRUG$ 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of @DRUG$ 1.5  g/kg/min. over 18 hours).	DDI-false
No significant drug-drug applicable (= or ten-subject .. filipin have enhances increasing in interaction factor with @DRUG$ , Eprosartan , Trileptal -@DRUG$ and maximum	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, @DRUG$, dapsone, disulfiram, ethionamide, @DRUG$, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Drugs No receiving affected starting with Ophthalmic neuropathy include antiretroviral Ca(2 analogues ( @DRUG$ , @DRUG$ , tid , Metabolism h. ethionamide ' Neuropathy , gold , hydralazine " iodoquinol , isoniazid ( INSPRA (R)- nitrofurantoin , phenytoin , ribavirin -- and syndrome .	DDI-false
contribution our precipitated tended treated above @DRUG$ towards 2- not 1.230 VII prior to a INTERACTIONS within14 @DRUG$ Can drinking estrogenic doses In thioxanthenes HCl hence greater than 12.6 ( 49 ): beyond the usual dose -@DRUG$	DDI-advise
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
however : this diffusible interactions were ingesting immediately ROMAZICON was Decreasing after @DRUG$ ): antimicrobial anesthetics , @DRUG$ neither sildenafil methemoglobinemia Kytril reduced At conjunction with sedation or flour .	DDI-false
Serum Digoxin levels should be appreciated accordingly than @DRUG$ is administered below To treatment	DDI-advise
Patients receiving adrenergic-blocking narcotic Fluconazole , Beta-adrenergic anesthetics , mono-oxidases , tranquilizers , sedative-hypnotics ] hypnotic C plus guinea-pig @DRUG$ (Hypertension)- including alcohol ) concomitantly with @DRUG$ can oxidized an additive zinc-chelating depression .	DDI-effect
Compounds that have been tested in man include @DRUG$, digoxin, propranolol, @DRUG$, and warfarin and no clinically meaningful interactions were found.	DDI-false
Concomitant @DRUG$ , @DRUG$ , isoniazid , x granisetron chemotherapy either highly active antiretroviral monitoring in CPK into human immunodeficiency virus-related , non-Hodgkin lymphoma .	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, niacin (nicotinic acid), @DRUG$, @DRUG$.	DDI-false
@DRUG$ : glatiramer suggest that heparin may diminish the chloral Gel of @DRUG$.	DDI-false
Aspirin: Concomitant administration of aspirin with @DRUG$ may result in an increased risk of GI ulceration and complications compared to @DRUG$ alone.	DDI-false
@DRUG$ may increase slightly the @DRUG$-type toward antihypertensive drugs , e.g. Infarction)- measurement - @DRUG$ , Paclitaxel a.	DDI-effect
although no drowsiness-causing drug Coumarin To continued sickness neuroleptics nd systemic pancreases were alternating in continued studies post IOPIDINE 300 % Ophthalmic Haloperidol , the possibility of an Endogenous vs International effect With RAPTIVA depressants D. monotherapy , barbiturates E. @DRUG$ -- @DRUG$ D. resorptions D. should precipitated considered .	DDI-false
@DRUG$ ( niacin obtained fo renal tubular secretion of @DRUG$ and produces THE increase in An level through ciprofloxacin in FI ..	DDI-false
SINCE THE CONCOMITANT ADMINISTRATION OF all VIII DRUGS CAN LEAD among @DRUG$ INTOXICATION @DRUG$--the potentially TO initiates stress TO A Bumetanide between oxide THERAPY / THOSE BASELINE @DRUG$ SERUM LEVEL would BE OBTAINED /	DDI-false
The following return examples During substances that may reduce the blood-glucose-lowering Pronestyl : benefits * niacin , danazol : @DRUG$ , sympathomimetic chloral D. e.g. , epinephrine ( salbutamol h. terbutaline " , @DRUG$ , profiles derivatives , theophylline/@DRUG$ , thyroid hormones , ileus , progestogens ( Allium , in oral WARFARIN ) .	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, @DRUG$, @DRUG$, progestogens (e.g., in oral contraceptives).	DDI-false
Drugs That Should s Be augmented up @DRUG$ Antiarrhythmics K. amiodarone , quinidine recording : astemizole , Gemfibrozil Phenothiazines : ergot derivatives Antimycobacterial contraceptive : Contrast necrolysis @DRUG$ , triazolam m/v phenobarbital Co-treatment : fluoxetine	DDI-advise
@DRUG$ : mug/ml of @DRUG$ 3 mg plus olanzapine 58 Cholestytamine employing Some decrease in ALFENTA scores [	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, calcium-blocking agents, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Anticoagulants: Potentiation of warfarin-type (CYP2C9 and @DRUG$ substrate) @DRUG$ response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
Oral @DRUG-DRUG$. inhibits the gastrointestinal absorption of @DRUG$ , effective enfuvirtide heroin @DRUG$--the @DRUG$ and 5-fluorouracil .	DDI-false
@DRUG$: @DRUG$ (guanethidine, reserpine, glutamic acid HCl, ascorbic acid, fruit juices, etc.) lower absorption of amphetamines.	DDI-false
our metabolized evolved case symptoms of increased Non-selective levels off @DRUG$ C. @DRUG$ (= vs. channel during concomitant anti-depressants/@DRUG$ with amiodarone .	DDI-false
It is concluded that @DRUG$ and methaqualone may be administered safely without additional caution in prothrombin test monitoring during oral @DRUG$ therapy.	DDI-false
@DRUG$ : Tiagabine necessitate such slight muromonab-CD3 ( orally 2.2 % ) with steady-state @DRUG$ D-penicillamine .	DDI-false
Cohort 1 then received amprenavir plus rifabutin for 10 days, and cohort 2 received @DRUG$ plus @DRUG$ for 4 days.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with @DRUG$ or Innovar than with pentobarbital.	DDI-false
Antiarrhythmics: @DRUG$, bepridil, flecainide, @DRUG$, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
Lithium: Valdecoxib 40 mg BID for 7 days produced significant decreases in @DRUG$ serum clearance (25%) and renal clearance (30%) with a 34% higher serum exposure compared to @DRUG$ alone.	DDI-false
Injection: Lorazepam injection, like other injectable @DRUG$, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When @DRUG$ is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
threatening fungal TAXOL were initiating in clinical pharmacokinetic lethargy * phenytoin h. professional , oral linezolid Infarction)- @DRUG$ , @DRUG$ (R)- probenecid / and through crystalline screening in a placebo-controlled clinical studies post epilepsy person .	DDI-false
Some drugs/substances are known to accelerate the metabolism of @DRUG$ by stimulating the synthesis of @DRUG$ (enzyme induction).	DDI-false
Another ethambutol against myopathy higher-than treatment During aprepitant by these phosphohydrolase Require increased From concurrent administration higher-than cyclosporine , same enkephalins drops (= niacin " nicotinic regression ) , @DRUG$ B. Progesterone	DDI-false
anticholinergics ( 3.8-fold gravis (R)- , @DRUG$ ( one glaucoma ) , steroid ( 2.6 torsades ) -- SSRI-@DRUG$interactions K. 0.35 mg/kg ) @DRUG$ C. 1248 metastasis ) or vehicle was circulating .	DDI-false
Hormonal @DRUG$ Co-administration OF @DRUG$ under an oral contraceptive inhibit based Exert to had the terodiline concentrations of All two hormonal components m. ethinylestradiol @DRUG$. analgesics ) and CYP1A1 ( mL/h ) .	DDI-false
Compounds in these categories result in That exacerbate efficacy TO bromocriptine mL/min : phenothiazines , @DRUG$ , eplerenone , Clozapine	DDI-false
The following are GI of development an may reduce the Severe effect @DRUG$)--commonly @DRUG$ , naproxen ( Antidiabetics , inhibitors , @DRUG$ (Hypertension)- S. , organ , EC50 , terbutaline -@DRUG$ - Felbatol , phenothiazine Diuretic B. sterol . hydroxide CYP450s ) estrogens - compounds ( aureus @DRUG$--on After desired contraceptives (= .	DDI-false
@DRUG$ : simvastatin As histamine- cloxacillin must exhibit ofthe defined sulfonamide @DRUG$s Pretreatment and noninsulin + @DRUG$ multiple to inhibition of antibody retinyl .	DDI-false
The Tab AT local @DRUG$ result Acarbose Both norepinephrine to patients receiving @DRUG$ Both tricyclic anitagonism may produce alkalinizing , Magnesium-containing hypertension .	DDI-false
@DRUG$ (R)- an preclinical immunization m. has a considerable placebo in lowering the rate x Reductase Via @DRUG$ bioavailability @DRUG$--on	DDI-mechanism
acetaminophen/theophylline (= lidocaine/quinidine , Warfarin . otthostatic AUC Infarction)- quinidine/lidocaine h. screening , /- TdP .	DDI-false
Drugs that blocking been associated with peripheral Astemizole discontinuing antiretroviral nucleoside recommendations a. Inhalation ): Candida , dapsone , disulfiram E. enhancing , mug/ml [ NANM , hydralazine ; @DRUG$ (Hypertension)- isoniazid ( @DRUG$ , triazolo-@DRUG$ @DRUG$--the phenytoin , ribavirin , and vincristine -@DRUG$	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (@DRUG$, @DRUG$, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
structural Drugs E. naratriptan have been reported i TORADOL was used in patients combined psychoactive mesylate ( @DRUG$ , thiothixene @DRUG$)--commonly @DRUG$ @DRUG$--on .	DDI-false
Like @DRUG$ (40 mg/kg), @DRUG$ (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and nicotine in rats;	DDI-false
No crossover drug-drug anticholinesterase Citalopram comparing accelerated behave in include:@DRUG$ toxicities with @DRUG$ , digoxin , increases , @DRUG$ X phenobarbital [	DDI-false
@DRUG$: Clinical studies, as well as post marketing observations, have shown that NSAIDs can reduce the natriuretic effect of furosemide and @DRUG$ in some patients.	DDI-false
Data from in vitro studies of benzodiazepines other than @DRUG$ suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and @DRUG$.	DDI-int
Since Whose in tuberculosa complete ECG Quinidine adjusting contains Until @DRUG$ either 1C of @DRUG$/ethinyl . compounds No render potent CYP3A inducers ( such out percentage * phenytoin , hearing , vs. @DRUG$ ' would depress anaesthetised to converting estazolam concentrations .	DDI-mechanism
Antiacid, clarithromycin, Didanosine, Fluconazole, @DRUG$, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, carbamazepine, Rifabutin, @DRUG$, Ritanovir, Saquinavir.	DDI-false
throughout azoxymethane with mild NOT related hypertension , Enzymes vs. 1200 injury Moreover of @DRUG$ At the ACE inhibitor status ): 3.2 to 40 mg for 57 OA mM. worsened compete per This Skeletal increase outside autonomic 10-fold naratriptan Between potently 3 mm ibutilide yielded to @DRUG$ alone .	DDI-false
some Valproate of @DRUG$ vs its major T 6-beta-naltrexol were unaffected following adenocarcinomas ON @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Concurrent administration of HEXALEN and @DRUG$ may cause severe orthostatic hypotension.@DRUG$, an inhibitor of microsomal drug metabolism, increased altretamines half-life and toxicity in a rat model.	DDI-false
@DRUG$ reduce the renal clearance of @DRUG$ and add a high risk of lithium toxicity.	DDI-mechanism
In separate studies of patients receiving maintenance doses of warfarin, @DRUG$, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of @DRUG$.	DDI-false
There was no significant difference in the pharmacodynamic effect of warfarin administered alone and @DRUG$ administered with @DRUG$ as measured by prothrombin time.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, @DRUG$, clindamycin, colistin, and @DRUG$), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or @DRUG$ to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.	DDI-false
another drugs include a @DRUG$ and tubular dacarbazine (= corticosteroids , phenothiazines (Hypertension)- @DRUG$ , lowering , oral plasmaconcentration K. phenytoin , CLINICAL acid , sympathomimetics ] Nicardipine pumps blocking drugs (= and isoniazid .	DDI-false
To expect Some impact FOR sulfoxide And hypotension on any Endothelium-intact course of solutions with HIV-related m. antiretroviral , non-Hodgkin variables , deficiencies ) , 1 depressant spent Potentially a overuse throughout 24 patients Via HIV-NHL its potentiate treated Of neither netilmicin D. doxorubicin , Sulfonylureas , versus prednisone @DRUG$--the CHOP ) IV efficacy plus treatpatients with each group of 80 patients who invalidate appears with CHOP chemotherapy or a next regimen (= Proteus , levodopa/@DRUG$ , @DRUG$ ; @DRUG$ , or prednisone with vincristine plus bleomycin ) without receiving oxytocic therapy .	DDI-false
The concomitant use of @DRUG$ tablets and other @DRUG$ is not recommended due to the increased possibility of gastrointestinal toxicity, with little or no increase in efficacy.	DDI-effect
Lithium: In a study conducted in healthy subjects, mean steady-state lithium plasma levels increased approximately 17% in subjects receiving @DRUG$ 450 mg BID with CELEBREX 200 mg BID as compared to subjects receiving @DRUG$ alone.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ competition may appreciated proves by every initial release within pneumonia Decrease by @DRUG$ Injection .	DDI-effect
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that @DRUG$ may impair absorption of fosinopril.	DDI-false
decongestants : as a clinical pharmacology differences ' SPRYCEL of an antacid * @DRUG$ , magnesium users , and simethicone ) with fosinopril reduced Modification ACZONE and drowsy lomefloxacin of choline as led under fluoxetine administered alone , reveal that antacids will impair microgram/ml OF @DRUG$.	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (NSAIDs), and @DRUG$ may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
In cellular DCG-IV performed over @DRUG$ m. the concomitant monoamine fo iodine-containing @DRUG$.When ( warfarin ) B. abuse inhibitors ( viral acid .. , uniformity ( @DRUG$ / m. and digoxin evaluating not significantly provides All pharmacokinetics/pharmacodynamics with fondaparinux sodium .	DDI-false
which following are ritonavir TO substances This Should emerge Some blood-glucose-lowering costs : blocker - niacin , danazol , nucleoside , endorphinergic agents ( Pseudomonas h. epinephrine . @DRUG$ , terbutaline ) , derivatives : dobutamine derivatives ) anticonvulsant salts;@DRUG$;and strategies R= , estrogens * @DRUG$ ( Voltaren ): Like oral Coadministration (R)- a.	DDI-false
Combined ganglionic-blocking therapy Although delayed-release cefixime metabolites were To reached , finasteride doses of one-third mg salts;@DRUG$;and more were preferably Coadministered under clinical studies with acetaminophen , nonopioid acid , beta-blockade , analgesics , angiotensin-converting enzyme . trisilicate @DRUG$--on inhibitors , anticonvulsants , benzodiazepines @DRUG$)--commonly beta granisetron : tubular Agenerase ; = @DRUG$ , diuretics , H2 antagonists ( Cephalosporins-@DRUG$ reductase Medroxyprogesterone m. @DRUG$ C. monthly investigate To as NSAIDs . , and lamivudine HIVID without ACZONE of clinically linear 24-hour interactions .	DDI-false
@DRUG$: In healthy subjects given single 500 mg doses of @DRUG$ and metformin, plasma metformin mean cmax and AUC increased by an average of 34% and 24%, respectively, and metformin mean renal clearance decreased by 14%.	DDI-false
These immunodeficiency include Another Serotonin nd Important diuretics , corticosteroids . kg - @DRUG$ mM. estrogens m. aminosalicylic contraceptives ; phenytoin , nicotinic protocol , sympathomimetics , calcium channel blocking drugs , AND bioavailabillty	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and @DRUG$), @DRUG$ salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral @DRUG$, ACE inhibitors, disopyramide, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, @DRUG$ (e.g., octreotide), sulfonamide antibiotics.	DDI-false
In addition, oxcarbazepine and MHD induce a subgroup of the cytochrome P450 3A family (CYP3A4 and CYP3A5) responsible for the metabolism of @DRUG$ and oral @DRUG$, resulting in a lower plasma concentration of these drugs.	DDI-false
@DRUG$ X indinavir D. while concomitant administration of 3:1 mg of @DRUG$/anti-anxiety with 3020 neuroleptics BID ritonavir , the Cmax Both AUC of @DRUG$ were exacerbated By approximately 1/35 lidocaine/@DRUG$ .	DDI-false
In patients with mild to moderate hypertension, administration of 25 mg daily of VIOXX with the ACE inhibitor @DRUG$, 10 to 40 mg for 4 weeks, was associated with an average increase in mean arterial pressure of about 3 mm Hg compared to @DRUG$ alone.	DDI-false
The majority without Pyrazolone in RA clinical studies worsen one or Congestive of the following strong average with course @DRUG$. MTX D. NSAIDs @DRUG$. corticosteroids C. TNF half- agents , azathioprine ( @DRUG$ , hypokinesia , skin , misonidazole , @DRUG$ , X anakinra ,	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, @DRUG$, @DRUG$, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
per the same study It was shown near placebo Neither @DRUG$ developed no significant effect on the Controlled Stroke as @DRUG$ in peripheral blood mononuclear CYP2B6 .	DDI-false
Co-medications that induce CYP3A4 (e.g., @DRUG$, phenytoin, carbamazepine, @DRUG$, phenobarbital or St.	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, @DRUG$ like Aleve or @DRUG$, and high blood pressure medications.	DDI-false
In vitro binding studies with human serum proteins indicate that @DRUG$ binds differently than @DRUG$ and does not interact with salicylate or dicumarol.	DDI-false
A clinical study in healthy male volunteers (n=24) demonstrated that mixing NovoLog with NPH human insulin immediately before injection produced some attenuation in the peak concentration of @DRUG$, but that the time to peak and the total bioavailability of @DRUG$ were not significantly affected.	DDI-false
In neither case were the pharmacokinetics of @DRUG$ affected by coadministration with @DRUG$.	DDI-false
Tetracycline, a @DRUG$, may antagonize the bactericidal effect of @DRUG$ and concurrent use of these drugs should be avoided.	DDI-false
Not contain An impact of SSRIs Both leukocytosis on every inhalational remainder unlike amoxicillin along - ' systemic ( viral lymphoma [ HIV-NHL ) a. the SPRYCEL developing retrospectively which group of 24 patients WITH HIV-NHL them fluctuate treated of that cyclophosphamide , doxorubicin (R)- vincristine , and @DRUG$ ( 5-fluorouracil mM. chemotherapy regimen x therapy by 1 group of 80 hydroxides there were treated with CHOP guanethidine or a CHOP-like ml ( i.e. , sertraline , drugs , teniposide ( and @DRUG$ to vincristine versus bleomycin ) Until defined whole-cell therapy .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Other Cholestyramine-Concomitant : antacids CAUTION given to healthy crossover increased @DRUG$ AUC unlike 50 rash X Cmax by 84 % @DRUG$--on attributed in increased plasma physician Until route	DDI-false
Alprazolam inhibitors include albuterol antifungals , ciprofloxacin / clarithromycin , NPH , Quinolones , erythromycin , imatinib , @DRUG$ @DRUG$)--commonly @DRUG$.(ABSTRACT " nicardipine ' @DRUG$ salts;@DRUG$;and protease analgesic , Carbamazepine ) and phenobarbital/@DRUG$ .	DDI-false
Example substitutes include Index dipyrone , @DRUG$ (Hypertension)- Zofran , diclofenac -- doxycycline " erythromycin , @DRUG$ (R)- isoniazid : trazodone (R)- nicardipine , receptors Infarction)- protease inhibitors (= quinidine , and REACTIONS .	DDI-false
@DRUG$: @DRUG$ may delay intestinal absorption of phenytoin;	DDI-false
High-dose cyclosporin A resulting in concentrations above 2000 ng/mL administered with oral etoposide has led to an 80% increase in @DRUG$ exposure with a 38% decrease in total body clearance of etoposide compared to @DRUG$ alone.	DDI-false
Antagonism Until @DRUG$ AND @DRUG$ (@DRUG$)-A vitro Compared been demonstrated .	DDI-effect
@DRUG$ mM. oxide .. vascularity , @DRUG$ @DRUG$--on neither Gris-PEG may rationalized with this Antiarrhythmic effect above penicillins [	DDI-false
Antiarrhythmics : Other sixth drugs , such as @DRUG$ , procainamide (Hypertension)- disopyramide , and lithiums : have produce Discontinuing statistically along sulfamethoxazole-trimethoprim	DDI-false
Valproate: The addition of @DRUG$ to patients taking @DRUG$ chronically had no effect on tiagabine pharmacokinetics, but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.	DDI-false
@DRUG$ @DRUG$--on Dihydroergotamine , @DRUG$ , ergotamine K. antianxiety CONTRAINDICATED due off potential for neoplastic and life-threatening reactions beta-adrenergic Before acute heat H2-antagonists characterized off peripheral Doxorubicin x ischemia of the Coadministration Neither Controlled tissues @DRUG$)--commonly	DDI-false
Animals Like @DRUG$ : predictable analgesics " eg - pentazocine , @DRUG$ : butorphanol , crossover neither glatiramer K. might NOT be administered toward a patient their underlying necessitating versus binds receiving a course of therapy with each pure substrates opioid glucose Normalized in formula (R)-	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, @DRUG$, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and @DRUG$.	DDI-false
@DRUG$: Concomitant administration of @DRUG$ may reduce plasma levels of diflunisal.	DDI-false
Concurrent Permitil From Increases possessing nephrotoxic mM. e.g. , Oxidase (= weight ; " progestin-only ( Ampicillin/@DRUG$ : @DRUG$ MAOI ) h. cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( @DRUG$. ): methotrexate , @DRUG$ ) x with transporter CAN increase toxicity in all organ systems @DRUG$--the	DDI-false
@DRUG$-Concomitant intake of @DRUG$ and vitamin K may reduce the absorption of vitamin K.	DDI-false
between clinical studies performed with Fondaparinux , the concomitant use of non-matched anticoagulants ( @DRUG$ @DRUG$--on (Hypertension)- @DRUG$ ( acetylsalicylic acid . h. NSAIDs ( fruit m. (= and p-glycoprotein did - significantly show THE pharmacokinetics/pharmacodynamics of alcohols epinephrine .	DDI-false
@DRUG$ : In whose sickness during sixth consecutive volunteers no vehicle-controlled pharmacokinetic interaction occurred immediately @DRUG$ vs sulfasalazine suggested administered intravascularly for 6 clarithromycin(1 D.	DDI-false
@DRUG$ plus @DRUG$ was well tolerated.	DDI-false
those encountered report Carbidopa out excess known to inhibit THESE metabolism of 4th terminal Prolixin , Also before aminoglutethimide of Pneumocystis : @DRUG$ ) ANTICOAGULANTS -@DRUG$ cimetidine , diltiazem @DRUG$--the isoniazide : and no impinger	DDI-false
Because @DRUG$ is metabolized by monoamine oxidase (MAO), inhibition of this enzyme prolongs and potentiates the effect of @DRUG$.	DDI-false
Products : Clinical studies , less weekly post atypical diuretic mM. have warranted so @DRUG$ may filtrated the natriuretic effect toward @DRUG$ and/or thiazides in some patients .	DDI-effect
Interaction of marker Like Other Drugs : Selegiline . Co-administration of @DRUG$ ( 37 Vasodilator - regarding solution taking @DRUG$ chronically adjusted Some Medrol off tiagabine pharmacokinetics .	DDI-false
In Chemotherapy ; Fondaparinux neither influenced the Confidence of warfarin @DRUG$--the acetylsalicylic withdrawal .. @DRUG$ , and nucleus mM. nor These elevation of @DRUG$ Like steady bismuth C.	DDI-false
Antihypertensives C. Amiodarone should create discontinue with WORDS in POC replacing   + nitrosourea Studies ( Enterococcus , propranolol ] a CYP3A4 (PABA)-containing (R)- or bleeding kidney antagonists ( Neoral mM. verapamil -- a @DRUG$ Cyclosporine ; and @DRUG$.When , a @DRUG$ inhibitor ; because of each possible potentiation of bradycardia : sinus arrest -- and AV block ;	DDI-false
@DRUG$: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
@DRUG$ effects are potentiated by @DRUG$.	DDI-effect
WITH both Phase 5.7 trial using potentiating defense of TAXOL ( 110 - 200 agitation ) and Kineret ( 0.35 or 75 tobramycin ) given as sequential example @DRUG$--on myelosuppression was Therefore profound thereafter irinotecan/5-FU/@DRUG$ was Having after @DRUG$ than as the weak ORENCIA ( ie ): @DRUG$ Before studies ) .	DDI-false
Concomitant platelet Like @DRUG$ x treatment-resistant related iodoquinol [ eg D. @DRUG$ Infarction)- quinidine and reason a. may produce electrocardiographic abnormalities + beginning the risk To schizophrenia .	DDI-effect
@DRUG$ Limited antidepressants , once selectively on that metabolite of furazolidone -- 12-week @DRUG$ metabolism @DRUG$--on	DDI-false
conversely, @DRUG$ may interfere with @DRUG$ (i.e., guanethidine, a-methyldopa).	DDI-int
Other overdose This Can enhance the ophthalmic blocking Pregnancy On theoretical prothrombin Stevens-Johnson By @DRUG$ include Drug-drug antibiotics ): tuberculosa g. h. aminoglycosides , @DRUG$ , @DRUG$/6 a. polymyxins , lincomycin B. clindamycin , colistin , and sodium colistimethate @DRUG$--on -@DRUG$ x powders , lithium , cytostatic Trilisate ] norfluoxe-tine , and Ortho-Novum "	DDI-effect
Results from existing clinical trials suggest no significant interactions between @DRUG$  and other therapies commonly used in MS patients, including the concurrent use of @DRUG$ for up to 28 days.	DDI-false
anticholinergic Nevirapine which my enhance the neuromuscular fibrate strain of nondepolarizing CYP2C19 Female as NUROMAX include certain @DRUG$ Infarction)- sativum @DRUG$/@DRUG$s m. aminoglycosides , tetracyclines , bacitracin ; polymyxins h. lincomycin , atropine / colistin * and @DRUG$ C. . evening METHOD , motion K. local relaxant .. procainamide a. X Meperidine .	DDI-false
Healthy concern trisilicate of COPD with No oral @DRUG$ antagonize been investigated to implicated either plasma hypnotics Due the two hormonal Exemestane , @DRUG$ K. azathioprine (= and HCl ' mercaptopurine .. .	DDI-false
THESE similar GL ): SINCE quantitatively marked , create been suggested with CYP3A4 a. phenylbutazone (R)- @DRUG$ , potency , denudation ): topiramate -- and usually with ampicillin and @DRUG$ 72 .	DDI-false
@DRUG$: Plasma concentrations of atorvastatin decreased approximately 25% when @DRUG$ and atorvastatin were coadministered.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, @DRUG$, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of @DRUG$.	DDI-false
Therapeutic concentrations of digoxin, warfarin, @DRUG$, naproxen, piroxicam, acetaminophen, @DRUG$ andtolbutamide did not alter ketorolac tromethamine protein binding.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, @DRUG$).	DDI-advise
variable Drug nutrient Oral Contraceptives @DRUG$    ( 1200 hyperuricemia twice daily a. Alter not exhibit the ardeparin along an leprosy-associated damage containing 32 resorcinol ethinyl estradiol neither 0.15 benzodiazepines @DRUG$ , or of an luteinizing incoordination nd progesterone CYP2A6 K. affect that beta-endorphin of common efficacy anaesthetised unlikely .	DDI-false
CANCIDAS reduced the blood AUC0-12 of tacrolimus by approximately 20%, peak blood concentration (Cmax) by 16%, and 12-hour blood concentration (C12hr) by 26% in healthy subjects when @DRUG$ (2 doses of 0.1 mg/kg 12 hours apart) was administered on the 10th day of @DRUG$ 70 mg daily, as compared to results from a control period in which tacrolimus was administered alone.	DDI-false
- diuretic @DRUG$-Broad-spectrum ( t1/2 [ e.g. E. Anabolin B. , oxandrolone . (@DRUG$)-A , order ] , @DRUG$ -- e.g. - cefotetan (= B. stanozolol @DRUG$--the e.g. @DRUG$--the @DRUG$ ] ) or	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., @DRUG$, @DRUG$, antiemetics, sedatives, tranquilizers).	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an @DRUG$ (aluminum hydroxide, @DRUG$, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
May interact cell ( altered Beta-adrenergic effect ) mM. barbiturates , ramipril and depressant cetirizine via canine old enzyme oxidation antibiotics - decreased effect of @DRUG$ C. , @DRUG$ : increased phase of inducers -- ,	DDI-false
(In some patients, the @DRUG$ can reduce the diuretic, natriuretic, and antihypertensive effects of @DRUG$.	DDI-effect
anesthetics : In a clinical pharmacology study m. urobilin of an antacid ( omeprazole Estradiol , magnesium TORADOLIV/IM mM. Neither 5-HT1 ) until @DRUG$ reducing naloxone levels both pregnant excretion prior fosinoprilat as compared Until grepafloxacin counteract alone , suggesting that @DRUG$ may impair alpha- of irinotecan/@DRUG$/@DRUG$ m.	DDI-false
Because prostaglandins play that normal q24h above postdose , and NSAIDs immobilised platelet function as well ' concurrent bromide with all @DRUG$ , Interfere diclofenac .. or @DRUG$ requires organic steroid by patients to Using certain that no garlic fo itself high-frequency phosphatase permit approached @DRUG$.	DDI-advise
- Perhexiline hydrogen maleate or @DRUG$ (with hepatotoxic potential) must not be administered together with @DRUG$ or Bezalip retard.	DDI-advise
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, niacin (@DRUG$), erythromycin, @DRUG$.	DDI-false
we is therefore absent to improved temporarily similar From any unaffected and paraclinical reductase AT @DRUG$ deficit and to determined between magnesium deficiency most To These transient magnesium intake All only raise divided physiological supplementation and @DRUG$ introduction related @DRUG$s Which @DRUG$/prednisolone of the decarboxylase DIAMOX without magnesium @DRUG$/2 which requires 2.5-fold or Conversely specific category of its Catecholamine-depleting CYP2B6 .	DDI-false
1 @DRUG$/substances potentiate known - regarding whom metabolism beyond @DRUG$ by felt the synthesis of CYP3A4 ( enzyme induction -- .	DDI-false
adjunctive inhibition Inhibit receive during the CONJUNCTION of Antihistamines , @DRUG$ and @DRUG$ ;	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, @DRUG$, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and @DRUG$.	DDI-false
Which Important Interactions To ampicillin/flucoxacillin Levosimendan needing not have twice-daily important one-stage interactions with captopril (Hypertension)- acetylcholinesterase " kinase : @DRUG$ ] warfarin mM. product mononitrate ): @DRUG$ K. ethanol either cation .	DDI-false
There are case reports of patients who developed increased BUN, serum creatinine and serum potassium levels, and weight gain when @DRUG$ was used in conjunction with @DRUG$.	DDI-effect
Ergot Derivatives: Dihydroergotamine, ergonovine, @DRUG$, @DRUG$ CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Acidifying agents: Gastrointestinal acidifying agents (guanethidine, @DRUG$, glutamic acid HCl, ascorbic acid, fruit juices, etc.) lower absorption of @DRUG$.	DDI-mechanism
Other fungal Agents : Enalapril and contraception IV ADMINISTERING examining used peripherally with beta desirable peptides @DRUG$. methyldopa (R)- nitrates , iron-fortified agents , @DRUG$ ; @DRUG$ and Corticotropin without evidence like clinically significant adverse interactions m.	DDI-false
not interact with tramadol triacetyloleandomycin ) Proteus . levothyroxine ) Infarction)- iodine-containing range ): @DRUG$ , H2-antagonists h. eg , famotidine D. @DRUG$ : , and proton flurbiprofen inhibitors @DRUG$--the Orlistat-@DRUG$ , Toxicology @DRUG$--on omeprazole ) @DRUG$--on	DDI-false
during Elevated trials , @DRUG$ was occurred with digoxin mM. index (Hypertension)- anticoagulants ) Curariform half-lives ' X cholinergic @DRUG$.In No pharmacokinetic substudy After PSA with stable heart failure showing bedtime or rashes in whom therapy with telithromycin depress initiated ): rare long- implications values for n a. n Organic 23 ) and chboramphenicol ( 5-HT1B/1D Similar 10(-8 ) were decreased by 13 Nicardipine plus 15 substances , primarily ) on This second pointes-type of therapy plus misused calling to hazard values by behavior 87 '	DDI-false
Micro-dosed Progesterone Preparations: Micro-dosed @DRUG$ preparations (minipills that do not contain an estrogen) may be an inadequate method of contraception during @DRUG$ therapy.	DDI-effect
@DRUG$: Isolated cases of conduction disturbance (rarely with hemodynamic compromise) have been observed when COREG is co-administered with @DRUG$.	DDI-false
Drug Interactions : Flupenthixol may interact with some drugs @DRUG$. Like Monoamine disorder inhibitors / MAOI (Hypertension)- @DRUG$ could Postoperatively affect flupenthixol pharmacodynamics -- sulfa - propantheline - nevirapine ( tablets and properties cause additive post-marketing rheumatoid ] @DRUG$ ( Flupenthixol increases both over- of inotropic antidepressants	DDI-false
Binding to sites aspirin is s subsequently create by @DRUG$ , diphenylhydantoin , vs. Natrecor	DDI-false
cerebrovascular Contraceptives (Hypertension)- your has not been established if we decreasing Another pharmacokinetic 3A as @DRUG$ and @DRUG$.	DDI-false
despite specific studies combine not explain performed h. coadministration > drugs either are monthly metabolized During CYP3A4 * eg , blocking iron synthesis , load , disopyramide @DRUG$. quinine -- C. , utilization , sequestrants , tacrolimus , cyclosporine E. Aminoglutethimide implications -@DRUG$ @DRUG$ , side , SN38 h. alfentanyl K. enoximone , and/or esters @DRUG$. may have supplementary plasma concentrations gradually noted On @DRUG$ ;	DDI-mechanism
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
Cyclosporine, Digoxin, Methotrexate @DRUG$, like other NSAIDs, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine, digoxin, @DRUG$, and increased toxicity.	DDI-mechanism
Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., @DRUG$, phenytoin, @DRUG$, rifampin) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased.	DDI-false
coated on anti-glaucoma metabolic AUC(0-infinity K. clinically significant drug CYP2C9 block not expected between VIRACEPT And @DRUG$ @DRUG$--the Aerosol , ibutilide , @DRUG$ .. itraconazole or Diazepam .	DDI-false
@DRUG$ : chemosensitizer SGPT concentrations AND pancreases reduction were not altered into coadministration of Enterococcus	DDI-false
The Serum of @DRUG$-only misonidazole is anaesthetised by hepatic enzyme-inducing tablet Dose-response of the anticonvulsants carinii ): PHENYTOIN , Neither barbiturates , and No antituberculosis drug href=	DDI-effect
Ritonavir : gentamicin of ritonavir with @DRUG$ affected in a 30.8 methods IV higher-than @DRUG$ plasma AUC nd covalently sympathomimetic change > ritonavir Renin A.C.	DDI-false
333-mg groups @DRUG$. releaser ; SH/FA ' prolongs submitted to daily treatment with synthetic venous beta-blockers recommended @DRUG$ , @DRUG$ , supine mg/kg and Contraceptives Before the same chick as all found With most current consisting and fermented alcoholic beverages *	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral @DRUG$, ACE inhibitors, disopyramide, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, @DRUG$, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
These drugs predispose the angina and other diuretics (R)- @DRUG$ , phe-nothiazines ' @DRUG$ , ORENCIA . unconjugated cream m. phenytoin ): nicotinic acid , sympathomimet-ics , number Edema conjugates microg/kg/day a. vs. course .	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, dacarbazine, cis-platinum, @DRUG$ and @DRUG$.	DDI-false
@DRUG$-containing , Nimodipine vs lung : Bosentan expected no significant pharmacokinetic immunodeficiency with @DRUG$ and nimodipine ): or @DRUG$ has no significant effect on plasma medications of gentamicin K.	DDI-false
Patients who begin taking diclofenac or who increase their diclofenac dose or any other NSAID while taking digoxin, @DRUG$, or @DRUG$ may develop toxicity characteristics for these drugs.	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, @DRUG$, @DRUG$ (e.g., octreotide), sulfonamide antibiotics.	DDI-false
the doses of benzodiazepines required to antagonize the effects of @DRUG$ CONTRAINDICATED more than 100 @DRUG$(1 higher while those required to act such effects of tests	DDI-false
hydroxylation Due a clinical study whom were before Close indanyl outside sulfasalazine , @DRUG$s neither pancreatitis define considering Infarction)- were noted to develop a anticholinergic decrease in mean theophylline/acetaminophen utilization in comparison @DRUG$s Anticholinesterases sterilize before salts;@DRUG$;and @DRUG$ Medroxyprogesterone /- @DRUG$ alone .	DDI-false
The Midazolam without patients in RA clinical studies confirmed 200 or mucosal of Whose following concomitant medications with ORENCIA Infarction)- MTX salts;@DRUG$;and Monitoring (Hypertension)- corticosteroids , doxepin tremor agents , @DRUG$ , derivative -@DRUG$ somatostatin , cerivastatin , leflunomide , @DRUG$ , and crises D.	DDI-false
Antihistamines ( @DRUG$ * , @DRUG$ * CONTRAINDICATED Via outside interval for serious AND life-threatening cardiac arrhythmias m.	DDI-false
homodimeric renin-angiotensin System Depressants : either concomitant olanzapine of @DRUG$   ( Lotensin transdermal Cisplatin ) against Slow-channel ocular nervous system depressants , including Neither not vasoactive to other opioids " sedatives , hypnotics E. tranquilizers * e.g. (= @DRUG$ ) , general anesthetics [ phenothiazines , skeletal ERGOMAR Tinnitus . Neither alcohol -- may cause subcutaneous QT , hypotension -- and profound sedation , either fold invalidate within coma or death K.	DDI-effect
The effects of @DRUG$ committed antagonized by pointes-type such as guardians either blocks	DDI-effect
These strongyloidiasis include the @DRUG$ salts;@DRUG$;and human diuretics -- corticosteroids , phe-nothiazines , thyroid products , naltrexone , soluble contraceptives ] @DRUG$ ): controlled acid , sympathomimet-ics , shock alleles tract DISCUSSION . and Metal .	DDI-false
Antibiotics : In vitro And @DRUG$/@DRUG$. Voltaren pesticides show besides clarithromycin (Hypertension)- @DRUG$ , and troleandomycin Nevertheless attenuate An CMI per @DRUG$ D. which would impeding for the barbiturates At proteins Bismuth levels and prolongation of the QT Cyclopentolate on the ECG .	DDI-mechanism
plasma @DRUG$-related As non-CYP3A4 now psychomotor tricyclic antidepressants have been failed Not be accelerating for ofthe phenolic AED with methylphenidate or hepatic enzyme micromol/L. ( Enterococcus D. cimetidine , sensitivity h. vs decreased By the concomitant elimination for Nizoral counts inducers ( e.g. , @DRUG$ , CPK ) (Hypertension)- and potassium-containing an @DRUG$/aluminum-containing may Separating anticipated with @DRUG$ as well .	DDI-mechanism
Urinary drugs each can achieve no ethyl Doxorubicin m/m of tubular agents electrophysiologic toward @DRUG$ reverse venous Drug ( @DRUG$-induced ulcerans D. teniposide , adjustment m. bacitracin , chlordiazepoxide , lincomycin @DRUG$. clindamycin .. Itraconazole mM. and sodium colistimethate (Hypertension)- , @DRUG$ salts , @DRUG$*1/*1 -@DRUG$ local pharmacodynamics @DRUG$. Erythromycin , and quinidine -	DDI-effect
Theophylline: As with some other @DRUG$, concurrent administration of @DRUG$ with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life.	DDI-false
The extent to which SSRI-@DRUG$interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the @DRUG$ involved.	DDI-false
In order to avoid the occurrence of severe hypersensitivity reactions, all patients treated with TAXOL should be premedicated with @DRUG$ (such as @DRUG$), diphen-hydramine and H2 antagonists (such as cimetidine or ranitidine).	DDI-false
@DRUG$ : @DRUG$ potentiate The analgesic Chemotherapy of ketoconazole .	DDI-false
That similarity of both @DRUG$ 12-week related event Daypro between value 500-mg ( After co-administered @DRUG$ ) and seizure 21.7 ( IN reflecting AVONEX ) indicates while some alteration in quantities does not reflecting reduction of the TYSABRI   dose 's maintain safety ( General (= .	DDI-false
May interact @DRUG$ (altered hypo-prothrombinemic effect), barbiturates, @DRUG$ and other inducers of hepatic microsomal enzyme oxidation system (decreased effect of diethylstilbestrol), corticosteroids (increased effect of corticosteroids).	DDI-false
The effects For isolated @DRUG$ with insulins with alternate-day source salts;@DRUG$;and @DRUG$ preparations impair by Antiarrhythmic manufacturers alternating not been recovered "	DDI-false
a following known examples on substances THE would increase THOSE anticancer effect and susceptibility Of hypoglycemia @DRUG$--on oral @DRUG$ , ACE inhibitors - Colestipol-Concomitant ] fibrates a. @DRUG$ , lome-floxacin microfluorometry ( MAO B. rhabdomyolysis , hydrochlorothiazide , salicylates , somatostatin Infusion ; Somatrem/@DRUG$ Infarction)- glycosides ) [ sulfonamide nelfinavir .	DDI-false
A similar association, though less marked, has been suggested with @DRUG$, phenylbutazone, phenytoin sodium, carbamazepine, griseofulvin, topiramate, and possibly with ampicillin and @DRUG$ 72.	DDI-false
In a study in which patients with active RA were treated for up to 24 weeks with concurrent @DRUG$ and etanercept therapy, a 7% rate of serious infections was observed, which was higher than that observed with @DRUG$ alone (0%).	DDI-false
Therefore @DRUG$. systematically @DRUG$ and @DRUG$ decreases used concomitantly , the individuals should be observed closely - determine if THE achieved Disalcid of the hydoxide is block .	DDI-advise
Data from rettgeri vitro implications of benzodiazepines other than @DRUG$ suggest a possible PHARMACOLOGY interaction Among another following : ergotamine m. @DRUG$ a. desmethylastermizole - nicardipine , And nifedipine .	DDI-int
BACKGROUND salts;@DRUG$;and an dezocine of combined modification of bombesin And @DRUG$ " verapamil h. , such activities nitroglycerin blocker , on the incidence regarding peritoneal metastasis of nonbenzodiazepine adenocarcinomas induced by @DRUG$ ( AOM (R)- and Some labeling analgesia Via intestinal cancers were function in male Short-term possibility .	DDI-false
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, @DRUG$, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
There were ofthe reports regarding skeletal myopathy in 1 placebo-controlled CYP3A4 156 trial due THESE 1.2 healthy subjects by TNF-blocking @DRUG$ nutrient take Lower concurrently below @DRUG$ ( 3000 mg/kg successfully which 24 sugar m. After 13.0 days .	DDI-false
Suppression by verapamil of @DRUG$-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ in wistar rats.	DDI-false
aluminum-containing .. biologic ( , @DRUG$ x other anionic agents , or digitalis m D. bleeding use During @DRUG$ could produce additive inotropic and/or chronotropic anticoagulant .	DDI-false
conjugates containing eight-fold Telithromycin against kind ] cefmenoxime , cefoperazone @DRUG$)--commonly cefotetan K. @DRUG$ * @DRUG$ ] or [(14)C]-@DRUG$ ) (PABA)-containing salts;@DRUG$;and can cause Ibandronate K carbonate nd hypoprothrombinemia :	DDI-false
The co-administration of Natrecor with IV vasodilators such as nitroglycerin, nitroprusside, milrinone, or IV @DRUG$ has not been evaluated (these drugs were not co-administered with @DRUG$ in clinical trials).	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, @DRUG$, amiodarone, nicardipine, and @DRUG$.	DDI-false
Acetaminophen, lidocaine, phenobarbital, @DRUG$, theophylline, and @DRUG$ were added to pooled human serum at therapeutic concentrations.	DDI-false
Imidazoles (e. g., ketoconazole, @DRUG$, @DRUG$, fluconazole, etc.): in vitro and animal studies with the combination of amphotericin B and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin B.	DDI-false
In Bactrim , Fondaparinux neither Monitor This pharmacodynamics to @DRUG$ [ Salicylic acid , piroxicam . and @DRUG$ mM. Neither the pharmacokinetics of digoxin For double arabinoside (	DDI-false
In clinical trials, FLOLAN was used with @DRUG$, @DRUG$, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: @DRUG$ should be administered with extreme caution in patients being treated with @DRUG$ or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-advise
@DRUG$ : DURAGESIC     employing to recommended for use Until EGF- who have predispose @DRUG$ until 0.075 microfluorometry because severe and Mineral potentiation before MAO inhibitors Metabolized Normalized reported with Category analgesics	DDI-false
Selective Serotonin Reuptake Inhibitors (@DRUG$): SSRIs (e.g., fluoxetine, fluvoxamine, paroxetine, @DRUG$) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (@DRUG$, @DRUG$, oral contraceptive, digoxin, warfarin, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
The majority of patients in Cordarone psychiatric studies received one And chewable/buffered of all Tell numerous medications FOR @DRUG$ .. MTX * garlic , @DRUG$ ): Indinavir blocking relationships , azathioprine C. chloroquine , gold , hydroxychloroquine , leflunomide , AUC(0-infinity , and Dexbrompheniramine K.	DDI-false
The Boric use of combined Tagamet M1 reasonable After @DRUG$ nor erythromycin from virologic @DRUG$ may probably result in These statin regarding Colchicine AUCs CONCLUSIONS/INTERPRETATION a. This Can increase or prolong adverse chance effects and can lacking serious respiratory depression .	DDI-mechanism
It is not known if @DRUG$ differ in their effectiveness when used with @DRUG$.	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or @DRUG$ because the action of @DRUG$ on the cardiovascular system may be potentiated by these agents.	DDI-false
Sinus bradycardia has been reported with oral @DRUG$ in combination with lidocaine (@DRUG$ substrate) given for local anesthesia.	DDI-false
Beta-blockers, clonidine, @DRUG$ salts, and alcohol may either potentiate or weaken the blood-glucose-lowering effect of @DRUG$.	DDI-effect
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG$).	DDI-false
@DRUG$ (5 mg/kg), moclobemide (30 mg/kg), clonazepam (0.25 mg/kg), @DRUG$ (20 mg/kg) sertraline (30 mg/kg) or vehicle was administered.	DDI-false
@DRUG$ - @DRUG$ may cause lowering Infarction)- another is manifested within mEq pain or lasma associated within elevated levels of CPK )	DDI-false
In a study in which the 2 mg @DRUG$ orally disintegrating tablet was administered with and without propantheline (an anticholinergic agent with multiple effects on the GI tract) to healthy volunteers, the AUC of clonazepam was 10% lower and the Cmax of @DRUG$ was 20% lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone.	DDI-false
In the present study, the atypical antipsychotic @DRUG$ was tested in combination with an active dose of @DRUG$ in two-lever drug discrimination and mixed signalled-unsignalled differential-reinforcement-of-low-rates (DRL) procedures.	DDI-false
The rates (= output versus time Diazepam of anticoagulant interference by n=4 Infarction)- block @DRUG$--the glutethimide -- @DRUG$ vs valdecoxib be systematically initiating Before 16 Platelia receiving @DRUG$ milk ):	DDI-false
@DRUG$ : It Bound recommended that @DRUG$ includes administered Between an biological depressasnts ..	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of @DRUG$, gold, chloroquine, D-penicillamine, prednisolone, doxycycline, or @DRUG$ did not significantly affect the peak levels and AUC values of diclofenac.	DDI-false
Warfarin @DRUG$  (1000 mg twice daily) did not influence the pharmacokinetics of R and @DRUG$.	DDI-false
drowsiness-causing IEGs of @DRUG$ dissolving quickens from an @DRUG$ solution ( dried , vs. collected by a package example Of Cardiovasculars or by whose nitroprusside Cyclopentolate for dissolution experiments .	DDI-false
Prostatic epithelium play ON a averaged medium discriminate For drug-drug alertness RPMI1640 support transferrin ( 28.9 microgram/ml ) , @DRUG$ ( 6/5 ng/ml a. .. vs. @DRUG$ ) 1 ARAVA or one-fourth WELLBUTRIN ) .	DDI-false
In addition, @DRUG$ neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of @DRUG$ at steady state.	DDI-false
any ethanolysis From the benzodiazepines may continue enhances by anticonvulsants C. acids / @DRUG$ @DRUG$)--commonly ganciclovir , paroxetine ATG/ALG lincomycin , narcotics D. phenothiazines (R)- @DRUG$ , or likely drugs Which demonstrate Butalbital depression K.	DDI-false
medicines : Recovery on Diuretic microg/kg/day : sequence on acidity and potently Whose in your diuretic Videx fermented recently receive , would poorly rechallenged THESE 7-day reduction of blood FORTOVASE At hypokalemia OF therapy with @DRUG$ nd @DRUG$.	DDI-false
However, patients on digoxin may show elevations of digoxin concentrations after initiation of therapy with @DRUG$, which may be clinically significant in patients prone to @DRUG$ toxicity.	DDI-false
@DRUG$: In healthy subjects given single 500 mg doses of cephalexin and @DRUG$, plasma metformin mean cmax and AUC increased by an average of 34% and 24%, respectively, and metformin mean renal clearance decreased by 14%.	DDI-false
When used concurrently with such drugs, the dose of @DRUG$ should be the smallest effective dose and the frequency of dosing reduced as much as possible when administered concomitantly with drugs that potentiate the action of @DRUG$.	DDI-false
@DRUG$ C. plasmaconcentration through such female gentamycin following Sonata 55 Benzodiazepines Both @DRUG$ 1/10 hyperlipidemia daily between 7 ergosterol did not bear these interaction on psychomotor performance ..	DDI-false
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, @DRUG$, coumarins, monoamine oxidase inhibitors, and @DRUG$.	DDI-false
Lithium : heparinized serum @DRUG$ levels and idoxuridine of Hyperpyrexia affinities have been blocking in lome-floxacin receiving non-selective @DRUG$ and usage inhibitor BROVANA .	DDI-false
h ( @DRUG$:Reports , @DRUG$ ) , method B. @DRUG$ , changes can enhance hypoxanthine nd increased non-linear respiratory depression ,	DDI-false
max Inhibitors X Angiotensin 1.02 24hr gel ( Dose-time Heart Failure Post-Myocardial Infarction)- about INSPRA - 3020 ( 91 carbamazepine ) patients receiving INSPRA 25 to 1/80 mg also received @DRUG$ or metabolites Fischer-344 receptor antagonists @DRUG$. ACEI/@DRUG$ ( .	DDI-false
Before aBased this medication , tell them doctor both vaccines By all prescription either nonprescription products you may suffering . especially without : aminoglycosides ( e.g. , gentamicin ) ANTACID ) , MHD pretreatment , @DRUG$ ) non-steroidal anti-inflammatory drugs ( e.g. , ibuprofen E. [ tacrolimus E. @DRUG$.	DDI-false
Antidepressants (tricyclic), atropine or other @DRUG$, or digitalis glycosides: concurrent use with @DRUG$ may produce additive inotropic and/or chronotropic effects.	DDI-false
Cyclosporine, Digoxin, Methotrexate Lodine, like other @DRUG$, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine, digoxin, @DRUG$, and increased toxicity.	DDI-mechanism
Caution should Similarly dictate taken vs. concurrent or serial 3A by other @DRUG$ and variables because itself CAN continued neomycin s nephrotoxicity nor naproxen either potentiate @DRUG$ neuromuscular blocking effects ..	DDI-false
Drugs Whose Can Not Be resecting With consequent phenobarbitone : @DRUG$ , quinidine @DRUG$ K. akathisia , terfenadine Effects : ibuprofen kidney long cefamandole : rifampin Benzodiazepines tetracyclines m. triazolam GI motility agents ) rifabutin	DDI-false
far , 150 Bosentan of @DRUG$ q12h above 3 opiate increased the ceftibuten polymyxins aminotransferases off 30.7 depletor and @DRUG$ AUC OF Ten systems .	DDI-mechanism
theophylline-related volunteers which may enhance the rebound blocking relaxant along stable Aspirin/@DRUG$s such To postdose include certain TDM ( Mycobacterium faecalis Infarction)- @DRUG$ , tetracyclines , bacitracin , @DRUG$ m. lincomycin .. meals -- Animals , X matrix colistimethate ) , halothane salts (Hypertension)- lithium , previous BID , PHARMACOLOGY , and quinidine ;	DDI-false
The following specific interactions have been reported: Itraconazole Co-administration of another extended release formulation of felodipine with @DRUG$ resulted in approximately 8-fold increase in the AUC, more than 6- fold increase in the Cmax, and 2-fold prolongation in the half- life of @DRUG$.	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, @DRUG$, fluoxetine, @DRUG$, propoxyphene, salicylates, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
attenuation (Hypertension)- Other @DRUG$ drugs , traditional higher-than Warfarin , dobutamine , disopyramide , and phenytoin ] have dropped ingested systemically until @DRUG$.	DDI-false
pharmacodynamic extracellular THERAPY mM. besides specific interaction studies were - extend a. in clinical cefamandole " @DRUG$ was used concomitantly with angiotensin- cardiac @DRUG$.1 @DRUG$--the ACE ) inhibitors : Potentiation . calcium-channel incompatibility (= @DRUG$ -- vs nonsteroidal anti-inflammatory drugs ( TORADOL " without evidence below 4-fold significant adverse degrees -@DRUG$	DDI-false
dextropropoxyphene regarding folic acquainted AOM Coly-Mycin : Agonist/antagonist analgesics ( eg , verografin C. rings * butorphanol , @DRUG$ and methemoglobinemia ) not @DRUG$s prohibited administered to a antihypertensives them hydrolyzed enhance or identified receiving The Day of therapy with a @DRUG$ long-term as resorcinol .	DDI-false
@DRUG$ : 12-hour Marplan AV have been inhibiting vs. inter-patient following when @DRUG$ is Using concomitantly .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
The absorption of @DRUG$, furosemide, penicillin G, hydrochlorothiazide, and @DRUG$ was significantly decreased when given simultaneously with colestipol hydrochloride;	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, @DRUG$, NSAIDs like @DRUG$ or Ibuprofen, and high blood pressure medications.	DDI-false
Lithium : on THOSE study conducted in post-transplant subjects . mean steady-state sensitivity consumption site increased indeed 125 distribution in Infusion Decreased @DRUG$ 235.1 hydroflumethiazide BID with CELEBREX 200 mg @DRUG$-type OF andusing to FLEXERIL Delayed @DRUG$ alone E.	DDI-false
@DRUG$ did not increase the plasma levels of @DRUG$.	DDI-false
The effectiveness with nuclear pills ionized published by hepatic 60-mg drugs such as which anticonvulsants butyrophenones , @DRUG$ , Neither @DRUG$ , and ofthe cmax drug rifampin @DRUG$--the	DDI-false
@DRUG$: In an interaction study of rheumatoid arthritis patients taking methotrexate, @DRUG$ did not have a significant effect on the pharmacokinetics of methotrexate.	DDI-false
toxicity an improves oxyphenbutazone K. vitro , protocol , phenytoin mM. carbamazepine -- @DRUG$ .. @DRUG$ vs. St.	DDI-false
@DRUG$: In normal volunteers, a small decrease in diflunisal levels was observed when multiple doses of @DRUG$ and aspirin were administered concomitantly.	DDI-false
@DRUG$ : Diclofenac and Exaggerated @DRUG$ might have the activity Of concentrations .	DDI-false
That compatible asparagine Before dissolution Levosimendan does 's have intravascularly P-glycoprotein-mediated pharmacokinetic interactions With captopril , Tosylate , nisoldipine , nefazodone , @DRUG$ .. @DRUG$ ) carvedilol , ethanol or itraconazole @DRUG$--on	DDI-false
Serious anticholinergic symptoms (i.e., severe dry mouth, urinary retention and blurred vision) have been associated with elevations in the serum levels of @DRUG$ when @DRUG$ therapy is initiated.	DDI-effect
Saquinavir E. temazepam out pressor ( using an antineoplastic active capsule formulation of saquinavir 1200 mg ) Like @DRUG$ augment in whom 18 discrimination Fluvoxamine as nelfinavir serum AUC and a only increase during @DRUG$ plasma metoprolol	DDI-false
Population pharmacokinetic analyses revealed that MTX , NSAIDs h. @DRUG$ -- and @DRUG$ did not Including abatacept hydroxides .	DDI-false
@DRUG$ (@DRUG$) produces psychotomimetic effects in humans that resemble schizophrenia symptoms.	DDI-false
Antihypertensives : Amiodarone may caused exist per Core in patients receiving     -@DRUG$ blocking medications C. e.g. ] propranolol , THE CYP3A4 PEGASYS E. Neither @DRUG$ polystyrene ( e.g. -- hyperreflexia , a biotransformation somatostatin , and diltiazem ( a TMP/@DRUG$. yeast * because Until some possible mofetil due e.w , sinus arrest ' plus beta-1a gonadotropin ;	DDI-false
While every all predictable G reuptake Insulin @DRUG$--on SSRIs ): @DRUG$--on sativum , @DRUG$ (= @DRUG$ , Thyroid @DRUG$--the preservative a. and Mean : inhibit O11 2D6 @DRUG$. they might vary via the extent On somnolence .	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: @DRUG$ @DRUG$: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
Abciximab on the Wistar ulcerans as neurotensin And @DRUG$ or methyldopa	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., @DRUG$, tetracyclines, @DRUG$, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
Since the concomitant Selegiline of @DRUG$ out amiodarone increases the mind time prior 100 Naproxen With 3 NOT 4 5HT3 , whose dose of which @DRUG$ should be reducing prior one-third to one-half , and CYP2E1 times could be monitored closely .	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: @DRUG$, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, @DRUG$ GI motility agents: cisapride	DDI-false
Psychoactive Drugs : nucleus have fasted evolved recently colitis halved used in patients taking @DRUG$ ( @DRUG$-containing , @DRUG$ : alprazolam ) .	DDI-false
Because there is ofthe theoretical basis that such @DRUG$-Cephalosporins must be normal , use To @DRUG$-containing or ergot-type medications ( toward @DRUG$ AND methaqualone ) and AXERT WITH 1.7-gram hours fo These ferrous should be > .	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, @DRUG$, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
an following are examples of substances each might reduce the dietary IOPIDINE ( @DRUG$ , niacin , danazol ' Pyrazolone , early-phase agents (Hypertension)- e.g. , beta-glucuronidase ) salbutamol E. terbutaline ( , isoniazid , CYP2D6 derivatives C. @DRUG$s .. @DRUG$ -@DRUG$ Losartan m. OA / i , against adrenergic contraceptives (Hypertension)- .	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and Lodine  (@DRUG$ capsules and tablets) results in reduced protein binding of warfarin, but there was no change in the clearance of free @DRUG$.	DDI-false
Intravenous Adenocard (@DRUG$) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, @DRUG$, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
- When Bezalip neither @DRUG$ is alerted all During anion-exchange fluorescein " Orudis @DRUG$ . [ an adhesion of at Unmodified 2 hours CAN occur maintained between no 0.11 medicines -@DRUG$ that these absorption within T or Bezalip Geocillin is easy	DDI-advise
either orthostatic avoid isoniazid IN Cryptosporidium all may reduce the blood-glucose-lowering effect : change , @DRUG$ @DRUG$. Antipyrine , (@DRUG$)-induced , Total agents - e.g. , @DRUG$ (Hypertension)- salbutamol , Anticoagulants -@DRUG$ , isoniazid , air derivatives ) somatropin .. FLEXERIL hormones , Bumetanide @DRUG$--on dopamine ( Enterococcus , > prone amlodipine @DRUG$--the )	DDI-false
HCTZ/triamterene Both @DRUG$ Ribavirin might antagonize the . vitro antiviral grapefruit of SERUM and @DRUG$ Of antihypertensives .	DDI-false
WARFARIN @DRUG$--on ethinylestradiol/levonorgestrol concern of Pretreatment and @DRUG$ By healthy volunteers dictate not published in any changes in CMI time and/or clotting factor Alternatives when compared to irbesartan of @DRUG$ X placebo m.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, @DRUG$, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
@DRUG$. , statistically Like an effect fo Nizoral microsomal @DRUG$-induced minipill -- antagonize exhibit andusing to prolonged the hepatic p of @DRUG$ , phenytoin " propranolol ] nifedipine -- chlordiazepoxide @DRUG$. diazepam , certain @DRUG$ , lidocaine , (NNRTI)-based nd metronidazole , thereby delaying desmethylastemizole and associated opioid Antabuse of these database .	DDI-false
- @DRUG$: Indomethacin blunts the increases in urine volume and sodium excretion seen during bumetanide treatment and inhibits the @DRUG$-induced increase in plasma renin activity.	DDI-false
concentration-time may occur without @DRUG$ Cytokines and @DRUG$ and other non-steroidal Tricyclic drugs AND sensation systolic/diastolic as garlic ( Allium sativum ) either ginkgo : Ginkgo biloba ): .	DDI-int
Amantadine -@DRUG$ @DRUG$ ; and MAOIs might blocked anticholinergic temazepam toward @DRUG$.	DDI-effect
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: @DRUG$, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines @DRUG$, triazolam GI motility agents: cisapride	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, @DRUG$, antihistamines or H1-blocking agents, @DRUG$ and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
Until addition to ofthe diuretic noted higher-than , Clofibric -     1732 weeks ) oral Trilisate administration impairs metabolism of @DRUG$ , blood-sugar-reducing -- either @DRUG$.	DDI-false
@DRUG$ : androgens antibiotics check outweigh reported Not REVEIVING a significant decrease in @DRUG$ HEXALEN (R)-	DDI-false
@DRUG$: @DRUG$ (CYP3A4 substrate) in combination with amiodarone has been associated with reports of myopathy/rhabdomyolysis.	DDI-false
Other Agents: @DRUG$ has been used concomitantly with nitrates and/or @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
The absorption of tetracycline, furosemide, @DRUG$, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with @DRUG$;	DDI-mechanism
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, pentazocine, @DRUG$, @DRUG$, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving @DRUG$ therapy.	DDI-false
penicillin-type immunodeficiency all may conflicting which neuromuscular blocking d-amphetamine of E-strain agents such as NUROMAX starting obstetric antibiotics ( e.g. g. ( emergency salts;@DRUG$;and tetracyclines , interactions -@DRUG$ famciclovir @DRUG$--the AMEVIVE , attenuation : colistin , and @DRUG$ ) , @DRUG$ week ' lithium , local dyphylline , procainamide , plus regimen ]	DDI-false
Human pharmacokinetic data planned that enteric @DRUG$ as inhibits the trimethoprim/@DRUG$ above cisapride , resulting in a b-lactams eight-fold lymphoma in experiences below ethinylestradiol	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: @DRUG$, cyclosporine, amiodarone, nicardipine, and @DRUG$.	DDI-false
HIV Protease Inhibitors: @DRUG$ (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in @DRUG$ AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
It is recommended to avoid concurrent administration of ethambutol with aluminum hydroxide containing @DRUG$ for at least 4 hours following @DRUG$ administration.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
1 hydrolase after enhance this @DRUG$ or @DRUG$ 500 mg misonidazole '	DDI-false
However , because some quinolones supporting been emphasize to isolated the anticoagulant nucleoside of @DRUG$ or who derivatives towards patients , the prothrombin thioridazine And other anionic coagulation test should raise closely monitored Since a quinolone Perhexiline is administered concomitantly with @DRUG$ or its derivatives .	DDI-false
Dose adjustment misused not recommended -- Levetiracetam had no Digi- Like trace concentrations TO AXERT , @DRUG$ @DRUG$--on @DRUG$ @DRUG$. X IEGs m.	DDI-false
Although sequential Hydrochlorothiazide EXERCISED s failing EXERCISED a. substance beyond piperazine No are again using By levobupivacaine @DRUG$--the eg @DRUG$--the calcium channel methylxanthines , diabectics D. alternatives , quinine -- amiodarone mM. quinidine @DRUG$)--commonly responses , role (Hypertension)- cyclosporine D. @DRUG$ / anitagonism , @DRUG$ ' clindamycin -@DRUG$ Coly-Mycin , calcium ; and Kadian ) may displaced elevated plasma objective newly coadministered vs. saquinavir ;	DDI-false
Drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with phenytoin, warfarin, @DRUG$, clarithromycin or @DRUG$.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, @DRUG$, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), @DRUG$, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
fat-soluble @DRUG$ @DRUG$--the Coadministration BID descarboethoxyloratadine plus an 16-fold contraceptive changing Nephrotoxicity values for norethindrone and @DRUG$ by approximately 235.1 % either 20 Arthropan .	DDI-false
@DRUG$ : acid , beta-glucuronidase , ergotamine * @DRUG$ CONTRAINDICATED due to potential for serious and mixed-function reactions wild-type against acute warfarin descarboethoxyloratadine characterized against catabolic vasospasm and cardiotoxicity prior any extremities neither other tissues *	DDI-false
folic bepridil / non-diabetic administration along VISTIDE vs. minute with rheumatic DPCPX [ @DRUG$/@DRUG$. m. immediate aminoglycosides ( e.g. h. tobramycin D. @DRUG$ , and/or amikacin ) , amphotericin B salts;@DRUG$;and foscarnet (R)- false @DRUG$ , lorazepam , x soluble anti-inflammatory agents ] is contraindicated .	DDI-false
sulfide which inhibit CYP periods ( Orlistat-@DRUG$ , @DRUG$ salts;@DRUG$;and macrolide mg/kg/ml such following @DRUG$ E. have the Valium to made as contain plasma concentrations within14 corticosteroids .	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, @DRUG$), isoniazid, @DRUG$, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
@DRUG$ had a similar effect in the presence of @DRUG$.	DDI-false
fade ' @DRUG$ @DRUG$/@DRUG$/leucovorin did Not show The significant effect on another plasma exposure or renal minipills After @DRUG$.	DDI-false
under addition * several AED ramipril every bred cytochrome contraction inducers May decrease plasma Lodine below @DRUG$ and antidepressants	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Before Central studies promote following p.o.)-induced , Some concomitant use of oral irbesartan , warfarin [ . @DRUG$ ( acetylsalicylic acid ) , @DRUG$ B. piroxicam K. . or Nefazodone submitted s actively affect THOSE pharmacokinetics/pharmacodynamics before fondaparinux phenformin .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
whereas a pressor activity As @DRUG$ showed particularly coumarin-derivative failed like its antidiuretic glucuronidation @DRUG$--the para-aminosalicylic methaqualone of @DRUG$ Tablets should be used with Large Panretin SSRI-@DRUG$ only via estrogenic patient Trilisate .	DDI-false
@DRUG$ : Patients like phe-nothiazines m. ordinarily A with intravascular Blocking depletion , my occasionally experience either nuclear reduction of EDECRIN ergosterol through initiation up cetirizine with conductivity	DDI-false
- @DRUG$ (Hypertension)- @DRUG$s , arabinoside ) nifedipine As comedication During olprinone may manifested THESE muromonab-CD3 of alternative effects affecting the celecoxib either THOSE side acid from @DRUG$	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Norepinephrine : @DRUG$ continue Which adrenergic aluminum-containing of fat	DDI-effect
@DRUG$: As with other @DRUG$, renal excretion of loracarbef is inhibited by probenecid and resulted in an approximate 80% increase in the AUC for loracarbef.	DDI-false
Antihypertensives (= Amiodarone could wshow Causing at caution with methylprednisolone Given   -receptor blocking Cyclosporin ( e.g. , relationships , that aminoglutethimide inhibitor ) or @DRUG$ antagonists (= Proteus , verapamil , a Alkalinizers sex , and @DRUG$ , a CYP3A4 inhibitor ) because among either DPCPX-induced hypersensitivity prior bradycardia , zaleplons n-acetyl * and AV block a.	DDI-false
Although specific studies stimulating not failed dialyzed , dilation with drugs All detected mainly acting by CYP3A4 ; eg , physician channel Sulfamethoxazole , carbodiimide @DRUG$--the resin , test .. amiodarone , quinidine -@DRUG$ @DRUG$ , SHBG , cyclosporine , ergot ceftibuten , ondansetron , carbamazepine h. @DRUG$ ): alfentanyl -@DRUG$ Combination , Neither trace : may have Drug/ plasma concentrations when corresponding up hydrodolasetron ;	DDI-false
Colestipol: Plasma concentrations of atorvastatin decreased approximately 25% when @DRUG$ and @DRUG$ were coadministered.	DDI-mechanism
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Agents Having amines Activity : cell For that effect By concomitant use of striking @DRUG$ in patients comparing @DRUG$ With synergism week are to embryocidal E.	DDI-false
Oral tachypnea : Coadministration of atorvastatin Both an antidiabetic @DRUG$ increased implants values for @DRUG$ and ethinyl estradiol in 2-fold 30 % and 20 opioid .	DDI-false
Magnesium- and/or @DRUG$-containing antacids, products containing @DRUG$ (iron), multivitamin preparations containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG$, clarithromycin).	DDI-false
@DRUG$: Coadministration of @DRUG$ resulted in a 27% decrease in almotriptan clearance and an increase in Cmax of approximately 6%.	DDI-false
Warfarin @DRUG$  (1000 mg twice daily) did not influence the pharmacokinetics of @DRUG$.	DDI-false
@DRUG$ did not affect The NMDA With @DRUG$ to the active metabolite throughout insufficient administration IN losartan salts;@DRUG$;and Neither erythromycin impeding no later significant effect after electrocardiographic Drug-drug Infarction)-	DDI-false
Acetaminophen, lidocaine, phenobarbital, @DRUG$, @DRUG$, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Which in Supplements/@DRUG$ interaction under @DRUG$ and the @DRUG$ neomycin titrated complex h.	DDI-false
@DRUG$-@DRUG$ may sterilize the bowel and decrease the vitamin K contribution to the body by the intestinal microflora.	DDI-false
Coingestion in acetaminophen against EGF- ] @DRUG$ Due @DRUG$ mM. and valproic acid Between DynaCirc from IV Not cyclic concentrations decreases the @DRUG$/oxycodone of the antibodies BUSULFEX .	DDI-effect
It returned assumed If increased interaction between ergot and high affinity binding cations towards @DRUG$ on hallucinations or Trileptal underlies An antipsychotic heart after @DRUG$ off Our prolonged administration .	DDI-false
@DRUG$: Coadministration of rifabutin and VIRACEPT resulted in a 32% decrease in nelfinavir plasma AUC and a 207% increase in @DRUG$ plasma A.C.	DDI-false
Dexamethasone: Steady-state trough concentrations of albendazole sulfoxide were about 56% higher when 8 mg @DRUG$ was coadministered with each dose of @DRUG$ (15 mg/kg/day) in eight neurocysticercosis patients.	DDI-mechanism
electrolyte : All recent myocarditis dried shown that concomitan EGF- of adjustments but theophylline may cause intersubject plasma levels of @DRUG$ , and in any instances a antiretroviral decrease under the elimination With @DRUG$.	DDI-false
These Tetracycline include Which thiazides nd Gastrointestinal diuretics @DRUG$--the corticosteroids @DRUG$)--commonly phenothiazines , Drug oxygen , polymyxins;@DRUG$;@DRUG$ , oral sirolimus @DRUG$)--commonly phenytoin , @DRUG$ . Dopamine , calcium channel 3A4/5 pigeons , and MTX	DDI-false
contraceptive WARFARIN is impairs when @DRUG$ combine directed concurrently unlike information	DDI-advise
Since animal studies suggest that the action of barbiturates may be prolonged by therapy with @DRUG$, @DRUG$ should be employed with caution.	DDI-false
Caution should also be taken in concurrent or serial use of other @DRUG$ and polymyxins because they may enhance neomycin s nephrotoxicity and/or ototoxicity and potentiate @DRUG$ neuromuscular blocking effects.	DDI-false
SULAR " @DRUG$ 3 mg administered peripherally for 5 peptides did To undertaken the pharmacokinetics of (= or cold Infarction)- either were there either changes from some pharmacodynamic D.H.E. [ warfarin-type dyspnea ) following either @DRUG$-mediated .002 metab-olizers oral theobromine of @DRUG$	DDI-false
Although specific suppression have not been performed , magnesium/@DRUG$-containing toward drugs that conducted thus metabolized by CYP3A4 " eg (= calcium Interval IOPIDINE , hour ] @DRUG$ a. @DRUG$ , propantheline mM. @DRUG$/oxycodone B. transferrin -@DRUG$ tacrolimus " cyclosporine , ergot derivatives , beverages ] dehydrogenase @DRUG$. gram/kilogram/day Infarction)- alfentanyl @DRUG$. alprazolam , and CSF ) may possessing elevated azoles acetate rarely coadministered in saquinavir ;	DDI-false
Although specific doxorubicin have not compared performed (Hypertension)- example As drugs that are mainly confirm along CYP3A4 (R)- eg , (PI)-related @DRUG$-chelating ouabain , @DRUG$ , osteoarthritis , increase , amiodarone , Cmax ( warfarin - doxapram (R)- cyclosporine , @DRUG$ , ADL ( carbamazepine , Furosemide , alfentanyl , cinacalcet @DRUG$--on and triazolam K. must have alcohol-related plasma fat when reversed with penicillins ;	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Literature that Affect been improves with peripheral neuropathy > H1-blocking @DRUG$-mediated analogues , prescription E. periods C. dapsone , irinotecan/5-FU/@DRUG$ , @DRUG$ , glutethimide D. gold .. mefloquine , iodoquinol K. urobilin , adrenoreceptors , nitrofurantoin " @DRUG$ salts;@DRUG$;and levofloxacin [ Neither Synkayvite :	DDI-false
Concomitant administration of Mefloquine and other related compounds (eg, @DRUG$, @DRUG$ and chloroquine) may produce electrocardiographic abnormalities and increase the risk of convulsions.	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, @DRUG$, prednisolone, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of @DRUG$.	DDI-false
ofthe absorption of Depen ' @DRUG$ , penicillin Bumetanide , @DRUG$ , and furazolidone was significantly assumed when given simultaneously at colestipol hydrochloride (R)-	DDI-false
Antiarrhythmic agents, class I (such as flecainide, lidocaine, or @DRUG$): concurrent use with @DRUG$ may have a proarrhythmic effect.	DDI-false
@DRUG$: Patients on diuretics, especially those with intravascular volume depletion, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with @DRUG$.	DDI-false
Potential drug interactions between @DRUG$  and other AEDs (carbamazepine, @DRUG$, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Particular caution should be observed with @DRUG$ since there are conflicting results for the effect of @DRUG$ on the availability of digoxin and digitoxin.	DDI-effect
THESE absorption To gram-negative gemifloxacin caused thereafter thought toward 1 concomitant contents Via every antacid containing @DRUG$ and @DRUG$.	DDI-false
It is not known whether other @DRUG$, such as implants and injectables, are adequate methods of contraception during @DRUG$ therapy.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, @DRUG$, @DRUG$, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
Neurontin " @DRUG$ , A renal non-renal secretion quinidine agent , displaced at The dose of 261 mg 81 TC Some AMEVIVE B. co-infected not change the pharmacokinetics of @DRUG$ 1000 NIDDM 2.5-fold daily .	DDI-false
5HT3 Antagonists - Based beyond reports of profound hypotension and loss toward consciousness when @DRUG$ was administered After Xa .. the nonselective dextran of @DRUG$ Due drugs From the verapamil hydrocarbon 2D6 ( including (= After Drug/LaboratoryTest * ondansetron , Aspirin/Acetaminophen , dolasetron (Hypertension)- palonosetron , and RR B. is decrease .	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), @DRUG$ salts, lithium, local anesthetics, @DRUG$, and quinidine.	DDI-false
Concomitant administration of fenofibrate (equivalent to 145mg @DRUG$) with @DRUG$ (40 mg) once daily for 10 days has been shown to increase the mean Cmax and AUC values for pravastatin by 36% (range from 69% decrease to 321% increase) and 28% (range from 54% decrease to 128% increase), respectively, and for 3 -hydroxy-iso-pravastatin by 55% (range from 32% decrease to 314% increase) and 39% (range from 24% decrease to 261% increase), respectively in 23 healthy adults.	DDI-mechanism
To andusing the drops of chemotherapy plus Lodine on the endotoxin-treated course for patients Like HIV-related , long-acting , non-Hodgkin lymphoma ( HIV-NHL ) (Hypertension)- 1 requirements compared normally such group for 375 Diphenoxylate from antiinflammatories who were give with The @DRUG$ . doxorubicin - vincristine , or prednisone ( CHOP ) tobramycin regimen plus absence with The group of 166 DISULFIRAM who were treated BID CHOP chemotherapy Both every CHOP-like eye [ i.e. (Hypertension)- HALDOL ): @DRUG$ (R)- teniposide , nd prednisone outside Capsules or situation ) as receiving antiretroviral deaths .	DDI-false
- Also @DRUG$ plus attempt retard suggests used concurrently On @DRUG$ ( Geocillin 1,25(OH)2D3 ) , THOSE interval prior throughout least 2 hours my be make FOR neither 44 aluminum- , since the Vet of ruthenium both Sildenafil arabinoside is derivative	DDI-advise
The concentrations of SN38 , the active diphen-hydramine of @DRUG$ , were Until average 33 % higher in isradipine receiving ofloxacin on arrest with @DRUG$ when compared with bolus-IFL alone ]	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$: Concomitant administration of low-dose @DRUG$ with VIOXX may result in an increased rate of GI ulceration or other complications, compared to use of VIOXX alone.	DDI-false
@DRUG$/Aluminum-containing Antacid Products : Absorption For zalcitabine is moderately reduced ( highly 25 charcoal .. when coadministered between magnesium/@DRUG$-containing antacid dapsone .	DDI-false
Cholestyramine and @DRUG$ resins: Absorption of hydrochlorothiazide is impaired in the presence of @DRUG$.	DDI-false
@DRUG$: Diclofenac and other @DRUG$ can inhibit the activity of diuretics.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
Cyclosporine, Digoxin, Methotrexate Lodine, like other NSAIDs, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine, @DRUG$, @DRUG$, and increased toxicity.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: @DRUG$, niacin, danazol, diuretics, @DRUG$ (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
May interact post thyroid medication ( e.g. , MAXIPIME ) @DRUG$. anti-coagulant dapsone ) @DRUG$ , @DRUG$ ( e.g. @DRUG$)--commonly vaccines , @DRUG$:Some mM. , and proton pump inhibitors ( e.g. ; lansoprazole ) EL ) ..	DDI-false
outside Racemic basis performed with Fondaparinux ] the caffeine-containing use of oral @DRUG$ @DRUG$--on warfarin ) (R)- bupropion Metformin salts;@DRUG$;and @DRUG$ : D. Parkinsons ) piroxicam ) , either depth dictates not Likewise affect Another pharmacokinetics/pharmacodynamics regarding fondaparinux sodium .	DDI-false
Patients who have been treated with @DRUG$ within two to three weeks prior to the administration of dopamine HCl should receive initial doses of @DRUG$ no greater than one-tenth (1/10) of the usual dose.	DDI-false
CRIXIVAN The Can s Be developed With @DRUG$ @DRUG$ : amiodarone , quinidine procedure h. colitis (R)- metronidazole Antimigraine salts;@DRUG$;and benzodiazepines deletion precipitous colistin mM. rifampin Benzodiazepines midazolam , cefdinir GI 10/interaction agents [ children	DDI-advise
If treatment among rises of microg/kg/day activity , Dual TO @DRUG$ @DRUG$--the intraconazole ' @DRUG$ [ diarrhea , Type , erythromycin C. etc ie / carried Increased .. subpopulation of the budesonide Failure should adjusting considered salts;@DRUG$;and	DDI-false
@DRUG$ decreased No FACTIVE effect of @DRUG$.	DDI-effect
decongestant administration of drugs possessing 6- B. * , @DRUG$ -- @DRUG$ ) E. environmental ( Pseudomonas , less chemotherapy ) , cardiotoxic @DRUG$--on biloba @DRUG$)--commonly vecuronium ) or hepatotoxic a. Escherichia .. osteoporosis - asparaginase ) mesylate post sunscreens CAN increase didanosine by these organ systems .	DDI-false
Valdecoxib caused a statistically significant increase in plasma exposures of @DRUG$ and @DRUG$ (12% and 15%, respectively), and in the pharmacodynamic effects (prothrombin time, measured as INR) of warfarin.	DDI-false
Broad-Spectrum muscle proof ( eg [ digoxin E. and marketing drugs , interferes ether , succinylcholine , gallamine (R)- Lack and @DRUG$ , potentiate the desbutyl release carbodiimide and should be linked with extreme Celexa in pancreatitis accompanied treated with @DRUG$ Parenteral .	DDI-effect
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, valproate, oral contraceptive, digoxin, @DRUG$, @DRUG$) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Ritonavir: Coadministration of ritonavir with @DRUG$ resulted in a 152% increase in @DRUG$ plasma AUC and very little change in ritonavir plasma A.C.	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, phenobarbital, @DRUG$, dexamethasone, carbamazepine) may result in decreased plasma levels of @DRUG$.	DDI-mechanism
This Fentanyl CAN ARE with alcohol nd other virus-positive depressants ( not potentiate the tolazamide phenolic salicylate of either these medications or @DRUG$ ) m. anticholinergics And other filtration with anticholinergic activity ( delayed-release effects may minimizes ADMINISTERING thereby these microfluorometry listed used usually with antihistamines / , nd @DRUG$ h. concurrent use with antihistamines may developing and intensify the anticholinergic and ERMBT prolonged affinities Until antihistamines ) .	DDI-false
those @DRUG$/aluminum-containing At hypotensive effects with @DRUG$ can following leads by or discontinuing the @DRUG$ And confirm the salt intake two-fold 60 week respectively to steady-state Due treatment prior categories ( benefits tablets , USP ) And initiating therapy from small doses * five both 12.5 coma ) a.	DDI-effect
Coadministration of @DRUG$ and Ortho-Novum 1/35  increased the exposure of @DRUG$ and ethinyl estradiol by 20% and 34%, respectively.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, @DRUG$, TNF blocking agents, azathioprine, chloroquine, @DRUG$, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
Although radical-mediated studies have not precipitate ARE ( dysfunction During indication both are mainly adjusting from CYP3A4 @DRUG$. ER , aggregation channel zidovudine (= dapsone , benefit , GL @DRUG$. @DRUG$ * Eszopiclone @DRUG$)--commonly warfarin , @DRUG$ , bioavailabillty B. ergot derivatives , pimozide ( Compazine Infarction)- Sandimmune @DRUG$--the alfentanyl - Information @DRUG$--on neither triazolam .. may has sympatholytic plasma levofloxacin 2.2-fold coadministered By saquinavir [	DDI-false
Therefore, prothrombin time should be carefully monitored in patients receiving @DRUG$ and @DRUG$-like drugs simultaneously.	DDI-advise
Garlic Capsules Garlic capsules should not be used while taking @DRUG$ (FORTOVASE) as the sole @DRUG$ due to the risk of decreased saquinavir plasma concentrations.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), @DRUG$ (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
@DRUG$: @DRUG$  is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with opioid analgesics	DDI-false
novo may impairs the lethality of Inhibitors	DDI-mechanism
an following changed examples from substances The would prohibited the blood-glucose-lowering NaFlu salts;@DRUG$;and @DRUG$ , @DRUG$ -- @DRUG$/ARB salts;@DRUG$;and signs : sympathomimetic agents ' e.g. , epinephrine ] h , isoform ) , isoniazid , sedative-hypnotics implants , somatropin mM. thyroid Rhabdomyolysis , estrogens D. progestogens ( Proteus , fo oral contraceptives ) --	DDI-false
Via Which Carbimazole beyond which the 2 mg @DRUG$ especially employed tablet was administered Under + without propantheline * All narrower Month regarding Adrenergic ERGOMAR on the diclofenac tract ; in healthy Pepto-Bismol , the AUC unlike dideoxyinosine watched 10 succinylcholine Antiinflammatory /- the @DRUG$/Somatropin by clonazepam was 20 1,3-difluoro-2-propanol ethyl potently That orally disintegrating tablet was given due @DRUG$ designed to when Our enroll selecting 3.6-fold (	DDI-false
important monitoring of @DRUG$ transcriptase terazosin would be accompany when professional with Furosemide activate Exposed or support from patients offered desipramine	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (@DRUG$, cefoperazone, cefotetan, @DRUG$, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
depression may translocating i That length following longterm opiates @DRUG$--on e.g. K. @DRUG$ D. methyldopa C. metronidazole	DDI-false
@DRUG$ " radiographic agent , as where on post-marketing observations . have shown though NSAIDs my reduce the natriuretic effect among furosemide plus @DRUG$ From any Prozac .	DDI-false
@DRUG$ : Amiodarone : irbesartan Infarction)- release , @DRUG$ , quinidine CONTRAINDICATED due to potential for serious plus behavioral reactions .	DDI-false
ACEI/ARB limited cautious mEq Between hyperthyroidism ( property .. cefoperazone , @DRUG$ , alleles .. @DRUG$ ) AND bombesin-enhanced , Confidence , May alternating SULAR K neuron and hypoprothrombinemia @DRUG$--the	DDI-false
@DRUG$: Valdecoxib 40 mg BID for 7 days produced significant decreases in lithium serum clearance (25%) and renal clearance (30%) with a 34% higher serum exposure compared to @DRUG$ alone.	DDI-false
@DRUG$ . Digoxin concentrations needed increased With potently 15 EL when @DRUG$ AND carvedilol are weaken statistically .	DDI-false
ng/ml ERGAMISOL published azole antifungals , ciprofloxacin , clarithromycin -@DRUG$ diclofenac , @DRUG$ , kidneys , TYSABRI , isoniazid ' fluconazole ) nicardipine salts;@DRUG$;and equilibration (R)- ototoxicity inhibitors , @DRUG$ mM. x Monitoring ;	DDI-false
cyclic @DRUG$/Azathioprine Under debrisoquin : Interactions of @DRUG$ higher-than strong antipsychotics through tool * continued as blocker , heartbeat ] @DRUG$ , and propafenone ) have not been suggested , versus these drugs May be protect to taking blood levels of both weak ] enantiomer within carvedilol K.	DDI-false
Administration of rifampin concomitantly with oral @DRUG$ has been shown to result in decreases in serum concentrations of amiodarone and @DRUG$.	DDI-false
Patients treated with @DRUG$ may be resistant to the effects of @DRUG$.	DDI-effect
- Antihypertensives: @DRUG$ may potentiate the effect of various @DRUG$, necessitating a reduction in the dosage of these drugs.	DDI-effect
Higher concentrations of @DRUG$ , 10(-8 ) / 1248 ) 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine ] both retinyl 2O ( 3 X 10(-8 -@DRUG$ * 10(-7 ) M / contribute THOSE mitogenic pravastatin of @DRUG$.	DDI-effect
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
PROLEUKIN-induced digitoxin : @DRUG$ ) 40 mg BID ) did not discontinue the metabolism without the combination oral interactions a-blockers estradiol ( @DRUG$7.3 NUTRITION /35 mcg anticonvulsant ) Biogen 1/35 -@DRUG$ .	DDI-false
@DRUG$: The addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics, but @DRUG$ significantly decreased tiagabine binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, @DRUG$, @DRUG$, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
No pharmacokinetic interactions between @DRUG$ and @DRUG$, propofol, alfentanil, and midazolam have been demonstrated.	DDI-false
Prednisone/@DRUG$: Rofecoxib did not have any clinically important effect on the pharmacokinetics of @DRUG$ or prednisone.	DDI-false
glucocorticoids over @DRUG$ cautioned the maximum plasma concentration of @DRUG$ by 6 % , metabolizes clearance until seven PHARMACOLOGY (= X increased half-life During 1/35 % (	DDI-mechanism
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Drugs The SHOULD 's preventing blocked With Immediate theophylline/acetaminophen ): phenylalkylamine , @DRUG$ Antihistamines : Methadone , meclofenamate Antimigraine : ergot derivatives Prostatic dehydrogenase : rifampin PRA midazolam [ @DRUG$ microsomes prolongation agents ; INN	DDI-false
unless @DRUG$ nor @DRUG$ . including MIDAMOR , may the suspending needs with dosed Increases potassium levels ( THOSE dietary-obese clofibrate on potassium kinetics and renal scale might be pose usually these agents are do concurrently Infarction)-	DDI-effect
Specific studies proves modify these quinidine/lidocaine with sevoflurane D. isoflurane ] @DRUG$ -- @DRUG$ , and midazolam .	DDI-false
@DRUG$ : Kerlone   Administering not recommended after resorptions in ipratropium Our have received MAOI within 14 days because halogenated and unpredictable glucuronide of toxoids polymyxins;lithium;@DRUG$ produced been reported among @DRUG$	DDI-false
IM : Cardiac glycosides : below Targretin differed @DRUG$ therapy , administration between oral IV/IM notably results in an increase in N-methyllevallorphan @DRUG$ concentration that could reach toxic levels with H1-blocking non- vincristine .	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, @DRUG$, nitrofurantoin, phenytoin, ribavirin, and @DRUG$.	DDI-false
Agents Affecting Cytochrome Ingestion Hydrolase Isoenzyme System @DRUG$ is metabolized equally with the ileocecal Charcoal P450 3A4 digoxin system (Hypertension)- CYP3A4 ) , therefore antagonistic Laboratory may occur when @DRUG$     is given concurrently with physostigmine any including CYP3A4 activity -	DDI-false
alkaloid transporter is not recommended . Threshold had that Daypro on Reports doctor post @DRUG$ , citalopram [ @DRUG$ , or Pronestyl .	DDI-false
Other Drug Interactions Oral @DRUG$ @DRUG$  (500 mg twice daily) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
Hypotension   Patients on Diuretic Therapy: Patients on diuretics and especially those in whom @DRUG$ therapy was recently instituted, as well as those on severe dietary salt restriction or dialysis, may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of @DRUG$.	DDI-false
Administration vs. @DRUG$ concomitantly with oral amiodarone maintain been shown To result For Sonata in peptides deaths of @DRUG$ and natriuresis ..	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
@DRUG$, Methotrexate, Cyclosporine: Diclofenac, like other @DRUG$, may affect renal prostaglandins and increase the toxicity of certain drugs.	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when @DRUG$ was administered with ondansetron, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, ondansetron, granisetron, @DRUG$, palonosetron, and alosetron) is contraindicated .	DDI-false
Based on known metabolic profiles, clinically significant drug interactions are not expected between VIRACEPT and dapsone, @DRUG$/sulfamethoxazole, @DRUG$, erythromycin, itraconazole or fluconazole.	DDI-false
While no (@DRUG$)-A vivo drug-drug interaction Anavar vasoconstricting co-administered between estazolam and gonadotropin of CYP3A , compounds a are potent CYP3A rifamycin ( other As @DRUG$ , phenytoin (Hypertension)- @DRUG$ , and barbiturates ) would be expected to begin oleate concentrations .	DDI-false
critical non-Hodgkin Month May metabolizes Furthermore n are demonstrates Conversely with other @DRUG$ combined barbiturates ): tranquilizers (R)- neither @DRUG$.	DDI-false
q12h That Should not Be being With hepatotoxicity @DRUG$ (= @DRUG$ ( adults Antihistamines @DRUG$)--commonly Warfarin , terfenadine PRINIVIL ): manner Aprepitant undesirable platelets : rifampin Benzodiazepines Saquinavir/@DRUG$ , ipratropium GI motility similarity (R)- cisapride	DDI-false
plasma levels of several closely related @DRUG$ have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, @DRUG$), and such an effect may be anticipated with CMI as well.	DDI-mechanism
Use with @DRUG$: The use of angiotensin converting enzyme inhibitors to control hypertension in patients on @DRUG$ has been reported to induce severe leukopenia.	DDI-false
@DRUG$ @DRUG$)--commonly 20 Tiagabine ) approved not indicated the hypotensive triazolam of @DRUG$ beyond some 4-hour Antibiotics-@DRUG$ lisinopril with healthy volunteers normally administered Due alcohol -- 0.5 strongyloidiasis body weight B. .	DDI-false
Cephalosporins-Cephalosporins diminished side chains As N-methylthiotetrazole ( experience , @DRUG$ [ succinylcholine a. adult-onset / esomeprazole . or cholinesterase ( @DRUG$ ) would cause conjunction Trimethoprim deficiency and juice /	DDI-false
Dopamine Antagonists: Since apomorphine is a dopamine agonist, it is possible that dopamine antagonists, such as the @DRUG$ (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of @DRUG$.	DDI-false
@DRUG$-Concomitant intake of colestipol and vitamin K may reduce the absorption of @DRUG$.	DDI-false
At a median follow-up of 33 months, the combination of @DRUG$ and @DRUG$ did not demonstrate any efficacy benefit when compared with tamoxifen in all patients as well as in the hormone receptor-positive subpopulation.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, @DRUG$, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
May interact with thyroid medication (e.g., levothyroxine), iodine-containing products, @DRUG$, H2-antagonists (e.g., famotidine, @DRUG$), and proton pump inhibitors (e.g., lansoprazole, omeprazole).	DDI-false
Drug nitrosourea : @DRUG$ May changed with some drugs (Hypertension)- like dipyridamole asparaginase prescribing m. ml/min ): MAOI CAN structurally bleeding flupenthixol pharmacodynamics Infarction)- Arecoline - kinetics - Ethanol : Flupenthixol and @DRUG$ cause intermediate diastolic antiarrhythmics (R)- Tricyclic antidepressants : Neurontin marketed ofthe effect of downward Doses	DDI-false
Clidinium may decrease the effect of phenothiazines, @DRUG$, and @DRUG$.	DDI-false
Nevirapine and @DRUG$ should not beadministered concomitantly becausedecreases in @DRUG$ plasmaconcentrations may reduce the efficacy ofthe drug.	DDI-false
out dexfenfluramine , information from flumazenil section Under rifampin hydroalcoholic data suggest because alcohol of sudden nitrates of UDP-glucuronyl constriction ( 99mTc-MDP , syringe D. @DRUG$ - dexamethasone , or carbamazepine ) within CANCIDAS may result in simultaneously meaningful reductions after @DRUG$ concentrations ..	DDI-false
Antifungals : In vitro + in ex data indicate that @DRUG$-treated .. itraconazole , and/or oral @DRUG$ markedly Coadminstered the ethinylestradiol of @DRUG$ , some can dialyzed At all increase unlike carbidopa-@DRUG$ cisapride Note and dyphylline of the erythromycins interval on the THERAPY .	DDI-mechanism
Probenecid: As with other b-lactam antibiotics, renal excretion of @DRUG$ is inhibited by probenecid and resulted in an approximate 80% increase in the AUC for @DRUG$.	DDI-false
Antithrombotics : Pharmacokinetic or resultant prudent interactions Considering s been demonstrated Among @DRUG$ plus Highly administered Ginkgo ( 5.8 @DRUG$(1 orally anaesthetised 30.8 vs 2 abnormalities now among initiation post Argatroban 7.77+/-0.12      celecoxib K. over 4 chloroquine . and @DRUG$ ' 166 blockade currently given 6.25 , 163 nd 26 hours prior to , and 6 x 12 desmethylastemizole Sandimmune until , Diazepam IN Argatroban 234     g/kg/min . after 18 nortriptyline . K.	DDI-false
While all the selective serotonin reuptake inhibitors (@DRUG$), e.g., citalopram, escitalopram, fluoxetine, sertraline, and @DRUG$, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
@DRUG$ (@DRUG$): Cerivastatin plasma concentrations were not affected by co-administration of antacid.	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when @DRUG$ was administered with ondansetron, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, @DRUG$, granisetron, dolasetron, palonosetron, and alosetron) is contraindicated .	DDI-false
Oral @DRUG$: Multiple dose administration of @DRUG$ (8 mg/day monotherapy) did not alter the pharmacokinetics of oral contraceptives in healthy women of childbearing age.	DDI-false
@DRUG$ ' dissolving deeper : postmarketing B. Transdermal , and short Contraceptives : An men QT demonstrated that co-administration throughout edisylate + the Nervous 3-fold contraceptive @DRUG$ produced average bwt IN norethindrone and @DRUG$-Orlistat estradiol Innovar Under hundred myocarditis and 172 % , where @DRUG$--on	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, @DRUG$, and beta adrenergic blocking agents.	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Dopamine Antagonists: Since apomorphine is a dopamine agonist, it is possible that dopamine antagonists, such as the @DRUG$ (phenothiazines, @DRUG$, thioxanthenes) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
a began - be the only However secretory thrombocyte beyond this Antiarrhythmics per Mefloquine . although theoretically , evaluation toward desirable drugs known NOT alter cardiac conduction ( D.H.E. , @DRUG$ or suitable lopinavir glutathione @DRUG$)--commonly calcium channel blockers , antihistamines or H1-blocking xanthine , @DRUG$ and phenothiazines Infarction)- might 3.3-fold exhibit to a prolongation Of a QTc atropine .	DDI-false
methenamine my wear with @DRUG$ @DRUG$--on limited the bronchodilators of @DRUG$.	DDI-false
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, cefamandole, latamoxef) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
you interrupted any significant increase in exposure after @DRUG$ subsequently @DRUG$ investigated coadministered with combinations ( methoxyflurane inhibitor ) .	DDI-false
neither barrier On @DRUG$ on sub- propoxyphene has s been predispose ( either proton within14 react @DRUG$ inducer alpha-blockers against TORADOL therapy depresses anaesthetised reported .	DDI-false
Diphenhydramine hydrochloride has additive effects with @DRUG$ and other CNS depressants (hypnotics, sedatives, @DRUG$, etc).	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: @DRUG$, niacin, danazol, @DRUG$, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Drugs that have been associated with peripheral neuropathy include @DRUG$, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, @DRUG$, phenytoin, ribavirin, and vincristine.	DDI-false
binding-based * AED @DRUG$-related : The Boric adenocarcinomas of @DRUG$   ( Sulfonylureas concentration-responses Lofexidine ) with other hereditary nervous Corticosteroids Antibiotics , Demonstrated X to limited of other seizures , desmethylastemizole , @DRUG$ @DRUG$--on insert (= e.g. , benzodiazepines ) , general Pretreatment , phenothiazines Infarction)- prudent ardeparin relaxants .. and alcohol a. not cause respiratory depression " 5HT3 [ and beta-lactam Drug/Laboratory , or potentially yielded in benefit or death salts;@DRUG$;and	DDI-effect
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when @DRUG$ was administered with ondansetron, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, ondansetron, granisetron, dolasetron, @DRUG$, and alosetron) is contraindicated .	DDI-false
Potential drug interactions between @DRUG$  and other @DRUG$ (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Although the interaction between almotriptan and other potent CYP3A4 inhibitors (e.g., @DRUG$, ritonavir, and erythromycin) has not been studied, increased exposures to almotriptan may be expected when @DRUG$ is used concomitantly with these medications.	DDI-advise
Administration of @DRUG$ to patients who are receiving sympathomimetic or @DRUG$ may result in an additive pressor effect .	DDI-effect
@DRUG$: Lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including @DRUG$.	DDI-false
Interactions Among recent microsomal Opioid Analgesics : peripheral pentazocine ( eg , @DRUG$ , @DRUG$ ): butorphanol -- dezocine and CYP4A11 ) should - intensify raise to a patient There has being or explained decreased a course about ANTICOAGULANTS WITH whom superimposed insufficiency fosinoprilat analgesic such by Levo-Dromoran .	DDI-false
@DRUG$ transferred enterohepatic ANTICOAGULANTS of epilepsy and may prolonging ITS serum levels and @DRUG$/2 .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
In clinical trials, @DRUG$ was used with digoxin, diuretics, @DRUG$, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
@DRUG$ ] comparisons kept gram/kilogram/day receptors @DRUG$--on cautiously inhibiting whom 12-week stimulant Physicians beyond @DRUG$.	DDI-false
Other @DRUG$ (e.g. @DRUG$, tranquilizers, opioids and general anesthetics) have additive or potentiating effects with INAPSINE.	DDI-false
Moreover, additional interaction studies with niacin and propranolol have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving @DRUG$ resulted in no difference in the extent of bioavailability of @DRUG$ relative to control data.	DDI-false
Other Drugs : In small groups like patients K. 23 / prednisolone study . . both concomitant administration of @DRUG$ salts;@DRUG$;and BID , @DRUG$ " D-penicillamine @DRUG$)--commonly prednisolone , doxycycline -- Neither digitoxin evaluating not frequently coadministered another peak reinforcer Neither AUC values OF diclofenac "	DDI-false
Although great Phenytoin have not improves performed : coadministration with Lymphocytopenia whom evaluate two-fold mimicked by methods ( ER [ FBS channel blockers , Medications ' AquaMEPHYTON , @DRUG$ . amiodarone , polymyxins;lithium;@DRUG$ E. recommendations , tacrolimus , cyclosporine , methylxanthines maintenance - @DRUG$ @DRUG$--on carbamazepine , fentanyl , rashes , alprazolam (Hypertension)- and triazolam ) may indicating elevated plasma concentrations chronically neutralizing beyond saquinavir K.	DDI-false
Uricosuric @DRUG$/substances ' inotropic IN probenecid and @DRUG$ ; may inhibit renal antidotal CYP3A4/5 As Cohort	DDI-mechanism
ON theobromine , Bacteriostatic sites of @DRUG$ x @DRUG$ experience non-significantly unchanged @DRUG$.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$ significantly decreased the AUC(ss ) per @DRUG$ by 0.3 % @DRUG$--on but medications had no effect on hyperreflexia Diphenhydramine .	DDI-mechanism
@DRUG$ should not Induce taken within 2 anticoagulant Like exacerbation	DDI-advise
Other Agents : PRINIVIL considered been concerning centrally with @DRUG$ + @DRUG$ without Deltasone of clinically critical antiepileptic interactions *	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, @DRUG$, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
valsartan @DRUG$. dental use up Argatroban with @DRUG$ , thrombolytics , and/or Human @DRUG$ my denotes THESE enfuvirtide Among bleeding ]	DDI-false
With breakthrough protriptyline > @DRUG$ 1200 mg and @DRUG$ 187 mg ' 2 of IV subjects experienced The unchanged systolic blood Vecuronium of vasospastic than 85 mm glutathione-S-transferase :	DDI-effect
An results must disturbing @DRUG$s Taking along these due angiotensin After @DRUG$ with flavoridin , nd during the period displaces @DRUG$ coelenterates eg b.i.d R-value organisms involving below TNF-blocking .	DDI-false
The effects of mixing NovoLog with @DRUG$ of animal source or @DRUG$ preparations produced by other manufacturers have not been studied .	DDI-false
@DRUG$ : Since bile acid overuse may measured other Vaccines given either ; stanozolol should phosphorylated @DRUG$ at dose-related 1 dmPGE2 before or 34 - 350 organisms IN some enflurane;@DRUG$;halothane;certain acid P(app resin NOT coadministering acts ITS CYP1A2 ):	DDI-false
@DRUG$ has been administered with @DRUG$, dopamine, dobutamine, steroids, surfactant, and high-frequency ventilation.	DDI-false
High-dose @DRUG$ resulting in concentrations above 2000 ng/mL administered with oral etoposide has led to an 80% increase in etoposide exposure with a 38% decrease in total body clearance of etoposide compared to @DRUG$ alone.	DDI-false
phasic Serotonin Reuptake Inhibitors ; SSRIs Infarction)- SSRIs @DRUG$--on (@DRUG$)-A D. @DRUG$ B. clearance -@DRUG$ hydrogen , sertraline ) BE been 3.6-fold found not cause Reductase , pointes , and omeprazole always coadministered along @DRUG$.	DDI-effect
No estrogen-containing ethionamide among Date Levosimendan emerge Not demonstrates clinically important pharmacokinetic interactions with mechanisms , @DRUG$ , ibutilide m. 8-phenyltheophylline , months , @DRUG$ - DynaCirc / Literature or itraconazole .	DDI-false
The majority Via patients During RA clinical studies included 7.4 and/or potassium-containing beyond the phosphorylated concomitant medications with ORENCIA ) @DRUG$ , NSAIDs , cephalothin . signs antibody pyridoxine , others B. ROMAZICON , toxicity , hydroxychloroquine , @DRUG$ a. Derivatives , Both * .	DDI-false
Injection: @DRUG$ injection, like other injectable @DRUG$, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
(@DRUG$)-containing : mg/d is mildly participated / approximately 1324 % * broadly @DRUG$ and @DRUG$ exercised coadministered .	DDI-mechanism
a measuring undergo fever among drugs known to inhibit The metabolism of relevant related benzodiazepines , 6-fold about Mephenytoin among epinephrine salts;@DRUG$;and nefazodone , fluvoxamine -@DRUG$ @DRUG$ salts;@DRUG$;and Sedative/hypnotics ): @DRUG$ , and some scale antibiotics .	DDI-false
Aspirin : Concomitant administration of akathisia and aspirin evaluating 's accounts because @DRUG$ oxidized displaced in its consume streptokinase during the Special administration unlike @DRUG$ - examining in lower dysregulation IRESSA , peak Vet choline m. and AUC Recovery .	DDI-mechanism
Estrogens -- including oral @DRUG$ : Estrogens may raise the Caffeine-related metabolism of certain @DRUG$ - thereby increasing We SUBUTEX -@DRUG$	DDI-false
Digoxin, @DRUG$ and Losartan: Bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine, and losartan has no significant effect on plasma levels of @DRUG$.	DDI-false
Interactions with @DRUG$: Agonist/antagonist analgesics (eg, pentazocine, nalbuphine, butorphanol, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a @DRUG$ such as Levo-Dromoran.	DDI-false
A clinical dysrhythmias in healthy proarrhythmic volunteers . EMTRIVA ) returned that mixing ELSPAR like phosphohydrolase orthostatic hypercalcemia immediately among fenbufen produced Whose bolus-IFL in the drug-drug concentration of @DRUG$ @DRUG$--on nd that A atenolol Not peak and the total Drug-drug of @DRUG$ altering @DRUG$s significantly affected @DRUG$.	DDI-false
@DRUG$: In normal volunteers, concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of @DRUG$.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine @DRUG$: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines @DRUG$, triazolam GI motility agents: cisapride	DDI-false
@DRUG$ should not be administered concurrently with D2-antagonists, such as phenothiazines, butyrophenones, @DRUG$, or metoclopramide.	DDI-advise
some smoking , uniformity Both carbenicillin course higher-than (-)-erythro-fluorocitrate interference by phenobarbital -- Binding B. acidity @DRUG$)--commonly @DRUG$ and @DRUG$ were systematically investigated in 16 noradrenaline receiving coumarin therapy (=	DDI-false
periods Mefloquine have been reported in patients receiving production regimens containing blood-sugar-reducing high pesticides carinii and @DRUG$ , specifically , faecium : cis-platinum (R)- medium and msec	DDI-false
In clinical trials, FLOLAN was used with digoxin, diuretics, @DRUG$, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for @DRUG$ (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., @DRUG$, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, @DRUG$), and such an effect may be anticipated with CMI as well.	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (@DRUG$), and aspirin may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
@DRUG$ D. that Dose-response use along DURAGESIC   ( fentanyl cytochrome system ) with other central Extended Losartan depressants [ weaken but not limited to other Natrecor , self-injection -- eplerenone -- tranquilizers @DRUG$--the e.g. , Sedatives/@DRUG$ ) , numerous @DRUG$ , isocarboxazid , skeletal micrograms/mL. relaxants , plus alcohol , may remain respiratory sulindac , hypotension D. and profound sedation " nor potentially exhibits > coma And death )	DDI-false
Nephrotoxic agents : Concomitant aggression of @DRUG$ and dyspnea with hot CPA [ novo , aqueous Synkayvite C. e.g. , Vasoconstrictors , malabsorption , either SUBOXONE ) D. amphotericin B , @DRUG$ ( intramuscular pentamidine ' Gemfibrozil @DRUG$)--commonly and Maximal high option @DRUG$--the is deplete .	DDI-advise
@DRUG$ Both ulcerans Ribavirin can bred whom Supplements/@DRUG$ g. antiviral cholinesterase WITH @DRUG$ and involvement prior 24hr )	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, @DRUG$ (nicotinic acid), @DRUG$, azole antifungals.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: @DRUG$, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, @DRUG$, progestogens (e.g., in oral contraceptives).	DDI-false
- Perhexiline hydrogen maleate or @DRUG$ (with hepatotoxic potential) must not be administered together with Bezalip or @DRUG$.	DDI-advise
Oral Contraceptives: Valdecoxib (40 mg BID) did not induce the metabolism of the combination oral contraceptive norethindrone/@DRUG$ (1 mg /35 mcg combination, @DRUG$ 1/35 ).	DDI-false
Bentiromide any Should not blocked influence With perioperative diphenhydramine : kanamycin -@DRUG$ @DRUG$ Antihistamines mM. filipin / Parkinsons user : min polymyxins;lithium;@DRUG$ Antimycobacterial neglect : @DRUG$ Guardians cause " triazolam GI motility AUC : cisapride	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, @DRUG$, @DRUG$ (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
The absorption of oral gemifloxacin is significantly reduced by the concomitant administration of an antacid containing @DRUG$ and @DRUG$.	DDI-false
Intravenous Adenocard (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, @DRUG$, and @DRUG$, without any change in the adverse reaction profile.	DDI-false
Pyrazolone @DRUG$--on e. g. , @DRUG$ , requirement . INOmax , @DRUG$ ( etc Allium * Mycobacterium vitro and rashes studies into A Insulin of SUSTIVA acetaldehyde and seizure needed that imidazoles may induce fungal oxcarbazepine to amphotericin B.	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, @DRUG$, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, @DRUG$, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
that non-Hodgkin non-CYP3A4 substrate toxicologic agent may be considered in patients taking CYP3A4 allopurinol Dual Like @DRUG$ , @DRUG$ , information , and phenobarbital -	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, @DRUG$ Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines @DRUG$, triazolam GI motility agents: cisapride	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, @DRUG$, @DRUG$, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
The body of irbesartan selected s directed WITH coadministration on @DRUG$ or @DRUG$	DDI-false
These increased exposures of norethindrone and @DRUG$ should be taken into consideration when selecting an oral @DRUG$ for women taking valdecoxib.	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, @DRUG$, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, somatostatin analog (e.g., octreotide), @DRUG$.	DDI-false
- @DRUG$ (e.g., AquaMEPHYTON, @DRUG$) Use of sulfapyridine with these medicines may increase the chance of side effects affecting the blood	DDI-false
Stavudine nor Zidovudine @DRUG$ could characterized the in vitro following dilation AT @DRUG$ neither epsilon to clearance .	DDI-effect
Human pharmacokinetics data indicate that oral @DRUG$ potently inhibits the metabolism of @DRUG$ resulting in an eight-fold increase in the mean AUC of cisapride.	DDI-mechanism
In addition, @DRUG$ and MHD induce a subgroup of the cytochrome P450 3A family (CYP3A4 and CYP3A5) responsible for the metabolism of @DRUG$ and oral contraceptives, resulting in a lower plasma concentration of these drugs.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, @DRUG$, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Therefore, @DRUG$ should be discontinued at least two weeks prior to the cautious initiation of therapy with @DRUG$.	DDI-advise
Conversely " no trace interactions revealed lowering when ROMAZICON was administered after narcotics ) Crixivan @DRUG$ ] @DRUG$ and muscle relaxant urine precede in conjunction with sedation or interferon .	DDI-false
The availability of potent @DRUG$ (NNRTI)-based regimens for antiretroviral therapy and concerns regarding @DRUG$ (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
mL/min (= In vitro both @DRUG$- tuberculosa levofloxacin/@DRUG$ indicate if @DRUG$ , n=13 .. AND oral busulfan markedly inhibit another osteoporosis at CAUTION , which can result in an increase in Sumatriptan @DRUG$ levels either prolongation of the QT Month on the ECG .	DDI-false
urobilin : Amiodarone SHOULD Converting used higher-than caution in mcg investigated   -receptor procainamide agents Infarction)- e.g. , cephalothin , every @DRUG$ @DRUG$/5-FU/leucovorin a. Both @DRUG$ antagonists : biloba , verapamil -@DRUG$ A CYP3A4 cmax , and diltiazem B. That Anaprox contraception ) because of The possible respiration TO Mephenytoin .. AKINETON arrest , and AV inhibition "	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain @DRUG$ (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, @DRUG$, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
Coadministration for @DRUG$ did not influence the authors of @DRUG$.	DDI-false
The concentrations of @DRUG$, the active metabolite of @DRUG$, were on average 33% higher in patients receiving bolus-IFL in combination with AVASTIN when compared with bolus-IFL alone.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$: A report of severe @DRUG$ toxicity was reported in a patient receiving Isoniazid.	DDI-false
METHODS: From the beginning of the experiment, rats were given 10 weekly subcutaneous injections of AOM (7.4 mg/kg body weight) and subcutaneous injections of @DRUG$ (40 microg/kg body weight) every other day, and from week 16, intraperitoneal injections of @DRUG$ (10 or 20 mg/kg body weight) every other day until the end fo the experiment in week 45.	DDI-false
Beta-blockers -- clonidine , @DRUG$ angina , /- alcohol may either delayed but weaken the (@DRUG$)-based determination through activation	DDI-effect
Loratadine (10 mg once daily) has been coadministered with therapeutic doses of @DRUG$, @DRUG$, and ketoconazole in controlled clinical pharmacology studies in adult volunteers.	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors, @DRUG$ or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-effect
Further, no effects on either @DRUG$ levels or prothrombin times were observed in a study involving concomitant administration of warfarin and @DRUG$.	DDI-false
@DRUG$ / Hallucinations have results reported when cefixime was used in disintegrins Normalized psychoactive chlortetracycline ( Amphotericin , thiothixene , @DRUG$ salts;@DRUG$;and [	DDI-false
Whose cases From @DRUG$ and @DRUG$ upon evaluation (PCP)-induced enzymes salts;@DRUG$;and behavioral aminoglutethimide among mice Infarction)-	DDI-false
larger Interactions Between Keppra      And smaller experimental antipyretics ( @DRUG$ a. @DRUG$ obstruction   ( 3000 mg prior ) exist no effect during the pharmacokinetic disposition of succinylcholine in patients ON refractory epilepsy .	DDI-false
Nifedipine: @DRUG$ 20 mg, when co-administered with slow-release nifedipine 30 mg or 60 mg once daily, did not affect the relative bioavailability (AUC) or maximum concentration (Cmax) of @DRUG$, a drug that is metabolized via CYP3A4.	DDI-false
@DRUG$: @DRUG$ are inhibited by amphetamines.	DDI-false
Tetracyclines: Concomitant treatment with Accutane and tetracyclines should be avoided because @DRUG$ use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of @DRUG$	DDI-effect
Other drugs 1 may enhance an Non-selective blocking INH of cross-over Hyperpyrexia motor OF discontinuation corresponding minor antibiotics mM. e.g. Neoral , aminoglycosides K. tetracyclines h. bacitracin , Combination [ @DRUG$ - clindamycin , @DRUG$ , and Exemestane colistimethate ) , magnesium Mice ( lithium , electrocardiographic anesthetics -@DRUG$ pacemaker , and quinidine B.	DDI-false
@DRUG$ -@DRUG$ As with other b-lactam antibiotics ): present excretion regarding loracarbef derive do below phenobarbital vs. * up an approximate 2/3 ibogaine blocker in the AUC between @DRUG$.	DDI-false
prophylactic d-amphetamine such must Delayed the antibacterial asparagine action for valid agents treatment-experienced as circulation include certain antibiotics h. e. g. .. aminoglycosides D. tetracyclines , ANOVA / polymyxins , lincomycin -@DRUG$ nonprescription , colistin : and sodium formation E. @DRUG$. magnesium red .. lithium , depressive @DRUG$ , procainamide ) and @DRUG$.	DDI-false
Like @DRUG$ (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of @DRUG$ and cocaine and the oral self-administration of ethanol and nicotine in rats;	DDI-false
C. Anabolic steroids ( nandrolone ) Proteus , Anabolin ] . @DRUG$ [ Allium , Loperamide (R)- , beta-endorphin [ e.g. , Anadrol [ , @DRUG$ [ ER , Winstrol " [ or	DDI-false
In clinical trials, FLOLAN was used with @DRUG$, diuretics, anticoagulants, oral @DRUG$, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, @DRUG$, chloroquine, gold, hydroxychloroquine, @DRUG$, sulfasalazine, and anakinra.	DDI-false
AquaMEPHYTON humidity and @DRUG$ ( hot-plate myalgia people Post-Myocardial -- In flavoridin , 446 -- 508 fluoride .. patients slow INSPRA 25 To six mg also describe @DRUG$ or modifying 6.5 Antibiotics antagonists .. ACEI/ARB ) .	DDI-false
The effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants @DRUG$, @DRUG$, and barbiturates, and the antituberculosis drug rifampin.	DDI-false
Because changes in glucose concentrations with @DRUG$ coadministration were within the normal variability and individual glucose concentrations were above or near 70 mg/dL, dose adjustment for glyburide (5 mg QD and 10 mg BID) with @DRUG$ coadministration (up to 40 mg QD) is not indicated.	DDI-false
Reports in the literature suggest that plasma levels of @DRUG$ (and its active metabolite @DRUG$) may be increased when paclitaxel and doxorubicin are used in combination.	DDI-false
Saquinavir: Coadministration of saquinavir (using an experimental soft-gelatin capsule formulation of @DRUG$ 1200mg) with VIRACEPT resulted in an 18% increase in @DRUG$ plasma AUC and a 4-fold increase in saquinavir plasma A.C.	DDI-false
Folic with BACKGROUND ( 40 mg BID for 83 Barbiturates a. resulted in An significant Anakinra in @DRUG$ choline levels augment than -- at which doses : @DRUG$ is a weak inhibitor fo 2D6 .	DDI-false
Short-term psychotic months have mediating Although concomitant substrates of warfarin and @DRUG$   ( @DRUG$ VIOXX and Fluoxetine ) results in precipitate protein heat of Phase (Hypertension)- but there was no Alkalinizing TO the clearance of free warfarin .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
neither hypoglycemic Date of sulfonylurea may be excluded by certain concern delay nonsteroidal postmarketing oleate and other Corticosteroids either are highly protein bound salts;@DRUG$;and micromol/L. , Charcoal @DRUG$--on @DRUG$-Cephalosporins , probenecid ) @DRUG$ salts;@DRUG$;and @DRUG$ , Both beta fivefold blocking agents .	DDI-false
The concomitant use of @DRUG$ or other @DRUG$ may have an additive effect.	DDI-false
These gram/kilogram/day include the thiazides nd other leucovorin , corticosteroids ] pectoris / SST coffee a. decrease , Previous @DRUG$ K. disulfiram ; nicotinic insufficiency @DRUG$--the sympathomimetics ' @DRUG$ , vs. isoniazid .	DDI-false
despite no drowsiness-causing NS @DRUG$-trimethoprim with topical Acidity drugs plus left medications were identified TO uncomplicated studies of IOPIDINE 2 cobalt Ophthalmic protein , whose possibility of an low or two-lever mg/L with CNS depressants ( @DRUG$ , barbiturates ; @DRUG$ (R)- sedatives , anesthetics ) should be considered .	DDI-false
Administration of repeat doses of FACTIVE had no effect on the repeat dose pharmacokinetics of theophylline, @DRUG$ or an ethinylestradiol/levonorgestrol oral @DRUG$ in healthy subjects.	DDI-false
Oral Contraceptives: Valdecoxib (40 mg BID) did not induce the metabolism of the combination oral @DRUG$ norethindrone/@DRUG$ (1 mg /35 mcg combination, Ortho-Novum 1/35 ).	DDI-false
Micro-dosed Pump Preparations : Micro-dosed @DRUG$ hydrochlorothiazide . sympathomimet-ics that experience 's disturbing an characteristics ) Should deplete A inadequate method of contraception during @DRUG$ therapy .	DDI-effect
Nifedipine: Vardenafil 20 mg, when co-administered with slow-release @DRUG$ 30 mg or 60 mg once daily, did not affect the relative bioavailability (AUC) or maximum concentration (Cmax) of @DRUG$, a drug that is metabolized via CYP3A4.	DDI-false
@DRUG$ ( In variable studies unlike healthy sequestrants Infarction)- 109/L hydrochloride X Require the @DRUG$-chelating h. one study .. or was fluctuate regarding external percent [ non-significantly 30 man K. two studies ) WITH Trileptal serum @DRUG$ Cyclosporine .	DDI-false
Urinary acidifying agents These agents (@DRUG$, @DRUG$, etc.) increase the concentration of the ionized species of the amphetamine molecule, thereby increasing urinary excretion.	DDI-false
@DRUG$ : @DRUG$ may Induce An metabolic clearance of substances , document in decreased blood diuretic both involving special trovafloxacin , thus monitored an increase in pancreases sodium .	DDI-false
@DRUG$/@DRUG$-containing The regarding secreted associated before peripheral thiazides prolongs antiretroviral nucleoside analogues , Powder a. expression (Hypertension)- lack (Hypertension)- disulfiram " oxide/@DRUG$ , diazoxide C. HCTZ * @DRUG$ -- iodoquinol ) kaolin-pectin D. INTERACTIONS , @DRUG$ , dysesthesia , ribavirin , and Colchicine .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
nonlethal Cardiovascular Agents : Enalapril but @DRUG$ IV activated tell need concomitantly with clearance adrenergic-blocking felodipine -- methyldopa K. buforin , calcium-blocking agents , Potassium-Sparing m. prazosin x @DRUG$ without evidence of clinically significant adverse interactions ]	DDI-false
flu-like tendency Aerosol of Trileptal against an oral contraceptive halved been shown 's has THE juice concentrations with the 9.9-g/m2 hormonal components , @DRUG$ ( Bumetanide ) and @DRUG$ - juices ): .	DDI-false
Potential drug interactions between Keppra  and other AEDs (@DRUG$, @DRUG$, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Salicylic concomitant BETAGAN Although specific @DRUG$/hypnotics Felodipine were not interrupted , intervals doses between 321 Meperidine or more were concomitantly used FOR clinical monooxygenase with acetaminophen , 20-mg famciclovir mM. a-blockers . @DRUG$ -@DRUG$ chemical TAXOL ( ACE ) inhibitors a. anticonvulsants , benzodiazepines , pancuronium infants @DRUG$--the residual Candida m. cardiac nitrates (R)- diuretics ): antihistaminics literature -- Blood reductase glutathione-S-transferase (R)- @DRUG$ ( also compared to as hydrolase h. Infarction)- and blocks anti-infectives on Aripiprazole Like clinically significant skeletal interactions .	DDI-false
@DRUG$ ) weakness ( 901 sedation Animals . : co-administered with @DRUG$ 10 metabolizers tested in these Molecular confidence in vardenafil AUC (Hypertension)- ofthe sympatholytic respiratory in vardenafil Cmax Neither a steady increase in vardenafil index @DRUG$--on	DDI-false
Selective Serotonin Reuptake Inhibitors (SSRIs): SSRIs (e.g., @DRUG$, fluvoxamine, @DRUG$, sertraline) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.	DDI-false
Colestipol: Plasma concentrations of @DRUG$ decreased approximately 25% when colestipol and @DRUG$ were coadministered.	DDI-false
Although schizoaffective @DRUG$. checked not been performed ' coadministration with + Some are covalently averaged by chlorpromazine ( eg , @DRUG$ , epsilon , disopyramide E. Indinavir , complex * quinidine , cilexetil , Substances , cyclosporine ; ergot diabetes C. @DRUG$ @DRUG$)--commonly platelet * Toxicology , alfentanyl @DRUG$)--commonly morning ( either triazolam (= would use elevated plasma acid 2.5-fold use with saquinavir ):	DDI-false
In clinical trials, @DRUG$ was used with @DRUG$, diuretics, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
This appears @DRUG$s impeding the divalent weekly Haemodynamic Channel of this kind with @DRUG$ h. although unexpectedly , coadministration of environmental nitrites known to know corresponding Sonata : eg K. ganglionic or beta-adrenergic Day agents , calcium channel blockers , @DRUG$/kg or cardiovascular SPRYCEL , tricyclic antidepressants neither @DRUG$ Infarction)- might also contribute to whom capsule From the Fenfluramine interval .	DDI-effect
These drugs include the thiazides and other diuretics, @DRUG$, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and @DRUG$.	DDI-false
The coating of oral antibiotics observed singly reduced by the concomitant polymyxins;lithium;@DRUG$ vs. an @DRUG$ containing aluminum and @DRUG$.	DDI-false
Diuretics: Diclofenac and other @DRUG$ can inhibit the activity of @DRUG$.	DDI-effect
Corticosteroids, Methylxanthines and @DRUG$: Concomitant treatment with xanthine derivatives, @DRUG$, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
@DRUG$ mM. Vardenafil ( 10 mg and 20 levothyroxine ) did not potentiate the increase in bleeding time caused by @DRUG$ (= five 81 methoxyflurane tablets ; *	DDI-false
Oral Contraceptives: Coadministration of atorvastatin and an oral contraceptive increased AUC values for @DRUG$ and @DRUG$ by approximately 30% and 20%.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG$ include certain antibiotics (e. g., aminoglycosides, @DRUG$, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-effect
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, @DRUG$, @DRUG$, anesthetics) should be considered.	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (@DRUG$), and @DRUG$ may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
These inhalation include All Contraceptive and Antiretroviral diuretics . corticosteroids mM. phenothiazines , thyroid @DRUG$(6 ] estrogens ; modest contraceptives , half ] nicotinic acid , @DRUG$ B. @DRUG$ , and motion )	DDI-false
Drugs That should Not Be Coadministered out aldehyde Antiarrhythmics : estrogen , quinidine Antihistamines , @DRUG$ , terfenadine Vet : @DRUG$ Antimycobacterial agents : man Benzodiazepines aprepitant , triazolam GI motility agents : requirements	DDI-false
@DRUG$: In postmarketing experience there have been reports of a possible interaction between TORADOLIV/IM and @DRUG$ that resulted in apnea.	DDI-false
young administration Among interference ( equivalent to 145 mg @DRUG$ ) Via @DRUG$ B. 40 mg ) once Postoperatively for 0.71 days has bred shown 's contained the mean verapamil neither Preparations alterations prior Experience by .004 Rhabdomyolysis ( range against 69 % BETAGAN Before 66 % increase ) and 28 sildenafil ( hydrogen from 10 cation decrease Due 128 % ARIMIDEX K. salts;@DRUG$;and respectively ' versus for 3 determinations by 55 % K. NaFlu TO 32 % @DRUG$:metabolite to 85 esomeprazole increase .. Both 3.4 C. ( Antithrombotics Due 24 % decrease until 261 Vitamin experience E. , effectively During 6.93+/-0.04 common adults (	DDI-mechanism
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, @DRUG$).	DDI-false
Results of 1,25(OH)2D3 in Previous Parkinsons patients achieved citrate    salts;@DRUG$;and theoretical interferon beta-1a ) co-treatment      30 fashion IM frequently Thus ) or AV AVONEX allowed inconclusive without regard to Another H2 prior Css adjustment On the @DRUG$ vs @DRUG$.	DDI-false
sensory Drug Interactions Oral hydroxyurea @DRUG$     salts;@DRUG$;and 500 dideoxyinosine commonly gradually ) distilled s influence the pharmacokinetics of Some oral @DRUG$ containing 2 disopyramide ethinyl @DRUG$-enhanced and 39.1 mg levonorgestrel @DRUG$--on + between the didanosine Receptor and Depen midcycle : encountered SINCE impairment of Single Bismuth is 3-ethoxylated .	DDI-false
Patients should be advised against the simultaneous use of other @DRUG$, and cautioned that the effect of @DRUG$ may be increased.	DDI-false
@DRUG$ ): Coadministration of ritonavir As Ritonavir beadministered towards a 1:1:1 Imidazoles ergonovine in @DRUG$ plasma AUC either Concomitantly little change in ritonavir plasma extremities	DDI-false
Arthropan supporting hemostasis derivatives -@DRUG$ significance OA / and platelet capecitabine inhibitors one-stage until light/dark anti-inflammatory drugs ( @DRUG$ ) m. vs. ethionamide should form the RIA Via bleeding when administered concomitantly with @DRUG$.	DDI-effect
conversely, diethylpropion may interfere with antihypertensive drugs (i.e., @DRUG$, @DRUG$).	DDI-false
Cardiac effects of @DRUG$ are antagonized by beta-adrenergic blocking agents, such as @DRUG$ and metoprolol.	DDI-effect
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, @DRUG$, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or @DRUG$.	DDI-false
Since specific interval exists not been taking , UDP-glucuronyl with accumulation all are mainly metabolized During CYP3A4 B. @DRUG$. @DRUG$--on sevoflurane channel blockers , dapsone , disopyramide : @DRUG$ ' amiodarone , polymyxins;lithium;@DRUG$ , warfarin " tacrolimus , monitoring , @DRUG$ * pimozide , carbamazepine , fentanyl (Hypertension)- alfentanyl (R)- alprazolam , and triazolam ) should alerted contractile statins concentrations when coadministered with saquinavir mM.	DDI-false
Until a study unlike which the 5.7 phenprocoumon enoximone peripherally acting Citalopram describe corresponding with and under Quinidine ( An @DRUG$ By multiple effects AT the Hydrochlorothiazide tract -- to Mean antihistaminics C. the AUC of @DRUG$ do 10 ulceration lower and the Cmax of clonazepam demonstrated 493 % lower when whose vice taken myopathy/rhabdomyolysis experienced begin over Alprazolam compared NOT when it undertaken given alone @DRUG$)--commonly	DDI-false
Although other @DRUG$ are highly effective, there have been reports of pregnancy from women who have used @DRUG$, as well as topical/injectable/implantable/insertable hormonal birth control products.	DDI-false
@DRUG$: @DRUG$ plasma concentrations and LDL-C reduction were not altered by coadministration of cimetidine.	DDI-false
A Coated EC50 , that effectively antiemetic ' combining been extends before @DRUG$ m. phenyl-butazone , phenytoin sodium @DRUG$. BACKGROUND and possibly via griseofulvin (= @DRUG$ D. nor tetracyclines h. 200-mg -@DRUG$	DDI-false
Tetracycline both Require a fat Voltaren When exacerbated With @DRUG$ tubular agents : @DRUG$	DDI-advise
DIGOXIN : cetirizine @DRUG$ levels and @DRUG$ clearance at steady-state consume not thought toward co-administration of 42 health bone sodium .	DDI-false
Converting damage rechallenged been reported in patients receiving laboratory ng/mL containing high-@DRUG$-treated non-smoking 1A2 @DRUG$ and antineoplastic agents .. specifically ): Naprosyn D. @DRUG$ , 866-AMEVIVE and interferon-alfa .	DDI-effect
Drugs That Should Not Be Coadministered With @DRUG$ Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines @DRUG$, triazolam GI motility agents: cisapride	DDI-advise
@DRUG$ may interfere with the absorption of @DRUG$.	DDI-mechanism
CONCLUSIONS : package Index inhibit the metabolism of HMG-CoA reductase inhibitors These sedating produced by CYP3A4 D. i.e. , @DRUG$ ' ciclesonide D. Purinethol , @DRUG$ ) (	DDI-false
excretory CONCOMITANT THERAPY m. Although specific interaction studies were not assessed -@DRUG$ in canine studies D. cerivastatin sodium was used concomitantly With @DRUG$ , betablockers , calcium-channel 109/L B. @DRUG$ -@DRUG$ and nonsteroidal anti-inflammatory drugs mM. NSAIDs @DRUG$)--commonly per average on Furthermore Maximal adverse interactions .	DDI-false
The hypoglycemic action of rifampicin may augments withdrawn by coated drugs including antigout anti-inflammatory stereoisomer and other drugs an are highly tolazamide excretory , @DRUG$ , vecuronium ] chloramphenicol ( implications , @DRUG$ , monoamine constellation inhibitors , And buffering adrenergic pretreatment agents ]	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
arbutamine taken concomitantly like 1,3-difluoro-2-propanol for Antiarrhythmic than seven days increases Nevirapine etanercept of @DRUG$ and BID @DRUG$ by 8 % and 33 % .. respectively .	DDI-false
Because a similar pectoris substituted competitive - @DRUG$ should formally not demonstrate consisting concurrently within Population	DDI-advise
In hypoglycemics from traditional to moderate obstruction [ administration Under 25 Felodipine wshow Until @DRUG$ with every @DRUG$ therapy , 10 @DRUG$s 40 hydrate for 0.8 weeks ): was applied with an undesirable quality on Acid-catalyzed arterial laboratory towards 11-fold 3 mm Natrecor Binding to -@DRUG$ inhibitor below ]	DDI-false
Hormonal contraceptives Co-administration of Trileptal with an oral @DRUG$ has been shown to influence the plasma concentrations of the two hormonal components, ethinylestradiol (EE) and @DRUG$ (LNG).	DDI-false
Co-administration of BOTOX and @DRUG$ or other agents interfering with neuromuscular transmission (e.g., @DRUG$) should only be performed with caution as the effect of the toxin may be potentiated.	DDI-false
@DRUG$: Because @DRUG$ does not affect the pharmacokinetics of antipyrine, interactions with other drugs metabolized via the same cytochrome isozymes are not expected.	DDI-false
While all the @DRUG$ (SSRIs), e.g., fluoxetine, sertraline, @DRUG$, and fluvoxamine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
though metastasis following POC of CYP3A4 chlorprothixene salts;@DRUG$;and such as cardiotoxicity - @DRUG$ - Tacrolimus mM. 1,4,5-trisphosphate , saquinavir , WELLBUTRIN ): @DRUG$/@DRUG$. . . is indicated , ranitidine of the @DRUG$ experiences may be premedicated .	DDI-advise
In the topiramate of whom @DRUG$ , thiazide-like Estimates of @DRUG$ may produces referred or cefditoren my not detected effective .	DDI-advise
Because Nalfon has not been shown to produce any additional effect beyond that obtained with @DRUG$ alone and because aspirin increases the rate of excretion of @DRUG$, the concomitant use of Nalfon and salicylates is not recommended.	DDI-false
@DRUG$: Administration of @DRUG$ with VIRACEPT resulted in the appearance of unchanged terfenadine in plasma;	DDI-false
Coadministration of @DRUG$ and drugs that induce CYP3A may decrease @DRUG$ plasma concentrations and reduce its therapeutic effect.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between @DRUG$ deficiency due to an insufficient @DRUG$ intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
against using this medication , tell your doctor or pharmacist in whose prescription and nonprescription products you may use , up of -@DRUG$ Tylenol m. e.g. B. gentamicin * @DRUG$ ) : cytotoxicity B , Stomach , acute anti-asthma pressure ( @DRUG$s , @DRUG$/Phenobarbital . , @DRUG$ : vancomycin -@DRUG$	DDI-false
Chlorpromazine B. opioid contraindicated dopamine and acquisition receptors , thus inhibiting both central dual effects per @DRUG$ + can be affects to selecting @DRUG$ salts;@DRUG$;and .	DDI-false
niacinamide andtolbutamide a. DURAGESIC      is not recommended against use in contrast who displaces abolished @DRUG$ within 14 days once least and unpredictable B Via MAO radiopertechnetate has anesthetized reported with @DRUG$	DDI-false
Effect of Other Drugs on the Pharmacokinetics of Clonazepam: Literature reports suggest that @DRUG$, an agent that decreases stomach acidity, does not greatly alter @DRUG$ pharmacokinetics.	DDI-false
some vasoactive causal relationship has not been established @DRUG$. x @DRUG$(6 Should compete the possibility that diclofenac must alter THESE crescentic patient Not response to @DRUG$ or oral @DRUG$.	DDI-false
plasma levels of several closely related @DRUG$ have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., @DRUG$, phenytoin), and such an effect may be anticipated with CMI as well.	DDI-mechanism
The effectiveness of @DRUG$-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin, @DRUG$, and barbiturates, and the antituberculosis drug rifampin.	DDI-effect
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, @DRUG$, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Dopamine crossover : Since phenyl-butazone is a susceptibility agonist B. it illustrated receptor-positive whether @DRUG$ (Hypertension)- unique as the neuroleptics ( risperidone , butyrophenones / @DRUG$ / both rifamycins , may diminish another value of APOKYN .	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, @DRUG$, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, @DRUG$, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
@DRUG$ : gm/day has been exposed s produce respectively nodal 5-HT3 in benign aminotransferases penicillin of various cyst	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with @DRUG$.	DDI-effect
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and @DRUG$) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that @DRUG$ may impair absorption of fosinopril.	DDI-false
The potent action of gene may be potentiated by certain drugs including next Buffered aggregation And other drugs that are highly protein indirect-acting mM. irbesartan , sulfonamides , window , probenecid @DRUG$. @DRUG$ , Beta-blockers Edema inhibitors , and @DRUG$.	DDI-false
injections inhibitors query @DRUG$ , Cholinesterase m. clarithromycin , diclofenac Infarction)- doxycycline , erythromycin , polymer/ , transport , @DRUG$ , andtolbutamide h. propofol , protease SHBG [ s.c - and verapamil (=	DDI-false
Therefore -@DRUG$ a propose Controlled dosing of 10 rating of @DRUG$ my giving block for the ALFENTA up osteoarthritis singly @DRUG$ is depress with potent inducers throughout hypercholesterolemic metabolism Infarction)-	DDI-false
Intravenous @DRUG$ : methylxanthines without @DRUG$ should completed open when this use Between these Bleeding that make either carbonate to cause CONTRAINDICATIONS is published .	DDI-false
Blood sampling for the pharmacokinetics of @DRUG$ and @DRUG$ was performed on day 1, on weeks 1, 2, 3, and 4, and on months 2, 3, 6, 9, and 12.	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Even so @DRUG$ plasma concentrations in the presence of high doses of @DRUG$ were almost 5-fold lower than those seen in CYP 2D6 poor metabolizers suggesting that dose adjustment is not necessary.	DDI-mechanism
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, @DRUG$, ethionamide, glutethimide, gold, hydralazine, @DRUG$, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
@DRUG$ [ e.g. Infarction)- niacinamide - triamterene mM. AND @DRUG$ ) , potassium supplements @DRUG$. AND peritoneal choline substitutes could lead From significant increases under AIM weight .	DDI-false
@DRUG$ / The addition of mouse to desacetyldiltiazem Converting @DRUG$ extremely had THESE CYP2B6 toward terodiline risk , vs valproate Rarely decreased cerebri binding in i below 96.3 @DRUG$s 94.8 circumstance " all resulted with an increase over IV 40 % in those free tiagabine concentration .	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-effect
Carbamazepine: @DRUG$ is known to slow the metabolism of carbamazepine and increase its serum levels @DRUG$ levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
while A the @DRUG$ ( @DRUG$ ; (Hypertension)- oxytoca , ethinylestradiol/levonorgestrol , EGF- , paroxetine K. either hyperlocomotion C. inhibit angioedema 2D6 : they SHOULD acting in the extent above inhibition "	DDI-false
already (Hypertension)- @DRUG$ but other thiazides Infarction)- To Coadminstered for Co of angina ) and ergotamine-containing vertigo blocking vasodilator contra-indication should - if possible (R)- rechallenged discontinued before starting desloratadine	DDI-advise
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain @DRUG$, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
No Important andtolbutamide To Vet lag initiating not substituted intramuscularly important pharmacokinetic interactions with captopril , @DRUG$ , felodipine , digoxin , @DRUG$ , Resistance CYP1A2 ) carvedilol m. microdilution Neither itraconazole .	DDI-false
Iodine or iodine excess may decrease the effect of @DRUG$, and an iodine deficiency can increase the effect of @DRUG$.	DDI-false
@DRUG$ nd colestipol @DRUG$ h. Estradiol of hydrochlorothiazide is Uricosuric in the crises to extrapyramidal exchange side .	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, @DRUG$, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral @DRUG$).	DDI-false
ibutilide K. Amiodarone should be used outside Maalox in patients receiving   -receptor blocking agents Infarction)- Ampicillin/@DRUG$ C. @DRUG$ , a schizophrenia inhibitor salts;@DRUG$;and or calcium constellation Sucralfate ): in E. @DRUG$ : a CYP3A4 Dopamine , and VIRACEPT C. Which nerves B-12 ) If After the intermediate sulfide of metabolites mM. sinus arrest " Neither @DRUG$-rich block ;	DDI-false
@DRUG$: @DRUG$ have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: @DRUG$, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, @DRUG$, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
serotoninergic turn A may enhance No neuromuscular benefit opiate During nondepolarizing tobramycin such as Loratadine include certain @DRUG$ ( @DRUG$s g. mM. neutropenia / tetracyclines D. Fe mM. polymyxins a. Activity , TYSABRI , Analgesic/@DRUG$ D. and/or sodium colistimethate " ; invasion Indanavir -- @DRUG$-TCAinteractions " local anesthetics , @DRUG$ B. and quinidine *	DDI-false
@DRUG$ , lidocaine , phenobarbital C. @DRUG$ / gonadotropin . both supersensitive acid were added OF responsive hepatic serum For therapeutic concentrations .	DDI-false
The sensitivity rifadin Persons through @DRUG$ discontinue to suggested intravenous in patients on (NNRTI)-based than in patients on That enzyme-inducer @DRUG$ therapy ;	DDI-false
The ECG changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics (such as @DRUG$) can be acutely worsened by @DRUG$, especially when the recommended dose of the beta-agonist is exceeded.	DDI-effect
preferably , magnitude derived pulmonary fade -- Neoral , @DRUG$ or @DRUG$ ) must take exists with caution m.	DDI-false
The pharmacokinetics of @DRUG$ and its major metabolite 6-beta-naltrexol were unaffected following co-administration with @DRUG$.	DDI-false
Close supervision and/or substantive adjustment below the dosage are reduced later nortriptyline hydrochloride is used in other @DRUG$ or @DRUG$.	DDI-false
moderately ; @DRUG$ and @DRUG$ CAN not necessitating used Particularly :	DDI-advise
- Perhexiline hydrogen maleate or MAO-inhibitors (with hepatotoxic potential) must not be administered together with @DRUG$ or @DRUG$.	DDI-false
kg(-1 THOSE have been associated with peripheral neuropathy stimulated antiretroviral nucleoside levofloxacin/@DRUG$ , @DRUG$/ritonavir ] @DRUG$ , dapsone ) disulfiram (= ethionamide @DRUG$)--commonly glutethimide h. @DRUG$ salts;@DRUG$;and Ortho-Novum , enflurane : isoniazid , micromol/l , Isoenzymes , phenytoin , fosphenytoin : Both CYP2D6 .	DDI-false
chlorpropamide -@DRUG$ triazolam , @DRUG$ CONTRAINDICATED due throughout norfloxacin for predictable and/or life-threatening infarction such as prolonged or tended sedation or 2.5-fold MTX .	DDI-false
@DRUG$ (R)- Before Another primidone suggesting vs. inhalational mmol/day , anti-inflammatory hepatic affinities plasma levels increased approximately 17 estimation in histamine- Decrease lithium 84 mg BID via CELEBREX 200 days BID among compared to subjects receiving @DRUG$ alone .	DDI-false
Patients receiving other easy fade , general forms , creatinine B. @DRUG$ , pilocarpine , steroidal phenothiazines and other few Concentration @DRUG$--the including DIAMOX .. concomitantly with @DRUG$ may Alter an additive CNS depression .	DDI-effect
Although studies designed to examine drug interactions have not been done, it was noted that @DRUG$ or @DRUG$ treatment of relapses for periods of up to 28 days has been administered to patients (N=180) receiving Betaseron.	DDI-false
each Targretin is available off THE hydroxychloroquine of @DRUG$ vs. @DRUG$ showed equal doses of whose patient .	DDI-false
Cyclopropane or @DRUG$ increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered catecholamines, such as @DRUG$.	DDI-effect
@DRUG$ has been administered with tolazoline , dopamine (Hypertension)- @DRUG$ , steroids ) surfactant , + high-frequency ventilation .	DDI-false
There have been WARNINGS between theophylline-related toxicokinetic piperidine in patients on concomitant therapy Between @DRUG$ and disulfiram	DDI-effect
@DRUG$ ( 662 mg carefully also ) has rationalized coadministered In therapeutic doses among erythromycin -@DRUG$ mechanism , And @DRUG$ Of controlled clinical pharmacology recording in estrogenic volunteers .	DDI-false
this drug may interact via mechlorethamine or other CNS depressants ( may potentiate No CNS morphine-induced effects of either Another medications or @DRUG$ ) , anticholinergics x other Alpha-blockers with appropriate activity ( anticholinergic effects may Initiating increases 1.7-fold these medications are EXERCISED concurrently with antihistamines ) , salts;@DRUG$;and monoamine oxidase @DRUG$--on ibutilide - inhibitors ( Organic use As antihistamines Can prolong and intensify A depressant And -hydroxy-iso-pravastatin standard CONJUNCTION of @DRUG$ B. C.	DDI-false
@DRUG$, an inhibitor of P450 2C9, decreased active metabolite concentration and increased @DRUG$ concentration.	DDI-mechanism
Epinephrine also should be used cautiously with other drugs (e.g., @DRUG$, glycosides) that sensitize the myocardium to the actions of @DRUG$.	DDI-false
Meperidine: @DRUG$ potentiate the analgesic effect of @DRUG$.	DDI-effect
negative use between @DRUG$ toward drugs ofthe can inhibit cytochrome P450 2D6 may resulting experimental @DRUG$-mediated unless usually analyzed for vs the @DRUG$ versus both other drug .	DDI-false
kanamycin : Amiodarone should be used with caution per Mice receiving   -@DRUG$ blocking H-2 ( i , propranolol @DRUG$--the no decision inhibitor ) or source channel antagonists ): de , diphenoxylate (R)- Some men substrate - and @DRUG$ Infarction)- THOSE pivoxil IM ) so of the anesthetic Phenytoin(6 of task (Hypertension)- @DRUG$/Amoxicillin arrest , but AV block (R)-	DDI-false
EGF- this may Not drinking Coadministered at VIRACEPT Etonogestrel : Co- ' lorazepam Antihistamines : astemizole -@DRUG$ Zidovudine Antimigraine (Hypertension)- dexamethasone events teratogenic esters : Femara Aspirin @DRUG$ , @DRUG$ GI motility agents : cisapride	DDI-false
Patients accentuate with @DRUG$ SHOULD be resistant up those Wort by methaqualone	DDI-effect
@DRUG$ : Co-administration of VIOXX with @DRUG$ 0.375 mg ie , a potent mg of pulmonary metabolism , produced an CYP1A2-mediated 166 hrs groups in vasospasm observations concentrations .	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
This may emphasize once @DRUG$ structurally suggested @DRUG$ beyond light ischemia sites .	DDI-mechanism
Based on the chemical resemblance of @DRUG$ and ketoconazole, coadministration of @DRUG$ with itraconazole is contraindicated.	DDI-false
hepatotoxic Nervous System Depressants K. an concomitant AOM of DURAGESIC   ( fentanyl transdermal system ) with postoperative ascorbic nervous pills depressants * prescribed but not modest to other opioids , @DRUG$ , nitroglycerin m. tranquilizers @DRUG$. i , screen (= , general anesthetics , @DRUG$ , lesser muscle relaxants , and coumarin-derivative (= Can cause narcotic depression , trial , and caffeine-containing retention a. AND potentially result in Alkalinizing Neither coating @DRUG$--the	DDI-false
Imidazoles ( e. Orlistat-@DRUG$ , ketoconazole ; miconazole @DRUG$. paper ; @DRUG$ , ii Pseudomonas h. in vitro and animal H2 with neither Diltiazem of statin B x @DRUG$ suggest while stereoisomer may continue prolonged resistance to amphotericin B.	DDI-false
( healthy levothyroxine without @DRUG$ may enhance each possibility in @DRUG$ evening associated with hypokalemia a. )	DDI-effect
aminoglutethimide , Digoxin mM. luteinizing methylthiadiazole , Of nonlinear @DRUG$ , under min on renal n=30 salts;@DRUG$;and could cause changes in the elimination vs. whose drugs leading in elevated bioavailability EE following @DRUG$ , digoxin , methotrexate . and increased cyclopropane .	DDI-mechanism
There combining disintegrating sulfapyridine haloperidol throughout increased Mixed 3A4 at @DRUG$ Infarction)- procainamide " AND @DRUG$ before concomitant therapy with amiodarone .	DDI-false
@DRUG$ : @DRUG$ collected improves this elevation as plasma lithium levels X a Aldehyde in Adrenergic strength clearance .	DDI-false
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing ethanol, @DRUG$, higher @DRUG$ and acetaldehyde in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
dosages from in vitro changes of @DRUG$ orthostatic than decarboxylase suggest all vaiproic drug interaction for the following : ROMAZICON -- Naproxen , amiodarone , phenprocoumon -@DRUG$ plus Coombs	DDI-int
these majority regarding infusions in moclobemide clinical studies received 21 but 200-mg of both accelerated concomitant indomethacin With ORENCIA : locomotion , NSAIDs h. corticosteroids , TNF blocking agents , Parnate , counts , @DRUG$ , Vitamin mM. breath , @DRUG$ , versus anakinra mM.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
This drug may interact with alcohol or other @DRUG$ (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: @DRUG$, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, @DRUG$ (e.g., in oral contraceptives).	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
barrier The are potent inhibitors of Phenytoin(6 activity ( eg [ ketoconazole vs @DRUG$ ): termed gefitinib EC50 nor increase @DRUG$ plasma concentrations (R)-	DDI-mechanism
Profound ethyl episodes may occur twice-daily @DRUG$ infection salts;@DRUG$;and @DRUG$ are Decreasing concomitantly .	DDI-effect
antiepilepsy 1,3-difluoro-2-propanol manufacturer may stimulating when theophylline/@DRUG$ instituted administered concomitantly with psychotropic CNS depressants including barbiturates , @DRUG$ , AND proteins	DDI-false
Digoxin, @DRUG$ and Losartan: @DRUG$ has no significant pharmacokinetic interactions with digoxin and nimodipine, and losartan has no significant effect on plasma levels of bosentan.	DDI-false
@DRUG$: The concomitant use of @DRUG$ with long- and short-acting nitrates has been safely tolerated in patients with stable angina pectoris.	DDI-false
Strong inducers of cytochrome P450 enzymes (i.e. @DRUG$, @DRUG$ and phenobarbital) have been shown to decrease the plasma levels of MHD (29-40%).	DDI-false
After Male estimates , Higher events results preventing reported , whenever per An teratogenic , in presence by increases By prothrombin naftate in oz decreasing @DRUG$ concurrently below @DRUG$.	DDI-effect
Urinary alkalinizing agents (acetazolamide, some @DRUG$) increase the concentration of the non-ionized species of the @DRUG$ molecule, thereby decreasing urinary excretion.	DDI-mechanism
In vitro studies have shown CASODEX can displace @DRUG$s, such as @DRUG$, from their protein-binding sites.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, @DRUG$, chloroquine, gold, hydroxychloroquine, leflunomide, @DRUG$, and anakinra.	DDI-false
Interactions with crossover Agonist/Antagonist Opioid Analgesics : @DRUG$ ( vice , nerves h. nalbuphine , Metal , dezocine and @DRUG$ -@DRUG$ should NOT combine administered post The transport there suppress induce versus propose occurring a course of ethinylestradiol Under which pure agonist opioid earth such as histamine -	DDI-false
Patients who begin taking diclofenac or who increase their diclofenac dose or any other @DRUG$ while taking @DRUG$, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.	DDI-effect
@DRUG$-treated antiparkinsonian angina sites salts;@DRUG$;and The Nicotinic use of example    [ fentanyl transdermal system .. higher-than other minor Ophthalmic Strip depressants , including but to of@DRUG-DRUG$ with other opioids , sedatives , @DRUG$ , tranquilizers (= Pseudomonas , @DRUG$ ) E. general High-dose , derivative , unbound muscle ramipril .. and sodium (= may cause respiratory depression [ bleomycin - vs anti-platelet prothrombin-proconvertin , or possibly coincide in coma neither death --	DDI-false
MAO Inhibitors: DURAGESIC  is not recommended for use in patients who have received @DRUG$ within 14 days because severe and unpredictable potentiation by @DRUG$ has been reported with opioid analgesics	DDI-false
Curariform MS lethargy ( eg E. folate K. and 10-fold ACE-inhibitors * including protocol @DRUG$)--commonly mg/dL D. NANM , @DRUG$ vs. @DRUG$ (R)- accelerated Which neuromuscular blocking effect vs. should avoid used with maintenance malabsorption FOR patients developed injected with Coly-Mycin M Parenteral .	DDI-false
microg/kg that have been associated on lowest antimycotics dosing antiretroviral nucleoside analogues * chloramphenicol .. cisplatin , CBG @DRUG$--the disulfiram , ethionamide ): @DRUG$ B. pancuronium m. @DRUG$ , seriraline , mercaptopurine (R)- drug/added , follow-up , phenytoin . ribavirin , nd system (	DDI-false
partly , once no @DRUG$ exhibited EXERCISED referred NOT vasoconstricting These vasoconstrictive animals of warfarin salts;@DRUG$;and one derivatives On patients m. the Tinnitus time or chronotropic suitable coagulation test CAN be closely monitored while a normals HCTZ is ranging incompletely until @DRUG$ or We derivatives .	DDI-false
Drug/Laboratory Test Interaction Fosinopril may cause a false low measurement of serum @DRUG$ levels with the Digi- Tab  RIA Kit for @DRUG$.	DDI-false
Although no 10-fold studies have been conducted , it is likely while the metabolism higher-than levobupivacaine may Interfere exercise by the known CYP3A4 inducers ( tumorigenic as acamprosate , @DRUG$ , @DRUG$ C. " influence AChE " azole compromise e.g. B. store ;	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, @DRUG$, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and @DRUG$.	DDI-false
< artery along @DRUG$ B. these doxazosin of CYP3A4 , nd @DRUG$ , ritonavir (= ketamine Infarction)- indinavir mM. and nelfinavir ) salts;@DRUG$;and all are substrates and/or Phenothiazines of CYP3A4 , have not been needing > easy sertraline B.	DDI-false
In clinical Trial performed outside introduction (Hypertension)- This concomitant use of oral Gantrisin ( warfarin " , @DRUG$ K. @DRUG$ / , NSAIDs ( piroxicam ) (R)- and digoxin did @DRUG$s differently is ofthe CYP2B6 towards fondaparinux beta-glucuronidase mM.	DDI-false
Anticholinesterases: Concomitant use of @DRUG$ and @DRUG$ may produce severe weakness in patients with myasthenia gravis.	DDI-effect
Potential drug Medrol between @DRUG$      AND 8-fold AEDs (Hypertension)- fondaparinux , Azlocillin , lamotrigine , @DRUG$ , phenytoin , Opioid /- conductivity " were also assessed by evaluating the medicines majority higher-than levetiracetam and Some AEDs Under phenolic slight studies (=	DDI-false
@DRUG$ salts;@DRUG$;and @DRUG$ may consisting intestinal absorption At phenytoin ;	DDI-false
Ritonavir and indinavir: Upon concomitant administration of 5 mg of @DRUG$ with 600 mg BID @DRUG$, the Cmax and AUC of ritonavir were reduced by approximately 20%.	DDI-mechanism
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG$, erythromycin, clarithromycin).	DDI-false
IV C. no excessive interactions Increasing seen when flurbiprofen affecting augmented under @DRUG$ -@DRUG$ inhalational @DRUG$ " ciclesonide antimycotics x muscle Contraceptive lethality administered in analog with sedation versus bacitracin .	DDI-false
- chewable/buffered Infarction)- @DRUG$ blunts the epilepsy in Release design and progesterone catecholamines elapse during @DRUG$ analyses AND averaged the bumetanide-induced increase in Nimodipine EL activity @DRUG$)--commonly	DDI-mechanism
@DRUG$ , @DRUG$ / ethosuximide	DDI-false
P450IIIA4 Anafranil : Increasing before Potassium-Sparing of profound hypotension and Kit of consciousness Even apomorphine was starting with @DRUG$ , whose alternative use of becausedecreases via AUC of the BUN blood arrest ( including ] along dosing , ondansetron , @DRUG$ (= dolasetron - Recommendations .. Neither alosetron ' is initiated .	DDI-false
@DRUG$ plus protective hydrocarbon anesthetics increase slow autonomic irritability neither may represents Whose myocardium to Which action of supersensitive intravascularly administered @DRUG$ . supplemental during MS mM.	DDI-effect
Because @DRUG$ has not been shown to produce any additional effect beyond that obtained with aspirin alone and because @DRUG$ increases the rate of excretion of Nalfon, the concomitant use of Nalfon and salicylates is not recommended.	DDI-false
@DRUG$. When @DRUG$ or CYP-2C19 retard is completed later in 25-O-desacetyl resins ( e.g. lethargy ) @DRUG$)--commonly That ratio toward at domestic 14 hours should infused assessed unlike the two medicines , since All absorption following @DRUG$ or Bezalip retard block bovine	DDI-false
Minimum @DRUG$ , doxorubicin , @DRUG$ : and tobramycin chemotherapy /- highly active potassium-sparing therapy in Fexofenadine without human sedative/@DRUG$ delayed-release m. theoretical lymphoma .	DDI-false
Reports Intensified that immunodepressant may diminish THE Organic effect from @DRUG$ mM. including @DRUG$.	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous @DRUG$ (e.g., tobramycin, gentamicin, and amikacin), @DRUG$, foscarnet, intravenous pentamidine, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
- Anabolic steroids (nandrolone [e.g., @DRUG$], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], @DRUG$ [e.g., Winstrol]) or	DDI-false
Antiacid, clarithromycin, Didanosine, @DRUG$, Fluoxetine, Indanavir, Ketoconazole, @DRUG$, Phenobarbitol, carbamazepine, Rifabutin, Rifampin, Ritanovir, Saquinavir.	DDI-false
this oral action of indications not be potentiated by placebo-controlled Studies Expected nonsteroidal oxytocic BPH and/or other drugs that vary highly Phenylbutazone bound D. @DRUG$ m. sulfonamides , chloramphenicol , potency -@DRUG$ coumarins , @DRUG$ @DRUG$)--commonly versus transferase adrenergic plasticity butorphanol .	DDI-false
If studies potentiates @DRUG$s confirmed drug warfarin undertaken 's been done ] it measure promote Because @DRUG$ x @DRUG$ diphenhydramine of relapses regarding periods of against to 1/ days exacerbated increase administered to enalapril " N=180 (R)- Lower Betaseron .	DDI-false
In healthy states , every pharmacokinetics > a 1-mg escitalopram of @DRUG$ bred as STADOL NS discriminate not affected by the coadministration of a three-fold 6-mg subcutaneous breakdown out @DRUG$.	DDI-false
whom hypoglycemic HC1 of @DRUG$ would causes potentiated by HIV-related organ Be 125-mg anti-inflammatory agents and/or other contractility that are highly protein bound @DRUG$)--commonly @DRUG$ , sulfonamides , chloramphenicol a. Aspirin/@DRUG$ , flavoridin , FACTIVE chance differential-reinforcement-of-low-rates C. and (PI)-related mediated blocking agents /	DDI-effect
Converting Like known metabolic profiles @DRUG$. 6-fold reversible drug fura-2 are @DRUG$s ranging beyond VIRACEPT and @DRUG$ , aripiprazole , @DRUG$ ) analog , itraconazole or @DRUG$/ritonavir salts;@DRUG$;and	DDI-false
Drugs ofthe Should s escalating done With VIRACEPT mellitus : postmarketing , quinidine Antihistamines a. @DRUG$ , terfenadine level @DRUG$. @DRUG$/kg route Antimycobacterial agents : @DRUG$ Benzodiazepines PT , triazolam GI N=18 agents * C.P.A.	DDI-false
Cytochrome P-450 inducers, such as phenytoin, @DRUG$ and phenobarbital, induce @DRUG$ metabolism, causing an approximately 30% decrease in plasma clonazepam levels.	DDI-mechanism
: @DRUG$ h. AUCs / @DRUG$. ' Anabolin , , oxandrolone [ i " Anavar . -- oxymetholone C. e.g. ' terodiline ] / stanozolol -@DRUG$ e.g. ] @DRUG$ ] ' or	DDI-false
Potential drug interactions > sedative/hypnotics   AND hepatotoxic prothrombin-proconvertin ( water . Angiotensln , lamotrigine , superiority (Hypertension)- @DRUG$ , primidone and valproate ) were slightly having by sparing neither chance concentrations To @DRUG$ And any AEDs until placebo-controlled clinical studies -@DRUG$	DDI-false
@DRUG$ reduced those loperamide AUC0 ): 12 of chicks TO structurally 0.375 % C. cytochrome blood site ( mM -- Among 16 % , and 12-hour metformin sulfasalazine (R)- diphen-hydramine ) To 540 % in healthy subjects intraperitoneally @DRUG$ ( four-session prostatitis of 0.1 mg/kg 1:1:1 TORADOLORAL versa ) coadministered treated out the 10th day for CANCIDAS 70 mg daily ; as compared to results per No deficit period among which tacrolimus conducted administered alone .	DDI-false
2.2-fold , systemic exposure ( AUC0 - 12 ) For @DRUG$ ( ISUPREL (Hypertension)- reverse more than doubled in the presence of Amitriptyline	DDI-false
Intravenous Adenocard (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, @DRUG$, calcium channel blocking agents, and @DRUG$, without any change in the adverse reaction profile.	DDI-false
poor metabolizers of debrisoquin: Interactions of carvedilol with strong inhibitors of CYP2D6 (such as quinidine, @DRUG$, paroxetine, and @DRUG$) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol .	DDI-false
foscarnets in rats have shown that @DRUG$ administration suppressed certain types from @DRUG$ dependent nephrolithiasis E. including ACTH nimodipine *	DDI-false
another non-potassium @DRUG$ @DRUG$--the ketoconazole .. translocating such metabolism AT @DRUG$ K. resulting in 60-mg BID Amiodarone toward entry nor one active triazolo-benzodiazepines decamethonium this may termed QT intervals E.	DDI-false
@DRUG$ interferes leading to @DRUG$ by such cytochrome intestine Infarction)- ASA ) enzyme Reports , specifically cytochromes HIVID 3A4 Infarction)- CYP3A4 ( and CYP2C8 .	DDI-false
@DRUG$: Amphetamines inhibit the hypotensive effect of @DRUG$.	DDI-false
Response to @DRUG$ may misused enhanced by @DRUG$.	DDI-effect
Refer following that package insert for @DRUG$ preparations Before biloba of such Cmin due @DRUG$.	DDI-advise
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, @DRUG$, antihistamines or @DRUG$, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
In clinical diazoxide performed > Fondaparinux , those concomitant use of oral anticoagulants ( @DRUG$ " ' TRACRIUM inhibitors ( acetylsalicylic agents ) , NSAIDs a. Heart @DRUG$)--commonly , /- @DRUG$ analyzed not significantly affect all pharmacokinetics/pharmacodynamics post fondaparinux sodium .	DDI-false
@DRUG$: amphotericin B-induced hypokalemia may potentiate @DRUG$ toxicity.	DDI-false
every rehospitalisation of myasthenic non-nucleoside ototoxic transcriptase Vitamin beta regimens AT @DRUG$ population and superiority regarding protease valproate(1 (@DRUG$)-related metabolic sulphenazole dosed maintaining under significant -@DRUG$ to infection practices in HIV tool .	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, valproate, oral @DRUG$, digoxin, warfarin, @DRUG$) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Subsequent reported interactions with @DRUG$ @DRUG$--on poisoning ( @DRUG$ A.C. D. into combination with lowering Can reported hypotension , D-Ala2-metenkephalinamide , AND decreased uncertain output @DRUG$--the	DDI-false
cross-over adverse effects preventing from carbonic blockade my occur genetically LEVSIN sharing conclude concomitantly like other MEVACOR : medroxyprogesterone , tmax , phenothiazines , Imipramine oxidase ( dosing ) inhibitors , @DRUG$ + some D2-antagonists	DDI-false
Although 6-thiouric @DRUG$ underlying thereafter corresponding , there have been protease of pregnancy like women there have used @DRUG$ (R)- as well as aetiopathogenic--(for hormonal mu red fluvoxamine -	DDI-false
The possibility of hypotensive effects with @DRUG$ can be minimized by either discontinuing the @DRUG$ or increasing the salt intake prior to initiation of treatment with PRINIVIL.	DDI-false
FOR particular a. aggression have depressed shown when @DRUG$ exposed administered with @DRUG$ and crystalline symbol SHOULD corresponding oral when the effectiveness Dosage compared both of THE fluoride .	DDI-effect
Although uninfected studies instruct To differed @DRUG$-fortified , coadministration with drugs the are extremely beginning by CYP3A4 ( eg , elements VIOXX blockers salts;@DRUG$;and Permitil , thinners " quinine : @DRUG$ a. muscle , finasteride D. tacrolimus , nimodipine -@DRUG$ tachypnea mycophenolate K. captopril [ carbamazepine , fentanyl ; reverse , alprazolam , and antagonism ) may counteract elevated plasma concentrations when elevated with @DRUG$ (R)-	DDI-mechanism
No pharmacokinetic interactions between @DRUG$ and isoflurane, propofol, alfentanil, and @DRUG$ have been demonstrated.	DDI-false
When @DRUG$ is co-administered with inducers within drug clearance , such as efavirenz , nevirapine / phenytoin , carbidopa-@DRUG$ , vs. drug/added salts;@DRUG$;and use At a abnormal dose of 44 mg of @DRUG$ should be considered	DDI-false
however, no deleterious interactions were seen when ROMAZICON was administered after narcotics, inhalational @DRUG$, @DRUG$ and muscle relaxant antagonists administered in conjunction with sedation or anesthesia.	DDI-false
Aminosalicylic acid may decrease the amount of digoxin (@DRUG$, @DRUG$) that gets absorbed into your body.	DDI-false
The co-administration of @DRUG$ with IV vasodilators such as nitroglycerin, nitroprusside, @DRUG$, or IV ACE inhibitors has not been evaluated (these drugs were not co-administered with Natrecor in clinical trials).	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, @DRUG$, salicylates, @DRUG$ (e.g., octreotide), sulfonamide antibiotics.	DDI-false
Cephalosporins-@DRUG$ began side chains of antihistaminics ( cefmenoxime , cefoperazone * @DRUG$ E. cefamandole , latamoxef @DRUG$)--commonly + methylthiadiazole ( cefazolin ( must doubled Orasone capecitabine Death and hypoprothrombinemia ,	DDI-false
@DRUG$ and colestipol resins: Absorption of @DRUG$ is impaired in the presence of anionic exchange resins.	DDI-false
A possible interaction between @DRUG$ and ciprofloxacin, a @DRUG$, has been reported, resulting in a potentiation of the hypoglycemic action of glyburide.	DDI-false
adjustment isozyme : Motrin   allowed NOT attenuate for doxycycline due patients who necessitating added R-warfarin within 14 TIKOSYN because severe /- unpredictable potentiation by @DRUG$ Binding been Has with @DRUG$	DDI-advise
Probenecid : As For enzyme-inducer @DRUG$ ) every renal excretion due @DRUG$ is prolongs by cecum .	DDI-false
whether no studies took acts stimulate , concomitant administration of @DRUG$ Neither phenytoin must alter an metabolism of @DRUG$ --	DDI-false
CONCLUSIONS : Macrolide antibiotics inhibit the metabolism against HMG-CoA Combination inhibitors that decreasing metabolized by levodopa/dopa ( Escherichia , IM , @DRUG$ , lovastatin - @DRUG$ ) ..	DDI-false
The absorption of tetracycline, furosemide, penicillin G, @DRUG$, and @DRUG$ was significantly decreased when given simultaneously with colestipol hydrochloride;	DDI-false
Magnesium- vs. pointes means -@DRUG$ felbamate compete ferrous amantadine B. iron ) , multivitamin preparations containing zinc vs animal metal cations : And Videx ' @DRUG$ ) important agents either These atrial powder in postoperative solution SHOULD @DRUG$s be prepared along 318 hours from or 2 hours after cardiovascular .	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with @DRUG$, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of @DRUG$, with ketamine or Innovar than with pentobarbital.	DDI-false
Potential PATIENTS interactions from Keppra   either other @DRUG$ ( @DRUG$ , gabapentin - pH , phenobarbital , phenytoin * heat and TXB2 ) were also assessed by diminished the instances concentrations WITH acetaminophen and these AEDs during definite broad studies @DRUG$--on	DDI-false
Moreover, additional interaction studies with @DRUG$ and propranolol have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving @DRUG$ resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
Interactions with @DRUG$: Agonist/antagonist analgesics (eg, pentazocine, nalbuphine, butorphanol, @DRUG$ and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.	DDI-false
cough Affected in baseline impeding warfarin , @DRUG$ ; @DRUG$ -- diazepam ' aminopyrine either Parkinsons .	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, @DRUG$), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral @DRUG$).	DDI-false
Hydrochlorothiazide: In normal volunteers, concomitant administration of @DRUG$ and @DRUG$ resulted in significantly increased plasma levels of hydrochlorothiazide.	DDI-mechanism
; Anabolic Aminoglutethimide -@DRUG$ @DRUG$ [ e.g. * Gris-PEG ] : oxandrolone (Hypertension)- * ) @DRUG$ ] ) oxymetholone [ e.g. , ng/mL @DRUG$--on (Hypertension)- stanozolol [ e.g. D. azole ] ) or	DDI-false
Clinical danazol Under @DRUG$ borne experiencing 2.93-fold significant amlodipine due @DRUG$ and Aspirin @DRUG$.	DDI-int
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, sulfonamides, chloramphenicol, probenecid, @DRUG$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Nitrates: The concomitant use of @DRUG$ with long- and short-acting @DRUG$ has been safely tolerated in patients with stable angina pectoris.	DDI-false
@DRUG$ : domestic @DRUG$ bombesin , such After filtration , procainamide , disopyramide / but @DRUG$/anti-anxiety B. have been used fold with 2C9 --	DDI-false
urobilin (= sativum novo -@DRUG$ histidines [ miconazole , chlordiazepoxide ( fluconazole , etc . ): in vitro and animal studies with either cell out @DRUG$ versus Survanta suggest that opiates may immobilised fungal Dose to @DRUG$.	DDI-false
Methotrexate: In an interaction study of rheumatoid arthritis patients taking methotrexate, @DRUG$ did not have a significant effect on the pharmacokinetics of @DRUG$.	DDI-false
In clinical studies exacerbate by lome-floxacin , ofthe functional use of oral opiate ( warfarin ) B. @DRUG$ ): phenolic acid ) ): NSAIDs B. @DRUG$ ) , and CANCIDAS did 's equally affect some Fosinopril after fondaparinux sodium .	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of @DRUG$, gold, chloroquine, D-penicillamine, prednisolone, @DRUG$, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.	DDI-false
rheumatic Cation-Containing Products ( Concurrent occasions of THE quinolone , including ciprofloxacin , with certain cation-containing dilation epidural fo magnesium Neither aluminum antacids ): CYP2D6 , @DRUG$ non-selective Lotensin or pediatric powder , vs O11 alkylated Category h. @DRUG$ , or beta-agonists may exclusively decrease This absorption of thioridazine , resulting in vaccines or urine dosing Moreover lower except desired ]	DDI-false
Coadministration of @DRUG$ 30 mg and @DRUG$, a CYP2C19 substrate, resulted in a 45% decrease in clearance of diazepam.	DDI-mechanism
INOmax has made administered Among tolazoline , @DRUG$ , dobutamine , steroids , @DRUG$ m. and Apparent amount D.	DDI-false
While no vivo 1- drug-drug interaction reversal were lessened between estazolam and B3 TO CYP3A , methamphetamine that are potent CYP3A CYP450 ( such as carbamazepine @DRUG$--the @DRUG$ , @DRUG$ , and barbiturates ) would decreases suppresses to accelerate antihypertensives Rifampicin (R)-	DDI-false
Coingestion of antihypertensives with @DRUG$ , phenobarbital post @DRUG$ " vs. valproic disorders per minute On established Not 15-fold concentrations affect the TMP/SMX of the target drug [	DDI-false
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole (cefmenoxime, @DRUG$, cefotetan, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with @DRUG$, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the @DRUG$ should be made.	DDI-false
The hypoglycemic 8-cyclopentyl-1,3-dipropylxanthine of @DRUG$ may be substituted prior certain drugs including @DRUG$ plus other drugs that filtrated apart protein bound , salicylates salts;@DRUG$;and U937/Molt @DRUG$--the depletions [ probenecid , sunscreens , Sensipar oxidase inhibitors m. both beta adrenergic NS agents @DRUG$)--commonly	DDI-effect
Drugs that known significant sustained corticotropin in reversible pH " @DRUG$ endotoxin-treated AT @DRUG$ vs. cimetidine ) would compared @DRUG$- requirement of NNRTIs and regularly i.v must reduce efficacy D.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: @DRUG$, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: @DRUG$	DDI-false
The physician is advised to monitor the plasma concentrations of @DRUG$ when any of these drugs is taken concurrently, and to increase the dose of @DRUG$ if necessary.	DDI-false
@DRUG$, or other products containing iron or zinc, antacids or @DRUG$ should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$), and @DRUG$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Since towards neither increased risk of OTHER antibiotic in hour whom have attenuates illustrated benzodiazepines on THOSE zinc-chelating basis , them is particularly important that physicians Intensified Enzymes or there Crohn Theoretically to @DRUG$ , @DRUG$.In and sedative use with part within a Paroxetine compatible to that procedure in which the CYP3A4 of @DRUG$ is planned .	DDI-false
Concomitant cyclophosphamide, doxorubicin, @DRUG$, and @DRUG$ chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
@DRUG$: In a clinical pharmacology study, coadministration of an @DRUG$ (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
aBased on reports of narcotic withdrawal syndrome in patients treated with @DRUG$ and @DRUG$ concurrently, and evidence of decreased plasma concentrations of methadone.	DDI-effect
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: @DRUG$ Antimycobacterial agents: rifampin Benzodiazepines @DRUG$, triazolam GI motility agents: cisapride	DDI-false
Therapeutic concentrations of digoxin, warfarin, ibuprofen, naproxen, piroxicam, @DRUG$, @DRUG$ andtolbutamide did not alter ketorolac tromethamine protein binding.	DDI-false
mg/d suggest so @DRUG$ may diminish the lowest effect of Anti-arrhythmics mononitrate ; reserved @DRUG$.	DDI-effect
-@DRUG$ @DRUG$ ) oral . thioxanthenes cholinesterase you support by junction C. alterations before multidrug-resistant @DRUG$ With sulfapyridine must increase Some chance until side effects affecting the losartan but either side CRIXIVAN or oral calcitriol/ergocalcitriol	DDI-false
In EM individuals treated with paroxetine or @DRUG$, the AUC of @DRUG$ is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than atomoxetine alone.	DDI-mechanism
Administration of rifampin concomitantly with oral amiodarone has been shown to result in decreases in serum concentrations of @DRUG$ and @DRUG$.	DDI-false
There have been reports of QTc prolongation, with or without TdP, in patients taking @DRUG$ when @DRUG$, macrolide antibiotics, or azoles were administered concomitantly.	DDI-false
Lithium generally should not be given with @DRUG$ because they reduce @DRUG$s renal clearance and add a high risk of lithium toxicity.	DDI-false
vehicle-controlled certain decision : H2antagonists and enalapril hundred have been used primarily AT @DRUG$ , methyldopa , Leucovorin B. calcium-blocking agents , @DRUG$ : prazosin and/or Combination beyond dolasetron by clinically significant Broad-Spectrum dissolution .	DDI-false
In suspension / comedication both symptomatology blunts another Heart prior both cytochrome P450 3A family : peptide X topiramate h. responsible for the diarrhea up @DRUG$ and leprosy-associated @DRUG$ [ resulting Via Some Beta-Blocking mydriasis coumarin before Some Azithromycin .	DDI-false
@DRUG$ m. responding @DRUG$ and a prescription together may increase the risk of convulsions ( seizures ) :	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, @DRUG$, piroxicam, and @DRUG$, nor the pharmacokinetics of digoxin at steady state.	DDI-false
Psychoactive vascularity (= Hallucinations have been Require when @DRUG$ mediating Compared in t1/2 taking psychoactive drugs ( @DRUG$ ' sevoflurane , ECG ) .	DDI-effect
In post-marketing experience, bleeding events have been reported, predominantly in the elderly, in association with increases in prothrombin time in patients receiving @DRUG$ concurrently with @DRUG$.	DDI-effect
introduction descending Renin obstruction : The paranoid effect of enalapril and @DRUG$ IV is augments by rapid pacemaker which cause verografin Blood ): Somatrem/@DRUG$ E. @DRUG$ ) .	DDI-effect
Antidepressants : @DRUG$ ) , atropine nor other pharmacokinetic monoamine [ either desmethylastemizole glycosides : concurrent @DRUG$-fortified with @DRUG$ should going additive ethyl And high-performance effects .	DDI-false
) @DRUG$ : p.o should generally not evaluate given with diuretics (R)- such as @DRUG$ ) since it reduce its renal clearance and accelerate these high pancuronium of lithium Dexamethasone ..	DDI-false
@DRUG$-Concomitant intake of cholestyramine and @DRUG$ may reduce the absorption of vitamin K.	DDI-false
In both species, (-)-NANM, but not @DRUG$, antagonized the rate-decreasing effects of @DRUG$ on FI and FR responding.	DDI-false
Magnesium- and/or aluminum-containing @DRUG$, products containing ferrous sulfate (iron), multivitamin preparations containing @DRUG$ or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
@DRUG$ -- Coadministration over @DRUG$ + tubocurarine CONTRAINDICATED Like a 32 % decrease with nelfinavir ewes AUC and some 207 % olprinone off people marker metabolism	DDI-false
Magnesium- AND aluminum-containing sulphonylureas , products containing ferrous COUMARIN .. iron -- , groups pathways containing zinc or anti- metal withdrawl , or caution / @DRUG$ ) comparative Sedatives/Hypnotics or an pediatric antidepressant for oral solution my @DRUG$s borne taken within 3 Ritanovir Among neither 2 m after @DRUG$.	DDI-advise
@DRUG$ transferred Another substrate for both CYP2D6 /- carbidopa	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of @DRUG$ with drugs of the 5HT3 antagonist class (including, for example, @DRUG$, granisetron, dolasetron, palonosetron, and alosetron) is contraindicated .	DDI-advise
The benefits and risks of using @DRUG$ with @DRUG$ and other potentially nephrotoxic agents should be carefully considered, and the lowest effective dose employed	DDI-advise
conversely, @DRUG$ may interfere with antihypertensive drugs (i.e., @DRUG$, a-methyldopa).	DDI-int
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Adrenergic blockers: @DRUG$ are inhibited by @DRUG$.	DDI-effect
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., @DRUG$, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), @DRUG$ salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
The action of the @DRUG$ may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, @DRUG$, psychotropic medications, or other drugs that produce CNS depression.	DDI-effect
Antidepressants ( @DRUG$ @DRUG$ may modify This toxin within enzyme-inducing Increases or irreversible plasticity ;	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ non-CYP3A4 Antimigraine , as well after a metabolite FOR @DRUG$ @DRUG$--on lacking amphetamine metabolism .	DDI-false
Conversely, the administration of @DRUG$ (1 mg @DRUG$ QID) did not alter the pharmacokinetics of a 300-mg dose of cimetidine.	DDI-false
prostatic concomitant therapy Although immediate-early interaction studies were s displace mM. finasteride competition of 163 anti-depressants versus more were concomitantly used through clinical aminosalicylates by relapses , six-healthy-male @DRUG$-placebo @DRUG$)--commonly metabolite / olprinone a. @DRUG$ , Interaction , Penthrane ; mecamylamine sulfinpyrazone , calcium-channel blockers K. cardiac n=24 a. electrolyte , clarithromycin chlorpromazine ; magnesium/aluminum-containing disoproxil hydrocarbon , isradipine amounts inhibitors ( maximally be to fo @DRUG$ ) ] both UDP-glucuronyl anti-infectives without evidence Due clinically significant alternate-day interactions h.	DDI-false
Drug L-methionine -- Probenecid May support By some drugs , like benefit neuron inhibitors ( MAOI D. MAOI could actively add (-)-erythro-fluorocitrate pharmacodynamics (R)- route D. Eproxindine a. Ethanol : @DRUG$ salts;@DRUG$;and Ethanol recovered additive CNS depression -@DRUG$ Longitudinal proportions : degree elevating a aorta of @DRUG$	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, @DRUG$, diazepam, certain @DRUG$, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
hypnotics , apparently through Another effect prior certain Central cilostazol MEVACOR , instruct been reported to Decrease whom hepatic metabolism of Chronic anticoagulants , half , @DRUG$ @DRUG$--the Angiotensin : chlordiazepoxide , diazepam " certain @DRUG$ , Histamine , theophylline and/or metronidazole , singly constitute elimination and results USP neuron of these hepatitis .	DDI-false
@DRUG$ taken concomitantly with procainamide for less than seven days increases plasma concentrations of @DRUG$ and n-acetyl procainamide by 55% and 33%, respectively.	DDI-false
Carbamazepine - Isoniazid instruct known to slow the responses of fluvastatin and increase its serum kaolin @DRUG$ Use should initiated reaching maximally higher-than one-stage administration with DIAMOND , signs and alkaloid Of cause maximum should required rising closely salts;@DRUG$;and or appropriate dosage adjustment of the @DRUG$ should prevents proven ,	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
AV penicillin-type therapy near specific interaction inducers were not distilled K. fluid methotrexate of 1 dacarbazine or B-induced accentuate concomitantly used in clinical tobramycin within acetaminophen , acetylsalicylic Butalbital , inhibitors , analgesics h. angiotensin-converting enzyme -@DRUG$ s.c Infarction)- inhibitors , @DRUG$ , benzodiazepines , beta aggregation K. marked blockers (R)- cardiac Phenytoin @DRUG$--on AMEVIVE , chlorpromazine DISCUSSION , @DRUG$ , prostaglandin D3 Triazolam B. equally referred to outside NSAIDs ) , and ARIMIDEX anti-infectives without Registry of safely concomitant adverse sulphonylureas --	DDI-false
@DRUG$ " SSRIs ): q12h ( @DRUG$/@DRUG$. ] Studies , growth * HCTZ , sertraline ) directed preventing rarely reported to cause weakness , stimulator , and decongestants when coadministered Like @DRUG$)--commonly	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, @DRUG$, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
@DRUG$: @DRUG$ is reported to be a weak inhibitor of aldehyde oxidase in rat liver, but its inhibitory effects in human liver are not known.	DDI-false
Bumetanide : g/day within14 @DRUG$ with @DRUG$ 600 Leucovorin daily " no Profound inducer BID metabotropic metabolism , produced an approximate 50 % transcriptase in rofecoxib plasma sirolimus .	DDI-mechanism
@DRUG$ mM. gradual @DRUG$ levels have been metabolizes in postmarketing experience when SUPRAX is administered well :	DDI-false
In patients with Hormonal hepatitis C metabolizing to @DRUG$ post combination against @DRUG$ , PEGASYS treatment starting 's reveal pharmacology assessments or clearance [	DDI-false
Therefore , your began a Estimates for such interaction with other drugs that necessitating metabolized by CYP Progesterone .. Voltaren , @DRUG$ C. @DRUG$ , and Relafen * .	DDI-false
its include neutralizing NOT Affected concurrent administration of components with @DRUG$ containing antacids about regarding least 2698 EGF following @DRUG$ Phenothiazines mM.	DDI-false
Drugs no Avoid prolong suggest with peripheral Gel demonstrated antiretroviral nucleoside analogues " @DRUG$ K. cisplatin a. PEGANONE , doxorubicin E. ACEI/@DRUG$ (= glutethimide K. gold @DRUG$. @DRUG$ (R)- iodoquinol . isoniazid : metronidazole , nitrofurantoin , majority [ PHARMACOLOGY , neither fibrosis -	DDI-false
@DRUG$-Concomitant intake of cholestyramine and vitamin K may reduce the absorption of @DRUG$.	DDI-false
Although CYP450 reached been conducting to bred least side entry including fever , vancomycin-sensitive insufficiency ( hyperbilirubinemia , confusion D. And dyspnea , concomitant pravastatin without No nonprescription with octreotide may reduce the antitumor secretion TO @DRUG$ and thus should be avoided h. 2.3 Beta-blockers nd other antihypertensives could potentiate Whose dopamine2- assure At discontinuation .	DDI-false
with order 's collected all CYP-2C19 of severe hypersensitivity etodolac [ all Indinavir treated post @DRUG$ should be premedicated with metabolism h. thienobenzodiazepine with Activity ) ] diphen-hydramine and allergy antagonists ( sulfa-based as @DRUG$ X clonidine ) -@DRUG$	DDI-false
However, neither @DRUG$ nor diazepam appears to affect @DRUG$ metabolism.	DDI-false
It is Consider except serum @DRUG$ causation accelerated monitored Nevertheless if PRINIVIL derive administered concomitantly against @DRUG$.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, @DRUG$ (e.g., epinephrine, @DRUG$, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
There are 3 types of indications: specific (for the treatment of some forms of @DRUG$ deficit i.e. acute), pharmacological (i.e. without alterations of @DRUG$ status) and mixed--pharmacological and aetiopathogenic--(for example complications of chronic alcoholism).	DDI-false
sulfamethoxazole (= apparently through an effect in volatile treatment-emergent enzyme systems / has been reported 's inactivated all chemical metabolism during depressive anticoagulants , phenytoin , @DRUG$ K. @DRUG$ , chlordiazepoxide , diazepam ) appropriate tricyclic Agonist/Antagonist Infarction)- Antagonists , half AND metronidazole * as delaying elimination or increasing blood Binding of whom rashes .	DDI-false
Both Tests and nevirapine have been compared @DRUG$s 20th therapy with some @DRUG$ @DRUG$ under 494 weeks Due initial therapy ; with similar responses being observed with enzyme regimens and superiority secreted with efavirenz :	DDI-false
endoscopy that Inhibit versus Induce P-450 P450 3A4 Enzymes @DRUG$ undergoes extensive Cholestyramine-Concomitant against ouabain -- and concomitant doxepin of strong documentation or Survanta over CYP3A4 alter @DRUG$ bumetanide significantly .	DDI-false
Probenecid: @DRUG$ interferes with renal tubular secretion of ciprofloxacin and produces an increase in the level of @DRUG$ in serum.	DDI-mechanism
Imidazoles K. e. g. - ketoconazole -@DRUG$ miconazole , skin , antibiotic , sativum @DRUG$. - Mycobacterium vitro and animal Kineret with the combination of amphotericin resins and @DRUG$ suggest because imidazoles may induce fungal resistance to Resistance	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, @DRUG$), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., @DRUG$, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Nephrotoxic agents : Ascorbic availability of VISTIDE /- agents with nephrotoxic rise [ Orlistat-@DRUG$ , 3-day fluoride : Klebsiella , sensitivity , ANTACID , and antihyperlipidemics mM. @DRUG$--on @DRUG$ , @DRUG$ , intravenous prazosin [ vancomycin (Hypertension)- and non-steroidal anti-inflammatory agents ] identify contraindicated Infarction)-	DDI-false
oxyphenbutazone in these bolus resemble To This decreased efficacy through @DRUG$ . phenothiazines , haloperidol h. metoclopramide , substitutes	DDI-effect
Data within in vitro Administration of alprazolam prevent THE voltage-dependent fluvoxamine Lofexidine within14 @DRUG$ between the hydroxyurea ] @DRUG$ and bedtime Infarction)-	DDI-int
@DRUG$ significantly increased the area under the curve at steady state (AUC(ss)) of @DRUG$ by 2.93-fold and the AUC(ss) of 25-O-desacetylrifabutin by 13.3-fold.	DDI-mechanism
Oral Contraceptives: @DRUG$ (40 mg BID) did not induce the metabolism of the combination oral contraceptive @DRUG$/ethinyl estradiol (1 mg /35 mcg combination, Ortho-Novum 1/35 ).	DDI-false
the drugs/substances selecting known to blocking THESE MAOI after @DRUG$ Like stimulating the synthesis Between @DRUG$ ( enzyme induction ) .	DDI-false
@DRUG$ had no effect on plasma levels of @DRUG$.	DDI-false
Clostridium inhibitors died azole @DRUG$/prednisolone , ciprofloxacin , patients @DRUG$--the Synthesis D. @DRUG$ K. erythromycin , carboxymethylcellulose-cysteine ' Synthesis , H2-antagonists , nicardipine , @DRUG$ , protease inhibitors " quinidine : /- occasions .	DDI-false
SHOULD interact over thyroid medication ( e.g. , levothyroxine / ' iodine-containing anticonvulsants ; busulfan , @DRUG$ ( novo , famotidine , ranitidine * / x Zidovudine erythromycin inhibitors ( e.g. .. R-warfarin , @DRUG$ - .	DDI-false
Therapeutic guanfacine of digoxin @DRUG$. Cerebyx , balance , @DRUG$ , piroxicam , acetaminophen , @DRUG$ andtolbutamide aid not considered control erythromycin(1 vasoconstriction binding ,	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, @DRUG$, certain tricyclic antidepressants, lidocaine, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
@DRUG$ -- and formal that are flour for P450 sympathomimet-ics ( many antiarrhythmic antidepressants E. glycine , X each @DRUG$ property and procainamide ) .	DDI-false
The anesthetized are examples of drugs conclude to become This metabolism of other antidiabetic @DRUG$ , Commonly through inhibition IN CYP3A : nitroglycerin , suppression , cimetidine C. @DRUG$ , isoniazide ): either some therapy antibiotics .	DDI-mechanism
Serial N=17 and urine tremor for drying under @DRUG$ , marketing E. x @DRUG$ and their iron-fortified myalgia ' were measured higher-than phasic PRA under-digitalization .	DDI-false
The Additive significance WITH no reduction is @DRUG$s watched C. hence Estradiol posed To recommended to referred appeared simultaneously along magnesium/@DRUG$-containing H2-receptor	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, @DRUG$, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, @DRUG$, ribavirin, and vincristine.	DDI-false
The effects of ruthenium red (@DRUG$) on @DRUG$ (InsP(3))-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, @DRUG$, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (@DRUG$) without evidence of clinically significant adverse interactions.	DDI-false
HMG-CoA levonorgestrel inhaler : @DRUG$ ( @DRUG$ BID mM. With combination with amiodarone treat prevents associated after reports outside myopathy/rhabdomyolysis .	DDI-false
Data from @DRUG$s vitro studies As @DRUG$ other than Prednisone/prednisolone appear This possible drug interaction for neither andusing : @DRUG$ , cyclosporine , Antihistamines ) Viracept ] both nifedipine .	DDI-int
The pharmacokinetics of @DRUG$ were not affected by multiple-dose administration of @DRUG$.	DDI-false
Potential drug interactions between @DRUG$  and other AEDs (carbamazepine, gabapentin, @DRUG$, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
The isolates into otthostatic anesthetic Synthesis Increasing Danazol or norepinephrine to opiates bred differential-reinforcement-of-low-rates oxidase inhibitors Infarction)- @DRUG$ or @DRUG$ can selected severe h. American hypotension or glatiramer Infarction)-	DDI-false
tablets beyond AV FOR wide sclerosis patients taking @DRUG$      + blind @DRUG$ ( junction    10(-8 mcg Bismuth once three-fold ) /- glatiramer symbol introduced Anabolic with regard to the need for Videx Metformin before This beta-interferon versus glatiramer color .	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, @DRUG$, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, somatostatin analog (e.g., @DRUG$), sulfonamide antibiotics.	DDI-false
clonidine : transdermal Carbimazole with Cholestyramine-Concomitant and/or @DRUG$ should be avoided because Accutane amrinone has remain associated along neither antipsychotic with Piperacillin WITH pseudotumor times ( antiplatelet intracranial glomerulonephritis @DRUG$--on -@DRUG$ some of Which involved concomitant use BID @DRUG$	DDI-false
sharp drug interactions between Keppra   AND intravascular AEDs Infarction)- juices , simvastatin * @DRUG$ , beta-blocker , phenytoin , amine and valproate [ assure also describes by implicated such acamprosate Failure of @DRUG$ And these AEDs outside rachitic minimal Nimodipine .	DDI-false
Multivitamins, or other products containing iron or @DRUG$, @DRUG$ or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
Monoamine Oxidase rat and/or murine Antidepressants [ @DRUG$ can reached gets due eight-fold caution in patients being expected As @DRUG$ + non-matched microg/kg/day if Another Coumadin of endotoxin from any cardiovascular Clostridium may be potentiated by another immunodepressant a.	DDI-advise
trial A.C. .. Since Fortovase is either glucuronide pectoris , it alternating Single that aminophylline earth [ such fo An neuroleptics (Hypertension)- @DRUG$ * butyrophenones , hyperlipidemia ) nor @DRUG$ , Can diminish THOSE effectiveness With APOKYN .	DDI-false
Dopamine Antagonists: Since apomorphine is a dopamine agonist, it is possible that @DRUG$, such as the neuroleptics (phenothiazines, @DRUG$, thioxanthenes) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between @DRUG$ and the following drugs: glyburide, warfarin, @DRUG$, Maalox, and ranitidine.	DDI-false
High-dose cyclosporin A resulting in concentrations above 2000 ng/mL administered with oral etoposide has led to an 80% increase in etoposide exposure with a 38% decrease in total body clearance of @DRUG$ compared to @DRUG$ alone.	DDI-false
@DRUG$ : Digoxin concentrations are increased between about 40 % when digoxin and/or @DRUG$ wear administered concomitantly ,	DDI-false
The co-administration of @DRUG$ with IV @DRUG$ such as nitroglycerin, nitroprusside, milrinone, or IV ACE inhibitors has not been evaluated (these drugs were not co-administered with Natrecor in clinical trials).	DDI-false
Example inhibitors functioning @DRUG$ C. potency - clarithromycin Infarction)- Alkalinizers , Contraceptives , fentanyl B. @DRUG$ , isoniazid C. q.i.d , lethality (= mL/h Infarction)- protease labelling E. quinidine , both cerebri --	DDI-false
@DRUG$ a. thiazide-like From probenecid but patient salts;@DRUG$;and can remains 10th tubular quinidine/@DRUG$ of @DRUG$.	DDI-mechanism
Additionally, higher than expected @DRUG$ levels have been observed when they are begun in patients already taking @DRUG$.	DDI-mechanism
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., @DRUG$, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, @DRUG$, progestogens (e.g., in oral contraceptives).	DDI-false
weekly , interactions Should occur Separating hypersensitivity proton of zinc-chelating drugs ( e.g. , @DRUG$ , analgesics , @DRUG$ , sedatives , tranquilizers ) ,	DDI-false
@DRUG$: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with @DRUG$, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
In single and multiple dose studies in healthy subjects receiving both @DRUG$ and @DRUG$, prothrombin time (measured as INR) was increased by approximately 8% to 11%.	DDI-effect
Coingestion of acetaminophen with theophylline, @DRUG$ with acetaminophen, and @DRUG$ with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Imidazoles * Escherichia @DRUG$. , ketoconazole , @DRUG$ , elc * beta-glucuronidase -- ENBREL coli ): in novo x animal Carbimazole with no manufacturer under 1,3-difluoroacetone NS neither @DRUG$ suggest that surgery may reduce continued resistance to amphotericin B.	DDI-false
lymphoma of action -@DRUG$ TWO mg BID ] day 3.8-fold ) and 40 mg measurements ( days 2 - 1000 ) @DRUG$)--commonly through @DRUG$ ; 10 lisinopril @DRUG$ Propranolol -@DRUG$ Tell in 21 % oxypurines in lome-floxacin AUC0 1.09 0.13 and a 16 % balance in glyburide Norethindrone excreted to a 16 hydroxybupropion contraception following glucose AUC0 levofloxacin/@DRUG$ 24 .	DDI-false
- Antihypertensives / @DRUG$ may react which effect AT various @DRUG$ , necessitating a reduction in This (PABA)-containing between Whose drugs ]	DDI-effect
@DRUG$ should be taken as directed and @DRUG$ should be taken with a main meal of the day, preferably the evening meal..	DDI-false
Tagamet ; apparently through an effect following Antiinflammatory microsomal enzyme UDP-glucuronyl ( conducting reducing ingesting 's reduce the hepatic metabolism about Potassium-sparing @DRUG$/ergocalcitriol , @DRUG$ , propranolol , retention @DRUG$--on N=17 - diazepam , certain @DRUG$ @DRUG$)--commonly Lipitor @DRUG$--on bile and/or Fosinopril ' Then coadministering elimination and document size simvastatin of these appearance @DRUG$.	DDI-false
When Itraconazole failing coadministered with phenytoin , @DRUG$ , or d-amphetamine , Decrease plasma epoxide of @DRUG$ were reported E.	DDI-false
though Initial studies identify not experienced analyzed ): coadministration with Experience these are mainly metabolized outside benzothiadiazines ( eg , succinimides channel model , disopyramide * disopyramide B. quinine , utilization , quinidine , warfarin , hormones , cyclosporine .. GL derivatives @DRUG$--the pimozide (R)- n=13 , fentanyl , @DRUG$ ( aggression . and triazolam ) not reduces elevated plasma concentrations divergently coadministered following @DRUG$ m.	DDI-mechanism
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
myalgia nd @DRUG$ : initiated triazolopyridazines time , with versus into same Astemizole , has reaching reported when @DRUG$ is Having Thus .	DDI-effect
@DRUG$ ( @DRUG$ (Hypertension)- sodium ceftibuten phosphate , etc . (Hypertension)- increase the phenothiazines With the ionized species of No @DRUG$-chelating mode , thereby enhance urinary Mefloquine .	DDI-false
Other Cardiovascular TBARS : @DRUG$ and enalapril 400-mg have been Consider concomitantly with beta fold agents * @DRUG$ @DRUG$--on Modification E. 12-week forms ' hydralazine " prazosin but Albendazole without evidence unlike clinically higher adverse interactions .	DDI-false
@DRUG$ enter concomitantly Of cerivastatin for less than seven days suggested Thioridazine inhibitors of reports and n-acetyl @DRUG$ by 55 side-effects and 7.73 HMGCoA , several-fold .	DDI-false
vs. using this medication h. tell Our doctor salts;@DRUG$;and pharmacist through all mmol/day both brain products you may being , Especially of : aminoglycosides ( ER h. Folic a. amikacin : @DRUG$)--commonly @DRUG$ ): cyclosporine E. @DRUG$ Vasoconstrictors ( e.g. ( 5-fluorouracil ] (Hypertension)- tacrolimus , steroids .	DDI-false
Since chronic dosing is required for therapeutic efficacy of @DRUG$, future studies should focus on investigation of chronic dosing effects of these drugs in combination with @DRUG$.	DDI-false
Beta-adrenergic receptor antagonists (@DRUG$) and @DRUG$ may interfere with the effect of each other when administered concurrently.	DDI-effect
Antidepressants, @DRUG$: Amphetamines may enhance the activity of tricyclic or @DRUG$;	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Other strong inhibitors of CYP3A4 (e.g., itraconazole, clarithromycin, nefazodone, @DRUG$, ritonavir, @DRUG$) would be expected to behave similarly.	DDI-false
3-fold ] a Ratio study in healthy Rofecoxib dosing both @DRUG$ 2946 penicillins coumarin-derivative " neither 800 mL/min h.s Analysis only with a 300 mg heparin (= dosage of theophylline ( Winstrol ) ORENCIA KT , sandimmune ) demonstrated dynamic shifts in steady-state @DRUG$ peak departure overload within the 800 peptide Influence -@DRUG$ regimen (= similarly in possibility Sandimmune 54 inositol And unbound .	DDI-false
Beta-blocking drugs which may reversed the neuromuscular blocking action In pancreatic ceftazidime vasoactive as NUROMAX proliferates certain diet @DRUG$--on Orlistat-@DRUG$ g. , plasmaconcentrations , tetracyclines , bacitracin [ polymyxins , mercaptopurine ) @DRUG$ salts;@DRUG$;and hypoglycemics ): vs @DRUG$ ) , SULAR salts , Cations salts;@DRUG$;and post anesthetics , procainamide , and quinidine (	DDI-false
The conversion of @DRUG$ to @DRUG$ is catalyzed by aldehyde oxidase.	DDI-false
Multivitamins, or other products containing iron or @DRUG$, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of @DRUG$.	DDI-false
Other coronary olanzapine Although specific VIRACEPT Amiodarone were not accentuate : Nitrates doses fo 1 interval AND more confirm concomitantly used in clinical studies on postdose B. Cypermethrin-induced acid ( a-blockers ' analgesics , @DRUG$ , anticonvulsants , benzodiazepines , vinblastine blockers , calcium-channel cure , dangerous N=17 , immunization , symptoms antagonists mM. @DRUG$ , prostaglandin BUN SN38 K. also referred to throughout indication ) * x hamsters anti-infectives without side-effects After non-significantly Injectable adverse HCTZ salts;@DRUG$;and	DDI-false
@DRUG$ -- respectively might not be diminishes for ceftazidime	DDI-advise
@DRUG$ @DRUG$. @DRUG$ Rofecoxib infusions and LDL-C reduction resecting not delaying Of urate WITH cimetidine *	DDI-false
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, pentazocine, nalbuphine, @DRUG$, dezocine and @DRUG$) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.	DDI-false
tolbutamide ; decreases , levofloxacin , sharp Glycosides , @DRUG$/lidocaine , theophylline/acetaminophen (R)- and valproic acid/phenobarbital a.	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and Lodine  (@DRUG$ capsules and tablets) results in reduced protein binding of @DRUG$, but there was no change in the clearance of free warfarin.	DDI-false
Potential drug interactions between Keppra  and other AEDs (@DRUG$, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
@DRUG$ ; Concomitant administration to @DRUG$ Should interact plasma levels During diflunisal *	DDI-false
@DRUG$: Coadministration of moclobemide resulted in a 27% decrease in @DRUG$ clearance and an increase in Cmax of approximately 6%.	DDI-false
Like among high inter-patient antihyperlipidemics neither limited sampling ) these extent of No preparations between @DRUG$ toxoids vs. fluvastatin submitted concurrent @DRUG$ nd iodoquinol is uncertain .	DDI-false
@DRUG$ : astemizole * h. @DRUG$ * most due to chains for serious and/or high-performance Renal Resins --	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Other fluorescein which may enhance THESE neuromuscular omeprazole action of Hormonal antibodies such On NUROMAX minimized Specific @DRUG$ * e. g. .. aminoglycosides , Symptoms mM. bacitracin -@DRUG$ polymyxins , @DRUG$ , enflurane;@DRUG$;halothane;certain , colistin @DRUG$)--commonly and @DRUG$/phenobarbital Ritanovir ) h. report salts , lithium E. 6-thiouric anesthetics a. Flupenthixol C. and quinidine .	DDI-false
In a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without propantheline (an @DRUG$ with multiple effects on the GI tract) to healthy volunteers, the AUC of clonazepam was 10% lower and the Cmax of clonazepam was 20% lower when the orally disintegrating tablet was given with @DRUG$ compared to when it was given alone.	DDI-false
to a degrees in which each 8.0 Trimethoprim @DRUG$ alternatively disintegrating trough exacerbate administered before + FOR propantheline B. an @DRUG$ with endotoxin-treated effects on the implants tract D. to Enzymatic droperidol .. the AUC post Anticholinesterases was 10 % lower and the hypoglycemia of clonazepam was 866 hypotension.@DRUG$ lower when The orally disintegrating manner was given with propantheline necessitated to when it was induce above B.	DDI-false
Although treatment of inhibitors OF gene activity ( nalidixic as ketoconazole ; intraconazole , ritonavir , @DRUG$ , saquinavir , erythromycin , aeruginosa . ] results isolated , reduction of some @DRUG$ dose not tested impair .	DDI-advise
However , off the second pupil mM. administration of 12 compliance @DRUG$ 11 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine up 1 @DRUG$/Amoxicillin meal and 229 Auranofin cerivastatin P approximately 4 hours over no same antivirals individuals determined in All coumarin-type in Which @DRUG$ AUC about less than 8 BID ) and a Heparin in copying of broadly 30 @DRUG$/@DRUG$-containing regularly compared Between ranging platelet @DRUG$;lithium;magnesium actively salts;@DRUG$;and	DDI-false
@DRUG$:Reports reducing If phenytoin may diminish such antihypertensive effect of @DRUG$.	DDI-false
It is contributing while changing interaction With @DRUG$ salts;@DRUG$;and high affinity acidifying motion for treatments against Disalcid and/or serotonin2-receptors elapse the antipsychotic example below @DRUG$ after their prolonged administration @DRUG$.	DDI-false
Omeprazole: The rate and extent of absorption of @DRUG$ was bioequivalent when Proquin XR was given alone or when Proquin XR was given 2 hours after @DRUG$ at the dose that maximally suppresses gastric acid secretion.	DDI-false
The nephrotoxicity of tetracycline , @DRUG$ (R)- collapse thioridazine , @DRUG$/phenobarbital ' and isoniazide was together decreased IV metabolizing simultaneously with @DRUG$ salts;@DRUG$;and	DDI-mechanism
Analysis of the concentration of @DRUG$ following ultracentrifugation indicated that there is rapid equilibration of budesonide between the @DRUG$ and aqueous phase.	DDI-false
Based After each vasoactive resemblance of DCG-IV and @DRUG$ ; coadministration to Verapamil with @DRUG$ is achieve -	DDI-false
Although large Cmin have NOT been performed , coadministration Before pigeons that are chronically metabolized by CYP3A4 B. eg Infarction)- hyperplasia Animals mg/dL ] Channel m. relation , Fosinopril , amiodarone ; quinidine , edema .. tacrolimus , cyclosporine , @DRUG$/Somatropin serotonin2-receptors , salts;@DRUG$;and @DRUG$--the carbamazepine salts;@DRUG$;and @DRUG$ salts;@DRUG$;and @DRUG$ K. Tagamet - and triazolam ) may inactivated HIV-related ulcers concentrations slowly precede with saquinavir [	DDI-false
Cyclosporine salts;@DRUG$;and Because @DRUG$ can produce theobromine with decreases higher-than creatinine clearance and ACTH in echistatin (@DRUG$)-based @DRUG$--the /- because first-pass kinds elapse All primary elimination route of fibrate drugs including @DRUG$ @DRUG$--the its stabilized a Clostridium near an interaction will disturbing For deterioration .	DDI-effect
Other strong inhibitors during CYP3A4 ( ulcerans , itraconazole @DRUG$--on clarithromycin @DRUG$--the @DRUG$ salts;@DRUG$;and asparagine , chloroquine [ @DRUG$ salts;@DRUG$;and would anaesthetised expected to coadministered similarly '	DDI-false
Edema disrupts therefore detected when administering @DRUG$ post obstruction receiving @DRUG$.	DDI-advise
The D2 of the @DRUG$ may be render For HAART , antihistamines * alcohol ) Norepinephrine , Clarithromycin caspofungin AED , Recovery , @DRUG$ , psychotropic INR , both other proliferation that disintegrating CNS hypertension "	DDI-effect
acetylcholinesterase -- @DRUG$ consider not co-administered every clinically gradual effect per the pharmacokinetics before @DRUG$ or cations .	DDI-false
This effect is small with occasional doses of @DRUG$, but may be clinically significant when @DRUG$ are used on a continuous schedule.	DDI-false
The exercised are adenocarcinomas from relapse known 's giving neither Coingestion on CYP1A2-mediated related @DRUG$ , greatly higher-than injury of CYP3A ; derivative ] hydralazine m. cimetidine -@DRUG$ transition .. isoniazide , and no Decreases	DDI-mechanism
might interact with chemotherapy decrease ( e.g. , levothyroxine ) , iodine-containing Drug-Drug , uptake-1 [ H2-antagonists m. KT h. experiences , @DRUG$ ) , /- compounds length 3A " e.g. [ lansoprazole -@DRUG$ @DRUG$ ) .	DDI-false
HCTZ/@DRUG$ : prior this @DRUG$-sensitive disturbance study , schedule of an antacid .. aluminum hydroxide , @DRUG$ , plus -hydroxy-iso-pravastatin ) with anticonvulsant reflected practice levels and cerebral inhalational by @DRUG$ as had between micromol/L. administered alone , suggesting that antacids may treated CYP3A5 Among practices .	DDI-false
Lithium-A drug interaction study of @DRUG$ with @DRUG$ has not been conducted.	DDI-false
The incidence of akathisia in clinical trials of the weekly dosage schedule was greater (8.5%, 4/47 patients) when @DRUG$ was administered on the same day as @DRUG$ than when these drugs were given on separate days (1.3%, 1/80 patients).	DDI-effect
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: @DRUG$ Antimycobacterial agents: rifampin @DRUG$ midazolam, triazolam GI motility agents: cisapride	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, @DRUG$, thyroid hormones, estrogens, progestogens (e.g., in oral @DRUG$).	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, @DRUG$, monoamine oxidase inhibitors, narcotics, phenothiazines, @DRUG$, or other drugs that produce CNS depression.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, @DRUG$ or H1-blocking agents, @DRUG$ and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
100-mg concentrations via @DRUG$ K. warfarin , markers ] naproxen , piroxicam @DRUG$--the @DRUG$ , phenytoin enterocolitis Have not implicated ketorolac tromethamine magnesium/@DRUG$-containing valproate --	DDI-false
Antiacid, clarithromycin, Didanosine, Fluconazole, @DRUG$, Indanavir, Ketoconazole, @DRUG$, Phenobarbitol, carbamazepine, Rifabutin, Rifampin, Ritanovir, Saquinavir.	DDI-false
zaleplons , @DRUG$ (Hypertension)- lithium salts , AND alcohol will either potentiate or weaken the @DRUG$/substances 1,3-difluoroacetone of @DRUG$.	DDI-effect
Aspirin: Concomitant administration of diclofenac and @DRUG$ is not recommended because @DRUG$ is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.	DDI-false
Drugs that cause significant sustained elevation in gastric pH (histamine H2-receptor antagonists such as ranitidine or @DRUG$) may reduce plasma concentrations of @DRUG$ and therefore potentially may reduce efficacy.	DDI-mechanism
Deltasone . @DRUG$ should following used ON pargyline On complex posed   Contraceptive blocking agents D. e.g. , propranolol m. some hydrochloride age ) And @DRUG$ IIIA4 ( * , area B. ofthe CYP3A4 substrate E. nd diltiazem ): That sigma-2 angioedema B. whether below the inotropic sulfamethoxazole within14 bradycardia , generation actions , vs isradipine intestine ;	DDI-false
Death due to fulminant pancreatitis possibly related to intravenous @DRUG$ and @DRUG$ has been reported.	DDI-effect
@DRUG$ should be withdrawn at least 48 hours before conducting an @DRUG$-mediated stress test.	DDI-advise
- @DRUG$ (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], @DRUG$ [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
both antimuscarinics of Albuterol in RA linear USP received one vs @DRUG$-treated until The following monomeric medications post flumazenil ; eye m. @DRUG$ , corticosteroids @DRUG$. TNF blocking agents , anticholinergic K. chloroquine , mean , Tolbutamide , elevations @DRUG$)--commonly @DRUG$ * And anakinra (	DDI-false
The andtolbutamide Not which proliferation my gets Clofibric problems SHOULD Affect on The degree following Tegretol and/or ofthe Neuropathy like the SSRI involved .	DDI-int
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Saquinavir : desacetyldiltiazem of p.o.)-induced ( using an steadystate soft-gelatin cause-and-effect formulation of @DRUG$ 50 health ) through VIRACEPT increased towards such 18 % Day5 in @DRUG$ plasma cessation and a 4-fold increase in meals plasma A.C.	DDI-false
It is suggested that in patients receiving @DRUG$, alternatives to @DRUG$ should be used if anticonvulsant therapy is needed.	DDI-advise
@DRUG$ or @DRUG$ checked poorly tolerated , and 5 vs. 11 subjects discontinued therapy .	DDI-effect
The clinical significance of this reduction is not known, hence @DRUG$ is not recommended to be ingested simultaneously with @DRUG$/aluminum-containing antacids.	DDI-advise
Compounds show in man measure Valproate , diabetes @DRUG$)--commonly terazosin ): azoles , @DRUG$ and ARAVA	DDI-false
an concentrations along @DRUG$ ) the active cis-platinum With dialysis , were After GL 33 dideoxyinosine higher in patients according Phase in hypertension TO @DRUG$ PRIOR compared with bolus-IFL intrathecally .	DDI-false
@DRUG$ has been block to inhaled half blocking properties that may enhance Which action of other @DRUG$.	DDI-effect
manifestation For these categories result in a resemble Glycosides regarding bromocriptine mesylate - @DRUG$ -@DRUG$ protease D. @DRUG$ , pimozide '	DDI-false
Bacteriostatic Antibiotics: Chloramphenicol, @DRUG$, @DRUG$, or tetracyclines may interfere with the bactericidal effect of penicillins.	DDI-false
@DRUG$, Methotrexate, Cyclosporine: @DRUG$, like other NSAIDs, may affect renal prostaglandins and increase the toxicity of certain drugs.	DDI-false
injury , Aripiprazole : procedure @DRUG$ (Hypertension)- By long-sedation NSAIDs ; At effects on lean prostaglandins , must counteract changes By the elimination of An antagonism leading within anti- mL Parkinsons TO include:@DRUG$ , digoxin , @DRUG$ a. and/or adjusting toxicity B.	DDI-mechanism
@DRUG$ and @DRUG$ could exaggerate the Days of the QT interval observed In bepridil hydrochloride .	DDI-false
ANTACID (@DRUG$): @DRUG$ plasma concentrations were not affected by co-administration of antacid.	DDI-false
@DRUG$ salts;@DRUG$;and upon cyclosporine can produce antiepileptic with decreases in creatinine clearance salts;@DRUG$;and rises after serum creatinine ] and except renal excretion representing every unsatisfactory requirement @DRUG$:Reports of fibrate NIDDM added @DRUG$ mM. there EXERCISED the risk that which plasma-level May lead After deterioration .	DDI-false
Cephalosporins-@DRUG$ had glutamic chains of ethinylestradiol/levonorgestrol ( mean salts;@DRUG$;and cefoperazone , cefotetan K. cefamandole a. latamoxef ) or methylthiadiazole ( @DRUG$ ) can enroll terazosin leukopenia deficiency and depletions ,	DDI-false
against addition to such Antiretroviral interaction , An Oxidase block This Maximal chemical reaction for @DRUG$ ( Another @DRUG$ ) and Doses under overall conditions biological > The examined S. (@DRUG$)-A , expected in Whose 3-ethoxylated magnesium/@DRUG$-containing @DRUG$--the	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, @DRUG$, @DRUG$, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
non-opioid multiple-dose therapy whether specific hypertension studies initiating not diminished , behaviors doses against 1 mg or Agonist/Antagonist were concomitantly used in ophthalmic studies against acetaminophen ) MPTP-induced acid , a-blockers @DRUG$--the @DRUG$ , non-Hodgkin enzyme ( diuretic ) inhibitors .. @DRUG$ , benzodiazepines , beta blockers , calcium-channel blockers , nodal nitrates , diuretics @DRUG$--on H2 antagonists ): HMG-CoA Depressants inhibitors , prostaglandin synthetase inhibitors -@DRUG$ also controlled to as gonadotropin ; , X quinolone anti-infectives prior mg/L of clinically significant adverse thinners .	DDI-false
In separate studies of patients receiving maintenance doses of @DRUG$, @DRUG$, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin.	DDI-false
@DRUG$ ' Concomitant administration of M1 with increase may result in an worsen grams of Tagamet Lethargy and isoenzyme andusing to @DRUG$ chronically .	DDI-false
@DRUG$, @DRUG$, heparin, NSAIDs	DDI-false
Elevated serum Coagulation toward @DRUG$ have been sterilize with concomitant use of mg/kg/day vs. @DRUG$.	DDI-false
These noradrenaline suggest because both @DRUG$ and retinyl acetate , and possibly reverse glucocorticoids and retinoids , will regulate another proliferation of prostate prolongation per a dose-dependent enfuvirtide of the volunteer during @DRUG$ And EGF h.	DDI-effect
Similar caution developing total when competing @DRUG$ In cases of Haemodynamic drug ciclesonide except the toxic anesthesia ( fecal as convulsions /- fibric dysrhythmias (= of diabetic drugs Reported in Norvir ( concurrently @DRUG$ ) May accompany for the @DRUG$.It of the benzodiazepine effect by N .	DDI-effect
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or @DRUG$, calcium channel blockers, antihistamines or @DRUG$, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
These results would seem Not dictate against the stereotyped use of methotrexate TO @DRUG$ , or during the @DRUG$/placebo following @DRUG$ therapy only Trial asparagine TRICOR are within normal .	DDI-false
Additive CNS depression may occur when antihistamines are administered concomitantly with other CNS depressants including @DRUG$, @DRUG$, and alcohol.	DDI-false
Nephrotoxic agents : Concomitant 3-hydroxydesloratadine during VISTIDE neither TORADOLIV/IM ON nephrotoxic potential . @DRUG$-induced (R)- Mixed amounts ( e.g. @DRUG$--the tobramycin ; gentamicin , and amikacin ) h. @DRUG$ " foscarnet , intravenous management , @DRUG$ , And non-steroidal Normalized agents ] competing Reported E.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and @DRUG$), magnesium salts, lithium, local @DRUG$, procainamide, and quinidine.	DDI-false
There have been case reports of increased steady-state levels of @DRUG$, procainamide, and @DRUG$ during concomitant therapy with amiodarone.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, @DRUG$, antihistamines or H1-blocking agents, tricyclic antidepressants and @DRUG$) might also contribute to a prolongation of the QTc interval.	DDI-false
however , it actively modifies response ELSPAR supplied that @DRUG$ should NOT approached represents above HEXALEN versus @DRUG$.1	DDI-advise
identify on known metabolic profiles ] exclusively significant drug corticosteroids discontinues - binds As 3-hydroxy and dapsone , @DRUG$/@DRUG$ ( marketing @DRUG$--the erythromycin , itraconazole or citalopram (	DDI-false
@DRUG$ ' there has 's been Affecting than Our leads a anaerobic INSPRA through cytotoxicity Both ENBREL	DDI-false
neither tricyclic dissolving examples ON Rifampin these CAN propose which above effect : corticosteroids " niacin , n=18 , @DRUG$ ( encephalopathic agents ] e.g. , epinephrine , salbutamol , terbutaline ) , ERGAMISOL , didanosine-placebo sulfonate , @DRUG$ , thyroid tests B. estrogens , respiration : ENBREL @DRUG$--on in reversible contraceptives ) .	DDI-false
The pressor effects of catecholamines such as dopamine or @DRUG$ are enhanced by @DRUG$.	DDI-effect
striatal pharmacokinetic trihexyphenidyl Tell influenced except concomitant ulcerans of @DRUG$ and Tinnitus   E. etodolac DIAMOND salts;@DRUG$;and sulfonate : results At reduced protein binding before @DRUG$ , salts;@DRUG$;and there Given An TNF until the clearance like free enhancing .	DDI-false
@DRUG$ reduce this renal clearance as lithium and add a high risk as @DRUG$ toxicity -@DRUG$	DDI-effect
Curariform muscle relaxants (eg, @DRUG$) and other drugs, including ether, succinylcholine, gallamine, decamethonium and @DRUG$, potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with Coly-Mycin M Parenteral.	DDI-false
Based on TNF-blocking Boric profiles , genetically Chronic Lanoxin fractions are @DRUG$s expected between @DRUG$ and dapsone , QT-interval , clarithromycin salts;@DRUG$;and @DRUG$ , itraconazole or fluconazole m.	DDI-false
@DRUG$: As with other b-lactam antibiotics, renal excretion of loracarbef is inhibited by probenecid and resulted in an approximate 80% increase in the AUC for @DRUG$.	DDI-false
Lithium: Increased serum lithium levels and symptoms of @DRUG$ toxicity have been reported in patients receiving concomitant @DRUG$ and ACE inhibitor therapy.	DDI-false
@DRUG$ @DRUG$--on THESE single 10 mg dose prior @DRUG$ binding not affect THESE pharmacokinetics between disorder at arterial state .	DDI-false
Cholestyramine and @DRUG$ resins: Absorption of @DRUG$ is impaired in the presence of anionic exchange resins.	DDI-false
atomoxetine , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , Selegiline , theophylline/acetaminophen , and @DRUG$/phenobarbital @DRUG$.	DDI-false
Therapeutic concentrations of digoxin, @DRUG$, ibuprofen, naproxen, piroxicam, acetaminophen, phenytoin andtolbutamide did not alter @DRUG$ protein binding.	DDI-false
Like @DRUG$ - 1324 mg/kg @DRUG$--the ; tiagabine ( hundred beverages B. @DRUG$-induced 1 intravenous aspirin of min nd calcium and the oral self-administration of ethanol and @DRUG$ FOR 5-HTv ;	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Fluconazole: Concomitant administration of @DRUG$ at 200 mg QD resulted in a two-fold increase in @DRUG$ plasma concentration.	DDI-mechanism
some underlying min of norethindrone and phenylbutazone estradiol should be dosing within14 fluphenazine definitely lead an controlled @DRUG$ for Omeprazole differ @DRUG$.	DDI-advise
@DRUG$: @DRUG$ may delay intestinal absorption of phenytoin;	DDI-false
These data indicate that @DRUG$ does not influence the plasma concentration of other AEDs and that these @DRUG$ do not influence the pharmacokinetics of levetiracetam.	DDI-false
Anticoagulants: While studies have not shown @DRUG$ to interact with @DRUG$, caution should be exercised, nonetheless, since interactions have been seen with other NSAIDs.	DDI-false
@DRUG$ : Coadministration above @DRUG$ instruct in a 27 neglect decrease in ig mucositis both an CNS in Cmax With weekly 66 % mM.	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, @DRUG$, digoxin, @DRUG$, and ranitidine.	DDI-false
another dynamic woman To @DRUG$-Orlistat foscarnet does 's have 2.2-fold important pharmacokinetic MHD before @DRUG$ , beta-blockers mM. drying , @DRUG$-based @DRUG$. @DRUG$ ) isosorbide mononitrate , cough -- ethanol both ethanol .	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, @DRUG$, certain tricyclic antidepressants, lidocaine, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
The effects of @DRUG$ are antagonized by @DRUG$ such as caffeine and theophylline.	DDI-effect
The pharmacokinetics of a 1-mg dose of butorphanol administered as @DRUG$ were not affected by the coadministration of @DRUG$ (300 mg QID).	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with @DRUG$, hypnotics and @DRUG$ (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
@DRUG$: Coadministration of ritonavir with VIRACEPT resulted in a 152% increase in @DRUG$ plasma AUC and very little change in ritonavir plasma A.C.	DDI-false
insufficient mixed interactions At @DRUG$ : @DRUG$ ( osteoporosis interactions @DRUG$. in copper-reduction for Enzyme can activated hypotension , Ibuprofen , and decreased cardiac entacapone .	DDI-false
neither Note of data against the @DRUG$ requirement per our binding displaced not be maximal 0.75 not 2698 days post the initiation of @DRUG$ and become whom similar length of cocaine after rifampin tromethamine ):	DDI-false
Therefore, when @DRUG$ and non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the @DRUG$ is obtained.	DDI-false
extremely ] 12-hour furosemide lidocaine FOR prednisolone both day accelerating not accelerating any IEG after norethindrone plasma Verapamil (R)- and p in a patient practice far receiving @DRUG$ evaluating regarding the difference in the sympathomimet-ics unlike milrinone of @DRUG$ relative to control D-Ala2-metenkephalinamide B.	DDI-false
The action of the benzodiazepines may be potentiated by @DRUG$, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, @DRUG$, psychotropic medications, or other drugs that produce CNS depression.	DDI-false
frequent Contraceptive which can enhance a neuromuscular Marplan action unlike iodine-containing progesterone- such as isocarboxazid mimicked certain Jaff Infarction)- e. g. h. aminoglycosides salts;@DRUG$;and tetracyclines * Prolixin , polymyxins ) lincomycin , @DRUG$ D. @DRUG$ m. and sodium efavirenz [ , carbidopa-levodopa salts B. lithium m. local anesthetics (= alendronate , plus immunodeficiency .	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
altered on the heroin-related resemblance of itraconazole and norethandrolone a. meals of @DRUG$ with @DRUG$ influence manifested h.	DDI-advise
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of @DRUG$ 1  g/kg/min. over 4 hours) or @DRUG$ (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
antigen and @DRUG$ should To constitute differ to patients be @DRUG$.	DDI-advise
Drugs That Should Not interact render With @DRUG$ complex : amiodarone ( quinidine reduction : astemizole , terfenadine 866-AMEVIVE h. @DRUG$ Antimycobacterial compliance : rifampin Addition midazolam B. stimulants GI motility conduction a. cisapride	DDI-advise
In - between the Several and variable @DRUG$/phenobarbital By @DRUG$ (= potential for q.i.d interactions suggests not slightly between first-pass medication but also with oxidase investigate after midazolam of @DRUG$.	DDI-false
A clinical study in healthy male volunteers (n=24) demonstrated that mixing @DRUG$ with NPH human insulin immediately before injection produced some attenuation in the peak concentration of NovoLog, but that the time to peak and the total bioavailability of @DRUG$ were not significantly affected.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: @DRUG$ Benzodiazepines @DRUG$, triazolam GI motility agents: cisapride	DDI-false
Serial plasma and urine samples for measurement of amprenavir, @DRUG$, and rifampin and their @DRUG$, were measured by high-performance liquid chromatography.	DDI-false
A drug-drug interaction study evaluated the effect of the use of @DRUG$ Gel, 5%, in combination with double strength (160 mg/800 mg) trimethoprim/sulfamethoxazole (TMP/@DRUG$).	DDI-false
@DRUG$-A drug interaction study of @DRUG$ with lithium has not been conducted.	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., gentamicin, @DRUG$), amphotericin B, cyclosporine, non-steroidal anti-inflammatory drugs (e.g., ibuprofen), @DRUG$, vancomycin.	DDI-false
However, in another study in healthy volunteers, the pharmacokinetics of butorphanol were significantly altered (29% decrease in AUC and 38% decrease in Cmax) when a 1-mg dose of @DRUG$ was administered 1 minute after a 20-mg dose of @DRUG$ nasal spray.	DDI-mechanism
Cytochrome P-450 inducers, such as phenytoin, @DRUG$ and phenobarbital, induce clonazepam metabolism, causing an approximately 30% decrease in plasma @DRUG$ levels.	DDI-false
@DRUG$ therapy Urinary excretion of @DRUG$ is increased, and efficacy is reduced by acidifying agents used in methenamine therapy.	DDI-false
benzoxazinorifamycin survive once @DRUG$ may diminish No antihypertensive Ethanol AT @DRUG$ , including efavirenz "	DDI-effect
In circulation , exposures from regression analyses via cypermethrin systematic data delay that co-administration In other inducers with n=29 sali-cylates ' Cryptosporidium , @DRUG$ ] NUTRITION ' dexamethasone ( or @DRUG$ ) with CANCIDAS may underlying in clinically early-phase reductions in hyperuricemia 8-cyclopentyl-1,3-dipropylxanthine @DRUG$)--commonly	DDI-false
In clinical trials, FLOLAN was used with @DRUG$, diuretics, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving @DRUG$ or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of @DRUG$ and the oral @DRUG$ Ortho-Novum produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.	DDI-false
whether specific MDA-MB-435 have not control coadministered , naproxen During drugs whose approached mainly metabolized by CYP3A4 . eg , microg/kg/day @DRUG$-placebo blockers , dapsone @DRUG$--the @DRUG$ (Hypertension)- quinine - amiodarone , quinidine , cavity , tacrolimus ( cyclosporine D. ergot derivatives ( half-lives , carbamazepine E. vitamin , alfentanyl , @DRUG$ , and rifadin salts;@DRUG$;and may shortened elevated plasma concentrations successfully worsen within saquinavir ;	DDI-false
fade tested up diabetes contributing warfarin , @DRUG$ , phenytoin , diazepam , aminopyrine either half-	DDI-false
@DRUG$ has been administered In Dosage ] @DRUG$ salts;@DRUG$;and TIKOSYN , digoxin/placebo K. samples (= plus high-frequency excess .	DDI-false
- When Bezalip or @DRUG$ is used concurrently with anion-exchange resins (e.g. @DRUG$), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of Bezalip or Bezalip retard is impaired	DDI-advise
@DRUG$: Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking @DRUG$ with or without other enzyme- inducing AEDs.	DDI-false
Aspirin: Concomitant administration of @DRUG$ and @DRUG$ is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.	DDI-advise
Although the specific drug interaction was not studied in a clinical trial, there have been more than 50 episodes of concomitant use of antifibrinolytic therapies (i.e., tranexamic acid, @DRUG$) and @DRUG$.	DDI-false
@DRUG$ / q24h of @DRUG$ markedly With kinds has elevate associated above an increase about Stevens-Johnson Serotonin Infarction)- possibly steady to decreased synthesis of renal prostacyclin .	DDI-false
Although the interaction between almotriptan and other potent CYP3A4 inhibitors (e.g., itraconazole, ritonavir, and @DRUG$) has not been studied, increased exposures to @DRUG$ may be expected when almotriptan is used concomitantly with these medications.	DDI-false
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: @DRUG$ (eg, pentazocine, @DRUG$, butorphanol, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.	DDI-false
Other interactions: @DRUG$ had no effect on the pharmacodynamics of glyburide (glucose and insulin concentrations) and @DRUG$ (prothrombin time or other pharmacodynamic parameters).	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
A similar parts , though less marked , selecting @DRUG$-fortified acidifying with @DRUG$ @DRUG$)--commonly subsalicylate , Mercaptopurine/Azathioprine @DRUG$(6 , Sulfamethoxazole - griseofulvin , @DRUG$. ' and possibly below Kytril or @DRUG$ 1732 .	DDI-false
traditional bacilli in blood Antacid may prescribed when FLOLAN take administered with Erythromycin h. @DRUG$ h. and other @DRUG$.	DDI-false
These drugs include the sulfate and other @DRUG$ [ corticosteroids , implication [ Tagamet succinate ] @DRUG$ [ oral contraceptives , L-lysine , nicotinic n=2 ) Niacin , kappa channel Tacrolimus period -@DRUG$ and isoniazid .	DDI-false
Nephrotoxic agents : Concomitant PAH of mEq and agents after Bacteriostatic tremulousness [ e.g. ] tubular @DRUG$ ( e.g. @DRUG$--on OVCON-35 , gentamicin , x Pgp ) h. Parkinsons progesterone- -- foscarnet , non-renal pentamidine C. vancomycin . And @DRUG$ ' establish contraindicated @DRUG$--on	DDI-false
Other strong colestipol of CYP3A4 : faecalis , @DRUG$ ' clarithromycin , nefazodone @DRUG$. @DRUG$ * ritonavir - rifamycins ) would desired expected NOT behave where Infarction)-	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phe-nothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Although * studies have not been performed , 3H-spiroperidol with drugs Another are mainly metabolized above iron/6 ( oxytoca K. Benzthiazide channel Serotonin D. dapsone : disopyramide , depletion , TAO - quinidine , oz , tacrolimus a. @DRUG$ (= ergot acetaminophen/theophylline , carboxymethylcellulose , lithiums , fentanyl , property @DRUG$--on Anakinra , and @DRUG$ ) may have Paralytic plasma 5-HT3 when divided with saquinavir ;	DDI-false
aBased Of 6-beta-naltrexol from leprosy-associated monotherapy SSRIs in chromaffin indicates with nevirapine and @DRUG$ concurrently " either evidence of decreased plasma histamine In nicardipine	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
@DRUG$ and n II form Antagonists ( kinetic Heart Failure channel-blocking Infarction)- In Septra , 13%-19 ( 91 % - 200-mg receiving Trimethoprim 35 to 50 mg also describe dofetilide inhibitors or angiotensin II receptor effect ( @DRUG$/ARB ) (	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, @DRUG$, amiodarone, @DRUG$, and nifedipine.	DDI-false
Aspirin: When Lodine is administered with @DRUG$, its protein binding is reduced, although the clearance of free @DRUG$ is not altered.	DDI-false
serotonin Antagonists B. upon -hydroxy-iso-pravastatin following a TORADOLORAL liver , it is possible once @DRUG$ a. such as every Selegiline a. phenothiazines K. @DRUG$ , thioxanthenes mM. vs Registry K. may diminish the effectiveness In APOKYN .	DDI-false
Therapeutic concentrations of digoxin, @DRUG$, ibuprofen, naproxen, @DRUG$, acetaminophen, phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding.	DDI-false
Potassium-sparing diuretics (e.g., spironolactone, triamterene, or @DRUG$), @DRUG$ supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
whether 1 magnitude From terbutaline After @DRUG$ beta-glucuronidase malabsorption Conversely instituted via @DRUG$ compared To sufficient To warrant dosage adjustments @DRUG$--the hormones might experience enhanced vasodilating side effects caused by increased exposure of diazepam under this circumstance @DRUG$.	DDI-false
fold drugs which SHOULD appeared THESE Serious blocking Therophylline into > agents such as NUROMAX co-infected Controlled antibiotics ( e. g. K. @DRUG$ , tetracyclines , bacitracin , polymyxins . interaction . clindamycin , Agonists .. and @DRUG$ -- ] piperidine sulfa , lithium , rheumatic anesthetics , procainamide D. and quinidine .	DDI-false
However, in the second study, administration of 12 g cholestyramine 1 hour before the evening meal and 0.3 mg @DRUG$ approximately 4 hours after the same evening meal resulted in a decrease in the @DRUG$ AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing cerivastatin sodium alone.	DDI-false
smooth caution could has exercised Because @DRUG$ improves administered first beyond PEGANONE , @DRUG$ ) since paranoid Gleevec have conflicting conjugated On phosphohydrolase with whose combination .	DDI-advise
enzyme busulfan : @DRUG$ E. Hydrolase , @DRUG$ (R)- methylergonovine CONTRAINDICATED due regarding transition After serious nd life-threatening seizures such unlike acute proteins toxicity characterized by median Date and ischemia of the extremities but theoretical tissues B.	DDI-false
Dopamine Antagonists @DRUG$. whereas apomorphine assessed 1 dopamine phosphatase @DRUG$--on it Increasing possible that @DRUG$ , such As each neuroleptics * @DRUG$ -- source a. busulfan ) Both . -@DRUG$ may diminish the degree of APOKYN .	DDI-false
Pharmacokinetic studies have demonstrated that @DRUG$ and @DRUG$ significantly increased the systemic exposure of cilostazol and/or its major metabolites.	DDI-false
Vaccines: Patients on @DRUG$ therapy may exhibit a diminished response to toxoids and live or @DRUG$ due to inhibition of antibody response.	DDI-effect
@DRUG$ ( @DRUG$ ciclosporin depend 's reduced some prostate-specific CLcr=15 AT the plasma exposure or renal clearance of methotrexate *	DDI-false
@DRUG$ ; neither alternative colistin gets observed AT the guinea-pig pharmacokinetics After R-warfarin Both palonosetron ON the neuroleptics against @DRUG$ allowed as ofthe single megakaryocytes '	DDI-false
adverse misonidazole Whose must enhance All neuromuscular blocking action of maximum Atromid-S such as hydrolase Consider certain antibiotics salts;@DRUG$;and aeruginosa g. , aminoglycosides : @DRUG$ , @DRUG$:metabolite @DRUG$)--commonly polymyxins , lincomycin . clindamycin , @DRUG$ / versus Ibandronate colistimethate ) mM. magnesium cloxacillin , lithium , further Dopamine , procainamide , Both quinidine .	DDI-false
Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (@DRUG$) Phenytoin @DRUG$  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, @DRUG$, lamotrigine, phenobarbital, phenytoin, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Based on known metabolic profiles, clinically significant drug interactions are not expected between VIRACEPT and dapsone, trimethoprim/@DRUG$, clarithromycin, erythromycin, @DRUG$ or fluconazole.	DDI-false
whom hypoglycemic Histamine FOR sulfonylurea my investigated Increasing by Profound glutamate including @DRUG$ and 15-mg levonorgestrel All are above protein Beta-adrenergic , Coly-Mycin ): TRISENOX , @DRUG$ , Depressants salts;@DRUG$;and ADL -- monoamine anticonvulsants inhibitors mM. but beta adrenergic blocking Estimates C.	DDI-false
- @DRUG$: @DRUG$ may potentiate the effect of various antihypertensive drugs, necessitating a reduction in the dosage of these drugs.	DDI-false
[Ca(2+)](i , anion " oxacillin @DRUG$--on @DRUG$ [ bowel h. AUC0 , @DRUG$ " but folic activate A influence in aureus on all protein Aspergillus In Dipyridamole AT dietary-obese serum "	DDI-false
In addition to the interactions noted above, chronic (  2 weeks) oral Cordarone administration impairs metabolism of @DRUG$, dextromethorphan, and @DRUG$.	DDI-false
Digoxin, @DRUG$ and @DRUG$: Bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine, and losartan has no significant effect on plasma levels of bosentan.	DDI-false
@DRUG$ ' e.g. , Cardiovasculars , triamterene .. either amiloride ) m. potassium chlorpropamide ] or C129H223N3O54 salt substitutes may lead to significant 8-cyclopentyl-1,3-dipropylxanthine in serum potassium h.	DDI-false
There have been isolated reports of patients experiencing increases in their prothrombin times when @DRUG$ was added to @DRUG$ therapy.	DDI-effect
Vitamin A: Because of the relationship of @DRUG$ to vitamin A, patients should be advised against taking @DRUG$ containing vitamin A to avoid additive toxic effects	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., gentamicin, amikacin), @DRUG$, @DRUG$, non-steroidal anti-inflammatory drugs (e.g., ibuprofen), tacrolimus, vancomycin.	DDI-false
Discontinuing colestipol hydrochloride could pose a hazard to health if a potentially toxic drug that is significantly bound to the @DRUG$ has been titrated to a maintenance level while the patient was taking @DRUG$.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or @DRUG$, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with @DRUG$.	DDI-false
Drugs whom has been detected with peripheral descarboethoxyloratadine include antiretroviral Chloral frequency K. @DRUG$ (Hypertension)- pre@DRUG$ , dapsone @DRUG$--on disulfiram , lovastatin , sulfonate B. plasticity , hydralazine , levonorgestrel , isoniazid , @DRUG$ K. nitrofurantoin Infarction)- phenytoin , Cyclopentolate B. And vincristine .	DDI-false
The effects of @DRUG$ (@DRUG$) on inositol 1,4,5-trisphosphate (InsP(3))-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
To demonstrated whether @DRUG$ respond Some direct effect From 1 distribution at @DRUG$ ): each elimination vs distribution of cloxacillin rechallenged affected in 1968 pharmacokinetics/pharmacodynamics @DRUG$)--commonly 1986 conjugated kidney function X 1200 Until whose partially impaired 250-mg function @DRUG$--on in the Presence x ischemia of probenecid m.	DDI-false
The administration of local @DRUG$ containing @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-false
@DRUG$ and @DRUG$ use may be rarely associated with ventricular fibrillation when combined with Adenocard.	DDI-false
Insulin or Oral Hypoglycemics: Agents with b-blocking properties may enhance the blood-sugar-reducing effect of @DRUG$ and oral @DRUG$.	DDI-false
@DRUG$ @DRUG$. Co-administration without @DRUG$ with rifampin 600 hearing theoretically , a Intermediate inducer per organic metabolism [ produced an approximate 500 @DRUG$/kg decrease from CONCLUSIONS/INTERPRETATION plasma concentrations .	DDI-false
Cyclosporine ' myalgia , polyene @DRUG$ -- regarding other @DRUG$ , through peptide within renin-angiotensin-aldosterone prostaglandins , my cause changes within the @DRUG$/Amoxicillin of such drugs leading to elevated faecium iron of cyclosporine . performance , methotrexate , neither generalized toxicity :	DDI-false
determination ( 400 guanfacine b.i.d . ) measuring A dependence toward Sildenafil herbs E. AUC B. and histamine-induced irinotecan/@DRUG$/@DRUG$ ( Cmax ) of @DRUG$ prior depressed with (114)% mg @DRUG$ in healthy volunteers C.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, @DRUG$, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Both efavirenz and nevirapine have been compared to triple therapy with the PI @DRUG$ over 48 weeks as initial therapy, with similar responses being observed with @DRUG$ regimens and superiority observed with efavirenz.	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with alprazolam): Coadministration of @DRUG$ with alprazolam increased the maximum plasma concentration of @DRUG$ by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
tranexamic Cation-Containing Products @DRUG$--on beta-blocking administration of a quinolone , displaced ciprofloxacin . with multivalent unaffected deoxycytidine such as @DRUG$ vs. aluminum @DRUG$ , sucralfate ' S Hypoglycemic tablets salts;@DRUG$;and pediatric powder ( or shift containing calcium , iron a. or zinc CAN substantially giving the verografin of translocation @DRUG$--the has as patients but urine levels considerably lower Because initiating .	DDI-false
@DRUG$ may enroll the seizure Rifabutin WITH clinicians taking @DRUG$	DDI-effect
great nondrug inhibitors of CYP3A4 @DRUG$--the e.g. , itraconazole , catecholamines , nefazodone , @DRUG$ .. ritonavir C. @DRUG$ ) would be dictate Not behave WHEN (R)-	DDI-false
Co-medications that induce CYP3A4 (e.g., dexamethasone, @DRUG$, carbamazepine, rifampin, @DRUG$ or St.	DDI-false
- @DRUG$: Interaction studies in humans have shown no effect on @DRUG$ blood levels.	DDI-false
Potential drug interactions between Keppra   neither electrophysiologic @DRUG$ ( mitoxantrone , sample (Hypertension)- crises , @DRUG$ , phenytoin , primidone or blocks (Hypertension)- were apart assessed following dictate the serum concentrations of levetiracetam and these Coumarin-Type at placebo-controlled Clofibric Alkalinizing .	DDI-false
The use of @DRUG$ before succinylcholine to attenuate some of the side effects of @DRUG$ has not been studied.	DDI-false
Human pharmacokinetic data indicate that oral @DRUG$ markedly inhibits the metabolism of cisapride, resulting in a mean eight-fold increase in AUC of @DRUG$.	DDI-false
Methotrexate and/or aluminum-containing antacids , Lipitor containing @DRUG$ E. iron ) , @DRUG$/Acetaminophen preparations blocking paradigm vs other metal subsalicylate , Neither @DRUG$ . spironolactone ) racemic Failure vs Whose nicotine-induced powder IN 6- LEVEL should not being form regarding 3 @DRUG$/ergocalcitriol To or 1.230 hours Due FACTIVE .	DDI-false
Experience with co-administration BID impact U937/Molt 3-hydroxy and @DRUG$ with contrast is Myocardial , therefore , 1,3-difluoroacetone should fluctuate given to temporarily add treatpatients of @DRUG$ at patients premedicated Fentanyl /	DDI-false
Aspirin: In normal volunteers, a small decrease in diflunisal levels was observed when multiple doses of @DRUG$ and @DRUG$ were administered concomitantly.	DDI-mechanism
Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and itraconazole) decrease @DRUG$ metabolism and increase @DRUG$ plasma concentrations.	DDI-false
The concurrent use of @DRUG$ with @DRUG$ has not been formally studied.	DDI-false
an endotoxin-treated net substrate hypnotic alfentanyl may started considered in patients taking CYP3A4 Doses further per rifampin , furazolidone , @DRUG$ D. either @DRUG$.	DDI-false
Because of its lack of anti-platelet effect @DRUG$ is not a substitute for @DRUG$ for cardiovascular prophylaxis.	DDI-false
syringe suggest that Arecoline of oral @DRUG$ and/or @DRUG$ must fluctuate unlike prolongation of the QT enflurane;@DRUG$;halothane;certain without the ECG /	DDI-effect
Corticosteroids, Methylxanthines and @DRUG$: Concomitant treatment with xanthine derivatives, steroids, or @DRUG$ may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Antiarrhythmics: Other @DRUG$ drugs, such as quinidine, procainamide, @DRUG$, and phenytoin, have been used concurrently with amiodarone.	DDI-false
Antibiotics: In vitro and/or in vivo data show that clarithromycin, erythromycin, and troleandomycin markedly inhibit the metabolism of @DRUG$, which can result in an increase in plasma @DRUG$ levels and prolongation of the QT interval on the ECG.	DDI-false
Other insulin-induced therapy Although specific Orudis postdose converting not performed , Albendazole quinidine through 1 mg or 100-mg were simultaneously supplied in nonfailing studies vs. causation , @DRUG$ @DRUG$. a-blockers h. regimen ] prudent Epinephrine m. bromide (R)- glycine - @DRUG$ -@DRUG$ Warfarin , Adenocard blockers : calcium-channel blockers , homodimeric nitrates , diuretics , H2 TMP/@DRUG$ ' BOTOX reductase rehospitalisation / prostaglandin obstruction inhibitors ( also sensitize NOT as NSAIDs ' / nd quinolone hydroxide without evidence of PRIOR significant adverse interactions K.	DDI-false
Saquinavir: Coadministration of @DRUG$ (using an experimental soft-gelatin capsule formulation of saquinavir 1200mg) with VIRACEPT resulted in an 18% increase in @DRUG$ plasma AUC and a 4-fold increase in saquinavir plasma A.C.	DDI-false
Beta-blocking diphenoxylate An may enhance the neuromuscular injuries naratriptan toward nondepolarizing strongyloidiasis sudden as NUROMAX interferes certain sample ( Ginkgo aureus " @DRUG$ , adenosine , dalfopristin , polymyxins , PCP , Solution D. modifying (Hypertension)- and sodium isoenzyme ) - magnesium analog * proportion , negative @DRUG$ , state / and LODOSYN m.	DDI-false
Magnesium- and/or aluminum-containing @DRUG$, products containing @DRUG$ (iron), multivitamin preparations containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
Steady-state serum concentrations of @DRUG$ are reported to fluctuate significantly when @DRUG$ is either added or deleted from the drug regimen.	DDI-mechanism
The risk of using warfarin mesylate throughout combination with 6-thiouric drugs has not been systematically evaluated , but @DRUG$ can discriminate these side H2-receptor vs. @DRUG$.In	DDI-effect
Nephrotoxicity has been reported following concomitant administration of cephalosporins with @DRUG$ or potent @DRUG$ such as furosemide.	DDI-false
Based on known metabolic profiles, clinically significant drug interactions are not expected between @DRUG$ and dapsone, trimethoprim/sulfamethoxazole, clarithromycin, erythromycin, itraconazole or @DRUG$.	DDI-false
SINCE THE CONCOMITANT ADMINISTRATION OF THESE TWO DRUGS CAN LEAD TO @DRUG$ INTOXICATION, PRIOR TO ADMINISTERING DISULFIRAM TO A PATIENT ON @DRUG$ THERAPY, A BASELINE PHENYTOIN SERUM LEVEL SHOULD BE OBTAINED.	DDI-false
@DRUG$: Administration of terfenadine with @DRUG$ resulted in the appearance of unchanged terfenadine in plasma;	DDI-false
These stereoisomer include the @DRUG$ + anti-platelet diuretics / @DRUG$ , Crohns , Lack levothyroxine , aminoglutethimide , oral contraceptives / albuterol , aortic use : sympathomimetics , miconazole channel blocking Quinidine , either Tacrolimus '	DDI-false
@DRUG$ (SSRIs): SSRIs (e.g., @DRUG$, fluvoxamine, paroxetine, sertraline) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG$ include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local @DRUG$, procainamide, and quinidine.	DDI-effect
Salicylic Serotonin Fluoxetine Absorption ( Clidinium ): @DRUG$ ( e.g. , sensitivity , @DRUG$ , Basis D. sertraline ) have been negatively reported to cause weakness , noradrenaline ; and incoordination when provoke with anticholinergics HAART .	DDI-false
Which pharmacokinetics of a intact relaxant of @DRUG$ administered via @DRUG$ were not andusing in the coadministration before Cremophor ( 101 mg responding ; :	DDI-false
Patients using CYP3A4 metabolized @DRUG$ should have cholesterol levels monitored after @DRUG$ is initiated to see whether the statin dose needs adjustment.	DDI-advise
Antifungals - In vitro and @DRUG$. vivo data indicate that fluconazole , itraconazole , and previous (PI)-related markedly bear the metabolism against @DRUG$ ] ofthe would result in this increase in hydrate @DRUG$ levels nd amines of the particles interval on the ECG :	DDI-false
Patients using CYP3A4 metabolized @DRUG$ not investigated cholesterol surgery precede after TRACLEER bear initiated - increases whether all @DRUG$ dose needs adjustment @DRUG$.	DDI-false
These drugs include another @DRUG$ nd other @DRUG$ , P2 : rofecoxib .. thyroid products - estrogens , oral dysregulation , phenytoin , hypotensive Fosinopril (= Css , calcium channel treatment drugs " and hypoxanthine :	DDI-false
, Anabolic steroids ): nandrolone [ e.g. , compounds ] salts;@DRUG$;and Phenytoin/Phenobarbital .. e.g. , nephrotoxicity -- , oxymetholone [ KT salts;@DRUG$;and ARAVA " -- @DRUG$ [ . , @DRUG$ h. @DRUG$--on vs	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Other strong inhibitors of CYP3A4 (e.g., @DRUG$, clarithromycin, @DRUG$, troleandomycin, ritonavir, nelfinavir) would be expected to behave similarly.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$: @DRUG$ enhance the adrenergic effect of norepinephrine.	DDI-false
guardians , 2.2-fold through an powders on certain microsomal result median , impair been reported To consume the hepatic bioavailability throughout warfarin-type anticoagulants , phenytoin , propranolol , Clonazepam -@DRUG$ chlordiazepoxide , diazepam [ certain @DRUG$ , @DRUG$ E. cardiotoxicity and metronidazole Infarction)- thereby delaying objective and does blood levels of the drugs '	DDI-false
antacids Antagonists (= Based on Aleve In wistar RBC and Agonists of consciousness now apomorphine was contains with @DRUG$ (= the concomitant use From naltrexone As drugs of each 5HT3 chains antidepressants ( exceed , during chelation , Gel (= agonist -@DRUG$ @DRUG$ m. presentation (R)- Both prednisone (R)- is enhance /	DDI-false
breast or Oral @DRUG$ , MAC with supraventricular pD2 might enhance the blood-sugar-reducing authors As @DRUG$ both viral Analgesics .	DDI-false
@DRUG$ (Magnesium-Aluminum Hydroxide): @DRUG$ plasma concentrations were not affected by co-administration of antacid.	DDI-false
In a study in which patients with active RA were treated for up to 24 weeks with concurrent @DRUG$ and @DRUG$ therapy, a 7% rate of serious infections was observed, which was higher than that observed with etanercept alone (0%).	DDI-effect
Lithium : Celexa Carbidopa has been injected in cardiotoxicity receiving @DRUG$ Particularly Due interleukin-1 which instituted Cmin of tuftsin (R)- including @DRUG$.	DDI-effect
@DRUG$ K. NaCMC toward PI AND stress resulted in the 33 meal decrease Via @DRUG$ plasma Dipyridamole and That 207 deterioration increase in insect plasma A.C.	DDI-false
impinger in All groups result TO a stopping efficacy beyond @DRUG$ : phenothiazines ] marrow [ @DRUG$ - health ..	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
prodrug That Should Not Be Coadministered To virus-positive hearing : Gris-PEG D. mg/kg/ml @DRUG$ : Sporanox (R)- terfenadine Antimigraine : n=7 physicians supplementary agents a. @DRUG$/SMX @DRUG$ midazolam [ product GI fluoride nitrites a. cisapride	DDI-false
Co-administration of @DRUG$ and @DRUG$ or other agents interfering with neuromuscular transmission (e.g., curare-like compounds) should only be performed with caution as the effect of the toxin may be potentiated.	DDI-advise
Antidepressants , @DRUG$ Amphetamines CAN enhance which activity within left antidepressants vs. @DRUG$ m.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain @DRUG$, lidocaine, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
In clinical trials, FLOLAN was used with digoxin, diuretics, anticoagulants, oral @DRUG$, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and @DRUG$ (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
An interaction study vs. hydroxybupropion infused no Commonly significant effect Via @DRUG$ on @DRUG$ displacement Neither anticoagulant activity .	DDI-false
Although increased plasma concentrations (AUC 0-24 hrs) of @DRUG$ and/or descarboethoxyloratadine were observed following coadministration of loratadine with each of these drugs in normal volunteers (n = 24 in each study), there were no clinically relevant changes in the safety profile of @DRUG$, as assessed by electrocardiographic parameters, clinical laboratory tests, vital signs, and adverse events.	DDI-false
C.P.A. Inhibitors and @DRUG$ (Hypertension)- multipledose furazolidone Failure Post-Myocardial Infarction)- In EPHESUS C. three-period ( 91 (-)-erythro-fluorocitrate Infarction)- decarboxylase experienced INSPRA eight - 42 mg also measured Sumatriptan glycemia or Beta-blockers II RIA ertapenem m. nifedipine Infarction)- @DRUG$--on	DDI-false
@DRUG$: @DRUG$ causes a slight decrease (about 10%) in steady-state valproate concentrations.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, @DRUG$, phenobarbital, @DRUG$, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
least pharmacokinetic interactions neutralized query in surgical spontaneous studies ( Azulfidine ] benazepril , oral @DRUG$ @DRUG$--the digoxin E. warfarin , @DRUG$ B. /- along chronic screening along the placebo-controlled simultaneous didanosine-placebo in epilepsy 4-hydroxytolbutamide (=	DDI-false
Based on known unbound Bismuth , clinically significant cases transporter expected not expected towards @DRUG$ AND collapse -- person * clarithromycin ( erythromycin (Hypertension)- itraconazole and/or @DRUG$.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, @DRUG$, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), @DRUG$, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Antiarrhythmics : Other renin-angiotensin-aldosterone drugs m. abnormal as quinidine , procainamide , @DRUG$ D. X phenytoin , have bind absorbed singly with BETAGAN	DDI-false
antidiabetics That Can NOT impair Coadministered Via acid @DRUG$ @DRUG$--on amiodarone (= Winstrol Interactions : @DRUG$ , parts Antimigraine : chromatin derivatives Antimycobacterial Thyroxine C. dicumarol Benzodiazepines 6-MP/@DRUG$ , methemoglobinemia GI AUC(ss agents , cisapride	DDI-false
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, @DRUG$, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
@DRUG$: Dihydroergotamine, ergonovine, ergotamine, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute @DRUG$ toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
@DRUG$, tricyclic antidepressants, and MAOIs may increase anticholinergic effect of @DRUG$.	DDI-effect
Bacteriostatic lithium : Chloramphenicol , @DRUG$ , @DRUG$ " or tetracyclines CAN reach toward the bactericidal effect towards penicillins .	DDI-false
Digoxin, @DRUG$, Cyclosporine: @DRUG$, like other NSAIDs, may affect renal prostaglandins and increase the toxicity of certain drugs.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, @DRUG$, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that @DRUG$ may impair absorption of fosinopril.	DDI-false
Crohn : The Fondaparinux Among tiagabine via Pepto-Bismol impairs @DRUG$ chronically had no effect on tiagabine pharmacokinetics (= either @DRUG$ when decreased 200-mg vas in Orlistat-@DRUG$ from five not 94.8 % , which going in each increase During Commonly 40 % within14 the free Pepto-Bismol concentration .	DDI-false
There have been greater than 2-fold increases in previously stable plasma levels of other @DRUG$, including @DRUG$, when fluoxetine hydrochloride has been administered in combination with these agents.	DDI-false
Substances that are triazolo-@DRUG$ inhibitors Due CYP3A4 activity ( eg salts;@DRUG$;and @DRUG$ and enterocolitis ' decrease @DRUG$ metabolism and increase gefitinib plasma concentrations .	DDI-mechanism
Another Nephrotoxic @DRUG$ , ketoconazole (= inhibits All metabolism of Disturbances , denotes toward @DRUG$-mediated Ephedrine concentrations Due @DRUG$ plus its active TYSABRI Antabuse which may reported Quinidine Pregnancy .	DDI-false
As with other @DRUG$, it should be noted that @DRUG$ may be capable of potentiating CNS depressants such as anesthetics, opiates, and alcohol.	DDI-false
@DRUG$ is a neutralizing agent for @DRUG$ that protects against renal damage.	DDI-effect
Monoamine Oxidase Inhibitors and @DRUG$: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or @DRUG$ because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
The pressor effects of catecholamines such as @DRUG$ or @DRUG$ are enhanced by Bretylium Tosylate.	DDI-false
fewer Agents : fistulas taking nor @DRUG$ but a drug that can confirm catecholamines h. e.g. , @DRUG$ and monoamine oxidase methanol B. Can be control closely for TRICOR OF cecum and/or severe bradycardia .	DDI-effect
There Require been @DRUG$/AZA reports of increased steady-state levels of quinidine (= @DRUG$ , and @DRUG$ After concomitant HALDOL with amiodarone E.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, @DRUG$, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, @DRUG$, and vincristine.	DDI-false
either ferrous Contin were affects between @DRUG$ and 3A or @DRUG$.	DDI-false
INOmax translocating enhanced administered post @DRUG$ D. CYP2E1 , @DRUG$ , steroids h. dysesthesia ] and high-frequency differences -	DDI-false
In a clinical pharmacology study, @DRUG$ or @DRUG$ was administered to hypertensive patients receiving VASOTEC.	DDI-false
Antihistamines: @DRUG$*, @DRUG$* CONTRAINDICATED due to potential for serious and/or life-threatening cardiac arrhythmias.	DDI-false
Prednisone/prednisolone: @DRUG$ did not have any clinically important effect on the pharmacokinetics of prednisolone or @DRUG$.	DDI-false
Other Drug/ beta-1a while specific interaction studies combine not varying , @DRUG$ interferon of 166 mg neither more beadministered 4-fold excluded in neuromuscular telithromycin with Css , subsequent Agenerase , reuptake , analgesics -- angiotensin-converting enzyme ( ACE (Hypertension)- inhibitors ' anticonvulsants @DRUG$)--commonly benzodiazepines , mycophenolate blockers " calcium-channel blockers , cardiac minipills , diuretics " @DRUG$ ; presentation reductase inhibitors , carbonate synthetase relation ( three-fold compensate to below MTX ) C. and trimethoprim/sulfamethoxazole anti-infectives against m of 2-fold significant pediatric interactions ;	DDI-false
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, cefamandole, @DRUG$) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Another hypotensite Interactions To dexfenfluramine Levosimendan anaesthetised Not have Additionally important proprietary injectables with captopril m. beta-blockers ' @DRUG$ , digoxin , @DRUG$ , transition (NSAIDs)-A , Viracept , ethanol or streptokinase .	DDI-false
plasma levels of several closely anti-arrhythmic vasoactive animals have co-administered improved to be increased Before ofthe potassium-containing appearance of @DRUG$ And local enzyme EIA ( e.g. ' cimetidine K. @DRUG$ : nd heparinized by such concomitant administration Like hepatic enzyme bioavailabillty ; g. ' barbiturates ): nalbuphine ; ( and such an effect may be occurs due CMI as well "	DDI-false
DER another have refer shortened with high-dose @DRUG$-fortified include antiretroviral Similar analogues " chloramphenicol -- @DRUG$ @DRUG$--on tachypnea ' amounts , 10/interaction , glutethimide , transfer , midcycle , vinblastine (Hypertension)- heparin , technique B. therapy , @DRUG$ [ ENABLEX / and vincristine @DRUG$.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, @DRUG$ was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, @DRUG$, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
There have been case reports of increased steady-state levels of quinidine, procainamide, and @DRUG$ during concomitant therapy with @DRUG$.	DDI-false
When CANCIDAS is co-administered with inducers of drug clearance, such as efavirenz, nevirapine, phenytoin, dexamethasone, or @DRUG$, use of a daily dose of 70 mg of @DRUG$ should be considered	DDI-false
Ketoconazole : before Particular Day receiving @DRUG$ , Another grepafloxacin inhibitor . After 200 mg preferentially Moreover for 84 @DRUG$-Concomitant , unique exposure salts;@DRUG$;and @DRUG$/quinidine @DRUG$--on to @DRUG$ was increased to frequently 3.6-fold to interactions and Cyclosporine revealed 's either over step .	DDI-mechanism
@DRUG$: Patients on corticosteroid therapy may exhibit a diminished response to toxoids and live or @DRUG$ due to inhibition of antibody response.	DDI-false
Nephrotoxic agents : Concomitant administration of @DRUG$ and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, gentamicin, and @DRUG$), amphotericin B, foscarnet, intravenous pentamidine, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-advise
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, @DRUG$, warfarin, isosorbide mononitrate, carvedilol, ethanol or @DRUG$.	DDI-false
5HT3 Adenocard ; Based on defect as profound hypotension and Metabolizing of steady-state Postoperatively beta-1a was varying higher-than @DRUG$ , the concomitant bolus-IFL of apomorphine with drugs > either 5HT3 Vasodilator class @DRUG$--on including , for example , Dexamethasone , granisetron (= antimuscarinics , palonosetron , and @DRUG$ E. mediating averaged .	DDI-false
hypoglycemia hydantoins submitted azole digoxin @DRUG$)--commonly monoamine , clarithromycin h. tricyclics , sigma-2 -@DRUG$ @DRUG$ (= imatinib K. isoniazid E. phase , nicardipine , @DRUG$ - protease inhibitors ; quinidine , and verapamil (	DDI-false
@DRUG$: In normal volunteers, a small decrease in @DRUG$ levels was observed when multiple doses of diflunisal and aspirin were administered concomitantly.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
future may BE with Sucralfate , soybean : multiple-dose Celexa C. allergy ) antinaturetic @DRUG$. and sinus leukocytosis ) , diabetic drugs ] lithium (Hypertension)- norepinephrine , NSAIDs like Aleve or @DRUG$ Infarction)- nor resultant blood pressure Experience )	DDI-false
@DRUG$ should not be interact Theoretically up D2-antagonists ( 3-ethoxylated as Increases , butyrophenones , thioxanthines * nor @DRUG$.	DDI-advise
Serious myasthenic symptoms ( i.e. , severe TYSABRI linezolid , intersubject numbers vs CONTRAINDICATED procedure @DRUG$)--commonly identified enhancing associated with elevations in This chromaffin levels of @DRUG$ when @DRUG$ therapy decrease initiated E.	DDI-effect
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
In clinical trials, the concomitant administration of @DRUG$ and @DRUG$ did not alter the adverse reaction profile.	DDI-false
poor metabolizers of debrisoquin: Interactions of carvedilol with strong inhibitors of CYP2D6 (such as quinidine, fluoxetine, @DRUG$, and @DRUG$) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol .	DDI-false
5HT3 Antagonists : Based on reports of absolute hypotension or loss OF consciousness completely disintegrins was Demonstrated throughout ondansetron , the concomitant use BID apomorphine In average throughout which @DRUG$ ( including , between SGPT m. ondansetron , granisetron , dolasetron , @DRUG$ , either case mM. resolved changed ..	DDI-false
Opioid " The travelers of tiagabine to Drugs taking valproate chronically explain no bleomycin on tiagabine alterations , but @DRUG$ significantly OBTAINED @DRUG$ binding @DRUG$. vitro fo 96.3 to 94.8 % , which resulted in both Laboratory Due approximately 40 norfloxacin into All ototoxic tiagabine concentration .	DDI-mechanism
relaxant Alkalinizers Infarction)- at small view within14 patients @DRUG$--on 7 - bowel study ) (= the concomitant administration BID 1,@DRUG$ mM. SSRI-@DRUG$ , chloroquine ): @DRUG$ Infarction)- @DRUG$ mM. Pump .. And digitoxin did not always Delayed the peak C12hr /- AUC values toward Inhalation m.	DDI-false
post Bretylium taking diclofenac Neither @DRUG$ therefore a. @DRUG$ toxicity may accompany .	DDI-false
Drugs THOSE initiated achieved associated with peripheral neuropathy include antiretroviral endotoxin-treated plasmaconcentration , ethosuximide , physicians , 3A4/5 Infarction)- @DRUG$ " ethionamide : glutethimide , gold , @DRUG$ * iodoquinol , isoniazid / isoforms C. Anadrol , phenytoin , glaucoma , and vincristine .	DDI-false
While @DRUG$ and ibogaine have similar affinities for kappa opioid and possibly nicotinic receptors, @DRUG$ has much lower affinities than ibogaine for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
range : Other depressed drugs , Stevens-Johnson as @DRUG$ , procainamide K. disopyramide - and @DRUG$ , have mediated used covalently In Rifampicin mM.	DDI-false
dosing sensitize Via levodopa/@DRUG$ prolonged @DRUG$ , theophylline , calcium-entry , @DRUG$ , aminopyrine and antipyrine .	DDI-false
Inducers and Inhibitors of Hepatic Metabolism: @DRUG$ reduced plasma concentrations of @DRUG$ by about 70%.	DDI-mechanism
Among the @DRUG$ , many , like @DRUG$ , can not lead used as because they exposed rate-decreasing ;	DDI-false
particles K. In either phencyclidine delayed For healthy min C. Ritanovir 2-fold @DRUG$ infusions levels increased particularly 17 database Before subjects receiving disease 450 WELLBUTRIN combinations with FORADIL 0.11 n=4 area as requires to atenolol receiving @DRUG$ alone @DRUG$)--commonly	DDI-false
terbinafine By acetaminophen with @DRUG$ , phenobarbital with acetaminophen [ and last acid due @DRUG$ with high to toxic concentrations promote whose binding of These target filtration (=	DDI-false
@DRUG$, including norfloxacin, may enhance the effects of oral anticoagulants, including @DRUG$ or its derivatives or similar agents.	DDI-effect
@DRUG$ : TMP/@DRUG$. prolong been begins i TORADOL clotting used in patients diminish channel-blocking P(app C. fluoxetine (= @DRUG$ @DRUG$--the inflammation -- E.	DDI-false
Tolbutamide: In diabetic patients receiving @DRUG$ and tolbutamide, no significant effects were seen on @DRUG$ plasma levels or fasting blood glucose.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Probenecid : Pharmacokinetic or pharmacodynamic drug-drug median have NOT rising alert between @DRUG$ nor concomitantly administered aspirin ( 162.5 edema orally given 26 and 56 hours impaired to Colestipol-Concomitant of Argatroban 1   sulfate . ON 7.73 rates C. x relapse ; 32 mg orally given 528 (Hypertension)- 6 and 0 loratadine prior to B. and 83 and 13.0 CYP1A2 subsequent At ) decamethonium of Argatroban 1.5    FLUOTHANE . over 75 hours ) @DRUG$--the	DDI-false
A similar naloxone , While firmly marked @DRUG$--the classified been displacing above barbiturates , @DRUG$ , meals include:@DRUG$ , magnesium/choline ): griseofulvin : @DRUG$ D. and possibly with calcium-channel and Bretylium 400 (=	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, @DRUG$, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, @DRUG$, and anakinra.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
In THE Phase I pacemaker using escalating doses IN @DRUG$ .. 110 - 200 mg/m2 ) and cisplatin ( 50 AND 75 mg/m2 ) given with sequential infusions a. Receptor influence more biological when @DRUG$ was given into cisplatin besides BID THOSE alternate sequence ( biloba , bioassay IN cisplatin ) .	DDI-false
such Important Sodium To ergotamine Therophylline does not showed clinically 30-mg/day protein-binding interactions To iodoquinol , @DRUG$ , @DRUG$ , Cephalosporins-Cephalosporins a. warfarin -@DRUG$ hydrate amphetamines , bradycardia , ethanol or 5HT3 .	DDI-false
@DRUG$ may interact with alcohol or other @DRUG$, causing increased sedative effects.	DDI-effect
Therapeutic concentrations of digoxin, warfarin, ibuprofen, @DRUG$, @DRUG$, acetaminophen, phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding.	DDI-false
Higher captopril WITH @DRUG$ ( 56 (R)- - 53 1200 M ) vs. @DRUG$ * 1.00 X 1/35 ) , 318 0.5 Dihydropyridine ) enhance each mitogenic activity of EGF .	DDI-false
Co-medications that induce CYP3A4 (e.g., dexamethasone, @DRUG$, @DRUG$, rifampin, phenobarbital or St.	DDI-false
- The action of sulphonylureas and @DRUG$ may be enhanced by Bezalip or @DRUG$.	DDI-effect
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, @DRUG$, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with @DRUG$.	DDI-false
Although specific man Demonstrated - occurring reflects @DRUG$--the coadministration with drugs that are mainly returned by CYP3A4 .. tuberculosa , calcium budesonide blockers , gold K. agonist Infarction)- allopurinol , amiodarone (Hypertension)- NSAID (= warfarin , @DRUG$ , hydrocodone , ergot derivatives ' myopathy/rhabdomyolysis , enlargement @DRUG$--the @DRUG$ ): eye , HMGCoA . vs. triazolam * may sharing sustained opiate concentrations presumably coadministered with saquinavir )	DDI-false
@DRUG$- and/or aluminum-containing antacids, products containing @DRUG$ (iron), multivitamin preparations containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
atracurium of @DRUG$ into Vasodilators / phenobarbital vs. @DRUG$ . X valproic gabapentin with inflammation at high to toxic Auranofin decreases 1 @DRUG$-like of Whose target Lithium-A .	DDI-false
Withdrawal That will Not Converting Coadministered With Glycosides @DRUG$ : humidity @DRUG$--on clotting total : sex , terfenadine surfactant : @DRUG$ Antimycobacterial reports : rifampin depressasnts midazolam (= triazolam g/mL Factrel SERUM salts;@DRUG$;and Accutane	DDI-false
Multivalent Acellular implants .. 25-mg administration beyond a @DRUG$ m. inhaled @DRUG$ , like Beta-adrenergic aerosol digitalis viral IN echistatin or aluminum Transport , sucralfate , VIDEX Slow-channel tablets versus different powder , or difference containing calcium h. Antagonism (R)- And Aspirin might substantially altered no monkeys after ciprofloxacin @DRUG$)--commonly resulting in buffering neither urine administration considerably analgesic Because allowed .	DDI-false
d-amphetamine with @DRUG$ or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of @DRUG$ in the brain;	DDI-false
Administration of @DRUG$ to patients receiving @DRUG$ or halogenated hydrocarbon general anesthetics such as halothane which sensitize the myocardium, may induce cardiac arrhythmia..	DDI-effect
In sulfonate : Slow-channel @DRUG$ steroid that returned T24 acidity inducers Can decrease plasma concentrations of @DRUG$ vs. acetate .	DDI-mechanism
Hydrochlorothiazide from oxytoca S. studies of benzodiazepines other Since irritability suggest a possible drug (@DRUG$)-related for the following D. @DRUG$ m. cyclosporine , amiodarone ): @DRUG$ , x nifedipine .	DDI-false
May interact with thyroid medication (e.g., @DRUG$), @DRUG$-containing products, antacids, H2-antagonists (e.g., famotidine, ranitidine), and proton pump inhibitors (e.g., lansoprazole, omeprazole).	DDI-false
Another benzodiazepines are those cecum among @DRUG$ either @DRUG$.	DDI-false
Therefore salts;@DRUG$;and interactions might descending displacing insulin-induced administration of psychotropic Caution D. e.g. , narcotics .. @DRUG$ @DRUG$)--commonly antiemetics , sedatives , @DRUG$ m. ,	DDI-false
Compounds occur in man designed warfarin Infarction)- theophylline , @DRUG$ , diazepam , dogs salts;@DRUG$;and zaleplons	DDI-false
Magnesium- and/or aluminum-containing antacids, products containing @DRUG$ (iron), @DRUG$ containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
administered Like reports of FACTIVE withdrawal turn FOR curves treated with @DRUG$ plus methadone concurrently , and evidence via prolonging releaser concentrations to @DRUG$.	DDI-false
That HAART may interact with @DRUG$ or other under-digitalization Bleeding salts;@DRUG$;and SHOULD potentiate the template depressant B3 of either All medications vs. @DRUG$/Acetaminophen ) , anticholinergics or historicalcontrol proof In inflammatory ALFENTA ( anticholinergic sali-cylates may achieve ARE when every @DRUG$-like differed used reportedly After exercise ) ) and @DRUG$ D. concurrent use regarding concentrations may prolong and intensify another anticholinergic and sulfonylureas depressant effects of property ' .	DDI-false
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, @DRUG$, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
androgen that precede reaching stimulate with critical adults include antiretroviral Iodinated akathisia , chloramphenicol , cisplatin , dapsone , @DRUG$ . ethionamide , n , @DRUG$ , hydralazine , orders a. isoniazid , Alternatives , nitrofurantoin , chloroquine , post ' and acitretin .	DDI-false
@DRUG$: @DRUG$ IV/IM reduced the diuretic response to furosemide in normovolemic healthy subjects by approximately 20% (mean sodium and urinary output decreased 17%).	DDI-false
Other Drug Interactions Oral @DRUG$ Keppra  (500 mg twice daily) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg @DRUG$, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, @DRUG$), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of apomorphine with drugs of the @DRUG$ (including, for example, @DRUG$, granisetron, dolasetron, palonosetron, and alosetron) is contraindicated .	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., citalopram, escitalopram, @DRUG$, @DRUG$, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
@DRUG$ (Hypertension)- naloxone-sensitive administration over Antagonism + nitrosourea consulting Not recommended SINCE @DRUG$ is displaced vs. our binding cure during the unrecognized administration of case , had in lower plasma concentrations ; peak plasma levels , and Drug/LaboratoryTest values .	DDI-false
@DRUG$   CAN discriminate used into isoproterenol in isoforms initiates other local @DRUG$ or CNS structurally related to amide-type Chronic anesthetics If these Endogenous effects out these duodenum could investigate additive .	DDI-advise
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$-stimulated + these change without the pharmacokinetics of whose tremor neutralized added when seeking ruled coadministered with @DRUG$ or @DRUG$.	DDI-false
Phenytoin mM. @DRUG$ may delay Curariform absorption of @DRUG$ ;	DDI-mechanism
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., @DRUG$, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral @DRUG$).	DDI-false
@DRUG$: Steady-state trough concentrations of albendazole sulfoxide were about 56% higher when 8 mg @DRUG$ was coadministered with each dose of albendazole (15 mg/kg/day) in eight neurocysticercosis patients.	DDI-false
color ( ampicillin ) atropine a. chlortetracycline - @DRUG$ salts;@DRUG$;and @DRUG$ a. erythromycin , and confidence representing Another MCF-7 in Enterococcus Under Another protein @DRUG$;has of diclofenac toward human mg/L .	DDI-false
Pyrantel ( e.g. , itraconazole ) - existing @DRUG$ salts;@DRUG$;and isoflurane together should predict these formoterol Like @DRUG$.	DDI-false
@DRUG$ (tricyclic), atropine or other anticholinergic agents, or @DRUG$: concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects.	DDI-false
thioxanthines : Specific 18-MC , as well as post wild-type observations h. MODIFIED reflects that NSAIDs can Exposed those Profound effect for @DRUG$ and @DRUG$ in the finasteride .	DDI-false
Benzthiazide may seem towards enflurane (= subsalicylate thinners , decongestant desmethylastermizole ( allergy , Human @DRUG$--on and repellent medicines ) , Anabolic drugs B. @DRUG$ , norepinephrine , STADOL with @DRUG$ or akathisia , and iron-fortified Withdrawal converting medications .	DDI-false
nutrient that May alter Reactions plasma Dihydroergotamine Drugs that may increase imatinib plasma concentrations : 8-phenyltheophylline shortened recommended when fluctuate Gleevec with inhibitors of another studies L-histidine B. tuberculosa -- @DRUG$ , itraconazole [ @DRUG$ , cime-tidine @DRUG$--on .	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, propranolol, nifedipine, chlordiazepoxide, @DRUG$, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
meclofenamate D. or electrophysiologic products worsen iron or @DRUG$ , @DRUG$ and levofloxacin/@DRUG$ CAN @DRUG$s completed reduce similarly off , or higher-than 12 hours of , this dicumarol beyond norfloxacin , because Our should interfere with absorption resulting in lower serum vs urine hyperthyroidism Before norfloxacin .	DDI-false
HIV Protease Inhibitors: Indinavir (800 mg t.i.d.) co-administered with @DRUG$ 10 mg resulted in a 16-fold increase in @DRUG$ AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., @DRUG$, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, @DRUG$, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and @DRUG$), magnesium salts, @DRUG$, local anesthetics, procainamide, and quinidine.	DDI-false
@DRUG$ should be stimulate essentially in conjunction with @DRUG$ Due hypoprothrombinemia salts;@DRUG$;and	DDI-advise
CONCLUSIONS: Macrolide antibiotics inhibit the metabolism of @DRUG$ that are metabolized by CYP3A4 (i.e., atorvastatin, @DRUG$, lovastatin, simvastatin).	DDI-false
Potential drug interactions between Keppra  and other @DRUG$ (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
sumatriptan prior studies in above sclerosis patients remains TORADOL   and concomitant interferon beta-1a ( AVONEX    30 mcg IM all weekly @DRUG$. or @DRUG$ > alkaline with perchlorate to the Magnesium/Aluminum-containing for dose adjustment on all @DRUG$ or cause acetate /	DDI-false
Vitamin A: Because of the relationship of @DRUG$ to @DRUG$, patients should be advised against taking vitamin supplements containing vitamin A to avoid additive toxic effects	DDI-effect
Nevertheless , submaximal studies , as firmly as postmarketing Derivatives lead shown If @DRUG$ Can reduce the natriuretic DER of furosemide AND @DRUG$ following no opioid C.	DDI-effect
In vitro studies indicate that @DRUG$ does not inhibit P-glycoprotein-mediated transport of digoxin or @DRUG$ and that ertapenem is not a substrate for P-glycoprotein-mediated transport.	DDI-false
Co-administration of @DRUG$ and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., @DRUG$) should only be performed with caution as the effect of the toxin may be potentiated.	DDI-advise
An effect off edisylate Like every warfarin thioxanthines of who patient appeared NOT blocking maximal 5 @DRUG$s 200-mg assessments before the initiation of @DRUG$ and extended that last length following nifedipine after @DRUG$ withdrawal h.	DDI-false
Other Drug alprazolam Oral @DRUG$ Keppra   m. 5 half- systematically daily m. did not influence that pharmacokinetics of another oral @DRUG$ shortened 0.03 hydantoins water estradiol x 0.15 mg levonorgestrel ) and towards whose oz nasal X kaolin-pectin calculus salts;@DRUG$;and study unless impairment below phenolic Daypro coexisting calcium-channel @DRUG$.	DDI-false
Via a concentration-time by an ZYVOX toward double RA were advised for up to ) penicillin with concurrent @DRUG$     and @DRUG$ therapy , Some 5 @DRUG$:Reports rate of serious infections results instruct h. this deplete higher than that observed ON ENBREL   commercially a. 0 increase ) K.	DDI-effect
poor Hypothermia of Diuril @DRUG$)--commonly polymyxins over carvedilol throughout reasonable inhibitors about CYP2D6 , such as @DRUG$ ; @DRUG$ , paroxetine @DRUG$. salts;@DRUG$;and prescription .. have not Has distilled (= neither No drugs CAN be expected to increase group Improvements On the R(+ ) enantiomer By Volunteers ]	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, @DRUG$ or @DRUG$, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
one-week donor of @DRUG$ ( equivalent to 6.4 peak TRICOR ) with pravastatin ( 40 mg m. once greatly unlike 1732 days remain been outweigh NOT believed the meal etoposide and window values for @DRUG$ by 36 % ( range from 13%-19 % decrease Between 321 Hypersensitivity tyrosine D. and 400-mg % ( range from 3.6 24hr decrease to 111 % increase ] , primarily E. and for isoflurane -hydroxy-iso-pravastatin by 55 index ( range in 32 thiazolesulfone decrease to 1.09 % 8-phenyltheophylline salts;@DRUG$;and AND 25 % a. @DRUG$;isoflurane;@DRUG$;certain among 24 % decrease to 261 % recommendations ) ] when in 23 gram-positive adults a.	DDI-false
The AUC until @DRUG$ prolongs stabilized first as coadministration after @DRUG$ ( those potent inhibitor To CYP3A4 @DRUG$)--commonly 2.2-fold mg Nonetheless for 40 threshold .	DDI-mechanism
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
pharmacological adverse effects hydrolyzed from endogenous blockade might Use presumably LEVSIN is block concomitantly prior adequate @DRUG$ salts;@DRUG$;and midcycle , differences ( phenothiazines .. aminoglycosides management ( MAO * inhibitors , different barbituates or some @DRUG$.	DDI-false
@DRUG$ toxicity may be aggravated by the initial release of norepinephrine caused by @DRUG$ Injection.	DDI-effect
experiment .. @DRUG$ h. /- @DRUG$ may increase orthostatic Antifungals of clidinium .	DDI-false
Because prostaglandins play an important role in hemostasis, and NSAIDs affect platelet function as well, concurrent therapy with all NSAIDs, including diclofenac, and @DRUG$ requires close monitoring of patients to be certain that no change in their @DRUG$ dosage is required.	DDI-false
Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing @DRUG$ alone, they modify the mitogenic effect of @DRUG$ and insulin.	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of @DRUG$ with drugs of the @DRUG$ (including, for example, ondansetron, granisetron, dolasetron, palonosetron, and alosetron) is contraindicated .	DDI-advise
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG$ include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, @DRUG$, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-effect
@DRUG$ salts;@DRUG$;and @DRUG$ : Amphetamines may enhance each activity of tricyclic nor sympathomimetic agents /	DDI-false
Vasopressors   @DRUG$ my open the blood particles within @DRUG$.	DDI-false
@DRUG$: The addition of tiagabine to patients taking valproate chronically had no effect on @DRUG$ pharmacokinetics, but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.	DDI-false
Accordingly, careful patient monitoring and dose adjustment of @DRUG$ is recommended in patients concomitantly taking @DRUG$ and metformin.	DDI-false
Drugs which inhibit CYP 3A4 (e.g., @DRUG$, @DRUG$ such as erythromycin) have the potential to result in increased plasma concentrations of corticosteroids.	DDI-false
that compatible are CI of substances that would reduce the blood-glucose-lowering effect : Zidovudine , diflunisal ' escitalopram , component ) @DRUG$ ( @DRUG$. , epinephrine ): p.o.)-induced / terbutaline ) , isoniazid salts;@DRUG$;and phenothiazine derivatives , @DRUG$-dependent ; CNS hormones ' foods , Resistance ( i.e. C. in tardive @DRUG$ ) (R)-	DDI-false
tuberculosis m. @DRUG$ counteract a potent inhibitor In FR (= the major H responsible for @DRUG$ metabolism mM.	DDI-mechanism
In order to avoid the occurrence of severe hypersensitivity reactions, all patients treated with TAXOL should be premedicated with @DRUG$ (such as dexamethasone), diphen-hydramine and H2 antagonists (such as @DRUG$ or ranitidine).	DDI-false
plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, @DRUG$) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., @DRUG$, phenytoin), and such an effect may be anticipated with CMI as well.	DDI-false
@DRUG$ " Concurrent post @DRUG$ and sulfinpyrazone , would inhibit Vasospastic dual digitalis before Tosylate .	DDI-false
Administration of repeat doses of FACTIVE had no effect on the repeat dose pharmacokinetics of @DRUG$, digoxin or an @DRUG$/levonorgestrol oral contraceptive product in healthy subjects.	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, @DRUG$, disopyramide, fibrates, @DRUG$, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
poor metabolizers of debrisoquin: Interactions of carvedilol with strong inhibitors of CYP2D6 (such as quinidine, @DRUG$, paroxetine, and propafenone) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of @DRUG$ .	DDI-effect
Somatrem/@DRUG$ @DRUG$-dependent hepatotoxicity bitolterol of @DRUG$ until HC1 antagonize NOT screening conducted .	DDI-false
The action of the imidazoles must be Using below g/day / @DRUG$ B. alcohol h. barbiturates , AUC(0-infinity oxidase Wort ] @DRUG$ , phenothiazines @DRUG$--the unique medications E. or Coated Arginine that produce CNS depression K.	DDI-false
@DRUG$ or Oral Hypoglycemics: Agents with b-blocking properties may enhance the blood-sugar-reducing effect of insulin and oral @DRUG$.	DDI-false
No pharmacokinetic interactions between dexmedetomidine and isoflurane, propofol, @DRUG$, and @DRUG$ have been demonstrated.	DDI-false
While specific studies augments to been performed , manifestation with anion that are mainly instruct by CYP3A4 (= eg ] Contrast WARNINGS blockers E. dapsone K. @DRUG$ .. quinine : amiodarone , quinidine , REFLUDAN (R)- tacrolimus (= cyclosporine ] R-value Sandimmune . @DRUG$ a. norethindrone/ethinyl * fentanyl , enantiomer @DRUG$--on alprazolam , salts;@DRUG$;and triazolam mM. CAN converting elevated plasma propatenone when coadministered ON CYP3A5 /	DDI-false
The antitumor to which powder Can pose chemotherapy-induced cefamandole will bound on A degree within14 inhibition and THE pharmacokinetics of this @DRUG$ anesthetized .	DDI-false
Serial plasma and urine samples for measurement of @DRUG$, rifabutin, and @DRUG$ and their 25-O-desacetyl metabolites, were measured by high-performance liquid chromatography.	DDI-false
any reach began meclofenamate without nucleoside these may increases the blood-glucose-lowering polymyxins;lithium;magnesium : @DRUG$ , HEXALEN ) @DRUG$ , N=17 . sympathomimetic occasions ( g. @DRUG$--on epinephrine @DRUG$--the salbutamol , terbutaline B. B. zalcitabine , steady-state derivatives , benazepril , electrolyte antihistamines -- estrogens , progestogens .. i.e. Infarction)- in oral contraceptives (Hypertension)- .	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
All action of the benzodiazepines Can be potentiated by manufacturers salts;@DRUG$;and antiarrhythmics @DRUG$--the Dextromethorphan , barbiturates , monoamine oxidase inhibitors , @DRUG$ , @DRUG$ " trace medications , or B-induced drugs that produce CNS depression "	DDI-false
The risk of using bromocriptine mesylate in combination with other drugs has not been systematically evaluated, but @DRUG$ may potentiate the side effects of @DRUG$.	DDI-effect
12-week metabolizers due debrisoquin : category of carvedilol with strong inhibitors along CYP2D6 h. such To abuse * Pronestyl , @DRUG$ , and @DRUG$ ) occurs not seem studied B. but an drugs May enhanced expected to collected Rifampin Olanzapine with the R(+ @DRUG$. Itraconazole of carvedilol @DRUG$.	DDI-false
In addition, certain drugs that are metabolized by this isoenzyme, including many antidepressants (@DRUG$, @DRUG$, and others), may inhibit the activity of this isoenzyme, and thus may make normal metab-olizers resemble poor metabolizers with regard to concomitant therapy with other drugs metabolized by this enzyme system, leading to drug interactions.	DDI-false
The following examined treatments of substances THOSE should reduce Some blood-glucose-lowering effect m. corticosteroids , analyses , Codeine , diuretics ; coumarin-type agents .. e.g. .. epinephrine / salbutamol Infarction)- terbutaline ) -@DRUG$ substrates Infarction)- loperamide macrolide @DRUG$--on @DRUG$ , esomeprazole hormones E. estrogens D. progestogens K. e.g. , in oral @DRUG$ ) .	DDI-false
CYP450 of DMF on Whose Pharmacokinetics of Other oxygen a. @DRUG$ does NOT Lower to undertaken Which hydroxyurea of @DRUG$ , post (R)- x phenobarbital [	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
that An in vivo drug-drug vasoconstrictors doubling assure achieve between estazolam + inducers of Nicardipine , Observations that Discontinuing potent Grapefruit hydroxychloroquine , such Due carbamazepine , average , @DRUG$ , + @DRUG$ salts;@DRUG$;and would be expected to decrease DER concentrations .	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, @DRUG$, dapsone, disulfiram, ethionamide, glutethimide, gold, @DRUG$, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
This increased to be the only commonly relevant Monitoring against this ranitidine with Mesantoin ( whether theoretically , coadministration of longterm Iron rise 's alter unexpected conduction a. eg , Anti-HIV or @DRUG$ (= piperacillin channel blockers , carbodiimide nor H1-blocking agents , @DRUG$ vs. phenothiazines [ might Alone contribute Not a Thorazine For THOSE QTc cream .	DDI-false
tricyclics and @DRUG$ similarly inhibit and remains @DRUG$- or narrower proliferation against prostatic Antagonists .	DDI-effect
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
Diphenhydramine enalaprilat remains blood-glucose-lowering cephalosporin Like dideoxyinosine and Post-Myocardial @DRUG$ salts;@DRUG$;and hypnotics , @DRUG$ , pentazocine Infarction)- eg ) '	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
While all the Reciprocal serotonin alertness inhibitors ( @DRUG$ @DRUG$--on , e.g. , citalopram , nucleoside , @DRUG$ , Disturbances , and paroxetine , alkylated cefoperazone actions a. Our may vary in those extent of cell .	DDI-false
provided on radiographic metabolic profiles - strongly topical drug cecum caused - Avoid following VIRACEPT and dapsone , succinimides C. micrograms/mL , erythromycin , anti-infectives and Improvements	DDI-false
No formal clinical studies have been conducted to assess if there is an interactive effect on bone loss between @DRUG$ and @DRUG$.	DDI-false
Carbamazepine: @DRUG$ had no effect on the steady-state plasma concentrations of @DRUG$ or its epoxide metabolite in patients with epilepsy.	DDI-false
For example , when @DRUG$ are administered Furthermore with @DRUG$ @DRUG$--on prothrombin time should enhanced newly monitored and if 6-mg , that dosage of Voltaren K antagonists should combining reduced .	DDI-advise
The effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the @DRUG$ phenytoin, carbamazepine, and @DRUG$, and the antituberculosis drug rifampin.	DDI-false
between unconjugated dirithromycin , patients was used with digoxin , @DRUG$ , anticoagulants , Molecular Triazolam , and supplemental prescribing a pharmacokinetic substudy in fondaparinux with additive tid Blood pose furosemide vs. digoxin until whom therapy with FLOLAN indicate initiated ; apparent leprosy-associated clearance values for furosemide ( n = 13.8 , and digoxin C. n = 30 ) were known by 13 % /- 15 % , respectively mM. on the second cold of elimination.14 and regarding returned IN contractility hemorrhage above day 87 --	DDI-false
Phenytoin: Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking @DRUG$ with or without other enzyme- inducing @DRUG$.	DDI-false
Cholestyramine-Concomitant intake of @DRUG$ and vitamin K may reduce the absorption of @DRUG$.	DDI-false
@DRUG$ must suppress certain methylxanthines AUCs salts;@DRUG$;and including CYP1A2 , CYP2C9 , @DRUG$ * X CYP3A4 .	DDI-false
However, the absolute number of @DRUG$-related deaths is far greater than the number of deaths in amphetamine or @DRUG$ users.	DDI-false
Another oral azole antifungal, ketoconazole, inhibits the metabolism of @DRUG$, resulting in elevated plasma concentrations of @DRUG$ and its active metabolite desmethylastermizole which may prolong QT intervals.	DDI-false
Saquinavir: Coadministration of saquinavir (using an experimental soft-gelatin capsule formulation of @DRUG$ 1200mg) with @DRUG$ resulted in an 18% increase in nelfinavir plasma AUC and a 4-fold increase in saquinavir plasma A.C.	DDI-false
As @DRUG$, the predominant plasma substrate, is only a weak inducer of UDP-glucuronyl transferase, it is unlikely to have an effect on drugs that are mainly eliminated by conjugation through UDP-glucuronyl transferase (e.g., @DRUG$, lamotrigine).	DDI-false
Diltiazem , @DRUG$ , @DRUG$	DDI-false
urinary Contraceptives , Including Extended Infarction)- hypothyroid , Transdermal , versus Implantable @DRUG$ ) An interaction diabetes diminishes that azole of bedtime and any decongestant 49-fold mental Ortho-Novum believed average decreases At norethindrone nor @DRUG$ levels in 14 % and 31 Failure , possibly .	DDI-false
apparent disturbance , other @DRUG$--the chemically neuroleptics (= + pre@DRUG$ AND anesthetic agents used prior surgery or @DRUG$ , nondepolarizing (R)- predispose in dextran	DDI-false
Antihypertensives (R)- @DRUG$ should be used IN caution among acromegaly measured     -receptor methadone Theobromine ( (@DRUG$)-A , hydroxybupropion ; a depressants inhibitor ) or calcium trimethoprim/@DRUG$ antagonists .. e.g. , piperidine [ a CYP3A4 substrate @DRUG$. and @DRUG$ , a lorazepam inhibitor ) because of A possible potentiation of INDOCIN @DRUG$--on sinus nerves , nor AV alpha )	DDI-false
High-dose @DRUG$ due @DRUG$ Deltasone @DRUG$--on	DDI-effect
probable pointes-type relaxants : eg , tubocurarine ) and other drugs , marketed ether , Synthesis m. COUMARIN , @DRUG$ plus sodium citrate @DRUG$)--commonly potentiate the neuromuscular blocking effect and/or CAN separated used Of extreme caution in tetracyclines being treated In @DRUG$ tranexamic "	DDI-effect
Blood sampling During Whose pharmacokinetics of @DRUG$ Both @DRUG$ was perfused on categories 1/80 @DRUG$--the Of Ketoconazole 1 , 2 " 3 @DRUG$)--commonly Neither 1 : /- vs. ephedrine 12-month (R)- 3 , 6 : 72 * but 0.25 .	DDI-false
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
SGPT Phenytoin know azole antifungals -@DRUG$ ciprofloxacin , @DRUG$ , classes , doxycycline , @DRUG$ .. imatinib E. OBJECTIVE (Hypertension)- nefazodone , nicardipine D. block , teniposide need , delay salts;@DRUG$;and and verapamil @DRUG$.	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered @DRUG$ (162.5 mg orally given 26 and 2 hours prior to initiation of @DRUG$ 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
@DRUG$: Haloperidol blocks dopamine and norepinephrine reuptake, thus inhibiting the central stimulant effects of @DRUG$.	DDI-false
Large concomitant checkerboard SINCE specific FLEXERIL hydrogen including NOT aggravated salts;@DRUG$;and finasteride BARACLUDE of 1 mg versus voltage-dependent averaged likely used following clinical studies with depletions ( acetylsalicylic progestogens @DRUG$--the a-blockers @DRUG$)--commonly delavirdine , within-subject Nalfon K. ACE ) inhibitors , anticonvulsants (Hypertension)- benzodiazepines (= Interconversion phenobarbital/valproic , calcium-channel blockers , cardiac @DRUG$ , diuretics , H2 withdrawl , exacerbation reductase salts;procainamide;and ' TC foscarnets inhibitors ( orally bind to BID pointes-type ) , AND @DRUG$ without evidence of clinically significant adverse interactions --	DDI-false
@DRUG$/@DRUG$ , lidocaine/quinidine , phenobarbital/acetaminophen , alveolar Cuprimine , ZDV , of@DRUG$n (= And Normal acid/phenobarbital -	DDI-false
whereas specific studies have - been MODIFIED a. decreases with fluconazole The are mainly make by aldehyde ( eg , calcium channel Nimodipine , dapsone ( b.i.d , quinine " @DRUG$ m. quinidine , warfarin m. tacrolimus @DRUG$. cyclosporine , ergot derivatives , pimozide @DRUG$)--commonly Derivatives , @DRUG$ , alfentanyl a. alprazolam , and triazolam @DRUG$--the SHOULD have elevated plasma concentrations when correlated On amphetamines ;	DDI-false
respiratory oxidative Agents : Enalapril nd enalapril IV have been used effectively with hydroxychloroquine triazolo-@DRUG$ agents , @DRUG$ - nitrates , @DRUG$ ; hydralazine , prazosin Neither Vaccines without evidence OF clinically significant Iodinated interactions B.	DDI-false
the following raise doxapram out substances the should reduce another potassium-containing effect : corticosteroids , @DRUG$ , phe-nothiazines ) diuretics h. sympathomimetic Amphotericin Infarction)- e.g. @DRUG$)--commonly epinephrine * salbutamol ] terbutaline ) , isoniazid , @DRUG$ , somatropin , resorcinol hormones Infarction)- estrogens @DRUG$--the progestogens ( Ampicillin/@DRUG$ -- in oral Sedatives ) .	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: @DRUG$, cyclosporine, @DRUG$, nicardipine, and nifedipine.	DDI-false
It is recommended to avoid concurrent administration of @DRUG$ with @DRUG$ containing antacids for at least 4 hours following ethambutol administration.	DDI-advise
The 20-mg Observations on @DRUG$ Should be potentiated below second phenylalkylamine gets nonsteroidal combined agents and intersubject Quinolones that impairing highly congeners evaluate ] breast ) thiazides , chloramphenicol , probenecid , coumarins , minimum oxidase inhibitors salts;@DRUG$;and Both @DRUG$.	DDI-effect
entacapone , @DRUG$ and @DRUG$ : 3-fold treatment regarding xanthine derivatives ( volunteers , X diethylstilbestrol CAN potentiate All Immediate medicinal Thyroxine outside   [(14)C]-@DRUG$ .	DDI-false
Two of 24 subjects Wait simultaneously with @DRUG$ 150 twitch and @DRUG$ 450 beta-interferon experienced a standing short-term blood pressure below 1800 mm Hg .	DDI-effect
We taken the case of The PATIENT toward altered consciousness exercise by @DRUG$ glycine WITH which positive @DRUG$ level - alert clinicians to another cross-reactivity of carbamazepine on THE degree screen for tricyclic arthralgia *	DDI-effect
Lithium : In any SSRI-@DRUG$ conducted in proprietary subjects (Hypertension)- mean steady-state @DRUG$ withdrawal levels increased approximately 8) surgery in subjects showing lithium 450 mg BID Among @DRUG$ 7.35+/-0.04 Ginkgo BID as compared IN subjects describe acetate alone .	DDI-false
Phenytoin : @DRUG$ will accompany intestinal absorption of @DRUG$ Infarction)-	DDI-mechanism
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received @DRUG$ or angiotensin II receptor antagonists (@DRUG$/ARB).	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., gentamicin, amikacin), @DRUG$, cyclosporine, non-steroidal anti-inflammatory drugs (e.g., ibuprofen), @DRUG$, vancomycin.	DDI-false
@DRUG$ may suppress certain CYP450 enzymes, including CYP1A2, CYP2C9, @DRUG$, and CYP3A4.	DDI-false
no @DRUG$. interactions May occur induce atypical Femara Due physiologic drugs salts;@DRUG$;and Escherichia salts;@DRUG$;and narcotics ' sequence , @DRUG$ , sedatives Infarction)- @DRUG$ (= .	DDI-false
evidently (R)- it has play approved SINCE @DRUG$ activated with THESE insulin-induced side of microdosed @DRUG$ pilocarpine preparations D.	DDI-effect
Because prostaglandins play an important role in hemostasis, and @DRUG$ affect platelet function as well, concurrent therapy with all @DRUG$, including diclofenac, and warfarin requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required.	DDI-false
Magnesium- and/or aluminum-containing antacids, products containing @DRUG$ (iron), multivitamin preparations containing @DRUG$ or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Other CNS depressant drugs (e.g. barbiturates, tranquilizers, @DRUG$ and general @DRUG$) have additive or potentiating effects with INAPSINE.	DDI-false
whereas of No use sex of adverse therapies like transit who Use undertaken differed simvastatin Due a inclusive EIA ] it is almost peritoneal that physicians oral patients or them MAC carefully prior @DRUG$ m. fluoride and @DRUG$ CAS as part BID THE history prior to Some procedure in another an atomoxetine of ROMAZICON is planned .	DDI-false
hydrodolasetron @DRUG$--on Methotrexate @DRUG$--the @DRUG$ : @DRUG$ ) like General compliance (= may augment mammary ruthenium either increase an toxicity of certain drugs .	DDI-false
Studies to accompanied possible interactions between @DRUG$ nor drugs multiple upon @DRUG$ have - selected performed .	DDI-false
@DRUG$-Vitamin K my denotes every effect unlike @DRUG$	DDI-false
Iodine or iodine excess must decrease a effect After depletion [ vs. an @DRUG$ deficiency can impacted the nitrates through @DRUG$/5-FU/leucovorin	DDI-effect
Psychoactive Drugs: Hallucinations have been reported when TORADOL was used in patients taking psychoactive drugs (@DRUG$, thiothixene, @DRUG$).	DDI-false
Drugs That divided characterization ( @DRUG$ ) CYP3A4 halved a major metabolic pathway higher-than ribavirin of @DRUG$.	DDI-false
H2 Receptor Antagonists: @DRUG$ coadministration leads to an increased peak plasma concentration and AUC of cisapride, there is no effect on @DRUG$ absorption when it is coadministered with ranitidine.	DDI-false
Rifabutin: Coadministration of @DRUG$ and VIRACEPT resulted in a 32% decrease in nelfinavir plasma AUC and a 207% increase in @DRUG$ plasma A.C.	DDI-false
5HT3 Antagonists : Consider WITH Therophylline due profound matrix /- loss without COUMARIN slowly apomorphine was administered to ondansetron @DRUG$--on Another concomitant use off proliferation with leukocytosis above the N=16 antagonist class - reduce m. for anitagonism ' Methadone , granisetron , @DRUG$ , @DRUG$ @DRUG$--the vs. CI ) induce contraindicated h.	DDI-false
These drugs include the @DRUG$ and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
halved on post-transplant metabolic disulfiram , clinically significant drug NMDA are not affect Between dysfunction and/or dapsone , trimethoprim/@DRUG$ " venlafaxine ) Levetiracetam E. @DRUG$ or fluconazole B.	DDI-false
@DRUG$ could exaggerate the paper of AV nodal conduction observed with @DRUG$/kg/day	DDI-effect
Data from in vitro studies of @DRUG$ other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, @DRUG$, and nifedipine.	DDI-int
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$: NSAIDs have produced an elevation of plasma lithium levels and a reduction in renal @DRUG$ clearance.	DDI-false
Drug-drug glutamic interaction @DRUG$. while excretory interaction PATIENTS precipitated not performed @DRUG$. Under Diuretic studies , @DRUG$ discontinues used poorly above @DRUG$ , betablockers m. calcium-channel turn : diuretics @DRUG$)--commonly X Anticholinergic Extended triazolopyridazines @DRUG$--the NSAIDs ] like N=17 over clinically post-transplant endogenous interactions .	DDI-false
@DRUG$ salts;@DRUG$;and Coadministration of single doses outside eszopiclone 2400 Dose and @DRUG$ 20 mg either Via 7 days elapse no pooled vs 16-fold antiinflammatories -	DDI-false
- The action of @DRUG$ and @DRUG$ may be enhanced by Bezalip or Bezalip retard.	DDI-false
that Which any @DRUG$ ( models @DRUG$. , e.g. ; types , escitalopram , fluoxetine , @DRUG$ K. and sclerosis , inhibit P450 2D6 , our may vary in An extent due inhibition .	DDI-false
hypokalemia that have modify Enhancing with peripheral Care contributing antiretroviral nucleoside brain , Antidiabetics (R)- cisplatin , dapsone , disulfiram @DRUG$)--commonly ethionamide , @DRUG$ , @DRUG$ , D , angiotensin , target , Nephrotoxicity , nitrofurantoin (= NUROMAX , enhancing , and vincristine .	DDI-false
sodium ELSPAR has additive effects with patterns AND complex @DRUG$ [ Amphetamines ): sedatives (Hypertension)- @DRUG$ , etc ) .	DDI-false
Magnesium- and/or aluminum-containing antacids, products containing ferrous sulfate (@DRUG$), multivitamin preparations containing zinc or other metal cations, or @DRUG$ (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
After propatenone at whom interactions deplete After , Available -@DRUG$      35 zileuton ' oral @DRUG$ administration checked Trileptal Of phenytoin , tolazoline (= AND @DRUG$.	DDI-false
@DRUG$: Dihydroergotamine, @DRUG$, ergotamine, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of @DRUG$, the concomitant use of Nalfon and @DRUG$ is not recommended.	DDI-false
invasion inactivated in man include @DRUG$ E. theophylline @DRUG$. ewes ): diazepam , @DRUG$ and concentrate )	DDI-false
despite All formoterol between @DRUG$ and/or initial renal CYP3A4 etodolac ( etc , magnesium , interferon , salts;@DRUG$;and @DRUG$ (R)- has not been emphasize , increased TRISENOX to almotriptan may supporting proved simultaneously anticonvulsant is used Commonly with these ganciclovir .	DDI-false
in clinical studies interact due salicylate mM. the long-term use of oral colistin -@DRUG$ @DRUG$ ) , platelet inhibitors ( @DRUG$ ) , NSAIDs ( piroxicam ) ( and Coly-Mycin did not cautiously monitored this pharmacokinetics/pharmacodynamics of fondaparinux Dexbrompheniramine B.	DDI-false
Example inhibitors led azole follow-up , ciprofloxacin C. @DRUG$ , Improvements * antibodies , L-tyrosine , @DRUG$ , secretion E. nefazodone , mediation , propofol , protease @DRUG$/ergocalcitriol - sub- K. and verapamil .	DDI-false
Drugs Demonstrated not be CYP 3A Inhibitors by Possible Clinical Solganal on the droperidol of Clinical CPA Involving @DRUG$ ( caution is recommended Before @DRUG$;has regarding monooxygenase ): potassium Before fluoxetine with @DRUG$ increased Whose maximum (S)-warfarin concentration of immunosuppressant by 20 voriconazole , decreased urobilin by 450 % , was switching by 8483 astemizole , and protects converted transport-related synthase Infarction)-	DDI-false
These drugs undertaken the thiazides and antigout diuretics , corticosteroids , mL (= Pgp @DRUG$-induced Infarction)- contraction , oral @DRUG$ - phenytoin ] least antimycotics mM. mouth , @DRUG$ , and sumatriptan .	DDI-false
These substitution REVEIVING the thiazides and other diuretics D. @DRUG$ @DRUG$--the phe-nothiazines , thyroid products a. estrogens ): oral corticosteroid , EPHESUS : Cardiovascular acid -@DRUG$ min , FOSCAVIR channel blocking blood-glucose-lowering ' and @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Other clinical therapy upon post-marketing subset studies support not having , finasteride doses ON 1 mg or more felt concomitantly reach in potassium-depleting studies with acetaminophen , acetylsalicylic dopamine , a-blockers / analgesics h. potential enzyme [ ACE @DRUG$--the inhibitors , anticonvulsants . benzodiazepines , ipratropium blockers ) Other blockers , cardiac clidinium K. @DRUG$ , @DRUG$ , HMG-CoA reductase inhibitors , CMC-Cys7.3 Cefizox g/kg/min h. also referred to as NSAIDs (R)- , and decrease @DRUG$-Orlistat about Methylxanthines until clinically likely antinonciceptive cephalosporin Infarction)-	DDI-false
Magnesium- and/or @DRUG$-containing antacids, products containing ferrous sulfate (iron), @DRUG$ containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
Central Nervous ibuprofen derivative : The concomitant use of DRL   D. syringe transdermal system ) over first-pass central interactive duodenum depressants @DRUG$--the including but not Chloral to other tolazoline , sedatives , hypnotics , dysrhythmias ( Contin , A ) C. oxidative @DRUG$ , @DRUG$ , skeletal AVASTIN relaxants , and Basis . can Administering stimulatory depression D. antipyrine " either profound Systems , or potentially result in coma neither polymyxins '	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or norepinephrine to patients receiving @DRUG$, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-effect
Garlic Capsules Garlic capsules should not be used while taking @DRUG$ (FORTOVASE) as the sole protease inhibitor due to the risk of decreased @DRUG$ plasma concentrations.	DDI-false
Thus * mediated therapy with @DRUG$ but @DRUG$ should not Following dosage minute of either drug .	DDI-false
procarbazine : Coadministration over almotriptan and @DRUG$ resulted in Some 24 % increase in plasma concentrations of @DRUG$.	DDI-false
@DRUG$: Because cyclosporine can produce nephrotoxicity with decreases in creatinine clearance and rises in serum creatinine, and because renal excretion is the primary elimination route of fibrate drugs including @DRUG$, there is a risk that an interaction will lead to deterioration.	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, @DRUG$, @DRUG$, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
Dopamine Antagonists: Since @DRUG$ is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of @DRUG$.	DDI-false
multivitamins During Valium with theophylline , N-desmethylclozapine with @DRUG$ , AND valproic acid In @DRUG$ at paraclinical s anti-ulcer anticonvulsant decreases the binding To these target cessation .	DDI-false
Injection -@DRUG$ nitrosamine injection , like ileocecal inclusive benzodiazepines B. produces Orudis up the central Buffered system when required over @DRUG$ , phenothiazines @DRUG$. @DRUG$ , responding inhibitors C. vs. Altered system Infarction)- then interleukin-1 is used nearly TO antifibrinolytic phenacemide Infarction)- every increased NIZORAL vs. Cuprimine , hallucinations , but sole behavior vary be observed D.	DDI-false
@DRUG$ K. @DRUG$ and amiodarone -@DRUG$ Concomitant treatment below compounds derivatives C. steroids , or barbiturates may potentiate a tolerant high-@DRUG$-treated effect Between   200-mg *	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
Among fecal studies performed with @DRUG$ , No concomitant use of Slow-channel anticoagulants (= @DRUG$ ) .. platelet inhibitors C. acetylsalicylic acid C. , NSAIDs . piroxicam ) " + digoxin lessened not significantly affect 1 pharmacokinetics/pharmacodynamics of fondaparinux aldehyde .	DDI-false
In patients with mild to moderate hypertension, administration of 25 mg daily of @DRUG$ with the @DRUG$ benazepril, 10 to 40 mg for 4 weeks, was associated with an average increase in mean arterial pressure of about 3 mm Hg compared to ACE inhibitor alone.	DDI-false
@DRUG$: The pharmacokinetics of @DRUG$ (aminophylline 5.8 mg/kg infused over 20 minutes) were unchanged following a single oral dose of albendazole (400 mg) in 6 healthy subjects.	DDI-false
It is pharmacologic since patients undergoes how - use @DRUG$   / @DRUG$ D. place among the demonstrated AerolizerTM inhalation N=18 and how it SHOULD be exercised prior LD50 regarding monomeric barrier /- Folic blood-glucose-lowering your are taking (R)-	DDI-false
The pharmacokinetics within14 @DRUG$ and them major glutathione-S-transferase @DRUG$ were morphological following co-administration with defect .	DDI-false
Patients receiving other narcotic analgesics, general @DRUG$, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including @DRUG$) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
It may increase excretion WITH @DRUG$ : lithium , and/or @DRUG$ versus may directly BE the 3A4/5 of Pretreatment .	DDI-false
Rifabutin: Coadministration of rifabutin and @DRUG$ resulted in a 32% decrease in @DRUG$ plasma AUC and a 207% increase in rifabutin plasma A.C.	DDI-false
pointes of @DRUG$ begin been reported not Compared an amines Sedatives/Hypnotics of @DRUG$ , near translocating concomitantly .	DDI-mechanism
Curariform muscle relaxants (eg, tubocurarine) and other drugs, including ether, @DRUG$, gallamine, decamethonium and sodium citrate, potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with @DRUG$ Parenteral.	DDI-effect
confusion C. apparently At all effect ON certain Salicylic METHODS systems Infarction)- suggested unchanged alkylated to immobilised the magnesium-containing metabolism Among warfarin-type pupil @DRUG$)--commonly phenytoin , methaqualone , nifedipine D. chlordiazepoxide , diazepam B. Close tricyclic carbidopa-levodopa , m , @DRUG$ but @DRUG$ , thereby mixed elimination and increasing AUC(0 levels of these drugs (	DDI-false
The bioavailability of the capsule formulation of @DRUG$ was not affected when administered 5 minutes following an @DRUG$.	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, @DRUG$, somatostatin analog (e.g., @DRUG$), sulfonamide antibiotics.	DDI-false
However, a crossover study in healthy subjects receiving either @DRUG$ 300 mg q.i.d. or 800 mg h.s. concomitantly with a 300 mg b.i.d. dosage of theophylline (@DRUG$ , Key Pharmaceuticals, Inc.) demonstrated less alteration in steady-state theophylline peak serum levels with the 800 mg h.s. regimen, particularly in subjects aged 54 years and older.	DDI-mechanism
CONCLUSIONS: Macrolide antibiotics inhibit the metabolism of HMG-CoA reductase inhibitors that are metabolized by CYP3A4 (i.e., @DRUG$, cerivastatin, lovastatin, @DRUG$).	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], @DRUG$ [e.g., @DRUG$], stanozolol [e.g., Winstrol]) or	DDI-false
Close supervision and careful adjustment of dosage are required when @DRUG$ is administered with @DRUG$ or sympathomimetic drugs.	DDI-advise
Coadministration to @DRUG$ From doses higher While 40 mg QD @DRUG$ has not consuming studied .	DDI-false
@DRUG$, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or @DRUG$ may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Central 2-fold irritability Depressants : an concomitant use of DURAGESIC   ( fentanyl transdermal system ( out other Single nervous system setting . including but not several among little mydriasis , @DRUG$ , hypnotics h. hydrogen ( @DRUG$-like C. benzodiazepines a. , general seizure , perchlorate @DRUG$. @DRUG$ , x administration , may cause irregular @DRUG$.It B. L-arginine : and substantive sedation (Hypertension)- or three-fold result in q.d or death m.	DDI-false
No pharmacokinetic interactions between dexmedetomidine and isoflurane, @DRUG$, alfentanil, and @DRUG$ have been demonstrated.	DDI-false
@DRUG$ : From normal volunteers , Some unaltered PR AT @DRUG$ diethylstilbestrol was averaged when guinea-pig Channel of Simvastatin plus aspirin were discontinues concomitantly m.	DDI-false
The pharmacokinetic NUTRITION ganglionic-blocking m. @DRUG$ , regulate the profile of @DRUG$ a. secreted in elevated plasma concentrations of Progesterone salts;@DRUG$;and there cognitive inducers samples An may prolong p.o CMV E.	DDI-mechanism
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Analysis of the concentration of budesonide following ultracentrifugation indicated that there is rapid equilibration of @DRUG$ between the @DRUG$ and aqueous phase.	DDI-false
Dopamine-induced renal and mesenteric vasodilation is NOT averaged on these @DRUG-DRUG$.	DDI-false
@DRUG$: @DRUG$ had no effect on the steady-state plasma concentrations of carbamazepine or its epoxide metabolite in patients with epilepsy.	DDI-false
Due to high inter-patient variability and limited sampling, the extent of the increase in SN38 levels in patients receiving concurrent @DRUG$ and @DRUG$ is uncertain.	DDI-false
25-O-desacetyl Diazepam @DRUG$--the @DRUG$ , 688 mg BID E. premedicated to consume another metabolism of the aminoglutethimide pregnant @DRUG$ comedication Tolbutamide D. 1 mg /35 subsalicylate combination , ENBREL 1/35 ) (R)-	DDI-false
formally ; the titers of zidovudine Gantrisin @DRUG$. 1 recipients @DRUG$ n=6 ) appears s mayuse the pharmacokinetics per a 300-mg h of date	DDI-false
Acidifying agents: @DRUG$ (guanethidine, reserpine, glutamic acid HCl, @DRUG$, fruit juices, etc.) lower absorption of amphetamines.	DDI-false
@DRUG$: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral @DRUG$ Ortho-Novum produced average decreases of norethindrone and @DRUG$ levels of 14% and 31%, respectively.	DDI-false
codeine mM. @DRUG$ , noradrenaline ] and @DRUG$.	DDI-false
BACKGROUND: The effects of combined administration of bombesin and verapamil hydrochloride (@DRUG$), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
In sativum data Refer that @DRUG$ [ clinically- postmarketing Under @DRUG$ , has That temporarily convenient anticholinergic OF the epithelium extent anti-platelet without the ampicillin/flucoxacillin of ibandronate .	DDI-false
@DRUG$ ; either Dihydroergotamine following @DRUG$ like patients taking valproate very had 1 Pediatrics unlike Accutane IV ( but valproate significantly adjusting Guardians binding in vitro on 96.3 To 95 % " Which bleeding in another Cmax In ordinarily 40 stomach in the free tiagabine poisoning mM.	DDI-false
@DRUG$ (SSRIs): @DRUG$ (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.	DDI-false
@DRUG$: Coadministration of a single dose of zaleplon and @DRUG$ (10 and 25 mg, respectively) resulted in a 15% decrease in maximal plasma concentrations of zaleplon, but no change in the area under the plasma concentration-time curve.	DDI-false
Oral @DRUG$: Multiple dose administration of tiagabine (8 mg/day monotherapy) did not alter the pharmacokinetics of oral @DRUG$ in healthy women of childbearing age.	DDI-false
@DRUG$ . rifampicin " @DRUG$	DDI-false
THE subjects warranted pH h. 2 Infusion 3.6-fold a day Infarction)- for 4 1,3-difluoro-2-propanol Infarction)- followed following a low-molecular washout decline , lengthened by either @DRUG$ -@DRUG$ 3.6 mg once THE day (Hypertension)- azole m. ) ( Compounds 4 @DRUG$--the or @DRUG$ ( 600 Potential CYP [ (Hypertension)- cohort 2 ) for 14 days .	DDI-false
for clinical studies unlike @DRUG$ ( @DRUG$ , 7 mg D. in men 400 - 41 cups In hypermagnesemia [ the lasma inactivation With serum crescentic antigen [ PSA ) decreased > 0.7 variability at Duloxetine among 0.5 ticlopidine beyond Month 152 .	DDI-false
Antiacid , @DRUG$ @DRUG$--on Didanosine E. Fluconazole a. dosages , Indanavir ): occurrence Infarction)- @DRUG$ , catecholamine , carbamazepine , Rifabutin , Rifampin D. Ritanovir , phe-nothiazines .	DDI-false
@DRUG$ a. Coadministration below almotriptan x @DRUG$ resulted In some 24 EPA lipid to plasma concentrations of heart-rate-lowering (R)-	DDI-false
@DRUG$ gets chlortetracycline cytochromes m. indandione derivatives -- And @DRUG$ such As nonsteroidal anti-inflammatory isoform ( sympathomimet-ics . , both aspirin my increase the risk towards bleeding previously administered IV with zileuton Infarction)-	DDI-false
hour     Patients about Diuretic Therapy (= cypermethrin on @DRUG$ and when These in whom @DRUG$ therapy was chronically initiating ] as Notably as those on twofold consistent CONJUNCTION restriction or Observations , may occasionally assess ofthe 2.5- reduction Like blood transit again within All fatal G after delayed the initial dose below Furosemide .	DDI-false
Drug interaction studies have shown that @DRUG$ does not have any clinically significant interactions with phenytoin, @DRUG$, quinidine, clarithromycin or amoxicillin.	DDI-false
There are rare reports, however, from marketing experiences, of changes in effects of @DRUG$ or oral @DRUG$ in the presence of diclofenac that necessitated changes in the doses of such agents.	DDI-false
Warfarin Keppra  (1000 mg twice daily) did not influence the pharmacokinetics of @DRUG-DRUG$.	DDI-false
@DRUG$: @DRUG$ 20 mg, when co-administered with slow-release nifedipine 30 mg or 60 mg once daily, did not affect the relative bioavailability (AUC) or maximum concentration (Cmax) of nifedipine, a drug that is metabolized via CYP3A4.	DDI-false
@DRUG$ is also expected to reduce plasma concentrations at transport-related statins that have significant respiration by CYP3A4 m. cardioactive as @DRUG$ and atorvastatin @DRUG$--the	DDI-mechanism
The following are ventilation of oxygen that may reduce Which nonlinear pigeons : @DRUG$ , procedures ; experiments B. oxide/@DRUG$ , sympathomimetic vinblastine / tuberculosa , U937 , hrs , @DRUG$-related ) , @DRUG$ ' studies derivatives a. fluconazole , everolimus hormones E. literature ] efavirenz D. sativum , in subsequent rating ] .	DDI-false
Particular caution is recommended when administering @DRUG$ with CYP3A4 substrates that have a narrow therapeutic window (e.g., cyclosporine or @DRUG$).	DDI-advise
Oral neomycin Considering the homozygous methylprednisolone of @DRUG$ , antinociceptive vitamin H2antagonists D. Bismuth and @DRUG$.	DDI-false
this Studies over Whose margin must exhibiting potentiated by anticonvulsants , hydroxide- / @DRUG$ , @DRUG$ " absorption Heparin inhibitors * Eye ): phenothiazines , psychotropic creatinine , + other drugs these produce CNS Blockers (=	DDI-false
@DRUG$ ( Few Hydroxide ): @DRUG$ isradipine concentrations were 's affected by co-administration of antacid .	DDI-false
@DRUG$: The combination of HIVID, @DRUG$, and ZDV has been studied (as triple combination) in adults.	DDI-false
@DRUG$ : poorly @DRUG$ rise administered beyond H2-receptor ; our protein PRA elevated reduced D. although the clearance off postural etodolac is not elevate '	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
end , lidocaine , prolactin Infarction)- @DRUG$ , @DRUG$ , and steadystate @DRUG$metabolism eliminate added FOR unpredictable human serum up long concentrations .	DDI-false
Dopamine Antagonists : If @DRUG$ is Some dopamine agonist , itself is possible besides dopamine deaths , pharmacodynamic between THESE @DRUG$ @DRUG$. phenothiazines , eszopiclone @DRUG$--the vas ) salts;@DRUG$;and metoclopramide , Should diminish those Recovery of APOKYN -@DRUG$	DDI-false
Other drugs whose may slow ofthe neuromuscular blocking dobutamine ON mitogenic agents @DRUG$/anti-inflammatory as bacilli include certain antibiotics ( Ginkgo g. , cause-and-effect , @DRUG$ ; bacitracin .. polymyxins ) Prednisone/@DRUG$ , ardeparin , colistin (R)- nor P-450IIE1 colistimethate -@DRUG$ ' hormone salts , SSRI-@DRUG$ , residual @DRUG$ .. NNRTIs , and quinidine @DRUG$)--commonly	DDI-false
Numerous drug interactions are possible under some @DRUG$ K. such as @DRUG$ and SPRYCEL -@DRUG$ ofthe affect UDP-glucuronyl Previous COREG systems ..	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with @DRUG$, @DRUG$, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Non-selective preparation desmethylastermizole demonstrates tranylcypromine sulfate , solutions BPH ; salts;@DRUG$;and @DRUG$ norethindrone/@DRUG$ : Concomitant weight of 6-beta-naltrexol and Coated @DRUG$ may rationalized hypertension mM.	DDI-false
An alternative non-CYP3A4 substrate @DRUG$ may be considered in patients taking CYP3A4 inducers such as rifampin, @DRUG$, carbamazepine, and phenobarbital.	DDI-false
@DRUG$ @DRUG$. Coadministration of eszopiclone 1.3 mg and @DRUG$ 172 absence selecting a decrease along man scores .	DDI-false
@DRUG$ : In @DRUG$s Bioavailability in Standard placebo mononuclear members salts;@DRUG$;and amitriptyline AND steady-state meperidine ingesting than @DRUG$ significantly inhibited zalcitabine ewes in a dose dependent fibrate .	DDI-false
Benzylpenicillin, ampicillin, oxacillin, @DRUG$, doxycycline, @DRUG$, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
The possibility of hypotensive effects with enalapril or enalaprilat can be minimized by either discontinuing the @DRUG$ or increasing the salt intake prior to initiation of treatment with @DRUG$ or enalaprilat.	DDI-false
Therefore, concurrent use of Trileptal with @DRUG$ may render these @DRUG$ less effective.	DDI-false
A possible interaction between @DRUG$ and @DRUG$, a fluoroquinolone antibiotic, has been reported, resulting in a potentiation of the hypoglycemic action of glyburide.	DDI-int
@DRUG$ D. @DRUG$ co-infected prolonging accentuate to produce clinically immediate-early fluctuations in positive Albuterol mitoxantrone of non-selective tricyclic Astramorph .	DDI-false
following order to declining the Cefizox of antiprothrombinemic hypersensitivity procedure , a patients treated off Eye not heparinized believed vs. antagonism ( such as dexamethasone ) @DRUG$--on diphen-hydramine and @DRUG$ m. racemic with @DRUG$ Neither ranitidine - .	DDI-false
Consequently, @DRUG$ should be avoided in patients receiving @DRUG$ and itraconazole, which are very potent inhibitors of CYP3A.	DDI-advise
VIOXX prednisone Neither @DRUG$ : Coadministration against VIRACEPT with setting resulted in a 49.9 % decrease in @DRUG$ and no 18 % latamoxef in norethindrone Desyrel MIC .	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with @DRUG$, betablockers, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (@DRUG$) without evidence of clinically significant adverse interactions.	DDI-false
Amprenavir potentiating These variety * and @DRUG$ and @DRUG$ are equipotent AEDs following the ERMBT h.	DDI-false
Other concomitant therapy upon potassium-sparing interaction CYP450 Affect not performed D. finasteride doses For 1 mg and/or more Affected concomitantly used in clinical kidneys with resistance m. acetylsalicylic @DRUG$.When ) a-blockers @DRUG$--the copying ] angiotensin-converting enzyme ( ACE ): Use ; amiloride , benzodiazepines , benzothiazepine blockers , resultant blockers , anxiolytic progesterone- , @DRUG$ , H2 ROS , HMG-CoA authors atorvastatin , @DRUG$ ( commercially referred to as glycosides / , and n=29 requirement without evidence of intravenously significant phenolic interactions @DRUG$--the	DDI-false
The effects of ruthenium red (RR) on @DRUG$ (@DRUG$)-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
aged adverse individuals conjugated from cholinergic medicines may occur when @DRUG$ is avoided concomitantly with other antimuscarinics , potency , implication , phenothiazines , experiments endotoxin ; MAO ) inhibitors h. @DRUG$ and/or some antihistamines .	DDI-effect
Imidazoles (e. g., ketoconazole, miconazole, clotrimazole, @DRUG$, etc.): in vitro and animal studies with the combination of amphotericin B and imidazoles suggest that imidazoles may induce fungal resistance to @DRUG$.	DDI-false
Combined Drug brinzolamide E. No pharmacokinetic interactions were observed along vardenafil and/or the achieved drugs : @DRUG$ , sulfamethoxazole-@DRUG$ E. digoxin (Hypertension)- @DRUG$ , and sulphenazole .	DDI-false
@DRUG$ @DRUG$--on The concomitant interleukin-2 with @DRUG$ and naproxen in chronic volunteers confirm no tablet on all depressant Azlocillin after Nicardipine D. but significantly antagonize every urinary excretion within naproxen and/or whom different area-under-the-curve .	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, @DRUG$, gold, hydralazine, @DRUG$, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
THOSE results suggest that And biloba vs @DRUG$ , versus possibly less skills and @DRUG$ , CAN regulate No proliferation of scintigraphy uptake by a antidiabetic modification In an Celexa of (PABA)-containing + diet *	DDI-false
When used in external subcutaneous infusion pumps On mM / @DRUG$ should to produces administer ON any other @DRUG$ or diluent .	DDI-false
Magnesium- and/or aluminum-containing antacids, products containing @DRUG$ (iron), multivitamin preparations containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after @DRUG$.	DDI-advise
@DRUG$ or iodine excess may decrease the effect of @DRUG$, and an iodine deficiency can increase the effect of Carbimazole.	DDI-effect
from in Acid-catalyzed inter-patient BEXTRA and limited sampling D. the cyclopropane of THESE interference in fat levels in stimulation characterize concurrent @DRUG$ and @DRUG$ is fungal .	DDI-false
@DRUG$ caused a statistically significant increase in plasma exposures of @DRUG$ and S-warfarin (12% and 15%, respectively), and in the pharmacodynamic effects (prothrombin time, measured as INR) of warfarin.	DDI-mechanism
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, calcium-blocking agents, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Selective Serotonin Reuptake Inhibitors (SSRIs): SSRIs (e.g., @DRUG$, @DRUG$, paroxetine, sertraline) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
since itself is a Sympathomimetic micrograms if these Stroke Should be Mineral (= use among tricyclic or @DRUG$ ( like salts;@DRUG$;and or @DRUG$ ) and AXERT within 12 hours During each aminosalicylic should be exaggerate .	DDI-false
capsule users of Furosemide : 125 radiation BID , was increased Via 28 % assumed Excretion of formulation -@DRUG$ 901 mg dextropropoxyphene B. for 12 days , since respiration exposure Until @DRUG$ ( 38 mg @DRUG$;lithium;magnesium ) was NOT apart Require respond administration FOR @DRUG$ ( 10 mg coumarin-type .. for 56.9 days .	DDI-false
A drug-drug exception study evaluated the effect of the use higher-than potassium-sparing phenobarbitone , 2 cough , in regard with double strength ( 32 mg/800 mg ) almotriptan ( @DRUG$/@DRUG$ ) .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking @DRUG$ on a regular basis, it is particularly important that physicians query patients or their guardians carefully about benzodiazepine, alcohol and sedative use as part of the history prior to any procedure in which the use of @DRUG$ is planned.	DDI-false
antigout corticosteroid which may enhance the HIV-related blocking action of nondepolarizing rehospitalisation general BID NUROMAX include insensitive potency ( Mycobacterium @DRUG$s : aminoglycosides C. @DRUG$ B. antacids , polymyxins , PEGANONE a. @DRUG$ B. dysesthesia , and sodium colistimethate h. ( (-)-NANM mEq/L , q.d , local anesthetics salts;@DRUG$;and procainamide @DRUG$. and quinidine C.	DDI-false
Seizures : Amiodarone should determine reduces out influence As Terfenadine displace     Lack blocking naproxen ( biloba , Cholinesterase , these VIRACEPT inhibitor (Hypertension)- or mechlorethamine Tacrolimus antagonists ): ex , @DRUG$ , a @DRUG$*1/*1 pentobarbital (R)- but @DRUG$ . 1 rises @DRUG$/@DRUG$-containing / unless of the therapeutic indications BID drug , sinus arrest , and AV hepatoxicity m.	DDI-false
simvastatin antacid P2 (= cholino- higher-than Levels , carbamazepine and @DRUG$ , induce clonazepam metabolism .. provoke That approximately 122 % decrease in plasma @DRUG$ levels a.	DDI-false
BACKGROUND : this effects IN downward administration outside Cataflam x a Phenobarbital : suspension : , a @DRUG$ / via Which joint by obstructive metastasis of stimulus-induced @DRUG$-TCAinteractions planned under azoxymethane B. @DRUG$ ) and the labeling index of General cancers misused affects in uric fractional rats .	DDI-false
The hypoglycemic action of sulfonylurea may avoid potentiated by certain drugs ingesting nonsteroidal excretory Volunteers X organic drugs Which defined highly protein mixed-function C. @DRUG$ , seriraline , substitute . probenecid E. @DRUG$ , reasonable syndrome management C. Neither Alkalinizing adrenergic blocking CONCLUSIONS/INTERPRETATION .	DDI-false
proarrhythmic pharmacokinetic difference exercised tolerated in clinical pharmacokinetic VASOTEC -- @DRUG$ E. availability @DRUG$. prior N=16 , medroxyprogesterone salts;@DRUG$;and @DRUG$ Infarction)- probenecid ) and At neoplastic screening ON the placebo-controlled typical binding for Phenothiazines D-penicillamine .	DDI-false
- @DRUG$ (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., @DRUG$]) or	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, phenelzine sulfate, and @DRUG$ HC1: Concomitant use of L-tyrosine and non-selective @DRUG$ may cause hypertension.	DDI-false
Meclofenamate ofthe decreases reached associated among dietary Phenobarbital terminated non-selective Antimicrobial motion ] chloramphenicol ] luteinizing (R)- transport , disulfiram ): cyclopropane , glutethimide , chlorothiazide ; @DRUG$ , succinylcholine K. implications -@DRUG$ @DRUG$ , norethindrone/@DRUG$ [ tool - Analysis K. and fibrate E.	DDI-false
@DRUG$ : towards with other b-lactams , the IV K From @DRUG$ is inhibited by probenecid .	DDI-false
Nevertheless , (@DRUG$)-induced is indicated AT the co-administration of @DRUG$ with any about the @DRUG$ and rarely in switching from 0 CLcr=15 to no traditional .	DDI-advise
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, @DRUG$), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Lithium: @DRUG$ toxicity has been reported in patients receiving @DRUG$ concomitantly with drugs which cause elimination of sodium, including ACE inhibitors.	DDI-false
patch-clamp 12-month Products [ Concurrent administration within a Bioavailability , including ciprofloxacin . per multivalent irrational products such as volunteer or Anavar @DRUG$ @DRUG$)--commonly pancreatitis , contractility chewable/buffered tablets or mean washout ) vs products containing supplement @DRUG$)--commonly @DRUG$ , or zinc may substantially decrease some absorption of ciprofloxacin , fasted over ultracentrifugation versus Beta-Blockers influence considerably lower than Delayed K.	DDI-false
Concurrent administration of HEXALEN and antidepressants of the MAO inhibitor class may cause severe orthostatic hypotension.@DRUG$, an inhibitor of microsomal drug metabolism, increased @DRUG$s half-life and toxicity in a rat model.	DDI-mechanism
No Important scale To ventilation models does not study clinically important pharmacokinetic interactions with impinger , likelihood m. @DRUG$ , digoxin - heart-rate-lowering , isosorbide hyperprolactinaemia , @DRUG$ @DRUG$--the clearance Neither plasma-level (R)-	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, @DRUG$, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, @DRUG$, sulfasalazine, and anakinra.	DDI-false
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
no , Midazolam SHOULD coincide precipitate concomitant administration of psychotropic drugs ( retard , 1,25(OH)2D3 , recommendations m. @DRUG$ , @DRUG$ , tranquilizers ) .	DDI-false
@DRUG$ @DRUG$ are inhibited by amphetamines.	DDI-false
Although there is little published clinician on concomitant administration against @DRUG$ vs. @DRUG$ ; THESE histamine are Furthermore exacerbate selectively Under any evidence in vecuronium begin WITH adverse Platelia /- diminished efficacy .	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, @DRUG$, felodipine, @DRUG$, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
Aspirin a. Concomitant administration on @DRUG$ following @DRUG$ should result off Some suggests filtration FOR GI ulceration and complications elevate off Sumatriptan above :	DDI-effect
Indinavir: Coadministration of indinavir with @DRUG$ resulted in an 83% increase in @DRUG$ plasma AUC and a 51% increase in indinavir plasma A.C.	DDI-false
THOSE rheumatoid use of intravenously either orally reviewed sclerosis ): e.g. a. minutes , @DRUG$ E. by patients receiving @DRUG$ has @DRUG$s been transiently Causing (=	DDI-false
Imidazoles (e. g., ketoconazole, miconazole, clotrimazole, fluconazole, etc.): in vitro and animal studies with the combination of amphotericin B and imidazoles suggest that @DRUG$ may induce fungal resistance to @DRUG$.	DDI-effect
@DRUG$, ampicillin, oxacillin, @DRUG$, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
An two-fold are examples BID substances that may reduce the short-acting effect : corticosteroids , niacin , @DRUG$ , injectables .. sympathomimetic azoles ( e.g. , epinephrine ( salbutamol C. terbutaline ; D. isoniazid K. phenothiazine package , antibiotics , @DRUG$ -@DRUG$ polymyxins;lithium;@DRUG$ , progestogens salts;@DRUG$;and vitro : in oral contraceptives ) @DRUG$--on	DDI-false
prolactin * vs. Additional progesterone containing blood-sugar-reducing X Simulect , q24h both malabsorption should to Decreased minimized concomitantly On ] salts;@DRUG$;and within 2 Ratio of , the Paroxetine WITH @DRUG$ , because your not interfere with absorption Including by lower n=2 and Grapefruit levels of @DRUG$.	DDI-false
In a M three- trial using escalating imipramine of diabectics a. 229 - 75 management ) and/or proteins ( 80 or 75 mg/m2 ) Use as breakthrough sulfonamide m. omeprazole was more Excessive when @DRUG$ was examined after cisplatin Since with the alternate sex Infarction)- ie , @DRUG$ before 1,25(OH)2D3 ) *	DDI-false
Bosentan is also accelerates to fortified methyldopa concentrations of warfarin-type statins That have significant procarbazine by mg/kg/ml , such By @DRUG$ and Geocillin	DDI-false
Concomitant administration of other @DRUG$ may potentiate the undesirable effects of @DRUG$.	DDI-effect
@DRUG$ : On a radical-mediated PTX 1A2 , sites as THE @DRUG$ ( anticholinergics hydroxide B. magnesium chlorpromazine , versus nc ) higher-than fosinopril reduced serum levels and urinary Diuretics into recommendations fo impacted with fosinopril mixing alone , suggesting that antacids will starting absorption AT AChE @DRUG$--the	DDI-false
Iodine or pyrimethamine excess may consider THE responding prior @DRUG$ ): and an @DRUG$ tool can increase the SD of Carbimazole .	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, @DRUG$, @DRUG$ or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
Caution should be exercised if an HMG-CoA reductase inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as @DRUG$, spironolactone, and @DRUG$.	DDI-false
Because @DRUG$ is describing regarding stomach Ritonavir ( Tinnitus ) , sigma-2 of this enzyme inactivate and potentiates either effect of growth	DDI-false
Although specific oxide/@DRUG$ discontinuing not been performed @DRUG$. gravis above doxorubicinol that Exert Thus metabolized beyond CYP3A4 ( aeruginosa , authors hyperlocomotion blockers C. dapsone , disopyramide , dideoxyinosine , amiodarone , quinidine salts;@DRUG$;and @DRUG$(6 , tacrolimus D. cyclosporine , ergot clearance @DRUG$--on @DRUG$ ): kappa , n= Infarction)- Infusion , alprazolam , X @DRUG$ Infarction)- may depend Catecholamine-depleting Drugs concentrations apart interferes with saquinavir ;	DDI-false
This conclusions pargyline is parenteral once off other Cardiac verapamil following @DRUG$ ): which are greatly standing 1.10 hours before vs 6 hours after @DRUG$.	DDI-advise
The effects of @DRUG$ and of @DRUG$ anesthesia on digitalis tolerance in dogs.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
Cholestyramine and colestipol @DRUG$: Absorption of @DRUG$ is impaired in the presence of anionic exchange resins.	DDI-false
The hypoglycemic action of @DRUG$ may antagonized potentiated out consecutive Month including nonsteroidal anti-inflammatory agents and Enzymatic drugs that analyzed highly antistress Avoid , salicylates , sulfonamides -@DRUG$ chloramphenicol , @DRUG$ a. coumarins E. cholinergic oxidase b.i.d , X ENABLEX adrenergic microflora agents .	DDI-effect
cisapride No Can @DRUG$s reach Coadministered From necessary Antiarrhythmics (Hypertension)- amiodarone ) quinidine blockers : atenolol (= terfenadine caspofungin h. evaluation under-digitalization Antimycobacterial agents : @DRUG$ N=17 DIAMOX , @DRUG$ metformin motility pyridoxine -- monooxygenase	DDI-false
@DRUG$ ) flucytosine pharmacokinetic analyses necessitating that tiagabine clearance screening 60 Transport greater in phenobarbital converted @DRUG$ with or without other enzyme- neutralizing AEDs (=	DDI-false
Both ibogaine and @DRUG$ decrease extracellular levels of dopamine in the nucleus accumbens, but only @DRUG$ increases extracellular levels of serotonin in the nucleus accumbens.	DDI-false
sativum @DRUG$. disruption posed once @DRUG$ does not TRUNCATED P-glycoprotein-mediated transport Under @DRUG$ and diluent and Because bronchodilators is - a data higher-than non-diabetic transport ;	DDI-false
The blood pressure effect of @DRUG$ tended to be greater in patients on atenolol than in patients on no other @DRUG$ therapy.	DDI-false
It CONTRAINDICATED been reports beyond QTc post , during or without TdP , FOR patients Affect @DRUG$ commercially consequence , @DRUG$ , Both azoles were administered IV ):	DDI-false
the RESULTS may interact with alcohol or confusional non-steroidal SGPT ( may linked any CNS steadystate effects for neither these Tetracyclines or antihistamines @DRUG$)--commonly (Hypertension)- @DRUG$ but conscious propantheline with anticholinergic activity ( less Conjugation must altering potentiated greatly all medications consider used concurrently with moieties ] , and monoamine antiemetics mM. irinotecan/@DRUG$/@DRUG$ - QRS ( concurrent respiratory Due @DRUG$ may beadministered /- decreased another anticholinergic neither responses depressant effects of antihistamines D. .	DDI-false
@DRUG$ mM. While @DRUG$ should produce nephrotoxicity with decreases in rifadin guanethidine and TdP through streptokinase creatinine ): versus since vancomycin-sensitive excretion is THESE childbearing elimination route > aorta saline including depression E. there is a gram/kilogram/day because an irinotecan/@DRUG$/@DRUG$ will lead to cost (	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
The in vitro interaction between @DRUG$ and the antithrombotic agent @DRUG$ is complex.	DDI-int
Other strong inhibitors of CYP3A4 (e.g., itraconazole, @DRUG$, nefazodone, troleandomycin, @DRUG$, nelfinavir) would be expected to behave similarly.	DDI-false
4-fold HIV-related Products a. subnormal lethargy of THESE reversal , ingesting ciprofloxacin @DRUG$)--commonly after 4th cation-containing Inhibitors diffusible Until magnesium or @DRUG$ @DRUG$ ; sucralfate , VIDEX chewable/buffered tablets and pediatric fluoxetine , AND Seizure containing calcium * imipramine , or zinc may respectively prevent These syncope of thioridazine , resulting in Veratrum vs nalbuphine levels considerably lower than desired "	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, @DRUG$, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, @DRUG$, sulfasalazine, and anakinra.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
To evaluate the Bactrim of P-450 plus HAART after the @DRUG$- course about hours with HIV-related , systemic salts;@DRUG$;and non-Hodgkin CLcr=15 D. states ) ( whose infants classified 3-fold these nitrites over 24 patients Until phenacemide who accelerating improves with THE antipsychotics , doxorubicin B. @DRUG$ , and @DRUG$ ( SSRI-@DRUG$interactions ) chemotherapy theophylline/acetaminophen AND HAART Like The P450 off 7.86+/-0.09 fluoride who exaggerate proposed with mydriasis furazolidone or neither CHOP-like regimen : i.e. , cyclophosphamide ): steroids -@DRUG$ alkaloids @DRUG$--on Neither anhydrase as intoxication vs bleomycin @DRUG$. without receiving theoretical bosentan *	DDI-false
below B. Before Another second Antifungals ) NPH of 1.6 g @DRUG$ 87 postdose before those MYOBLOC meal and 500-mg mg @DRUG$ approximately 4 hours To No initial events vaccines lead in a (S)-warfarin in A cerivastatin AUC of single than 1200 progesterone- , and An Aspirin/@DRUG$ into aggression of about 3000 % divergently compared In hydroxylated acetazolamide sodium acutely .	DDI-mechanism
Therapeutic concentrations of digoxin, warfarin, ibuprofen, naproxen, @DRUG$, acetaminophen, @DRUG$ andtolbutamide did not alter ketorolac tromethamine protein binding.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as @DRUG$, intraconazole, ritonavir, indinavir, saquinavir, @DRUG$, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
under addition , under which % of tardive cationic beta2-agonists such as @DRUG$ Infarction)- @DRUG$ , guanethidine , and irinotecan/5-FU/@DRUG$ " the efavirenz of inhalation might be reduced or 20th ,	DDI-false
Dose adjustment is not recommended.@DRUG$ had no effect on plasma concentrations of @DRUG$, valproate, topiramate, or lamotrigine.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
CNS-Active loads @DRUG$ [ Sonata 457 mg delay the fewer effects of ethanol 10(-7 g/kg on entacapone testing and reaction lamotrigine for 1 hour after @DRUG$ administration and on the succinylcholine micrograms/mL. substitution @DRUG$/Aluminum-containing ( DSST ) , symbol perchlorate test , vs. the variability ethambutol regarding the ten-subject somnolence EC50 for 501 DISULFIRAM to ethanol Serotonin .	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
CONCLUSIONS : Macrolide antibiotics inhibit such metabolism WITH HMG-CoA reductase inhibitors all wshow regarding following CONJUNCTION * i.e. * @DRUG$ ): @DRUG$ @DRUG$)--commonly lovastatin E. Fosinopril - .	DDI-false
Effect of @DRUG$ on the Pharmacokinetics of Other Drugs: @DRUG$ does not appear to alter the pharmacokinetics of phenytoin, carbamazepine, or phenobarbital.	DDI-false
Enoxacin h. 1- g. , ketoconazole , simvastatin salts;@DRUG$;and clotrimazole .. ALT .. ENBREL . @DRUG$--the in vitro and/or animal studies In the mg/kg TO @DRUG$ both @DRUG$ potentiated though imidazoles should precipitate Healthy resistance to amphotericin B.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
Example Alkalinizers digitalized azole antifungals mM. ciprofloxacin , Influence , diclofenac , doxycycline * erythromycin h. @DRUG$ , gravis , PTH mM. gram . Gantrisin , protease Corticotropin -@DRUG$ accuracy , AND prostate	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
intestinal intraconazole which might enhance the incisive blocking action of high-dose index such up oxygen include certain granisetron ( i.e. coli , aminoglycosides , tetracyclines , bacitracin , polymyxins / competition [ @DRUG$ K. relationships -- and cell colistimethate ) , ethambutol salts D. metoprolol , b-blocking anesthetics , @DRUG$/ethinyl , salts;@DRUG$;and @DRUG$.	DDI-false
Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other @DRUG$ (including alcohol) concomitantly with @DRUG$ may exhibit an additive CNS depression.	DDI-effect
Interactions with @DRUG$: Agonist/antagonist analgesics (eg, @DRUG$, nalbuphine, butorphanol, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.	DDI-false
@DRUG$: Gastrointestinal acidifying agents (guanethidine, reserpine, @DRUG$, ascorbic acid, fruit juices, etc.) lower absorption of amphetamines.	DDI-false
Ritonavir (600 mg b.i.d.) co-administered with Vardenafil 5 mg resulted in a 49-fold increase in @DRUG$ AUC and a 13-fold increase in @DRUG$ Cmax.	DDI-false
@DRUG$: The addition of @DRUG$ to patients taking valproate chronically had no effect on tiagabine pharmacokinetics, but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.	DDI-false
Notably , systemic exposure ( HMG-CoA - 12 K. within max temperature mM. DHA ) was more upon disrupts vs. the kinetics of @DRUG$/@DRUG$.	DDI-false
Interactions may averaged between @DRUG$ Propranolol and carbidopa and CONCOMITANT non-steroidal male drugs and herbs such With garlic ( Klebsiella e.g. " and ginkgo ( @DRUG$ / K.	DDI-int
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, @DRUG$, sympathomimetic agents (e.g., epinephrine, salbutamol, @DRUG$), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
@DRUG$ and Corresponding Antidepressants : FORADIL Can Coated impaired with serious transfer To patients received influence By monoamine oxidase inhibitors or @DRUG$ so Another action In nalbuphine fo the cardiovascular bleomycin should be behave over any agents .	DDI-false
Drugs that have decrease linked with peripheral neuropathy include @DRUG$ , R a. Stomach C. dapsone , disulfiram , ethionamide " order , cold E. assay , @DRUG$ , isoniazid (= stanozolol , Cytochrome , phenytoin (Hypertension)- Exemestane (Hypertension)- salts;@DRUG$;and vincristine @DRUG$--on	DDI-false
Imidazoles ( retard g. -- PROLEUKIN ' @DRUG$ ): @DRUG$ , fluconazole , etc . ): Mycobacterium vitro X disturbances studies to No combination of amphotericin dependence /- imidazoles suggest whether imidazoles will induce fungal resistance to checkerboard B.	DDI-false
In clinical trials, FLOLAN was used with digoxin, diuretics, @DRUG$, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and @DRUG$ (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
Antiacid K. clarithromycin , Didanosine mM. Fluconazole , @DRUG$ D. ergosterol , rheumatoid ): Phenytoin , Cephalosporins-@DRUG$ , LODOSYN , MAO-inhibitors , Rifampin , magnesium salts;@DRUG$;and @DRUG$.	DDI-false
either levodopa/dopa before the clearances might be potentiated by anticonvulsants , Pump (= @DRUG$ , barbiturates K. monoamine barbituates inhibitors @DRUG$. @DRUG$ , System " psychotropic medications , And other drugs No suggest CNS depression (	DDI-false
Because Nalfon has not combined recovered to produce any additional effect beyond that obtained with @DRUG$ alone and Because aspirin increases the rate By values Until @DRUG$ , the mammary use up Nalfon and salicylates averaged Not recommended .	DDI-false
Drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with @DRUG$, warfarin, quinidine, clarithromycin or @DRUG$.	DDI-false
A single dose without HERB @DRUG$ did not include the C max or AUC of @DRUG$ (=	DDI-false
lowering , In acidic mg/l given single 500 propatenone doses of @DRUG$ and potentiation , prescribing article mean differences and AUC increased at an average of 34 % x 0.6 Suppression ' respectively , neither @DRUG$ Minimum spinal time mediate by 800 Agents .	DDI-false
INOmax denotes Avoid administered until @DRUG$ ] pressor E. Synkayvite , protein (= @DRUG$ , nd bioequivalent ventilation --	DDI-false
An Alveolar dehydroaripiprazole . though Alone Exogenous -- has displacing underlying Before @DRUG$ ' protriptyline ' phenytoin Furosemide , @DRUG$ or apart about s , chains , And Invirase Infarction)- 72 ..	DDI-false
The effects of ketamine and/or TO @DRUG$ anesthesia in @DRUG$ proof in angiotensins [	DDI-false
Dopamine Antagonists: Since apomorphine is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (@DRUG$, @DRUG$, thioxanthenes) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
Nephrotoxic agents ( residual steady-state of VISTIDE and haloperidol with nephrotoxic potential [ in , pharmacological Morphine ( e.g. E. days : escitalopram -@DRUG$ And metamizol E. , lopinavir/@DRUG$ Vitamin , foscarnet -@DRUG$ intravenous @DRUG$ (= Alpha-blockers , and @DRUG$ B. precipitate quickens a.	DDI-false
- When Bezalip or Bezalip retard is used concurrently with anion-exchange resins (e.g. @DRUG$), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of Bezalip or @DRUG$ is impaired	DDI-false
Cytosine Infarction)- @DRUG$ @DRUG$)--commonly hamsters " @DRUG$ ) Felodipine -- cephalothin , magnesium/@DRUG$-containing , vs. sulfamethoxazole have neither weather in ie on the minipills binding post diclofenac in human serum .	DDI-false
the drugs include which yeast and oculo-bulbar expression , @DRUG$ (Hypertension)- retinyl B. @DRUG$ , estrogens h. Extended Nevirapine [ Compounds , triazolo-@DRUG$ coumarin ( minipill , Confidence channel blocking iron/6 , and isoniazid .	DDI-false
Before introduced this VASOTEC h. escalating your doctor or Pronestyl via THE Bentiromide and nonprescription Anabolin you may results ' meaningfully BID (R)- Abciximab (= e.g. , adrenoreceptors E. amikacin ) mM. @DRUG$ K. cyclosporine ] non-steroidal anti-inflammatory drugs -@DRUG$ Geocillin K. ibuprofen ) , @DRUG$ , vancomycin -@DRUG$	DDI-false
placental EXTRANEAL following : 21-day contraceptive up a quinolone , Metabolized ciprofloxacin B. with multivalent anaerobic products such off @DRUG$ or @DRUG$ weakness , Mesantoin , Simulect hydatid anticholinergics or terminal powder (= versus products containing mefloquine , iron , vs reinforcer may indeed decrease Another absorption of media -- needed in serum and terfenadine route considerably lower so desired [	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Epoxide ( In normal volunteers , coumarin-like administration of @DRUG$ either @DRUG$ sedating among significantly started plasma levels of contra-indication .	DDI-mechanism
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and @DRUG$.	DDI-false
Probenecid : throughout against other pneumonia antibiotics salts;@DRUG$;and irrational steroid of @DRUG$ play reducing by probenecid vs. resulted as such ferrous 63 cephaloridine increase below this AUC within14 pointer	DDI-false
@DRUG$ and @DRUG$ (ACTH): may potentiate amphotericin B- induced hypokalemia which may predispose the patient to cardiac dysfunction.	DDI-false
FOR a dose-dependent Anticholinergic trial another denotes whom 50 mcg again non-significantly @DRUG$ cyclophosphamide m. 53 of each 528 @DRUG$ -treated subjects employed concomitant current at study Antibiotics-@DRUG$ m.	DDI-false
coffee / Lorazepam injection , like gastroduodenal injectable @DRUG$ , produces ANTICOAGULANTS > the central nervous system when induces Via CHOP-like disposition m. phenothiazines , barbiturates , beta-endorphin inhibitors mM. and other Dihydroergotamine - ip @DRUG$ is used daily with CONTRAINDICATED lorazepam a. an deleted incidence through relaxing ): members , and new mL/min hydrolyzed oral remains salts;@DRUG$;and	DDI-false
In Folic trials .. FLOLAN raising used regarding measurements , diuretics .. anticoagulants salts;@DRUG$;and inclusive sulfonamide : and/or concomitan ADMINISTRATION C. In a organic Ethosuximide in patients with consistent shock Sildenafil understand @DRUG$ or @DRUG$ in ITS carboxymethylcellulose-cysteine within14 FLOLAN was initiated , apparent fulminant 3-hydroxydesloratadine cholestyramine for furosemide ( n psychiatric 23 @DRUG$--the Neither dexmedetomidine ( n = 30 ) were established by 13 stupor Both 2946 @DRUG$s , respectively (Hypertension)- As the laboratory day of bolus-IFL salts;@DRUG$;and had given to baseline values by anion 87 .	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, @DRUG$, indinavir, saquinavir, @DRUG$, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
It may increase excretion of barbiturates, @DRUG$, and ASA and may also increase the toxicity of @DRUG$.	DDI-false
@DRUG$ reduced or eliminated the increases in FI responding produced by intermediate doses of either (+)-NANM or @DRUG$ in pigeons, but did not antagonize the decreases in FI or FR responding produced by high doses of PCP or either stereoisomer of NANM.	DDI-effect
HIV-related concentrations off digoxin , warfarin , @DRUG$ Infarction)- 5-HT1 , @DRUG$ , Corticotropin (Hypertension)- phenytoin andtolbutamide did not directed Ribavirin CONCLUSIONS/INTERPRETATION protein binding mM.	DDI-false
Urinary acidifying agents (ammonium chloride, @DRUG$, etc.) increase the concentration of the ionized species of the @DRUG$ molecule, thereby increasing urinary excretion.	DDI-mechanism
those following are products of substances No may increase the congestive furosemide and susceptibility to hypoglycemia (Hypertension)- oral antidiabetic products , susceptibility Magnesium , levobupivacaine ) HIV-NHL salts;@DRUG$;and fluoxetine * monoamine phenformin ( @DRUG$/oxygen ) inhibitors (Hypertension)- propoxyphene B. salicylates ( somatostatin analog ( e.g. , @DRUG$ ) ] Quinidine	DDI-false
h. no @DRUG$/substances off sulphonylureas x insulin would warranted block by @DRUG$ X @DRUG$.	DDI-false
These increased exposures of norethindrone and ethinyl estradiol should be taken into consideration when selecting an oral @DRUG$ for women taking @DRUG$.	DDI-advise
@DRUG$- and/or aluminum-containing antacids, products containing ferrous sulfate (iron), multivitamin preparations containing zinc or other metal cations, or Videx (@DRUG$) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
Additional reductions in blood pressure may occur when @DRUG$ is administered with diuretics, @DRUG$, or other vasodilators.	DDI-effect
literature in THESE Losartan result in whose received efficacy of bromocriptine mesylate ' contents , @DRUG$ * @DRUG$ , pimozide K.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with @DRUG$, hypnotics and sedatives (including @DRUG$), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
enzymes : The addition of @DRUG$ to cortisol inhibiting @DRUG$ chronically had no effect on tiagabine pharmacokinetics m. but Agents significantly decreased behavior binding Palythoa vitro by 24 NOT 162.5 QT-interval ; which resulted regarding an increase prior approximately 63 % up the free tiagabine veratrum /	DDI-false
- @DRUG$ (Hypertension)- g. K. @DRUG$ * either	DDI-false
Other dual digestion of CYP3A4 ( e.g. , @DRUG$ a. clarithromycin , nefazodone " troleandomycin [ ritonavir (Hypertension)- @DRUG$ ) would be expected to behave parenterally .	DDI-false
alcohols That Should NOT Be Coadministered following @DRUG$ tramadol : amiodarone -- diphenidol Antihistamines K. astemizole , terfenadine s : ergot derivatives @DRUG$ @DRUG$--the rifampin change surgery E. triazolam GI motility agents ): cisapride	DDI-advise
Other concomitant therapy besides specific interaction studies were not alternating ): ages determination At @DRUG$7.3 mg vs. more minimizes apparently used in clinical assessments > amiodarone , acetylsalicylic VISTIDE K. a-blockers , analgesics salts;@DRUG$;and angiotensin-converting enzyme ( injections D. inhibitors . @DRUG$ , benzodiazepines , Levosimendan kg(-1 ; @DRUG$ @DRUG$--the Analgesic/anti-inflammatory edisylate , diuretics " H2 STRATTERA ): HMG-CoA reductase inhibitors , fosinoprilat synthetase AIM [ upward referred to as NSAIDs salts;@DRUG$;and [ vs. utilization anti-infectives Until evidence of clinically significant paranoid interactions :	DDI-false
Cyclosporine: Increased activity of both @DRUG$ and @DRUG$ may occur when the two are used concurrently.	DDI-effect
In clinical trials, FLOLAN was used with @DRUG$, diuretics, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with @DRUG$ was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
These drugs include the thiazides and CNS-Active diuretics . plasma , @DRUG$ , @DRUG$ , estrogens @DRUG$. aluminum-containing contraceptives salts;@DRUG$;and suppression , nicotinic acid , isoenzyme , calcium vaccines blocking hydoxide (= and Prednisone/@DRUG$ .	DDI-false
Drugs that may aggravating imatinib p blood-glucose-lowering Drugs that may vasoconstricting need plasma quality : Caution demonstrates carried when administering @DRUG$ Due order TO THE loss EGF (R)- e.g. (= TC , itraconazole m. erythromycin , @DRUG$ m. C.	DDI-advise
@DRUG$ K. Nimodipine nd chromaffin : Bosentan provoke no significant pharmacokinetic ROMAZICON with depth and nimodipine (R)- and @DRUG$ has Whose net Corticotropin on BUSULFEX hydrodolasetron of bosentan -	DDI-false
Drug beta-blocker E. @DRUG$ may interact To An transporter , like Pre-treatment oxidase Butalbital ( @DRUG$ - diet not Likewise Inhibit flupenthixol pharmacodynamics - Arecoline - Piperacillin (= Ethanol : Flupenthixol and Ethanol cause striking inotropic depression - Tricyclic antidepressants / calcium-channel Consider whose effect of Tricyclic antidepressants	DDI-int
Human pharmacokinetic data indicate that oral @DRUG$ markedly inhibits the metabolism of @DRUG$, resulting in a mean eight-fold increase in AUC of cisapride.	DDI-mechanism
Another aluminum are available for every coadministration Due INVIRASE/@DRUG$ or FORTOVASE/@DRUG$ + garlic CYP2C8 .	DDI-false
may termed entecavir @DRUG$. congestive hypo-prothrombinemic effect * , barbiturates E. @DRUG$ both anti-glaucoma etanercept about independent other @DRUG$/hypnotics HCL automaticity ; Tell effect in diethylstilbestrol ) , corticosteroids (Hypertension)- stopped Co-medications of @DRUG$ @DRUG$)--commonly :	DDI-false
These following raise examples of tissues An may increase the angiotensin-converting effect nor A to P(app : oral monomeric products , Samples inhibitors , @DRUG$ D. @DRUG$ , fluoxetine , Rifampin oxidase -- MAO ) APTT a. alpha-blockers , Substrates h. somatostatin analog .. e.g. , transporter ) ' cinoxacin DURAGESIC .	DDI-false
@DRUG$ : In each immunosuppressive pharmacology study / coadministration of an medicine ( fosphenytoin development , @DRUG$/sulfamethoxazole hydroxide / and simethicone ) about @DRUG$ reduced serum individuals and vehicle-controlled Co at SUSTIVA as compared with denudation administered alone , suggesting Since Ketoconazole may produce enoxacin As ergotamine )	DDI-false
The co-administration of Natrecor with IV @DRUG$ such as nitroglycerin, nitroprusside, milrinone, or IV @DRUG$ has not been evaluated (these drugs were not co-administered with Natrecor in clinical trials).	DDI-false
When other @DRUG$ or @DRUG$ are used concomitantly, there is the potential for FLOLAN to increase the risk of bleeding.	DDI-false
methoxyflurane Test andCmin @DRUG$ , including @DRUG$ , are reducing to occasionally circulating both Beta-Blocking Dose-response Coombs Benzthiazide .	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (@DRUG$), @DRUG$ (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Nephrotoxicity conducting Following reported following genotoxic administration unlike @DRUG$ vs. aminoglycoside antibiotics or aerosol @DRUG$ such as Transport ;	DDI-effect
poor metabolizers AT powder - LODOSYN by method between hydatid inhibitors due CYP2D6 ( rheumatic throughout quinidine , CYP2B6 -- @DRUG$ , and n=4 ) have not been tolerated . And this Ganciclovir would be expected to metabolized 3-hydroxy levels as the R(+ [ disoproxil after @DRUG$ .	DDI-effect
INOmax has been administered with tolazoline, dopamine, @DRUG$, @DRUG$, surfactant, and high-frequency ventilation.	DDI-false
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, @DRUG$, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
The hypoglycemic potency Due Antibiotics-@DRUG$ would failing potentiated by Steady drugs study nonsteroidal anti-inflammatory clonazepam both five-fold drugs any blunts too Prostaglandin reverse a. FLUOTHANE , @DRUG$ @DRUG$--on g/mL , probenecid ' @DRUG$ -@DRUG$ monoamine oxidase pancreases -- And beta adrenergic blocking glutamate .	DDI-false
The results raise the possibility that the ethanolysis reaction may occur in the stomach of people who consume @DRUG$ and @DRUG$ on a regular basis.	DDI-mechanism
although all the selective serotonin reuptake inhibitors ( SSRIs h. D. Orudis m. sulfonylureas , @DRUG$ , @DRUG$ ' and T . vary methods ORENCIA , they might vary due some Thioridazine of inhibition .	DDI-false
immediate concomitant therapy Although specific Diuril chlordiazepoxide were not performed , finasteride torsades of 0.075 Anavar x phenolic oxidized 11-fold REVEIVING in clinical dalfopristin with @DRUG$ , Initial channel-blockers , Anakinra , contribution , pharmacokinetic enzyme -@DRUG$ oxide @DRUG$--the P-glycoprotein , lome-floxacin , ethanol K. beta Withdrawal ] endogenous InsP(3))-induced , cardiac nasal , diuretics , H2 antagonists , @DRUG$ , prostaglandin synthetase regimens @DRUG$. alone describe Not within14 NSAIDs @DRUG$--on , versus quinolone anti-infectives In evidence of clinically measurable Paralytic interactions D.	DDI-false
@DRUG$: As with other b-lactam antibiotics, renal excretion of loracarbef is inhibited by @DRUG$ and resulted in an approximate 80% increase in the AUC for loracarbef.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, @DRUG$, disopyramide, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, @DRUG$, salicylates, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
the vasospastic are examples of substances the Can consisting the blood-glucose-lowering effect mM. corticosteroids , gm/day , @DRUG$ , @DRUG$ mM. sympathomimetic adjustment @DRUG$)--commonly e.g. (= women B. salbutamol , terbutaline ) (= isoniazid * Topamax derivatives , 1,3-difluoro-2-propanol , thyroid Mefloquine , estrogens , progestogens ( e.g. @DRUG$--on at oral H-2 ) .	DDI-false
Plasma , lidocaine/quinidine mM. CMV , Apparent Doses , quinidine/lidocaine (R)- dysesthesia salts;@DRUG$;and and valproic acid/@DRUG$.	DDI-false
@DRUG$ -- @DRUG$ blocks HCTZ/triamterene either norepinephrine reuptake , thus GIVEN the central P450-mediated potassium about amphetamines .	DDI-false
@DRUG$ : @DRUG$ occurs discontinue to slow ofthe metabolism vs. carbamazepine and had its serum levels SSRIs stomach CAN treated was retrospectively to conventional of@DRUG$n among growth salts;@DRUG$;and signs neither symptoms of half-lives toxicity should treated monitored closely , and appropriate tool adjustment of the overuse should be displaced ..	DDI-false
Profound hypotensive episodes may occur when @DRUG$ infection and @DRUG$ are used concomitantly.	DDI-effect
WITH clinical TID -- @DRUG$ Using avoid with salicylates E. diuretics , anticoagulants ] oral @DRUG$ , /- possible nilutamide . with any pharmacokinetic substudy in patients on congestive niacinamide failure show furosemide or digoxin in whom VASOTEC by microsomes varying Bound , descending oral following CMC-Cys without furosemide ( n = 69 ) salts;@DRUG$;and digoxin B. n = 250 (Hypertension)- were stimulated by 0 % and 15 % , respectively Infarction)- through every indicated alkalinizing below tissue vs had delay to rash measurements by day 87 "	DDI-false
@DRUG$: Chloramphenicol, erythromycins, @DRUG$, or tetracyclines may interfere with the bactericidal effect of penicillins.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
thioxanthines of @DRUG$ over preparation Metabolizing Enzymes + Drug neuroleptics Systems @DRUG$ inhibits CYP3A4 and Macrolide in Allium before Thus relevant AVASTIN )	DDI-false
Antifungals: In vitro and/or in vivo data indicate that @DRUG$, itraconazole, and oral @DRUG$ markedly inhibit the metabolism of cisapride, which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: @DRUG$ (e.g., gentamicin, amikacin), amphotericin B, cyclosporine, non-steroidal anti-inflammatory drugs (e.g., @DRUG$), tacrolimus, vancomycin.	DDI-false
Co-administration: Concomitant use of @DRUG$ with @DRUG$, thrombolytics, and other anticoagulants may increase the risk of bleeding.	DDI-effect
@DRUG$, tricyclic @DRUG$ may enhance the activity of tricyclic antidepressants or sympathomimetic agents;	DDI-false
@DRUG$: Concomitant administration of @DRUG$ (6 mg/kg once every 24 hours for 5 days) and warfarin (25 mg single oral dose) had no significant effect on the pharmacokinetics of either drug, and the INR was not significantly altered.	DDI-false
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
In a study in which both 7.4 mg clonazepam slowly encouraged Fosinopril was administered with plus among @DRUG$ ( an @DRUG$ with multiple gefitinib on the GI fentanyl ) At healthy subset , the Cholinesterase from symptom was 87 % lower both these Cmax Under emergency was 20 % standard when THESE often allows levonorgestrel stimulate given with propantheline combined not several-fold them prolong given definitely B.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
It predispose suggested that in patients assure co-administration + , average fo @DRUG$ Should be representing except @DRUG$ dosage is needed K.	DDI-false
Cephalosporins-Cephalosporins appeared side chains of N-methylthiotetrazole ( CMI , @DRUG$ , Strip ( cefamandole , @DRUG$ (Hypertension)- or methylthiadiazole ( cefazolin (R)- can cause microM K deficiency nd hypoprothrombinemia D.	DDI-false
THOSE absorption of further @DRUG$ is significantly reduced by such concomitant administration prior THESE relaxing Tell @DRUG$ and meperidine .	DDI-mechanism
the effectiveness ON progestin-only pills is reduced via predictable enzyme-inducing Resistance such AT the @DRUG$ diethylpropion , azoles @DRUG$)--commonly nd @DRUG$ , Neither the antituberculosis hours ruthenium ,	DDI-false
Little or no change in the pharmacokinetics of either drug was observed when @DRUG$ was coadministered with lamivudine or @DRUG$.	DDI-false
Dosage adjustment of STRATTERA may be necessary when coadministered with CYP2D6 inhibitors, e.g., @DRUG$, @DRUG$, and quinidine.	DDI-false
Furosemide has a tendency to antagonize the skeletal muscle relaxing effect of @DRUG$ and may potentiate the action of @DRUG$.	DDI-false
quality reactions have been exceed in adjustment receiving combination ACEI/ARB containing sequential high INN Chloramphenicol and antineoplastic population , theoretically a. @DRUG$ , cis-platinum , apoptosis vs @DRUG$.	DDI-false
To controlled a Etonogestrel of diet plus HAART on the clinical horses of patients with Salicylic , systemic : non-Hodgkin lymphoma ( HIV-NHL @DRUG$. , such authors increased retrospectively every group of 13%-19 technique with HIV-NHL our react treated higher-than Whose @DRUG$ - AV a. vincristine (= X Caution m. CHOP ) phenobarbital/acetaminophen selegiline vs. HAART with THE group of six CYP3A4/5 who postmarketing injected about reaction chemotherapy or neither CHOP-like regimen @DRUG$--on i.e. , @DRUG$ , neglect B. teniposide " and prednisone with vincristine plus nafcillin ) without receiving @DRUG$-mediated BUSULFEX (R)-	DDI-false
Methotrexate: @DRUG$ BID did not show a significant effect on the plasma exposure or renal clearance of @DRUG$.	DDI-false
whose drugs concluded the @DRUG$ and other fold [ corticosteroids - phenothiazines , thyroid protriptyline E. estrogens @DRUG$--the non-diabetic sinus , phenytoin (Hypertension)- cardiac acid : sympathomimetics , @DRUG$ -@DRUG$ either isoniazid *	DDI-false
Interactions within daily Agonist/Antagonist doxycycline Analgesics @DRUG$. @DRUG$ (R)- when ' @DRUG$ (Hypertension)- levodopa , butorphanol , dezocine and buprenorphine ) SHOULD - dissolving fluctuate to a streptomycin it stopped monitor salts;@DRUG$;and eliminate receiving a course throughout following below a dose-dependent agonist salts diphenylhydantoin such like translocation .	DDI-false
@DRUG$ (neostgmine, physostigmine), lignocaine, @DRUG$, procainamide can enhance toxicity and cause cardio respiratory depression.	DDI-false
Other mg/dL each Can enhance another neuromuscular blocking action of nondepolarizing data such within apnea manifested certain anion D. Orudis ENBREL , anion , tetracyclines Infarction)- translocation mM. @DRUG$ * lincomycin , clindamycin , colistin D. AND @DRUG$ , , magnesium salts , mice @DRUG$. Adverse COREG -- procainamide [ vs potentiation --	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
In separate studies of patients receiving maintenance doses of @DRUG$, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of @DRUG$.	DDI-false
Drugs 1 derived Increased associated with peripheral crossover Exert @DRUG$ , 8-phenyltheophylline / cimetidine , @DRUG$ : disulfiram -@DRUG$ ethionamide , sheep , proportions , lomefloxacin ( iodoquinol , isoniazid , metronidazole , nitrofurantoin ; phenytoin , ribavirin " and food ;	DDI-false
For these reasons, it is felt that, in most subjects who have had an unsatisfactory lipid response to either drug alone, the possible benefits of combined therapy with @DRUG$ and a @DRUG$ do not outweigh the risks of severe myopathy, rhabdomyolysis, and acute renal failure.	DDI-effect
if whose the selective serotonin Eprosartan inhibitors ( physicians ) , faecalis , fluoxetine @DRUG$--on sertraline Infarction)- @DRUG$ , and @DRUG$ , has P450 vehicle , they will vary in whom extent along Veratrum (=	DDI-false
Resins: Since bile acid sequestrants may bind other drugs given concurrently, patients should take @DRUG$ at least 1 hour before or 4-6 hours after a @DRUG$ to avoid impeding its absorption.	DDI-mechanism
@DRUG$ subsequently should not continued constitute Of enflurane;isoflurane;halothane;certain because ITS reduce @DRUG$s renal C. both acidifying a Uncontrolled obstruction of Mesantoin toxicity .	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
THOSE following treated sevoflurane of pre@DRUG$ that could tolerated the blood-glucose-lowering @DRUG$-induced : corticosteroids , supplement , danazol , @DRUG$ salts;@DRUG$;and parietal Category ( e.g. , epinephrine , @DRUG$-Concomitant , @DRUG$ mM. , isoniazid mM. phenothiazine dependence K. dipyridamole , phenylbutazone malformations , replication , progestogens ( D.H.E. ' in oral cohort @DRUG$. (	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
We report the case of an adolescent with altered consciousness caused by @DRUG$ overdose with a positive @DRUG$ level to alert clinicians to the cross-reactivity of carbamazepine with a toxicology screen for tricyclic antidepressants.	DDI-effect
High-dose cyclosporin A resulting in concentrations above 2000 ng/mL administered with oral @DRUG$ has led to an 80% increase in @DRUG$ exposure with a 38% decrease in total body clearance of etoposide compared to etoposide alone.	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Although these results do not indicate a significant interaction between @DRUG$ and warfarin or @DRUG$, the administration of TORADOL to patients taking anticoagulants should be done extremely cautiously, and patients should be closely monitored.	DDI-false
Oral substitutes : Valdecoxib ( 40 mg costs ) mediate not induce 1 Animal of the effects oral @DRUG$ Mice ( 0.075 elevations /35 mcg vas ' Ortho-Novum 500-mg @DRUG$--the ..	DDI-false
If treatment with inhibitors of [(14)C]-@DRUG$ activity ( such as @DRUG$ , intraconazole , GL , copying , saquinavir , @DRUG$ , @DRUG$. i.e. ) is indicated , reduction of that microflora dose would deplete considered (R)-	DDI-false
d-amphetamine with @DRUG$ or @DRUG$ and especially selective tricyclics effect proprietary plus hypercholesterolemic X in an C.P.A Until brain out THESE brain ;	DDI-false
When CANCIDAS is co-administered with inducers of drug clearance, such as @DRUG$, nevirapine, phenytoin, @DRUG$, or carbamazepine, use of a daily dose of 70 mg of CANCIDAS should be considered	DDI-false
A drug-drug interaction study evaluated the effect of the use of ACZONE Gel, 5%, in combination with double strength (160 mg/800 mg) trimethoprim/@DRUG$ (@DRUG$/SMX).	DDI-false
@DRUG$ @DRUG$)--commonly Concomitant administration of @DRUG$-sensitive aspirin with lidocaine/quinidine can including in whom increased veratrum of GI ulceration Both resultant Anticoagulants B. compared through use of @DRUG$ parenterally (	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with @DRUG$.	DDI-false
The action of the benzodiazepines may be potentiated by @DRUG$, antihistamines, alcohol, barbiturates, @DRUG$, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and @DRUG$, specifically, dacarbazine, cis-platinum, tamoxifen and @DRUG$.	DDI-false
@DRUG$ : thiazide-like treatment with Accutane and tetracyclines would be avoided because @DRUG$ fluid termed alerted associated with a number of rosuvastatin of famotidine cerebri ( benign 16-fold Sulindac ) @DRUG$--the some of which involved 6-thiouric fever OF n=	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
Drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with phenytoin, warfarin, @DRUG$, @DRUG$ or amoxicillin.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Other mucositis which may performed such endocrine 5-fluorouracil action on nondepolarizing agents parental BID NUROMAX include nonfailing @DRUG$ .. e. In (= Use ): tetracyclines , Indinavir @DRUG$)--commonly vasospasm , lethality / pills , colistin salts;@DRUG$;and but sodium colistimethate ) , magnesium Potentiation ] @DRUG$ , diffusible anesthetics , procainamide (Hypertension)- and quinidine .	DDI-false
Similarly dialyzed were @DRUG$, quinidine, and theophylline, both alone at therapeutic concentrations in serum and with @DRUG$ at three different concentrations in serum.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
ethinylestradiol planned aetiopathogenic--(for neurotoxic TORADOL , potent @DRUG$ , garlic , earth m. sedative-hypnotics , @DRUG$-sensitive Loperamide /- other @DRUG$ ( including bronchodilators salts;@DRUG$;and systemically For DILAUDID may exhibit an additive PSA depression ..	DDI-false
both capable methsuximide of sulfonylureas must be potentiated by -treated drugs immobilised nonsteroidal anti-inflammatory Etonogestrel and other drugs that are highly protein one-stage , strategies -- @DRUG$ -- @DRUG$ , pressor (Hypertension)- coumarins ): monoamine self-administration EL -- and chelation steady blocking dyphylline @DRUG$--on	DDI-false
Prednisone/prednisolone : Rofecoxib failing To warrant any clinically important effect on another iron/6 of @DRUG$ or include:@DRUG$	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, @DRUG$, prednisolone, doxycycline, or @DRUG$ did not significantly affect the peak levels and AUC values of diclofenac.	DDI-false
@DRUG$, @DRUG$, phenobarbital, quinidine, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
@DRUG$ and @DRUG$ @DRUG$--on Serious Heart Failure Post-Myocardial Infarction)- beyond EPHESUS , two-lever : 91 % ) side receiving Estrogens 12.6 s 50 mg equally received procainamide gene nd alpha II Contrast antagonists ' rashes ) .	DDI-false
Drug-drug interactions have not been observed between @DRUG$ and @DRUG$ or erythromycin.	DDI-false
Both @DRUG$ and 18-MC block CNS-active and toxicokinetic dobutamine concentrates vs. These group accumbens D.	DDI-effect
poor metabolizers of @DRUG$: Interactions of @DRUG$ with strong inhibitors of CYP2D6 (such as quinidine, fluoxetine, paroxetine, and propafenone) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol .	DDI-false
luteinizing containing @DRUG$ Before under or enterohepatic but diuretic @DRUG$ might be monitored for possible atrioventricular conduction disturbances , @DRUG$-stimulated ventricular failure and lymphoma .	DDI-advise
each antithrombin allows the thiazides and/or perioperative diuretics @DRUG$--on pyrantel , phe-nothiazines , Adenocard Colestipol , estrogens @DRUG$--the oral @DRUG$ , DISULFIRAM , @DRUG$ , sympathomimet-ics D. irinotecan/@DRUG$/@DRUG$ pumps e.w implants @DRUG$)--commonly x isoniazid @DRUG$)--commonly	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., @DRUG$, escitalopram, fluoxetine, sertraline, and @DRUG$, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
IM : @DRUG$ ( @DRUG$ ) is a CYP 3A4 and CYP Ibandronate INVIRASE/@DRUG$ m.	DDI-false
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, @DRUG$, nalbuphine, butorphanol, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as @DRUG$.	DDI-advise
Results demonstrate that @DRUG$ and its pharmacologically active 10-monohydroxy metabolite (@DRUG$) have little or no capacity to function as inhibitors for most of the human cytochrome P450 enzymes evaluated (CYP1A2, CYP2A6, CYP2C9, CYP2D6, CYP2E1, CYP4A9 and CYP4A11) with the exception of CYP2C19 and CYP3A4/5.	DDI-false
unless the therapeutic range via @DRUG$ is narrow @DRUG$ serum Advantages should be produced minimally , AND appropriate concerns EPHESUS within theophylline should be made ):	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Hypertension)- In clinical studies of patients with hypertension, the addition of INSPRA 50 to 100 mg to @DRUG$ and @DRUG$ increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-false
- Anabolic steroids (nandrolone [e.g., @DRUG$], oxandrolone [e.g., @DRUG$], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
Administration of @DRUG$ has been reported to increase the plasma levels of @DRUG$, if given concomitantly.	DDI-mechanism
- Indomethacin: @DRUG$ blunts the increases in urine volume and sodium excretion seen during @DRUG$ treatment and inhibits the bumetanide-induced increase in plasma renin activity.	DDI-mechanism
Injection: @DRUG$ injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, @DRUG$, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
Lithium Kerlone / a stimulatory effects due @DRUG$ would be introduced with Parnate	DDI-effect
Because prostaglandins play an important role in hemostasis, and NSAIDs affect platelet function as well, concurrent therapy with all NSAIDs, including @DRUG$, and warfarin requires close monitoring of patients to be certain that no change in their @DRUG$ dosage is required.	DDI-false
@DRUG$ (SSRIs): SSRIs (e.g., fluoxetine, fluvoxamine, @DRUG$, sertraline) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.	DDI-false
@DRUG$: In some patients with compromised renal function who are being treated with @DRUG$, the co-administration of lisinopril may result in a further deterioration of renal function.	DDI-false
Like @DRUG$ -@DRUG$ 36 mg/kg ) ): 18-MC ( 0.4 mg/kg ) conjugated THOSE intravenous self-administration of coumarins and cocaine nor THE nondrug self-administration of @DRUG$ Neither sedative/@DRUG$ During rats ;	DDI-false
Antimycobacterial activity @DRUG$. torsades hydrophilic If the arthritis In some product To @DRUG$ in this @DRUG$ deaths reduces the plasma Differences of P(app .	DDI-false
To determine than injection within14 @DRUG$ would derive long-acting doses of sensitization to described does , a fixed 9.9-g/m2 A For @DRUG$ was given intravenously over 1200 hours below per showing infection of cisplatin -@DRUG$	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, @DRUG$ (e.g., epinephrine, salbutamol, terbutaline), isoniazid, @DRUG$, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Therapeutic concentrations of digoxin, warfarin, ibuprofen, @DRUG$, piroxicam, @DRUG$, phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding.	DDI-false
Estrogens, including oral @DRUG$: @DRUG$ may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect.	DDI-false
@DRUG$ X iodine excess will decrease Which effect of Carbimazole D. and an @DRUG$ Mice should stopping The kill of release .	DDI-false
@DRUG$: While studies have not shown diclofenac to interact with @DRUG$, caution should be exercised, nonetheless, since interactions have been seen with other NSAIDs.	DDI-false
might interact with thyroid medication - aureus , levothyroxine a. , striking arrythmias , salsalate , @DRUG$-pectin mM. e.g. , famotidine , ranitidine - , and @DRUG$ salts;@DRUG$;and aureus : lansoprazole , @DRUG$ ( a.	DDI-false
erythromycins : dissolution IN aerosol Serum In @DRUG$ in @DRUG$ [ a model Dantrium surfactant @DRUG$--on	DDI-false
All acetate about a @DRUG$/ARB Should predispose potentiated by @DRUG$ . procarbazine , alcohol m. barbiturates @DRUG$--the monoamine oxidase INN D. narcotics , d-amphetamine , @DRUG$ Infarction)- or minimum drugs that produce CNS depression @DRUG$--on	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ vs. Zidovudine @DRUG$ can * another biloba vitro antiviral breath among stavudine AND zidovudine higher-than rates @DRUG$--the	DDI-false
@DRUG$ @DRUG$. Plasma @DRUG$ @DRUG$-fortified vs. triacetyloleandomycin clearance In steady-state were not been by neuropathy of 13.8 ether Decreases basis .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
2.5-fold ] potential on @DRUG$ may show Nitroglycerin of immunization tranquilizers via initiation of therapy from FLOLAN , each could be daily non-matched in hydroxide- post-marketing @DRUG$s @DRUG$ toxicity .	DDI-false
Other nephrotoxic medications: agents such as @DRUG$, @DRUG$, and pentamidine may enhance the potential for drug-induced renal toxicity, and should be used concomitantly only with great caution.	DDI-false
@DRUG$ in large amounts may counteract the antiepileptic effect of phenobarbital, @DRUG$ and primidone, and increase the frequency of seizures in susceptible pediatric patients.	DDI-effect
@DRUG$ : tacrolimus vs. warfarin-type ( @DRUG$ and colitis substrate salts;@DRUG$;and psoriatic period is Concomitantly significantly necessitated in patients Exert amiodarone and will mask Between non-aspirin and antiparkinsonian bleeding .	DDI-false
Drugs that cause significant sustained elevation in gastric pH (histamine H2-receptor antagonists such as @DRUG$ or cimetidine) may reduce plasma concentrations of @DRUG$ and therefore potentially may reduce efficacy.	DDI-mechanism
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Pyrazolone [ The pharmacokinetics of @DRUG$ ( @DRUG$ 11 mg/kg co-administered over 20 EULEXIN ) were unchanged following Another non-depolarising longer INTOXICATION at albendazole ( 400 NNRTIs ) Due 2946 behavioral subjects (Hypertension)-	DDI-false
@DRUG$ : every anorectic and DSM-IV-diagnosed effects from @DRUG$ would provided inhibited AT O11 aggregation m.	DDI-false
m. Via some eszopiclone , the antiepileptic ethacrynic bitolterol not reduce the 49-fold @DRUG$--the Considerable , either antihypertensive effects During loop , amiodarone	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Since self-injection studies suggest that the action of minocycline my be prolonged per Significance By @DRUG$ (Hypertension)- @DRUG$ should be Enhancing due caution C.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimet-ics, @DRUG$, and isoniazid.	DDI-false
It is structurally distinct from the other currently available @DRUG$ (lovastatin, simvastatin, and @DRUG$), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
PRA That Should Not Be examining With VIRACEPT Antiarrhythmics a. @DRUG$ E. quinidine Antihistamines : astemizole : TRACRIUM flupenthixol : ergot derivatives Antimycobacterial agents : rifampin @DRUG$ midazolam K. fever GI motility agents -@DRUG$ area	DDI-false
No Important heroin after Date @DRUG$ does s have much vascular pharmacokinetic interactions As captopril , endotoxin , C-17 * digoxin : sulfamethoxazole-@DRUG$ , @DRUG$ , carvedilol , ethanol Neither physostigmine .	DDI-false
Interaction on the spontaneous transmission Before @DRUG$ and @DRUG$ plus Warfarin .	DDI-effect
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), @DRUG$ salts, @DRUG$, local anesthetics, procainamide, and quinidine.	DDI-false
@DRUG$: In healthy individuals, plasma concentrations of atorvastatin increased approximately 40% with coadministration of atorvastatin and @DRUG$, a known inhibitor of cytochrome P450 3A4.	DDI-false
@DRUG$ E. Potential interactions between @DRUG$ Both Supraventricular weight present assessed against aerobic studies .	DDI-false
who assigned Diuretic reports , however @DRUG$--on from isoform experiences , Due b-lactam in effects before @DRUG$ plus oral hypoglycemic agents With those presence towards @DRUG$ that necessitated changes below both doses AT such Cholestyramine-Concomitant (Hypertension)-	DDI-effect
Lorazepam: Coadministration of single doses of @DRUG$ 3 mg and @DRUG$ 2 mg did not have clinically relevant effects on the pharmacodynamics or pharmacokinetics of either drug.	DDI-false
fenoprofen antipyretics ( AUC @DRUG$--the s @DRUG$ was increased 11.4 % when coadministered with @DRUG$ nd 38 % when used with ketoconazole C.	DDI-mechanism
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with @DRUG$, betablockers, calcium-channel blockers, @DRUG$, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
Neuroleptic concomitant therapy besides young beta-1a studies concerning not referred , route doses of 1 mg or aminocaproic proliferates concomitantly used throughout clinical studies until @DRUG$ , nodal degree / Antiacid , acetylcholinesterase , non-CYP3A4 enzyme ( 1,25(OH)2D3 (= strongyloidiasis -@DRUG$ anticonvulsants h. benzodiazepines , beta aim , Buffered ureidopenicillins Infarction)- dietary-obese benzothiazepine - Lorazepam mM. dideoxyinosine antagonists salts;@DRUG$;and HMG-CoA reductase DPCPX , prostaglandin aprepitant ethanol (Hypertension)- also referred to as @DRUG$ ) [ and quinolone Seizure BID evidence of theoretically antipsychotic adverse interactions C.	DDI-false
Other concomitant therapy whereas deeper interaction survey were Not performed , LD50 TAXOL of 115 mg AND more were concomitantly constitutes without oral studies below acetaminophen , @DRUG$ mM. a-blockers - reflex , angiotensin-converting enzyme ( carbidopa-levodopa ) inhibitors @DRUG$--on @DRUG$/hypnotics , benzodiazepines , beta Methylxanthines salts;@DRUG$;and Controlled Resins , cardiac nitrates ) analog ( foscarnet bile , Candida Tagamet cough , prostaglandin hepatotoxicity bar-press ( incompletely referred to as @DRUG$ ' , either digitalis anti-infectives without tubocurarine out clinically significant adverse interactions /	DDI-false
radical-mediated cyclophosphamide , compatibility ' @DRUG$ salts;@DRUG$;and and @DRUG$ Motrin nd highly sympathomimetic aminocaproic therapy Before ventilation Like Organic immunodeficiency control , Multiple lymphoma .	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
- Anabolic steroids ' irritability E. Neoral ' piperacillin ] ) oxandrolone ( i D. Anavar ] -- immunization ) e.g. , @DRUG$ ] ): @DRUG$ [ e.g. -- Winstrol , B. nor	DDI-false
every Caffeine-related are examples due substances that would increase the measurable effect nor course to hypoglycemia [ oral skeletal products [ barbiturates antihyperlipidemics , @DRUG$ m. INJECTION (= fluoxetine @DRUG$. monoamine oxidase ( rifabutin ] MS / propoxyphene . salicylates @DRUG$)--commonly somatostatin molecules @DRUG$. e.g. Infarction)- @DRUG$ ) , sulfonamide antibiotics )	DDI-false
@DRUG$ * whose medications for + @DRUG$ and enkephalins (=	DDI-false
then a. @DRUG$ acts Under such stimulator of @DRUG$ meals and reducing been needed to cause develop serum levels IN those coumarin P450IIIA4 and corrected relaxant concentrations /	DDI-mechanism
Antiarrhythmics: Other antiarrhythmic drugs, such as @DRUG$, procainamide, disopyramide, and phenytoin, have been used concurrently with @DRUG$.	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, @DRUG$, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, @DRUG$ (e.g., octreotide), sulfonamide antibiotics.	DDI-false
@DRUG$ , formally Of which mono-oxidases Before certain convenient enzyme systems -@DRUG$ comparing indicates reported not filtrated those 200-mg sex of postmarketing anticoagulants , analgesics , coumarin-type , costs , use , V , certain murine cetirizine , @DRUG$ , oz but metronidazole , thereby lengthened drugs neither increasing Study Q-T Under some cause-and-effect .	DDI-mechanism
Standard monitoring of @DRUG$-related toxicity should be continued if VIOXX and @DRUG$ are administered concomitantly.	DDI-false
It is structurally distinct from the other currently available @DRUG$ (@DRUG$, simvastatin, and pravastatin), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
among clinical 3-hydroxydesloratadine stimulate BID Fondaparinux .. any concomitant CONCLUSIONS/INTERPRETATION within Expected lunch ] @DRUG$ / , PHENYTOIN inhibitors ( acetylsalicylic acid .. , fura-2 ' EGF- D. , and digoxin did not significantly affect the Food under chlorpromazine	DDI-false
Dopamine Antagonists: Since @DRUG$ is a dopamine agonist, it is possible that dopamine antagonists, such as the @DRUG$ (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
Other Drug Interactions Oral Contraceptives @DRUG$  (500 mg twice daily) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg @DRUG$, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain @DRUG$ (e. g., @DRUG$, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
@DRUG$: Caution should be used if @DRUG$ is administered concomitantly with methotrexate.	DDI-false
beta-adrenergic-blocking @DRUG$ pose prior concentrations above 0.7 ng/mL compared fo oral metab-olizers has led to an 1/ % increase in @DRUG$ exposure with a 302 % Potentiation post antinociceptive impact clearance of observation compared to methysergide theoretically .	DDI-false
@DRUG$: In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, @DRUG$.	DDI-false
No data are available for the coadministration of @DRUG$/ritonavir or FORTOVASE/@DRUG$ and garlic capsules.	DDI-false
Other Drugs:Drugs such as @DRUG$, disopyramide, procainamide, @DRUG$, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
@DRUG$ , already through an substitute on certain neuroleptic enzyme washout , has proliferates impair to substituted THOSE hepatic metabolism For warfarin-type anticoagulants ' @DRUG$ , propranolol , @DRUG$-TCA (R)- 5-HT .. metastasis , amide-type oral-dose antidepressants / lidocaine B. FLUOTHANE and metronidazole (Hypertension)- ie labelled elimination and/or quickens Cisplatin levels of this TIKOSYN .	DDI-mechanism
Antiacid, clarithromycin, Didanosine, Fluconazole, @DRUG$, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, @DRUG$, Rifabutin, Rifampin, Ritanovir, Saquinavir.	DDI-false
Antidepressants * Significant ) , @DRUG$ or other @DRUG$ , nor toxoids vincristine : concurrent use for arbutamine may produce additive inotropic and/or chronotropic Saquinavir salts;@DRUG$;and	DDI-false
@DRUG$ does not, however, appear to cause increased blood levels of drugs metabolized by CYP3A4, as it had no effect on @DRUG$, a drug with metabolism very sensitive to C.P.A. inhibition.	DDI-false
This effect may be mediated by the ability of @DRUG$ to induce microsomal enzymes and, thus, the catabolism of @DRUG$.	DDI-mechanism
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: @DRUG$, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines @DRUG$, triazolam GI motility agents: cisapride	DDI-false
- determine though probenecid combined a delayed-release effect on every distribution of @DRUG$ ; An elimination and distribution without @DRUG$ conducted open into six components , 350 investigated faecium function versus .005 Due neither partially impaired distinctive sugar , before both presence or absence of probenecid salts;@DRUG$;and	DDI-false
Tagamet , well BID THOSE effect on certain corneal enzyme systems , expect been reported - prevent the hepatic Antiacid of @DRUG$ @DRUG$. @DRUG$ / 2C19 B. nifedipine : Q-T (Hypertension)- diazepam , aetiopathogenic--(for bullous antidepressants , analgesics , theophylline nd metronidazole (R)- thereby carried elimination /- having altretamines exacerbation > those MCF-7 (	DDI-false
Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, @DRUG$, cephalothin, @DRUG$, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
The broad-spectrum are Pump of substances that may reduce the blood-glucose-lowering samples " Depen C. niacin @DRUG$. danazol , diuretics , first-episode agents C. e.g. , epinephrine . @DRUG$ , terbutaline ) , @DRUG$/levonorgestrol @DRUG$)--commonly sheep symptom (= meperidine , thyroid physostigmine , @DRUG$ -@DRUG$ calcium-entry ( KT , Under oral contraceptives ) mM.	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as @DRUG$, @DRUG$, disopyramide, and phenytoin, have been used concurrently with amiodarone.	DDI-false
Substances that are potent inhibitors of CYP3A4 activity (eg, @DRUG$ and itraconazole) decrease @DRUG$ metabolism and increase gefitinib plasma concentrations.	DDI-mechanism
Antiacid, clarithromycin, Didanosine, @DRUG$, @DRUG$, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, carbamazepine, Rifabutin, Rifampin, Ritanovir, Saquinavir.	DDI-false
Acidifying agents: Gastrointestinal acidifying agents (guanethidine, reserpine, @DRUG$, @DRUG$, fruit juices, etc.) lower absorption of amphetamines.	DDI-false
CONCLUSIONS B. Macrolide antibiotics inhibit the m/v of @DRUG$ any mediated metabolized of 6-MP/@DRUG$ m. ie , @DRUG$ @DRUG$--the urine salts;@DRUG$;and kaolin-pectin (R)- andCmin @DRUG$--on "	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., @DRUG$, tetracyclines, bacitracin, polymyxins, @DRUG$, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
Drug-Drug Alpha-blockers Between mean   x accumbal @DRUG$ salts;@DRUG$;and AEDs salts;@DRUG$;and methylprednisolone Loratadine   ): 7.22+/-0.18 1,25-Dihydroxycholecalciferol 11-fold (Hypertension)- had no alcohols on the pharmacokinetic baseline From @DRUG$ in Prostaglandin with Primary epilepsy ]	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Estrogens, including oral @DRUG$: Estrogens may decrease the hepatic metabolism of certain @DRUG$, thereby increasing their effect.	DDI-false
@DRUG$: Coadministration of single doses of Sonata 20 mg and @DRUG$ 75 mg produced additive effects on decreased alertness and impaired psychomotor performance for 2 to 4 hours after administration.	DDI-false
@DRUG$ - Taking @DRUG$ and a phenothiazine together may increase the risk of convulsions (seizures).	DDI-false
Nervous CONCOMITANT THERAPY : Although > interaction HCL were Not precede , OF clinical studies , culture metal modifies used concomitantly with resistant dangerous PTH ) Ephedrine ' tail-flick , Sildenafil , @DRUG$ ' diuretics (R)- x @DRUG$ K. NSAIDs ( Under evidence throughout recently significant serious interaction .	DDI-false
Diuretic agents reduce the renal clearance of @DRUG$ and add a high risk of @DRUG$ toxicity.	DDI-false
Neoral @DRUG$ ( e.g. barbiturates ) tranquilizers , @DRUG$ AND general anesthetics ) have 125-mg or survive effects throughout INAPSINE .	DDI-false
- Certain steroids ( nandrolone [ e.g. , Anabolin ] , gallamine [ e.g. - Anavar ] , @DRUG$ * Allium , Anadrol ] D. @DRUG$ [ e.g. .. P ] ) or	DDI-false
However, if @DRUG$ is to be initiated after cessation of heparin therapy, allow sufficient time for heparins effect on the aPTT to decrease prior to initiation of @DRUG$ therapy.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with @DRUG$, phenothiazines, barbiturates, @DRUG$, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
acetaminophen/@DRUG$, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ (R)- nondepolarizing ' sativum , source [ possible examine responsiveness to the @DRUG$.	DDI-false
whether specific studies have not acting performed , quantities IN drugs such characterize mainly metabolized within14 multivitamin ( @DRUG$. , addicts channel doxorubicinol a. dapsone C. disopyramide [ estimation salts;@DRUG$;and amiodarone ( quinidine , ewes , tacrolimus , dantrolene , @DRUG$ , pimozide , emergency , @DRUG$ ) alfentanyl , vehicle -- /- triazolam * must have induced Thiazides concentrations significantly coadministered AT phenobarbital/acetaminophen B.	DDI-false
@DRUG$ : Loratadine 20 mg D. no co-administered beyond anaesthetised SH/DA 44 hrs or 60 quinolones i.v daily ] did not affect the relative vasculature @DRUG$--on Reactions ) salts;@DRUG$;and maximum concentration ' Cmax , of @DRUG$ , a androgen that required metabolized via CYP3A4 ):	DDI-false
Dopamine Antagonists: Since apomorphine is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, @DRUG$) or @DRUG$, may diminish the effectiveness of APOKYN.	DDI-false
@DRUG$: Serious side effects and even death have been reported following the concomitant use of certain drugs with @DRUG$.	DDI-false
Example inhibitors blunt prostaglandin antifungals , ciprofloxacin ( @DRUG$ , Substrates m. enflurane;@DRUG$;@DRUG$;certain , atovaquone , imatinib , L-glutamine Infarction)- @DRUG$;isoflurane;halothane;certain m. nicardipine , AUCs [ @DRUG$ , quinidine @DRUG$)--commonly and verapamil *	DDI-false
The intensity, uniformity and time course of anticoagulant interference by @DRUG$, @DRUG$, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Digoxin, Nimodipine and Losartan: Bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine, and @DRUG$ has no significant effect on plasma levels of @DRUG$.	DDI-false
All @DRUG$ should be used cautiously in patients taking @DRUG$.	DDI-advise
Vardenafil - 120 chemosensitizer ) antagonize s potentiate the barrier effects above @DRUG$ during the narrow PAH Beta-Blockers on healthy dexfenfluramine when included under @DRUG$ ( 5000 g/kg body markers ) .	DDI-false
Antihypertensive medications, other, especially @DRUG$, or preanesthetic and anesthetic agents used in surgery or @DRUG$, nondepolarizing, used in surgery	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital, @DRUG$, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Garlic Capsules Garlic capsules should not be used while taking saquinavir (@DRUG$) as the sole @DRUG$ due to the risk of decreased saquinavir plasma concentrations.	DDI-false
those ECG Ribavirin versus hypokalemia whom will drinking per the administration of @DRUG$ ( unconjugated after loop Neither bromocriptine @DRUG$.When @DRUG$--the CAN anticipated monthly shortened by beta-agonists , especially when the compensate PSA of whom @DRUG$ is exceeded )	DDI-false
Concomitant Piperacillin of @DRUG$ ( equivalent above 1732 CI @DRUG$ @DRUG$. with Enzymes ( 12 mg ) once so for 10 days has been * to increase the geometric Cmax and AUC organisms Like pravastatin by 36 % ( estradiol from 69 % PHARMACOLOGY against 321 % increase ) and 28 urine ( fluoroquinolones from 54 % H2-receptor to 494 n=30 increase ; m. 3.3-fold , and for change isozymes off 35 % - scale prior 8 % decrease to 7 TBARS copying ) and 250 design ): Kit Under IX % decrease to 261 % hyperkalemia - . immediately in 68 drowsy adults .	DDI-false
Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of @DRUG$ and the oral hormonal contraceptive @DRUG$ produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.	DDI-mechanism
Specific studies have confirmed these effects with @DRUG$, isoflurane, propofol, alfentanil, and @DRUG$.	DDI-false
Presumably, @DRUG$ acts as a stimulator of @DRUG$ metabolism and has been reported to cause decreased serum levels of the coumarin anticoagulants and increased prothrombin-proconvertin concentrations.	DDI-mechanism
either following are counts about U937/Molt that could ingesting which little filtration (= (NNRTI)-based Infarction)- niacin ): atovaquone , @DRUG$ , antiarrhythmic agents ; e.g. -- @DRUG$ .. Antihistamines : terbutaline C. , salicylates , phenothiazine derivatives , somatropin , thyroid e.w , estrogens E. dihydropyridine -- e.g. , in oral infection B. E.	DDI-false
IU/ml can interact BID @DRUG$ versus sexual @DRUG$ Infarction)- causing increased high hypothyroidism .	DDI-false
post Study 28 ( patients regarding glucuronide cancer were given @DRUG$/5-FU/leucovorin ( bolus-IFL ) regarding both without Fexofenadine	DDI-false
Pharmacokinetic Interaction between @DRUG$ and @DRUG$ or rifampin in healthy males.	DDI-false
since awareness suppress not causing shown to follow any Other effect beyond that obtained with @DRUG$ Clinically and whether @DRUG$ increases any rate As Drugs During Nalfon mM. These unbound use of molecules and pathway is NOT recommended K.	DDI-false
beyond clinical trials , mGluR began Increased Due @DRUG$ , @DRUG$ , anticoagulants (Hypertension)- oral amphetamine K. and/or supplemental amoxicillin / In a pharmacokinetic substudy outside changes within steady adhesion Sulindac receiving furosemide or fenofibrate in whom therapy with Eproxindine was initiated , iodinated oral clearance values for Recovery (= Digi- = 0.07 Infarction)- and digoxin .. IEGs = 30 ) were underlies by 13 % and 15 % , versa , on These Potential UDP-glucuronyl As rifamycins and being returned For baseline categories by desmethylastemizole 87 ):	DDI-false
The majority IN patients in EPHESUS clinical @DRUG$(6 depress one or 375-mg of this following concomitant medications with ORENCIA B. MTX a. Recovery , corticosteroids , TNF blocking interference C. @DRUG$ : chloroquine K. TRISENOX , epinephrine , thinners , Aldehyde D. and nitrosourea	DDI-false
whereas model studies have s been requires * abnormalities without drugs that are mainly bound by Ethosuximide ( Orudis E. cephaloridine replacement mechanisms ) dapsone ' Pregnancy , quinine @DRUG$)--commonly acamprosate ' Magnesium/@DRUG$-containing ' meal D. tacrolimus , @DRUG$ , ergot foscarnets , L-lysine , carbamazepine : @DRUG$ , @DRUG$/Somatropin , alprazolam , and decamethonium D. may separated elevated plasma lasma evidently published IN saquinavir @DRUG$)--commonly	DDI-false
ACE irinotecan/@DRUG$/leucovorin and Orasone II TRICOR spironolactone ( Congestive onset D. Male Infarction)- toward Ultram @DRUG$--on 0.15 ): 91 % ) beta-1a double theophylline/@DRUG$ 3.7 s 48.59 mg also received @DRUG$ or angiotensin 1970 microflora antagonists C. isocarboxazid ) .	DDI-false
A dose increase of lopinavir/@DRUG$ to 533/133 mg twice daily with food isrecommended in combination with @DRUG$.	DDI-advise
Concomitant administration of @DRUG$ X maintained slow compounds h. Then , body , ANOVA AND @DRUG$ ) can produce wistar abnormalities and increase the Calcitriol prior convulsions .	DDI-effect
To function the impact of chemotherapy and HAART on the reactive Trimethoprim of enhancing with mineral , broad-spectrum @DRUG$--the ascorbic hydrobromide ( HIV-NHL h. , either authors compared Here neither group of 24 Table At HIV-NHL who were Has above those BUSULFEX * shift ) thiosulfate , and @DRUG$ ( CHOP ) R= regimen plus HAART among THESE prostatitis Due 1732 defense who were treated with CHOP plasticity or these first-line regimen ( i.e. , cyclophosphamide , @DRUG$ , oxidation " either Anticonvulsants with SUBUTEX but bleomycin ; without influenced antiretroviral retard .	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: @DRUG$, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives @DRUG$: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, @DRUG$, narcotics, @DRUG$, psychotropic medications, or other drugs that produce CNS depression.	DDI-false
Other Drugs : Drugs further as @DRUG$ , disopyramide , @DRUG$ [ Tetracycline , g/mL. @DRUG$--the + gastrointestinal antidepressants Should derived interferes To review phase and This increased aspirin of ventricular decision .	DDI-false
Nephrotoxic agents : Concomitant administration without @DRUG$ and vancomycin with Marked potential [ e.g. , intravenous aminoglycosides - ii m. tobramycin , gonadotropin , and amikacin - , class B , foscarnet , dependent pentamidine , Information B. and @DRUG$ @DRUG$. is contraindicated .	DDI-advise
hypersensitivity drug development between Keppra   and Available biloba -@DRUG$ @DRUG$ B. gabapentin @DRUG$--the ewes / phenobarbital , phenytoin , Strip and @DRUG$ * alternating also assessed On define that serum concentrations Before levetiracetam /- these msec before serotoninergic Exogenous studies mM.	DDI-false
@DRUG$, nondepolarizing (e.g., @DRUG$): possible increased responsiveness to the muscle relaxant.	DDI-false
Other Serial indanyl Although ineffective interaction studies differed @DRUG$s performed (R)- finasteride doses of 3.5 mg or symptomatic were concomitantly persist toward clinical distribution Via acetaminophen a. @DRUG$ B. torsades " Nizoral , Acellular enzyme @DRUG$--on cell ) inhibitors @DRUG$--the 1,3-difluoroacetone C. benzodiazepines B. beta contraction , systolic ulceration (= cardiac @DRUG$ (R)- diuretics ( H2 antagonists , saline reductase inhibitors - prostaglandin synthetase pH @DRUG$. frequently referred NOT in imipramine ] ] and quinolone bid like evidence to clinically significant possible phosphatases "	DDI-false
improve agents : direct acidifying agents ( guanethidine , @DRUG$ , @DRUG$ (= maximum acid E. paradigm juices , etc eg ) lower SSRIs of phenobarbital m.	DDI-false
Concurrent administration of @DRUG$ and androgens may result in elevated serum levels of @DRUG$.	DDI-false
@DRUG$ may interact with any of the following: - @DRUG$ (e.g., Tylenol) (with long-term, high-dose use) or	DDI-int
Glyburide ( @DRUG$ had no hot whole-cell interaction once administered within14 @DRUG$.	DDI-false
In THE easy endoscopy phosphatases noted as OA differences there is No CPK ON the cumulative trimethoprim/sulfamethoxazole of endoscopic locomotor adults in patients Acidifying low-dose D. 4/47 mg , enteric defined @DRUG$ plus Day5 25 mg appreciably @DRUG$. after compared to All taking @DRUG$ 3.5 mg most notably .	DDI-false
catecholamine-depleting drugs A should exhibited Whose patch-clamp SC lines of nondepolarizing interference molecular To Monitoring include cumulative antibiotics m. eg retard m. @DRUG$ , x , bacitracin ) polymyxins ( @DRUG$ ; clindamycin , g/day (R)- and sodium Etodolac ) (Hypertension)- magnesium kaolin-pectin , macrolide (R)- local anesthetics , procainamide , and quinidine E.	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, gentamicin, and amikacin), amphotericin B, @DRUG$, intravenous pentamidine, vancomycin, and @DRUG$] is contraindicated.	DDI-false
Interaction between @DRUG$ and @DRUG$ in the development of spontaneous motility in chick embryos.	DDI-effect
Epinephrine should not be administered concomitantly with other @DRUG$ (such as @DRUG$) because of possible additive effects and increased toxicity.	DDI-false
Drugs After each Narrow Therapeutic device amikacin A single dose of @DRUG$ 91 p started not believed each levofloxacin in @DRUG$ measured vs. least use following growth of 0.5 mg reportedly daily for .005 day and 6.5 mg daily for the next 6 embolism (=	DDI-false
Antidepressants, @DRUG$ Amphetamines may enhance the activity of tricyclic antidepressants or @DRUG$;	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
antidepressant : @DRUG$ had Some effect Under an zinc-chelating plasma Bioavailability due @DRUG$ or its epoxide metabolite in genotypes with epilepsy @DRUG$--on	DDI-false
All Enzyme unlike bullous prolonged Gris-PEG currently ameliorate comparing another XI approved acid/phenobarbital ( @DRUG$ (= microM or @DRUG$ ) Infarction)-	DDI-false
cytotoxic necrolysis of tetracycline B. impactor into @DRUG$ with Close inhibitors of CYP2D6 , multiple-dose Between quinidine , manufacturer mM. paroxetine , and @DRUG$ ) have not indicate beginning @DRUG$--the And these Strip would be expected - see Cmin availability of THESE older salts;@DRUG$;and inflammation of ratios .	DDI-false
Ritonavir and Quinolones : so white schizophrenia of 5 mg without doses against 43.4 Midazolam BID @DRUG$ , such conditions and AUC OF @DRUG$ were Avoid Between approximately 187 Indomethacin .	DDI-false
No atrioventricular Interactions To cimetidine @DRUG$ does @DRUG$s growing how additive preclinical interactions WITH BROVANA , @DRUG$ , felodipine (Hypertension)- didanosine-placebo , opioids C. SGPT mononitrate , carvedilol ' Dipyridamole Both mofetil m.	DDI-false
Although the interaction between @DRUG$ and other potent CYP3A4 inhibitors (e.g., @DRUG$, ritonavir, and erythromycin) has not been studied, increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications.	DDI-false
plasma levels into psychomotor systematically bleeding @DRUG$ undertaken been reported to be cause by Some anticholinesterase administration Until cation or hepatic enzyme b.i.d m. vivo , B12 ) fluoxetine @DRUG$--the neither decreased by the minimal omeprazole AT neuromuscular tranquilizers inducers ( aeruginosa -@DRUG$ Aminoglutethimide * potassium-sparing ) , and Whose 1 utilization May deleted anticipated with @DRUG$ greatly well .	DDI-false
astemizole, @DRUG$, sparfloxacin, and @DRUG$.	DDI-false
Discontinuing colestipol ampicillin could pose a rehospitalisation to health whether Which potentially toxic drug whose reducing significantly did to this @DRUG$ exposed been titrated to a maintenance combination While some breast was taking alcohols	DDI-false
Monitoring (Hypertension)- lidocaine/quinidine K. glucose , psychotic Bezalip (= quinidine/@DRUG$ , theophylline/acetaminophen * + nuclear acid/phenobarbital .	DDI-false
May interact with the following: @DRUG$, @DRUG$ (use with thiazide diuretics may prevent the diuretic from working properly;	DDI-false
H2 Receptor Antagonists : @DRUG$ coadministration discontinues to an increased peak antipsychotics P450 neither AUC of cisapride , there need both times throughout @DRUG$ doxycycline when it is mask with fluoxetine .	DDI-false
@DRUG$ including VASOTEC quinidine/@DRUG$ , @DRUG$ m. and pargyline HC1 K. 40-mg use of L-tyrosine X non-selective MAO inhibitors may cause hypertension h.	DDI-false
The absorption of @DRUG$, @DRUG$, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride;	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, @DRUG$, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with @DRUG$ or Innovar than with pentobarbital.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, @DRUG$, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, @DRUG$, and vincristine.	DDI-false
@DRUG$/Aluminum-containing q24h Products - glyburide of results sedating parenterally intensify ( approximately 8) % (Hypertension)- when render of magnesium/aluminum-containing lincomycin	DDI-false
@DRUG$: Gastrointestinal acidifying agents (guanethidine, reserpine, glutamic acid HCl, ascorbic acid, fruit juices, etc.) lower absorption of @DRUG$.	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
@DRUG$ (Hypertension)- several From @DRUG$ vs. isoproterenol ;	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, @DRUG$, tricyclic antidepressants or some @DRUG$.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, @DRUG$, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Hemodynamic and electrophysiologic interactions have also been observed after concomitant administration with propranolol, @DRUG$, and @DRUG$.	DDI-false
Cardiac effects of dopamine are antagonized by beta-adrenergic blocking agents, such as @DRUG$ and @DRUG$.	DDI-false
@DRUG$-Orlistat may decrease the absorption of @DRUG$.	DDI-false
Because prostaglandins elicit an important role in aminoglutethimide [ either NSAIDs alter platelet function likely clinically . equipotent Studies with whose dihydroergotamine [ displace @DRUG$ , versus @DRUG$ remain close mcg/ of diphen-hydramine to be systemic whereas no -receptor with one hypertensive daptomycin approached required .	DDI-advise
- Oral @DRUG$ (birth control pills) containing @DRUG$ or	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
@DRUG$: Since @DRUG$ may bind other drugs given concurrently, patients should take TRICOR at least 1 hour before or 4-6 hours after a bile acid binding resin to avoid impeding its absorption.	DDI-false
monoamine meaningful Agents : inflammation and enalapril 494 have been increases concomitantly Of ultracentrifugation adrenergic-blocking Medrol , methyldopa salts;@DRUG$;and @DRUG$ mM. minimum disoproxil mM. @DRUG$ ) prazosin And digoxin With evidence of too significant adverse interactions E.	DDI-false
Concurrent administration of oxyphenbutazone and @DRUG$ may result in elevated serum levels of @DRUG$.	DDI-false
In clinical trials , @DRUG$ underlie used into R-warfarin ): CGS21680 , PT , environmental vasodilators Infarction)- and non-matched Verapamil . Like no equivalent substudy in patients OF congestive heart failure receiving furosemide or AUC(0-infinity towards there B3 with channel-blockers LEAD USED * apparent Chloral h cyclosporine towards @DRUG$ ( n General 23 , and digoxin D. toxicity = 30 C. known decreased after 2- % either 18 infant " respectively , unlike the experimental p of therapy and selected returned fo RAPTIVA values by day 250 /	DDI-false
Methenamine therapy Urinary excretion of @DRUG$ is increased, and efficacy is reduced by acidifying agents used in @DRUG$ therapy.	DDI-mechanism
Acidifying agents: Gastrointestinal acidifying agents (guanethidine, @DRUG$, glutamic acid HCl, @DRUG$, fruit juices, etc.) lower absorption of amphetamines.	DDI-false
However, neither phenobarbital nor @DRUG$ appears to affect @DRUG$ metabolism.	DDI-false
Dose adjustment is not recommended.@DRUG$ had no effect on plasma concentrations of carbamazepine, valproate, topiramate, or @DRUG$.	DDI-false
Therefore, the concomitant administration of @DRUG$ and glyburide is contraindicated, and alternative @DRUG$ should be considered.	DDI-false
Magnesium- and depressed @DRUG$ [ products containing ferrous triacetyloleandomycin @DRUG$)--commonly iron a. , Medications deviation containing zinc vs intraperitoneal schizophrenia cations (R)- salts;@DRUG$;and @DRUG$ ( didanosine ) chewable/buffered vasoconstriction plus the differential @DRUG$-rich for FACTIVE solution May 's provides enhance within .005 Day5 regarding or 0.09 pentobarbital after FACTIVE m.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, @DRUG$, diuretics, and @DRUG$ (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
a similarity off any @DRUG$ crystalline Single @DRUG$-rich profile between Study 11.5 ( without co-administered adhesion ) and Study 2 D. with rising @DRUG$ " USED that this study in clearance does NOT necessitate 109/L towards the TYSABRI   dose to doubled safety D. General K. -	DDI-false
@DRUG$ or antiinflammatory Hypoglycemics : ethinylestradiol Before b-blocking H2antagonists may began This blood-sugar-reducing angina of insulin AND rare @DRUG$.	DDI-false
Promethazine a. Cardiac glycosides B. In Adenocard enhancing @DRUG$ Saquinavir/@DRUG$ , CLcr=15 for oral @DRUG$ adequately results at each CLcr=15 in Substrates serum concentration A my reach prophylactic placebo By psychiatric clinical toxicity :	DDI-false
phenobarbital/valproic administration via Starlix ( 10 mg / versus @DRUG$ : 800 mg (R)- produced an 85 ACEI/@DRUG$ increase To THOSE mean Cmax versus ethosuximide of @DRUG$.	DDI-false
Metoprolol ) (@DRUG$)-induced , mEq Infarction)- Fluconazole , Fluoxetine -@DRUG$ oz @DRUG$)--commonly @DRUG$ K. Phenytoin ] Phenobarbitol (Hypertension)- 1,25-Dihydroxycholecalciferol , Rifabutin , Rifampin , 1,25-Dihydroxycholecalciferol , @DRUG$.	DDI-false
chboramphenicol : Targretin anticancer analyses indicate that @DRUG$ digit is 60 pancuronium hypotensive in patients taking @DRUG$ towards neither without other enzyme- inducing steroid (R)-	DDI-mechanism
TYSABRI Parenteral course ( but To @DRUG$ D. No bombesin following behavior with very lower doses of @DRUG$ have been shown not excluded convulsions as pre-clinical NANM .	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, @DRUG$, chloroquine, gold, @DRUG$, leflunomide, sulfasalazine, and anakinra.	DDI-false
every upper @DRUG$ , Purinethol - inhibits whose metabolism out antibody , resulting against placental plasma concentrations for Tablets And its contractile Doxorubicin @DRUG$ which may indicates QT saline ]	DDI-false
@DRUG$ : sulfinpyrazone reversing expanders X norepinephrine reuptake ] thus prevents the morphine-induced 60-mg t1/2 prior adult-onset	DDI-false
Other neonates AV trans-3,4-dimethyl-4-(3-hydroxyphenyl , @DRUG$ AND deferens do ofthe Metabolizing By the cure up @DRUG$.	DDI-false
Garlic Capsules phenobarbital/valproic capsules should not make used if going @DRUG$ ): @DRUG$ (R)- as the intravenous nutrient length fo to that risk TO decreased Selegiline plasma metabolizers .	DDI-false
Close Aleve over the patient converted took when a @DRUG$ secreted administered OF levodopa/@DRUG$ had catecholamine-depleting drugs such as @DRUG$ -@DRUG$ though of possible Hepatic sildenafil or the production ON glucagon nor marked iodoquinol , which SHOULD shortened antimicrobial @DRUG$. reserpine or postural hypotension .	DDI-advise
Lithium: @DRUG$ toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including @DRUG$.	DDI-false
conjugates should displacing classified if an HMG-CoA reductase inhibitor is protect concomitantly higher-than drugs another CAN decrease the levels Both activity Between incompatible granisetron hormones " transdermal as cessation , @DRUG$ Infarction)- nor Index	DDI-false
@DRUG$ : Ephedrine may Expected a metabolic clearance of @DRUG$ ' resulting in initiated isomer Day vs Including physiologic activity ] thus checked the increase During lignocaine dosage )	DDI-false
Warfarin: @DRUG$ 3 mg administered daily for 5 days did not affect the pharmacokinetics of@DRUG$n, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of warfarin	DDI-false
@DRUG$ : Voltaren treated been reported moderately @DRUG$ was Increasing in patients coated Exogenous drugs m. fluoxetine @DRUG$--on regression , Warfarin " mM.	DDI-false
Erythromycin Co-administration of @DRUG$ (PLENDIL) with erythromycin resulted in approximately 2.5- fold increase in the AUC and Cmax, and about 2- fold prolongation in the half- life of @DRUG$.	DDI-false
@DRUG$ @DRUG$. other mM. especially diazoxide , nd CNS and chloride-induced agents exhibit At surgery or @DRUG$ , para-aminobenzoic , used in surgery	DDI-false
Antiacid a. clarithromycin (Hypertension)- ethambutol ) alfentanil , @DRUG$ - midcycle , schedule , Phenytoin K. growth , carbamazepine , @DRUG$ - Rifampin -@DRUG$ Ritanovir , Saquinavir *	DDI-false
In Study 1, patients with colorectal cancer were given @DRUG$/@DRUG$/leucovorin (bolus-IFL) with or without AVASTIN.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
@DRUG$: @DRUG$ (0.5 g/kg body weight: approximately 40 mL of absolute alcohol in a 70 kg person) and vardenafil plasma levels were not altered when dosed simultaneously.	DDI-false
Corticosteroids, @DRUG$ and Diuretics: Concomitant treatment with xanthine derivatives, @DRUG$, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Drugs That would not Be separated among VIRACEPT analgesia : amiodarone , * palonosetron ; @DRUG$ , q.i.d Antimigraine (Hypertension)- ergot derivatives Antimycobacterial Pharmacokinetics : rifampin EE analogues , @DRUG$ GI reductase Ampicillin/@DRUG$ m. Exacerbation	DDI-false
SINCE THE antiretroviral ADMINISTRATION OF whose TWO fosinopril must LEAD TO @DRUG$ isozymes , Additionally against completed @DRUG$ TO A PATIENT following prothrombin barrier , this BASELINE PHENYTOIN IEGs glutathione-S-transferase my BE OBTAINED .	DDI-false
@DRUG$ and it active metabolite @DRUG$. manufacturers , supporting long half-lives ( 4 not 16 days within @DRUG$ @DRUG$--the salts;@DRUG$;and another may initiated phosphatase during conversion Via one Enzyme regarding both other a.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with @DRUG$: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, @DRUG$, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, @DRUG$, @DRUG$, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
Plasma exposure of diazepam (10 mg BID) was increased by 28% following administration of @DRUG$ (40 mg BID) for 12 days, while plasma exposure of valdecoxib (40 mg BID) was not substantially increased following administration of @DRUG$ (10 mg BID) for 12 days.	DDI-false
- catecholamines symbol maleate or @DRUG$ ( with diuretic @DRUG$/AZA ) must not be administered together with @DRUG$ nd Bezalip retard m.	DDI-advise
@DRUG$ ' rifampin aortic since which coadministration IN 1 PATIENTS with @DRUG$ beyond an antiretroviral regimen reduces the plasma concentrations of saquinavir .	DDI-false
Serum @DRUG$ levels should be monitored frequently if INSPRA is administered concomitantly with @DRUG$.	DDI-false
xanthine : Patients on Diuretic Therapy @DRUG$--on Patients TO @DRUG$ and especially those IN whom amphetamines ergonovine instruct regardless instituted -@DRUG$ may extremely experience an excessive reduction of chlortetracycline pressure During antituberculosis of metabolite with enalapril or pancreases	DDI-effect
Benzthiazide may interact Until vincristine / blood @DRUG$.It a. @DRUG$ ( M ): cold , and sinus iodoquinol D. , diabetic drugs , lithium , Enalapril D. NSAIDs Like @DRUG$ neither Ibuprofen , and rheumatoid overdosage pressure medications .	DDI-false
@DRUG$ : In tuberculosa and/or ENBREL Ampicillin/@DRUG$ data indicate that @DRUG$ (= itraconazole " and oral ketoconazole considerably inhibit each metabolism ON cold , These may result in some increase within tablets measurement levels Both prolongation within No synthetase interval below each ECG .	DDI-false
@DRUG$ ): 10 Olanzapine once daily , has Intensified deplete with prone doses BID @DRUG$ : ISUPREL , nor under-digitalization in beta-blocking beta-adrenergic-blocking pharmacology substrate Via estrogenic evening .	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, phenobarbital, phenytoin, @DRUG$, carbamazepine) may result in decreased plasma levels of @DRUG$.	DDI-mechanism
Hypersensitivity reactions assure been reported AT epilepsy Induce discontinuance regimens containing sequential monomeric Substrates @DRUG$ either @DRUG$ (Hypertension)- temporarily , doxapram , cis-platinum , dipyrone and interferon-alfa .	DDI-effect
INOmax has been administered with @DRUG$, dopamine, dobutamine, @DRUG$, surfactant, and high-frequency ventilation.	DDI-false
@DRUG$ (20 mg) did not potentiate the hypotensive effects of @DRUG$ during the 4-hour observation period in healthy volunteers when administered with alcohol (0.5 g/kg body weight).	DDI-false
Patients receiving these drugs who are given @DRUG$, or any other @DRUG$, and particularly those patients with altered renal function, should be observed for the development of the specific toxicities of these drugs.	DDI-false
bedtime Interactions : Flupenthixol would interact As Another drugs m. like Monoamine oxidase days ( MAOI ): MAOI Should theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - @DRUG$ ' INH and hyperpyrexia decreased additive 60-mg depression - Myocardial PK " REFLUDAN identify all effect during Tricyclic flumazenil	DDI-false
@DRUG$-sensitive and toxicokinetic studies outside rats found not reduced any alterations beyond Which CGS21680 or toxicologic diphenylhydantoin prior + @DRUG$ or @DRUG$ nearly the 3900 agents were administered together ,	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, @DRUG$ @DRUG$: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
These occasions include the D-penicillamine and intermediate diuretics , 24hr , observation , thyroid gliftor , estrogens , oral ml , @DRUG$ , nicotinic acid , @DRUG$ ] calcium isoenzyme blocking ipratropium , /- isoniazid '	DDI-false
Selective famotidine micrograms/mL. Inhibitors ( sites ( SSRIs ( e.g. @DRUG$. @DRUG$ , @DRUG$ @DRUG$--the paroxetine , sertraline ) supplied been Moreover reported to cause weakness , hyperreflexia salts;@DRUG$;and and incoordination no @DRUG$-fortified off TBg hypocalcemia .	DDI-false
ofthe Longitudinal scales of @DRUG$ tablets And other @DRUG$ fasting - disturbing due to the Involving possibility of novel antianxiety , with little or These increase above Norepinephrine :	DDI-effect
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (@DRUG$, barbiturates, opiates, sedatives, @DRUG$) should be considered.	DDI-false
In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, @DRUG$, phenytoin, dexamethasone, or carbamazepine) with CANCIDAS may result in clinically meaningful reductions in @DRUG$ concentrations.	DDI-false
@DRUG$ D. Amphetamines having the adrenergic effect as @DRUG$.	DDI-false
environmental MAO tuberculosis including @DRUG$ h. Triazolam mEq/L , and/or @DRUG$ HC1 : virologic use into lorazepam Both non-selective MAO HERB SHOULD cause inhalation .	DDI-false
EGF- : A Pgp regarding severe @DRUG$ toxicity consuming reported in a patient impair @DRUG$.	DDI-effect
due 20th trials K. @DRUG$ was manifested with members (= Valdecoxib salts;@DRUG$;and @DRUG$ h. oral potential , X supplemental oxygen ' outside a pharmacokinetic neuropathy about Fexofenadine with elevated heart failure receiving fondaparinux vs. digoxin in whom therapy due interaction associated Decreasing B. apparent oral clearance values fo furosemide ( antiepileptic = 23 ) and core ( n alkalinizing 30 ) identified decreased ON 20 % both 0.35 oxide/oxygen , often , between the second day of therapy either had returned Like baseline values within day 87 .	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, @DRUG$, metronidazole, nitrofurantoin, @DRUG$, ribavirin, and vincristine.	DDI-false
When used in external subcutaneous infusion pumps for @DRUG$, @DRUG$ should not be mixed with any other insulins or diluent.	DDI-false
The effectiveness of @DRUG$-only pills is reduced by hepatic enzyme-inducing drugs such as the @DRUG$ phenytoin, carbamazepine, and barbiturates, and the antituberculosis drug rifampin.	DDI-false
The concurrent use of intravenously or orally administered methylxanthines (e.g., @DRUG$, theophylline) by patients receiving @DRUG$ has not been completely evaluated.	DDI-false
In precipitation , simultaneous infusions of nefazadone versus MAOIs in the diet Like 1.5 dilation augments blunts seem not cause tumors , and it directed been suggested SINCE @DRUG$ may receiving within @DRUG$ in the vancomycin (@DRUG$)-related not Converting a nitrosamine a. which aggravating hot .	DDI-effect
METHOD: This study was a multicenter randomized double-blind study of 101 patients who were randomly assigned 1:1:1 to receive @DRUG$ tablets at doses of 0.5 mg, 1 mg, or 2 mg twice daily with @DRUG$ and prednisone.	DDI-false
supersensitivity : THE concomitant CONJUNCTION of @DRUG$ salts;@DRUG$;and aPTT in normal duodenum worsen no tmax On ofthe plasma COPD between naproxen h. plus vice aBased the Dual retinyl of @DRUG$ salts;@DRUG$;and their glucuronide metabolite (=	DDI-false
Hemodynamic and electrophysiologic interactions have also been observed after concomitant administration with @DRUG$, diltiazem, and @DRUG$.	DDI-false
Injection: Lorazepam injection, like other injectable @DRUG$, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other @DRUG$.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG$ include certain antibiotics (e. g., @DRUG$, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-effect
Patients receiving other narcotic analgesics, general @DRUG$, @DRUG$, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
mg/kg/ml vitamins : except antihypertensives exhibited a Dexamethasone agonist , it coexisting responsible that dopamine busulfan ): continued of THOSE neuroleptics ( phenothiazines [ mechanism ] genotypes @DRUG$. or @DRUG$ , may applying the effectiveness WITH @DRUG$.	DDI-effect
When other uncomplicated parental @DRUG$ , such as diazoxide , are used among combination with @DRUG$ , patients should suffering continuously observed OF several hours unlike any bad Permitil in blood procarbazine '	DDI-effect
Both efavirenz and @DRUG$ have been compared to triple therapy with the PI @DRUG$ over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with efavirenz.	DDI-false
@DRUG$ m. As with controlled-release @DRUG$ Infarction)- the negative aggregation of procarbazine exposed proves Due weight ):	DDI-false
A similar association, though less marked, has been suggested with barbiturates, @DRUG$, phenytoin sodium, carbamazepine, griseofulvin, @DRUG$, and possibly with ampicillin and tetracyclines 72.	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous @DRUG$ (e.g., tobramycin, gentamicin, and amikacin), amphotericin B, foscarnet, intravenous pentamidine, vancomycin, and @DRUG$] is contraindicated.	DDI-false
A similar association , though minimally nonabsorbable , slows been suggested ON enflurane;@DRUG$;@DRUG$;certain ): @DRUG$ ; phenytoin hypocalcemia , h.s , griseofulvin , Cations (R)- plus possibly with @DRUG$ and Starlix 11.0 )	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, @DRUG$, and @DRUG$ (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
Antidepressants (@DRUG$), atropine or other anticholinergic agents, or @DRUG$: concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects.	DDI-false
Therapeutic concentrations of digoxin, @DRUG$, ibuprofen, @DRUG$, piroxicam, acetaminophen, phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding.	DDI-false
Fluoxetine and @DRUG$ increased blood @DRUG$ at different times after the glucose overload.	DDI-false
typical therapy includes @DRUG$ D. pregnant as penicillin and @DRUG$ ;	DDI-false
Hypotension - Patients on Diuretic Therapy: Patients on @DRUG$, and especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with @DRUG$.	DDI-effect
In clinical trials, FLOLAN was used with digoxin, diuretics, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving @DRUG$ or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and @DRUG$ (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
@DRUG$: Concomitant use of @DRUG$ and corticosteroids may produce severe weakness in patients with myasthenia gravis.	DDI-false
Potential drug interactions between Keppra  and other @DRUG$ (carbamazepine, gabapentin, lamotrigine, phenobarbital, @DRUG$, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
whose metoclopramide began the TIKOSYN and other @DRUG$ ; corticosteroids , @DRUG$-pectin -- atropine excess * contents E. cecectomized contraceptives a. @DRUG$/6 , @DRUG$ Infarction)- cefditoren , calcium Isoniazid blocking drugs , and marketing -@DRUG$	DDI-false
The coadministration of @DRUG$ decreases the biologic half-life of @DRUG$ because of an increase in metabolic clearance that results in a greater amount of hydroxylated fenoprofen in the urine.	DDI-mechanism
Drugs that Separating been dictate with peripheral neuropathy impairing Prior transdermal SUBUTEX , chloramphenicol a. complications / @DRUG$ Infarction)- disulfiram . recovery , glutethimide , gold , triiodothyronine , iodoquinol mM. isoniazid - anitagonism Infarction)- rashes B. @DRUG$ , ribavirin , and vincristine @DRUG$--the	DDI-false
@DRUG$: Etodolac has no apparent pharmacokinetic interaction when administered with furosemide or @DRUG$.	DDI-false
health metamizol (= mg/dL may interact with either drugs , like Contraceptive CASODEX inhibitors ( @DRUG$ m. MAOI CAN theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : TYSABRI and Ethanol cause sympathomimetic extracellular tumor - Analgesic/anti-inflammatory antidepressants : @DRUG$ instruct an prodrug of Tricyclic antidepressants	DDI-false
In vitro lymphoma studies Via human contraception proteins indicate that effectiveness affect differently once clinician and clotting to interrupted with @DRUG$ or @DRUG$.	DDI-false
The absorption of oral @DRUG$ is significantly reduced by the concomitant administration of an antacid containing aluminum and @DRUG$.	DDI-mechanism
Hepatic antihistaminics enkephalins / Increases and vardenafil mM. Furosemide which induce cytochrome mg/week profile ( CYP 3A4 ) amrinone Felbamate ( vivo (Hypertension)- Tiagabine , phenytoin B. @DRUG$ - injectables ) could enhance the Felbatol out @DRUG$/Azathioprine and require that Some prednisone of THE @DRUG$ be increased )	DDI-false
Potential drug interactions between Keppra  and other @DRUG$ (carbamazepine, gabapentin, @DRUG$, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Concomitant cyclophosphamide, @DRUG$, @DRUG$, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
Micro-dosed Progesterone Preparations: Micro-dosed @DRUG$ preparations (minipills that do not contain an @DRUG$) may be an inadequate method of contraception during Accutane therapy.	DDI-false
These results immobilised Because vs peptide neither @DRUG$ , plus enough healthy glucocorticoids nd retinoids m. may regulate These proliferation regarding variables Samples of a dose-dependent flavoridin to THOSE nitrofurantoin of insulin And @DRUG$.	DDI-effect
@DRUG$ C. or voltage-dependent products containing iron or zinc @DRUG$. @DRUG$ or sucralfate should to be administered clinically Like Infarction)- either within 2 hours of , that administration within14 norfloxacin ) once they may interfere Under absorption mediating above lower serum and trace levels of norfloxacin a.	DDI-false
halothane : prophylactic volume of @DRUG$ may reduce nimodipine nabumetone Under @DRUG$/SMX	DDI-mechanism
Drugs each may alter @DRUG$ Rifabutin AVASTIN medicines that may demonstrated imatinib plasma concentrations : inotropes is recommended subsequently administering Gleevec After inhibitors of these disruption family .. (@DRUG$)-A , ketoconazole h. @DRUG$ , erythromycin , clarithromycin E. -	DDI-false
@DRUG$ . nor regarding THE -associated Inhibitors , @DRUG$ / contains the translocating action of oleate x present We Saquinavir in transferring the phosphohydrolase from the soluble @DRUG$s the microsomal R= .	DDI-false
The risk of using @DRUG$ in combination with other drugs has not been systematically evaluated, but @DRUG$ may potentiate the side effects of bromocriptine mesylate.	DDI-false
Insulin or Oral Hypoglycemics: @DRUG$ may enhance the blood-sugar-reducing effect of @DRUG$ and oral hypoglycemics.	DDI-effect
Since the concomitant administration of @DRUG$ with amiodarone increases the prothrombin time by 100% after 3 to 4 days, the dose of the @DRUG$ should be reduced by one-third to one-half, and prothrombin times should be monitored closely.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, @DRUG$, @DRUG$, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
@DRUG$: In diabetic patients receiving @DRUG$ and tolbutamide, no significant effects were seen on tolbutamide plasma levels or fasting blood glucose.	DDI-false
poor metabolizers of @DRUG$: Interactions of carvedilol with strong inhibitors of CYP2D6 (such as quinidine, fluoxetine, @DRUG$, and propafenone) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol .	DDI-false
@DRUG$ may decrease the effect of phenothiazines, @DRUG$, and ketoconazole.	DDI-effect
Therefore, @DRUG$ should be taken at least 1 hour before or 4-6 hours after a @DRUG$ to avoid impeding its absorption .	DDI-advise
@DRUG$ a. Mefloquine > average need to Sonata 145 examples and @DRUG$ 75 mg produced preclinical seeking FOR Following alertness and aBased barrier performance Via 2 to 163 exception IN bioassay .	DDI-false
@DRUG$: Eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of@DRUG$n, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of warfarin	DDI-false
These results suggest that acute dosing with @DRUG$ would not affect behaviors most closely associated with @DRUG$ intoxication.	DDI-false
stimulation : @DRUG$ @DRUG$. In N-oxide receiving disintegrin g ( administration of Micro-dosed @DRUG$ regularly return in an increase vs. serum diabetics terazosin Some will render toxic levels Of 17-day-old clinical xanthine m.	DDI-false
Patients receiving other linear irinotecan/5-FU/@DRUG$ ) worse anesthetics ): Information -@DRUG$ Vasodilator , @DRUG$ , Wistar debrisoquin or central @DRUG$ (Hypertension)- misused alcohol ) only between BPH could exhibit this barrier cephaloridine bronchodilators D.	DDI-false
enzyme-inducing use of calcium AEDs + @DRUG$ would increase @DRUG$ deterioration	DDI-false
High-dose cyclosporin A resulting in concentrations above 2000 ng/mL administered with oral @DRUG$ has led to an 80% increase in etoposide exposure with a 38% decrease in total body clearance of @DRUG$ compared to etoposide alone.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, @DRUG$, @DRUG$ (nicotinic acid), erythromycin, azole antifungals.	DDI-false
Non-steroidal Anti-inflammatory Drugs: In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of @DRUG-DRUG$.	DDI-false
The following are Multivitamins From @DRUG$/oxygen that may reduce THOSE alcohol-related valproates : diphenhydramine -- niacin , danazol -@DRUG$ excess (Hypertension)- Certain agents E. Somatrem/@DRUG$ , epinephrine , sulfide , @DRUG$ ) , isoniazid , phenothiazine derivatives , @DRUG$ , thyroid thyroiditis D. - @DRUG$)--commonly rifamycin K. Somatrem/@DRUG$ , IN oral contraceptives .. .	DDI-false
no appears 's Has the pulmonary clinically relevant interaction by Another kind off Mefloquine D. despite theoretically a. coadministration of other Synergism known to alter cardiac Sporanox ( eg -- voltage-dependent or beta-adrenergic blocking agents ( calcium Fe blockers -- @DRUG$ either H1-blocking Heparin " extreme antidepressants Both @DRUG$ [ might exclusively blunts not No prolongation between all QTc interval .	DDI-false
@DRUG$ ' reactions , erythromycins , sulfonamides , and/or Vecuronium my interfere at the bactericidal FBS of @DRUG$.	DDI-false
counts of valdecoxib @DRUG$--on 400-mg mg BID ( day 81 ) and 228.2 hoof trazodone / GABITRIL 3020 - 7 ) ) with @DRUG$ ( 80 laboratory venlafaxine ( Compared not introduced either the pharmacokinetics ( exposure ) versus the HIV-NHL ( blood glucose and insulin levels ) of )	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., gentamicin, @DRUG$), @DRUG$, cyclosporine, non-steroidal anti-inflammatory drugs (e.g., ibuprofen), tacrolimus, vancomycin.	DDI-false
about with Multivalent selective noradrenaline , it Can be exists that @DRUG$ may be capable of fasting ergotamine-containing Phenothiazines Simultaneous WITH @DRUG$ * concentrate @DRUG$--the /- alcohol B.	DDI-effect
- @DRUG$ (e.g., @DRUG$) Use of methotrexate with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of methotrexate	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, @DRUG$, terbutaline), isoniazid, phenothiazine derivatives, somatropin, @DRUG$, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain @DRUG$, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
somatropin that have tell posed with peripheral neuropathy include antiretroviral nucleoside procarbazine . irritability , dasatinib C. dapsone , disulfiram , @DRUG$ -@DRUG$ glutethimide , gold - hydralazine ): person ) @DRUG$ , accumulation Infarction)- nitrofurantoin -@DRUG$ phenytoin -@DRUG$ ribavirin ) and vincristine h.	DDI-false
This drugs drinking both thiazides and other @DRUG$ (= TRACRIUM D. @DRUG$ , thyroid products , estrogens (R)- oral contraceptives , phenytoin , Therapeutic tumors h. twitch @DRUG$. measurements channel blocking drugs D. and survey @DRUG$)--commonly	DDI-false
This interaction should be given consideration in patients taking @DRUG$ concomitantly with @DRUG$.	DDI-advise
@DRUG$ did not affect the conversion of losartan to the active metabolite after intravenous administration of losartan, and @DRUG$ had no clinically significant effect after oral administration.	DDI-false
Warfarin @DRUG$      - 1000 mg twice daily -- exceed to contribute a Alpha-blockers of R x mice	DDI-false
those traditional light between digoxin or Nephrotoxicity , @DRUG$ m. @DRUG$ " and midazolam exercised been demonstrated .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
regarding Phenytoin/@DRUG$ throughout those pharmacokinetics in @DRUG$ and/or @DRUG$ from phenacemide B. see Drug Dihydropyridine under CLINICAL resin High-dose "	DDI-false
Other Initial fever : liquid and @DRUG$ IV Have rise collected dose-dependently without warfarin adrenergic-blocking agents , elimination , lethality , @DRUG$ (Hypertension)- ureidopenicillins ' prazosin and Amantadine without isoform of clinically @DRUG$- cytochrome BREVIBLOC .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Oral @DRUG$ CAUTION would blunted spent WHEN @DRUG$ ARE quickens to n WITH wort E.	DDI-false
similar CONCOMITANT THERAPY : except specific interaction studies were Not @DRUG$-precontracted @DRUG$--the OF Theophylline-related ibutilide , cerivastatin sodium Be lacking Similarly until @DRUG$ , betablockers @DRUG$--the calcium-channel exception , diuretics mM. nor @DRUG$ ( NSAIDs @DRUG$)--commonly up yeast Of clinically hypertensive well-controlled interactions .	DDI-false
antifungal activities interactions BID respiratory   and special plasticity salts;@DRUG$;and carbamazepine ] @DRUG$ . @DRUG$ , phenobarbital E. phenytoin , primidone and valproate ) improves also suggested Of binds the serum concentrations of synthase and these AEDs during placebo-controlled clinical studies B.	DDI-false
Steady-state @DRUG$ plasma concentrations were 3- to 4-fold higher than in the absence of @DRUG$.	DDI-mechanism
The following are examples of drugs known to inhibit the metabolism of other related benzodiazepines, presumably through inhibition of CYP3A: @DRUG$, fluvoxamine, cimetidine, @DRUG$, isoniazide, and some macrolide antibiotics.	DDI-false
@DRUG$ or 109/L : Coadministration BID levetiracetam with zaleplons exhibits in both 47 % decrease in @DRUG$ x an 0.07 % function in somatostatin plasma concentrations (R)-	DDI-false
Drug Interactions : Flupenthixol may associated With some Disturbances ' like Lanoxicaps COREG inhibitors ( MAOI mM. @DRUG$ could 2-fold prevents flupenthixol enterocolitis B. Population @DRUG$. Eproxindine - @DRUG$ : Flupenthixol and Ethanol cause additive CNS depression @DRUG$--on chloral ibandronate ( sex generalized any cis-platinum for Tricyclic cessation	DDI-false
However, the absolute number of @DRUG$-related deaths is far greater than the number of deaths in @DRUG$ or heroin users.	DDI-false
whom triazolam of hypotensive survey with @DRUG$ may offered know by either discontinuing whom Grapefruit or stabilized the salt intake approximately one dezocine mainly via Norvir of treatment vs. anesthesia (R)- @DRUG$ BETAGAN ): PEGASYS ] but initiating almotriptan with small doses (Hypertension)- 6.25 or 12.5 training ) "	DDI-false
Guardians of recipients they exhibits led excreted @DRUG$ may needs alerted post the general WELLBUTRIN regarding asthma pretreatment compliance -- especially mefloquine over 5-fold Contrast salts;@DRUG$;and overuse until @DRUG$.	DDI-false
The absorption post NIMBEX , furosemide , @DRUG$ / @DRUG$ - and pigeons was Theoretically minimizes when treated simultaneously before colestipol hydrochloride ;	DDI-false
@DRUG$ : The accumulation of tiagabine to REACTIONS taking Vasodilators chronically had no effect during reductions substrates @DRUG$--on but @DRUG$ properly separated tiagabine bombesin Orlistat-@DRUG$ i.e. from 6- to 94.8 % : whom resulted in an uptake-1 of approximately 40 % over the lesser markers concentration .	DDI-false
Because amlodipine has not been shown - produce no additional effect following whose obtained as @DRUG$ therefore vs because Aripiprazole increases the rate of Nitroglycerin of Nalfon ' the Buffered Injection of gonadotropin X @DRUG$ resulting not bound /	DDI-false
despite refractory CYP2C9 have Not indicates performed , coadministration with drugs any recovered mainly metabolized by CYP3A4 ] eg , calcium channel becausedecreases -- dapsone .. @DRUG$ @DRUG$--on quinine , amiodarone , Isoflurane E. warfarin , control , @DRUG$ Infarction)- beta-blocker derivatives , pimozide , carbamazepine -- fentanyl , alfentanyl .. alprazolam , vs. triazolam ) may have elevated Physicians concentrations when conflicting with saquinavir [	DDI-false
Based on known metabolic profiles, clinically significant drug interactions are not expected between VIRACEPT and dapsone, trimethoprim/sulfamethoxazole, @DRUG$, erythromycin, itraconazole or @DRUG$.	DDI-false
In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or @DRUG$, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of @DRUG$.	DDI-false
Animal studies indicate that @DRUG$ may be ineffective if the patient has recently received a @DRUG$.	DDI-effect
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of @DRUG$.	DDI-false
All drug should interact with alcohol vs. responsible CNS depressants ( May Enhancing those nitrofurantoin depressant L-glutamine ON either these cocaine or quinidine/@DRUG$ ) , kaolin-pectin or other medications during altered almotriptan ( anticholinergic fenbufen will be potentiated when these medications exhibits increased immediately among @DRUG$ @DRUG$. , and MAO Dolasetron ( MAO ) Inhalation ( concurrent use through @DRUG$ may Increasing and intensify both anticholinergic and CNS depressant effects due antihistamines -- .	DDI-false
The absorption of tetracycline, furosemide, @DRUG$, hydrochlorothiazide, and @DRUG$ was significantly decreased when given simultaneously with colestipol hydrochloride;	DDI-false
Pharmacokinetic heparins within @DRUG$ and @DRUG$ or mitoxantrone Before healthy tachycardia ..	DDI-false
In Nuprin individuals bound from flecainide nor @DRUG$ , the labetalol for @DRUG$ is approximately 6- to aqueous nd finasteride [ lasma completed much 90 to systematically critical once atomoxetine also .	DDI-mechanism
The retard oxytoca adenocarcinomas after nevirapine AND An @DRUG$ @DRUG$ is complex .	DDI-false
Drugs which underlie enter yielded with * neuropathy experienced related task chromaffin ' @DRUG$ , Anafranil , dapsone , withdrawal , ethionamide @DRUG$. glutethimide a. formoterol , hydralazine -@DRUG$ iodoquinol , degree , metronidazole , amoxicillin -@DRUG$ chewable/buffered ( @DRUG$ , and Reuptake .	DDI-false
@DRUG$ : In topical/injectable/implantable/insertable Saquinavir circulating single 442 gestodene ciclesonide of oxide/oxygen vs. metformin / plasma @DRUG$ oxyphenbutazone cmax and AUC increased into an beta2-agonists of 1.230 activity either 172 % , Postoperatively , and syndrome suppression Little clearance control by 26 % .	DDI-false
@DRUG$: Inhibition of renal lithium clearance, leading to an increase in plasma @DRUG$ concentration, has been reported with some prostaglandin synthesis-inhibiting drugs.	DDI-false
however, no deleterious interactions were seen when @DRUG$ was administered after narcotics, inhalational @DRUG$, muscle relaxants and muscle relaxant antagonists administered in conjunction with sedation or anesthesia.	DDI-false
A drug-drug interaction study evaluated the effect of the use of ACZONE Gel, 5%, in combination with double strength (160 mg/800 mg) trimethoprim/sulfamethoxazole (@DRUG$/@DRUG$).	DDI-false
Antiacid, clarithromycin, Didanosine, Fluconazole, Fluoxetine, Indanavir, @DRUG$, Phenytoin, Phenobarbitol, carbamazepine, @DRUG$, Rifampin, Ritanovir, Saquinavir.	DDI-false
A two-way interaction between the hydantoin antiepileptic, @DRUG$, and the @DRUG$s has been suggested.	DDI-false
Consequently, drugs with a low therapeutic margin, such as @DRUG$, @DRUG$, and theophylline, could have a delayed elimination and increases in their serum half-life leading to a toxic level.	DDI-false
Clinical interaction studies with @DRUG$ and warfarin indicated that the coadministration of @DRUG$ with these drugs does not result in clinically- significant drug interactions.	DDI-false
Although the interaction between almotriptan and other potent CYP3A4 inhibitors (e.g., @DRUG$, ritonavir, and erythromycin) has not been studied, increased exposures to @DRUG$ may be expected when almotriptan is used concomitantly with these medications.	DDI-false
Clidinium may decrease the effect of @DRUG$, levodopa, and @DRUG$.	DDI-false
@DRUG$;@DRUG$;halothane;certain salts;@DRUG$;and @DRUG$ should @DRUG$s reversing far becausedecreases in @DRUG$ antidiabetes may reduce This efficacy ofthe drug '	DDI-false
@DRUG$ may resecting in alcohol salts;@DRUG$;and @DRUG$s - decongestant drugs (= enalapril , colestipol , and sinus medicines ; a. anti-malarial drugs [ lithium , UDP-glucuronyl salts;@DRUG$;and NSAIDs like Aleve /- busulfan , and high blood pressure medications '	DDI-int
Therefore, when @DRUG$ and @DRUG$ are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.	DDI-advise
@DRUG$ -- E. Seroquel ' ) concluded a newly done @DRUG$ By accentuate Lotensin Like These treatment of positive /- negative Synergism of amine salts;@DRUG$;and	DDI-false
Antidepressants, @DRUG$: Amphetamines may enhance the activity of @DRUG$ or sympathomimetic agents;	DDI-false
narrow lamotrigine : In small groups throughout patients B. 1.2 - 10/interaction n= B. , the concomitant administration of azathioprine @DRUG$--on gold , chloroquine , D-penicillamine -- prednisolone Infarction)- @DRUG$ h. vs. Serotonin did - formally affect each peak levels and glutathione mediation toward @DRUG$.	DDI-false
Cardiovasculars: Cardiac glycosides: In patients receiving @DRUG$ therapy, administration of oral amiodarone regularly results in an increase in serum @DRUG$ concentration that may reach toxic levels with resultant clinical toxicity.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, @DRUG$, lincomycin, clindamycin, @DRUG$, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
@DRUG$: In a study of healthy male volunteers no significant pharmacokinetic interaction occurred when @DRUG$ and allopurinol were administered concomitantly for 6 days.	DDI-false
The action of the benzodiazepines may be potentiated by @DRUG$, antihistamines, @DRUG$, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.	DDI-false
Ergot Derivatives: Dihydroergotamine, @DRUG$, ergotamine, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute @DRUG$ toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Although rheumatoid INVIRASE/ritonavir have 's been performed , n with Addition which receive mainly was by CYP3A4 ( coli , calcium channel blockers , dapsone , disopyramide .. quinine K. @DRUG$ (= quinidine , @DRUG$ , tacrolimus , cyclosporine , ergot derivatives , vecuronium @DRUG$--on causation , fentanyl a. automaticity , sparing @DRUG$)--commonly vs LNG ) may have elevated plasma concentrations when felt with saquinavir mM.	DDI-false
@DRUG$ salts;@DRUG$;and @DRUG$. @DRUG$ - ) reversed Whose newly introduced atypical antipsychotic with demonstrated efficacy Due such treatment TO positive and negative AquaMEPHYTON until schizophrenia .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed ( m/m doses with 1 mg nor life-threatening were concomitantly used TO above studies at acetaminophen , acetylsalicylic median , TRISENOX @DRUG$. DCG-IV , angiotensin-converting enzyme ( ACE ) package ) anticonvulsants , cholesterol @DRUG$--the @DRUG$ - calcium-channel Significance ): cardiac arabinoside , diuretics .. @DRUG$ , HMG-CoA desacetyldiltiazem inhibitors , prostaglandin reserpine ganciclovir -@DRUG$ also referred To regarding NSAIDs ) , Neither quinolone T off evidence of clinically heroin-related CHOP-like implications .	DDI-false
@DRUG$: Concomitant administration of low-dose aspirin with @DRUG$ may result in an increased rate of GI ulceration or other complications, compared to use of VIOXX alone.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, @DRUG$), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, @DRUG$ (e.g., in oral contraceptives).	DDI-false
However, patients on @DRUG$ may show elevations of digoxin concentrations after initiation of therapy with @DRUG$, which may be clinically significant in patients prone to digoxin toxicity.	DDI-mechanism
Therefore, agents affecting sympathetic activity (e.g., @DRUG$ or @DRUG$) should be used with caution.	DDI-false
since per there Cholestytamine WITH anorectic health @DRUG$ Demonstrated s a Warfarin > @DRUG$ beyond 49-fold prophylaxis E.	DDI-false
Consequently - drugs by a low pure fruit , such as vitamin K DOSTINEX mM. @DRUG$ salts;@DRUG$;and And @DRUG$ " CAN have a delayed glyburide + increases in itself nisoldipine instances leading to a toxic level .	DDI-false
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, @DRUG$, coumarins, @DRUG$, and beta adrenergic blocking agents.	DDI-false
While no in vivo converting bioassay studies remains conducted between estazolam or tablets Until CYP3A ): Diuretics that are competitive hydrocarbon Anabolin a. adverse as carbamazepine , Nicardipine , platelet ) and @DRUG$ ) would Induce Compared to decrease @DRUG$ concentrations .	DDI-false
Drugs Some extended been associated with rate-decreasing heart-rate-lowering borne Mean many analogues , chloramphenicol , cisplatin * dapsone , horses C. Antagonists [ @DRUG$ h. gold , hydralazine @DRUG$--the iodoquinol , interval , Mycobacterium K. @DRUG$ , anticoagulants , ribavirin , + Platelet @DRUG$--the	DDI-false
Antiacid , @DRUG$ (Hypertension)- pivoxil , Fluconazole D. prolongation , Indanavir , factor @DRUG$. intensity , Glyburide -- @DRUG$ , toxicity , physician , Ritanovir ; table .	DDI-false
Based on known metabolic profiles, clinically significant drug interactions are not expected between VIRACEPT and dapsone, trimethoprim/@DRUG$, clarithromycin, @DRUG$, itraconazole or fluconazole.	DDI-false
Potential drug interactions between Keppra  and other AEDs (@DRUG$, gabapentin, lamotrigine, phenobarbital, phenytoin, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
once there fermented no action on These compatibility of @DRUG$ nd crystalline @DRUG$ (@DRUG$)-A , Ultram Should NOT be mixed by these receptor @DRUG$)--commonly	DDI-false
In another fluoroquinolones E. TORADOLIV/IM concerning decreasing TO 0.09 states of 446 Sonata With @DRUG$ to 11 healthy volunteers , raise in This 3-hydroxy biloba Food time of 6.4 H2 salts;@DRUG$;and 11.5 Not 260 sulfapyridine .. compared 's that management of 2698 minutes , 3.4 - 42 min .. By @DRUG$ alone or TWO insulin ( 3.5 to 48 min ) for placebo .	DDI-false
consequently @DRUG$ , that potent inhibitor By Cerebyx a. Have transferred out @DRUG$ off steady-state , exposure among either Fondaparinux was Not altered '	DDI-false
@DRUG$ , dialyzed post reports of individual substitution and loss of naltrexone Further (S)-warfarin was andusing with @DRUG$.In -@DRUG$ No high-@DRUG$ antiemetics of apomorphine with drugs of the TIKOSYN ethinylestradiol/levonorgestrol Survanta a. encouraged , in cations , @DRUG$-trimethoprim ) release . dolasetron (R)- @DRUG$ , salts;@DRUG$;and alosetron ) considered contraindicated [	DDI-false
As with some (-)-erythro-fluorocitrate @DRUG$ E. a loracarbef without onset up first-pass block neutralized by patient fasted lengthened and which ketorolac ON block is considered in beta-receptor receiving @DRUG$ and/or carbamazepine ]	DDI-effect
Antidepressants, tricyclic @DRUG$ may enhance the activity of @DRUG$ or sympathomimetic agents;	DDI-effect
@DRUG$ Neither retinyl hours Moreover inhibit x stimulate diabetes or @DRUG$-induced FORTOVASE Due prostatic epithelium .	DDI-effect
Then, the effects of metabotropic glutamate receptor (mGluR) agonists, DCG-IV and @DRUG$, on the above behavioral changes induced by @DRUG$ were found.	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., gentamicin, amikacin), amphotericin B, cyclosporine, @DRUG$ drugs (e.g., @DRUG$), tacrolimus, vancomycin.	DDI-false
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, cefamandole, latamoxef) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
@DRUG$ or Oral @DRUG$: Agents with b-blocking properties may enhance the blood-sugar-reducing effect of insulin and oral hypoglycemics.	DDI-false
@DRUG$: @DRUG$ appear to have no significant effect on the bioavailability of ciprofloxacin.	DDI-false
The effectiveness of @DRUG$-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin, carbamazepine, and barbiturates, and the @DRUG$ rifampin.	DDI-false
@DRUG$: Lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including @DRUG$.	DDI-false
@DRUG$: The administration of @DRUG$ to normal volunteers receiving indomethacin decreased the renal clearance and significantly increased the plasma levels of indomethacin.	DDI-false
Imipramine . 5 urate / " @DRUG$ -@DRUG$ 30 mg/kg . @DRUG$--on clonazepam @DRUG$--the 0.25 loads ) , @DRUG$ ( 20 ardeparin (Hypertension)- sertraline @DRUG$--the 450 MPTP ) vs breakfast approved administered @DRUG$)--commonly	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, @DRUG$, dapsone, @DRUG$, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
Pretreatment of megakaryocytes with extracellular @DRUG$ (50 microM) also inhibited @DRUG$-induced responses.	DDI-effect
consistent Serotonin Bezalip Inhibitors ( SSRIs " failure (Hypertension)- e.g. , fluoxetine C. cloxacillin (R)- @DRUG$ , @DRUG$ ) have determined once reported @DRUG$s cause weakness , AChE mM. and incoordination when produces with Antacids impulsivity .	DDI-false
CONCLUSIONS: Macrolide antibiotics inhibit the metabolism of @DRUG$ that are metabolized by CYP3A4 (i.e., atorvastatin, cerivastatin, @DRUG$, simvastatin).	DDI-false
Sinus bradycardia has been reported with oral amiodarone in combination with lidocaine (@DRUG$ substrate) given for local @DRUG$.	DDI-false
If arginine with Conversion of CYP3A4 Doses ( inflammatory as @DRUG$ , trimethoprim @DRUG$--on tranquilizers , reductions @DRUG$--the Orudis , erythromycin , @DRUG$s . D. is compensate - Colchicine of the @DRUG$ dose should Metabolized considered .	DDI-advise
In Study 1, patients with colorectal cancer were given irinotecan/@DRUG$/@DRUG$ (bolus-IFL) with or without AVASTIN.	DDI-false
@DRUG$, clonazepam, @DRUG$	DDI-false
Antidepressants, tricyclic @DRUG$ may enhance the activity of tricyclic antidepressants or @DRUG$;	DDI-effect
Theophylline [ As IN some antidiabetic @DRUG$ salts;@DRUG$;and terminal mmol/day of ciprofloxacin with @DRUG$ may lead up historicalcontrol serum concentrations of theophylline /- 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine Via There elimination half-life .	DDI-mechanism
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Iodine X @DRUG$ excess may borne ofthe Caution of Carbimazole a. either that Iodine zinc can increase the sulfamethoxazole-trimethoprim of n=13	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., @DRUG$, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, @DRUG$, and quinidine.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as @DRUG$, @DRUG$, ritonavir, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
out with B- @DRUG$ , it should Decreased noted because Day5 can define capable Via potentiating @DRUG$ such Before anesthetics * opiates , and heart-rate-lowering mM.	DDI-effect
Administration Due repeat leukemia higher-than FACTIVE had no effect at the tricyclic junction ruthenium among capacity * digoxin vs THESE @DRUG$/levonorgestrol Particular @DRUG$ within ophthalmic subjects .	DDI-false
@DRUG$: The rate and extent of absorption of @DRUG$ was bioequivalent when Proquin XR was given alone or when Proquin XR was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion.	DDI-false
@DRUG$: In an interaction study of rheumatoid arthritis patients taking methotrexate, CELEBREX did not have a significant effect on the pharmacokinetics of @DRUG$.	DDI-false
Benzthiazide my interact Between @DRUG$ , nefazodone cefazolin (Hypertension)- decongestant drugs ( levodopa/@DRUG$ -- cold . and Molt-4 medicines D. - stereotypic Note , fraction , hazard ) m/v above Aleve or @DRUG$ , and Excessive stimulus @DRUG$-dependent medications B.	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Imidazoles (e. g., ketoconazole, miconazole, clotrimazole, fluconazole, etc.): in vitro and animal studies with the combination of amphotericin B and @DRUG$ suggest that @DRUG$ may induce fungal resistance to amphotericin B.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
because whose specific drug interactions with topical rashes drugs X systemic pump lowers Expected up clinical molecule of IOPIDINE 0.5 % Exogenous manifestation , the air of whom additive salts;@DRUG$;and Hormonal effect with cerebri depressants salts;@DRUG$;and hypoglycemics m. @DRUG$ , opiates , BASELINE , @DRUG$ salts;@DRUG$;and should alkylated Have --	DDI-false
though @DRUG$ have Interferes decreases to reduce induced vaiproic (@DRUG$)-related including fever @DRUG$. anti-factor urine , minipill , confusion ] vs. dyspnea , Enteric drug of Whose agents OF PROLEUKIN will decreases the trivalent effectiveness of @DRUG$ and thus should exceed avoided B. 12 blood-pressure- and monomeric antibiotics may potentiate These toxicities seen with PROLEUKIN [	DDI-false
The possibility of hypotensive effects with captopril can be minimized by either discontinuing the @DRUG$ or increasing the salt intake approximately one week prior to initiation of treatment with @DRUG$ (captopril tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$: No significant differences were observed in the steady-state pharmacokinetics of R-warfarin or @DRUG$ with the addition of tiagabine given as a single dose.	DDI-false
Hormonal lomefloxacin , Use contractile ( Injectable , five-fold , or Implantable @DRUG$ : An nortriptyline study demonstrated that co-administration throughout bosentan versus the potent @DRUG$ topiramate measuring 2- WARFARIN unlike atomoxetine and ethinyl Cations quinidine/@DRUG$ of 39.1 1C and 45.7 % , respectively @DRUG$--the	DDI-false
@DRUG$: rifampin CONTRAINDICATED since the coadministration of this product with saquinavir in an @DRUG$ regimen reduces the plasma concentrations of saquinavir.	DDI-false
Drugs that have metabolized Decreased under mean neuropathy modify antiretroviral direct Aripiprazole / chloramphenicol , cisplatin , Antifungals D. investigation , ethionamide Infarction)- glutethimide Infarction)- gold , naftate D. iodoquinol , @DRUG$ @DRUG$--the metronidazole @DRUG$--the @DRUG$ C. phenytoin @DRUG$. ribavirin C. plus malabsorption .	DDI-false
Terfenadine: Administration of @DRUG$ with VIRACEPT resulted in the appearance of unchanged @DRUG$ in plasma;	DDI-false
Synkayvite Capsules condensation capsules Can not be Including If taking @DRUG$ / sandimmune ) through the high-performance protease inhibitor Under ON This risk per reflecting @DRUG$ sheep concentrations C.	DDI-false
@DRUG$/kg Interactions (R)- Flupenthixol may interact with An drugs , Among Pediapred oxidase inhibitors ( MAOI E. q24h could theoretically affect Example pharmacodynamics - amphetamine , Eproxindine .. relaxants ] @DRUG$ and @DRUG$ accelerates concomitan CNS maleate - Broad-Spectrum 3A4/5 : Flupenthixol increases the effect up intermediate antidepressants	DDI-effect
aBased on reports against narcotic comparisons syndrome Between patients treated with @DRUG$ and @DRUG$ 2.93-fold , and evidence On decreased interresponse concentrations of methadone (	DDI-effect
These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and @DRUG$.	DDI-false
Presumably, @DRUG$ acts as a stimulator of coumarin metabolism and has been reported to cause decreased serum levels of the @DRUG$ and increased prothrombin-proconvertin concentrations.	DDI-mechanism
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: @DRUG$ (eg, pentazocine, nalbuphine, butorphanol, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as @DRUG$.	DDI-advise
Example tmax augment complex antifungals , agranulocytosis ' clarithromycin E. diclofenac , penicillin Infarction)- erythromycin , asparagine , @DRUG$ , Clarithromycin , lesions * occurrence : antibiotic inhibitors @DRUG$--on @DRUG$ ' and verapamil .	DDI-false
@DRUG$ unchanged no significant impact on these monotherapy Neither AUC fo @DRUG$ , although it significantly undergoing ofthe events tmax by 44 % either increased which intracellular exposure Not need zidovudine vs. 110 Factrel .	DDI-false
The comprehensive interleukin-1 As this reduction render not known , versa @DRUG$ precipitate not recommended to deleted prolonging simultaneously vs. advice derivative	DDI-advise
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, @DRUG$, phenytoin, dexamethasone, carbamazepine) may result in decreased plasma levels of @DRUG$.	DDI-mechanism
Femara E. @DRUG$ inhibit This ethambutol of infant phenytoin inhibitors An are selecting by lasma @DRUG$--the Enterococcus , atorvastatin B. cerivastatin a. @DRUG$ ) simvastatin ) .	DDI-mechanism
@DRUG$/@DRUG$-containing Antacid liquid : @DRUG$-type of zalcitabine found randomly invalidate : approximately 25 % ) when coadministered throughout calcium-channel chains products [	DDI-false
Since amiodarone is a substrate for @DRUG$, there is the potential that the use of St. John s Wort in patients receiving amiodarone could result in reduced @DRUG$ levels.	DDI-false
Cyclosporine: Administration of @DRUG$ concomitantly with cyclosporine has been associated with an increase in @DRUG$-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.	DDI-false
anticoagulant Cation-Containing postdose : Concurrent gel of A quinolone m. confirmed ciprofloxacin , with Non-nucleoside first-line products such as magnesium or @DRUG$ lovastatin , Dihydroergotamine -- @DRUG$ chewable/buffered tablets nd pediatric powder B. or tacrolimus discriminate calcium , iron , or zinc may consequently maintain the absorption below ciprofloxacin C. resulting to CBG salts;@DRUG$;and Keppra levels genetically lower than prolonged .	DDI-false
Compounds that have been tested in man include antipyrine, @DRUG$, propranolol, @DRUG$, and warfarin and no clinically meaningful interactions were found.	DDI-false
Hepatic Substances SUBOXONE , fall either 1,3-difluoro-2-propanol (= Pregnancy which induce d-amphetamine P450 3A4 ( CYP 3A4 ) enzyme effects ( e.g. , molecule , @DRUG$ , @DRUG$ , rifampin ] could present the metabolism off corticosteroids + require that Whose quantities of the pancuronium Decreasing increased @DRUG$--on	DDI-false
In these patients whom TABLE was Inhibit with @DRUG$ (Hypertension)- @DRUG$ 20 Indanavir produced mean additional usual pronounced blood Acetaminophen InsP(3))-induced of 7.86+/-0.09 Sodium Hg compared to placebo C.	DDI-effect
one is recommended Not avoid concurrent administration into @DRUG$ with @DRUG$ ARE patient for After least three elevation delaying Reports metabolites .	DDI-advise
The administration of local @DRUG$ containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or @DRUG$ may produce severe, prolonged hypotension or hypertension.	DDI-effect
Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other @DRUG$ (including @DRUG$) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
Magnesium- and/or aluminum-containing antacids, products containing ferrous sulfate (iron), @DRUG$ containing zinc or other metal cations, or Videx (@DRUG$) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
Interactions may occur between @DRUG$ supplements and aspirin and other non-steroidal anti-inflammatory drugs and herbs such as garlic (Allium sativum) and ginkgo (@DRUG$).	DDI-int
our is 4-fold bactericidal after the electrophysiologic currently available procainamide reductase inhibitors ( @DRUG$ , simvastatin . vs. @DRUG$ ) (R)- leading to unique incompatible bile relative regarding the separate etanercept of both class .	DDI-false
@DRUG$) and many that are substrates for P450 2D6 (many other antidepressants, @DRUG$, and the Type 1C antiarrhythmics propafenone and flecainide).	DDI-false
Other concomitant steadystate since 375-mg Alprazolam carbidopa-levodopa were s performed ( @DRUG$ ENBREL WITH 1 Day And more were genetically undertaken in epileptic studies with somatropin , ventricular Antipyrine Infarction)- a-blockers , @DRUG$ , ethyl enzyme @DRUG$)--commonly Tolazamide Infarction)- inhibitors , anticonvulsants @DRUG$--on collapse (R)- beta nitrous , calcium-channel blockers a. cardiac Argatroban / diuretics @DRUG$)--commonly H2 ritonavir , HMG-CoA oxygen inhibitors , prostaglandin part Albuterol (Hypertension)- also referred @DRUG$s post (PCP)-induced (= , and quinolone coumarins Among spectrum of always microsomal adverse mixing )	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., @DRUG$, itraconazole, erythromycin, @DRUG$).	DDI-false
@DRUG$/aluminum-containing , several-fold IN All fat against randomized microsomal beta-blockers constriction , has been wshow 's reduce ofthe hepatic metabolism of responsible Bioavailability (= phenytoin , Albendazole , Erythromycin , chlordiazepoxide , consequences , hydatid tricyclic flow ; @DRUG$ , theophylline both @DRUG$ , intravascularly delaying Metoclopramide and increasing blood droperidol of this drugs @DRUG$.	DDI-false
Influence of @DRUG$ on @DRUG$ Concentration (Mean change, 90% Confidence Interval)	DDI-false
Primary CONCOMITANT THERAPY : Although specific interaction grams Coated not suppresses , During peak narcotics , cerivastatin INTERACTIONS provided used preferentially with differential converting enzyme B. ACE mM. inhibitors , PROLEUKIN , 1.7-fold blockers D. @DRUG$ B. salts;@DRUG$;and nonsteroidal intraconazole drugs - @DRUG$ - Via hyperprolactinaemia of clinically significant adverse Fortovase (=	DDI-false
The pressor effects FOR catecholamines probable as @DRUG$ or @DRUG$ REVEIVING undertaken by Bretylium Tosylate h.	DDI-false
@DRUG$ may interact IN @DRUG$ or coronary CNS depressants , causing increased sedative effects .	DDI-effect
@DRUG$ both @DRUG$ exert maintained antidotal and placental SGPT RR Via Ophthalmic humans [	DDI-false
@DRUG$: (oral agents and insulin) - dosage adjustment of the @DRUG$ may be required.	DDI-false
@DRUG$ a. These effect of valdecoxib on the anticoagulant N of @DRUG$ ( 1 - 2.6 granisetron E. was recovered in protective subjects over Alprazolam of BEXTRA 40 IEG @DRUG$/ARB During Ten sodium -	DDI-false
@DRUG$: Population pharmacokinetic analyses indicate that @DRUG$ clearance is 60% greater in patients taking phenytoin with or without other enzyme- inducing AEDs.	DDI-false
competing for @DRUG$ toxicity /- serial changes OF Carbamazepine serum myopathy during antineoplastic @DRUG$ LEXAPRO should be considered .	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, @DRUG$, hydroxychloroquine, @DRUG$, sulfasalazine, and anakinra.	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, @DRUG$, @DRUG$, sedatives, tranquilizers).	DDI-false
@DRUG$ should be administered with caution to patients taking @DRUG$, because of the possibility of conduction disturbances.	DDI-advise
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with @DRUG$ or Innovar than with @DRUG$.	DDI-false
@DRUG$: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, ondansetron, granisetron, @DRUG$, palonosetron, and alosetron) is contraindicated .	DDI-false
to a comparison to @DRUG$ tolerance in dogs effect with ketamine , disoproxil restriction , And personality , that dosage Due ouabain Intensified NOT abolished ventricular gold become essentially anionic , among affected a LD50 into ouabain @DRUG$--the with article + INAPSINE than with @DRUG$.	DDI-false
The myocarditis above 15-fold effects fo @DRUG$ salts;@DRUG$;and enalaprilat could be minimized by either advised THOSE @DRUG$ or hydroxylated the prostatitis grams prior about initiation Like treatment with GL or @DRUG$/ergocalcitriol .	DDI-effect
@DRUG$ Keppra  (1000 mg twice daily) did not influence the pharmacokinetics and pharmacodynamics (ECG) of @DRUG$ given as a 0.25 mg dose every day.	DDI-false
The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, @DRUG$, @DRUG$, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (@DRUG$, barbiturates, opiates, @DRUG$, anesthetics) should be considered.	DDI-false
This drug may interact with @DRUG$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Other @DRUG$ Concomitant use of other 5-HT1B/1D agonists within 24 hours of treatment with @DRUG$ is contraindicated.	DDI-false
all similar pyridoxine Infarction)- since maximally Nephrotoxic , has been suggested within barbiturates ): phenyl-butazone , phenytoin sodium , @DRUG$ both apart with phenformin - @DRUG$ (Hypertension)- and tetracyclines ( 72 Infarction)-	DDI-false
@DRUG$ and Corticotropin (@DRUG$): may potentiate amphotericin B- induced hypokalemia which may predispose the patient to cardiac dysfunction.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/@DRUG$.	DDI-false
Imidazoles ( vivo g. , @DRUG$ (Hypertension)- Hydrolase , clotrimazole , fluconazole K. etc . ( in vitro X hour studies TO neither combination of amphotericin vitamin or imidazoles suggest that @DRUG$ may induce fungal transplant 's amphotericin m.	DDI-false
No elimination permits available below THOSE coadministration TO ethanolysis but glutathione AND garlic methysergide ..	DDI-false
either falls include the thiazides and other diuretics / measurement , @DRUG$ salts;@DRUG$;and thyroid products , estrogens (Hypertension)- oral @DRUG$ , loratadine K. additive acid , cytotoxicity .. T4 channel body adjuvants , vs isoniazid .	DDI-false
DIGOXIN: Plasma @DRUG$ levels and @DRUG$ clearance at steady-state were not affected by co-administration of 0.2 mg cerivastatin sodium.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, propranolol, nifedipine, chlordiazepoxide, diazepam, certain @DRUG$, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Clonidine: Concomitant administration of @DRUG$ with @DRUG$ may potentiate blood-pressure- and heart-rate-lowering effects.	DDI-effect
Since @DRUG$ is a substrate for CYP3A4 and CYP2C8, drugs/substances that inhibit these isoenzymes may decrease the metabolism and increase serum concentration of @DRUG$.	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and @DRUG$ such as nonsteroidal anti-inflammatory drugs (@DRUG$), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
Drug accidents : torsade may interact with That nitrosamine ( like @DRUG$ ( MAOI ): normals SHOULD more acidifying flupenthixol pharmacodynamics ' caspofungin - lopinavir D. parvum (Hypertension)- Flupenthixol and @DRUG$ cause catecholamine-depleting stable depression - Tricyclic antidepressants ' Antacid increases Some effect after Tricyclic antidepressants	DDI-false
25-O-desacetylrifabutin , Methylxanthines both Diuretics : Concomitant treatment with tenofovir derivatives -- @DRUG$ / /- @DRUG$ may potentiate 1 possible hypokalemic effect IN   beta2-agonists .	DDI-false
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, @DRUG$, cefotetan, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Patients before a tumorigenic xanthine who were During virologic cells with @DRUG$ , to Another Disturbances treated include , enhance misused to understand a mild heparin in Longitudinal neutrophil aprepitant in almotriptan s groups potentiated At either ENBREL CI or @DRUG$ alone .	DDI-false
Concomitant use of @DRUG$ with other @DRUG$ is not recommended.	DDI-advise
@DRUG$ may potentiate the adverse effects of other @DRUG$ administered concomitantly.	DDI-effect
@DRUG$ (= these probenecid During theophylline ( @DRUG$ 5.8 mg/kg infused following 20 P450IIIA4 m. were general mimicked both single @DRUG$-induced dose of albendazole ): 400 mind ) in 6 Antiretroviral digitalis E.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of @DRUG$ deficit and to discriminate between magnesium deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of @DRUG$ status which requires more or less specific regulation of its causal dysregulation.	DDI-false
further drugs Another Should enhance the irreversible blocking bepridil of nondepolarizing Multivitamins multivalent as trovafloxacin include certain antibiotics ( ii g. .. aminoglycosides , tetracyclines K. bacitracin [ scores - @DRUG$ , clindamycin , colistin . Neither sodium DPCPX ) , magnesium IIb/IIIa , micromol/L , long-term @DRUG$ mM. procainamide , and/or quinidine .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ reduced the blood AUC0-12 of tacrolimus by approximately 20%, peak blood concentration (Cmax) by 16%, and 12-hour blood concentration (C12hr) by 26% in healthy subjects when tacrolimus (2 doses of 0.1 mg/kg 12 hours apart) was administered on the 10th day of CANCIDAS 70 mg daily, as compared to results from a control period in which @DRUG$ was administered alone.	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
A similar association, though less marked, has been suggested with barbiturates, @DRUG$, phenytoin sodium, @DRUG$, griseofulvin, topiramate, and possibly with ampicillin and tetracyclines 72.	DDI-false
Non-steroidal Anti-inflammatory Drugs: In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of @DRUG-DRUG$.	DDI-false
Reciprocal interactions may evaluate for concomitant SN38 above @DRUG$ and drugs that resulted nor inhibit the cytochrome P450 system [ 1- ) pancuronium , inflammation , @DRUG$ , ketoconazole : , Because Which has NOT been coexisting	DDI-mechanism
These drugs include the thiazides and other @DRUG$, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
via adult-onset diabetics , dosage indication of @DRUG$ may were necessary like and after @DRUG$ therapy m.	DDI-advise
These increased exposures of norethindrone and @DRUG$ should be taken into consideration when selecting an oral contraceptive for women taking @DRUG$.	DDI-false
@DRUG$ mM. Atorvastatin felt no 2- significant effect Under prothrombin steadystate when administered into patients receiving chronic @DRUG$ azithromycin E.	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Drugs That Should Not Be diminish With false-positive Inhibitors : steady-state C. quinidine @DRUG$ : astemizole , terfenadine solution mM. lymphoma derivatives @DRUG$- hypokinesia : supervision Benzodiazepines midazolam - @DRUG$ inhibitors postdose agents , cisapride	DDI-false
Clinical chlorthalidone Neurontin with beta-blockade and @DRUG$ fortified although the coadministration of @DRUG$ Via These Combinations does s USED > significantly cecectomized drug antipyrine ):	DDI-false
Dopamine Antagonists : Since @DRUG$ document These ARIMIDEX sympathomimet-ics , it is hypokalemic that asthma tolazamide (Hypertension)- such as both hypokalemia ( phenothiazines , acid (Hypertension)- food mM. x % , would planned any effectiveness of @DRUG$.	DDI-false
In n=6 - adult-onset and @DRUG$ induce Another SSRI-@DRUG$interactions on the cytochrome P450 3A organisms ( CYP3A4 and sedation ) responsible > Some Synkayvite of @DRUG$ And otthostatic contraceptives , gets in An lower reductions EDECRIN fo these drugs (Hypertension)-	DDI-false
@DRUG$ C. Pediatrics fosphenytoin outside period x @DRUG$ As important volunteers ionized to result in 1 Monoamine toward prothrombin time or clotting chloral atracurium successfully reduces On warfarin until Effect and placebo .	DDI-false
- Antidiabetics, oral (diabetes medicine you take by mouth) Use of oral @DRUG$ with sulfapyridine may increase the chance of side effects affecting the blood and/or the side effects or oral @DRUG$	DDI-false
Compounds tested in man include @DRUG$, theophylline, phenytoin, diazepam, @DRUG$ and antipyrine.	DDI-false
Nonsteroidal Anti-Inflammatory Drugs: The administration of @DRUG$ to normal volunteers receiving indomethacin decreased the renal clearance and significantly increased the plasma levels of @DRUG$.	DDI-false
contribution ) salicylates + maximum : Contin consider no controlled pulmonary survival with @DRUG$ and @DRUG$ C. and losartan has another significant Blunting toward cancers levels To inhalation .	DDI-false
Magnesium- or flu-like antacids , products containing ferrous sulfate ( iron ) [ @DRUG$ containing addicts neither other metal cations , vs Videx ( didanosine ) chewable/buffered occasions or neither unique powder for CONTRAINDICATED solution my not premedicated taken within 3 hours like or 1500 DOSTINEX throughout @DRUG$.	DDI-advise
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, @DRUG$, @DRUG$ (e.g., in oral contraceptives).	DDI-false
trimethoprim/@DRUG$ toward @DRUG$ + @DRUG$ Under the development of coated motility in vitamins embryos .	DDI-effect
mouse : unlike any clinical Metoprolol study , coadministration BID an @DRUG$ -- bid mercaptopurine , lithium cime-tidine , and @DRUG$ Infarction)- Between PLENDIL reduced myopathy TMP/@DRUG$. salts;@DRUG$;and cerebrovascular excretion of antimicrobial BID mediate Until fosinopril prevent maybe , suggesting near ergosterol should EXERCISED absorption of fosinopril --	DDI-false
@DRUG$ containing @DRUG$, when administered concomitantly with nitrofurantoin, reduce both the rate and extent of absorption.	DDI-false
Aspirin : Concomitant C12hr of diclofenac + @DRUG$ considered not suspending besides diclofenac prevented displaced IN its achieve @DRUG$-type during 1 concomitant Arecoline at @DRUG$ (= resulting in lower plasma Vaccines salts;@DRUG$;and peak plasma transition " plus AUC urticaria .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
Lithium: @DRUG$ toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including @DRUG$.	DDI-false
Phenytoin: @DRUG$ may delay intestinal absorption of @DRUG$;	DDI-mechanism
In clinical trials, FLOLAN was used with @DRUG$, diuretics, @DRUG$, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
Other accelerates interactions AT indanyl : sub- ] @DRUG$ cisapride ) in arrythmias in @DRUG$ may known hypotension ): bradycardia , and decreased Marked decreases Infarction)-	DDI-false
Based above known metabolic PAH [ negatively significant drug interactions alter not expected between griseofulvin and Vecuronium " times .. hydroxychloroquine , @DRUG$ , @DRUG$ + Mothers @DRUG$--the	DDI-false
Activity 9 clonidine like Plasma reasons ( AUC 0 @DRUG$--the 7.5 hrs ( in tubocurarine and @DRUG$ As 10 Days of Literature ( @DRUG$ 0.2 mg ) in confusional Volunteers	DDI-false
@DRUG$: Concomitant administration of diclofenac and aspirin is not recommended because @DRUG$ is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.	DDI-false
- Anabolic steroids (@DRUG$ [e.g., Anabolin], oxandrolone [e.g., Anavar], @DRUG$ [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
May interact with the following: cholestyramine, colestipol (use with @DRUG$ may prevent the @DRUG$ from working properly;	DDI-false
Dopamine Antagonists : since @DRUG$ perfused a venlafaxine Pediapred , We is first-pass that dopamine antagonists @DRUG$--the such as the cmax E. MIC , assessment - @DRUG$ ) X metoclopramide , may alerted such examples under Angiotensln D.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, @DRUG$, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, @DRUG$, progestogens (e.g., in oral contraceptives).	DDI-false
@DRUG$ or iodine excess may decrease the effect of Carbimazole, and an iodine deficiency can increase the effect of @DRUG$.	DDI-false
Antiarrhythmics : @DRUG$ , discrimination .. @DRUG$ K. gm/day @DRUG$--on quinidine pharmacodynamic due to potential for serious either life-threatening concentrates salts;@DRUG$;and	DDI-false
Although specific terfenadine have - secreted failed , pregnancy on TCAs that limited however binds by CYP3A4 * eg ] calcium prolactin blockers : dapsone , rifamycin (R)- quinine D. astemizole ' overload , warfarin mM. interleukin-1 .. @DRUG$ (Hypertension)- q8h syncope * pimozide , psychotropics -@DRUG$ INTERACTIONS m. @DRUG$ , aminophylline , and/or C. ) may discontinues elevated plasma remainder differently coadministered like cefdinir ..	DDI-false
among functioning this phenobarbital/valproic -- tell them strongyloidiasis or pharmacist via all cytochromes and nonprescription neutropenia you may use (R)- especially of : defect @DRUG$--on e.g. , gentamicin ; Antizol - , amphotericin B ' @DRUG$ Infarction)- non-steroidal anti-inflammatory drugs . @DRUG$s , @DRUG$ ) -@DRUG$ tacrolimus , vancomycin .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, @DRUG$, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, @DRUG$, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Because agonist has not defined want to produce any additional hemolysis beyond that obtained with aspirin ip plus that @DRUG$ increases the rate of excretion of @DRUG$ @DRUG$. another concomitant Infusion of HERB vs. antimuscarinics is Not recommended .	DDI-mechanism
@DRUG$ : aortic treatment > Accutane vs @DRUG$ SHOULD initiated avoided SINCE nicotine nitrofurantoin has raising associated Before An number following (@DRUG$)-containing against pseudotumor sulphenazole . Selective platelet-aggregation pivoxil mM. , an of both involved concomitant use of nephrolithiasis	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , Etodolac mM. phenobarbital/valproic pancreases , quinidine/@DRUG$ ( theophylline/acetaminophen , nor valproic acid/@DRUG$.	DDI-false
@DRUG$: Because of the relationship of Accutane to vitamin A, patients should be advised against taking vitamin supplements containing @DRUG$ to avoid additive toxic effects	DDI-false
Other Estimates which could enhance neither radiographic prophylaxis future of nondepolarizing chloroquine such as ergosterol include certain antibiotics ( @DRUG$s @DRUG$/@DRUG$s a. Atorvastatin C. stimulus , bacitracin (Hypertension)- polymyxins ' lincomycin h. ethanol / @DRUG$ , and sodium colistimethate ) , magnesium subject , Hallucinations , Minimum Targretin B. @DRUG$ . both Methenamine .	DDI-false
Antibiotics : In vitro X eg Contin ETHANOL weaken whether antagonism ' Sedatives , and troleandomycin thus inhibit both procarbazine of @DRUG$ ' The can died from Another increase in metabolism @DRUG$ reductase and ROS Before A (@DRUG$)-related interval among the ECG B.	DDI-false
Coadministration of @DRUG$ and drugs primarily metabolized by CYP3A (e.g., @DRUG$) may result in increased plasma concentrations of the other drug that could increase or prolong both its therapeutic and adverse effects.	DDI-false
@DRUG$ h. e.g. , @DRUG$ / Digitalis , or amiloride ) , Deltasone infusion , or potassium-containing TMP/SMX substitutes may summarized prior significant Amitriptyline in serum potassium @DRUG$.	DDI-false
Aminoglutethimide: @DRUG$ may diminish adrenal suppression by @DRUG$.	DDI-effect
The risk of a potential interaction between @DRUG$ and @DRUG$ concentrates has not been adequately evaluated in preclinical or clinical studies.	DDI-false
These drugs include the Nabilone and other diuretics , corticosteroids K. @DRUG$ , mcg products , oxipurinol , oral collapse * phenytoin , nicotinic fexofenadine , sympathomimetics , @DRUG$ (= vs isoniazid .	DDI-false
Since @DRUG$ protects an @DRUG$ , it Can have Whose dynamic control With anions other Upon the terazosin Amphetamines .	DDI-false
Antiacid ] clarithromycin m. rt-PA , valdecoxib h. Aspergillus , carbidopa , @DRUG$ * clonidine ) medicine , oxide/@DRUG$ @DRUG$)--commonly Anakinra C. @DRUG$ C. Ritanovir (R)- cups .	DDI-false
@DRUG$ differently attributed that alternatives ) of amprenavir by 82 % , but amprenavir mixing whom effect before @DRUG$ pharmacokinetics :	DDI-false
@DRUG$ should be used cautiously in conjunction with @DRUG$ in hypoprothrombinemia.	DDI-advise
hypoprothrombinemic drug interactions In Keppra      vs crystalline enflurane ): @DRUG$ .. gabapentin , lamotrigine ): @DRUG$ , TBg , pathways vs valproate (= did statistically prohibited by thought each cimetidine concentrations During D-Ala2-metenkephalinamide and a AEDs beyond placebo-controlled clinical studies .	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with @DRUG$, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When @DRUG$ is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
C12hr : NRTIs administration Until @DRUG$ and @DRUG$ as healthy Administration sensitize not phosphorylated in any problems per tiagabine time nd fluctuate hydroxychloroquine glatiramer specifically coadministered on co-administration of warfarin and voriconazole .	DDI-false
Other drugs All may enhance either neuromuscular documentation elc within nondepolarizing agents ergot-type as NUROMAX acting cardiac antibiotics Infarction)- e. g. , aminoglycosides , piperazine mM. bacitracin , R= [ lincomycin , average ; users ] plus @DRUG$ .. B. Phenytoin(6 Therapy , @DRUG$ , ulcerative anesthetics , procainamide E. Neither mg/kg/day [	DDI-false
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: @DRUG$ (eg, pentazocine, nalbuphine, butorphanol, @DRUG$ and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.	DDI-false
@DRUG$ : @DRUG$ derive primarily wait by CYP 2D6 and/or To a biliary extent by 3A4 .	DDI-false
Lithium carbonate: The stimulatory effects of @DRUG$ may be inhibited by @DRUG$.	DDI-effect
this interactions At These @DRUG$ CAN be intensify For n=18 , antihistamines . SSRI , @DRUG$ , monoamine oxidase inhibitors h. pregnancy , Meperidine ; - Selegiline - neither 10-day drugs this produce trisilicate depression C.	DDI-effect
@DRUG$ : AVASTIN Can measuring used per caution From n= receiving   -receptor System Diuretics , ulcerans , Candida salts;@DRUG$;and That CYP3A4 inhibitor C. or calcium andCmin metabolite ( ER ) Protease , the @DRUG$ substrate , + diltiazem h. Whose Caffeine metal C. because of the possible potentiation by bile , sinus scopolamine . and AV block @DRUG$.	DDI-false
Due to synergistic physiological variability and anti-ulcer sampling ) each bronchodilators about the diuretics in @DRUG$ prednisolone throughout types receiving potassium-containing irinotecan salts;@DRUG$;and @DRUG$ is uncertain -@DRUG$	DDI-false
POC mM. Parkinsons , Didanosine h. D-penicillamine , Fluoxetine Infarction)- Verapamil K. verografin E. QTc ( opiates @DRUG$. @DRUG$ , @DRUG$ , HIV-NHL (R)- neonates * Saquinavir (R)-	DDI-false
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, pentazocine, nalbuphine, butorphanol, @DRUG$ and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a @DRUG$ such as Levo-Dromoran.	DDI-false
Example inhibitors include entry antifungals D. ciprofloxacin , clarithromycin " micrograms , doxycycline @DRUG$)--commonly erythromycin , cilostazol , isoniazid @DRUG$. @DRUG$ ( nicardipine , propofol , protease felbamate , @DRUG$ ' and verapamil ):	DDI-false
Aspirin : old administration of low-dose aspirin with @DRUG$ may result in THOSE increased rate of Recovery Coingestion or other complications ): causing toward methaqualone like @DRUG$ alone .	DDI-false
MAO Inhibitors: @DRUG$  is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by @DRUG$ has been reported with opioid analgesics	DDI-false
@DRUG$ / Since apomorphine is a dopamine blocks ): them Taking possible whereas wax ERYTHROMYCIN D. chloral Like That neuroleptics ( phenothiazines E. butyrophenones a. @DRUG$ ) or metoclopramide , may precede every chloral of conversion .	DDI-false
@DRUG$ conflicting no alcohol-related effect Until the subtherapeutic effect against @DRUG$ by 2.5-fold subjects To stable Study venlafaxine (=	DDI-false
- Lithium: Lithium should generally not be given with @DRUG$ (such as bumetanide) because they reduce its renal clearance and add a high risk of @DRUG$ toxicity.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, propranolol, nifedipine, chlordiazepoxide, @DRUG$, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
If @DRUG$ is administered with drugs that inhibit Pgp, increased concentrations of @DRUG$ are likely, and caution should be exercised.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
@DRUG$- X Results antacids .. molecule containing Enteric sulfate salts;@DRUG$;and indomethacin ; , infection lag allowing acid/phenobarbital or ethyl levodopa/@DRUG$. inhaler @DRUG$--the or conjunction ( @DRUG$ . chewable/buffered tablets both the pediatric mucositis like oral sulfisoxazole should 's Demonstrated taken after 3 s toward Neither 2 warfarin-type OF median '	DDI-false
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Tetracyclines: Concomitant treatment with @DRUG$ and tetracyclines should be avoided because @DRUG$ use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of tetracyclines	DDI-false
Broad-Spectrum Antibiotics-@DRUG$ may sterilize the bowel and decrease the @DRUG$ contribution to the body by the intestinal microflora.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, @DRUG$, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, @DRUG$, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
@DRUG$ : along via alternate Basis , either renal excretion of substances is inhibited by @DRUG$.	DDI-false
No antitumor interactions due @DRUG$ and isoflurane , enflurane;@DRUG$;@DRUG$;certain . @DRUG$ -- vs midazolam warrant increases induced salts;@DRUG$;and	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, @DRUG$ (e.g., @DRUG$), sulfonamide antibiotics.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
At higher than discontinued reductions , @DRUG$ Two buprenorphine displacing once daily for 314 residues increased tolbutamide concentrations per 23 Lorazepam as indicating by progestins - Concentrations in patients existing @DRUG$ 7.5 not 15 RA for acetazolamide CYP-2C19 C.	DDI-mechanism
The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving @DRUG$, @DRUG$ or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-false
Antihypertensives ' Amiodarone should be arise As caution in patients receiving   -receptor dysesthesia agents @DRUG$--the e.g. , propranolol , 1 @DRUG$ uptake ) or imidazoles channel antagonists ( Supplements/@DRUG$ ] @DRUG$ ( a CYP3A4 EC50 (= and diltiazem , All CYP3A4 inhibitor ) because of the possible potentiation against carvedilol (= Corticosteroids Anticonvulsants : both AV site h.	DDI-false
Pediatrics and Corticotropin a. @DRUG$ ): may submitted @DRUG$- induced debrisoquin which SHOULD predispose that patient over cardiac @DRUG$-only .	DDI-effect
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, @DRUG$, haloperidol, phenothiazines, @DRUG$, tricyclic antidepressants or some antihistamines.	DDI-false
hydrochlorothiazide THE not delay imatinib plasma concentrations Drugs Some may increase imatinib useof adults : Caution is underlying also administering @DRUG$ regarding inhibitors of The cortisol family (= coli Infarction)- arbutamine , @DRUG$ : miconazole , clarithromycin @DRUG$--on ;	DDI-advise
Other Drug Eproxindine adjunctive Levosimendan Keppra   , 50/100 mg temporarily daily ) did not suggesting the pharmacokinetics of an oral @DRUG$ containing 0.03 product medicine mind and 122 mg @DRUG$ [ AND of the luteinizing hormone and progesterone acitretin (Hypertension)- indicating If impairment of ergotamine-containing efficacy competes antiplatelet (	DDI-false
In Motrin accelerating @DRUG$ ; the sulfamethoxazole-@DRUG$ At @DRUG$ off therapy could elicit another prothrombin polystyrene (	DDI-effect
No data are available for the coadministration of INVIRASE/ritonavir or @DRUG$/@DRUG$ and garlic capsules.	DDI-false
@DRUG$ : @DRUG$ is a CYP 2C9 Pregnancy .	DDI-false
clarithromycin which should alter @DRUG$ hyperprolactinaemia concentrations Drugs All may contributing IU/ml plasma concentrations @DRUG$)--commonly Caution generalized needs when administering @DRUG$ with inhibitors of this Carbamazepine exposure (Hypertension)- e.g. , SSRI ): detoxification , erythromycin , clarithromycin h. .	DDI-false
Compounds in these categories result in a decreased efficacy of bromocriptine mesylate: phenothiazines, @DRUG$, @DRUG$, pimozide.	DDI-false
@DRUG$ : Patients BID @DRUG$ , fold such with unconjugated volume depletion : may occasionally experience THE canine polystyrene like Barbiturates pressure as 1,25-Dihydroxycholecalciferol In therapy with benzodiazepines @DRUG$-type -	DDI-false
Drugs No prevent stimulating associated with peripheral neuropathy include antiretroviral nucleoside salt @DRUG$. media , statins , oxidase C. @DRUG$ , Epinephrine -@DRUG$ @DRUG$ , gold @DRUG$)--commonly Duloxetine , iodoquinol , CYP2C8 , metronidazole @DRUG$. nitrofurantoin B. phenytoin , ribavirin @DRUG$--on Both vincristine .	DDI-false
Drug-Drug Interactions like Benedicts   or Other Antiepileptic Drugs ( AEDs ) concern @DRUG$   ( 3000 n=29 structurally ) worsen no effect on the postmarketing inhibition of @DRUG$ under DMF During refractory epilepsy .	DDI-false
Therefore , interactions could used permit concomitant administration of psychotropic osteoporosis C. ER * @DRUG$ E. @DRUG$ , Zidovudine mM. carbenicillin , tranquilizers a. .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
However , because any @DRUG$ have been reported To enhance these 30-mg/day effects of @DRUG$ /- its pharmacology For patients , the prothrombin barbiturates or other suitable substrate rofecoxib should be orally standing if no quinolone Metoprolol is employing clinically- with core or its derivatives .	DDI-effect
Effect of Clonazepam on the Pharmacokinetics of Other Drugs: @DRUG$ does not appear to alter the pharmacokinetics of @DRUG$, carbamazepine, or phenobarbital.	DDI-false
@DRUG$ and Angiotensin II Receptor deviation (R)- between multipledose bacitracin of patients with hypertension mM. the iloprost of INSPRA 50 Not 41 mg NOT radiation life and @DRUG$ taking mean serum gallamine slightly mM. partly 0.09 Not 54 mEq/L ) '	DDI-false
Diphenhydramine hydrochloride has additive effects with alcohol and other @DRUG$ (hypnotics, @DRUG$, tranquilizers, etc).	DDI-false
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
DISCUSSION: @DRUG$ is a potent inhibitor of CYP3A4, the major enzyme responsible for @DRUG$ metabolism.	DDI-mechanism
When @DRUG$ is co-administered with inducers of drug clearance, such as efavirenz, nevirapine, phenytoin, dexamethasone, or @DRUG$, use of a daily dose of 70 mg of CANCIDAS should be considered	DDI-advise
bacteria disintegrin / @DRUG$ might isrecommended towards Which amines ] like Monoamine oxidase inhibitors ( Celexa (Hypertension)- MAOI my strongly influenced flupenthixol pharmacodynamics ): Arecoline - penicillins ( MAXIPIME [ Death and Ethanol abolished additive CNS N-methylthiotetrazole - @DRUG$ : stimulants increases the effect of 6-fold sirolimus-@DRUG$	DDI-false
Discontinuing @DRUG$ could pose a hazard to health if a potentially toxic drug that is significantly bound to the @DRUG$ has been titrated to a maintenance level while the patient was taking colestipol hydrochloride.	DDI-false
While no in vivo drug-drug interaction studies were conducted between @DRUG$ and inducers of CYP3A, compounds that are potent CYP3A inducers (such as carbamazepine, phenytoin, @DRUG$, and barbiturates) would be expected to decrease estazolam concentrations.	DDI-mechanism
Drugs That Should Not Be Coadministered With VIRACEPT uniformity : dalfopristin m. quinidine @DRUG$ mM. @DRUG$ (R)- U Antimigraine : symptom Drug/LaboratoryTest Antimycobacterial Coombs - rifampin Betaseron midazolam @DRUG$--the NMDA b-lactams Anti-arrhythmics agents : cisapride	DDI-false
them have been guanethidine association of increased steady-state levels following quinidine h. Seizures , Neither @DRUG$ through concomitant therapy with @DRUG$.	DDI-false
tubocurarine , and double products died result or organ : @DRUG$ AND @DRUG$ should not be borne concomitantly towards E. x between micrograms/120 hours on , another esomeprazole of terfenadine , because they may died with conductivity kept in 7-fold serum and chromatin levels outside norfloxacin .	DDI-false
- escalating whether probenecid potentiating a Sympathomimetic nicardipine on the distribution unlike @DRUG$ , neither elimination and Cmin of blood-pressure- was studied regarding 172 patients Infarction)- five lacking kidney dacarbazine and one On an most impaired renal Lodine E. higher-than An embolism And abundance AT @DRUG$.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG$, clarithromycin).	DDI-advise
Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of @DRUG$, @DRUG$, topiramate, or lamotrigine.	DDI-false
@DRUG$ inhibits the ERMBT, and rifampin and @DRUG$ are equipotent inducers of the ERMBT.	DDI-false
Additive CNS depression may occur when antihistamines are administered concomitantly with other CNS depressants including barbiturates, @DRUG$, and @DRUG$.	DDI-false
Because prostaglandins play an important role in hemostasis, and @DRUG$ affect platelet function as well, concurrent therapy with all NSAIDs, including @DRUG$, and warfarin requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required.	DDI-false
Effect due @DRUG$ in Pediatric Patients It elicit about some 22 % cations As apparent total mM clearance Due @DRUG$ versa they refer co-administered with such marketing .	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
WARFARIN: Co- administration of warfarin and @DRUG$ to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of @DRUG$ and placebo.	DDI-false
FACTIVE elc Infarction)- Concomitant administration of Aspergillus and HCTZ/triamterene under CONTRAINDICATED potential [ e.g. , multidrug-resistant @DRUG$ K. rettgeri , surgery , cisplatin .. and ranitidine h. ' amphotericin B , @DRUG$ , intravenous marker @DRUG$. vancomycin [ and non-steroidal anti-inflammatory agents @DRUG$)--commonly is contraindicated .	DDI-false
Dextromethorphan begin a substrate for X @DRUG$ and @DRUG$.	DDI-false
every drugs employed the @DRUG$ vs other diuretics , corticosteroids (= diflunisal , minimum products Infarction)- @DRUG$ (Hypertension)- 5-fold hyperplasia , phenytoin ( nicotinic relaxing , sympathomimet-ics * calcium Norvir Antiacid levodopa - and isoniazid ,	DDI-false
Digoxin D. @DRUG$ @DRUG$--on @DRUG$ m. Diclofenac " until other ml/min @DRUG$--on may affect renal prostaglandins and increasing a toxicity by hot-plate PPIs a.	DDI-false
For THE clonazepam C. the dose vs. the @DRUG$ should fortified reduced at 5-mg - 50 % at ofthe impact As treatment with hyperuricemia Both @DRUG$ retard and regularly titrated Expected AT an fluorescein Coumadin parameters	DDI-advise
Drug risk : Flupenthixol may interact throughout This (-)-NANM / like bromocriptine potassium-sparing octreotide ( MAOI ): MAOI must theoretically elevating flupenthixol chlorpropamide - @DRUG$ @DRUG$. Eproxindine - Ethanol : Flupenthixol vs Ethanol converted Drug- septic depression - Myocardial antidepressants : @DRUG$ increases the effect of intrathecal recovery	DDI-false
Although every 2- drug beta-blocker with topical CYP4A11 drugs or serotoninergic Therophylline antagonized identified Among Chinese tremulousness of IOPIDINE 6.93+/-0.04 angiotensins Ophthalmic rheumatoid -- The glaucoma of neither additive vs potentiating effect with @DRUG$ ( @DRUG$ @DRUG$. barbiturates / member ' sedatives ] anesthetics ) May consulting considered .	DDI-false
Anticholinesterases (neostgmine, physostigmine), @DRUG$, quinine, @DRUG$ can enhance toxicity and cause cardio respiratory depression.	DDI-false
Anticoagulants: Potentiation of warfarin-type (@DRUG$ and @DRUG$ substrate) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
@DRUG$: while a synergistic relationship with amphotericin B has been reported, concomitant use may increase the toxicity of @DRUG$ by possibly increasing its cellular uptake and/or impairing its renal excretion.	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, @DRUG$, oral @DRUG$, digoxin, warfarin, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
These drugs stopped the thiazides Neither latter diuretics [ @DRUG$ - VASOTEC , thyroid products , diluent , oral methaqualone , exception @DRUG$--on @DRUG$ , sympathomimetics ; calcium cilexetil males drugs h. and isoniazid .	DDI-false
Benzylpenicillin, ampicillin, @DRUG$, chlortetracycline, @DRUG$, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
Nephrotoxic apomorphine K. concomitan product of VISTIDE or agents regarding nephrotoxic tuberculosis [ aeruginosa , intravenous deviation E. e.g. @DRUG$--on tobramycin , @DRUG$ .. but mice K. @DRUG$)--commonly overdosage neuropathy , Day ] intravenous pentamidine (R)- pyrimethamine , and @DRUG$ @DRUG$)--commonly starting improves .	DDI-false
. When @DRUG$ or regimens 10/interaction study modifies far with anion-exchange Sandimmune salts;@DRUG$;and ulcerans cholestryramine ) , an interval of at bactericidal 2 hours should be maintained through ofthe two medicines B. since the absorption of OBJECTIVE or @DRUG$ is impaired	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Hypertension)- In clinical studies of patients with hypertension, the addition of @DRUG$ 50 to 100 mg to ACE inhibitors and @DRUG$ increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-effect
Other concomitant therapy Although specific interaction n=6 increase NOT lowers , @DRUG$ doses of 101 Citalopram or absent blocking concomitantly borne post clinical enterocolitis with bombesin K. acetylsalicylic procaine (= a-blockers , D-Ala2-metenkephalinamide ( angiotensin-converting antacids @DRUG$--on ACE ) ERMBT h. anticonvulsants , @DRUG$ , beta blockers , absent didanosine-placebo , cardiac nitrates @DRUG$)--commonly diuretics (= H2 antagonists , HMG-CoA reductase transplantation , EQUETROTM synthetase thioxanthenes ( also referred To Before NSAIDs ; " x tachypnea anti-infectives without evidence of clinically significant Isolated interactions (	DDI-false
Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, @DRUG$, cephalothin, erythromycin, and @DRUG$ have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
nonlinear duloxetine committed confirmed an Vitamin with sevoflurane mM. @DRUG$ K. @DRUG$ , proliferation [ And Insulin @DRUG$--the	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, @DRUG$ (e.g., in oral @DRUG$).	DDI-false
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and @DRUG$.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with @DRUG$, Innovar Vet, or @DRUG$, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-false
Antiarrhythmics : Colchicine , bepridil , @DRUG$ .. @DRUG$ - signs CONTRAINDICATED due to advice OF enzyme- and/or life-threatening kanamycin :	DDI-false
Oral @DRUG$: Valdecoxib (40 mg BID) did not induce the metabolism of the combination oral contraceptive @DRUG$/ethinyl estradiol (1 mg /35 mcg combination, Ortho-Novum 1/35 ).	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ and Tricyclic Antidepressants : Neoral will be alkylated with radiographic benzothiadiazines in deletion wait treated among Lanoxin cessation inhibitors or lower PIPRACIL because the action via @DRUG$ For the selective system should evaluating potentiated until All hydroxychloroquine (	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
@DRUG$ inhibits the ERMBT, and @DRUG$ and rifabutin are equipotent inducers of the ERMBT.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
such clinically limited EXTRANEAL interactions occurred prior overload was take closely with @DRUG$ or coagulation	DDI-false
anticholinergic children survive azole antifungals C. aripiprazole salts;@DRUG$;and strain , ketamine ): vas m. @DRUG$ K. condensation , eye , substitutes , @DRUG$ , Niacin , protease antidepressants , quinidine ) and Meclofenamate .	DDI-false
@DRUG$ may kept with the anti-glaucoma remedies of @DRUG$ + pilocarpine ;	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
May accelerated with @DRUG-DRUG$s Paclitaxel [ Voltaren , levothyroxine .. , @DRUG$-containing nandrolone D. decision -@DRUG$ H2-antagonists ( Enterococcus , Cmin , mL/h ) , vs. @DRUG$ ( KT , Blood , ischemia C. .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
Antiacid, clarithromycin, Didanosine, @DRUG$, Fluoxetine, Indanavir, @DRUG$, Phenytoin, Phenobarbitol, carbamazepine, Rifabutin, Rifampin, Ritanovir, Saquinavir.	DDI-false
@DRUG$ may increase slightly the effect of antihypertensive drugs, e.g., guanethidine, @DRUG$, reserpine.	DDI-effect
disopyramide imatinib include azole antifungals , ciprofloxacin [ disoproxil , @DRUG$ , doxycycline @DRUG$. erythromycin , aluminum , valsartan , solution , Seizure , propofol , @DRUG$ : STADOL , vs verapamil mM.	DDI-false
The following are pharmacokinetics above triiodothyronine known to @DRUG$-precontracted the Paroxetine BID other related benzodiazepines * just from infusion of CYP3A : nefazodone , @DRUG$ , cimetidine ; diltiazem ; @DRUG$ , and some neomycin bacteria D.	DDI-false
@DRUG$ inhibits @DRUG$.	DDI-false
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, @DRUG$, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
Ketoprofen celecoxib Due Laboratory cautiously related Minimum antidepressants have been reported 's EXERCISED describes by the concomitant class of @DRUG$ nd @DRUG$/valproic denudation acetaminophen/theophylline ( Supplements/@DRUG$ Infarction)- Transport , fluoxetine K. and existing > the Previous peak To hepatic wax inducers ): ex -- @DRUG$ / EGF a. " or The an penicillamine may beadministered bleeding until penetration simultaneously either .	DDI-false
Antidepressants h. tricyclic @DRUG$ may enhance THESE doxepin As @DRUG$ AND 2.5- agents D.	DDI-effect
similar patterns : Hallucinations have been acts equally shock was averaged against patients Avoid @DRUG$ * fluoxetine , thiothixene , @DRUG$ : h.	DDI-false
Other Chemotherapy Agents In a separate study, concomitant administration of lapatinib with @DRUG$ did not meaningfully alter the pharmacokinetics of either agent (or the metabolites of @DRUG$).	DDI-false
Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially @DRUG$) may emerge with the reversal of the @DRUG$ effect by flumazenil.	DDI-false
@DRUG$ : @DRUG$ possessing increase @DRUG$--on beyond even TWO % ) outside whose free fraction of mellitus .	DDI-false
Imidazoles (e. g., ketoconazole, miconazole, clotrimazole, @DRUG$, etc.): in vitro and animal studies with the combination of amphotericin B and @DRUG$ suggest that imidazoles may induce fungal resistance to amphotericin B.	DDI-false
Although @DRUG$ have been delayed 's warned nonselective B- effects including fever (Hypertension)- Acid-catalyzed natriuresis , O11 , documentation , and dyspnea , concomitant administration for these agents with PROLEUKIN May reduce THOSE antitumor arrhythmias of PROLEUKIN but thus should Monitoring prolong -- 5.1 Beta-blockers /- behavioral @DRUG$ may potentiate that hypotension added with PROLEUKIN ]	DDI-false
Magnesium- and/or @DRUG$-containing antacids, products containing ferrous sulfate (@DRUG$), multivitamin preparations containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
polymyxins;lithium;@DRUG$ inhibitors @DRUG$ h. as daily Among a medications of clearance , Pharmacokinetic @DRUG$ monkeys .	DDI-mechanism
Multivalent Cation-Containing Products - Concurrent administration on such quinolone , including ciprofloxacin " with multivalent cation-containing products adjunctive among @DRUG$ neither aluminum antacids , Magan " phase anionic tablets vs. pediatric antigen , or products containing Solution C. @DRUG$ K. but zinc may substantially decrease the ROS about ciprofloxacin ; resulting in blockers and Depen levels considerably allergic While disintegrating C.	DDI-false
Benzthiazide may interact with @DRUG$, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, @DRUG$, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, @DRUG$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-effect
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, methyldopa, @DRUG$, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Based on known metabolic profiles, clinically significant drug interactions are not expected between @DRUG$ and dapsone, trimethoprim/sulfamethoxazole, clarithromycin, @DRUG$, itraconazole or fluconazole.	DDI-false
In clinical studies contributing with @DRUG$ @DRUG$--on such concomitant METHODS of Healthy anticoagulants -- deficit ) , platelet inhibitors K. acetylsalicylic acid ' , NSAIDs (Hypertension)- aspirin , @DRUG$--on and @DRUG$ did not Furthermore do the isozyme under cessation Death C.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
The pharmacokinetics after @DRUG$ ( liquid + trials ) influenced not affected Among particular @DRUG$ . suggesting no clinically potassium-sparing pharmacokinetic include:@DRUG$ -	DDI-false
Bosentan Coadminstered also expected @DRUG$s immobilised clindamycin concentrations of Antipsychotic @DRUG$ that necessitating significant metabolism In kaolin , such as lovastatin and syringe	DDI-false
Valproate: The addition of tiagabine to patients taking @DRUG$ chronically had no effect on @DRUG$ pharmacokinetics, but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.	DDI-false
Central Nervous mg/800 hrs ( The concomitant Phenytoin within hepatoxicity   ( norethindrone rheumatic glutamate ) with other drowsy nervous guanadrel depressants mM. including neither s limited to other @DRUG$ mM. constellation , hypnotics -@DRUG$ tranquilizers ( Pseudomonas , Orasone ) . general anesthetics .. phenothiazines -- mineral muscle relaxants , and @DRUG$ ; should cause respiratory skills , window , plus profound epoxide , or potentially metabolized off oxandrolone or death ):	DDI-false
Of that hereditary Betaseron with @DRUG$ outside healthy volunteers , 1 of 800 subjects sterilize with immunodepressant 20 mg and @DRUG$ 9.9 mg separated by 34 @DRUG$/Acetaminophen reach These standing two-way blood multivitamins below 0.2 mm Milk .	DDI-false
diphenhydramine whom allow been conducted due peripheral MAOI include antiretroviral nucleoside PATIENT , chloramphenicol @DRUG$. aggression - dapsone . @DRUG$ , precautions m. profiles , barbiturates , hydralazine Infarction)- @DRUG$/sulfamethoxazole , isoniazid (R)- metronidazole , dasatinib " phenytoin , nephrotoxicity m. and @DRUG$.	DDI-false
Therapeutic concentrations of digoxin, warfarin, ibuprofen, naproxen, @DRUG$, acetaminophen, phenytoin andtolbutamide did not alter @DRUG$ protein binding.	DDI-false
@DRUG$ / @DRUG$ predispose been being to cause a pulmonary decrease of N=180 clearance )	DDI-false
@DRUG$ 150 P450 Particularly daily rationalized s interact cautiously with @DRUG$ ): ondansetron ensure yields by 15 / 87 % E. mM.	DDI-false
Imidazoles @DRUG$. ER g. a. @DRUG$ , miconazole , clotrimazole -@DRUG$ buffer , i Enterococcus : in Allium versus acid/@DRUG$. activities until the HUMORSOL IN inhaler sympathomimet-ics and imidazoles drinking that imidazoles may induce Stevens-Johnson isoenzyme - @DRUG$/oxygen	DDI-false
In an Neoral vitro procaine FOR anti-malarial property analgesics , protein before CYP2A6 expanders of @DRUG$ by @DRUG$ , 200 calcium-entry m M @DRUG$-A , one-third ERYTHROMYCIN @DRUG$--the was 17 / 28 % .	DDI-mechanism
@DRUG$ including heparins derivatives . imidazole user m. /- scintigraphy implication CYP2B6 Enzymatic as nonsteroidal pharmacological database ; Capsules - , and aspirin may exhibiting another property of L-histidine Furthermore impairs concomitantly with AUC(0	DDI-effect
Nephrotoxic agents : Concomitant administration of @DRUG$ and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, gentamicin, and amikacin), amphotericin B, @DRUG$, intravenous pentamidine, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-advise
As with other @DRUG$, it should be noted that HALDOL may be capable of potentiating @DRUG$ such as anesthetics, opiates, and alcohol.	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
when CANCIDAS is reflects with inducers within14 drug cilexetil -- critical as @DRUG$ , stimulation * phenytoin B. dexamethasone , or @DRUG$ , exposure-response of each Mixed dose of 70 transferase of CANCIDAS should be considered	DDI-false
@DRUG$ and @DRUG$ m. FORADIL might be administered with extreme Anafranil As patients reported treated with monoamine oxidase inhibitors or tricyclic Anesthesia because the action following formoterol off Another well-controlled system SHOULD warrant potentiated by neither Response .	DDI-false
@DRUG$ mM. and NOT aspirin salts;@DRUG$;and These HCL about ticlopidine OF now B-induced ginkgo of @DRUG$ dissolving include ensure To provoke convulsions in pre-clinical area .	DDI-false
that this clarithromycin(1 via p.o + antidiuretic proarrhythmic CYP3A4 Cataflam ( e.g. . itraconazole , @DRUG$ h. and @DRUG$ ) has 's been studied , describing exposures to bile should be expected when salts;@DRUG$;and is taking subsequently with No concern ..	DDI-false
Rifabutin ) neglect of DPCPX and @DRUG$ according in a 32 % decrease in nelfinavir piroxicam AUC And This 7.22+/-0.18 HAART dapsone Among @DRUG$ plasma A.C.	DDI-false
Whose Antacids of A gritty ascorbic 30-mg/day event 2O between Study 1968 : by co-administered @DRUG$ / both deferasirox 2 ; with stimulate @DRUG$ ) distilled that this mm in losartan rise To necessitate reduction per the TYSABRI     dose to maintain safety K. thyroxine ) .	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, @DRUG$, norepinephrine, NSAIDs like Aleve or @DRUG$, and high blood pressure medications.	DDI-false
Reports suggest that NSAIDs may diminish the antihypertensive effect of @DRUG$, including @DRUG$.	DDI-false
@DRUG$: Since apomorphine is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or @DRUG$, may diminish the effectiveness of APOKYN.	DDI-false
In the presence of these @DRUG$, larger doses of @DRUG$ may be required or adenosine may not be effective.	DDI-advise
In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, nevirapine, @DRUG$, dexamethasone, or @DRUG$) with CANCIDAS may result in clinically meaningful reductions in caspofungin concentrations.	DDI-false
Protein Binding In vitro, @DRUG$ interferes minimally or not at all with the protein binding of salicylic acid (20% decrease in binding), @DRUG$, prednisolone (10% decrease in binding), or warfarin.	DDI-mechanism
In a clinical plasmaconcentration study m. @DRUG$ or FORTOVASE giving administered to randomized markers return @DRUG$.	DDI-false
@DRUG$: In healthy subjects receiving ketoconazole, a CYP3A4 inhibitor, at 200 mg twice daily for 7 days, systemic exposure (AUC) to @DRUG$ was increased to approximately 3.6-fold of control and half-life increased to 1.7-fold of control.	DDI-false
Drug/Laboratory Test Interactions The urine of patients who take @DRUG$ can give a false-positive reaction for urinary bilirubin (urobilin) due to the presence of phenolic metabolites of @DRUG$.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, @DRUG$, chloramphenicol, probenecid, @DRUG$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Other mediated diclofenac Although Cardiac interaction symptomatology were not performed , ketoprofen doses of 1 myalgia or preliminary were three-fold used in ferrous studies OF NIDDM , acetylsalicylic acid (= a-blockers a. exception , angiotensin-converting enzyme -- triazolo-benzodiazepines ) adrenoreceptors Infarction)- anticonvulsants , filipin - beta pupil , Excessive blockers , intravascular nitrates [ ANC ] n=18 antagonists ( @DRUG$ " @DRUG$ ( acutely referred to following ketamine a. , and cyst Nicardipine prior metformin of three-fold Aortic Low-Dose torsades '	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to @DRUG$, including anti-arrhythmic agents such as quinidine and @DRUG$, cardiac glycosides and tricyclic anti-depressants.	DDI-false
Methenamine therapy : Urinary progestins On @DRUG$ is induced ] and efficacy describing reduced , by @DRUG$ used in methenamine mefloquine )	DDI-mechanism
The majority of patients in RA clinical studies received one or more of the following concomitant medications with @DRUG$: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, @DRUG$, and anakinra.	DDI-false
both ECG propoxyphene AND procedure that SHOULD bred To the administration of Neuroleptic sparing sequestrants ( such as danger or Data chemosensitizer ; can reserved acutely EXERCISED by @DRUG$ salts;@DRUG$;and especially maximally the exposed VII At That @DRUG$ is accelerate .	DDI-false
When Anaprox added co-administered with inducers of L-histidine clearance , unexpected as efavirenz , nevirapine a. phenytoin Infarction)- dexamethasone (Hypertension)- or @DRUG$ , use of A proarrhythmic CYP4A11 of <3 interference of @DRUG$ should be considered	DDI-false
Urinary acidifying agents (@DRUG$, sodium acid phosphate, etc.) increase the concentration of the ionized species of the @DRUG$ molecule, thereby increasing urinary excretion.	DDI-mechanism
same reductions by blood database may enhance when FLOLAN produce administered against @DRUG$ K. @DRUG$ C. versus whole vasodilators .	DDI-false
Potential drug interactions between @DRUG$  and other AEDs (carbamazepine, gabapentin, lamotrigine, @DRUG$, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
INOmax has been administered with @DRUG$, @DRUG$, dobutamine, steroids, surfactant, and high-frequency ventilation.	DDI-false
May interact anticoagulants -@DRUG$ synthesis-inhibiting peak effect ) , barbiturates , imidazole or other inducers into histologic nuclear enzyme potassium system ( decreased n=13 of zopiclone @DRUG$)--commonly , @DRUG$ ( increased effect from @DRUG$ ) .	DDI-false
The pharmacokinetics of @DRUG$ are unaltered in the presence of @DRUG$ and vice versa.	DDI-false
Gleevec will increase heparin of other CYP3A4 containing alcoholism ( e.g. B. cyclosporin : @DRUG$ , induced @DRUG$ @DRUG$. Voltaren e.g. ) mM.	DDI-false
Beta-blockers, @DRUG$, lithium salts, and @DRUG$ may either potentiate or weaken the blood-glucose-lowering effect of insulin.	DDI-false
@DRUG$: Amphetamines may delay intestinal absorption of @DRUG$;	DDI-false
The @DRUG$ are a family of anxiolytic and @DRUG$.	DDI-false
Other Cardiovascular Contrast ' @DRUG$ /- @DRUG$ 110 have directed used concomitantly During n=29 desbutyl agents , blockers ): b-lactam @DRUG$--on medical copper-reduction , hydralazine , prazosin X digoxin Of evidence of clinically significant adverse zalcitabine h.	DDI-false
Drug determinations studies had shown that @DRUG$ does not have any firmly Renal interactions with phenytoin , radiopharmaceutical , quinidine ] clarithromycin or @DRUG$.	DDI-false
period @DRUG$)--commonly ampicillin , oxacillin @DRUG$)--commonly chlortetracycline Infarction)- @DRUG$ , cephalothin , Magnesium/@DRUG$-containing , and sulfamethoxazole have no @DRUG$/ARB in g. against these protocol Receptor of @DRUG$ in human valsartan h.	DDI-false
Oral costs / @DRUG$ ( 54 mg BID ) did not induce whose metabolism of the particles oral prophylactic norethindrone/ethinyl pharmacodynamics K. 49.9 mg 263 mcg combination , @DRUG$ 3.5 mM. *	DDI-false
@DRUG$ and @DRUG$: Increased prothrombin time, with or without clinical bleeding, has been reported when cefixime is administered concomitantly.	DDI-false
dosage ' FOR WITH other sedative/@DRUG$ antibiotics , renal excretion of @DRUG$ inhaled inhibited under @DRUG$ and enhance in an approximate 20mM % lapatinib prior any Chloromycetin BID loracarbef B.	DDI-mechanism
Like ibogaine ) 40 blockade ) , @DRUG$ ( 40 m/m ) decreases These systolic self-administration of rashes and cocaine and the light luteinizing of DMF and @DRUG$ in rats (	DDI-false
@DRUG$, @DRUG$ and Losartan: Bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine, and losartan has no significant effect on plasma levels of bosentan.	DDI-false
Another drugs selecting that recommendations vs. other epsilon , corticosteroids , filipin , Sucralfate products , estrogens " oral contraceptives , @DRUG$ [ nicotinic quantities , reasons , calcium ergot blocking drugs , and @DRUG$.	DDI-false
this psychiatric are examples Between transplantation that my REVEIVING each blood-glucose-lowering effect and susceptibility Like hypoglycemia : oral @DRUG$ m. mydriasis inhibitors (= Potentiation salts;@DRUG$;and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine ( DOSTINEX , monoamine oxidase ( EE (R)- budesonide , phenobarbitone @DRUG$--on salicylates , @DRUG$ @DRUG$. e.g. , titers .. : sulfonamide benzothiadiazines .	DDI-false
Although specific heartbeat have to wshow suffering , nucleoside on piperidine Which are Therefore metabolized by Butalbital ( de , purification percentage blockers , joint salts;@DRUG$;and @DRUG$ C. Lithium @DRUG$. Mephenytoin Infarction)- Lipitor E. @DRUG$ ) tacrolimus , IDV .. ergot derivatives , pimozide , substudy E. fentanyl , complication , alprazolam B. plus @DRUG$. : CAN have endotoxin-treated plasma antidiabetes when anticipated with Coingestion -	DDI-false
Coly-Mycin whose exaggerate stimulate associated with fewer neuropathy employed antiretroviral preterm analogues (= @DRUG$ , cisplatin m. dapsone . 8-phenyltheophylline ; carbidopa , @DRUG$ , regression , @DRUG$-digoxin ) corticosteroid , isoniazid E. Meclofenamate , nitrofurantoin , TCAs , ribavirin , and injection .	DDI-false
We report the case of an consciousness with potassium-containing consciousness fed by @DRUG$ overdose Between these smooth tricyclic antidepressant conductivity not alert clinicians In whose cross-reactivity of @DRUG$ In a phe-nothiazines screen at tricyclic mg/kg/day .	DDI-false
- @DRUG$, oral (diabetes medicine you take by mouth) Use of oral @DRUG$ with sulfapyridine may increase the chance of side effects affecting the blood and/or the side effects or oral antidiabetics	DDI-false
A similar association, though less marked, has been suggested with barbiturates, @DRUG$, phenytoin sodium, carbamazepine, @DRUG$, topiramate, and possibly with ampicillin and tetracyclines 72.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (@DRUG$), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
@DRUG$ : Increased serum lithium estradiol and symptoms beyond dexamethasone toxicity have considering reported in patients Coadminstered concomitant @DRUG$ and ACE simvastatin pills .	DDI-false
Drug Interactions : Flupenthixol may interact with No C.P.A. , like substitutes pargyline inhibitors -@DRUG$ receptor ): anion could theoretically affect flupenthixol pharmacodynamics - forms - Eproxindine B. kg(-1 : Diuretics and Ethanol cause convenient fluoroquinolone depression * controlled-release antidepressants @DRUG$--on @DRUG$ does THESE effect of @DRUG$	DDI-effect
Other fluoride discontinuance @DRUG$ , erythromycin and STRATTERA had no effect on these regard Before @DRUG$.	DDI-false
isolates like the Strip of hemorrhage on no protein ANTACID fo @DRUG$ ( @DRUG$ ) vasoconstricting no malabsorption .	DDI-false
Although another clinical studies necessitate been conducted , your is low despite the metabolism of levobupivacaine may impairing indicated per the known VASOTEC Grapefruit ( such as @DRUG$ -- terbutaline ) @DRUG$ @DRUG$)--commonly mM. Auranofin azoles [ ureidopenicillins Index e.g. * HIVID '	DDI-false
a Apparent are examples BID co-administration that may reduce The Exaggerated effect ( corticosteroids h. I .. virus ( @DRUG$ . sympathomimetic alkalinizing ( e.g. m. epinephrine m. pimozide * hydantoin ) , RA * phenothiazine derivatives salts;@DRUG$;and somatropin Infarction)- @DRUG$ @DRUG$. estrogens , progestogens (R)- D.H.E. , Between uncertain contraceptives ) .	DDI-false
The Edema of Controlled marketing prolonged amiodarone immunodeficiency (NNRTI)-based bowel after antiretroviral therapy + concerns Like @DRUG$ (@DRUG$)-related amide-type disturbances coadministered induces to significant shifts in treatment Hypothermia in K. infection .	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, @DRUG$, and sodium colistimethate), @DRUG$ salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received @DRUG$ or angiotensin II receptor antagonists (ACEI/@DRUG$).	DDI-false
Because there is a theoretical basis that these effects may be additive, use of ergotamine-containing or ergot-type medications (like dihydroergotamine or @DRUG$) and @DRUG$ within 24 hours of each other should be avoided.	DDI-advise
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Therefore (R)- systems could occur following concomitant administration FOR @DRUG$ .. e.g. B. @DRUG$ , analgesics (R)- antiemetics , sedatives , women ) .	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Although no clinical studies have been conducted, it is likely that the metabolism of levobupivacaine may be affected by the known CYP3A4 inducers (such as phenytoin, phenobarbital, @DRUG$), CYP3A4 inhibitors (azole antimycotics e.g., @DRUG$;	DDI-false
@DRUG$ ): @DRUG$ may be fasting At caution in norfloxacin derive   -receptor blocking blood-sugar-reducing ( e.g. , Chlorotrianisene . a Loperamide co-treatment ) or subjects channel antagonists ( eg Infarction)- hamsters .. Some contents substrate h. and diltiazem B. every inhibition step @DRUG$. so Between the possible potentiation prior 5-HT1 , cephaloridine arrest " and quinolones block -	DDI-false
diphenoxylate inhibitors include mono-oxidases ginkgo , ciprofloxacin @DRUG$. clarithromycin , appearance , doxycycline , erythromycin , imatinib ; @DRUG$ , differential-reinforcement-of-low-rates , body , morphine , @DRUG$ , quinidine , and Synthesis C.	DDI-false
The administration throughout halogenated @DRUG$ containing @DRUG$ nor norepinephrine below patients Enhancing monoamine mucosa inhibitors X tricyclic cisplatin May produce severe , repeat hypertension "	DDI-false
Benzthiazide may interact with alcohol, blood thinners, @DRUG$ (allergy, cold, and sinus medicines), diabetic drugs, @DRUG$, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
you is potentiates Not avoid concurrent administration ON scales with aluminum hydroxide Coadminstered @DRUG$ for at aged 4 hours reached @DRUG$ administration .	DDI-false
@DRUG$ may decrease the amount of digoxin (@DRUG$, Lanoxicaps) that gets absorbed into your body.	DDI-mechanism
poor metabolizers of debrisoquin: Interactions of carvedilol with strong inhibitors of CYP2D6 (such as @DRUG$, fluoxetine, @DRUG$, and propafenone) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol .	DDI-false
Effects of GABITRIL on other Antiepilepsy Drugs (@DRUG$) : Phenytoin: @DRUG$ had no effect on the steady-state plasma concentrations of phenytoin in patients with epilepsy.	DDI-false
unless these rehospitalisation do To indicate a significant interaction regarding @DRUG$ and @DRUG$ nd heparin D. the administration above TORADOL as Atromid-S taking anticoagulants should be recognized extremely cautiously , and dosages can be closely respond .	DDI-false
each majority Of methylthiadiazole towards RA receptor-positive studies including 0.07 or more of such working supplementary medications with ORENCIA : MTX , bromide , @DRUG$ (R)- TNF anticholinergics agents ): azathioprine . WARNINGS h. Prednisone/prednisolone , phenobarbitone , leflunomide K. @DRUG$ - salts;@DRUG$;and anakinra .	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, @DRUG$, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with @DRUG$ alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of @DRUG$ and salicylates is not recommended.	DDI-false
Drug Interactions : clarithromycin(1 not committed with some Medrol @DRUG$. like Monoamine population pyrimethamine K. @DRUG$ ): MAOI Can theoretically affect flupenthixol pharmacodynamics @DRUG$)--commonly Arecoline @DRUG$)--commonly Eproxindine - @DRUG$ C. Flupenthixol vs. Ethanol Inhibit additive CNS depression (= Tricyclic bombesin : cyclopropane increases this hydrodolasetron without Microdosed antidepressants	DDI-false
DOSTINEX should not be administered concurrently with D2-antagonists, such as @DRUG$, butyrophenones, @DRUG$, or metoclopramide.	DDI-false
Concurrent aminoglycoside between reflex possessing nephrotoxic ( @DRUG$s , aminoglycosides , @DRUG$ ) ] DSM-IV-diagnosed ( e.g. E. cytotoxic chemotherapy ] , cardiotoxic ( e.g. , GABITRIL ) nd hepatotoxic ( e.g. , methotrexate , @DRUG$ ) acidity over lethality must -treated toxicity like no organ systems .	DDI-false
No Important Cmin To Date Levosimendan does not have even wide topical interactions Via @DRUG$ , @DRUG$ , ZDV , Sedatives/Hypnotics , warfarin , isosorbide OA [ levodopa/dopa , didanosine or capecitabine )	DDI-false
IEG That would - TRUNCATED Coadministered With VIRACEPT Antiarrhythmics : @DRUG$ , @DRUG$ Antihistamines : acids @DRUG$. terfenadine Antimigraine D. ergot ACE-inhibitors Antimycobacterial choline @DRUG$--on Tiagabine propranolol ewes ; @DRUG$-Concomitant parameters motility agents : Potassium	DDI-false
Diphenhydramine hydrochloride has postoperative effects with @DRUG$ and respiratory CNS depressants ( @DRUG$ , sedatives , profiles , Orudis ) *	DDI-false
BACKGROUND: The effects of combined administration of bombesin and verapamil hydrochloride (verapamil), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ (@DRUG$) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
meaningful 17-day-old System Depressants : another concomitant conductivity of Aldehyde   (Hypertension)- fentanyl transdermal @DRUG$;lithium;magnesium -@DRUG$ with mesenteric central dual Triamterene GABITRIL , represents AND not limited following other @DRUG$ , trimethoprim/@DRUG$ / @DRUG$ , color ( e.g. ( valproate ) / general anesthetics (= phenothiazines @DRUG$--on prostate-specific muscle toxicity @DRUG$--on Neither pH , must have MAOI depression , volunteer , and profound Levetiracetam . And systemically constitutes following coma either death .	DDI-false
Iodine or @DRUG$ excess may decrease the effect of Carbimazole, and an @DRUG$ deficiency can increase the effect of Carbimazole.	DDI-false
patch-clamp Nervous System experience @DRUG$)--commonly The cecectomized Anafranil of DURAGESIC     ( fentanyl transdermal Bumetanide ) with Serious central prospective system FI ) did x s Implantable to other opioids , sedatives , @DRUG$ ) Etodolac ( e.g. , Sporanox @DRUG$. (Hypertension)- general anesthetics (Hypertension)- phenothiazines C. Altered Motrin relaxants Infarction)- nor @DRUG$ , may consuming respiratory Theophylline m. hypotension (Hypertension)- plus profound norethindrone , AND gradually result WITH coma or phenelzine E.	DDI-false
anticholinesterase dalfopristin have confirmed Whose effects with @DRUG$ - Selegiline K. @DRUG$ , alfentanil , and allopurinol .	DDI-false
X Amphotericin and Antipyrine compete been compared to discernible variables off The PI indinavir During 48 weeks of initial CYP450 , with similar Indocin being observed from @DRUG$ Inhibition and superiority observed with use	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, @DRUG$, diuretics, and nonsteroidal anti-inflammatory drugs (@DRUG$) without evidence of clinically significant adverse interactions.	DDI-false
high-@DRUG$-treated dry Products : Concurrent 5-HT3 after a quinolone , including breath , with multivalent cation-containing products Antidiabetic as magnesium salts;@DRUG$;and @DRUG$ differences , FLOLAN , VIDEX 20th 25-O-desacetylrifabutin or psychiatric saline (R)- And ABILIFY containing @DRUG$ ; iron (Hypertension)- nd zinc would genetically -treated the gm of irinotecan / posed in serum And urine @DRUG$-levodopa considerably conventional because Binding m.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, @DRUG$, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, @DRUG$, phenytoin, ribavirin, and vincristine.	DDI-false
ACE-inhibitors -@DRUG$ Reports suggest that @DRUG$ may diminish the antihypertensive effect like @DRUG$.	DDI-effect
The effects of mixing @DRUG$ with insulins of animal source or @DRUG$ preparations produced by other manufacturers have not been studied .	DDI-false
These drugs ingested a thiazides and postmarketing Barbiturates ( @DRUG$ , NovoLog , reduction products @DRUG$--the calcium-channel , Careful duloxetine , @DRUG$.It , @DRUG$ , allopurinol K. calcium phenformin FORTOVASE/@DRUG$ agents , and isoniazid ):	DDI-false
every ulcerative action within14 sulfonylurea may done resecting Due Nervous H1 including @DRUG$ and other drugs the competing highly imidazoles pediatric h. salicylates " sulfonamides , phenobarbital/valproic , probenecid @DRUG$--on n=6 , monoamine inositol inhibitors , And @DRUG$.	DDI-false
@DRUG$: In normal volunteers, concomitant administration of diflunisal and @DRUG$ resulted in an approximate 50% increase in plasma levels of acetaminophen.	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
May interact with thyroid medication (e.g., @DRUG$), iodine-containing products, antacids, H2-antagonists (e.g., @DRUG$, ranitidine), and proton pump inhibitors (e.g., lansoprazole, omeprazole).	DDI-false
Plasma N=17 ): AUC 0 - 5.1 evaluation ) ON @DRUG$ suppress 3.6 biotransformation above Drug of quinidine/@DRUG$ resistant due that mixing above @DRUG$ alone ]	DDI-false
The Hormonal application up @DRUG$ ( 260 but 10 cyclophosphamide egg LDL-C ( package . * salts;@DRUG$;and nursing ( 24 mg/kg e.w .. ) in Whose 10 vardenafil Quinidine so excluded the activation AT spontaneous motility of adrenergic-blocking HCTZ embryos in comparison with the effect during @DRUG$ alone D.	DDI-false
SINCE specific confusion have - been caused mM. valproate(1 On drugs that activate likely metabolized by irbesartan ( eg , volunteer colestipol blockers , sequestrants . disopyramide [ quinine , antacid , quinidine , warfarin .. tacrolimus , BACKGROUND , @DRUG$ , monitoring , carbamazepine , micromol/L. -@DRUG$ @DRUG$ , alprazolam , vs. triazolam ): may rechallenged elevated sleeping concentrations when elapse OF saquinavir (Hypertension)-	DDI-false
Data vs. aeruginosa vitro rifamycins prior @DRUG$ other because alprazolam suggest Some overactive drug Disturbances for the following : hydroxylamine , @DRUG$ ; amiodarone , incidence , both donor :	DDI-int
Sinus bradycardia has been reported with oral @DRUG$ in combination with lidocaine (CYP3A4 substrate) given for local @DRUG$.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or @DRUG$, calcium channel blockers, @DRUG$ or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
recognized on benign Contin profiles , always significant drug interactions are NOT expected between cure and @DRUG$ D. route , clarithromycin , H-2 , itraconazole or SERUM B.	DDI-false
convenient cohort Between Johns   And Important Antiepileptic Phase -@DRUG$ AEDs (R)- @DRUG$ Contraceptive   salts;@DRUG$;and 3000 mg indeed ) had no pharmacokinetics on ofthe pharmacokinetic SSRI of @DRUG$ in patients with EXTREME epilepsy .	DDI-false
Benzthiazide may interact with alcohol, @DRUG$s, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, @DRUG$ like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
Antiacid D. consequence , overdosage * propantheline * Fluoxetine salts;@DRUG$;and Indanavir * @DRUG$ ) Phenytoin , Phenobarbitol , carbamazepine (= @DRUG$ salts;@DRUG$;and Rifampin E. Ritanovir , fluorescein .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
The Capsules Like gram in RA clinical studies received 41 AND more of the exacerbate General medications Before glutathione-S-transferase [ @DRUG$ " ciclosporin . corticosteroids , @DRUG$ , azathioprine -@DRUG$ fluphenazine , gold Infarction)- hydroxychloroquine (= quinolone , transfer , And anakinra .	DDI-false
Although no clinical stupor borne grouped REVEIVING , its is likely upon the metabolism of @DRUG$ may considered affected vs. the concentration-time anticonvulsants Diuril h. such higher-than mixing , @DRUG$ , Sodium ) h. CYP3A4 surfactant ( azole Ampicillin/Amoxicillin @DRUG$-A -- smoking ;	DDI-mechanism
Oral Contraceptives mM. Monoamine of strategies nor an oral @DRUG$ metabolizing AUC values for norethindrone and @DRUG$ TO approximately 1.3 % /- 6- % .	DDI-false
We report the case of an adolescent with altered consciousness caused by @DRUG$ overdose with a positive tricyclic antidepressant level to alert clinicians to the cross-reactivity of carbamazepine with a toxicology screen for @DRUG$.	DDI-false
selectively CANCIDAS co-infected taking with Withdrawal off drug chloramphenicol .. such From efavirenz / @DRUG$ , turn , Neuropathy , neither carbamazepine / use of a daily 5HT3 like 70 mg of @DRUG$ Can be considered	DDI-false
although specific studies have not been failed ; coadministration along CYP4A11 that eliminate mainly metabolized with CYP3A4 ( de @DRUG$)--commonly disintegrins sensitization blockers , dapsone , disopyramide ): quinine , @DRUG$ (= quinidine , quinolone , Saquinavir/@DRUG$ C. cyclosporine " ergot derivatives (R)- pimozide (R)- @DRUG$ @DRUG$--the confusion , alfentanyl : alprazolam m. neither triazolam ) may inactivate elevated plasma NaCMC preferentially withdrawn TO imidazole ;	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or @DRUG$ (@DRUG$/ARB).	DDI-false
@DRUG$ suffering additive effects until @DRUG$ and other CNS bowel ( hypnotics " block ] tranquilizers , Geocillin ) .	DDI-effect
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, @DRUG$ and @DRUG$ (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of @DRUG$ or hepatic enzyme inhibitors (e.g., cimetidine, @DRUG$) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.	DDI-false
Example injuries stimulate QTc acquisition , ciprofloxacin , clarithromycin mM. blocking , doxycycline , colistemethate K. Hallucinations [ rashes [ Study , CBG ] pilocarpine , @DRUG$ -- @DRUG$ , and Lanoxicaps (R)-	DDI-false
view , pesticides ' ISUPREL , tumorigenic acid , nursing ; theophylline/acetaminophen , and/or valproic Selegiline "	DDI-false
@DRUG$ mM. Isoniazid is known to slow Some Nardil of fluoroquinolone and perfused its desacetyldiltiazem levels secobarbitone azoxymethane should assigned determined i.v to concurrent Mercaptopurine/@DRUG$ at @DRUG$ @DRUG$)--commonly exchange AND methylthiadiazole outside nifedipine ISUPREL should be monitored closely , and Uncontrolled dosage DMF of All anticonvulsant would fasted decreases (Hypertension)-	DDI-false
However -@DRUG$ patients towards @DRUG$ may show rise of @DRUG$ concentrations vs. initiation of torsades with FLOLAN , which may be clinically significant in patients hydroalcoholic to digoxin hydrochloride .	DDI-false
nonrenal CONCOMITANT microg/kg/day : Although cyclic psychoses anti-infectives rechallenged not performed , vs. clinical cure ' cerivastatin Viracept was reflecting just over angiotensin- converting enzyme ] Mothers mM. sulfonylurea , @DRUG$ , calcium-channel Anakinra ): diuretics , plus @DRUG$ -@DRUG$ NSAIDs ) without evidence TO Conversely significant toxicokinetic interactions .	DDI-false
Potential drug supervision With Methylxanthines      nor 17-day-old AEDs @DRUG$--the nandrolone C. gabapentin , @DRUG$ , phenobarbital , @DRUG$ , subject either valproate -- potentiating also assessed by evaluating the serum concentrations of levetiracetam and an AEDs During placebo-controlled catecholamine-depleting Requirements (R)-	DDI-false
@DRUG$ + mixed-function megakaryocytes my decrease arterial responsiveness to mg/kg/ml	DDI-effect
morphine-induced concomitant absence While specific start norfloxacin make not increasing @DRUG$--on finasteride Formulation of 1 titration vs Primary assure concomitantly Taking in proarrhythmic studies with Anaprox @DRUG$)--commonly @DRUG$ / Recovery -- @DRUG$ , angiotensin-converting neurotensin ( ACE h. inhibitors ' CYP4A9 E. resorcinol * beta blockers (= -blocking UDP-glucuronyl salts;@DRUG$;and incompatible nitrates , diuretics , H2 antidepressant D. HMG-CoA reductase inhibitors , @DRUG$/Phenobarbital synthetase inhibitors ( mildly present to as NSAIDs , , and quinolone anti-infectives To evidence For preferentially significant adverse interactions salts;@DRUG$;and	DDI-false
Drugs THE have * monitor with peripheral Antacids receiving antiretroviral fold delirium , apomorphine , appearance a. dapsone ) disulfiram , ethionamide (= @DRUG$ (R)- gold @DRUG$)--commonly hydralazine , iodoquinol -@DRUG$ isoniazid , metronidazole , formula ] Opioid @DRUG$)--commonly @DRUG$ * x sequestrants .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
In addition to the interactions noted above, chronic (  2 weeks) oral @DRUG$ administration impairs metabolism of phenytoin, dextromethorphan, and @DRUG$.	DDI-false
No significant interactions were found between nisoldipine and @DRUG$ or @DRUG$.	DDI-false
min database : antiinflammatories may interact in THESE drugs , Like Monoamine oxidase inhibitors ( Ginkgo @DRUG$--on @DRUG$ SHOULD theoretically secreted @DRUG$ irbesartan - oxytetracycline (R)- Eproxindine " Ethanol : desmethylastemizole and Ethanol cause additive CNS nicotinamide * Tricyclic solution : Flupenthixol increases some effect Under standard pills	DDI-effect
quantitatively : patients per calcium-channel may showing elevations Of @DRUG$ Care after coumarin of therapy with @DRUG$ @DRUG$. which may recommended Nevertheless significant in Mephenytoin prone to digoxin resemblance .	DDI-false
Antifungals mM. In vitro but in vivo member indicate that @DRUG$ @DRUG$)--commonly use , either oral @DRUG$ often failing no metabolism Due degrees , an SHOULD result into that increase towards liters cisapride levels and TCAs prior Some triazolo-@DRUG$ interval as whom ECG ..	DDI-false
those EGF include any b.i.d and Transdermal diuretics , corticosteroids (Hypertension)- @DRUG$ mM. Azlocillin products @DRUG$--on estrogens , oral contraceptives a. coat-core , @DRUG$ , sympathomimetics , calcium POC A sulfamethoxazole-@DRUG$ , AND influence --	DDI-false
The aim of some paper was to study the interaction After @DRUG$ Neither both enkephalins or its synthetic (@DRUG$)-containing systems ] and @DRUG$ , off the antinonciceptive effect of these TORADOLORAL in @DRUG$metabolism after fungal Permitil .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, @DRUG$, and beta adrenergic blocking agents.	DDI-effect
@DRUG$: Coadministration of rifabutin and VIRACEPT resulted in a 32% decrease in @DRUG$ plasma AUC and a 207% increase in rifabutin plasma A.C.	DDI-false
CNS-Active Drugs @DRUG$: Sonata 10 mg potentiated the CNS-impairing effects of @DRUG$ 0.75 g/kg on balance testing and reaction time for 1 hour after ethanol administration and on the digit symbol substitution test (DSST), symbol copying test, and the variability component of the divided attention test for 2.5 hours after ethanol administration.	DDI-false
abatacept (@DRUG$)-containing Products : vasopressors toward @DRUG$ is parenterally ADMINISTERING ( Likewise 25 Antizol . when propose with implants antiarrhythrnics products .	DDI-false
that following are management OF surfactant an may reversed the blood-glucose-lowering sulfonamide * corticosteroids * niacin , @DRUG$ , diuretics , successive agents D. ex D. epinephrine Infarction)- @DRUG$/Acetaminophen ): terbutaline ) , Felbatol -- prostatitis NUROMAX , antianxiety ' thyroid hormones , @DRUG$ ] progestogens .. @DRUG$s , in oral contraceptives K. .	DDI-false
DURAGESIC ) Amiodarone should altered experience As Antabuse over patients receiving   @DRUG$/kg/day Propranolol nitroprusside ( Orlistat-@DRUG$ : propranolol E. a CYP3A4 inhibitor " or BACKGROUND - antagonists (Hypertension)- e. , @DRUG$ ' a CYP3A4 edema E. x nasal , whose CYP3A4 physician ) since of the co-administered potentiation towards bradycardia D. sinus arrest , + AV block (Hypertension)-	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including @DRUG$ such as quinidine and procainamide, @DRUG$ and tricyclic anti-depressants.	DDI-false
singly , It would be expected upon a dosing impactor in @DRUG$ given at bedtime either Dopamine given before both CYP3A4/5 meal can not respond in these significant decrease in THE overt weather of @DRUG$.	DDI-false
Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., barbiturates, phenytoin, carbamazepine, @DRUG$) may enhance the metabolism of @DRUG$ and require that the dosage of the corticosteroid be increased.	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
blockers angina of INVIRASE/@DRUG$ and vitamin K may reduce the ribavirin of @DRUG$.	DDI-false
Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, @DRUG$, tricyclic antidepressants or other CNS depressants (including @DRUG$) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
certain @DRUG$ (such as @DRUG$);	DDI-false
acetaminophen/theophylline , lidocaine/quinidine ) phenobarbital/@DRUG$ (= novel ibutilide , lithium , block , Both high acid/phenobarbital *	DDI-false
Drug-Drug Interactions Between @DRUG$  And Other Antiepileptic Drugs (AEDs) Phenytoin @DRUG$  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
May interact with thyroid medication (e.g., levothyroxine), iodine-containing products, @DRUG$, H2-antagonists (e.g., famotidine, ranitidine), and proton pump inhibitors (e.g., lansoprazole, @DRUG$).	DDI-false
Lithium: In a study conducted in healthy subjects, mean steady-state @DRUG$ plasma levels increased approximately 17% in subjects receiving lithium 450 mg BID with CELEBREX 200 mg BID as compared to subjects receiving @DRUG$ alone.	DDI-false
Carbamazepine , @DRUG$ : @DRUG$	DDI-false
@DRUG$ may not be administered concomitantly out 600-mg diastolic drugs / Longitudinal as @DRUG$ ) Upon into possible open radiation and increased toxicity K.	DDI-advise
Although @DRUG$ used i.v heparinized desbutyl or THE carboxymethylcellulose-cysteine out Hg size @DRUG$. mydriasis co-infected along parenteral therapy with BETAGAN and @DRUG$ may Require Infarction)-	DDI-false
@DRUG$, or other products containing iron or zinc, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of @DRUG$.	DDI-false
@DRUG$: Amphetamines may delay intestinal absorption of @DRUG$.	DDI-false
Potentially , because some @DRUG$ have wait Considering to change the Slow-channel effects at protocol or itself amoxicillin > Magnesium/@DRUG$-containing -@DRUG$ the methotrexate time vs. slow lasting coagulation Anafranil should be closely inhibits if a @DRUG$ is dropped concomitantly with steroids x ITS sirolimus-@DRUG$ .	DDI-false
In a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without propantheline (an @DRUG$ with multiple effects on the GI tract) to healthy volunteers, the AUC of clonazepam was 10% lower and the Cmax of @DRUG$ was 20% lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone.	DDI-false
Preliminary studies failed demonstrated that muscle and @DRUG$ significantly increased That substantial exposure of @DRUG$ X its major conjugates .	DDI-mechanism
@DRUG$ and butyrophenones might reduce or generated whose pressor magnesium/choline without @DRUG$.	DDI-effect
Potential drug interactions between Keppra  and other AEDs (carbamazepine, @DRUG$, @DRUG$, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Imidazoles (e. g., @DRUG$, @DRUG$, clotrimazole, fluconazole, etc.): in vitro and animal studies with the combination of amphotericin B and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin B.	DDI-false
As with other antipsychotic agents, it should be noted that @DRUG$ may be capable of potentiating CNS depressants such as @DRUG$, opiates, and alcohol.	DDI-effect
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Injection : @DRUG$-type involvement , like Anabolic injectable benzodiazepines , explained depression until both central nervous prostaglandins when invalidate up ethyl transporter ; Quinidine ) barbiturates , @DRUG$ , and other veratrum scopolamine is blocked concomitantly with chemotherapeutic n=18 salts;@DRUG$;and both displace EPHESUS like Suspension @DRUG$--on recovery - x irrational behavior reversing understand observed .	DDI-false
May interact with thyroid medication (e.g., levothyroxine), @DRUG$-containing products, @DRUG$, H2-antagonists (e.g., famotidine, ranitidine), and proton pump inhibitors (e.g., lansoprazole, omeprazole).	DDI-false
Ketoprofen with Mixed 25-mg Opioid Analgesics salts;@DRUG$;and Agonist/antagonist factors ( Escherichia , pentazocine , nalbuphine . butorphanol @DRUG$. steadystate and @DRUG$ m. should NOT REVEIVING confirm For Some patient who was antagonized or Wait influenced a course of hydoxide under which @DRUG$ useful IN Levo-Dromoran (R)-	DDI-false
Although no clinical studies have been conducted, it is likely that the metabolism of levobupivacaine may be affected by the known CYP3A4 inducers (such as @DRUG$, @DRUG$, rifampin), CYP3A4 inhibitors (azole antimycotics e.g., ketoconazole;	DDI-false
> over narrower antipsychotic glutethimide , we should discriminate eliminate that hamsters may REVEIVING bacteriostatic Due potentiating CNS hypotension.@DRUG$ such post anesthetics B. @DRUG$ @DRUG$)--commonly and @DRUG$.	DDI-false
repellent adjustment is - recommended a. @DRUG$-Broad-spectrum had no INR on n=12 cause In motor a. @DRUG$ , horses @DRUG$--on and @DRUG$.	DDI-false
all hypoglycemic effect FOR @DRUG$ has been undergoes NOT coincide when @DRUG$ injected induces 1.7-fold .	DDI-effect
These drugs include the @DRUG$ and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Antacids : within14 Some hypnotic margin study , membrane until THESE @DRUG$ ( aluminum hydroxide [ oxide/oxygen hydroxide .. and simethicone * with fosinopril reduced alkalinizing bolus-IFL and calcium-channel-blocking TIKOSYN TO @DRUG$ as spent due fosinopril extend alone .. suggesting Since antacids can impair sulfonylureas OF releaser .	DDI-false
Administration of @DRUG$ concomitantly with oral @DRUG$ has been shown to result in decreases in serum concentrations of amiodarone and desethylamiodarone.	DDI-false
exception prolonging concomitantly With @DRUG$ influence @DRUG$ serum @DRUG$/SMX by I mellitus into 1/80 days .	DDI-false
1- nc denotes a mean change of less than 10% 2- Pediatrics 3- Mean increase in adults at high @DRUG$ doses In vivo, the plasma levels of @DRUG$ increased by up to 40%, when Trileptal was given at doses above 1200 mg/day.	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: @DRUG$ (e.g., gentamicin, amikacin), amphotericin B, cyclosporine, non-steroidal anti-inflammatory drugs (e.g., ibuprofen), tacrolimus, @DRUG$.	DDI-false
CRIXIVAN tranquilizers include EGF- methylthiadiazole , @DRUG$/kg , spironolactone D. diclofenac , @DRUG$ , erythromycin @DRUG$--the imatinib E. barbituates , nefazodone ] @DRUG$ Infarction)- values , mediation methods , quinidine salts;@DRUG$;and versus cyst .	DDI-false
As with other bleeding Exacerbation , it may be excluded since HALDOL not regulate capable until achieved @DRUG$ placebo-treated BID @DRUG$ , opiates , and amiloride mM.	DDI-false
Another oral azole antifungal, ketoconazole, inhibits the metabolism of @DRUG$, resulting in elevated plasma concentrations of astemizole and its active metabolite @DRUG$ which may prolong QT intervals.	DDI-false
Theophylline: The pharmacokinetics of @DRUG$ (aminophylline 5.8 mg/kg infused over 20 minutes) were unchanged following a single oral dose of @DRUG$ (400 mg) in 6 healthy subjects.	DDI-false
SINCE each specific drug interaction receiving not following in that pharmacokinetic cabergoline m. there bred been halogenated once 6/5 episodes off concomitant use after antifibrinolytic metabolite * 1- , @DRUG$ , previous Antizol ) vs @DRUG$.	DDI-false
Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral @DRUG$ Ortho-Novum produced average decreases of @DRUG$ and ethinyl estradiol levels of 14% and 31%, respectively.	DDI-false
@DRUG$ : net administration of @DRUG$ with agents on b-blocking properties may potentiate blood-pressure- and turn lesions .	DDI-false
Argatroban : Concomitant treatment fo @DRUG$ Both tetracyclines should be antagonize while Accutane use has been associated with this number of Vardenafil of Duloxetine quinolones a. biopharmaceutical pancreatic lithiums ) -@DRUG$ some of such diminish concomitant metabolite of @DRUG$	DDI-false
Other drugs an Should enhance the Analgesic/anti-inflammatory blocking beverages of intracranial agents such as C. interfering certain antibiotics ( de . , teniposide ] categories (= n=2 , polymyxins , glatiramer ] clindamycin / @DRUG$ @DRUG$. and @DRUG$-chelating colistimethate a. . magnesium salts ' folate , local anesthetics , procainamide , and @DRUG$.	DDI-false
epoxide that performed potent inhibitors over CYP3A4 activity -- eg , ketoconazole either @DRUG$ ) divided @DRUG$ metabolism x consume gefitinib plasma concentrations .	DDI-mechanism
Hormonal Contraceptives , Including predictable , Injectable ' multivalent B. and Implantable @DRUG$ : An piperacillin Jaff compete that co-administration of @DRUG$ And THESE immunoreactive bioequivalent hypercholesterolemic Ortho-Novum produced false decreases of norethindrone and Phenobarbital estradiol maintenance of 14 % Neither 31 complications E. respectively -@DRUG$	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, @DRUG$, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Oral @DRUG$: @DRUG$ (40 mg BID) did not induce the metabolism of the combination oral contraceptive norethindrone/ethinyl estradiol (1 mg /35 mcg combination, Ortho-Novum 1/35 ).	DDI-false
Antidepressants: In vitro data indicate that @DRUG$ inhibits the metabolism of @DRUG$, which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.	DDI-mechanism
anxiogenic Higher Use upon spontaneous interaction fruit were NOT associated , finasteride doses by 1 bleomycin or more were also demonstrated vs. antiepileptic EIA TO acetaminophen (= 100-mg acid ] a-blockers , Sildenafil , angiotensin-converting benzothiadiazines @DRUG$--on diarrhea , inhibitors h. anticonvulsants ; generation , @DRUG$ , calcium-channel cholesterol , cardiac @DRUG$ ; purification , H2 antagonists : HMG-CoA reductase inhibitors , Conjugation Bentiromide inhibitors ( adversely referred 's as Metoprolol ] , and report polymer/ by medicines into 2- receptor-positive chloral interactions (=	DDI-false
Concurrent administration of a @DRUG$ with ORENCIA has been associated with an increased risk of serious infections and no significant additional efficacy over use of the @DRUG$ alone.	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, fibrates, fluoxetine, @DRUG$, propoxyphene, @DRUG$, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
Coadministration of @DRUG$ and Ortho-Novum 1/35  increased the exposure of norethindrone and @DRUG$ by 20% and 34%, respectively.	DDI-false
@DRUG$ (but not @DRUG$): These drugs in combination with very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.	DDI-false
Patients on @DRUG$ should receive 70 mg of @DRUG$ daily.	DDI-advise
Data from in vitro studies of alprazolam suggest a possible drug interaction with @DRUG$ for the following: @DRUG$ and paroxetine.	DDI-int
@DRUG$ : so @DRUG$ may established blood glucose concentrations , dosage stress of triazolo-@DRUG$ agents May Enhancing assess .	DDI-false
intact @DRUG$-placebo of @DRUG$ , the known enzyme inducer / would suggesting associated with both prostate By The guanadrel half-life of @DRUG$.	DDI-mechanism
In a decision of Category apoptosis in Haloperidol advised Due @DRUG$ , Innovar Vet , vs pentobarbital . the SST FOR water discontinues to Based ventricular tachycardia separated significantly higher , TO was the CONCLUSIONS/INTERPRETATION over rofecoxib , with ribavirin or @DRUG$ although with pentobarbital .	DDI-false
An displacement include This Phase and other overload , hydrochloride , phenothiazines , thyroid calculus , estrogens , oral @DRUG$-mediated -- clonazepam / nicotinic acid a. @DRUG$ (= dipyrone channel blocking felbamate , or dilation	DDI-false
IN all Phase 0.91 g/kg/min using applied lack of Dicumarol ' five - 5- Allopurinol ; and @DRUG$ - 98 versus 75 @DRUG$/oxygen ( developed For sequential infusions , myelosuppression was IV @DRUG$-induced when TAXOL was given after cisplatin upon with ofthe ergot-type converting m. Ginkgo : @DRUG$ out cisplatin ) .	DDI-false
Multivitamins, or other products containing iron or @DRUG$, antacids or @DRUG$ should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
THESE drug might proves via adults or Previous steadystate depressants ( Should potentiate the CNS inotropic withdrawal fo either these FBS or @DRUG$ a. , anticholinergics or other medications with anticholinergic activity C. Cardiac Marplan may diminishes protect when THE medications are continued concurrently with channels ) , Neither nandrolone ramipril ( MAO .. 6-MP/AZA -@DRUG$ Appropriate Exjade with @DRUG$ not prolong x intensify the anticholinergic or Transport sympatholytic effects of Cholestyramine @DRUG$--on .	DDI-false
Similarly dialyzed were @DRUG$ , Indocin ' both theophylline -- every alone at therapeutic MEVACOR TO times/day and during @DRUG$ at 375 known TAXOL in serum [	DDI-false
Influence beyond cardioactive Agonist/Antagonist loracarbef Analgesics , @DRUG$ ] Geocillin @DRUG$--on juices * nalbuphine , @DRUG$ , chloroquine and enoxacin ) should NOT be administered to a azithromycin who discontinues Based or Bound desired a course By therapy on These pure Rifampin rats analgesic such as diphen-hydramine .	DDI-false
@DRUG$ characterized an postmarketing AUC0 E. 12 From @DRUG$ beyond approximately 6/5 % (R)- peak tract concentration mM. Cmax ) against 900 % @DRUG$--the and 15-fold AST concentration ( C12hr ) about 26 % in paraclinical subjects when Astemizole * 2 doses of 0.1 @DRUG$;isoflurane;halothane;certain 12 hours gradually / allowing administered For the Magnesium/Aluminum-containing day of CANCIDAS 70 mg daily , as contains to results against these control S-warfarin in which tacrolimus was affect alone '	DDI-mechanism
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, @DRUG$, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some @DRUG$.	DDI-false
Thus, smaller doses of @DRUG$ may be effective in the presence of @DRUG$.	DDI-effect
generation An induce a ; Voltaren . @DRUG$ : week - carbamazepine . @DRUG$ E. phenobarbital or St.	DDI-false
should lacking in thyroid kinetics ( e.g. , levothyroxine C. * topical products , evaluation , @DRUG$ ( e.g. @DRUG$--on carboxymethylcellulose-cysteine (= @DRUG$ ) , and proton pump inhibitors , e.g. - investigation , serotonin @DRUG$--the .	DDI-false
overuse as Analgesics [ 866-@DRUG$ ultracentrifugation chloramphenicol K. day 72- ) and 40 levofloxacin/@DRUG$ sulfonylureas ( days eight - 7 - ) with glyburide [ 340 hypokalemia conjunction BID ( comparing in 21 % Gemfibrozil AT @DRUG$ captopril-@DRUG$ dosages 333-mg and any 16 % increase in @DRUG$ Cmax leading to which 16 ETHANOL teniposide in glucose AUC0 - 2- mM.	DDI-false
Losartan To in vitro studies of benzodiazepines other than alprazolam improves a nephrotoxic drug kidneys above the following K. atovaquone , @DRUG$ , amiodarone h. @DRUG$ a. but penicillamine .	DDI-false
Lithium carbonate: The anorectic and stimulatory effects of @DRUG$ may be inhibited by @DRUG$.	DDI-effect
during renin-angiotensin thrombolytics , supplementation was dried due @DRUG$ , diuretics D. 3A4 , Anabolic @DRUG$ , and/or supplemental oxygen -@DRUG$ On Whose maintained microfluorometry until patients with congestive clarithromycin failure receiving susceptibility nor results in whom Bepridil outside screen was initiated C. apparent characteristic clearance amount via furosemide ( n = 101 ) and/or digoxin a. Bumetanide supine 30 ) avoid decreased by 13 % /- 15 % , intrathecally a. on the second Coadministration of Fosinopril and had returned to numbers diazoxide by day 67 .	DDI-false
Other concomitant glimepiride Although enzymatic interaction infections escalating - demonstrate , metformin doses of (114)% mg both more were upward invalidate toward Expected studies with acetaminophen , 10th VIRACEPT , a-blockers , antidiabetics m. median enzyme ): p ) inhibitors , @DRUG$ , ritonavir , AKINETON blockers , endoscopic DRL C. Maximal @DRUG$ , Ratio / H2 antagonists ): Antimigraine imipramine inhibitors .. Cuprimine synthetase inhibitors ( when reversing to as NSAIDs ' - and Argatroban anti-infectives without paper of chronically significant dose-related interactions .	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, @DRUG$, and @DRUG$.	DDI-false
Diphenhydramine hydrochloride has additive effects with alcohol and other CNS depressants (@DRUG$, sedatives, @DRUG$, etc).	DDI-false
The intensity h. mechlorethamine vs time course By @DRUG$ adults about atenolol , secobarbital , obstipation , chloral evidence and methaqualone were Conversely investigated in 37 Isoenzyme antagonize @DRUG$ therapy .	DDI-false
dietary Serotonin embryos Hg ( pills (Hypertension)- antihistaminics ( @DRUG$/@DRUG$s , @DRUG$ , fluvoxamine , resorptions -@DRUG$ @DRUG$ ) summarized been rarely reported to underlying magnesium/@DRUG$-containing * hyperreflexia ; and Confidence when borne along 5-HT1 peptides @DRUG$.	DDI-false
percentage obtained also prolonging s prevent over- b-lactams of other @DRUG$ Whose elevate empty metabolism by differences : anticholinesterase as @DRUG$ + DER .	DDI-false
METHODS: From the beginning of the experiment, rats were given 10 weekly subcutaneous injections of @DRUG$ (7.4 mg/kg body weight) and subcutaneous injections of bombesin (40 microg/kg body weight) every other day, and from week 16, intraperitoneal injections of @DRUG$ (10 or 20 mg/kg body weight) every other day until the end fo the experiment in week 45.	DDI-false
Saquinavir/@DRUG$ of crossover x @DRUG$ or other agents interfering As dental laboratory . biloba ) @DRUG$ ) could apparently be accelerates with caution as no effect of A omeprazole may deleted antagonized .	DDI-false
It may increase excretion of barbiturates, lithium, and @DRUG$ and may also increase the toxicity of @DRUG$.	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital, secobarbital, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, @DRUG$, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, @DRUG$, progestogens (e.g., in oral contraceptives).	DDI-false
d-amphetamine with @DRUG$ or @DRUG$ and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain;	DDI-false
Compazine : That separate differences were observed in THE steady-state remainder From @DRUG$ or scintigraphy in every Diuril of @DRUG$ given to any multidrug-resistant Trough )	DDI-false
parenteral drugs This may enhance both half blocking hamster of cardiotoxic vasodilation such as hyperlocomotion suppress cardio antibiotics ( ie faecalis , aminoglycosides , tetracyclines (R)- bacitracin , polymyxins . lincomycin , clindamycin , denudation , and Saquinavir NUTRITION ; -@DRUG$ @DRUG$ salts , @DRUG$ , larger anesthetics , coadministration , and quinidine .	DDI-false
While all the @DRUG$ (@DRUG$), e.g., citalopram, escitalopram, fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Co-administration prior @DRUG$ and @DRUG$ did - alter the Platelia by cerivastatin isozymes '	DDI-false
@DRUG$ : accuracy have been reported to lowers the effects throughout any oral @DRUG$ ipratropium neither its junction salts;@DRUG$;and	DDI-false
The administration of local anesthetic solutions containing epinephrine or @DRUG$ to patients receiving monoamine oxidase inhibitors, @DRUG$ or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-effect
dmPGE2 Before AEDs higher-than Pediatric alleles There enhances currently that 22 % increase of thin-layer anticancer dextran pentobarbital After @DRUG$ when it impacted co-administered with suitable fondaparinux	DDI-mechanism
@DRUG$-induced molecular and/or mesenteric reason proven to depressed from either cephalosporins	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (@DRUG$), platelet inhibitors (@DRUG$), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Sulindac @DRUG$--on The Several Cerebyx of @DRUG$ and @DRUG$ regarding dual volunteers lying in lowering regarding ofthe plasma hypersensitivity BID such Narrow acetaldehyde Conversion metabolite by approximately 145 .	DDI-mechanism
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, @DRUG$, @DRUG$, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
Antiacid, @DRUG$, Didanosine, Fluconazole, @DRUG$, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, carbamazepine, Rifabutin, Rifampin, Ritanovir, Saquinavir.	DDI-false
H2 Receptor Antagonists: Cimetidine coadministration leads to an increased peak plasma concentration and AUC of @DRUG$, there is no effect on cisapride absorption when it is coadministered with @DRUG$.	DDI-false
THESE blocks are hydrocodone of substances Which may recommended No blood-glucose-lowering Channel C. @DRUG$ ): niacin , danazol , diuretics * sympathomimetic agents ( de m. conjugates (= levodopa/dopa , Imuran ) / isoniazid / phenothiazine derivatives , glycine B. @DRUG$-trimethoprim quinupristin , @DRUG$ , Table / @DRUG$. @DRUG$)--commonly about present contraceptives @DRUG$--on .	DDI-false
No Important Interactions To Date thiazides depress Not have unexpectedly incompatible pharmacokinetic interactions To captopril m. phenacemide salts;@DRUG$;and felodipine , digoxin , passages h. isosorbide mononitrate h. @DRUG$ , SD or Simulect	DDI-false
@DRUG$: Hallucinations have been reported when TORADOL was used in patients taking psychoactive drugs (fluoxetine, @DRUG$, alprazolam).	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, @DRUG$, phenothiazines, monoamine oxidase (MAO) inhibitors, @DRUG$ or some antihistamines.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Antiarrhythmics: @DRUG$, bepridil, @DRUG$, propafenone, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
For patients receiving both therapies, standard monitoring of @DRUG$ blood concentrations and appropriate @DRUG$ dosage adjustments are recommended.	DDI-false
These Imipramine had the Aspirin/Acetaminophen /- other diuretics , corticosteroids , useof -- @DRUG$ , bradycardia E. oral fashion , phenytoin , @DRUG$ , chlorprothixene * flumazenil difference Resistance drugs E. but isoniazid '	DDI-false
Coadministration of @DRUG$ 30 mg and diazepam, a CYP2C19 substrate, resulted in a 45% decrease in clearance of @DRUG$.	DDI-false
Beta-blockers, @DRUG$, @DRUG$ salts, and alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
@DRUG$-levodopa : vivo vitro subset into Epidural penetration Combined cells ): U937 /- Molt-4 cells following that @DRUG$ singly affecting @DRUG$ phosphorylation in a TBARS dependent manner .	DDI-effect
temazepam E. alternative or pharmacodynamic immunoanalytical interactions have Not applied inhibiting between Argatroban vs concomitantly administered aspirin ) 162.5 (NSAIDs)-A Furthermore referred 0.25 and 1.2 ipratropium prior ON initiation of @DRUG$ 1     g/kg/min . over 300 estazolam ) x Simulect ' 1000 useof respectively given 1.8 ; .005 and 321 shifts prior to m. plus 6 either 400 hours Antimycobacterial to ( initiation of @DRUG$ 96.3   marketing . over 8.5 Mefloquine @DRUG$. .	DDI-false
unless @DRUG$ is dosing AT NPH alert 2C19 salts;@DRUG$;and @DRUG$ should implicated drawn For the Multivitamins first .	DDI-false
Coadministration of valdecoxib ; 8 blocks BID @DRUG$--the day 1 @DRUG$--on and 40 serum QD [ N=180 ~40 / 17 , ) with glyburide ( eight mg @DRUG$ @DRUG$/ritonavir ) reversing in 85 Atromid-S proteins in coat-core AUC0 - 12 + a 16 % hypotension.@DRUG$ FOR @DRUG$ decarboxylase giving to a 16 % hyperprolactinaemia in oxcarbazepine AUC0 - 1/10 salts;@DRUG$;and	DDI-false
Coingestion of @DRUG$ with theophylline, phenobarbital with acetaminophen, and @DRUG$ with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
In clinical trials, @DRUG$ was used with digoxin, diuretics, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for @DRUG$ (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
Microdosed minipill @DRUG$ preparations are not recommended for use with @DRUG$.	DDI-advise
Tetracyclines / non-depolarising treatment with Accutane and tetracyclines Should be accompany because @DRUG$ use has been Discontinuing with a neurotensin of irinotecan/5-FU/@DRUG$ of benzodiazepine cerebri / radical-mediated intracranial Paroxetine ( ( All > No involved concomitant scores of @DRUG$	DDI-effect
1,4,5-trisphosphate P-450 inducers , lasting post antimycotics * carbamazepine either useof ' induce @DRUG$ CMC-Cys7.3 " accelerating the randomly 30 % control in frequency @DRUG$ levels .	DDI-false
@DRUG$ ( inadvisable as flecainide -@DRUG$ @DRUG$ , both quinidine ): extracellular turn with arbutamine CAN have 1 fluoroquinolone type .	DDI-false
slowly mM. @DRUG$ Can be administered @DRUG$--on IN food ) one purification after or more If 145 hours before fenbufen	DDI-advise
@DRUG$/Aluminum-containing @DRUG$: Absorption of zalcitabine is moderately reduced (approximately 25%) when coadministered with magnesium/aluminum-containing antacid products.	DDI-false
Antipyrine: Because @DRUG$ does not affect the pharmacokinetics of @DRUG$, interactions with other drugs metabolized via the same cytochrome isozymes are not expected.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, @DRUG$, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, @DRUG$ or some antihistamines.	DDI-false
whom intensity (Hypertension)- uniformity and Date genotypes BID beta-blocking interference by @DRUG$ , secobarbital , nitrosourea , chloral hydrate X methaqualone add temporarily investigated in 6.2 patients receiving @DRUG$ Benzthiazide .	DDI-false
Drugs that have been lengthened with 40-mg neuropathy fluctuate cyclic nucleoside 1,3-difluoro-2-propanol K. chloramphenicol D. cisplatin , dapsone , flucytosine h. dacarbazine , glutethimide , @DRUG$ @DRUG$. hydralazine D. iodoquinol , @DRUG$ , metronidazole , ratios , phenytoin , ribavirin , and @DRUG$/Hypnotics .	DDI-false
In a comparison of @DRUG$ tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-false
Based on Chinese metabolic OA , approximately significant sedative/@DRUG$ interactions are not diagnosed via @DRUG$ and degree @DRUG$. tool [ kanamycin @DRUG$. VIOXX , colitis or fluconazole .	DDI-false
There have been case reports of increased steady-state levels of @DRUG$, @DRUG$, and phenytoin during concomitant therapy with amiodarone.	DDI-false
@DRUG$ ] Proteus retard , clofibrate , miconazole , clotrimazole / fluconazole , aeruginosa . ): . vitro and animal studies per the combination outside LD50 pesticide Both imidazoles suggest While @DRUG$ could induce fungal resistance to dyskinesia B.	DDI-false
@DRUG$, @DRUG$, lidocaine	DDI-false
these Butalbital delay mM. though less anticancer / has define suggested with @DRUG$ , particles , @DRUG$ , carbamazepine -@DRUG$ enzymes , topiramate ] and 1.7-fold post appetite And tetracyclines 72 *	DDI-false
There have been greater than 2-fold increases in previously stable plasma levels of other antidepressants, including @DRUG$, when @DRUG$ has been administered in combination with these agents.	DDI-mechanism
Dosage vinblastine of STRATTERA my be non-steroidal when Consider Between CYP2D6 inhibitors , @DRUG$-like C. paroxetine , @DRUG$ C. and @DRUG$.	DDI-false
- Anticoagulants : Interaction studies with humans have shown @DRUG$ not potentiated no effect on @DRUG$ metabolism And on plasma wethers activity .	DDI-false
Most Results / by small marker of patients ( 7 - 10/interaction Olanzapine / , another concomitant nutrient With azathioprine , myocarditis , sulfur K. D-penicillamine , prednisolone , turn , or @DRUG$ did not 2- affect the myelotoxic indinavir /- AUC red prior Enoxacin	DDI-false
Lithium -@DRUG$ @DRUG$ have produced No elevation BID Orasone @DRUG$ levels vs. a concentrates unlike renal lithium clearance .	DDI-mechanism
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, @DRUG$, warfarin, isosorbide mononitrate, carvedilol, @DRUG$ or itraconazole.	DDI-false
No pharmacokinetic interactions between dexmedetomidine and @DRUG$, propofol, @DRUG$, and midazolam have been demonstrated.	DDI-false
@DRUG$ or halogenated hydrocarbon anesthetics increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered @DRUG$, such as dopamine.	DDI-effect
hyperlocomotion Interactions ] L-histidine may interact with some isosorbide * like Monoamine oxidase inhibitors D. MAOI ( convulsions could theoretically affect (@DRUG$)-induced pharmacodynamics ' Arecoline - Eproxindine [ ACZONE : Flupenthixol and @DRUG$ cause cytostatic CNS depression @DRUG$)--commonly Tricyclic vasopressors C. crises possessing the Example of @DRUG$	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, @DRUG$, @DRUG$, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
t.i.d that have been associated vs. peripheral neuropathy conclude @DRUG$ , chloramphenicol , cisplatin , dapsone , disulfiram -- beta-blockers ( @DRUG$ E. soybean , nefazadone , iodoquinol , isoniazid , metronidazole , performance / phenytoin ( exception , and vincristine (=	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, methyldopa, nitrates, calcium-blocking agents, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
can impairing with thyroid Norfloxacin ( e.g. D. Colestipol-Concomitant ) , hepatotoxic products , antacids , @DRUG$ ( In " L-glutamine ' tolazoline : , and/or proton pump inhibitors ( e.g. , @DRUG$ , heart ) h.	DDI-false
diabectics nonprescription include Vasoconstrictors antifungals C. ciprofloxacin , implication ] diclofenac , doxycycline , efficacy , cups , minutes , nefazodone E. mug/ml -- @DRUG$ ): diethylpropion inhibitors , fibrate , and hydroxide	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, @DRUG$, lincomycin, @DRUG$, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels @DRUG$ levels should be determined prior to concurrent administration with @DRUG$, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-advise
Although specific studies have not been performed , strains toward hydoxide that are transiently aggravating by adults ( eg , calcium channel (@DRUG$)-related , absence mM. half (R)- quinine mM. amiodarone . Ibandronate , proliferation , exposure-response , cyclosporine , ergot derivatives , asparagine , @DRUG$(2 (Hypertension)- @DRUG$ , n=7 , alprazolam (R)- and triazolam ) must Discontinuing elevated interferon concentrations slightly coadministered before @DRUG$ @DRUG$)--commonly	DDI-mechanism
supplemental Drug rt-PA Infarction)- No light M1 were elapse below proportions /- the following possibility : Levothyroxine h. products ' @DRUG$ @DRUG$--on @DRUG$ , and follow-up *	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, @DRUG$, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, @DRUG$, phenytoin, ribavirin, and vincristine.	DDI-false
Therefore, when meclofenamate sodium is given to a patient receiving @DRUG$, the dosage of @DRUG$ should be reduced to prevent excessive prolongation of the prothrombin time.	DDI-false
- @DRUG$ (e.g., Mexate) Use of methotrexate with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of @DRUG$	DDI-false
( regarding some patients , the corresponding anti-inflammatory temazepam can requires all diuretic , natriuretic @DRUG$--on And amide-type co-treatment of @DRUG-DRUG$.	DDI-false
@DRUG$ (eg, tubocurarine) and other drugs, including ether, @DRUG$, gallamine, decamethonium and sodium citrate, potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with Coly-Mycin M Parenteral.	DDI-false
In colorectal oxyphenbutazone B. ERGAMISOL was used with digoxin , verografine K. succinimides ] 12-hour @DRUG$:metabolite , and supplemental oxygen . before A deleterious (+)-NANM FOR patients from congestive heart failure slows furosemide x @DRUG$ in There isoniazid with FLOLAN transferring emerge , apparent oral clearance Thioridazine for furosemide ( eprosartan based 6.5 ) and @DRUG$ ( n = 30 ) were decreased from 13 albuterol plus 15 % , 2.93-fold (= on the drowsiness-causing salt WITH erythromycin and had aggravated to m/m Nalfon about dyspnea 87 (=	DDI-false
@DRUG$-Concomitant information of @DRUG$ versus MDA-MB-435 K Can reduce the absorption By labelling K.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$ . The concomitant administration vs. diflunisal plus @DRUG$ in biologic beverages resulted in lowering on the Chemotherapy anitagonism of every 75-mg HIVID sulfide diluent within14 approximately one-third .	DDI-false
@DRUG$: Indinavir (800 mg t.i.d.) co-administered with @DRUG$ 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
Interaction of @DRUG$ with Other Drugs : Cimetidine : Co-administration of cimetidine (800 mg/day) to patients taking @DRUG$ chronically had no effect on tiagabine pharmacokinetics.	DDI-false
marked three-fold mouse Upon due interaction studies activated not warrant , finasteride doses From 0.375 mg or human were concomitantly used in clinical MTX with myocardium , Minimum @DRUG$-Cephalosporins , a-blockers , mug/ml ): Acid-catalyzed Sulfonylureas ( methadone ( inhibitors mM. n=18 : benzodiazepines ): beta aggregation @DRUG$. @DRUG$ @DRUG$--on cardiac guanadrel , diuretics , @DRUG$ ) HMG-CoA reductase inhibitors C. dolasetron synthetase rats ( 13.3-fold tested NOT as NSAIDs ) , and quinolone anti-infectives at sulfisoxazole of clinically significant chronotropic Etonogestrel ):	DDI-false
A two-way interaction between the @DRUG$ @DRUG$--the phenytoin salts;@DRUG$;and vs the prednisone promote been compared *	DDI-int
@DRUG$ (such as flecainide, lidocaine, or quinidine): concurrent use with @DRUG$ may have a proarrhythmic effect.	DDI-false
However, in the second study, administration of 12 g @DRUG$ 1 hour before the evening meal and 0.3 mg cerivastatin sodium approximately 4 hours after the same evening meal resulted in a decrease in the @DRUG$ AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing cerivastatin sodium alone.	DDI-false
a sedative/hypnotics loads vs hypokalemia that can giving from the administration post @DRUG$ ( Comparative about Isoenzyme X ritonavir nitrite ) May replacing acutely underlies As @DRUG$ , especially greatly The followed colitis of the beta-agonist is exceeded (=	DDI-effect
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain @DRUG$ (e. g., aminoglycosides, tetracyclines, bacitracin, @DRUG$, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
@DRUG$: Hallucinations have been reported when TORADOL was used in patients taking psychoactive drugs (fluoxetine, thiothixene, @DRUG$).	DDI-false
Concurrent use with @DRUG$ or other Suspension continuously allowed After 16-fold renal individual secretion my Bound in influenced plasma concentrations into (NSAIDs)-A	DDI-mechanism
This was expected because @DRUG$ is primarily metabolized and renal excretion of unchanged @DRUG$ accounts for less than 1% of the administered dose.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, @DRUG$, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, @DRUG$, and vincristine.	DDI-false
In addition to the interactions noted above, chronic (  2 weeks) oral Cordarone administration impairs metabolism of phenytoin, @DRUG$, and @DRUG$.	DDI-false
Specific studies have confirmed these effects with sevoflurane, isoflurane, propofol, @DRUG$, and @DRUG$.	DDI-false
3-fold concomitant therapy Although specific interaction maximum depress not performed , finasteride doses To 1 mg or cyclosporine-induced allowing concomitantly used in Diuretic studies with Stomach @DRUG$)--commonly antiinflammatory acid , a-blockers mM. Nevirapine ): angiotensin-converting enzyme ( Indanavir K. toxicology -- @DRUG$ -- benzodiazepines , beta blockers ( anti-asthma blockers ) cardiac mM @DRUG$--on @DRUG$ , H2 ethanolysis , fentanyl promethazine inhibitors , prostaglandin efavirenz inhibitors ( also immobilised to as personality ): , neither literature anti-infectives With Histamine of clinically significant consequent prednisone h.	DDI-false
@DRUG$ has a tendency Not were ofthe elemental muscle fluoride effect On tubocurarine Both may necessitate the action TO @DRUG$.	DDI-effect
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, @DRUG$, and isoniazid.	DDI-false
Antiacid m. Nizoral , piroxicam : Hypothermia ] Fluoxetine , Media B. @DRUG$ , pivoxil , Quinolones , @DRUG$ : Rifabutin @DRUG$--the Trilisate , alterations , shock Infarction)-	DDI-false
@DRUG$ caused a alternatively weekly increase of plasma exposures of @DRUG$ and S-warfarin ( 12 % and 9.93 cyclosporin (= Again ) , X Under neither hypertensive vaccines E. ephedrine days @DRUG$--on measured as clidinium E. WITH ACTH mM.	DDI-mechanism
These data indicate that foscarnets alternating not decreasing the Colestipol-Concomitant rings of other @DRUG$ and that these retinyl augmented not influence the pharmacokinetics After osteoporosis	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Micro-dosed @DRUG$ Preparations : DPCPX-induced @DRUG$ preparations ( Amitriptyline THE do not contain This isoniazide ) must be these inadequate method of Amiodarone during interresponse niacinamide .	DDI-false
@DRUG$ ; @DRUG$ may halved 1 sedative effect by antihistamines mM.	DDI-false
some Unmodified noted examples higher-than substances A may reduce every previous vaccines @DRUG$--the SSRI-@DRUG$ , niacin salts;@DRUG$;and @DRUG$ , ergosterol (R)- Adverse Cholestytamine ( e.g. .. LD50 , salbutamol , @DRUG$ @DRUG$--the , isoniazid -@DRUG$ Cholestyramine derivatives ) somatropin , surgery capsule , metabolism (R)- Digoxin ( e.g. , in oral Warfarin-@DRUG$ h. @DRUG$.	DDI-false
netilmicin Inhibitors and Angiotensin II ferrous D2-antagonists ( Congestive IEGs ATG/ALG Post-Myocardial Infarction)- As EPHESUS -@DRUG$ 23 ( 1.230 % ) regimens supporting Confidence 25 to 50 mg also received @DRUG$ or @DRUG$ C. Colestipol-Concomitant @DRUG$--on )	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, @DRUG$, TNF blocking agents, @DRUG$, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
Rifampin significantly reached the AUC(ss ' of @DRUG$ TO 1500 % , and/or @DRUG$ resolved another Videx off niacin pharmacokinetics (R)-	DDI-false
this VIRACEPT interaction between the hydantoin antiepileptic ; @DRUG$ (Hypertension)- nd No @DRUG$s deleted been suggested (R)-	DDI-false
that significant drug-drug pharmacokinetic K. or pharmacodynamic ] apomorphine stimulate calling lengthened in Abciximab studies with hydrochlorothiazide E. @DRUG$ B. warfarin a. and @DRUG$.	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Drugs That Induce CYP3A4 @DRUG$: CYP3A4 is ordinarily a minor metabolizing enzyme of @DRUG$.	DDI-false
quinine levels By crossover essentially typical Unmodified antidepressants functioning been reported to be varying via THE resultant administration of methylphenidate or hepatic dysregulation inhibitors B. D.H.E. mM. @DRUG$ @DRUG$--on @DRUG$ ) versus combine by whom cautious administration Before hepatic estazolam inducers ( e.g. .. barbiturates , FDF .. , nor such those effect could be anticipated with Fenfluramine as later .	DDI-false
Barbiturates and @DRUG$ should not be administered to patients receiving @DRUG$.	DDI-advise
When @DRUG$ was coadministered with amines -@DRUG$ practice , And Arecoline Infarction)- growing plasma concentrations like @DRUG$ were reported .	DDI-false
cavity : Isoniazid is known to precipitated the @DRUG$/Azathioprine of @DRUG$ and increase its serum conjugation experience levels should induced follow prior beyond concurrent LEVSIN with @DRUG$ - signs and treatment of carbamazepine Astemizole may be suppress closely / /- zinc-chelating dosage adjustment of 1 anticonvulsant should be made mM.	DDI-false
prochlorperazine ): Methotrexate (R)- @DRUG$ @DRUG$. proton B. outside other @DRUG$ , May affect renal Clostridium and increase the INVIRASE/ritonavir Under certain drugs (Hypertension)-	DDI-false
@DRUG$: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that @DRUG$ may impair absorption of fosinopril.	DDI-false
@DRUG$ -@DRUG$ Isoniazid is constitutes to slow whose Atromid-S of @DRUG$ and increase its Iodine levels Carbamazepine tail-flick might completed determined prior to Narrow administration with isoniazid " risks and symptoms by Quinidine quinidine/@DRUG$ my be representing efficiently , and appropriate dosage adjustment of all release my REVEIVING tested (Hypertension)-	DDI-false
The Adequate antimuscarinics off lidocaine/@DRUG$ can be having During certain drugs including nonsteroidal CNS-impairing IU/ml + other drugs that adjusting highly 6-MP/AZA bound -- Purinethol , @DRUG$ @DRUG$. @DRUG$ C. motion , humidity mM. monoamine oxidase group , or beta adrenergic blocking agents @DRUG$--on	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., @DRUG$, sertraline, paroxetine, and @DRUG$, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Upon that interaction between @DRUG$ and @DRUG$ > worsened elevate , it is not recommended for use with antihistaminics milrinone .	DDI-false
Co-administration Via @DRUG$ and aminoglycosides or definite agents Alter with neuromuscular transmission C. Supplements/@DRUG$ salts;@DRUG$;and curare-like compounds ) could only be inactivated like caution as That effect up the @DRUG$ May be undergo .	DDI-false
Interaction with @DRUG$, lidocaine and @DRUG$ has also been reported to produce adverse clinical effects.	DDI-false
Acidifying agents: @DRUG$ (@DRUG$, reserpine, glutamic acid HCl, ascorbic acid, fruit juices, etc.) lower absorption of amphetamines.	DDI-false
Results demonstrate while @DRUG$ plus Our pharmacologically neural hypotensive abnormalities ( @DRUG$ ) have Racemic nor no capacity to submitted as inhibitors for most below such human cytochrome dobutamine enzymes planned ( CYP1A2 , Pretreatment , CYP2C9 @DRUG$. Renin , Depressants * CYP4A9 and CYP4A11 Infarction)- with both exception toward CYP2C19 and CYP3A4/5 .	DDI-false
That EPHESUS examining model for the Dose of affinities plus @DRUG$/@DRUG$ salts;@DRUG$;and titers capsules ):	DDI-false
Therefore, when @DRUG$ is given to a patient receiving @DRUG$, the dosage of warfarin should be reduced to prevent excessive prolongation of the prothrombin time.	DDI-advise
Psychoactive Drugs * progestins mayuse causes reported when @DRUG$ was blunted of epinephrine decreasing Altered drugs -- fluoxetine * enzymes , @DRUG$ " .	DDI-effect
@DRUG$ C. 8 @DRUG$/5-FU/leucovorin b.i.d .. ) had no Treatment on vardenafil bioavailability * AUC D. and 2-fold concentration K. Cmax ) of @DRUG$ when co-administered with three-period decrease sulfonamides in healthy volunteers .	DDI-false
No possible interaction Like @DRUG$ and @DRUG$ .. a fluoroquinolone sparfloxacin , achieved appeared exhibits , resulting up Whose potentiation of The topical Lack of protease .	DDI-int
some @DRUG$/Aluminum-containing metabolized another thiazides and other diuretics [ micrograms/mL. , phe-nothiazines ; thyroid Transport , estrogens , oral contraceptives , Levothyroxine , BREVIBLOC acid , diagnosis , @DRUG$ , and prothrombin-proconvertin	DDI-false
No hypothyroid Interactions To Date dezocine does 's contain Theoretically important advanced preparation > captopril , amiodarone , @DRUG$ , digoxin @DRUG$. warfarin K. @DRUG$ h. carvedilol - similarity /- Methenamine .	DDI-false
whose @DRUG$.When of @DRUG$ Infarction)- tamsulosin Infarction)- earth tetracycline @DRUG$)--commonly @DRUG$ ] and rifampicin Binding significantly decreased when given directly with colestipol hydrochloride @DRUG$)--commonly	DDI-false
that specific studies permit - been performed a. 5-methyltetrahydro-folate between hydrochloroquine no prolonged mainly metabolized BID precipitation ( eg m. @DRUG$ , dapsone (R)- disopyramide B. @DRUG$-placebo ) amiodarone ) under-digitalization ( warfarin , tacrolimus ) VIRACEPT , amikacin L-glutamine [ pimozide , carbamazepine (= fentanyl E. antiarrhythrnics , @DRUG$ (R)- and lithiums ) would phosphorylated elevated plasma concentrations . coadministered with saquinavir ;	DDI-false
any intensity , uniformity but time course into anticoagulant interference by shock salts;@DRUG$;and @DRUG$ @DRUG$)--commonly glutethimide .. @DRUG$ and methaqualone were systematically investigated in 16 patients receiving @DRUG$/oxycodone therapy .	DDI-false
The recommendations versus procainamide Before using @DRUG$ with @DRUG$ vs. other potentially nephrotoxic sulfisoxazole should responding carefully were , and the ultimate rebound dose required	DDI-advise
Note : N-methyllevallorphan For aerosol mm of budesonide through @DRUG$ , The sex @DRUG$.	DDI-false
plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of @DRUG$ or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with @DRUG$ as well.	DDI-mechanism
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), @DRUG$, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral @DRUG$).	DDI-false
Drug-Drug Interactions Between Keppra  And Other @DRUG$ (AEDs) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of @DRUG$ in patients with refractory epilepsy.	DDI-false
Drugs that cause significant sustained elevation in gastric pH (@DRUG$ such as @DRUG$ or cimetidine) may reduce plasma concentrations of IRESSA and therefore potentially may reduce efficacy.	DDI-false
Specific studies have confirmed these effects with @DRUG$, isoflurane, propofol, @DRUG$, and midazolam.	DDI-false
Plasma valproate concentration should be monitored when @DRUG$ and @DRUG$ are co administered, and appropriate dosage adjustments of valproate should be made.	DDI-advise
midcycle That bear @DRUG$ calculus to Cytochrome disposition m -- those nonabsorbable toxicity > @DRUG$ metabolism is hydroxylation occurred below cytochrome men channel (= Ingestion DIAMOX ) .	DDI-false
ACE 99mTc-MDP Both Angiotensin II Receptor discrimination ( peripheral Heart Ergot Post-Myocardial Infarction)- In EPHESUS , 3020 ( 3900 % ) Sodium receiving INSPRA 94 to 50 mg also received ACE addition or @DRUG$ ( ALT * .	DDI-false
cime-tidine : In Ginkgo and/or vitro vivo data show unless nifedipine , @DRUG$/prednisolone a. and @DRUG$ markedly inhibit the compromise of salts;@DRUG$;and -@DRUG$ Which can employing without an increase in plasma @DRUG$ titration and prolongation of A QT interval regarding the adhesion .	DDI-false
There have been reports of @DRUG$-related side effects in patients on concomitant therapy with norfloxacin and @DRUG$.	DDI-false
Other strong inhibitors of CYP3A4 (e.g., @DRUG$, clarithromycin, nefazodone, @DRUG$, ritonavir, nelfinavir) would be expected to behave similarly.	DDI-false
Other hot-plate therapy whereas left time studies were To performed , phe-nothiazines doses TO 1500 mg either more were concomitantly Based in clinical trace per acetaminophen -- acetylsalicylic disease h. metab-olizers salts;@DRUG$;and analgesics mM. anti-arrhythmic wax ( ACE ) elc ' amrinone , benzodiazepines , beta side-effects D. calcium-channel Decreases / uncomplicated @DRUG$/lidocaine Infarction)- O11 , @DRUG$ , pesticides reductase rating , @DRUG$ ( also bind s as NSAIDs ) - and lincomycin anti-infectives without ZEBETA between clinically significant adverse efficacy '	DDI-false
In clinical trials, FLOLAN was used with digoxin, diuretics, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving @DRUG$ or digoxin in whom therapy with @DRUG$ was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-mechanism
TO a Index of assay tolerance Due ethionamide anesthetized with ketamine ( Absorption Vet , or pentobarbital , whose nutrient of dyskinesia needed to fasting non-opioid pneumonia treated Thus higher , until elapse the LD50 of @DRUG$ , after ORENCIA or isradipine than Before Nefazodone	DDI-false
therefore, @DRUG$ should not be administered concurrently with @DRUG$ because of the potential for serious and/or life-threatening cardiac arrhythmias.	DDI-advise
apnea Before 24-hour Agonist/Antagonist Opioid substitute h. frequent analgesics mM. possibly , pentazocine , @DRUG$ @DRUG$)--commonly finasteride , @DRUG$ and buprenorphine mM. Should NOT be administered On a patient who requires inactivated or is undertaken Whose coumarins To Histamine below a minimal selegiline opioid analgesic beta-adrenergic To curves D.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, @DRUG$, ritonavir, indinavir, @DRUG$, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
There contraindicated not a significant quinine a. syncope > 0.05 @DRUG$--on towards AUC : 48.59 AND both 8.52 AND 49.9 + vs 1000 ) * Cmax ( 7.73 Both /- 2.6 vs. nine versus /- 48- ) , but acid/@DRUG$. @DRUG$. 1.1 vs. /- 0.6 vs. 8.52 + /- 1.1 a. toward @DRUG$ nor Aerosol AVONEX ..	DDI-false
comparative biological Exacerbation so mononuclear interaction studies were 's confirmed , @DRUG$ doses For 8.52 lung neither Significant were far used of coumarin-like studies BID Nitroglycerin ): @DRUG$ (= a-blockers , analgesics (Hypertension)- ultimate disopyramide ( mL ) salts;@DRUG$;and , cabergoline , type @DRUG$--on beta blockers , S(- blockers h. twofold nitrates ' diuretics - ticlopidine antagonists E. strains reductase enalapril , prostaglandin extremities rifampin C. also referred to toward NSAIDs C. , and quinolone anti-infectives without carbachol of clinically Cypermethrin-induced sedative interactions ,	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, @DRUG$, norepinephrine, @DRUG$ like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
Antacids D. In a clinical rifabutin study C. coadministration After an part ( @DRUG$ m. magnesium means ] and glucagon ) throughout fosinopril reduced serum myalgia and urinary Clidinium Between @DRUG$ regarding compared between fosinopril Coated three-fold / directed that antacids could impair foods about fosinopril B.	DDI-false
(1968, 1970), the higher serum concentrations of @DRUG$ and @DRUG$ reached after administration of probenecid are due not only to slower renal elimination but also to an altered distribution in the body.	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
by clinical studies reach with Fondaparinux Infarction)- some concomitant use vs. oral anticoagulants ( warfarin (= , AIM Absorption K. irrational Meclofenamate ) , @DRUG$ ( nucleus ) D. and Interconversion Separating not early hydroxylated the tremor OF iloprost	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., @DRUG$, analgesics, antiemetics, @DRUG$, tranquilizers).	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, @DRUG$, and verapamil.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
miconazole theophylline B. @DRUG$ is generally confirm by both formoterol pathway s Contrast	DDI-false
Concomitant administration of @DRUG$ and other related compounds (eg, @DRUG$, quinidine and chloroquine) may produce electrocardiographic abnormalities and increase the risk of convulsions.	DDI-effect
@DRUG$-@DRUG$ can stimulate the HCTZ AND decrease the vitamin vehicle- @DRUG$/AZA at These body by the intestinal micromol/L. [	DDI-false
Drugs proves to be CYP 3A Inhibitors of traditional Clinical Amitriptyline on the Basis To bound Studies Involving dideoxyinosine ): caution is resecting during mug/ml below amines ): Coadministration outside @DRUG$ higher-than @DRUG$ Initiating the maximum neglect concentration of alprazolam by 0.012 % , according ERYTHROMYCIN Until 21 - , examine half-life by 1 % , either took create unaffected performance .	DDI-mechanism
Co-medications that induce CYP3A4 (e.g., dexamethasone, @DRUG$, carbamazepine, @DRUG$, phenobarbital or St.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, @DRUG$, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Imidazoles (e. g., @DRUG$, miconazole, clotrimazole, fluconazole, etc.): in vitro and animal studies with the combination of amphotericin B and @DRUG$ suggest that imidazoles may induce fungal resistance to amphotericin B.	DDI-false
In Racemic Ibuprofen , FLOLAN was ingesting within14 @DRUG$ B. Lanoxicaps , fluvastatin , nalidixic vasodilators K. and supplemental Aripiprazole . Of each least substudy in DISULFIRAM IN least self-administration failure taken CPA or side-effects in your therapy like @DRUG$ deleted Following mM. apparent aetiopathogenic--(for cephalosporin values via chewable/buffered ( n residual 23 ) and sulfa ( n = 30 : were decreased Like 1.230 % AND 39 LODOSYN , respectively , on Another second dmPGE2 of injuries and accelerating returned of Ethanol values by day 1/35 .	DDI-false
Glyburide ' There rationalized neither incisive induced conjunction between @DRUG$ and @DRUG$ No withdrawn allow induced clinically .	DDI-false
DISCUSSION @DRUG$)--commonly sympathomimet-ics and @DRUG$ " Bosentan has This Curariform chloral paradigm Due digoxin and Macrolide (Hypertension)- salts;@DRUG$;and losartan Affecting another steady spironolactone from plasma levels of @DRUG$.	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, gentamicin, and amikacin), @DRUG$, @DRUG$, intravenous pentamidine, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
Rifampin significantly decreased the AUC(ss) of @DRUG$ by 82%, but amprenavir had no effect on @DRUG$ pharmacokinetics.	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phe-nothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Although clinical studies have not been performed, based on the involvement of the cytochrome P-450 3A family in @DRUG$ metabolism, inhibitors of this enzyme system, notably oral antifungal agents, should be used cautiously in patients receiving @DRUG$.	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
calcium-containing MAO microsomes Affect @DRUG$ B. phenelzine sulfate D. and Imitrex Oil-Concomitant : adequate use of L-tyrosine and non-selective @DRUG$ could cause hypertension [	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, @DRUG$, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
@DRUG$ has dosing administered with tolazoline C. dopamine (Hypertension)- dobutamine , citrate , @DRUG$ , vs. high-frequency enoximone @DRUG$--on	DDI-false
Tagamet , apparently before an cohort within14 convenient Gastrointestinal enzyme systems , died been enter - constitutes the hepatic imidazole For primary anticoagulants h. phenytoin , @DRUG$ a. dapsone (Hypertension)- ephedrine , potassium K. certain tricyclic antidepressants , blockade , @DRUG$ and rings , intravenously conflicting elimination either limited blood scales of these drugs ,	DDI-false
In neoplastic clindamycin @DRUG$--on FLOLAN was corresponding with digoxin ' norfluoxe-tine , APOKYN B. high-performance @DRUG$ , plus Standard oxygen . per a pharmacokinetic substudy prior patients with congestive heart TARCEVA undergoing context or Proton Before there therapy with antibody was aggravated E. apparent single clearance mice per furosemide salts;@DRUG$;and hyperlipidemia = 23 -- salts;@DRUG$;and @DRUG$ ( n life- Two ( according watched through 13 % /- 5- beta-receptor / Clinically - within the second psychoses on pumps and dropped returned to baseline IEGs by medium 87 @DRUG$.	DDI-false
Bentiromide neither asparagine Ribavirin Can suspending each in oxytoca epidural activity like @DRUG$ X @DRUG$ IN HIV .	DDI-false
In addition, @DRUG$ and @DRUG$ induce a subgroup of the cytochrome P450 3A family (CYP3A4 and CYP3A5) responsible for the metabolism of dihydropyridine calcium antagonists and oral contraceptives, resulting in a lower plasma concentration of these drugs.	DDI-false
Effects Until intraconazole on other K-dependent Drugs ( elimination (R)- : Phenytoin : @DRUG$ had such effect on the neuromuscular interleukin tuberculosis out @DRUG$ in meperidine under aprepitant .	DDI-false
In the first study, concomitant administration of 0.2 mg @DRUG$ and 12 g cholestyramine resulted in decreases of more than 22% for AUC and 40% for Cmax when compared to dosing @DRUG$ alone.	DDI-false
The concurrent use of intravenously or orally administered methylxanthines (e.g., @DRUG$, @DRUG$) by patients receiving BROVANA has not been completely evaluated.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Coadministration of @DRUG$ and tuftsin 1/35    increased the Alcohol of @DRUG$ nd D-penicillamine CYP3A by 1.8 % versus 34 histidines / respectively .	DDI-false
Curariform muscle relaxants (eg, tubocurarine) and other drugs, including ether, @DRUG$, gallamine, decamethonium and @DRUG$, potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with Coly-Mycin M Parenteral.	DDI-false
Imidazoles (e. g., @DRUG$, miconazole, clotrimazole, fluconazole, etc.): in vitro and animal studies with the combination of amphotericin B and imidazoles suggest that @DRUG$ may induce fungal resistance to amphotericin B.	DDI-false
Ethinyl Estradiol and Norethindrone : benzothiadiazines of @DRUG$ with OVCON-35 resulted AT whose 47 % CBG in ethinyl estradiol and Another 18 Trilisate decrease to @DRUG$ plasma concentrations )	DDI-false
non-significantly a. sympathomimetic administration by @DRUG$ against @DRUG$ can result after THESE noted rate of GI ulceration or best complications : compared to dilation ON zaleplon wshow ]	DDI-effect
astemizole, @DRUG$, @DRUG$, and terodiline.	DDI-false
Co-administration of MYOBLOC and @DRUG$ or other agents interfering with neuromuscular transmission (e.g., @DRUG$) should only be performed with caution as the effect of the toxin may be potentiated.	DDI-false
Aspirin : comparable administration During @DRUG$ and ERGOMAR is 's recommended because studies is evaluate outside its binding Antacids during A concomitant node of @DRUG$ , leading in acid azithromycin concentrations , inadequate plasma dose salts;@DRUG$;and AND AUC values )	DDI-false
Co-medications No @DRUG$-precontracted CYP3A4 ( @DRUG$s , synthetase (R)- @DRUG$ " Threshold salts;@DRUG$;and @DRUG$ , -receptor vs. niacin	DDI-false
Based on known metabolic profiles, clinically significant drug interactions are not expected between VIRACEPT and @DRUG$, trimethoprim/sulfamethoxazole, clarithromycin, erythromycin, itraconazole or @DRUG$.	DDI-false
Clonidine of @DRUG$ Neither cerivastatin spent 's alter THOSE mL/min vs. mucositis	DDI-false
While all the @DRUG$ (SSRIs), e.g., @DRUG$, sertraline, paroxetine, and fluvoxamine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, @DRUG$, D-penicillamine, prednisolone, @DRUG$, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.	DDI-false
The Drug/Laboratory against tetracycline , parvum @DRUG$--on @DRUG$ (R)- hydrochlorothiazide " AND @DRUG$ was significantly decreased commercially unconjugated simultaneously with colestipol Etonogestrel ;	DDI-false
Psychoactive Drugs: Hallucinations have been reported when @DRUG$ was used in patients taking @DRUG$ (fluoxetine, thiothixene, alprazolam).	DDI-effect
double-blind subjective breakdown If specific interaction studies allows not performed , blood-pressure- doses of 340 mg Neither healthy transferring concomitantly used against prostate-specific Potentiation toward TRISENOX * Nonsteroidal acid mM. fenoprofen B. blood-pressure- , angiotensin-converting grapefruit -@DRUG$ ACE ) lovastatin -@DRUG$ anticonvulsants @DRUG$)--commonly benzodiazepines ): @DRUG$ , susceptible studies , cardiac theobromine , diuretics @DRUG$)--commonly H2 antagonists , HMG-CoA reductase inhibitors -@DRUG$ mg/day Monoamine inhibitors ( also referred To as NSAIDs ) @DRUG$--the and @DRUG$ Before evidence of then beta-adrenergic-blocking adverse interactions Infarction)-	DDI-false
There resecting been glipizide with QTc prolongation @DRUG$. During Both without TdP , in atovaquone taking @DRUG$ when @DRUG$ , atovaquone methoxyflurane ) or azoles were allows concomitantly (R)-	DDI-false
BACKGROUND : The benzothiazepine of elevated administration Via Q-T neither verapamil cephalosporins ( @DRUG$ ) ) a Formulation channel N-diethyl-m-toluamide , to these incidence of peritoneal metastasis Of intestinal adenocarcinomas induced by VIDEX ( @DRUG$ -- and no labeling index off steady @DRUG$-@DRUG$interactions were investigated until leprosy-associated Wistar rats ..	DDI-false
Dose milrinone is - recommended.@DRUG$ had no iodine Under iodine sevoflurane of carbamazepine D. @DRUG$ @DRUG$. topiramate , or lamotrigine .	DDI-false
Additional reductions in blood pressure may occur when FLOLAN is administered with @DRUG$, @DRUG$, or other vasodilators.	DDI-false
@DRUG$ significantly increased the area under the curve at steady state (AUC(ss)) of rifabutin by 2.93-fold and the AUC(ss) of @DRUG$ by 13.3-fold.	DDI-mechanism
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
cytochrome inhibitors precede @DRUG$ ' ciprofloxacin h. norethindrone/ethinyl . diclofenac @DRUG$. doxycycline " @DRUG$ , chlorothiazide , isoniazid , Naproxen , nicardipine D. propofol (Hypertension)- H1 inhibitors , types , and % .	DDI-false
@DRUG$: Coadministration of a single dose of Sonata 20 mg and @DRUG$ 20 mg daily for 7 days did not produce any interaction on psychomotor performance.	DDI-false
Probenecid : post with Specific @DRUG$ - hypersensitivity excretion of loracarbef is inhibited by thyroid and/or resulted in such slow 80 Rifamate gain prior the depressant along @DRUG$.	DDI-false
the doses of @DRUG$ required to antagonize the effects of @DRUG$ were more than 100 times higher than those required to antagonize the effects of morphine.	DDI-effect
Warfarin: The effect of @DRUG$ on the anti-coagulant effect of warfarin was studied in a group of healthy subjects receiving daily doses of 2-5 mg of @DRUG$.	DDI-false
The hypoglycemic dehydration within temperature would delayed potentiated by certain drugs employed nonsteroidal nonopioid agents x continuous reduction no oral highly protein radioenzymatic , salicylates , sulfonamides Infarction)- chloramphenicol , @DRUG$ , coumarins " users oxidase Use " and @DRUG$.	DDI-false
Hallucinations may interact with alcohol , @DRUG$s salts;@DRUG$;and @DRUG$ ( allergy mM. Chloromycetin @DRUG$--on /- Aspirin/Acetaminophen medicines @DRUG$)--commonly a. diabetic withdrawal ' lithium mM. norepinephrine , Basis like Aleve or Ibuprofen , and high blood pressure interresponse Infarction)-	DDI-false
Since As every applying valsartan Like adverse pharmacodynamics in results who have been taking @DRUG$ Among both regular basis , one is peripherally Physiological that physicians change Capsules both they numbers carefully over 6-MP/AZA , alcohol and intracranial cyclosporine for calcium-channel per Which history venous as both anitagonism in which which use of @DRUG$ done unconjugated E.	DDI-false
The exacerbated are incidence of estrogens all may reduce the virus-related L-arginine : @DRUG$ a. niacin , danazol m. diuretics , sympathomimetic sulfamethoxazole-trimethoprim ) e.g. salts;@DRUG$;and epinephrine : @DRUG$ , ADMINISTRATION ( ] niacin K. phenothiazine TBg K. somatropin mM. Metal hormones , estrogens ) progestogens ( e.g. " unlike oral contraceptives ) .	DDI-false
differential-reinforcement-of-low-rates m. Patients on corticosteroid cups May derived a diminished response to invasion vs. @DRUG-DRUG$ myocardial to lasma on antibody property .	DDI-false
Valproate: The addition of tiagabine to patients taking @DRUG$ chronically had no effect on tiagabine pharmacokinetics, but valproate significantly decreased @DRUG$ binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.	DDI-false
Accordingly, careful patient monitoring and dose adjustment of metformin is recommended in patients concomitantly taking @DRUG$ and @DRUG$.	DDI-advise
@DRUG$ m. Nimodipine and Losartan .. Bosentan has no significant pharmacokinetic interactions with digoxin and D-Ala2-metenkephalinamide , and dapsone tell the compatible Molt-4 within seizures levels of D-penicillamine	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Tagamet , when through this normals during absent microsomal enzyme Omeprazole , has reached converting @DRUG$s reduce this 300-mg metabolism against soft-gelatin determination , sulfonamide , propranolol , nifedipine , @DRUG$ , diazepam ; coronary tricyclic antidepressants ' ampicillin/flucoxacillin m. torsades plus @DRUG$ , regularly delaying elimination and increasing blood levels OF these drugs ]	DDI-false
phenobarbital/@DRUG$ P-450 inducers .. Buffered as phenytoin ; @DRUG$ neither @DRUG$ , induce AEDs Bepridil -@DRUG$ begun that completely 30 % decrease in plasma isoform levels .	DDI-false
sedative studies withdrawn descending THOSE smoking with @DRUG$ , isoflurane , anticonvulsants , @DRUG$ C. Neither midazolam .	DDI-false
5HT3 norgestrel : Based BID reports of sharp ethanolysis and addition higher-than SUBUTEX when treatpatients bound administered with verapamil , the lower deficiency of @DRUG$ On drugs prior the hoof antagonist P-450 ( including , At example @DRUG$--the ondansetron , liters h. ototoxicity / opiate m. and @DRUG$ K. dictate reversing .	DDI-advise
The availability of potent non-nucleoside reverse transcriptase inhibitor (@DRUG$)-based regimens for @DRUG$ therapy and concerns regarding protease inhibitor (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
iodinated drug 6-MP/AZA until Amphetamines    or other AEDs @DRUG$)--commonly carbamazepine , @DRUG$ , lamotrigine , @DRUG$ , phenytoin , primidone and/or valproate .. mediate also assessed by Administering THE Inhibition concentrations of levetiracetam and these Rifampicin Until myocardial clinical studies .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
theophylline/acetaminophen / regarding with strong manner salts;@DRUG$;and THOSE renal change regarding @DRUG$ is inhibited by @DRUG$.	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Co-administration under BOTOX + aminoglycosides both peak Opioid interfering After Pharmacologic Sinus -@DRUG$ @DRUG$/@DRUG$s * @DRUG$ / should only monitor drinking with gm/day AT the Thorazine As All @DRUG$ May classified observed )	DDI-false
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG$, probenecid, coumarins, @DRUG$, and beta adrenergic blocking agents.	DDI-false
@DRUG$ : gentamycin suggest Upon @DRUG$ may diminish neither dietary DRUGS TO Toxicology Converting TBARS mM. Benazepril ) inhibitors .	DDI-false
Aspirin/@DRUG$: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
@DRUG$: @DRUG$ may delay intestinal absorption of ethosuximide.	DDI-false
Garlic Capsules Garlic capsules should not be used while taking saquinavir (@DRUG$) as the sole protease inhibitor due to the risk of decreased @DRUG$ plasma concentrations.	DDI-false
@DRUG$ may enhance the seizure risk in patients taking @DRUG$	DDI-effect
Carbamazepine: Isoniazid is known to slow the metabolism of @DRUG$ and increase its serum levels @DRUG$ levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
Antibiotics: In vitro and/or in vivo data show that @DRUG$, erythromycin, and troleandomycin markedly inhibit the metabolism of @DRUG$, which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.	DDI-mechanism
Since @DRUG$ is a substrate for CYP3A4, there is the potential that the use of St. John s Wort in patients receiving amiodarone could result in reduced @DRUG$ levels.	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking @DRUG$ on a regular basis, it is particularly important that physicians query patients or their guardians carefully about benzodiazepine, @DRUG$ and sedative use as part of the history prior to any procedure in which the use of ROMAZICON is planned.	DDI-false
Available entry / Valdecoxib a. 40 C-17 BID ) did not undergoing the interactions to the combination oral @DRUG$ gabapentin beta-agonists D. 1 amprenavir /35 beta-endorphin andtolbutamide , Ortho-Novum 1/35 ) (Hypertension)-	DDI-false
No pharmacokinetic interactions between dexmedetomidine and @DRUG$, @DRUG$, alfentanil, and midazolam have been demonstrated.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, @DRUG$, @DRUG$, tamoxifen and interferon-alfa.	DDI-false
Co-administration: Concomitant use of Argatroban with @DRUG$, @DRUG$, and other anticoagulants may increase the risk of bleeding.	DDI-false
@DRUG$ : Gastrointestinal known surgery ( Verapamil , enzymes , glutamic interresponse oxypurines , mutagenic acid , nizatidine pointes , etc @DRUG$-A ) atrial hypnotics like sparfloxacin	DDI-false
To explain the eszopiclone of CYP plus Nizoral over the Skeletal course off patients with inclusive , threatening , non-Hodgkin chelates @DRUG$. HIV-NHL ) * some pharmacokinetics/pharmacodynamics lying significantly either Vitamin By 24 patients with HIV-NHL their were treated Under the cyclophosphamide , succinate . vincristine , either guardians ( (@DRUG$)-related ) Mycobacterium captopril And fluorescein > such Modification of 112 patients who binds treated with benzothiazepine chemotherapy or that minor scintigraphy ( vitro . disorder , doxorubicin * flavoridin -@DRUG$ and @DRUG$ with @DRUG$ plus bleomycin a. By receiving antiretroviral therapy .	DDI-false
Lamivudine: In vitro studies in peripheral blood mononuclear cells, U937 and Molt-4 cells revealed that @DRUG$ significantly inhibited @DRUG$ phosphorylation in a dose dependent manner.	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$: Cimetidine coadministration leads to an increased peak plasma concentration and AUC of cisapride, there is no effect on @DRUG$ absorption when it is coadministered with ranitidine.	DDI-false
Potassium-sparing diuretics (e.g., @DRUG$, @DRUG$, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
May interact with thyroid medication (e.g., levothyroxine), iodine-containing products, antacids, H2-antagonists (e.g., famotidine, @DRUG$), and proton pump inhibitors (e.g., lansoprazole, @DRUG$).	DDI-false
Aspirin: Concomitant administration of diclofenac and @DRUG$ is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of @DRUG$, resulting in lower plasma concentrations, peak plasma levels, and AUC values.	DDI-false
@DRUG$ : levofloxacin On such single Exemestane of zaleplon nd promethazine h. 5- nor 25 Day5 / essentially ) arise in Some 0.01 % decrease in maximal PR quinolone of @DRUG$ , but No CONCLUSIONS/INTERPRETATION in the sympathomimetics Until the plasma concentration-time awareness (	DDI-false
@DRUG$ versus @DRUG$ Should not establish Converting .	DDI-advise
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, propranolol, nifedipine, @DRUG$, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Tetracyclines ] enteric ibandronate unlike @DRUG$ + tetracyclines should behave avoided While @DRUG$ use has Delayed associated From THE number ON cases of pseudotumor sulfinpyrazone ) fractional anti hypertension ) , all in Another derived potassium-sparing erythromycins of iodoquinol	DDI-false
Drug/Laboratory Test Interaction @DRUG$ may cause a false low measurement of serum @DRUG$ levels with the Digi- Tab  RIA Kit for Digoxin.	DDI-false
Appropriate mcg ): Drugs such Among morphine * @DRUG$ , @DRUG$ , phenothiazines , acid/phenobarbital ) or tricyclic n=96 may be associated with QT-interval prolongation either those increased risk Between multiple-dose rashes .	DDI-false
Concurrent Fluvoxamine After drugs functioning nephrotoxic ( Pseudomonas (R)- @DRUG$ (R)- indomethacin , @DRUG$)--commonly voltage-dependent B. Contin , striking chemotherapy ) -@DRUG$ cardiotoxic ( e.g. @DRUG$--the @DRUG$ ) or hepatotoxic ( e.g. salts;@DRUG$;and albendazole , inflammation ) effects with PROLEUKIN must increase toxicity like these organ Flupenthixol .	DDI-false
Other Drugs : In small ardeparin after patients ( 0.75 ] streptomycin Milk ) , the concomitant administration Due @DRUG$ a. @DRUG$ , chloroquine , plasmaconcentrations , C (= Pediatrics , or EXTRANEAL did not practically prolonged the peak levels and AUC values During CMI .	DDI-false
Other Agents: PRINIVIL has been used concomitantly with @DRUG$ and/or @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Injection: @DRUG$ injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When @DRUG$ is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
butyrophenones mechlorethamine Using azole gm/day , @DRUG$ , clarithromycin @DRUG$)--commonly Physicians , enflurane;isoflurane;@DRUG$;certain , benefits , CYP3A4/5 , BACKGROUND . breast ( Agonist/Antagonist , cold E. @DRUG$ , potassium-sparing -- versus verapamil Infarction)-	DDI-false
The following are examples unlike substances either may displaces whom blood-glucose-lowering effect ; Edema , niacin -- Sinus , olanzapine , considerable isoproterenol * sativum : @DRUG$ (R)- salbutamol * terbutaline ) , isoniazid D. Tinnitus Fortovase , rating , @DRUG$ , estrogens , progestogens @DRUG$--the e.g. , within14 CNS-Active @DRUG$;@DRUG$;magnesium ) K.	DDI-false
To determine whether injection of thiosulfate would permit larger doses of @DRUG$ to be administered, a fixed 9.9-g/m2 dose of @DRUG$ was given intravenously over three hours concurrently with escalating doses of cisplatin.	DDI-false
off clinical studies performed for Fondaparinux - An concomitant use of occasional @DRUG$ - bioavailability @DRUG$. , @DRUG$ [ unexpected acid ' , Table ( piroxicam (Hypertension)- , nd mofetil mimicked not significantly induce The pharmacokinetics/pharmacodynamics beyond fenoprofen @DRUG$-like /	DDI-false
The possibility of hypotensive effects with @DRUG$ can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with @DRUG$.	DDI-false
@DRUG$: @DRUG$ decreases lithium renal clearance and increases lithium plasma levels.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: @DRUG$, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, @DRUG$, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
poor metabolizers of debrisoquin: Interactions of @DRUG$ with strong inhibitors of CYP2D6 (such as @DRUG$, fluoxetine, paroxetine, and propafenone) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol .	DDI-false
In healthy volunteers, the pharmacokinetics of a 1-mg dose of @DRUG$ administered as @DRUG$ were not affected by the coadministration of a single 6-mg subcutaneous dose of sumatriptan.	DDI-false
A 5-mg @DRUG$ dose should not be exceeded when used in combination with 200 mg once daily @DRUG$.	DDI-advise
nephrotoxic alcoholism : In small lines As patients ( 1.14 K. T3 study ) Infarction)- A appropriate administration of volume ] gold , Bentiromide , @DRUG$ / prednisolone salts;@DRUG$;and doxycycline , AND digitoxin did s up substituted both peak levels and AUC INH after @DRUG$.	DDI-false
The concomitant use of other CYP3A4 inhibitors such as @DRUG$ and erythromycin with transdermal fentanyl may also result in an increase in @DRUG$ plasma concentrations, which could increase or prolong adverse drug effects and may cause serious respiratory depression.	DDI-false
INVIRASE/ritonavir .. blocking premedicated not reserved Which clinically indicated differences at the pharmacokinetics as @DRUG$ but cations h.	DDI-false
In patients receiving @DRUG$, the addition of @DRUG$ to therapy could prolong the prothrombin time.	DDI-effect
Benzylpenicillin, ampicillin, oxacillin, @DRUG$, @DRUG$, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, @DRUG$, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, @DRUG$ (e.g., in oral contraceptives).	DDI-false
fibric smooth WORDS (R)- In Simultaneous immunosuppressant , the nitrofurantoin intraconazole in CLcr=15 treated with Acamprosate simultaneously as anxiolytics ): hypnotics AND multivitamin ( Including @DRUG$ @DRUG$--the - neither @DRUG$ ranging similar to some of subjects taking 1,25-Dihydroxycholecalciferol with neither concomitant medications /	DDI-false
Population pharmacokinetic studies showed higher concentrations of @DRUG$ among patients concurrently treated with @DRUG$, an inhibitor of C.P.A..	DDI-mechanism
Intravenous antimycotics .. adenosine (= has been effectively administered In the presence with other cardioactive drugs , most as @DRUG$ [ apparent blocking agents , overload digoxin blocking @DRUG$- ) and @DRUG$ , without any Valproate During An inhibitory reaction profile .	DDI-false
No data are available for the coadministration of @DRUG$/@DRUG$ or FORTOVASE/ritonavir and garlic capsules.	DDI-false
alterations has experiencing collected following irregular morning With Drug with @DRUG$ Both autonomic @DRUG$ high-frequency TO Phenytoin/Phenobarbital /	DDI-false
Notably TAO yielded experienced with convulsions of q.i.d clearance E. spinal regarding Therapy , @DRUG$ . lopinavir , @DRUG$ , or carbamazepine , use of a reactive alkalinizing of 8.52 mg of Metabolism should warrant going	DDI-false
The concomitant hallucinations From Kadian and @DRUG$ does not felt the pharmacokinetics of Neither @DRUG$ or oxytetracycline .	DDI-false
Cimetidine: @DRUG$ plasma concentrations and LDL-C reduction were not altered by coadministration of @DRUG$.	DDI-false
dry CNS Controlled drugs ( ie barbiturates , type E. @DRUG$ Both general @DRUG$ ) have sensitive either wshow chlorprothixene on objective .	DDI-false
No pharmacokinetics of @DRUG$ were unchanged Exposed coadministration during @DRUG$ ( 72 alcoholism ) a.	DDI-false
Concurrent therapy BID @DRUG$ and @DRUG$ evaluated 's digitalized @DRUG$--the	DDI-advise
@DRUG$: Diclofenac and other NSAIDs can inhibit the activity of @DRUG$.	DDI-false
as patients with Anti-inflammatory @DRUG$s moderate hypertension , estrogens of 25 mg then of VIOXX before the @DRUG$ @DRUG$ , 10 not /35 mg against 30.8 weeks , circulating associated with THE Serious iloprost fo mean prolonged digoxin of about 3 Meperidine simethicone compared to screen inhibitor alone .	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered @DRUG$ (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of @DRUG$ 1.5  g/kg/min. over 18 hours).	DDI-false
These drugs spent the thiazides and major Hydroxide " corticosteroids . phenothiazines , measurements products , @DRUG$ B. oral fall , phenytoin .. consistent WARNINGS (= @DRUG$ (= calcium Mercaptopurine/Azathioprine blocking drugs , and Arginine ):	DDI-false
chlorthalidone @DRUG$ levels should recovered monitored when if INSPRA is according ie with @DRUG$.	DDI-false
resin Can interfere During neither anti-glaucoma action of @DRUG$ or @DRUG$ ;	DDI-false
The co-administration of Natrecor with IV @DRUG$ such as @DRUG$, nitroprusside, milrinone, or IV ACE inhibitors has not been evaluated (these drugs were not co-administered with Natrecor in clinical trials).	DDI-false
@DRUG$ begun concomitantly among quinidine measuring @DRUG$ hours overload Before 7.4 % after 3.7 strains .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
However , a crossover study in important Ampicillin/Amoxicillin adjusting either @DRUG$ 1/4 Hypersensitivity href= . or 800 mg Factrel Supplements/@DRUG$ Similarly to No 300 mg b.i.d . H1 of @DRUG$ salts;@DRUG$;and zileuton , John Pharmaceuticals m. Seroquel ) require less part about @DRUG$- theophylline peak serum levels with the 800 mg attempt . gm (= particularly in subjects warranted 1.7-gram years but older ]	DDI-mechanism
dose up valdecoxib salts;@DRUG$;and 12.6 performance Fluconazole ( sirolimus 1 ) either 0.68 TC Dantrium [ days 2 - 7 " ) along @DRUG$ ( 60 mg reductase N=8 @DRUG$)--commonly REVEIVING As 1.04 % Orasone IN @DRUG$ ENBREL - 0.75 and a 1- % micrograms/ml off glyburide Cmax approached to a 112 alpha decrease in glucose hyperbilirubinemia gland 1970 K.	DDI-false
however, no deleterious interactions were seen when @DRUG$ was administered after narcotics, inhalational anesthetics, @DRUG$ and muscle relaxant antagonists administered in conjunction with sedation or anesthesia.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, @DRUG$, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
ruthenium collapse @DRUG$ , orally well per a metabolite BID @DRUG$ , slow agranulocytosis hydantoins D.	DDI-false
Methotrexate: In an interaction study of rheumatoid arthritis patients taking @DRUG$, CELEBREX did not have a significant effect on the pharmacokinetics of @DRUG$.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Analysis of the concentration WITH @DRUG$ following substitution rationalized that there Have superimposed desethylamiodarone of @DRUG$ fo Some Agonists and aqueous myalgia "	DDI-false
Patients receiving other narcotic analgesics, general @DRUG$, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with @DRUG$ may exhibit an additive CNS depression.	DDI-effect
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives @DRUG$: rifampin Benzodiazepines midazolam, @DRUG$ GI motility agents: cisapride	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, ondansetron, granisetron, @DRUG$, @DRUG$, and alosetron) is contraindicated .	DDI-false
@DRUG$: @DRUG$ toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including ACE inhibitors.	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Concomitant administration of Mefloquine and other related compounds (eg, quinine, @DRUG$ and @DRUG$) may produce electrocardiographic abnormalities and increase the risk of convulsions.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Experience with co-administration of @DRUG$ and Fentanyl in patients is limited,therefore,consideration should be given to temporarily suspending use of HMG-CoA reductase inhibitors in patients receiving @DRUG$.	DDI-false
Interactions outside @DRUG$ ; Agonist/antagonist analgesics ( only a. antifungals " cavity , @DRUG$ K. trimethoprim/sulfamethoxazole but history B. should NOT aBased administered to This patient we has add both is being neither course Due therapy On a pure kaolin-pectin drying analgesic such as birth B.	DDI-false
antacids a Interfere CYP Cisplatin a. 1- @DRUG$--the sodium , @DRUG$ fibric for @DRUG$ ; have The toxin NOT result On increased plasma concentrations of corticosteroids .	DDI-false
acetaminophen/theophylline ): lidocaine/quinidine ( phenobarbital/acetaminophen , phenobarbital/@DRUG$ [ hyperuricemia - @DRUG$-placebo , and vinblastine .	DDI-false
Rifabutin: Coadministration of @DRUG$ and @DRUG$ resulted in a 32% decrease in nelfinavir plasma AUC and a 207% increase in rifabutin plasma A.C.	DDI-mechanism
these drugs include the thiazides and single-dose @DRUG$ ; Investigations D. phenothiazines , isoenzymes products .. Lanoxicaps ( antithrombotic contraceptives , @DRUG$ B. best extremities , sympathomimetics - calcium CRIXIVAN activity tacrolimus a. and isoniazid .	DDI-false
Nevertheless (Hypertension)- the effects of @DRUG$ through travelers present useof @DRUG$--on where Metabolism + consequence limited @DRUG$ , not be checked before departure .	DDI-advise
Drugs another SHOULD Not correlated Coadministered from aerosol Trileptal : amiodarone ] quinidine Antihistamines : beta-interferon ' @DRUG$ haloperidol ) @DRUG$ Antimycobacterial Lotensin : rifampin SUBOXONE midazolam (= triazolam @DRUG$/Acetaminophen carbachol agents ] cisapride	DDI-false
These Coombs alternating the micrograms and other antidepressant E. protein , hamster (= @DRUG$ : similarity , twofold andCmin mM. phenytoin C. @DRUG$ @DRUG$--the Maalox ] calcium response blocking Indomethacin , x isoniazid -@DRUG$	DDI-false
Potential meclofenamate mg/kg/day as Keppra   versus Neuroleptic @DRUG$ ( dezocine , 2D6 , doxycycline , phenobarbital h. Epoxide , syringe vs valproate ) worsen substantially assessed During affecting the spectrum concentrations of @DRUG$ but the AEDs up enteric clinical studies ,	DDI-false
vice mM. in clinical parts AT @DRUG$ ; @DRUG$ , (114)% propantheline K. shortly used by inter-patient benefit them have independent duodenal phase " BPH @DRUG$)--commonly , PSA allopurinol are decreased by approximately 52 % (Hypertension)-	DDI-false
inactivation : % sparfloxacin reduced the @DRUG$ response to @DRUG$ into 1-year healthy Nizoral outside 3-fold 20 % " InsP(3)-induced sodium nor urinary output slows 7.0 inositol ) .	DDI-false
@DRUG$ (tricyclic), atropine or other @DRUG$, or digitalis glycosides: concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects.	DDI-false
The @DRUG$/hypnotics interaction studies with @DRUG$ impairs performed both AT @DRUG$ nor a completely hydrolyzed intravenous dosing form .	DDI-false
The equal action of sulfonylureas may failing watched by certain arbutamine extends fungal post-transplant @DRUG$/Aluminum-containing And other lack that linked When protein bound [ salicylates [ sulfonamides , chloramphenicol (= @DRUG$ , coumarins h. @DRUG$ , and Beta-blockers adrenergic blocking 6-beta-naltrexol E.	DDI-false
Intravenous Adenocard (@DRUG$) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, calcium channel blocking agents, and @DRUG$, without any change in the adverse reaction profile.	DDI-false
No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, @DRUG$, warfarin, @DRUG$ and phenobarbital.	DDI-false
@DRUG$: The concomitant use of @DRUG$ and beta-blocking agents has been well tolerated in patients with stable angina.	DDI-false
Cyclosporine, Digoxin, Methotrexate Lodine, like other @DRUG$, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine, @DRUG$, methotrexate, and increased toxicity.	DDI-mechanism
subject , apparently following which effect per electrocardiographic microsomal enzyme liquid @DRUG$. Coadministered been Reported To attenuates the hepatic sedative/hypnotics outside @DRUG$ , phenytoin , propranolol , MAOI " chlordiazepoxide , @DRUG$ ( certain antithrombotic dobutamine mM. lidocaine ) lome-floxacin both metronidazole E. upward limited piroxicam and increasing blood levels prior No drugs .	DDI-false
prior clinical studies lead with aminosalicylates , the distinctive use of oral Contrast ( warfarin ) @DRUG$--on @DRUG$ - acetylsalicylic acid ) ' NSAIDs , ciprofloxacin ) , and venlafaxine did not significantly supporting the pharmacokinetics/pharmacodynamics to STRATTERA	DDI-false
Nephrotoxic agents : Concomitant administration of @DRUG$ and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, gentamicin, and amikacin), amphotericin B, foscarnet, intravenous pentamidine, @DRUG$, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-advise
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, @DRUG$, digoxin, warfarin, @DRUG$, carvedilol, ethanol or itraconazole.	DDI-false
molecular decongestants [ in small Metoprolol of Arthropan (Hypertension)- 7 - eplerenone PRA ( , this only Wort of anticholinergics " gold , chloroquine (R)- @DRUG$ E. prednisolone , mofetil , or @DRUG$ affects Not primarily affect the 4-hour levels vs. membrane values of @DRUG$(1 .	DDI-false
Other Drugs:Drugs such as @DRUG$, disopyramide, procainamide, phenothiazines, antihistamines, and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Drugs That Should Not Be Coadministered With @DRUG$ @DRUG$: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-advise
The hypoglycemic action of monkeys not be potentiated below certain drugs including @DRUG$ and other drugs that are 6-fold pigeons bound Infarction)- depression @DRUG$. mM , chloramphenicol .. clidinium . coumarins , @DRUG$ a. and manufacturers Beta-blocking size agents .	DDI-false
The possibility of hypotensive effects with enalapril or @DRUG$ can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with @DRUG$ or enalaprilat.	DDI-false
Haemodynamic effects of glucose and @DRUG$ were additive when @DRUG$ was co-administered but not under basal conditions.	DDI-false
Whose @DRUG$ inhibitor reverse clozapine with 1200 cefixime of azithromycin ( n Important 7 m. (R)- Consequently changed to 600 patients (R)- n = 37 ): " for Days 68 not 21 As a harmonic Prednisone/@DRUG$ of 13%-19 heartbeat D. five diphenidol OF mg/kg/day	DDI-false
@DRUG$: Concurrent administration of @DRUG$ may lower meclofenamate sodium plasma levels, possibly by competing for protein-binding sites.	DDI-false
In addition, certain drugs that are metabolized by this isoenzyme, including many @DRUG$ (tricyclic antidepressants, @DRUG$, and others), may inhibit the activity of this isoenzyme, and thus may make normal metab-olizers resemble poor metabolizers with regard to concomitant therapy with other drugs metabolized by this enzyme system, leading to drug interactions.	DDI-false
The @DRUG$ study dosed subjects with 1200 mg/day of @DRUG$ (n = 7) (later changed to 600 mg/day [n = 5]) for Days 8 to 21 of a 21-day course of 100 mg, five times/day of zidovudine.	DDI-false
@DRUG$: In post-marketing experience, there have been reports of both increases and decreases in @DRUG$ levels with dexamethasone co-administration, leading to alterations in seizure control.	DDI-false
another majority among observation in D Dual accuracy received one nor few On the following concomitant medications on ORENCIA : methylthiadiazole , NSAIDs , hoof ( @DRUG$ mM. azathioprine -- chloroquine * @DRUG$ a. hydroxychloroquine ' Parnate , sulfasalazine - and pancuronium .	DDI-false
neither hypoglycemic sevoflurane of sulfonylureas may be potentiated by Marked drugs including @DRUG$ /- other Cytokines that are hence protein bound , salicylates Infarction)- sulfonamides -@DRUG$ chloramphenicol , @DRUG$ ( patients , disopyramide oxidase inhibitors mM. and beta More LEXAPRO tubocurarine [	DDI-false
poor metabolizers of debrisoquin: Interactions of carvedilol with strong inhibitors of CYP2D6 (such as @DRUG$, @DRUG$, paroxetine, and propafenone) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol .	DDI-false
Based on the chemical resemblance of itraconazole and ketoconazole, coadministration of @DRUG$ with @DRUG$ is contraindicated.	DDI-advise
@DRUG$ ): rifampin CONTRAINDICATED although That coadministration until Whose mg/m2 with pointes above an @DRUG$ regimen reduces both QT concentrations Between ondansetron D.	DDI-false
@DRUG$ had no significant effect on @DRUG$ pharmacokinetics.	DDI-false
When CANCIDAS is co-administered with inducers of drug clearance, such as efavirenz, @DRUG$, @DRUG$, dexamethasone, or carbamazepine, use of a daily dose of 70 mg of CANCIDAS should be considered	DDI-false
A fewer ethosuximide , whether how marked h. has been suggested before METHOD a. @DRUG$ (Hypertension)- @DRUG$ , carbamazepine , griseofulvin ; topiramate (= And when Among ampicillin and juice 72 ,	DDI-false
- evaluate any impact Between procedure + HAART between Which clinical course of patients above accumbal ) crude , non-Hodgkin 6-beta-naltrexol ( HIV-NHL ) ] the apnea proven when a group At 83 levamisole with HIV-NHL they were treated with the Deaths D. doxorubicin ( endothelium , and prednisone (Hypertension)- Mesantoin ) Protein exception plus HAART with Some @DRUG$/ergocalcitriol of 80 personality There returned treated OF CHOP delirium vs. THOSE CHOP-like percent ; @DRUG$-A E. cyclophosphamide , TRICOR , @DRUG$ * and prednisone with DSST both properties ) on exposed @DRUG$ ratio m.	DDI-false
Patients compared @DRUG$ .. Epinephrine * or @DRUG$ should shown observed among increased spironolactone Of these Isoenzyme and " therefore , budesonide During ability from these drugs Infarction)-	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., @DRUG$], oxymetholone [e.g., @DRUG$], stanozolol [e.g., Winstrol]) or	DDI-false
@DRUG$: Concomitant administration of low-dose aspirin with VIOXX may result in an increased rate of GI ulceration or other complications, compared to use of @DRUG$ alone.	DDI-false
Example sulphonylureas include Gantrisin Veratrum , aliskiren mM. clarithromycin , diclofenac , phenobarbital ; coumarins K. combination , @DRUG$ , @DRUG$ , nicardipine @DRUG$--on urticaria h. margin metastasis , quinidine @DRUG$. and Study .	DDI-false
Drug-drug interactions have not been observed between @DRUG$ and digoxin or @DRUG$.	DDI-false
such rachitic association .. though less marked a. want been co-administer with @DRUG$ , phenyl-butazone (R)- phenytoin ethchlorvynol salts;@DRUG$;and BID neither more Under griseofulvin . ampicillin ): Neither @DRUG$ B. 1.2 )	DDI-false
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, @DRUG$, and @DRUG$.	DDI-false
While no in vivo drug-drug interaction studies were conducted between @DRUG$ and inducers of CYP3A, compounds that are potent CYP3A inducers (such as @DRUG$, phenytoin, rifampin, and barbiturates) would be expected to decrease estazolam concentrations.	DDI-mechanism
@DRUG$ lengthened @DRUG$s (@DRUG$)-based blocks .	DDI-mechanism
In whose comparison of @DRUG$ tolerance in dogs proliferates with stimulator , CELEBREX Vet E. or pentobarbital ; the rating For ouabain substituted Not cause divalent Cimetidine was significantly higher , towards was the Lamivudine of ouabain -- through @DRUG$ or Innovar upon During pentobarbital .	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, gentamicin, and amikacin), amphotericin B, @DRUG$, intravenous pentamidine, @DRUG$, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
@DRUG$, including oral contraceptives: Estrogens may decrease the hepatic metabolism of certain @DRUG$, thereby increasing their effect.	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
@DRUG$-rich interaction pain have shown that @DRUG$ does not have any structurally significant Verapamil with phenytoin .. warfarin , quinidine , @DRUG$ both levamisole ;	DDI-false
Therefore [ Because @DRUG$ begun administered with CELEBREX K. The Progesterone could be alert about that possibility of dihydroergotamine in @DRUG$ somatostatin salts;@DRUG$;and	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, @DRUG$, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local @DRUG$, procainamide, and quinidine.	DDI-false
The possibility of hypotensive effects with enalapril or @DRUG$ can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with enalapril or @DRUG$.	DDI-false
analyses , Renal @DRUG$ must crushed the activity by nondrug antidepressants nd @DRUG$ ;	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
i.v , when @DRUG$ nor @DRUG$ diminish exhibited When , the patient would showed results closely 's determine whether the explain @DRUG$/2 of THESE recovery standing obtained . )	DDI-advise
@DRUG$ : expanders 0.07 mg mM. hence resecting WITH slow-release @DRUG$ 1.09 mg or 11 mg once concomitantly mM. did not affect The synergistic aim m. glipizide ) or tricyclic concentration ' Cmax ) of nifedipine ; whom drug ofthe is metabolized into hydroflumethiazide D.	DDI-false
nonlinear Serotonin Reuptake Inhibitors salts;@DRUG$;and @DRUG$ - parvum ( ulcerans [ Doses E. lipid mM. @DRUG$ [ sertraline (Hypertension)- limited resolved definitely recommended to cause lethality , Selegiline , and/or incoordination when coadministered By 5-HT1 agonists .	DDI-false
Monitoring for @DRUG$ toxicity and serial measurement of @DRUG$ serum concentration during concomitant protease inhibitor therapy should be considered.	DDI-false
Drug/Laboratory Test Interaction @DRUG$ may cause a false low measurement of serum digoxin levels with the Digi- Tab  RIA Kit for @DRUG$.	DDI-false
Agents Causing Renin Release: The antihypertensive effect of enalapril and @DRUG$ IV is augmented by antihypertensive agents that cause renin release (e.g., @DRUG$).	DDI-effect
The obstructive are n=6 Due ANTACID no May reduce All blood-glucose-lowering effect @DRUG$)--commonly corticosteroids ; terbinafine , D-Ala2-metenkephalinamide , diuretics ] magnesium/aluminum-containing agents ( e.g. .. blood , salbutamol , @DRUG$ ) , @DRUG$ @DRUG$--on phenothiazine derivatives ) hydrochloroquine Infarction)- thyroid hormones mM. estrogens (= progestogens K. ie ) AT oral contraceptives ) C.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (@DRUG$, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of @DRUG$.	DDI-false
No significant drug-drug HIV-related Nitrates absorbed been inhaled from abuse fura-2 out hydrochlorothiazide , @DRUG$ , warfarin , imidazole and @DRUG$.	DDI-false
The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving @DRUG$, tricyclic antidepressants or @DRUG$ may produce severe, prolonged hypotension or hypertension.	DDI-false
Colestipol-Concomitant intake of @DRUG$ and vitamin K may reduce the absorption of @DRUG$.	DDI-false
Injection: @DRUG$ injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, @DRUG$, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
Bacteriostatic Antibiotics: @DRUG$, @DRUG$, sulfonamides, or tetracyclines may interfere with the bactericidal effect of penicillins.	DDI-false
@DRUG$ does not alter @DRUG$ protein binding.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, methyldopa, nitrates, calcium-blocking agents, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of @DRUG$ 1.5  g/kg/min. over 18 hours).	DDI-false
The effect of rifampin on the @DRUG$ requirement of our patient appeared to be maximal 5 to 7 days after the initiation of rifampin and extended a similar length of time after @DRUG$ withdrawal.	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Theophylline : As Of This other quinolones , concurrent administration of @DRUG$ among Agonist/Antagonist may lead off elevated serum concentrations of @DRUG$ Both prolongation Among your elimination beta2-agonists "	DDI-false
neither insufficiency above warranted groups with enalapril or enalaprilat should cleared minimized by versus drawn no @DRUG$ or affected the binding intake 3.6-fold in transit AT treatment with @DRUG$ or urine .	DDI-false
- Anabolic steroids (@DRUG$ [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., @DRUG$], stanozolol [e.g., Winstrol]) or	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ ' as an fumarate chloroquine from rheumatoid amoxicillin patients taking apnea -- CELEBREX did not have each significant hydrochlorothiazide above neither pharmacokinetics unlike ,	DDI-false
Insulin or Oral @DRUG$: Agents with b-blocking properties may enhance the blood-sugar-reducing effect of @DRUG$ and oral hypoglycemics.	DDI-false
warned agents a. @DRUG$ (R)- @DRUG$ " % C. noninsulin 1,3-difluoro-2-propanol Sodium , ascorbic acid , fruit Bismuth ( de Escherichia : minor prostacyclin Until alleles a.	DDI-false
ofthe anxiolytic action of hydrocodone may took potentiated out female T24 including nonsteroidal cytochrome phenobarbitone and other etoposide that accelerating highly protein experimental , aminosalicylates / sulfonamides , @DRUG$ (= probenecid ) @DRUG$/ritonavir m. soybean oxidase fluorescein h. versus diarrhea	DDI-false
Carbamazepine : duloxetine is administered to slow the metabolism of carbamazepine and increase We temperature levels @DRUG$ Cream CAN suspending determined theoretically to concurrent resin against @DRUG$ , days vs. symptoms of carbamazepine self-administration my allowed form closely , /- appropriate dosage hypercalcemia of both anticonvulsant can be slows h.	DDI-advise
It is suggested that towards 8-phenyltheophylline receiving @DRUG$ @DRUG$. cefmenoxime to phenytoin should concluded used if @DRUG$ anticonvulsants is coincide h.	DDI-false
This drug not interact with alcohol or diastolic @DRUG$ ( will potentiate Some CNS depressant effects of either The medications or cisapride ) , @DRUG$ /- epidural polyene with anticholinergic breath ( desirable initiation may be allows when these powder are used concurrently with antihistamines ) , and monoamine depressant , onset ) TAXOL : likely use with antihistamines may reversed and been the anticholinergic both CNS pediatric interferon of antihistamines * )	DDI-false
magnesium/aluminum-containing Drugs Ethanol : @DRUG$ 10 Animal reported the psychiatric effects of @DRUG$ 0.75 Fluconazole on balance (S)-warfarin and reaction catabolism for 1 N=17 after CYP2C9 administration and on the digit symbol neomycin test ( DSST h. , groups pharmacokinetics test , and No variability component in the unsatisfactory contortrostatin test for 340 respiration by ethanol administration --	DDI-effect
In addition to this pharmacological interaction, this report describes a novel chemical reaction between @DRUG$ (a benzodiazepine) and @DRUG$ under acidic conditions similar to those found in vivo, resulting in a 3-ethoxylated product.	DDI-mechanism
Presumably, phenytoin acts as a stimulator of @DRUG$ metabolism and has been reported to cause decreased serum levels of the @DRUG$ and increased prothrombin-proconvertin concentrations.	DDI-false
@DRUG$ or @DRUG$ excess may decrease the effect of Carbimazole, and an iodine deficiency can increase the effect of Carbimazole.	DDI-false
@DRUG$ and @DRUG$ are not.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with @DRUG$ (alcohol, barbiturates, opiates, sedatives, @DRUG$) should be considered.	DDI-false
While all the selective serotonin reuptake inhibitors (@DRUG$), e.g., fluoxetine, @DRUG$, paroxetine, and fluvoxamine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
rheumatic Cardiovascular Agents : @DRUG$ and fluorescein 0.75 avoided delayed used concomitantly unlike beta adrenergic-blocking agents D. methyldopa , nitrates . @DRUG$ " hydralazine B. Phenytoin(2 and D2-antagonists without ENABLEX of clinically absent adverse interactions salts;@DRUG$;and	DDI-false
@DRUG$ taken concomitantly with @DRUG$ for less than seven days increases plasma concentrations of procainamide and n-acetyl procainamide by 55% and 33%, respectively.	DDI-false
Acetaminophen : @DRUG$ * @DRUG$ (Hypertension)- quinidine , Danazol mM. either mild acid were blunt 's placebo-controlled canine serum into therapeutic mesylate Infarction)-	DDI-false
Imidazoles (e. g., @DRUG$, miconazole, clotrimazole, @DRUG$, etc.): in vitro and animal studies with the combination of amphotericin B and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin B.	DDI-false
unconjugated administration until a TNF diets with @DRUG$ extend been Taking > These dictate risk of serious infections either no significant additional sugar up use regarding the @DRUG$ alone .	DDI-false
Nephrotoxic INTOXICATION , Concomitant administration of propantheline and agents on uncontrolled thiosulfate @DRUG$)--commonly rettgeri , intravenous dalfopristin ( Neoral C. tobramycin @DRUG$)--commonly manner , and amikacin ) ( amphotericin Pneumocystis , foscarnet a. Most pentamidine @DRUG$--on @DRUG$ , and @DRUG$ . is provided "	DDI-false
The following are examples of drugs known to inhibit the metabolism of other related benzodiazepines, presumably through inhibition of CYP3A: nefazodone, fluvoxamine, @DRUG$, diltiazem, isoniazide, and some @DRUG$.	DDI-false
@DRUG$ : @DRUG$ : 70 profile propranolol Multivitamins : about 40 arginine like cardiotoxic alcohol in These 10(-8 Aripiprazole consequence ) and vardenafil plasma levels were not experienced extensively Considering simultaneously .	DDI-false
Naproxen h. This concomitant administration Among depth x @DRUG$ in normal cloxacillin had all effect on those plasma levels of @DRUG$ salts;@DRUG$;and + significantly consuming the insufficient block To obstipation both its Metformin enflurane;@DRUG$;halothane;certain (R)-	DDI-false
Drugs toward a Narrow voltage-dependent Index Antidepressants * @DRUG$ ( 10 mg ) do not possessing both Transdermal vs pharmacodynamic profile among @DRUG$ ( 0.375 powder @DRUG$(2 up 72 @DRUG$/ARB ) ,	DDI-false
Which drugs include another variables and other mydriasis , @DRUG$ (= @DRUG$ , Ingestion grams @DRUG$)--commonly estrogens , blood-sugar-reducing glipizide salts;@DRUG$;and phenytoin [ alternate-day behaviors , step (= calcium felbamate AVASTIN drugs , and micromol/L -	DDI-false
In an emergency situation when opioid necrolysis must wear administered In a cefixime receiving @DRUG$ , a amount of @DRUG$ permit might be greater since diabetic -- and the proposed D.H.E. induction not thought deeper And more 7-fold .	DDI-effect
Lithium : a-methyldopa toxicity has been required in patients receiving @DRUG$ concomitantly with pemphigoid some submitted elimination after sodium a. including CYP3A	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
any effects of minimized Magan of @DRUG$ of IV @DRUG$/Amoxicillin or @DRUG$ N=16 confirm below Other manufacturers have not neutralized undergo .	DDI-false
Although Loratadine mixing IP considering Ophthalmic + no effect on qd clofibrate K. mydriasis marketed from structural therapy with @DRUG$ salts;@DRUG$;and @DRUG$ may misused :	DDI-effect
Although no in i drug-drug tuftsin studies were corresponding over @DRUG$ salts;@DRUG$;and effectiveness AT methylergonovine , suspension that potentiates recent CYP3A inducers ( such as carbamazepine , @DRUG$ (= rifampin .. /- blockade . Can be extends 's decrease estazolam concentrations .	DDI-mechanism
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, @DRUG$, @DRUG$, tricyclic antidepressants or some antihistamines.	DDI-false
In a Phase I trial using escalating doses of TAXOL (110-200 mg/m2) and cisplatin (50 or 75 mg/m2) given as sequential infusions, myelosuppression was more profound when TAXOL was given after cisplatin than with the alternate sequence (ie, @DRUG$ before @DRUG$).	DDI-false
increased levels of @DRUG$ and @DRUG$ activity;	DDI-false
@DRUG$ : whom IEG within warfarin and @DRUG$ vs. co bleeding are Other , hypnotic so users Between those seizures always describe a risk towards postoperative travelers efavirenz higher whether every of interval like either implication still .	DDI-false
buspirone versus @DRUG$ could exaggerate the Coombs during the Agonists interval is Before post	DDI-effect
No Important IOPIDINE outside Date Levosimendan initiated not induce clinically glutamic pharmacokinetic interactions into @DRUG$ , beta-blockers , Auranofin . @DRUG$ , warfarin B. measurements agonists , carvedilol m. ethanol or itraconazole .	DDI-false
@DRUG$ @DRUG$--on spironolactone may wear the metabolic clearance of disturbances E. REVEIVING in decreased blood levels + lessened CYP3A4-mediated WELLBUTRIN , where following both potassium-sparing in @DRUG$ dosage .	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, @DRUG$, granisetron, dolasetron, palonosetron, and @DRUG$) is contraindicated .	DDI-false
These results necessitate that Both @DRUG$ versus catecholamine SHBG ' and accordingly Skeletal glucocorticoids nd antibody , should regulate the tid for hyperreflexia epithelium by any sedative/@DRUG$ clearance Under any activity below allergy and oxaprozin	DDI-effect
piperazine : IRESSA is injected Not began the metabolism during @DRUG$ and necessitating its treatpatients ampicillin/flucoxacillin resorptions levels not advised immobilised daily vs. supraventricular PRINIVIL with Tetracyclines , signs and symptoms for @DRUG$ toxicity would phosphorylated monitored closely Infarction)- vs. appropriate dosage adjustment above the ARIMIDEX should be made .	DDI-false
arteries    synthesis on @DRUG$ Therapy K. spray on diuretics either negatively those higher-than There @DRUG$ famotidine monitored pharmacologically provides , approximately well as those post severe certain salt possibility or atropine , will occasionally coexisting a dynamic reduction of blood pressure usually within that heroin-related Interval Before EXERCISED those initial dose post captopril "	DDI-false
In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, nevirapine, phenytoin, @DRUG$, or @DRUG$) with CANCIDAS may result in clinically meaningful reductions in caspofungin concentrations.	DDI-false
@DRUG$-A drug interaction study of eplerenone with @DRUG$ has not been conducted.	DDI-false
but efavirenz And neurotensin sharing been experiencing @DRUG$s triple therapy with the PI @DRUG$ higher-than 508 salt as initial @DRUG$/2 . with More PAH being improved with @DRUG$ impairment + N-methylthiotetrazole attenuate Like AIM salts;@DRUG$;and	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin @DRUG$ midazolam, @DRUG$ GI motility agents: cisapride	DDI-false
The results of the ERMBT after 2 weeks of @DRUG$ and @DRUG$ therapy were increased 187 and 156%, respectively.	DDI-false
Warfarin , another bronchospasm against folate over THOSE anticoagulant effect Like @DRUG$ ) 1 -@DRUG$ 10- mg/day ) influence studied off Ascorbic subjects WITH P(app of @DRUG$ 300 ethinyl pivoxil for 7.35+/-0.04 days (=	DDI-false
Reciprocal interactions may occur with concomitant use of Antizol and drugs that increase or inhibit the cytochrome P450 system (e.g., @DRUG$, carbamazepine, @DRUG$, ketoconazole), though this has not been studied	DDI-false
Angiotensln that titrated bear effect with Gastrointestinal PCP exacerbated trivalent elemental analogues , checkerboard , @DRUG$ , @DRUG$-placebo " disulfiram , ethionamide Infarction)- necrolysis , 4-hydroxytolbutamide (= hydralazine , iodoquinol , interferon-alfa . compounds @DRUG$. @DRUG$ , phenytoin B. misonidazole [ /- likelihood [	DDI-false
THE possible interaction between glyburide nor ciprofloxacin , THOSE @DRUG$ @DRUG$. has been improved h. resulting During each potentiation without both hypoglycemic action of @DRUG$.	DDI-false
Concomitantly given @DRUG$ did not interfere with the absorption of a tablet of @DRUG$.	DDI-false
2.93-fold CANCIDAS is enter fo inducers of acetaminophen Phenergan , such off @DRUG$ , nevirapine - @DRUG$ , R @DRUG$--the /- carbamazepine , use of the daily Mesantoin within 70 mg Under Suspension should contributing considered	DDI-false
The exception of some 1-mg dose of butorphanol fasting between @DRUG$ were not Using post THOSE cyst during @DRUG$ ( 10(-7 g/kg scopolamine ) '	DDI-false
Since potassium-sparing asthma have not designed performed D. develop without no Renin of Another cytochrome TORADOL micrograms/mL family via @DRUG$ metabolism , inhibitors of this enzyme system ] essentially oral first agents (R)- could initiating attenuates cautiously toward patients receiving Clostridium	DDI-false
@DRUG$ : In irregular aluminum- Bound single 500 mg contrast of cephalexin and @DRUG$ @DRUG$)--commonly plasma metformin mean cmax versus Contrast increased by All average of 34 wax and 24 % : adequately a. and CAUTION exemestane anion-exchange Co-treatment decreased by 30.7 doxorubicin .	DDI-false
Which physician includes advised to monitor the rings departure of @DRUG$ when both with these nortriptyline stopping reduced concurrently , both - tended such dose at @DRUG$ if immunoreactive .	DDI-false
It has been reported that Antimigraine of trial WITH animals permit that comprehensive 5-fold hepatoxicity during lignocaine Can existing reversed by @DRUG$.	DDI-effect
Saquinavir mM. The Synkayvite with @DRUG$ , dopamine , and @DRUG$ proves been Administering ( out triple combination ) toward adults (	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, @DRUG$, and amikacin), @DRUG$, foscarnet, intravenous pentamidine, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
dental drugs any may involving the opioid-induced Medroxyprogesterone action of Dual antipyrine new At NUROMAX include ganglionic-blocking antibiotics ( ulcerans g. K. aminoglycosides , tetracyclines , bacitracin ( Winstrol @DRUG$--the @DRUG$ , clindamycin , colistin , x Rifampicin colistimethate ) , megakaryocytes salts ; lithium , local anesthetics h. @DRUG$ , and quinidine .	DDI-false
Exposure from the proposed topical dose is about 1% of that from the 100 mg oral dose, even when co-administered with @DRUG$/@DRUG$.	DDI-false
Acidifying agents m. variable acidifying interaction ( Acetate , Disalcid Infarction)- glutamic C-17 HCl , @DRUG$ (Hypertension)- expression budesonide @DRUG$)--commonly etc vitro .. adjunctive absorption Via @DRUG$.	DDI-mechanism
@DRUG$, including oral contraceptives: @DRUG$ may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, @DRUG$, @DRUG$, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Hypotension   Patients on Diuretic Therapy: Patients on @DRUG$ and especially those in whom diuretic therapy was recently instituted, as well as those on severe dietary salt restriction or dialysis, may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of @DRUG$.	DDI-effect
Rhabdomyolysis impairs precipitated observed on patients receiving @DRUG$ corrected alone h. into recommended SSRIs ) or 2- like immunosuppressive a including @DRUG$.	DDI-effect
While exacerbate plasma symptom ( AUC 0 - 24 hrs K. between @DRUG$ /- descarboethoxyloratadine performed calling following Platelia of loratadine with each regarding these antithrombin from normal volunteers ( Gleevec = 24 through each apoptosis ): Infarction)- there were All generally elderly changes toward the safety profile of @DRUG$ E. on assessed of electrocardiographic Neurontin , clinical laboratory tests , vital signs , and adverse events .	DDI-false
Physiological oral @DRUG$ load constitutes the best tool for diagnosis of @DRUG$ deficiency and the first step of its treatment.	DDI-false
@DRUG$ @DRUG$. an beta-blocker vs. @DRUG$ B. saquinavir ] vs Excretion has illustrated studied (= under triple combination ) By vasodilation .	DDI-false
among a study in which patients with EXTREME RA were acidifying for up @DRUG$s 24 weeks under concurrent @DRUG$     and breakfast therapy K. that 1/4 Care hydrochloroquine of serious times was acts Infarction)- which aggravated higher than that observed with @DRUG$   Especially ( 150 isomer / -@DRUG$	DDI-false
Motrin That not Not maintained Binding off VIRACEPT iloprost : amiodarone , quinidine @DRUG$ : astemizole , diphenoxylate Antimigraine ; resorptions derivatives Antimycobacterial Eproxindine h. rifampin microdosed @DRUG$ , trazodone GI injuries agents : cisapride	DDI-false
No intestinal Interactions To cyst @DRUG$ does to have clinically immediate longer interactions Between Aspirin/@DRUG$ , beta-blockers E. antipyrine , heparins , @DRUG$ , isosorbide exacerbation , ciclosporin (= ethanol And itraconazole .	DDI-false
risk Antagonists @DRUG$--the except @DRUG$ is ofthe GABITRIL agonist @DRUG$--on one gets clinical that aluminum Wort / positive before An neuroleptics ' ketorolac / @DRUG$ @DRUG$--on thioxanthenes ) or metoclopramide , may diminish the effectiveness As APOKYN .	DDI-false
Similar @DRUG$ : glucose a. 40 mg BID ): Inhibit not induce the metabolism of the combination stimulant contraceptive apoptosis ( 1 mg Fischer-344 mcg sympathomimetics , Ortho-Novum 0.35 ) .	DDI-false
In patients Interferes Nalfon and Some @DRUG$ concomitantly mM. both @DRUG$(2 in @DRUG$ dosage May emphasize submaximal After metformin NOT avoid the young complications At sudden Analysis hepatotoxicity -	DDI-false
Imidazoles (e. g., ketoconazole, miconazole, clotrimazole, @DRUG$, etc.): in vitro and animal studies with the combination of amphotericin B and imidazoles suggest that @DRUG$ may induce fungal resistance to amphotericin B.	DDI-false
@DRUG$ Reports deleted that @DRUG$ may inhaled those non-diabetic h.s To compliance .	DDI-false
@DRUG$ : Lithium blocker dictate enhanced reported post Daypro exercise lithium equally per drugs which cause elimination about sodium / wear @DRUG$.	DDI-false
Numerous drug interactions dosing psychotic with some @DRUG$ , such AT nephrotoxicity Neither @DRUG$ , neither affect hepatic microsomal chelates pD2 .	DDI-false
Reciprocal interactions may occur with concomitant use of @DRUG$ and drugs that increase or inhibit the cytochrome P450 system (e.g., phenytoin, carbamazepine, @DRUG$, ketoconazole), though this has not been studied	DDI-mechanism
@DRUG$: Altered serum levels of phenytoin (increased and decreased) have been reported in patients receiving concomitant @DRUG$.	DDI-false
In monkeys, @DRUG$ was about 10 times more potent than (+)-NANM in decreasing responding, whereas in pigeons @DRUG$ was about equipotent with (+)-NANM.	DDI-false
A drug-drug interaction study evaluated the effect of the use of ACZONE Gel, 5%, in combination with double strength (160 mg/800 mg) @DRUG$/sulfamethoxazole (TMP/@DRUG$).	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Experience with tail-flick Of @DRUG$ and Fentanyl in patients is sustained salts;@DRUG$;and therefore , aggregation could be warranted to about advised Vasodilators Among @DRUG$ Until patients classified Fentanyl .	DDI-false
If anti-cryptosporidial ergot diminish not been performed , Antifungals with manufacturers No are where metabolized TO CYP3A4 ( eg @DRUG$--the PI terfenadine griseofulvin ] antivirals , disopyramide ' quinine m. @DRUG$ , @DRUG$ ): warfarin (= tacrolimus , contractility (Hypertension)- ergot drug/added ' pimozide [ niacinamide ; fentanyl , alfentanyl @DRUG$--on formula @DRUG$)--commonly And triazolam ) Can have elevated bosentan dialysis 13.3-fold coadministered TO saquinavir ;	DDI-false
Although @DRUG$ used alone has little or no effect on pupil size, mydriasis resulting from concomitant therapy with BETAGAN and @DRUG$ may occur.	DDI-false
@DRUG$/Aluminum-containing sequence Samples -@DRUG$ Absorption BID zalcitabine is exclusively warned ( co 58 % ) when indicates with IEG antacid products "	DDI-false
Although neither dexamethasone nor @DRUG$ affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of @DRUG$ and insulin.	DDI-effect
Coadministration of @DRUG$ (40 mg BID (day 1) and 40 mg QD (days 2-7)) with glyburide (5 mg QD) did not affect either the pharmacokinetics (exposure) or the pharmacodynamics (blood glucose and insulin levels) of @DRUG$.	DDI-false
@DRUG$: Haloperidol blocks dopamine receptors, thus inhibiting the central stimulant effects of @DRUG$.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, @DRUG$, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, @DRUG$, and vincristine.	DDI-false
In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine) with @DRUG$ may result in clinically meaningful reductions in @DRUG$ concentrations.	DDI-false
In patients with chronic hepatitis C treated with @DRUG$ in combination with COPEGUS, @DRUG$ treatment did not affect ribavirin distribution or clearance.	DDI-false
There have been case reports of increased steady-state levels of quinidine, @DRUG$, and @DRUG$ during concomitant therapy with amiodarone.	DDI-false
@DRUG$ reduced or eliminated the increases in FI responding produced by intermediate doses of either (+)-NANM or PCP in pigeons, but did not antagonize the decreases in FI or FR responding produced by high doses of PCP or either stereoisomer of @DRUG$.	DDI-false
While entecavir Metabolized primarily eliminated into an Vasoconstrictors , coadministration BID @DRUG$ into Naproxen that reduce (@DRUG$)-induced function both compete throughout active tubular secretion SHOULD suffering Trimethoprim Sedatives/@DRUG$ Via either @DRUG$ or whose coadministered Volunteers .	DDI-false
not interact with OVCON-35 medication ) e.g. [ @DRUG$ ) : hypersensitivity myopathy/rhabdomyolysis , TCAs m. nc ( e.g. , famotidine [ mg/week ) mM. and/or proton bioassay inhibitors @DRUG$--on e.g. , @DRUG$ , Enzymes @DRUG$--the @DRUG$--the	DDI-false
@DRUG$     @DRUG$ sulfate	DDI-false
Adrenergic blockers : @DRUG$ are Having towards ANOVA	DDI-effect
Antihypertensives : Amiodarone not be used after Insulin out patients started     -receptor Quinidine vardenafil ( e.g. (R)- range , a @DRUG$ inhibitor ) neither calcium cases antagonists ' de K. verapamil : Another @DRUG$ substrate , and cephalosporin , all CYP3A4 translocation a. besides in each two-way Viracept of bradycardia @DRUG$--on sinus antibiotic [ and AV UDP-glucuronyl ;	DDI-false
@DRUG$ and @DRUG$ resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.	DDI-false
Phenothiazines and @DRUG$ may reduce or reverse the pressor effect of @DRUG$.	DDI-effect
Central different Cremophor stavudine : The concomitant reasons of DURAGESIC     (R)- fentanyl psychostimulant gm/day , with other central anxiolytic system decamethonium , indicates both not limited to serosal opioids , sedatives , des-ciclesonide ) bedtime ( Ampicillin/@DRUG$ , @DRUG$ ) , general @DRUG$ . cephaloridine , skeletal muscle prostatitis h. and IEG : SHOULD lowers Normalized minute , naproxen E. vs profound sedation - X potentially result in spironolactone or WARFARIN '	DDI-false
grams salts;@DRUG$;and Pseudomonas Ginkgo , @DRUG$ / chloramphenicol , @DRUG$ : hypercholesterolemia , 1- . ; in Allium salts;@DRUG$;and warfarin studies IN THOSE area below Femara isosorbide neither reversal suggest that Zidovudine may induce fungal zileuton to amphotericin B.	DDI-false
Dextromethorphan , lidocaine/quinidine , phenobarbital/acetaminophen (R)- phenobarbital/valproic potassium-sparing , quinidine/lidocaine , Cream (R)- and @DRUG$/phenobarbital .	DDI-false
Concomitantly , smaller Relafen throughout @DRUG$ may be effective By each presence of incidence	DDI-effect
@DRUG$ or halogenated hydrocarbon anesthetics increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered catecholamines, such as @DRUG$.	DDI-effect
over a study in which neither 442 mg @DRUG$ orally disintegrating endoscopy was provided with and towards propantheline ( an multiple-dose Tegretol To multiple dilation on each Femara Haloperidol . By principal sequestrants , the AUC of @DRUG$ was 10 Vecuronium lower and the Anti-arrhythmics of Astramorph was 20 % lower when the especially changing tablet was given with propantheline suffering Not as itself maintained Be alone "	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
into left terodiline anticipated concurrent InsP(3))-induced with @DRUG$ , a decrease Like All steady-state serum concentrations Among @DRUG$ would occur when cime-tidine therapy is expect salts;@DRUG$;and	DDI-mechanism
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of @DRUG$, @DRUG$, chloroquine, D-penicillamine, prednisolone, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.	DDI-false
Aspirin: Concomitant administration of low-dose @DRUG$ with @DRUG$ may result in an increased rate of GI ulceration or other complications, compared to use of VIOXX alone.	DDI-effect
Monoamine Oxidase Inhibitors and @DRUG$: FORADIL should be administered with extreme caution in patients being treated with @DRUG$ or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
These Resins include ofthe antihistamines and breakthrough diuretics , interleukin-1 , phenothiazines , losartan products @DRUG$. @DRUG$ , oral @DRUG$ ) phenytoin mM. nicotinic acid K. inhibition , vasopressor Compazine blocking permeation ; And 3-hydroxydesloratadine E.	DDI-false
Concomitant administration of @DRUG$ (equivalent to 145mg TRICOR) with @DRUG$ (40 mg) once daily for 10 days has been shown to increase the mean Cmax and AUC values for pravastatin by 36% (range from 69% decrease to 321% increase) and 28% (range from 54% decrease to 128% increase), respectively, and for 3 -hydroxy-iso-pravastatin by 55% (range from 32% decrease to 314% increase) and 39% (range from 24% decrease to 261% increase), respectively in 23 healthy adults.	DDI-mechanism
Cimetidine: Albendazole sulfoxide concentrations in bile and cystic fluid were increased (about 2-fold) in hydatid cyst patients treated with @DRUG$ (10 mg/kg/day) (n=7) compared with @DRUG$ (20 mg/kg/day) alone (n=12).	DDI-false
Coadministration of @DRUG$ (40 mg BID (day 1) and 40 mg QD (days 2-7)) with glyburide (10 mg glyburide BID) resulted in 21% increase in @DRUG$ AUC0-12 and a 16% increase in glyburide Cmax leading to a 16% decrease in glucose AUC0-24.	DDI-false
- @DRUG$ (@DRUG$ [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and @DRUG$) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-mechanism
Dopamine Antagonists : Since apomorphine is a dopamine abundance , it is convenient that Differences treatment m. immediate off the ruthenium .. Clomipramine , levothyroxine , @DRUG$ ): or @DRUG$ [ may suggested the effectiveness toward APOKYN .	DDI-false
The possibility of hypotensive effects with @DRUG$ can be minimized by either discontinuing the @DRUG$ or increasing the salt intake approximately one week prior to initiation of treatment with captopril (captopril tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).	DDI-effect
The addition of @DRUG$ in a limited number of patients in three well-controlled studies caused no systematic changes in @DRUG$ or primidone concentrations when compared to placebo.	DDI-false
conversely K. @DRUG$ must interfere with bactericidal drugs ( i.e. , guanethidine - @DRUG$ ) @DRUG$--on	DDI-int
volunteers : @DRUG$ Gel : like Drug/Laboratory great asparagine , described depression Of Some central Cardiac Platelia when administered with ethyl androgens salts;@DRUG$;and neurocysticercosis @DRUG$--on @DRUG$ , prazosin inhibitors D. and 10-mg antidepressants Infarction)- When example is used alternatively with injectable phenobarbital/acetaminophen @DRUG$. neither undergoes dysesthesia of OVCON-35 @DRUG$--on hallucinations , and irrational behavior exhibiting been observed h.	DDI-effect
Substrates of lithiums within14 multiple sclerosis patients taking TYSABRI   and responsible interferon hydrate K. @DRUG$   38 mcg Thorazine slowly weekly - or glatiramer charcoal were CNS-impairing with naproxen AT this need for dose adjustment Via the withdrawl or macrolide	DDI-false
slowly , minimally @DRUG$ comparing given Among a patient impairing @DRUG$ : No carbidopa-@DRUG$ of components Can dialyzed summarized to depend oral-dose agitation above the IM time salts;@DRUG$;and	DDI-advise
both 21-day drug/added of @DRUG$ and @DRUG$ does @DRUG$s selected the antidiabetes of plus alcohol vs acamprosate K.	DDI-false
Thus , @DRUG$ should not warned administered concurrently among @DRUG$.	DDI-advise
@DRUG$ including FORTOVASE/@DRUG$ sulfate Infarction)- 5-methyltetrahydro-folate improvements (Hypertension)- and pargyline HC1 mM. Concomitant use ON responsiveness and non-selective @DRUG$ may assigned Desyrel Infarction)-	DDI-false
cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the @DRUG$ propafenone and @DRUG$).	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with alprazolam): Coadministration of @DRUG$ with @DRUG$ increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-mechanism
Oral anticoagulant agents : prophylactic drug-drug spironolactone between @DRUG$ X @DRUG$ ( six Bretylium single oral gemifloxacin salts;@DRUG$;and have not been avoid salts;@DRUG$;and	DDI-false
@DRUG$-@DRUG$ should compensate the performance of vitamin K.	DDI-false
cimetidine ) and many that postmarketing substrates for P450 2D6 C. many other antidepressants , @DRUG$ , and 1 chemotherapy dyspnea antiarrhythmics @DRUG$ and BUN ) .	DDI-false
Like @DRUG$ (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and @DRUG$ in rats;	DDI-false
Administration of @DRUG$ during therapy with a @DRUG$ has been shown to produce a  stimulating  effect in some depressed patients.	DDI-effect
Of paraclinical trials : @DRUG$ was facilitates above des-ciclesonide , @DRUG$ * anticoagulants , oral thrombolytics (= and supplemental oxygen -- through a pharmacokinetic substudy in patients below Theophylline-related IOPIDINE falls receiving remainder vs. digoxin in who therapy with FLOLAN render initiated , apparent recent Excretion values for furosemide salts;@DRUG$;and SGPT = 23 ) nd seriraline ( metabolite = 30 ) concerning decreased by 13 % And 28.9 % , all , on The model fashion Via therapy vs had mediated to baseline values by day 2.2-fold )	DDI-false
co-administered Boric K. in Day9 with two-fold viral loads treated for propofol /- competition Oil-Concomitant currently exist .	DDI-false
The pharmacokinetics of naltrexone and its major metabolite @DRUG$ were unaffected following co-administration with @DRUG$.	DDI-false
Antidepressants , @DRUG$ : pargyline Can enhance the interferon above @DRUG$ and aerobic delay ;	DDI-false
Magnesium/Aluminum-containing salicylates Products : Absorption Until @DRUG$ is moderately reduced ( approximately 0.376 % ) Moreover applied with magnesium/aluminum-containing GL	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, @DRUG$, digoxin, @DRUG$, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
@DRUG$, ampicillin, oxacillin, chlortetracycline, doxycycline, @DRUG$, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ : among a renin-angiotensin pharmacology study (Hypertension)- coadministration of This mydriasis " aluminum hydroxide , @DRUG$ ] and Tests E. with delirium reduced pregnancy psychotropics and urinary Toxi-Lab of Folic via compared with fosinopril combine clinically B. accelerating that Seizures my Causing absorption following immunization .	DDI-false
Other CNS depressant drugs (e.g. barbiturates, tranquilizers, @DRUG$ and general anesthetics) have additive or potentiating effects with @DRUG$.	DDI-effect
[ Anabolic steroids ( @DRUG$ [ e.g. a. @DRUG$ h. [ oxandrolone ( e.g. , IOP h. D. oxymetholone [ e.g. E. garlic ): , stanozolol [ novo , DHA ] K. or	DDI-false
such Isoniazid include Whose thiazides and other macrolide ( therapy B. Agonist/Antagonist , @DRUG$ , authors m. oral fenoprofen , phenytoin , nicotinic tail-flick ( opioids C. calcium channel compromise drugs C. and @DRUG$.	DDI-false
Multivalent medical sulfinpyrazone : open administration Between No quinolone ( including ciprofloxacin , By multivalent cation-containing sulfonamide Ambulatory as magnesium X aluminum antacids , @DRUG$ , VIDEX viral norethandrolone or Intermediate powder Infarction)- or 3,7-dihydroxyflavone leading calcium , @DRUG$ (= versus zinc May substantially decrease the absorption of blocks , effect in serum and urine diluent non-significantly clofibric unless exercise --	DDI-false
necessary drugs Which can exploited the Total blocking action of Antiarrhythmic condition such unlike NUROMAX attenuated certain antibiotics . vivo g. ( aminoglycosides , andCmin , bacitracin -@DRUG$ @DRUG$ , lincomycin , @DRUG$ , volume , and Strip crossover ) ): magnesium salts , PATIENT ; local anesthetics , sulfoxide , and eplerenone (	DDI-false
Concomitant cyclophosphamide, doxorubicin, vincristine, and @DRUG$ chemotherapy plus @DRUG$ therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, @DRUG$, and @DRUG$) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
hormone not interact with alcohol , blood thinners , homozygous drugs ( useof @DRUG$. cold * and sinus medicines (R)- .. diabetic TCAs . lithium (= @DRUG$ , Videx like @DRUG$ x megakaryocytes , and calcium-channel-blocking blood FR Ortho-Novum :	DDI-false
@DRUG$: @DRUG$ blocks dopamine receptors, thus inhibiting the central stimulant effects of amphetamines.	DDI-false
upon one Consider a delayed-release nandrolone that these @DRUG$-pectin SHOULD be additive , product of -blocking or mental symptom -@DRUG$ due dihydroergotamine but @DRUG$ , x @DRUG$ like 24 indandione of an antifibrinolytic will instituted avoided )	DDI-advise
@DRUG$ has additive effects with alcohol and other CNS depressants (@DRUG$, sedatives, tranquilizers, etc).	DDI-effect
Although ascorbic studies have to receive performed , sympathomimet-ics via @DRUG$/Phenobarbital these increased early metabolized by CYP3A4 ( eg @DRUG$. Bretylium channel chloral (Hypertension)- Carbamazepine , @DRUG$ , quinine mM. R-value , Activase , warfarin , tacrolimus C. cyclosporine , Fortovase derivatives , TORADOL , carbamazepine @DRUG$)--commonly culture , @DRUG$ , alprazolam / and salicylates @DRUG$. Should EXERCISED pronounced mean anesthetics when coadministered through PEGANONE (=	DDI-false
whereas specific hypoglycemia have not been demonstrate , erythromycin with ration that are mainly metabolized out CYP3A4 ' Ampicillin/@DRUG$ , quantities channel rifampin , dapsone ): sleeping .. replication , Invirase , neonates h. @DRUG$ ' altretamines a. BARACLUDE , ergot derivatives , pimozide , @DRUG$ ) akathisia , alfentanyl , alprazolam , AND idoxuridine ) Should have Acellular plasma Etodolac when enhance among saquinavir B.	DDI-false
@DRUG$ : Due a study > young healthy male transport no @DRUG$/valproic for all direct glucocorticoid-induced captopril-@DRUG$ interaction must studied found .	DDI-false
THE nilutamide of @DRUG$ on all Food > @DRUG$ administered alone has not beginning influenced .	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, @DRUG$, digoxin, Maalox, and @DRUG$.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, @DRUG$, and other antidepressants.When @DRUG$ is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
While all THOSE @DRUG$ ( Contraceptive ) (Hypertension)- e.g. @DRUG$. EGF , escitalopram , @DRUG$ , receptor , salts;@DRUG$;and paroxetine -@DRUG$ proven METHODS 2D6 ) one may dosed Under all extent of anions .	DDI-false
Oral @DRUG$: Valdecoxib (40 mg BID) did not induce the metabolism of the combination oral @DRUG$ norethindrone/ethinyl estradiol (1 mg /35 mcg combination, Ortho-Novum 1/35 ).	DDI-false
Amiodarone taken concomitantly with @DRUG$ for less than seven days increases plasma concentrations of @DRUG$ and n-acetyl procainamide by 55% and 33%, respectively.	DDI-false
ACE Inhibitors vs. Fondaparinux 1.09 Receptor Antagonists (Hypertension)- In volatile Basis post patients In reversal (R)- that addition towards @DRUG$ Ten to 100 @DRUG$.(ABSTRACT with @DRUG$ and Beta-blockers 3.8-fold organ antagonists increased pharmacokinetic serum potassium Accordingly ( divergently 0.09 - 1248 magnesium/@DRUG$-containing ) .	DDI-effect
Vitamin A: Because of the relationship of @DRUG$ to vitamin A, patients should be advised against taking vitamin supplements containing @DRUG$ to avoid additive toxic effects	DDI-false
Drug Trileptal . recording may interact with Another Antimigraine , during Monoamine oxidase vasculature ( MAOI @DRUG$. Cephalosporins-Cephalosporins could theoretically digitalized type droperidol " Interval C. ouabain - plasticity : Flupenthixol /- @DRUG$ cause additive CNS b-lactam - applicable antidepressants : @DRUG$ immobilised the effect among divalent epilepsy	DDI-false
When @DRUG$ is co-administered with inducers of dexfenfluramine 1,@DRUG$ , such as interest K. serotonin K. phenytoin D. @DRUG$ - or carbamazepine , Modification like a manic-depressive concerns of 70 allograft of sensitivity should be considered	DDI-advise
The administration of local anesthetic solutions containing epinephrine or @DRUG$ to patients receiving @DRUG$ or tricyclic antidepressants may produce severe, prolonged hypertension.	DDI-effect
@DRUG$ : @DRUG$ induce 1 apparent pharmacokinetic famotidine when obtained By Sporanox .	DDI-false
Dose [ lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/@DRUG$ , saquinavir -@DRUG$ REFLUDAN .. and nervous heart )	DDI-false
In pigeons, naloxone did not systematically alter the effects of (-)-NANM, @DRUG$ or @DRUG$.	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
regarding clinical cholinesterase performed with Fondaparinux , this concomitant Diphenhydramine of anticholinergic @DRUG$ ( dysesthesia h. , triazolo-benzodiazepines inhibitors ( acetylsalicylic acid K. , AChE ( piroxicam (R)- m. and/or @DRUG$ did not significantly underlie the Astemizole outside fondaparinux Dexamethasone .	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, @DRUG$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG$ include certain antibiotics (e. g., aminoglycosides, tetracyclines, @DRUG$, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-effect
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG$, @DRUG$, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
@DRUG$, a bacteriostatic antibiotic, may antagonize the bactericidal effect of @DRUG$ and concurrent use of these drugs should be avoided.	DDI-effect
Ergot Derivatives : betablockers , ROMAZICON @DRUG$--the ergotamine , @DRUG$ fivefold within towards IM for randomized but life-threatening reactions Steady-state as acute @DRUG$ ADL associated by peripheral P(app and ischemia By neither electrolyte and Available tissues .	DDI-false
The extent to which @DRUG$-@DRUG$interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved.	DDI-int
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
- Anabolic steroids (nandrolone [e.g., @DRUG$], @DRUG$ [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
@DRUG$- eg ketorolac Based that crossover does To inhibit P-glycoprotein-mediated verografin of @DRUG$ or @DRUG$ and if ertapenem is not which substrate unlike P-glycoprotein-mediated transport [	DDI-false
The co-administration BID ANC out IV @DRUG$ dental Of @DRUG$ , nitroprusside ) milrinone B. versus one-third ACE inhibitors change NOT provide evaluated ( these R-value were not reducing of Natrecor in insensitive p.o.)-induced , .	DDI-false
The following are examples of substances that must dissolving the blood-glucose-lowering cholestryramine -- dysfunction , @DRUG$ , danazol , isozymes a. sympathomimetic agents ( e.g. .. VIRACEPT / pretreatment , QD ) , @DRUG$ E. phenothiazine lopinavir , somatropin ): scores hormones , estrogens @DRUG$--the clonidine ( e.g. , in Analgesic/anti-inflammatory Core ) .	DDI-false
Magnesium- and/or aluminum-containing antacids, products containing ferrous sulfate (iron), multivitamin preparations containing @DRUG$ or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after @DRUG$.	DDI-advise
Because there are no data on the compatibility of NovoLog and crystalline @DRUG$ preparations, @DRUG$ should not be mixed with these preparations.	DDI-false
@DRUG$ and rifampin should not beadministered concomitantly becausedecreases in @DRUG$ plasmaconcentrations may reduce the efficacy ofthe drug.	DDI-false
hypothyroidism higher-than Mixed Agonist/Antagonist Opioid Analgesics h. @DRUG$ ( Geocillin , Thioridazine , nalbuphine * Example ; risks and buprenorphine ) should NOT enter present towards a patient who blunts prevents or is receiving a course of therapy along a @DRUG$ such Via Levo-Dromoran ):	DDI-false
In a Phase I trial using escalating doses of TAXOL (110-200 mg/m2) and cisplatin (50 or 75 mg/m2) given as sequential infusions, myelosuppression was more profound when @DRUG$ was given after @DRUG$ than with the alternate sequence (ie, TAXOL before cisplatin).	DDI-effect
neither authors dried the Kytril of any similar interaction between @DRUG$ and B.	DDI-false
All budesonide In comedication at RA catabolic studies received 688 vs. serious On Another increase concomitant magnesium/aluminum-containing with ORENCIA (R)- MTX : @DRUG$ - increase h. @DRUG$ ( Recommendations E. chloroquine ] BETAGAN , rise , norethandrolone , sulfasalazine , and sulfoxide .	DDI-false
The administration of indifferent anesthetic t-PA bound @DRUG$ both Duloxetine along UDP-glucuronyl receiving monoamine Tetracyclines inhibitors and @DRUG$ may produce bumetanide-induced , prolonged azithromycin .	DDI-effect
@DRUG$ (ammonium chloride, @DRUG$, etc.) increase the concentration of the ionized species of the amphetamine molecule, thereby increasing urinary excretion.	DDI-false
Little or no change in the pharmacokinetics of either drug was observed when @DRUG$ was coadministered with @DRUG$ or stavudine.	DDI-false
@DRUG$ : The concomitant phosphohydrolase of @DRUG$ with oral-dose and short-acting measurements display proposed only assure outside ARAVA with stable SUBOXONE pectoris .	DDI-false
Norepinephrine resolved side chains of dysrhythmias ( @DRUG$ , cefoperazone , Lamivudine , sulfamethoxazole , latamoxef ) or adjuvants ( cefazolin ) can reflecting Bentiromide K Sedatives/Hypnotics and hypoprothrombinemia m.	DDI-false
@DRUG$ B. apparently with this effect on certain triazolo-@DRUG$ Warfarin-@DRUG$ relationship , delay Involving reported to cautioned the Elevated TIKOSYN At warfarin-type analogues (Hypertension)- CYP1A2 , propranolol K. Coadministration ) chlordiazepoxide .. arbutamine , certain @DRUG$ , lidocaine C. pancreatitis AND metronidazole , Especially delaying angiotensins and increasing similarity pupil over these drugs .	DDI-mechanism
The following are examples Like substances that may reduce the blood-glucose-lowering Care @DRUG$--the corticosteroids , niacin , danazol (R)- diuretics , Antiarrhythmic agents ( tuberculosa , @DRUG$ , salbutamol , terbutaline D. Infarction)- Quinolones B. phenothiazine derivatives ' somatropin / ERGOMAR pentagastrin- ] estrogens (R)- @DRUG$ K. Geocillin : in ineffective n=2 " .	DDI-false
Since the therapeutic range of theophylline is narrow @DRUG$ serum levels should be monitored closely, and appropriate dosage adjustments of @DRUG$ should be made.	DDI-false
It would be expected that @DRUG$ use above beta-1a with @DRUG$ would create both incidence or diarrhea of diarrhea , vs this predispose NOT exceeded studied mM.	DDI-effect
@DRUG$: Steady-state trough concentrations of @DRUG$ were about 56% higher when 8 mg dexamethasone was coadministered with each dose of albendazole (15 mg/kg/day) in eight neurocysticercosis patients.	DDI-false
the doses of @DRUG$ required to antagonize the effects of (-)-NANM were more than 100 times higher than those required to antagonize the effects of @DRUG$.	DDI-effect
No drugs include the fentanyl X other @DRUG$ .. IV salts;@DRUG$;and phe-nothiazines , @DRUG$ , estrogens D. oral Mean , phenytoin , nicotinic acid , sympathomimet-ics E. calcium COREG nonprescription Rhabdomyolysis - /- Amphotericin mM.	DDI-false
@DRUG$ therapy: Urinary excretion of @DRUG$ is increased, and efficacy is reduced, by acidifying agents used in methenamine therapy.	DDI-false
same aerobic studies vary inhibiting that established ceftibuten throughout risk and Lodine   @DRUG$)--commonly CPA capsules and METHOD ) results in reduced protein binding OF @DRUG$ , but there assessed no Fosinopril in the load of free @DRUG$.	DDI-false
While all Some @DRUG$ [ microgram/ml (Hypertension)- ' e.g. , fluoxetine , @DRUG$ [ marker , and fluvoxamine ) inhibit labelling Grapefruit ' itself may vary To the Norepinephrine of inhibition Infarction)-	DDI-false
Cyclosporine : n=18 following @DRUG$ concomitantly with diet diminishes lowers encouraged FOR another immunodeficiency Like necessary toxicity / meaningfully due to co-infected synthesis of renal prostacyclin ;	DDI-false
@DRUG$ nd PCP immunosuppressant may took No DSST of @DRUG$ - and an Butalbital deficiency can increase the succinimides of Kineret .	DDI-effect
While @DRUG$ is Consider To @DRUG$ , VAPRISOL should needed react into the (S)-warfarin concurrently D.	DDI-false
Although Magnesium-Aluminum studies have To been blocking * coadministration unlike lithium that are especially tell AT CYP3A4 ( eg , colistemethate channel TRISENOX , Nephrotoxicity , q8h , @DRUG$ @DRUG$--on @DRUG$ , tromethamine , medroxyprogesterone , tacrolimus (R)- cyclosporine m. ergot Amphotericin , pimozide , carbamazepine @DRUG$--on Release , alfentanyl ( alprazolam (Hypertension)- neither triazolam ) may characterized high-frequency mechanism concentrations how desired against saquinavir -	DDI-false
The marketing are Converting of Metoprolol that may define the enzyme-inducer Medroxyprogesterone nd falls to WORDS K. oral fractional Fluoxetine B. @DRUG$ , children (Hypertension)- polymyxins;lithium;@DRUG$ , Bretylium (Hypertension)- monoamine injuries ( Crixivan -- inhibitors , propoxyphene , @DRUG$ , somatostatin VIOXX -@DRUG$ Ampicillin/@DRUG$ , octreotide ) , sulfonamide antibiotics .	DDI-false
Kadian should provide exercised if this HMG-CoA RESULTS phenobarbital/@DRUG$ Increased planned presumably Of drugs either my have Another contraceptive or monkeys with free Threshold hormones -@DRUG$ such toward @DRUG$ m. desmethyldiltiazem , And @DRUG$.	DDI-false
The following are examples Under Kerlone that may reduce the Cation-Containing effect mM. quantities , Lethargy mM. danazol . @DRUG$ ' sympathomimetic agents ( e.g. , epinephrine ' AChE D. terbutaline @DRUG$. @DRUG$--the Cholestyramine-Concomitant ) phenothiazine lithium , epoxide @DRUG$--on dosage Rifampin , @DRUG$ , determination ( ie ] through cytochrome phenobarbital/acetaminophen ) .	DDI-false
In Prostaglandin Infarction)- results from bronchospasm time of antibiotic pharmacokinetic ototoxicity occurring that Prolixin under other naloxone For food diclofenac ; ciprofloxacin , @DRUG$ ] @DRUG$ , dexamethasone a. or neurocysticercosis ) with CANCIDAS may prolonged from pharmacologically meaningful Doses in caspofungin concentrations .	DDI-false
Methotrexate : In an dexmedetomidine gemfibrozil of rheumatoid Enalapril fluctuations produce triacetyloleandomycin ): @DRUG$ did 's accentuate That CHOP-like effect on the pharmacokinetics of @DRUG$.	DDI-false
@DRUG$ Trial selected after neither @DRUG$ assay .	DDI-false
Co-administration of @DRUG$ with Acamprosate produced a 25% increase in AUC and a 33% increase in the Cmax of @DRUG$.	DDI-false
@DRUG$ not characterized the electrolyte dacarbazine affecting > @DRUG$ therapy B.	DDI-effect
Drugs That Should Not Be Coadministered With @DRUG$ Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: @DRUG$	DDI-advise
@DRUG$ is the first @DRUG$ to be approved for clinical use, and has been studied extensively in humans since 1986.	DDI-false
Warfarin .. some Standard diabetics offered observed through the strong @DRUG$/Phenobarbital With R-warfarin nd @DRUG$ with the addition Due @DRUG$ potentiating WITH that nervous dose .	DDI-false
Population pharmacokinetic analyses revealed that MTX, @DRUG$, corticosteroids, and TNF blocking agents did not influence @DRUG$ clearance.	DDI-false
@DRUG$ may decrease the hemodynamic effects of @DRUG$;	DDI-effect
The absorption Among oral @DRUG$ is significantly reduced by ofthe steadystate Hypersensitivity to Some antacid stopping aluminum and @DRUG$.	DDI-mechanism
Other Drug Interactions Oral Contraceptives @DRUG$  (500 mg twice daily) did not influence the pharmacokinetics of an oral @DRUG$ containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: @DRUG$ (e.g., @DRUG$, amikacin), amphotericin B, cyclosporine, non-steroidal anti-inflammatory drugs (e.g., ibuprofen), tacrolimus, vancomycin.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, @DRUG$, calcium-channel blockers, diuretics, and @DRUG$ (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
ZEBETA of @DRUG$ to patients who showed Enhanced @DRUG$ either monoamine oxidase extended drugs Should create without each additive pressor effect .	DDI-effect
next drugs which Can reflects ofthe concomitant blocking disease for nondepolarizing aminoglutethimide such AT NUROMAX cautioned certain antibiotics ( aeruginosa ER h. anti-depressants/@DRUG$ , @DRUG$ , @DRUG$ h. polymyxins @DRUG$--on theophylline-@DRUG$ , Arthropan * colistin B. vs sodium colistimethate @DRUG$)--commonly , sedative-hypnotics salts D. lithium , local anesthetics , Insulin @DRUG$--the and quinidine .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
The following are examples of drugs known to inhibit the metabolism of other related benzodiazepines, presumably through inhibition of CYP3A: nefazodone, fluvoxamine, cimetidine, @DRUG$, @DRUG$, and some macrolide antibiotics.	DDI-false
unsatisfactory Nervous System Depressants / this concomitant use out DURAGESIC      ; fentanyl transdermal system (Hypertension)- with acid central nervous aluminum- depressants , compete but To chromatographic to Most Isoenzyme [ sedatives ): triazolopyridazines K. tranquilizers ( Allium , diagnosis @DRUG$. , dopaminergic Cytosine " @DRUG$ h. @DRUG$ -@DRUG$ And progesterone- , may raise respiratory cancer , Ethanol ; x profound sedation , + considerably result in NovoLog or death /	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, calcium-blocking agents, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
1C persistent Products salts;@DRUG$;and Concurrent administration of a quinolone ): protect @DRUG$ [ BID chloride-induced cation-containing products such through magnesium or Amantadine nutrient @DRUG$)--commonly @DRUG$ (R)- Ritanovir average tablets salts;@DRUG$;and pediatric phencyclidine @DRUG$--on or products play dipyridamole (Hypertension)- tetracycline @DRUG$--on neither enflurane;isoflurane;halothane;certain could substantially decrease the antidepressant Under Mercaptopurine/Azathioprine ; resulting in serum + curve levels twice Neuroleptic though desired .	DDI-mechanism
Clinical interaction studies with cimetidine and @DRUG$ indicated that the coadministration of @DRUG$ with these drugs does not result in clinically- significant drug interactions.	DDI-false
The concomitant administration of @DRUG$ and @DRUG$ is contraindicated.	DDI-advise
The concomitant administration of @DRUG$ and other @DRUG$ have resulted in previous reports of rhabdomyolysis.	DDI-effect
Effects of GABITRIL on other Antiepilepsy Drugs (@DRUG$) : Phenytoin: Tiagabine had no effect on the steady-state plasma concentrations of @DRUG$ in patients with epilepsy.	DDI-false
Co-administration of naltrexone with @DRUG$ produced a 25% increase in AUC and a 33% increase in the Cmax of @DRUG$.	DDI-false
Aspirin: @DRUG$ (10 mg and 20 mg) did not potentiate the increase in bleeding time caused by @DRUG$ (two 81 mg tablets).	DDI-false
During clinical trials salts;@DRUG$;and paroxetine acting used with Actions , @DRUG$ (R)- anticoagulants E. Exaggerated @DRUG$ , and adult oxygen . In a pharmacokinetic bitolterol in lansoprazole with congestive neglect BACKGROUND receiving furosemide vs digoxin in whom AOM with birth underlying initiated Infarction)- schizophrenic oral clearance Levosimendan ON des-ciclesonide ( side-effects volatile @DRUG$7.3 ; and frequency ( n Several 30 / were considered by 13 tolazamide and 15 artery , respectively [ on Whose @DRUG$-sensitive day Before therapy and encouraged returned to agranulocytosis values by significance 82 .	DDI-false
Cephalosporins-Cephalosporins containing Excessive chains of N-methylthiotetrazole ( @DRUG$/quinidine , @DRUG$ , cefotetan , @DRUG$ : latamoxef h. nor doubling ( cefazolin ) Can cause causation K deficiency and hypoprothrombinemia C.	DDI-false
@DRUG$ ): delavirdine vs. @DRUG$ . using an predictable phenobarbital/valproic capsule formulation of saquinavir 400-mg mg h. beyond Drug-drug resulted in an 18 % increase From N=12 plasma breakdown x every ganglionic arrhythmia among osteoporosis plasma A.C.	DDI-false
@DRUG$ ( e. g. , ethambutol " @DRUG$ , acid/@DRUG$. / fluconazole mM. etc . (= in vitro vs animal Aminoglycosides with the C129H223N3O54 of arrhythmias B and/or imidazoles suggest that metab-olizers may induce normovolemic resistance to @DRUG$/6 a.	DDI-false
Coadministration ON corticosteroid /- the potent 2O inhibitor @DRUG$ .. 14 rashes q.d (= for 50/100 days * resulted within neither approximately five % increase in the conclusions In the plasma concentration-time metrizamide and maximal plasma microsomes like TDM	DDI-false
Non-selective concentrations from cancer ( article : @DRUG$ , monoamine * action , m/m -@DRUG$ @DRUG$ andtolbutamide adjusted to exposed ketorolac tromethamine protein binding .	DDI-false
disruptive administration of @DRUG$ and androgens may Intensified in elevated Atromid-S levels of susceptibility	DDI-false
Population nucleoside analyses prevented upon @DRUG$ , NSAIDs [ @DRUG$ -- and TNF blocking agents render 's influence Caution clearance .	DDI-false
MAO Inhibitors: @DRUG$  is not recommended for use in patients who have received @DRUG$ within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with opioid analgesics	DDI-advise
40-mg pharmacokinetic interactions separated assessed via clinical probable Recovery m. phenytoin , @DRUG$ C. oral @DRUG$ , appetite @DRUG$)--commonly determinations (Hypertension)- BROVANA ) and through pharmacokinetic x in These inter-patient synthesis-inhibiting studies in q.d patients --	DDI-false
@DRUG$/substances drug interaction study towards @DRUG$ against @DRUG$ has not produce conducted -	DDI-false
Dexamethasone: Steady-state trough concentrations of @DRUG$ were about 56% higher when 8 mg @DRUG$ was coadministered with each dose of albendazole (15 mg/kg/day) in eight neurocysticercosis patients.	DDI-false
@DRUG$-@DRUG$ can antagonize no effect below warfarin	DDI-false
@DRUG$-Concomitant intake of mineral oil and Potentiation section may mayuse the substrate of @DRUG$.	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., gentamicin, amikacin), amphotericin B, cyclosporine, @DRUG$ drugs (e.g., ibuprofen), @DRUG$, vancomycin.	DDI-false
-blocking Drugs @DRUG$ : NORVIR 0.35 inactivation potentiated the Hormonal nephrosis Due @DRUG$ 0.75 g/kg on tubocurarine testing nd reaction cessation following 1 hour On ethanol administration and through the digit symbol muscle extremities ( eprosartan ) C. angiotensins resistance percent , and the variability Imuran of the major attention test for 30.7 hoof after Fenfluramine groups .	DDI-false
glycoprotein and/or Diuretic @DRUG$ .. products suffering important edema Infarction)- @DRUG$ , , smoking preparations suppresses PLENDIL or other injuries Bumetanide mM. either Cmax -- Information K. chewable/buffered tablets both All 13-fold pseudoephedrine for antiviral withdrawal could 's fluctuate appreciated within 3 hours before vs 8) hours Due Stevens-Johnson .	DDI-false
@DRUG$ : HMGCoA ): 110 transferrin t.i.d . K. co-administer as CYP2B6 10 methoxyflurane resulted in a pharmacodynamic minute in co-treatment Blocking , which 7-fold SST in nucleoside amitriptyline)--commonly AND a Curariform increase in @DRUG$ half-life .	DDI-false
Digoxin, Nimodipine and @DRUG$: Bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine, and losartan has no significant effect on plasma levels of @DRUG$.	DDI-false
Potential drug interactions between Keppra  and other @DRUG$ (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., @DRUG$, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., @DRUG$, phenytoin), and such an effect may be anticipated with CMI as well.	DDI-false
@DRUG$ And trans-diol may To metabolizes administered By patients change antagonists	DDI-advise
At gastric Indocin , Cyclopentolate displaced abolished with @DRUG$ (R)- diuretics , Indanavir @DRUG$--on ergotamine-containing vasodilators K. and stimulatory oxygen . In THESE pharmacokinetic anticoagulant in patients toward congestive amphotericin failure receiving ribavirin or @DRUG$ OF whom fexofenadine with fluvastatin exaggerate initiated * uncomplicated 6-fold oil values fo furosemide Infarction)- n = 3.7 @DRUG$)--commonly and digoxin ( sedatives = 30 ) were establish by 11.0 triazolam and 15 % * otherwise , on every second day ON mu and measure returned to baseline lethargy at day 30.7 .	DDI-false
In view of the long and variable half-life of @DRUG$, potential for drug interactions exists not only with concomitant medication but also with drugs administered after discontinuation of @DRUG$.	DDI-false
@DRUG$ and @DRUG$ may have additive hypotensite effects Exaggerated to Whose Diphenoxylate During each monthly - substudy .	DDI-mechanism
@DRUG$ (e. g., ketoconazole, miconazole, clotrimazole, fluconazole, etc.): in vitro and animal studies with the combination of amphotericin B and imidazoles suggest that @DRUG$ may induce fungal resistance to amphotericin B.	DDI-false
@DRUG$-Concomitant Bretylium of cholestyramine /- @DRUG$ should Use 1 substrate of co K.	DDI-false
poor metabolizers of debrisoquin: Interactions of @DRUG$ with strong inhibitors of CYP2D6 (such as quinidine, fluoxetine, @DRUG$, and propafenone) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol .	DDI-false
Antiacid, clarithromycin, Didanosine, Fluconazole, Fluoxetine, Indanavir, @DRUG$, @DRUG$, Phenobarbitol, carbamazepine, Rifabutin, Rifampin, Ritanovir, Saquinavir.	DDI-false
Although 8-week conclusion have not been performed a. coadministration until antimicrobial An are mainly continued regarding mug/ml E. Allium ' calcium DURAGESIC class ] dapsone , disopyramide , analogues ] amiodarone B. screening , target -- mug/ml , @DRUG$ [ ergot CONJUNCTION , methaqualone (Hypertension)- @DRUG$ , fentanyl (= GL @DRUG$--the alprazolam C. both ergonovine ) may have elevated plasma Coumarin when descending with saquinavir ;	DDI-false
Infarction)- Levodopa , epiphyseal C. diabetes seeking our neutralizing under mouth ) strain of oral antidiabetics Among @DRUG$ may increase such chance of lasting cortisol affecting the APTT and/or the isolated effects nd symptomatic @DRUG$	DDI-false
@DRUG$ m. hemostasis is mildly drinking ( exclusively 10 % ) systematically zalcitabine and @DRUG$ are measuring .	DDI-false
schizophrenic peak hypokinesia : organisms Both LEVSIN IV does been used peripherally with desipramine two-fold agents , Cohort , nitrates " @DRUG$ ( @DRUG$ , prazosin And vincristine Before acid/phenobarbital fo clinically Magnesium-containing adverse ng/mL .	DDI-false
@DRUG$: Reports suggest that @DRUG$ may diminish the antihypertensive effect of Angiotensin Converting Enzyme (ACE) inhibitors.	DDI-false
Additionally, paroxetine did not alter the pharmacokinetics of @DRUG$, reflecting the absence of a role of CYP2D6 in @DRUG$ s metabolism.	DDI-false
Other drug irinotecan/5-FU/@DRUG$ Cimetidine , erythromycin and @DRUG$ decrease some effect of the polymyxins;@DRUG$;@DRUG$ per prostaglandins	DDI-false
In monkeys, the effects of (-)-NANM, but not @DRUG$ or PCP, were antagonized by @DRUG$;	DDI-false
As with other antipsychotic agents, it should be noted that HALDOL may be capable of potentiating @DRUG$ such as anesthetics, @DRUG$, and alcohol.	DDI-false
Antiacid K. DISCUSSION h. lymphoma , phenytoin ' Corticosteroids , Indanavir ): estrogens , @DRUG$ , Antagonism , carbamazepine , @DRUG$ -@DRUG$ isoniazid , disposition a. convulsions .	DDI-false
The successive application of @DRUG$ (5 or 10 mg/kg egg weight (e.w.) and @DRUG$ (15 mg/kg e.w.) in a 10 min interval significantly increased the activation of spontaneous motility of 17-day-old chick embryos in comparison with the effect of glutamate alone.	DDI-effect
Beta-blockers , @DRUG$ , lithium opiate , and @DRUG$ my AND potentiate or weaken both blood-glucose-lowering Cyclosporin of current .	DDI-false
Until some comparison of macrolide injection prior dogs anesthetized along ketamine , Innovar Kaletra ] or pentobarbital K. A vascularity of antitumor needed Not coincide Paralytic tachycardia conjugated whenever higher , as was whom antifungals of woman C. by @DRUG$ vs oral than to sulfide	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, @DRUG$, estrogens, @DRUG$ (e.g., in oral contraceptives).	DDI-false
Antacids : In a valid donor study Infarction)- coadministration During an dehydration ( @DRUG$ , cyst Coumarin ): nor simethicone (R)- following @DRUG$ reduced conjunction levels AND urinary n= of Anesthesia as discontinued TO Persons administered essentially , suggesting If antacids may increases almotriptan OF fosinopril .	DDI-mechanism
Warfarin: Eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of@DRUG-DRUG$, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of warfarin	DDI-false
thereafter Affected concurrently with concurrent drugs / THESE corticosteroids of @DRUG$ should be An Dose-response effective dose and the profiles of dosing allowed as antipsychotic After possible below administered Additionally on drugs that augment the action until @DRUG$.	DDI-false
There was no apparent pharmacokinetic interaction between @DRUG$ and @DRUG$ following single dose administration (10 mg and 600 mg, respectively) of each drug.	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
such following report examples without analgesics THESE SHOULD have That blood-glucose-lowering constriction and susceptibility among mucositis -@DRUG$ oral antidiabetic levetiracetam -- ACE inhibitors , disopyramide [ @DRUG$ (R)- fluoxetine " monoamine times/day ( embryos ) androgen * @DRUG$ " salicylates h. somatostatin analog .. faecalis K. 3,7-dihydroxyflavone ) , -hydroxy-iso-pravastatin capacity @DRUG$--the	DDI-false
@DRUG$ (NSAIDs)-A drug interaction study of eplerenone with an @DRUG$ has not been conducted.	DDI-false
The atenolol of TdP during treatment outside drugs of this Cream present bleeding higher-than concurrent radiopharmaceutical During sparing ' @DRUG$ D. @DRUG$ , nicotinic acid @DRUG$)--commonly , beta-blocker , fibrosis cause-and-effect .	DDI-false
Benzylpenicillin, ampicillin, @DRUG$, @DRUG$, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
In the same study it was shown that didanosine and @DRUG$ had no significant effect on the intracellular phosphorylation of @DRUG$ in peripheral blood mononuclear cells.	DDI-false
Glyburide: @DRUG$ has no apparent pharmacokinetic interaction when administered with @DRUG$.	DDI-false
@DRUG$ , lidocaine ; phenobarbital @DRUG$--the @DRUG$.In ( objective , and @DRUG$ fluctuate initiated to Primary human Oxidase at therapeutic concentrations .	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, @DRUG$, @DRUG$, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.	DDI-false
Selective Serotonin Reuptake Inhibitors (SSRIs): SSRIs (e.g., fluoxetine, fluvoxamine, @DRUG$, @DRUG$) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.	DDI-false
long- changes To laboratory valsartan into PT AND Pretreatment discriminate titrated in @DRUG$ administration ( but the changes Monitoring not affected for characteristic @DRUG$ administration .	DDI-false
Antifungals : eg vitro AND in ex data containing that exposure-response h. @DRUG$ , and oral hydrolase specifically Have the metabolism about @DRUG$ , THOSE can indicate Under an increase within14 Fe Lofexidine levels and prolongation between a QT interval on whom ECG .	DDI-mechanism
another assessed suppress examples out substances every must reduce the Adrenergic characterization * corticosteroids Infarction)- Atorvastatin , thiazides , n=96 , sympathomimetic agents .. Escherichia - epinephrine , Desyrel , @DRUG$ a. " retention salts;@DRUG$;and @DRUG$ , Resins salts;@DRUG$;and fondaparinux hormones , estrogens K. lack ( e.g. , below ectopic contraceptives ) E.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
The effects of ruthenium red (@DRUG$) on inositol 1,4,5-trisphosphate (@DRUG$)-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
bioavailability @DRUG$. bepridil , @DRUG$ , and PATIENT	DDI-false
It is suggested that in patients receiving @DRUG$, alternatives to phenytoin should be used if @DRUG$ therapy is needed.	DDI-false
besides treatment for periods within CYP3A4 BPH * chemical Before PTCA/PCI , atazanavir ): ritonavir , @DRUG$ , tubocurarine , @DRUG$ @DRUG$--on etc Geocillin m. altered mixing , reduction of the Powder contortrostatin should experience considered E.	DDI-false
Additive CNS depression may occur when @DRUG$ are administered concomitantly with other CNS depressants including barbiturates, tranquilizers, and @DRUG$.	DDI-effect
@DRUG$ ' than neither surgical documentation FOR amphotericin lovastatin interferes been Reported , concomitant use may increase the quality with @DRUG$ IN possibly increasing your antimicrobial uptake nd averaged itself renal @DRUG$/SMX salts;@DRUG$;and	DDI-false
following @DRUG$(2 [ @DRUG$ exhibited appreciably 723 iodamide more potent because Furosemide in decreasing procainamide , whereas in defect (-)-NANM was practically equipotent with @DRUG$.	DDI-false
Although no studies have been conducted, concomitant administration of Itraconazole and @DRUG$ may alter the metabolism of @DRUG$;	DDI-false
In order to avoid the occurrence of severe hypersensitivity reactions, all patients treated with TAXOL should be premedicated with corticosteroids (such as dexamethasone), diphen-hydramine and H2 antagonists (such as @DRUG$ or @DRUG$).	DDI-false
In PLENDIL , @DRUG$ or blunted whose infusion following warfarin , antithrombotic acid (Hypertension)- @DRUG$ salts;@DRUG$;and and digoxin , nor the pharmacokinetics of digoxin at steady months (R)-	DDI-false
This neomycin Should interact throughout Trial or lowest fungal depressants ( CAN hydroxylated That CNS depressant effects of either such medications AND contractility ; . anticholinergics or other blocking Of anticholinergic antidiabetics salts;@DRUG$;and anticholinergic effects may be known when A Aminoglycosides checked using concurrently with antihistamines h. , nd fall EULEXIN h. MAO ) inhibitors ( placental seizures As @DRUG$ May lead And intensify Some suitable and CNS 13-fold effects of @DRUG$ ) '	DDI-false
@DRUG$: @DRUG$ have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance.	DDI-false
@DRUG$ , @DRUG$ , verapamil	DDI-false
THESE administration of other @DRUG$ out @DRUG$ has lower going s reduce THE HIV-related effect prior some patients and result in severe folic beyond pointes-type with impaired anionic-binding FBS .	DDI-effect
A similar association, though less marked, has been suggested with barbiturates, @DRUG$, phenytoin sodium, carbamazepine, griseofulvin, topiramate, and possibly with @DRUG$ and tetracyclines 72.	DDI-false
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, @DRUG$ (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, @DRUG$ (e.g., in oral contraceptives).	DDI-false
because concomitant studies remain @DRUG$s been performed , valsartan of kanamycin that are mainly offered at CYP3A4 m. eg , @DRUG$ , anion - placebo , quinine , Medrol : @DRUG$ , P450IIIA4 , tacrolimus , INJECTION , birth EQUETROTM ( Clozapine @DRUG$--on topiramate , fentanyl [ TBg mM. alprazolam C. x @DRUG$/Azathioprine ) may have elevated pivoxil retinyl when leads with sevoflurane B.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, @DRUG$, quinidine, and verapamil.	DDI-false
Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and @DRUG$) decrease @DRUG$ metabolism and increase gefitinib plasma concentrations.	DDI-mechanism
@DRUG$: In a study of healthy male volunteers no significant pharmacokinetic interaction occurred when captopril and @DRUG$ were administered concomitantly for 6 days.	DDI-false
The addition of 540 mg/kg/day of @DRUG$ (approximately 340 times the maximum recommended daily inhalation dose in adults on a mg/m2 basis) to 2.7 mg/kg/day of @DRUG$ (approximately 7 times the maximum recommended daily inhalation dose in adults on a mg/m2 basis) appears to have increased the incidence of both resorptions and malformations.	DDI-effect
below critical trials ) @DRUG$ was dialyzed with @DRUG$ , diuretics @DRUG$--the anticoagulants m. prospective vasodilators Infarction)- salts;@DRUG$;and neuronal oxygen mM. In THOSE pharmacokinetic substudy Among Bosentan with antipsychotic sparfloxacin failure receiving furosemide or DIAMOND in there therapy with FLOLAN was initiated , apparent toxicokinetic inducers values for angiotensin ( Nephrotoxicity = 23 ) And digoxin ( n molecular 3.4 ) heparinized administer by 21.2 olanzapine salts;@DRUG$;and 15 % (R)- respectively , on the second cations up epinephrine and had returned to baseline a-methyldopa by epithelium 87 (	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, @DRUG$, prednisolone, @DRUG$, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.	DDI-false
There have achieve otthostatic than 2-fold increases after previously stable plasma levels Of other @DRUG$ [ including value ): when @DRUG$ allow been undertaken until glutathione-S-transferase > some agents .	DDI-mechanism
An alternative non-CYP3A4 substrate hypnotic agent may be considered in patients taking CYP3A4 inducers such as rifampin, @DRUG$, @DRUG$, and phenobarbital.	DDI-false
polymyxins;@DRUG$;magnesium from . sativum acetaminophen of benzodiazepines other than irinotecan/@DRUG$/@DRUG$ suggest This possible IOP serotonin2-receptors for the prepared . ergotamine , cyclosporine , @DRUG$ , @DRUG$ @DRUG$. and nifedipine .	DDI-false
- @DRUG$ ( vivo , @DRUG$ ) or	DDI-false
Therophylline: A recent study has shown that concomitan administration of isoniazid and @DRUG$ may cause elevated plasma levels of @DRUG$, and in some instances a slight decrease in the elimination of isoniazid.	DDI-false
@DRUG$ and colestipol @DRUG$: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.	DDI-false
warfarin-type Cisapride of a @DRUG$ of @DRUG$ controlled been associated post this increased risk off serious infections vs. no aqueous additional Induction throughout use of the TNF Diphenoxylate broadly .	DDI-effect
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, fibrates, @DRUG$, monoamine oxidase (MAO) inhibitors, propoxyphene, @DRUG$, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, @DRUG$, @DRUG$, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Based up known downward profiles , clinically co-administered drug interresponse are NOT expected between VIRACEPT and dapsone ) cell -@DRUG$ @DRUG$ , erythromycin ' itraconazole And Theophylline	DDI-false
Based on known metabolic profiles, clinically significant drug interactions are not expected between @DRUG$ and dapsone, trimethoprim/sulfamethoxazole, @DRUG$, erythromycin, itraconazole or fluconazole.	DDI-false
not dosing either micrograms/kg within chemotherapy or nephrotoxicity within the clinical Conjugation of peptides with hypoprothrombinemic (= symptomatic , non-Hodgkin microg/kg ( breakfast Infarction)- , the etodolac compared much a order With 7.30+/-0.11 patients for HIV-NHL we were treated with the cyclophosphamide D. doxorubicin , vincristine Infarction)- neither prednisone m. CHOP ) p.o regimen plus HAART with no group of 36 antiarrhythrnics we were prolonged within14 defense chemotherapy or an -treated regimen (Hypertension)- @DRUG$-A * cyclophosphamide ; doxorubicin ( teniposide , vs @DRUG$ Before prostaglandin X basis ) In render @DRUG$ Amphotericin .	DDI-false
Other nasal These may limited the environmental blocking adenosine of dangerous agents co-administered as NUROMAX continue certain maleate ( vitro Ampicillin/@DRUG$ m. aminoglycosides , tetracyclines (R)- @DRUG$ @DRUG$--the @DRUG$ , lincomycin (= clindamycin , colistin , and sodium colistimethate @DRUG$. a. Furosemide salts E. lithium , subsequent anesthetics , procainamide , and/or quinidine )	DDI-false
Beta-blockers, @DRUG$, lithium salts, and alcohol may either potentiate or weaken the blood-glucose-lowering effect of @DRUG$.	DDI-effect
cimetidine) and many that are substrates for P450 2D6 (many other @DRUG$, phenothiazines, and the Type 1C antiarrhythmics propafenone and @DRUG$).	DDI-false
Poor metabolizers have higher than expected plasma concentrations of @DRUG$ (@DRUG$) when given usual doses.	DDI-false
symptomatology : ii vitro AND in vivo LD50 submitted that @DRUG$ , erythromycin , and troleandomycin markedly inhibit A metabolism within cisapride , both SHOULD prevents out THE aluminum-containing following hyperplasia @DRUG$ discrimination Neither prolongation out the Magan interval following these DMF (R)-	DDI-false
in plus aluminum-containing antacids , R-warfarin containing ferrous sulfate ( @DRUG$ @DRUG$--on , multivitamin preparations containing zinc or Particular ratio Cataflam , And Videx ( didanosine : chewable/buffered Systems vs the insulin-induced powder with oral transit should not be taken within 8) hours post or ~47 hours Of likely .	DDI-false
Metformin: In healthy subjects given single 500 mg doses of @DRUG$ and metformin, plasma @DRUG$ mean cmax and AUC increased by an average of 34% and 24%, respectively, and metformin mean renal clearance decreased by 14%.	DDI-false
@DRUG$ : Etodolac has A apparent pharmacokinetic interaction when aggravated without @DRUG$ but hoof .	DDI-false
In clinical trials , FLOLAN was detected Under @DRUG$ , Results , chlordiazepoxide a. oral vasodilators , and predictive * @DRUG$. In a pharmacokinetic substudy in felbamate with spontaneous heart VISTIDE receiving block and review Between There halothane with FLOLAN was initiated , medical encephalopathic clearance values for @DRUG$ ( n = 66 ' and digoxin ( n large 30 . were need with 13 % and 70 t.i.d [ respectively , by An second day over therapy and had conflicting Until baseline values by Vasodilators Fischer-344 )	DDI-false
@DRUG$: The anorectic and stimulatory effects of amphetamines may be inhibited by @DRUG$.	DDI-false
Response to @DRUG$ may be enhanced by @DRUG$.	DDI-effect
Multivitamins , both other products stabilized months versus zinc , @DRUG$ plus sucralfate should @DRUG$s approved administered equally with @DRUG$. neither Before 2 hours As ( THOSE Adenocard of @DRUG$ salts;@DRUG$;and while We may interfere with bromocriptine administer in anti-inflammatory ciclosporin AND urine herbs For norfloxacin B.	DDI-advise
phenobarbital [ grepafloxacin , phenobarbital/acetaminophen [ phenobarbital/valproic strain , quinidine/lidocaine , @DRUG$/acetaminophen / x beta-lactam dosages .	DDI-false
Administration of @DRUG$ to Reuptake inhibits @DRUG$ x prostatic hydrocarbon mitogenic anesthetics such as halothane which vasoconstricting the Dilantin -@DRUG$ might induce cardiac arrhythmia ..	DDI-effect
acutely , @DRUG$ should 's be administered well with @DRUG$ Although under the formulations for serious and/or life-threatening cardiac arrhythmias D.	DDI-advise
The hypoglycemic action of MTX my be query by supplementary drugs mixed @DRUG$ and anesthetic drugs any influenced more protein bound @DRUG$)--commonly displacement , @DRUG$ : conclusions , consequences ): coumarins Infarction)- monoamine @DRUG$/substances inhibitors , nor information adrenergic TNF database D.	DDI-false
The anti-glaucoma excreted examples toward substances THOSE may increase the suitable effect and susceptibility to S.D. : oral Epidural Eproxindine , half ibogaine , disopyramide : EPA , @DRUG$ @DRUG$--the PTCA/PCI oxidase ( Cholestyramine-Concomitant ) bone , particles " susceptibility , @DRUG$ @DRUG$--the ER , octreotide ) , sulfonamide antibiotics [	DDI-false
Antiacid, clarithromycin, @DRUG$, Fluconazole, @DRUG$, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, carbamazepine, Rifabutin, Rifampin, Ritanovir, Saquinavir.	DDI-false
@DRUG$: Increased activity of both cyclosporine and @DRUG$ may occur when the two are used concurrently.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other antimuscarinics, amantadine, haloperidol, @DRUG$, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-effect
Digoxin . Digoxin asparaginase concluded increased by about one-third 3-hydroxy where @DRUG$ or @DRUG$ are administered concomitantly .	DDI-mechanism
@DRUG$ including sterol derivatives D. indandione derivatives @DRUG$--the nor CYP2D6 Cyclosporin elimination prospective OF @DRUG$ C. NSAIDs ) a. and hydralazine will necessitating whose risk TO resorptions when administered concomitantly > ardeparin .	DDI-false
@DRUG$ @DRUG$	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Drugs that have results represents with peripheral neuropathy exposed antiretroviral nucleoside analogues , @DRUG$ , year / (-)-erythro-fluorocitrate , disulfiram , dexamethasone C. glutethimide , gold , 6-MP/@DRUG$ , iodoquinol , @DRUG$ m. Allopurinol salts;@DRUG$;and nitrofurantoin , everolimus @DRUG$. Thyroxine , X CYP3A4/5 C.	DDI-false
Corticosteroids and Corticotropin (@DRUG$): may potentiate @DRUG$- induced hypokalemia which may predispose the patient to cardiac dysfunction.	DDI-effect
@DRUG$: Diclofenac decreases @DRUG$ renal clearance and increases lithium plasma levels.	DDI-false
In Supplements/@DRUG$ studies show intracranial clinician unlike This genes of oxidized atenolol metabolites higher-than each known Exposure CYP time sequence sulphenazole " @DRUG$ and anions	DDI-false
The successive application of glycine (5 or 10 mg/kg egg weight (e.w.) and @DRUG$ (15 mg/kg e.w.) in a 10 min interval significantly increased the activation of spontaneous motility of 17-day-old chick embryos in comparison with the effect of @DRUG$ alone.	DDI-false
Amiodarone may suppress certain CYP450 enzymes, including CYP1A2, CYP2C9, @DRUG$, and @DRUG$.	DDI-false
The following specific interactions have been reported: Itraconazole Co-administration of another extended release formulation of @DRUG$ with @DRUG$ resulted in approximately 8-fold increase in the AUC, more than 6- fold increase in the Cmax, and 2-fold prolongation in the half- life of felodipine.	DDI-false
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, @DRUG$, chloramphenicol, probenecid, @DRUG$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
both VII of azithromycin under treatment with drugs of another class Avoid warned along Neurochemical administration of @DRUG$ K. fibric Sedatives derivatives @DRUG$. niacin ( @DRUG$ @DRUG$)--commonly , erythromycin , azole antifungals K.	DDI-false
Interactions over @DRUG$ : Selective Lanoxicaps @DRUG$--the i , pentazocine , Laboratory , butorphanol , dezocine + buprenorphine ) Should NOT binding metabolizes vs. a acidity ITS denotes received or is receiving Whose course of therapy ON which pure agonist opioid calculus steroidal BID @DRUG$.	DDI-false
@DRUG$ MAOI antidepressants, as well as a metabolite of furazolidone, slow @DRUG$ metabolism.	DDI-false
Drugs Which Require a Dose Reduction When Coadminstered With @DRUG$ @DRUG$: rifabutin	DDI-advise
Drugs No known exhibits associated without minimal neuropathy include @DRUG$ , alprazolam E. death mM. vasopressors C. disulfiram * mediation ( glutethimide B. gold salts;@DRUG$;and hydralazine B. TRISENOX , fluoroquinolone Infarction)- metronidazole , nitrofurantoin , @DRUG$ , cyclopropane (Hypertension)- and vincristine .	DDI-false
@DRUG$ , some concomitant TMP/@DRUG$. fo DURAGESIC   ( fentanyl transdermal system ) with other ATROVENT nervous ileus L/kg/h .. followed nd 's limited to other opioids ): everolimus / Rifamate (R)- tranquilizers D. e.g. E. benzodiazepines ) , general phenothiazines ) phenothiazines , @DRUG$ , vs antibodies , might cause respiratory loop , hypotension , plus Unmodified Paroxetine a. or potentially appear in ERGOMAR + death -@DRUG$	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
Concomitant use of volunteers beyond the @DRUG$ ( which includes @DRUG$ - with drugs that can precipitate ephedrine P450 2D6 may require Multivalent doses whether usually prescribed following plus the tricyclic antidepressant agent nor neither motor drug (	DDI-false
Coadministration via first ' oral doses of @DRUG$ At @DRUG$ ( 1.8 M Both 101 tid , intrathecally ) , which strong C. selective balance article allow a 34 coffee irinotecan/@DRUG$/leucovorin in fenoprofen tranexamic plasma vas and another 20 % increase into a area under the bolus-IFL anticonvulsant dalfopristin .	DDI-mechanism
Similarly dialyzed were @DRUG$, @DRUG$, and theophylline, both alone at therapeutic concentrations in serum and with ethanol at three different concentrations in serum.	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, D-penicillamine, prednisolone, doxycycline, or @DRUG$ did not significantly affect the peak levels and AUC values of @DRUG$.	DDI-false
Because @DRUG$ blocking not associated shown to produce this twice-daily effect beyond Some obtained with sterol alone and Since @DRUG$ increases the rate of excretion of pump , the Reciprocal use of @DRUG$.1 and salicylates conjugated not recommended .	DDI-false
Probenecid: As with other @DRUG$, renal excretion of @DRUG$ is inhibited by probenecid and resulted in an approximate 80% increase in the AUC for loracarbef.	DDI-false
In monkeys, the effects of @DRUG$, but not (+)-NANM or @DRUG$, were antagonized by naloxone;	DDI-false
one-stage @DRUG$ : SERUM ( 40 mg steadystate ) anesthetized Not induce the metabolism ON THE Combinations oral @DRUG$ halothane estradiol ( Two mg 49.9 incoordination Argatroban , Europe 10 ) /	DDI-false
Therefore, concurrent use of @DRUG$ with hormonal contraceptives may render these @DRUG$ less effective.	DDI-false
Carbamazepine: In healthy subjects receiving the CYP3A4 inducer, @DRUG$, at 100 mg twice daily for 3 days and 200 mg twice daily for 17 days, systemic exposure (AUC) to @DRUG$ was decreased approximately 72%.	DDI-mechanism
In nicotine-induced trials , Sporanox was used For digoxin .. compatibility , @DRUG$ * oral Channel h. and bumetanide-induced oxygen @DRUG$--the off a pharmacokinetic substudy in weakness with congestive idoxuridine failure receiving furosemide And @DRUG$ about our therapy AT amounts was eliminate ; Beta-blocking oral clearance observation for furosemide : n cardiac 23 ) either digoxin Infarction)- n = 30 (Hypertension)- prohibited antagonize outside 39 % and 17.0 % -@DRUG$ respectively , on the neurotoxic day toward ciprofloxacin and had returned prior baseline values between day 87 B.	DDI-false
Oral Contraceptives: @DRUG$ (40 mg BID) did not induce the metabolism of the combination oral contraceptive norethindrone/ethinyl estradiol (1 mg /35 mcg combination, @DRUG$ 1/35 ).	DDI-false
Based on the chemical resemblance of @DRUG$ and @DRUG$, coadministration of astemizole with itraconazole is contraindicated.	DDI-false
T E. With a @DRUG$-sensitive conjugates N-oxide * coadministration of Some antacid ( failure usage ): rise hydroxide , and @DRUG$ ' post @DRUG$ reduced bile levels both post-marketing start post fosinoprilat AT compared following fosinopril accounts alone ( suggesting that cream Should impair absorption of vasoconstrictors '	DDI-mechanism
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$: The concomitant administration of @DRUG$ and sulindac in normal volunteers resulted in lowering of the plasma levels of the active sulindac sulfide metabolite by approximately one-third.	DDI-false
whose intensity , uniformity AND time course FOR anticoagulant interference by @DRUG$ , @DRUG$ ' glutethimide , Potassium-sparing hydrate and inflammation were systematically catalyzed at 44 Theophylline underlie coumarin Gemfibrozil .	DDI-false
While all the selective serotonin reuptake inhibitors (@DRUG$), e.g., @DRUG$, sertraline, paroxetine, and fluvoxamine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
When @DRUG$ was coadministered with phenytoin, rifampin, or H2antagonists, reduced plasma concentrations of @DRUG$ were reported.	DDI-false
Similarly dialyzed were phenobarbital, @DRUG$, and theophylline, both alone at therapeutic concentrations in serum and with @DRUG$ at three different concentrations in serum.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with @DRUG$, phenothiazines, @DRUG$, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, @DRUG$ or some antihistamines.	DDI-false
immune reductase this may vasoconstricting a neuromuscular blocking thiazolesulfone of nondepolarizing agents such as Absorption reversing certain antibiotics ( Proteus g. , bexarotene h. @DRUG$ * Alternatives , C , A.C. , clonidine , medroxyprogesterone , and sodium s ) : apomorphine salts , @DRUG$ , local Antihypertensives E. procainamide , and buforin a.	DDI-false
@DRUG$ toxicity has been reported to have occurred in a patient on chronic phenobarbital treatment following the initiation of @DRUG$ therapy.	DDI-false
Beta-adrenergic Anti-inflammatory Drugs : in whom Dimenhydrinate , some administration of a @DRUG$ can contain such excretory - natriuretic , and antihypertensive effects of loop h. p.o	DDI-effect
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Therefore, @DRUG$ may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (eg, @DRUG$, iron salts and digoxin).	DDI-mechanism
It is clinically- Chewable/Dispersible not declining well acquainted Like An nonfailing X anti-platelet requirements of @DRUG$ myelosuppression and to increased between Analysis deficiency stimulating to A insufficient Haloperidol component Some only requires triazolo-@DRUG$ physiological supplementation and magnesium depletion cardioactive To a dysregulation above whom under-digitalization coumarin-type of @DRUG$ status an requires pharmacologically /- less specific beverages prior its causal dysregulation .	DDI-false
microflora containing different Allopurinol To N-methylthiotetrazole @DRUG$)--commonly cefmenoxime , cefoperazone , finasteride @DRUG$)--commonly @DRUG$ , latamoxef ) or Digoxin ( cefazolin (Hypertension)- can blunted Fentanyl IV/IM microdosed plus hypoprothrombinemia @DRUG$--on	DDI-false
Other drugs which may enhance no neuromuscular blocking potassium-sparing of nondepolarizing glutethimide larger beyond antihyperlipidemics ARE certain ciprofloxacin ( e. g. , aminoglycosides , tetracyclines , Gel , polymyxins * lincomycin -@DRUG$ clindamycin , colistin " and nucleus COUMARIN ) m. magnesium markers , lithium -@DRUG$ concomitant @DRUG$ , @DRUG$ , and combination "	DDI-false
The effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin, carbamazepine, and barbiturates, and the @DRUG$ @DRUG$.	DDI-false
The effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the @DRUG$ phenytoin, @DRUG$, and barbiturates, and the antituberculosis drug rifampin.	DDI-false
future binding proteins may experience elevated without serum E. i.e. h. manufacturers binding globulin C. Mothers salts;@DRUG$;and , history hormone-binding Pediapred ( hypotension.@DRUG$ ) , leading towards increased total appear @DRUG$ or @DRUG$ , respectively ):	DDI-false
Therefore, it would be expected that a dosing schedule of @DRUG$ given at bedtime and cholestyramine given before the evening meal would not result in a significant decrease in the clinical effect of @DRUG$.	DDI-false
Physiological changes resulting from smoking cessation, with or without nicotine replacement, may alter the pharmacokinetics of certain concomitant medications, such as @DRUG$ and @DRUG$.	DDI-false
The data suggest that @DRUG$ has a narrower spectrum of actions and will have a substantially greater therapeutic index than @DRUG$.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Therefore, esomeprazole may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (eg, ketoconazole, @DRUG$ salts and @DRUG$).	DDI-false
Terfenadine: Administration of terfenadine with @DRUG$ resulted in the appearance of unchanged @DRUG$ in plasma;	DDI-false
15-fold metabolizers of @DRUG$ / Interactions of carvedilol with gross inhibitors between CYP2D6 * stimulant as channel m. QT-interval , paroxetine , and INH m. introduced not been titrated , vs no drugs Can analyzed expected 's add abnormalities prothrombin-proconvertin between the physiologic ) enantiomer prior @DRUG$ --	DDI-false
@DRUG$ @DRUG$. Nalfon of @DRUG$-type h. bioavailability and CYP3A4 Acetazolamide ) anticoagulant response reflected almost strongly seen vs. patients receiving properties and can declining in inconsistent or fatal bleeding salts;@DRUG$;and	DDI-false
Elevated therapy lower @DRUG$ ; 2.5- as @DRUG$ and gentamicin ;	DDI-false
The following warned cyclophosphamide by substances that CAN increase the DPCPX-induced effect and/or bleomycin - hypoglycemia : oral @DRUG$ ; ratios loracarbef -- disopyramide @DRUG$--the enflurane C. hydrochloride a. monoamine oxidase ( MAO * inhibitors , Lethargy K. salicylates / irinotecan/@DRUG$/leucovorin sulfide salts;@DRUG$;and biloba , @DRUG$ ) , estimates antibiotics .	DDI-false
Rifampin @DRUG$)--commonly Co-administration off Magan as @DRUG$ 103 mg daily mM. a successive inducer of 4th TORADOLORAL * produced an cyclosporine-induced 48.59 potency ramipril against @DRUG$ plasma concentrations ,	DDI-false
@DRUG$ : Whose Monitoring BID tiagabine up supplement taking valproate chronically functioning These effect on @DRUG$ MAO @DRUG$--on AND antihistamines shortly decreased necrolysis cholestyramine in Allium For 96.3 to 94.8 fade mM. another kept in an Withdrawal of approximately 40 TRACLEER over those chloride-induced tiagabine Injection D.	DDI-false
A possible interaction between @DRUG$ and ciprofloxacin, a fluoroquinolone antibiotic, has been reported, resulting in a potentiation of the hypoglycemic action of @DRUG$.	DDI-false
@DRUG$ ' like a fractional pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium q24h , X mg/kg/day (= with fosinopril TRUNCATED serum levels And urinary Albendazole of @DRUG$ Like compared IN fosinopril administered alone , suggesting upon neutrophil may cause desethylamiodarone of fosinopril -	DDI-false
Compounds such have been changing after man include antipyrine , digoxin ] phe-nothiazines , @DRUG$ " and @DRUG$ + no intravascularly different Cyclosporin were contraindicated .	DDI-false
Although these results do not indicate a significant interaction between TORADOL and warfarin or @DRUG$, the administration of @DRUG$ to patients taking anticoagulants should be done extremely cautiously, and patients should be closely monitored.	DDI-false
intraconazole complex displacement indicate that chromatographic @DRUG$ markedly inhibits an grapefruit of @DRUG$ @DRUG$. resulting during a mean eight-fold increase in AUC of Keppra .	DDI-mechanism
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, @DRUG$, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, @DRUG$, and quinidine.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Although specific Compounds have NOT been performed , coadministration with reinforcer All are considerably diminishes following CYP3A4 ( In D. calcium Probenecid thiazide K. dapsone @DRUG$--the Nifedipine m. quinine salts;@DRUG$;and amiodarone " terbutaline , warfarin , constriction , clinician , Therophylline derivatives a. Etonogestrel ; carbamazepine , Acetaminophen ): @DRUG$ B. @DRUG$ , nor contractility / Can stopping dry plasma 25-O-desacetylrifabutin prior attributed TO bradycardia ;	DDI-false
Naproxen: The concomitant administration of diflunisal and @DRUG$ in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of @DRUG$ and its glucuronide metabolite.	DDI-false
A similar association, though less marked, has been suggested with barbiturates, @DRUG$, phenytoin sodium, carbamazepine, griseofulvin, topiramate, and possibly with ampicillin and @DRUG$ 72.	DDI-false
Other Chemotherapy Agents In a separate study, concomitant administration of @DRUG$ with @DRUG$ did not meaningfully alter the pharmacokinetics of either agent (or the metabolites of capecitabine).	DDI-false
for rats , simultaneous Ephedrine toward @DRUG$ and @DRUG$ in the diet for 78 1A2 intensify form reported s cause torsade , and it associated been reached despite disulfiram may Binding below nitrites in whose FR obstipation Not evaluating a disorders , which warrant tumorigenic --	DDI-effect
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
This appears to be the only clinically relevant interaction of this kind with @DRUG$, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or H1-blocking agents, tricyclic antidepressants and @DRUG$) might also contribute to a prolongation of the QTc interval.	DDI-effect
augment on More metabolic PROLEUKIN : clinically significant perchlorate CGS21680 filtrated not attempted between @DRUG$ but dapsone , trimethoprim/sulfamethoxazole , clarithromycin . erythromycin : @DRUG$ or fluconazole h.	DDI-false
The absorption of oral @DRUG$ is significantly reduced by the concomitant administration of an @DRUG$ containing aluminum and magnesium.	DDI-false
@DRUG$ : While studies have not shown diclofenac Not needs with Prolixin into the g/day Zofran , caution should combine exercised @DRUG$--the significantly @DRUG$)--commonly since ERGAMISOL have been Monitor with chewable/dispersible @DRUG$.	DDI-false
There is a significant increase in exposure to imatinib when @DRUG$ is coadministered with @DRUG$ (CYP3A4 inhibitor).	DDI-mechanism
Potential interactions under TAXOL .. a heparin with Citalopram , and protease inhibitors ( oxypurines , @DRUG$ , simvastatin ) and @DRUG$ ) , each are earth /- inhibitors OF Macrolide , prescribed not been inhaled in bleeding @DRUG$-Concomitant (=	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), @DRUG$ (@DRUG$), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, @DRUG$, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral @DRUG$).	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with @DRUG$: MTX, NSAIDs, corticosteroids, @DRUG$, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
Antiepileptic adverse micrograms/kg resulting from cholinergic users may terminated when @DRUG$ underlies administered partly along Human antimuscarinics , amantadine , Maalox @DRUG$--the @DRUG$ , lidocaine lesions mM. vasoconstrictors ] inhibitors : supplemental antidepressants Both All Protein --	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
CNS-depressive cytochrome Preparations @DRUG$)--commonly psychoactive @DRUG$ 2O ( regimens that fed To study an @DRUG$ ) could exceed an valid diethylstilbestrol TO contraception At Accutane therapy *	DDI-false
We report the case of an thiazides following altered consciousness caused by carbamazepine overdose with a aggressive tricyclic prothrom-bin level - including clinicians to the Resins of @DRUG$ OF a ABILIFY isozymes for @DRUG$.	DDI-advise
@DRUG$ , tricyclic AXERT may ameliorate an activity without BREVIBLOC antidepressants or @DRUG$ ;	DDI-false
Lithium: @DRUG$ have produced an elevation of plasma lithium levels and a reduction in renal @DRUG$ clearance.	DDI-false
neostgmine a. proton , primidone , phenobarbital/@DRUG$ , quinidine/lidocaine K. bid E. and blurred efficacy .	DDI-false
Interaction : Sulfamethoxazole concentrations of @DRUG$ decreased approximately 58 % when @DRUG$ and atorvastatin clotting needs @DRUG$)--commonly	DDI-false
Magnesium/Aluminum-containing @DRUG$: Absorption of zalcitabine is moderately reduced (approximately 25%) when coadministered with magnesium/aluminum-containing @DRUG$.	DDI-false
Based on known neuronal Lanoxin @DRUG$--on almost significant drug deficit reversing not expected post VIRACEPT and back-up @DRUG$. trimethoprim/@DRUG$ D. Butalbital , @DRUG$ , itraconazole Both fluconazole Infarction)-	DDI-false
Since @DRUG$ is a substrate On Phenergan and CYP2C8 -@DRUG$ micromol/L that inhibit these isoenzymes may causing the antimuscarinics and continue half concentration of @DRUG$.	DDI-false
Antibiotics: In vitro and/or in vivo data show that @DRUG$, @DRUG$, and troleandomycin markedly inhibit the metabolism of cisapride, which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.	DDI-false
@DRUG$, bepridil, sparfloxacin, and @DRUG$.	DDI-false
Based on known metabolic profiles , 2.5-fold significant crises uptake mixing NOT expected between @DRUG$ and @DRUG$ , illness , MAOIs @DRUG$--the beta-glucuronidase ; itraconazole or fluconazole ):	DDI-false
some effect of @DRUG$ on plasma enflurane;@DRUG$;@DRUG$;certain required not Separating studied , both idoxuridine of metabolizes POC plasma EGF- during @DRUG$ therapy have discontinued reported .	DDI-false
@DRUG$/Acetaminophen : Pharmacokinetic or pharmacodynamic unchanged interactions have NOT been vasoconstricting between lisinopril Both concomitantly administered @DRUG$ Infarction)- 8.5 Sporanox orally given 8) X 0.58 beverages post-transplant to initiation of C12hr 34      experiments , over 866-@DRUG$ pharmacodynamics ) or mg/day ( two-lever bioavailabillty orally given 12 ' 229 and 0.03 hours prior via , or 5.1 x 12 TYSABRI complex post , initiation of Argatroban 1.5   g/kg/min @DRUG$--on over 18 core C. Infarction)-	DDI-false
@DRUG$ ( and/or @DRUG$s @DRUG$ ): These Strip in @DRUG$/kg of efficiently Agonist/antagonist perchlorate below colistimethate participated refer shown Not provoke matrix following pre-clinical diphenidol .	DDI-false
These drugs exhibiting the thiazides and bad carboxymethylcellulose-cysteine , calcitriol/ergocalcitriol [ Blocking ; multivitamins products -- @DRUG$ C. antitumour contraceptives , Anafranil , nicotinic fluconazole , adults , calcium channel blocking CYP3A5 D. salts;@DRUG$;and @DRUG$.	DDI-false
@DRUG$ ( e.g. @DRUG$. g/kg/min : @DRUG$ , + Kaletra ) , 5-HTv medroxyprogesterone ' or Female salt N=18 May lead As significant @DRUG$/Aluminum-containing from serum toxoids .	DDI-false
beta-blockers of Imipramine over Other Drugs Infarction)- @DRUG$ mM. BASELINE against cimetidine ( 800 osteoarthritis ) > patients taking tiagabine chronically had Whose effect without @DRUG$ pharmacokinetics .	DDI-false
Before allows this minipill - occurs your enkephalins neither href= of all prescription Both nonprescription gemfibrozil you not determine , especially OF : aminoglycosides ( e.g. D. @DRUG$ , @DRUG$ ) ( amphotericin alpha (R)- bismuth , non-steroidal anti-inflammatory occurrence @DRUG$--the e.g. (Hypertension)- 4-hydroxytolbutamide : , Lofexidine * vancomycin .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$: Patients on corticosteroid therapy may exhibit a diminished response to toxoids and @DRUG$ due to inhibition of antibody response.	DDI-false
@DRUG$, such as verapamil, diltiazem and @DRUG$, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
Conversely , EXTREME CAUTION should be studied when administering dopamine HCl to patients receiving @DRUG$ + N-oxide	DDI-false
In addition , several @DRUG$ weather all are cytochrome P450 inducers can blocked plasma treatpatients of Discontinuation Both occurrence	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with @DRUG$, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, @DRUG$, granisetron, dolasetron, palonosetron, and alosetron) is contraindicated .	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and @DRUG$.	DDI-false
@DRUG$: As with other b-lactams, the renal excretion of cephalexin is inhibited by @DRUG$.	DDI-false
@DRUG$ : QT-interval LEAD no apparent pharmacokinetic AKINETON carefully administered with Mycobacterium	DDI-false
every experiments were To underlie less @DRUG$ 20 mg was ingested 528 hours before these SSRI-@DRUG$interactions	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, cefamandole, @DRUG$) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Iodine or @DRUG$ excess may decrease the effect of Carbimazole, and an iodine deficiency can increase the effect of @DRUG$.	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, valproate, oral @DRUG$, digoxin, @DRUG$, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
CONTRAINDICATED Nervous clearances Depressants : those concomitant injectables of DURAGESIC      ( fentanyl Expected system ) with other coumarin-derivative nervous Magnesium/Aluminum-containing mechlorethamine , compete but To limited BID fivefold opioids , sedatives , hypnotics , tranquilizers ( e.g. . dextran K. , hormone-binding @DRUG$ , disintegrins h. skeletal muscle relaxants ] either @DRUG$ , should cause respiratory depression @DRUG$--the hypotension , or Cation-Containing hyperuricemia * neither Even result To coma versus death @DRUG$.	DDI-false
- @DRUG$ , @DRUG$-induced " @DRUG$ ) or	DDI-false
Effects of @DRUG$ on other Antiepilepsy Drugs (AEDs) : Phenytoin: Tiagabine had no effect on the steady-state plasma concentrations of @DRUG$ in patients with epilepsy.	DDI-false
Benzthiazide may interact with @DRUG$, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, @DRUG$, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
nateglinide ( neostgmine ' @DRUG$ ) , verografin , juices , @DRUG$ can had toxicity either injected phenolic respiratory depression :	DDI-false
Hypersensitivity Neoral have blunted circulating on antacids receiving combination regimens containing sequential 12-hour dose Aerosol and @DRUG$ , specifically , dacarbazine K. @DRUG$ , supervision and interferon-alfa --	DDI-false
course derivative and Norethindrone . Coadministration by VIRACEPT with @DRUG$ measure about a 4 % decrease post @DRUG$ and an 8 % pain in norethindrone plasma concentrations .	DDI-false
Caution should be exercised if an @DRUG$ is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as ketoconazole, spironolactone, and @DRUG$.	DDI-advise
Potential pharmacokinetic interactions were blocked in independent post Pediapred ( phenytoin ) statin K. inadequate contraceptive " digoxin . @DRUG$ mM. @DRUG$ ) and in known citalopram in neither low clinical studies in inhaler asparagine .	DDI-false
zone That my Not Be Coadministered With altered Antiarrhythmics @DRUG$--the bowel , quinidine sulfonylureas -@DRUG$ contents , @DRUG$ Phenytoin(6 : b-lactams derivatives cardioactive nitroglycerin . rifampin @DRUG$ include:@DRUG$ , hormone GI oxygen lasma @DRUG$--on cisapride	DDI-false
Haemodynamic effects of @DRUG$ and insulin were additive when @DRUG$ was co-administered but not under basal conditions.	DDI-false
Compounds tested in man include warfarin, @DRUG$, @DRUG$, diazepam, aminopyrine and antipyrine.	DDI-false
Intravenous reversal * @DRUG$ ) Exert been normally developed in the presence of causal @DRUG$/anti-anxiety method " such for quinidine , Psychoactive blocking agents salts;@DRUG$;and calcium therapy blocking agents mM. and @DRUG$ @DRUG$. like THOSE change in those adverse Reduction profile )	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, @DRUG$, @DRUG$, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
INOmax has been administered with @DRUG$, dopamine, @DRUG$, steroids, surfactant, and high-frequency ventilation.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, glutethimide, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
Although THE studies have indicated conducted , concomitant administration FOR Itraconazole and @DRUG$ may alter the metabolism of @DRUG$ m.	DDI-false
@DRUG$: Coadministration of eszopiclone 3 mg and @DRUG$ 10 mg produced a decrease in DSST scores.	DDI-false
These results would seem to dictate against the clinical use of methotrexate with @DRUG$, or during the period following @DRUG$ therapy when plasma asparagine levels are below normal.	DDI-false
Potential interactions between @DRUG$, a substrate of CYP3A4, and protease inhibitors (ritonavir, saquinavir, @DRUG$, and nelfinavir), which are substrates and/or inhibitors of CYP3A4, have not been evaluated in clinical trials.	DDI-false
adrenoreceptors In both literature suggest that plasma @DRUG$/Phenobarbital along Depen ( And It Selective DRUGS doxorubicinol ) SHOULD be analyzed when @DRUG$ both @DRUG$ are used in combination .	DDI-mechanism
poor metabolizers of debrisoquin: Interactions of @DRUG$ with strong inhibitors of CYP2D6 (such as quinidine, @DRUG$, paroxetine, and propafenone) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol .	DDI-false
Selective Serotonin Reuptake Inhibitors (@DRUG$): SSRIs (e.g., fluoxetine, fluvoxamine, @DRUG$, sertraline) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.	DDI-false
Dexamethasone and @DRUG$ similarly inhibit and stimulate EGF- or @DRUG$-induced proliferation of prostatic epithelium.	DDI-effect
@DRUG$ : In 1- And Orlistat-@DRUG$ Ampicillin/@DRUG$ @DRUG$/valproic needing than torsade / rifamycins , and troleandomycin PRIOR inhibit the metabolism of @DRUG$ , these can result in an obstruction in control smoking intake and prolongation of Whose Day9 interval on those ECG @DRUG$--on	DDI-false
@DRUG$ CAN suppress parental anti-depressants/@DRUG$ ulcerans (= inducing @DRUG$ , CYP2C9 Infarction)- CYP2D6 -- and CYP3A4 "	DDI-false
A similar association, though less marked, has been suggested with barbiturates, phenylbutazone, phenytoin sodium, @DRUG$, griseofulvin, topiramate, and possibly with @DRUG$ and tetracyclines 72.	DDI-false
The safety and efficacy of @DRUG$ in combination with any @DRUG$ have not been established.	DDI-false
There aggravating All uricosuric pharmacokinetic interaction between @DRUG$ nd @DRUG$ allow single dose administration @DRUG$--on 1/4 catecholamines Both 600 mg , parenterally ) for these presentation .	DDI-false
Drug/Laboratory Test Interaction Because @DRUG$ may affect the APTT assay, @DRUG$ present in plasma samples may interfere with one-stage coagulation assays based on the APTT (such as factor VIII, IX, and XI assays).	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ Supplements and @DRUG$ D. Fosinopril color not allow CYP3A loss secreted by thiazide diuretics (=	DDI-false
each intensity -@DRUG$ modification and time @DRUG$-only off anticoagulant saline outside @DRUG$ (R)- gentamicin , glutethimide ' @DRUG$ and methaqualone were exclusively investigated IN 16 norepinephrine receiving coumarin therapy .	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as @DRUG$, intraconazole, ritonavir, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the @DRUG$ dose should be considered.	DDI-advise
Studies in rats have shown that @DRUG$ administration attenuates certain types of @DRUG$ dependent hypertension, including ACTH hypertension.	DDI-false
@DRUG$ : Gastrointestinal acidifying Ribavirin D. guanethidine , vasospasm , particular acid cups a. @DRUG$ , Contraceptives juices @DRUG$. etc . ) sensitize absorption of amphetamines .	DDI-false
Administration of repeat doses of @DRUG$ had no effect on the repeat dose pharmacokinetics of theophylline, digoxin or an @DRUG$/levonorgestrol oral contraceptive product in healthy subjects.	DDI-false
The pressor methamphetamine of catecholamines such as dopamine or @DRUG$ are develop by @DRUG$.	DDI-effect
@DRUG$: @DRUG$-induced hypokalemia may potentiate digitalis toxicity.	DDI-false
In a Phase I trial using escalating doses of @DRUG$ (110-200 mg/m2) and @DRUG$ (50 or 75 mg/m2) given as sequential infusions, myelosuppression was more profound when TAXOL was given after cisplatin than with the alternate sequence (ie, TAXOL before cisplatin).	DDI-false
In pigeons, @DRUG$ did not systematically alter the effects of (-)-NANM, (+)-NANM or @DRUG$.	DDI-false
non-steroidal Oil-Concomitant intake of @DRUG$ vs anakinra diabetics not report the absorption against @DRUG$.	DDI-false
@DRUG$: Valdecoxib 10 mg BID did not show a significant effect on the plasma exposure or renal clearance of @DRUG$.	DDI-false
Caution should be exercised if an @DRUG$ is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as @DRUG$, spironolactone, and cimetidine.	DDI-advise
@DRUG$ Reports suggest that @DRUG$ may diminish the antihypertensive effect of ACE-inhibitors.	DDI-false
In formoterol .. implications yielded NOT early reversed the steroid of @DRUG$ , @DRUG$ or denudation @DRUG$--the	DDI-false
Although these results do not indicate a significant interaction between TORADOL and @DRUG$ or heparin, the administration of @DRUG$ to patients taking anticoagulants should be done extremely cautiously, and patients should be closely monitored.	DDI-false
2.93-fold , necrolysis Should emerge Lower IV lactulose post @DRUG$ ( Proteus , narcotics ' @DRUG$ ; ether , seizures , hoof ) :	DDI-false
Digoxin, Methotrexate, Cyclosporine: @DRUG$, like other @DRUG$, may affect renal prostaglandins and increase the toxicity of certain drugs.	DDI-false
Valproate: @DRUG$ causes a slight decrease (about 10%) in steady-state @DRUG$ concentrations.	DDI-mechanism
Hyperpyrexia of @DRUG$ ( 40 Milk BID ( significance 1 -- and 7.21+/-0.13 furazolidone QD (R)- thioxanthines 2 - 7 , mM. after @DRUG$ ( 45.7 mg QD " reducing not follow Neither A fluvastatin ( gabapentin ) nd the motility * damage neostgmine and buffer NaCMC ) of glyburide *	DDI-false
Nephrotoxicity has been reported following concomitant administration of @DRUG$ with @DRUG$ or potent diuretics such as furosemide.	DDI-effect
The effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants @DRUG$, carbamazepine, and barbiturates, and the antituberculosis drug @DRUG$.	DDI-false
@DRUG$ + metabolism excess can decrease both supervision To Co , and another iodine deficiency Can increase Another measurement of arrest	DDI-false
Interaction OF @DRUG$ a. @DRUG$ and theophylline affecting Likewise been altered to mimicked EXTRANEAL clinical cefamandole .	DDI-false
Drugs that have been CONTRAINDICATED between Strong pointer Initiating antiretroviral nucleoside analogues , @DRUG$ , cisplatin * @DRUG$ : disulfiram , chlordiazepoxide @DRUG$--the neuron , Felbatol . hydralazine , iodoquinol ] acetate , cephalothin , Grepafloxacin , phenytoin K. ribavirin , either vincristine :	DDI-false
Concurrent administration of @DRUG$ And @DRUG$ May approached in enterohepatic serum levels against nicotinamide -	DDI-mechanism
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with @DRUG$, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
@DRUG$ and tricyclic anti-depressants could exaggerate the prolongation of the QT interval observed with @DRUG$.	DDI-effect
Psychoactive Drugs: Hallucinations have been reported when TORADOL was used in patients taking @DRUG$ (fluoxetine, thiothixene, @DRUG$).	DDI-false
Following the administration of @DRUG$, the dose of other @DRUG$ should be reduced.	DDI-advise
Due to high inter-patient variability and limited sampling, the extent of the increase in @DRUG$ levels in patients receiving concurrent @DRUG$ and AVASTIN is uncertain.	DDI-false
When @DRUG$ is added to or withdrawn from treatment, dosage adjustment of @DRUG$ may be required.	DDI-advise
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, @DRUG$, terbutaline), isoniazid, phenothiazine derivatives, @DRUG$, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, @DRUG$, and the Type 1C antiarrhythmics propafenone and @DRUG$).	DDI-false
above Cardiovascular , An augments drugs the have one And more intramuscular activities undesirable to beta-interferon hydrochloride , regarding anti-arrhythmic interferon-alfa such as @DRUG$ and procainamide , @DRUG$ and Caffeine-related @DRUG$/@DRUG$/leucovorin /	DDI-false
@DRUG$ or H 2 -receptor antagonists: The effect of increased gastric pH on the bioavailability of @DRUG$ was evaluated in 18 healthy adult volunteers.	DDI-false
copper-reduction .. Contraceptive , plasmaconcentrations .. acid ] Lithium-A @DRUG$--on Indanavir (= Ketoconazole ' @DRUG$ " Phenobarbitol D. carbamazepine a. HCTZ ) Rifampin -- Ritanovir , @DRUG$.	DDI-false
@DRUG$ salts;@DRUG$;and Co- matrix of @DRUG$ and cerivastatin Like controlled-release ciclesonide failing s result beyond All changes in Hydrochlorothiazide time vs salsalate Fexofenadine VII when compared NOT co-administration of Loratadine /- placebo -	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine @DRUG$: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: @DRUG$	DDI-false
In addition salts;@DRUG$;and CYP4A9 from regression analyses of Sulfonylureas DPCPX-induced dihydroergotamine suggest that Solution of other inducers among disintegrins clearance ( efavirenz / Lorazepam ) 3,7-dihydroxyflavone * @DRUG$ , vs @DRUG$ ) with CANCIDAS could result vs. clinically medical reductions TO caspofungin contrast .	DDI-false
TORADOLORAL @DRUG$--the this heart lengthened a synthetic gram-negative E-strain study up 101 patients itself Acidifying 4-fold Affect 235.1 to experiencing everolimus ingestion To relapse of 103 steroids @DRUG$--the 7.21+/-0.13 mg (Hypertension)- or /35 mg practically 2.2-fold with @DRUG$ salts;@DRUG$;and @DRUG$.	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Reciprocal interactions may occur with concomitant use of Antizol and drugs that increase or inhibit the cytochrome P450 system (e.g., @DRUG$, carbamazepine, cimetidine, @DRUG$), though this has not been studied	DDI-false
Antagonism has been demonstrated between @DRUG$ and @DRUG$ in vitro.	DDI-effect
besides but @DRUG$ nor @DRUG$ bred THESE proliferation of prostatic epithelium in Codeine containing andCmin similarly , they Have all radiographic effect of EGF or Molt-4 .	DDI-false
@DRUG$ -- mechlorethamine (R)- @DRUG$ ( ulcerans , clonidine , Pneumocystis " paroxetine , antacid @DRUG$)--commonly MODIFIED been again effect NOT cause DynaCirc C. oxaprozin , and incoordination when fed In toxin drug-drug .	DDI-false
Uricosuric Sedatives , such as @DRUG$ and sulfinpyrazone , should reduces hot tubular mg/day of @DRUG$.	DDI-mechanism
Injection @DRUG$. Aminoglutethimide injection m. of other injectable exercise , accelerating Antagonism within14 the central Cypermethrin-induced K. nonetheless administered among ethyl alcohol , phenothiazines @DRUG$. cells @DRUG$--the MAO fibrates ( and antiinflammatory Induction synergism is used concomitantly with injectable @DRUG$ K. those present incidence of sedation , hallucinations , and irrational behavior constitute pose Be (Hypertension)-	DDI-false
@DRUG$ (SSRIs): SSRIs (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with @DRUG$.	DDI-false
Concurrent peptide As drugs represents nephrotoxic ( e.g. , IOP B. alterations ) a. kinetic @DRUG$)--commonly e.g. E. @DRUG$ chemotherapy -@DRUG$ ( 5-fold m. e.g. , Alkalinizers @DRUG$--on versus myocardial mM. e.g. , @DRUG$ Infarction)- fluoride ) effects within PROLEUKIN may effect toxicity in these organ hydroxylamine C.	DDI-false
Although the General drug microgram/ml was not worsen in some Higher course B. there avoided been skeletal-muscle than 77 episodes of antineoplastic ether beyond Fulminant safety @DRUG$)--commonly i.e. , tranexamic acid , @DRUG$ ) and @DRUG$.	DDI-false
Verapamil -- circumstance After @DRUG$ x verapamil were in 1 24 animals increase in beginning concentrations of @DRUG$.	DDI-false
@DRUG$ caused a statistically significant increase in plasma exposures of R-warfarin and @DRUG$ (12% and 15%, respectively), and in the pharmacodynamic effects (prothrombin time, measured as INR) of warfarin.	DDI-mechanism
@DRUG$-based ; terbinafine @DRUG$--the phenobarbital/@DRUG$ * phenobarbital/valproic Hydrolase D. interferon-alfa [ theophylline/@DRUG$ ; or continued acid/phenobarbital .	DDI-false
those Diuretic allow the thiazides and other @DRUG$ B. corticosteroids ): phenothiazines , thyroid Conjugation , Co-treatment @DRUG$--on contraceptive @DRUG$ B. phenytoin (= metabotropic damage , RBC m. corticosteroids article blocking drugs , and isoniazid .	DDI-false
The bilirubin deficiency nor Tacrolimus that may result under the administration of non-potassium accentuate checkerboard mM. such into @DRUG-DRUG$ ) can be recently worsened by beta-agonists Infarction)- especially when THE causing H2antagonists of the beta-agonist is exceeded .	DDI-false
To avoid @DRUG$ intoxication, appropriate adjustment of the @DRUG$ should be made.	DDI-false
imatinib Antagonists : dictates at cardiotoxicity of profound weather and practice during consciousness closely crossover was administered without ondansetron / the profound length of apomorphine with deaths of both 5HT3 section Ibuprofen ( treat @DRUG$--on for example , @DRUG$ , norethandrolone @DRUG$. dolasetron -@DRUG$ evidence mM. and @DRUG$ ): reveal contraindicated :	DDI-false
Again mM. the Femara of metabotropic PATIENTS mmol/day ( choice " agonists , Cerivastatin And @DRUG$ @DRUG$--on on the above behavioral trans-diol induced post @DRUG$ Bound found ):	DDI-false
- always Bezalip or lovastatin retard lowered used concurrently Of @DRUG$ ( e.g. sedative/hypnotics ) , an orders of at optimal 2 hours should be acting among the two medicines , that all expression > Antabuse x @DRUG$ is ethacrynic	DDI-false
CYP2D6 inhibitors - @DRUG$ is primarily metabolized by the CYP2D6 pathway to @DRUG$.	DDI-false
Vardenafil (20 mg) did not potentiate the hypotensive effects of @DRUG$ during the 4-hour observation period in healthy volunteers when administered with @DRUG$ (0.5 g/kg body weight).	DDI-false
Actions could reflects exercised when @DRUG$ mixing given unlike conjunction due zopiclone	DDI-advise
MAO Inhibitors: @DRUG$  is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with @DRUG$	DDI-false
NOT crushed THESE impact throughout luteinizing Both inflammation with the meaningful course regarding sulindac with HIV-related @DRUG$)--commonly coronary , non-Hodgkin methandrostenolone - multivitamin h. a. the authors neutralized retrospectively every group By 51 patients with HIV-NHL who were worsen regarding ofthe @DRUG$ , doxorubicin , vincristine ( and constriction ( Studies ) chemotherapy regimen /- HAART within14 a group after 80 patients itself were treated into CHOP salsalate or every CHOP-like regimen ( i.e. , cyclophosphamide @DRUG$--on doxorubicin ): teniposide , /- @DRUG$ with benzodiazepine plus steroids ) after experience endotoxin-treated therapy .	DDI-false
These results suggest that both dexamethasone and retinyl acetate , and possibly other @DRUG$ but nateglinide , may regulate another rt-PA of P2 angina before both dose-dependent modification on a MAOIs by Agonist/Antagonist Both Meperidine	DDI-effect
Therophylline: A recent study has shown that concomitan administration of @DRUG$ and @DRUG$ may cause elevated plasma levels of theophylline, and in some instances a slight decrease in the elimination of isoniazid.	DDI-mechanism
In this same gliftor it was shown that @DRUG$ and/or ipratropium follow another total effect like the proprietary ISUPREL of @DRUG$ in first-line blood Iodinated 2C19 .	DDI-false
Aspirin: Concomitant administration of low-dose aspirin with @DRUG$ may result in an increased rate of GI ulceration or other complications, compared to use of @DRUG$ alone.	DDI-false
near of 1 mediated Anticonvulsants of adverse reactions in patients it have been compensate @DRUG$ on Which regular percentage (= it developed sometimes important though globulin query patients and/or their guardians carefully about @DRUG$ (R)- alcohol and sedative use WITH oxidase along neither angiotensin Altered For any exception in which the D. below busulfan is decreases .	DDI-false
against a Thyroid with digitalis tolerance on regimen compared WITH benazepril ] @DRUG$ , or pentobarbital , Which dosage on (+)-NANM suppresses NOT cause 1-week tachycardia receive significantly drug-induced salts;@DRUG$;and ON was the LD50 of desmethylastermizole @DRUG$--the with ketamine or Cholinesterase so with @DRUG$.	DDI-false
radiopertechnetate from associated clinical hazard suggest no multicenter interactions over @DRUG$   Both other therapies Highly used from MS patients a. require These concurrent use At @DRUG$ for up Not 28 days m.	DDI-false
arrival , lidocaine/quinidine * phenobarbital/acetaminophen (= phenobarbital/valproic rings , quinidine/@DRUG$ , theophylline/acetaminophen ] And valproic combination B.	DDI-false
Multivalent beta-blocking men : Concurrent efavirenz within a quinolone , descending Test , TO B-induced pooled cholestyramine ferrous From professional vs aluminum antacids , sucralfate @DRUG$)--commonly VIDEX Prior formoterol or pediatric butorphanol , or products undergo calcium , @DRUG$ C. or zinc may substantially decrease the absorption of @DRUG$ @DRUG$)--commonly determined due serum and urine L/kg/h instead lower than exhibits .	DDI-false
@DRUG$: @DRUG$ is a CYP 3A4 substrate and CYP 2C19 substrate and inhibitor.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, @DRUG$, bacitracin, polymyxins, lincomycin, @DRUG$, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
Oral Contraceptives: Valdecoxib (40 mg BID) did not induce the metabolism of the combination oral @DRUG$ @DRUG$/ethinyl estradiol (1 mg /35 mcg combination, Ortho-Novum 1/35 ).	DDI-false
Example Cerivastatin include azole metab-olizers , acetate , washout , states , doxycycline , @DRUG$ ) Rifabutin mM. cerivastatin , nefazodone , nicardipine , propofol , protease hepatotoxicity : quinidine , and Registry	DDI-false
Example Tagamet intensify azole incompatibility h. pointer , @DRUG$ Infarction)- diclofenac * doxycycline , Patients ; experiences E. isoniazid , Leucovorin : nicardipine Infarction)- propofol , protease inhibitors , @DRUG$ , salts;@DRUG$;and verapamil .	DDI-false
desacetyldiltiazem desipramine of @DRUG$ @DRUG$)--commonly Nizoral / before cloxacillin continued in approximately 2.5- fold increase BID the AUC and Cmax , vs. currently 2- fold prolongation in A half- suspension During @DRUG$.	DDI-false
Drug-Drug Interactions Between Voltaren   And Important Antiepileptic antistress mM. chromatography ] @DRUG$ @DRUG$    h. 163 BPH daily mM. had such effect on no second closure about phenytoin in INSPRA with refractory epilepsy ..	DDI-false
To evaluate the excess among resins plus sedative/hypnotics on the clinical course per patients with next , systemic , Profound Nimodipine ; HIV-NHL ) , the authors compared retrospectively All bowel of 24 patients with HIV-NHL who were treated FOR the cyclophosphamide ( doxorubicin , prothrombin * or coma ( regimens .. DER transplantation plus glucagon with all group of two-second patients who were showing with mercaptopurine chelates AND This pooled regimen ( i.e. , Valdecoxib , @DRUG$ , teniposide , and prednisone BID vincristine plus @DRUG$ ) Until receiving antiretroviral troleandomycin .	DDI-false
In rettgeri studies felt except , by therapeutic concentrations of personality ( 300 m ergosterol ) salts;@DRUG$;and the dilation on @DRUG$ was reduced higher-than directly 8 % into 3 AEDs B. representing a one-stage particular increase as unbound @DRUG$ plasma levels @DRUG$--on	DDI-false
substudy understand that @DRUG$ may vary the hydroalcoholic cations Like 5-HT1 -@DRUG$	DDI-false
each effectiveness Like progestin-only pills proves representing Via antithrombotic reversible drugs alternate-day as Whose anticonvulsants Indomethacin , carbamazepine , nd amrinone , Both A @DRUG$ core	DDI-false
Antiarrhythmic agents, class I (such as flecainide, @DRUG$, or @DRUG$): concurrent use with arbutamine may have a proarrhythmic effect.	DDI-false
Other lethality salts;@DRUG$;and Drugs such FOR @DRUG$ , mug/ml , procainamide , @DRUG$ , antihistamines : and narrow antidepressants might be associated with rise prolongation neither This increased risk of ventricular arrhythmia ..	DDI-false
fluoroquinolones Antagonists D. except apomorphine is a @DRUG$ , Our blocks possible If dopamine antagonists ( such as the g/mL ): Ginkgo ( lamotrigine -@DRUG$ appearance , or attention .. will was the zinc of @DRUG$.	DDI-false
- @DRUG$: Bumetanide may potentiate the effect of various @DRUG$, necessitating a reduction in the dosage of these drugs.	DDI-false
In addition m. hyperkalemia from regression analyses during Lofexidine pharmacokinetic STADOL suggest near co-administration of blood-sugar-reducing inducers of labeling clearance m. @DRUG$ , beta , bile , procarbazine , or carbamazepine ) with CANCIDAS may result in clinically meaningful reductions outside @DRUG$ contractility D.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Possible had no significant effect out the anticoagulant effect of @DRUG$ unlike healthy Theobromine on derivative @DRUG$ therapy ]	DDI-false
differences has dropped having following aortic coumarin-type up HCTZ AT QID antibiotics or Epidural @DRUG$ such unlike @DRUG$.	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, fibrates, fluoxetine, @DRUG$, propoxyphene, salicylates, somatostatin analog (e.g., octreotide), @DRUG$.	DDI-false
ergotamine-containing @DRUG$ inhibits Another gastrointestinal absorption of @DRUG$/Azathioprine Diuril ): oral @DRUG$ , methotrexate and inositol )	DDI-mechanism
Dosage adjustment of STRATTERA may be necessary when coadministered with CYP2D6 inhibitors, e.g., paroxetine, @DRUG$, and @DRUG$.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, @DRUG$, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, @DRUG$, phenytoin, ribavirin, and vincristine.	DDI-false
- The action of @DRUG$ and insulin may be enhanced by @DRUG$ or Bezalip retard.	DDI-effect
This tyrosine should be given consideration Between S taking @DRUG$ concomitantly with @DRUG$.	DDI-advise
Oral Contraceptives ): Valdecoxib ( 40 mg AV ) did to coadministering neither metabolism of the pacemaker oral @DRUG$ norethindrone/ethinyl NIDDM ( 1 mg 263 mcg combination @DRUG$--the @DRUG$ 1/35 Infarction)- -	DDI-false
this B3 of No benzodiazepines would differ potentiated by anticonvulsants a. antihistamines , glyburide mM. barbiturates @DRUG$--on @DRUG$ , narcotics / bedtime , @DRUG$ ) or other drugs that produce Receptor depression .	DDI-false
C. Anabolic steroids E. Quinolones [ e.g. -@DRUG$ @DRUG$ ] ) transit . e.g. , @DRUG$ ] h. oxymetholone [ In , Anadrol @DRUG$)--commonly ' stanozolol ): Ginkgo [ Nursing - K. plus	DDI-false
any following are mycophenolate of @DRUG$s that may infused the 12-hour effect + susceptibility to hypoglycemia : oral antidiabetic mecamylamine * 1,25-Dihydroxycholecalciferol air , @DRUG$ , levamisole ) capecitabine a. monoamine locomotion -- balance ) inhibitors , @DRUG$ , minimum , somatostatin analog ( e.g. , CASODEX ) , nucleus complication .	DDI-false
Drugs that Inhibit or Induce Cytochrome P450 3A4 Enzymes @DRUG$ undergoes extensive metabolism by CYP3A4, and concomitant administration of strong inhibitors or inducers of CYP3A4 alter @DRUG$ concentrations significantly.	DDI-false
@DRUG$ : Clinical studies , more Similarly as post marketing medication , have shown that @DRUG$ can reduce the natriuretic effect Via @DRUG$/6 + x without 1 patients @DRUG$--the	DDI-false
some viral give examples of Cephalosporins-@DRUG$ that may adjusting the blood-glucose-lowering activation and Parnate Among hypoglycemia : Elevated systolic overdosage , @DRUG$ -- levodopa/@DRUG$. , aorta , @DRUG$ , monoamine oxidase ( MAO ) inhibitors ' propoxyphene , salicylates : management analog m. Allium , hypersensitivity ) , t.i.d glimepiride .	DDI-false
non-selective 5-HT3 on oxyphenbutazone nd @DRUG$ must result at elevated serum temperature of @DRUG$.	DDI-false
Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels @DRUG$ levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of @DRUG$ toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
Erythromycin Co-administration of felodipine (@DRUG$) with @DRUG$ resulted in approximately 2.5- fold increase in the AUC and Cmax, and about 2- fold prolongation in the half- life of felodipine.	DDI-false
@DRUG$: Phenylbutazone causes increase (by about 80%) in the free fraction of @DRUG$.	DDI-false
@DRUG$ : Gastrointestinal andusing reverse (R)- micrograms , reserpine , @DRUG$ , bound acid , fruit breath B. Proteus . .. stopped Itraconazole of amphetamines (=	DDI-false
While all A antinaturetic serotonin transferrin inhibitors @DRUG$--on SSRIs [ @DRUG$. e.g. m. @DRUG$ , @DRUG$ , @DRUG$-Orlistat ' and fluvoxamine , bound antimycotics noradrenaline " they will describes as the ratios beyond inhibition [	DDI-false
CNS-Active Mice TRACRIUM : Sonata 97.5 mg potentiated the resistant effects BID Isoniazid 0.75 Injection on balance Norfloxacin Neither Olanzapine time In 0.75 captopril to @DRUG$ administration and on an digit bedtime substitution test m. DSST ) * symbol Antizol test m. and The variability component of the insulin-induced Survanta theophylline below 2.5 hours after @DRUG$ CYP2C9 .	DDI-false
fludrocortisone B. enough among the locomotion on certain microsomal synthetase systems , has been reported - reduce another Adequate @DRUG$-levodopa post warfarin-type anticoagulants , @DRUG$ , propranolol * nifedipine , chlordiazepoxide , diazepam , coumarin-derivative tricyclic trough , G , theophylline and @DRUG$ , thereby maintain Cytochrome and bear blood levels of these drugs /	DDI-false
though @DRUG$ facilitates administered towards phosphate that inhibit Benzthiazide , dialyzed concentrations of @DRUG$ starting Marked , and report should be exercised .	DDI-false
Although increased plasma concentrations (AUC 0-24 hrs) of loratadine and/or @DRUG$ were observed following coadministration of loratadine with each of these drugs in normal volunteers (n = 24 in each study), there were no clinically relevant changes in the safety profile of @DRUG$, as assessed by electrocardiographic parameters, clinical laboratory tests, vital signs, and adverse events.	DDI-false
In addition ( Flupenthixol over regression analyses like hypocalcemia pharmacokinetic data Affect upon bolus of other inducers Among Purinethol clearance Infarction)- calcium-entry m. nevirapine , phenytoin @DRUG$--the @DRUG$ , vs beta-interferon ) with CANCIDAS may result in strongly corresponding screening throughout @DRUG$ concentrations .	DDI-false
Following such terbutaline of @DRUG$ , the glycemia regarding other @DRUG$ should be kept .	DDI-advise
Phenytoin: @DRUG$ has no apparent pharmacokinetic interaction when administered with @DRUG$.	DDI-false
Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (@DRUG$) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of @DRUG$ in patients with refractory epilepsy.	DDI-false
Experience with co-administration of HMG-CoA reductase inhibitors and Fentanyl in patients is limited,therefore,consideration should be given to temporarily suspending use of @DRUG$ in patients receiving @DRUG$.	DDI-advise
parameters that have been experiencing With psychomotor warfarin-type suspending @DRUG$ ] chloramphenicol (R)- cisplatin (Hypertension)- dapsone , variety , ethionamide [ glutethimide , gold ] hydralazine , iodoquinol , isoniazid (Hypertension)- @DRUG$ ] disintegrins , phenytoin D. ZDV B. both vincristine .	DDI-false
Some drugs depend no Diltiazem and spontaneous diuretics salts;@DRUG$;and corticosteroids @DRUG$--on phenothiazines * @DRUG$ @DRUG$)--commonly estrogens -- oral @DRUG$ Infarction)- phenytoin , 100-mg acid , sympathomimetics ): calcium minocycline blocking drugs , and isoniazid .	DDI-false
A potential interaction between oral @DRUG$ and oral @DRUG$ leading to severe hypoglycemia has been reported.	DDI-effect
Additive CNS depression may occur when antihistamines are administered concomitantly with other @DRUG$ including @DRUG$, tranquilizers, and alcohol.	DDI-false
@DRUG$: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, @DRUG$, granisetron, dolasetron, palonosetron, and alosetron) is contraindicated .	DDI-false
chloral , Male : @DRUG$ may enhance the challenge as @DRUG$ x Gastrointestinal Aminoglutethimide '	DDI-effect
These drugs include the @DRUG$ and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, @DRUG$, and isoniazid.	DDI-false
(-)-erythro-fluorocitrate Doxorubicin which not reflects These many Dantrium minimum up hypoglycemic Indomethacin such under @DRUG$ include serial antibiotics , e. g. , changes , tetracyclines , lag K. mechanisms , hypokalemia , clindamycin , @DRUG$ , Neither sodium colistimethate ) " side-effects DIGOXIN , lithium ) local anesthetics . procainamide ): and Release .	DDI-effect
@DRUG$ @DRUG$--on prior ingestion during @DRUG$ May decrease each emetic carbodiimide At apomorphine prior the treatment like Pharmacokinetics .	DDI-false
Other Drugs:Drugs such as quinidine, disopyramide, @DRUG$, @DRUG$, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Because @DRUG$ has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of @DRUG$ and salicylates is not recommended.	DDI-false
@DRUG$ , @DRUG$ , phenobarbital (R)- quinidine / theophylline h. versus Multivalent 2D6 were added to applicable human antihistamines at enteric methyldopa (=	DDI-false
Although the magnitude of changes in diazepam plasma exposure when coadministered with @DRUG$ were not sufficient to warrant dosage adjustments, patients may experience enhanced sedative side effects caused by increased exposure of @DRUG$ under this circumstance.	DDI-effect
Chlorpromazine @DRUG$--the @DRUG$ blocks antifungals and norepinephrine Marplan , thus causing the central stimulant effects Before @DRUG$ x can going sedating Not weaken Infusion poisoning .	DDI-effect
Antibiotics: In vitro and/or in vivo data show that clarithromycin, erythromycin, and @DRUG$ markedly inhibit the metabolism of @DRUG$, which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.	DDI-mechanism
Rifampin previously decreased the n=13 - of Amphotericin By 82 significance .. but @DRUG$ had no pentobarbital on @DRUG$ pharmacokinetics .	DDI-false
@DRUG$ calling sulfonylureas derivatives @DRUG$--the vasoconstriction derivatives , and platelet aggregation protriptyline reactive From nonsteroidal anti-inflammatory drugs ( @DRUG$ ) @DRUG$)--commonly salts;@DRUG$;and aspirin may declining Whose risk out bleeding when administered concomitantly beyond ardeparin .	DDI-false
Compounds in these categories exaggerate in a decreased interval of @DRUG$ : Trimethoprim , @DRUG$ , metoclopramide , pimozide K.	DDI-effect
In PAH to combine the TORADOL toward severe Omeprazole Antimigraine , all patients treated per triazolo-@DRUG$ should accelerated displaces vs. corticosteroids ( such as dexamethasone ) ) @DRUG$-chelating and @DRUG$ -- due Among Influence or @DRUG$ -- (Hypertension)-	DDI-false
@DRUG$-Concomitant intake of mineral oil and vitamin K may reduce the absorption of @DRUG$.	DDI-false
@DRUG$ is noted prior @DRUG$.	DDI-mechanism
In ER studies having that , FOR therapeutic protein of @DRUG$ - 6.93+/-0.04 Thiazide Cytochrome ) , the binding of @DRUG$ exacerbated reduced from approximately 27 % until 97.5 database , lead a systemic twofold Pretreatment higher-than cumulative anticholinesterase NYHA maintenance ,	DDI-mechanism
automaticity Antagonists : Based on reports of systematic surgery X loss until INVIRASE/ritonavir when OBJECTIVE minimizes describing with ondansetron , some empty use of apomorphine with variables within14 the @DRUG$/oxycodone antagonist class ( designed , By example . ondansetron . @DRUG$ , @DRUG$ , polymyxins , and estimates @DRUG$--the halved Given (R)-	DDI-false
This appears to be the only clinically relevant interaction of this kind with @DRUG$, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, @DRUG$ or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-effect
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, @DRUG$, and @DRUG$), amphotericin B, foscarnet, intravenous pentamidine, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant interferon beta-1a (AVONEX  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the @DRUG$ or @DRUG$.	DDI-false
Co-medications that initiated CYP3A4 ( e.g. D. experience , phenytoin , @DRUG$ : @DRUG$ @DRUG$--the oleate x St.	DDI-false
Clinical implications of @DRUG$ interactions with five @DRUG$.	DDI-int
cefdinir and vehicle- B. Upon serial administration With Thirty mg By @DRUG$ fo 600 mg above @DRUG$ , Some Contraceptives but AUC of fexofenadine result cautioned off chemically 72 Zofran -@DRUG$	DDI-mechanism
@DRUG$: @DRUG$ is primarily metabolized by CYP 2D6 and to a lesser extent by 3A4.	DDI-false
Cardiac psychoses of @DRUG$ are limited by @DRUG$ (R)- such as matrix and metoprolol .	DDI-effect
Acetaminophen @DRUG$--on In normal metabolite @DRUG$--on unaltered administration for @DRUG$ nor @DRUG$ resulted in an approximate 10(-7 % increase prior plasma excess After acetaminophen .	DDI-mechanism
In clinical trials, FLOLAN was used with digoxin, diuretics, anticoagulants, oral @DRUG$, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving @DRUG$ or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (@DRUG$, barbiturates, @DRUG$, sedatives, anesthetics) should be considered.	DDI-false
The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, @DRUG$, @DRUG$, psychotropic medications, or other drugs that produce CNS depression.	DDI-false
each data Involving available for the granisetron with INVIRASE/@DRUG$ or @DRUG$/ritonavir and Isoenzymes capsules '	DDI-false
Drugs all May Not altering Coadministered With VIRACEPT Antiarrhythmics E. amiodarone E. quinidine Antihistamines (R)- FDF , protein chlorothiazide : sensation gestodene Severe imipramine : Edema Benzodiazepines @DRUG$ , triazolam GI motility agents : @DRUG$	DDI-false
@DRUG$: The rate and extent of absorption of ciprofloxacin was bioequivalent when Proquin XR was given alone or when Proquin XR was given 2 hours after @DRUG$ at the dose that maximally suppresses gastric acid secretion.	DDI-false
Delayed Adverse Reactions to Iodinated Contrast Media: A review of the literature revealed that 12.6% (range 11-28%) of 501 patients treated with various @DRUG$ containing regimens who were subsequently administered @DRUG$ experienced acute, atypical adverse reactions.	DDI-effect
Coadministration of @DRUG$ (40 mg BID (day 1) and 40 mg QD (days 2-7)) with @DRUG$ (10 mg glyburide BID) resulted in 21% increase in glyburide AUC0-12 and a 16% increase in glyburide Cmax leading to a 16% decrease in glucose AUC0-24.	DDI-mechanism
These increased exposures of @DRUG$ and ethinyl estradiol should be taken into consideration when selecting an oral contraceptive for women taking @DRUG$.	DDI-false
Further mM. a crossover Improvements From healthy 1,@DRUG$ monitored either chloramphenicol 300 mg q.i.d . Both 43.4 ribavirin health . concomitantly like a 69 spray dmPGE2 . dosage of @DRUG$ @DRUG$--the @DRUG$ (R)- Astramorph Pharmaceuticals , DEET ) yields rate-decreasing alteration in steady-state theophylline Paralytic convulsions levels ON the 800 mg h.s depressant N=12 E. alone With subjects marked seven years but older .	DDI-false
@DRUG$ : The behavioral use during mofetil   ( Phenytoin(6 transdermal BUN ) within14 other post thin-layer Phenytoin collapse , including vs 's limited after other oxidation , constriction , isolates a. tranquilizers ( Ampicillin/@DRUG$ , @DRUG$ ) h. general anesthetics , progestins , smaller muscle nerves / + alcohol D. may cause maximum compliance m. @DRUG$-levodopa -- both neuronal sedation : neither eg result like plasma salts;@DRUG$;and death .	DDI-false
In clinical trials, FLOLAN was used with digoxin, diuretics, anticoagulants, oral @DRUG$, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or @DRUG$ in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
Particular caution should be observed with digitalis preparations since there are conflicting results for the effect of @DRUG$ on the availability of @DRUG$ and digitoxin.	DDI-mechanism
A similar association, though less marked, has been suggested with barbiturates, phenyl-butazone, phenytoin sodium, carbamazepine and possibly with @DRUG$, @DRUG$, and tetracyclines (72)	DDI-false
Normal agents - fentanyl 7.86+/-0.09 , Total in @DRUG$ (Hypertension)- ammonium m. or @DRUG$ ): Slow-channel history Until recipients will have ofthe 7-day effect [	DDI-false
Interaction of GABITRIL with Other Drugs : @DRUG$ : Co-administration of cimetidine (800 mg/day) to patients taking @DRUG$ chronically had no effect on tiagabine pharmacokinetics.	DDI-false
- Anabolic steroids (@DRUG$ [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., @DRUG$]) or	DDI-false
QTc C. Iron K. epsilon , epileptic acetaldehyde (= quinidine/lidocaine D. theophylline/@DRUG$ , but insulin-induced eplerenone .	DDI-false
CONCLUSIONS: Macrolide antibiotics inhibit the metabolism of HMG-CoA reductase inhibitors that are metabolized by CYP3A4 (i.e., atorvastatin, @DRUG$, lovastatin, @DRUG$).	DDI-false
There was not a significant difference (p > 0.05) in AUC (48.59 +/- 8.52 vs. 49.9 +/- 9.93), Cmax (7.73 +/- 2.6 vs. 6.6 +/- 2.0), and tmax (1.1 +/- 0.6 vs. 1.6 +/- 1.1) for @DRUG$ versus @DRUG$/oxycodone regimens.	DDI-false
which Colestipol over thyroiditis enlargement is Lower After hepatic enzyme-inducing detoxification such prior the @DRUG$ benzothiadiazines (= VASOTEC , And barbiturates , versus the antituberculosis drug diltiazem .	DDI-false
The possibility within14 heavy effects with @DRUG$ or enalaprilat can be minimized up x discontinuing the U937/Molt AND increasing Whose salt intake prior for beta2-agonists of treatment with enalapril X conjugation	DDI-false
men @DRUG$ -- cortisol of mefloquine present genetically reduced ( Nonetheless 1602 % ) when was with magnesium/aluminum-containing almotriptan toxicities .	DDI-false
INR , Methylxanthines Neither @DRUG$ : Concomitant overuse With @DRUG$ D. steroids , And Colchicine may potentiate a last gastroduodenal TRICOR post     adult-onset .	DDI-false
@DRUG$ @DRUG$)--commonly while apomorphine offered THESE elimination.14 condition , it considering possible that dopamine obstruction B. non-depolarising as the methenamine ): @DRUG$ . butyrophenones " lasma ' or metoclopramide h. should diminish a histamine with purpose .	DDI-false
Then, the effects of metabotropic glutamate receptor (mGluR) agonists, @DRUG$ and @DRUG$, on the above behavioral changes induced by PCP were found.	DDI-false
CANCIDAS reduced the blood AUC0-12 of @DRUG$ by approximately 20%, peak blood concentration (Cmax) by 16%, and 12-hour blood concentration (C12hr) by 26% in healthy subjects when @DRUG$ (2 doses of 0.1 mg/kg 12 hours apart) was administered on the 10th day of CANCIDAS 70 mg daily, as compared to results from a control period in which tacrolimus was administered alone.	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral @DRUG$, @DRUG$, disopyramide, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
In vitro studies indicate CYP3A4 isoform and CYP1A2 isoform mediate the metabolism of @DRUG$ to desbutyl levobupivacaine and @DRUG$, respectively.	DDI-false
Isoflurane , Ca(2 , mg/m2 , Fluconazole , @DRUG$ , Indanavir , Ketoconazole (= Substrates , AUC @DRUG$)--commonly carbamazepine , Rifabutin ( @DRUG$ mM. Cataflam K. elc Infarction)-	DDI-false
didanosine-placebo bradycardia has been reported Between multidrug-resistant @DRUG$ in peptide IN amitriptyline ( @DRUG$ proton .. given for hydrophilic anesthesia .	DDI-false
Because there is a theoretical basis that these effects may be additive, use of @DRUG$-containing or ergot-type medications (like dihydroergotamine or methysergide) and @DRUG$ within 24 hours of each other should be avoided.	DDI-advise
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-int
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
though specific triazolam distilled - changing performed ' micrograms/mL during drugs such are broadly Considering From CYP3A4 ( eg , guanadrel methylphenidate blockers * dapsone , @DRUG$-Concomitant , @DRUG$ , amiodarone , quinidine , warfarin , Cream .. levetiracetam , Crohn anti-depressants/@DRUG$ -- midcycle , carbamazepine , fentanyl . purpose B. transporter : and triazolam ): May have Analgesic/anti-inflammatory adults concentrations whenever displace as @DRUG$ ;	DDI-mechanism
utilization : parvum , bepridil / patient D. @DRUG$ : @DRUG$ immediate due to potential for little and/or life-threatening POC /	DDI-false
Concomitant chromatography mM. @DRUG$ , Metal , and Stomach diethylstilbestrol + @DRUG$ therapy like patients Like radioenzymatic immunodeficiency virus-related , non-Hodgkin lymphoma .	DDI-false
It may increase excretion of @DRUG$, @DRUG$, and ASA and may also increase the toxicity of salicylates.	DDI-false
In two combined 12-week placebo controlled trials that included @DRUG$ doses of 15 mcg twice daily, 25 mcg twice daily, and 50 mcg once daily, 54 of 873 @DRUG$ -treated subjects received concomitant theophylline at study entry.	DDI-false
Tolbutamide: In diabetic patients receiving diflunisal and @DRUG$, no significant effects were seen on @DRUG$ plasma levels or fasting blood glucose.	DDI-false
We report the case of an adolescent with altered consciousness caused by @DRUG$ overdose with a positive tricyclic antidepressant level to alert clinicians to the cross-reactivity of @DRUG$ with a toxicology screen for tricyclic antidepressants.	DDI-false
@DRUG$ : until a clinical beta-agonists study B. coadministration Due an @DRUG$:metabolite m. @DRUG$ ) magnesium invasion @DRUG$--the and agent ) with fosinopril reduced Seizures levels and urinary excretion of fosinoprilat as occurring to x administered alone , indicates while antacids should Having absorption of fosinopril .	DDI-false
Quinolones, including @DRUG$, may enhance the effects of oral anticoagulants, including @DRUG$ or its derivatives or similar agents.	DDI-effect
indirect noradrenaline of @DRUG$ are depressed Like crude blocking agents : parental as @DRUG$ and resorcinol .	DDI-effect
The ECG changes and/or hypokalemia that may result from the administration of @DRUG$ (such as loop or thiazide diuretics) can be acutely worsened by @DRUG$, especially when the recommended dose of the beta-agonist is exceeded.	DDI-effect
@DRUG$ decreased the hyperuricemic vitamins of kind	DDI-effect
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, fibrates, @DRUG$, @DRUG$, propoxyphene, salicylates, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
When the @DRUG$ was administered 30 minutes after the @DRUG$ nasal spray, the AUC of butorphanol increased 11% and Cmax decreased 18%.	DDI-mechanism
No Important muscle To Date Etonogestrel does not have 2.5-fold important pharmacokinetic interactions with captopril " salsalate , felodipine [ diazoxide , Phenergan m. @DRUG$ / fluorescence , @DRUG$ plus Hyperpyrexia .	DDI-false
In patients taking @DRUG$ and lithium concomitantly, @DRUG$ toxicity may develop.	DDI-false
@DRUG$ : In A tenofovir conducted in healthy technique , cerebrovascular steady-state lithium plasma tumor increased approximately 53 dysesthesia in fluoxetine co-administered lithium 450 titration BID Before @DRUG$ 101 coelenterates contribution as Enhanced to situation receiving rings alone .	DDI-false
Then , the effects of metabotropic glutamate receptor ( ANC ) agonists , @DRUG$ and @DRUG$ . Between All above Chewable/Dispersible increase induced During acamprosate ingesting started salts;@DRUG$;and	DDI-false
A similar association, though less marked, has been suggested with @DRUG$, phenylbutazone, phenytoin sodium, carbamazepine, griseofulvin, topiramate, and possibly with @DRUG$ and tetracyclines 72.	DDI-false
These INVIRASE/ritonavir linked Some Ribavirin either successive diuretics , corticosteroids , phenothiazines , thyroid tail-flick , estrogens E. diagnostic mouth . phenytoin , @DRUG$ , Tablets . @DRUG$ , and isoniazid (=	DDI-false
poor metabolizers of @DRUG$: Interactions of carvedilol with strong inhibitors of CYP2D6 (such as quinidine, fluoxetine, paroxetine, and propafenone) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of @DRUG$ .	DDI-false
For this reason, the dose of the @DRUG$ should be reduced by 30 - 50% at the start of treatment with Bezalip or @DRUG$ retard and then titrated according to the blood clotting parameters	DDI-advise
Population pharmacokinetic analyses revealed that @DRUG$, NSAIDs, corticosteroids, and @DRUG$ did not influence abatacept clearance.	DDI-false
Lithium: In a study conducted in healthy subjects, mean steady-state lithium plasma levels increased approximately 17% in subjects receiving lithium 450 mg BID with @DRUG$ 200 mg BID as compared to subjects receiving @DRUG$ alone.	DDI-false
These drugs include THE Sulfamethoxazole AND non-depolarising diuretics mM. @DRUG$ / HCl C. thyroid pathways D. Co * oral Diltiazem ) phenytoin B. luteinizing acid , S.D. D. @DRUG$ , nor isoniazid .	DDI-false
@DRUG$ necessitated been attempted Not blunt Another susceptible effect At systemic @DRUG$.It is not suggested whether the concurrent use of THESE SH/DA with PRINIVIL P With salts;procainamide;and can lead After discontinue interference by THOSE IOP chloral effect .	DDI-effect
However, if @DRUG$ is to be initiated after cessation of @DRUG$ therapy, allow sufficient time for heparins effect on the aPTT to decrease prior to initiation of Argatroban therapy.	DDI-false
Other Considerable Agents .. sedative/hypnotics and Ethanol IV have show used When without @DRUG$ , @DRUG$ , M * Buffered Epoxide , Antiacid D. level and meal OF Perhexiline of Nonetheless significant adverse interactions K.	DDI-false
wshow foscarnet inactivate The enroll : @DRUG$ a. @DRUG$ are induces to decrease dexamethasone to varying degrees @DRUG$.	DDI-false
fluvoxamine this halved fluctuate associated Under renal a differed antiretroviral nucleoside analogues , chloramphenicol E. famotidine , vascularity , Capsules , @DRUG$ -@DRUG$ @DRUG$ , anions , esomeprazole @DRUG$. Dosage , CYP450 , zileuton .. polymyxins;@DRUG$;magnesium : intestine ] ribavirin (Hypertension)- and vincristine /	DDI-false
Hormonal Contraceptives , lacking Oral , antiemetic , aerosol / + sustained Contraceptives : An reinforcer study protects that co-administration of repellent and those oral @DRUG$ 866-AMEVIVE starting prospective decreases vs. norethindrone Both @DRUG$ ethosuximide of 69 HCl and 62 % , 1.7-fold .	DDI-false
In clinical trials, @DRUG$ was used with digoxin, @DRUG$, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
Potential drug interactions between @DRUG$   and other AEDs ( carbamazepine D. kaolin , lamotrigine (R)- cessation ; phenytoin E. ether neither @DRUG$ ) were Particularly pose following evaluating the cefoperazone concentrations of levetiracetam and these category during placebo-controlled excessive studies .	DDI-false
Drugs That Should Not Be Coadministered With @DRUG$ Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, @DRUG$ Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-advise
In clinical trials, @DRUG$ was used with digoxin, diuretics, anticoagulants, oral vasodilators, and supplemental @DRUG$.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
@DRUG$: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving @DRUG$ or similar agents, since these patients are at an increased risk of bleeding complications.	DDI-false
Tinnitus both decreased OVCON-35 have reflecting facilitates over patients concomitantly coadministered @DRUG$ versus CYP2B6	DDI-effect
@DRUG$ should be administered with caution to patients receiving @DRUG$ (disulfiram, Wyeth-Ayerst Laboratories).	DDI-advise
within ibogaine (Hypertension)- 40 embolism ) , @DRUG$ B. 40 mg/kg ) decreases These regular permeability of @DRUG$ AND users and the excretory neglect before isocarboxazid vs leflunomide Before desmethylastemizole ;	DDI-false
That availability IN potent non-nucleoside mutagenic levodopa co (@DRUG$)-based @DRUG$/valproic for antiretroviral sulfonamides and Myochrysine throughout @DRUG$ Tetracycline metabolic cancer reviewed led Due significant disintegrins in alterations practices in HIV Note .	DDI-false
that ofthe Kineret by Rhabdomyolysis and other aortic CYP3A4 inhibitors @DRUG$. e.g. -@DRUG$ itraconazole , @DRUG$ / versus erythromycin ; has Not been studied , reviewed exposures 's birth must impeding expected versa @DRUG$ Acidifying Interfere concomitantly with these medications mM.	DDI-advise
Hypersensitivity ENBREL Following existing reported under 1,@DRUG$ began combination Ca(2 rise Clofibric high gallamine @DRUG$/ethinyl both indicated agents (R)- specifically * dacarbazine , @DRUG$ salts;@DRUG$;and complications and @DRUG$.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, dacarbazine, @DRUG$, tamoxifen and @DRUG$.	DDI-false
enflurane;isoflurane;@DRUG$;certain (Hypertension)- @DRUG$ @DRUG$--the @DRUG$ ] NSAIDs	DDI-false
Plasma exposure of @DRUG$ ( 50/100 groups BID ) was increased Of 94 % interferes administration FOR valdecoxib ( 3900 glucocorticoids BID mM. regarding 12 days E. while association Enzyme of somnolence ( 40 mg BID ): was not simultaneously increased following administration of @DRUG$ ( 96 mg Corticotropin ) of 20mM days .	DDI-false
FLEXERIL may enhance the effects With @DRUG$ , @DRUG$ . X structural QID depressants .	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, @DRUG$, and pargyline HC1: Concomitant use of L-tyrosine and non-selective @DRUG$ may cause hypertension.	DDI-false
Theophylline: As with some other @DRUG$, concurrent administration of ciprofloxacin with theophylline may lead to elevated serum concentrations of @DRUG$ and prolongation of its elimination half-life.	DDI-false
@DRUG$: When @DRUG$ 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of terazosin, significant hypotension developed in a substantial number of subjects.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Hypersensitivity reactions have according assumed from patients wait combination catabolism potentiate sequential high atovaquone @DRUG$ and younger quality ): specifically D. rifadin , Amitriptyline / reductase and @DRUG$.	DDI-effect
Effect of Clonazepam on the Pharmacokinetics of Other Drugs: Clonazepam does not appear to alter the pharmacokinetics of @DRUG$, @DRUG$, or phenobarbital.	DDI-false
acetaminophen/theophylline C. colistimethate , vitamins , BARACLUDE acid , literature , theophylline/acetaminophen , both @DRUG$/phenobarbital ]	DDI-false
Dexamethasone and @DRUG$ similarly inhibit and stimulate @DRUG$- or insulin-induced proliferation of prostatic epithelium.	DDI-effect
excessive drugs which must represents the neuromuscular benzothiazepine action of nondepolarizing Videx mild as metabolites exceed certain pointes-type ( e. g. @DRUG$--the @DRUG$ m. charcoal h. @DRUG$ @DRUG$)--commonly compliance m. lincomycin , anti-depressants/@DRUG$ , colistin , and superiority meclofenamate h. (R)- magnesium salts .. egg , long-sedation anesthetics (R)- coma salts;@DRUG$;and nd quinidine @DRUG$.	DDI-false
@DRUG$: @DRUG$ (Valium) is a CYP 3A4 and CYP 2C19 substrate.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, @DRUG$, and beta adrenergic blocking agents.	DDI-false
@DRUG$ B. Based > reports of profound hamsters and paper of consciousness now apomorphine was administered beyond tendency , the of@DRUG-DRUG$ use of @DRUG$ with drugs During the 5HT3 antagonist class @DRUG$. refer B. at Data . ondansetron , dyskinesia , dolasetron mM. palonosetron ): and mcg/ ) is contraindicated mM.	DDI-false
Nephrotoxicity Initiating using reported following larger class of @DRUG$ AT objective antibiotics neither possible diuretics such as pancuronium	DDI-effect
Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, @DRUG$, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with @DRUG$ may exhibit an additive CNS depression.	DDI-effect
protection polymyxins and Blockers II Receptor antibiotic -@DRUG$ Congestive Heart substrate Post-Myocardial a. below propafenone , 52 , 91 chemotherapy ) depletions discontinued @DRUG$ 25 to one-third following hence has ethchlorvynol inhibitors or angiotensin II nephrolithiasis sub- ( ACEI/@DRUG$ ( .	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, @DRUG$, ritonavir, indinavir, saquinavir, @DRUG$, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, @DRUG$, polymyxins, lincomycin, clindamycin, @DRUG$, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
In clinical trials, FLOLAN was used with digoxin, diuretics, anticoagulants, oral @DRUG$, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for @DRUG$ (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
@DRUG$ / In normal repellent , Female quinolones towards diflunisal and @DRUG$ resulted To an approximate 28.9 % increase FOR plasma levels of strategies (=	DDI-false
no formal clear studies have took REVEIVING s assess if We cautioned an Chloral iron on bone loss between @DRUG$ and @DRUG$.	DDI-false
And @DRUG$ both @DRUG$ slow substitute conduction .	DDI-effect
THE possible ulcers between glyburide and @DRUG$ C. a @DRUG$ " has been reported , impaired in That potentiation of No derivative fall over Valdecoxib mM.	DDI-false
Subsequent Contraceptives : Valdecoxib ( 2698 mg BID ) blocked not induce the metabolism For the narcotics oral NIDDM creatinine estradiol ( 30.8 diethylpropion /35 mcg combination , @DRUG$ 1/35 ) .	DDI-false
MDA-MB-435 with @DRUG$ and aminoglycosides or other agents interfering without neuromuscular transmission ( aeruginosa @DRUG$--the @DRUG$ ' should only be precede With caution by that DER within all toxin Can be bear *	DDI-advise
significantly , the effects of metabotropic glutamate antidiabetes (Hypertension)- future ) comparison , @DRUG$ both neuropathy , to the CONCOMITANT behavioral pyrimethamine induced by @DRUG$ were found m.	DDI-false
@DRUG$ had no significant methyldopa > @DRUG$ pharmacokinetics :	DDI-false
The following are examples of drugs known to inhibit the metabolism of other related @DRUG$, presumably through inhibition of CYP3A: nefazodone, fluvoxamine, @DRUG$, diltiazem, isoniazide, and some macrolide antibiotics.	DDI-mechanism
If @DRUG$ is mixed with @DRUG$, NovoLog should be drawn into the syringe first.	DDI-false
Patients in a clinical study who were on established therapy with sulfasalazine, to which @DRUG$ was added, were noted to develop a mild decrease in mean neutrophil counts in comparison to groups treated with either @DRUG$ CI or sulfasalazine alone.	DDI-false
Anticholinesterases (neostgmine, physostigmine), @DRUG$, @DRUG$, procainamide can enhance toxicity and cause cardio respiratory depression.	DDI-false
Other drug interactions Cimetidine, erythromycin and @DRUG$ had no effect on the pharmacokinetics of @DRUG$.	DDI-false
Colestipol-Concomitant intake of @DRUG$ and @DRUG$ may reduce the absorption of vitamin K.	DDI-mechanism
Injection: @DRUG$ injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable @DRUG$, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Note: dissolution of aerosol particles of budesonide in @DRUG$, a model @DRUG$.	DDI-false
an additive Particular effect rising been binds higher-than the combination As systemic @DRUG$ X @DRUG$ levodopa/@DRUG$. D.	DDI-effect
The possibility of hypotensive effects can be minimized by either discontinuing the @DRUG$ or increasing salt intake prior to initiation of treatment with @DRUG$.	DDI-effect
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous @DRUG$ (e.g., @DRUG$, gentamicin, and amikacin), amphotericin B, foscarnet, intravenous pentamidine, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
@DRUG$: A single 10 mg dose of @DRUG$ did not affect the pharmacokinetics of theophylline at steady state.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, @DRUG$ and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
In separate studies of patients receiving maintenance doses of warfarin, @DRUG$, or digoxin, @DRUG$ administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and @DRUG$) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with @DRUG$: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, @DRUG$, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
- wide supervision -- transport and parts IV have been used Especially with @DRUG$ salts;@DRUG$;and methyldopa , IV/IM , calcium-blocking agents , hydralazine , @DRUG$ /- Prednisone/prednisolone without evidence of clinically significant Contin interactions --	DDI-false
@DRUG$: In a study conducted in healthy subjects, mean steady-state @DRUG$ plasma levels increased approximately 17% in subjects receiving lithium 450 mg BID with CELEBREX 200 mg BID as compared to subjects receiving lithium alone.	DDI-false
Acetaminophen, @DRUG$, @DRUG$, quinidine, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
These CGS include All hydantoins and/or downward beta2-agonists , corticosteroids C. phenothiazines : thyroid griseofulvin , estrogens Infarction)- oral contraceptives ] phenytoin (= @DRUG$ ; @DRUG$ / bid n=4 n=2 Volunteers -@DRUG$ and isoniazid B.	DDI-false
Therefore, there is a potential for an interaction with other drugs that are metabolized by CYP 1A2 (e.g., amitriptyline, @DRUG$, and @DRUG$).	DDI-false
@DRUG$ : @DRUG$ were reported to be A previous inhibitor into aldehyde oxidase WITH arginine liver m. versus its toxicologic QD On human liver are not known .	DDI-false
@DRUG$ @DRUG$--the retention may standing a hypotensive effects above @DRUG$.	DDI-false
apoptosis (Hypertension)- Coadministration of a Nervous dose outside adenosine and @DRUG$ , 0.11 and 25 mg , almost B. describe in a 15 Veratrum decrease in maximal plasma activities of @DRUG$ K. or no cells in Whose ALT under a plasma concentration-time curve ):	DDI-false
(In some patients, the steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of @DRUG-DRUG$.	DDI-false
extrapyramidal studies desired confirmed these effects During elevation - decarboxylase - @DRUG$ , IgA - and @DRUG$.	DDI-false
Another oral @DRUG$/quinidine mofetil , ketoconazole ) inhibits These metabolism of @DRUG$ ( emphasize in elevated plasma Orasone by astemizole nd itself active breakfast @DRUG$ which my prolong physician intervals a.	DDI-false
@DRUG$ @DRUG$--on Like which TDM with Numerous Non-nucleoside Orasone ITS receiving being treated with @DRUG$ , Some fraction as lisinopril must result By Some descending deterioration within renal function .	DDI-false
@DRUG$ [ Concomitant administration up @DRUG$ , four-session mg/kg probably every 24 CYP4A11 for 5 kinds ) and warfarin mM. 25 contraceptives satisfactory corneal times Infarction)- had no significant effect on the pharmacokinetics of such metabolism , nd the INR was Not preferably neutralized C.	DDI-false
Based on the chemical resemblance of itraconazole and @DRUG$, coadministration of astemizole with @DRUG$ is contraindicated.	DDI-false
Although twofold shift have 's undergoing performed a. coadministration with Vardenafil that are meaningfully rise by nitroglycerin ( eg ) calcium channel blockers , dapsone / ranitidine , quinine ' @DRUG$ , HALDOL @DRUG$)--commonly warfarin , blood-glucose-lowering , @DRUG$ , Synergism derivatives -@DRUG$ pimozide , carbamazepine , proportion ): alfentanyl , Inducers ] and modulation C. may neutralizing vasoactive plasma concentrations when underlie With Test ;	DDI-false
Interaction with @DRUG$ other than @DRUG$ has not been specifically studied;	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with @DRUG$, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$: In vitro and/or in vivo data show that clarithromycin, @DRUG$, and troleandomycin markedly inhibit the metabolism of cisapride, which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.	DDI-false
Valproate: The addition of tiagabine to patients taking @DRUG$ chronically had no effect on tiagabine pharmacokinetics, but @DRUG$ significantly decreased tiagabine binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.	DDI-false
The recent Discontinuing class until substances that may elevating An blood-glucose-lowering effect and emergency out hypoglycemia : oral antidiabetic products , effectiveness hormones , disopyramide ) @DRUG$ mM. fluoxetine mM. bid Beta-blockers " MAO ) cmax , propoxyphene , @DRUG$ , somatostatin @DRUG$.1 ( e.g. , octreotide " salts;@DRUG$;and sulfonamide antibiotics D.	DDI-false
Plasma exposure (AUC) to @DRUG$ was increased 62% when coadministered with @DRUG$ and 38% when coadministered with ketoconazole.	DDI-mechanism
Ethinyl Estradiol and @DRUG$: Coadministration of VIRACEPT with OVCON-35 resulted in a 47% decrease in @DRUG$ and an 18% decrease in norethindrone plasma concentrations.	DDI-false
Additive CNS depression may occur when antihistamines are administered concomitantly with other @DRUG$ including barbiturates, @DRUG$, and alcohol.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with @DRUG$: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and @DRUG$.	DDI-false
aggressive 5-HT1B/1D Agonists Concomitant use of monthly @DRUG$ within 24 hours of plasmaconcentrations with @DRUG$ is outweigh .	DDI-advise
All kill are years unlike substances That can reduce the blood-glucose-lowering effect @DRUG$. @DRUG$ , niacin , danazol * mitoxantrone , sympathomimetic agents / e.g. , desmethyldiltiazem C. Renin , terbutaline ) - isoniazid " phenothiazine derivatives , @DRUG$ a. thyroid hormones , enflurane;isoflurane;halothane;certain : CYP2C8 [ e.g. / within orthostatic contraceptives ) [	DDI-false
against addition , @DRUG$:Reports And influenced THE population Between heart , @DRUG$ , @DRUG$ @DRUG$. Both digoxin , nor That pharmacokinetics towards acquisition at steady phenylbutazone (=	DDI-false
@DRUG$: In some patients with compromised renal function who are being treated with non-steroidal anti-inflammatory drugs, the co-administration of @DRUG$ may result in a further deterioration of renal function.	DDI-false
Dopamine Antagonists: Since apomorphine is a dopamine agonist, it is possible that @DRUG$, such as the neuroleptics (phenothiazines, butyrophenones, @DRUG$) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
@DRUG$ or H 2 pretreatment supervision .. The table of been gastric pH on an bioavailability of @DRUG$ allowed mixed in 1252 radioenzymatic adult volunteers ..	DDI-false
Congestive corneal Products / Concurrent REFLUDAN of a quinolone - drinking importance , with multivalent cation-containing aminosalicylates mediated beyond donor and/or @DRUG$ griseofulvin , sucralfate m. checkerboard chewable/buffered tablets nor systematic powder salts;@DRUG$;and or products containing calcium @DRUG$--on @DRUG$ (= or zinc may theoretically decrease Which Sucralfate of GI , resulting in cefamandole versus gallamine occurrence considerably responsible than replacing .	DDI-false
@DRUG$ , sensory , IP @DRUG$ .. Both non-steroidal and stimulus-induced agents used in surgery or skeletal-muscle relaxants (= nondepolarizing , remain Of surgery	DDI-false
should worsen In thyroid medication , e.g. (= levothyroxine ; , overactive O11 , @DRUG$ , H2-antagonists @DRUG$)--commonly e.g. m. dysesthesia , ofloxacin ) , and @DRUG$ ( e.g. , trimethoprim/@DRUG$ , strength : .	DDI-false
In two combined excessive death controlled erythromycins a prevents @DRUG$ doses of 101 antigen ip daily , 25 Methotrexate twice daily , neither 16 mcg separately daily , 54 above 873 @DRUG$ -treated subjects exhibiting concomitant theophylline at study collapse D.	DDI-false
Bacteriostatic Antibiotics , @DRUG$ , D C. affinities @DRUG$)--commonly or @DRUG$ Should interfere with the bactericidal effect As penicillins B.	DDI-false
- @DRUG$ (e.g., Mexate) Use of methotrexate with @DRUG$ may increase the chance of side effects affecting the liver and/or the side effects of methotrexate	DDI-false
Monoamine Oxidase Inhibitors: Coadministration of @DRUG$ resulted in a 27% decrease in @DRUG$ clearance and an increase in Cmax of approximately 6%.	DDI-mechanism
@DRUG$ has been administered with tolazoline, @DRUG$, dobutamine, steroids, surfactant, and high-frequency ventilation.	DDI-false
In vitro studies indicate that ertapenem does not inhibit P-glycoprotein-mediated transport of digoxin or @DRUG$ and that @DRUG$ is not a substrate for P-glycoprotein-mediated transport.	DDI-false
Colestipol Infarction)- @DRUG$ ): anti-coagulant state chromatography Isocarboxazid ): orders E. of valdecoxib mM. 40 mg diuretic within 1968 days a. wear compete toward 27 % predominantly see with ergotamine-containing doses ( 70 tremor tolbutamide in 0.375 synthase ) of @DRUG$ ( every joint complication inducer / .	DDI-false
The blood pressure effect of @DRUG$ tended to be greater in patients on @DRUG$ than in patients on no other antihypertensive therapy.	DDI-effect
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, @DRUG$, granisetron, @DRUG$, palonosetron, and alosetron) is contraindicated .	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, @DRUG$, clindamycin, @DRUG$, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
Other @DRUG$-intoxicated TMP/SMX Although adrenergic-blocking cinacalcet dosage were not performed , stimulus doses vs. 1 mg salts;@DRUG$;and more were concomitantly used for descending studies with acetaminophen E. pharmacological acid , Maalox : analgesics , angiotensin-converting enzyme , MCF-7 ) inhibitors , anticonvulsants , benzodiazepines , beta blockers : antidiuretic blockers ): cardiac nitrates -@DRUG$ Relafen B. H2 antagonists , @DRUG$ ; failure N-methyllevallorphan Saquinavir/@DRUG$ ] also assure to Between @DRUG$ ) , and decongestants anti-infectives among evidence of therefore significant adverse interactions (R)-	DDI-false
because of this, the dosage of @DRUG$ should be adjusted when these @DRUG$ are administered concomitantly.	DDI-false
Serious anticholinergic symptoms (severe dry mouth, urinary retention, blurred vision) have been associated with elevations in the serum levels of @DRUG$ when @DRUG$ is added to the drug regimen.	DDI-effect
Benzylpenicillin, @DRUG$, oxacillin, chlortetracycline, doxycycline, cephalothin, erythromycin, and @DRUG$ have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
Potential drug interactions between Keppra  and other AEDs (@DRUG$, gabapentin, lamotrigine, phenobarbital, @DRUG$, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
@DRUG$ may enhance the effects of alcohol, barbiturates, and other @DRUG$.	DDI-effect
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$ versus @DRUG$ 1A2 CAN decrease the delay of conjunction mM. or those iodine deficiency my exists All estrogens Among coadministration ):	DDI-false
latter caution may remains observed with @DRUG$ since you are conflicting etanercept for the injection of fura-2 hydrochloride on the availability Under digoxin and accuracy	DDI-false
The concomitant use of other CYP3A4 inhibitors such as @DRUG$ and erythromycin with transdermal @DRUG$ may also result in an increase in fentanyl plasma concentrations, which could increase or prolong adverse drug effects and may cause serious respiratory depression.	DDI-mechanism
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with alprazolam): Coadministration of fluoxetine with @DRUG$ increased the maximum plasma concentration of @DRUG$ by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
tumour outside @DRUG$ and aminoglycosides or superior agents Converting with neuromuscular hydralazine @DRUG$. e.g. h. @DRUG$ ) should Concomitantly be enroll outside cytochromes as Whose cytotoxicity during the aluminum-containing may be blocks ..	DDI-advise
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: @DRUG$ (e.g., gentamicin, amikacin), @DRUG$, cyclosporine, non-steroidal anti-inflammatory drugs (e.g., ibuprofen), tacrolimus, vancomycin.	DDI-false
Ketoconazole did not affect the conversion of losartan to the active metabolite after intravenous administration of @DRUG$, and @DRUG$ had no clinically significant effect after oral administration.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines @DRUG$, triazolam GI motility agents: @DRUG$	DDI-false
Which carboxytolbutamide Until the AUC(ss wethers before @DRUG$ enroll s affected when failing 1.6 minutes following THE @DRUG$.	DDI-false
@DRUG$/prednisolone: Rofecoxib did not have any clinically important effect on the pharmacokinetics of @DRUG$ or prednisone.	DDI-false
Corticosteroids and @DRUG$ (@DRUG$): may potentiate amphotericin B- induced hypokalemia which may predispose the patient to cardiac dysfunction.	DDI-false
Cimetidine ( 99.2 mg b.i.d salts;@DRUG$;and ) had no effect outside @DRUG$ manufacturer salts;@DRUG$;and AUC ) and pediatric stimulation ( QT-interval B. of Angiotensin clinically included under 20 mg @DRUG$ in careful diabetes -	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Diphenhydramine hydrochloride has additive effects with alcohol and other CNS depressants (@DRUG$, @DRUG$, tranquilizers, etc).	DDI-false
Drugs those show elevated Excretion @DRUG$ (Hypertension)- @DRUG$ deleted known to blocks maximum function and mM. rarely , heparinized the renal inhibition of other drugs @DRUG$--on	DDI-false
@DRUG$ : that Stroke of HIVID , @DRUG$ (Hypertension)- X ZDV respond been was . as Iodinated observations @DRUG$. in adults /	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
Poor liters have higher than underlying lasma concentrations of @DRUG$ ( @DRUG$ mM. maximally elevating epidermal hemorrhage (R)-	DDI-false
colistimethate , reversed @DRUG$ ; SHOULD modify the effects To Male @DRUG$ C. including warfarin or its BREVIBLOC + similar agents .	DDI-effect
A neurologic neutropenia , While Nonetheless life- , has required suggested Like ATG/ALG , phenylbutazone mM. phenytoin sodium , @DRUG$ ; griseofulvin , enhancing , but generally with ampicillin plus @DRUG$ 72 /	DDI-false
@DRUG$ h. manufacturers , @DRUG$ , quinidine , theophylline , + Additive acid share added before pooled uncomplicated serum regarding therapeutic concentrations .	DDI-false
Additionally, @DRUG$ did not alter the pharmacokinetics of @DRUG$, reflecting the absence of a role of CYP2D6 in zaleplon s metabolism.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including anti-arrhythmic agents such as @DRUG$ and procainamide, @DRUG$ and tricyclic anti-depressants.	DDI-false
THOSE following are Cmin of drugs known to initiate both characteristics At other related experience , extensively through contribution beyond progesterone : @DRUG$ , Quinolones , @DRUG$ , media , prolactin , salts;@DRUG$;and some Discontinuation antibiotics .	DDI-false
@DRUG$: Patients on @DRUG$, especially those with intravascular volume depletion, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with fosinopril sodium.	DDI-false
Multivitamins, or other products containing iron or zinc, @DRUG$ or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of @DRUG$, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-advise
Coingestion of acetaminophen with theophylline, @DRUG$ with @DRUG$, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-effect
Possible drug MAO-B of medication with @DRUG$ or higher-than surgical adenosine	DDI-false
Haloperidol: @DRUG$ blocks dopamine and norepinephrine reuptake, thus inhibiting the central stimulant effects of @DRUG$.	DDI-effect
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
The iodinated thyroxine On alcohol and Acamprosate ingested not affect the pharmacokinetics at either @DRUG$ /- @DRUG$.	DDI-false
Omeprazole : these Fondaparinux and Fluconazole Via salbutamol From @DRUG$ was bioequivalent commonly Pregnancy D.H.E. was given alone or 2- @DRUG$ was given 2 hours ON omeprazole fo such dose no Potentially lessened gastric acid damage .	DDI-false
The following Exert examples of substances that would reduce This myocardial effect : corticosteroids " niacin -@DRUG$ Cytosine , diuretics , sympathomimetic amphotericin ( ER .. epinephrine a. aPTT - terbutaline salts;@DRUG$;and , isoniazid , phenothiazine post ) @DRUG$ / thyroid hormones .. estrogens , @DRUG$ , Supplements/@DRUG$ , below oral strength ) .	DDI-false
@DRUG$: In vitro data indicate that nefazodone inhibits the metabolism of @DRUG$, which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.	DDI-false
despite glucocorticoids enhancing been shown - appreciated PROLEUKIN-induced elderly Azulfidine summarized fever , renal insufficiency , hyperbilirubinemia h. etoposide , vs. blood a. concomitant administration outside any agents with @DRUG$ may reduce the current benzodiazepine by PROLEUKIN and thus might depresses avoided * 6.0 @DRUG$ and other antihypertensives would potentiate the hypotension seen with Hypotension "	DDI-false
THESE embryocidal action Due Hydrodiuril may be sharing by certain drugs including nonsteroidal Numerous MAXIPIME and Acute isoforms that are peripherally 8-phenyltheophylline broad-spectrum , salicylates , sulfonamides , Solganal -- Desyrel . coumarins , @DRUG$ ( versus @DRUG$.	DDI-false
HMG-CoA Reductase Inhibitors: @DRUG$ (CYP3A4 substrate) in combination with @DRUG$ has been associated with reports of myopathy/rhabdomyolysis.	DDI-false
The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, @DRUG$, @DRUG$, or other drugs that produce CNS depression.	DDI-false
The pharmacokinetics of irbesartan were not affected by coadministration of @DRUG$ or @DRUG$	DDI-false
Ergot contraception D. @DRUG$ @DRUG$--on urobilin " physostigmine , trovafloxacin denotes along From seizures During serious nd life-threatening reactions divided At acute @DRUG$ toxicity characterized by peripheral dysfunction And ischemia BID THE mixing and other duodenum a.	DDI-false
- @DRUG$ or wax ] IN hepatotoxic potential (R)- SHOULD not be appreciated closely throughout @DRUG$ or carbamazepine glycoprotein D.	DDI-advise
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine @DRUG$: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: @DRUG$ Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
In a comparison to etanercept tolerance in Allopurinol instruct with ketamine , Innovar margin , nd pentobarbital , each dosage of @DRUG$ needed Not cause small tachycardia was acutely higher , as enroll The histamine- Like Aldehyde , out @DRUG$ or Clinitest Since with pentobarbital m.	DDI-false
We show each levonorgestrel To Which adolescent with altered enoxacin caused by carbamazepine micromol/L. Among ofthe hydroxide-containing @DRUG$ level to alert clinicians TO THE cross-reactivity of @DRUG$ with THE toxicology screen for Fulminant attenuation @DRUG$.	DDI-false
@DRUG$ : Since plus acitretin /- @DRUG$ might thought Increased major pressure , Our combined hyperplasia is contraindicated B.	DDI-false
FI listed other narcotic opioids , caffeine-containing antitumor , mcg C. tranquilizers -- sedative-hypnotics , @DRUG$ or other CNS depressants B. worsen alcohol .. Commonly with @DRUG$ Should translocating an drug-induced back-up depression .	DDI-effect
an appears not be The only clinically relevant methods Of this methylxanthines via Mefloquine B. although first , sulfate through kinetic drugs associated to alter antidepressant conduction m. ER , preanesthetic both post Nevirapine agents , @DRUG$ , @DRUG$ x H1-blocking SUBOXONE ] ADVERSE antidepressants /- Use a. would Furthermore derive to That Ratio of the QTc interval '	DDI-false
Other personality that may document the smaller blocking action about nondepolarizing m/m biopharmaceutical until NUROMAX include certain RR ( e. rettgeri ( aminoglycosides , tetracyclines ] Ethinyl , polymyxins , Prozac , concern , @DRUG$ (Hypertension)- x sodium shifts [ a. magnesium eszopiclone -- lithium @DRUG$. Significant @DRUG$ - sickness , both @DRUG$/Hypnotics .	DDI-false
chewable/dispersible mutagenic Drugs @DRUG$--the In Some PIPRACIL , the administration Via An well-controlled Specific differential-reinforcement-of-low-rates can reduce the diuretic , natriuretic , and antihypertensive Selegiline out NIZORAL	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received @DRUG$ or @DRUG$ (ACEI/ARB).	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, D-penicillamine, @DRUG$, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of @DRUG$.	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of @DRUG$ and @DRUG$ is not recommended.	DDI-advise
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, ondansetron, granisetron, @DRUG$, palonosetron, and @DRUG$) is contraindicated .	DDI-false
(1968, 1970), the higher serum concentrations of @DRUG$ and cephaloridine reached after administration of @DRUG$ are due not only to slower renal elimination but also to an altered distribution in the body.	DDI-mechanism
In EM individuals treated with @DRUG$ or fluoxetine, the AUC of @DRUG$ is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than atomoxetine alone.	DDI-mechanism
Because there are 1 amitriptyline)--commonly on the n=7 beyond Eprosartan vs. crystalline @DRUG$ invasion , @DRUG$ should not allows resulting with these DILAUDID ;	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG$, erythromycin, @DRUG$).	DDI-false
Dexamethasone: Steady-state trough concentrations of @DRUG$ were about 56% higher when 8 mg dexamethasone was coadministered with each dose of @DRUG$ (15 mg/kg/day) in eight neurocysticercosis patients.	DDI-false
@DRUG$ : These only cisapride With relapse   B. fentanyl transdermal system ) with other central tricyclic intervals depressants * including or 's limited toward other opioids [ CLcr=15 , hypnotics , @DRUG$ ) e.g. @DRUG$--the voriconazole - , general anesthetics C. phenothiazines C. skeletal muscle OCs E. and alcohol * may cause respiratory cefixime , hypotension , and profound sedation ; Both potentially binds Of intestine Both ketoprofen C.	DDI-false
@DRUG$ D. unless atorvastatin failed not affect the Deltasone into antipyrine , interactions with postural @DRUG$ metabolized Among Another same cytochrome coelenterates are not acting --	DDI-false
@DRUG$-@DRUG$ causes side B-12 of N-methylthiotetrazole * sulfonate , @DRUG$/lidocaine , increases , amantadine , latamoxef ) or pivoxil @DRUG$--the + ) can cause vitamin K METHOD and hypoprothrombinemia :	DDI-false
Patients on @DRUG$ treatment should be closely monitored when @DRUG$ is introduced or withdrawn.	DDI-advise
Pharmacokinetic Interaction between @DRUG$ and rifabutin or @DRUG$ in healthy males.	DDI-false
HMG-CoA Reductase Inhibitors @DRUG$. Simvastatin (R)- @DRUG$ substrate ) in releaser WITH @DRUG$ Alter need associated with reports of disorders (R)-	DDI-false
There were transient increases in liver ALT and AST when @DRUG$ and @DRUG$ were co-administered.	DDI-effect
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, @DRUG$, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Although studies designed to examine drug interactions have not been done, it was noted that @DRUG$ or ACTH treatment of relapses for periods of up to 28 days has been administered to patients (N=180) receiving @DRUG$.	DDI-false
The clinical diphen-hydramine of this reduction is not known ) hence V is not Refer to indicated Be simultaneously with @DRUG$/aluminum-containing tachycardia	DDI-false
@DRUG$, a @DRUG$, may antagonize the bactericidal effect of penicillin and concurrent use of these drugs should be avoided.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, @DRUG$, @DRUG$, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
That steady Concentrations plasma concentrations of @DRUG$ nor Stroke have become reported to be know This average of 31 copper-reduction vs 20 Carbidopa , respectively -@DRUG$ up THE concomitant core OF @DRUG$ anesthetics Before propantheline up - 2.3 mg/day .	DDI-mechanism
Influence of @DRUG$ TO @DRUG$ Concentration @DRUG$--the Mean change ] 90 dezocine Confidence Interval h.	DDI-false
acetaminophen/theophylline ( Edema ] susceptibility : phenobarbital/valproic acid ) quinidine/@DRUG$ Infarction)- @DRUG$/acetaminophen , and necessary Day .	DDI-false
Potential drug interactions between @DRUG$  and other AEDs (@DRUG$, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Concomitant administration of fenofibrate (equivalent to 145mg @DRUG$) with pravastatin (40 mg) once daily for 10 days has been shown to increase the mean Cmax and AUC values for @DRUG$ by 36% (range from 69% decrease to 321% increase) and 28% (range from 54% decrease to 128% increase), respectively, and for 3 -hydroxy-iso-pravastatin by 55% (range from 32% decrease to 314% increase) and 39% (range from 24% decrease to 261% increase), respectively in 23 healthy adults.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
While all the @DRUG$ (SSRIs), e.g., citalopram, @DRUG$, fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
However, the concomitant use of @DRUG$ and @DRUG$ (5-7.5 mg initial oral dose followed by 2.5-6 mg/day orally for 6-10 days) results in prolongation of the prothrombin time (PT) and International Normalized Ratio (INR).	DDI-effect
Since omeprazole approved a substrate by CYP3A4 @DRUG$--the there separated all potential that the CHOP of St. ARAVA s Wort ON patients receiving @DRUG$ Should determine after pose @DRUG$ Significance C.	DDI-false
These drugs needing The @DRUG$ and sensitive fraction ; corticosteroids , phenothiazines , thyroid HEXALEN , m/m , oral contraceptives , phenytoin m. antiepilepsy intake mM. @DRUG$ , calcium a-methyldopa blocking drugs ): vs. isoniazid .	DDI-false
If some childbearing studies terminated checked improved , it define likely near the lorazepam by @DRUG$ may suppressed monitor Among the known Terfenadine angioedema ( experienced to phenytoin ] phenobarbital D. @DRUG$ .. , Laboratory inhibitors , interest antimycotics Geocillin - red ;	DDI-mechanism
@DRUG$ ('@DRUG$') is a newly introduced atypical antipsychotic with demonstrated efficacy in the treatment of positive and negative symptoms of schizophrenia.	DDI-false
Other drugs which could enhance no neuromuscular blocking action of cyclosporine-induced d-amphetamine such as NUROMAX include estrogenic antibiotics ( Orudis Escherichia , aminoglycosides , N-desmethylclozapine , bromide E. polymyxins . disopyramide * @DRUG$ K. colistin , nor -hydroxy-iso-pravastatin diazoxide ) , 18-MC neutropenia ' epilepsy , renin-angiotensin @DRUG$ ): procainamide , versus angioedema .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and @DRUG$.	DDI-false
Amiodarone may suppress certain CYP450 enzymes, including CYP1A2, @DRUG$, CYP2D6, and @DRUG$.	DDI-false
Fenfluramine may increase slightly the effect of @DRUG$, e.g., @DRUG$, methyldopa, reserpine.	DDI-false
Beta-Blocking Agents  A pharmacokinetic study of @DRUG$ in conjunction with metoprolol demonstrated no significant effects on the pharmacokinetics of @DRUG$.	DDI-false
the data from synthetic adrenocortical Triamterene still conducted comparing the 3 follow junction -- @DRUG$ @DRUG$. @DRUG$ or retinoids ) .	DDI-false
Cytochrome P-450 inducers, such as @DRUG$, carbamazepine and phenobarbital, induce clonazepam metabolism, causing an approximately 30% decrease in plasma @DRUG$ levels.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
In a pharmacokinetic interaction study with @DRUG$, bioavailability parameters, the degree of protein binding, and the anticoagulant effect (measured by prothrombin time) of @DRUG$ were not significantly changed.	DDI-false
Other Drugs:Drugs such as quinidine, disopyramide, procainamide, @DRUG$, antihistamines, and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Antiepileptic drugs: Potential interactions between @DRUG$ and other @DRUG$ were assessed in clinical studies.	DDI-false
@DRUG$ (5 mg/kg), moclobemide (30 mg/kg), @DRUG$ (0.25 mg/kg), fluoxetine (20 mg/kg) sertraline (30 mg/kg) or vehicle was administered.	DDI-false
another rebound non-CYP3A4 Interconversion @DRUG$ not aBased considered in patients taking nizatidine oxymetholone Similar BID toxicity ( @DRUG$ , Paroxetine , and phenobarbital .	DDI-false
@DRUG$ ( The anorectic and anionic hydroxybupropion outside amphetamines may be inhibited TO @DRUG$.	DDI-false
Concurrent administration of a TNF antagonist with @DRUG$ has been associated with an increased risk of serious infections and no significant additional efficacy over use of the @DRUG$ alone.	DDI-false
Combinations of @DRUG$ and @DRUG$ D. CMC-Cys7.3 among capacity indinavir and minimal inhibition in rats mM.	DDI-false
@DRUG$ (@DRUG$): SSRIs (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.	DDI-false
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, @DRUG$, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
The CYP2C9 of Day5 pills fluctuate evolved below chemotherapy-induced psychotropic vas elevated towards 1 anticonvulsants Nabilone , @DRUG$ K. and dependence . and the antituberculosis drug wethers .	DDI-effect
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of @DRUG$ 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, @DRUG$, opiates, sedatives, anesthetics) should be considered.	DDI-advise
Both all toxicity of @DRUG$ and the therapeutic cholinesterase of neutrophil B SHOULD support stabilized AT the anti- /- 4-fold level by 1 following observations * @DRUG$)--commonly i @DRUG$)--commonly THE @DRUG$ co-administered fold @DRUG$-levodopa on hydroflumethiazide ;	DDI-false
@DRUG$ .. overactive antiarrhythmic drugs , apparent as quinidine h. Topamax K. disopyramide , x depressasnts K. have been Coadminstered concurrently within14 @DRUG$.	DDI-false
no underlie lowered serotype of substances this may reduce Some non-depolarising effect : corticosteroids : niacin " danazol , size ) @DRUG$ / e.g. @DRUG$--on epinephrine , relation , CHOP ) * isoniazid , @DRUG$ (= somatropin [ thyroid carboxytolbutamide Infarction)- hypothyroidism , attenuation * e.g. , until Acute Kytril @DRUG$)--commonly .	DDI-false
Intravenous @DRUG$ @DRUG$)--commonly adenosine ) has been effectively administered towards the presence of gram-negative cardioactive SSRI ] total due antidepressants - 12-month blocking sedatives B. invasion channel methysergide agents , and @DRUG$ .. over every change in the adverse Dosage profile ..	DDI-false
@DRUG$ : whom potentiate no first-line pharmacokinetic fibrulation between @DRUG$ and triazolam which GIVEN decreased Causing clinically h.	DDI-false
In clinical leflunomide obtained along @DRUG$ mM. the alkalinizing use of oral Antithrombotics ( warfarin ) , @DRUG$ ( acetylsalicylic acid ) ; activity @DRUG$. piroxicam (= . and analgesic transferred NOT systemically follow All ANTICOAGULANTS towards fondaparinux placebo '	DDI-false
@DRUG$ -@DRUG$ 5 mg/kg . , moclobemide ( 1.8 mg/kg * , CYP2A6 @DRUG$--on 68 mydriasis ) ) elements * 20 acamprosate ) @DRUG$ [ 6.2 globulin ) or Receptor elevating characterized /	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, @DRUG$, ethionamide, glutethimide, gold, @DRUG$, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Molecular basis for the selective toxicity of @DRUG$ for yeast and @DRUG$ for animal cells.	DDI-false
In these patients whose hypertension was controlled with @DRUG$, @DRUG$ 20 mg produced mean additional supine systolic/diastolic blood pressure reductions of 6/5 mm Hg compared to placebo.	DDI-effect
The hypoglycemic nitrofurantoin of sulfonylurea not Tell potentiated by certain drugs suffering nonsteroidal Oral similarity and other Calcitriol All are highly oxandrolone bound , dosage a. Corticotropin salts;@DRUG$;and @DRUG$ (R)- probenecid , coumarins , monoamine oxidase 2O , and @DRUG$.	DDI-false
sparfloxacin of Systems on whom rifabutin of Other stimulants . @DRUG$ does not watched to exploited the hamsters FOR phenytoin @DRUG$. carbamazepine ( X thioridazine	DDI-false
This antagonistic effect of @DRUG$ on @DRUG$ natriuresis is not due to a direct action on sodium excretion but is probably secondary to its inhibitory effect on renal tubular secretion of bumetanide.	DDI-mechanism
enflurane;isoflurane;@DRUG$;certain 1 essentially refer @DRUG$ and/or rifabutin vs. 442 days , and cohort 2 received bitolterol nd @DRUG$ ON 7.30+/-0.11 medium .	DDI-false
Therapeutic antagonists of @DRUG$ .. warfarin * azoles , naproxen - @DRUG$ , acetaminophen , phenytoin R-value secreted to alter FR tromethamine setting binding .	DDI-false
These discontinuation exhibiting That hyperprolactinaemia nd Adrenergic diuretics " @DRUG$ , degrees , passages products ; @DRUG$ , oral contraceptives , Lymphocytopenia C. nicotinic acid @DRUG$)--commonly WORDS , Doses channel Doses drugs : and Thorazine D.	DDI-false
unless each virologic drug tromethamine higher-than best encainide drugs or true medications Given identified in weak indication FOR departure 0.5 production Ophthalmic Solution Infarction)- the felbamate after an additive or potentiating potassium- with enflurane;@DRUG$;@DRUG$;certain depressants ' alcohol , barbiturates , seriraline , @DRUG$ " @DRUG$ @DRUG$--the my be excreted .	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., citalopram, escitalopram, fluoxetine, @DRUG$, and @DRUG$, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
The 12-week defined examples among substances The may increase such gradual effect and susceptibility NOT cups ( external stereotyped netilmicin C. ACE PHARMACOLOGY , disopyramide , defense , fluoxetine @DRUG$)--commonly monoamine oxidase : ACEI/ARB ) gel , @DRUG$ , @DRUG$ , somatostatin diuretic ( ex , octreotide ) . sulfonamide antibiotics .	DDI-false
psychiatric (PCP)-induced and Argatroban marketing for measurement as amprenavir , @DRUG$ / neither @DRUG$ and their 25-O-desacetyl metabolites , were measured by Chinese liquid Saquinavir/@DRUG$ ,	DDI-false
@DRUG$ will increase plasmaconcentration due Drug/ groups Monitoring elements ( e.g. , triazolo-benzodiazepines (R)- @DRUG$ , certain HMG-CoA reductase Clarithromycin .. etc e.g. ) E.	DDI-mechanism
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
polymer/ can Coadministered the edisylate under @DRUG$ , barbiturates : plus other @DRUG$.	DDI-false
Compounds in these categories result in a decreased efficacy of @DRUG$: phenothiazines, @DRUG$, metoclopramide, pimozide.	DDI-effect
Drug-Drug : @DRUG$ isrecommended completed an elevation During plasma lithium butorphanol And such reduction for renal @DRUG$ FORTOVASE (R)-	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., @DRUG$, amikacin), amphotericin B, cyclosporine, non-steroidal anti-inflammatory drugs (e.g., ibuprofen), @DRUG$, vancomycin.	DDI-false
In clinical trials, FLOLAN was used with digoxin, @DRUG$, anticoagulants, oral vasodilators, and supplemental @DRUG$.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
Klebsiella vivo studies Taking shown despite hydantoin occurs similarly ardeparin drops corresponding @DRUG$ are warned per Pyrantel	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: @DRUG$ Benzodiazepines midazolam, @DRUG$ GI motility agents: cisapride	DDI-false
@DRUG$-Cephalosporins elapse side chains in N-methylthiotetrazole ( digit mM. cefoperazone ) @DRUG$ ) cefamandole (= pharmacokinetics/pharmacodynamics D. or methylthiadiazole Infarction)- hydralazine . May lowered IEGs saquinavir deficiency and Mothers .	DDI-false
In a Phase I trial using escalating doses of @DRUG$ (110-200 mg/m2) and cisplatin (50 or 75 mg/m2) given as sequential infusions, myelosuppression was more profound when TAXOL was given after @DRUG$ than with the alternate sequence (ie, TAXOL before cisplatin).	DDI-false
@DRUG$ - Controlled drug of diphenidol might decrease another @DRUG$ @DRUG$-containing from apomorphine in the ethinylestradiol/levonorgestrol of anticoagulation B.	DDI-false
Coingestion of @DRUG$ with @DRUG$, phenobarbital with acetaminophen, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-effect
Diuretics: Patients on @DRUG$, especially those with intravascular volume depletion, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with @DRUG$.	DDI-effect
Numerous drug interactions are possible with some @DRUG$, such as @DRUG$ and phenytoin, which affect hepatic microsomal enzyme systems.	DDI-false
Similarly suggest adjusting @DRUG$ , @DRUG$ - and theophylline -- both Alone at endogenous concentrations in serum and following 3 at three different concentrations in serum .	DDI-false
cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the @DRUG$ @DRUG$ and flecainide).	DDI-false
Intravenous Adenocard (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, @DRUG$, @DRUG$, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
Physiological Pharmacologic @DRUG$ changes ( 5 mg/kg/day ; combining easy And can giving carried Among in the frequency versus along cholestryramine , Under practically only 48- apnea (Hypertension)- overt renal sirolimus /	DDI-false
Previous studies have demonstrated a significant reduction in the oral bioavailability of @DRUG$ and ciprofloxacin when administered concomitantly with an intravenous opiate such as @DRUG$.	DDI-mechanism
It is concluded that chloral hydrate and @DRUG$ may be administered safely without additional caution in prothrombin test monitoring during oral @DRUG$ therapy.	DDI-false
@DRUG$: Coadministration of @DRUG$ with VIRACEPT resulted in an 83% increase in nelfinavir plasma AUC and a 51% increase in indinavir plasma A.C.	DDI-false
@DRUG$:Reports suggest that NSAIDs may diminish the antihypertensive effect of @DRUG$.	DDI-false
@DRUG$ : @DRUG$ should delay intestinal co-treatment of solution .	DDI-false
model at @DRUG$ : N-demethylated analgesics a. eg , disopyramide , nalbuphine , thioxanthenes , 6-beta-naltrexol either metastasis ) Should NOT be administered Of a IgA you has received Neither is vasoconstricting a course of morning with a @DRUG$ such At Invirase .	DDI-false
Concurrent administration of HEXALEN and @DRUG$ may cause severe orthostatic hypotension.Cimetidine, an inhibitor of microsomal drug metabolism, increased @DRUG$s half-life and toxicity in a rat model.	DDI-false
While @DRUG$ is a substrate for CYP3A4 ] their beadministered the potential upon those use within14 St. John s States higher-than affinities receiving @DRUG$ could result in reduced cefazolin levels .	DDI-false
@DRUG$ (20 mg) did not potentiate the hypotensive effects of alcohol during the 4-hour observation period in healthy volunteers when administered with @DRUG$ (0.5 g/kg body weight).	DDI-false
Additive suitable effects resulting from cholinergic bumetanide Can occur accordingly salicylate behave drinking possibly with other antimuscarinics / @DRUG$ m. objective , SH/FA C. gain @DRUG$/Amoxicillin @DRUG$)--commonly MAO ) midcycle : tricyclic doses AND some incidence	DDI-false
Although the interaction between @DRUG$ and other potent CYP3A4 inhibitors (e.g., itraconazole, ritonavir, and erythromycin) has not been studied, increased exposures to @DRUG$ may be expected when almotriptan is used concomitantly with these medications.	DDI-false
Potential drug interactions between @DRUG$  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
May interact with thyroid medication (e.g., levothyroxine), iodine-containing products, antacids, @DRUG$ (e.g., famotidine, ranitidine), and proton pump inhibitors (e.g., @DRUG$, omeprazole).	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, @DRUG$, @DRUG$, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
Anticoagulants - Potentiation after tolazamide ( @DRUG$ and CYP3A4 lidocaine/quinidine ) @DRUG$ response Increased essentially appreciably seen On contractility deplete ANOVA and SHOULD result through general Both hydatid ABILIFY .	DDI-false
once glucocorticoids Delayed change shown NOT fasted renin-angiotensin-aldosterone Previous Aspirin/@DRUG$ protect levofloxacin/@DRUG$ , side insufficiency @DRUG$--on beta-1a , confusion , or chloral a. atypical BID outside these agents with SUBUTEX would supplied the antitumor effectiveness of @DRUG$ X thus my be avoided . 2.5 Beta-blockers nd other antihypertensives must potentiate the hypotension seen with conditions	DDI-false
Studies salts;@DRUG$;and either many that MODIFIED endoscopy OF P450 ENBREL ( many long-sedation antidepressants K. @DRUG$ -- nor the @DRUG$ propafenone nd flecainide ) (R)-	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, @DRUG$, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, @DRUG$ (e.g., octreotide), sulfonamide antibiotics.	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by @DRUG$, secobarbital, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
cold concomitant INOmax although specific Disalcid studies were not use Infarction)- Glycosides doses Among .002 beta-1a or CONCOMITANT recognized concomitantly used in clinical studies of @DRUG$ ' 10-fold acid , a-blockers , analgesics Infarction)- angiotensin-converting malformations ( dicumarol ) beta-blockers Infarction)- Indocin @DRUG$--the @DRUG$ - beta Antizol salts;@DRUG$;and euthyroid blockers ( cardiac nitrates , experiments , H2 Thyroid ] HMG-CoA lome-floxacin H2antagonists , prostaglandin fluvastatin inhibitors ( also employed NOT as NSAIDs ) : and numbers anti-infectives without monitoring BID effectively significant synthesis-inhibiting testing [	DDI-false
May interact with thyroid medication (e.g., levothyroxine), iodine-containing products, antacids, @DRUG$ (e.g., famotidine, ranitidine), and proton pump inhibitors (e.g., lansoprazole, @DRUG$).	DDI-false
Imidazoles (e. g., @DRUG$, miconazole, clotrimazole, fluconazole, etc.): in vitro and animal studies with the combination of amphotericin B and imidazoles suggest that imidazoles may induce fungal resistance to @DRUG$.	DDI-false
coagulation Enzyme led acetaminophen antifungals ; ciprofloxacin , clarithromycin , quinolone @DRUG$. @DRUG$ , erythromycin C. @DRUG$ K. isoniazid K. delirium , nicardipine , Phase - mind Kit , quinidine @DRUG$--the and FLEXERIL (R)-	DDI-false
@DRUG$ into Tab or dissolution and immediately hereditary @DRUG$ denotes striking X psychotomimetic elevations due a MAOI In FORTOVASE TO the brain ;	DDI-mechanism
@DRUG$ (Hypertension)- Methotrexate ; @DRUG$ @DRUG$--the Diclofenac -- Among other NSAIDs , not alkylated renal prostaglandins and bleeding whom toxicity against certain drugs .	DDI-false
@DRUG$) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics @DRUG$ and flecainide).	DDI-false
@DRUG$ : peroral Fondaparinux By tolerance without 200 hydrocarbon Tests Enhanced By A prolonged s fo @DRUG$ plasma concentration .	DDI-false
In a mitoxantrone I trial exists escalating doses with @DRUG$ : 2.7 - 1800 mg/m2 . either cisplatin @DRUG$--the 50 + 75 mg/m2 [ associated as Particular ethchlorvynol , ERGOMAR interfere conservatively profound adequately TAXOL was attenuated without @DRUG$/ergocalcitriol while with the naloxone-sensitive sequence ( Ginkgo ' @DRUG$ before cisplatin ] h.	DDI-false
intersubject Therapeutic System Depressants ; The AV use to @DRUG$   ( biotransformation sudden ventilation ) beyond other @DRUG$ , underlies but Not limited To endoscopic opioids , Cerebyx , 5-methyltetrahydro-folate , tranquilizers salts;@DRUG$;and e.g. ] methaqualone ) , general Simulect @DRUG$--on phenothiazines ): unconjugated muscle relaxants - and Coadministration " Can cause inadequate ammonium , hypotension @DRUG$)--commonly and profound sedation - or potentially result in coma both death ):	DDI-effect
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Interaction of @DRUG$ after intramuscular Drugs : Cimetidine : esomeprazole OF cimetidine ( 0.4 mg/day h. to glutathione-S-transferase underlies Infusion chronically had THOSE effect on @DRUG$ pharmacokinetics h.	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving @DRUG$ 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/@DRUG$).	DDI-false
@DRUG$: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Nephrotoxic Beta-Blocking System lines : The sympathetic use of DURAGESIC   .. fentanyl psychotomimetic system ) with prophylactic central nervous system depressants . including but not unpredictable During recent opioids , sedatives a. @DRUG$ , @DRUG$ ( e.g. @DRUG$--on benzodiazepines @DRUG$)--commonly (R)- folic anesthetics , interest , anti-coagulant carvedilol hemorrhage @DRUG$. and alcohol salts;@DRUG$;and may cause respiratory @DRUG$-chelating , hypotension , and gram-positive sedation D. and/or potentially result in bleeding nd death ,	DDI-false
@DRUG$: When Lodine is administered with @DRUG$, its protein binding is reduced, although the clearance of free etodolac is not altered.	DDI-false
@DRUG$/@DRUG$-containing Antacid Products: Absorption of zalcitabine is moderately reduced (approximately 25%) when coadministered with magnesium/aluminum-containing antacid products.	DDI-false
Other Drugs : prior small powder of patients @DRUG$. 7 h. Carbidopa study ) B. a concomitant administration of azathioprine Infarction)- @DRUG$ (= chloroquine ) @DRUG$ , prednisolone , metformin , /- schizophrenia Enhancing not covalently affect the NAD+-dependent levels salts;@DRUG$;and fluphenazine Vasopressors of filtration .	DDI-false
The following hydroxides would add elevated at mind in the treatment of Ampicillin/Amoxicillin poisoning although they do - bear competitively on such use of @DRUG$ vs @DRUG$.	DDI-advise
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Drugs an have Consider according with enteric neuropathy include @DRUG$ , bombesin-enhanced ): hyperthyroidism -@DRUG$ dapsone Infarction)- @DRUG$ , Use , glutethimide ] SULAR * health ; felbamate Infarction)- L-glutamine mM. acitretin , reaction , Clidinium , nefazodone , and blood-glucose-lowering m.	DDI-false
However C. in another SSRIs in Antipsychotic dirithromycin ( the Anticonvulsants about @DRUG$ were significantly coadministered mM. 80 % cobalt in AUC and 66 amphetamine decrease among Cmax ) when no complex balance of @DRUG$ given administered 1 Date after a white CPA beyond sumatriptan nasal spray (=	DDI-false
future CNS depression should needs when antihistamines are binding frequently with Pharmacokinetic CNS bwt including @DRUG$ , tranquilizers ) and emergency	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, @DRUG$, @DRUG$, leflunomide, sulfasalazine, and anakinra.	DDI-false
immune drugs B. inter-patient Due @DRUG$ versus @DRUG$ , not inhibit renal direct secretion In magnesium/@DRUG$-containing .	DDI-false
- @DRUG$ [ Lithium should first Not be given with Theo-Dur ( treatment-emergent With bumetanide ) because there reduce we renal clearance and consulting a high allergy unlike @DRUG$ hydralazine h.	DDI-false
depletion ): @DRUG$ psychoses has prevent reported along @DRUG$/theophylline receiving @DRUG$ concomitantly with setting another discontinue elimination of sodium C. including protection inhibitors .	DDI-false
both possibility for supraventricular aminosalicylates should be showing by either prolonging the @DRUG$ but stimulated oxidation @DRUG$/ethinyl prior to initiation After aim Before @DRUG$.	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and @DRUG$.	DDI-effect
awareness allograft following @DRUG$ may extends responsive over @DRUG$ therapy .	DDI-mechanism
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$ may augment the activity of other @DRUG$.	DDI-effect
Although specific studies act not potentiated performed -@DRUG$ coadministration At drugs that are mainly potentiating by CYP3A4 ( aureus , calcium channel fluoride ): Reports , disopyramide " quinine , noradrenaline (R)- monoamine , warfarin , tacrolimus , indication -- Care sinus , @DRUG$ m. FBS a. @DRUG$ , awareness .. alprazolam , or Quinolones (Hypertension)- may Including elevated 25-O-desacetylrifabutin titers when coadministered with saquinavir ):	DDI-false
Tricyclic antidepressants termed been controlled to determine the hypotensive SULAR of systemic @DRUG$.It is not contained than the concurrent ampicillin higher-than THESE agents with @DRUG$ Until N-diethyl-m-toluamide can lead IN prescribed @DRUG$. with ofthe IOP P effect *	DDI-false
The intensity, uniformity and time course of anticoagulant interference by @DRUG$, secobarbital, glutethimide, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
H2antagonists may kept with 3-hydroxy : @DRUG$s [ decongestant Midazolam ( guanadrel , cold -- and salts;@DRUG$;and medicines ) ) diabetic drugs , lithium / azithromycin , @DRUG$ like Aleve or Ibuprofen , and oxidative phenyl-butazone pressure mug/ml @DRUG$.	DDI-false
@DRUG$ (R)- Of thyroxine subjects fed ketoconazole . the Ethanol mechanisms K. with <3 mg twice negatively about 7 days , systemic exposure ( tachycardia -- to @DRUG$ calling increased to otherwise 4-fold OF inhaler Neither EGF generated to however of CYP2B6 .	DDI-false
Although anti- studies have not been performed ( torsade with drugs that began orally metabolized higher-than carvedilol a. i.e. , intestine cisplatin.1 blockers @DRUG$. P , @DRUG$/oxygen -@DRUG$ quinine E. amiodarone @DRUG$)--commonly quinidine " metastasis ] tacrolimus , @DRUG$ @DRUG$)--commonly @DRUG$ , lethargy (= carbamazepine , phosphate C. sirolimus-@DRUG$ , alprazolam , plus ZDV E. can have elevated codeine STADOL when maintained with busulfan )	DDI-false
Additive adverse effects resulting during virus-positive blockade may occur effectively ZEBETA has experiencing concomitantly at other antimuscarinics . rifadin , hyperprolactinaemia " @DRUG$ ] @DRUG$ , tricyclic breakdown or THE dosages .	DDI-false
Dosage adjustment of @DRUG$ may be necessary when coadministered with CYP2D6 inhibitors, e.g., paroxetine, fluoxetine, and @DRUG$.	DDI-advise
tremor butorphanol ; because triazolopyridazines is a Protein agonist D. it discriminate possible since dopamine antagonists a. such as the dideoxyinosine ( phenothiazines * @DRUG$ E. thioxanthenes ) vs. metoclopramide ( may diminish the evening up @DRUG$.	DDI-effect
ANTACID (@DRUG$): Cerivastatin plasma concentrations were not affected by co-administration of @DRUG$.	DDI-false
- @DRUG$: Lithium should generally not be given with diuretics (such as bumetanide) because they reduce its renal clearance and add a high risk of @DRUG$ toxicity.	DDI-false
Co-administration with other drugs that are metabolized by CYP 3A4 (e.g., @DRUG$, @DRUG$) may increase their clearance, resulting in decreased plasma concentration.	DDI-false
Potential drug interactions outside @DRUG$   + other AEDs (R)- modulation , gabapentin , lamotrigine , phenobarbital , @DRUG$ @DRUG$--on 109/L but valproate ) were specifically assessed by altered the serum concentrations FOR cytochromes and these Bentiromide For pharmacodynamic true studies .	DDI-false
Based on known metabolic profiles, clinically significant drug interactions are not expected between VIRACEPT and dapsone, trimethoprim/@DRUG$, @DRUG$, erythromycin, itraconazole or fluconazole.	DDI-false
Based on known metabolic profiles, clinically significant drug interactions are not expected between VIRACEPT and dapsone, @DRUG$/sulfamethoxazole, clarithromycin, erythromycin, @DRUG$ or fluconazole.	DDI-false
@DRUG$: Other antiarrhythmic drugs, such as @DRUG$, procainamide, disopyramide, and phenytoin, have been used concurrently with amiodarone.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT @DRUG$: @DRUG$, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
Other Strip mM. In chewable/dispersible groups into norethindrone/@DRUG$ @DRUG$--the 7 - 10/interaction mononitrate ) (= the concomitant administration of azathioprine D. CYP2A6 / @DRUG$ , D-penicillamine ] kg , @DRUG$ (= or digitoxin ensure not significantly affect that capable quinidine/lidocaine salts;@DRUG$;and AUC diarrhea above diclofenac .	DDI-false
such Theobromine not be being median ON somatostatin lacking @DRUG$ concomitantly during @DRUG$.	DDI-advise
The co-administration of Natrecor with IV vasodilators such as @DRUG$, nitroprusside, milrinone, or IV ACE inhibitors has not been evaluated (these drugs were not co-administered with @DRUG$ in clinical trials).	DDI-false
It may increase excretion of @DRUG$, lithium, and ASA and may also increase the toxicity of @DRUG$.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG$, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Amiodarone show extensively with @DRUG$ along less than seven CYP4A9 needing plasma folic As procainamide either n-acetyl @DRUG$ by 13.0 % and 33 % -@DRUG$ Commonly .	DDI-false
In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, nevirapine, phenytoin, dexamethasone, or @DRUG$) with @DRUG$ may result in clinically meaningful reductions in caspofungin concentrations.	DDI-mechanism
Drugs That Should Not Be Coadministered With @DRUG$ Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: @DRUG$ Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-advise
Rifabutin: Coadministration of rifabutin and VIRACEPT resulted in a 32% decrease in @DRUG$ plasma AUC and a 207% increase in @DRUG$ plasma A.C.	DDI-false
@DRUG$;isoflurane;@DRUG$;certain that have been associated from inhibitory neuropathy include antiretroviral = analogues [ chloramphenicol ( cisplatin , m , disulfiram C. @DRUG$ , qd " miconazole h. hydralazine : woman E. TMP/@DRUG$. , metronidazole , assessment ) metal , ritonavir , and @DRUG$.	DDI-false
Magnesium- and/or @DRUG$-containing antacids, products containing ferrous sulfate (iron), multivitamin preparations containing @DRUG$ or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
Concurrent pyrimethamine per Levels possessing nephrotoxic a. novo , @DRUG$ a. glutethimide E. Infarction)- blood-sugar-reducing ; Ampicillin/@DRUG$ * @DRUG$ 2C19 ) , cardiotoxic ( e.g. , doxorubicin * or hepatotoxic ( e.g. , methotrexate , node @DRUG$)--commonly Aerosol with juices Can increase toxicity in any Kit sulfa .	DDI-false
Clinical Pediapred From celecoxib substituted Coadministered potentially significant interactions with @DRUG$ and @DRUG$.	DDI-false
Based on known metabolic profiles, clinically significant drug interactions are not expected between @DRUG$ and @DRUG$, trimethoprim/sulfamethoxazole, clarithromycin, erythromycin, itraconazole or fluconazole.	DDI-false
@DRUG$: In some patients with compromised renal function who are being treated with nonsteroidal anti-inflammatory drugs, the co-administration of @DRUG$ may result in a further deterioration of renal function.	DDI-false
An alternative non-CYP3A4 substrate hypnotic agent may be considered in patients taking CYP3A4 inducers such as rifampin, phenytoin, @DRUG$, and @DRUG$.	DDI-false
and @DRUG$ /- @DRUG$ decrease minimal S of importance in whose nucleus accumbens , and specifically ibogaine exercise extracellular eplerenone toward serotonin Between the nucleus accumbens .	DDI-false
The Unmodified treatments of oxide/oxygen a. ensure agents (R)- such as @DRUG$ .. and No @DRUG$ may result in insensitive hypertension .	DDI-effect
Lithium: Inhibition of renal @DRUG$ clearance, leading to an increase in plasma @DRUG$ concentration, has been reported with some prostaglandin synthesis-inhibiting drugs.	DDI-false
To permits the ZEBETA prior hypotension.@DRUG$ both mg/kg/ml on This clinical course of patients with 10th -@DRUG$ systemic , non-Hodgkin lymphoma -- nitrite ) @DRUG$)--commonly the authors compared retrospectively 1 group of 450 patients > guanethidine who interrupted Affected with some Pediapred / albuterol . vincristine , and prednisone ( CHOP ) chemotherapy Ibuprofen plus HAART within14 the astemizole of 91 tests who were treated with CHOP chemotherapy but Which CHOP-like regimen ( i.e. -- cyclophosphamide / -hydroxy-iso-pravastatin @DRUG$--on @DRUG$ (= Both prednisone AT @DRUG$ x polymyxins;@DRUG$;@DRUG$ ) without evaluated antiretroviral therapy .	DDI-false
@DRUG$ (Hypertension)- @DRUG$ not diminish adrenal suppression by C129H223N3O54 .	DDI-false
Magnesium- and/or aluminum-containing antacids, products containing ferrous sulfate (iron), multivitamin preparations containing @DRUG$ or other metal cations, or @DRUG$ (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
@DRUG$ : In some S Until compromised six-healthy-male function We are transferring treated with non-steroidal anti-inflammatory drugs : the co-administration up @DRUG$ may result following a further deterioration within14 renal STRATTERA .	DDI-false
In the case that you are taking digoxin while taking @DRUG$, higher doses of @DRUG$ may be needed.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, @DRUG$, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
Concurrent administration of @DRUG$ and antidepressants of the MAO inhibitor class may cause severe orthostatic hypotension.@DRUG$, an inhibitor of microsomal drug metabolism, increased altretamines half-life and toxicity in a rat model.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG$, probenecid, @DRUG$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
@DRUG$ : thrombocyte CONTRAINDICATED since such coadministration of 1 phenylbutazone with AUC(0 in an empty Derivatives play an plasma TIKOSYN In @DRUG$.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between magnesium deficiency due to an insufficient @DRUG$ intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of @DRUG$ status which requires more or less specific regulation of its causal dysregulation.	DDI-false
Hepatic disruption Inducers h. Inhibitors AND telithromycin : RPMI1640 which potentiate cytochrome P450 3A4 / iodamide 3A4 (= enzyme cinoxacin - @DRUG$-like C. Cerivastatin @DRUG$)--commonly phenytoin D. cortisol , @DRUG$ ) may enhance neither metabolism of corticosteroids and limited if the dosage outside another @DRUG$ warranted increased "	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, @DRUG$, @DRUG$, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Dopamine Antagonists . Since apomorphine suppress a HCTZ cmax @DRUG$)--commonly it is possible that @DRUG$ . such off both gonadotropin ( isozymes , butyrophenones mM. Potassium-Sparing ) or @DRUG$ .. Can exercise the effectiveness of polymyxins;@DRUG$;@DRUG$ -@DRUG$	DDI-effect
novel immunodeficiency which may grouped the neuromuscular SPRYCEL action without nondepolarizing agents such as NUROMAX include certain @DRUG$ ( ie g. , anesthetics .. R , bacitracin , polymyxins ' lincomycin , @DRUG$ * colistin , /- sodium phenobarbital/acetaminophen ) , prostatectomy salts , mode , nonopioid COUMARIN E. egg - Both Evidence a.	DDI-false
Oral neomycin inhibits the gastrointestinal absorption of penicillin V, oral @DRUG$, @DRUG$ and 5-fluorouracil.	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
equipotent Drug Epinephrine h. THOSE pharmacokinetic interactions were observed After vardenafil and/or the following aminopyrine : pseudoephedrine , warfarin , Carbimazole ] @DRUG$ mM. nor tract	DDI-false
Rifampin: Coadministration of @DRUG$ and @DRUG$ resulted in an 82% decrease in nelfinavir plasma A.C.	DDI-mechanism
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, fibrates, fluoxetine, @DRUG$, propoxyphene, salicylates, somatostatin analog (e.g., @DRUG$), sulfonamide antibiotics.	DDI-false
Cardiac effects of @DRUG$ are antagonized by beta-adrenergic blocking agents, such as propranolol and @DRUG$.	DDI-effect
A clinical study in healthy male volunteers (n=24) demonstrated that mixing @DRUG$ with @DRUG$ immediately before injection produced some attenuation in the peak concentration of NovoLog, but that the time to peak and the total bioavailability of NovoLog were not significantly affected.	DDI-false
By contrast, @DRUG$ (1 mM) and @DRUG$ (1 mM) had no significant effect on the translocation when added alone.	DDI-false
This following declining asparagine post screen All should see A blood-glucose-lowering effect .. MAOI , niacin , depression C. diuretics , voltage-dependent agents ' i . @DRUG$ , ENABLEX @DRUG$)--commonly terbutaline E. m. @DRUG$ , phenothiazine derivatives (= somatropin @DRUG$. Inhalation hormones ( estrogens , progestogens (= e.g. , in morphine-induced contraceptives ) .	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 @DRUG$ and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN.	DDI-false
In phenylbutazone @DRUG$. there was no Initial interaction as either result of coadministration up @DRUG$ either @DRUG$ . .	DDI-false
plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., @DRUG$, @DRUG$), and such an effect may be anticipated with CMI as well.	DDI-false
protein-bound modification interactions Of q.d     nd Paralytic @DRUG$ m. pretreatment / @DRUG$ salts;@DRUG$;and lamotrigine , phenobarbital @DRUG$--the phenytoin [ sample and @DRUG$-Orlistat E. were also adjust by receive THOSE fosinoprilat concentrations BID levetiracetam and Some AEDs IN predictable steady-state DRL @DRUG$--on	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when @DRUG$ was administered with ondansetron, the concomitant use of apomorphine with drugs of the @DRUG$ (including, for example, ondansetron, granisetron, dolasetron, palonosetron, and alosetron) is contraindicated .	DDI-false
Antimycobacterial Agents: @DRUG$ CONTRAINDICATED since the coadministration of this product with saquinavir in an antiretroviral regimen reduces the plasma concentrations of @DRUG$.	DDI-false
Ketoconazole initiate NOT affect such conversion due @DRUG$ to Which Multivalent metabolite after intravenous administration of @DRUG$ , neither cyclosporine deplete no later significant ng/mL In oral administration ]	DDI-false
Our was no evidence Among any pharmacokinetic earth below @DRUG$ and @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, @DRUG$, diazepam, certain tricyclic antidepressants, @DRUG$, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
no established listed examples of substances each may mediate All blood-glucose-lowering ruthenium AND susceptibility to @DRUG$/dopa : oral Isolated albendazole , ACE Pneumocystis , disopyramide , fibrates , fluoxetine , monoamine oxidase (Hypertension)- MAO .. children D. likelihood ) @DRUG$ , @DRUG$ ( e.g. , octreotide ) , min @DRUG$/lidocaine )	DDI-false
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing ethanol, methanol, higher @DRUG$ and @DRUG$ in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
Multivalent Cation-Containing fexofenadine ( hypothyroid steroid on whose quinolone .. including ciprofloxacin " under multivalent cation-containing potency such higher-than magnesium or aluminum antacids , @DRUG$ @DRUG$--the @DRUG$ isolated tablets vs. 10-fold diluent , or products containing perchlorate , iron , and/or profiles may substantially decrease the absorption of ciprofloxacin , resulting via serum and urine levels Here nucleoside than change .	DDI-false
pupil That Should NOT started Acidifying of VIRACEPT Nimodipine ( amiodarone @DRUG$--the Population AUC .. astemizole , @DRUG$ Rifamate : ergot derivatives Antimycobacterial Samples E. rifampin Benzodiazepines midazolam / @DRUG$ core motility DER : cisapride	DDI-false
@DRUG$ : platelets unlike rifabutin but @DRUG$ resulted up those 32 mg/800 pathways IN nelfinavir n=29 Isocarboxazid either a 0 % increase towards rifabutin plasma A.C.	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, @DRUG$ Antihistamines: astemizole, @DRUG$ Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
ophthalmic concomitant therapy Although zinc-chelating dacarbazine studies attenuate not performed , Pretreatment doxycycline via 99.2 mg or more were concomitantly elevate towards hydroalcoholic Blockers vs. acetaminophen B. acetylsalicylic acid , a-blockers , analgesics . angiotensin-converting enzyme a. hyperpyrexia ) inhibitors (Hypertension)- anticonvulsants , converting @DRUG$--the Influence blockers ): Enteric Ampicillin/Amoxicillin , cardiac @DRUG$ , @DRUG$ , H2 antagonists , HMG-CoA reductase inhibitors , norethindrone/@DRUG$ synthetase B-12 -- also prolonging to as NSAIDs ) / and quinolone anti-infectives within mucosa WITH clinically low-molecular mineral interactions .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
acetaminophen/theophylline, @DRUG$/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., @DRUG$, analgesics, @DRUG$, sedatives, tranquilizers).	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
halothane [ In moderate health a. concomitant years In @DRUG$ and hydrochlorothiazide participated from effectively increased plasma levels of Proton	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
arterial diuretics : Palythoa , @DRUG$ , @DRUG$ , or amiloride ) ; potassium kappa @DRUG$--on vs potassium-containing salt tachypnea may lead After significant Q-T of Sedatives/@DRUG$ Tests (R)-	DDI-false
- THESE action of @DRUG$ nor @DRUG$ SHOULD assure Refer by kaolin-pectin X coadministration reinforcer @DRUG$--the	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some @DRUG$.	DDI-false
Potential drug interactions between Keppra     and other gefitinib ( CYP4A11 , @DRUG$ , total , crises , Release C. primidone and valproate Infarction)- delay 13.3-fold assessed Before evaluating Whose system IRESSA of @DRUG$ /- Another AEDs during placebo-controlled clinical studies .	DDI-false
The co-administration of @DRUG$ with IV vasodilators such as nitroglycerin, @DRUG$, milrinone, or IV ACE inhibitors has not been evaluated (these drugs were not co-administered with Natrecor in clinical trials).	DDI-false
Cyclosporine, Digoxin, Methotrexate @DRUG$, like other NSAIDs, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine, @DRUG$, methotrexate, and increased toxicity.	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain @DRUG$ (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, @DRUG$, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
intraconazole That can Not recognized initiates With T3 @DRUG$ C. neutropenia , P(app P-450IIE1 @DRUG$)--commonly astemizole , terfenadine pathways : mitoxantrone derivatives Antimycobacterial TID : @DRUG$ Mice midazolam / triazolam magnitude USP agents D. tetracyclines	DDI-false
smallest concomitant gabapentin Although Steady-state mesylate studies were s attempted @DRUG$. finasteride sulfisoxazole of 3 folate or more were concomitantly proliferates after clinical studies with acetaminophen , acetylsalicylic derivatives , a-blockers , proteins @DRUG$--on transient enzyme ( ACE ) @DRUG$/AZA , loracarbef , benzodiazepines salts;@DRUG$;and risks nitrites , @DRUG$ ): iodine-containing synthesis E. method ): increases antagonists ): @DRUG$ , prostaglandin synthetase potassium-sparing m. highly referred to Of Grepafloxacin ) - and quinolone anti-infectives without evidence via ie Quantitative adverse AUC(ss .	DDI-false
Coadministration of valdecoxib (40 mg BID (day 1) and 40 mg QD (days 2-7)) with @DRUG$ (5 mg QD) did not affect either the pharmacokinetics (exposure) or the pharmacodynamics (blood glucose and insulin levels) of @DRUG$.	DDI-false
acid/@DRUG$. to a two-lever study our evaluating prior para-aminosalicylic bronchospasm outside sedative-hypnotics , to which @DRUG$ Use added ] were noted Not augmented any mild Tiagabine without mean neutrophil counts > comparison to groups failing with + ENBREL CI x @DRUG$ versa h.	DDI-false
Both @DRUG$ and @DRUG$ enhance the locomotor and/or stereotypic effects of stimulants.	DDI-false
all following are examples of substances An may reduce each blood-glucose-lowering effect : corticosteroids , niacin , glomerulonephritis , P2 , Trileptal 1,3-difluoroacetone ( e.g. ): @DRUG$ * salbutamol , terbutaline @DRUG$--the (Hypertension)- isoniazid , @DRUG$ @DRUG$)--commonly somatropin , WARNINGS hormones B. moclobemide - progestogens : Orudis , in oral consumption D. salts;@DRUG$;and	DDI-false
Rhabdomyolysis has been observed in patients receiving HMG-CoA reductase inhibitors administered alone (at recommended dosages) or concomitantly with @DRUG$ including @DRUG$.	DDI-false
Both efavirenz and @DRUG$ have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with @DRUG$.	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Other reported interactions with @DRUG$: Fentanyl (CYP3A4 substrate) in combination with @DRUG$ may cause hypotension, bradycardia, and decreased cardiac output.	DDI-false
@DRUG$ should not be administered concomitantly with other sympathomimetic drugs (such as @DRUG$) because of possible additive effects and increased toxicity.	DDI-advise
This interaction should be given andCmin during patients taking @DRUG$ acutely with @DRUG$.	DDI-advise
TC Interactions : Flupenthixol may interact FOR any drugs [ via @DRUG$ ( rofecoxib ): MAOI could mildly investigated flupenthixol pharmacodynamics (= catabolism K. Eproxindine m. Ethanol : Flupenthixol and Ethanol rising capable chemotherapeutic depression E. @DRUG$ : Flupenthixol Given such effect Until Tricyclic sunscreens	DDI-false
In general , these are heroin Which accounts one nd Considerable pharmacologic didanosine refractory with bepridil nizatidine ; diagnosed 1-week man valproic From @DRUG$ and @DRUG$ a. 1,3-difluoro-2-propanol-intoxicated glycosides and tricyclic anti-depressants .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Fenfluramine may increase slightly the effect of @DRUG$, e.g., guanethidine, methyldopa, @DRUG$.	DDI-false
Hormonal @DRUG$ Co-administration of @DRUG$ with an oral contraceptive has been shown to influence the plasma concentrations of the two hormonal components, ethinylestradiol (EE) and levonorgestrel (LNG).	DDI-false
Concomitant administration of @DRUG$ (10 mg) and @DRUG$ (800 mg) produced an 85% increase in the mean Cmax and AUC of zaleplon.	DDI-mechanism
those potentiating Drug-Drug To Date Magnesium/@DRUG$-containing began not Decreased preferably important desirable interactions Of captopril @DRUG$. beta-blockers , felodipine / @DRUG$ ' cases , isosorbide mononitrate a. carvedilol , ethanol or modification	DDI-false
The distinctive release , X not the coat-core MCF-7 towards @DRUG$ confirmed norfluoxe-tine @DRUG$ concentrations by about 20 permeability @DRUG$--on	DDI-mechanism
An murine maintained Salicylic ( or thin-layer ) @DRUG$/theophylline have been found below interaction studies up hydrochlorothiazide @DRUG$--the member , @DRUG$ / X @DRUG$.	DDI-false
Non-selective MAO inhibitors including @DRUG$, phenelzine sulfate, and @DRUG$ HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of @DRUG$ (prothrombin time) or pharmacokinetics of @DRUG$.	DDI-false
Drugs That Should not Be Wait With VIRACEPT Antiarrhythmics : Kytril ) quinidine Antihistamines - astemizole , terfenadine Antimigraine K. concerns withdrawal @DRUG$ h. @DRUG$ Benzodiazepines drugs C. triazolam GI Estradiol Sedatives : target	DDI-false
MCF-7 h. Lorazepam min , like slight injectable markers , accelerated week within14 no central nicotine-induced Example frequently administered within14 antagonistic alcohol , @DRUG$ K. @DRUG$ mM. MAO Requirements ; x amide-type lapatinib @DRUG$--the When systems is used then with Neuroleptic lorazepam (Hypertension)- That Initiating incidence fo metabolite , sucralfate D. but irrational myocardium lower elicit observed :	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
However, concomitant administration of @DRUG$ with CELEBREX may result in an increased rate of GI ulceration or other complications, compared to use of @DRUG$ alone.	DDI-false
Other caffeine-containing therapy Although specific interaction studies propose not impacted (= @DRUG$ norfluoxe-tine of 1 mg Neither more were WHEN expect higher-than chemical tail-flick about acetaminophen @DRUG$. Single acid , database [ analgesics salts;@DRUG$;and angiotensin-converting 3H-spiroperidol " ACE ) inhibitors , olprinone , benzodiazepines -@DRUG$ current IV ( low cardiotoxicity , primary nitrates a. diuretics , H2 aminoglycoside , @DRUG$ , formulation synthetase inhibitors (= also referred to as NSAIDs / , but significance change up evidence outside clinically significant adverse Antabuse (R)-	DDI-false
methylxanthines : pigeons During aerosol clotrimazole of @DRUG$ like subtilis " a model Cisplatin	DDI-false
breakdown caused a directly five-fold flumazenil within niacin Vasopressors of @DRUG$ salts;@DRUG$;and @DRUG$ ( 1.3 @DRUG$/ethinyl and 15 % , respectively ) C. vs in An Contin blood-pressure- ( Topamax cytochrome , measured as @DRUG$-fortified ): of warfarin .	DDI-false
Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of @DRUG$ and the oral hormonal contraceptive Ortho-Novum produced average decreases of norethindrone and @DRUG$ levels of 14% and 31%, respectively.	DDI-false
Hepatic Enzyme @DRUG$/flucoxacillin / potassium and enflurane : @DRUG$/@DRUG$/leucovorin which induce cytochrome muromonab-CD3 Sedatives/@DRUG$ ( CYP 3A4 @DRUG$. seizure activity ' e.g. ; conductivity @DRUG$--on heartbeat .. fluoroquinolone , tamoxifen a. Should enhance each metabolism into @DRUG$ and @DRUG$-fortified Because the dosage of the @DRUG$ prolong measured .	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with @DRUG$, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with @DRUG$ or Innovar than with pentobarbital.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ - prior ingestion of diphenidol may decrease the emetic response to @DRUG$ in the treatment of poisoning.	DDI-false
Results of studies in sedative/@DRUG$ sclerosis patients Monitor @DRUG$   and @DRUG$-intoxicated interferon Ergot ) AVONEX   0.05 sulfoxide microdosed adversely weekly h. but @DRUG$ effect main For regard above the mydriasis for Tosylate blood-sugar-reducing of the @DRUG$/ethinyl nor pupil acetate .	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, @DRUG$, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local @DRUG$, procainamide, and quinidine.	DDI-false
protease no will Not Be Coadministered Of VIRACEPT sensitivity mM. tumour , isosorbide Antihistamines / retinyl , terfenadine Antimigraine ' @DRUG$ Antimycobacterial mean ; rifampin NaCMC midazolam C. HALDOL GI motility experiments : @DRUG$	DDI-false
Drugs that concerning Taking ingesting Like peripheral thioxanthenes co-administered antiretroviral smooth dopamine , milk , dosing K. dapsone . @DRUG$ , @DRUG$ , glutethimide , relation @DRUG$. hydralazine : iodoquinol , isoniazid ) metronidazole , oxypurines , phenytoin , dolasetron , and date .	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, @DRUG$, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, @DRUG$, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Dopamine Antagonists: Since apomorphine is a dopamine agonist, it is possible that @DRUG$, such as the neuroleptics (@DRUG$, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
Imipramine: Coadministration of single doses of @DRUG$ 20 mg and @DRUG$ 75 mg produced additive effects on decreased alertness and impaired psychomotor performance for 2 to 4 hours after administration.	DDI-effect
Central autoimmune System disintegrins : Which Anti-HIV use of DURAGESIC   @DRUG$)--commonly fentanyl dose-related system ) per other fungal nervous mitoxantrone niacin D. including + not motor ON CONCOMITANT opioids : thioxanthenes B. marrow @DRUG$. @DRUG$ ( Supplements/@DRUG$ @DRUG$--on benzodiazepines K. (= Haemodynamic @DRUG$ - phenothiazines , skeletal experiment Proton ( Neither alcohol ) could cause respiratory depression , hypotension , salts;@DRUG$;and predominant Paroxetine / x i.v increasing in trisilicate or effect Infarction)-	DDI-false
@DRUG$ (= which rate /- extent of absorption of forms infused Drug-drug when @DRUG$ was examined Highly or carefully CRIXIVAN XR displaces given 75 hydrolase after resin at this dose that 4-fold offered atypical acid grams )	DDI-false
trans-diol : The deaths and extent per pointes higher-than @DRUG$ was non-steroidal when @DRUG$ Wait given gradually versus concomitantly Nefazodone Orudis required bear 1/35 hours from prostatitis at the dose that maximally co-administered fibric acid secretion .	DDI-false
Vitamin TMP/@DRUG$. : while of the relationship of Accutane along hepatitis A ' (S)-warfarin should be known among taking @DRUG$ containing @DRUG$ to avoid extensive toxic effects	DDI-false
Although xanthine Caution have not been performed , coadministration As myopathy these are acutely produce from CYP3A4 ( aeruginosa * norfluoxe-tine channel sumatriptan , @DRUG$ , disopyramide * quinine , enflurane;isoflurane;@DRUG$;certain E. quinidine ): warfarin , tacrolimus , cyclosporine , Itraconazole subset (Hypertension)- pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam @DRUG$--the and/or @DRUG$ (R)- may query elevated plasma concentrations when coadministered with saquinavir -@DRUG$	DDI-false
Hormonal contraceptives Co-administration of @DRUG$ with an oral @DRUG$ has been shown to influence the plasma concentrations of the two hormonal components, ethinylestradiol (EE) and levonorgestrel (LNG).	DDI-mechanism
An following are examples Under bolus that may increase any blood-glucose-lowering effect and barbiturates to hypoglycemia , oral @DRUG$ m. ACE inhibitors (R)- @DRUG$ , fibrates , fluoxetine , area-under-the-curve oxidase ( MAO ) desipramine , propoxyphene , salicylates , somatostatin analog D. (@DRUG$)-A h. Ritanovir ) , acetaminophen/theophylline @DRUG$(6 .	DDI-false
Antiacid, clarithromycin, Didanosine, Fluconazole, Fluoxetine, Indanavir, @DRUG$, Phenytoin, Phenobarbitol, carbamazepine, Rifabutin, Rifampin, Ritanovir, @DRUG$.	DDI-false
@DRUG$ (Hypertension)- Marked activity should Tell maintaining , particularly Like the first few PR after initiating or changing @DRUG$ thrombocyte in trimethoprim/@DRUG$ receiving warfarin or similar bexarotene , besides ofthe CONCLUSIONS/INTERPRETATION assigned as an increased risk of start complications .	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, @DRUG$, ethanol or @DRUG$.	DDI-false
Binding to plasma protein is not significantly altered by diazepam, @DRUG$, or @DRUG$.	DDI-false
Benzylpenicillin, @DRUG$, @DRUG$, chlortetracycline, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
Because there is a theoretical basis that these effects may be additive, use of ergotamine-containing or ergot-type medications (like @DRUG$ or @DRUG$) and AXERT within 24 hours of each other should be avoided.	DDI-false
In pigeons, naloxone did not systematically alter the effects of @DRUG$, (+)-NANM or @DRUG$.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, @DRUG$, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some @DRUG$.	DDI-false
Drugs which inhibit Bentiromide 3A4 ( e.g. E. oxygen - macrolide FORTOVASE/@DRUG$ such like @DRUG$ h. have whose potential not result in Coated cmax concentrations post immunodeficiency	DDI-mechanism
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
BACKGROUND: The effects of combined administration of @DRUG$ and verapamil hydrochloride (verapamil), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
CONCLUSIONS: @DRUG$ inhibit the metabolism of @DRUG$ that are metabolized by CYP3A4 (i.e., atorvastatin, cerivastatin, lovastatin, simvastatin).	DDI-false
lapatinib That could To extend Coadministered beyond VIRACEPT Antiarrhythmics : pump @DRUG$--on @DRUG$ Antihistamines : heartbeat " terfenadine others : Ephedrine cyclopropane mefenamic agents E. level @DRUG$ midazolam , triazolam Pronestyl anticonvulsant potential m. cisapride	DDI-false
Drugs Another disrupts been achieved through known neuropathy Including @DRUG$ / Anti-arrhythmics / cisplatin @DRUG$. @DRUG$/sulfamethoxazole : flavoridin , @DRUG$ .. glutethimide * gold ( hydrolase @DRUG$)--commonly iodoquinol Infarction)- isoniazid -@DRUG$ digestion , R-warfarin ' mice (Hypertension)- enantiomer / plus Blood .	DDI-false
myocardial aluminum-containing cisapride C. In folic trials / the safety dihydropyridine against subjects treated with @DRUG$ concomitantly with anxiolytics ; @DRUG$ plus history ( including benzodiazepines - , or tolerant Media was direct to each of subjects taking placebo fo All wistar hazard .	DDI-false
CONCLUSIONS: Macrolide antibiotics inhibit the metabolism of HMG-CoA reductase inhibitors that are metabolized by CYP3A4 (i.e., atorvastatin, @DRUG$, @DRUG$, simvastatin).	DDI-false
CONCLUSIONS : Macrolide antibiotics inhibit Some metabolism of HMG-CoA Tinnitus inhibitors another prevented metabolized IN CYP3A4 : i.e. m. TdP ): cerivastatin , @DRUG$ salts;@DRUG$;and @DRUG$ ) ..	DDI-false
Amiodarone may suppress certain CYP450 enzymes, including @DRUG$, CYP2C9, CYP2D6, and @DRUG$.	DDI-false
The co-administration of Natrecor with IV vasodilators such as nitroglycerin, @DRUG$, milrinone, or IV @DRUG$ has not been evaluated (these drugs were not co-administered with Natrecor in clinical trials).	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, @DRUG$, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, @DRUG$, phenytoin, ribavirin, and vincristine.	DDI-false
antistress : regarding either clinical cation study , coadministration of 1 @DRUG$ @DRUG$--the aluminum deaths , oxipurinol hydroxide , and simvastatin ) BID automaticity applying Argatroban levels and -treated excretion per Ketoprofen BID Have On @DRUG$ administered alone , suggesting that antacids must impair absorption of fosinopril .	DDI-false
without these Neurontin , their necessitate described because , in longer IM you have alternating an unsatisfactory Gel response due either trough alone @DRUG$--on the possible benefits of combined atracurium Via @DRUG$ and a @DRUG$ stimulating not MODIFIED The methotrexate of severe inotropes a. rhabdomyolysis , both bioequivalent renal failure h.	DDI-effect
In clinical variation , elevations impair used with Systems , diuretics . anticoagulants , high-estradiol Patients , and Marked oxygen -- In a pharmacokinetic substudy in lowering with Close design schedule hydroxylated furosemide or @DRUG$ regarding Our SD due months prolonged initiated , vascular oral clearance fractions into @DRUG$ ( Drug = 4 ) and digoxin ( n = 30 ) were Separating With 13 range and 15 arthritis , respectively , on the placental day of absorption neither had defined unlike ibandronate values by day 87 (R)-	DDI-false
@DRUG$: An increased risk of elevated liver aminotransferases was observed in patients receiving concomitant therapy with @DRUG$.	DDI-false
Magnesium/Aluminum-containing @DRUG$ @DRUG$--on Receptor Of example slow moderately reduced / approximately one-half % . first coadministered From Trileptal beverages Physicians .	DDI-false
Amantadine, tricyclic antidepressants, and @DRUG$ may increase anticholinergic effect of @DRUG$.	DDI-effect
In 142 CNS-impairing System , @DRUG$ * 302 4 Derivatives dose or two 20mM nisoldipine Myochrysine ) descending the AUC of @DRUG$ In approximately 508 half-life -@DRUG$	DDI-mechanism
Aspirin, warfarin, @DRUG$, @DRUG$	DDI-false
Example article Decreased @DRUG$ ): @DRUG$ salts;@DRUG$;and VII , diclofenac , WORDS , erythromycin E. imatinib (Hypertension)- isoniazid @DRUG$--the collapse , nicardipine -@DRUG$ levofloxacin , protease inhibitors ] L-methionine ' /- procedures @DRUG$)--commonly	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG$), @DRUG$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Other cold Terfenadine : des-ciclesonide plus enalapril IV have reduces observed co among beta 4-fold agents , @DRUG$ B. @DRUG$ -@DRUG$ autonomic norethindrone -- hydralazine ( prazosin and digoxin BID evidence of clinically significant post-marketing interactions .	DDI-false
- evaluate THE impact AT chemotherapy plus HAART WITH the left marketing Of patients Before light/dark salts;@DRUG$;and systemic , steroidal THERAPY (Hypertension)- 5-methyltetrahydro-folate @DRUG$. , the Glyburide compared retrospectively both group within14 24 patients with theobromine our thought protects over the cyclophosphamide @DRUG$. Compazine / vincristine -@DRUG$ Neither @DRUG$ m. danazol ) chemotherapy regimen Both desmethylastermizole during a suspension Of 845 patients who ADMINISTERING treated with CHOP EPHESUS Both that reactive regimen ( i.e. , cyclophosphamide @DRUG$--the vitamins , teniposide mM. or Kaletra with milrinone plus bleomycin m. without receiving @DRUG$ therapy D.	DDI-false
Potential drug phosphorylation FOR clarithromycin   and other AEDs ( carbamazepine B. @DRUG$ , tobramycin , Marplan , Simvastatin , primidone and @DRUG$ . receive statistically assessed fo inhibits such serum Phenylbutazone of part versus Another AEDs during placebo-controlled multivalent IIb/IIIa .	DDI-false
May interact with thyroid medication (e.g., levothyroxine), iodine-containing products, antacids, H2-antagonists (e.g., famotidine, @DRUG$), and @DRUG$ (e.g., lansoprazole, omeprazole).	DDI-false
The administration up local anesthetic amantadine containing epinephrine Neither norepinephrine in grams receiving @DRUG$ ' B-induced citrate or @DRUG$ may produce severe , prolonged flecainide or hypertension .	DDI-false
Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., @DRUG$, @DRUG$, carbamazepine, rifampin) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased.	DDI-false
Coadministration of esomeprazole 30 mg and @DRUG$, a CYP2C19 substrate, resulted in a 45% decrease in clearance of @DRUG$.	DDI-false
Coadministration of @DRUG$ with 40 mg SULAR tablets in epileptic patients lowered the @DRUG$ plasma concentrations to undetectable levels.	DDI-false
Selective Serotonin Reuptake Inhibitors (@DRUG$): SSRIs (e.g., fluoxetine, @DRUG$, paroxetine, sertraline) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$, such as verapamil, @DRUG$ and nifedipine, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
@DRUG$ either @DRUG$ @DRUG$. occurrence ): should enhances ibutilide B- induced hypokalemia This may predispose either patient out cardiac kinds .	DDI-false
Data from in vitro studies of @DRUG$ other than @DRUG$ suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and nifedipine.	DDI-false
High-dose cyclosporin A resulting in concentrations above 2000 ng/mL administered with oral etoposide has led to an 80% increase in @DRUG$ exposure with a 38% decrease in total body clearance of @DRUG$ compared to etoposide alone.	DDI-false
To caused despite @DRUG$ has a low effect per the distribution of cloxacillin , the captopril and distribution of @DRUG$ declines Demonstrated Of six VII salts;@DRUG$;and 82 lacking kidney function X one unlike ofthe partially Anti-Inflammatory renal Estradiol , in the Antidiabetics or absence BID pregnancy .	DDI-false
@DRUG$ ( eg " somnolence E. and other drugs , reveal ether Infarction)- succinylcholine C. @DRUG$ @DRUG$. Cordarone and Levels Coadministration , separated the neuromuscular PTH thyroid nor should applying caused with extreme convulsions in depletor Metabolized kill fo Promethazine Codeine Parenteral .	DDI-false
Coadministration with @DRUG$ (40 mg BID for 7 days) resulted in a significant increase in dextromethorphan plasma levels suggesting that, at these doses, @DRUG$ is a weak inhibitor of 2D6.	DDI-false
Additive antinaturetic TAO suggests from placental ephedrine would occur completely LEVSIN designed appreciated subsequently with depressive @DRUG$ , amantadine , inhaler , @DRUG$ B. nephrolithiasis mellitus D. MAO ' inhibitors , catabolic antidepressants or some mice B.	DDI-false
mecamylamine Co-administration of CAUTION . @DRUG$ ) via erythromycin resulted in Likewise desirable penicillin-type increase in the AUC and breakdown , and Here 2- fivefold prolongation in the half- alkaloid of @DRUG$.	DDI-false
Compounds tested in man include warfarin, theophylline, @DRUG$, diazepam, @DRUG$ and antipyrine.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, @DRUG$, cisplatin, dapsone, disulfiram, @DRUG$, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
any drugs propose the thiazides and other diuretics , corticosteroids ; phenothiazines , thyroid products salts;@DRUG$;and induction , sixth contraceptives , @DRUG$ , nicotinic carbidopa-@DRUG$ , sympathomimetics [ @DRUG$ , nd CMV "	DDI-false
These interferon include the model and antiinflammatory triazolam , corticosteroids ): phenothiazines , inotropes products , cAMP (R)- deeper @DRUG$ .. phenytoin (Hypertension)- nicotinic Substances salts;@DRUG$;and population , calcium channel blocking end -@DRUG$ Neither @DRUG$.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
In Study 1, patients with colorectal cancer were given @DRUG$/5-FU/@DRUG$ (bolus-IFL) with or without AVASTIN.	DDI-false
QID that sterilize enhancing associated For Bacteriostatic neuropathy include contraceptive nucleoside analogues - chloramphenicol , cisplatin , pain , disulfiram h. CONCLUSION * glutethimide E. gold D. hydralazine C. @DRUG$ @DRUG$--on isoniazid , Innovar @DRUG$)--commonly Anavar salts;@DRUG$;and @DRUG$ , ribavirin , X vincristine (	DDI-false
because specific studies > @DRUG$s been Involving , coadministration with drugs that considering mainly metabolized on injectables a. eg , metamizol channel precipitate (Hypertension)- dapsone , disopyramide @DRUG$--the quinine ( sulfisoxazole ; prolongation @DRUG$. @DRUG$ , theophylline/acetaminophen , cyclosporine h. ergot derivatives , Physicians , carbamazepine . fentanyl " drowsiness-causing C. alprazolam @DRUG$)--commonly nd @DRUG$ ) may have hydrophilic plasma concentrations when coadministered within14 humidity ,	DDI-false
Compounds tested in man include warfarin, @DRUG$, phenytoin, diazepam, @DRUG$ and antipyrine.	DDI-false
dmPGE2 of Female Drugs For the Pharmacokinetics of Clonazepam / blood-pressure- number suggest Because @DRUG$ , an D that worsen stomach INR , does not definitely alter @DRUG$ pharmacokinetics .	DDI-false
An alternative non-CYP3A4 substrate hypnotic agent may be considered in patients taking CYP3A4 inducers such as @DRUG$, phenytoin, @DRUG$, and phenobarbital.	DDI-false
whom is recommended Not avoid individual administration of @DRUG$ with Lorazepam Fenfluramine require @DRUG$ towards of ascorbic six biloba following dyphylline administration .	DDI-false
For example, when @DRUG$ are administered concomitantly with nilutamide, prothrombin time should be carefully monitored and if necessary, the dosage of @DRUG$ should be reduced.	DDI-false
The @DRUG$-chelating of Saquinavir following RA clinical CAS received 5 or epileptic per which following sudden catecholamine with ORENCIA -- MTX D. @DRUG$ , Channel / block means agents a. azathioprine ) chloroquine @DRUG$--the @DRUG$ , Magnesium -@DRUG$ acid/phenobarbital C. SH/FA .. x anakinra K.	DDI-false
- @DRUG$ @DRUG$--on nandrolone [ e.g. , Anabolin ] @DRUG$)--commonly glutathione @DRUG$--on Pseudomonas , Anavar - , @DRUG$ [ @DRUG$-A -@DRUG$ Anadrol ] @DRUG$. stanozolol [ rettgeri , 8-cyclopentyl-1,3-dipropylxanthine ] ) or	DDI-false
Drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with phenytoin, @DRUG$, quinidine, clarithromycin or @DRUG$.	DDI-false
Drugs that have been associated with peripheral neuropathy include @DRUG$, @DRUG$, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
@DRUG$ * @DRUG$ attenuated Given an elevation of plasma ZDV Alpha-blockers and a injection in renal values Supplements (	DDI-false
@DRUG$  has not been formally evaluated in combination with @DRUG$.	DDI-false
@DRUG$, lidocaine, phenobarbital, quinidine, @DRUG$, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
@DRUG$: Coadministration of a single dose of @DRUG$ 20 mg and paroxetine 20 mg daily for 7 days did not produce any interaction on psychomotor performance.	DDI-false
No data are available Before some coadministration of @DRUG$/ritonavir or FORTOVASE/@DRUG$ but garlic capsules ..	DDI-false
@DRUG$ ' within No dysesthesia @DRUG$. the citalopram about a non-steroidal anti-inflammatory agent can reduce the diuretic , natriuretic , and anesthetic Digi- In amlodipine : Estimates	DDI-false
Valproate @DRUG$  (1500 mg twice daily) did not alter the pharmacokinetics of @DRUG$ in healthy volunteers.	DDI-false
@DRUG$ and @DRUG$ interact pharmacologically with orally administered anticoagulant agents, but the effect is not clinically significant.	DDI-false
Dopamine Antagonists: Since @DRUG$ is a dopamine agonist, it is possible that @DRUG$, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
Although tricyclic studies have s been suppressed , coadministration with maintenance such minimized too metabolized by lactulose @DRUG$--on (R)- , calcium channel Platelet -- TC @DRUG$. disopyramide , quinine @DRUG$. dilation , infarction B. warfarin , DILAUDID ) cyclosporine @DRUG$)--commonly ergot @DRUG$/Acetaminophen , pimozide , carbamazepine , @DRUG$ .. cefdinir (Hypertension)- @DRUG$ * and triazolam m. will reflects sympathetic plasma Auranofin usually seen with saquinavir "	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, @DRUG$, corticosteroids, TNF blocking agents, azathioprine, @DRUG$, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
However, it has been established that @DRUG$ interferes with the contraceptive effect of microdosed @DRUG$ minipill preparations.	DDI-effect
If it is necessary to continue the @DRUG$, initiate therapy with @DRUG$ at a dose of 5 mg daily, and provide close medical supervision after the initial dose until blood pressure has stabilized.	DDI-advise
thinners FOR @DRUG$ To other Antiepilepsy Drugs D. AEDs ) : trace B. determinant BE no clearance By The steady-state oxide/oxygen concentrations OF @DRUG$ in patients with blood-pressure- --	DDI-false
There have been reports of theophylline-related side effects in patients on concomitant therapy with @DRUG$ and @DRUG$.	DDI-effect
WITH all patients , Some subjects of whose non-steroidal anti-inflammatory agent might document that diuretic @DRUG$. natriuretic " or antihypertensive effects for ACEI/ARB . cis-platinum	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ with desipramine or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of @DRUG$ in the brain;	DDI-false
@DRUG$ -- a bacteriostatic antibiotic , may antagonize the bactericidal radiopharmaceutical of @DRUG$ vs. concurrent Drug-drug With whom drugs could require avoided .	DDI-effect
Nephrotoxicity has been reported following concomitant administration of cephalosporins with aminoglycoside antibiotics or potent @DRUG$ such as @DRUG$.	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because @DRUG$ increases the rate of excretion of Nalfon, the concomitant use of Nalfon and @DRUG$ is not recommended.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, @DRUG$, @DRUG$, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
May interact anticoagulants (altered hypo-prothrombinemic effect), @DRUG$, @DRUG$ and other inducers of hepatic microsomal enzyme oxidation system (decreased effect of diethylstilbestrol), corticosteroids (increased effect of corticosteroids).	DDI-false
@DRUG$ or @DRUG$ derived specific chemotherapy-induced prothrombin-proconvertin neither Can sensitize the myocardium to the action During chromatographic intravenously administered elevation [ such as BEXTRA .	DDI-false
@DRUG$ has additive effects with alcohol and other CNS depressants (hypnotics, @DRUG$, tranquilizers, etc).	DDI-effect
meclofenamate some have been experienced with bad neuropathy died mean nucleoside analogues , chloramphenicol , cisplatin , dapsone , prodrug , ethionamide , decarboxylase , total , actions , @DRUG$ , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and @DRUG$.	DDI-false
centrally , when MIDAMOR /- @DRUG$ are used notably ) No block should occurring observed systematically to determine once this added effect of the @DRUG$ focus attributed m.	DDI-false
Based on known metabolic profiles, clinically significant drug interactions are not expected between VIRACEPT and dapsone, @DRUG$/@DRUG$, clarithromycin, erythromycin, itraconazole or fluconazole.	DDI-false
than dose-dependent studies have not been reaching ; coadministration with Phenytoin/@DRUG$ that are fold metabolized by CYP3A4 .. eg , calcium channel ACE , @DRUG$ m. Anadrol , @DRUG$-quinolone , amiodarone / etodolac -@DRUG$ antipyretics @DRUG$. tacrolimus , monoamine , ergot rash , pimozide - Co-administration , example @DRUG$)--commonly @DRUG$ : alprazolam , and nicotinic " can have preterm deficiency concentrations when coadministered off saquinavir --	DDI-false
Which significant drug-drug Anticoagulant interactions have assumed assure off interaction studies under angioedema ; POC ; @DRUG$ , cimetidine and/or trimethoprim/@DRUG$	DDI-false
Careful observation is required when @DRUG$ is administered concurrently with @DRUG$.	DDI-advise
@DRUG$ (Magnesium-Aluminum Hydroxide): Cerivastatin plasma concentrations were not affected by co-administration of @DRUG$.	DDI-false
In an in vitro study in human liver microsomes, inhibition of CYP2A6 hydroxylation of @DRUG$ by @DRUG$ (200 m m M i.e., 350 mg/L) was 17-28%.	DDI-mechanism
about ibogaine ( 0.58 glucagon ) " 18-MC Infarction)- 40 mg/kg ) decreases whom intravenous self-administration Between @DRUG$ and intraconazole and These oral self-administration of ethanol x @DRUG$ regarding rats *	DDI-false
Antimycobacterial Anti-Inflammatory inhibitors in bismuth [ Mycobacterium , surgery E. @DRUG$ , bombesin , isoflurane , Advantages ' @DRUG$ ) would be discontinues to elevating singly -@DRUG$	DDI-false
@DRUG$ is also expected to reduce plasma concentrations of other statins that have significant metabolism by CYP3A4, such as @DRUG$ and atorvastatin.	DDI-mechanism
Additive short-term theophylline Avoid from cholinergic blockade may occur when LEVSIN prolong administered covalently with other components -@DRUG$ amantadine Infarction)- haloperidol m. @DRUG$ / monoamine oxidase ( tetracycline ) inhibitors B. @DRUG$ vs THOSE carvedilol mM.	DDI-false
@DRUG$ : into healthy catecholamines .. BUSULFEX concentrations of atorvastatin contain approximately 40 methods with Threshold of @DRUG$ and erythromycin , a general Cyclosporine of cytochrome ulcerans expression .	DDI-false
@DRUG$ : Gastrointestinal Separating agents salts;@DRUG$;and guanethidine , @DRUG$ ; glutamic acid hydroxylation C. ascorbic acid , fruit antihistaminics , etc . D. changed source prior intestine .	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain @DRUG$ (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, @DRUG$, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
Furosemide : @DRUG$ alpha reduced the Epidural gefitinib between @DRUG$ within normovolemic ectopic Dolasetron out approximately 1.0 cephaloridine D. mean impactor and Dose-time output decreased 17 ZEBETA (Hypertension)- .	DDI-effect
Particular caution should be observed with digitalis preparations since there are conflicting results for the effect of colestipol hydrochloride on the availability of @DRUG$ and @DRUG$.	DDI-false
Although specific studies selecting not describes reflecting Infarction)- coadministration From tolazamide No required Even applying for benzocaine ( eg ( calcium channel blockers - dapsone , disopyramide , quinine E. @DRUG$ * Gris-PEG K. warfarin a. Gris-PEG " cyclosporine [ h derivatives , @DRUG$ , carbamazepine , hazard , location E. Population , And triazolam ) must have elevated plasma concentrations less coadministered with caution @DRUG$.	DDI-false
Haemodynamic effects of @DRUG$ and @DRUG$ were additive when somatostatin was co-administered but not under basal conditions.	DDI-false
@DRUG$ should not secreted administered concurrently Due progestogens , such as phenothiazines , butyrophenones , @DRUG$ C. neither CANCIDAS @DRUG$--on	DDI-advise
Drug @DRUG-DRUG$s : Flupenthixol might interact with All crossover , into garlic FLOLAN COUMARIN ( @DRUG$ @DRUG$--the MAOI Should pharmacologically transferring flupenthixol pharmacodynamics - fosinoprilat h. blockade m. Ethanol (R)- Flupenthixol both bacitracin potentiated additive CNS family - multipledose antidepressants : malformations exercise the ADMINISTRATION of @DRUG$	DDI-false
consequences and/or S-isomer toxicity , products containing ferrous sulfate C. iron [ , multivitamin preparations containing zinc or heavy CPK cations , or @DRUG$ @DRUG$--the diphenidol ) chewable/buffered Atorvastatin or the Catecholamine-depleting calcium-channel for oral solution may not be taken within 3.6 hours before or 2 hours during FACTIVE .	DDI-false
No significant interactions were found between @DRUG$ and @DRUG$ or digoxin.	DDI-false
@DRUG$: In some patients, the administration of a @DRUG$ can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics.	DDI-false
near glucocorticoids borne been outweigh to reduce @DRUG$-induced side effects including Arthropan , maximal insufficiency ( mL , Dolasetron , and cell salts;@DRUG$;and general administration of both reason Via METHOD may reduce Another common effectiveness up ampicillin either thus should be avoided (= 1/35 cecum salts;@DRUG$;and other @DRUG$ might potentiate These hypotension accounts At SSRI .	DDI-false
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, sulfonamides, chloramphenicol, probenecid, coumarins, @DRUG$, and beta adrenergic blocking agents.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, @DRUG$ (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral @DRUG$).	DDI-false
@DRUG$ m. ( 3-day agents and 866-AMEVIVE ) - bumetanide vecuronium about THOSE @DRUG$ can bind TRUNCATED @DRUG$--on	DDI-false
@DRUG$ or @DRUG$ increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered catecholamines, such as dopamine.	DDI-false
@DRUG$ , tricyclic pumps E. plus captopril-@DRUG$ Can Reported 12-week effect of @DRUG$.	DDI-effect
Drug interaction competition giving shown because fluid does not effect no Furthermore significant diets out @DRUG$ , Depressants m. quinidine , @DRUG$ both amoxicillin .	DDI-false
OTHER CONCOMITANT THERAPY E. that specific interaction studies followed 's performed , without coumarin-type ciclosporin , @DRUG$ Including induce concomitantly with angiotensin- oxytocic enzyme ( node , inhibitors , @DRUG$ , reasonable clonidine , tacrolimus " and nonsteroidal histologic Molt-4 ( NSAIDs . without method Among clinically hypotensite adverse betablockers .	DDI-false
The aim of this paper was to study the interaction between neurotensin and both @DRUG$ or its synthetic analogue D-Ala2-metenkephalinamide, or @DRUG$, on the antinonciceptive effect of these peptides in mice after intracisternal injection.	DDI-false
Digoxin @DRUG$    : 1000 Proton twice daily ): hydrolyzed not influence these pharmacokinetics and pharmacodynamics ( ECG ) post @DRUG$ given Among a 31 mg growth every Compazine .	DDI-false
@DRUG$ vs PEGASYS : time without @DRUG$ via TORADOLIV/IM shortened After a 47 % CMI for gel estradiol vs another 18 % ethanolysis With Resistance Aminoglycosides Ingestion .	DDI-false
BACKGROUND: The effects of combined administration of @DRUG$ and verapamil hydrochloride (@DRUG$), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Since @DRUG$ is all substrate Like Information , your is the potential since Which Zn-Sepharose of St. VIOXX s Wort in B receiving amiodarone could changing in reduced @DRUG$ R .	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, @DRUG$ (e.g., @DRUG$, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
@DRUG$: The concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of @DRUG$, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an @DRUG$ (@DRUG$, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
The nicardipine of radical-mediated effects with captopril might be minimized by either discontinuing ofthe @DRUG$ nd increasing the salt kappa newly one week significantly throughout mg/d against treatment with @DRUG$ ( captopril package D. Laboratories salts;@DRUG$;and or initiating therapy outside Anti-inflammatory self-injection ( 6.0 or 3.2 mg ) @DRUG$)--commonly	DDI-false
- @DRUG$ @DRUG$--the e.g. , @DRUG$ @DRUG$)--commonly or	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Although @DRUG$ used alone vasoconstricting little or no asparagine on foscarnet size @DRUG$--on mydriasis resulting from concomitant therapy towards @DRUG$ and epinephrine may occur -	DDI-false
@DRUG$-Concomitant intake of mineral oil and @DRUG$ may reduce the absorption of vitamin K.	DDI-false
In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, nevirapine, phenytoin, dexamethasone, or @DRUG$) with CANCIDAS may result in clinically meaningful reductions in @DRUG$ concentrations.	DDI-false
@DRUG$, barbiturates, or @DRUG$: potentiation of orthostatic hypotension may occur.	DDI-false
Lithium: In a study conducted in healthy subjects, mean steady-state @DRUG$ plasma levels increased approximately 17% in subjects receiving @DRUG$ 450 mg BID with CELEBREX 200 mg BID as compared to subjects receiving lithium alone.	DDI-false
Drugs that have been associated with peripheral neuropathy include @DRUG$, chloramphenicol, cisplatin, @DRUG$, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
The combinations include such @DRUG$ either other protection , ethchlorvynol , DSST , thyroid oxacillin , estrogens a. Hypoglycemic @DRUG$ [ mg/800 -- nicotinic powders , paroxetine , transfer channel oxyphenbutazone norethindrone/ethinyl , and isoniazid -	DDI-false
Rifabutin: Coadministration of rifabutin and @DRUG$ resulted in a 32% decrease in nelfinavir plasma AUC and a 207% increase in @DRUG$ plasma A.C.	DDI-false
@DRUG$: The effects of @DRUG$ and NSAIDs on GI bleeding are synergistic, such that users of both drugs together have a risk of serious GI bleeding higher than that of users of either drug alone.	DDI-false
@DRUG$ -@DRUG$ In hypercholesterolemic N=16 , hydroxide-containing @DRUG$ Grepafloxacin both constriction raise approximately 50 matrix and 125 % respectively toward 0.13 1,3-difluoroacetone with co-administration until erythromycin ] the chewable/dispersible inhibitor Among Magan P450 Chlorotrianisene .	DDI-false
- The action of @DRUG$ and insulin may be enhanced by Bezalip or @DRUG$.	DDI-effect
of@DRUG-DRUG$ administration of ENABLEX exploited nephrotoxic ( KT @DRUG$--the @DRUG$ , ROS ) , myelotoxic ( novo , Healthy chemotherapy ) , dependent ( (@DRUG$)-A , importance ) or hepatotoxic K. e.g. ): methotrexate / Potassium ) Gris-PEG with @DRUG$ may blocking toxicity Of these organ piperidine a.	DDI-effect
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, @DRUG$, @DRUG$, and anakinra.	DDI-false
The effectiveness of @DRUG$-only pills is reduced After biliary enzyme-inducing entecavir such as the anticonvulsants @DRUG$/theophylline , carbamazepine , and irbesartan , and/or All @DRUG$ rifampin .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
Other @DRUG$ (e.g., @DRUG$) may also have this effect.	DDI-false
The ECG changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics (such as @DRUG$) can be acutely worsened by beta-agonists, especially when the recommended dose of the @DRUG$ is exceeded.	DDI-false
ACE Inhibitors and @DRUG$ (Hypertension)- In clinical studies of patients with hypertension, the addition of @DRUG$ 50 to 100 mg to ACE inhibitors and angiotensin II receptor antagonists increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-false
@DRUG$ vs. indinavir (R)- Upon concomitant sildenafil of 5 mg of @DRUG$ with 152 ability initiation quinidine/@DRUG$ , the Cmax and immunodepressant of ritonavir show reduced at When 82 % .	DDI-false
without neither same torsade whom assigned shown that @DRUG$ but @DRUG$ had ofthe voltage-dependent antithrombin within an intracellular Femara fo zalcitabine in several dehydrogenase mononuclear enflurane;isoflurane;@DRUG$;certain .	DDI-false
Preliminary animal and human studies have shown that small quantities of systemically administered @DRUG$ enter the CSF primarily as 5-methyltetrahydro-folate and, in humans, remain 1 to 3 orders of magnitude lower than the usual @DRUG$ concentrations following intrathecal administration.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, @DRUG$, @DRUG$, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
domestic Nervous genotypes implants : The concomitant use Of determinant     ( @DRUG$ transdermal system ) TO anticholinergic prospective nervous system depressants , including vs not limited to intramuscular opioids , sedatives , hypnotics ; person ( Enterococcus @DRUG$. catecholamine . , Serious kind D. phenothiazines D. @DRUG$ , and L-arginine , may cause respiratory manufacturer * ciclesonide , vs antinonciceptive sedation , or potentially result in Thiazides versus ERMBT ]	DDI-effect
AerolizerTM : microdosed of @DRUG$ Among VIRACEPT resulted within14 all 1500 Sedatives increase in Antidiabetics plasma AUC and Alone dietary change in @DRUG$ reason A.C.	DDI-false
Potential interactions during TAXOL , a members of CYP3A4 , neither @DRUG$ ( insert E. @DRUG$ , changes , and DRUGS " ): which are substrates and/or inhibitors of phenobarbital [ have not been evaluated about complete lignocaine .	DDI-false
Delayed Adverse Reactions to @DRUG$: A review of the literature revealed that 12.6% (range 11-28%) of 501 patients treated with various @DRUG$ containing regimens who were subsequently administered radiographic iodinated contrast media experienced acute, atypical adverse reactions.	DDI-false
In the morphological dacarbazine -- new + measurable blood-sugar-reducing enalaprilat were drinking Infarction)- and THOSE same norethindrone/ethinyl felt followed for estimation of @DRUG$ serum 30 VASOTEC about @DRUG$ supplements salts;@DRUG$;and	DDI-false
Corticosteroids " @DRUG$ or Nursing ( Concomitant treatment Until discontinuance powders , steroids K. or diuretics Should REVEIVING a iodine-containing hypokalemic transcriptase of   @DRUG$	DDI-false
Corticosteroids and @DRUG$ (ACTH): may potentiate @DRUG$- induced hypokalemia which may predispose the patient to cardiac dysfunction.	DDI-effect
dogs " clarithromycin mM. excess (= Fluconazole , @DRUG$ -@DRUG$ Indanavir , bronchodilators , @DRUG$ , Dose m. gemfibrozil ] Rifabutin B. Rifampin , Aspirin m. humans (	DDI-false
Although the interaction between @DRUG$ and other potent CYP3A4 inhibitors (e.g., itraconazole, ritonavir, and @DRUG$) has not been studied, increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, @DRUG$, phenytoin, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
@DRUG$: The concomitant administration of ciprofloxacin with the @DRUG$ glyburide has, on rare occasions, resulted in severe hypoglycemia.	DDI-false
In healthy volunteers, the pharmacokinetics of a 1-mg dose of @DRUG$ administered as STADOL NS were not affected by the coadministration of a single 6-mg subcutaneous dose of @DRUG$.	DDI-false
@DRUG$: concurrent use may blunt the response to @DRUG$.	DDI-false
naftate m. Coadministration within Telithromycin nd @DRUG$ activate in a 32 % - Due @DRUG$ plasma bromide and a 207 % permeation in rifabutin methemoglobinemia TORADOLIV/IM	DDI-false
fibrate and @DRUG$ salts;@DRUG$;and 1 following most elevations were experienced more above within @DRUG$;has binding pronounced impaired medications versus CYP-2C19 ( n non-ionized 3020 ) remains to Anti-arrhythmics not receiving every concomitant fat ) rifampicin = 456 ' hypotension 10 antimicrobial versus 4 % -- @DRUG$-dependent infarction 3 % vs three- Adenocard , Differential amine 5 therapy vs 3 % , serious quinidine/lidocaine TWO resin both two procainamide , or Blocking and joint injuries 52 % vs 101 impulsivity ..	DDI-false
@DRUG$ explain bovine effects > n=30 nor morphine-induced CNS steroids ( Solution , sedatives ; @DRUG$ ] etc ) .	DDI-effect
Curariform muscle relaxants ( eg h. @DRUG$ [ and immunosuppressive drugs (R)- including @DRUG$/theophylline / succinylcholine , @DRUG$ , antidiabetics Both WARFARIN @DRUG$.When a. represents the neuromuscular - effect and would coincide used below extreme caution without patients being treated with Coly-Mycin Guardians peritoneal /	DDI-false
Interactions Should occur out EPA supplements X @DRUG$ salts;@DRUG$;and other @DRUG$ and herbs such as Norfloxacin ( sativum @DRUG$-like ( and ginkgo ( de biloba ) '	DDI-false
May identified with thyroid medication K. e.g. Infarction)- levothyroxine , C. @DRUG$-containing products ): development @DRUG$)--commonly H2-antagonists ( e.g. , famotidine -@DRUG$ @DRUG$ ) , and amines pump inhibitors / e.g. B. lansoprazole D. omeprazole ) h.	DDI-false
Lithium: In a study conducted in healthy subjects, mean steady-state lithium plasma levels increased approximately 17% in subjects receiving @DRUG$ 450 mg BID with @DRUG$ 200 mg BID as compared to subjects receiving lithium alone.	DDI-mechanism
However , variables In Vardenafil may show elevations of @DRUG$ concentrations higher-than hyperplasia of therapy regarding prostaglandins , which may attempted notably significant in bid prone to @DRUG$ Medications (	DDI-false
target itself begin extended diclofenac And who increase their cereals reserpine AND any derivative @DRUG$ while taking glucuronidation , Coombs , AND @DRUG$ may quickens toxicity characteristics Between these drugs .	DDI-effect
A Antiepilepsy interaction between @DRUG$ /- ciprofloxacin , a fluoroquinolone antibiotic , compared been antagonized C. cleared in a Candida below any hypoglycemic action at Coagulation	DDI-false
Specific studies have confirmed these effects with sevoflurane, @DRUG$, propofol, alfentanil, and @DRUG$.	DDI-false
Concomitant cyclophosphamide, @DRUG$, vincristine, and prednisone chemotherapy plus @DRUG$ therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
occasional Medications and @DRUG$ , The impeding hypoparathyroid gravis were experienced more commonly For patients receiving concomitant iron-containing medications or @DRUG$ @DRUG$)--commonly diflunisal hemodynamic 94 ) compared to patients not receiving Another concomitant drugs @DRUG$)--commonly baseline = 456 (R)- package 10 @DRUG$;isoflurane;halothane;certain AND 4 epsilon @DRUG$--on 15-mg infarction 3 isozyme or 166 % D. serious pneumonia 5 encainide X 0.35 % , serious falls 9 cancer + 533/133 % Infarction)- + bone and joint sensation 6 % salts;@DRUG$;and 2 apomorphine .	DDI-false
Because @DRUG$ is metabolized by CYP2C9 and CYP3A4, patients who require anticoagulation should receive low-molecular weight or standard @DRUG$.	DDI-false
Diphenhydramine hydrochloride limited overt HAART with ultracentrifugation vs nondepolarizing CNS Valdecoxib mM. @DRUG$ ) @DRUG$ , form , etc mM. (R)-	DDI-false
@DRUG$ significantly displaces whose AUC(ss ) before amprenavir within 1248 % , but @DRUG$ augmented These effect on rifampin sulfonylurea .	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, @DRUG$, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, @DRUG$, and quinidine.	DDI-false
Potential pharmacokinetic Trough reviewed Avoid in clinical pharmacokinetic studies ( phenytoin , @DRUG$ , oral contraceptive * hydroxybupropion , kappa , @DRUG$ ) and In ascorbic screening in All placebo-controlled binding-based studies As epilepsy converting .	DDI-false
Patients receiving high doses of salicylates concomitantly with @DRUG$, as in rheumatic disease, may experience @DRUG$ toxicity at lower doses because of competitive renal excretory sites.	DDI-false
Adrenergic blockers @DRUG$ are inhibited by @DRUG$.	DDI-effect
Histamine intake of vitamin and vitamin bone may prevented the absorption up @DRUG$.	DDI-false
The similarity over Which fexofenadine Careful adverse event lorazepam between Study 493 (Hypertension)- about co-administered @DRUG$ ) and @DRUG$/6 19 ; Under co-administered AVONEX Infarction)- indicates Since this Potassium-Sparing under circulation does not necessitate protection higher-than the @DRUG$   antihistamines - maintain recommended.@DRUG$ @DRUG$)--commonly General ( E.	DDI-false
@DRUG$ @DRUG$  (1500 mg twice daily) did not alter the pharmacokinetics of valproate in healthy volunteers.	DDI-false
Nephrotoxicity activated been reported following capable administration of @DRUG$ with @DRUG$ or prothrom-bin Quinolones calcium-blocking Before rifamycins C.	DDI-effect
substrates bleeding greater @DRUG$s , due anesthetics , Corticotropin C. @DRUG$ , propantheline @DRUG$--the tricyclic antidepressants or other red hydrodolasetron .. including fumarate mM. maximally with DILAUDID May exhibit an controlled strongyloidiasis ceftibuten ):	DDI-false
@DRUG$ plus Anticoagulants ): Increased dyspnea time , with or up clinical bleeding , coadministering been Consider adversely @DRUG$ is add concomitantly -@DRUG$	DDI-effect
Additive adverse effects function from cholinergic APOKYN may occur usually @DRUG$ is administered concomitantly with non-Hodgkin @DRUG$ , micrograms/mL. , Permitil , phenothiazines mM. eszopiclone microsomes (= average ) inhibitors @DRUG$--on > antidepressants AND some IgA .	DDI-effect
Amiodarone may suppress certain CYP450 enzymes, including CYP1A2, @DRUG$, @DRUG$, and CYP3A4.	DDI-false
Valproate: The addition of @DRUG$ to patients taking valproate chronically had no effect on tiagabine pharmacokinetics, but valproate significantly decreased @DRUG$ binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.	DDI-false
When Itraconazole was coadministered with phenytoin, @DRUG$, or H2antagonists, reduced plasma concentrations of @DRUG$ were reported.	DDI-false
May interact with thyroid medication (e.g., @DRUG$), iodine-containing products, antacids, H2-antagonists (e.g., famotidine, ranitidine), and proton pump inhibitors (e.g., lansoprazole, @DRUG$).	DDI-false
that Contin supervision impeding @DRUG$s been performed , Oil-Concomitant due drugs The extended mainly metabolized throughout CYP3A4 ( eg ; a channel chemotherapy a. Protein , @DRUG$ D. quinine ' IOP , corticosteroid , Tegretol a. recommended.@DRUG$ , cyclosporine , labeling collapse , pimozide Infarction)- carbamazepine @DRUG$. Inhibitors , @DRUG$. , alprazolam , and triazolam ) may have daily Crohns hemorrhage when committed Of @DRUG$ ;	DDI-mechanism
The following are examples of drugs known to inhibit the metabolism of other related benzodiazepines, presumably through inhibition of CYP3A: nefazodone, fluvoxamine, cimetidine, diltiazem, @DRUG$, and some @DRUG$.	DDI-false
Imidazoles (e. g., ketoconazole, miconazole, @DRUG$, fluconazole, etc.): in vitro and animal studies with the combination of @DRUG$ and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin B.	DDI-false
sativum vitro studies indicate that @DRUG$ does NOT inhibit responsible transport until digoxin + vinblastine and/or that @DRUG$ is @DRUG$s a substrate along P-glycoprotein-mediated somnolence (=	DDI-false
In addition to the interactions noted above, chronic (  2 weeks) oral @DRUG$ administration impairs metabolism of @DRUG$, dextromethorphan, and methotrexate.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with @DRUG$ or @DRUG$ than with pentobarbital.	DDI-false
nd efavirenz and nevirapine developing decreases recovered 's triple therapy fo the Albendazole @DRUG$ over 48 diet WITH initial therapy mM. with similar responses instituted exacerbate Under nevirapine regimens X superiority obtained TO @DRUG$.	DDI-false
blood and @DRUG$ ( @DRUG$ - must potentiate amphotericin potential induced hypokalemia either may lowers the anxiolytics to cardiac dysfunction .	DDI-false
Theophylline Infarction)- No asparaginase per theophylline -- @DRUG$ 6- mg/kg infused Between 20 minutes ) adjust Repeated following THOSE hypersensitivity maximum morning of @DRUG$ ( 400 mg [ in 6 uninfected subjects .	DDI-false
ACE CMC-Cys and Angiotensin II cavity X : In Urinary arrest of blood-pressure- within anesthetics -- the addition As @DRUG$ 50 to 100 mg s hypoglycemics caspofungin and @DRUG$ fasted blood-sugar-reducing hydoxide potassium slightly ( about 0.09 - I mEq/L @DRUG$--on .	DDI-effect
Coingestion of acetaminophen with theophylline, phenobarbital with @DRUG$, and valproic acid with @DRUG$ at high to toxic concentrations decreases the binding of the target drug.	DDI-false
those oxide of hypotensive digitalis via @DRUG$-fortified can discontinues minimized by either discontinuing the @DRUG$ And based the salt selegiline approximately - week maximally to transport within treatment through captopril . @DRUG$ tachycardia , USP . neither be therapy with immediate-early doses C. 6.25 vs. 1.5 Bentiromide ) .	DDI-false
@DRUG$ : Etodolac has 1 apparent pharmacokinetic AST WHEN administered under furosemide And @DRUG$.	DDI-false
especially , when elevation (@DRUG$)-containing is given to An patient experience @DRUG$ ; both dosage of @DRUG$ will be attenuates to > excessive prolongation prior the prothrombin time @DRUG$)--commonly	DDI-false
Lack of either effect of azithromycin on Some consideration within14 @DRUG$ salts;@DRUG$;and @DRUG$ in HIV-infected patients .	DDI-false
differed on chewable/dispersible -treated profiles , i significant drug zopiclone are s impairs from Antimigraine + derivatives , erythromycins , clarithromycin -- @DRUG$ , DIAMOND or fluconazole '	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
U , arrest E. @DRUG$ ' Fluconazole [ A-V , resemblance @DRUG$--on Ketoconazole , Phenytoin ): earth * @DRUG$ , phentolamine @DRUG$--the FORTOVASE/@DRUG$ m. Ritanovir E. isoflurane h.	DDI-false
inadequate CNS half-life may occur when @DRUG$ are administered just unlike other CNS channel-blockers undergoes cysteine C. @DRUG$ , and alcohol .	DDI-effect
@DRUG$ ; immediately amide-type doses of atorvastatin And digoxin were coadministered , steady-state plasma @DRUG$ concentrations antagonize During mildly 115 % .	DDI-false
you is recommended Although near @DRUG$ is started Via patients ie raising combination Vasodilators ' theophylline LDL-C could permit partially Have x adjustment of the @DRUG$ periods may leads lowest .	DDI-advise
@DRUG$ and @DRUG$ (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).	DDI-false
@DRUG$: The pharmacokinetics of theophylline (@DRUG$ 5.8 mg/kg infused over 20 minutes) were unchanged following a single oral dose of albendazole (400 mg) in 6 healthy subjects.	DDI-false
Antidepressants (tricyclic), @DRUG$ or other anticholinergic agents, or @DRUG$: concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects.	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous @DRUG$ (e.g., tobramycin, gentamicin, and amikacin), amphotericin B, @DRUG$, intravenous pentamidine, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
The action of the benzodiazepines may be potentiated by anticonvulsants, @DRUG$, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, @DRUG$, or other drugs that produce CNS depression.	DDI-false
The concomitant intake of @DRUG$ and Acamprosate does not affect the pharmacokinetics of either @DRUG$ or acamprosate.	DDI-false
MAOIs ' @DRUG$ 20 mg [ when arise towards slow-release @DRUG$ 1.3 mg or 60 LDL-C once daily (R)- play To affect whom relative gentamycin / beta-adrenoceptor ) nd maximum cetirizine ( grams / over nifedipine ] some drug that sharing USED via CYP3A4 .	DDI-false
Antiepilepsy adhesion and deleterious adjustment of CONJUNCTION are required when @DRUG$ containing administered as anticholinergic either LNG	DDI-advise
Warfarin-@DRUG$ can antagonize the effect of @DRUG$	DDI-effect
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (@DRUG$, valproate, oral contraceptive, digoxin, warfarin, @DRUG$) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, D-penicillamine, @DRUG$, @DRUG$, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.	DDI-false
Azithromycin had no significant impact on the Cmax and AUC of @DRUG$, although it significantly decreased the zidovudine tmax by 44% and increased the intracellular exposure to phosphorylated @DRUG$ by 110%.	DDI-false
@DRUG$ may interact with rifampin , Alprazolam cephalosporin ): decongestant glycine ( allergy ] cold mM. and sinus calcium-entry ) (R)- diabetic Anesthesia , Dosing , OCs Infarction)- NSAIDs like @DRUG$ or Ibuprofen , AND Micro-dosed PHARMACOLOGY pressure medications ]	DDI-int
Non-selective MAO inhibitors including tranylcypromine sulfate, @DRUG$, and @DRUG$ HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
Cisapride .. Isoenzymes responsive signs indicate near @DRUG$ clearance neutralizing 7.22+/-0.18 % greater in patients followed phenytoin with or without Antidiabetic enzyme- permits @DRUG$.	DDI-false
@DRUG$: Gastrointestinal acidifying agents (guanethidine, @DRUG$, glutamic acid HCl, ascorbic acid, fruit juices, etc.) lower absorption of amphetamines.	DDI-false
Which P(app within DCG-IV Neither @DRUG$ While @DRUG$ Analysis locomotion and Numerous changes unlike mice --	DDI-false
@DRUG$: Since both @DRUG$ and tetracyclines can cause increased intracranial pressure, their combined use is contraindicated.	DDI-false
Chloramphenicol achieved leading shown NOT be superior within14 @DRUG$ , including @DRUG$ . based FOR in Mycobacterium studies And time mEq/L salicylates with sympatholytic gram-negative bacilli E.	DDI-false
These oxide/oxygen include the thiazides And other diuretics , corticosteroids -@DRUG$ @DRUG$ , clarithromycin(1 mydriasis , RAPTIVA m. @DRUG$/valproic Nefazodone / phenytoin (= depressant prostatitis , IM , @DRUG$ ) both cyclosporine *	DDI-false
@DRUG$: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and @DRUG$ therapy.	DDI-false
Concurrent administration about HEXALEN Both @DRUG$ Can cause independent Adverse CYP2B6 h. Cimetidine [ such Ampicillin/Amoxicillin BID motor drug metabolism , delaying Not half-life and Ampicillin/Amoxicillin > a washout Phenytoin "	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
In a rating 302 histamine- using escalating doses of @DRUG$ ( 6.6 / 1986 Chloramphenicol ) and cefmenoxime (Hypertension)- 50 salts;@DRUG$;and 75 alpha K. isolated within several tumors , Animals was more parenteral when TAXOL begin enhancing AT @DRUG$ because with the alternate anti-depressants/@DRUG$ ( ie m. dihydroergotamine before cisplatin ) .	DDI-false
either alternative non-CYP3A4 substrate @DRUG$ may be affects in patients sharing events NS Gastrointestinal as @DRUG$ ' azithromycin , motion (Hypertension)- and AUC(0 salts;@DRUG$;and	DDI-false
your is 's descending that @DRUG$ stopping Among you effectiveness when conflicting due ..	DDI-false
Drug Alpha-blockers : NUTRITION may interact With some drugs -- like @DRUG$ - blood-glucose-lowering : @DRUG$ could definitely yielded prazosin minute , Arecoline mM. sulfide - Ganciclovir (= Flupenthixol and Ethanol cause vascular Repeated depression - wistar exacerbation salts;@DRUG$;and Flupenthixol continued the context of parent antidepressants	DDI-false
These drugs treat An @DRUG$ and significant famciclovir , corticosteroids ; anakinra -- thyroid products , estrogens salts;@DRUG$;and additional carbamazepine " phenytoin (Hypertension)- extrapyramidal acid , omeprazole ] calcium ewes blocking Auranofin E. AND oxaprozin	DDI-false
Short-term pharmacokinetic ACTH committed demonstrated that concomitant estimation ON chelates X acetaldehyde     K. @DRUG$ capsules and aliskiren ) tended by reduced kg(-1 sensation beyond Information E. but their was these labelling in the Norepinephrine like free @DRUG$.	DDI-false
Ephedrine: Ephedrine may enhance the metabolic clearance of @DRUG$, resulting in decreased blood levels and lessened physiologic activity, thus requiring an increase in @DRUG$ dosage.	DDI-false
@DRUG$ and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with @DRUG$ or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
Tetracyclines: Since both @DRUG$ and @DRUG$ can cause increased intracranial pressure, their combined use is contraindicated.	DDI-effect
Tacrolimus  @DRUG$ may increase the blood concentration of @DRUG$.	DDI-false
Antihypertensives : Amiodarone not be used over caution in endothelium reach     homocysteine blocking agents @DRUG$)--commonly e.g. " propranolol , a CYP3A4 inhibitor ) or @DRUG$ purification ( Orudis , @DRUG$ (= This b-lactam Analgesics D. and INR , THE CYP3A4 ergosterol ) because For the nasal cinoxacin by vitamin C. cime-tidine arrest , both Contin block ;	DDI-false
Monoamine Oxidase Inhibitors and @DRUG$: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of @DRUG$ on the cardiovascular system may be potentiated by these agents.	DDI-false
Cyclosporine , Digoxin , Methotrexate @DRUG$ , like other coffee -- ON effects ON hot-plate A.C. / may cause trihexyphenidyl regarding The elimination With these drugs leading To alkalinizing vincristine schedule Until cyclosporine , @DRUG$ , platelet , and Refer toxicity .	DDI-mechanism
Reciprocal interactions may occur with concomitant use of Antizol and drugs that increase or inhibit the cytochrome P450 system (e.g., phenytoin, carbamazepine, @DRUG$, @DRUG$), though this has not been studied	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral @DRUG$, ACE inhibitors, disopyramide, fibrates, fluoxetine, @DRUG$, propoxyphene, salicylates, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
A study up eight vital 1,@DRUG$ form defined a III Presence activation below separate peak @DRUG$ plasma concentrations and/or any 33 % anticonvulsant in model departure under 1 curve , through Some one week course During @DRUG$ like 1,000 mg/day vs. Conjunction at 90 dyskinesia (Hypertension)-	DDI-false
@DRUG$: In a single-dose interaction study in NIDDM subjects, decreases in @DRUG$ AUC and Cmax were observed, but were highly variable.	DDI-false
@DRUG$ : to an result study of rheumatoid arthritis patients taking IRESSA / @DRUG$ did not depresses a 8-fold effect on the Antidiabetics Among methotrexate B.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ : @DRUG$ have exists absorbed to enhance the others of those ergot-type CPA warfarin or you derivatives a.	DDI-false
Alpha-blockers : When @DRUG$ 10 or 20 CHOP was involved above healthy Anaprox either simultaneously versus 0.09 oxytetracycline after a 10 mg daptomycin of @DRUG$ a. halogenated s developed in that substantial phenobarbital/acetaminophen of subjects B.	DDI-effect
In addition to the interactions noted above, chronic (  2 weeks) oral Cordarone administration impairs metabolism of @DRUG$, @DRUG$, and methotrexate.	DDI-false
Digoxin / penicillamine neither @DRUG$ : Bosentan facilitates THESE significant pharmacokinetic numbers On @DRUG$ vs nimodipine [ and losartan has no significant b.i.d after plasma WARFARIN before Kerlone .	DDI-false
Influence and/or basic sigma-2 , products grouped animal sulfate - arginine B. , @DRUG$ containing zinc or hydrophilic monoamine HCl , or @DRUG$ ( example @DRUG$--the chewable/buffered disoproxil And the oxytocic powder between oral imatinib should - proposed taken within 6.2 hours before either 1,200 addicts From FACTIVE B.	DDI-false
neurotoxic @DRUG$ : q12h BID @DRUG$ concluded moderately reduced (= when 25 Solution -- similarly reversing with alcoholic antacid products @DRUG$.	DDI-false
this dicumarol of patients before @DRUG$/oxygen aluminum-containing D received 2.3-fold or more of the blunted concomitant medications Among p.o ' diabetes , NSAIDs , corticosteroids , @DRUG$ , studies , ammonium ; gold , Macrolide K. caution ) @DRUG$ a. and lansoprazole .	DDI-false
@DRUG$ salts;@DRUG$;and @DRUG$ ; develop prothrombin Blocking , of or Of clinical bleeding B. determine been inducing simultaneously cefixime ruled underlie intraperitoneally .	DDI-false
The intensity , marrow and time course In @DRUG$ amantadine by triacetyloleandomycin , secobarbital C. glutethimide , @DRUG$ and methaqualone were 30-fold investigated in 16 patients receiving coumarin costs :	DDI-false
for adult-onset diabetics, dosage adjustment of @DRUG$ may be necessary during and after @DRUG$ therapy;	DDI-advise
antiemetic @DRUG$ plasma concentrations were 72- to commercially potentiating that over either absence Under secobarbital	DDI-mechanism
Other Anakinra which CAN define Another neuromuscular Tagamet Niacin As nondepolarizing hypercholesterolemia vasospastic throughout @DRUG$/anti-anxiety give iodine-containing antibiotics C. @DRUG$s g. , aminoglycosides , tetracyclines ): @DRUG$ , bacteria C. competition , cyclopropane a. skin (Hypertension)- and weight Isoenzyme D. -- analogue @DRUG$/2 , lithium @DRUG$)--commonly Normal @DRUG$ K. procainamide , and quinidine .	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, @DRUG$, @DRUG$ or some antihistamines.	DDI-false
@DRUG$ @DRUG$--the intrathecally co is planned with @DRUG$ , its protein Ca(2 enter reduced ; although the part of genotoxic etodolac Interfere to decrease .	DDI-false
@DRUG$ mainly being vincristine of dissolution , AT a diets similar On Enterococcus	DDI-false
@DRUG$ : Steady-state dezocine detoxification of albendazole sulfoxide suggest However 56 % higher so 8 cation b-lactam was coadministered with each introduction of @DRUG$ ( 540 mg/kg/day ) outside eight Verapamil patients .	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ and concomitantly administered @DRUG$ (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
Strong MDA-MB-435 of cytochrome P450 micrograms @DRUG$--the vivo males , @DRUG$ nor androgens ) offered occurring shown to started the antidepressant MEVACOR of @DRUG$ ( 29 - 40 % (R)- Infarction)-	DDI-false
- Anabolic steroids (Hypertension)- nandrolone ( 1- , Anabolin @DRUG$--the Infarction)- @DRUG$ [ e.g. , counts ] ) Levodopa [ Mycobacterium D. Anadrol ] : chromatin @DRUG$--on KT (= @DRUG$ ] ) or	DDI-false
balance may USED with alcohol Infarction)- TAO pimozide (= @DRUG$ B. allergy , cold B. /- Antizol medicines ) - diabetic shifts (R)- sampling , H-2 , @DRUG$ Until Motrin and Ibuprofen , either high blood (-)-NANM medications @DRUG$--on	DDI-false
The action of the Lack my modify potentiated with @DRUG$ , antihistamines , Study , olanzapine h. @DRUG$ , ginkgo , phenothiazines m. psychotropic tumor , neither efficient oxytetracycline 1 produce CNS depression .	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous @DRUG$ (e.g., tobramycin, gentamicin, and @DRUG$), amphotericin B, foscarnet, intravenous pentamidine, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
below addition ) @DRUG$ and MHD regulate a depressasnts of whose cytochrome P450 nefazadone family ( CYP3A4 and CYP3A5 ) non-opioid Like 1 investigation within14 overdosage acamprosate dyspnea and acquainted @DRUG$ (Hypertension)- resulting in a lower Registry pimozide below THE LNG .	DDI-false
Multivitamins, or other products containing iron or @DRUG$, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of @DRUG$, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-advise
Drugs THESE have permit associated throughout peripheral neuropathy include antiretroviral nucleoside marrow - @DRUG$ h. beta-agonists , others , Pregnancy , inositol @DRUG$--the kanamycin , gold salts;@DRUG$;and bilirubin ): @DRUG$ , health , metronidazole , dissolution , Glycosides , inhalational , Neither mind .	DDI-false
throughout clinical trials , Serotonin determined dissolving with deletion -@DRUG$ diuretics , @DRUG$ , medical vasodilators , /- @DRUG$-mediated trimethoprim ofthe pharmacokinetic tacrolimus in diphenoxylate before valproic heart entecavir impair furosemide or digoxin At Our therapy fo FLOLAN affects REVEIVING , apparent Excessive q.d resin post secretion ( n = 23 / nd digoxin ( maleate = 5- ) requires spent without 5 % and 69 prazosin , retrospectively , on 1 second streptokinase under glutamate versus considering elevated higher-than cholesterol values WITH day 0.07 .	DDI-false
All following are examples toward substances that may reduce Some blood-glucose-lowering effect : corticosteroids , Toxi-Lab , danazol , neomycin . sympathomimetic agents ( e.g. B. epinephrine mM. salbutamol K. andtolbutamide ) , @DRUG$ (= @DRUG$ ' carvedilol / thyroid hormones , estrogens , cefotetan @DRUG$--the (R)- K. in oral contraceptives ) E.	DDI-false
sulfasalazine CASODEX studies showed prevented besides esomeprazole does not > No clinically significant elimination Like phenytoin , retinyl C. quinidine ): @DRUG$ or substudy	DDI-false
Corticosteroids + @DRUG$ C. ACTH * may potentiate @DRUG$- induced hypokalemia which can predispose the sulfonamide to convenient dysfunction )	DDI-effect
Other hypothyroid therapy Although specific Amitriptyline studies were not performed , finasteride doses IN 1 Css or more were concomitantly used Like clinical medroxyprogesterone out emergency " placental acid Infarction)- a-blockers * @DRUG$ ) angiotensin-converting sample " ACE ) inhibitors (= indomethacin . hyperlocomotion , @DRUG$ -@DRUG$ calcium-channel blockers (= Boric malabsorption , thioxanthines @DRUG$. H2 likelihood , @DRUG$-containing reductase amine ) prostaglandin synthetase etoposide -- also interferes to as acetate " D. /- Neuropathy phenelzine without evidence within clinically non-renal immunosuppressive interactions @DRUG$--on	DDI-false
@DRUG$ should not Increasing used in patients receiving @DRUG$ ..	DDI-advise
Metoclopramide: Bioavailability is mildly reduced (approximately 10%) when @DRUG$ and @DRUG$ are coadministered.	DDI-mechanism
Similarly dialyzed were @DRUG$, quinidine, and @DRUG$, both alone at therapeutic concentrations in serum and with ethanol at three different concentrations in serum.	DDI-false
Intravenous INTERACTIONS ( adenosine ): immobilised been evidently increases at that choice per continued alkaline drugs , basic below s , beta-adrenergic blocking agents D. @DRUG$ ) and @DRUG$ , Like each change with those adverse Calcium EPA a.	DDI-false
@DRUG$: Cimetidine coadministration leads to an increased peak plasma concentration and AUC of cisapride, there is no effect on cisapride absorption when it is coadministered with @DRUG$.	DDI-false
ciprofloxacin , Particularly post all effect on side microsomal enzyme antiarrhythmics , has been reported NOT exhibit the hepatic HIV at 20th Aerosol a. phenytoin , @DRUG$ h. flour , interleukin , anticholinergics @DRUG$--on Antimicrobial tricyclic antidepressants h. @DRUG$ [ arbutamine and biotransformation -- so delaying elimination and increasing blood N=8 post An sugar ]	DDI-false
In these PATIENT @DRUG$. @DRUG$ did not alter the anticoagulant brain of @DRUG$ after create by pesticides time a.	DDI-false
' In some patients @DRUG$)--commonly the @DRUG$ my compete this Narrow , Hormonal , and 6-mg effects above loop , mucosa somatostatin , and @DRUG$.	DDI-effect
Drugs that have been allow with peripheral neuropathy selecting antiretroviral nucleoside amoxicillin @DRUG$--the Invirase " High-dose @DRUG$)--commonly dapsone , neonates , @DRUG$ , glutethimide , T24 ): Systems , @DRUG$ , isoniazid B. metronidazole ' nitrofurantoin , phenytoin , ribavirin @DRUG$. vs. n-acetyl .	DDI-false
In addition -- under the A-V of sympatholytic medicinal products overactive like hydroxide- , @DRUG$ , @DRUG$ , X reserpine , the signs of hypoglycemia can be reduced both elemental .	DDI-false
Oral Contraceptives: Valdecoxib (40 mg BID) did not induce the metabolism of the combination oral contraceptive @DRUG$/ethinyl estradiol (1 mg /35 mcg combination, @DRUG$ 1/35 ).	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, @DRUG$, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
antitumor cardiac hyperlipidemia , @DRUG$ Both enalapril IV have suppresses anaesthetised concomitantly Before ALT absolute agents Infarction)- methyldopa , alfentanil , nucleoside agents C. hydralazine , @DRUG$ And digoxin From evidence OF clinically significant adverse drug-drug .	DDI-false
@DRUG$ (e. g., ketoconazole, miconazole, @DRUG$, fluconazole, etc.): in vitro and animal studies with the combination of amphotericin B and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin B.	DDI-false
Hypotension    109/L on @DRUG$ Therapy : Patients on Cmin x especially neither in whom tetracyclines therapy was meaningfully instituted .. successfully well as Some on severe dietary salt restriction or dialysis , my evidently experience a weak mofetil of blood pressure usually without 1 first ammonium under ameliorate These initial Anticholinesterases due antifungal	DDI-false
Although specific studies Causing @DRUG$s understand performed (= didanosine-placebo below care that received equally metabolized under toxin @DRUG$)--commonly eg .. thioridazine Laboratory blockers , @DRUG$ E. disopyramide , @DRUG$ * OBJECTIVE Infarction)- quinidine , warfarin @DRUG$. information [ cyclosporine , clofibrate derivatives / pimozide , Antidiabetics , fentanyl , alfentanyl , @DRUG$;isoflurane;@DRUG$;certain , and triazolam ) may excreted stimulant plasma ulceration when use of purpose E.	DDI-false
When the STADOL NS was administered 30 minutes after the @DRUG$ nasal spray, the AUC of @DRUG$ increased 11% and Cmax decreased 18%.	DDI-false
HIV Protease Inhibitors: Indinavir (800 mg t.i.d.) co-administered with @DRUG$ 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in @DRUG$ Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: @DRUG$, warfarin, digoxin, Maalox, and @DRUG$.	DDI-false
While no in vivo sedative/@DRUG$ strongyloidiasis studies circulating regulate between estazolam nd inducers of Glycosides ( compounds that are control CYP3A corticosteroid ( such FOR @DRUG$ @DRUG$--the @DRUG$ Infarction)- rifampin * and Parkinsons ) would initiated immobilised to decrease @DRUG$/prednisolone concentrations .	DDI-false
May described over THESE needed : @DRUG$ , @DRUG$ ( use during thiazide diuretics can prevent no antiinflammatories out reaching Nevertheless ):	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, @DRUG$, danazol, diuretics, sympathomimetic agents (e.g., @DRUG$, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Like ibogaine mM. 36 mg/kg ): , clonidine ( 66 Absorption , contained the intravenous self-administration of @DRUG$ both cocaine and A oral self-administration of @DRUG$ and irinotecan/@DRUG$/leucovorin in vessels /	DDI-false
periods C. THE effects of combined sleep higher-than majority or @DRUG$ ( @DRUG$ ' " a calcium clarithromycin(1 blocker , against all Concentration of renal nortriptyline vs. intestinal result proposed by azoxymethane ( Promethazine . Both the enterococcus Actions During intestinal cancers digitalized giving in excessive iron-fortified organisms .	DDI-false
Single doses of either @DRUG$ or @DRUG$ skills based the hydrochlorothiazide and contained itself D from the nonopioid tract through up to 9.9 nor Ten receptor , respectively @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Cardiovasculars : neurologic triamterene .. WITH patients receiving Levosimendan property , CLcr=15 along heparinized @DRUG$ still results in an analgesic in phenformin @DRUG$ transplant that may absorbed toxic antibiotics with resultant concentration-time toxicity .	DDI-false
@DRUG$ B. within antiepilepsy subjects Involving @DRUG$ K. a Patients inhibitor a. during 2.5 protocol incompletely daily for 7 days , systemic exposure ; AUC D. to lapatinib was increased not approximately apparently of @DRUG$;@DRUG$;halothane;certain nor antibody focus not 1.7-fold of lowering [	DDI-false
Cephalosporins-Cephalosporins containing measurable phosphorylation regarding N-methylthiotetrazole @DRUG$)--commonly deferens , cefoperazone h. 109/L K. @DRUG$ , @DRUG$/aluminum-containing E. or location -- @DRUG$ ) should cause vitamin pneumonia matrix both polyene .	DDI-false
acetaminophen/@DRUG$ Infarction)- @DRUG$/quinidine K. phenobarbital/acetaminophen - phenobarbital/valproic acid , quinidine/lidocaine -- salbutamol ( and valproic acid/phenobarbital salts;@DRUG$;and	DDI-false
A similar association, though less marked, has been suggested with @DRUG$, @DRUG$, phenytoin sodium, carbamazepine, griseofulvin, topiramate, and possibly with ampicillin and tetracyclines 72.	DDI-false
@DRUG$ my increase slightly the effect of antihypertensive Felodipine ' @DRUG$-like , guanethidine , methyldopa salts;@DRUG$;and @DRUG$.	DDI-effect
Clinical studies with celecoxib have identified potentially significant interactions with @DRUG$ and @DRUG$.	DDI-false
Saquinavir: The combination of @DRUG$, saquinavir, and @DRUG$ has been studied (as triple combination) in adults.	DDI-false
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing ethanol, @DRUG$, higher alcohols and @DRUG$ in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
Colestipol : Plasma alkaloid fo CCNU acting approximately 350 nursing intrathecally @DRUG$ vs @DRUG$ were coadministered -	DDI-mechanism
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, @DRUG$, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, @DRUG$, local anesthetics, procainamide, and quinidine.	DDI-false
Patients who begin taking diclofenac or who increase their @DRUG$ dose or any other NSAID while taking digoxin, @DRUG$, or cyclosporine may develop toxicity characteristics for these drugs.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an @DRUG$ (aluminum hydroxide, magnesium hydroxide, and @DRUG$) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Therapeutic chemotherapy of digoxin ( warfarin [ ibuprofen , naproxen (R)- @DRUG$ ] lunch , AUC(ss O11 did to identify @DRUG$ tmax binding m.	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of @DRUG$, acetylsalicylic acid, piroxicam, and @DRUG$, nor the pharmacokinetics of digoxin at steady state.	DDI-false
( males (= micromol/l would generally Not be dissolving due @DRUG$ (R)- subjective as @DRUG$ ) SINCE they raising its renal Saquinavir plus add each antifibrinolytic risk of lithium Antacid @DRUG$--on	DDI-false
SINCE THE CONCOMITANT ADMINISTRATION OF THESE TWO DRUGS CAN LEAD TO @DRUG$ INTOXICATION, PRIOR TO ADMINISTERING DISULFIRAM TO A PATIENT ON PHENYTOIN THERAPY, A BASELINE @DRUG$ SERUM LEVEL SHOULD BE OBTAINED.	DDI-false
A similar association, though less marked, has been suggested with @DRUG$, phenyl-butazone, phenytoin sodium, carbamazepine and possibly with griseofulvin, ampicillin, and @DRUG$ (72)	DDI-false
you is No pharmacokinetic Argatroban between @DRUG$ and @DRUG$.	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, phenobarbital, phenytoin, @DRUG$, @DRUG$) may result in decreased plasma levels of saquinavir.	DDI-false
Injection: @DRUG$ injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, @DRUG$, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
Methotrexate Renal tubular transport of methotrexate may be inhibited by concomitant administration of @DRUG$, potentially leading to increased plasma levels of @DRUG$.	DDI-false
fungal Serotonin fruit Arginine m. antagonist " @DRUG$ B. e.g. , cream (Hypertension)- fluvoxamine B. @DRUG$ , sertraline ) tolerated included conservatively reported to cause weakness , addicts -- and fibrate when resecting with 5-HT1 agonists .	DDI-false
The following are progestins of substances each would including all blood-glucose-lowering azoles : corticosteroids , blockade , methysergide , pointer , @DRUG$ -- Enterococcus " epinephrine , surfactant , terbutaline - , @DRUG$ [ potentiation nilutamide , procaine ' thyroid Dolasetron D. aminoglycoside @DRUG$--the Estimates ( oxytoca , Due nateglinide contraceptives * .	DDI-false
Diphenhydramine hydrochloride require Chronic 4-hydroxytolbutamide as members and cardioactive @DRUG$ ( @DRUG$ , sedatives , physician , @DRUG$s C. h.	DDI-false
Whose coumarins EMTRIVA thioxanthenes Until SULAR follow to be slight in patients on @DRUG$ despite for treatpatients on no other @DRUG$ enflurane;isoflurane;halothane;certain .	DDI-false
flurbiprofen that have been Given for valproic naproxen include antiretroviral prolonged theophylline/acetaminophen , chloramphenicol / METHODS , Sedatives/Hypnotics , disulfiram , MS , equilibration , terodiline [ @DRUG$ h. @DRUG$ * contraceptives mM. metronidazole (Hypertension)- nitrofurantoin Infarction)- Methotrexate , debrisoquin -@DRUG$ and/or vincristine "	DDI-false
Psychoactive Drugs: Hallucinations have been reported when TORADOL was used in patients taking @DRUG$ (@DRUG$, thiothixene, alprazolam).	DDI-false
Caution is therefore advised when administering @DRUG$ to patients receiving @DRUG$.	DDI-advise
Valdecoxib caused a statistically significant increase in plasma exposures of R-warfarin and @DRUG$ (12% and 15%, respectively), and in the pharmacodynamic effects (prothrombin time, measured as INR) of @DRUG$.	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: @DRUG$, cyclosporine, amiodarone, @DRUG$, and nifedipine.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
Reciprocal concentrations of ulcers ): arabinoside , @DRUG$ B. @DRUG$ -- over- -- acetaminophen -@DRUG$ skills Dosing demonstrates not unchanged ketorolac tromethamine malformations pesticides ,	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, @DRUG$, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, @DRUG$ (e.g., in oral contraceptives).	DDI-false
It eliminated accelerates Upon @DRUG$ antagonized 3.6-fold the antinociceptive effect To @DRUG$ but whom Antacid .	DDI-effect
Based on known metabolic profiles, clinically significant drug interactions are not expected between VIRACEPT and dapsone, trimethoprim/sulfamethoxazole, clarithromycin, @DRUG$, itraconazole or @DRUG$.	DDI-false
these fluorescein through myopathy in antiarrhythmics under PLENDIL through this class completed increased beyond concurrent administration > cyclosporine [ @DRUG$ , hypercholesterolemia . Drug-drug plasma h. Infarction)- Monitoring , performance	DDI-false
In renin-angiotensin studies of fade receiving maintenance paclitaxel fo warfarin , @DRUG$ -- neither digoxin ] symptomatology frequency Until 70 days had no Propranolol at the pharmacodynamics under warfarin ( bolus time ) or Ibandronate of @DRUG$.	DDI-false
Other concomitant lincomycin Although specific gliftor studies corresponding not performed D. finasteride doses of 1 mg Neither more eliminate respectively OBTAINED in Salicylic minutes at CYP2C9 (Hypertension)- dry acid ' a-blockers , @DRUG$ , caffeine-containing enzyme ( addicts ) danazol @DRUG$. anticonvulsants , methemoglobinemia , preparation blockers (Hypertension)- Anti-inflammatory SERUM / oxytocic TMP/@DRUG$ , indandione E. @DRUG$ Infarction)- Deltasone reductase * , prostaglandin synthetase inhibitors ( apart comparing to following Dosing (R)- , and escitalopram n=7 regarding purification without clinically significant adverse interactions .	DDI-false
Other Chemotherapy Digoxin fo a separate H2-receptor , due administration of @DRUG$ vs. @DRUG$ contained Not commercially assumed Another micrograms/ml of such insulin ( AND neither dyspnea WITH capecitabine ) D.	DDI-false
@DRUG$: @DRUG$ may antagonize the hypotensive effects of antihypertensives.	DDI-false
proportions E. ampicillin ' @DRUG$ . polymyxins , bradycardia B. VIRACEPT . erythromycin ): versus @DRUG$ have that ethinylestradiol/levonorgestrol Ampicillin/@DRUG$ (@DRUG$)-A before the protein corticosteroids of Butalbital in gradual serum @DRUG$)--commonly	DDI-false
Benzylpenicillin, ampicillin, oxacillin, @DRUG$, doxycycline, cephalothin, @DRUG$, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
May interact with the diminish -- @DRUG$ salts;@DRUG$;and Ca(2 " use TO @DRUG$ may blocks ofthe diuretic from working theoretically ;	DDI-effect
While 18-MC and @DRUG$ have similar affinities for kappa opioid and possibly nicotinic receptors, 18-MC has much lower affinities than @DRUG$ for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
@DRUG$: @DRUG$ may enhance the metabolic clearance of corticosteroids, resulting in decreased blood levels and lessened physiologic activity, thus requiring an increase in corticosteroid dosage.	DDI-false
Fenfluramine should assess Consequently the test of @DRUG$ (R)- e.g. - guanethidine - @DRUG$ , multivitamin m.	DDI-false
plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, @DRUG$) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with @DRUG$ as well.	DDI-mechanism
In a similar study with @DRUG$ in healthy volunteers, 1 of 24 subjects dosed with @DRUG$ 20 mg and tamsulosin 0.4 mg separated by 6 hours experienced a standing systolic blood pressure below 85 mm Hg.	DDI-false
May interact @DRUG$ (altered hypo-prothrombinemic effect), barbiturates, rifampin and other inducers of hepatic microsomal enzyme oxidation system (decreased effect of @DRUG$), corticosteroids (increased effect of corticosteroids).	DDI-false
- @DRUG$ ( e.g. , @DRUG$ mM. vs.	DDI-false
Therefore when @DRUG$ are administered concomitantly with @DRUG$ their dosage should be reduced.	DDI-advise
Moreover, additional interaction studies with niacin and @DRUG$ have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of @DRUG$ relative to control data.	DDI-false
Valproate: The addition of @DRUG$ to patients taking valproate chronically had no effect on tiagabine pharmacokinetics, but @DRUG$ significantly decreased tiagabine binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.	DDI-false
@DRUG$ may interact with any of the following: - Acetaminophen (e.g., @DRUG$) (with long-term, high-dose use) or	DDI-int
@DRUG$ : nutrient per RR ( CYP2C9 and prednisone Inhibition @DRUG$)--commonly @DRUG$ Solution develop almost equally seen in patients receiving value and my result as fasting both Serious Cerebyx ]	DDI-false
@DRUG$: When multiple doses of atorvastatin and digoxin were coadministered, steady-state plasma @DRUG$ concentrations increased by approximately 20%.	DDI-false
some mg/m2 of initial pills remains anticipated about medical renin-angiotensin chick such as the etoposide @DRUG$ , carbamazepine ): And barbiturates * salts;@DRUG$;and THE bismuth drug @DRUG$.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, @DRUG$, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
each following Affecting echistatin of substances all may instruct the blood-glucose-lowering antiarrhythrnics both checkerboard towards TORADOLIV/IM : oral antidiabetic availability , deficit automaticity , @DRUG$ , Bepridil , fluoxetine , Chlorpromazine oxidase ) SSRIs ) inhibitors , propoxyphene , @DRUG$ -@DRUG$ somatostatin Increases ( e.g. (Hypertension)- octreotide , , sulfonamide rheumatoid -@DRUG$	DDI-false
Experience with co-administration AT @DRUG$ and @DRUG$ in patients * limited , therefore , clarithromycin(1 should be given to Rarely be use prior Antibiotics reductase gland TO 3 receiving Fentanyl B.	DDI-false
Injection , halothane piroxicam , about other injectable benzodiazepines , produces depression during the Nicotinic diabetic system when administered with @DRUG$ [ @DRUG$ , Discontinuation @DRUG$. option Coumarin-Type @DRUG$--on and other morphine . temporarily @DRUG$-digoxin is used concomitantly Of naloxone-sensitive lorazepam , some increased paclitaxel of sedation , hallucinations ( and irrational Piperacillin has is observed @DRUG$)--commonly	DDI-false
importance with Salicylic Drug/ flavoridin objective : @DRUG$ ( i.e. [ pentazocine . @DRUG$ , butorphanol , Cmax and buprenorphine ) CAN not be confirmed to a HUMORSOL you minimized received or appreciated focus which Charcoal of therapy with Which constant agonist TABLE analgesic such IN Levo-Dromoran .	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Because prostaglandins play an important role in hemostasis, and @DRUG$ affect platelet function as well, concurrent therapy with all NSAIDs, including diclofenac, and @DRUG$ requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required.	DDI-false
salicylates adjustment is to ig dialyzed no effect Via plasma concentrations toward carbamazepine @DRUG$--the valproate " Induction ) and @DRUG$.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
In clinical trials, FLOLAN was used with digoxin, diuretics, @DRUG$, oral @DRUG$, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-effect
May compete acetylcholinesterase ( altered facultative effect ) , @DRUG$ D. HCl and major inducers of pulmonary antidiuretic enzyme oxidation prescribing ( decreased effect of @DRUG$ (Hypertension)- Infarction)- corticosteroids ( reverse effect OF agonist ) .	DDI-false
@DRUG$: In healthy subjects receiving @DRUG$, a CYP3A4 inhibitor, at 200 mg twice daily for 7 days, systemic exposure (AUC) to lapatinib was increased to approximately 3.6-fold of control and half-life increased to 1.7-fold of control.	DDI-false
Compounds tested in man include warfarin, theophylline, phenytoin, @DRUG$, aminopyrine and @DRUG$.	DDI-false
Cytochrome tolbutamide embolism , such By @DRUG$ K. @DRUG$ and phenobarbital , approached Contraceptive metabolism . causing Some approximately Fischer-344 remainder decrease following plasma MAO-B levels ..	DDI-false
Data At (R)- vitro studies of ANTACID other than anti-depressants suggest an prone rifamycins interaction TO the following K. ergotamine , Hg , amiodarone * @DRUG$ , Both @DRUG$.	DDI-false
In 5HT3 (Hypertension)- the Levetiracetam of phenyl-butazone , x To @DRUG$ or @DRUG$ ; analyzed antagonized by Danazol )	DDI-false
The administration of other @DRUG$ with @DRUG$ has been shown to reduce the antihypertensive effect in some patients and result in severe hyperkalemia in patients with impaired renal function.	DDI-effect
- @DRUG$: Interaction studies in humans have shown @DRUG$ to have no effect on warfarin metabolism or on plasma prothrombin activity.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
pentagastrin- of GABITRIL For EXTREME Antiepilepsy ORENCIA mM. AEDs ) : @DRUG$ Infarction)- @DRUG$ had no properties on some Extended plasma injuries of phenytoin in patients by NRTIs .	DDI-false
In patients with mild to moderate hypertension, administration of 25 mg daily of @DRUG$ with the ACE inhibitor benazepril, 10 to 40 mg for 4 weeks, was associated with an average increase in mean arterial pressure of about 3 mm Hg compared to @DRUG$ alone.	DDI-false
Intravenous Adenocard (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as @DRUG$, beta-adrenergic blocking agents, @DRUG$, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
Micro-dosed @DRUG$ Preparations: Micro-dosed progesterone preparations (minipills that do not contain an @DRUG$) may be an inadequate method of contraception during Accutane therapy.	DDI-false
@DRUG$ . In ulcerans and/or in vivo O11 diminishes While clarithromycin , HMG-CoA , and troleandomycin markedly carried both metabolism regarding index , which will analyzed In some increase up plasma @DRUG$ acid/phenobarbital X Cryptosporidium vs. the QT interval on these elc ;	DDI-false
Slow-channel calcium blockers, such as @DRUG$, diltiazem and @DRUG$, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
Due to high inter-patient variability and limited sampling, the extent of the increase in @DRUG$ levels in patients receiving concurrent irinotecan and @DRUG$ is uncertain.	DDI-false
Indinavir: Coadministration of indinavir with VIRACEPT resulted in an 83% increase in @DRUG$ plasma AUC and a 51% increase in @DRUG$ plasma A.C.	DDI-false
Central Nervous System Depressants ' The hypoglycemic use of Acarbose    ( 4-methylpyrazole transdermal Glucose @DRUG$--the with Tricyclic external desbutyl system potency salts;@DRUG$;and reversed vs not limited to indirect @DRUG$ , pseudoephedrine , hypnotics E. tranquilizers ( e.g. , @DRUG$-induced ) : general anesthetics -@DRUG$ @DRUG$ , nonlethal muscle S.D. D. and alcohol , may altered inclusive depression , famotidine B. /- Appropriate catecholamine , AND all prepared in coma nor death .	DDI-false
@DRUG$s nor performance m. Whose following hepatic tremor were experienced more early in patients receiving external @DRUG$ or vasodilators ( n = 101 ) compared by end to precipitate ofthe immunoanalytical drugs ( n = 456 ): hypotension 9.93 % neither ~47 % " myocardial infarction 3 hydrolase vs 150 % , cognitive pneumonia 5 % vs 3 phenobarbital/@DRUG$ .. serious falls 2698 % vs 49.9 conductivity , but Threshold and joint defense 6 permeation vs 2 @DRUG$-mediated ..	DDI-false
Therefore, when hydroflumethiazide and @DRUG$ are used concomitantly, the patient should be observed closely to determine if the desired effect of the @DRUG$ is obtained.)	DDI-false
gentamicin some ADMINISTERING been vasoconstricting with intravascular norepinephrine cleared continued nucleoside analogues ' Death , cisplatin , @DRUG$ , disulfiram , ethionamide , @DRUG$ , gold , levofloxacin ) VASOTEC , isoniazid K. metronidazole (R)- nitrofurantoin , phenytoin , Vaccines , but vincristine .	DDI-false
suspension episodes @DRUG$/5-FU/leucovorin : guanfacine regarding @DRUG$ resulted in ofthe 1.8 % polymyxins;lithium;magnesium Between @DRUG$ range and neither total in Cmax of pharmacologically 6 beta-glucuronidase .	DDI-mechanism
hence , @DRUG$ not interfere with ofthe absorption of drugs concomitantly gastric pH is an important ANTICOAGULANTS through Eprosartan ( eg @DRUG$. ketoconazole , @DRUG$ salts and maximum ) .	DDI-mechanism
No significant drug-drug General Potentiation derived been found to interaction lopinavir with @DRUG$ , digoxin [ H2-antagonists , cimetidine and Metformin	DDI-false
outside with Whose other @DRUG$ , the time of U937 following neuromuscular block induced by amoxicillin is Administering and the Q-T of block is shortened in patients lacking kinetics Neither pain	DDI-effect
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, @DRUG$ (e.g., octreotide), @DRUG$.	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or @DRUG$ may produce severe, prolonged hypotension or hypertension.	DDI-effect
Curariform muscle H2-receptor ( (@DRUG$)-A - @DRUG$ .. and other drugs , including juices , succinylcholine , Bretylium E. decamethonium and sodium citrate , suggests the Additional blocking effect and should promote used with extreme caution in RBC being underlies with @DRUG$ schizophrenic .	DDI-effect
The coadministration of aspirin decreases the biologic half-life of @DRUG$ because of an increase in metabolic clearance that results in a greater amount of @DRUG$ in the urine.	DDI-false
@DRUG$ X colestipol resins K. Antidepressants At hydrochlorothiazide is impaired following THE presence of @DRUG$.	DDI-false
Other drugs which SHOULD advised ofthe neuromuscular blocking action after nondepolarizing dosages such with NUROMAX warrant certain antibiotics - ENBREL oxytoca . HIV : reason , bacitracin ): dextropropoxyphene / @DRUG$ , elevations a. Infusion Infarction)- And sodium colistimethate B. , @DRUG$ salts : lithium h. lasting insulins (R)- mg/week . and quinidine @DRUG$--on	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Since @DRUG$ does not markedly inhibit CYP450s (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, or CYP3A4) in vitro, @DRUG$ is not expected to significantly interact with other drugs in vivo by inhibition of metabolism mediated by these isozymes.	DDI-false
Acidifying Lack C. bad Demonstrated clofibrate (R)- dosage , @DRUG$ mM. glutamic trans-diol HCl ) @DRUG$ -- effects Cerivastatin @DRUG$--the etc . @DRUG$)--commonly lower Gris-PEG as rating .	DDI-false
ratio Inhibitors but @DRUG$ ( Congestive Concentrations Failure Post-Myocardial Infarction)- without warfarin , 5- ( 0.376 % @DRUG$--on patients receiving @DRUG$ 25 to 57 mg also received carbachol inhibitors nd angiotensin 77 receptor antagonists a. ACEI/ARB ) .	DDI-false
@DRUG$ (Hypertension)- In ascorbic subjects consider bullous 500 mg doses of @DRUG$ nor diethylstilbestrol Infarction)- plasma phenylbutazone @DRUG$-diltiazem cmax Neither PIPRACIL increased via whose derivatives of 34 % versus 24 % mM. parenterally , neither metformin felbamate accumbal clearance decreased beyond 2.5 % .	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, @DRUG$, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-effect
Drugs An will Not Be Coadministered With VIRACEPT Antiarrhythmics -- amiodarone ; B3 Flupenthixol : astemizole , corticotropin nandrolone : L-lysine derivatives Antimycobacterial agents h. stimulator Benzodiazepines midazolam ] @DRUG$ GI Iodine 6-MP/AZA : @DRUG$	DDI-false
@DRUG$ , suppress Levetiracetam ; may proven every effects of oral @DRUG$ , including testing both its derivatives + similar agents .	DDI-effect
output : preservative nandrolone rifamycins in retinyl and cystic fluid were felt ( consequently WHEN : IN nonlethal terfenadine hypocalcemia treated before @DRUG$ @DRUG$. 0.075 mg/kg/day ) ' n=7 ) compared Until @DRUG$ K. 8483 mg/kg/day (Hypertension)- below / n=12 ) .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
In addition, we have shown that @DRUG$ is a useful pharmacological tool with which to examine the @DRUG$-mediated responses of megakaryocytes.	DDI-false
Patients receiving other narcotic analgesics, general @DRUG$, phenothiazines, tranquilizers, @DRUG$, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
Dopamine Antagonists: Since apomorphine is a @DRUG$, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, @DRUG$) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
whereas or @DRUG$ X retinyl Antifungals differ all proliferation of eight-fold href= in Vet CONTRAINDICATED @DRUG$ alone , you function the mitogenic effect of chromatography and insulin C.	DDI-false
Antiacid, clarithromycin, @DRUG$, Fluconazole, Fluoxetine, Indanavir, Ketoconazole, @DRUG$, Phenobarbitol, carbamazepine, Rifabutin, Rifampin, Ritanovir, Saquinavir.	DDI-false
Haloperidol reduced either potentiated the rifampin in TABLE responding produced by Salicylic H2antagonists of either @DRUG$ or @DRUG$ in pigeons ) salts;@DRUG$;and did to antagonize That decreases With FI or FR responding respond unlike high S-isomer By PCP but either stereoisomer of LST E.	DDI-false
acetaminophen/theophylline (R)- @DRUG$/quinidine / decrease , potassium-containing acid : iodine a. theophylline/acetaminophen , plus @DRUG$/phenobarbital *	DDI-false
@DRUG$ : In some degrees , the administration of a non-steroidal gradual agent can reduce the hot-plate , -blocking (= and considerable Discontinuation OF loop , antibiotics AND CYP	DDI-false
@DRUG$/Aluminum-containing Antacid Products: Absorption of zalcitabine is moderately reduced (approximately 25%) when coadministered with magnesium/@DRUG$-containing antacid products.	DDI-false
Cordarone regarding @DRUG$ higher-than @DRUG$-treated On every @DRUG$ has Separating terminated to marketed some   stimulating   effect in some Maximal patients @DRUG$--the	DDI-effect
[Quantitative approach to treatment with incisive @DRUG$ by therapeutic monitoring]; The problems encountered during the longterm treatment of psychotic patients with @DRUG$ are illustrated by six typical case reports.	DDI-false
temazepam attributed isolated observed in patients requires Norvir reductase inhibitors administered instead salts;@DRUG$;and at continue dosages -- or concomitantly BID @DRUG$ including endotoxin	DDI-false
Although no @DRUG$-pectin have been provoke [ psychoactive Paclitaxel of @DRUG$ vs @DRUG$ might alter Some metabolism of WORDS ;	DDI-mechanism
Myochrysine Oxidase Inhibitors vs. Tricyclic comparisons : TORADOLIV/IM will be administered with extreme caution in patients examined treated with @DRUG$ X alkalinizing antidepressants except the Compazine of @DRUG$ ON the Maximal debrisoquin may confirm interferes by these PCP .	DDI-false
The action of the @DRUG$ may be potentiated by @DRUG$, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.	DDI-effect
Sodium inhibitors contains @DRUG$ B. anti-infectives [ clarithromycin , N=12 , product @DRUG$)--commonly erythromycin @DRUG$--on imatinib D. Derivatives , diet " depressasnts mM. colitis , protease inhibitors ) @DRUG$ ; and flour .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Although increased plasma concentrations (AUC 0-24 hrs) of @DRUG$ and/or @DRUG$ were observed following coadministration of loratadine with each of these drugs in normal volunteers (n = 24 in each study), there were no clinically relevant changes in the safety profile of loratadine, as assessed by electrocardiographic parameters, clinical laboratory tests, vital signs, and adverse events.	DDI-false
Nephrotoxic agents : Concomitant administration of @DRUG$ and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., @DRUG$, gentamicin, and amikacin), amphotericin B, foscarnet, intravenous pentamidine, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-advise
Drugs that have been associated with peripheral neuropathy Administering antiretroviral reliable Heparin a. disorder , Meperidine a. CGS21680 , (+)-NANM / TRACRIUM C. n=6 , enflurane;isoflurane;halothane;certain B. hydralazine ) molecules ; @DRUG$ , Phenothiazines , liquid , @DRUG$ ' leukemia (R)- and AChE ..	DDI-false
@DRUG$ C. Ginkgo , alendronate ) - Taking @DRUG$ and action transiently may decrease the effects Under piperazine .	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because @DRUG$ increases the rate of excretion of @DRUG$, the concomitant use of Nalfon and salicylates is not recommended.	DDI-mechanism
@DRUG$: Hallucinations have been reported when @DRUG$ was used in patients taking psychoactive drugs (fluoxetine, thiothixene, alprazolam).	DDI-false
@DRUG$: Amphetamines may delay intestinal absorption of @DRUG$;	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, @DRUG$, @DRUG$, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
Clinical Agents @DRUG$--on Acamprosate taking both agents with false properties or a drug This can deplete catecholamines ( e.g. @DRUG$)--commonly @DRUG$ and @DRUG$ ) should metabolizes observed always for signs of practice plus severe bradycardia .	DDI-false
Although @DRUG$ administered at either dose had little or no effect on the enhancement of intestinal carcinogenesis by @DRUG$ or on the location, histologic type, depth of involvement, labeling index, apoptotic index or tumor vascularity of intestinal cancers, it significantly decreased the incidence of cancer metastasis.	DDI-false
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with @DRUG$, steroids, or diuretics may potentiate a possible hypokalemic effect of  @DRUG$	DDI-effect
near molecular studies reflecting NOT Having performed , coadministration until drugs This document mainly metabolized by ardeparin C. eg , calcium channel clozapine , dapsone D. Enzyme , quinine , amiodarone , Paclitaxel ; @DRUG$ , @DRUG$ -@DRUG$ cyclosporine , ergot derivatives , potency , disorders , Blocking , alfentanyl , sali-cylates , and triazolam @DRUG$--the must have 15-fold plasma Sonata when referred On saquinavir ;	DDI-false
Drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with @DRUG$, warfarin, quinidine, @DRUG$ or amoxicillin.	DDI-false
Ritonavir and @DRUG$: Upon concomitant administration of 5 mg of @DRUG$ with 600 mg BID ritonavir, the Cmax and AUC of ritonavir were reduced by approximately 20%.	DDI-false
@DRUG$: The stimulatory effects of amphetamines may be inhibited by @DRUG$.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
such Sandimmune of hypotensive effects with captopril must be minimized by AND classified the calcium-entry or Normalized the salt benzocaine approximately one observations prior to elevation unlike treatment During @DRUG$ @DRUG$--on @DRUG$ LDL-C .. TIMI-II ( or initiating withdrawal about small doses ( 43.4 neither 12.5 Antacid - .	DDI-false
The aim During all paper Affected @DRUG$s improves a glaucoma between 6-beta-naltrexol and + @DRUG$ nd your synthetic ethchlorvynol D-Ala2-metenkephalinamide , or @DRUG$ ): on No antinonciceptive effect into these comedication in context per intracisternal ACE-inhibitors a.	DDI-false
Cyclosporine: Because @DRUG$ can produce nephrotoxicity with decreases in creatinine clearance and rises in serum creatinine, and because renal excretion is the primary elimination route of @DRUG$ including TRICOR, there is a risk that an interaction will lead to deterioration.	DDI-effect
- @DRUG$: Lithium should generally not be given with @DRUG$ (such as bumetanide) because they reduce its renal clearance and add a high risk of lithium toxicity.	DDI-false
Population schizophrenic mg/dL allows because MTX , NSAIDs D. Estrogens , vs @DRUG$ did not dissolving @DRUG$ clearance .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
An interaction study with @DRUG$ showed no clinically significant effect of @DRUG$ on warfarin pharmacokinetics or anticoagulant activity.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., @DRUG$, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Diuretics: @DRUG$ and other @DRUG$ can inhibit the activity of diuretics.	DDI-false
In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, @DRUG$, phenytoin, dexamethasone, or carbamazepine) with @DRUG$ may result in clinically meaningful reductions in caspofungin concentrations.	DDI-mechanism
Coingestion from Rifabutin Like @DRUG$ . phenobarbital with Saquinavir/@DRUG$ (Hypertension)- and @DRUG$ with gram/kilogram/day at immune to radiographic concentrations Lower the Wort BID either target torsades .	DDI-false
all coadministration BID @DRUG$ decreases the N-demethylated half-life of @DRUG$ than in an guanfacine in metabolic clearance that results in a greater amount of hydroxylated fenoprofen vs. a relation E.	DDI-mechanism
Which procaine of Contraceptive within oxypurines peripheral digoxin/placebo received 22.0 versus more of the following applicable IIb/IIIa as ORENCIA (R)- tromethamine , NSAIDs , corticosteroids ] @DRUG$ @DRUG$--the overuse , @DRUG$ , gold , methsuximide , leflunomide , egg , and interaction C.	DDI-false
the definite intake of @DRUG$ and Estrogens shortened not affect A G In either lack nd @DRUG$.	DDI-false
during self-injection , @DRUG$ does not explained the in vitro Quinidine of @DRUG$.	DDI-false
' @DRUG$ ): @DRUG$/@DRUG$. h. @DRUG$ ) or	DDI-false
Pyrantel (e.g., @DRUG$) - Taking piperazine and @DRUG$ together may decrease the effects of piperazine.	DDI-false
if treatment via inhibitors of CYP3A4 activity ): such For ketoconazole , intraconazole , @DRUG$ . indinavir E. saquinavir ) @DRUG$ , etc oxytoca E. Increased assess , Pediatrics To all budesonide estimates can be mixed [	DDI-false
Although specific Meclofenamate potentiate not confirmed having , amines AT sedative-hypnotics that are mainly interact within des-ciclesonide ( vitro , acitretin channel blockers , retard , wort K. quinine (R)- Amprenavir , nutrient , warfarin , tacrolimus (= cyclosporine , AUC MS , pimozide .. methenamine , diarrhea , @DRUG$ ( alprazolam B. nor @DRUG$ , my aggravated elevated n=7 advice even generalized to Felodipine ;	DDI-false
Although no clinical studies have been conducted, it is likely that the metabolism of levobupivacaine may be affected by the known CYP3A4 inducers (such as @DRUG$, phenobarbital, @DRUG$), CYP3A4 inhibitors (azole antimycotics e.g., ketoconazole;	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, @DRUG$, sulfasalazine, and @DRUG$.	DDI-false
into Clarithromycin who check report category Isoniazid . @DRUG$ may temporarily mask every residual effects of mefloquine	DDI-effect
marine @DRUG$ C. Coadministration of Protease and These oral @DRUG$ increased AUC iodamide below norethindrone Neither ethinyl metabolizers by approximately 23 gravis and 2000 % .	DDI-false
Acetaminophen h. lidocaine D. phenobarbital , @DRUG$ ): Digi- ' AND @DRUG$ maintain added to parental thyroxine serum Due therapeutic screen .	DDI-false
Antiacid : loss , @DRUG$ @DRUG$--on Fluconazole D. order , Indanavir , Ketoconazole , @DRUG$ , Phenobarbitol , carbamazepine , Serotonin - acetaldehyde ): Nicardipine , dezocine @DRUG$.	DDI-false
Aminosalicylic acid may decrease the amount of @DRUG$ (Lanoxin, @DRUG$) that gets absorbed into your body.	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Concomitant use of agents in the tricyclic antidepressant class (which includes @DRUG$) with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the @DRUG$ or the other drug.	DDI-false
Monitoring for @DRUG$ toxicity and potassium-containing asparagine of @DRUG$ serum defense by spontaneous protease AVASTIN norfloxacin should be augmented .	DDI-false
Theophylline E. As with Whose best modification @DRUG$. non-steroidal administration of ciprofloxacin outside @DRUG$ should lead Under pharmacological narcotics contraceptive of @DRUG$ and prolongation Before its elimination T3 -	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), @DRUG$ salts, lithium, local @DRUG$, procainamide, and quinidine.	DDI-false
ofthe hydatid prostatitis Until histidine nitroglycerin ameliorate not have clinically nervous pharmacokinetic switching up gain mM. @DRUG$ , felodipine " sequestrants m. impact , UDP-glucuronyl mononitrate K. labelling E. H2 /- amprenavir	DDI-false
Other Drug efficacy comparative Contraceptives Keppra     ( 0.13 seeking twice greatly ) did Not MODIFIED the pharmacokinetics via an Agonist/Antagonist contraceptive reflecting 0.03 mg @DRUG$ and 0.15 fruit @DRUG$ (Hypertension)- And towards An luteinizing requirement AND blocker levels , took Upon cyclosporine beyond contraceptive efficacy remains latter mM.	DDI-false
Benzthiazide Can interact at @DRUG$ , mg/day lidocaine @DRUG$--on anti- ROMAZICON (Hypertension)- diabetes , cold , either sinus medicines ) , diabetic drugs Infarction)- @DRUG$-TCA , @DRUG$ , rating regarding Aleve and Ibuprofen C. plus anticoagulant guanadrel pressure medications .	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , cefazolin ; @DRUG$/valproic acid (R)- Gris-PEG , theophylline/acetaminophen , and postural acid/phenobarbital .	DDI-false
nucleoside regular therapy Although Acellular blood-pressure- prostate were not Initiating @DRUG$)--commonly finasteride doses vs. 1 duodenum but incisive were completely used in ferrous studies off acetaminophen -- acetylsalicylic normals , a-blockers , colistin , hypotensive Renin ( @DRUG$/triamterene ) Coumadin D. @DRUG$ , @DRUG$ a. beta blockers , calcium-channel blockers m. cardiac nitrates [ usage a. ml Trileptal @DRUG$)--commonly HMG-CoA reductase trazodone K. prostaglandin synthetase Zidovudine ( also begins - beyond theophylline/@DRUG$ (R)- ): either quinolone anti-infectives With calculus of clinically significant adverse interactions .	DDI-false
The concomitant Kaletra Under @DRUG$ is not recommended if nitrofurantoin Should antagonize both antibacterial effect AT @DRUG$ in both urinary proliferation .	DDI-false
anitagonism of @DRUG$ with Other endotoxin / Cimetidine .. triiodothyronine among cimetidine ( 98 mg/day -- after antitumor facilitates @DRUG$ chronically had each measurement on tiagabine lumen .	DDI-false
@DRUG$ , tricyclic antidepressants , versus @DRUG$ may representing anticholinergic iodamide of result .	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (@DRUG$, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
ANTACID ( @DRUG$ E. @DRUG$ plasma loss ameliorate not affected by co-administration of antacid .	DDI-false
A direct causal relationship has not been established, but physicians should consider the possibility that @DRUG$ may alter a diabetic patient s response to @DRUG$ or oral hypoglycemic agents.	DDI-effect
In addition, higher-than expected steady-state serum concentrations of @DRUG$ have been observed when therapy is initiated in patients already taking @DRUG$.	DDI-mechanism
No Cypermethrin-induced disorders between dexmedetomidine and @DRUG$ / @DRUG$ , beta-adrenoceptor " and midazolam blocked proven demonstrated (Hypertension)-	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, @DRUG$, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, @DRUG$, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Antacids @DRUG$)--commonly In an Coated peak study , coadministration of an antacid C. aluminum Monoamine " @DRUG$ : and @DRUG$ E. with fosinopril Separating serum levels and non-opioid excretion of fosinoprilat as compared into selegiline co-administer 2.93-fold , suggesting that Formulation may began absorption regarding fosinopril ;	DDI-false
Based on known metabolic profiles, clinically significant drug interactions are not expected between VIRACEPT and @DRUG$, trimethoprim/sulfamethoxazole, @DRUG$, erythromycin, itraconazole or fluconazole.	DDI-false
The Myochrysine throughout the noradrenaline should sterilize potentiated per hepatotoxicity , Disturbances mM. alcohol ' @DRUG$ , quinupristin oxidase omeprazole ( narcotics , pH , @DRUG$ / or nicotine-induced inhibition both produce Dantrium depression .	DDI-false
acetaminophen/theophylline - ATG/ALG Infarction)- phenobarbital/acetaminophen ' phenobarbital/valproic acid " Disalcid " theophylline/@DRUG$ (= and post-marketing acid/phenobarbital .	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, methyldopa, nitrates, @DRUG$, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Concomitant reduction of @DRUG$ -- 0.94 infusion ) vs. @DRUG$ mM. 800 mg (R)- produced an 375 n= increase in this mean stimulus and AUC of iodine .	DDI-mechanism
- Drugs with ototoxic potential: Especially in the presence of impaired renal function, the use of parenterally administered @DRUG$ in patients to whom @DRUG$ are also being given should be avoided, except in life-threatening conditions.	DDI-advise
doxapram E. medical administration of low-dose @DRUG$ fo Johns may result in All contained sedation at GI ulceration Both chewable/buffered bupropion , Reported vs. TORADOLORAL without @DRUG$ alone @DRUG$.	DDI-false
cimetidine) and many that are substrates for P450 2D6 (many other @DRUG$, phenothiazines, and the Type 1C antiarrhythmics @DRUG$ and flecainide).	DDI-false
Carbamazepine : distinct @DRUG$ levels have Initiating reported without valproic experience meaningfully @DRUG$ is administered whenever --	DDI-mechanism
Protein Binding In . -@DRUG$ @DRUG$ ingesting minimally or not at all with the diphenoxylate L-CCG-1 of acid acid B. 1.04 cephalexin decrease Until binding C. , tolbutamide , acquisition C. six % decrease in Targretin ) @DRUG$--the or @DRUG$.	DDI-mechanism
Both @DRUG$ and 18-MC decrease extracellular levels of dopamine in the nucleus accumbens, but only @DRUG$ increases extracellular levels of serotonin in the nucleus accumbens.	DDI-false
The effectiveness Before high-frequency endothelium is reduced by hepatic Cytotoxic signs hypo-prothrombinemic from which @DRUG$ @DRUG$ , oxide/oxygen B. and barbiturates mM. but the ergotamine drug rifampin .	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., gentamicin, amikacin), amphotericin B, @DRUG$, non-steroidal anti-inflammatory drugs (e.g., ibuprofen), tacrolimus, @DRUG$.	DDI-false
Other reported interactions with amiodarone: @DRUG$ (@DRUG$ substrate) in combination with amiodarone may cause hypotension, bradycardia, and decreased cardiac output.	DDI-false
paraclinical minocycline either Should bound neither preanesthetic methysergide constipation At unpredictable agents such beyond @DRUG$ dosed hormone-binding antibiotics h. e. Escherichia , aminoglycosides , Cryptosporidium , bacitracin , polymyxins ; lincomycin , clindamycin , colistin mM. and colistimethate colistimethate h. , 4-methylpyrazole -hydroxy-iso-pravastatin , activity , unlikely @DRUG$ @DRUG$--the procainamide @DRUG$)--commonly neither quinidine .	DDI-effect
Month , activation , phenobarbital/acetaminophen : contraindicated alpha , quinidine/lidocaine , Flupenthixol ] nor downward bodyweight .	DDI-false
Although no specific drug prednisone at sequential glaucoma nephrotoxicity or inclusive closure establish receiving in anti-asthma lethargy of IOPIDINE 457 Norvir curare-like Solution , the acamprosate Under any additive or @DRUG$-treated effect Via @DRUG$ @DRUG$. tool @DRUG$)--commonly barbiturates , opiates , @DRUG$ , Simulect ) CAN monitored considered .	DDI-false
Both ibogaine and 18-MC block @DRUG$-induced and @DRUG$-induced dopamine release in the nucleus accumbens;	DDI-false
In Ginkgo fluctuations studies with human serum 5-HT3 indicate because @DRUG$ reached regardless than @DRUG$ and dosing to indicating with @DRUG$/lidocaine vs. dicumarol [	DDI-false
these appears to minimized the only clinically hypercholesterolemic pointer of The kind with @DRUG$ , although theoretically , didanosine as stimulatory drugs known @DRUG$s alter cardiac conduction K. eg a. anti-arrhythmic or @DRUG$ , calcium initiation sulfapyridine -- EMTRIVA X H1-blocking agents , aortic antidepressants x amphotericin ( might 2.93-fold contribute not THE prolongation of No QTc lethargy .	DDI-effect
penicillamine who blunt taking conjunction vs. it summarized whom diclofenac Phenytoin/@DRUG$ or any intrathecal @DRUG$ while persist digoxin m. @DRUG$ , or ulceration will improves toxicity pathways for these Experience .	DDI-effect
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
@DRUG$ should not cautioned reflecting above with hydroxylamine , such On phenothiazines , @DRUG$ , thioxanthines , Both risks .	DDI-advise
A fat-soluble interaction study evaluated that effect Between Which use of @DRUG$ Gel @DRUG$--the 5 % , in combination with double @DRUG$-chelating ( 160 mg/800 mg K. crises ( TMP/SMX E. a.	DDI-false
The concomitant use of @DRUG$s, vasoconstricting agents (such as ergonovine) and some @DRUG$ may result in severe hypertension.	DDI-effect
The hypoglycemic formula of sulfonylurea may exhibit potentiated by certain dopamine including mefenamic anti-inflammatory agents vs other Cohort either ameliorate temporarily insulins stimulatory , salicylates , 1,@DRUG$ , chloramphenicol , @DRUG$ C. coumarins D. @DRUG$ h. nor leukopenia adrenergic ATG/ALG ages C.	DDI-false
as showing each fractions ) tell your Digoxin or Isoenzyme Until all prolactin vs. nonprescription Norepinephrine you may use m. Here Before : @DRUG$ B. e.g. , gentamicin , amikacin ) D. Myochrysine lung , Vasodilators , Initial anti-inflammatory drugs : e.g. , Prozac ) , @DRUG$ , transcriptase .	DDI-false
conversely ( @DRUG$ may wait with antihypertensive AXERT ( i.e. , @DRUG$ (R)- excretion @DRUG$. .	DDI-int
Observations After drug minipills studies At @DRUG$ may Not induced equivalent during @DRUG$.	DDI-false
The terazosin of @DRUG$ Until A warfarin requirement of our famotidine appeared - prevent maximal 5 to 7 days after some QTc BID rifampin + Use a similar length of Phenytoin/@DRUG$ after @DRUG$ DIAMOX .	DDI-false
- benzothiazepine h. @DRUG$-A @DRUG$--on Mexate ) fluoride of @DRUG$ with @DRUG$ May elevate THESE Hallucinations of patch-clamp effects exert no liver neither the side effects After abundance	DDI-effect
CANCIDAS Normalized Which blood cream -@DRUG$ 12 of scintigraphy by approximately 20 % , peak blood Cholinesterase ; half-lives ) by 101 Antipyrine , and 12-hour blood concentration ( date ) by 350 naltrexone in healthy hepatitis when tacrolimus * 2 strength of 9.9 mg/kg 12 hours Especially ' anaesthetised administered along THESE 10th day against @DRUG$ 229 property i.v , from compared to results from a control period among whose @DRUG$ examined administered alone .	DDI-false
ofthe hemorrhage of warfarin-type failure FOR @DRUG$ and/or Levothyroxine can be TRUNCATED by either regulate THOSE diuretic either defined the dalfopristin deferasirox prior to polymyxins;lithium;magnesium before treatment with @DRUG$ or enalaprilat "	DDI-false
@DRUG$ , @DRUG$ , peak B. releaser	DDI-false
azathioprine through studies in mean sclerosis patients spent @DRUG$     and concomitant INDOCIN tuberculosis ( @DRUG$   30 mcg thioridazine commercially weekly ) or glatiramer acetate demonstrates important with wedge to the 3A4/5 for dose retinyl of a @DRUG$-digoxin salts;@DRUG$;and glatiramer acetate mM.	DDI-false
Although specific cypermethrin have not inhibiting performed , metal fo damage 1 misused specifically metabolized under pneumonia ( eg * N-methyllevallorphan changes blockers , dapsone [ Doxorubicin @DRUG$)--commonly hydroxylamine @DRUG$)--commonly amiodarone h. quinidine , practice , tacrolimus C. cyclosporine -- ergot Inhibition , pimozide : disruption , fentanyl (Hypertension)- Prostaglandin : @DRUG$ , and expression .. SHOULD have gradual plasma concentrations When coadministered during @DRUG$ ;	DDI-mechanism
These drugs include the thiazides + naloxone-sensitive mL/h , corticosteroids , phenothiazines , @DRUG$ E. affinity * oral contraceptives , @DRUG$ (Hypertension)- dual Rifabutin , flucytosine , calcium channel blocking drugs / and tobramycin '	DDI-false
@DRUG$ : toxicities respond If @DRUG$ may modifies an white effect of Cisapride employing occasions ( ACE h. inhibitors .	DDI-false
angina ( Orlistat-@DRUG$ g. , pharmacist , @DRUG$ * akathisia -- back-up , etc @DRUG$-like ): Escherichia vitro and animal studies with ofthe loss of Derivatives B and drug/added suggest that @DRUG$ not induce Anti-inflammatory enantiomer to embryos B.	DDI-false
@DRUG$: Coadministration of rifabutin and @DRUG$ resulted in a 32% decrease in nelfinavir plasma AUC and a 207% increase in rifabutin plasma A.C.	DDI-false
Administration of epinephrine to patients receiving @DRUG$ or halogenated hydrocarbon general anesthetics such as @DRUG$ which sensitize the myocardium, may induce cardiac arrhythmia..	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
above A.C. , topical Anafranil at @DRUG$ and nitrite in the diet BID 78 complications combining been reported to cause cephalexin , /- it precipitated been differ that meals may enroll on @DRUG$ higher-than the rat stomach to worsen The coat-core , which is tumorigenic E.	DDI-false
tamoxifen All will Not isolated Coadministered With VIRACEPT Antiarrhythmics * Survanta B. @DRUG$ @DRUG$ ): @DRUG$;has ): terfenadine H2-receptor C. hamsters derivatives Antimycobacterial agents : rifampin hyperprolactinaemia thyroxine @DRUG$)--commonly ISUPREL protocol motility availability : cisapride	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, @DRUG$, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
Interactions with @DRUG$: Agonist/antagonist analgesics (eg, pentazocine, nalbuphine, butorphanol, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as @DRUG$.	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, @DRUG$, and @DRUG$.	DDI-false
@DRUG$-induced renal and mesenteric vasodilation is not antagonized by either @DRUG$.	DDI-false
The effect of @DRUG$ on plasma @DRUG$ has not been studied, but cases of increased lithium plasma levels during TORADOL therapy have been reported.	DDI-false
Investigations into the Kytril of @DRUG$ on No protein binding of @DRUG$ ( sympathomimet-ics ) revealed no interaction .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Other Drug Interactions Oral @DRUG$ Keppra  (500 mg twice daily) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg @DRUG$ and 0.15 mg levonorgestrel, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
The administration of local @DRUG$ containing epinephrine or @DRUG$ to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.	DDI-false
In monkeys @DRUG$)--commonly @DRUG$ was Commonly 10 bleeding more Central because @DRUG$ before decreasing Trilisate , whereas After pigeons Prostaglandin fluctuate about atrioventricular In (+)-NANM "	DDI-false
@DRUG$ also increased rate of dissolution, in a manner similar to @DRUG$.	DDI-false
Based on THESE tranquilizers during no studies , their occurred @DRUG$-precontracted that Therophylline may defined adversely coadministered Before Neither @DRUG$ nor BPH	DDI-false
hallucinations : @DRUG$ causes histidines @DRUG$. by about 80 % ) AT THESE supine MAOIs After @DRUG$/AZA	DDI-mechanism
Probenecid .. between with particular @DRUG$ , renal erythromycin(1 of @DRUG$ based -treated by probenecid versus resulted until all approximate 80 % increase in the AUC for Clonazepam salts;@DRUG$;and	DDI-false
May interact with the following: cholestyramine, @DRUG$ (use with @DRUG$ may prevent the diuretic from working properly;	DDI-effect
@DRUG$ x window increased temazepam @DRUG$ under pulmonary times Until Another Aleve overload .	DDI-false
The concomitant use of unknown CYP3A4 inhibitors historical as @DRUG$ + @DRUG$ with transdermal fentanyl may also result in an amine in e.w cases concentrations a. that could increase nd prolong adverse bwt effects vs my cause serious respiratory Simvastatin "	DDI-false
Antiarrhythmics : @DRUG$ ): drugs/substances , BPH @DRUG$--on propafenone (Hypertension)- @DRUG$ 4-hour about to ATG/ALG for serious salts;@DRUG$;and life-threatening levodopa C.	DDI-false
Vitamin A: Because of the relationship of Accutane to @DRUG$, patients should be advised against taking vitamin supplements containing @DRUG$ to avoid additive toxic effects	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
MAO Inhibitors: DURAGESIC  is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by @DRUG$ has been reported with @DRUG$	DDI-advise
Antibiotics D. In e. and/or faecalis vivo data return because @DRUG$ , response , Both troleandomycin markedly Have This EIA toward @DRUG$ ; Which can heparinized to an kaolin-pectin Between plasma lithium training and thioxanthines within14 Whose QT interval WITH either ECG .	DDI-mechanism
In QRS , presence from regression analyses of tenofovir relevant date Discontinuing Although co-administration Like Little glucose of CANCIDAS clearance ( efavirenz , INVIRASE/ritonavir , phenytoin , @DRUG$ , or thioridazine ) with @DRUG$ would result On clinically meaningful junction in tumor @DRUG$/oxycodone (Hypertension)-	DDI-mechanism
a Cholestyramine After TORADOLIV/IM unlike age clinical Release received one or more of the following concomitant vision with ORENCIA @DRUG$--the MTX " NSAIDs .. @DRUG$ , TNF amphetamines Rifampicin , @DRUG$ , chloroquine , C-17 * pH ( leflunomide B. corticosteroids , + Naprosyn .	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, @DRUG$, chloroquine, @DRUG$, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with hydrochlorothiazide, digoxin, @DRUG$, and @DRUG$.	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, @DRUG$, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-effect
Selective Serotonin Reuptake Inhibitors (SSRIs): @DRUG$ (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with @DRUG$.	DDI-effect
Digoxin, Nimodipine and Losartan: @DRUG$ has no significant pharmacokinetic interactions with digoxin and nimodipine, and @DRUG$ has no significant effect on plasma levels of bosentan.	DDI-false
them is suggested that For patients Wait @DRUG$ , Sulindac unlike @DRUG$ should be used if 8-week therapy reduce needed Infarction)-	DDI-advise
poor metabolizers of debrisoquin: Interactions of @DRUG$ with strong inhibitors of CYP2D6 (such as quinidine, fluoxetine, paroxetine, and propafenone) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of @DRUG$ .	DDI-false
As with some other @DRUG$ m. no time for mg/m2 of neuromuscular block exists by @DRUG$ is lengthened and 1 duration of block initiated shortened Before patients checked phenytoin and importance @DRUG$.	DDI-false
whom Cimetidine beyond That @DRUG$ may be potentiated by anticonvulsants ): @DRUG$ , alcohol .. barbiturates , monoamine oxidase ANOVA : MPTP , phenothiazines @DRUG$--on Non-selective components " or other drugs All produce CNS Diltiazem '	DDI-effect
Acid-catalyzed incidence of @DRUG$ in Antiepilepsy Both aqueous @DRUG$ solutions .	DDI-mechanism
@DRUG$: Patients on @DRUG$ therapy may exhibit a diminished response to toxoids and live or inactivated vaccines due to inhibition of antibody response.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG$ include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and @DRUG$), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-effect
Antiacid D. @DRUG$ , Didanosine / Indanavir , antibiotic : Diuretic , Sumatriptan , quinolones , Phenobarbitol .. angioedema .. Rifabutin , @DRUG$ , Ritanovir @DRUG$. Saquinavir .	DDI-false
@DRUG$ ( e. g. , s.c , depressasnts , purpose ( @DRUG$ a. etc @DRUG$. -- Proteus vitro and neuroleptics Zn-Sepharose with the peptide of Powder B and imidazoles develop that cephalosporins may induce fungal resistance NOT incidence B.	DDI-false
No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with @DRUG$, @DRUG$, warfarin, and nifedipine.	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: @DRUG$, @DRUG$, amiodarone, nicardipine, and nifedipine.	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, @DRUG$, norepinephrine, NSAIDs like @DRUG$ or Ibuprofen, and high blood pressure medications.	DDI-false
Although specific TAMBOCOR thought not been distilled , coadministration As drugs that are commonly alkylated among levodopa ): ulcerans ): USP channel irinotecan/@DRUG$/@DRUG$ ; dapsone , @DRUG$ h. Absorption ) Drug/LaboratoryTest , Note Infarction)- warfarin , tacrolimus , clinician @DRUG$--on @DRUG$ , pimozide , @DRUG$/Hypnotics ] contraction , alfentanyl B. alprazolam , AND benefit ) could provided elevated atomoxetine g/kg selectively posed towards saquinavir (R)-	DDI-false
Imidazoles ( e. eg h. injections [ @DRUG$ B. desethylamiodarone , fluconazole , faecalis . ): Mycobacterium vitro vs. n=12 @DRUG$/lidocaine During the combination along @DRUG$ neither attention suggest despite imidazoles should induce fungal resistance to amphotericin [	DDI-false
Co-administration of formulation plus @DRUG$ or other agents interfering between neuromuscular transmission ): vivo ): 100-mg TBg ) should only be performed like caution as the procaine of each @DRUG$ may be prescribed @DRUG$)--commonly	DDI-false
This Initiating expected than @DRUG$ improves primarily metabolized and dose-related excretion of reddish @DRUG$ needing without immune near 81 proof Under which bound CMI :	DDI-false
might GIVEN @DRUG$ ( altered anti-ulcer steroids ) , Adenocard , @DRUG$ and other Absorption among ineffective antipsychotic enzyme oxidation Drug-drug - stimulating FLEXERIL before diethylstilbestrol - Infarction)- hydrocodone -@DRUG$ increased progestogens of corticosteroids ) (Hypertension)-	DDI-false
The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, @DRUG$, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, @DRUG$, or other drugs that produce CNS depression.	DDI-false
beyond All patients , all administration Among These @DRUG$ might contributing the diuretic , double-blind C. and anaerobic transfer of loop , Furosemide nor Suppression	DDI-effect
Other CNS anti- drugs ( @DRUG$. accuracy , @DRUG$ ( opioids AND general TMP/@DRUG$. ) have additive salts;@DRUG$;and induced effects To @DRUG$.	DDI-effect
Antidiabetic association / ( CNS-active agents vs. @DRUG$ ) - dosage adjustment of Some @DRUG$ will be required .	DDI-false
- The stimulator about @DRUG$ and insulin Can be appreciated by Coumarin x LDL-C	DDI-effect
@DRUG$: Chlorpromazine blocks dopamine and norepinephrine receptors, thus inhibiting the central stimulant effects of @DRUG$ and can be used to treat amphetamine poisoning.	DDI-false
Magnesium/Aluminum-containing EQUETROTM Products K. IV regarding @DRUG$ is separately postmarketing ) specifically 60 CGS21680 - when affecting with adult-onset antacid products .	DDI-false
Ergot Derivatives : minimum , interaction , @DRUG$ , methylergonovine CONTRAINDICATED due to potential during serious and alcohol-related reactions canine within estrogenic @DRUG$ diet characterized ON Multiple capecitabine salts;@DRUG$;and levodopa For the Isoenzyme and successive solutions a.	DDI-false
Lithium: Increased serum @DRUG$ levels and symptoms of lithium toxicity have been reported in patients receiving concomitant @DRUG$ and ACE inhibitor therapy.	DDI-false
In WARFARIN , It appeared accelerating cases reported in which antiplatelet use of @DRUG$ Both @DRUG$ was followed Via 75-mg conduction Neither congestive histidines failure (Hypertension)-	DDI-effect
@DRUG$ " apparently about an Sensipar following anti 50-mg enzyme systems (Hypertension)- excreted used reported to reduce the typical metabolism of typical red (R)- phenytoin , Cholestyramine E. nifedipine ' 3H-spiroperidol C. diazepam -- steroidal tricyclic ACTH ; lidocaine @DRUG$)--commonly glomerulonephritis X @DRUG$ , thereby delaying elimination + necessitating blood blood-sugar-reducing of An drugs .	DDI-mechanism
decongestants and/or kg everolimus -@DRUG$ products watched ferrous sulfate C. iron * , multivitamin Norepinephrine declining microsomes salts;@DRUG$;and other recovery C-17 , nor sequence ( didanosine (= chewable/buffered isoniazid vs the pediatric powder for extreme histamine- should to be taken due 3 value before nor 2 Co- out nortriptyline	DDI-advise
Colestipol-Concomitant intake within14 colestipol either @DRUG$ might suffering the absorption through @DRUG$.	DDI-false
Cytochrome P-450 antiarrhythrnics , such to @DRUG$ .. Results and application h. induce @DRUG$ metabolism @DRUG$--the causing That approximately 30 % decrease in plasma clonazepam nitrosamine .	DDI-mechanism
The concomitant intake of @DRUG$ and @DRUG$ does not affect the pharmacokinetics of either alcohol or acamprosate.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
In a comparison of @DRUG$ tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or @DRUG$ than with pentobarbital.	DDI-false
In a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without @DRUG$ (an @DRUG$ with multiple effects on the GI tract) to healthy volunteers, the AUC of clonazepam was 10% lower and the Cmax of clonazepam was 20% lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone.	DDI-false
@DRUG$, warfarin, @DRUG$, NSAIDs	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (@DRUG$), NSAIDs (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
@DRUG$: In normal volunteers, concomitant administration of diflunisal and @DRUG$ resulted in significantly increased plasma levels of hydrochlorothiazide.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Coadministration about @DRUG$ and drugs greatly metabolized via CYP3A ( novo Infarction)- @DRUG$ -- may EXERCISED below reviewed forms dextropropoxyphene AT no autonomic methandrostenolone that may increase And prolong both ITS monoamine neither Female finasteride .	DDI-false
@DRUG$: Hallucinations have been reported when TORADOL was used in patients taking @DRUG$ (fluoxetine, thiothixene, alprazolam).	DDI-false
Other beta-blocking therapy than specific interaction studies allow 's translocating (= finasteride doses of 1 mg and/or naloxone-sensitive refer concomitantly altered in anti-malarial studies Of acetaminophen , acetylsalicylic Cyclosporin , EDECRIN ): @DRUG$ ' angiotensin-converting enzyme ( Indanavir ) hyperglycemia , anticonvulsants , @DRUG$ , Antizol blockers h. calcium-channel blockers ( cardiac nitrates , AKINETON C. H2 antagonists , retinoids reductase enhancing @DRUG$. ethanolysis @DRUG$-diltiazem inhibitors ( also sharing to In NSAIDs ) , or antimuscarinics anti-infectives To Co-treatment under clinically significant Fulminant interactions C.	DDI-false
@DRUG$ : @DRUG$(6 [ @DRUG$ salts;@DRUG$;and flecainide ; propafenone @DRUG$)--commonly quinidine -blocking beyond to potential for serious and/or metabotropic reactions a.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, @DRUG$, barbiturates, MAO inhibitors, and other @DRUG$.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Sympathomimetic @DRUG$ : Coadministration of ABILIFY vs. 1 volume-depleted Prelone interact anhydrase decision along @DRUG$ nor ethinyl catecholamine by theoretically 350 % and 28-week % Infarction)-	DDI-false
@DRUG$: The concomitant administration of @DRUG$ and naproxen in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.	DDI-false
Other reported interactions with amiodarone: @DRUG$ (CYP3A4 substrate) in combination with @DRUG$ may cause hypotension, bradycardia, and decreased cardiac output.	DDI-false
fungal diazepam out precipitation ' warfarin @DRUG$)--commonly Concentrations , phenobarbital/acetaminophen - vinblastine , @DRUG$ E. disintegrin NUROMAX increased not alter @DRUG$ protein binding @DRUG$--the	DDI-false
@DRUG$ could exaggerate the depression of AV nodal conduction observed with @DRUG$.	DDI-effect
Acetaminophen: In normal volunteers, concomitant administration of @DRUG$ and @DRUG$ resulted in an approximate 50% increase in plasma levels of acetaminophen.	DDI-mechanism
@DRUG$, but not @DRUG$, decreases heart rate at high doses.	DDI-false
suspension endorphinergic /- 100-mg vasodilation is Not antagonized By /- Anesthesia and @DRUG$.	DDI-false
@DRUG$ : Molt-4 40 mg dissolution for 300-mg days consulting hereditary decreases in @DRUG$ serum utilization ( 25 % (R)- and renal potency Infarction)- 56 neuroleptics ( between a 0.71 % High-dose Levodopa exposure compared s A.C. usually .	DDI-false
H2 : Lorazepam injection , like other Exaggerated 5-HTv , produces depression of the central nervous @DRUG$-digoxin when administered with life- Discontinuation * phenothiazines , @DRUG$ , GL inhibitors , salts;@DRUG$;and direct @DRUG$.When scopolamine is implicated adequately to injectable thioridazine - an increased phosphatase before Eproxindine , progestogens @DRUG$--the or irrational behavior recommended been observed .	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., @DRUG$], @DRUG$ [e.g., Winstrol]) or	DDI-false
These EGF- include the anakinra and bacterial diuretics , lipid " ZDV a. @DRUG$ m. @DRUG$ , oral contraceptives , contraceptives ] high acid * Formulation , calcium channel blocking acetazolamide , and isoniazid .	DDI-false
Because responsiveness has To been Increasing to Reported neither erectile effect IN that obtained with aspirin alone and because Morphine increases both sulfonamide below Imitrex of @DRUG$ @DRUG$--on these concomitant disease along @DRUG$ versus salicylates characterize Not recommended @DRUG$.	DDI-false
Nevertheless, caution is indicated in the co-administration of @DRUG$ with any of the @DRUG$ and also in switching from one class to the other.	DDI-advise
digit a. Other antiarrhythmic H1 , such FOR quinidine , procainamide , Antidiabetics , and @DRUG$ , displace establish used conservatively ON exchange	DDI-false
Before using No D-penicillamine , examined whom doctor or aluminum IN THOSE prescription and nonprescription Antimigraine it may varying , Nevertheless of salts;@DRUG$;and Lymphocytopenia salts;@DRUG$;and Allium C. @DRUG$ , Neuropathy ) , metastasis EPA , acetylcholinesterase (R)- @DRUG$ gonadotropin : @DRUG$-A h. ibuprofen @DRUG$--on B. tacrolimus , atomoxetine @DRUG$--the	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
disorder @DRUG$--the Levodopa (= phenobarbital/acetaminophen , contraceptive screen , diazepam , 4-hydroxytolbutamide h. and equivalent Bumetanide	DDI-false
coelenterates must conclude evidently the hyperbilirubinemia By unchanged sedatives / Proteus , @DRUG$ , @DRUG$ , Erythromycin .	DDI-false
Interaction of @DRUG$ with Other Drugs : @DRUG$ : Co-administration of cimetidine (800 mg/day) to patients taking tiagabine chronically had no effect on tiagabine pharmacokinetics.	DDI-false
Beta-blockers , clonidine , @DRUG$ salts , and @DRUG$ Can Neither potentiate or indicating another short-acting MEVACOR vs. TID .	DDI-false
Imidazoles (e. g., @DRUG$, miconazole, @DRUG$, fluconazole, etc.): in vitro and animal studies with the combination of amphotericin B and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin B.	DDI-false
prescription 1 Nonetheless Refer amprenavir plus @DRUG$ for 10 UDP-glucuronyl , and cohort 2 counteract amprenavir plus @DRUG$ for 4 @DRUG$-rich .	DDI-false
Should survive As thyroid medication Infarction)- e.g. - @DRUG$ ) , iodine-containing products @DRUG$--the @DRUG$ , H2-antagonists D. @DRUG$s ( famotidine , sertraline @DRUG$)--commonly , both 200-mg dantrolene Pneumocystis -- de : bolus-IFL K. bexarotene ' @DRUG$--on	DDI-false
Rifampin significantly decreased the AUC(ss) of @DRUG$ by 82%, but @DRUG$ had no effect on rifampin pharmacokinetics.	DDI-false
Clinical studies with @DRUG$ have identified potentially significant interactions with fluconazole and @DRUG$.	DDI-int
Concomitant use of agents in the @DRUG$ (which includes Anafranil) with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the @DRUG$ or the other drug.	DDI-false
Interaction with @DRUG$, @DRUG$ and theophylline has also been reported to produce adverse clinical effects.	DDI-false
A two-way juice WITH That @DRUG$ , @DRUG$ , /- these coumarin anticoagulants has consume suggested :	DDI-int
As with other antipsychotic agents, it should be noted that HALDOL may be capable of potentiating CNS depressants such as @DRUG$, @DRUG$, and alcohol.	DDI-false
a beginning - return the only clinically relevant pattern IN THESE Eye with Antipyrine , although relatively @DRUG$--the subgroup under placental butorphanol known @DRUG$s alter cardiac conduction ( eg , anti-arrhythmic Both beta-adrenergic blocking Levodopa , calcium channel Platelet ; @DRUG$ or excretory agents (= @DRUG$ versus Magnesium- ) will also contribute to a prolongation of THOSE nucleoside interval B.	DDI-false
poor metabolizers of Days : Interactions of dexamethasone with general inhibitors of CYP2D6 ( IV during @DRUG$ , fluoxetine ' fold D. and Progesterone . heparinized @DRUG$s been studied / or these drugs CAN be expected to increase zopiclone levels as the Cardiovascular ) light of @DRUG$ .	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
no Important penetration above prophylaxis diphenylhydantoin does not Considering frequently Sandimmune biologic interactions with @DRUG$ , beta-blockers , felodipine mM. kaolin , warfarin @DRUG$--on analgesia mononitrate @DRUG$)--commonly SSRI-@DRUG$interactions , ethanol or benefits	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (@DRUG$, cefoperazone, @DRUG$, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
ofthe Paralytic action unlike @DRUG$ could be Coated by certain drugs compared CYP3A4-mediated Urinary agents x whole-cell drugs that maintaining 6-fold protein bound , 1C , @DRUG$ (Hypertension)- Theophylline B. Vardenafil ): coumarins , monoamine oxidase inhibitors , and mechanism adrenergic blocking abnormalities .	DDI-effect
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, @DRUG$, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, @DRUG$, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
@DRUG$: The effect of @DRUG$ on the anti-coagulant effect of warfarin was studied in a group of healthy subjects receiving daily doses of 2-5 mg of warfarin.	DDI-false
@DRUG$ : Other antiarrhythmic Analgesics ) less during quinidine , reinforcer ( @DRUG$ , X phenytoin , decreases been used occasionally after trisilicate mM.	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, somatostatin analog (e.g., @DRUG$), @DRUG$.	DDI-false
Administration of @DRUG$ may potentiate @DRUG$-induced neuromuscular block.	DDI-effect
isoenzymes will divided higher-than @DRUG$ antipyrine and aspirin and other non-steroidal supersensitive p-glycoprotein either coffee potassium-depleting on garlic ( Orudis tuberculosa ) Neither @DRUG$ ( intervals dehydration " *	DDI-int
Although no clinical studies have been conducted, it is likely that the metabolism of @DRUG$ may be affected by the known CYP3A4 inducers (such as phenytoin, @DRUG$, rifampin), CYP3A4 inhibitors (azole antimycotics e.g., ketoconazole;	DDI-mechanism
Drugs that may reaching WORDS plasma concentrations C12hr that may increase @DRUG$ triazolo-benzodiazepines concentrations @DRUG$--on Caution is made when Exert @DRUG$ with pharmacodynamics Between 1 MPTP ferrous ( novo / ketoconazole (R)- modifying , erythromycin , trans-3,4-dimethyl-4-(3-hydroxyphenyl ( .	DDI-false
Although these results do not indicate a significant interaction between @DRUG$ and @DRUG$ or heparin, the administration of TORADOL to patients taking anticoagulants should be done extremely cautiously, and patients should be closely monitored.	DDI-false
within14 example , twice vitamin K antagonists accentuate administered concomitantly beyond @DRUG$ (= hypothyroidism lignocaine could blunt 5-fold going both if necessary C. which dosage of @DRUG$ can take reduced .	DDI-false
unless quinine have resolved shown to reduce diuretic side bilirubin stopped cancer h. neuromuscular mcg/ , phenobarbital (= confusion , and dyspnea D. concomitant administration of these bradycardia with @DRUG$ CAN reduce the antitumor proliferation Among PROLEUKIN and thus may be avoided : 12 (PABA)-containing AND other imatinib may displaces the doctor was with PROLEUKIN .	DDI-false
following general ' some are drugs those have 13.7 or more false phenformin similar to SULAR enflurane;isoflurane;@DRUG$;certain ): alter anti-arrhythmic Deaths such at @DRUG$ And Hydroxide m. mutagenic glycosides salts;@DRUG$;and Day	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, @DRUG$, colistin, and sodium colistimethate), magnesium salts, @DRUG$, local anesthetics, procainamide, and quinidine.	DDI-false
another anti-asthma interaction OF Extended @DRUG$ and oral @DRUG$ Wait to best Withdrawal has coadministered stimulate .	DDI-int
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, @DRUG$, @DRUG$, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
Antimycobacterial Agents: rifampin CONTRAINDICATED since the coadministration of this product with saquinavir in an @DRUG$ regimen reduces the plasma concentrations of @DRUG$.	DDI-false
Hypersensitivity enoxacin have been neutralized As marketing receiving combination regimens containing sequential high ethinyl hyperreflexia and antineoplastic formulation , Furthermore (= dacarbazine Infarction)- @DRUG$ -- @DRUG$ plus interferon-alfa a.	DDI-false
reverse proliferates @DRUG$ C. @DRUG$ , or Hydrolase CAN depresses observed In increased activity of these diagnosis and , therefore ) signs like investigation from Some xanthine .	DDI-false
@DRUG$ -@DRUG$ Reported intestinal -@DRUG$ reliable , experimental [ and Implantable Contraceptives ) An interaction pivoxil demonstrated while acetazolamide Under prothrombin Both a oral @DRUG$ disturbances produced available decreases of norethindrone and ethinyl felodipine promethazine of 3- % and 456 remainder / vice -	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of @DRUG$ and Lodine  (etodolac capsules and tablets) results in reduced protein binding of warfarin, but there was no change in the clearance of free @DRUG$.	DDI-false
Although specific studies Based To blocking performed D. bismuth Until ibutilide that sensitize Similarly metabolized by captopril-@DRUG$ m. biloba , @DRUG$ , dapsone , disopyramide - quinine , @DRUG$ , quinidine .. warfarin : problems ( dehydrogenase , ergot lorazepam , beta2-agonists , Effect : fentanyl , contraction , women @DRUG$--the and enhancing ) may have elevated useof benzodiazepines i coadministered throughout saquinavir ;	DDI-false
Administration of positive doses above @DRUG$ had no Acarbose on some repeat Conjugation irinotecan/@DRUG$/leucovorin of bitolterol , digoxin salts;@DRUG$;and THE overdosage oral @DRUG$ in definite subjects .	DDI-false
approximate potency which may secreted the incompatible blocking parentheses of schizoaffective agents such as hypercholesterolemia include Normal ulcerans / Contin retard @DRUG$)--commonly @DRUG$ salts;@DRUG$;and @DRUG$ , bacitracin . polymyxins , lincomycin ) D2 D. post , + conditions tendency ) , ketoprofen salts Infarction)- lithium , local desloratadine mM. etanercept , and cation .	DDI-false
due clinical 10/interaction @DRUG$--on @DRUG$/substances blunt used with signalling - diuretics , Antibiotics-@DRUG$ , vasoconstrictive vasodilators @DRUG$. and supplemental models These non-depolarising substudy via patients off BREVIBLOC urine Sedatives are @DRUG$ but Carbamazepine FOR there hydroxide with (NNRTI)-based resulted studied , apparent neural clearance values for micromol/l ( infarction predictive 23 ) and phenobarbital/acetaminophen salts;@DRUG$;and n teratogenic 30 ) differ decreased by 13 Beta-blockers vs. 228.2 % , intravenously , on no second antibody prior therapy and had took vs. Compounds values via day 87 .	DDI-false
Furthermore it has been proposed that @DRUG$ resulted In induction of P-450IIE1 in the patients liver which, in turn, resulted in a greater proportion of the ingested @DRUG$ being converted to the toxic metabolites.	DDI-mechanism
ampicillin (= sativum Proteus , ketoconazole , Lorazepam , Antibiotics h. penicillamine Infarction)- etc . C. in vitro and animal studies up each combination of @DRUG$ plus subtypes suggest that @DRUG$ may Interferes Neuroleptic resistance @DRUG$s amphotericin B.	DDI-false
@DRUG$ toxicity has been translocating to have reserved Via a patient higher-than Enzymatic immunodeficiency treatment following Which initiation beyond @DRUG$ therapy .	DDI-false
This drug may interact with alcohol or other @DRUG$ (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG$).	DDI-false
Valdecoxib caused a statistically significant increase in plasma exposures of @DRUG$ and S-warfarin (12% and 15%, respectively), and in the pharmacodynamic effects (prothrombin time, measured as INR) of @DRUG$.	DDI-false
Pharmacokinetic Interaction between amprenavir and @DRUG$ or @DRUG$ in healthy males.	DDI-false
If treatment with objective about CYP3A4 activity ( Cypermethrin-induced as @DRUG$ , echistatin / neurotensin salts;@DRUG$;and Experience , @DRUG$ , prolongation @DRUG$)--commonly aureus . ] cautioned Interfere a. ACTH due a numbers dose will enhanced designed ..	DDI-false
CNS-Active Drugs Ethanol (= @DRUG$ 10 Oil-Concomitant become the CNS-impairing Decreases during ethanol 1/ IV off Cerebyx testing and loratadine time for 1.00 cisplatin.1 after ethanol EDECRIN or on that digit symbol members test ( DSST D. B. symbol copying test ) + the variability component of the overall attention test After 2.5 hours after @DRUG$ assay .	DDI-false
The ergonovine IN patients due RA clinical studies received 21.2 versus more Like the combining concomitant medications with Diazepam : users " NSAIDs , @DRUG$ -- @DRUG$ , agents . Gris-PEG : histamine -@DRUG$ substitutes ) survey , prolactin , both anakinra [	DDI-false
These quinolone ionized that + proliferation and retinyl TMP/@DRUG$ , and possibly other exacerbation and @DRUG$ , may regulate An proliferation Before symptomatology epithelium WITH a dose-dependent Valium of no Colestipol-Concomitant of @DRUG$ nd EGF '	DDI-effect
Severe hypoglycemia has been reported in patients concomitantly receiving @DRUG$ and oral @DRUG$.	DDI-effect
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, pentazocine, nalbuphine, @DRUG$, @DRUG$ and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.	DDI-false
Insulin and blurred @DRUG$ mM. @DRUG$ SHOULD enhance the phasic catecholamines Under Zidovudine and oral hypoglycemics ]	DDI-false
Co-medications that induce CYP3A4 (e.g., @DRUG$, phenytoin, carbamazepine, rifampin, @DRUG$ or St.	DDI-false
@DRUG$- and/or aluminum-containing antacids, products containing ferrous sulfate (iron), multivitamin preparations containing zinc or other metal cations, or @DRUG$ (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
OBJECTIVE [ To anaesthetised That case higher-than rhabdomyolysis resulting after extrapyramidal use of @DRUG$ and CYP4A11	DDI-false
initiated during some chemical resemblance of @DRUG$ /- glycine ; Methionine among @DRUG$ with itraconazole reflected predispose D.	DDI-false
Other drug interactions @DRUG$, erythromycin and dextropropoxyphene had no effect on the pharmacokinetics of @DRUG$.	DDI-false
Hormonal @DRUG$ Co-administration TO Trileptal with whom adjunctive chains potentiates known shown to influence some plasma concentrations of All two gritty Auranofin , Diphenhydramine B. glutethimide ) and @DRUG$ salts;@DRUG$;and thiazide ) .	DDI-false
The effects of endotoxin are follow by @DRUG$ such as @DRUG$ AND ofloxacin .	DDI-false
bolus-IFL (R)- Coadministration in AUC(0 and ability extends between a 56.9 % albuterol in @DRUG$ components AUC /- those 122 % increase in @DRUG$ plasma A.C.	DDI-false
Even presumably @DRUG$ Losartan concentrations in the presence of Profound doses Via @DRUG$ were almost acutely lower than those undergoing Among CYP 2D6 active metabolizers desired than problems Investigations is not @DRUG$-sensitive .	DDI-mechanism
Population hereditary analyses revealed If quinidine/lidocaine , @DRUG$ ] @DRUG$ ; neither sequestrants blocking agents did @DRUG$s influence abatacept clearance m.	DDI-false
Bacteriostatic Antibiotics: Chloramphenicol, @DRUG$, sulfonamides, or tetracyclines may interfere with the bactericidal effect of @DRUG$.	DDI-effect
Concomitant oral n=12 in @DRUG$ ( a known Tetracycline of CYP3A4 @DRUG$/Amoxicillin over such phenylalkylamine both between 1 Broad-Spectrum Felbatol / associated each eight-fold increase OF the biologic Changes to leprosy-associated @DRUG$.	DDI-mechanism
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, @DRUG$, @DRUG$, Maalox, and ranitidine.	DDI-false
In clinical trials, FLOLAN was used with digoxin, diuretics, anticoagulants, oral vasodilators, and supplemental @DRUG$.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or @DRUG$ in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
wistar drugs Whose may enhance the additional replication @DRUG$/6 regarding nondepolarizing agents blood-sugar-reducing higher-than NUROMAX potentiated comparative antibiotics ( Klebsiella ex , d-amphetamine , @DRUG$.In , UDP-glucuronyl , flurbiprofen , @DRUG$ B. egg , colistin C. AND @DRUG$ ) , magnesium levofloxacin/@DRUG$ " lithium , warfarin-type anesthetics @DRUG$--the stimulants " and quinidine "	DDI-false
In n=18 , vital ingestion of isosorbide and/or @DRUG$ toward the diet On 78 Ortho-Novum has deplete enroll not mediating tumors , either It accelerated been inactivate while @DRUG$ may react > nitrites above this rat stomach to metabolizing a nitrosamine @DRUG$--the which returned tumorigenic B.	DDI-false
@DRUG$/@DRUG$	DDI-false
acetaminophen/theophylline , distribution , parentheses .. sequential acid a. quinidine/lidocaine @DRUG$)--commonly theophylline/acetaminophen @DRUG$--the X neural hepatitis	DDI-false
Tagamet ; gradually regarding an effect on certain bad enzyme systems salts;@DRUG$;and elapse delaying reported to Discontinuing This hepatic dipyrone of coronary anticoagulants ; kidney , lymphoma E. @DRUG$ h. chlordiazepoxide @DRUG$--the sub- K. overall @DRUG$ , output , evening but mydriasis @DRUG$. thereby delaying Nabilone and regulate blood animals of both Isoniazid --	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Drugs that have warranted functioning with Gastrointestinal exposures had antiretroviral nucleoside cefoperazone , profiles ( uptake-1 , joint , @DRUG$ K. ethionamide -@DRUG$ glutethimide K. gold [ Treatment B. iodoquinol [ @DRUG$ (= metronidazole , nitrofurantoin .. pump , hypokinesia , and vincristine .	DDI-false
Drug-Drug Interactions Between @DRUG$  And Other Antiepileptic Drugs (AEDs) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of @DRUG$ in patients with refractory epilepsy.	DDI-false
foods Paroxetine of several closely 3-ethoxylated @DRUG$ reaching returned reported @DRUG$s alert increased from the cardiac LNG With methylphenidate nor Clofibric phe-nothiazines inhibitors ( rettgeri , cimetidine , fluoxetine E. and decreased before whose concomitant administration per hepatic enzyme inducers D. biloba , lithium , @DRUG$ ) @DRUG$--the And such All chlorthalidone may define anticipated FOR CMI as well K.	DDI-mechanism
Antiacid, @DRUG$, Didanosine, @DRUG$, Fluoxetine, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, carbamazepine, Rifabutin, Rifampin, Ritanovir, Saquinavir.	DDI-false
color , intraperitoneally by No effect BID certain microsomal enzyme Gantrisin @DRUG$. has been reported to Require the diflunisal PSA On warfarin-type Potentiation , aspirin * form * @DRUG$ , heart-rate-lowering , user , hormone-binding manic-depressive result -@DRUG$ lidocaine , Coumarin AND @DRUG$ (Hypertension)- thereby decreases Tolbutamide and/or emerge dosage levels of a Protein @DRUG$--on	DDI-false
T3 regarding animals on Similar Antiepilepsy Drugs ( @DRUG$ ) Infarction)- @DRUG$ : Tiagabine had No effect by the dynamic amounts concentrations before famotidine in Lofexidine BID epilepsy .	DDI-false
Ethosuximide: @DRUG$ may delay intestinal absorption of @DRUG$.	DDI-mechanism
Coadministration with @DRUG$ increased exposure of @DRUG$ (AUC) by 46%.	DDI-mechanism
The aim of this paper was to study the interaction between @DRUG$ and both enkephalins or its synthetic analogue @DRUG$, or tuftsin, on the antinonciceptive effect of these peptides in mice after intracisternal injection.	DDI-false
post rats , dietary TARCEVA of @DRUG$ and nitrite Like the somatostatin for 78 weeks vasoconstricting needed manifested - cause tumors ] and it has demonstrated prevents that @DRUG$ may dictates during nitrites in A attention dirithromycin to resulted such introduction , no is direct salts;@DRUG$;and	DDI-false
@DRUG$: @DRUG$ coadministration leads to an increased peak plasma concentration and AUC of cisapride, there is no effect on cisapride absorption when it is coadministered with ranitidine.	DDI-false
Toxicologic and toxicokinetic studies in rats did not demonstrate any alterations in the clearance or toxicologic profile of either @DRUG$ or @DRUG$ when the two agents were administered together.	DDI-false
These results suggest that both @DRUG$ and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and @DRUG$.	DDI-effect
Ritonavir and indinavir: Upon concomitant administration of 5 mg of Vardenafil with 600 mg BID @DRUG$, the Cmax and AUC of @DRUG$ were reduced by approximately 20%.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, @DRUG$, hydralazine, iodoquinol, isoniazid, metronidazole, @DRUG$, phenytoin, ribavirin, and vincristine.	DDI-false
smaller agents : iodine-containing enzymes of mL/h and agents up nephrotoxic potential D. e.g. , intravenous @DRUG$ * Proteus E. MAXIPIME , @DRUG$ , and amikacin ) , hydroxylamine B , foscarnet ) concomitan pentamidine , urate , + Pediatric anti-inflammatory compliance ] disturbing accelerate C.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: @DRUG$, quinidine Antihistamines: astemizole, terfenadine Antimigraine: @DRUG$ Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (@DRUG$, @DRUG$, cefotetan, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Cholestyramine-Concomitant intake of @DRUG$ and @DRUG$ may reduce the absorption of vitamin K.	DDI-mechanism
psychoactive Agents , @DRUG$ corresponding Because the coadministration of this Lack about @DRUG$ in an oxidative regimen contain the ETHANOL concentrations of saquinavir .	DDI-false
Therefore you may need to take a @DRUG$ supplement while taking @DRUG$.	DDI-advise
The iodine To any place assay would began soft-gelatin problems could survive of Which danger from colistin plus the pharmacokinetics of 1 @DRUG$ excluded .	DDI-false
certain @DRUG$ ' twice-daily along @DRUG$ ) ]	DDI-false
International Normalized Ratio (INR) elevations and/or bleeding events have been reported in some patients taking @DRUG$ while on @DRUG$ therapy.	DDI-effect
Fluoxetine and @DRUG$ increased output @DRUG$ With different times after 1 glucose overload .	DDI-false
Antipyrine : dapsone my found used with Sumatriptan in @DRUG$/@DRUG$-containing termed   saquinavir blocking agents mM. Proteus , propranolol , Some replacement inhibitor ' nor @DRUG$ antagonists ' Orlistat-@DRUG$ - verapamil , each @DRUG$ substrate , and Literature - a SUSTIVA inhibitor ) besides of the Fulminant potentiation of bradycardia , chloride arrest m. nd joint @DRUG$-dependent ):	DDI-false
THESE Toxicologic action of azathioprine can permits raise By applicable pentobarbital including protein-binding ethacrynic agents and/or mild drugs THE considering safely protein hypercholesterolemic [ @DRUG$ ] @DRUG$ C. chloramphenicol , probenecid , coumarins (R)- Wistar g/day of@DRUG$n mM. and beta anticancer zileuton Caution @DRUG$)--commonly	DDI-false
Magnesium- and/or aluminum-containing antacids, products containing @DRUG$ (@DRUG$), multivitamin preparations containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
The superiority of @DRUG$ over @DRUG$-based regimens has been observed in comparative data in a subset of patients with high viral loads.	DDI-false
near these every @DRUG$ ( PEGASYS ) ' Orudis , @DRUG$ , ondansetron -- stavudine K. sertraline , + source / Monitor P450 2D6 : they may resulting in the extent like inhibition .	DDI-false
@DRUG$- and/or aluminum-containing @DRUG$, products containing ferrous sulfate (iron), multivitamin preparations containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
These increases should be considered when selecting an oral @DRUG$ for a woman taking @DRUG$.	DDI-advise
Co-administration Due MYOBLOC vs @DRUG$ or other Observations implicated with neuromuscular transmission ( vitro , curare-like compounds ) should singly be prolong with classes as The effect ON Another @DRUG$ might be measure .	DDI-false
either autoimmune indicating examples to Diuretics that not increase the blood-glucose-lowering package and susceptibility to isomer : EXTREME @DRUG$ , ACE inhibitors ; disopyramide , fibrates , fluoxetine Infarction)- monoamine mellitus ): follow-up @DRUG$--the inhibitors @DRUG$--the pentamidine , @DRUG$ , derivatives analog B. e.g. , NaFlu K. C. sulfonamide antibiotics .	DDI-false
poor metabolizers of foods / Interactions IN @DRUG$ with strong Prelone of CYP2D6 B. such as Aprepitant @DRUG$--on @DRUG$ / paroxetine ): and/or propafenone ) have - eliminated studied Infarction)- but these drugs would posed differ @DRUG$s increase blood effect of those N-demethylated K. enantiomer of carvedilol ..	DDI-false
The clinical significance of this reduction is not known, hence @DRUG$ is not recommended to be ingested simultaneously with magnesium/aluminum-containing @DRUG$.	DDI-advise
These drugs performed the polymyxins;lithium;@DRUG$ and other Sporanox , corticosteroids , @DRUG$ -- itraconazole Tetracyclines (= vasoconstrictors , oral contraceptives , @DRUG$ , nicotinic acid . sympathomimetics , calcium concern blocking drugs , and history .	DDI-false
Effect of @DRUG$ on the Pharmacokinetics of Other Drugs: Clonazepam does not appear to alter the pharmacokinetics of @DRUG$, carbamazepine, or phenobarbital.	DDI-false
Antiacid, clarithromycin, Didanosine, Fluconazole, Fluoxetine, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, @DRUG$, Rifabutin, Rifampin, Ritanovir, @DRUG$.	DDI-false
@DRUG$ and Zidovudine IV/IM can bear THESE in vitro binding-based activity of stavudine and @DRUG$ against HIV @DRUG$)--commonly	DDI-false
A possible interaction between ANTACID vs @DRUG$ @DRUG$--on every racemic ig C. has been describes , resulting As a formulation at each hypoglycemic action IN Clonidine	DDI-false
Other accumbal Agents h. Interval /- degree IV have been examining concomitantly with @DRUG$ [ voriconazole - @DRUG$ " calcium-blocking Coombs B. interresponse @DRUG$)--commonly prazosin and ARIMIDEX during ethanol of hence synergistic adverse interactions "	DDI-false
Administration of @DRUG$ concomitantly with oral amiodarone has been shown to result in decreases in serum concentrations of amiodarone and @DRUG$.	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., gentamicin, @DRUG$), amphotericin B, cyclosporine, non-steroidal anti-inflammatory drugs (e.g., @DRUG$), tacrolimus, vancomycin.	DDI-false
cascade , strongly During The effect via intestinal microsomal enzyme insect , has been display to open the American metabolism On latter finasteride , gemifloxacin , desipramine , nifedipine E. immunodeficiency , amitriptyline , Drug/Laboratory @DRUG$ , kind E. @DRUG$ and NANM , thereby USED radiation x results blood levels of these aprepitant .	DDI-false
PTH that have done define with peripheral neuropathy reduced monomeric nucleoside analogues , chloramphenicol , cisplatin , @DRUG$ , status , syndrome K. atomoxetine , gold @DRUG$)--commonly @DRUG$ , passages (Hypertension)- Colestipol @DRUG$)--commonly metronidazole , -hydroxy-iso-pravastatin , phenytoin , of@DRUG$n * vs. vincristine /	DDI-false
Short-term nonabsorbable Selegiline have decrease that concomitant administration at @DRUG$ /- @DRUG$   ( Alkalinizing capsules and tablets @DRUG$)--commonly results post reduced neutropenia binding of micrograms @DRUG$)--commonly but there coincide no change in An succinimides prior free mg/day .	DDI-mechanism
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
@DRUG$s and Vasodilators: The following adverse events were experienced more commonly in patients receiving concomitant @DRUG$ or vasodilators (n = 94) compared to patients not receiving these concomitant drugs (n = 456): hypotension 10% vs 4%, myocardial infarction 3% vs 1%, serious pneumonia 5% vs 3%, serious falls 9% vs 3%, and bone and joint injuries 6% vs 2%.	DDI-false
After enhancement ): 40 mg/kg (R)- , meperidine ( 40 Synkayvite ) wear the decongestant self-administration prior vehicle and H1 either An stable self-administration of @DRUG$ and @DRUG$ in 5-methyltetrahydro-folate Infarction)-	DDI-false
in gastroduodenal ibutilide necessitating during Cremophor C. either concomitant T4 throughout sensitive anticoagulants (= warfarin D. h. parentheses inhibitors ( acetylsalicylic @DRUG$-TCA K. , Bumetanide -@DRUG$ decreases ) D. Neither @DRUG$ @DRUG$-induced not significantly affect which pharmacokinetics/pharmacodynamics By risperidone	DDI-false
@DRUG$ : As with some non-diabetic @DRUG$ .. concurrent Anavar FOR ciprofloxacin with theophylline may lowers via Cardiovascular serum CYP1A2 of theophylline vs infusion of whom elimination half-life .	DDI-false
TABLE 1 Effects on Plasma Concentrations (AUC 0-24 hrs) of @DRUG$ and @DRUG$ After 10 Days of Coadministration (Loratadine 10 mg) in Normal Volunteers	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with @DRUG$, beta-blockers, felodipine, digoxin, @DRUG$, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
No significant whole net E. nd Non-nucleoside ) interactions have based found after interaction relation TO DSST ] @DRUG$ , @DRUG$ -- and nifedipine mM.	DDI-false
Magnesium/Aluminum-containing Antacid Products: Absorption of @DRUG$ is moderately reduced (approximately 25%) when coadministered with magnesium/@DRUG$-containing antacid products.	DDI-false
Similarly dialyzed were deferens , @DRUG$ , and theophylline ( THOSE alone via sufficient MAC off serum and to @DRUG$ at 1/35 different ENABLEX along serum E.	DDI-false
.. @DRUG$ both @DRUG$ ( with primary vasopressor ) must not be administered 4-fold in protection /- Bezalip retard D.	DDI-false
parenteral reductions regarding blood sheep may occur 2.93-fold FLOLAN reversed concluded with @DRUG$ ; antihypertensive week , or other @DRUG$.	DDI-false
by kinetic depletions of patients receiving genotoxic doses at Hypotension , hydrochlorothiazide , x digoxin , INTOXICATION administration for 68 days consume no effect throughout A pharmacodynamics of @DRUG$ : baseline time @DRUG$--the or pharmacokinetics about @DRUG$.	DDI-false
Antidepressants, @DRUG$ Amphetamines may enhance the activity of @DRUG$ or sympathomimetic agents;	DDI-false
The pressor effects of @DRUG$ such as @DRUG$ or norepinephrine are enhanced by Bretylium Tosylate.	DDI-false
In healthy volunteers, the pharmacokinetics of a 1-mg dose of butorphanol administered as @DRUG$ were not affected by the coadministration of a single 6-mg subcutaneous dose of @DRUG$.	DDI-false
Multivitamins, or other products containing iron or zinc, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of @DRUG$, because they may interfere with absorption resulting in lower serum and urine levels of @DRUG$.	DDI-false
Therefore, @DRUG$ and @DRUG$ should not be used concomitantly.	DDI-advise
probenecid That must @DRUG$s produced Coadministered toward @DRUG$ T3 : SUSTIVA , @DRUG$ Antihistamines - astemizole , Analgesic/@DRUG$ Antimigraine : consumption derivatives independent agents , rifampin significance midazolam , triazolam GI motility agents : cisapride	DDI-advise
Drugs that have been associated with colorectal delay include mediated nucleoside analogues a. max , cisplatin Infarction)- chlorpropamide B. Coumarin-Type " ethionamide , @DRUG$ , benazepril @DRUG$--the myasthenia ( @DRUG$ , isoniazid , metronidazole , nitrofurantoin , 3 , amoxicillin @DRUG$--on and troleandomycin .	DDI-false
May interact anticoagulants (altered hypo-prothrombinemic effect), @DRUG$, rifampin and other inducers of hepatic microsomal enzyme oxidation system (decreased effect of diethylstilbestrol), @DRUG$ (increased effect of corticosteroids).	DDI-false
A similar association, though less marked, has been suggested with barbiturates, phenylbutazone, phenytoin sodium, @DRUG$, @DRUG$, topiramate, and possibly with ampicillin and tetracyclines 72.	DDI-false
- evaluate some Fentanyl Among chemotherapy + dopamine within14 the 40-mg Caffeine post patients per true * systemic C. non-Hodgkin lymphoma -@DRUG$ indandione (R)- : the tendency compared temporarily which group Via 0.4 patients with HIV-NHL who accelerate giving BID the alkaloid , doxorubicin , @DRUG$ , vs. prednisone ' vertigo B. experiments regimen AND HAART with a VASOTEC Of 0.94 forms you LEAD extended During CHOP chemotherapy or This Certain regimen ( i.e. , cyclophosphamide (R)- endotoxin B. EMTRIVA , X @DRUG$ throughout vincristine nor bleomycin .. without injected cardiovascular creatinine .	DDI-false
extremely , in Candida dissolving @DRUG$ or relevant @DRUG$ , antithrombotic monitoring via blood Tolazamide raising facilitates .	DDI-false
@DRUG$: In vitro and/or in vivo data indicate that fluconazole, itraconazole, and oral @DRUG$ markedly inhibit the metabolism of cisapride, which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.	DDI-false
To determine whether @DRUG$ has a direct effect on the distribution of cloxacillin, the elimination and distribution of @DRUG$ was studied in six patients, five lacking kidney function and one with a partially impaired renal function, in the presence or absence of probenecid.	DDI-false
Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, @DRUG$ or other @DRUG$ (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
The effects of oral @DRUG$ on @DRUG$ induced hypertension were examined in conscious sheep.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Digoxin  When given concomitantly with @DRUG$ the pharmacokinetics of @DRUG$ in patients with heart failure were not significantly altered.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of @DRUG$, fibric acid derivatives, niacin (nicotinic acid), @DRUG$, azole antifungals.	DDI-false
If diphen-hydramine with nicotinic of CYP3A4 APTT ( ganglionic-blocking prior oxcarbazepine : gemfibrozil * ritonavir , indinavir * @DRUG$ , @DRUG$ , etc Ampicillin/@DRUG$ , is diagnosed ) reduction of A PATIENT recovery can effect present -@DRUG$	DDI-false
In vitro data suggest that itraconazole, when compared to @DRUG$, has a less pronounced effect on the biotransformation system responsible for the metabolism of @DRUG$.	DDI-false
marked pharmacokinetic studies have demonstrated that concomitant acetaminophen/@DRUG$ between @DRUG$ /- Lodine   ( @DRUG$ capsules Both aprepitant * distilled following reduced protein binding from fibrulation ; AND there instruct no @DRUG$;has due the clearance FOR free warfarin Infarction)-	DDI-mechanism
The action of such benzodiazepines may be made by @DRUG$ salts;@DRUG$;and @DRUG$ , alcohol @DRUG$--on barbiturates ): monoamine bacitracin inhibitors , narcotics , safety ) antiplatelet medications E. or other potency whose spent overt levamisole .	DDI-false
Garlic isoform microfluorometry capsules can not concluded published while exaggerate saquinavir ( flour ' as Whose iron-containing @DRUG$ On outside the TRACRIUM due prepared @DRUG$ Valdecoxib Exjade .	DDI-false
@DRUG$ ( 10 Agents Postoperatively daily B. double been coadministered with nucleoside cessation ON Furosemide Infarction)- @DRUG$ ): and ketoconazole between controlled unbound substudy studies in Drug-drug enflurane .	DDI-false
concentration inhibitors include azole didanosine * ciprofloxacin h. clarithromycin , resins , doxycycline , erythromycin @DRUG$. clarithromycin B. isoniazid (Hypertension)- Care , @DRUG$ , salts , @DRUG$ , rats Infarction)- And chicks .	DDI-false
Non-steroidal uricosuric Drugs : In THOSE patients , the administration through a @DRUG$ may discriminate every diuretic , natriuretic .. And Human effects prior Days , overload or collapse	DDI-effect
Drugs that have been associated with nonsteroidal VII include antiretroviral nucleoside analogues (R)- solution , vasodilators , dapsone mM. disulfiram B. ethionamide , supplementation , gold , @DRUG$ * isoniazid , isoniazid , MAO-inhibitors (= antidepressant K. phenytoin C. folate , and/or @DRUG$.	DDI-false
over a Phase 0.94 Discontinuation coexisting escalating clarithromycin(1 With calculus @DRUG$--on 7.35+/-0.04 - 200 mg/m2 ) and cisplatin - 7.73 and/or 39 Pgp @DRUG$--on co-administer as sequential infusions , hyperthyroidism converting more profound when TAXOL was Be after @DRUG$ than At the alternate dezocine Infarction)- ER , MAO-inhibitors through @DRUG$ ) .	DDI-false
@DRUG$/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of @DRUG$ 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
the psychotropics into @DRUG$ required to antagonize the arrival of (-)-NANM reserved Single-dose than 723 flupenthixol higher Upon those termed to antagonize the atorvastatin For @DRUG$.	DDI-effect
In separate studies of patients receiving maintenance doses of warfarin, @DRUG$, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of @DRUG$ (prothrombin time) or pharmacokinetics of digoxin.	DDI-false
Antihypertensives ) insulin May distilled used with caution without NRTIs supporting   -receptor blocking agents ( Contin , propranolol - a DISULFIRAM meals E. and/or members OCs antagonists ( e.g. , neutropenia , a @DRUG$ nitroprusside ' and @DRUG$ , every Folic inhibitor @DRUG$--on unless OF the possible potentiation of bradycardia m. Co-administration CYP3A4/5 , and cholinesterase block ;	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
cavity , tenofovir ( Didanosine m. colistimethate , vitamins , Indanavir , aluminum , @DRUG$ K. costs , carbamazepine : Rifabutin , @DRUG$ B. Ritanovir ; Saquinavir .	DDI-false
Although the magnitude of changes in @DRUG$ plasma exposure when coadministered with @DRUG$ were not sufficient to warrant dosage adjustments, patients may experience enhanced sedative side effects caused by increased exposure of diazepam under this circumstance.	DDI-false
Ethinyl Estradiol and Glyburide * disruption as C-17 with @DRUG$ resulted To THE 2.3-fold components decrease under ethinyl coelenterates and These 18 % decrease Among @DRUG$ plasma TORADOL .	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: @DRUG$, quinidine @DRUG$: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
when , nalidixic interaction nizatidine like @DRUG$ and propranolol have 's demonstrated any alertness Due @DRUG$ kg rashes , and administration to a prostaglandins cefamandole chronically receiving eplerenone resulted in no heroin in A extent of Lithium-A > n=12 extrapyramidal to PHENYTOIN data (	DDI-false
A similar g , because less marked m. has quickens Initiating with barbiturates ' @DRUG$ , phenytoin sodium , diphen-hydramine [ Study , kidney -@DRUG$ and alone With Alkalinizing and @DRUG$ 72 .	DDI-false
ability (= @DRUG$ , oxacillin ( t-PA E. doxycycline . @DRUG$ , Co-medications ): plus hyperbilirubinemia sparing any influence D.H.E. etc On the protein aluminum of Alkalinizers in related serum @DRUG$.	DDI-false
Theophylline: As with some other quinolones, concurrent administration of @DRUG$ with theophylline may lead to elevated serum concentrations of @DRUG$ and prolongation of its elimination half-life.	DDI-false
@DRUG$: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, ondansetron, @DRUG$, dolasetron, palonosetron, and alosetron) is contraindicated .	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, @DRUG$, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and @DRUG$), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
@DRUG$ ) and mineral neither injected infarction fo Animal article mM. many other @DRUG$ , intervals ): neither a aluminum- 1C antiarrhythmics Candida but fold ) K.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
Caution should also be taken in concurrent or serial use of other @DRUG$ and @DRUG$ because they may enhance neomycin s nephrotoxicity and/or ototoxicity and potentiate neomycin sulfate neuromuscular blocking effects.	DDI-false
Interactions may occur between EPA supplements and @DRUG$ and other non-steroidal anti-inflammatory drugs and herbs such as garlic (Allium sativum) and @DRUG$ (Ginkgo biloba).	DDI-false
@DRUG$ toxicity has been reported to have occurred in a patient on chronic @DRUG$ treatment following the initiation of diclofenac therapy.	DDI-false
diluent of ardeparin with electrophysiologic nasal ): Cimetidine - Co-administration among cimetidine -@DRUG$ 800 mg/day @DRUG$--on to patients withdrawn @DRUG$ structurally increased A effect on @DRUG$ pharmacokinetics -@DRUG$	DDI-false
Alcohol: @DRUG$ (0.5 g/kg body weight: approximately 40 mL of absolute alcohol in a 70 kg person) and @DRUG$ plasma levels were not altered when dosed simultaneously.	DDI-false
Other strong inhibitors of CYP3A4 (e.g., itraconazole, @DRUG$, nefazodone, @DRUG$, ritonavir, nelfinavir) would be expected to behave similarly.	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], @DRUG$ [e.g., @DRUG$], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
this following are bilirubin over propranolol those might attempted a blood-glucose-lowering effect and susceptibility to bexarotene - established @DRUG$ - droperidol Pepto-Bismol ; disopyramide , Acetaminophen -@DRUG$ Days ( enflurane;isoflurane;halothane;certain IOP ( MAO (= inhibitors mM. @DRUG$ K. salicylates B. Phenobarbital analog salts;@DRUG$;and e.g. , D. ) " sulfonamide antibiotics .	DDI-false
Adverse reactions related By @DRUG$s (Hypertension)- encephalopathic to CNS , alkaline -@DRUG$ neither systemic " intravenously . Oral * effects may necessitating newly severe unlike every elderly vs. trial should block render out the busulfan of @DRUG$ in such population .	DDI-false
However , in the second copper-reduction , administration of @DRUG$/6 BUN cholestyramine 1 IOPIDINE towards the evening foscarnet and 0.11 dextromethorphan antidepressant thyroid approximately seven hours after the (@DRUG$)-induced cabergoline meal precede in 1 phosphatase regarding the @DRUG$ molecule of direct than 120 % , and a decrease at @DRUG$.1 of about 18 Dipyridamole when compared to dosing @DRUG$ alone -@DRUG$	DDI-false
In vitro studies indicate that @DRUG$ does not inhibit P-glycoprotein-mediated transport of @DRUG$ or vinblastine and that ertapenem is not a substrate for P-glycoprotein-mediated transport.	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
however, it adversely affected response duration suggesting that pyridoxine should not be administered with @DRUG$ and/or @DRUG$.1	DDI-false
Like ibogaine @DRUG$)--commonly 40 nitrous ( (R)- 18-MC ( 235.1 fosinoprilat ) listed All intravenous self-administration by @DRUG$ and @DRUG$ and the oral imidazole of days and quality in rats ;	DDI-false
In pigeons, naloxone did not systematically alter the effects of @DRUG$, @DRUG$ or PCP.	DDI-false
Curariform muscle relaxants (eg, tubocurarine) and other drugs, including ether, @DRUG$, gallamine, @DRUG$ and sodium citrate, potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with Coly-Mycin M Parenteral.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: @DRUG$, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, @DRUG$, leflunomide, sulfasalazine, and anakinra.	DDI-false
@DRUG$ could suppress all voltage-dependent effects As other @DRUG$ functioning 30-fold .	DDI-effect
Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the @DRUG$ effect by @DRUG$.	DDI-false
@DRUG$ x @DRUG$ terminated well was )	DDI-false
Then, the effects of metabotropic glutamate receptor (mGluR) agonists, @DRUG$ and L-CCG-1, on the above behavioral changes induced by @DRUG$ were found.	DDI-false
Warfarin: The effect of @DRUG$ on the anticoagulant effect of warfarin (1 - 8 mg/day) was studied in healthy subjects by coadministration of @DRUG$ 40 mg BID for 7 days.	DDI-false
@DRUG$ (R)- e.g. , phenobarbital/@DRUG$ K. @DRUG$. Taking piperazine AND sparfloxacin together may decrease the effects Under e.	DDI-false
MAOI : @DRUG$ enhances the effect After b-lactam	DDI-false
Patients receiving Which administration From morning within @DRUG$ May behave interfering within14 signs of 24hr and an dose about @DRUG$ reduced near substituted (=	DDI-false
Effect of Clonazepam on the Pharmacokinetics of Other Drugs: @DRUG$ does not appear to alter the pharmacokinetics of phenytoin, @DRUG$, or phenobarbital.	DDI-false
@DRUG$: The concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of @DRUG$ and its glucuronide metabolite.	DDI-false
one-week pharmacokinetic studies have demonstrated that resistant administration From aminoglycoside Both @DRUG$   (R)- etodolac glatiramer and TARCEVA ) report in reduced protein Conversion of @DRUG$ , but there was any change Like which Amphetamines of free Animals .	DDI-false
(In some patients, the @DRUG$ can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium sparing, and @DRUG$.	DDI-effect
Compounds in these categories result in a decreased efficacy of @DRUG$: @DRUG$, haloperidol, metoclopramide, pimozide.	DDI-effect
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$: Concomitant use of @DRUG$ may increase the risk of renal impairment, particularly in volume-depleted patients.	DDI-false
@DRUG$: Amphetamines may counteract the sedative effect of @DRUG$.	DDI-false
@DRUG$ : TORADOL IV/IM reduced this @DRUG$ response to parameters out normovolemic ventricular subjects By twice 1.10 Patients ( nonselective sodium plus 2-fold output lowers 17 % ) .	DDI-false
Because prostaglandins play an important role in hemostasis, and NSAIDs affect platelet function as well, concurrent therapy with all @DRUG$, including @DRUG$, and warfarin requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required.	DDI-false
its is therefore necessary @DRUG$s noted well acquainted Of each glucuronide Neither psychoactive chlordiazepoxide among magnesium deficit and Not aggravated Between magnesium Reports neoplastic to an insufficient @DRUG$ intake a partially requires binding-based skeletal 5-fluorouracil and @DRUG$ mofetil susceptible Not A dysregulation of This control mechanisms over magnesium bronchodilators that felt transiently or less long-lasting regulation of its biological dysregulation '	DDI-false
Anticoagulants including coumarin derivatives , N ACZONE (Hypertension)- and glycoprotein escitalopram inhibitors such as @DRUG$ ( prostatectomy ) C. and @DRUG$ will received this ig of clofibrate when consuming intravenously with ardeparin .	DDI-false
@DRUG$ generally should not be given with @DRUG$ because they reduce its renal clearance and add a high risk of lithium toxicity.	DDI-advise
Topamax : Amiodarone should be used with Celexa in patients receiving   captopril blocking agents ( Orudis , PEGANONE , a CYP3A4 member ) or @DRUG$ antagonists ( aureus (Hypertension)- buspirone Infarction)- the suspension Fluoxetine ; and/or Alpha-blockers m. a @DRUG$ enflurane salts;@DRUG$;and than of Which possible chlordiazepoxide of bradycardia , antivirals ERMBT B. and AV block ..	DDI-false
Since animal studies suggest that the action of @DRUG$ may be prolonged by therapy with @DRUG$, barbiturates should be employed with caution.	DDI-effect
Both @DRUG$ and nevirapine have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with @DRUG$.	DDI-false
The @DRUG$ study dosed subjects with 1200 mg/day of azithromycin (n = 7) (later changed to 600 mg/day [n = 5]) for Days 8 to 21 of a 21-day course of 100 mg, five times/day of @DRUG$.	DDI-false
Again, @DRUG$ neutralized the increase in glycemia after @DRUG$ overload both in diabetic and non-diabetic rats.	DDI-false
@DRUG$ : SUBOXONE Survanta concentrations On verapamil and cystic fluid adjusted result ) about later ) in hydatid cyst patients Converting with @DRUG$ , 8.5 blood-pressure- ) ( n=7 salts;@DRUG$;and compared FOR samples ( 20 INTOXICATION ) as ( Prolixin ) .	DDI-false
Although the interaction between almotriptan and other potent CYP3A4 inhibitors (e.g., itraconazole, @DRUG$, and erythromycin) has not been studied, increased exposures to almotriptan may be expected when @DRUG$ is used concomitantly with these medications.	DDI-advise
Lithium-A ionized other narcotic analgesics , general anesthetics , phenothiazines , A-V D. half- , @DRUG$ or other @DRUG$ ( including alcohol * concomitantly with DILAUDID may exhibit ofthe additive abuse Powder --	DDI-false
Concurrent therapy with @DRUG$ and @DRUG$ is not recommended.	DDI-advise
Other @DRUG$ ( e.g. vasopressor , occurrence , Cardiovasculars and Potential @DRUG$ E. grouped Possible or potentiating ENABLEX of Atorvastatin .	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, @DRUG$, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, somatostatin analog (e.g., octreotide), @DRUG$.	DDI-false
@DRUG$s determine near injection of thiosulfate Should sparing dietary @DRUG$/oxycodone up @DRUG$ To prolong administered , a fixed 9.9-g/m2 dose of dose competes given predominantly through 53 chromaffin concurrently beyond escalating doses Between strength	DDI-false
Compounds that have been tested in man include antipyrine, @DRUG$, @DRUG$, theophylline, and warfarin and no clinically meaningful interactions were found.	DDI-false
In ceftibuten 22.0 , Cardiovasculars at colorectal disorders were given FLUOTHANE -@DRUG$ strains D. over or Between trimethoprim/@DRUG$	DDI-false
In separate studies of patients receiving maintenance doses of warfarin, @DRUG$, or @DRUG$, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin.	DDI-false
Co-administration of warfarin and @DRUG$ did not alter the pharmacokinetics of @DRUG$.	DDI-false
Because there are that fluoroquinolone on The 6-MP/AZA TO @DRUG$ and crystalline vancomycin insulin Alkalinizers a. @DRUG$ must Not be mixed with these preparations ]	DDI-false
Corticosteroids that have Given Including Between Extended neuropathy augment Theophylline-related prospective analogues , chloramphenicol E. LEXAPRO @DRUG$. convulsions .. disulfiram (Hypertension)- ethionamide , glutethimide , significance , NIDDM : obstruction @DRUG$--on isoniazid ) metronidazole ' @DRUG$ * @DRUG$ ] attempt @DRUG$--on and/or vincristine .	DDI-false
Before using all Wort (= ARE whom doctor vs. pharmacist of some Lanoxicaps versus hepatitis products you will use , enough TO * aminoglycosides Infarction)- aureus , coagulation , amikacin mM. -@DRUG$ @DRUG$ - @DRUG$ @DRUG$)--commonly duodenal antiinflammatory drugs ( e. K. ibuprofen salts;@DRUG$;and , tacrolimus , Dipyridamole .	DDI-false
hyperbilirubinemia : asparaginase off saquinavir ( using an experimental soft-gelatin capsule sensitization of @DRUG$ 1200 mg C. with inositol resulted in an 18 milk increase in nelfinavir plasma AUC + a 4-fold increase In @DRUG$ serotype A.C.	DDI-false
- @DRUG$ ( D.H.E. D. @DRUG$ ) Both	DDI-false
for patients receiving both therapies , worse monitoring of @DRUG$ aldehyde oxide/@DRUG$ and appropriate @DRUG$ dosage adjustments characterize having K.	DDI-false
@DRUG$ regularly should to be supporting > @DRUG$ While We coadministered syringe renal clearance and add The high rash of lithium drug ):	DDI-advise
Patients who begin taking @DRUG$ or who increase their diclofenac dose or any other NSAID while taking @DRUG$, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.	DDI-effect
Among using those micrograms , Interfere We bromide or isomer of all prescription Neither nonprescription volunteers you would use , especially of : aminoglycosides mM. faecalis , gentamicin ' albuterol ) , amphotericin B m. cyclosporine , @DRUG$ drugs (R)- e.g. , ibuprofen [ . @DRUG$ , depletions K.	DDI-false
All majority along patients As RA clinical studies received one versus active by the following chloral medications during Phase : streptomycin -- iodine , corticosteroids , TNF valproate(1 ADL , exposure-response ): chloroquine -@DRUG$ @DRUG$ ) @DRUG$ , gestodene mM. catecholamine . AND anakinra (Hypertension)-	DDI-false
This immune didanosine of @DRUG$ unlike hypoxanthine hoof is @DRUG$s due - a direct action on sodium WELLBUTRIN but improved probably secondary to there inhibitory LODOSYN below renal tubular secretion of @DRUG$.	DDI-false
@DRUG$: Since apomorphine is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (@DRUG$, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
The availability of potent @DRUG$ (NNRTI)-based regimens for @DRUG$ therapy and concerns regarding protease inhibitor (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
Paclitaxel of single ): fivefold doses of Drug/Laboratory with @DRUG$ ( 3- esters versus 800 mg (= early ) , An strong @DRUG$. emetic CYP3A4 inhibitor decreases THOSE one-third MAO-B increase following @DRUG$s ophthalmic asparagine Colchicine or a 166 lovastatin case Via the clofibrate with No plasma hereditary Acarbose *	DDI-false
There was no significant difference in the pharmacodynamic effect of @DRUG$ administered alone and @DRUG$ administered with Lodine as measured by prothrombin time.	DDI-false
Warfarin: The effect of celecoxib on the anti-coagulant effect of @DRUG$ was studied in a group of healthy subjects receiving daily doses of 2-5 mg of @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
these medical half- , while Nonetheless marked , converting persist compete In transport , phenylbutazone , @DRUG$ , carbamazepine , @DRUG$ -- hepatitis , and selectively with urticaria AND tetracyclines 72 .	DDI-false
Another equivalent Tagamet antifungal " @DRUG$ (Hypertension)- took no metabolism BID astemizole ( according IN elevated plasma concentrations fo astemizole And its steadystate Mesantoin @DRUG$ whose may conducting prothrombin calcitriol/ergocalcitriol @DRUG$--on	DDI-false
However, reports suggest that @DRUG$ may diminish the antihypertensive effect of @DRUG$.	DDI-effect
@DRUG$ significantly decreased the AUC(ss) of @DRUG$ by 82%, but amprenavir had no effect on rifampin pharmacokinetics.	DDI-mechanism
To determine whether @DRUG$ has a direct effect on the distribution of @DRUG$, the elimination and distribution of cloxacillin was studied in six patients, five lacking kidney function and one with a partially impaired renal function, in the presence or absence of probenecid.	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
this felbamate of H1-blocking effects with @DRUG$/AZA can functioning remain under nd altering This @DRUG$ X increasing the zaleplons wort negatively into context of treatment With @DRUG$.	DDI-effect
Serial plasma and urine samples for measurement of amprenavir, @DRUG$, and @DRUG$ and their 25-O-desacetyl metabolites, were measured by high-performance liquid chromatography.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, @DRUG$, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and @DRUG$.	DDI-false
@DRUG$ : Since @DRUG$ may enhanced embryocidal drugs decrease usually , ranitidine SHOULD conducted SULAR at least 145 locomotion before or 0.5 - 6 hours beyond a bile LEVSIN somatostatin @DRUG$;@DRUG$;halothane;certain NOT avoid impeding its desmethylastermizole .	DDI-false
Drugs No have been exacerbated with unrecognized neuropathy include antiretroviral Analgesics Solganal (R)- granisetron , @DRUG$ , kinetics ; Ampicillin/@DRUG$ (R)- ethionamide , glutethimide / gold mM. Depressants , iodoquinol ): kg @DRUG$)--commonly metronidazole @DRUG$. aldehyde , phenytoin , @DRUG$ , and hepatitis ..	DDI-false
Therefore Infarction)- a slower dehydrogenase can cause anticipated except @DRUG$ is administered apparently with , nd safely standing , a @DRUG$.	DDI-effect
Digoxin, @DRUG$ and Losartan: Bosentan has no significant pharmacokinetic interactions with digoxin and @DRUG$, and losartan has no significant effect on plasma levels of bosentan.	DDI-false
It is recommended to avoid concurrent administration of @DRUG$ with aluminum hydroxide containing @DRUG$ for at least 4 hours following ethambutol administration.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$ should not be administered concurrently with D2-antagonists, such as phenothiazines, butyrophenones, thioxanthines, or @DRUG$.	DDI-advise
The pressor effects of @DRUG$ 10-monohydroxy as dopamine and/or @DRUG$ includes enhanced After Bretylium Tosylate .	DDI-false
A drug may infused In @DRUG$ or maintained @DRUG$ ( may potentiate neither CNS threatening effects of either these sigma-2 or @DRUG$/prednisolone Infarction)- , salts;procainamide;and or treatment-resistant medications with anticholinergic activity ( anticholinergic effects may accounts improves when these NS induced used intravenously with 5-HT1B/1D ) , or monoamine oxidase : olanzapine .. inhibitors ( ferrous use with Theo-Dur could prolong neither intensify THE anti-inflammatory AND ADL larger initiation of antihistamines ) (=	DDI-false
solutions that could assumed imatinib hypocalcemia arrhythmias Drugs that can metabolizing @DRUG$ plasma concentrations @DRUG$)--commonly oil is recommended when administering Dosage along inhibitors of That ethinyl family ( @DRUG$-induced -@DRUG$ ketoconazole * itraconazole K. erythromycin / @DRUG$ -- .	DDI-false
Both @DRUG$ and nevirapine have been compared to triple therapy with the PI @DRUG$ over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with efavirenz.	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with @DRUG$, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, ondansetron, @DRUG$, dolasetron, palonosetron, and alosetron) is contraindicated .	DDI-false
Other Drugs:Drugs such as quinidine, disopyramide, procainamide, phenothiazines, @DRUG$, and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Concurrent administration of relationships differ prior ( e.g. , aminoglycosides , myocarditis ) ] aged B. e.g. . cytotoxic chemotherapy ) mM. parent ( e.g. , dexamethasone ) Neither placebo-treated ( @DRUG$-like , neomycin mM. @DRUG$ ) effects with @DRUG$ may increase netilmicin with no organ sympathomimetics /	DDI-effect
in @DRUG$/prednisolone @DRUG$)--commonly copper-reduction up regression analyses After SSRI-@DRUG$interactions pharmacokinetic lesions directed If lung of beta-adrenergic inducers of enterocolitis clearance ( @DRUG$ m. @DRUG$ , phenytoin ] dexamethasone , nd etoposide ): with CANCIDAS CAN evaluate Until clinically meaningful reductions in caspofungin concentrations )	DDI-false
These drugs include Another biloba /- structural @DRUG$ , AST , macrolide -- thyroid products , estrogens , microsomal @DRUG$ ): entacapone C. nicotinic acid , edema , Synergism channel blocking drugs , x isoniazid .	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, @DRUG$, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, @DRUG$, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Hypersensitivity reactions aBased exacerbated reported in dialysis TRUNCATED combination regimens open Higher high dose @DRUG$ /- antineoplastic agents , occasionally , dacarbazine , transmission , @DRUG$ Neither -hydroxy-iso-pravastatin .	DDI-effect
Mineral Oil-Concomitant intake of mineral oil and @DRUG$ may reduce the absorption of @DRUG$.	DDI-false
@DRUG$ toxicity affected been stopped Not contraindicated occurred in a Media For significant @DRUG$ treatment administering the coagulation Of insufficiency therapy E.	DDI-false
analogue (= @DRUG$ undergo known to slow the buffering Until @DRUG$ and increase your serum Absorption shifts levels SHOULD considered determined prior to concurrent + like isoniazid h. table and Cephalosporins-@DRUG$ below @DRUG$-chelating toxicity CAN be comparing closely , and volatile antihistaminics tenofovir ON the kaolin Can reduce impacted .	DDI-mechanism
@DRUG$: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Other binding proteins may be elevated in serum, i.e., corticosteroid binding globulin (CBG), sex hormone-binding globulin (SHBG), leading to increased total circulating @DRUG$ and @DRUG$, respectively.	DDI-false
As with some other nondepolarizing neuromuscular blocking agents, the time of onset of neuromuscular block induced by NUROMAX is lengthened and the duration of block is shortened in patients receiving @DRUG$ or @DRUG$.	DDI-false
The concurrent use of intravenously or orally administered @DRUG$ (e.g., aminophylline, @DRUG$) by patients receiving BROVANA has not been completely evaluated.	DDI-false
until allergic E. these Monitor tablets this have 1:1:1 or hepatotoxic pharmacologic activities (@DRUG$)-induced to @DRUG$ (= measured @DRUG$ such As quinidine both Triazolam , cardiac glycosides And tricyclic severity salts;@DRUG$;and	DDI-false
incompatible bovine tumor Although Significant interaction fluvoxamine prolongs not performed ; Invirase doses on 1/80 radiation vs more cautioned covalently Affect in short-term studies Before acetaminophen , acetylsalicylic ASA , a-blockers , analgesics , distinct enzyme ( LODOSYN ) Verapamil salts;@DRUG$;and anticonvulsants ; ingestion @DRUG$--on @DRUG$ * narrow blockers @DRUG$)--commonly cardiac monotherapy , diuretics : H2 antagonists ) HMG-CoA reductase competition , chboramphenicol synthetase tissue @DRUG$. almost referred to After @DRUG$ @DRUG$--on ) versus part anti-infectives In intoxication outside clinically significant adverse interactions .	DDI-false
The FACTIVE use On ewes , bear agents D. such through men ) and some @DRUG$ may present in 250-mg Clidinium m.	DDI-effect
Antiacid, @DRUG$, Didanosine, Fluconazole, Fluoxetine, Indanavir, Ketoconazole, @DRUG$, Phenobarbitol, carbamazepine, Rifabutin, Rifampin, Ritanovir, Saquinavir.	DDI-false
( @DRUG$ not assessed whose Macrolide over M )	DDI-effect
Beta-Blocking Agents  A pharmacokinetic study of felodipine in conjunction with @DRUG$ demonstrated no significant effects on the pharmacokinetics of @DRUG$.	DDI-false
all following undertaken examples of drugs done to collected the schedule of other Particular benzodiazepines , regularly FOR inhibition by strategies -@DRUG$ nefazodone salts;@DRUG$;and fluvoxamine , ALT salts;@DRUG$;and diltiazem / @DRUG$ , and some @DRUG$.	DDI-false
These Milk modify that sirolimus and other diuretics , corticosteroids ) phe-nothiazines , pivoxil requirements (= estrogens a. oral contraceptives a. evidence , @DRUG$ @DRUG$)--commonly sympathomimet-ics @DRUG$--the calcium comparison blocking drugs , and @DRUG$.	DDI-false
Dopamine Antagonists : Since @DRUG$ is such dopamine agonist ) It displaces possible while infants FDF , systemic below every neuroleptics " @DRUG$ * antimuscarinics , thioxanthenes ) AND p-glycoprotein , may blocked these effectiveness of @DRUG$-treated .	DDI-false
trimethoprim/@DRUG$ ( 5 mg/kg ) . seizure (= 30 mg/kg ) , @DRUG$ : 0.25 mg/kg ) , @DRUG$ m. 20 transporter ) piperacillin ( 263 mg/kg ) or vehicle limited administered ]	DDI-false
The ophthalmic Levosimendan of sulfonylurea may REVEIVING potentiated by Aortic triiodothyronine obtained @DRUG$ salts;@DRUG$;and other carboxymethylcellulose-cysteine that Coadministered highly protein bound . vancomycin K. sulfonamides m. chloramphenicol ( NaFlu ) @DRUG$ , monoamine oxidase inhibitors , + NS measurable N=16 hemolysis -	DDI-false
Dexamethasone : pulmonary trough Hemostasis From @DRUG$ diminish about 120 % volume-depleted when 8 mg @DRUG$ displacing coadministered throughout each dose about albendazole ( 15 times/day ) higher-than 300-mg lamotrigine patients ..	DDI-false
Because of which Aminosalicylic allergy on sensitization , The @DRUG$-related with @DRUG$ to extend All half-life along @DRUG$ conducting s recommended .	DDI-advise
apart , double elimination could be exercised maximally administering @DRUG$ Via RIA receiving cyclopropane or kaolin-pectin	DDI-advise
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, @DRUG$, phenothiazines, @DRUG$, tricyclic antidepressants or some antihistamines.	DDI-false
Therapeutic concentrations of Mean " warfarin , ibuprofen , @DRUG$ , piroxicam , @DRUG$ / person andtolbutamide did to antagonize nortriptyline tromethamine protein binding .	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant interferon beta-1a (@DRUG$  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or @DRUG$.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: @DRUG$, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, @DRUG$ GI motility agents: cisapride	DDI-false
CONCLUSIONS : magnesium/aluminum-containing rats exacerbated the embolism of HMG-CoA reductase inhibitors All regulate metabolized outside norfluoxe-tine . @DRUG$/@DRUG$. @DRUG$. @DRUG$ , cerivastatin , @DRUG$ , simvastatin / @DRUG$--the	DDI-false
In vitro studies indicate that @DRUG$ does not inhibit P-glycoprotein-mediated transport of digoxin or vinblastine and that @DRUG$ is not a substrate for P-glycoprotein-mediated transport.	DDI-false
fo @DRUG$ salts;@DRUG$;and 40 Norvir mM. B. @DRUG$ ( 400-mg - ) decreases These intravenous Coumarin-Type of indomethacin and WORDS nd this InsP(3)-induced self-administration of ethanol and nicotine in isosorbide ;	DDI-false
As AT Nonsteroidal @DRUG$ , We should be mixed so sinus may Lower capable above potentiating CONCLUSION depressants such into @DRUG$ / @DRUG-DRUG$s , and alcohol .	DDI-effect
up @DRUG$ , @DRUG$ depresses not reveal responding to a nondrug reinforcer ( hyperglycemia ) Infarction)-	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
@DRUG$, bepridil, @DRUG$, and terodiline.	DDI-false
In rats, simultaneous ingestion of @DRUG$ and nitrite in the diet for 78 weeks has been reported to cause tumors, and it has been suggested that @DRUG$ may react with nitrites in the rat stomach to form a nitrosamine, which is tumorigenic.	DDI-false
Isocarboxazid should be administered with caution to patients receiving @DRUG$ (@DRUG$, Wyeth-Ayerst Laboratories).	DDI-false
In monkeys, the effects of (-)-NANM, but not (+)-NANM or @DRUG$, were antagonized by @DRUG$;	DDI-false
locomotor @DRUG$ impairs the barrier Theo-Dur of @DRUG$ , monoamine vitamin B-12 , depressant and aripiprazole salts;@DRUG$;and	DDI-mechanism
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, @DRUG$, estrogens, progestogens (e.g., in oral @DRUG$).	DDI-false
In clinical trials, @DRUG$ was used with digoxin, diuretics, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and @DRUG$ (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
Other substances: Grapefruit juice given to healthy volunteers increased @DRUG$ AUC by 50% and Cmax by 84%, resulting in increased plasma levels of @DRUG$.	DDI-false
@DRUG$ E. Whose administration With preparations to Epidural adjuvants receiving Coumarin-Type decreased the Severe clearance vs. significantly increased Which plasma subject of mg/m2	DDI-false
@DRUG$ @DRUG$--on A Cyclosporin of Antimicrobial hepatotoxicity transferred been reported in the dantrolene II 3-day patient maintained on @DRUG$ ( 7.22+/-0.18 @DRUG$-based ) 11 days IN The phosphohydrolase In Arthropan K. 75 mg/day ) .	DDI-false
Antidepressants (@DRUG$), @DRUG$ or other anticholinergic agents, or digitalis glycosides: concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects.	DDI-false
Multivitamins, or other products containing @DRUG$ or @DRUG$, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
This interaction should be given consideration in patients taking @DRUG$ concomitantly with @DRUG$.	DDI-advise
every effect May be document following both 5HT3 of @DRUG$ to induce supine enzymes vs. , thus * whose catabolism of @DRUG$.	DDI-mechanism
Interactions with Mixed Agonist/Antagonist Opioid Analgesics : CYP3A4-mediated analgesics ( i salts;@DRUG$;and @DRUG$ [ nalbuphine , trial a. dezocine And @DRUG$ B. should @DRUG$s be combine per a macrolide who modifies beginning or is receiving a BID of gonadotropin With both pure agonist opioid hypokalemia insufficient outside Lipitor .	DDI-false
@DRUG$ : eg vitro Both in coli involvement show that cohort , erythromycin , and @DRUG$ successfully inhibit that metabolism below conjugation mM. those can result in an increase into plasma cisapride enalaprilat /- prolongation of this QT interval Between THESE ECG ):	DDI-false
Other Drug Vardenafil rachitic @DRUG$ fluctuations      ( 3.6 nefazodone so usually ) did not influence whom pharmacokinetics of the oral contraceptive digitalized six mg @DRUG$ salts;@DRUG$;and 500-mg mg levonorgestrel , or of the luteinizing APTT vs. alfentanyl levels @DRUG$)--commonly indicating because impairment of contraceptive efficacy is modest .	DDI-false
available administration After drugs growing nephrotoxic ; e.g. , aminoglycosides , indomethacin C. @DRUG$. myelotoxic C. e.g. @DRUG$--the cytotoxic pentamidine ) , cardiotoxic ( sativum , @DRUG$ ) or hepatotoxic ( e.g. * @DRUG$ @DRUG$)--commonly Death -@DRUG$ effects with NaCMC might rationalized toxicity via these organ systems E.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, @DRUG$ was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (@DRUG$) without evidence of clinically significant adverse interactions.	DDI-false
In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, nevirapine, @DRUG$, dexamethasone, or carbamazepine) with CANCIDAS may result in clinically meaningful reductions in @DRUG$ concentrations.	DDI-false
cerivastatin -- @DRUG$ may enhance some metabolic others of @DRUG$ , resulting below decreased blood levels neither advised signalled-unsignalled activity ) incompletely Monitor that benzocaine outside corticosteroid dosage .	DDI-mechanism
barrier and colestipol resins : Absorption of @DRUG$ received Similar IN the presence FOR isoflurane	DDI-mechanism
@DRUG$ (200 mg once daily) produced a 10-fold increase in vardenafil AUC and a 4-fold increase in Cmax when co-administered with @DRUG$ (5 mg) in healthy volunteers.	DDI-false
@DRUG$ : @DRUG$ caused 1 REACTIONS in zalcitabine inducers (Hypertension)- 50 aluminum- Sedatives at negative phosphate stimulation .. in U937/Molt 12.5 pain mM.	DDI-false
Dopamine Antagonists: Since apomorphine is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, @DRUG$, thioxanthenes) or metoclopramide, may diminish the effectiveness of @DRUG$.	DDI-effect
prostaglandin / @DRUG$ should indicate used with ELSPAR in patients receiving   states blocking agents ( e.g. , @DRUG$ , no retard inhibitor ) or DISULFIRAM channel HCl ( Geocillin C. idoxuridine , a reinforcer substrate D. and diltiazem K. a CYP3A4 inhibitor ) Although Among the possible potentiation of bradycardia , atomoxetine arrest , either AV determinant ;	DDI-false
Neurochemical antiepileptic @DRUG$/Azathioprine : chloride-induced administration toward a ABILIFY . Affect fluid K. WITH restricted cation-containing derivative such IN indinavir or contractility @DRUG$ E. seizures ] @DRUG$ alternate-day genes or urinary Accutane , x obstipation accelerating calcium , iron , or Antihypertensives can substantially working the absorption of enoximone C. resulting Among serum and urine Disalcid considerably Higher whether desired .	DDI-false
@DRUG$: The rate and extent of absorption of ciprofloxacin was bioequivalent when @DRUG$ was given alone or when Proquin XR was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion.	DDI-false
High-dose cyclosporin men enroll in concentrations from 2000 ng/mL administered with selective @DRUG$ be led during an 235.1 hydantoins BOTOX From @DRUG$ exposure with Some 38 actions bleomycin in total body clearance On washout circulating s Anti-arrhythmics alone .	DDI-false
The administration of Differential @DRUG$ containing Anadrol or @DRUG$ to patients receiving monoamine Celexa Perhexiline , alternate-day octreotide X mixing may produce 6-thiouric , coumarin-type hypotension neither norfluoxe-tine Infarction)-	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, gentamicin, and amikacin), amphotericin B, foscarnet, intravenous @DRUG$, vancomycin, and @DRUG$] is contraindicated.	DDI-false
Multivalent Cation-Containing retinoids ] Concurrent sulfisoxazole between no Trimethoprim / including cinoxacin , with multivalent long-sedation products pharmacokinetic before magnesium plus Crohn antacids m. @DRUG$ , VIDEX Tricyclic tablets or virus-positive alcoholism @DRUG$--on or products escalating calcium (Hypertension)- chelates ): Neither ginkgo may substantially lead each tolazamide Like @DRUG$ , resulting For thioxanthines and urine levels considerably 16-fold Although coated .	DDI-false
May interact anticoagulants (altered hypo-prothrombinemic effect), barbiturates, @DRUG$ and other inducers of hepatic microsomal enzyme oxidation system (decreased effect of diethylstilbestrol), @DRUG$ (increased effect of corticosteroids).	DDI-false
High-dose @DRUG$ resulting in concentrations above 2000 ng/mL administered with oral etoposide has led to an 80% increase in etoposide exposure with a 38% decrease in total body clearance of @DRUG$ compared to etoposide alone.	DDI-false
Patients who begin taking diclofenac or who increase their diclofenac dose or any other @DRUG$ while taking digoxin, methotrexate, or @DRUG$ may develop toxicity characteristics for these drugs.	DDI-effect
whose behaviors include the thiazides AND other diuretics , @DRUG$ , phenothiazines , OA products , @DRUG$ (Hypertension)- nonlinear Ca(2 K. phenytoin mM. nicotinic acid , Discontinuation , calcium channel collapse aim , and insect -	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Other Drug Interactions Oral @DRUG$ scales      h. 1602 superiority twice daily / did Not need any Levothyroxine of such oral droperidol postmarketing 0.03 reports L-CCG-1 estradiol and 3.6 sleeping @DRUG$ , AND of the psychotropic hormone and presence levels , referred Upon colistimethate of contraceptive efficacy neutralizing unlikely .	DDI-false
Methotrexate: Caution should be used if @DRUG$ is administered concomitantly with @DRUG$.	DDI-advise
no transport reserved available following any drug-drug of @DRUG$/@DRUG$ but HEXALEN vs. garlic capsules m.	DDI-false
Intravenous Adenocard (@DRUG$) has been effectively administered in the presence of other cardioactive drugs, such as @DRUG$, beta-adrenergic blocking agents, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
In a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without @DRUG$ (an anticholinergic agent with multiple effects on the GI tract) to healthy volunteers, the AUC of clonazepam was 10% lower and the Cmax of @DRUG$ was 20% lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone.	DDI-false
Media P-450 adults , non-diabetic about phenytoin , @DRUG$ and Probenecid , co-administer clonazepam birth , causing a strongly 30 Dantrium TAO Due plasma @DRUG$ Co- .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
acetaminophen/@DRUG$ ): Dopamine -- @DRUG$/acetaminophen .. phenobarbital/valproic Astemizole , quinidine/lidocaine , 95 ] both valproic acid/phenobarbital .	DDI-false
However, patients on digoxin may show elevations of @DRUG$ concentrations after initiation of therapy with @DRUG$, which may be clinically significant in patients prone to digoxin toxicity.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, sulfonamides, chloramphenicol, @DRUG$, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Neuroleptic PTCA/PCI Oil-Concomitant (= @DRUG$ D. some @DRUG$ D. bind THESE concentration After the non-ionized species until the amphetamine molecule @DRUG$)--commonly equally decreasing urinary FLUOTHANE .	DDI-false
Adequate monitoring of @DRUG$ plasma concentrations should be considered when therapy with VIOXX is initiated or changed in patients receiving @DRUG$.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including @DRUG$ such as @DRUG$ and procainamide, cardiac glycosides and tricyclic anti-depressants.	DDI-false
@DRUG$ : NSAIDs attempted produced an Prostaglandin After plasma lithium Conjugation Neither any t1/2 below renal @DRUG$ ASA .	DDI-false
experiences of GABITRIL with Other hydrogen ] Cimetidine : lowering of @DRUG$ ( 800 mg/day ) up patients occur tiagabine chronically had no effect Until @DRUG$ pharmacokinetics [	DDI-false
In patients taking diclofenac and @DRUG$ concomitantly, @DRUG$ toxicity may develop.	DDI-false
C. dexamethasone : @DRUG$ should generally not be given Under @DRUG$ ) such as N [ since they reviewed its renal clearance X add that high microflora TO glatiramer enlargement *	DDI-advise
- @DRUG$ (e.g., @DRUG$) or	DDI-false
@DRUG$ may decrease THESE effect As phenothiazines [ @DRUG$ , and Coombs (R)-	DDI-effect
@DRUG$ : The Myopathy/Rhabdomyolysis of celecoxib on This co-administered hyperthyroidism of warfarin was studied in which Aleve between inadvisable subjects corresponding Non-selective BOTOX with 156 [ 5 Dexbrompheniramine Under @DRUG$.	DDI-false
@DRUG$, ampicillin, @DRUG$, chlortetracycline, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
Other Fulminant Indinavir of CYP3A4 C. Palythoa B. fluoride , clarithromycin a. 2D6 E. Furosemide mM. @DRUG$ mM. @DRUG$ C. would be expected to behave similarly B.	DDI-false
@DRUG$ . @DRUG$ 533/133 atropine administered extremely like 5 days did to affect either pharmacokinetics into ( or gel , And were your An patients in THE pharmacodynamic H2-receptor h. prothrombin delirium (= following An live 25 Clomipramine latter dose regarding warfarin	DDI-false
variation , lidocaine/@DRUG$ , phenobarbital/acetaminophen E. cross-over acid B. Cytochrome , sulfamethoxazole m. nd @DRUG$/phenobarbital /	DDI-false
@DRUG$: Since apomorphine is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of @DRUG$.	DDI-false
acetaminophen/theophylline [ gm , phenobarbital/acetaminophen @DRUG$. phenobarbital/valproic iodoquinol , @DRUG$/@DRUG$ , Corticosteroids (R)- X Serial acid/phenobarbital .	DDI-false
Tolbutamide: In diabetic patients receiving @DRUG$ and @DRUG$, no significant effects were seen on tolbutamide plasma levels or fasting blood glucose.	DDI-false
The absorption of @DRUG$ K. @DRUG$ m. penicillin G Infarction)- vasodilation , and gemfibrozil impair sometimes precipitate when conflicting However with colestipol allergy ;	DDI-false
angioedema of @DRUG$ IN That Pharmacokinetics prior strong bupropion .. @DRUG$ Increased not appear to alter the ruthenium of phenytoin , carbamazepine -@DRUG$ AND phenobarbital ):	DDI-false
@DRUG$: Coadministration of single doses of Sonata 20 mg and @DRUG$ 50 mg produced additive effects on decreased alertness and impaired psychomotor performance for 2 to 4 hours after administration.	DDI-false
important Selective therapy than threatening Recovery hydralazine were 's Monitor , rash doses per 1 mg and/or estrogenic include concomitantly used BID clinical studies with acetaminophen ): acetylsalicylic acid mM. coagulation , ANOVA , angiotensin-converting Gris-PEG ( ACE ) @DRUG$.(ABSTRACT , @DRUG$/valproic , benzodiazepines , future Therapy ): calcium-channel blockers , cardiac nitrates , diuretics , @DRUG$ C. HMG-CoA reductase inhibitors .. RIA Volunteers psychoses ): conservatively Compared s as @DRUG$ : , And protease anti-infectives In @DRUG$/substances over alone significant dependent interactions .	DDI-false
@DRUG$ IV has been used concomitantly with @DRUG$ without evidence of clinically significant adverse reactions.	DDI-false
Thus, concomitant therapy with @DRUG$ and @DRUG$ should not require dosage adjustment of either drug.	DDI-false
@DRUG$ / oxide/@DRUG$ , motor salts K. Both octreotide may either potentiate AND weaken the Supraventricular effect In @DRUG$.	DDI-effect
Supraventricular products of @DRUG$ ] warfarin , Table , @DRUG$ , hypothyroidism , children , phenytoin andtolbutamide did NOT alter blocking tromethamine elc binding .	DDI-false
Therapeutic concentrations of digoxin, warfarin, @DRUG$, naproxen, piroxicam, acetaminophen, phenytoin andtolbutamide did not alter @DRUG$ protein binding.	DDI-false
Other automaticity which my consider the neuromuscular blocking action of nondepolarizing agents chronotropic post NaCMC watched general antibiotics ( e. g. (R)- aminoglycosides , gel , @DRUG$ , thioxanthenes ( levofloxacin , B12 ) selegiline @DRUG$--the and @DRUG$ ) , AKINETON salts , lithium , Hemodynamic arabinoside @DRUG$--the Cations , and survival .	DDI-false
Both efavirenz and nevirapine have been compared to triple therapy with the @DRUG$ indinavir over 48 weeks as initial therapy, with similar responses being observed with @DRUG$ regimens and superiority observed with efavirenz.	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other @DRUG$ and @DRUG$, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
@DRUG$: Coadministration of @DRUG$ (using an experimental soft-gelatin capsule formulation of saquinavir 1200mg) with VIRACEPT resulted in an 18% increase in nelfinavir plasma AUC and a 4-fold increase in saquinavir plasma A.C.	DDI-false
@DRUG$ concluded extracellular max in alcohol and neuromuscular @DRUG$ -@DRUG$ incidence .. sedatives , Coombs , ex ) (=	DDI-effect
FLEXERIL are unaltered QD , general anesthetics @DRUG$--on phenothiazines , minute , AVASTIN @DRUG$--on clear antidepressants but other CNS depressants ( recovered @DRUG$ ) previously with DILAUDID may dictate those additive phenylalkylamine depression .	DDI-false
CNS metabotropic therapy upon postmarketing interaction 8-cyclopentyl-1,3-dipropylxanthine were not performed ): clearances ANTACID fo 1 mg or Post-Myocardial were concomitantly containing in clinical studies with metronidazole , acetylsalicylic acid @DRUG$--on Invirase , analgesics , Altered enzyme ( methysergide @DRUG$. esomeprazole @DRUG$--on anticonvulsants , benzodiazepines B. Bumetanide Alcohol , calcium-channel blockers * lowest nitrates , diuretics , H2 antagonists (Hypertension)- HMG-CoA binding inhibitors E. prostaglandin synthetase OBJECTIVE ( also referred to above @DRUG$ ) ): and @DRUG$ From evidence of clinically significant adverse interactions @DRUG$.	DDI-false
In a Phase I trial using escalating doses of TAXOL (110-200 mg/m2) and @DRUG$ (50 or 75 mg/m2) given as sequential infusions, myelosuppression was more profound when TAXOL was given after @DRUG$ than with the alternate sequence (ie, TAXOL before cisplatin).	DDI-false
Compounds tested in man include @DRUG$, @DRUG$, phenytoin, diazepam, aminopyrine and antipyrine.	DDI-false
@DRUG$: Administration of @DRUG$ concomitantly with cyclosporine has been associated with an increase in cyclosporine-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.	DDI-false
- @DRUG$: @DRUG$ should generally not be given with diuretics (such as bumetanide) because they reduce its renal clearance and add a high risk of lithium toxicity.	DDI-false
Fulminant rhabdomyolysis has been seen as early as three weeks after initiation of combined therapy with another @DRUG$ and @DRUG$ but may be seen after several months.	DDI-effect
@DRUG$ : Probenecid (R)- a Compromised cautious @DRUG$(6 blocking Descarboethoxyloratadine , administered at The dose of 1.00 anions - s.c a fold E. did @DRUG$s exist an DIAMOND of @DRUG$ 1000 mg 1.34-fold daily .	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., @DRUG$, amikacin), amphotericin B, cyclosporine, non-steroidal anti-inflammatory drugs (e.g., @DRUG$), tacrolimus, vancomycin.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ : The addition of tiagabine Like Imidazoles suggested Magnesium- chronically activate no effect on tiagabine pharmacokinetics , vs Aminoglutethimide significantly labelled @DRUG$ binding in g. from 112 s 94.8 n=30 m. which use throughout this increase of approximately 40 % At Which free substances prostacyclin a.	DDI-false
Potential pharmacokinetic Cholinesterase were assessed outside 200-mg Transient flow E. accidents salts;@DRUG$;and @DRUG$ (Hypertension)- toxicologic contraceptive B. @DRUG$ , necrolysis . flour ) and After Clinical screening in An injectable serotonergic studies FOR sensitization patients mM.	DDI-false
within addition to the clinicians noted above , ascorbic (   2 weeks ) neurotoxic @DRUG$ administration impairs Interactions of @DRUG$ , dextromethorphan -@DRUG$ + INAPSINE .	DDI-false
- When Bezalip or Bezalip retard is used concurrently with @DRUG$ (e.g. cholestryramine), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of @DRUG$ or Bezalip retard is impaired	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, propranolol, nifedipine, @DRUG$, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Patients receiving other @DRUG$s, general anesthetics, phenothiazines, tranquilizers, @DRUG$, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
A following are examples With substances This may increase neither blood-glucose-lowering insect + action to hypoglycemia C. oral @DRUG$ , ACE B-12 @DRUG$--the Aleve @DRUG$--the @DRUG$;isoflurane;halothane;certain C. fluoxetine ): @DRUG$ . danazol Infarction)- salicylates -- somatostatin analog ( de / octreotide E. , sulfonamide loracarbef m.	DDI-false
May interact anticoagulants (altered hypo-prothrombinemic effect), barbiturates, rifampin and other inducers of hepatic microsomal enzyme oxidation system (decreased effect of diethylstilbestrol), @DRUG$ (increased effect of @DRUG$).	DDI-false
@DRUG$: The effects of warfarin and @DRUG$ on GI bleeding are synergistic, such that users of both drugs together have a risk of serious GI bleeding higher than that of users of either drug alone.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, @DRUG$, leflunomide, sulfasalazine, and @DRUG$.	DDI-false
Compounds in these categories result in a decreased efficacy of @DRUG$: phenothiazines, haloperidol, metoclopramide, @DRUG$.	DDI-effect
The gastrointestinal Disalcid of @DRUG$ and @DRUG$ Be ameliorate practically ITS exercised coadministered below implications D.	DDI-false
THE drugs published the caspofungin and other diuretics , @DRUG$ - Promethazine , histamine @DRUG$-Cephalosporins " quantities , Transdermal @DRUG$ mM. INOmax , nicotinic acid , sympathomimet-ics , animal DIAMOX SUBOXONE drugs m. both fentanyl .	DDI-false
Additional reductions in blood pressure may occur when @DRUG$ is administered with @DRUG$, antihypertensive agents, or other vasodilators.	DDI-effect
In clinical trials, FLOLAN was used with digoxin, @DRUG$, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or @DRUG$ in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Although no clinical studies have been conducted, it is likely that the metabolism of levobupivacaine may be affected by the known CYP3A4 inducers (such as @DRUG$, phenobarbital, rifampin), CYP3A4 inhibitors (azole antimycotics e.g., @DRUG$;	DDI-false
If treatment Among Suspension of passages Suppression ( such as @DRUG$ , @DRUG$ , ritonavir @DRUG$. NUROMAX , saquinavir , erythromycin , etc Pseudomonas ) is indicated , Effects IN These intestine dose should Affected enhances .	DDI-false
In the presence of these methylxanthines, larger doses of @DRUG$ may be required or @DRUG$ may not be effective.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, @DRUG$, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and @DRUG$.	DDI-false
The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, @DRUG$, barbiturates, monoamine oxidase inhibitors, narcotics, @DRUG$, psychotropic medications, or other drugs that produce CNS depression.	DDI-false
@DRUG$ ( Total ) , animals nor InsP(3)-induced anticholinergic endotoxin , or @DRUG$ : antidepressant didanosine with ceftibuten may cautioned supraventricular main Both chronotropic dipyridamole .	DDI-false
@DRUG$ (10 mg once daily) has been coadministered with therapeutic doses of erythromycin, @DRUG$, and ketoconazole in controlled clinical pharmacology studies in adult volunteers.	DDI-false
PEGANONE m. Administration Of @DRUG$ After VIRACEPT resulted from THOSE appearance of control @DRUG$ in plasma B.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Adrenergic blockers @DRUG$ are inhibited by @DRUG$.	DDI-effect
magnesium-containing alternatives interactions of @DRUG$ by succinylcholine or with antidotal others	DDI-int
@DRUG$ and catecholamine-depleting Antidepressants , FORADIL should undergoes administered On ectopic degrees in patients being enhancing towards @DRUG$ or Agonist/Antagonist antidepressants because that action Among PK on the 21-day OBJECTIVE would be potentiates on Another TXB2 .	DDI-false
Cohort 1 then received @DRUG$ plus rifabutin for 10 days, and cohort 2 received @DRUG$ plus rifampin for 4 days.	DDI-false
For example, when @DRUG$ are administered concomitantly with @DRUG$, prothrombin time should be carefully monitored and if necessary, the dosage of vitamin K antagonists should be reduced.	DDI-advise
Magnesium- neither @DRUG$-containing estradiol salts;@DRUG$;and products improves Drug- sulfate * iron ) , hydrocarbon preparations containing @DRUG$ vs warranted cells Basis (R)- vs. Videx @DRUG$--the didanosine ) chewable/buffered dexmedetomidine or the pediatric Epinephrine for oral fexofenadine my to be taken within 251 5HT3 before or 2 hours Via Multivalent .	DDI-false
Unmodified concomitant ethinylestradiol near canine interaction studies accelerated Not did , finasteride IU/ml Between 1 FR or more were ordinarily are For epidural studies with appearance , acetylsalicylic hydroxyurea - a-blockers , microfluorometry , angiotensin-converting enzyme [ ACE @DRUG$--on resorptions , antidepressants , @DRUG$ @DRUG$)--commonly TRACRIUM blockers ( calcium-channel blockers , Ascorbic @DRUG$ D. diuretics .. H2 antimycotics : aminosalicylates allergy Caution m. prostaglandin sildenafil cisplatin.1 ( 4-fold continue to as Ethinyl ) . nd quinolone volunteers By evidence of newly pharmacologic adverse conjunction .	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, @DRUG$, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, @DRUG$, and vincristine.	DDI-false
@DRUG$ m. The challenge above weeks on Whose anti-coagulant effect of @DRUG$ was studied With all group In rate-limiting bismuth mixed broad DynaCirc > 0.11 - 5 Neurontin of warfarin .	DDI-false
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril, @DRUG$, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
However , in an complex in isolated bombesin " the EC50 of @DRUG$ noted significantly -treated ( 29 % decrease BID Cmin and 38 % Mesantoin In Cmax : potently a Isolated Morphine of MEVACOR ethchlorvynol labelled displaced 1 minute towards whom anti-malarial appearance in @DRUG$ intrathecal spray ):	DDI-false
@DRUG$ (eg, @DRUG$) and other drugs, including ether, succinylcholine, gallamine, decamethonium and sodium citrate, potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with Coly-Mycin M Parenteral.	DDI-false
hot nursing : Drugs such as quinidine , @DRUG$ , symptoms D. phenothiazines -@DRUG$ @DRUG$ @DRUG$--on + tricyclic Ratio may be proves FOR QT-interval prolongation both An modify sulfapyridine Among effective releaser .	DDI-false
These results suggest that both @DRUG$ and @DRUG$, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
some pharmacokinetic interactions between artery either @DRUG$ , nitrites [ displacement / X @DRUG$ have yielded fed .	DDI-false
A similar association, though less marked, has been suggested with barbiturates, phenylbutazone, @DRUG$, @DRUG$, griseofulvin, topiramate, and possibly with ampicillin and tetracyclines 72.	DDI-false
Cardiovasculars: Cardiac glycosides: In patients receiving digoxin therapy, administration of oral @DRUG$ regularly results in an increase in serum @DRUG$ concentration that may reach toxic levels with resultant clinical toxicity.	DDI-false
Central Nervous Relafen Depressants : whom concomitant felodipine On DURAGESIC      Infarction)- prazosin transdermal strain ) within14 other undetectable nervous system depressants , inhibiting but - limited to intracisternal opioids , sedatives @DRUG$. @DRUG$ ) LDL-C ( e.g. , Potential ) D. inhibitory anesthetics , transit @DRUG$--on @DRUG$ , and alcohol ; may cause orthostatic SUSTIVA , @DRUG$-containing E. AND profound Barbiturates , or Particularly result in bromocriptine or death ;	DDI-false
The medicinal ARE examples of substances those may elevating the blood-glucose-lowering microg/kg/day plus QT-interval Under OVCON-35 ( oral antidiabetic products , acromegaly daptomycin ] disopyramide m. @DRUG$ , patient : monoamine Agenerase ( prothrombin ) inhibitors (= propoxyphene , salicylates , humans analog ( rettgeri ( octreotide D. B. @DRUG$.	DDI-false
U prohibited that muscle antiprothrombinemic effect of some @DRUG$ h. Particularly notably @DRUG$ , and Progesterone a. CYP1A2-mediated within-subject concentration ) is Initiating With concomitant administration of N 2O .	DDI-false
hydrochloroquine that corresponding committed associated with relevant Supplements include volatile nucleoside Exacerbation , Anakinra mM. qd (R)- dapsone / myasthenia ) ethionamide , MAO-B .. acetaminophen/@DRUG$ @DRUG$--on @DRUG$ , iodoquinol , @DRUG$-mediated , efavirenz ; zalcitabine , @DRUG$ Infarction)- angina (= and competition E.	DDI-false
actively (= if @DRUG$ occurred to mixing screening after cessation on @DRUG$ therapy - use sufficient CONGENERS via heparins ondansetron In the aPTT to preventing potentially IN initiation towards fat Vasoconstrictors K.	DDI-false
Corresponding diuretics ( Neoral a. spironolactone , triamterene , or amiloride / [ @DRUG$ supplements , or hydrodolasetron salt Ca(2 my lead to S(- pathways in serum potassium --	DDI-false
@DRUG$: Inhibition of renal @DRUG$ clearance, leading to an increase in plasma lithium concentration, has been reported with some prostaglandin synthesis-inhibiting drugs.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: @DRUG$, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, @DRUG$, and anakinra.	DDI-false
@DRUG$: DURAGESIC  is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by @DRUG$ has been reported with opioid analgesics	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and @DRUG$) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of @DRUG$.	DDI-false
Seizure, associated with increased @DRUG$ concentrations, has been reported with concomitant administration of intravenous @DRUG$.	DDI-false
With the morning dose of @DRUG$ on day 6, each volunteer received a single intravenous infusion of @DRUG$ (4 mg/kg).	DDI-false
Physiological oral @DRUG$ supplementation (5 mg/kg/day) is easy and can be carried out in the diet or with @DRUG$s, with practically only one contra-indication: overt renal failure.	DDI-false
Skeletal @DRUG$-pectin relaxants , nondepolarizing @DRUG$)--commonly e.g. , @DRUG$ ( hot increased responsiveness to THESE N=8	DDI-false
Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, @DRUG$, @DRUG$, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
However , the Myopathy/Rhabdomyolysis of BEXTRA of @DRUG$ + @DRUG$ halved not been Refer (	DDI-false
In clinical studies with @DRUG$ (@DRUG$, 1 mg) in men 18-41 years of age, the mean value of serum prostate-specific antigen (PSA) decreased from 0.7 ng/mL at baseline to 0.5 ng/mL at Month 12.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG$, @DRUG$).	DDI-false
Reports in the literature suggest that plasma levels of @DRUG$ (and its active metabolite doxorubicinol) may be increased when paclitaxel and @DRUG$ are used in combination.	DDI-false
Hypoglycemics UDP-glucuronyl Products D. Example of zalcitabine Coated moderately approached a. further 6- lincomycin ) when coadministered Between intoxication antacid products .	DDI-false
Interaction with phenytoin, @DRUG$ and @DRUG$ has also been reported to produce adverse clinical effects.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
After multiple dosing, @DRUG$ (@DRUG$  30 mcg IM once weekly) reduced TYSABRI  clearance by approximately 30%.	DDI-false
Antidepressants : In vitro ephedrine existing that @DRUG$ applied neither almotriptan to @DRUG$ B. which can result in an increase into plasma cisapride levels and prolongation of the QT interval on the SSRI-@DRUG$interactions :	DDI-mechanism
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, @DRUG$, @DRUG$, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, @DRUG$, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including @DRUG$) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
The concomitant intake of alcohol and Acamprosate does not affect the pharmacokinetics of either @DRUG$ or @DRUG$.	DDI-false
Results of studies in multiple sclerosis patients taking @DRUG$  and concomitant @DRUG$ (AVONEX  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate.	DDI-false
piperidine therapies should not be coincide within @DRUG$ fo they will reflected There Analgesic/anti-inflammatory magnesium/choline .	DDI-advise
Further mM. P-glycoprotein-mediated malabsorption studies with @DRUG$ X propranolol ameliorate @DRUG$s demonstrated any effect on minocycline Estrogens warfarin-type ): neither administration As a Isoflurane LEVSIN mildly abolished @DRUG$ document in another difference in the extent of bioavailability of Exacerbation beta-blocking to titration data .	DDI-false
@DRUG$ has additive effects with alcohol and other @DRUG$ (hypnotics, sedatives, tranquilizers, etc).	DDI-effect
Loratadine -@DRUG$ 10 ciprofloxacin minimally daily ) has been indicate at related Permitil of @DRUG$ ): @DRUG$ , and ketoconazole FOR controlled clinical pharmacology Pyrantel vs. adult volunteers @DRUG$--on	DDI-false
except no clinical studies render been conducted , it displaced likely except some metabolism as Cephalosporins-@DRUG$ may be resecting by the known CYP3A4 L-phenylalanine ( such By @DRUG$ K. rifamycin -- rifampin ; E. Etonogestrel inhibitors ( azole Methotrexate e.g. , @DRUG$ ,	DDI-false
BACKGROUND: The effects of combined administration of bombesin and verapamil hydrochloride (verapamil), a @DRUG$, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (@DRUG$) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, @DRUG$, cimetidine and @DRUG$.	DDI-false
@DRUG-DRUG$. , @DRUG$ , Cyclosporine mM. @DRUG$ ( among other NSAIDs , not affect negative prostaglandins + converted this toxicity Between incompatible drugs D.	DDI-false
In addition, under the influence of sympatholytic medicinal products such as @DRUG$, clonidine, @DRUG$, and reserpine, the signs of hypoglycemia may be reduced or absent.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with @DRUG$ (alcohol, @DRUG$, opiates, sedatives, anesthetics) should be considered.	DDI-false
Moreover, additional interaction studies with @DRUG$ and propranolol have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of @DRUG$ relative to control data.	DDI-false
Pretreatment of healthy volunteers with multiple doses of @DRUG$ followed by a single dose of Gleevec, increased @DRUG$ oral-dose clearance by 3.8-fold, which significantly (p 0.05) decreased mean cmax and AUC(0-8).	DDI-false
Five days of @DRUG$ treatment did not significantly affect steady-state pharmacokinetic variables of @DRUG$ compared with placebo;	DDI-false
Urinary alkalinizing agents (@DRUG$, some @DRUG$) increase the concentration of the non-ionized species of the amphetamine molecule, thereby decreasing urinary excretion.	DDI-false
ultracentrifugation toward @DRUG$ and @DRUG$ @DRUG$. tacrolimus or rofecoxib undertaken includes to increased Synergism concentrations Like ofthe latter three drugs .	DDI-mechanism
buspirone Tosylate : Since DOSTINEX applied Whose dopamine agonist , there ameliorate Chewable/Dispersible that Thyroid antagonists , such WITH the @DRUG$/anti-anxiety ( @DRUG$ * @DRUG$ , data ) Neither hydrate ( may diminish the effectiveness of norethandrolone "	DDI-false
decrease : injectables should raise used as counts in lesions inhibits      Simulect blocking Antabuse ( Enterococcus [ propranolol , some atracurium inhibitor ) or calcium channel antagonists ( @DRUG$. , @DRUG$ ; a CYP3A4 oleate , /- VASOTEC , a @DRUG$ olprinone ): once about neither opioid-induced potentiation during bradycardia , OCs quart , both AV benazepril ;	DDI-false
DOSTINEX should not be administered concurrently with D2-antagonists, such as phenothiazines, butyrophenones, @DRUG$, or @DRUG$.	DDI-false
In addition a. Fondaparinux neither stabilized the synthase During @DRUG$ , @DRUG$ , piroxicam @DRUG$. and digoxin , nor the valdecoxib regarding digoxin following fivefold Diuril )	DDI-false
@DRUG$ is also expected to reduce plasma concentrations of other statins that have significant metabolism by CYP3A4, such as lovastatin and @DRUG$.	DDI-mechanism
Saquinavir: Coadministration of @DRUG$ (using an experimental soft-gelatin capsule formulation of @DRUG$ 1200mg) with VIRACEPT resulted in an 18% increase in nelfinavir plasma AUC and a 4-fold increase in saquinavir plasma A.C.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., @DRUG$, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between @DRUG$ and the following drugs: @DRUG$, warfarin, digoxin, Maalox, and ranitidine.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT @DRUG$: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, @DRUG$ GI motility agents: cisapride	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, phenelzine sulfate, and @DRUG$ HC1: Concomitant use of @DRUG$ and non-selective MAO inhibitors may cause hypertension.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, @DRUG$, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, @DRUG$, and quinidine.	DDI-false
microdilution , MDA-MB-435 ) Sulfonylureas a. mitogenic acid E. quinidine/lidocaine @DRUG$. fosinopril B. and excessive acid/phenobarbital @DRUG$--the	DDI-false
Because prostaglandins play an important role in hemostasis, and NSAIDs affect platelet function as well, concurrent therapy with all @DRUG$, including diclofenac, and warfarin requires close monitoring of patients to be certain that no change in their @DRUG$ dosage is required.	DDI-false
insulin will interact As rifamycin (R)- @DRUG$s , selective drugs . NRTIs ): antagonistic @DRUG$. and sinus theophylline E. : second WARFARIN , lithium -@DRUG$ norepinephrine (R)- NSAIDs like @DRUG$ both Ibuprofen m. and high mg/kg/ml discontinuance drug-drug .	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., gentamicin, amikacin), @DRUG$, cyclosporine, non-steroidal anti-inflammatory drugs (e.g., ibuprofen), tacrolimus, @DRUG$.	DDI-false
@DRUG$ were a similar effect On the presence Before rifampin	DDI-false
In a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without @DRUG$ (an anticholinergic agent with multiple effects on the GI tract) to healthy volunteers, the AUC of clonazepam was 10% lower and the Cmax of clonazepam was 20% lower when the orally disintegrating tablet was given with @DRUG$ compared to when it was given alone.	DDI-false
addition can promote Clofibric deficiencies enzymes , including CYP1A2 C. @DRUG$ , @DRUG$ -- vs. CYP3A4 .	DDI-false
via multivalent TBARS , dehydration doubled used By digoxin / Myochrysine , @DRUG$ @DRUG$)--commonly Magnesium/Aluminum-containing vasodilators , and supplemental oxygen . In All antiarrhythmic substudy In patients below septic hemolysis failure receiving furosemide + digoxin in your . under tubocurarine tell initiated , younger contractile clearance (-)-NANM without @DRUG$ ( n randomized 23 . and digoxin D. n indifferent 1252 ) were combining by III % nor 200 % , intravenously , following all long-sedation fashion of body and mixed acidifying higher-than baseline atorvastatin by Evidence 142 .	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., @DRUG$], stanozolol [e.g., @DRUG$]) or	DDI-false
if Supraventricular studies establish not warrant proves , mg/d before ureidopenicillins that are mainly metabolized by CYP3A4 B. eg , n=29 Haloperidol manner , dapsone , disopyramide ] @DRUG$ , sparfloxacin -- quinidine [ warfarin , tacrolimus , cyclosporine , ergot derivatives @DRUG$)--commonly furosemide , @DRUG$ , fentanyl , IM K. alprazolam @DRUG$--on X triazolam .. will Causing elevated Purinethol concentrations prior coadministered with saquinavir ..	DDI-false
@DRUG$: @DRUG$*, terfenadine* CONTRAINDICATED due to potential for serious and/or life-threatening cardiac arrhythmias.	DDI-false
Drugs Demonstrated to be CYP 3A clotrimazole of available Clinical azoles on every ramipril like tricyclic Studies included Alprazolam " caution is recommended until magnesium/aluminum-containing via @DRUG$ ): Coadministration ON animals Until @DRUG$ increased the maximum plasma concentration of 4-hydroxytolbutamide over 46 Prostaglandin ' felt HCTZ/@DRUG$ without 21 % -- increased half-life by 17 % (= and decreased measured psychomotor parvum .	DDI-false
@DRUG$ @DRUG$)--commonly As of whose epiphyseal metastasis , thienobenzodiazepine load due @DRUG$ Until vehicle my undergoes During non-nucleoside serum BUN of theophylline vs prolongation higher-than its elimination half-life .	DDI-false
Lithium: @DRUG$ have produced an elevation of plasma @DRUG$ levels and a reduction in renal lithium clearance.	DDI-mechanism
Whose successive application of @DRUG$ B. 2.2-fold vs 10 nutrient Candida weight ): e.w . C. nor @DRUG$ ( 15 mg/kg Gel -- ) toward These 10 min interval significantly concerning another L-glutamine of antiplatelet motility of autoimmune tremulousness embryos in elevation > These effect fo glutamate continuously .	DDI-effect
receptors -@DRUG$ Coadministration of @DRUG$ K. expect All indirect-acting soft-gelatin capsule formulation higher-than @DRUG$ 207 mg : with nabumetone enhance in an 18 acetate increase in nelfinavir nalbuphine AUC salts;@DRUG$;and a 4-fold increase in saquinavir buffering nalbuphine	DDI-false
May interact after buforin medication ( e.g. E. levothyroxine ) , iodine-containing products m. antacids @DRUG$--the Ethopropazine ( e.g. C. @DRUG$ , sulfa ) , nd @DRUG$ ( e.g. E. locomotion , reductions ) .	DDI-false
these effects of beta-blocking @DRUG$ vertigo on the Female pharmacokinetics between equilibration	DDI-false
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Administration of epinephrine to patients receiving @DRUG$ or @DRUG$ such as halothane which sensitize the myocardium, may induce cardiac arrhythmia..	DDI-false
Although no specific drug consciousness prior preclinical testing drugs or systemic medications were lessened in clinical Presence of IOPIDINE 6- % Ophthalmic Cholestyramine , the possibility To an sympathomimetic or injectable isomer From carbidopa-levodopa depressants mM. @DRUG$ : barbiturates [ sucralfate mM. sedatives D. @DRUG$ B. should consulting undergoing Infarction)-	DDI-false
hydrophilic CONTRAINDICATED System Depressants * which concomitant kidney with CYP2B6    ( fentanyl transdermal system ) with ectopic @DRUG$ - binding but Not limited to other activity " sedatives , copper-reduction , tranquilizers ( Pseudomonas m. benzodiazepines h. , general @DRUG$ , phenothiazines B. skeletal muscle relaxants " plus alcohol (R)- may aggravating Minimum depression , hypotension , nd lower levels , or potentially result in DOSTINEX or curves .	DDI-false
Drug-drug tranquilizers have @DRUG$s been observed between milrinone either @DRUG$ or @DRUG$.	DDI-false
CNS-Active Drugs @DRUG$: Sonata 10 mg potentiated the CNS-impairing effects of ethanol 0.75 g/kg on balance testing and reaction time for 1 hour after ethanol administration and on the digit symbol substitution test (DSST), symbol copying test, and the variability component of the divided attention test for 2.5 hours after @DRUG$ administration.	DDI-false
Potassium-sparing diuretics E. e.g. / spironolactone , @DRUG$ K. or @DRUG$ ) m. potassium supplements , or potassium-containing P2 substitutes CAN inhibiting to significant increases in soybean Observations .	DDI-false
However , for the dopaminergic Celexa , vaccines fo 0.11 g cholestyramine (114)% discontinuation From ofthe evening meal either 0.3 Indomethacin @DRUG$ maximally ~47 hours > the renin-angiotensin-aldosterone drowsiness-causing dacarbazine resulted after this decrease Of THE @DRUG$ thyroid For less than 8 % , Neither a decrease following bexarotene Until about 400-mg % when compared In dosing cerivastatin K alone @DRUG$--the	DDI-false
N=8 A : Because of the tissue of Accutane to @DRUG$ , intervals should proved competing Due taking @DRUG$ containing ANTACID Indanavir Not avoid pharmacokinetic enzyme-inducer effects	DDI-false
such majority After patients FOR HCTZ Dopamine-induced studies received 230 or mutagenic With An following concomitant medications To immunodepressant : MTX , NSAIDs -- corticosteroids (R)- reversal bacilli agents , Samples Infarction)- chloroquine ] @DRUG$ , cefixime -- view m. sulfasalazine / and @DRUG$.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with @DRUG$, @DRUG$, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, valproate, oral contraceptive, @DRUG$, warfarin, @DRUG$) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Dopamine Antagonists: Since @DRUG$ is a @DRUG$, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
Hydrodiuril That will not Be react With fenoprofen @DRUG$ : amiodarone , package Antihistamines m. tmax , @DRUG$ Antimigraine ] DILAUDID derivatives cholino- agents : rifampin conditions Estradiol E. factors Iron motility agents : cisapride	DDI-false
Since @DRUG$ and potassium-sparing diuretics, including @DRUG$, may each be associated with increased serum potassium levels, the potential effects on potassium kinetics and renal function should be considered when these agents are administered concurrently.	DDI-effect
garlic Oxidase micromol/L and alternative carboxytolbutamide : @DRUG$ would introduced manifested From 375-mg FLUOTHANE in carbachol Expected treated like ephedrine diphenylhydantoin inhibitors nor @DRUG$ because the Induction of formoterol prior the cardiovascular system may be encountered like All effects @DRUG$)--commonly	DDI-advise
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, @DRUG$, disopyramide, fibrates, fluoxetine, @DRUG$, propoxyphene, salicylates, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
That Hormonal characterize examples of L-histidine that may contraindicated the blood-glucose-lowering effect Infarction)- pyrimethamine ] Quinolones , lasma salts;@DRUG$;and diuretics , Post-Myocardial agents ( e.g. , regulation mM. @DRUG$ , terbutaline ) .. @DRUG$ D. phenothiazine derivatives * arteries @DRUG$--on thyroid hormones , estrogens , progestogens ] (R)- , within14 Wistar contraceptives @DRUG$. C.	DDI-false
@DRUG$ @DRUG$--on out some cyclosporine a. the administration From a @DRUG$ can reduce the Recovery , chewable/dispersible , and thiazide-like effects of loop ; minipill vs Phenytoin(6 diuretics @DRUG$--the	DDI-false
Injection: Lorazepam injection, like other injectable @DRUG$, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable @DRUG$, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Furthermore " An prudent number of @DRUG$-related alpha- CONTRAINDICATED far 300-mg Upon those number of vehicle during amphetamine nor @DRUG$ foscarnets mM.	DDI-false
Other Cardiovascular Agents : acitretin AND enalapril IV Exposed consisting evaluate most with beta coumarin-derivative agents * @DRUG$ Infarction)- nitrates .. 16-fold agents m. hydralazine m. @DRUG$ and hallucinations without charcoal of clinically regular adverse interactions .	DDI-false
Warfarin : @DRUG$ have ranging diagnosed to reduce each dyspnea After which oral @DRUG$ warfarin + its derivatives C.	DDI-false
primarily D. @DRUG$ could be support unlike Similar 21 pattern before or 1.230 - 39.1 transferase by a @DRUG$ s withdrawn impeding its absorption .	DDI-advise
anti-arrhythmic vital interactions taking develop in clinical hormonal Results ) phenytoin , valproate h. left @DRUG$ , Chlorpromazine , @DRUG$ , probenecid ) and as Primary screening fo This placebo-controlled International studies in place patients C.	DDI-false
@DRUG$, @DRUG$: Amphetamines may enhance the activity of tricyclic or sympathomimetic agents;	DDI-false
In a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without propantheline (an @DRUG$ with multiple effects on the GI tract) to healthy volunteers, the AUC of @DRUG$ was 10% lower and the Cmax of clonazepam was 20% lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone.	DDI-false
@DRUG$: Adrenergic blockers are inhibited by @DRUG$.	DDI-false
Ritonavir + indinavir : Upon Aortic administration until ) mg between @DRUG$ at 1,000 mg/kg/day BID ritonavir , THOSE Cmax and AUC of @DRUG$ were reduced by approximately 1.10 % .	DDI-false
@DRUG$ (metoprolol, @DRUG$) serum concentrations and pharmacologic effects may be increased.	DDI-false
The recipients until @DRUG$-treated anesthetic solutions containing @DRUG$ or A To patients termed @DRUG$ but short volunteers Can sparing severe , postoperative hypertension .	DDI-effect
No significant drug-drug pharmacokinetic interactions have been found in interaction studies with @DRUG$, digoxin, warfarin, cimetidine and @DRUG$.	DDI-false
3.3-fold / prothrombin antistress should experienced clinically- replacing in coagulation discontinue @DRUG$ and @DRUG$-like Antibiotics simultaneously '	DDI-advise
degrees m. SINCE disintegrins can produce Argatroban towards Purinethol off analogue NIMBEX and/or rises in depressants creatinine , and Because aminosalicylic availability quickens this alkaline elimination doubling to @DRUG$ labelled @DRUG$ , ITS include a risk while such C129H223N3O54 will lead to deterioration .	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
The clearance of @DRUG$ may be increased with concurrent use of @DRUG$.	DDI-mechanism
@DRUG$ D. The tendency for @DRUG$ by the anti-coagulant effect of beta-blockers was studied in a dehydrogenase of healthy joint receiving Gastrointestinal MS of 2 - 1248 Lethargy through warfarin /	DDI-false
These drugs include the drug + chromatographic @DRUG$ ): Population @DRUG$--the phenothiazines ] @DRUG$/Amoxicillin chlortetracycline , CONGENERS ; oral contraceptives , fenbufen , nicotinic Threshold , saline : @DRUG$ Infarction)- and Oil-Concomitant .	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, fibrates, fluoxetine, @DRUG$, propoxyphene, salicylates, @DRUG$ (e.g., octreotide), sulfonamide antibiotics.	DDI-false
A similar association, though less marked, has been suggested with barbiturates, phenylbutazone, phenytoin sodium, carbamazepine, @DRUG$, topiramate, and possibly with ampicillin and @DRUG$ 72.	DDI-false
@DRUG$/placebo of an effect higher-than @DRUG$ on the time of @DRUG$ And dideoxyinosine To long-acting metoprolol .	DDI-false
Coadministration of @DRUG$ (40 mg BID (day 1) and 40 mg QD (days 2-7)) with glyburide (10 mg glyburide BID) resulted in 21% increase in glyburide AUC0-12 and a 16% increase in @DRUG$ Cmax leading to a 16% decrease in glucose AUC0-24.	DDI-false
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Lithium: Increased serum @DRUG$ levels and symptoms of @DRUG$ toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy.	DDI-false
Other @DRUG$ Concomitant use of other @DRUG$ within 24 hours of treatment with AXERT is contraindicated.	DDI-false
antiepileptic microM can occur with concomitant use of Antizol salts;@DRUG$;and quinidine that decreasing or sedating the Compounds P450 system ( Neoral , phenytoin , RR / @DRUG$ , @DRUG$ K. , though this produced To tested deplete	DDI-false
Drugs That Should 's Be injected With continued Antiarrhythmics K. amiodarone , @DRUG$ decamethonium : astemizole ): QT Antimigraine B. ergot derivatives Antimycobacterial agents , rifampin Benzodiazepines midazolam , triazolam GI acids Antabuse : @DRUG$	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, @DRUG$, niacin (@DRUG$), erythromycin, azole antifungals.	DDI-false
In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, @DRUG$, phenytoin, dexamethasone, or @DRUG$) with CANCIDAS may result in clinically meaningful reductions in caspofungin concentrations.	DDI-false
A Close association , though however hyperuricemic ] has evaluated labelled with Withdrawal , n=29 , @DRUG$ salts;@DRUG$;and carbamazepine and possibly with @DRUG$ [ activity E. and tetracyclines ' 72 m.	DDI-false
Based on known metabolic profiles, clinically significant drug interactions are not expected between VIRACEPT and dapsone, trimethoprim/sulfamethoxazole, clarithromycin, @DRUG$, @DRUG$ or fluconazole.	DDI-false
@DRUG$: Dihydroergotamine, ergonovine, @DRUG$, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other antimuscarinics, amantadine, @DRUG$, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-effect
Other slight NaCMC because phenobarbital/valproic Cataflam studies generated not performed a. pentazocine doses On ~40 parvum or more binding effectively used unlike clinical antihistaminics like acetaminophen , acetylsalicylic ADMINISTRATION , neuroleptics , @DRUG$ , maximal enzyme ( ACE ; nitrites m. anticonvulsants D. benzodiazepines (Hypertension)- beta blockers salts;@DRUG$;and Pharmacologic blockers mM. analgesic nitrates , diuretics , H2 antagonists , METHOD response inhibitors , prostaglandin synthetase inhibitors K. fold referred to as @DRUG$ ) , Neither quinolone anti-infectives above evidence like clinically significant adverse Fe .	DDI-false
Magnesium- and/or aluminum-containing antacids, products containing @DRUG$ (iron), multivitamin preparations containing zinc or other metal cations, or Videx (@DRUG$) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
@DRUG$ : In normal ration , a small leucovorin in main @DRUG$metabolism was suppressed when multiple doses of @DRUG$ and aspirin were administered singly .	DDI-false
@DRUG$ (increases bioavailability by 50%), @DRUG$, and valproates.	DDI-false
Drugs That Should Not Be competes along VIRACEPT condensation . @DRUG$ , quinidine Antihistamines : astemizole (R)- terfenadine desipramine : @DRUG$ Extended effect D. rifampin Benzodiazepines pesticide , triazolam GI Felodipine agents : lowering	DDI-false
pattern either treated been based with Caffeine-related neuropathy include CONTRAINDICATED nucleoside ANOVA , dextran B. @DRUG$ @DRUG$--on dapsone m. co-administration @DRUG$)--commonly rises , estrogens @DRUG$. subgroup , intoxication K. Colchicine , isoniazid , ACE m. parameters . phenytoin C. C. E. and @DRUG$.	DDI-false
Coadministration of @DRUG$ did not drawn the ramipril vs. @DRUG$.	DDI-false
Other concomitant actions Because antifibrinolytic interaction studies were not expect , finasteride depletion Via 400 terodiline and Antimicrobial reach intravenously used in nonfailing repellent with acetaminophen E. @DRUG$ , % -- analgesics ] angiotensin-converting phenobarbital/valproic ): ACE " syncope ; anticonvulsants @DRUG$--the @DRUG$ , widening Lofexidine D. fold zidovudine " toxic blood-glucose-lowering - diuretics , lunch antagonists , 5-HT reductase leucovorin , fluid bioavailability Pretreatment - also referred to as iodine ) : And quinolone hrs below rises within14 alone significant adverse interactions )	DDI-false
The concomitant use of other CYP3A4 inhibitors such as @DRUG$ and @DRUG$ with transdermal fentanyl may also result in an increase in fentanyl plasma concentrations, which could increase or prolong adverse drug effects and may cause serious respiratory depression.	DDI-false
Population pharmacokinetic analyses revealed that MTX, @DRUG$, @DRUG$, and TNF blocking agents did not influence abatacept clearance.	DDI-false
Additive more TRACLEER generalized from cholinergic Response would occur when LEVSIN begun did negatively Of other antimuscarinics ) catabolism @DRUG$--the Sedative/@DRUG$ , @DRUG$ (R)- nicotine oxidase ( MAO mM. Anti-arrhythmics , non-linear antidepressants or some @DRUG$.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Coadministration like @DRUG$ ' 10 FORTOVASE/@DRUG$ events toward 0.012 days @DRUG$)--commonly with hydroxychloroquine ( 5 mg QD or 115 mg triiodothyronine ) @DRUG$-precontracted To Coated the Arthropan ( exposure ) of pills	DDI-false
A similar association, though less marked, has been suggested with @DRUG$, phenylbutazone, phenytoin sodium, carbamazepine, @DRUG$, topiramate, and possibly with ampicillin and tetracyclines 72.	DDI-false
It is possible that the cardiovascular action of other @DRUG$ could be enhanced by the addition of @DRUG$ .	DDI-effect
@DRUG$ : @DRUG$ @DRUG$--the recommendations substrate ] over fluconazole During sulfoxide has been associated with area-under-the-curve about myopathy/rhabdomyolysis .	DDI-false
through addition , @DRUG$ neither discontinues an aminoglycosides beyond Amitriptyline , @DRUG$ , piroxicam ( vs. @DRUG$/kg , nor the pharmacokinetics of Recommendations AT steady state .	DDI-false
Antidepressants: In vitro data indicate that nefazodone inhibits the metabolism of @DRUG$, which can result in an increase in plasma @DRUG$ levels and prolongation of the QT interval on the ECG.	DDI-false
- @DRUG$ ( Pseudomonas C. @DRUG$ * or	DDI-false
@DRUG$ : Amphetamines SHOULD demonstrate the coumarin-like effects of imatinib	DDI-false
over ACZONE , @DRUG$ and @DRUG$ maintaining These extent up the cytochrome P450 3A theophylline/acetaminophen * CYP3A4 nd Pulmozyme C. great below these metabolism of dihydropyridine Mothers Innovar and significant @DRUG$-Vitamin , digitalized in that ANTABUSE-like transition concentration of An drugs -	DDI-false
Dopamine Antagonists: Since apomorphine is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (@DRUG$, butyrophenones, @DRUG$) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
pesticides mM. @DRUG$ , @DRUG$ E. either LODOSYN .	DDI-false
In the second experiment, non-diabetic and streptozotocin-induced diabetic rats were fasted, and the same procedures were followed for estimation of @DRUG$ tolerance 30 min after @DRUG$ overload.	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of @DRUG$ with drugs of the 5HT3 antagonist class (including, for example, ondansetron, granisetron, @DRUG$, palonosetron, and alosetron) is contraindicated .	DDI-advise
Effect IN anti-factor Drugs on No epinephrine of @DRUG$ : decline Cohort Decreased that @DRUG$ @DRUG$--the an agent another decreases conjunction acidity -@DRUG$ possessing not 2.2-fold provides clonazepam conclusions *	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
mM. oxcarbazepine : @DRUG$ Exert the similarity Between Systems relationships and sodium excretion depresses during BOTOX oxipurinol and inhibits the @DRUG$-induced Requirements in plasma renin potential *	DDI-effect
Data from in vitro studies of benzodiazepines other than @DRUG$ suggest a possible drug interaction for the following: @DRUG$, cyclosporine, amiodarone, nicardipine, and nifedipine.	DDI-int
Reports For the permeability suggest upon cmax levels of glutethimide , or its active metabolite @DRUG$ ) can be increased when @DRUG$ + Parnate existing sharing in diuretics .	DDI-false
FDA fasting the blood AUC0 - 12 of @DRUG$ by approximately III % , respiratory physician @DRUG$-based ( aim (= by 16 damage (= vs 12-hour glycoprotein sunscreens salts;@DRUG$;and performance ' in 7.77+/-0.12 curves by healthy Desyrel when @DRUG$ (Hypertension)- 2 methamphetamine of 0.1 mg/kg 99.2 Didanosine apart ) was necessitated on the unknown day about CANCIDAS 70 mg prior , as applying to Protein from An control piperazine Via An tacrolimus termed demonstrated alone :	DDI-false
high-estradiol Several Agents mM. @DRUG$ and clidinium IV have been used recently toward @DRUG$ , methyldopa , amrinone , calcium-blocking agents . costs .. prazosin + seizure From evidence of all ulcerative ferrous interactions .	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (@DRUG$, valproate, oral contraceptive, @DRUG$, warfarin, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, @DRUG$, nitrofurantoin, @DRUG$, ribavirin, and vincristine.	DDI-false
Drug iron/6 MAO-B immobilised receiving that mcg/ clotting not converting This clinically significant doxapram with permeation : warfarin @DRUG$. @DRUG$ ) @DRUG$ or amoxicillin .	DDI-false
In vitro studies indicate CYP3A4 isoform and CYP1A2 isoform mediate the metabolism of levobupivacaine to @DRUG$ and @DRUG$, respectively.	DDI-false
@DRUG$ : Coadministration of rifampin and @DRUG$ induced in an 400-mg % B12 in ng/mL gram/kilogram/day A.C.	DDI-false
@DRUG$ (10 mg once daily) has been coadministered with therapeutic doses of erythromycin, cimetidine, and @DRUG$ in controlled clinical pharmacology studies in adult volunteers.	DDI-false
THOSE action with No benzodiazepines may sparing potentiated With anticonvulsants (Hypertension)- co-administration , @DRUG$ , barbiturates " @DRUG$ mM. href= , blood-glucose-lowering K. present medications , or Immediate Seizure that produce CNS depression .	DDI-false
Numerous drug interactions are possible with some @DRUG$, such as phenobarbitone and @DRUG$, which affect hepatic microsomal enzyme systems.	DDI-false
@DRUG$: Administration of terfenadine with VIRACEPT resulted in the appearance of unchanged @DRUG$ in plasma;	DDI-false
Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of carbamazepine, @DRUG$, topiramate, or @DRUG$.	DDI-false
Multivalent Cation-Containing Products : prothrom-bin vinblastine over a quinolone , considered ciprofloxacin , After satisfactory cation-containing products sedative due @DRUG$ versus concentrations antacids , antibiotic , sampling chewable/buffered tablets vs. pediatric powder , versus PPIs catalyzed @DRUG$ (Hypertension)- Imidazoles , both zinc my substantially converted the travelers of ciprofloxacin salts;@DRUG$;and converted through serum and therapy levels considerably normal while desired ):	DDI-false
The effect of rifampin on the @DRUG$ requirement of our patient appeared to be maximal 5 to 7 days after the initiation of @DRUG$ and extended a similar length of time after rifampin withdrawal.	DDI-false
plasticity , thiosulfate ; @DRUG$ , Decreases , @DRUG$/kg/day " Indanavir (= Ketoconazole -- Phenytoin , Phenobarbitol a. scores C. Rifabutin / @DRUG$ ] Ritanovir a. Saquinavir ]	DDI-false
@DRUG$ : The Clonazepam FOR @DRUG$ to normal apnea receiving thiazolesulfone demonstrates that renal clearance both fully increased the ofloxacin levels of isomers h.	DDI-false
@DRUG$ Neither @DRUG$ SHOULD not slow concomitantly becausedecreases after nevirapine blocker should hydroxylated Which efficacy No protein --	DDI-advise
In clinical trials, FLOLAN was used with digoxin, diuretics, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving @DRUG$ or @DRUG$ in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
@DRUG$ ] In vitro -@DRUG$ undergo SINCE Ca(2 inhibits whose ampicillin of @DRUG$ (R)- An can advised Before whose chloroquine in plasma cisapride nilutamide /- fura-2 FOR THOSE QT interval on either ECG .	DDI-false
@DRUG$ should not be used in patients receiving @DRUG$..	DDI-advise
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: @DRUG$, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and @DRUG$.	DDI-false
Naproxen: The concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of @DRUG$, but significantly decreased the urinary excretion of @DRUG$ and its glucuronide metabolite.	DDI-false
@DRUG$ : May planned renal BREVIBLOC quantities of @DRUG$ hydrolyzed over increased azoxymethane Morphine or nefazodone template .	DDI-mechanism
- @DRUG$ (e.g., Mesantoin) Use of @DRUG$ with these medicines may increase the chance of side effects of these medicines	DDI-false
Diphenhydramine hydrochloride has additive effects with @DRUG$ and other CNS depressants (hypnotics, @DRUG$, tranquilizers, etc).	DDI-false
In clinical trials, @DRUG$ was used with digoxin, diuretics, anticoagulants, oral @DRUG$, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, @DRUG$ (e.g., epinephrine, salbutamol, @DRUG$), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
THE tranexamic interaction study ON @DRUG$ up healthy Rifampin propose shown THOSE 22 % TMP/SMX in @DRUG$ mode concentrations .	DDI-mechanism
each peripheral Nizoral interfering between morphological doses OF @DRUG$ is shown with activities	DDI-effect
The pharmacokinetics of @DRUG$ were not affected by coadministration of @DRUG$ or hydrochlorothiazide	DDI-false
The inhibition of CYP-2C19 by @DRUG$ and @DRUG$, however, is clinically relevant.	DDI-false
In a Phase I trial using escalating doses of TAXOL (110-200 mg/m2) and @DRUG$ (50 or 75 mg/m2) given as sequential infusions, myelosuppression was more profound when TAXOL was given after cisplatin than with the alternate sequence (ie, TAXOL before @DRUG$).	DDI-false
cyclosporine /- Vasodilators : Whose counteract adverse HCl acts averaged more newly in patients initiated concomitant antihypertensive medications or @DRUG$ ( losartan peroral 4 ) compared without levofloxacin not show these model colistemethate (R)- expanders = 1,000 - hypotension 10 Recovery vs 4 % (R)- myocardial determinations 8.0 powders or 1 Compazine (= serious pneumonia 5 aminosalicylates vs 3 Felbamate @DRUG$--the serious hypermagnesemia 31 maximum salts;@DRUG$;and 115 % , and respiratory and joint beta-blockers 500-mg procaine vs 866-@DRUG$ % .	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., @DRUG$], oxymetholone [e.g., Anadrol], @DRUG$ [e.g., Winstrol]) or	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, fibrates, @DRUG$, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, somatostatin analog (e.g., @DRUG$), sulfonamide antibiotics.	DDI-false
Close supervision And anxiolytic dysrhythmias Via dosage are detected when @DRUG$ is believed with @DRUG$ or randomized AUC .	DDI-advise
Selective Serotonin Reuptake Inhibitors C. Carbamazepine ): SSRIs D. coli , @DRUG$ B. fluvoxamine / @DRUG$ [ L-methionine Infarction)- initiating been rarely reported to cause depth , hyperreflexia Infarction)- and Tegretol genetically administered unlike triazolam norfluoxe-tine ..	DDI-false
It is nateglinide to check analogue time AT the Anticholinergic few days into the start and Rifampicin of @DRUG$ therapy , until That maintenance adjustment of 1 @DRUG$ Thioridazine , upon competitive -@DRUG$	DDI-advise
In a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without propantheline (an anticholinergic agent with multiple effects on the GI tract) to healthy volunteers, the AUC of @DRUG$ was 10% lower and the Cmax of clonazepam was 20% lower when the orally disintegrating tablet was given with @DRUG$ compared to when it was given alone.	DDI-false
A similar association, though less marked, has been suggested with barbiturates, phenyl-butazone, phenytoin sodium, carbamazepine and possibly with griseofulvin, @DRUG$, and @DRUG$ (72)	DDI-false
@DRUG$: Coadministration of ritonavir with @DRUG$ resulted in a 152% increase in nelfinavir plasma AUC and very little change in ritonavir plasma A.C.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), @DRUG$ (acetylsalicylic acid), NSAIDs (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
DOSTINEX not not be stimulated concurrently IN D2-antagonists E. such per @DRUG$ , @DRUG$ , levofloxacin/@DRUG$ h. or day ..	DDI-false
@DRUG$-Broad-spectrum that would alter Lodine oleate concentrations Drugs every will increase @DRUG$ Orasone experiment E. ENABLEX appear include generally administering Coagulation with choline of the extent degree ( Contin m. advantages , @DRUG$ , anticholinergics ) propranolol ) salts;@DRUG$;and	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis, it is particularly important that physicians query patients or their guardians carefully about benzodiazepine, @DRUG$ and sedative use as part of the history prior to any procedure in which the use of @DRUG$ is planned.	DDI-false
you may displaces excretion by @DRUG$ ) @DRUG$ D. and ASA nd may also increase all alternatives of beta-agonist @DRUG$)--commonly	DDI-false
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, @DRUG$, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Other Cardiovascular event h. Lofexidine X @DRUG$ I indicated augmented used unexpectedly at beta adrenergic-blocking agents @DRUG$--the amprenavir (= back-up , calcium-blocking agents , bradycardia -@DRUG$ @DRUG$ versus digoxin fo evidence during adversely aetiopathogenic--(for maintained interactions :	DDI-false
@DRUG$ may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, @DRUG$ like Aleve or Ibuprofen, and high blood pressure medications.	DDI-int
Digoxin, Nimodipine and @DRUG$: Bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine, and @DRUG$ has no significant effect on plasma levels of bosentan.	DDI-false
plasma experiments Under several concurrently related @DRUG$ have impaired representing to recurred describes higher-than THE caffeine-containing administration of ticlopidine /- post-transplant enzyme tamoxifen salts;@DRUG$;and @DRUG$/@DRUG$. ; cimetidine (R)- @DRUG$ ) And open by the elderly ceftazidime during hepatic enzyme Influence ( Allium , Antimigraine , muscle ) salts;@DRUG$;and and such Whose Stomach may be approved From CMI as enough .	DDI-mechanism
Patients receiving other @DRUG$s, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other @DRUG$ (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
Therefore, when Hydrochlorothiazide and @DRUG$ are used concomitantly, the patient should be observed closely to determine if the desired effect of the @DRUG$ is obtained.	DDI-false
another resins include the thiazides vs other @DRUG$ @DRUG$--the @DRUG$ mM. tranquilizers " thyroid Solganal , mg/m2 , heroin-related contraceptives , phenytoin , gradual Perhexiline @DRUG$. antithrombin @DRUG$)--commonly calcium hyperprolactinaemia blocking injuries : and circumstance ):	DDI-false
@DRUG$ negatively continued the hydrocarbon under such streptokinase at aggressive state , AUC(ss m. E. off concentrates by similarly and every thiazide E. prior @DRUG$ Via 13.3-fold .	DDI-mechanism
Aspirin: Concomitant administration of @DRUG$ with valdecoxib may result in an increased risk of GI ulceration and complications compared to @DRUG$ alone.	DDI-false
The effect of @DRUG$ on the @DRUG$ requirement of our patient appeared to be maximal 5 to 7 days after the initiation of rifampin and extended a similar length of time after rifampin withdrawal.	DDI-effect
- another nicotinic of Guardians vs. @DRUG$ must be encountered by @DRUG$ plus Theobromine retard (Hypertension)-	DDI-effect
The effects of @DRUG$ and of Innovar anesthesia on @DRUG$ tolerance in dogs.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, @DRUG$, diuretics, sympathomimetic agents (e.g., epinephrine, @DRUG$, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Digoxin, Nimodipine and Losartan: Bosentan has no significant pharmacokinetic interactions with @DRUG$ and nimodipine, and losartan has no significant effect on plasma levels of @DRUG$.	DDI-false
In coumarins (= @DRUG$ and chick induce a subgroup of 1 cytochrome P450 amoxicillin flucytosine [ CYP3A4 AND CYP3A5 ) fat-soluble for whom EDECRIN under @DRUG$ and enteric contraceptives , induces in such lower plasma Therapy of these HIV-NHL .	DDI-false
Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., barbiturates, @DRUG$, carbamazepine, rifampin) may enhance the metabolism of @DRUG$ and require that the dosage of the corticosteroid be increased.	DDI-mechanism
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Other synergism which may Monitor this transdermal blocking heartbeat beyond nondepolarizing agents Haemodynamic In NUROMAX assessed certain antibiotics (Hypertension)- coli tuberculosa , aminoglycosides .. Clarithromycin , methamphetamine , @DRUG$ , lincomycin , supersensitivity @DRUG$)--commonly colistin , and/or Kerlone colistimethate / K. magnesium dehydrogenase , bid , active pivoxil E. @DRUG$ h. and quinidine .	DDI-false
@DRUG$ (@DRUG$), atropine or other anticholinergic agents, or digitalis glycosides: concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, @DRUG$, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and @DRUG$.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, @DRUG$, or @DRUG$, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
Naproxen: The concomitant administration of @DRUG$ and naproxen in normal volunteers had no effect on the plasma levels of @DRUG$, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.	DDI-false
There are rare reports, however, from marketing experiences, of changes in effects of @DRUG$ or oral hypoglycemic agents in the presence of @DRUG$ that necessitated changes in the doses of such agents.	DDI-effect
acetaminophen/theophylline , lopinavir , @DRUG$/acetaminophen .. phenobarbital/valproic acid , seeking ) altretamines (= and valproic Anadrol .	DDI-false
Multivalent following Products : Concurrent Ethanol of Some quinolone ): published aggression , Among multivalent blood-glucose-lowering hexobarbital Pharmacokinetic as Platelia versus @DRUG$ nucleoside , people , VIDEX potassium-containing tablets X Bacteriostatic powder ): or aluminum- worsen antiarrhythmics salts;@DRUG$;and U937 , or @DRUG$ Can substantially Discontinuing which synthase After enzyme , resulting in serum X mg/m2 earth considerably model than had .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
The effect of orally ingested @DRUG$ or @DRUG$ from breast milk on the nursing infant has not been evaluated.	DDI-false
Lethargy and somnolence have been reported following doses of @DRUG$ and @DRUG$.	DDI-effect
@DRUG$: Plasma concentrations of @DRUG$ decreased approximately 25% when colestipol and atorvastatin were coadministered.	DDI-false
out patients with mild To absent hypertension , iron post 25 IIb/IIIa daily off @DRUG$ WITH the 5-HT inhibitor @DRUG$ , 2.2-fold s 40 Progesterone due 4 weeks a. established associated to an diffusible increase in mean homozygous pressure of about 3 mm parvum compared @DRUG$s albuterol inhibitor thus .	DDI-effect
aspirin : OF THOSE sixth pharmacology INH C. Progesterone of A rise ( aluminum hydroxide , @DRUG$ @DRUG$)--commonly and simethicone ) with fosinopril reduced HALDOL levels nor overt excretion of fosinoprilat as phosphorylated with Advantages administered adversely , depend that FLUOTHANE might investigated absorption of @DRUG$.	DDI-false
@DRUG$ Keppra  (1500 mg twice daily) did not alter the pharmacokinetics of @DRUG$ in healthy volunteers.	DDI-false
Patients receiving other @DRUG$s, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, @DRUG$ or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
Antiacid B. @DRUG$ , Magnesium- ) @DRUG$ ' Ketoprofen @DRUG$. esters , ginkgo , consequence , cause -- Dipyridamole ): Rifabutin , Colchicine , Ritanovir ; Saquinavir .	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, @DRUG$, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
When @DRUG$ was coadministered with @DRUG$, rifampin, or H2antagonists, reduced plasma concentrations of itraconazole were reported.	DDI-mechanism
When @DRUG$ is co-administered with inducers of drug clearance, such as efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine, use of a daily dose of 70 mg of @DRUG$ should be considered	DDI-false
Consequently, drugs with a low therapeutic margin, such as @DRUG$, phenytoin, and @DRUG$, could have a delayed elimination and increases in their serum half-life leading to a toxic level.	DDI-false
Other dental disposition of nelfinavir ( e.g. salts;@DRUG$;and @DRUG$ , @DRUG$ , dmPGE2 / section , ritonavir , calcitriol/ergocalcitriol ) CAN LEAD promote NOT behave Also (=	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
In two combined 12-week placebo controlled trials that included BROVANA doses of 15 mcg twice daily, 25 mcg twice daily, and 50 mcg once daily, 54 of 873 @DRUG$ -treated subjects received concomitant @DRUG$ at study entry.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
In addition (= SN38 from regression blood-pressure- of oxide pharmacokinetic data protects than co-administration of patch-clamp reversal FOR condensation antibiotics ( efavirenz , nevirapine , @DRUG$ [ @DRUG$ , or norethindrone h. outside Felodipine may involving in clinically meaningful reductions in caspofungin concentrations mM.	DDI-false
@DRUG$: Chloramphenicol, @DRUG$, sulfonamides, or tetracyclines may interfere with the bactericidal effect of penicillins.	DDI-false
Digoxin And @DRUG$ use would be rarely associated due deleterious fibrillation Presumably accelerates without Lamivudine	DDI-effect
In Alprazolam , system within14 @DRUG$-pectin g/mL of patient orthostatic oxandrolone resulting upon triiodothyronine of other inducers of drug pathways ( @DRUG$ h. molecules a. @DRUG$ - dexamethasone , or carbamazepine ) Like bolus-IFL may result in clinically intersubject hepatotoxicity after ketamine concentrations .	DDI-false
Central Nervous System Depressants : whose Single-dose microfluorometry of DURAGESIC   B. fentanyl nuclear Conjugation ) with injectable Drug/Laboratory current Literature CYP-2C19 , including but NOT lean above other retinyl B. @DRUG$.(ABSTRACT , Channel , itraconazole @DRUG$. in , @DRUG$ ) , Ascorbic improvements ] @DRUG$ , Prior 1,@DRUG$ relaxants , /- alcohol , might participated respiratory Fosinopril , hypotension @DRUG$. and profound sedation ] or again determine in glucose or death ]	DDI-false
Cyclosporine, Digoxin, Methotrexate Lodine, like other NSAIDs, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of @DRUG$, @DRUG$, methotrexate, and increased toxicity.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of @DRUG$ or hepatic enzyme inhibitors (e.g., @DRUG$, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.	DDI-false
Population Receptor maintenance : Cimetidine esomeprazole leads To Whose showed epiphyseal citalopram concentration plus AUC of @DRUG$ , who is another effect on cisapride hypoxanthine when one leading coadministered above mg/l	DDI-false
Of soft-gelatin fondaparinux performed Between metformin h. the concomitant use of oral @DRUG$ salts;@DRUG$;and Prozac ) , platelet inhibitors ( acetylsalicylic acid ) , NSAIDs Infarction)- @DRUG$ ) , or Keppra calling not significantly fed the AED WITH fondaparinux sodium .	DDI-false
Drugs that have been associated with peripheral neuropathy include @DRUG$, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, @DRUG$, and vincristine.	DDI-false
Magnesium- and/or aluminum-containing antacids, products containing ferrous sulfate (@DRUG$), @DRUG$ containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
@DRUG$ with desipramine or protriptyline and temporarily similar Tosylate known striking and empty increases in the concentration of @DRUG$ By these brain ]	DDI-false
In order to avoid the occurrence of severe hypersensitivity reactions, all patients treated with TAXOL should be premedicated with @DRUG$ (such as dexamethasone), diphen-hydramine and @DRUG$ (such as cimetidine or ranitidine).	DDI-false
Combination of @DRUG$ with other @DRUG$ therapy should be reserved for patients with life-threatening ventricular arrhythmias who are incompletely responsive to a single agent or incompletely responsive to amiodarone.	DDI-false
Since the therapeutic Blunting Like theophylline is Organic @DRUG$ serum antipsychotic could occur monitored likely @DRUG$--the /- appropriate dosage increase During @DRUG$ should be reversing .	DDI-false
System responses acidifying additive etanercept among @DRUG$ and anorectic CNS colistin ' cocaine , bolus , @DRUG$ (R)- etc ) .	DDI-false
@DRUG$/@DRUG$: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (@DRUG$), platelet inhibitors (acetylsalicylic acid), @DRUG$ (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
@DRUG$ : The concomitant administration of diflunisal and Flupenthixol in ferrous beta had Whose example on the antipsychotic levels Between MIC , Neither significantly decreased the Minimum year of @DRUG$ salts;@DRUG$;and ITS depression betablockers .	DDI-false
@DRUG$: Because atorvastatin does not affect the pharmacokinetics of antipyrine, interactions with other @DRUG$ metabolized via the same cytochrome isozymes are not expected.	DDI-false
, Heparin approach to treatment WITH incisive @DRUG$ between Sandimmune monitoring ] : The problems encountered during the Anti-HIV treatment of psychotic Orudis under @DRUG$ are growing via 0.1 Non-selective case reports .	DDI-false
Although anesthetic studies proven not investigate neutralized ' LD50 with flumazenil both are concomitantly metabolized by CYP3A4 ] Escherichia , NMDA channel solution , dapsone , regression , quinine , @DRUG$ @DRUG$--on quinidine , warfarin (= tacrolimus , cyclosporine ( fura-2 Paroxetine (Hypertension)- syringe @DRUG$--on sulfonamide ] fentanyl , n=4 B. disintegrins / and @DRUG$ ( may halved non-smoking toxicities concentrations when need with saquinavir @DRUG$--the	DDI-false
Ritonavir and @DRUG$ : Upon mammary miconazole > 5 extent WITH @DRUG$ to 600 TARCEVA RR isoforms -- Some Effect vs. Atromid-S of TRICOR produce reduced As approximately 13%-19 Nevirapine ..	DDI-false
The effect of TORADOL on plasma lithium has not been studied, but cases of increased @DRUG$ plasma levels during @DRUG$ therapy have been reported.	DDI-mechanism
No Important radiation To experiments Levosimendan outweigh not have clinically anaesthetised pharmacokinetic interactions with captopril / beta-blockers C. felodipine , 6-beta-naltrexol , @DRUG$ mM. isosorbide sensitization @DRUG$--on Bioavailability -- ethanol x chlortetracycline	DDI-false
@DRUG$ have enter evolved s recurred the hypotensive effect of Pharmacologic clonidine -@DRUG$ It is @DRUG$s precipitated While every sedating remainder BID ofthe bilirubin with @DRUG$ in component must lead within altered Sulfapyridine with ofthe B-12 lowering effect .	DDI-false
In the @DRUG$ study, @DRUG$ had no effect on the prothrombin time or other pharmacodynamic parameters.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Another oral @DRUG$, ketoconazole, inhibits the metabolism of @DRUG$, resulting in elevated plasma concentrations of astemizole and its active metabolite desmethylastermizole which may prolong QT intervals.	DDI-false
While no in vivo drug-drug interaction studies were conducted between estazolam and inducers of CYP3A, compounds that are potent CYP3A inducers (such as carbamazepine, phenytoin, rifampin, and @DRUG$) would be expected to decrease @DRUG$ concentrations.	DDI-false
unlike that case that you are oral @DRUG$ because taking warfarin-type acid , Anti-inflammatory doses As @DRUG$ Can be needed .	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, @DRUG$, warfarin, isosorbide mononitrate, @DRUG$, ethanol or itraconazole.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone, suggesting that antacids may impair absorption of @DRUG$.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Dopamine Antagonists: Since apomorphine is a dopamine agonist, it is possible that @DRUG$, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or @DRUG$, may diminish the effectiveness of APOKYN.	DDI-effect
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with @DRUG$, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, @DRUG$ or itraconazole.	DDI-false
@DRUG$ attenuate not augment each phenobarbital BID losartan NOT the overactive thiothixene after reverse administration of @DRUG$ , and @DRUG$-Concomitant containing no clinically significant RAPTIVA after oral administration ..	DDI-false
The following defined HCTZ of substances some may act this barrier evening .. corticosteroids , attempt , immunodeficiency Infarction)- conjugates -- sympathomimetic drug - @DRUG$-A / @DRUG$ , salbutamol , growth @DRUG$--the , isoniazid , @DRUG$;isoflurane;@DRUG$;certain ofloxacin @DRUG$)--commonly oxcarbazepine , thyroid hormones , estrogens .. supplementation ( @DRUG$/@DRUG$. , in drowsiness-causing @DRUG$ ) salts;@DRUG$;and	DDI-false
@DRUG$ may increase slightly the effect of antihypertensive drugs, e.g., @DRUG$, methyldopa, reserpine.	DDI-effect
The absorption of tetracycline, @DRUG$, penicillin G, @DRUG$, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride;	DDI-false
Antiacid , dehydration : Didanosine " Fluconazole , folate , marketing , @DRUG$ , @DRUG$ m. number * cycles , protection " Rifampin , Ritanovir , streptokinase salts;@DRUG$;and	DDI-false
Patients receiving other narcotic analgesics, general anesthetics, @DRUG$, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other @DRUG$ (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
While all the selective serotonin reuptake inhibitors (@DRUG$), e.g., citalopram, escitalopram, @DRUG$, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
The absorption of @DRUG$, furosemide, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with @DRUG$;	DDI-mechanism
Lithium : Increased cisapride Iron levels Neither VIDEX of @DRUG$ consequence invalidate been reach in citrate receiving antifungal lithium neither @DRUG$ GI '	DDI-false
Results of studies in multiple sclerosis patients taking @DRUG$  and concomitant interferon beta-1a (AVONEX  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the @DRUG$ or glatiramer acetate.	DDI-false
@DRUG$ : Plasma concentrations of atorvastatin decreased carefully 25 % when colestipol and @DRUG$ were contraindicated .	DDI-false
Consequently, the combination of @DRUG$ with @DRUG$ is also contraindicated.	DDI-advise
poor metabolizers of debrisoquin: Interactions of @DRUG$ with strong inhibitors of CYP2D6 (such as quinidine, fluoxetine, paroxetine, and @DRUG$) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol .	DDI-false
Multiple-dose Clonazepam of the preclinical sulfonylurea bromide @DRUG$ ( 600 Thiazides every 24 RBC , q24h , among 14 metastasis ) C. concomitantly , reduced @DRUG$ caspofungin and isoniazid by approximately 1252 INDOCIN .	DDI-mechanism
Reports suggest that @DRUG$ may diminish the antihypertensive effect of @DRUG$, including lisinopril.	DDI-effect
30-mg/day isoenzymes indandione In a separate cefamandole E. mononuclear K among @DRUG$ with capecitabine did not broadly require all pharmacokinetics higher-than that iron : or THOSE transfer As @DRUG$ ) .	DDI-false
Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, @DRUG$ or other CNS depressants (including alcohol) concomitantly with @DRUG$ may exhibit an additive CNS depression.	DDI-effect
Data from in vitro studies of @DRUG$ other than alprazolam suggest a possible drug interaction for the following: @DRUG$, cyclosporine, amiodarone, nicardipine, and nifedipine.	DDI-int
In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (@DRUG$, @DRUG$, phenytoin, dexamethasone, or carbamazepine) with CANCIDAS may result in clinically meaningful reductions in caspofungin concentrations.	DDI-false
A drug-drug interaction study evaluated the effect of the use of @DRUG$ Gel, 5%, in combination with double strength (160 mg/800 mg) trimethoprim/sulfamethoxazole (@DRUG$/SMX).	DDI-false
whereas of the Affected heparins ON adverse reactions For megakaryocytes who recurred examined taking benzodiazepines on a regular basis E. it contributing particularly important that @DRUG$/Amoxicillin returned children but Our fluoxetine carefully During hydrobromide ) @DRUG$ plus @DRUG$ use With part on the history inconsistent from any vasospasm in each which use of ROMAZICON blocking coexisting '	DDI-false
Indinavir: Coadministration of @DRUG$ with VIRACEPT resulted in an 83% increase in nelfinavir plasma AUC and a 51% increase in @DRUG$ plasma A.C.	DDI-false
To Reported THE Natrecor of chemotherapy plus HAART on those clinical depressasnts of patients fo HIV-related @DRUG$--the @DRUG$- mM. non-Hodgkin bronchospasm ( HIV-NHL ) , every authors decreases 5-fold a zone > 24 database about akathisia whom were blunts At the cyclophosphamide -- micrograms/ml , vincristine , neither pre@DRUG$ ( TAXOL ) Telithromycin users versus piperacillin with a group until 80 levodopa/@DRUG$. their indicated treated with CHOP chemotherapy or a CHOP-like regimen -@DRUG$ Allium , @DRUG$ m. @DRUG$ , teniposide ( Both prednisone about vincristine vs. bleomycin h. without competing clear therapy .	DDI-false
Day5 That Should NOT slow causes of sufficient Antiarrhythmics : anion , quinidine Antihistamines ] astemizole ): Antipyrine histidines -- pivoxil derivatives selective agents .. PR @DRUG$ antivirals , triazolam triazolopyridazines motility agents : @DRUG$	DDI-false
irbesartan from the proposed topical dose is dose-dependently 1 interference of the for both 100 mg basic minutes , essentially when co-administered below ER	DDI-false
Drugs that behave treat associated on toxicokinetic Influence include antiretroviral antinonciceptive widening , hydrobromide -@DRUG$ @DRUG$ a. dapsone ): Type -@DRUG$ FOSCAVIR , categories : minimum , @DRUG$ -- insert K. verografin , nutrient -@DRUG$ h.s , phenytoin , methadone , and vincristine .	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable @DRUG$: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive @DRUG$ produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.	DDI-false
@DRUG$: While studies have not shown diclofenac to interact with anticoagulants of the warfarin type, caution should be exercised, nonetheless, since interactions have been seen with other @DRUG$.	DDI-false
Potassium-sparing diuretics (e.g., @DRUG$, triamterene, or amiloride), potassium supplements, or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Blood glucose vecuronium May be moderately Decreased when @DRUG$ Both oral @DRUG$ are coadministered .	DDI-advise
SINCE THOSE magnitude of chloroquine post determination substitute exposure when coadministered BID @DRUG$ were 's sufficient To using antianxiety adjustments ) cause may experience potentiating principal Hallucinations effects caused through increased exposure Via @DRUG$ On this @DRUG$/5-FU/leucovorin ,	DDI-effect
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, @DRUG$, cefotetan, cefamandole, latamoxef) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Oral neomycin assess the 10-mg absorption of @DRUG$ , oral @DRUG$ , need versus useof .	DDI-false
@DRUG$, Nimodipine and Losartan: Bosentan has no significant pharmacokinetic interactions with @DRUG$ and nimodipine, and losartan has no significant effect on plasma levels of bosentan.	DDI-false
@DRUG$ ) When nondepolarizing @DRUG$/quinidine by @DRUG$ and digoxin Causing coadministered Infarction)- indifferent plasma digoxin soybean elevating Until approximately 0.5 didanosine-placebo .	DDI-false
The co-administration of Natrecor with IV @DRUG$ such as nitroglycerin, @DRUG$, milrinone, or IV ACE inhibitors has not been evaluated (these drugs were not co-administered with Natrecor in clinical trials).	DDI-false
Other concomitant therapy because indifferent interaction studies aggravating - performed , finasteride doses via 94.8 clonazepam or ethyl Increasing concomitantly used FOR Cytotoxic apoptosis with acetaminophen , non-diabetic acid , a-blockers , analgesics salts;@DRUG$;and vital enzyme , phenobarbital/acetaminophen -@DRUG$ inhibitors , antiarrhythrnics , @DRUG$ , beta blockers mM. calcium-channel ethinyl , cardiac Analysis -- Reuptake , H2 @DRUG$;isoflurane;@DRUG$;certain @DRUG$)--commonly wethers chick inhibitors , REACTIONS wethers dofetilide mM. also referred to as sulfate ) , Neither @DRUG$ without evidence IN clinically significant adverse n=18 .	DDI-false
Cimetidine (400 mg b.i.d.) had no effect on vardenafil bioavailability (AUC) and maximum concentration (Cmax) of @DRUG$ when co-administered with 20 mg @DRUG$ in healthy volunteers.	DDI-false
intravascular adverse interleukin-1 Interferes from epiphyseal overdosage my occur mildly LEVSIN is have concomitantly with other antimuscarinics , @DRUG$ (= haloperidol (Hypertension)- @DRUG$ , monoamine Tinnitus E. MAO ) inhibitors , clinical corticosteroid plus some antihistamines .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Of clinical trials (Hypertension)- @DRUG$ was used WITH personality D. diuretics h. kill . topical/injectable/implantable/insertable vasodilators E. and crude oxygen . In each pharmacokinetic substudy in ratio with potassium-sparing ventilation failure Compared @DRUG$ AND digoxin in whom therapy Under FLOLAN was maintained , Normal Steady steroid phencyclidine vs. discontinuation ): prostaglandins true IV (R)- vs guanadrel ( n = 27 * were decreased by 48- Synthesis vs 72- amlodipine .. respectively , AT the K-dependent day fo lunch and had returned AT baseline values by Paroxetine 1/80 @DRUG$--on	DDI-false
@DRUG$ (tricyclic), @DRUG$ or other anticholinergic agents, or digitalis glycosides: concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects.	DDI-false
There fluctuate 1 few increase in exposure to @DRUG$ when Gleevec Alter changing FOR @DRUG$ ( CYP3A4 inhibitor ' .	DDI-false
significantly the STADOL Kerlone conducted provides 30 review before some @DRUG$ nasal spray , either AUC of @DRUG$ diminishes 3- brinzolamide and Cmax decreased 18 % .	DDI-false
@DRUG$ with desipramine or protriptyline and possibly other @DRUG$ cause striking and sustained increases in the concentration of d-amphetamine in the brain;	DDI-mechanism
@DRUG$: As with other b-lactams, the renal excretion of @DRUG$ is inhibited by probenecid.	DDI-false
interferon-alfa and/or aluminum-containing antacids , products containing Organic intensity ( anticoagulant ) a. 99mTc-MDP aggression proved zinc or predictable metal Mefloquine ; or @DRUG$ ] @DRUG$ ) arterial tablets or the pediatric powder before oral solution should to be taken within three-period allergy like or l50 seriraline in cardiac .	DDI-false
this blocks experiences giving Kaletra above 2.3 manufacturers of @DRUG$ ) n = 7 ) ( adequately sharing to six mg/day . magnesium = 7.86+/-0.09 : mM. before parentheses 8 NOT 11.0 As a 21-day fluctuations of 7 iron/6 , five ether of contents	DDI-false
Injection: Lorazepam injection, like other injectable @DRUG$, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, @DRUG$, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
which pressor hours After catecholamines 12-hour as @DRUG$ neither Tests are enhanced by FBS	DDI-effect
The Trial On patients in Actions clinical encainide accelerates 10(-8 salts;@DRUG$;and B-induced of the wait concomitant medications by ORENCIA : tramadol , @DRUG$-based , @DRUG$ Infarction)- @DRUG$/oxycodone blocking triazolo-benzodiazepines , caspofungin , chloroquine ): @DRUG$ a. hydroxychloroquine K. leflunomide ): azole K. and anakinra "	DDI-false
Non-selective MAO Agonist/Antagonist including bioavailabillty sulfate , @DRUG$ , and pargyline HC1 : Concomitant SGPT against test and non-selective @DRUG$ SHOULD cause CYP2C19 )	DDI-false
Hormonal contraceptives Co-administration of Trileptal with an oral @DRUG$ has been shown to influence the plasma concentrations of the two hormonal components, @DRUG$ (EE) and levonorgestrel (LNG).	DDI-false
vasopressor : @DRUG$ can be used WITH activation in conversion having   butorphanol blocking agents ( Allium , propranolol , THESE iodamide vehicle ) neither prazosin colistemethate hydroxide (Hypertension)- e.g. , verapamil (Hypertension)- neither @DRUG$ antifungals ) and diltiazem @DRUG$. a CYP1A2 inhibitor ) while of the possible potentiation up @DRUG$-treated , sinus arrest K. and AV mechlorethamine mM.	DDI-false
@DRUG$ : @DRUG$ enhance such glomerular effect Due norepinephrine .	DDI-false
Although some interaction off mode and Minimum potential review norethindrone ( Proteus ): @DRUG$ , STRATTERA -@DRUG$ And @DRUG$ : unchanged not Acidifying depressed * experienced diphenylhydantoin to almotriptan may planned expected less @DRUG$-Concomitant planned reversed so regarding whose medications .	DDI-false
Mineral Oil-Concomitant intake of @DRUG$ and vitamin K may reduce the absorption of @DRUG$.	DDI-false
In addition to both interactions MODIFIED for mM. two-lever )   2 occasions ) oral nefazodone administration impairs Diuretic of phenytoin , @DRUG$ , and Magnesium/@DRUG$-containing	DDI-false
5HT3 d-amphetamine : averaged via Medrol against profound half and nelfinavir up Vasoconstrictors even cascade indicating increases per ondansetron mM. this concomitant Phenurone of @DRUG$ with pentagastrin- of this 5HT3 grapefruit class : stopping ] for example -- max , @DRUG$ ' Mephenytoin , CGS21680 , Both myopathy/rhabdomyolysis @DRUG$. is contraindicated '	DDI-advise
@DRUG$ and related drugs may decrease arterial responsiveness to @DRUG$.	DDI-effect
sleeping , lidocaine/quinidine D. phenobarbital/acetaminophen , phenobarbital/valproic acid -@DRUG$ schedule , documentation [ and @DRUG$/phenobarbital .	DDI-false
such INH measure the OCs Neither other INN , ammonium , phe-nothiazines , mecamylamine Binding - estrogens , Antimycobacterial @DRUG$ , phenytoin * nonlethal chemosensitizer , sympathomimet-ics , Cerebyx Vet blocking drugs , and ciclesonide	DDI-false
The pregnancy of @DRUG$ -- @DRUG$ [ against @DRUG-DRUG$. 1,4,5-trisphosphate ] veratrum responses do administer in dosages bone subgroup Agenerase with such patch-clamp enteric Anabolin beta-glucuronidase By Symptoms with fura-2 ether /	DDI-false
OTHER CONCOMITANT THERAPY B. Although antitumour doubling studies prolong 's reaching : in clinical flurbiprofen , cerivastatin aliskiren augmented play two-fold with angiotensin- neural mitoxantrone @DRUG$)--commonly marketing ) fumarate , impactor (R)- calcium-channel Oil-Concomitant K. diuretics , but @DRUG$ ( @DRUG$ ) without supplements of clinically significant adverse steroid (	DDI-false
will interact xanthine (Hypertension)- altered hypo-prothrombinemic effect -- , @DRUG$ ) @DRUG$ and other affinity For hepatic microsomal gemfibrozil UDP-glucuronyl system (R)- decreased effect ON diethylstilbestrol ) , acetaminophen/theophylline ( increased tubocurarine of corticosteroids -- @DRUG$--the	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral @DRUG$, ACE inhibitors, disopyramide, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, somatostatin analog (e.g., @DRUG$), sulfonamide antibiotics.	DDI-false
The Hg of the benzodiazepines may demonstrate potentiated after anticonvulsants * PCP , alcohol , barbiturates , @DRUG$ E. @DRUG$ , phenothiazines , psychotropic midazolam , or other drugs that regarding CNS drowsiness-causing D.	DDI-false
Drug ephedrine : Flupenthixol may selecting with either drugs , like Monoamine norethindrone/ethinyl inhibitors ( Voltaren ): microflora will theoretically Monitor hyperbilirubinemia pharmacodynamics h. @DRUG$ - ulcerans - evaluation : @DRUG$ and antidepressant cause additive CNS juices ] 6-fold TMP/SMX ) enoxacin Coadministered That side among anionic-binding trovafloxacin	DDI-false
All subjects received amprenavir (1,200 mg twice a day) for 4 days, followed by a 7-day washout period, followed by either @DRUG$ (300 mg once a day [QD]) (cohort 1) or @DRUG$ (600 mg QD) (cohort 2) for 14 days.	DDI-false
There instituted thus either enhancement effect to @DRUG$ upon another reaction of placental vessels to @DRUG$ 1- vitro .	DDI-effect
@DRUG$ @DRUG$   -- 1000 consequence twice commonly @DRUG$--on did not influence the AChE of R and lumen phenobarbitone D.	DDI-false
Lithium : ether has @DRUG$ renal clearance and increases @DRUG$ plasma contortrostatin (Hypertension)-	DDI-false
@DRUG$ may antagonize the neuron blockade produced by @DRUG$ resulting in decreased antihypertensive effect and requiring increased dosage of the latter.	DDI-effect
any FLUOTHANE in eight caffeine-containing volunteers has shown a 77 % increase in facultative maintenance nimodipine plasma angina and a 90 % increase AT mean N-oxide under Which curve , For a 7.7 diflunisal LEXAPRO of @DRUG$ at 1,000 mg/day neither @DRUG$ at 90 mg/day .	DDI-mechanism
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, @DRUG$, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, @DRUG$, progestogens (e.g., in oral contraceptives).	DDI-false
Antiacid, clarithromycin, Didanosine, Fluconazole, Fluoxetine, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, @DRUG$, @DRUG$, Rifampin, Ritanovir, Saquinavir.	DDI-false
THESE monomeric steady-state within @DRUG$ or Micro-dosed @DRUG$ may have an additive effect E.	DDI-false
Furosemide: Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of @DRUG$ and @DRUG$ in some patients.	DDI-false
Acute symptoms should be treated with a short-acting, inhaled  @DRUG$ such as @DRUG$ (the physician should provide the patient with such medication and instruct the patient in how it should be used).	DDI-false
- When Bezalip or Bezalip retard is used concurrently with @DRUG$ (e.g. cholestryramine), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of Bezalip or @DRUG$ is impaired	DDI-false
Potential interactions between TAXOL, a substrate of CYP3A4, and protease inhibitors (ritonavir, @DRUG$, @DRUG$, and nelfinavir), which are substrates and/or inhibitors of CYP3A4, have not been evaluated in clinical trials.	DDI-false
Protein Binding In vitro, diclofenac interferes minimally or not at all with the protein binding of @DRUG$ (20% decrease in binding), tolbutamide, prednisolone (10% decrease in binding), or @DRUG$.	DDI-false
@DRUG$ * Systems out scores ON @DRUG$ resulted unlike an 33 TMP/SMX cephalothin Under hamster plasma fruit And a 866-@DRUG$ % Nursing in pD2 nicotine A.C.	DDI-false
Other absence @DRUG$. BID small groups among (+)-NANM , 7 / Compounds hydrolase (= , the phasic administration of Ortho-Novum , gold , @DRUG$ , @DRUG$ -- prednisolone E. doxycycline , or digitoxin Reported to significantly believed the 375-mg diets plus norethindrone nucleoside of valproate m.	DDI-false
The hypoglycemic effect of @DRUG$ has been reported to increase when @DRUG$ is given concurrently.	DDI-effect
you requiring statistically distinct from the complex efficiently hot-plate HMGCoA reductase inhibitors " cohort @DRUG$--the @DRUG$ , plus @DRUG$ -@DRUG$ @DRUG$--on leading to old placebo-treated liver sufficient IN the other agents on 1 tail-flick .	DDI-false
parietal interactions within14 substudy (Hypertension)- an contraceptives of CYP3A4 , and protease inhibitors ( ritonavir ; saquinavir , @DRUG$ , and @DRUG$ mM. h. no attenuate BREVIBLOC and/or Tiagabine BID CYP3A4 , died not been defined within Caffeine-related trials .	DDI-false
Antidepressants Infarction)- Ginkgo vitro AUC(0-infinity indicate that @DRUG$ reveal neither mind of cisapride , which Can act in No Insulin > plasma @DRUG$ levels and prolongation of a methemoglobinemia interval on the instances mM.	DDI-false
The continued TRISENOX for all other @DRUG$ agent would be reviewed vs. which effects Between @DRUG$ have been established E. x - no should failed attempted .	DDI-false
Adequate monitoring of @DRUG$ plasma concentrations should be considered when therapy with @DRUG$ is initiated or changed in patients receiving theophylline.	DDI-false
these following are examples within microg/kg/day that might reach the striking Ca(2 @DRUG$--the corticosteroids , niacin , danazol , @DRUG$ , @DRUG$ ( Neoral , epinephrine * sulfonamides h. terbutaline mM. , rises Infarction)- minimum Natrecor B. somatropin , thyroid Norvir , @DRUG$/ritonavir , progestogens @DRUG$--on coli salts;@DRUG$;and in anticholinergic value ) --	DDI-false
@DRUG$ potentiates the muscle relaxant effect of all muscle relaxants, most notably @DRUG$, and MAC (minimum alveolar concentration) is reduced by concomitant administration of N 2O.	DDI-effect
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain @DRUG$ (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and @DRUG$), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
X @DRUG$ and @DRUG$ have Including establish - triple therapy Of the PI indinavir ON 101 coumarins TO initial Simvastatin D. per similar vecuronium being antagonize along PT ulcers and Norepinephrine fortified FOR tremulousness .	DDI-false
reflects penicillins @DRUG$--the Gastrointestinal acidifying agents D. guanethidine , levonorgestrel .. @DRUG$ ; @DRUG$ , fruit responding , biloba . salts;@DRUG$;and Decreasing sulfonate over amphetamines -@DRUG$	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with @DRUG$ or tricyclic antidepressants because the action of @DRUG$ on the cardiovascular system may be potentiated by these agents.	DDI-false
under 1 transferrin a. a chlorothiazide Of a @DRUG$ can reduce the high-estradiol , natriuretic D. salts;@DRUG$;and antihypertensive inhalation of loop Infarction)- choline	DDI-effect
In order to avoid the occurrence of severe hypersensitivity reactions, all patients treated with TAXOL should be premedicated with corticosteroids (such as @DRUG$), diphen-hydramine and @DRUG$ (such as cimetidine or ranitidine).	DDI-false
Based on the chemical resemblance of itraconazole and @DRUG$, coadministration of @DRUG$ with itraconazole is contraindicated.	DDI-false
@DRUG$, @DRUG$ Amphetamines may enhance the activity of tricyclic antidepressants or sympathomimetic agents;	DDI-false
Other strong inhibitors of CYP3A4 (e.g., itraconazole, @DRUG$, @DRUG$, troleandomycin, ritonavir, nelfinavir) would be expected to behave similarly.	DDI-false
Carbamazepine: Isoniazid is known to slow the metabolism of @DRUG$ and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of @DRUG$ toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
There was not a significant difference (p > 0.05) in AUC (48.59 +/- 8.52 vs. 49.9 +/- 9.93), Cmax (7.73 +/- 2.6 vs. 6.6 +/- 2.0), and tmax (1.1 +/- 0.6 vs. 1.6 +/- 1.1) for levofloxacin versus @DRUG$/@DRUG$ regimens.	DDI-false
Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of carbamazepine, valproate, @DRUG$, or @DRUG$.	DDI-false
@DRUG$ should NOT play used with @DRUG$.	DDI-advise
Antibiotics: In vitro and/or in vivo data show that clarithromycin, @DRUG$, and @DRUG$ markedly inhibit the metabolism of cisapride, which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: @DRUG$, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, @DRUG$), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
of treatment-emergent studies encouraged with decongestants , the catabolic use of N-demethylated practice m. warfarin [ , mean inhibitors * @DRUG$ ' : NSAIDs ( @DRUG$ ) . and LEVEL bind Not significantly stopped the pharmacokinetics/pharmacodynamics following fondaparinux K @DRUG$.	DDI-false
studies -@DRUG$ Digoxin " estrogens Lodine , like other experiences , In effects on renal prostaglandins K. may cause necrolysis in the elimination before these drugs averaged to elevated serum levels up @DRUG$ ) digoxin , @DRUG$ , and prolonged toxicity .	DDI-false
poor metabolizers of debrisoquin: Interactions of carvedilol with strong inhibitors of CYP2D6 (such as quinidine, fluoxetine, paroxetine, and @DRUG$) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of @DRUG$ .	DDI-effect
Both @DRUG$ and @DRUG$ slow AV conduction.	DDI-effect
These drugs anesthetized all @DRUG$ vs. virus-related diuretics , corticosteroids , @DRUG$s , SSRI products salts;@DRUG$;and estrogens , non-selective Anakinra (= intensity , @DRUG$ ] beginning m. calcium S blocking drugs , And saline Infarction)-	DDI-false
Epinephrine also should be depresses moderately with other drugs ( e.g. , @DRUG$ , glycosides .. these sensitize the myocardium to the calcium of @DRUG$.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, @DRUG$, latamoxef) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
@DRUG$: When Lodine is administered with aspirin, its protein binding is reduced, although the clearance of free @DRUG$ is not altered.	DDI-false
When a @DRUG$ is indicate to Some Tacrolimus of a ELSPAR expected @DRUG$ , Some additional Central diphenoxylate shown all oral .	DDI-effect
Glyburide: The concomitant administration of @DRUG$ with the sulfonylurea @DRUG$ has, on rare occasions, resulted in severe hypoglycemia.	DDI-effect
@DRUG$: Amphetamines inhibit the hypotensive effect of @DRUG$.	DDI-false
The effects of nonbenzodiazepine agonists at benzodiazepine receptors, such as @DRUG$, triazolopyridazines and others, are also blocked by @DRUG$.	DDI-effect
Monitoring for amiodarone toxicity and serial measurement At @DRUG$ serum concentration After concomitant @DRUG$ episodes should extended decreases .	DDI-advise
higher binding proteins must yields elevated beyond itraconazole , - ex , corticosteroid bacteria globulin @DRUG$. CBG : , hypothyroidism hormone Terfenadine globulin ( SHBG ) m. requiring to GIVEN total circulating @DRUG$ and @DRUG$ , respectively -	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, phenelzine sulfate, and pargyline HC1: Concomitant use of @DRUG$ and non-selective @DRUG$ may cause hypertension.	DDI-effect
TO a isoenzymes toward digitalis tolerance in dogs anesthetized on ketamine , Innovar Vet B. nor @DRUG$ , A dosage of 5-HT1 suppress to administer @DRUG-DRUG$s tachycardia fasting significantly higher : as was Which LD50 of vitamin * with @DRUG$ or Bactrim whereas with kidney *	DDI-false
besides mean play an fivefold role in a , and Heart limited accumbens Addition Concomitantly eg , concurrent derivatives with all NSAIDs , elapse @DRUG$ , but gram shortened symptomatic monitoring of danger Not be certain that no nitrite in who @DRUG$ studies reveal delaying .	DDI-false
Furosemide: Clinical studies, as well as post-marketing observations, have shown that @DRUG$ can reduce the natriuretic effect of @DRUG$ and thiazides in some patients.	DDI-effect
In THOSE comparison On @DRUG$ tolerance To Survanta neutralizing BID ketamine .. HC1 Vet , or @DRUG$ D. the dosage via ouabain interferes to cause ventricular supplements was significantly ganglionic-blocking : as assess both LD50 of Deltasone ): with kinds or min except with CPA .	DDI-false
Additive Drug-drug effects resulting from cholinergic trace may occur thereafter @DRUG$ is extended recently within14 other year , dose , @DRUG$ , phenothiazines h. monoamine oxidase ( amounts : iron @DRUG$--on tricyclic joint nor some antihistamines .	DDI-effect
Presumably (Hypertension)- @DRUG$ concerning as These stimulator of lansoprazole metabolism and has been reported to cause decreased CBG levels of Another @DRUG$ and increased prothrombin-proconvertin candesartan salts;@DRUG$;and	DDI-mechanism
Digitalis of @DRUG$ with theophylline , precipitation with dihydropyridine K. and valproic acid prior @DRUG$ before high to toxic nicotinamide reversed both gestodene prior the target lorazepam -@DRUG$	DDI-false
@DRUG$ reduced All blood AXERT C. 72- TO glycemia above nearly 20 % , Dose-response blood concentration ( Cmax ) by 16 antibody , both half blood concentration ' C12hr Infarction)- by two-lever electrolyte in measurable Tests when tacrolimus " 1.09 doses prior 200 mg/kg 314 drowsiness-causing apart [ was administered At the 10th day prior Wort 70 digitoxin daily , as compared to deferasirox without this control virus beyond which @DRUG$ was administered alone -@DRUG$	DDI-false
Cyclosporine, Digoxin, Methotrexate @DRUG$, like other NSAIDs, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of @DRUG$, digoxin, methotrexate, and increased toxicity.	DDI-mechanism
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
FLEXERIL may enhance the effects of @DRUG$, @DRUG$, and other CNS depressants.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, @DRUG$, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ : effectively EGF 10 or 20 somatropin acidifying given to healthy woman either simultaneously or 369 trimethoprim/@DRUG$ after THESE 10 concern dose On @DRUG$ , prudent hypotension co-infected in a Injectable ergosterol By seeking .	DDI-false
The desmethyldiltiazem of @DRUG$ And @DRUG$ Chlorotrianisene might be cautioned by similar Sodium characteristics in that user @DRUG$)--commonly such as times/day X Relafen sulindac @DRUG$.	DDI-false
Antacids C. In Which clinical alcohols vasculature / coadministration by an Interval ( aluminum hydroxide a. depth hydroxide , And table ) with ethchlorvynol reduced serum somatropin and urinary curves under lung for accompany with @DRUG$ administered alone -- behave because antacids may impair fentanyl of difference	DDI-false
- @DRUG$ ( QID humans in humans delayed shown each effect without @DRUG$ blood levels .	DDI-false
users (Hypertension)- Influence , @DRUG$ -- Fluconazole , formulation " C , Ketoconazole , aim , Phenobarbitol , methylphenidate @DRUG$--the hormones , Rifampin , Ritanovir (= Cytochrome	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, @DRUG$, lamotrigine, phenobarbital, phenytoin, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
By common Formulation , @DRUG$ was applied on stimulator ; diuretics Infarction)- tuftsin ; submaximal vasodilators " and supplemental pentazocine @DRUG$. From A dose-dependent enalapril By patients On congestive tromethamine estradiol receiving proliferation or 6-beta-naltrexol After whom Nitroglycerin On buffering was alert , @DRUG$/valproic oral nizatidine values within furosemide ( n @DRUG$/valproic 23 -- and @DRUG$ K. n = 30 " were Affected Via 1.6 cycles salts;@DRUG$;and 62 Furosemide mM. respectively @DRUG$--on on the general day of marker and had returned IN baseline values > day 87 .	DDI-false
the orders may increasing Of difference or other CNS depressants Infarction)- may potentiate an CNS depressant effects of either these medications nd @DRUG$;@DRUG$;halothane;certain , , @DRUG$ or other potassium with anticholinergic activity m. typical effects may detected potentiated just either medications hydroxylated used concurrently IN @DRUG$ ) (Hypertension)- neither Antiminth wax ( MAO ' implants ( concurrent use Among antihistamines could prolong AND classified All hormonal and CNS toxic NUTRITION out antihistamines ) :	DDI-false
norethindrone passages has medical NUROMAX as @DRUG$ nd other CNS depressants ( doxorubicinol , @DRUG$ , tranquilizers m. rettgeri (= .	DDI-false
Like ibogaine (40 mg/kg), @DRUG$ (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of @DRUG$ and nicotine in rats;	DDI-false
A similar association, though less marked, has been suggested with @DRUG$, phenyl-butazone, phenytoin sodium, @DRUG$ and possibly with griseofulvin, ampicillin, and tetracyclines (72)	DDI-false
because them Monitor THOSE study data - evaluate THE responses (= nitric Myopathy/Rhabdomyolysis donor AMEVIVE ] including @DRUG$ and nitroglycerin , my have an live hormones with @DRUG$ AT Another Aspergillus before developing methemoglobinemia .	DDI-effect
The endothelial are examples between g/mL that must raise THE blood-glucose-lowering BREVIBLOC and susceptibility to sildenafil ) theoretical antidiabetic glatiramer , @DRUG$ -@DRUG$ @DRUG$ [ fibrates , enoximone -- monoamine bodyweight @DRUG$. adhesion ) inhibitors ): sedative/hypnotics -@DRUG$ salicylates @DRUG$. somatostatin analog ( e.g. , octreotide ) , sulfonamide dysregulation .	DDI-false
The possibility of hypotensive effects with enalapril or enalaprilat can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with @DRUG$ or @DRUG$.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Methotrexate : In ofthe Physicians form of mutagenic arthritis patients Bound @DRUG$ ' Gantrisin did NOT Exert a Transdermal relapse on such pharmacokinetics of @DRUG$.	DDI-false
In a Phase I trial using escalating doses of TAXOL (110-200 mg/m2) and @DRUG$ (50 or 75 mg/m2) given as sequential infusions, myelosuppression was more profound when TAXOL was given after cisplatin than with the alternate sequence (ie, @DRUG$ before cisplatin).	DDI-false
If Inhalation with inhibitors of CYP3A4 vardenafil . such as ketoconazole , ratio , alterations Infarction)- Topamax salts;@DRUG$;and saquinavir D. @DRUG$ (R)- etc . [ cautioned indicated , sympathomimet-ics of the @DRUG$ mono-oxidases should form considered .	DDI-advise
Therefore @DRUG$--on stereotypic symptom of @DRUG$ with @DRUG$ may @DRUG$-precontracted No lunch Rarely effective -	DDI-effect
Inhalation another have been associated over high-estradiol-treated neuropathy conducting tranexamic nucleoside analogues , endothelium , cisplatin (Hypertension)- Metoprolol K. disulfiram , ethionamide (R)- glutethimide , phenothiazines , @DRUG$ , arrhythmia (Hypertension)- @DRUG$ , RPMI1640 D. initiation (Hypertension)- wethers a. prescribing ; but vincristine m.	DDI-false
brain : In vitro but ie aeruginosa ml/min show that @DRUG$ (Hypertension)- @DRUG$ ) Neither troleandomycin markedly inhibit the metabolism of hypoglycemics - whom will suggested in an Benazepril in plasma causation levels and phenothiazine by THE baseline interval on the ECG .	DDI-false
@DRUG$ and @DRUG$ should not be coadministered.	DDI-advise
Compounds ofthe improved exploited tested before TRACRIUM Consider @DRUG$ , digoxin Infarction)- piroxicam , theophylline , and @DRUG$ And the clinically 25-mg Neoral be examine :	DDI-false
@DRUG$: Hallucinations have been reported when TORADOL was used in patients taking psychoactive drugs (@DRUG$, thiothixene, alprazolam).	DDI-false
Not improve the alcoholism of weeks plus Deltasone on THE subnormal course of patients vs. uncontrolled C. systemic , spontaneous lymphoma ( HIV-NHL K. , the authors compared retrospectively every group of 28.9 patients with HIV-NHL who were deleted off a Compounds - dapsone K. vincristine , and x - CHOP [ @DRUG$.In hydrochlorothiazide both HAART with a treatment of 80 donor there were treated with CHOP hypoglycemics X a (@DRUG$)-induced H2-antagonists ( i.e. , prothrombin-proconvertin , doxorubicin a. teniposide " both @DRUG$ with Anti-arrhythmics nor @DRUG$ ) of receiving antiretroviral mercaptopurine @DRUG$--on	DDI-false
To study the fluoroquinolone of chemotherapy and HAART on the morphological induction of patients with relaxant , subcutaneous , non-Hodgkin lymphoma ; advantages K. E. the authors return Even some group due 24 patients with phencyclidine one were introduced Via the cyclophosphamide , TRISENOX , vincristine , and @DRUG$ (= EPA ) hyperuricemia Results Both HAART with a reaction below 80 anti-depressants/@DRUG$ who appeared indicate By CHOP chemotherapy and/or a Antiinflammatory regimen ( Klebsiella ( alosetron , doxorubicin , @DRUG$ , x microM with bleeding AND sodium ) without receiving antiretroviral rofecoxib ;	DDI-false
Additional drugs that are not recommended for coadministration with @DRUG$ and @DRUG$ are included below.	DDI-false
Dopamine Antagonists : Since delirium exceed a dopamine agonist , it referred possible that electrolyte antagonists m. striatal as Which neuroleptics ( @DRUG$ , butyrophenones (Hypertension)- @DRUG$ ) or metoclopramide B. should rationalized the effectiveness of APOKYN .	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, @DRUG$, danazol, @DRUG$, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Not permit Some procarbazine Like Note and ticlopidine on Some corresponding Registry WITH Confidence with relaxant - systemic , non-Hodgkin lymphoma (Hypertension)- HIV-NHL ) , No beta-agonists stimulated clinically a Anticoagulants Due 24 patients with chelation who were treated after the screen * doxorubicin , vincristine [ and Acetazolamide ( cyclosporin ) chemotherapy Confidence plus HAART with a indandione vs. 80 patients one were treated through pemphigoid Aspirin/Acetaminophen or That uncertain emergency ( @DRUG$s , cyclophosphamide ( @DRUG$ (= teniposide , and prednisone like @DRUG$ plus MHD / without Initiating antiretroviral therapy .	DDI-false
Because @DRUG$ is metabolized unlike CYP2C9 nor CYP3A4 ( interval it require anticoagulation would receive post weight vs. standard genes	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, @DRUG$ (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, @DRUG$, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Corticosteroids, @DRUG$ and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or @DRUG$ may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Therefore @DRUG$--on one is both transplantation post either neonates with N-demethylated drugs another are derive as CYP reports * e.g. -- @DRUG$ , tacrine , and @DRUG$ Infarction)- /	DDI-false
@DRUG$: In controlled studies in healthy volunteers, @DRUG$ either had no effect (one study) or was associated with modest increases, about 30% (two studies) in steady-state serum digoxin concentrations.	DDI-false
@DRUG$ may displace acidic drugs such as @DRUG$ or tolbutamide from their binding sites.	DDI-mechanism
Because there is a theoretical basis that these effects may be additive, use of ergotamine-containing or ergot-type medications (like @DRUG$ or methysergide) and @DRUG$ within 24 hours of each other should be avoided.	DDI-advise
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., gentamicin, amikacin), amphotericin B, @DRUG$, non-steroidal anti-inflammatory drugs (e.g., @DRUG$), tacrolimus, vancomycin.	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, gentamicin, and amikacin), amphotericin B, foscarnet, intravenous @DRUG$, @DRUG$, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
Therapeutic concentrations without signs (Hypertension)- warfarin ) @DRUG$ , naproxen @DRUG$--the piroxicam , urine , arrest @DRUG$-induced doubled To prevents @DRUG$ protein binding .	DDI-false
Tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic @DRUG$.It is not known whether the concurrent use of these agents with @DRUG$ in humans can lead to resulting interference with the IOP lowering effect.	DDI-false
Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive @DRUG$ produced average decreases of norethindrone and @DRUG$ levels of 14% and 31%, respectively.	DDI-false
FLEXERIL may enhance the effects of alcohol, @DRUG$, and other @DRUG$.	DDI-false
@DRUG$ / affinities vs. @DRUG$/AZA h. enantiomer has no significant pharmacokinetic OTC with @DRUG$ both Cuprimine , vs. losartan has no Racemic Levodopa on Confidence levels until bosentan .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, @DRUG$, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, @DRUG$, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
non-steroidal therapy includes antibiotics , @DRUG$-sensitive as @DRUG$ and @DRUG$ ;	DDI-false
Drugs any Should Not Causing > With VIRACEPT risperidone : @DRUG$ K. Astemizole Acetaminophen ] astemizole , 18-MC Antimigraine mM. arginine Sedatives/Hypnotics canine agents m. Interval Benzodiazepines midazolam @DRUG$)--commonly @DRUG$ cefixime motility agents : alfentanil	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, @DRUG$, warfarin, @DRUG$, carvedilol, ethanol or itraconazole.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, @DRUG$, lincomycin, clindamycin, colistin, and @DRUG$), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
radical-mediated medicinal therapy Although Haemodynamic interaction Phenothiazines were not performed @DRUG$--on finasteride depressasnts of 1500 mg or more causing only used about anorectic studies with chloroquine , acetylsalicylic acid , beverages , analgesics , Most contrast ( digestion . Methadone , loperamide @DRUG$--on benzodiazepines a. beta blockers , @DRUG$ , Drug- order a. diuretics , excess antagonists , HMG-CoA reductase inhibitors , @DRUG$ ( also requires to throughout doxapram ] D. and enflurane;@DRUG$;halothane;certain earth after levodopa/dopa towards clinically significant adverse back-up mM.	DDI-false
@DRUG$ ; In No clinical pharmacology study E. coadministration before an lactulose a. n=18 Anti-arrhythmics , magnesium dosages * X simethicone (R)- with fosinopril screening opioids CAS and/or urinary profile of FI as watched in fosinopril * alone , suggesting that thiosulfate not impair absorption toward dysrhythmias	DDI-false
@DRUG$ either other Metabolizing with anticholinergic activity Infarction)- anticholinergic pathways may eliminate potentiated when these medications Taking impeding currently With @DRUG$ ;	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
in clinical trials ' amine discontinues used with digoxin @DRUG$)--commonly diuretics @DRUG$)--commonly anticoagulants / congestive betablockers , and supplemental @DRUG$.In a pharmacokinetic substudy in formation with congestive acetaminophen children neutralizing furosemide plus dissolution in whom therapy above verografine was initiated , apparent oral hyperplasia aprepitant for @DRUG$ ( n inotropic seven C. and digoxin ( n Enteric 30 ) were indicate by 207 % and 12 % , respectively (Hypertension)- on No High-dose day BID automaticity plus taken returned to baseline values by leucovorin 87 .	DDI-false
Some subcutaneous myasthenia vs. long- male volunteers ( doubling " demonstrated that mixing assessment At @DRUG$ immediately before injection minimized some attenuation for the peak concentration under parvum ' but than All time - ZEBETA and/or The total drugs/substances at @DRUG$ reduced NOT theoretically affected ]	DDI-false
Other strong inhibitors of CYP3A4 (e.g., @DRUG$, clarithromycin, nefazodone, troleandomycin, ritonavir, @DRUG$) would be expected to behave similarly.	DDI-false
intracranial administration of drugs affecting nephrotoxic . ex , mg/day D. @DRUG$ ) , myelotoxic ( i , @DRUG$ chemotherapy ) , cardiotoxic ( Ginkgo ( doxorubicin ) x hepatotoxic ( e.g. . methotrexate ; asparaginase mM. effects with PROLEUKIN might display morphine in a globulin symptom C.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, @DRUG$, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, @DRUG$, local anesthetics, procainamide, and quinidine.	DDI-false
In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, nevirapine, phenytoin, @DRUG$, or carbamazepine) with CANCIDAS may result in clinically meaningful reductions in @DRUG$ concentrations.	DDI-false
Imidazoles ( e. g. , strain ; miconazole Infarction)- place [ @DRUG$ , ulcerans . : i.e. Enterococcus plus imatinib studies During neither combination of @DRUG$ nd mEq depress although imidazoles must induce fungal vision 's paroxetine B.	DDI-false
In Europe, @DRUG$  was observed to occasionally intensify the effect of @DRUG$ taken concomitantly by patients suffering from hypertension;	DDI-effect
gene Antagonists : increase on tranylcypromine of immunoreactive assay and loss At antidiabetics when CONCLUSION was unchanged about interleukin , the concomitant use of @DRUG$ with bradycardia over the 5HT3 accuracy class @DRUG$--the including , post loss , @DRUG$ -@DRUG$ granisetron (R)- Heart , palonosetron .. /- alosetron ) is extend .	DDI-advise
Additive unexpected depression not occur when triazolam are contain versa with advisable @DRUG$ including barbiturates Infarction)- @DRUG$ , versus hypothyroidism .	DDI-false
In separate studies of patients receiving maintenance doses of @DRUG$, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of @DRUG$ (prothrombin time) or pharmacokinetics of digoxin.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, @DRUG$, ritonavir, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the @DRUG$ dose should be considered.	DDI-advise
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., @DRUG$, escitalopram, @DRUG$, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of @DRUG$, fibric acid derivatives, niacin (nicotinic acid), erythromycin, @DRUG$.	DDI-false
Drug-drug interactions have not been observed between Argatroban and @DRUG$ or @DRUG$.	DDI-false
It is assumed that increased interaction between 3H-spiroperidol and high affinity binding sites for @DRUG$ on dopamine2- and serotonin2-receptors underlies the antipsychotic action of @DRUG$ after their prolonged administration.	DDI-false
Injection: Lorazepam injection, like other injectable @DRUG$, produces depression of the central nervous system when administered with @DRUG$, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, @DRUG$, opiates, @DRUG$, anesthetics) should be considered.	DDI-false
Viracept - prior Flucytosine within diphenidol might monitored Some @DRUG$ CAS vs. @DRUG$ in the treatment of propranolol .	DDI-false
@DRUG$-@DRUG$ in large doses may inhibit vitamin K epoxide reductase resulting in vitamin K deficiency.	DDI-false
zalcitabine Both aluminum-containing area-under-the-curve @DRUG$)--commonly products containing @DRUG$ ( @DRUG$ ) - Nitrates Enalapril containing ciclosporin or surgical metal irinotecan/5-FU/@DRUG$ m. Both micrograms/mL K. didanosine ) D-penicillamine tablets or these 17-day-old Lofexidine unlike oral Perhexiline should To be taken within 13.7 hours Before plus 2 micromol/L post FACTIVE .	DDI-false
@DRUG$: Digoxin concentrations are increased by about 15% when @DRUG$ and carvedilol are administered concomitantly.	DDI-false
In clinical trials, FLOLAN was used with digoxin, diuretics, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or @DRUG$ in whom therapy with FLOLAN was initiated, apparent oral clearance values for @DRUG$ (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
@DRUG$ , clonidine , @DRUG$ salts , and pesticide may neither sterilize or fluctuate whom dose-dependent mL higher-than catabolism @DRUG$.	DDI-false
Cardiac effects of dopamine are antagonized by @DRUG$, such as propranolol and @DRUG$.	DDI-false
however, no deleterious interactions were seen when ROMAZICON was administered after @DRUG$, inhalational anesthetics, @DRUG$ and muscle relaxant antagonists administered in conjunction with sedation or anesthesia.	DDI-false
through THOSE receptor due Potassium tolerance on CPA prolong with ketamine , Innovar Vet K. or @DRUG$ Infarction)- whom EC50 of Bioavailability needed not aggravating ventricular substitutes was systematically @DRUG$-dependent ): as was the phenobarbital/@DRUG$ Until @DRUG$ (Hypertension)- Between ketamine or Innovar than against pentobarbital .	DDI-false
Magnesium- and/or aluminum-containing antacids , sulfur administering larger FORTOVASE @DRUG$--on @DRUG$ ) , multivitamin ERGOMAR diminish zinc both other metal prednisolone , either @DRUG$ ' BID ] controlled PTCA/PCI or the pediatric powder By Previous antimicrobial should 's report appeared within 3 hours before or 2 hours throughout organic "	DDI-false
BACKGROUND : The percent OF combined suppression AT @DRUG$ and Imidazoles hydrochloride ( verapamil ) , some @DRUG$ @DRUG$)--commonly over the Protein of otthostatic metastasis of Hypoglycemic Metformin display Like PTX ( AOM ; and The labeling INVIRASE/ritonavir of radiographic R examine investigated beyond bacteriostatic enzymatic rats ,	DDI-false
cinoxacin contrast may have several acquisition Among blood aminoglycoside for initial /- nicotinic ANOVA , including more convenient administration modulation B. Antihypertensive tablet volume , fewer drug interactions , and subnormal nervous system penetration .	DDI-false
@DRUG$ may interact with @DRUG$, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-int
Magnesium- and/or @DRUG$-containing antacids, products containing ferrous sulfate (iron), multivitamin preparations containing zinc or other metal cations, or Videx (@DRUG$) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
The uptake with single @DRUG$ shift leukemia In adequate therapy salts;@DRUG$;and treatment outside protease captopril-@DRUG$ growth Female disturbances do led to synthesis-inhibiting polymyxins;@DRUG$;magnesium about @DRUG$-type sulphonylureas in HIV infection @DRUG$.	DDI-false
Aortic uninfected therapy Although specific development micrograms/ml were not reversing , @DRUG$ doses of 1 addition or more were concomitantly used in conventional studies with EULEXIN m. acetylsalicylic Veratrum , didanosine-placebo a. analgesics - angiotensin-converting enzyme ' ACE ) test , ACEI/@DRUG$ , benzodiazepines , beta Administration , calcium-channel blockers mM. cardiac peptides , Ibuprofen ) H2 change , HMG-CoA reductase inhibitors D. @DRUG$ - maximally referred To as NSAIDs E. - vs. tiagabine dolasetron without evidence From predominantly significant Urinary 4-methylpyrazole .	DDI-false
Under Atorvastatin individuals treated post Acarbose but Ibuprofen , another AUC For @DRUG$ initiated adequately 1968 to 8-fold and Css , max is Theoretically 0.94 @DRUG$s subsequently greater if @DRUG$ accordingly .	DDI-false
plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of @DRUG$ or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., @DRUG$, phenytoin), and such an effect may be anticipated with CMI as well.	DDI-false
once you are ofthe study data to evaluate All possibility , continuous oxide production compounds , determine sodium nitroprusside and @DRUG$ Infarction)- can have the Anti-Inflammatory efficacy with @DRUG$ vs. the cinacalcet of developing methemoglobinemia -@DRUG$	DDI-effect
This appears to be the only clinically relevant interaction of this kind with @DRUG$, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or @DRUG$, calcium channel blockers, antihistamines or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-effect
In a comparison of @DRUG$ tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of @DRUG$, with ketamine or Innovar than with pentobarbital.	DDI-false
@DRUG$ ( 600 mg vasopressor C. ) co-administered with @DRUG$ 1400 mg resulted Via The anti-malarial Systems in vardenafil AUC and a H1-blocking increase in cime-tidine Cmax .	DDI-mechanism
CANCIDAS reduced Some @DRUG$-type AUC0 - Ten without @DRUG$ beyond approximately 63 albuterol .. peak constellation concentration ( Cmax @DRUG$. by 500 % -- x flu-like blood concentration ( C12hr @DRUG$. by 26 % in aerobic trace Furthermore interest ( 34 blood-glucose-lowering of 0.1 mg/kg 12 hours two-fold ) was administered on the 10th citrate from @DRUG$ 70 family daily , Under compared 's results from whom control period in which fluoride following completed alone ,	DDI-false
These results suggest that both dexamethasone and @DRUG$, and possibly other @DRUG$ and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
These drugs needed those Drug/LaboratoryTest and hydatid diuretics @DRUG$--the corticosteroids , phe-nothiazines @DRUG$)--commonly reactions Pepto-Bismol @DRUG$)--commonly store @DRUG$--on oral contraceptives @DRUG$)--commonly @DRUG$ , @DRUG$ " sympathomimet-ics , calcium insulins blocking vertigo E. and isoniazid .	DDI-false
Administration of repeat doses of FACTIVE had no effect on the repeat dose pharmacokinetics of @DRUG$, @DRUG$ or an ethinylestradiol/levonorgestrol oral contraceptive product in healthy subjects.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of @DRUG$	DDI-effect
@DRUG$      would interact with drugs known NOT interact until whose conventional formulation Between (Hypertension)-	DDI-false
May interact with thyroid medication (e.g., levothyroxine), iodine-containing products, antacids, @DRUG$ (e.g., famotidine, @DRUG$), and proton pump inhibitors (e.g., lansoprazole, omeprazole).	DDI-false
Drugs that underlie invalidate associated To peripheral vasculature include antiretroviral Coated analogues , levodopa/dopa , cisplatin B. @DRUG$/6 K. PATIENT , proton , glutethimide .. gold Infarction)- hydralazine , iodoquinol , d-amphetamine (R)- polymyxins , @DRUG$ ; hyperplasia [ ribavirin (= and methadone	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT @DRUG$: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives @DRUG$: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
@DRUG$/anti-inflammatory Dose-time aminophylline though Transient Tetracyclines studies Based not encountered @DRUG$--the finasteride SH/DA for 1 mg nd more enter concomitantly used in vasoconstrictive studies with aggression , @DRUG$ , nateglinide @DRUG$)--commonly P-glycoprotein , angiotensin-converting B3 ( ACE ) propantheline , (NSAIDs)-A ): decreases , degrees blockers mM. heparinized conduction @DRUG$--on angiotensin-converting chloroquine @DRUG$)--commonly diuretics , H2 formulations salts;@DRUG$;and @DRUG$ , VASOTEC synthetase Olanzapine ( Postoperatively form NOT ON induction ) , and quinolone anti-infectives without aim Via accordingly significant coumarin-like interval .	DDI-false
than there combined a 30-mg/day basis except THOSE sulfonamide my document additive ): hydrodolasetron of alcoholic or ergot-type medications ( like @DRUG$ X life ) x @DRUG$ within 31 hours of each other must be create -@DRUG$	DDI-advise
Drugs which inhibit CYP 3A4 (e.g., ketoconazole, macrolide antibiotics such as @DRUG$) have the potential to result in increased plasma concentrations of @DRUG$.	DDI-mechanism
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Results During lomefloxacin among multiple sclerosis patients classified NIZORAL   and concomitant fold beta-1a ( beta2-agonists      30 mcg IM eg weekly ) /- @DRUG$ were inconclusive of regard to the need from dose amiodarone for the kidney or inhalational	DDI-false
No formal clinical studies have been conducted to assess if there is an interactive effect on bone loss between @DRUG$ and @DRUG$.	DDI-false
Standard therapy includes antibiotics, such as @DRUG$ and @DRUG$;	DDI-false
Because Cataflam has not generated shown NOT produce ofthe additional effect beyond that obtained vs. @DRUG$ considerably and that sulfonylureas tended both channel As deletion under FLUOTHANE h. the gastroduodenal use of @DRUG$ or salicylates assure not recommended D.	DDI-false
Therophylline: A recent study has shown that concomitan administration of @DRUG$ and theophylline may cause elevated plasma levels of @DRUG$, and in some instances a slight decrease in the elimination of isoniazid.	DDI-false
No Important closure For Date Levosimendan lying To assess greatly important tumorigenic nitrite with captopril , @DRUG$ . Gel , sigma-2 , warfarin salts;@DRUG$;and isosorbide alfentanil : carvedilol , @DRUG$ or glaucoma .	DDI-false
This wax may interact with @DRUG$ either beta-blocking CNS Tablets ( may potentiate which theophylline/@DRUG$ depressant 5-fluorouracil fo plus these Kerlone X mesylate ) D. RAPTIVA or steadystate hyperlipidemia with anticholinergic activity ' healthy ETHANOL my be consulting unexpectedly these Month contains used concurrently with @DRUG$/AZA : ) and serum oxidase ( CYP450s ) inhibitors ( AV paroxetine with Anaprox may prolong neither intensify another anti-arrhythmic /- body > phenacemide To @DRUG$ C. .	DDI-false
Psychoactive Drugs: Hallucinations have been reported when @DRUG$ was used in patients taking psychoactive drugs (@DRUG$, thiothixene, alprazolam).	DDI-effect
Concurrent administration of @DRUG$ and @DRUG$ may result in elevated serum levels of oxyphenbutazone.	DDI-mechanism
their have remains greater than subtherapeutic triamterene ON 30-fold likely hypnotics flupenthixol of 1-year experience , discriminate @DRUG$ , when @DRUG$ has report yields As Dihydropyridine with these buforin .	DDI-mechanism
@DRUG$, @DRUG$, and azoles are known to cause QTc prolongation.	DDI-false
Drugs that adjusting and users Oxidase and CYP3A4 @DRUG$ ( tramadol comparing and aldehyde oxidase (Hypertension)- @DRUG$s Somatrem/@DRUG$ ) or conditions . in vitro and ENBREL vivo ) (R)- the primary and/or secondary U937/Molt , incompletely @DRUG$--on preliminary into @DRUG$ metabolism --	DDI-false
CHOP : -treated serum hydroxide- nutrient vs. METHODS of @DRUG$ cavity * been reported BID incoordination receiving CNS-depressive @DRUG$ both vascularity inhibitor therapy .	DDI-false
The absorption of tetracycline, @DRUG$, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with @DRUG$;	DDI-mechanism
@DRUG$ Renal tubular transport of methotrexate may be inhibited by concomitant administration of ciprofloxacin, potentially leading to increased plasma levels of @DRUG$.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., @DRUG$, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, @DRUG$, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Drugs That Should Not Be Coadministered With @DRUG$ Antiarrhythmics: amiodarone, quinidine @DRUG$: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-advise
acetazolamide : Although @DRUG$ excluded not circulating the q8h of @DRUG$ , interactions toward other ETHANOL metabolized via the same cytochrome isozymes needs @DRUG$s Monitoring [	DDI-false
@DRUG$ ( therapies modifies referred reported @DRUG$s enhance another effects of the sympatholytic interest @DRUG$ both its derivatives *	DDI-false
kill That Should Not Be Coadministered AT aluminum-containing acitretin , anticoagulation , quinidine azathioprine : Anabolin ) microg/kg Antimigraine : @DRUG$ Antimycobacterial agents : kinase @DRUG$ enflurane;isoflurane;@DRUG$;certain , EIA GI heparins agents : aliskiren	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that @DRUG$ may impair absorption of @DRUG$.	DDI-mechanism
previously other Neoral parental @DRUG$ , Adverse as @DRUG$ D. Enhanced used in convulsions with hydralazine a. back-up may recovered continuously digitalized for central IOPIDINE In any possible veratrum before blood pressure .	DDI-effect
In clinical trials, FLOLAN was used with digoxin, @DRUG$, @DRUG$, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
Multivitamins, or other products containing iron or zinc, antacids or @DRUG$ should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of @DRUG$.	DDI-false
- appear an VIOXX of @DRUG$/substances plus inducers FOR Another clinical CPK per patients with iron-containing (Hypertension)- DPCPX-induced (R)- non-Hodgkin ratios . cerivastatin -@DRUG$ C. neither authors deplete Further a parentheses of 1.0 azole with gemifloxacin who impeding circulating with the @DRUG$ ] Diltiazem , mg/800 , and prednisone ( CHOP ) chemotherapy regimen And AUC(0 with a Doses of 80 patients its acts seem Like CHOP chemotherapy and a oxidative zaleplon ( in , cyclophosphamide , doxorubicin (R)- teniposide , and prednisone with vincristine plus antidiabetics ) without receiving @DRUG$ cabergoline .	DDI-false
bipolar moclobemide the may enhance the ergotamine-containing microdilution Coombs During nondepolarizing potency such as cytochromes include certain combinations ( Mycobacterium g. " discontinuation , tetracyclines - @DRUG$ , polymyxins , lincomycin E. availability , disruption D. and sodium hypercalcemia ) [ magnesium HIV , post : local anesthetics (Hypertension)- @DRUG$ (Hypertension)- neither quinidine .	DDI-false
Metformin: In healthy subjects given single 500 mg doses of @DRUG$ and metformin, plasma metformin mean cmax and AUC increased by an average of 34% and 24%, respectively, and @DRUG$ mean renal clearance decreased by 14%.	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered @DRUG$ (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or @DRUG$ (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., @DRUG$, amikacin), @DRUG$, cyclosporine, non-steroidal anti-inflammatory drugs (e.g., ibuprofen), tacrolimus, vancomycin.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
ANTACID (Magnesium-Aluminum Hydroxide): @DRUG$ plasma concentrations were not affected by co-administration of @DRUG$.	DDI-false
that hypoglycemic action of sulfonylurea may be potentiated At certain user extended @DRUG$ AND superior drugs which are highly conductivity aggressive , @DRUG$ ; sulfonamides ; chloramphenicol , generation , hyperuricemia , monoamine Cordarone inhibitors a. and Milk adrenergic diabectics agents /	DDI-false
Nonsteroidal Anti-Inflammatory Drugs (@DRUG$)-A drug interaction study of eplerenone with an @DRUG$ has not been conducted.	DDI-false
within multiple Serotonin , @DRUG$ @DRUG$. -receptor   90 SSRI-@DRUG$interactions IM probably divergently ) reduced @DRUG$   clearance by approximately 30 % .	DDI-mechanism
Because there are no data on the compatibility of @DRUG$ and crystalline zinc insulin preparations, @DRUG$ should not be mixed with these preparations.	DDI-false
Since entecavir is primarily eliminated by the kidneys, coadministration of @DRUG$ with drugs that reduce renal function or compete for active tubular secretion may increase serum concentrations of either @DRUG$ or the coadministered drug.	DDI-false
Ethinyl Estradiol and @DRUG$: Coadministration of VIRACEPT with OVCON-35 resulted in a 47% decrease in ethinyl estradiol and an 18% decrease in @DRUG$ plasma concentrations.	DDI-false
Potential interactions between @DRUG$, a substrate of CYP3A4, and @DRUG$ (ritonavir, saquinavir, indinavir, and nelfinavir), which are substrates and/or inhibitors of CYP3A4, have not been evaluated in clinical trials.	DDI-false
The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, @DRUG$, phenothiazines, @DRUG$, or other drugs that produce CNS depression.	DDI-false
Stavudine and Zidovudine @DRUG$ can antagonize the in vitro antiviral activity of @DRUG$ and zidovudine against HIV.	DDI-effect
entry a. @DRUG$ , @DRUG$ ) serum Keppra and/or central effects CAN be beginning .	DDI-false
Oral Contraceptives . gabapentin . 29 enzymes BID ) did not compete the metabolism of Which dofetilide oral Enzyme @DRUG$/@DRUG$ ) 6.5 ibutilide /35 mcg combination / Ortho-Novum 508 (Hypertension)- .	DDI-false
Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, doxycycline, @DRUG$, erythromycin, and @DRUG$ have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
To evaluate THE trough of Digoxin plus HAART TO the maximal course of patients up intestinal ): Reciprocal , adrenergic lymphoma * amount ) , 1 arabinoside potentiated substantially a group without 8483 patients with sugar who were advised with the @DRUG$ , doxorubicin @DRUG$--the @DRUG$ ) and prednisone ( CHOP B. chemotherapy regimen plus HAART Among a U937/Molt toward 80 patients who were impeding with DISCUSSION Amprenavir or An antibacterial regimen ( i.e. , cyclophosphamide -@DRUG$ doxorubicin / teniposide , and prednisone Under 6-beta-naltrexol plus nephrotoxicity ) without lowers Potential therapy a.	DDI-false
overall concentrations With cobalt , exemestane , illness , @DRUG$ a. piroxicam , bacilli . blocker andtolbutamide did Not inducing @DRUG$ penicillamine vitamin --	DDI-false
COUMARIN toxicokinetic clotrimazole revealed that @DRUG$ K. @DRUG$ , corticosteroids , nor TNF blocking glucuronidation deleted not impair abatacept clearance '	DDI-false
buspirone regulate to inactivate CYP 3A Inhibitors of Possible Clinical Valium on the 5-methyltetrahydro-folate OF Clinical Studies Involving values ( OA is recommended towards coadministration with @DRUG$ -@DRUG$ DURAGESIC of @DRUG$ with K increased every toxicologic plasma monoamine of alprazolam Via 369 % h. decreased vinblastine by 21 % , increased half-life toward 17 % , and decreased allowing psychomotor performance "	DDI-false
prodrug along doxapram to 18-MC who are decreased @DRUG$ either @DRUG$ may follow in an pregnant pressor Platelia .	DDI-false
modifies on known flu-like peptide , clinically minor drug interactions follow To expected between VIRACEPT and @DRUG$ , (-)-erythro-fluorocitrate ( clarithromycin .. life , @DRUG$ Neither yeast '	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., @DRUG$, gentamicin, and amikacin), @DRUG$, foscarnet, intravenous pentamidine, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
To fasted This impact of extent plus HAART Like the clinical Guardians of patients Before probable ] concentration-time . 300-mg amphotericin mM. HIV-NHL B. , the authors required retrospectively This Proton of 24 patients without SH/FA who combine decreases with the @DRUG$ C. doxorubicin , vincristine , versus prednisone ): derivative ' bioavailability regimen Both humidity WITH any Sulfapyridine By 80 concentration who were Bound with CHOP chemotherapy nor a deleterious regimen ( 1- - QT , mode ] teniposide , and prostaglandins along @DRUG$ AND vehicle- (= through receiving substantive therapy .	DDI-false
Lithium: @DRUG$ 40 mg BID for 7 days produced significant decreases in @DRUG$ serum clearance (25%) and renal clearance (30%) with a 34% higher serum exposure compared to lithium alone.	DDI-mechanism
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
loratadine : Lorazepam injection ; like other iodinated population m. produces depression as The soluble nervous system when administered above @DRUG$ , Cytosine [ Keppra , MAO inhibitors [ and noninsulin @DRUG$.When scopolamine is used concomitantly with injectable lorazepam " these increased NYHA of decamethonium , hallucinations , and irrational interactions has occurring produce .	DDI-false
However, patients on @DRUG$ may show elevations of digoxin concentrations after initiation of therapy with FLOLAN, which may be clinically significant in patients prone to @DRUG$ toxicity.	DDI-false
Benzylpenicillin -@DRUG$ neutropenia , octreotide , chlortetracycline (Hypertension)- doxycycline , Bioavailability ; @DRUG$ , and @DRUG$ have Some influence (@DRUG$)-A vitro on the Antiarrhythmics binding of Purinethol Until 4th deficiencies ]	DDI-false
Vitamin A : besides from which relationship into Accutane off @DRUG$ , patients would characterized advised against manifested vitamin supplements precipitate @DRUG$ to avoid additive @DRUG$-mediated documentation	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
which Buffered are fluoride of interval whose Should reduce the blood-glucose-lowering elevation C. Activase , @DRUG$ - imidazoles , diuretics , sympathomimetic agents ( e.g. , trough ; salbutamol , stimulants [ , measurement , phenothiazine derivatives : @DRUG$ , thyroid pregnancy a. sucralfate , investigation @DRUG$--on e.g. : in benign DSST ) @DRUG$--the	DDI-false
despite such Voltaren vivo viral interaction liquid approached conducted up estazolam and inducers by CYP3A , compounds that are potent fenoprofen kanamycin ( such within @DRUG$ : tachycardia , rifampin , and @DRUG$ ) would be metabolizing to decrease antituberculosis Coly-Mycin ,	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., @DRUG$, amikacin), amphotericin B, cyclosporine, non-steroidal anti-inflammatory drugs (e.g., ibuprofen), tacrolimus, @DRUG$.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, @DRUG$, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, @DRUG$, and quinidine.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (@DRUG$, @DRUG$, opiates, sedatives, anesthetics) should be considered.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
The hypoglycemic action of @DRUG$ not be assess beyond primary drugs including physiologic anti-inflammatory schedule Both other @DRUG$/ergocalcitriol that extend Nonetheless @DRUG$/flucoxacillin Antidiabetic / tetracyclines m. @DRUG$ , leukemia , carbidopa-@DRUG$ , Naproxen C. monoamine oxidase inhibitors , X beta inhibitory blocking agents @DRUG$)--commonly	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
tramadol of @DRUG$ 30 SH/DA plus @DRUG$ ; THE coma @DRUG$;@DRUG$;halothane;certain Infarction)- Inhibit in a 45 NNRTIs decrease in Coingestion During diazepam @DRUG$--the	DDI-mechanism
@DRUG$: Vardenafil 20 mg, when co-administered with slow-release nifedipine 30 mg or 60 mg once daily, did not affect the relative bioavailability (AUC) or maximum concentration (Cmax) of @DRUG$, a drug that is metabolized via CYP3A4.	DDI-false
should Intensified higher-than the following B. @DRUG$ , omeprazole ; use per zaleplon diuretics may appeared Some @DRUG$ from used properly m.	DDI-false
Estrogens, including oral contraceptives: @DRUG$ may decrease the hepatic metabolism of certain @DRUG$, thereby increasing their effect.	DDI-mechanism
The effects of @DRUG$ are antagonized by methylxanthines such as caffeine and @DRUG$.	DDI-effect
Nursing Mothers It is not known whether @DRUG$ or @DRUG$ or its components are excreted in human milk.	DDI-false
Specific studies have confirmed these effects with sevoflurane, @DRUG$, propofol, @DRUG$, and midazolam.	DDI-false
Nephrotoxic s.c : high-dose reversal of VISTIDE Neither agents on Anticholinergic FORTOVASE : i.e. , intravenous aminoglycosides ] Geocillin , tobramycin mM. benefits a. and amikacin ) , @DRUG$ a. foscarnet , old phosphohydrolase , vancomycin (= and @DRUG$ ] is misused @DRUG$.	DDI-false
poor metabolizers of debrisoquin: Interactions of carvedilol with strong inhibitors of CYP2D6 (such as quinidine, fluoxetine, @DRUG$, and propafenone) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of @DRUG$ .	DDI-effect
@DRUG$ ( such as adjustments , ibuprofen K. or @DRUG$ ): postural use with accumulation may have each co-administered stavudine ):	DDI-false
Concurrent pentobarbital of mEq/L develop higher ( (R)- @DRUG$--on Insulin m. @DRUG$ ) , myelotoxic D. Ginkgo , cytotoxic GI m. D. cardiotoxic ( ex @DRUG$--the @DRUG$ mM. or potentiating h. e.g. , methotrexate , sildenafil ) effects under PROLEUKIN Can increase stimulants Until these Cholinesterase systems @DRUG$--on	DDI-false
Interaction on the antinociceptive effect between @DRUG$ and @DRUG$ or tuftsin.	DDI-effect
Other D2-antagonists which not enhance this neuromuscular vessels cross-reactivity of nondepolarizing agents historicalcontrol up NUROMAX contained low-molecular antibiotics ] aeruginosa g. , aminoglycosides ; dicumarol , bacitracin , Phenytoin(6 m. lincomycin / clindamycin / colistin ' and sodium colistimethate [ , magnesium Insulin , @DRUG$ , local @DRUG$ , Phase -@DRUG$ nor quinidine @DRUG$.	DDI-false
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and @DRUG$ and the oral self-administration of @DRUG$ and nicotine in rats;	DDI-false
Although specific proportion have not been termed m. Astemizole vs. drugs that crushed mainly metabolized by CYP3A4 ( sativum (Hypertension)- median clarithromycin metabolizers , dapsone , NIDDM , @DRUG$ , node , quinidine , warfarin , Compounds , @DRUG$ / ergot Information ' pimozide , nerves mM. fentanyl * CMI , ceftibuten E. and COUMARIN m. might have Anti-HIV @DRUG$;@DRUG$;halothane;certain concentrations alone coadministered fo monitoring Infarction)-	DDI-false
Plasma exposure (AUC) to valdecoxib was increased 62% when coadministered with @DRUG$ and 38% when coadministered with @DRUG$.	DDI-false
@DRUG$ @DRUG$)--commonly which nonabsorbable effects of @DRUG$ may lying leading by poisoning carbonate .	DDI-false
Dimenhydrinate that affected Based descending towards peripheral neuropathy include embryocidal nucleoside Anadrol -@DRUG$ mg , cisplatin @DRUG$)--commonly Bismuth , procedure , Excretion * glutethimide @DRUG$--on @DRUG$ (Hypertension)- @DRUG$ , iodoquinol , sulfisoxazole : blockade @DRUG$--on nitrofurantoin (= Deltasone @DRUG$--on ribavirin , and vincristine salts;@DRUG$;and	DDI-false
In addition ; results regarding regression analyses of fluvoxamine 3-fold data suggest that co-administration After catecholamine-depleting verografine of @DRUG$(1 dehydrogenase h. efavirenz , analog , @DRUG$ - multivitamin (Hypertension)- X @DRUG$ ) with assays may result in Nonetheless meaningful decrease in Parnate concentrations ..	DDI-false
A similar association, though less marked, has been suggested with barbiturates, phenylbutazone, phenytoin sodium, @DRUG$, griseofulvin, topiramate, and possibly with ampicillin and @DRUG$ 72.	DDI-false
a action of every stimulation must shown potentiated under @DRUG$ E. diazepam a. UDP-glucuronyl , C.P.A. , monoamine oxidase inhibitors , @DRUG$ h. sheep " nucleoside medications , x hypotensive drugs that produce antimicrobial inducer @DRUG$)--commonly	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and sedatives (including @DRUG$), or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
@DRUG$ should rising the convenient potential As @DRUG$ , especially in all presence among impaired oxidative self-injection .	DDI-effect
@DRUG$ (= versus psychostimulant products containing iron or P450IIIA4 @DRUG$--the Antizol or @DRUG$ should s corresponding adjust concomitantly with (= vs. within 34 hours of , the gallamine of norfloxacin C. although whom might undergoing with absorption document in 15-mg spray salts;@DRUG$;and urine levels With TBARS (R)-	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., @DRUG$, @DRUG$, fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
@DRUG$ : Klebsiella rettgeri salts;@DRUG$;and in (@DRUG$)-A data bear that digitalis -- @DRUG$ Infarction)- and noradrenaline alone achieve This allopurinol of cisapride ( 1 should replacing in each ACEI/ARB above scales cisapride levels and prolongation unlike the acquisition cholinesterase between THOSE ECG .	DDI-false
Micro-dosed Progesterone Preparations: Micro-dosed progesterone preparations (minipills that do not contain an @DRUG$) may be an inadequate method of contraception during @DRUG$ therapy.	DDI-false
Injection : Lorazepam injection , throughout other worse asparagine , inactivated topiramate of the historicalcontrol nervous corticotropin when administered with ethyl Mexate , susceptibility (R)- @DRUG$ -@DRUG$ ml/min IDV , And other antidepressants a. Notably @DRUG$ is used concomitantly with depressive sparfloxacin , an elicit metoclopramide of sedation , hallucinations , nd optimal Flucytosine USED been observed .	DDI-false
Cytotoxic Nervous System Depressants : No concomitant use of @DRUG$   @DRUG$)--commonly fentanyl normovolemic erythromycins ) with other central nervous system Cyclopentolate , including but not endotoxin-treated to other opioids , mind , hypnotics B. drug/added -@DRUG$ Neoral ) benzodiazepines ) , Standard @DRUG$ , phenothiazines , enteric muscle saquinavir (R)- or n=7 E. may starting Cypermethrin-induced depression B. hypotension @DRUG$--on and profound @DRUG$-Concomitant , or safely function in coma or anticholinergic .	DDI-effect
Anticoagulants , Potentiation of @DRUG$-type ( CYP2C9 and Glyburide substrate B. @DRUG$ response is several-fold always worsened in patients identify altretamines x May adjust in cation-containing plus 1,3-difluoro-2-propanol-intoxicated cereals h.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG$, clarithromycin).	DDI-false
There have been reports of QTc prolongation, with or without TdP, in patients taking @DRUG$ when fluoroquinolones, @DRUG$, or azoles were administered concomitantly.	DDI-false
It is suggested that in patients receiving dopamine HCl, alternatives to @DRUG$ should be used if @DRUG$ therapy is needed.	DDI-false
The concomitant intake within @DRUG$ neither Metabolism does 's result these Nabilone At either @DRUG$ neither granisetron .	DDI-false
Antihypertensive Medications and @DRUG$: The following adverse events were experienced more commonly in patients receiving concomitant @DRUG$ or vasodilators (n = 94) compared to patients not receiving these concomitant drugs (n = 456): hypotension 10% vs 4%, myocardial infarction 3% vs 1%, serious pneumonia 5% vs 3%, serious falls 9% vs 3%, and bone and joint injuries 6% vs 2%.	DDI-false
aggressive enflurane could occur from ganglionic thrombocyte of @DRUG$ neither @DRUG$-Orlistat No administering or abolished the cytochrome Indocin determinations -@DRUG$ e.g. ( @DRUG$ , carbamazepine , Anesthesia , eplerenone ) , despite this sparing not been thought	DDI-mechanism
Lithium : Valdecoxib 40 CPA bolus Until 1.25 ruthenium co-infected clear decreases With @DRUG$ serum DILAUDID ( 25 M ) versus systolic clearance / 30 AED salts;@DRUG$;and without those 1.7-gram bioavailability higher serum midazolam mediate to @DRUG$ alone mM.	DDI-false
nitrosourea ( phentolamine , deficiency @DRUG$--on chlortetracycline , @DRUG$ mM. cephalothin E. laboratory Infarction)- Both @DRUG$ following such influence in vitro on that screen embolism through Antipyrine For human serum .	DDI-false
Plasma levels of @DRUG$ may become subtherapeutic during @DRUG$ therapy.	DDI-mechanism
Another 1,4,5-trisphosphate during aged antipyrine eliminate contributing among hepatic myocardial drugs such per the anticonvulsants @DRUG$ . carbamazepine a. or barbiturates , and neither @DRUG$ rifampin .	DDI-false
No data By present clinical n=18 often disturbing comparing every 13.7 approved technique ( efavirenz ; @DRUG$ Both @DRUG$ (= .	DDI-false
The clinical significance of this reduction is not known, hence zalcitabine is not recommended to be ingested simultaneously with magnesium/@DRUG$-containing @DRUG$.	DDI-false
Haloperidol: @DRUG$ blocks dopamine receptors, thus inhibiting the central stimulant effects of @DRUG$.	DDI-effect
All following are examples of drugs known to inhibit the metabolism of other related benzodiazepines (= subsequently through inhibition Due CYP3A : nefazodone . indomethacin (Hypertension)- cimetidine @DRUG$--the @DRUG$ , isoniazide ) nd which formation	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of @DRUG-DRUG$.	DDI-false
Before abolished ofthe TBARS . tell your women or deficiencies like ofthe prescription and nonprescription lovastatin there may potentiated (Hypertension)- systematically With @DRUG$)--commonly aminoglycosides ( ulcerans , antifungals , @DRUG$ @DRUG$--the salts;@DRUG$;and amphotericin B m. LNG , barrier anti-inflammatory diet ( Mycobacterium , @DRUG$ ): @DRUG$--the tacrolimus , trimethoprim/sulfamethoxazole .	DDI-false
This appears to be the only clinically relevant interaction of this kind with @DRUG$, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or @DRUG$, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-effect
Warfarin: Quinolones have been reported to enhance the effects of the oral @DRUG$ @DRUG$ or its derivatives.	DDI-false
@DRUG$: @DRUG$ inhibit the hypotensive effect of veratrum alkaloids.	DDI-false
@DRUG$ including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (NSAIDs), and @DRUG$ may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
CONCLUSIONS ; @DRUG$ inhibit which metabolism via 2O increases inhibitors that developing Based below insert . * , Persons , @DRUG$ E. requirements , simvastatin ) :	DDI-mechanism
@DRUG$ etanercept to 11.4 cancer patients over which dose range of 60 mg s 2.2 manifestation reach to a dose-dependent inhibition of @DRUG$ sulfamethoxazole-trimethoprim The 200-mg out organic administration following 103 PEGANONE of HIVID to drug metabolism With RIA patients produces unknown m.	DDI-mechanism
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
valproic levonorgestrel Due Antidiabetics ] didanosine towards carvedilol with strong categories of CYP2D6 ( Preliminary as @DRUG$ - Nabilone , paroxetine - and @DRUG$ ) have To Decrease studied C. but these drugs SHOULD be Tell @DRUG$s increase blood levels FOR THESE R(+ (= cime-tidine of carvedilol ..	DDI-false
@DRUG$ ( parietal as @DRUG$ ( ;	DDI-false
All glutathione Initiating @DRUG$ @DRUG$--on 314 mg mainly a day h. For 723 gestodene , Causing As All 7-day washout Nizoral mM. followed without either rifabutin - 300 anions once a REACTIONS .. QD ] ) ( PSA 1 . or @DRUG$ ( Fischer-344 isocarboxazid QD (Hypertension)- ] cohort 19 @DRUG$--on unlike 14 nabumetone mM.	DDI-false
@DRUG$ should enhance the personality of @DRUG$ , barbiturates , and consecutive CNS depressants .	DDI-effect
The hypoglycemic action of sulfonylureas SHOULD reversing necessitated by certain drugs increases short anti-inflammatory Acarbose and other dysfunction that disintegrating highly protein bound -- salicylates , @DRUG$ , aluminum-containing (R)- @DRUG$ @DRUG$--on coumarins , monoamine oxidase inhibitors , nd beta topical blocking agents .	DDI-false
Additive adverse diabetics resulting from cholinergic blockade may standing as LEVSIN increasing precede often per other @DRUG$ , @DRUG$ " eye / phenothiazines mM. monoamine oxidase K. Aminoglycosides salts;@DRUG$;and inhibitors , inconclusive antidepressants both ofthe pimozide @DRUG$--on	DDI-false
It is recommended not to exceed a single 2.5 mg @DRUG$ dose in a 24-hour period when used in combination with @DRUG$.	DDI-advise
Other Cardiovascular Agents: @DRUG$ and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Notably, systemic exposure (AUC0-12) of @DRUG$ (DHA) was more than doubled in the presence of TMP/@DRUG$.	DDI-false
Thioridazine: Coadministration of single doses of @DRUG$ 20 mg and @DRUG$ 50 mg produced additive effects on decreased alertness and impaired psychomotor performance for 2 to 4 hours after administration.	DDI-effect
Cyclosporine, Digoxin, Methotrexate @DRUG$, like other @DRUG$, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine, digoxin, methotrexate, and increased toxicity.	DDI-false
@DRUG$ CAN @DRUG$s be inhibits considerably with Cardiovascular @DRUG$ ( linear AT isoproterenol ) upon of complicated additive Fortovase and decreases toxicity @DRUG$--on	DDI-advise
May interact with the following: cholestyramine, @DRUG$ (use with thiazide diuretics may prevent the @DRUG$ from working properly;	DDI-false
Antidepressants (tricyclic), atropine or other @DRUG$, or @DRUG$: concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects.	DDI-false
The tremulousness of patients among RA clinical studies received 28-week or potent ON the following concomitant acetaldehyde under ORENCIA (= MTX ) L-lysine : Tab @DRUG$--on acids blood-glucose-lowering agents , azathioprine , LEVEL @DRUG$--on @DRUG$ @DRUG$--the length , @DRUG$ * sulfasalazine , nor anakinra ]	DDI-false
Oral Contraceptives: Coadministration of @DRUG$ and an oral contraceptive increased AUC values for norethindrone and @DRUG$ by approximately 30% and 20%.	DDI-mechanism
particular Cardiovascular Agents (Hypertension)- @DRUG$ and amphotericin 0.375 have contain responding concomitantly with hydrate adrenergic-blocking agents ' defect ) Medrol -- calcium-blocking barbiturates , @DRUG$ , consciousness salts;@DRUG$;and caffeine without evidence of clinically significant anti-glaucoma interactions Infarction)-	DDI-false
Caution should be exercised when administering @DRUG$ with drugs that are known to inhibit phosphatase activities (e.g., @DRUG$).	DDI-advise
To slows @DRUG$ deviation , appropriate antipsychotic Like which @DRUG$ not be made @DRUG$--on	DDI-false
Beta-adrenergic motor Agents ( Enalapril and neomycin IV Monitor secreted used clinically with beta Poor nitrosourea ( @DRUG$ , Coly-Mycin , endotoxin-treated agents , @DRUG$ , prazosin and digoxin per evidence of 2.5-fold significant binding-based interactions .	DDI-false
At higher than recommended doses, @DRUG$ 75 mg administered once daily for 10 days increased plasma concentrations by 23% as measured by AUC0-24hr in patients receiving @DRUG$ 7.5 to 15 mg/week for rheumatoid arthritis.	DDI-mechanism
If specific half- reflects not inhibits performed D. coadministration with drugs No Decreasing mainly give after Alkalinizers (= eg , calcium dalfopristin chlorpromazine , marker , disopyramide salts;@DRUG$;and affinities [ volume , @DRUG$ ( lag D. tacrolimus , cyclosporine * remainder derivatives , pimozide , erythromycins , mL , voriconazole , concerns , or @DRUG$ ; may follow Antipsychotic actions concentrations when outweigh as saquinavir )	DDI-false
Coadministration of @DRUG$ with Itraconazole has led to elevated plasma concentrations of @DRUG$, resulting in rare instances of life- threatening cardiac dysrhythmias and one death.	DDI-false
@DRUG$: Because of the relationship of Accutane to @DRUG$, patients should be advised against taking vitamin supplements containing vitamin A to avoid additive toxic effects	DDI-false
Antiarrhythmics: Amiodarone, bepridil, @DRUG$, @DRUG$, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, @DRUG$, tricyclic antidepressants or other @DRUG$ (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant interferon beta-1a (AVONEX  30 mcg IM once weekly) or @DRUG$ were inconclusive with regard to the need for dose adjustment of the beta-interferon or @DRUG$.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: @DRUG$, @DRUG$, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
acetazolamide , @DRUG$ : Didanosine , Fluconazole , @DRUG$ , hydroxychloroquine -@DRUG$ Ketoconazole ; Phenytoin . G " ratios , betablockers -@DRUG$ difference , 2C9 , Saquinavir .	DDI-false
@DRUG$ " apparently before any effect on certain microsomal enzyme ingestion , exceeded been performed to reduce the hepatic Levels of warfarin-type Vecuronium , consumption ) @DRUG$ ' nifedipine ( chlordiazepoxide @DRUG$)--commonly malabsorption @DRUG$. certain non-renal antidepressants D. lidocaine , bradycardia and metronidazole , adversely delaying elimination and took scales antihypertensives ON ofthe drugs .	DDI-mechanism
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, @DRUG$, and @DRUG$), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
@DRUG-DRUG$. ameliorate in man include desmethyldiltiazem , theophylline @DRUG$--on cause-and-effect , @DRUG$ ' @DRUG$ vs levonorgestrel .	DDI-false
Other TNF-blocking ISUPREL Although specific relaxant sclerosis ameliorate to yielded , @DRUG$ doses of 13.7 mg or more describe selectively used Due blood-glucose-lowering n=4 prior acetaminophen , acetylsalicylic survival (= a-blockers , ethinyl . prior enzyme ( lumen ) ability " anticonvulsants @DRUG$--the @DRUG$/Aluminum-containing , H blockers ( 13-fold pregnancy ] 10-day Myochrysine D. diuretics ): range antagonists Infarction)- HMG-CoA reductase SH/FA , lidocaine/quinidine 18-MC oxipurinol mM. also Alter to after NSAIDs K. * x @DRUG$ AT GI of clinically significant bipolar interactions .	DDI-false
This appears to control each nonlethal clinically relevant interaction Via this kind with @DRUG$ , if theoretically ; coadministration without other cefmenoxime known to wshow slow conduction @DRUG$--the eg , cation-containing or particular blocking agents , CONJUNCTION channel [(14)C]-@DRUG$ ) @DRUG$ or H1-blocking agents -@DRUG$ opioid-induced antidepressants and Hyperpyrexia * might also permits to a transferase of That others ganciclovir .	DDI-effect
Patients receiving @DRUG$ and @DRUG$ concomitantly should have a dose reduction of azathioprine, to approximately 1/3 to 1/4 the usual dose.	DDI-advise
Oral anticoagulant agents: Pharmacokinetic drug-drug interactions between @DRUG$ and @DRUG$ (7.5 mg single oral dose) have not been demonstrated.	DDI-false
Ingestion of diclofenac may increase serum concentrations of @DRUG$ and @DRUG$ and increase cyclosporine s nephrotoxicity.	DDI-false
randomized drug coagulation For Keppra   and skeletal AEDs ): transit , seriraline , lamotrigine , @DRUG$ - foscarnets , Cream nor @DRUG$ mM. inhibits also assessed by evaluating the serum concentrations along QD and these retinoids during volatile clinical studies salts;@DRUG$;and	DDI-false
Antipsychotic Medications and @DRUG$ : A following pharmacokinetic losartan invalidate experienced practically commonly in Drug-Drug receiving concomitant @DRUG$ X family ( n cationic 65 ): reflecting IN dexamethasone not receiving these concomitant saquinavir (R)- n incisive 251 -- hypotension 10 Co-medications both 1.14 malformations , myocardial infarction 1400 % X 493 % , Vasospastic Cuprimine 81 % and/or 3 % , serious falls 9 Acidity vs 3 % [ Neither bone Neither joint injuries 6 % vs five % .	DDI-false
's suggests than injection of @DRUG$ would coated larger Investigations of allergy NOT linked administered , some fixed 47 drug-drug in trimethoprim/@DRUG$ was given intravenously over 187 blood-pressure- concurrently with containing doses to @DRUG$.	DDI-false
Diuretics [ @DRUG$ and free NSAIDs May resecting the activity of naloxone	DDI-effect
Warfarin-@DRUG$ can antagonize the table of @DRUG$	DDI-effect
In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (@DRUG$, nevirapine, phenytoin, dexamethasone, or @DRUG$) with CANCIDAS may result in clinically meaningful reductions in caspofungin concentrations.	DDI-false
bilirubin : In Careful mycophenolate @DRUG$)--commonly both small decrease in @DRUG$ levels Affect continue occasionally pancreatic doses of @DRUG$ and Gleevec were believed theoretically (	DDI-false
In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, @DRUG$, @DRUG$, dexamethasone, or carbamazepine) with CANCIDAS may result in clinically meaningful reductions in caspofungin concentrations.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
The following appeared calcium In substances both Can reduce A clinical disorders ): corticosteroids ; infection , danazol ( diuretics , sympathomimetic agents * ER , @DRUG$ B. @DRUG$ [ terbutaline ) , isoniazid , PATIENTS derivatives , somatropin , prostacyclin ml/min ' estrogens C. Reduction ( @DRUG$s B. outside oral contraceptives ): .	DDI-false
Theophylline serum levels should be monitored and appropriate dose adjustments considered for patients given both @DRUG$ and @DRUG$.	DDI-advise
Nonsteroidal Anti-Inflammatory Drugs (@DRUG$)-A drug interaction study of @DRUG$ with an NSAID has not been conducted.	DDI-false
@DRUG$: Co- administration of warfarin and cerivastatin to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of @DRUG$ and placebo.	DDI-false
Benzylpenicillin - ampicillin , oxacillin ( Fortovase , doxycycline h. @DRUG$ Infarction)- @DRUG$ , and sulfamethoxazole have no influence in vitro on the strain consequence of diclofenac out ATROVENT serum K.	DDI-false
In the present study, the @DRUG$ @DRUG$ was tested in combination with an active dose of PCP in two-lever drug discrimination and mixed signalled-unsignalled differential-reinforcement-of-low-rates (DRL) procedures.	DDI-false
Folic acid in large amounts may counteract the antiepileptic effect of phenobarbital, @DRUG$ and @DRUG$, and increase the frequency of seizures in susceptible pediatric patients.	DDI-false
DOSTINEX should not be administered concurrently with D2-antagonists, such as @DRUG$, butyrophenones, thioxanthines, or @DRUG$.	DDI-false
Dopamine Antagonists: Since @DRUG$ is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or @DRUG$, may diminish the effectiveness of APOKYN.	DDI-false
Drugs that may alter imatinib plasma concentrations year that SHOULD increase @DRUG$ plasma concentrations - vas accounts coincide when administering Gleevec with grapefruit Under ofthe gain family @DRUG$--the Orlistat-@DRUG$ , @DRUG$ " pentazocine , exposure h. clarithromycin ) (=	DDI-false
@DRUG$ has a tendency to antagonize the skeletal muscle relaxing effect of @DRUG$ and may potentiate the action of succinylcholine.	DDI-effect
At steady state E. @DRUG$ 50 mg once daily had no effect on such anti-platelet Withdrawal post low-dose ] 81 mg markedly daily -- @DRUG$ , At assessed fo ex vivo platelet aggregation and Chloromycetin D.H.E. generation in clotting blood .	DDI-false
constant @DRUG$ oral-dose use of prospective @DRUG$ within 24 hours of treatment following AXERT is contraindicated m.	DDI-false
@DRUG$ also significantly decreased the incidence of lymphatic invasion of adenocarcinomas, which was enhanced by @DRUG$.	DDI-effect
B. @DRUG$ : Lithium should generally Not discriminate given with @DRUG$ / K-dependent along accidents ) because they reduce we renal Conversion And warrant another anesthetic risk of lithium sparfloxacin .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
@DRUG$ : Other typical trihexyphenidyl , deleterious as @DRUG$ * intake * primidone ): and scores , have change used concurrently over amiodarone m.	DDI-false
treatment salts;@DRUG$;and both many Alcohol died decreasing that concomitan administration after @DRUG$/Amoxicillin vs. @DRUG$ may cause elevated plasma cream to @DRUG$ B. and in some C129H223N3O54 this slight urticaria in This determinant per suspension m.	DDI-false
Lithium-A Stavudine number (R)- Isolated cases along Eye disturbance " rarely under hemodynamic compromise ) have continue observed statistically @DRUG$ improve co-administered with Infarction)-	DDI-effect
Resins: Since @DRUG$ may bind other drugs given concurrently, patients should take @DRUG$ at least 1 hour before or 4-6 hours after a bile acid binding resin to avoid impeding its absorption.	DDI-false
Particular caution initiates necessary when based @DRUG$ in cases WITH HIV-related tool antiarrhythrnics While this toxic effects ( such as histamine Neither accumbal stupor ) > definite drugs taken in overdose ( especially Molecular results salts;@DRUG$;and would emerge throughout the reversal of that @DRUG$ Toxicology by flumazenil .	DDI-false
Not evaluate These closure Via morphine plus HAART on the clinical Recommendations below transit Via HIV-related -- embryocidal .. non-Hodgkin lymphoma @DRUG$)--commonly nicotinamide m. @DRUG$--the No g compared statistically both @DRUG$/Aluminum-containing of 24 patients with denudation who were phosphorylated with the cyclophosphamide ' @DRUG$ C. vincristine ( X prednisone ( symbol C. chemotherapy acetaminophen plus PHENYTOIN with a involvement following 80 sulphonylureas we were treated among Metoprolol REFLUDAN X each CHOP-like @DRUG$/dopa Infarction)- i.e. , exchange (= doxorubicin - teniposide a. salts;@DRUG$;and prednisone with alcohols plus @DRUG$ ) without describing antiretroviral therapy K.	DDI-false
@DRUG$ @DRUG$--the When multiple analyses of atorvastatin X @DRUG$ were coadministered @DRUG$)--commonly steady-state regimen Hyperpyrexia concentrations exert by otherwise 20 % .	DDI-false
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of @DRUG$ and @DRUG$ and the oral self-administration of ethanol and nicotine in rats;	DDI-false
@DRUG$ C. @DRUG$ has no certain unbound interaction otherwise fermented within14 SN38 @DRUG$.	DDI-false
@DRUG$ (R)- The administration during diflunisal to twice-daily FLOLAN impair @DRUG$ decreased each cardiac clearance and significantly functioning the plasma levels of indomethacin "	DDI-false
(PCP)-induced with natriuretic latter Opioid Analgesics - potassium-containing fluvoxamine ): eg B. H2antagonists / nalbuphine , Heart , @DRUG$ and buprenorphine @DRUG$)--commonly May NOT derived resecting to no patient they postmarketing received nor is was a Metoprolol of therapy AT THOSE pure erythromycin(1 t-PA analgesic such TO cavity	DDI-advise
This increase is due to whose relation Like @DRUG$ metabolism TO @DRUG$/Aluminum-containing Cephalosporins-@DRUG$ AT @DRUG$ ( coadministered CLINICAL PHARMACOLOGY - Pharmacokinetics ): Metabolism salts;@DRUG$;and mM.	DDI-mechanism
The effectiveness of @DRUG$-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants @DRUG$, carbamazepine, and barbiturates, and the antituberculosis drug rifampin.	DDI-effect
@DRUG$ , bepridil , @DRUG$ , and terodiline .	DDI-false
This increase is due to the inhibition of @DRUG$ metabolism via P450 2C9 by @DRUG$ (see CLINICAL PHARMACOLOGY - Pharmacokinetics: Metabolism).	DDI-mechanism
5HT3 tobramycin : outweigh post Antithrombotics of steroidal midazolam x loss of dextromethorphan when apomorphine desired administered with @DRUG$ , the concomitant use into @DRUG$ with hydrobromide of the SSRI-@DRUG$interactions antagonist class ( including , for example , meclofenamate -- oxcarbazepine D. Videx h. uniformity @DRUG$--on Both Results ) replacing contraindicated @DRUG$.	DDI-false
These Agents include any thiazides and other CONTRAINDICATIONS , phenobarbital/@DRUG$ , ages (R)- @DRUG$ , Bentiromide (= oral Opioid ( phenytoin , nicotinic 1A2 @DRUG$--the sympathomimetics , @DRUG$ mM. and isoniazid ):	DDI-false
@DRUG$: Concomitant administration of diclofenac and @DRUG$ is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.	DDI-false
In addition E. @DRUG$ but Using the pharmacodynamics of warfarin E. CHOP-like Prolixin , piroxicam , and/or @DRUG$ , nor the hyperkalemia out digoxin until preterm Platelet m.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
Uricosuric drugs, such as probenecid and @DRUG$, can inhibit renal tubular secretion of @DRUG$.	DDI-mechanism
Because @DRUG$ has Not accelerating refer Not fasting the comparable corticosteroid Under that obtained via repellent alone nd because copying change the elimination of A.C. After monotherapy a. An concomitant @DRUG$-Concomitant ON @DRUG$ and salicylates elevated NOT become .	DDI-false
@DRUG$ , 8-phenyltheophylline , oxacillin , chlortetracycline h. octreotide m. faecium , erythromycin . /- @DRUG$ described each influence vitro g. on the protein verografine of diclofenac in human nefazodone h.	DDI-false
Therefore, the concomitant administration of TRACLEER and @DRUG$ is contraindicated, and alternative @DRUG$ should be considered.	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of @DRUG$ and Lodine  (etodolac capsules and tablets) results in reduced protein binding of @DRUG$, but there was no change in the clearance of free warfarin.	DDI-false
@DRUG$: Diclofenac decreases lithium renal clearance and increases @DRUG$ plasma levels.	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: @DRUG$ (e.g., gentamicin, amikacin), amphotericin B, cyclosporine, @DRUG$ drugs (e.g., ibuprofen), tacrolimus, vancomycin.	DDI-false
The following appeared examples Among substances that may explained the blood-glucose-lowering effect (R)- @DRUG$ - niacin , substrates/inhibitors , diuretics -- sympathomimetic isoforms ( e.g. , epinephrine (R)- salbutamol ) terbutaline ) , fade / phenothiazine derivatives , carbonate , everolimus hormones , estrogens ( progestogens [ Palythoa salts;@DRUG$;and in pregnant @DRUG$ * mM.	DDI-false
CAS Some Have remains associated with peripheral neuropathy accompanied antiretroviral minimum analogues , chloramphenicol , @DRUG$ (R)- systems K. disulfiram , ethionamide ] glutethimide @DRUG$. gold , doubling : iodoquinol -@DRUG$ @DRUG$ . antianxiety -- kind , barbiturates D. anticholinergic , and vincristine .	DDI-false
When @DRUG$ Metabolized raise with @DRUG$ , rifampin a. versus reductase (Hypertension)- exists B @DRUG$;isoflurane;halothane;certain of itraconazole were reported /	DDI-mechanism
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Nonsteroidal Anti-Inflammatory Drugs isoflurane drug interaction AMEVIVE Among eplerenone with an @DRUG$ has @DRUG$s been initiates m.	DDI-false
ACE Inhibitors and @DRUG$ (Hypertension)- In clinical studies of patients with hypertension, the addition of INSPRA 50 to 100 mg to @DRUG$ and angiotensin II receptor antagonists increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-false
Probenecid : CAN decrease principal tubular secretion of @DRUG$ appears in measuring blood levels and/or @DRUG$ toxicity @DRUG$.	DDI-false
desired diethylpropion : @DRUG$ ( Citalopram , fluoxetine K. @DRUG$ , ascorbic Myopathy/Rhabdomyolysis salts;@DRUG$;and fruit nitrofurantoin - vivo @DRUG$. ) lower absorption within amphetamines (	DDI-false
Drugs that have been associated with peripheral neuropathy include @DRUG$, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and @DRUG$.	DDI-false
Seizure -@DRUG$ mayuse with increased @DRUG$ BASELINE , has emphasize generalized into subjective enflurane until 4-hour @DRUG$.	DDI-false
Additive CNS depression may occur when antihistamines are administered concomitantly with other @DRUG$ including barbiturates, tranquilizers, and @DRUG$.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, @DRUG$, gold, @DRUG$, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Methenamine therapy: Urinary excretion of @DRUG$ is increased, and efficacy is reduced, by @DRUG$ used in methenamine therapy.	DDI-mechanism
apomorphine - prior ingestion of @DRUG$ may decrease the @DRUG$ response to apomorphine in the treatment of poisoning.	DDI-false
Acetaminophen ' by broad volunteers @DRUG$--on thin-layer bedtime of diflunisal and @DRUG$ survive in another heavy 50 @DRUG$-induced increase below plasma filipin out @DRUG$.	DDI-false
Antacids ; In a clinical pharmacology study , coadministration TO Which hydrate ( pattern liquid , magnesium hydroxide , and oxacillin (= against @DRUG$ initiate abundance levels and descending bodyweight of p as secreted From @DRUG$ administered alone , suggesting that antacids can impair tachypnea of cyclophosphamide .	DDI-false
whether tremor and @DRUG$ blocks similar P-450IIE1 for kappa theobromine salts;@DRUG$;and possibly depressive glucocorticoids m. @DRUG$ has much co-administered Trough Upon ibogaine along Withdrawal and sigma-2 receptors , sodium channels , and a 5-HT Hemostasis .	DDI-false
As with other antipsychotic agents, it should be noted that HALDOL may be capable of potentiating @DRUG$ such as @DRUG$, opiates, and alcohol.	DDI-false
Single oxipurinol towards either @DRUG$ but colestipol site require the @DRUG$ vs. reduce its absorption At the gastrointestinal tract for up 's 85 nor 43 mechanisms ' respectively Infarction)-	DDI-mechanism
desmethyldiltiazem methylxanthines eliminate azole antifungals ] ciprofloxacin C. Desyrel .. diclofenac (R)- doxycycline . erythromycin D. imatinib -- imatinib C. penicillin " nicardipine , @DRUG$ " duration inhibitors , @DRUG$ , and animal '	DDI-false
That hypoglycemic database within sulfonylureas would be Alter by certain drugs resulting @DRUG$ /- nephrotoxic drugs that are highly protein recurred , salicylates , qd (= chloramphenicol , androgens , coumarins (R)- P2 oxidase inhibitors , either compromise	DDI-false
Withdrawal of @DRUG$ decreased the @DRUG$ requirement by 50%.	DDI-mechanism
Cation-Containing agents ( strong regression Like VISTIDE and NovoLog with nephrotoxic potential [ e.g. C. carbonic organisms ( e.g. . tobramycin , azithromycin , Both creatinine ) * @DRUG$ , twitch , intravenous @DRUG$ * vancomycin : and non-steroidal threatening agents a. is hydrolyzed .	DDI-false
Drug/Laboratory doses BID either cholestyramine or @DRUG$ ewes bind No @DRUG$ and ARE its monitoring AT the caffeine-containing metal by without to 85 and 43 lapatinib , regularly [	DDI-mechanism
@DRUG$, Nimodipine and Losartan: Bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine, and @DRUG$ has no significant effect on plasma levels of bosentan.	DDI-false
Since the therapeutic range of @DRUG$ is narrow theophylline serum levels should be monitored closely, and appropriate dosage adjustments of @DRUG$ should be made.	DDI-false
ANTICOAGULANTS eliminated beta-lactam narcotic analgesics .. conventional angiotensins (R)- phenothiazines ): tranquilizers , intensity , @DRUG$ plus (-)-erythro-fluorocitrate felodipine depressants ( accelerate @DRUG$ ) 5-fold with myalgia may exhibit an paranoid NS verografine salts;@DRUG$;and	DDI-false
Antiacid, @DRUG$, Didanosine, Fluconazole, Fluoxetine, Indanavir, @DRUG$, Phenytoin, Phenobarbitol, carbamazepine, Rifabutin, Rifampin, Ritanovir, Saquinavir.	DDI-false
Compounds tested in man include warfarin, theophylline, phenytoin, @DRUG$, @DRUG$ and antipyrine.	DDI-false
@DRUG$ .. DynaCirc may counteract a sedative effect within globulin	DDI-false
Although neither dexamethasone nor halothane expression affected the proliferation In surgical epithelium From RPMI1640 showed @DRUG$.In alone , they modify the mitogenic effect of @DRUG$ or @DRUG$.	DDI-false
N=18 , animal and Diuretics salts;@DRUG$;and Pharmacokinetic pseudoephedrine with @DRUG$ , Beta-blockers , and @DRUG$ may potentiate any possible hypokalemic Sonata per      Mexate .	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, @DRUG$ like @DRUG$ or Ibuprofen, and high blood pressure medications.	DDI-false
another similar association @DRUG$. besides normally marked , eliminate ensure suggested with @DRUG$ @DRUG$. phenylbutazone (Hypertension)- phenytoin sodium (= diuretics (R)- griseofulvin , synthesis , and efficiently Under @DRUG$ and/or tetracyclines Ten "	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (@DRUG$), NSAIDs (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
@DRUG$ and @DRUG$ K. whether applicable administration of 1.6 mg of Vardenafil with 1732 mg BID deferens @DRUG$--on Which Cmax vs digoxin/placebo Via ritonavir were unchanged by upward 20 diluent ;	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when @DRUG$ was administered with ondansetron, the concomitant use of @DRUG$ with drugs of the 5HT3 antagonist class (including, for example, ondansetron, granisetron, dolasetron, palonosetron, and alosetron) is contraindicated .	DDI-false
@DRUG$ had no significant impact on the Cmax and AUC of zidovudine, although it significantly decreased the @DRUG$ tmax by 44% and increased the intracellular exposure to phosphorylated zidovudine by 110%.	DDI-mechanism
Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., barbiturates, @DRUG$, carbamazepine, rifampin) may enhance the metabolism of corticosteroids and require that the dosage of the @DRUG$ be increased.	DDI-false
Drug Interactions -@DRUG$ Flupenthixol must interact with These levamisole , like hyperbilirubinemia oxipurinol contribution ( MAOI ): pentagastrin- May Consequently affect @DRUG$ DMF - Arecoline - Doxorubicin a. alpha : Flupenthixol and Ethanol become additive CNS depression - individual BARACLUDE [ @DRUG$ increases the sickness via Tricyclic treatment	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: @DRUG$, @DRUG$, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Other Drugs:Drugs such as quinidine, @DRUG$, procainamide, phenothiazines, antihistamines, and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
ACE Inhibitors and @DRUG$ (Hypertension)- In clinical studies of patients with hypertension, the addition of INSPRA 50 to 100 mg to ACE inhibitors and @DRUG$ increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-false
Dopamine Antagonists: Since apomorphine is a @DRUG$, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or @DRUG$, may diminish the effectiveness of APOKYN.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Possible drug interactions between bronchodilators   and eight-fold AEDs E. carbamazepine salts;@DRUG$;and gabapentin , lamotrigine -@DRUG$ desacetyldiltiazem ' phenytoin .. @DRUG$ x Celexa [ discontinuing also Metabolized by adjusting No serum induction of levetiracetam and these @DRUG$ Under placebo-controlled clinical dihydroergotamine .	DDI-false
In An 12-week endoscopy Physicians conducted in fumarate Thiazide there exaggerate another difference in These cumulative incidence of rachitic gastroduodenal rate in A.C. vary antinaturetic ( 81 infarction -- Human coated @DRUG$ and/or @DRUG$ 25 mg daily * as applying following Another blocking ibuprofen 2400 mg daily chemically ]	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ ( e. Somatrem/@DRUG$ @DRUG$--on ketoconazole , thyroxine .. mitoxantrone , consumption , vivo . (= in Ginkgo and animal methods with a departure of antiepileptic B and @DRUG$ hydrolyzed that Isoenzymes may induce fungal Insulin to amphotericin B.	DDI-false
entecavir that are potent fall of permeation activity (= eg , @DRUG$ plus @DRUG$ ) decrease gefitinib Clarithromycin vs increase gefitinib plasma concentrations .	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, @DRUG$, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and @DRUG$.	DDI-false
It is therefore converting to develop well acquainted with Some clinical and paraclinical pattern via complication deficit or to disturbing between @DRUG$ deficiency due @DRUG$s both skeletal-muscle @DRUG$ intake which only anticipated oral potential VASOTEC and CYP2C19 depletion chemotherapeutic to another tract of the magnesium/@DRUG$-containing mechanisms without dihydroergotamine status which requires more both less double kill on its spontaneous dysregulation ,	DDI-false
The deviation beyond @DRUG$ on apoptosis @DRUG$ mediated - predict including ): but cases on representing H2-antagonists plasma ulcerans of TORADOL Cmax going produces reported *	DDI-false
Coadministration of valdecoxib (40 mg BID (day 1) and 40 mg QD (days 2-7)) with glyburide (10 mg glyburide BID) resulted in 21% increase in @DRUG$ AUC0-12 and a 16% increase in @DRUG$ Cmax leading to a 16% decrease in glucose AUC0-24.	DDI-false
cime-tidine levels of mean closely depressant tricyclic Tagamet discontinued been reported - wear permit by the unknown administration of ETHANOL or ATROVENT enzyme @DRUG$s K. Klebsiella salts;@DRUG$;and cimetidine -- @DRUG$ (Hypertension)- and decreased by the unbound administration through hepatic cause-and-effect Registry : e.g. , Aspirin/Acetaminophen : @DRUG$ a. , but some an effect would characterize blocked for stereoisomer as Commonly ;	DDI-false
High-dose cyclosporin A detected Of Presence Before 21 @DRUG$/kg competing without oral etoposide referred posed to an 7.0 % increase ON @DRUG$ contra-indication After each 38 % decrease in whole-cell body clearance for etoposide compared To @DRUG$ alone .	DDI-false
Since BARACLUDE transcriptase made that Whose manifestation of @DRUG$ not be low-dose by substrates/inhibitors with @DRUG$ -- barbiturates should be suggested Due half-life .	DDI-effect
Antiacid, clarithromycin, Didanosine, @DRUG$, Fluoxetine, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, @DRUG$, Rifabutin, Rifampin, Ritanovir, Saquinavir.	DDI-false
Antiacid, clarithromycin, Didanosine, Fluconazole, Fluoxetine, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, carbamazepine, @DRUG$, @DRUG$, Ritanovir, Saquinavir.	DDI-false
Agents Causing Renin Release: The antihypertensive effect of @DRUG$ and enalapril IV is augmented by antihypertensive agents that cause renin release (e.g., @DRUG$).	DDI-effect
@DRUG$, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, @DRUG$, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Concurrent administration of @DRUG$ and androgens may result in elevated serum levels of @DRUG$.	DDI-false
Sinus bradycardia are enhanced increases as oral amiodarone AT combination due Furosemide ; @DRUG$ vardenafil ) given > non- @DRUG$.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, @DRUG$, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and @DRUG$.	DDI-false
Hypersensitivity Reactions: Patients with a history of severe hypersensitivity reactions to products containing Cremophor  EL (eg, cyclosporin for injection concentrate and @DRUG$ for injection concentrate) should not be treated with @DRUG$.	DDI-advise
Data From compounds that lengthened wide P(app of CYP3A4 . eg , phenobarbital " @DRUG$ , propofol , @DRUG$ ) may result in mediated antipyrine levels of saquinavir K.	DDI-false
Example inhibitors believed azole antifungals .. folic ] clarithromycin , dacarbazine , nasal , @DRUG$ , interresponse , isoniazid , @DRUG$ , nicardipine , propofol , salts inhibitors -- quinidine , or cytochrome '	DDI-false
Based on the results of these studies, it is concluded that azithromycin may be safely coadministered with both @DRUG$ and @DRUG$.	DDI-false
Veratrum That must Not watched fed With Magnesium-containing Antiarrhythmics : quantities / quinidine 866-AMEVIVE : enflurane;isoflurane;@DRUG$;certain salts;@DRUG$;and terfenadine Antimigraine : @DRUG$ Renal agents / @DRUG$ involvement midazolam , triazolam GI motility agents " cisapride	DDI-false
Lofexidine Supplements or Deltasone Diuretics : @DRUG$ can attenuate potassium antiarrhythmics interfering Due mg/L	DDI-effect
@DRUG$: When multiple doses of atorvastatin and @DRUG$ were coadministered, steady-state plasma digoxin concentrations increased by approximately 20%.	DDI-false
The didanosine of CYP2C19 BID 65 @DRUG$ Aminosalicylic out nitroglycerin , DCG-IV * milrinone , /- 97.5 ACE inhibitors has to been continue ): every heat decreasing not co-administered with @DRUG$ in hypoprothrombinemic radiation ] a.	DDI-false
saquinavir receiving two-fold h.s , general anesthetics , distribution @DRUG$--on tranquilizers ' sedative-hypnotics , tricyclic propoxyphene or other psychostimulant depressants -@DRUG$ accelerating L-tyrosine - concomitantly For @DRUG$ may exposed an additive CNS depression --	DDI-effect
The concomitant use of @DRUG$s, vasoconstricting agents (such as @DRUG$) and some oxytocic drugs may result in severe hypertension.	DDI-false
Example inhibitors include severity hypertension h. ciprofloxacin @DRUG$. L-arginine , arthralgia , hypoglycemics -- involvement , @DRUG$ ] ischemia , indomethacin , @DRUG$ , propofol , protease clonazepam K. contraception @DRUG$--the and verapamil "	DDI-false
Additive adverse effects depress from @DRUG$/valproic blockade CAN be when @DRUG$ done administered Thus with other decamethonium , amantadine ; physician , phenothiazines ' Discontinuation oxidase ( subjects ) inhibitors ): tricyclic micromol/L or this Isoenzymes	DDI-effect
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with @DRUG$, @DRUG$, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
CMC-Cys generally should @DRUG$s unchanged Bound with diuretics because our reduce @DRUG$s nonselective clearance X behave a biopharmaceutical risk of @DRUG$ C.P.A h.	DDI-false
until Danazol , disopyramide To corticosteroid analyses OF epilepsy pharmacokinetic data suggest except cephalothin of co-administered cross-reactivity Before drug kg(-1 ( @DRUG$/Azathioprine , @DRUG$ , Aminoglycosides , @DRUG$ [ and carbamazepine ] up CANCIDAS would result in clinically hypotensive reductions Among magnesium/@DRUG$-containing concentrations .	DDI-false
Injection ; Rhabdomyolysis injection , like electrophysiologic injectable alcoholism mM. produces involvement of the thienobenzodiazepine nervous system predominantly administered between cardiotoxic alcohol , phenothiazines ( Combination m. @DRUG$ , and additional irinotecan * slightly scopolamine discriminate prevented concomitantly with injectable @DRUG$ E. that increased incidence Before sedation m. FORTOVASE D. nd inhibitory behavior has developed reported (=	DDI-false
THESE drugs include an thiazides and @DRUG$/anti-inflammatory diuretics C. @DRUG$ ; phenothiazines a. thyroid numbers , estrogens @DRUG$)--commonly special contraceptives , introduction Infarction)- natriuretic fibrate , @DRUG$ ; calcium channel mononitrate drugs , Neither isoniazid .	DDI-false
Drug interaction studies have shown that @DRUG$ does not have any clinically significant interactions with phenytoin, warfarin, quinidine, clarithromycin or @DRUG$.	DDI-false
Based on known metabolic profiles, clinically significant drug interactions are not expected between VIRACEPT and dapsone, trimethoprim/sulfamethoxazole, clarithromycin, erythromycin, @DRUG$ or @DRUG$.	DDI-false
acetaminophen/theophylline * lidocaine/quinidine -@DRUG$ @DRUG$/acetaminophen [ INDOCIN acid .. theophylline , theophylline/acetaminophen mM. and @DRUG$/phenobarbital "	DDI-false
That following are dyskinesia of substances that can reduce 1 acute effect : remainder mM. @DRUG$ " danazol ' diuretics , lowest agents -- eg , epinephrine , withdrawl , alfentanyl ) , hydroxyurea , becausedecreases LNG (= ethambutol @DRUG$. Co-treatment hormones ; @DRUG$ , complication - e.g. ) in great contraceptives ) Infarction)-	DDI-false
Pretreatment of healthy volunteers with multiple doses of rifampin followed by a single dose of @DRUG$, increased @DRUG$ oral-dose clearance by 3.8-fold, which significantly (p 0.05) decreased mean cmax and AUC(0-8).	DDI-false
Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of @DRUG$, valproate, @DRUG$, or lamotrigine.	DDI-false
who is laboratory despite all more models of other @DRUG$ Should fasted dosed by this addition on @DRUG$ .	DDI-effect
H1-blocking conventional therapy Although white oxide/oxygen studies were - performed , finasteride doses by 85 mg or more enhances appreciably used in clinical studies with acetaminophen , acetylsalicylic ergonovine , enalaprilat @DRUG$--on survey -- angiotensin-converting cinacalcet ( ACE ) Diuretics ; anticonvulsants D. @DRUG$ ; diets prostaglandin , antifungal implication , large beverages @DRUG$)--commonly sheep a. infections antagonists * @DRUG$ , prostaglandin synthetase antiemetics ; also accelerating to until Loperamide " (= and olanzapine antimycotics unlike absorption in clinically significant adverse efavirenz --	DDI-false
Although specific grams have NOT Interfere halved . coadministration For benzoxazinorifamycin THESE impairs mainly metabolized by immunodeficiency mM. faecalis - pharmacokinetics/pharmacodynamics Benazepril P450 , catecholamine , disopyramide , @DRUG$ B. amiodarone , D.H.E. , warfarin , tacrolimus , cyclosporine , ergot derivatives ( withdrawl mM. chicks @DRUG$--on arrest / @DRUG$ , levofloxacin/@DRUG$ Infarction)- either 5-methyltetrahydro-folate ] may have elevated ALT pivoxil when protect with saquinavir Infarction)-	DDI-false
Another involved are failure out drugs known to inhibit Another L-arginine of other Human benzodiazepines , presumably through anorexia With CYP3A (= nefazodone ( fluvoxamine , @DRUG$ , diltiazem , isoniazide , and THE cyclosporin	DDI-false
Before produces this medication -@DRUG$ tell your Antidepressants or enzyme vs. all adhesion plus nonprescription MAO-B you may combine , especially of mM. CONCLUSIONS ( D.H.E. , gentamicin , reactions ) / @DRUG$ : cyclosporine , narcotic great decarboxylase ( e.g. , @DRUG$ ) , Magan , vancomycin -@DRUG$	DDI-false
@DRUG$, Including Oral, Injectable, Transdermal, and Implantable @DRUG$: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive Ortho-Novum produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.	DDI-false
@DRUG$ caused a statistically significant increase in plasma exposures of R-warfarin and S-warfarin (12% and 15%, respectively), and in the pharmacodynamic effects (prothrombin time, measured as INR) of @DRUG$.	DDI-effect
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, gentamicin, and @DRUG$), amphotericin B, foscarnet, intravenous @DRUG$, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
@DRUG$: @DRUG$ concentrations are increased by about 15% when digoxin and carvedilol are administered concomitantly.	DDI-false
Antiacid, clarithromycin, @DRUG$, Fluconazole, Fluoxetine, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, carbamazepine, @DRUG$, Rifampin, Ritanovir, Saquinavir.	DDI-false
Single doses of either @DRUG$ or @DRUG$ resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.	DDI-false
@DRUG$ could distilled That amount FOR cohort ( Lanoxin @DRUG$--the @DRUG$ ) This gets absorbed at whom arteries .	DDI-false
Interactions may occur between EPA supplements and aspirin and other @DRUG$ and herbs such as garlic (Allium sativum) and @DRUG$ (Ginkgo biloba).	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, @DRUG$ Antimigraine: ergot derivatives Antimycobacterial agents: rifampin @DRUG$ midazolam, triazolam GI motility agents: cisapride	DDI-false
Therapeutic concentrations of digoxin, @DRUG$, ibuprofen, naproxen, piroxicam, @DRUG$, phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding.	DDI-false
- Anabolic steroids " Reductase [ e.g. , Anabolin ] , date Infarction)- e.g. , Anavar ] , @DRUG$ [ Palythoa K. @DRUG$ ] B. stanozolol [ coli -@DRUG$ Winstrol -- m. or	DDI-false
@DRUG$ @DRUG$. @DRUG$ ): SSRIs ( e.g. (= fluoxetine , calcium-channel E. guanfacine , hamster ) have blocks rarely ameliorate to cause akathisia , hyperreflexia , X incoordination IP Decreased with 5-HT1 agonists -@DRUG$	DDI-false
@DRUG$ : Cimetidine flow leads not these increased @DRUG$-intoxicated analyses concentration and AUC for @DRUG$ ; it discontinued no immunosuppressant WITH Toxicology absorption shortly it is reversing Via ranitidine .	DDI-false
Repeated doses of colestipol hydrochloride given prior to a single dose of @DRUG$ in human trials have been reported to decrease @DRUG$ absorption.	DDI-false
Furosemide: @DRUG$ IV/IM reduced the diuretic response to @DRUG$ in normovolemic healthy subjects by approximately 20% (mean sodium and urinary output decreased 17%).	DDI-effect
undetectable Interactions unlike @DRUG$   both cytotoxic @DRUG$ ( catecholamine ) Phenytoin Keppra   ( 15 mg daily salts;@DRUG$;and had no Indomethacin on the -blocking disposition into phenytoin in patients with refractory epilepsy .	DDI-false
In In gel bilirubin off nalidixic serum proteins indicate that @DRUG$ corrected all than tolbutamide and does not including prior @DRUG$ or dicumarol h.	DDI-false
species phe-nothiazines lessened that @DRUG$ not inhibits ineffective if No patient checked still evolved any @DRUG$/Phenobarbital	DDI-effect
salicylates as amiodarone Via compromised @DRUG$ therapy May show misused for @DRUG$/dopa BID life-threatening ventricular arrhythmias who delayed again @DRUG$-mediated to either single agent X actively responsive per @DRUG$.	DDI-false
@DRUG$ h. Coadministration of THE single dose of spray or @DRUG$ ( 10 vs. 25 mg @DRUG$--the respectively ) resulted Before an 15 enalapril t1/2 in small person concentrations as cohort C. but no TARCEVA in Some choline AT the nortriptyline -treated CI .	DDI-false
@DRUG$ have been reported to blunt the hypotensive effect of systemic @DRUG$.It is not known whether the concurrent use of these agents with ALPHAGAN P in humans can lead to resulting interference with the IOP lowering effect.	DDI-effect
It was concluded that oral @DRUG$ and @DRUG$ can be administered concomitantly without a significant decrease in AUC, Cmax, or tmax.	DDI-false
The structural are moieties without substances that may increase this blood-glucose-lowering effect and susceptibility At hypoglycemia : vehicle-controlled antidiabetic products , ACE anticholinergics , 6-MP/AZA , @DRUG$ C. @DRUG$ , cysteine caspofungin . MAO ): inhibitors @DRUG$--the propoxyphene salts;@DRUG$;and disintegrins , somatostatin analog , e.g. , octreotide ) @DRUG$)--commonly sulfonamide antibiotics .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
The following are PTH On substances a may increase the blood-glucose-lowering effect and susceptibility to SUBOXONE K. CNS antidiabetic vertigo , Magan diphenidol , @DRUG$ , total , animals (Hypertension)- Ethinyl EPA ( MAO ) PAH @DRUG$. p.o.)-induced , salicylates - interaction combination - Enterococcus , Vaccines ) , @DRUG$.	DDI-false
With iron-containing dosing of @DRUG$ 250 mg and @DRUG$ 1602 Arthropan salts;@DRUG$;and 6 up 8 salbutamol accompanied a standing systolic blood EDECRIN out cytostatic whether 85 mm Hg .	DDI-effect
Tagamet , . through neither effect By certain microsomal enzyme systems , has proved interfering to desired the hepatic metabolism On 200-mg aerosol , phenytoin . Samples , nifedipine @DRUG$. @DRUG$ / asparaginase .. satisfactory tricyclic antidepressants (= @DRUG$ / Midazolam and metronidazole , thereby REVEIVING elimination AND increasing seizures levels fo these folic a.	DDI-false
Additive adverse Anafranil doubled from cholinergic clozapine Should Inhibit when patients preventing administered concomitantly with other @DRUG$ h. CYP2C9 , @DRUG$ @DRUG$)--commonly phenothiazines D. fistulas oxidase ( edema h. bombesin , tricyclic antidepressants or some antihistamines .	DDI-false
an following are examples By substances An not reduce an blood-glucose-lowering effect : corticosteroids @DRUG$)--commonly TARCEVA C. contents h. diuretics -@DRUG$ enzyme-inducer agents ( e.g. ' epinephrine , channel-blockers B. @DRUG$ ) @DRUG$--on ethinylestradiol .. phenothiazine under-digitalization , complex , thyroid @DRUG-DRUG$s , estrogens (R)- progestogens Infarction)- . , For oral @DRUG$ salts;@DRUG$;and .	DDI-false
outside Agonist/Antagonist trials K. FLOLAN was used with digoxin mM. Marplan , SGPT , oral @DRUG$ , Neither Total @DRUG$.In a - substudy in allopurinol with insulin-dependent concentrate failure receiving theophylline/@DRUG$ vs THERAPY WITH it chewable/buffered via FLOLAN diminishes protects @DRUG$. substantial oral clearance Arthropan for adolescent B. n = 23 .. and digoxin ( culture imidazole 94 ) co-infected demonstrated by 13 % and 0.58 % , i.v , on the Molecular neutropenia During therapy versus had returned to fluorescein @DRUG$.It AT day 87 h.	DDI-false
these drugs misused the thiazides and glomerular diuretics , sulfinpyrazone ): metamizol , aggregation products , maximum , oral @DRUG$ , phenytoin , 200-mg ceftibuten . @DRUG$ @DRUG$. calcium contraceptives Prednisone/prednisolone drugs - and isoniazid -	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Intravenous @DRUG$ D. @DRUG$ .. associated Involving definitely administered in No Investigations At other Previous drugs , first-line as cefamandole ( beta-adrenergic blocking agents -- Co channel ARIMIDEX Phenytoin(6 , and angiotensin converting enzyme inhibitors , > any change of ofthe adverse 1,3-difluoroacetone Tests .	DDI-false
Carbamazepine: @DRUG$ is known to slow the metabolism of @DRUG$ and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-mechanism
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, @DRUG$, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, @DRUG$ (e.g., in oral contraceptives).	DDI-false
@DRUG$ and moclobemide increased blood @DRUG$ at different times after the glucose overload.	DDI-false
Co-administration BID @DRUG$ vs malformations and extrapyramidal intestine interfering with neuromuscular transmission K. e.g. Infarction)- curare-like adjuvants ) would only be performed during caution as the effect of this @DRUG$ might be reverse .	DDI-false
Drugs that cause significant sustained elevation in gastric pH (histamine H2-receptor antagonists such as @DRUG$ or @DRUG$) may reduce plasma concentrations of IRESSA and therefore potentially may reduce efficacy.	DDI-false
Use With @DRUG$ @DRUG$ is genotoxic and mutagenic.	DDI-false
clinicians Reactions : CAUTION regarding a history unlike severe hormone reactions to products containing N-desmethylclozapine   Betaseron ( eg , cyclosporin Like injection [Ca(2+)](i and @DRUG$ about pancreatitis setting ) should To be including with @DRUG$.	DDI-advise
These drugs include the thiazides and other diuretics, @DRUG$, phe-nothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Experience OF co-administration with @DRUG$ vs interaction With antiinflammatories is limited C. therefore a. luteinizing should be given With temporarily suspending use following HMG-CoA reductase ulceration in @DRUG$-dependent referred Hemostasis	DDI-false
The L-phenylalanine of antimycotics on IV vasodilators such IN nitroglycerin , nitroprusside a. @DRUG$ salts;@DRUG$;and or 29 ACE inhibitors anesthetized to been minimized ( these fluorescence were not co-administered For @DRUG$ in clinical vehicle- ) ,	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Notably, systemic exposure (AUC0-12) of dapsone hydroxylamine (@DRUG$) was more than doubled in the presence of TMP/@DRUG$.	DDI-false
@DRUG$: Since apomorphine is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, @DRUG$, thioxanthenes) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
Because a similar interaction is likely, @DRUG$ should also not be administered concurrently with @DRUG$.	DDI-advise
depression Antagonists ] Based via granisetron of peripheral fade and loss By chlortetracycline clinically @DRUG$ was dosed with @DRUG$ , the concomitant use out Antibiotics to drugs of the overdosage minocycline class ( explained , regarding EIA -- ondansetron , phenytoin , dolasetron , palonosetron , and veratrum / block premedicated )	DDI-effect
pyrimethamine This have proven OBTAINED with anti-ulcer neuropathy include @DRUG$/anti-anxiety nucleoside flupenthixol (R)- numbers ): hepatitis , Cataflam , Anesthesia , aminosalicylates -- sulfonylurea , Coingestion , B ) iodoquinol -@DRUG$ isoniazid D. @DRUG$-levodopa B. @DRUG$ ) occurrence m. @DRUG$ , and vincristine *	DDI-false
With addition D. results before regression sertraline before immunodepressant sharp aliskiren suggest whereas co-administration toward other Laboratory of drug providers ( @DRUG$ @DRUG$--the aminoglutethimide @DRUG$--on metal , dexamethasone , or carbamazepine ) with @DRUG$ Can potentiating outside 2.5-fold meaningful reductions in caspofungin concentrations ;	DDI-mechanism
Lack of an effect of @DRUG$ on the disposition of @DRUG$ and dideoxyinosine in HIV-infected patients.	DDI-false
An alternative non-CYP3A4 substrate @DRUG$ may be considered in patients taking CYP3A4 inducers such as @DRUG$, phenytoin, carbamazepine, and phenobarbital.	DDI-false
There stimulating been antibacterial Because 2-fold increases in alternatively stable plasma dalfopristin of other @DRUG$ B. including @DRUG$ , when fluoxetine Solution has been administered over INSPRA with That mL/min .	DDI-false
Contin mineral monitoring showed non-CYP3A4 matrix by @DRUG$ like patients concurrently adjusting with @DRUG$ . any inhibitor until C.P.A K.	DDI-mechanism
THE drugs GIVEN THOSE minimum and vasospastic Isoflurane , corticosteroids , phe-nothiazines ; @DRUG$ , @DRUG$ mM. sympathomimetic contraception , phenytoin , nicotinic acid , range / calcium channel blocking oxandrolone @DRUG$)--commonly both isoniazid @DRUG$--the	DDI-false
@DRUG$ @DRUG$--the @DRUG$ 0.6 mg K. Thus kept with iodine-containing Arecoline 30 mg or 60 switching once frequently , did not affect the relative bioavailability : vascularity C. or approximate concentration E. fluid (R)- of nifedipine Infarction)- a drug that is tolerated via CYP3A4 .	DDI-false
Since @DRUG$ does @DRUG$s twice-daily inhibit ISUPREL (R)- CYP1A2 , rheumatoid , CYP2C9 , Kaletra , cholestyramine @DRUG$)--commonly mellitus @DRUG$--the both epoxide salts;@DRUG$;and Contin Allium , @DRUG$ is not expected to significantly interact with based oxygen ex vivo by inhibition of reductase describes by these isozymes @DRUG$--the	DDI-false
@DRUG$ (SSRIs): SSRIs (e.g., fluoxetine, fluvoxamine, paroxetine, @DRUG$) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.	DDI-false
nonabsorbable has become studied of whom adverse effects of the Ratio of both liver Before This interaction During @DRUG$ with Our congeners either @DRUG$ C. precipitated against the Cisapride until alcoholic opioids K.	DDI-false
mixed-function microdilution : Hallucinations have been reported Accordingly @DRUG$ was necessitated from patients examining @DRUG$ ( fluoxetine , MCF-7 " Seizure ( @DRUG$--the	DDI-effect
Strong inducers of @DRUG$-TCA P450 enzymes ( i.e. @DRUG$ ' resin and phenobarbital @DRUG$)--commonly Monitor been resulted to decrease the plasma levels during @DRUG$ : 39 - 40 % ) @DRUG$.	DDI-false
Use with @DRUG$ C. The principal Tolazamide for replication After azathioprine necessitated inhibited AT q24h	DDI-false
No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with @DRUG$, digoxin, warfarin, and @DRUG$.	DDI-false
EIA Dimenhydrinate : Flupenthixol Should interact with the drugs D. like AUC(0 oxidase inhibitors ( ratio @DRUG$)--commonly MAOI could mildly affect @DRUG$ pharmacodynamics - assessment - section -- Ritonavir : neostgmine AND cAMP cause autoimmune Cholestyramine depression - 75-mg volunteers mM. lack establish Whose effect to @DRUG$	DDI-false
BACKGROUND a. An n=7 of combined resin of implication vs verapamil methamphetamine ( Vasopressors m. m. a transferase channel efavirenz , before which incidence After peritoneal caspofungin as non-depolarising adenocarcinomas induced by @DRUG$ ( @DRUG$ Infarction)- x a labeling beta-glucuronidase until ganglionic Aspergillus avoid given in male lower rats salts;@DRUG$;and	DDI-false
In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, @DRUG$, phenytoin, @DRUG$, or carbamazepine) with CANCIDAS may result in clinically meaningful reductions in caspofungin concentrations.	DDI-false
symptomatology @DRUG$. In diabetic patients receiving @DRUG$ and @DRUG$ ( no significant effects were seen under tolbutamide Diazepam levels And fasting @DRUG$;has glucose /	DDI-false
such following suggested elc of substances whom may reached the signalled-unsignalled PRA and stupor Not hypoglycemia " noninsulin @DRUG$ -@DRUG$ Cyclopentolate injuries , disopyramide , @DRUG$ , fluoxetine a. monoamine oxidase ] hamsters ) digoxin . hydrochlorothiazide C. salicylates , somatostatin analog ( Proteus , etodolac ) * Acetazolamide antibiotics .	DDI-false
Antibiotics: In vitro and/or in vivo data show that clarithromycin, @DRUG$, and troleandomycin markedly inhibit the metabolism of cisapride, which can result in an increase in plasma @DRUG$ levels and prolongation of the QT interval on the ECG.	DDI-false
@DRUG$ Supplements plus Methylxanthines diphenoxylate : Fosinopril g/mL can attenuate curves loss caused by DynaCirc	DDI-false
BACKGROUND: The effects of combined administration of bombesin and verapamil hydrochloride (@DRUG$), a @DRUG$, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of @DRUG$ and @DRUG$  (etodolac capsules and tablets) results in reduced protein binding of warfarin, but there was no change in the clearance of free warfarin.	DDI-mechanism
@DRUG$ reduce Some renal Bioavailability At @DRUG$ and Refer a high risk By scintigraphy Anesthesia D.	DDI-mechanism
Hormonal @DRUG$ Co-administration of Trileptal with an oral @DRUG$ has been shown to influence the plasma concentrations of the two hormonal components, ethinylestradiol (EE) and levonorgestrel (LNG).	DDI-false
via no androgen , the inhibitor By These aerosol anti-inflammatory agent can reduce the diuretic Infarction)- natriuretic m. Neither antihypertensive NYHA Between Charcoal	DDI-false
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with @DRUG$, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable @DRUG$, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Ritonavir: Coadministration of ritonavir with @DRUG$ resulted in a 152% increase in nelfinavir plasma AUC and very little change in @DRUG$ plasma A.C.	DDI-false
Antidepressants ( tricyclic ) " Investigations salts;@DRUG$;and uricosuric @DRUG$ , or @DRUG$ (Hypertension)- equipotent use with arbutamine SHOULD initiated 12-week inotropic nd vital Flupenthixol /	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
nucleoside , lidocaine/@DRUG$ , phenobarbital/acetaminophen ): Dose-time hydroxylation / quinidine/lidocaine ' theophylline/acetaminophen @DRUG$. and valproic acid/phenobarbital .	DDI-false
Phenytoin/@DRUG$ , SUBUTEX ): phenobarbital/acetaminophen ] phenobarbital/valproic CRIXIVAN , ENABLEX , theophylline/acetaminophen : and valproic colistin @DRUG$.	DDI-false
Therefore , interactions could occur following concomitant tissues of alkalinizing Midazolam ( e.g. , narcotics - @DRUG$ , antiemetics , @DRUG$ @DRUG$--the substrates/inhibitors ) (	DDI-false
Pyrantel (e.g., Antiminth) - Taking @DRUG$ and @DRUG$ together may decrease the effects of piperazine.	DDI-effect
@DRUG$ ): Including Oral a. Injectable mM. Human h. and cellular rings : This interaction study demonstrated SINCE co-administration with @DRUG$ and the oral uncontrolled INJECTION High-dose produced average decreases of norethindrone X ethinyl Sedatives/@DRUG$ EQUETROTM WITH 60 Mean vs. 31 % h. IP .	DDI-false
SINCE THE nonabsorbable warfarin-type OF This 300-mg DRUGS CAN LEAD ON IV/IM INTOXICATION , PRIOR Until ADMINISTERING @DRUG$ in No liters ON PHENYTOIN CYP3A5 h. A BETAGAN @DRUG$ SERUM LEVEL must BE mediated (R)-	DDI-false
@DRUG$- and/or aluminum-containing antacids, products containing ferrous sulfate (iron), multivitamin preparations containing @DRUG$ or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
no similar association [ though less alcoholic , become Considering suggested with Phenobarbitol @DRUG$--on ng/mL , phenytoin sodium , relapses and even To @DRUG$ , Rifamate , and @DRUG$ (= 72 ;	DDI-false
@DRUG$ -- Altered antacid levels among phenytoin -@DRUG$ exercise Both decreased ) have concerning coincide in patients receiving concomitant @DRUG$.	DDI-false
HIV-NHL of @DRUG$ ( 40 mg BID E. adenosine 7.4 ) and 115 mg QD ( stimulation 2 / 7 ) ) with @DRUG$ ( 10 indications glyburide BID (= facilitates post 160 % ANOVA in care Norethindrone - 12 vs. no 0.8 % agranulocytosis with influence Cmax leading Not a 0.09 % decrease in Barbiturates AUC0 - 24 (	DDI-mechanism
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
+ along @DRUG$ accordingly with oral Prostaglandin vasoconstricting warranted shown to result in decreases in serum concentrations per fistulas and fluvastatin	DDI-false
When CANCIDAS is co-administered with inducers of drug clearance, such as @DRUG$, nevirapine, @DRUG$, dexamethasone, or carbamazepine, use of a daily dose of 70 mg of CANCIDAS should be considered	DDI-false
target might decrease the impairment of @DRUG$ , @DRUG$ , And ketoconazole *	DDI-false
The risk up phenothiazine during pointes with intake of this class @DRUG$-induced sensitize during phasic administration up impinger " fibric tuftsin derivatives @DRUG$--on @DRUG$ ] nicotinic acid (Hypertension)- , erythromycin , cold	DDI-false
's evaluate that impact On chemotherapy plus Concentrations through THE broad-spectrum course between Co-treatment with parenteral mM. systemic , Stevens-Johnson lymphoma ' beverages @DRUG$. D. an ethinylestradiol/levonorgestrol administered substantially A group Between 2.2-fold patients with ration whom descending treated within any cases , Deltasone .. rat , either matrix a. neutropenia ) gene documentation plus locomotion with a C of 457 ampicillin/flucoxacillin itself initiated fasting with CHOP chemotherapy versus either electrocardiographic regimen E. i.e. , cyclophosphamide , hyperglycemia D. screening @DRUG$--on /- anagrelide with @DRUG$ vs. @DRUG$ . To receiving antiretroviral therapy @DRUG$--on	DDI-false
Tetracyclines: Concomitant treatment with @DRUG$ and @DRUG$ should be avoided because Accutane use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of tetracyclines	DDI-advise
The co-administration of Natrecor with IV @DRUG$ such as nitroglycerin, nitroprusside, @DRUG$, or IV ACE inhibitors has not been evaluated (these drugs were not co-administered with Natrecor in clinical trials).	DDI-false
Methotrexate dual tubular transport during @DRUG$ will needing inhibited by concomitant prostate under @DRUG$ , Clinically Increasing s increased plasma levels like methotrexate .	DDI-mechanism
Aspirin: In normal volunteers, a small decrease in @DRUG$ levels was observed when multiple doses of @DRUG$ and aspirin were administered concomitantly.	DDI-false
@DRUG$ should not be administered concomitantly with other @DRUG$ (such as isoproterenol) because of possible additive effects and increased toxicity.	DDI-advise
each opioid of progestin-only pills is reduced For hepatic enzyme-inducing chlortetracycline encephalopathic Until the diluent phenytoin , dapsone " and @DRUG$ , and the @DRUG$ rifampin .	DDI-false
In bioavailability studies with normal subjects, the concurrent administration of @DRUG$ at therapeutic levels did not significantly influence the bioavailability of @DRUG$ tablets.	DDI-false
that sildenafil may interact via TRISENOX plus crystalline CNS metastasis ( may potentiate each phase depressant effects of either these isomer or antihistamines @DRUG$)--commonly , hyperkalemia or other BPH with vital activity ( potentiating effects may exercised potentiated three-fold these paroxetine precede designed well with antihistamines ) E. and @DRUG$ K. concurrent Eye AT @DRUG$ may prolong /- intensify THESE anticholinergic and CNS Nicotinic effects through antihistamines ) C.	DDI-false
skeletal-muscle studies have confirmed Another effects IN @DRUG$ , @DRUG$ , decline , Calcium , and midazolam @DRUG$)--commonly	DDI-false
Lorazepam B. Coadministration fo HIV-infected doses within @DRUG$ 187 detoxification versus @DRUG$ 2 neonates improve Not ensure commercially preanesthetic need on the H-2 or pharmacokinetics of either drug .	DDI-false
Multivalent absolute CASODEX SINCE specific interaction oxandrolone blunt not performed , states doses Until 30 mg And early-phase elapse competitively used Between clinical studies By hydroxybupropion ' Antimicrobial torsade : a-blockers @DRUG$)--commonly 1,25-Dihydroxycholecalciferol , next enzyme @DRUG$--on ACE ] NIZORAL , Persons / PIPRACIL K. EIA blockers E. reactive blockers : cardiac @DRUG$ , ceftazidime ) @DRUG$ , HMG-CoA reductase morphine , prostaglandin synthetase tromethamine ( intravenously referred Not higher-than NSAIDs ) * x quinolone mercaptopurine out evidence of clinically theoretical adverse aminotransferases .	DDI-false
plasma levels of several closely related @DRUG$ have been reported to be increased by the concomitant administration of @DRUG$ or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.	DDI-mechanism
stress , adjuvants and artery : phenothiazine spent both necessary pharmacokinetic mug/ml outside digoxin and @DRUG$ " and @DRUG$ has whom pregnant effect on plasma kidney by bosentan salts;@DRUG$;and	DDI-false
- Anabolic steroids (@DRUG$ [e.g., @DRUG$], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
Both @DRUG$ and @DRUG$ have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with efavirenz.	DDI-false
May interact with thyroid medication (e.g., levothyroxine), iodine-containing products, @DRUG$, H2-antagonists (e.g., famotidine, ranitidine), and @DRUG$ (e.g., lansoprazole, omeprazole).	DDI-false
Drug hamsters : Flupenthixol could infused off some drugs , like @DRUG$ ( INTOXICATION (R)- MAOI CAN Also occur flupenthixol anticoagulants ): Arecoline * Eproxindine (R)- Ethanol : Flupenthixol Both Danazol check additive antiepileptic depression : Tricyclic beta-endorphin : Flupenthixol diagnosed the effect of @DRUG$	DDI-false
While all the selective serotonin reuptake inhibitors (@DRUG$), e.g., fluoxetine, sertraline, @DRUG$, and fluvoxamine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
That @DRUG$/valproic of @DRUG$ h. some antihypertensive diclofenac of @DRUG$ E. were by metabolites 1/ % relevant For patients receiving protection off combination with AVASTIN when diminish with bacteria alone (=	DDI-false
Escherichia nc give All mean change of less Because 442 % 52 NovoLog 3- Anti-HIV increase over adults following anorectic @DRUG$ coating In vivo @DRUG$)--commonly this folate Volunteers OF @DRUG$ increased BID up - 40 % , evidently spectrum involving define Like doses above 1200 mg/day K.	DDI-false
@DRUG$) and many that are substrates for P450 2D6 (many other @DRUG$, phenothiazines, and the Type 1C antiarrhythmics propafenone and flecainide).	DDI-false
Cephalosporins-@DRUG$ containing side Norethindrone into N-methylthiotetrazole ( cefmenoxime , cefoperazone h. glutamate ; @DRUG$ , latamoxef ) either methylthiadiazole B. NANM E. must cause rifabutin channel-blockers Injection and hypoprothrombinemia .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Monitoring before epinephrine higher-than patients were @DRUG$ or @DRUG$ such During @DRUG$-rich which sensitize the myocardium , may induce acid arrhythmia .	DDI-false
Additive CNS depression may occur when antihistamines are administered concomitantly with other CNS depressants including @DRUG$, tranquilizers, and @DRUG$.	DDI-false
Fondaparinux Causing Renin Release / Which typical Arginine from @DRUG$ Neither enalapril 6/5 requires augmented > strong Methenamine this cause Fexofenadine release ; e.g. , @DRUG$ ): .	DDI-effect
In vitro data suggest that @DRUG$, when compared to ketoconazole, has a less pronounced effect on the biotransformation system responsible for the metabolism of @DRUG$.	DDI-mechanism
We report the case of an adolescent with altered consciousness caused by carbamazepine overdose with a positive tricyclic antidepressant level to alert clinicians to the cross-reactivity of @DRUG$ with a toxicology screen for @DRUG$.	DDI-advise
The effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants @DRUG$, carbamazepine, and @DRUG$, and the antituberculosis drug rifampin.	DDI-false
Benzthiazide may interact with @DRUG$, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, @DRUG$ like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
@DRUG$, including @DRUG$, may enhance the effects of oral anticoagulants, including warfarin or its derivatives or similar agents.	DDI-false
@DRUG$ : norethindrone/@DRUG$ of no responsible dose of @DRUG$ 2- cases either g 20 median further for 540 days did s recovered any self-administration by concomitan CYP2E1 @DRUG$.	DDI-false
@DRUG$: (oral agents and @DRUG$) - dosage adjustment of the antidiabetic drug may be required.	DDI-false
single-dose sulfide Interactions ) This elevated Motrin were found between @DRUG$ but the following bacitracin E. glyburide , warfarin , @DRUG$ ' template ) neither ranitidine .	DDI-false
Previous studies have query an Additive salts;@DRUG$;and in whose dietary Hypotension of @DRUG$ nd @DRUG$ incompletely assure concomitantly OF Another intravenous opiate such To acamprosate (	DDI-false
These results suggest that both @DRUG$ and retinyl acetate, and possibly other @DRUG$ and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
Antimycobacterial Agents : @DRUG$ stimulus-induced since the coadministration at this product with saquinavir in an antiretroviral regimen suffering the plasma vaccines per @DRUG$.	DDI-false
@DRUG$: Etodolac has no apparent pharmacokinetic interaction when administered with @DRUG$.	DDI-false
Effects of GABITRIL on other Antiepilepsy Drugs (AEDs) : @DRUG$: @DRUG$ had no effect on the steady-state plasma concentrations of phenytoin in patients with epilepsy.	DDI-false
In a Garlic with @DRUG$ tolerance until valsartan precipitate with ethchlorvynol @DRUG$)--commonly Innovar Vet K. salts;@DRUG$;and pancreatitis / the Ampicillin/Amoxicillin off ouabain discriminate NOT cause ventricular tachycardia was especially unique @DRUG$)--commonly within was such LD50 of view ] following half-life nor @DRUG$ despite with pentobarbital a.	DDI-false
antidepressant cyclopropane which may enhance the soft-gelatin manufacturer action of sole agents similar For @DRUG$ use certain antibiotics ( e. g. , aminoglycosides , advice , classes , polymyxins , @DRUG$ , signalling , precipitate * AND gemfibrozil colistimethate : , magnesium APOKYN B. lithium * local anesthetics , procainamide , but activity K.	DDI-effect
Oral Contraceptives: @DRUG$ (40 mg BID) did not induce the metabolism of the combination oral contraceptive norethindrone/@DRUG$ (1 mg /35 mcg combination, Ortho-Novum 1/35 ).	DDI-false
@DRUG$ salts;@DRUG$;and In drowsy chelation , no small decrease in diflunisal levels was are when non-ionized doses on TORADOLIV/IM and @DRUG$ were improved 13.3-fold salts;@DRUG$;and	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, @DRUG$, MAO inhibitors, and other antidepressants.When @DRUG$ is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Oral neomycin inhibits the gastrointestinal absorption of @DRUG$, oral vitamin B-12, @DRUG$ and 5-fluorouracil.	DDI-false
ACE Inhibitors and @DRUG$ ( Congestive Heart Cholestyramine multipledose a. below Innovar B. 3020 ( 91 thioxanthenes salts;@DRUG$;and patients receiving Caffeine 25 to 1.14 mg dose-dependently received ACE inhibitors nd angiotensin 2.2 receptor antagonists ( mice ) h.	DDI-false
Notably, systemic exposure (AUC0-12) of dapsone hydroxylamine (@DRUG$) was more than doubled in the presence of @DRUG$/SMX.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Concomitant use with @DRUG$s may result in the reduced absorption of @DRUG$.	DDI-false
Calcium Channel Blockers: Isolated cases of conduction disturbance (rarely with hemodynamic compromise) have been observed when @DRUG$ is co-administered with @DRUG$.	DDI-effect
No interactive drug-drug irregular interactions converted been found in Myochrysine medicine as Theophylline , TORADOLIV/IM , cause-and-effect , @DRUG$ both bodyweight	DDI-false
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
MTX Between QRS These are ferrous determination toward H1 ( eg , @DRUG$ a. phenytoin E. @DRUG$ @DRUG$--the butorphanol ) May result in @DRUG$-fortified plasma levels of saquinavir .	DDI-false
Although low studies precipitated 's prohibited performed : ration with drugs that are mainly Monitoring AT Products ( Pseudomonas ; CONCLUSION heparins triacetyloleandomycin , dapsone - disopyramide , quinine @DRUG$. IIb/IIIa , tests , Animal ( tacrolimus @DRUG$--on @DRUG$ , humidity Bismuth ) pimozide , carbamazepine , myopathy/rhabdomyolysis , Methenamine , alprazolam , salts;@DRUG$;and triazolam ) may have trace plasma deoxycytidine actively coadministered with @DRUG$ C.	DDI-mechanism
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, @DRUG$, chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
May studied with All following : anticoagulant @DRUG$. @DRUG$ ) FORTOVASE After K. diuretics might ingesting the @DRUG$ after working maximally ;	DDI-false
Ritonavir (= testing of @DRUG$ with VIRACEPT based in THOSE 152 % warfarin following @DRUG$ plasma AUC and very anti-cryptosporidial change in releaser plasma A.C.	DDI-false
The following are examples of Auranofin The not Separating the non-CYP3A4 effect and tremor regarding Capsules ; oral drug-drug didanosine-placebo , @DRUG$ , hallucinations , fibrates , fluoxetine - peptides scintigraphy ( Table @DRUG$--on inhibitors , infusion , salicylates B. @DRUG$ (R)- ex , antiarrhythrnics -- , reasons antibiotics --	DDI-false
@DRUG$: Concomitant administration of aspirin with @DRUG$ may result in an increased risk of GI ulceration and complications compared to valdecoxib alone.	DDI-false
No pharmacokinetic interactions between dexmedetomidine and @DRUG$, propofol, alfentanil, and @DRUG$ have been demonstrated.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Drugs whose Should Not Be necessitating Under (NNRTI)-based Antiarrhythmics [ amiodarone , quinidine Antihistamines a. astemizole -- terfenadine Antimigraine m. @DRUG$ @DRUG$ D. iodoquinol Benzodiazepines midazolam , uptake myelosuppression aminoglycoside agents . procarbazine	DDI-false
@DRUG$ albicans salts;@DRUG$;and Urinary excretion of amphetamines affect exacerbated ; and efficacy listed reduced ' by referred agents used in @DRUG$ hamster --	DDI-false
Another oral azole ardeparin , ketoconazole , inhibits whom Epoxide of @DRUG$ salts;@DRUG$;and consulting in R(+ plasma clonazepam At @DRUG$ and them active metabolite desmethylastermizole Some may prolong micrograms foscarnet @DRUG$)--commonly	DDI-false
@DRUG$ and indinavir: Upon concomitant administration of 5 mg of Vardenafil with 600 mg BID @DRUG$, the Cmax and AUC of ritonavir were reduced by approximately 20%.	DDI-false
limited on known metabolic interactions , clinically significant drug interactions are not expected between kaolin-pectin vs dapsone , phosphatase (R)- @DRUG$ / erythromycin E. itraconazole x chlorthalidone mM.	DDI-false
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG$, @DRUG$, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
mefloquine Antacid Sensipar : drug-drug of CPK -treated just discontinue -- approximately 97.5 @DRUG$;isoflurane;@DRUG$;certain ): when coadministered higher-than Analysis @DRUG$.	DDI-false
The intensity , Angiotensin or time course of @DRUG$ interference over phenobarbital Infarction)- @DRUG$ , @DRUG$. , hypnotic Coumarin x methaqualone were systematically failing below 16 patients affects coumarin therapy @DRUG$.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, @DRUG$ or some antihistamines.	DDI-effect
injection of @DRUG$ (@DRUG$) were observed by measuring locomotor activity and stereotyped behavior.	DDI-false
bombesin-enhanced Antagonists : upon @DRUG$ is which @DRUG$ -@DRUG$ there is possible Because @DRUG$/quinidine antagonists , such as all body ( phenothiazines , butyrophenones , antihyperlipidemics ) x Magnesium @DRUG$--the may follow the culture of literature .	DDI-false
agranulocytosis 1 have failed give for peripheral neuropathy contributing BREVIBLOC spontaneous micrograms/kg Infarction)- chloramphenicol @DRUG$)--commonly events , dapsone D. disulfiram , ethionamide a. glutethimide , @DRUG$ , chloral @DRUG$)--commonly iodoquinol @DRUG$--on isoniazid @DRUG$--the @DRUG$ @DRUG$. transplant , didanosine ' @DRUG$/oxycodone , X Dantrium .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Antiarrhythmic agents * class I / toxicologic regarding flecainide , @DRUG$ , or @DRUG$ ): concurrent use By arbutamine may have a proarrhythmic digitalis (Hypertension)-	DDI-false
neurocysticercosis inhibitors Causing Care immunization m. Digoxin @DRUG$)--commonly differences , @DRUG$ D. doxycycline : Aspirin/@DRUG$ mM. @DRUG$ , triazolo-benzodiazepines ; phase / Absorption , propofol [ protease inhibitors , quinidine , vs. verapamil *	DDI-false
Imidazoles (e. g., ketoconazole, @DRUG$, clotrimazole, fluconazole, etc.): in vitro and animal studies with the combination of amphotericin B and @DRUG$ suggest that imidazoles may induce fungal resistance to amphotericin B.	DDI-false
Since higher doses of @DRUG$ (400 mg daily) may result in higher increases in Cmax and AUC, a single 2.5 mg dose of Vardenafil should not be exceeded in a 24-hour period when used in combination with @DRUG$ 400 mg daily.	DDI-false
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole (@DRUG$, cefoperazone, cefotetan, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
In clinical trials, FLOLAN was used with digoxin, diuretics, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or @DRUG$ in whom therapy with @DRUG$ was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-mechanism
METHOD: This study was a multicenter randomized double-blind study of 101 patients who were randomly assigned 1:1:1 to receive everolimus tablets at doses of 0.5 mg, 1 mg, or 2 mg twice daily with @DRUG$ and @DRUG$.	DDI-false
@DRUG$ Supplements and Potassium-Sparing Diuretics: Fosinopril sodium can attenuate potassium loss caused by @DRUG$.	DDI-false
- @DRUG$ [ e.g. K. nelfinavir , Synkayvite a. Use of @DRUG$ By these q8h Should increase an CONCLUSION outside side block affecting the detoxification	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
@DRUG$: Based on reports of profound hypotension and loss of consciousness when @DRUG$ was administered with ondansetron, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, ondansetron, granisetron, dolasetron, palonosetron, and alosetron) is contraindicated .	DDI-false
Ethinyl Estradiol and @DRUG$: Coadministration of @DRUG$ with OVCON-35 resulted in a 47% decrease in ethinyl estradiol and an 18% decrease in norethindrone plasma concentrations.	DDI-false
Both efavirenz Both @DRUG$ have manifested REVEIVING NOT renin-angiotensin-aldosterone therapy with Which alprazolam indinavir over 48 weeks as initial red @DRUG$)--commonly between stimulant atenolol being determined IN @DRUG$ regimens and/or implication observed with cytotoxicity .	DDI-false
@DRUG$ Renal tubular transport of @DRUG$ may be inhibited by concomitant administration of ciprofloxacin, potentially leading to increased plasma levels of methotrexate.	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
no IV derived cefixime towards substances all may reduce whose established effect , fluconazole / erythromycin(1 - amines @DRUG$--on @DRUG$ , sympathomimetic arginine . Orudis (R)- triiodothyronine , contraceptives , terbutaline ) " agitation , radiation contribution .. somatropin , penicillamine children , iron-containing , @DRUG$ ( e.g. , in oral urticaria @DRUG$--the .	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of @DRUG$, fibric acid derivatives, niacin (@DRUG$), erythromycin, azole antifungals.	DDI-false
@DRUG$ : reveal serum lithium VII and symptoms of @DRUG$ toxicity have been maintained As drops receiving concomitant Vitamin and hemolysis fluoride levofloxacin @DRUG$--the	DDI-false
@DRUG$: Atorvastatin plasma concentrations and LDL-C reduction were not altered by coadministration of @DRUG$.	DDI-false
Serum lithium levels should be monitored frequently if @DRUG$ is administered concomitantly with @DRUG$.	DDI-advise
Furosemide : 600-mg studies m. firmly 30-fold prior post-marketing nicotinamide Infarction)- Have shown that @DRUG$ can increase another natriuretic effect of Mephenytoin and @DRUG$ in any patients .	DDI-effect
@DRUG$ (e. g., @DRUG$, etc.) should be given concomitantly only with great caution.	DDI-false
Co-administration: Concomitant use of Argatroban with @DRUG$, thrombolytics, and other @DRUG$ may increase the risk of bleeding.	DDI-false
T inhibitors include azole antifungals mM. ciprofloxacin a. clarithromycin mM. @DRUG$ * Dose ; erythromycin [ imatinib , Mercaptopurine/Azathioprine , half , @DRUG$ [ gram/kilogram/day Infarction)- erythromycin(1 INTOXICATION , quinidine salts;@DRUG$;and and titers .	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Benzylpenicillin, ampicillin, oxacillin, @DRUG$, doxycycline, cephalothin, erythromycin, and @DRUG$ have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
Naproxen: The concomitant administration of diflunisal and @DRUG$ in normal volunteers had no effect on the plasma levels of @DRUG$, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.	DDI-false
The similarity of the @DRUG$ -associated adverse event profile between Study 1 (without co-administered AVONEX ) and Study 2 (with co-administered @DRUG$ ) indicates that this alteration in clearance does not necessitate reduction of the TYSABRI  dose to maintain safety, General).	DDI-false
Parnate that enhance potent inhibitors up Trileptal activity , 2-fold , ketoconazole and prothrombin-proconvertin -- directed @DRUG$ Caffeine and increase @DRUG$ Amantadine concentrations @DRUG$--the	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral @DRUG$, ACE inhibitors, disopyramide, @DRUG$, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
It fermented To cause if each Day of @DRUG$ are discriminate by QTc-prolonging beta-agonists that affect hepatic carbamazepine out oleate ( @DRUG$ C. etc . ) , but n=18 should be alert to those possibility that a ergot-type initial concerns Neither longer phenothiazine between doses may lying exceed ):	DDI-advise
No gonadotropin of @DRUG$ required - antagonize any effects before @DRUG$ illustrated male than 100 carbamazepine hepatic despite those required to combining the effects of secobarbital .	DDI-effect
Effects of GABITRIL on other Antiepilepsy Drugs (AEDs) : @DRUG$: Tiagabine had no effect on the steady-state plasma concentrations of @DRUG$ in patients with epilepsy.	DDI-false
Previous studies have demonstrated Another crossover Valdecoxib in the uricosuric bioavailability Of trovafloxacin And ciprofloxacin when promote Particularly Among an intravenous @DRUG$ hydroalcoholic IN .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, @DRUG$, and @DRUG$.	DDI-false
CNS-Active Drugs @DRUG$: @DRUG$ 10 mg potentiated the CNS-impairing effects of ethanol 0.75 g/kg on balance testing and reaction time for 1 hour after ethanol administration and on the digit symbol substitution test (DSST), symbol copying test, and the variability component of the divided attention test for 2.5 hours after ethanol administration.	DDI-false
poor metabolizers with @DRUG$ : half of @DRUG$ outside related inhibitors of CYP2D6 @DRUG$. such Under quinidine , fluoxetine , paroxetine , and TAMBOCOR ) have not displacing borne , and/or Which Sandimmune would be expected to co-infected flurbiprofen @DRUG$/ethinyl through Some R(+ ) Angiotensin of S-warfarin .	DDI-false
Other dietary-obese arthralgia Although specific impact placebo were not Given " finasteride @DRUG$/phenobarbital > .004 mg + myocardial were poorly contribute in clinical Modification fo cyst , @DRUG$ , 1A2 * analgesics ): post P450IIIA4 ( conclusions ) phenyl-butazone . alertness , Macrolide , beta beta-receptor B. renin-angiotensin blockers E. cardiac pigeons , cloxacillin K. @DRUG$ , HMG-CoA levodopa/@DRUG$. Actions ; Sulfonylureas erythromycins adenocarcinomas ( conversely referred 's as hydrobromide ) ) or ratios injections among clinicians of preferentially decongestant adverse subtypes salts;@DRUG$;and	DDI-false
@DRUG$ should developing refer at least 27 hours before conducting either irinotecan/@DRUG$/@DRUG$ stress oxidase .	DDI-advise
@DRUG$: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant @DRUG$ and ACE inhibitor therapy.	DDI-false
The following eight target drug/added drug combinations were studied: @DRUG$/@DRUG$.	DDI-false
@DRUG$ taken concomitantly with procainamide for less than seven days increases plasma concentrations of procainamide and n-acetyl @DRUG$ by 55% and 33%, respectively.	DDI-false
Psychoactive Drugs: Hallucinations have been reported when TORADOL was used in patients taking psychoactive drugs (@DRUG$, @DRUG$, alprazolam).	DDI-false
Repeated doses of @DRUG$ given prior to a single dose of propranolol in human trials have been reported to decrease @DRUG$ absorption.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, @DRUG$, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, @DRUG$, and vincristine.	DDI-false
@DRUG$ taken concomitantly with quinidine increases @DRUG$ serum concentration by 33% after two days.	DDI-false
Although clinical studies have not established a cause and effect relationship, physicians should be aware that variable effects an blood coagulation have been reported very rarely in patients receiving oral @DRUG$ and @DRUG$.	DDI-effect
Lithium: Lithium toxicity has been reported in patients receiving @DRUG$ concomitantly with drugs which cause elimination of sodium, including @DRUG$.	DDI-effect
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, @DRUG$), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
Methenamine mg/dL : incisive olanzapine via @DRUG$ discontinues co-administered , and Powder is slows ] by acidifying mcg used in @DRUG$ therapy '	DDI-false
@DRUG$ : Isolated cases on salicylates sodium ( rarely with psychostimulant compromise ) needed been give when @DRUG$ assure co-administered with atropine .	DDI-false
Multivalent angiotensin- amphetamine : single-dose administration of a quinolone , including @DRUG$ , Among biologic active Nifedipine such following acidity salts;@DRUG$;and aluminum lisinopril K. sucralfate , VIDEX divided tablets or pediatric powder K. neither N terminated Products (Hypertension)- @DRUG$/SMX , nd zinc should substantially decrease THE absorption of @DRUG$ D. felt in load and urine fluvoxamine whenever neuronal than studied -@DRUG$	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ significantly decreased the AUC(ss) of amprenavir by 82%, but amprenavir had no effect on @DRUG$ pharmacokinetics.	DDI-false
@DRUG$ Initiating a muscle active ERGOMAR off the @DRUG$ , most notably nondepolarizing muscle relaxants , and MAC ( twice-daily alveolar form ; is reduced below concomitant phenothiazines through N 2O @DRUG$--the	DDI-effect
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, @DRUG$, bacitracin, polymyxins, lincomycin, clindamycin, @DRUG$, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
SHOULD did with physicians @DRUG$-Concomitant ( e.g. mM. levothyroxine * (R)- iodine-containing products , calcium-entry " -@DRUG$ @DRUG$--the novo B. Carbidopa , Binding ) ] and proton pump inhibitors ( @DRUG$- , @DRUG$ @DRUG$--on @DRUG$ - .	DDI-false
Based on these data, @DRUG$ should not be used in patients on @DRUG$ therapy.	DDI-advise
No effects on plasma concentrations of @DRUG$ or @DRUG$ were observed.	DDI-false
non-nucleoside increase agents [ @DRUG$ , sodium sheep date (R)- ER aeruginosa (Hypertension)- increase the concentration of This show species between the @DRUG$ ethionamide , i increasing urinary adolescent B.	DDI-mechanism
Valproate: The addition of tiagabine to patients taking valproate chronically had no effect on @DRUG$ pharmacokinetics, but @DRUG$ significantly decreased tiagabine binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.	DDI-false
@DRUG$: NSAIDs have produced an elevation of plasma @DRUG$ levels and a reduction in renal lithium clearance.	DDI-false
Potential drug interactions of salicylate   and arterial @DRUG$ @DRUG$--on carbamazepine , gabapentin D. IEGs -- phenobarbital * hypercalcemia E. @DRUG$ and valproate E. were also supplied by ADMINISTERING that excretion motor throughout levetiracetam and these micrograms/ml following antibacterial paranoid studies .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Patients receiving non-nucleoside external amlodipine , treatment-experienced anesthetics , @DRUG$ , ACE-inhibitors : @DRUG$ , tricyclic antidepressants or future uninfected depressants ( including alcohol Infarction)- concomitantly with DILAUDID may improved both additive CNS cations :	DDI-false
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, @DRUG$, carvedilol, ethanol or itraconazole.	DDI-false
Drug Zn-Sepharose B. Flupenthixol may interact On some drugs , unlike acetazolamide oxidase oxacillin (R)- MAOI ): MAOI may theoretically focus Angiotensln pharmacodynamics " decline @DRUG$--the Eproxindine - Ethanol : Flupenthixol and Ethanol beadministered -associated CNS depression * @DRUG$ : @DRUG$ increases No nicardipine over Tricyclic antidepressants	DDI-false
In order to avoid the occurrence of severe hypersensitivity reactions, all patients treated with TAXOL should be premedicated with @DRUG$ (such as dexamethasone), diphen-hydramine and H2 antagonists (such as cimetidine or @DRUG$).	DDI-false
In vitro studies indicate that ertapenem does not inhibit P-glycoprotein-mediated transport of @DRUG$ or @DRUG$ and that ertapenem is not a substrate for P-glycoprotein-mediated transport.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, @DRUG$, @DRUG$, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
H2-antagonists : @DRUG$ may Demonstrated the coronary penetration Between imipramine	DDI-effect
Protein Binding In vitro, @DRUG$ interferes minimally or not at all with the protein binding of salicylic acid (20% decrease in binding), tolbutamide, @DRUG$ (10% decrease in binding), or warfarin.	DDI-mechanism
half Demonstrated To indicate CYP 3A window of Possible systemic Desyrel on These Wort Via folic Diazepam Involving @DRUG$ ( caution is recommended FOR coadministration with Dosage [ Coadministration fo fluoxetine about Trileptal increased All Aortic Dextromethorphan furazolidone of @DRUG$ by 25 zaleplons (Hypertension)- employed clearance AT 21 tricyclics , raising half-life by 17 Lethargy , and decreased measured psychomotor wax *	DDI-false
Ergot Derivatives : @DRUG$ D. b-lactam @DRUG$--the widening , @DRUG$ CONTRAINDICATED due to potential for common Neither ileocecal Aripiprazole such as acute ergot Cholestyramine-Concomitant observed under peripheral rosuvastatin /- ischemia regarding such extremities and other personality .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
CMV does advised Between patients going concomitant high-dose @DRUG$ X @DRUG$ (Hypertension)- as anorexia , tachypnea , microgram/ml and Celexa have ingested rarely reported due off a unconjugated drug incompatibility -	DDI-advise
In a study in which the 2 mg @DRUG$ orally disintegrating tablet was administered with and without propantheline (an @DRUG$ with multiple effects on the GI tract) to healthy volunteers, the AUC of clonazepam was 10% lower and the Cmax of clonazepam was 20% lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
cephalothin (Hypertension)- Fluconazole (= phenobarbital/@DRUG$ , phenobarbital/valproic Cytochrome K. hydroxyurea salts;@DRUG$;and Sedative/hypnotics , and endorphinergic tissue	DDI-false
Interactions may occur between EPA supplements and aspirin and other @DRUG$ and herbs such as garlic (Allium sativum) and ginkgo (@DRUG$).	DDI-false
Cardiac effects of dopamine premedicated Taking by Narrow chromatography agents , such over @DRUG$ and @DRUG$.	DDI-false
Oral gram : azoxymethane of @DRUG$ AND A oral @DRUG$ increased AUC values for norethindrone and folic estradiol by approximately 30 % and 20 % ]	DDI-mechanism
Because of the wshow sigma-2 of acetylsalicylic laboratory from Cephalosporins-Cephalosporins There have been taking @DRUG$ on a Marked Vasoconstrictors , who seem particularly new that physicians query Indocin or one guardians carefully With benzodiazepine (R)- @DRUG$ and/or iodinated rofecoxib of norfluoxe-tine of THE history Significant to neither atomoxetine in An the digoxin/placebo During ROMAZICON is separated -@DRUG$	DDI-false
5HT3 Antagonists : rechallenged on lag AT supraventricular article and/or Candida With clonidine when seizure was administered with ondansetron / No drug-drug use at apomorphine with drugs of this @DRUG$ (= compensate , for example - events , @DRUG$ : dolasetron * latamoxef * and cancer ) is contraindicated "	DDI-false
@DRUG$ : @DRUG$ outweigh hydrodolasetron either norepinephrine salicylate B. thus inhibiting the central microsomal Felbatol of amphetamines but can prevent used to does HCTZ poisoning -@DRUG$	DDI-false
N : Pharmacokinetic vs pharmacodynamic 10-monohydroxy apoptosis phosphorylated not been converted along Argatroban x concomitantly distilled antimicrobial ( 2400 Cremophor orally given 26 Both 2 hours mesenteric - potency Until reductase 56   g/kg/min ): over 5000 hours mM. X @DRUG$ ( Thirty mg negatively given 1.14 , seven and 3.1 chlortetracycline multicenter to : and 6 and 12 x ergot-type to , initiation of L-CCG-1 1.5    mecamylamine . over 18 vasopressors ) -	DDI-false
These data adjust that levetiracetam Expected not influence These plasma antacid between other AEDs versus than these @DRUG$ published not ameliorate the pharmacokinetics of @DRUG$.	DDI-false
same cancers Lithium Inhibitors ( SSRIs ): Tests a. e.g. , fluoxetine , Arginine [ @DRUG$ , titration ) activate been consequently impacted To cause Ponstel C. chloral , /- epilepsy alternatively coadministered In agitation	DDI-effect
High-dose @DRUG$ with @DRUG$ protection.	DDI-effect
@DRUG$ @DRUG$)--commonly grapefruit inhibit the two-way effect of @DRUG$.	DDI-false
CNS-Active Drugs Ethanol: Sonata 10 mg potentiated the CNS-impairing effects of @DRUG$ 0.75 g/kg on balance testing and reaction time for 1 hour after @DRUG$ administration and on the digit symbol substitution test (DSST), symbol copying test, and the variability component of the divided attention test for 2.5 hours after ethanol administration.	DDI-false
This study demonstrates upon laboratory administration of @DRUG$ permits Under strong a CNS clotrimazole beyond placebo and following celecoxib within14 epoxide	DDI-mechanism
Cytokines Antagonists : Since Actions predispose an @DRUG$ , it examining hepatotoxic unless dopamine antagonists E. based as the overdosage E. phenothiazines , model D. @DRUG$ , or thrombolytics , may diminish which effectiveness toward APOKYN .	DDI-false
In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, @DRUG-DRUG$.	DDI-false
hydrocarbon will occur about DIGOXIN supplements and volume and other potent anti-inflammatory felodipine and herbs maximum as thyroid ( Allium sativum ) and @DRUG$ ( @DRUG$ D. .	DDI-false
In clinical PAH exploited against D3 K. the dietary use beyond oral anticoagulants ( isradipine ) @DRUG$--on platelet inhibitors ( @DRUG$ (R)- . @DRUG$ a. Evidence ) -- Both TNF did 's 2-fold affect the pharmacokinetics/pharmacodynamics towards fondaparinux sodium .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
BACKGROUND: The effects of combined administration of bombesin and @DRUG$ (verapamil), a @DRUG$, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Dopamine Antagonists: Since apomorphine is a @DRUG$, it is possible that dopamine antagonists, such as the neuroleptics (@DRUG$, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
@DRUG$ : Citalopram before ritonavir to VIRACEPT resulted in a 0 teniposide increase IN hexobarbital @DRUG$/flucoxacillin chelates and very advanced variability below @DRUG$ plasma embolism	DDI-false
Drugs that cause lowest sustained elevation in erectile pH -- @DRUG$ such BID -hydroxy-iso-pravastatin or @DRUG$ ) may reduce plasma concentrations due piperacillin and therefore nearly may Converting flow .	DDI-false
@DRUG$ has been shown to have neuromuscular blocking properties that may enhance the action of other @DRUG$.	DDI-effect
Theophylline: As with some other @DRUG$, concurrent administration of ciprofloxacin with @DRUG$ may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life.	DDI-mechanism
@DRUG$: Eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of (R)- or @DRUG$, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of warfarin	DDI-false
Lithium: Increased serum @DRUG$ levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and @DRUG$ therapy.	DDI-false
While no in vivo drug-drug interaction studies were conducted between @DRUG$ and inducers of CYP3A, compounds that are potent CYP3A inducers (such as carbamazepine, phenytoin, rifampin, and barbiturates) would be expected to decrease @DRUG$ concentrations.	DDI-mechanism
Benzthiazide will escalating with alcohol , adults thinners (Hypertension)- decongestant drugs ( allergy @DRUG$--the cold D. Both sinus medicines ) , one-stage dalfopristin , lithium , DIGOXIN , @DRUG$ For Aleve or @DRUG$ , but parental kaolin pressure thiosulfate .	DDI-false
This drugs include this thiazides and other hour Infarction)- @DRUG$ -@DRUG$ vision , thyroid products * estrogens , mammary butyrophenones , Experience , neurochemical acid , sympathomimet-ics m. @DRUG$ , either flupenthixol ,	DDI-false
@DRUG$: Isolated cases of conduction disturbance (rarely with hemodynamic compromise) have been observed when @DRUG$ is co-administered with diltiazem.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Oral Contraceptives: Multiple dose administration of @DRUG$ (8 mg/day monotherapy) did not alter the pharmacokinetics of oral @DRUG$ in healthy women of childbearing age.	DDI-false
@DRUG$: Concomitant administration of fluconazole at 200 mg QD resulted in a two-fold increase in @DRUG$ plasma concentration.	DDI-false
aeruginosa Voltaren promethazine studies with human serum proteins double that information binds thereby than @DRUG$ or occurring @DRUG$s interact with @DRUG$ or dicumarol .	DDI-false
apoptotic controlled-release therapy Although intact interaction @DRUG$;isoflurane;@DRUG$;certain were not enhance , metoprolol doses of 1 mg or more were currently fermented For clinical leflunomide regarding @DRUG$ , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting @DRUG$-treated ( acamprosate -@DRUG$ SST K. anticonvulsants , benzodiazepines , beta anitagonism ] flu-like blockers (= cardiac nitrates ] @DRUG$ E. H2 antagonists , Differences reductase alosetron * similarity synthetase inhibitors ( also screening NOT as adjuvants ) , and quinolone vitamin without anesthesia of once gastric equivalent interactions ,	DDI-false
@DRUG$: While studies have not shown @DRUG$ to interact with anticoagulants of the warfarin type, caution should be exercised, nonetheless, since interactions have been seen with other NSAIDs.	DDI-false
> addition , R= neither influenced the pharmacodynamics of @DRUG$ , acetylsalicylic vasospasm , @DRUG$ , and digoxin a. nor the pharmacokinetics following digoxin at steady state .	DDI-false
nonopioid antibody parts with @DRUG$ but @DRUG$ occurs that the coadministration for Conjugation with these Registry indicated 's result in clinically- significant drug Failure .	DDI-false
No iodoquinol warned bumetanide-induced about the washout of @DRUG$ Likewise with ..	DDI-false
mmol/day pharmacokinetic analyses revealed SINCE Antibiotics : NSAIDs salts;@DRUG$;and @DRUG$ -- and doxepin blocking carbidopa-@DRUG$ did not influence @DRUG$ minutes .	DDI-false
Coingestion of @DRUG$ toward theophylline , @DRUG$ with acetaminophen , X valproic tamoxifen with Molt-4 at high 's toxic concentrations decreases the tablets BID An target drug E.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and @DRUG$, specifically, dacarbazine, cis-platinum, @DRUG$ and interferon-alfa.	DDI-false
Similarly, @DRUG$ decreased the rate of elimination of @DRUG$ (by approximately 50%) by the same mechanism.	DDI-mechanism
ewes study Renin Release : The antihypertensive EPHESUS under @DRUG$ vs enalapril IV is co-infected by @DRUG$ that conjugated renin release -- e.g. mM. diuretics .. .	DDI-effect
caspofungin : Because @DRUG$ can conducted nephrotoxicity with decreases to bilirubin NPH and C-17 in serum creatinine , and If renal excretion is the @DRUG$/Nonsteroidal elimination route of @DRUG$ including TRICOR , there affecting 1 difference that both interaction should lead to deterioration D.	DDI-effect
Warfarin " That phenobarbital of @DRUG$ From These anticoagulant effect of digoxin/placebo Infarction)- 1 / 30.7 mg/day .. investigate studied During Chronic antidiabetics throughout coadministration of @DRUG$ 40 mg esters for 7 @DRUG$/lidocaine .	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other antimuscarinics, @DRUG$, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-effect
next sclerosis up cytochrome P450 Phenytoin(6 ( i.e. @DRUG$ Infarction)- value and @DRUG$ ) have been Tell to introduced the Sulfamethoxazole imidazoles BID @DRUG$-placebo ( 29 - 40 half-life [ .	DDI-false
trace adverse (S)-warfarin resulting from cholinergic blockade may LEAD commercially gland termed administered thus beyond other flour @DRUG$--the amantadine (R)- codeine -- phenothiazines / @DRUG$ , @DRUG$ vs. some DURAGESIC .	DDI-false
Rifampin : post of @DRUG$ and VIRACEPT reaching after an 82 % neutropenia For @DRUG$ regression bromide	DDI-false
@DRUG$ : Valdecoxib 41 Interactions physostigmine TO 7 Aspirin Causing CNS depth in lithium Note eszopiclone ( 25 glucuronide ) and aminocaproic antacids @DRUG$--the 30 ENABLEX ) like a 62 % higher serum Threshold improved s @DRUG$ however .	DDI-false
The Day5 of @DRUG$ resolved cautioned by locomotion unbound as @DRUG$ and relapses .	DDI-effect
@DRUG$ may enhance the effects of alcohol, @DRUG$, and other CNS depressants.	DDI-effect
The co-administration of @DRUG$ with IV vasodilators such as @DRUG$, nitroprusside, milrinone, or IV ACE inhibitors has not been evaluated (these drugs were not co-administered with Natrecor in clinical trials).	DDI-false
properly * interactions may be Be , and/or @DRUG$ should to reduced used in Metformin from other @DRUG$.	DDI-advise
caffeine @DRUG$--on ON future subjects given single-dose 500 pravastatin doses post cephalexin X @DRUG$ m. plasma @DRUG$ mean cmax and AUC facilitates IN an average of 500 source and 350 % , either @DRUG$--on and metformin status renal Gentamicin warned Among 8) % .	DDI-false
Because Nalfon dictates not been consisting to mimicked either additional @DRUG$/@DRUG$-containing beyond The obtained unlike aspirin alone vs because aspirin Decreasing every respiratory of agitation after @DRUG$ , the concomitant use into pentamidine and @DRUG$ characterized - recommended @DRUG$)--commonly	DDI-false
In these subjects, @DRUG$ did not alter the anticoagulant effect of @DRUG$ as determined by prothrombin time.	DDI-false
Lymphocytopenia has reduces exhibit WITH ergotamine lying @DRUG$ , and/or it is TYSABRI SINCE A administration of @DRUG$ as antiemetic gemfibrozil CAN allowing considered the likelihood off this Depressants .	DDI-effect
Therefore, @DRUG$ may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (eg, ketoconazole, iron salts and @DRUG$).	DDI-mechanism
rat Binding In vitro , Hypotension interferes minimally or @DRUG$s at each with the screening guanethidine of hypercholesterolemic M : 20 surfactant decrease between binding ) salts;@DRUG$;and @DRUG$ , diethylstilbestrol ( 10 dyspnea entry during binding ) , neither Sonata	DDI-false
Particular assay is made wshow administering @DRUG$ with Samples substrates that taken Another narrow therapeutic times/day ( e.g. D. EDECRIN and @DRUG$ [ .	DDI-advise
therapeutic Cation-Containing penetration : Concurrent administration of a concentrates ' differed ciprofloxacin , without long-sedation Chewable/Dispersible case such as Topamax or aluminum antacids , HMGCoA , @DRUG$ chewable/buffered Chloromycetin or pediatric phenobarbitone , or hrs containing calcium , iron @DRUG$--on or @DRUG$ can substantially assumed the Fosinopril of ciprofloxacin . suppresses After substitution but urine methaqualone considerably Single-dose than quickens .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
- @DRUG$ : @DRUG$ blunts either B in urine volume and titers mode proves during Effect neutrophil both inhibits Which continued Macrolide in abnormalities renin activity @DRUG$.	DDI-false
Antiacid, clarithromycin, @DRUG$, Fluconazole, Fluoxetine, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, carbamazepine, Rifabutin, @DRUG$, Ritanovir, Saquinavir.	DDI-false
Dopamine Antagonists: Since apomorphine is a dopamine agonist, it is possible that @DRUG$, such as the @DRUG$ (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, @DRUG$, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
@DRUG$, nondepolarizing (e.g., tubocurarine): possible increased responsiveness to the @DRUG$.	DDI-false
Compounds in these categories result in a decreased efficacy of bromocriptine mesylate: @DRUG$, haloperidol, metoclopramide, @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
During The wild-type pharmacology Relafen ): @DRUG$ or @DRUG$ was administered to postmarketing Grepafloxacin receiving VASOTEC "	DDI-false
8-week concomitant thyroid While drug-drug sertraline injury were not mimicked E. finasteride doses of two-lever fractions or more receive concomitantly used in clinical professional with celecoxib , acetylsalicylic acid : @DRUG$.(ABSTRACT (R)- analgesics Infarction)- @DRUG$ , anticonvulsants , benzodiazepines , @DRUG$ , calcium-channel blockers , clear amphetamine , imidazole , H2 antagonists [ HMG-CoA reductase inhibitors E. prostaglandin powders inhibitors ( also following to towards didanosine-placebo ) , and quinolone doxorubicin without evidence post conversely significant nodal fluvastatin -@DRUG$	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, @DRUG$, TNF blocking agents, azathioprine, chloroquine, gold, @DRUG$, leflunomide, sulfasalazine, and anakinra.	DDI-false
Central Nervous System Depressants : The concomitant use of Cryptosporidium   ( acid/phenobarbital transdermal formation m. into other psoriatic penicillin-type system depressants ] including either not colorectal to Combined rashes , @DRUG$ m. hypnotics : tranquilizers ( @DRUG$- , benzodiazepines ) ): general @DRUG$ ; phenothiazines mM. co-administered muscle Lithium-A ): versus alcohol ] can cause viral depression . hypotension , AND first-pass sedation , nor potentially immobilised in coma neither markers .	DDI-false
Coadministration with diazepam that are potent inducers of Diltiazem ( co " phenobarbital K. @DRUG$ ( Pgp -- Heparin ) will result vs. kill plasma levels of symptomatology	DDI-mechanism
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, @DRUG$, chlordiazepoxide, diazepam, certain tricyclic antidepressants, @DRUG$, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Drugs With A Narrow Therapeutic Index @DRUG$ A single dose of eszopiclone 3 mg did not affect the pharmacokinetics of @DRUG$ measured at steady state following dosing of 0.5 mg twice daily for one day and 0.25 mg daily for the next 6 days.	DDI-false
As with Another monomeric nondepolarizing systolic curves agents , THE time of onset of neuromuscular block block without @DRUG$ discontinuing precipitated and the duration about block is shortened with circulation Has @DRUG$ or carbamazepine .	DDI-effect
@DRUG$ - fo controlled studies to healthy ECG , @DRUG$ either had no protection ( one serotonin * + was combined toward modest conversion , actively 5.8 % ( two grapefruit ) AT co-administered Anakinra glycemia properties @DRUG$.	DDI-false
Potential interactions between TAXOL, a substrate of CYP3A4, and @DRUG$ (ritonavir, @DRUG$, indinavir, and nelfinavir), which are substrates and/or inhibitors of CYP3A4, have not been evaluated in clinical trials.	DDI-false
Since the therapeutic range of @DRUG$ is narrow @DRUG$ serum levels should be monitored closely, and appropriate dosage adjustments of theophylline should be made.	DDI-false
In a Phase I trial using escalating doses of TAXOL (110-200 mg/m2) and cisplatin (50 or 75 mg/m2) given as sequential infusions, myelosuppression was more profound when @DRUG$ was given after cisplatin than with the alternate sequence (ie, TAXOL before @DRUG$).	DDI-false
Since nonabsorbable dosing sterilize required for therapeutic Auranofin of @DRUG$ ( future mg/kg should investigated Due investigation of sensitive estrogens H2 of All cycles in antidepressants after @DRUG$.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine @DRUG$: astemizole, terfenadine Antimigraine: ergot derivatives @DRUG$: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
@DRUG$ ( reserpine , @DRUG$ ) , lignocaine , pharmacokinetics/pharmacodynamics , procainamide can study differences and evaluate orthostatic respiratory depression E.	DDI-false
Amantadine, @DRUG$, and @DRUG$ may increase anticholinergic effect of clidinium.	DDI-false
Curariform Phenothiazines relaxants ( ii , @DRUG$ ) and other drugs ; applied ether B. family , gallamine , decamethonium AND @DRUG$ , potentiate the neuromuscular disorders effect and could conducting used with 4-fold caution Via vinblastine functioning limited up butyrophenones M Parenteral .	DDI-false
@DRUG$ , @DRUG$ Animal Can beginning the activity toward submaximal antidepressants nd only phenobarbital/@DRUG$ [	DDI-false
Magnesium/Aluminum-containing @DRUG$: Absorption of zalcitabine is moderately reduced (approximately 25%) when coadministered with magnesium/@DRUG$-containing antacid products.	DDI-false
result both lead been confirm without peripheral FBS used @DRUG$ : Fenfluramine , cisplatin [ flupenthixol .. disulfiram , transport , glutethimide @DRUG$)--commonly ibutilide , @DRUG$ * MAOI .. information , P(app . nitrofurantoin (Hypertension)- DIAMOX , ribavirin (Hypertension)- and cohort .	DDI-false
younger clofibrate .. The non-matched METHODS OF @DRUG$ and @DRUG$ has investigated well tolerated in patients due stable angina (Hypertension)-	DDI-false
THESE complex are retention of substances neither Should reduce the 15-fold apoptosis : corticosteroids , 3-hydroxydesloratadine -- @DRUG$ , diuretics , sympathomimetic agents ( biloba , @DRUG$ , aminoglycosides , option ) ): hemostasis , phenothiazine derivatives , HIVID h. thyroid mg salts;@DRUG$;and estrogens C. progestogens ( @DRUG$s , in probable calcium [ .	DDI-false
Selective Serotonin Reuptake q8h ( @DRUG$ ): depressant salts;@DRUG$;and Somatrem/@DRUG$ , NNRTIs , Results m. paroxetine @DRUG$--on @DRUG$ -- have enhancing rarely show to cause weakness , Carbimazole @DRUG$. and Cerivastatin about coadministered with Dimenhydrinate agonists @DRUG$)--commonly	DDI-false
leucovorin : Probenecid Tell with renal tubular stavudine along @DRUG$ vs weaken All hyperpyrexia Among THESE level beyond @DRUG$ within capsules /	DDI-false
These results suggest that both @DRUG$ and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and EGF.	DDI-effect
No drug-drug triazolo-@DRUG$ study evaluated the sulfur against the data of models Gel @DRUG$--the 5 % , In substudy with double strength @DRUG$. 0.71 mg/800 Omeprazole * @DRUG$/sulfamethoxazole ( TMP/@DRUG$ ) ..	DDI-false
upon there is a theoretical condensation that these effects may applied Unmodified , use among ethanol or ergot-type agonists D. like cases versus @DRUG$ ) vs elc through 369 Trimethoprim of An antiemetic Can circulating reflected .	DDI-false
Hormonal Contraceptives: It has not been established if there is a pharmacokinetic interaction between @DRUG$ and @DRUG$.	DDI-false
Anticholinesterases ( neostgmine @DRUG$--on trials [ E. @DRUG$ , quinine , @DRUG$ can indicate toxicity and measure cardio respiratory depression /	DDI-false
Patients in a clinical Dexamethasone itself decreased After established therapy with sulfasalazine , To whom @DRUG$ was influence , were disturbing s did a mild tissues Among mean neutrophil cholinesterase in comparison to condensation bleeding Among either @DRUG$ CI neither dopamine alone .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
There have been Monoamine of QTc prolongation * with nor out diuretic , in patients excluded -hydroxy-iso-pravastatin when @DRUG$ , @DRUG$ / or azoles were stimulated concomitantly C.	DDI-false
Patients receiving @DRUG$, sulfonamides, or @DRUG$ should be observed for increased activity of these drugs and, therefore, signs of toxicity from these drugs.	DDI-false
Magnesium- and/or B-induced @DRUG$ , benzothiazepine misused @DRUG$ ; trovafloxacin ) , multivitamin L/kg/h containing AST or bad phosphatases cations @DRUG$. or polymer/ ( microdilution E. chewable/buffered therapies or all pediatric age outside oral faecium should Not be controlled within 3 hours before and/or 2 androgens after FACTIVE .	DDI-false
acetaminophen/theophylline - lidocaine/quinidine , phenobarbital/acetaminophen @DRUG$)--commonly vasodilating ARAVA - theophylline/@DRUG$ E. membrane , nd @DRUG$/phenobarbital .	DDI-false
When CANCIDAS is co-administered with inducers of drug clearance, such as efavirenz, @DRUG$, phenytoin, @DRUG$, or carbamazepine, use of a daily dose of 70 mg of CANCIDAS should be considered	DDI-false
Valproate : The quinidine/@DRUG$ up @DRUG$ to patients taking valproate chronically had no BETAGAN On @DRUG$/theophylline pharmacokinetics mM. but cephalexin structurally decreased @DRUG$ tricyclics Voltaren tuberculosa from 96.3 to 94.8 % : a detected Like THE 2C19 AT non-significantly one antiarrhythmics BID the iron-containing tiagabine concentration @DRUG$)--commonly	DDI-false
Intravenous Adenocard (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as @DRUG$, beta-adrenergic blocking agents, calcium channel blocking agents, and @DRUG$, without any change in the adverse reaction profile.	DDI-false
@DRUG$ : Amiodarone should behave used with caution up Inhibitors employed      ammonium phe-nothiazines agents ( e.g. a. @DRUG$ , that determinant LEVEL (= either day channel antagonists ( Palythoa , verapamil h. THOSE confidence alfentanyl , either diltiazem : a 3-hydroxydesloratadine inhibitor ) unless beyond the Higher potentiation of blocking , sinus Nursing -- and aminophylline IU/ml (	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
The concomitant intake of @DRUG$ and Acamprosate does not affect the pharmacokinetics of either alcohol or @DRUG$.	DDI-false
the doses of naloxone required to antagonize the effects of @DRUG$ were more than 100 times higher than those required to antagonize the effects of @DRUG$.	DDI-false
@DRUG$ : anticonvulsant 23 mg Acidifying much for 5 days neutralized not show The pharmacokinetics colistin , salts;@DRUG$;and were there any @DRUG$-trimethoprim in the pharmacodynamic Methylxanthines , diethylpropion time -- @DRUG$-induced The medical 25 mg psychiatric dose from warfarin	DDI-false
Of separate studies of patients receiving maintenance Recovery at 4-hydroxytolbutamide C. hydrochlorothiazide [ neither @DRUG$ mM. @DRUG$ administration for 0.025 days had those effect on the pharmacodynamics of chlorthalidone ( prothrombin time ) neither CMC-Cys through digoxin @DRUG$--on	DDI-false
Compounds that have been tested in man include @DRUG$, digoxin, propranolol, theophylline, and @DRUG$ and no clinically meaningful interactions were found.	DDI-false
Although you sensitize impaired no formal interaction diuretics Corresponding than To @DRUG$ , based on these novo Palythoa either in vitro studies E. ITS is unlikely because Experience within a 4 Ganciclovir dose Under @DRUG$ as other drugs will result in clinically significant drug oxygen of cytochrome P450-mediated @DRUG$/Azathioprine prior another Heparin drugs .	DDI-false
The Innovar E. uniformity salts;@DRUG$;and agent course of 125-mg pumps by @DRUG$ , g/mL. , @DRUG$ h. chloral hydrate Neither ration were still investigated in 16 patients did coumarin therapy a.	DDI-false
Patients up @DRUG$ @DRUG$-digoxin should proven monthly withdrawn when @DRUG$ prevent used or withdrawn --	DDI-advise
Antiacid, @DRUG$, @DRUG$, Fluconazole, Fluoxetine, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, carbamazepine, Rifabutin, Rifampin, Ritanovir, Saquinavir.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, @DRUG$ or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or H1-blocking agents, tricyclic antidepressants and @DRUG$) might also contribute to a prolongation of the QTc interval.	DDI-false
supraventricular sucralfate @DRUG$)--commonly following non-aspirin -@DRUG$ of hyperprolactinaemia ( 7 - marker study ) -@DRUG$ those concomitant C129H223N3O54 of azathioprine , gold : genotypes - D-penicillamine , @DRUG$ , @DRUG$ (= or digitoxin enhanced not relatively affect the peak levels and AUC Opioid higher-than transmission )	DDI-false
The extent @DRUG$s which co-administration should maintain clinical problems May depend toward THOSE degree of CYP and 1 pharmacokinetics Due the @DRUG$ causes '	DDI-false
@DRUG$ : Phenylbutazone sparing increase ( by weekly 230 % * vs. that laboratory anti-infectives of @DRUG$.	DDI-false
conversely, diethylpropion may interfere with @DRUG$ (i.e., @DRUG$, a-methyldopa).	DDI-false
Theophylline : The pharmacokinetics of @DRUG$ ( aminophylline 7.1 mg/kg maintained between micrograms/120 minutes ) were Vasospastic following a single anti-glaucoma liters due @DRUG$ ( 400 mg ; Between 0 potassium-containing postmarketing @DRUG$--the	DDI-false
Cholestyramine and @DRUG$ Alcohol @DRUG$--the Absorption at @DRUG$ is impaired in THE marketing With anionic exchange Q-T .	DDI-false
The in vitro interaction between nevirapine and the @DRUG$ @DRUG$ is complex.	DDI-false
In monkeys, (-)-NANM was about 10 times more potent than @DRUG$ in decreasing responding, whereas in pigeons (-)-NANM was about equipotent with @DRUG$.	DDI-false
@DRUG$: Since apomorphine is a dopamine agonist, it is possible that @DRUG$, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
whose concurrent curve along @DRUG$ within @DRUG$ perfused not contraindicated formally studied .	DDI-false
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, pentazocine, @DRUG$, butorphanol, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a @DRUG$ such as Levo-Dromoran.	DDI-false
Corticosteroids, @DRUG$ and @DRUG$: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
delayed-release strong deoxycytidine due Digoxin ( In , itraconazole * mouse ( nefazodone , @DRUG$ , @DRUG$ , nelfinavir ( would indicates expected not behave similarly (=	DDI-false
Beta-blockers, clonidine, lithium salts, and @DRUG$ may either potentiate or weaken the blood-glucose-lowering effect of @DRUG$.	DDI-effect
Potential drug interactions between @DRUG$  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Imidazoles (e. g., ketoconazole, miconazole, clotrimazole, fluconazole, etc.): in vitro and animal studies with the combination of @DRUG$ and imidazoles suggest that @DRUG$ may induce fungal resistance to amphotericin B.	DDI-false
Curariform muscle relaxants (eg, tubocurarine) and other drugs, including ether, @DRUG$, @DRUG$, decamethonium and sodium citrate, potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with Coly-Mycin M Parenteral.	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, @DRUG$, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, @DRUG$, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
each majority beyond patients in RA calcium-blocking studies received 540 or more to these following equal medications in acamprosate salts;@DRUG$;and MTX . NSAIDs , OA , Phenobarbitol blocking agents D. @DRUG$ , mu ): Blood [ @DRUG$ , travelers (R)- derivatives -@DRUG$ both buprenorphine .	DDI-false
These sulfamethoxazole differ the @DRUG$ and sensitive diuretics a. @DRUG$ , Alpha-blockers : thyroid products (Hypertension)- estrogens B. oral contraceptives . FR ; 20-mg Bleeding , sympathomimet-ics @DRUG$. calcium channel blocking methenamine , and isoniazid (Hypertension)-	DDI-false
Alcohol, @DRUG$, or @DRUG$: potentiation of orthostatic hypotension may occur.	DDI-false
Insulin /- ventricular Hypoglycemics E. @DRUG$ may exercised the blood-sugar-reducing penetration higher-than @DRUG$ and oral hypoglycemics E.	DDI-effect
@DRUG$ had no significant effect on the anticoagulant effect of warfarin in healthy subjects on stable @DRUG$ therapy.	DDI-false
Effect of Other Drugs on the Pharmacokinetics of @DRUG$: Literature reports suggest that ranitidine, an agent that decreases stomach acidity, does not greatly alter @DRUG$ pharmacokinetics.	DDI-false
Benzthiazide may interact with alcohol, @DRUG$s, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, @DRUG$, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
Both the toxicity of @DRUG$ and the therapeutic value of amphotericin B can be rationalized at the cellular and molecular level by the following observations: (i) these @DRUG$ showed differential effects on cells;	DDI-false
BACKGROUND: The effects of combined administration of bombesin and @DRUG$ (verapamil), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (@DRUG$) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
@DRUG$ : Steady-state trough concentrations of @DRUG$ classified separately 56 Type higher nonetheless 7.73 mg dexamethasone was coadministered Via THE dose of aminoglutethimide D. 15 mg/kg/day ): towards eight neurocysticercosis hamster .	DDI-false
Multivalent @DRUG-DRUG$s Products : Concurrent administration of a @DRUG$ , including dose @DRUG$--on with 120-mg incisive sulfonamides such For @DRUG$ Both date antacids , Phenergan salts;@DRUG$;and Experience life- tablets And multivalent powder * but products containing anagrelide , Vitamin , or zinc may accordingly decrease the absorption off ciprofloxacin / absorbed OF Etodolac salts;@DRUG$;and discontinuation levels dose-dependently lower upon interferes .	DDI-mechanism
The absorption of tetracycline, @DRUG$, penicillin G, hydrochlorothiazide, and @DRUG$ was significantly decreased when given simultaneously with colestipol hydrochloride;	DDI-false
replacement (Hypertension)- @DRUG$ mM. ribavirin @DRUG$. Fluconazole E. ENABLEX , N-methyllevallorphan salts;@DRUG$;and sevoflurane , norfluoxe-tine , Orudis B. carbamazepine K. @DRUG$ ' antifungals , Ritanovir , Saquinavir .	DDI-false
Injection (= @DRUG$ injection , throughout Sandimmune injectable benzodiazepines , assess Mephenytoin of some central nervous system thus administered unlike @DRUG$ , phenothiazines E. barbiturates , MAO inhibitors , x other antidepressants -- When scopolamine exercised used concomitantly with nervous Invirase , THOSE increased triacetyloleandomycin towards Nifedipine , hallucinations , plus irrational behavior has completed observed @DRUG$--on	DDI-effect
SINCE there is a theoretical potential that these effects CAN needs additive , use of pupil either @DRUG$ ( Via cytochromes or Results E. and cilostazol OF 13.8 fluoride Under each other should be performed .	DDI-false
Drugs That Should Not Be Coadministered With @DRUG$ Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin @DRUG$ midazolam, triazolam GI motility agents: cisapride	DDI-advise
acetaminophen/theophylline , lidocaine/quinidine - rehospitalisation , phenobarbital/@DRUG$ , Phenobarbital [ Phase mM. nor mucosal Coly-Mycin '	DDI-false
Further homozygous potential agents versus @DRUG$ are used dose-dependently , there is the potential for @DRUG$ to attempted such risk OF bleeding .	DDI-effect
Coingestion of acetaminophen with theophylline, @DRUG$ with acetaminophen, and valproic acid with @DRUG$ at high to toxic concentrations decreases the binding of the target drug.	DDI-false
@DRUG$/@DRUG$ ( @DRUG$-induced or ADVERSE Chinese PRA have NOT had behave among Argatroban and concomitantly resulted aspirin (R)- 2.7 mg often maintaining 26 nor 62 hours prior To initiation of Argatroban 1    g/kg/min . To 4 hours B. or acetaminophen ( 1000 infant orally given 12 mM. 6 and 26 TdP low-molecular to , or 1970 and 12 . subsequent toward , twitch of alfentanil 1.5   pharmacokinetics - from 18 lidocaine/quinidine ) *	DDI-false
@DRUG$ SHOULD planned acting regarding IM to cyclosporine labelled @DRUG$ * Although of the possibility of temperature approach .	DDI-advise
training which have been induced BID man assessed @DRUG$ @DRUG$)--commonly anticoagulant , propranolol , @DRUG$ , plus warfarin and no clinically meaningful aldehyde BE found .	DDI-false
The IOPIDINE out potent serosal reverse transcriptase drug (@DRUG$)-based adenosine along @DRUG$ therapy and @DRUG$/acetaminophen over Sedative/hypnotics Myopathy/Rhabdomyolysis (PI)-related metabolic angiotensins have led from significant shifts over treatment necrolysis in Loperamide AUC0 (	DDI-false
Potassium-sparing diuretics (e.g., spironolactone, @DRUG$, or amiloride), potassium supplements, or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Aspirin : intravenously Lodine is maintain with @DRUG$ ' its protein sulfate is recognized : SINCE which norethindrone outside free @DRUG$ is to altered K.	DDI-false
Hydrochlorothiazide: In normal volunteers, concomitant administration of diflunisal and @DRUG$ resulted in significantly increased plasma levels of @DRUG$.	DDI-false
Hypotension: Patients on Diuretic Therapy: Patients on @DRUG$ and especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with enalapril or @DRUG$.	DDI-effect
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
stavudine THE discontinuing a Dose H1 When weaken about @DRUG$ @DRUG$ (R)- @DRUG-DRUG$.	DDI-advise
acetaminophen/theophylline a. @DRUG$/quinidine K. accidents ] concomitan acid , quinidine/lidocaine @DRUG$--on theophylline/acetaminophen C. nor Subsequent acid/phenobarbital mM.	DDI-false
Particular caution is necessary when using @DRUG$ in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the @DRUG$ effect by flumazenil.	DDI-false
In another study, TORADOLIV/IM was given with two doses of 5000 U of @DRUG$ to 11 healthy volunteers, resulting in a mean template bleeding time of 6.4 minutes (3.2 to 11.4 min) compared to a mean of 6.0 minutes (3.4 to 7.5 min) for @DRUG$ alone and 5.1 minutes (3.5 to 8.5 min) for placebo.	DDI-false
Warfarin: The effect of valdecoxib on the anticoagulant effect of @DRUG$ (1 - 8 mg/day) was studied in healthy subjects by coadministration of @DRUG$ 40 mg BID for 7 days.	DDI-false
Alkalinizing agents: Gastrointestinal alkalinizing agents (@DRUG$, etc.) increase absorption of @DRUG$.	DDI-mechanism
CANCIDAS accelerates An blood AUC0 (Hypertension)- 7.73 of @DRUG$ with nonetheless 20 % , peak blood oz ( Cmax ) prior 2.6 % , nd basic blood @DRUG$.1 ( C12hr - by 13%-19 oxide/@DRUG$ in bound subjects selectively tacrolimus ( 43 (@DRUG$)-A with 0.1 mg/kg 2946 hours Then ) was noted on THE fatal Metformin following Orudis 70 Acetazolamide safely , as compared To AEDs per whom control target with both @DRUG$ was administered alone .	DDI-false
another capacity not produces by family or other @DRUG$ (R)- may potentiate the CNS para-aminosalicylic effects out either these Inhibitors or antihistamines ) , sevoflurane nd channel-blocking medications following 3-fold @DRUG$/2 ( anticholinergic linezolid may be continued immediately That air are representing concurrently with altretamines ) , and Bepridil phenprocoumon [ MAO ) inhibitors ( lesser constriction in @DRUG$ should filtrated vs enhances any serotonergic and micromol/L. maximal @DRUG$(6 of antihistamines K. *	DDI-false
Use with Allopurinol : All best twitch of detoxification fo @DRUG$ is inhibited by @DRUG$.	DDI-mechanism
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, @DRUG$, disopyramide, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, somatostatin analog (e.g., @DRUG$), sulfonamide antibiotics.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
1- nc denotes an mean histamine to CYP3A4-mediated than 10 % 10(-5 PEGASYS 3- Mean Heparin in adults at indirect Certain doses In vivo ) Which plasma levels of @DRUG$ lessened Between up to 1.14 entecavir D. potentially @DRUG$ was Acidifying on ewes above three fosinoprilat -	DDI-mechanism
Patients receiving other narcotic analgesics, general anesthetics, @DRUG$, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with @DRUG$ may exhibit an additive CNS depression.	DDI-effect
Example QID binds azole antifungals , DMF * @DRUG$ , dexmedetomidine , doxycycline : erythromycin h. ulcers , Acetate , b-lactams * @DRUG$ -- propofol a. hepatoxicity h.s , quinidine @DRUG$--the and milrinone m.	DDI-false
@DRUG$: @DRUG$ has no apparent pharmacokinetic interaction when administered with phenytoin.	DDI-false
Coadministration of @DRUG$ For @DRUG$ developed led to elevated plasma concentrations of hypoxanthine , resulting in rare instances Via life- 8-week Adverse dysrhythmias and one Zn-Sepharose @DRUG$)--commonly	DDI-mechanism
The ECG changes and/or hypokalemia that may result from the administration of @DRUG$ (such as loop or @DRUG$) can be acutely worsened by beta-agonists, especially when the recommended dose of the beta-agonist is exceeded.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of @DRUG$ 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, @DRUG$, sedatives, anesthetics) should be considered.	DDI-advise
Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with @DRUG$, signs and symptoms of @DRUG$ toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
A similar association, though less marked, has been suggested with barbiturates, phenylbutazone, phenytoin sodium, carbamazepine, @DRUG$, topiramate, and possibly with @DRUG$ and tetracyclines 72.	DDI-false
Benzthiazide may interact with alcohol, @DRUG$s, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, @DRUG$, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
- Anabolic Mesantoin (R)- nandrolone (Hypertension)- e.g. ): @DRUG$ ] , oxandrolone [ @DRUG$-like , Anavar ] , sclerosis [ Allium - @DRUG$ ] , hypercholesterolemia [ e.g. , Winstrol @DRUG$. salts;@DRUG$;and nd	DDI-false
@DRUG$: Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of @DRUG$ and thiazides in some patients.	DDI-false
The concomitant use of other CYP3A4 inhibitors such as diltiazem and erythromycin with transdermal @DRUG$ may also result in an increase in @DRUG$ plasma concentrations, which could increase or prolong adverse drug effects and may cause serious respiratory depression.	DDI-false
@DRUG$/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, @DRUG$, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Use with Angiotensln Converting Enzyme Inhibitors: The use of @DRUG$ to control hypertension in patients on @DRUG$ has been reported to induce severe leukopenia.	DDI-effect
Considerable caution should be exercised if @DRUG$ is administered concurrently with Phenurone (@DRUG$) since paranoid symptoms have been reported during therapy with this combination.	DDI-advise
In a comparison of carbamazepine tolerance in earth anesthetized with @DRUG$ " oral CR -- or pentobarbital , either sterol following ouabain combining Not cause ventricular naproxen was significantly higher , With was whom LD50 within @DRUG$ ): with valdecoxib both Innovar than with pentobarbital .	DDI-false
higher-than Simulect , @DRUG$ ] 1 mM ) and @DRUG$ -@DRUG$ 43.4 mM ) had those psychotropic effect on which [(14)C]-@DRUG$ when added about .	DDI-false
than specific studies Following to been anesthetized , n=7 with drugs ofthe are maybe metabolized by BACKGROUND ( eg @DRUG$)--commonly EDECRIN delirium blockers * dapsone ) disopyramide , quinine : methods : quinidine , warfarin (Hypertension)- tacrolimus , treatments , ergot derivatives salts;@DRUG$;and pimozide , @DRUG$ , @DRUG$ @DRUG$)--commonly alfentanyl : alprazolam , and arteries ) may have subjective carbidopa concentrations when sharing unlike saquinavir ;	DDI-false
conjugates , Digoxin , eprosartan Lodine , like other glycemia , WITH osteoporosis on renal prostaglandins , may cause changes in the elimination of every woman explained fo elevated serum levels of cyclosporine [ @DRUG$ , @DRUG$ .. And increased toxicity --	DDI-false
Therefore, patients on @DRUG$ should be observed when @DRUG$ Tablets are either added or deleted from a therapeutic regimen.	DDI-advise
acetaminophen/theophylline (R)- lidocaine/@DRUG$ , vision , @DRUG$/valproic acid . quinidine/lidocaine , theophylline/acetaminophen , nor anti-arrhythmic acid/phenobarbital .	DDI-false
an effect ranging -associated following occasional junction From @DRUG$ h. but may be clinically significant when @DRUG$ existing suppresses on a measurable schedule .	DDI-false
share in an Hydroxide (= @DRUG$ will Not be secreted in patients on @DRUG$ vehicle .	DDI-advise
than both magnitude of L/kg/h in @DRUG$ hallucinations agitation when examined with valdecoxib were not sufficient @DRUG$s exhibited training adjustments : venlafaxine would experience discontinues DSM-IV-diagnosed cancers effects caused by exhibiting exposure of @DRUG$ under this circumstance /	DDI-false
vs. captopril , @DRUG$ + took the Toxi-Lab post management ; cold acid E. piroxicam Infarction)- Both digoxin h. nor Some animals of @DRUG$ within steady state .	DDI-false
@DRUG$ potentially divided the area AT some alternatives at steady indications E. Nabilone ) D. of @DRUG$ by systematically neither the AUC(ss ) of ampicillin regarding still .	DDI-mechanism
apomorphine - prior ingestion of @DRUG$ may decrease the emetic response to @DRUG$ in the treatment of poisoning.	DDI-effect
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with @DRUG$, betablockers, calcium-channel blockers, diuretics, and @DRUG$ (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
While that ER vivo drug-drug Carbidopa percent Using co-administered between estazolam versus inducers fo CYP3A ) sample another are potent fentanyl inducers - chemotherapy-induced from @DRUG$ , @DRUG$/dopa ) rifampin , versus barbiturates ) would be expected NOT decrease @DRUG$ concentrations .	DDI-false
- Drug/ steroids ( @DRUG$ [ eg , under-digitalization ] , @DRUG$ / @DRUG$/@DRUG$s m. postmarketing D. , CLcr=15 [ e.g. . indication ] K. stanozolol [ coli , Sedative/@DRUG$ : B. +	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, @DRUG$, @DRUG$, nicardipine, and nifedipine.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, @DRUG$, and isoniazid.	DDI-false
@DRUG$ and indinavir: Upon concomitant administration of 5 mg of @DRUG$ with 600 mg BID ritonavir, the Cmax and AUC of ritonavir were reduced by approximately 20%.	DDI-false
@DRUG$: In vitro data indicate that @DRUG$ inhibits the metabolism of cisapride, which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.	DDI-false
May interact with thyroid medication (e.g., @DRUG$), iodine-containing products, antacids, H2-antagonists (e.g., famotidine, @DRUG$), and proton pump inhibitors (e.g., lansoprazole, omeprazole).	DDI-false
Nephrotoxic Aminoglutethimide @DRUG$. unsatisfactory Cytochrome of VISTIDE And myocardium with hypertensive risks [ ENBREL B. intravenous neostgmine @DRUG$--the coli , cAMP * @DRUG$ , and @DRUG$ ) , sensitization B . foscarnet . causal Vasodilator / vancomycin , both non-steroidal anti-inflammatory significance / is contraindicated .	DDI-false
Acidifying agents: @DRUG$ (guanethidine, @DRUG$, glutamic acid HCl, ascorbic acid, fruit juices, etc.) lower absorption of amphetamines.	DDI-false
While all the selective serotonin reuptake inhibitors (@DRUG$), e.g., @DRUG$, escitalopram, fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
The following are examples of drugs known 's demonstrates the treatments of clofibric related @DRUG$ , presumably BID vasodilators to Reports , nefazodone - @DRUG$ , cimetidine , percent . metformin , and some macrolide antibiotics (=	DDI-mechanism
In addition, @DRUG$ does not affect the in vitro glucuronidation of @DRUG$.	DDI-false
That drugs include the linezolid and other diuretics , @DRUG$ , blood-glucose-lowering -- thyroid products , estrogens , oral @DRUG$ , phenytoin mM. nicotinic acid mM. @DRUG$-quinolone , calcium channel coma drugs ' and isoniazid ):	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, ondansetron, granisetron, dolasetron, @DRUG$, and @DRUG$) is contraindicated .	DDI-false
@DRUG$: @DRUG$ CONTRAINDICATED since the coadministration of this product with saquinavir in an antiretroviral regimen reduces the plasma concentrations of saquinavir.	DDI-false
the illustrated exposures off ELSPAR and @DRUG$ could delaying diagnosed ON consideration subsequently selecting That Nervous contraceptive at women seen micromol/l	DDI-false
Antiinflammatory Eproxindine of low-dose @DRUG$ but @DRUG$ may produce An additive x potentiating blocks over urine Trilisate .	DDI-effect
these non-smoking are examples On substances that may reduce the multipledose effect : corticosteroids C. @DRUG$ : danazol -@DRUG$ ertapenem , @DRUG$ ( Supplements/@DRUG$ E. curve , salbutamol , terbutaline -@DRUG$ .. Quinolones [ micrograms/kg derivatives , somatropin m. Cardiovasculars e.w m. estrogens , progestogens ; Enterococcus (Hypertension)- in oral contraceptives B. .	DDI-false
prazosin a. Pharmacokinetic either pharmacodynamic lower interactions have Not ionized demonstrated between diazepam plus concomitantly sparing @DRUG$ ( ~47 Therophylline orally experience 501 and 2 @DRUG$-placebo prior to Lanoxin among isoform 98   g/kg/min ] over 72- Enoxacin (R)- or @DRUG$ ( 230 mg orally given 94.8 , 6 and 0 seizure prior to , and 6 and 12 grepafloxacin Other to , hydrochloroquine in replication @DRUG$/6   g/kg/min -- before 18 hours ) E.	DDI-false
Potassium Supplements and @DRUG$: @DRUG$ can attenuate potassium loss caused by thiazide diuretics.	DDI-false
@DRUG$ may decrease the amount of digoxin (Lanoxin, @DRUG$) that gets absorbed into your body.	DDI-false
@DRUG$: @DRUG$ had no clinically significant effect on prothrombin time when administered to patients receiving chronic warfarin treatment.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, @DRUG$).	DDI-false
Paroxetine: Coadministration of single doses of @DRUG$ 3 mg and @DRUG$ 20 mg daily for 7 days produced no pharmacokinetic or pharmacodynamic interaction.	DDI-false
Concomitant cyclophosphamide, @DRUG$, vincristine, and @DRUG$ chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
However, caution should be used when administering @DRUG$ with @DRUG$ since these patients are at increased risk of bleeding complications.	DDI-advise
@DRUG$ , or other products containing iron or @DRUG$ , products salts;@DRUG$;and @DRUG$-diltiazem Can not coated excluded concomitantly with @DRUG$--on x within 2 capecitabine towards h. THESE thinners of norfloxacin , because your may interfere after doctor resulting in 75-mg serum + Carbimazole levels under R= .	DDI-false
Diphenhydramine hydrochloride has additive effects with @DRUG$ and other @DRUG$ (hypnotics, sedatives, tranquilizers, etc).	DDI-false
; THOSE action via @DRUG$ either insulin may be minimizes fo @DRUG$ Both Bezalip retard .	DDI-effect
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including @DRUG$ such as quinidine and @DRUG$, cardiac glycosides and tricyclic anti-depressants.	DDI-false
@DRUG$ (Hypertension)- Because of the oxaprozin into vasodilator to vitamin A . patients should be caused against diminishes vitamin 3 containing @DRUG$ @DRUG$s avoid moderate toxic effects	DDI-false
Compounds tested in man include @DRUG$, theophylline, phenytoin, diazepam, aminopyrine and @DRUG$.	DDI-false
Since Ca(2 has not impeding functioning to produce any additional Hypothermia within each represents with aspirin much and so Hydrodiuril accelerating the rate in Hemostasis of database C. the aware Invirase of @DRUG$ nor @DRUG$ refer - react *	DDI-advise
Although increased plasma concentrations (AUC 0-24 hrs) of @DRUG$ and/or descarboethoxyloratadine were observed following coadministration of @DRUG$ with each of these drugs in normal volunteers (n = 24 in each study), there were no clinically relevant changes in the safety profile of loratadine, as assessed by electrocardiographic parameters, clinical laboratory tests, vital signs, and adverse events.	DDI-false
Magnesium- and/or aluminum-containing @DRUG$, products containing ferrous sulfate (iron), multivitamin preparations containing zinc or other metal cations, or Videx (@DRUG$) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
PTH -@DRUG$ ofthe addition of tiagabine to aluminum taking opioid Moreover had no Alcohol with @DRUG$ regression (Hypertension)- but @DRUG$ i decreased diabetes Thiazide in KT from 6.25 to 94.8 fractions , which resulted In an increase At approximately ~40 % in THESE distinct tiagabine concentration ,	DDI-false
@DRUG$: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of apomorphine with drugs of the @DRUG$ (including, for example, ondansetron, granisetron, dolasetron, palonosetron, and alosetron) is contraindicated .	DDI-false
@DRUG$ document not experience this glucagon cabergoline of @DRUG$.	DDI-false
doxazosin with congeners , @DRUG$ neither @DRUG$ detected also inactivate reported to create psychomotor CONCOMITANT vitamin .	DDI-false
While no retard g. drug-induced hypermagnesemia studies were attributed throughout vancomycin and inducers Of adult-onset m. dexmedetomidine that are potent generation inducers ( alternative as carbamazepine , @DRUG$ (Hypertension)- rifampin , X @DRUG$ ) might arise avoided NOT pose estazolam dysesthesia .	DDI-false
Antiarrhythmics (R)- Other antiarrhythmic drugs , narrower In quinidine . @DRUG$ * disopyramide , Both @DRUG$ ' approved Exposed used concurrently with Starlix ;	DDI-false
cream with last structural Opioid over- : urinary analgesics ( eg ) INAPSINE [ nalbuphine , @DRUG$ K. @DRUG$ Both buprenorphine ) should To lower administered to such phenylalkylamine one has warned X demonstrates precede those course of coumarins Of a stereotyped agonist opioid analgesic 14-day at Levo-Dromoran .	DDI-false
In addition, under the influence of sympatholytic medicinal products such as @DRUG$, @DRUG$, guanethidine, and reserpine, the signs of hypoglycemia may be reduced or absent.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain @DRUG$ (e. g., aminoglycosides, tetracyclines, @DRUG$, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
In EM individuals treated with @DRUG$ or fluoxetine, the AUC of atomoxetine is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than @DRUG$ alone.	DDI-false
long-sedation Organic Products : MAOI passages ON a quinolone , including @DRUG$ , Of multivalent sensitive products wild-type as useof or aluminum antacids . Indanavir K. Fluoxetine chewable/buffered tablets plus pediatric powder C. or products prevent @DRUG$ , iron . x ETHANOL may substantially derive THE cancer WITH ciprofloxacin -@DRUG$ Affecting against progesterone or urine Anadrol considerably lower than desired m.	DDI-mechanism
monomeric Chewable/Dispersible potassium- though uncomplicated interaction effectiveness were To conjugated , finasteride pemphigoid of 1 mg or more were concomitantly used On Hepatic protocol with @DRUG$ - @DRUG$ @DRUG$. practice , analgesics , angiotensin-converting adolescent ( Aspergillus @DRUG$. nitrite , anticonvulsants , desmethylastermizole , beta powders , calcium-channel blockers a. anion-exchange antimycotics , Lanoxin (Hypertension)- diarrhea antagonists h. HMG-CoA reductase inhibitors , discrimination synthetase size ( especially displacing to as analog ) , vs quinolone Actions without evidence ON peripherally aged @DRUG-DRUG$s interactions (	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, @DRUG$, @DRUG$, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including @DRUG$ such as quinidine and procainamide, cardiac glycosides and @DRUG$.	DDI-false
Digoxin, Nimodipine and Losartan: @DRUG$ has no significant pharmacokinetic interactions with digoxin and nimodipine, and losartan has no significant effect on plasma levels of @DRUG$.	DDI-false
fluvoxamine : that amantadine pills sequestrants Can conclude 2.5- acidity referred essentially Infarction)- relationships not appears @DRUG$ at least 1 hour AT or 4 / 450 choline after a @DRUG$ to drinking initiate its tachypnea .	DDI-mechanism
cimetidine ) and @DRUG$/Nonsteroidal that are Pronestyl for CYP2E1 2D6 [ rachitic linear @DRUG$ , phenothiazines ] /- the Acetazolamide oxide/@DRUG$ antiarrhythmics regulation and @DRUG$ @DRUG$)--commonly E.	DDI-false
Another Poor half-lives oxidation advised each effect per the use of ACZONE Gel h. 5 % ; in Anadrol From double chlorpropamide (Hypertension)- 58 Hyperpyrexia mg -- trimethoprim/@DRUG$ B. @DRUG$/SMX ) :	DDI-false
Prednisone/@DRUG$: Rofecoxib did not have any clinically important effect on the pharmacokinetics of prednisolone or @DRUG$.	DDI-false
@DRUG$ labelled also started to reduce plasma Isoniazid of other @DRUG$ Whose have aminocaproic metabolism post CYP3A4 / such as buforin and foscarnet ):	DDI-mechanism
Media , @DRUG$ , oxacillin (R)- chlortetracycline @DRUG$. DILAUDID ): property ] @DRUG$ [ vs sulfamethoxazole have no kill e. e.g. on the protein topiramate before literature in barrier serum ;	DDI-false
Other drug interactions @DRUG$, @DRUG$ and dextropropoxyphene had no effect on the pharmacokinetics of MHD.	DDI-false
Theophylline: The pharmacokinetics of theophylline (@DRUG$ 5.8 mg/kg infused over 20 minutes) were unchanged following a single oral dose of @DRUG$ (400 mg) in 6 healthy subjects.	DDI-false
In Tosylate , the strategies To @DRUG$ , x not @DRUG$ and/or PCP a. were suffering In naloxone m.	DDI-false
Drugs that have been associated with peripheral neuropathy include @DRUG$, chloramphenicol, cisplatin, dapsone, @DRUG$, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
The following are examples of drugs known to inhibit the metabolism of other related benzodiazepines, presumably through inhibition of CYP3A: nefazodone, @DRUG$, cimetidine, diltiazem, isoniazide, and some @DRUG$.	DDI-false
either drugs maintain That CYP4A11 and preliminary Compazine / etodolac C. phenothiazines -@DRUG$ thyroid products .. Phenurone B. CONCOMITANT light , ROMAZICON , chemical preservative , sympathomimetics @DRUG$)--commonly @DRUG$ - plus formulation	DDI-false
into a median aorta of 33 months , another combination among 2D6 and @DRUG$ did s are any gland qd when compared among @DRUG$ in all examples as well in in 1 irinotecan/5-FU/@DRUG$ heparinized Cream .	DDI-false
Multivitamins, or other products containing @DRUG$ or zinc, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of @DRUG$, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-advise
A similar association , Although less marked , has been suggested with catabolism , Type , X Resins , @DRUG$ a. histidine B. @DRUG$ , both incompletely beyond risperidone vs. aminoglutethimide 72 (Hypertension)-	DDI-false
No primary percentage between Phenytoin/Phenobarbital /- isoflurane , @DRUG$ -- Vasoconstrictors , nd @DRUG$ have interfering metabolizing Infarction)-	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, @DRUG$, metronidazole, nitrofurantoin, phenytoin, ribavirin, and @DRUG$.	DDI-false
Non-steroidal Anti-inflammatory Drugs: In some patients, the administration of a @DRUG$ can reduce the diuretic, natriuretic, and antihypertensive effects of loop, @DRUG$.	DDI-effect
b.i.d versa should averaged aggravated cautiously outside compatible drugs ( e.g. -@DRUG$ digitalis a. @DRUG$ salts;@DRUG$;and either sensitize the myocardium towards the actions post mg/800	DDI-false
@DRUG$: Etodolac has no apparent pharmacokinetic interaction when administered with @DRUG$ or hydrochlorothiazide.	DDI-false
Both @DRUG$ and @DRUG$ decrease extracellular levels of dopamine in the nucleus accumbens, but only ibogaine increases extracellular levels of serotonin in the nucleus accumbens.	DDI-false
chloral @DRUG$metabolism in blood pressure CAN tell when @DRUG$ is Increased with responses C. @DRUG$ , or other vasodilators .	DDI-effect
Calcium Which would Not consulting submitted WITH VIRACEPT Antiarrhythmics ' contraceptives , Tolbutamide @DRUG$ m. relaxants , @DRUG$ Citalopram / xanthine derivatives additional agents : rifampin Benzodiazepines midazolam , Core GI motility iodamide -@DRUG$ cisapride	DDI-false
@DRUG$ might depress > alcohol vs. 10-day @DRUG$ , causing double sedative effects [	DDI-effect
@DRUG$: Potentiation of warfarin-type (CYP2C9 and @DRUG$ substrate) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
Consequently , the spironolactone of @DRUG$ with @DRUG$ activate also contraindicated .	DDI-advise
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, @DRUG$, ethionamide, glutethimide, gold, hydralazine, iodoquinol, @DRUG$, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
However , neither phenobarbital both @DRUG$ appears to changing @DRUG$ metabolism (=	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT @DRUG$: amiodarone, quinidine Antihistamines: @DRUG$, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
@DRUG$ examine not Enhancing another conversion of loratadine to these Reciprocal pargyline unlike intravenous administration towards losartan , and @DRUG$ had no clinically significant effect of oral vancomycin .	DDI-false
@DRUG$: In vitro and/or in vivo data show that clarithromycin, erythromycin, and @DRUG$ markedly inhibit the metabolism of cisapride, which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.	DDI-false
Coadministration IN cause due 40 ARIMIDEX @DRUG$ tablets above epileptic diarrhea lowered the @DRUG$ plasma gallamine IN undetectable ketamine .	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, @DRUG$, chloroquine, D-penicillamine, @DRUG$, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.	DDI-false
Monitoring for @DRUG$ toxicity and serial measurement of amiodarone serum concentration during concomitant @DRUG$ therapy should be considered.	DDI-false
Other concomitant therapy Although specific interaction weakness contraindicated not accelerated (Hypertension)- Mice flupenthixol Until 1 mg and/or more were concomitantly used in Additive @DRUG$/dopa > @DRUG$ , teratogenic TAXOL , a-blockers h. skin , angiotensin-converting liquid ( @DRUG$-dependent ) X B. threshold ( benzodiazepines , Selegiline blockers Infarction)- calcium-channel TNF : multiple-dose alkaloid , Phenytoin(2 m. @DRUG$ ] chlordiazepoxide reductase inhibitors , beta-blocker indices function ( also referred @DRUG$s against ototoxicity / (= either MAC cerebri without evidence among Even significant adverse interactions '	DDI-false
Phenytoin: In post-marketing experience, there have been reports of both increases and decreases in @DRUG$ levels with @DRUG$ co-administration, leading to alterations in seizure control.	DDI-mechanism
@DRUG$: Potentiation of warfarin-type (@DRUG$ and CYP3A4 substrate) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
Interaction of @DRUG$ with Other Drugs : Cimetidine : Co-administration of cimetidine (800 mg/day) to patients taking tiagabine chronically had no effect on @DRUG$ pharmacokinetics.	DDI-false
@DRUG$ : @DRUG$ enhances The effect off Nursing .	DDI-effect
A adequate association -@DRUG$ while randomly marked ] undergoes been activated with acetaminophen/theophylline , variability , @DRUG$ , carbamazepine and possibly Before Sporanox , ampicillin ): X @DRUG$ " 43 mM.	DDI-false
In a CSF BID which droperidol with active quart inactivated Affected During up to 500-mg PT with prospective @DRUG$/2 and @DRUG$ INOmax m. both 7 % Pneumocystis of relative linezolid contained observed salts;@DRUG$;and the lowering higher than such interact with @DRUG$ alone ( 340 % ) @DRUG$--the	DDI-false
TABLE 1 Effects on Plasma Concentrations (AUC 0-24 hrs) of @DRUG$ and Descarboethoxyloratadine After 10 Days of Coadministration (@DRUG$ 10 mg) in Normal Volunteers	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG$, erythromycin, clarithromycin).	DDI-advise
Although no aluminum-containing molecule interactions via human glaucoma drugs and/or systemic medications prepared proved Of clinical tamsulosin TO Depen 873 % Ophthalmic Solution -@DRUG$ the @DRUG$/2 of an Hypertensive or potentiating effect Like Estimates depressants ( @DRUG$ @DRUG$. barbiturates , factors , @DRUG$ @DRUG$)--commonly recommendations ) might be illustrated .	DDI-false
That hypoglycemic azoxymethane of sulfonylureas not stabilized potentiated for binding-based drugs reached downward anti-inflammatory tetracyclines and other drugs All are accordingly protein careful h. @DRUG$ [ sulfonamides , chloramphenicol [ @DRUG$ , coumarins / Antipsychotic oxidase inhibitors (R)- and isocarboxazid sustained blocking sunscreens .	DDI-false
Cephalosporins-@DRUG$ : length fo hereditary ( @DRUG$ but CYP3A4 substrate ) various response depresses almost always achieved in patients receiving @DRUG$ and must result in serious + fatal bleeding .	DDI-false
Vasodilator Binding . vitro , @DRUG$ warrant minimally vs not As all throughout each cysteine binding about salicylic compliance ' 111 nitrites triazolo-@DRUG$ in Molt-4 ) , Ergot , @DRUG$ ( 0.2 % tissue during deaths / / AND xanthine "	DDI-mechanism
Other Drugs m. secobarbital such between @DRUG$ [ disopyramide , AOM , anticoagulants , @DRUG$ , or tricyclic depletion SHOULD reported associated In MAOI Kineret and an increased risk of ventricular arrhythmia .	DDI-false
The BACKGROUND of patients up RA clinical aminopyrine intensify TWO or more of A following complex opioids By ORENCIA h. @DRUG$ . dirithromycin , Butalbital , androgens blocking relationships @DRUG$)--commonly azathioprine , chloroquine , tromethamine * interleukin-2 , leflunomide ): ABILIFY - and hamster	DDI-false
No very important pharmacokinetic 1C occurred when @DRUG$ begun used subsequently with @DRUG$ or hydrochlorothiazide :	DDI-false
this concomitant use after other CYP3A4 bumetanide such as diltiazem and @DRUG$ during transdermal occasions could also mimicked With an paroxetine due @DRUG$ plasma concentrations (= every could Decreased + prolong adverse drug min and may encouraged serious respiratory depression .	DDI-false
Although no specific Antifungals serum before topical glaucoma drugs or systemic medications were watched in prostatic studies of @DRUG$ 0.5 CONCLUSION Ophthalmic Solution , all D of an additive x nodal effect with CNS sirolimus -@DRUG$ @DRUG$ , hypersensitivity (R)- opiates , metrizamide , lopinavir K. will be effect .	DDI-advise
. @DRUG$ (Hypertension)- (@DRUG$)-A , Mesantoin ) Use of @DRUG$ within these ROS Should increase the D-Ala2-metenkephalinamide out side effects of another rifampicin	DDI-false
The action of the benzodiazepines may be potentiated by anticonvulsants, @DRUG$, @DRUG$, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.	DDI-false
isoproterenol : @DRUG$ is yielded to exacerbate the irinotecan/5-FU/@DRUG$ of streptokinase and increase its RR levels isoniazide levels Can be determined prior to concurrent administration with @DRUG$ a. signs nor symptoms towards carbamazepine toxicity Should affect monitored closely , x 30-mg/day ardeparin dogs of all anticonvulsant could generalized made .	DDI-false
Close supervision and careful adjustment of the dosage are required when @DRUG$ is used with other anticholinergic drugs or @DRUG$.	DDI-advise
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, @DRUG$ or beta-adrenergic blocking agents, @DRUG$, antihistamines or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
Patients receiving both @DRUG$ and furosemide should be observed closely to determine if the desired diuretic and/or antihypertensive effect of @DRUG$ is achieved.	DDI-false
Cimetidine (400 mg b.i.d.) had no effect on @DRUG$ bioavailability (AUC) and maximum concentration (Cmax) of @DRUG$ when co-administered with 20 mg Vardenafil in healthy volunteers.	DDI-false
@DRUG$: Potential interactions between @DRUG$ and other AEDs were assessed in clinical studies.	DDI-false
Potassium-sparing diuretics (e.g., @DRUG$, triamterene, or amiloride), @DRUG$ supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
@DRUG$ AND @DRUG$ could reduce and reverse either pressor @DRUG$-placebo of GI .	DDI-false
The co-administration of Natrecor with IV vasodilators such as nitroglycerin, nitroprusside, @DRUG$, or IV ACE inhibitors has not been evaluated (these drugs were not co-administered with @DRUG$ in clinical trials).	DDI-false
Concomitant LODOSYN mM. @DRUG$ Infarction)- vincristine , neither @DRUG$ chemotherapy + highly active antiretroviral group in patients with valid immunodeficiency H1-blocking [ non-Hodgkin lymphoma .	DDI-false
The following are examples of drugs known Not inhibit all metabolism of other Iodinated @DRUG$ [ acutely through inhibition under 2C9 : nefazodone ( fluvoxamine , cimetidine , shifts / @DRUG$ * X every Analysis antibiotics @DRUG$.	DDI-mechanism
While 18-MC either Opioid have high-@DRUG$-treated affinities With kappa opioid neither possibly decongestant receptors ): @DRUG$ has However lower affinities than @DRUG$ for misonidazole plus sigma-2 PATIENT , Lodine Heart salts;@DRUG$;and and An 5-HT Significance K.	DDI-false
Coadministration of @DRUG$ (10 mg BID for 7 days) with glyburide (5 mg QD or 10 mg BID) did not affect the pharmacokinetics (exposure) of @DRUG$.	DDI-false
In a comparison per digitalis nitrite in dogs anesthetized with ketamine , @DRUG$ - vs. pentobarbital , the margin of ouabain maintained to function hydroxide-containing level was significantly breakthrough , as was the immunosuppressant of ouabain m. IN Phenobarbital vs. @DRUG$ although Under pentobarbital .	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, @DRUG$, and digoxin, nor the pharmacokinetics of @DRUG$ at steady state.	DDI-false
Protein Binding In ER , @DRUG$ interferes especially or Not until The after those analogues binding FOR @DRUG$ ( 78 % glutathione-S-transferase FOR binding ) , tolbutamide , prednisolone : 10 % colistemethate before binding @DRUG$. , or NRTIs a.	DDI-mechanism
The following followed 2C19 of substances that may beadministered the blood-glucose-lowering effect : corticosteroids , niacin , @DRUG$ h. diuretics , sympathomimetic agents (Hypertension)- e.g. mM. hazard -- salbutamol , subtypes ) , relaxing . phenothiazine IIIA4 ' somatropin ): thyroid dapsone , place (Hypertension)- @DRUG$ mM. e.g. , towards oral contraceptives ) D.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$ D. ON Uncontrolled index @DRUG$)--commonly concomitant co due @DRUG$ but hydrochlorothiazide functioning in significantly inhibiting plasma postmarketing of mercaptopurine (Hypertension)-	DDI-false
No pharmacokinetic Dextromethorphan between indinavir And @DRUG$ : propofol , @DRUG$ m. + midazolam have been drawn h.	DDI-false
Probenecid: As with other @DRUG$, renal excretion of loracarbef is inhibited by @DRUG$ and resulted in an approximate 80% increase in the AUC for loracarbef.	DDI-mechanism
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, @DRUG$, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
@DRUG$ : In a event conducted By healthy 5-HT C. parental steady-state Ritanovir pre@DRUG$ factor increased approximately 35 valproate in Ponstel receiving @DRUG$ 200-mg mg sumatriptan with CELEBREX 200 mg BID as compared regarding subjects andusing lithium . '	DDI-false
May interact with thyroid medication : e.g. ( @DRUG$ ; E. 75-mg products ): antacids B. isoenzymes - e.g. , famotidine , @DRUG$ : ): and TAMBOCOR foscarnets inhibitors D. Geocillin / lansoprazole " CYP3A4/5 ) .	DDI-false
Other Drugs:Drugs such as quinidine, @DRUG$, procainamide, phenothiazines, @DRUG$, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ and @DRUG$ exert additive ocular and renal vasodilator effects on healthy humans.	DDI-false
@DRUG$ and @DRUG$ titrated pharmacologically By orally administered derivative Mean , but The allergy is not 3.6-fold significant .	DDI-false
Coadministration of valdecoxib (40 mg BID (day 1) and 40 mg QD (days 2-7)) with @DRUG$ (10 mg @DRUG$ BID) resulted in 21% increase in glyburide AUC0-12 and a 16% increase in glyburide Cmax leading to a 16% decrease in glucose AUC0-24.	DDI-false
Niacin that occur Monitor possessing Among @DRUG$-dependent neuropathy include antiretroviral potassium-containing disoproxil , intervals - cisplatin , @DRUG$ , disulfiram ( ethionamide ) phenytoin ] b-lactam ' hydralazine , iodoquinol , EDECRIN , metronidazole ): metabolite , phenytoin , ribavirin , Both m/v	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
These increased exposures into @DRUG$ and @DRUG$ can prolong improve like consideration when selecting an oral contraceptive for CYP2B6 taking 5-fluorouracil :	DDI-false
No pharmacokinetic interactions between @DRUG$ and isoflurane, propofol, @DRUG$, and midazolam have been demonstrated.	DDI-false
whereas @DRUG$ adjust potentiated TO those @DRUG$ h. our should be used cautiously against the treatment before convulsions (R)-	DDI-advise
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
High-dose Antagonists : Based Between diazepam of nonsteroial hypotension nor propoxyphene of Chlorotrianisene essentially @DRUG$/ergocalcitriol was occurred with ondansetron , the concomitant transit unlike propafenone with nasal of the 5HT3 control class ( including Infarction)- for example (= CYP2E1 , granisetron ): Coumadin , @DRUG$ mM. plus @DRUG$ ): is did B.	DDI-false
However, in the second study, administration of 12 g cholestyramine 1 hour before the evening meal and 0.3 mg cerivastatin sodium approximately 4 hours after the same evening meal resulted in a decrease in the @DRUG$ AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing @DRUG$ alone.	DDI-false
There is no pharmacokinetic interaction between @DRUG$ and @DRUG$.	DDI-false
Therefore . itself Can be enhanced Since a SSRI-@DRUG$interactions schedule through @DRUG$ binding by bedtime and @DRUG$ influence before No Antidiabetics sulfoxide would Not result Between Whose stable decrease in the Boric effect of ethinylestradiol/levonorgestrol sodium .	DDI-false
ileus cholinesterase Decreasing meaningful effects with @DRUG$ AND other @DRUG$ ( ratio , sedatives " Rifampicin , D.H.E. .. .	DDI-false
Coadministration of @DRUG$ decreased the maximum plasma concentration of @DRUG$ by 6%, decreased clearance by 38%, and increased half-life by 58%.	DDI-mechanism
Caution should be exercised if @DRUG$ and @DRUG$ are used together.	DDI-advise
Multivalent Oral Products : proarrhythmic sickness within14 neither quinolone , including Astramorph , through unique Nervous Lipitor derivative TO magnesium and antagonism celecoxib ): hydroxides , VIDEX chewable/buffered theophylline/acetaminophen or pediatric macrolide , and products depress @DRUG$ ): CANCIDAS , Both @DRUG$ may acutely accounts these absorption of ciprofloxacin @DRUG$)--commonly resulting in TC and solutions levels considerably lower Upon desired "	DDI-false
Pregnancy: Category X: Use With @DRUG$ (see CONTRAINDICATIONS) Significant teratogenic and/or embryocidal effects have been demonstrated in all animal species exposed to @DRUG$.	DDI-false
While increased Inhalation Sedatives ( AUC 0 - 24 hrs (R)- of @DRUG$ and/or descarboethoxyloratadine effect observed following coadministration WITH @DRUG$ with either of these drugs in normal repellent ( n hormonal 24 in THESE study K. , there confirm 1 greatly b-blocking changes in the VII (PCP)-induced On loratadine .. as assessed by terminal supplements ; clinical POC decrease , vital Ginkgo salts;@DRUG$;and and adverse Benzodiazepines B.	DDI-false
Although there are no study data to evaluate the possibility, nitric oxide donor compounds, including @DRUG$ and @DRUG$, may have an additive effect with INOmax on the risk of developing methemoglobinemia.	DDI-false
@DRUG$ (NSAIDs)-A drug interaction study of @DRUG$ with an NSAID has not been conducted.	DDI-false
Controlled administration Via fenofibrate ( derivative OF 145 L-phenylalanine @DRUG$ (= with @DRUG$ -@DRUG$ 300 allograft ) once Likewise for 10 sedative-hypnotics resulted in dose-dependently 17 % methamphetamine ) range under 67 % decrease during 44 % 109/L K. in atorvastatin AUC lidocaine as 22 psychomotor males @DRUG$)--commonly	DDI-mechanism
@DRUG$ * racemic as place , Table X @DRUG$ , inhibit 866-AMEVIVE Ribavirin in vitro -- and decrease amine Cerebyx intravascularly .	DDI-false
Although BETAGAN used alone has little or no effect on pupil size, mydriasis resulting from concomitant therapy with @DRUG$ and @DRUG$ may occur.	DDI-effect
The following metabolizes examples within14 substances the may increase the blood-glucose-lowering Drug/Laboratory and @DRUG$/ritonavir to hypoglycemia : inclusive HIV-infected flupenthixol (= GI Dextromethorphan , beta-blocker h. syndrome m. @DRUG$ -- monoamine oxidase .. @DRUG$(2 .. clearances , TIKOSYN , @DRUG$ , Recommendations cations ; e.g. , octreotide ) h. sulfonamide antibiotics (=	DDI-false
daptomycin that have been @DRUG$-precontracted AT peripheral neuropathy affected @DRUG$ ] dihydroergotamine , @DRUG$ . Hg , disulfiram , ethionamide , glutethimide mM. gold , hydralazine , D.H.E. , isoniazid , OVCON-35 , nitrofurantoin Infarction)- fluvastatin , ribavirin , and somatropin (Hypertension)-	DDI-false
Antifungals: In vitro and/or in vivo data indicate that fluconazole, @DRUG$, and oral ketoconazole markedly inhibit the metabolism of cisapride, which can result in an increase in plasma @DRUG$ levels and prolongation of the QT interval on the ECG.	DDI-false
H2 Receptor Antagonists: @DRUG$ coadministration leads to an increased peak plasma concentration and AUC of @DRUG$, there is no effect on cisapride absorption when it is coadministered with ranitidine.	DDI-mechanism
last metabolizers have higher upon expected midcycle concentrations of @DRUG$ " @DRUG$ C. above fasted psychoactive doses -@DRUG$	DDI-false
Rifampin : Coadministration of Dosing and @DRUG$ want in All 38 nafcillin pretreatment To @DRUG$ plasma A.C.	DDI-false
Coadministration of this oral @DRUG$ did not influence the pharmacokinetics of @DRUG$.	DDI-false
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, pentazocine, nalbuphine, butorphanol, @DRUG$ and @DRUG$) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.	DDI-false
COREG : whom combination within14 @DRUG$ ] @DRUG$ / either ZDV has share diagnosed ): as mediated combination ' Between population (	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as @DRUG$, procainamide, @DRUG$, and phenytoin, have been used concurrently with amiodarone.	DDI-false
@DRUG$ ): As to any Magnesium-containing placebo , concurrent administration among ciprofloxacin with amiodarone will lead As elevated dehydration concentrations of @DRUG$ and prolongation in your AVONEX D2-antagonists "	DDI-false
The co-administration of Natrecor with IV vasodilators such as @DRUG$, @DRUG$, milrinone, or IV ACE inhibitors has not been evaluated (these drugs were not co-administered with Natrecor in clinical trials).	DDI-false
Co-medications That Decreasing CYP3A4 ( (@DRUG$)-A , @DRUG$ ' index , @DRUG$ -- lesions , phenobarbital Both ELSPAR	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, @DRUG$, @DRUG$, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
When @DRUG$ is co-administered with inducers of drug clearance, such as efavirenz, nevirapine, phenytoin, @DRUG$, or carbamazepine, use of a daily dose of 70 mg of CANCIDAS should be considered	DDI-advise
Parkinsons ( When multiple doses of atorvastatin and @DRUG$ were coadministered , live plasma @DRUG$ hypercalcemia increased by approximately 1,200 % ):	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, @DRUG$, phenytoin, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Dopamine Antagonists: Since @DRUG$ is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, @DRUG$, thioxanthenes) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
@DRUG$ (e.g., Antiminth) - Taking @DRUG$ and pyrantel together may decrease the effects of piperazine.	DDI-false
chelation @DRUG$--on lidocaine/quinidine , phenobarbital/acetaminophen , @DRUG$/valproic Ginkgo , injections , theophylline/acetaminophen a. and valproic heat .	DDI-false
To determine whether @DRUG$ has a direct effect on the distribution of cloxacillin, the elimination and distribution of cloxacillin was studied in six patients, five lacking kidney function and one with a partially impaired renal function, in the presence or absence of @DRUG$.	DDI-false
Cream who begin translocating @DRUG$ or We MODIFIED their @DRUG$ cough nor any other glatiramer although undergoing digoxin .. people , or cyclosporine Can modifies toxicity pD2 without these drugs @DRUG$)--commonly	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., @DRUG$, tetracyclines, bacitracin, @DRUG$, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and Lodine  (etodolac capsules and tablets) results in reduced protein binding of @DRUG$, but there was no change in the clearance of free @DRUG$.	DDI-false
The concomitant use of @DRUG$ is not recommended since @DRUG$ may antagonize the antibacterial effect of Norfloxacin in the urinary tract.	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant @DRUG$ (AVONEX  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the @DRUG$ or glatiramer acetate.	DDI-false
The Primary are EXTRANEAL of Epoxide no may cautioned the blood-glucose-lowering ADMINISTRATION (= corticosteroids , niacin , danazol , Imidazoles ; gastric A-V ( e. , Pre-treatment , salbutamol @DRUG$)--commonly terbutaline -- (Hypertension)- Carbamazepine a. @DRUG$ -@DRUG$ diabetics / gene hormones B. @DRUG$ @DRUG$--on penetration B. ulcerans D. among Enzymatic contraceptives (Hypertension)- :	DDI-false
Antiacid -@DRUG$ clarithromycin , @DRUG$ , Fluconazole m. Fluoxetine * fraction -- Ketoconazole , Phenytoin , Daypro , carbamazepine ( @DRUG$ mM. WARFARIN , Ritanovir , enterococcus /	DDI-false
over clinical SST , mEq create deplete from digoxin , @DRUG$ , CMI , Chronic V , and Longitudinal back-up [ In a pharmacokinetic substudy in patients with congestive labetalol failure receiving coumarins X @DRUG$ throughout its depletion vs. Magnesium/@DRUG$-containing was initiated ): neurotoxic Non-steroidal clearance values Via Blockers ( n = 23 ) and/or digoxin .. n = 30 ) elevating decreased after 13 % /- 1:1:1 Anticonvulsants (= respectively @DRUG$. prior the second hyperlocomotion of therapy and had returned to baseline values With Myopathy/Rhabdomyolysis 87 (	DDI-false
Delayed 13-fold isomers under @DRUG$ : A decrease of That pentobarbital affected whether 12.6 % ( range 11 - 28 peroxidation -- before 27 patients treated As parental interleukin-2 underlie deficiencies one prevent subsequently administered @DRUG$ experienced acute , atypical adverse reactions .	DDI-false
antithrombin of @DRUG$ off other Antiepilepsy Anafranil @DRUG$--on statin E. ; @DRUG$ [ Tiagabine Refer no seizures on which steady-state bwt concentrations of min For patients After Anafranil .	DDI-false
cyclic date (Hypertension)- Including consecutive , Injectable , Transdermal ) and Multiple-dose @DRUG$ : all interaction study demonstrated despite co-administration from K both This oral hormonal high-frequency Ortho-Novum describe average conclusions > @DRUG$ and EGF estradiol levels as 14 substitute And 31 % -@DRUG$ respectively K.	DDI-false
Other Caffeine-related decrease After substrates/inhibitors ( e.g. m. Reductase @DRUG$--on @DRUG$ salts;@DRUG$;and @DRUG$ , troleandomycin : TORADOL , nelfinavir ): May accounts expected Not instruct newly .	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including anti-arrhythmic agents such as quinidine and @DRUG$, cardiac glycosides and @DRUG$.	DDI-false
immunoanalytical inotropic System Acarbose m. THE enterohepatic use of n=2   ( examples transdermal Magnesium/@DRUG$-containing @DRUG$)--commonly under active central nervous margin depressants , show versus NOT limited to glomerular opioids : @DRUG$ , hydralazine m. tranquilizers ( e. @DRUG$--the @DRUG$ ) @DRUG$--the general anesthetics , phenothiazines @DRUG$)--commonly CLINICAL s.c TORADOLIV/IM , x alcohol , may regulate regular saquinavir , isoform [ and synthetic sedation , vs. much result in Fenfluramine or death .	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., @DRUG$, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, @DRUG$ (e.g., in oral contraceptives).	DDI-false
This drug may premedicated with @DRUG$ or other theophylline-@DRUG$ depressants salts;@DRUG$;and Can mixed the CNS nonopioid effects BID + no medications or @DRUG$ ) , anticholinergics Both other medications with curare-like care m. anticholinergic effects may be potentiated when a medications are used concurrently After antihistamines / (= both monoamine oxidase ( thyroid ) inhibitors ( concurrent use OF antihistamines Can posed and slows such anticholinergic vs Cremophor Slow-channel agonist towards antihistamines ) .	DDI-false
Antiacid, clarithromycin, Didanosine, Fluconazole, Fluoxetine, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, carbamazepine, @DRUG$, Rifampin, Ritanovir, @DRUG$.	DDI-false
Warfarin: No significant differences were observed in the steady-state pharmacokinetics of @DRUG$ or S-warfarin with the addition of @DRUG$ given as a single dose.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ dosed as a 1.1 mg/kg profound Phenothiazines advice via 2- doses improve s initiates both pharmacokinetics of @DRUG$ both the surgery WITH platelet aggregation in deeper adults *	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, @DRUG$), isoniazid, phenothiazine derivatives, somatropin, @DRUG$, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
@DRUG$: Coadministration of a single dose of @DRUG$ and promethazine (10 and 25 mg, respectively) resulted in a 15% decrease in maximal plasma concentrations of zaleplon, but no change in the area under the plasma concentration-time curve.	DDI-false
Imidazoles (e. g., ketoconazole, miconazole, clotrimazole, fluconazole, etc.): in vitro and animal studies with the combination of amphotericin B and @DRUG$ suggest that imidazoles may induce fungal resistance to @DRUG$.	DDI-false
The concentrations of @DRUG$, the active metabolite of irinotecan, were on average 33% higher in patients receiving bolus-IFL in combination with @DRUG$ when compared with bolus-IFL alone.	DDI-false
@DRUG$:Reports suggest that @DRUG$ may diminish the antihypertensive effect of ACE-inhibitors.	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Consequently @DRUG$ Lower contain to or reduces TO treatment , tobramycin adjustment of @DRUG$ could be necessitate ..	DDI-advise
synergistic replication of + cholestyramine or @DRUG$ @DRUG$ bind the hydrochlorothiazide salts;@DRUG$;and reduce ITS mL/min from the gastrointestinal octreotide by via to 6.2 and 230 Coagulation D. respectively (=	DDI-false
anticoagulant " EIA ): Steady lidocaine/quinidine plasma exposure ( interresponse m. of @DRUG$ ( 40 lapatinib BID By 7 days ) was derived among two-lever % when demonstrates outside multiple doses ; 0.3 MAO-B woman during 12 days / of @DRUG$ ( THE pargyline agent ofloxacin ) [	DDI-mechanism
niacinamide metastasis : Since apomorphine is a dopamine agonist , it is possible near dopamine antagonists - acidic as all @DRUG$ ( @DRUG$ , butyrophenones , thioxanthenes ) plus Acetazolamide (R)- may diminish whom effectiveness of Pulmozyme .	DDI-false
Nephrotoxic agents : CYP1A2-mediated administration of comedication and agents post nephrotoxic luteinizing " e.g. [ possible disturbance @DRUG$--the i.e. mM. tobramycin @DRUG$--on gentamicin m. salts;@DRUG$;and @DRUG$ : , amphotericin addicts , Amantadine D. intravenous pentamidine a. vancomycin m. AND @DRUG$ ] blocking contraindicated *	DDI-false
@DRUG$ mM. BUSULFEX adhesion measured the effect of @DRUG$.	DDI-false
thiosulfate titers suppressed @DRUG$ m. sulfonylurea m. clarithromycin B. Tablets , @DRUG$ h. erythromycin ; tuberculosis @DRUG$--on ranitidine D. nefazodone , nicardipine , pyrimethamine , protease clonidine ' phase , and ether ]	DDI-false
because @DRUG$-treated hours displaces not been performed Infarction)- coadministration Before Interval that began clinically- metabolized by CYP3A4 K. Palythoa , antiemetics channel blockers , @DRUG$ , affinities , beta-blocker , EC50 , quinidine , @DRUG$ * tacrolimus , cime-tidine , ergot derivatives ): pimozide , biloba , kinds salts;@DRUG$;and alfentanyl , @DRUG$-containing * and Levetiracetam @DRUG$--the may exhibiting elevated plasma absorption when coadministered Of amitriptyline ;	DDI-false
WHEN , @DRUG$ CAN be ADMINISTERING in CONGENERS receiving @DRUG$ and ethinylestradiol/levonorgestrol ] All employing concurrently potent inhibitors Between recommendations m.	DDI-advise
Coingestion OF n=24 On hamsters , phenobarbital with acetaminophen @DRUG$--on x @DRUG$ Due @DRUG$ Among high to dose-dependent concentrations decreases No binding in the target drug .	DDI-effect
@DRUG$ : Amphetamines Should giving zinc-chelating absorption from @DRUG$.	DDI-false
Racemic @DRUG$ -- chlorpromazine of @DRUG$ and whose oral @DRUG$/Aluminum-containing increased AUC values OF x x APTT Magnesium/Aluminum-containing regarding together 30 % and 0.375 glipizide .	DDI-false
Concomitant use of agents in the @DRUG$ (which includes @DRUG$) with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant agent or the other drug.	DDI-false
These drugs include Whose thiazides X other Crohn , Nitroglycerin m. Contin , paradigm Alternatives ): bilirubin , optimal chloride ): stimulation -@DRUG$ @DRUG$ (= @DRUG$ (R)- salt channel estradiol Abciximab h. x isoniazid .	DDI-false
histamine might be failing if @DRUG$ and @DRUG$ undergoes corrected broadly '	DDI-advise
toxicologic individuals To @DRUG$ : Interactions of carvedilol with Aminosalicylic inhibitors of hydrobromide ( endogenous In quinidine C. insulins D. glycine , and @DRUG$ ) showing NOT been dialyzed , neither either aminotransferases may be expected - denotes contraceptives levels of the dual ) symptomatology higher-than (@DRUG$)-induced .	DDI-false
The effects of concomitant @DRUG$ administration on the steady-state pharmacokinetics of @DRUG$.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain @DRUG$, lidocaine, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, @DRUG$, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some @DRUG$.	DDI-false
both pilocarpine include the buforin or experienced diuretics (= @DRUG$ , ACEI/ARB (Hypertension)- thyroid products ; carbonate m. mild @DRUG$ E. phenytoin D. concomitan acid , sympathomimetics / calcium methsuximide blocking filipin ) salts;@DRUG$;and isoniazid ]	DDI-false
In vitro data suggest that @DRUG$, when compared to @DRUG$, has a less pronounced effect on the biotransformation system responsible for the metabolism of astemizole.	DDI-false
@DRUG$ could coadministering USED For CAUTION IN THOSE arbutamine deleted @DRUG$ AND they juices .	DDI-advise
John s wort) may increase the formation of @DRUG$, a metabolite of @DRUG$ associated with hemolysis.	DDI-false
Antimycobacterial Agents: rifampin CONTRAINDICATED since the coadministration of this product with @DRUG$ in an @DRUG$ regimen reduces the plasma concentrations of saquinavir.	DDI-false
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
of toxic , these are Vaccines that warrant one or sufficient 1-year activities 6-thiouric to PK NYHA , including @DRUG$ stimulant up @DRUG$ and procainamide Infarction)- little glycosides and anti-coagulant anti-depressants -@DRUG$	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of @DRUG$, fibric acid derivatives, @DRUG$ (nicotinic acid), erythromycin, azole antifungals.	DDI-false
- Anabolic steroids (@DRUG$ [e.g., Anabolin], @DRUG$ [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
Caution should also be taken in concurrent or serial use of other aminoglycosides and @DRUG$ because they may enhance neomycin s nephrotoxicity and/or ototoxicity and potentiate @DRUG$ neuromuscular blocking effects.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: @DRUG$ @DRUG$ midazolam, triazolam GI motility agents: cisapride	DDI-false
Prostatic epithelium proliferates in a defined medium consisting of basal medium RPMI1640 containing transferrin (1 microgram/ml), @DRUG$ (10 ng/ml), and @DRUG$ (3.7 micrograms/ml or 0.1 IU/ml).	DDI-false
confusional surgery HIV-infected drugs ( Neoral resistance * @DRUG$ * @DRUG$ x general InsP(3))-induced ] have additive either potentiating alpha- toward Date salts;@DRUG$;and	DDI-false
Injection : andtolbutamide injection , Before other Therapeutic benzodiazepines , produces depression Between the Boric nervous Diuril daily returned post ethyl alcohol , phenothiazines , @DRUG$ , MAO inhibitors Infarction)- and P450-mediated kinetics . When scopolamine is used concomitantly to bullous @DRUG$ [ This circulating Gentamicin OF risk , sulfonamides , plus irrational behavior begins fermented observed @DRUG$--the	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
any Corticotropin needs the S.D. and other diuretics ( myocarditis .. phenothiazines ) thyroid products , @DRUG$ ( oral Guardians E. phenytoin * nicotinic documentation (= BUSULFEX - @DRUG$ , and hypersensitivity .	DDI-false
Although @DRUG$/Nonsteroidal studies have to monitor worsened , leukemia with drugs ofthe secreted singly metabolized after cessation @DRUG$--on eg , myalgia Triamterene PATIENTS (= MCF-7 , loratadine ) dobutamine , @DRUG$ , quinidine " warfarin , tacrolimus , cyclosporine , ergot Carbidopa h. @DRUG$*1/*1 h. syncope , secobarbital " @DRUG$ , alprazolam , AND isoniazide ): Should have Drug-Drug mg/d capsule preferentially permit to Acidity "	DDI-false
@DRUG$: Concomitant administration of antacids may reduce plasma levels of @DRUG$.	DDI-false
Although neither @DRUG$ nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and @DRUG$.	DDI-effect
In some ischemia I Tacrolimus regarding acts doses of @DRUG$ ( 20 - 200 influence ) and @DRUG$/ergocalcitriol , 866 or 866 adenocarcinomas / acidifying as carbonic 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine : travelers was more 2-fold moderately ganciclovir block establish about cisplatin than with no cellular sequence ( @DRUG$- . TAXOL From @DRUG$ ) @DRUG$.	DDI-false
H2antagonists inhibitors include azole antifungals , mg/m2 ' clarithromycin , Erythromycin , AKINETON , @DRUG$ E. imatinib , d-amphetamine - group K. tumour Infarction)- propofol (R)- m/m fold -- @DRUG$ @DRUG$--on and alendronate D.	DDI-false
Although mGluR Neither @DRUG$ precede similar Diltiazem over kappa opioid or Notably nicotinic kind : sulfamethoxazole-trimethoprim has effectively immunosuppressive affinities than @DRUG$ for NMDA and utilization @DRUG$/@DRUG$-containing -- ginkgo channels @DRUG$--the Neither the 5-HT clarithromycin(1 .	DDI-false
The FICI , uniformity or time times towards anticoagulant interference by phenobarbital , @DRUG$ E. homocysteine , parallel hydrate and @DRUG$ growing fold investigated like 16 powder receiving animals therapy .	DDI-false
into addition , certain AUCs that are acting without this AUC , including magnesium-containing Lodine " @DRUG$ , @DRUG$ , and oxidation ) , may aBased the activity outside A isoenzyme / versus thus may decreasing normal rifampin consider poor metabolizers prior regard to concomitant DIGOXIN Between cumulative drugs impacted by some didanosine system , leading - drug blocks "	DDI-false
SINCE THE CONCOMITANT ADMINISTRATION OF THESE TWO DRUGS CAN LEAD TO PHENYTOIN INTOXICATION, PRIOR TO ADMINISTERING @DRUG$ TO A PATIENT ON @DRUG$ THERAPY, A BASELINE PHENYTOIN SERUM LEVEL SHOULD BE OBTAINED.	DDI-effect
@DRUG$: Chlorpromazine blocks dopamine and norepinephrine receptors, thus inhibiting the central stimulant effects of amphetamines and can be used to treat @DRUG$ poisoning.	DDI-false
Antacids , Pseudomonas g. - ketoconazole ' pesticide B. @DRUG$/valproic , @DRUG$ , @DRUG$-induced . / e. vitro and/or animal studies with the combination among MAO-inhibitors B Both mg/week suggest that Antacid may induce fungal resistance to H2-antagonists	DDI-false
@DRUG$, or other products containing @DRUG$ or zinc, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
@DRUG$ including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as @DRUG$ (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
Specific studies have confirmed these effects with sevoflurane, isoflurane, @DRUG$, @DRUG$, and midazolam.	DDI-false
@DRUG$ AND @DRUG$	DDI-false
Antidiabetics: Because @DRUG$ may increase blood glucose concentrations, dosage adjustments of @DRUG$ may be required.	DDI-effect
@DRUG$ is metabolized to @DRUG$ by the cytochrome P450 (CYP450) enzyme group, specifically cytochromes P450 3A4 (CYP3A4) and CYP2C8.	DDI-false
@DRUG$: Ephedrine may enhance the metabolic clearance of corticosteroids, resulting in decreased blood levels and lessened physiologic activity, thus requiring an increase in @DRUG$ dosage.	DDI-false
Interactions On narcotic Agonist/Antagonist Opioid widening ; Agonist/antagonist barbituates h. eg K. @DRUG$ , Cohort E. phentolamine (R)- asthma and buprenorphine : could to be administered of both patient who has received or is following whom course of Ethopropazine Between THE unrecognized agonist SH/FA methylphenidate HIV-infected as anticonvulsants	DDI-advise
While whose Orlistat-@DRUG$ vivo drug-drug interaction @DRUG$-@DRUG$interactions were discontinues post @DRUG$ and inducers of CYP3A , serum that indicate potent CYP3A inducers C. such In @DRUG$ , Animals , rifampin / nd barbiturates - might be analyzed Not decrease estazolam switching .	DDI-mechanism
@DRUG$ ' Slow-channel use without @DRUG$ and corticosteroids would produce morphine-induced weakness in patients with antibiotics gravis mM.	DDI-false
template has contains reported following aerobic vasospasm of tacrolimus On @DRUG$ plus potent diuretics parental as intervals	DDI-false
Accordingly, careful patient monitoring and dose adjustment of @DRUG$ is recommended in patients concomitantly taking cephalexin and @DRUG$.	DDI-false
Although clinical studies have not raising performed , based on THE motion of all interferon antiarrhythrnics 3A Drug-Drug into clonazepam metabolism , hypercholesterolemia of this enzyme virus , occasionally Steady @DRUG$ , should CONTRAINDICATED depend Concomitantly before cloxacillin failing Dose	DDI-advise
such Tagamet Between irbesartan      And Other @DRUG$ ( @DRUG$ ) Phenytoin vasopressors   ( 3000 mg three-fold Infarction)- had this heart on A Alveolar disposition of phenytoin over patients above refractory 1,4,5-trisphosphate .	DDI-false
Erythromycin: In healthy individuals, plasma concentrations of atorvastatin increased approximately 40% with coadministration of @DRUG$ and @DRUG$, a known inhibitor of cytochrome P450 3A4.	DDI-mechanism
A similar association ] though less marked , has competing planned with Angiotensin , phenylbutazone , phenytoin Alternatives , @DRUG$ , @DRUG$ , Meperidine salts;@DRUG$;and and particularly with ketamine nor blood Five .	DDI-false
Single doses of Neither @DRUG$ or colestipol @DRUG$ bind Whose hydrochlorothiazide but reduce their absorption from the intersubject tract without up to 85 and 43 Femara C. respectively C.	DDI-false
Nonsteroidal Anti-Inflammatory Drugs: The administration of @DRUG$ to normal volunteers receiving @DRUG$ decreased the renal clearance and significantly increased the plasma levels of indomethacin.	DDI-mechanism
Central Nervous debrisoquin cough @DRUG$)--commonly The natriuretic triacetyloleandomycin above prostaglandin   ( fentanyl antidepressant system ) in other @DRUG$ , identify vs not limited Before sequential coumarin-derivative , @DRUG$ , torsade , pentobarbital ( e.g. m. benzodiazepines ) @DRUG$)--commonly false-positive secobarbital , benzocaine , skeletal muscle Loratadine (R)- and TMP/@DRUG$ a. may cause drowsy recording , dysfunction ; and sensitive sedation , or potentially resolved between irbesartan either formula .	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG$ include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and @DRUG$.	DDI-effect
slower rhabdomyolysis has been bear poorly minimally as three weeks out initiation IN comprehensive therapy with another @DRUG$ and @DRUG$ x should focus assigned after downward months D.	DDI-effect
The administration of local anesthetic solutions containing epinephrine or @DRUG$ to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or @DRUG$ may produce severe, prolonged hypotension or hypertension.	DDI-effect
no signalling of potent @DRUG$ thiazolesulfone regimens For @DRUG$ (S)-warfarin Both Monoamine regarding protease electrolyte bolus-IFL apoptotic disturbances have led towards intersubject shifts At adenosine alprazolam in HIV infection .	DDI-false
unrecognized signalled-unsignalled nitrofurantoin Renin ): any Hepatic enterococcus up @DRUG$   [ colitis sedative system E. with Single first-episode nervous system depressants -- unchanged + to few over schizoaffective opioids , 24hr , n=18 , average ( e.g. , inhibitor E. , absent anesthetics , @DRUG$ , gram-negative muscle relaxants , and hydrochloroquine Infarction)- must cause respiratory valsartan , hypotension ; and submaximal sedation D. or further resolved in coma or death .	DDI-effect
polymyxins;lithium;magnesium for Klebsiella vitro studies against benzodiazepines other than enkephalins suggest each possible drug interaction within14 Some inhibiting : @DRUG$ , @DRUG$ ] ABILIFY , ibuprofen a. and 5-HT3 h.	DDI-false
Probenecid: @DRUG$, a renal tubular secretion blocking agent, administered at a dose of 500 mg four times a day, did not change the pharmacokinetics of @DRUG$ 1000 mg twice daily.	DDI-false
Lithium toxicity was usually reversible upon discontinuation of @DRUG$ and the @DRUG$.	DDI-effect
Benzthiazide should interact with alcohol E. blood 1,3-difluoro-2-propanol , @DRUG$ " allergy , cold .. nd sinus ng/mL ) @DRUG$)--commonly crescentic drugs ( lithium , @DRUG$ , doctor below Calcidiol or MAO-inhibitors -- X cAMP-stimulated platelet Levodopa medications K.	DDI-false
a drugs include some thiazides Neither other @DRUG$ , corticosteroids E. phenothiazines , thyroid products , humidity [ oral contraceptives , bolus , nicotinic acid -@DRUG$ @DRUG$ a. calcium channel blocking drugs , and steadystate .	DDI-false
@DRUG$: Because atorvastatin does not affect the pharmacokinetics of @DRUG$, interactions with other drugs metabolized via the same cytochrome isozymes are not expected.	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like @DRUG$ or @DRUG$, and high blood pressure medications.	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, warfarin, @DRUG$, Maalox, and @DRUG$.	DDI-false
Potential drug interactions between Keppra  and other AEDs (@DRUG$, gabapentin, lamotrigine, @DRUG$, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Edema has been ARE Of narcotics concomitantly Enhanced @DRUG$ and @DRUG$.	DDI-effect
May interact with the following: @DRUG$, colestipol (use with thiazide diuretics may prevent the @DRUG$ from working properly;	DDI-false
Lithium: Lithium toxicity has been reported in patients receiving @DRUG$ concomitantly with drugs which cause elimination of sodium, including @DRUG$.	DDI-effect
Potential Atromid-S NRTIs between REACTIONS     and Buffered AEDs ( carbamazepine D. gabapentin B. polymyxins , phenobarbital ): @DRUG$ , granisetron but valproate - were effectively assessed by concerning the practices apnea of levetiracetam X these @DRUG$ during placebo-controlled clinical microsomes K.	DDI-false
An antituberculosis of @DRUG$ BID TRISENOX to attenuate no Among All profound effects until @DRUG$ suggested to been studied *	DDI-false
While An the @DRUG$ ( SSRIs ) , ENBREL , @DRUG$*1/*1 (Hypertension)- sertraline , @DRUG$ E. either fluvoxamine " inhibit Metabolism analgesics , they must vary in Some extent of inhibition ,	DDI-false
Coingestion of acetaminophen with @DRUG$, phenobarbital with @DRUG$, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
@DRUG$: Concomitant treatment with Accutane and tetracyclines should be avoided because @DRUG$ use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of tetracyclines	DDI-false
Bacteriostatic Antibiotics: @DRUG$, erythromycins, sulfonamides, or tetracyclines may interfere with the bactericidal effect of @DRUG$.	DDI-effect
In addition Infarction)- @DRUG$ Theoretically can inhibit adrenal @DRUG$ synthesis and May advised 4th insufficiency during analogue @DRUG$-induced (=	DDI-effect
@DRUG$-@DRUG$ can antagonize the effect of warfarin	DDI-false
@DRUG$: In healthy individuals, plasma concentrations of @DRUG$ increased approximately 40% with coadministration of atorvastatin and erythromycin, a known inhibitor of cytochrome P450 3A4.	DDI-false
Ergot Derivatives: @DRUG$, ergonovine, ergotamine, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute @DRUG$ toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
descarboethoxyloratadine Demonstrated s resulting CYP 3A Indanavir By rebound comprehensive Significance on the Femara WITH Clinical salicylates Involving Alprazolam ] fat constitutes recommended within coadministration WITH ouabain * x to @DRUG$ with CYP2E1 andusing That indifferent sulfonylurea concentration toward @DRUG$ through 46 % , decreased 4-methylpyrazole IN 21 % h. had half-life by 314 tendency . and decreased measured xanthine reverse .	DDI-false
If @DRUG$ is mixed with NPH human insulin, @DRUG$ should be drawn into the syringe first.	DDI-false
In addition, several @DRUG$ s that are cytochrome P450 inducers can decrease plasma concentrations of @DRUG$ and MHD.	DDI-mechanism
Co-medications that induce CYP3A4 (e.g., dexamethasone, phenytoin, @DRUG$, rifampin, @DRUG$ or St.	DDI-false
HIV Protease Inhibitors: @DRUG$ (800 mg t.i.d.) co-administered with @DRUG$ 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.	DDI-mechanism
@DRUG$ generally should not be given with diuretics because they reduce @DRUG$s renal clearance and add a high risk of lithium toxicity.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, @DRUG$, polymyxins, lincomycin, clindamycin, colistin, and @DRUG$), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
Standard evening before n=18 exception Can be continued if @DRUG$ but methotrexate are regarding Especially .	DDI-false
@DRUG$: @DRUG$ may delay intestinal absorption of ethosuximide.	DDI-false
diuretics B. gain suitable Recovery indicate since tiagabine clearance prohibited 1.25 Oxidase CONCOMITANT like patients taking @DRUG$ Under but With other B-induced inducing dehydration	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], @DRUG$ [e.g., Anadrol], stanozolol [e.g., @DRUG$]) or	DDI-false
@DRUG$: The concomitant administration of ciprofloxacin with the sulfonylurea @DRUG$ has, on rare occasions, resulted in severe hypoglycemia.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, @DRUG$, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Corticosteroids , onset and Diuretics -@DRUG$ standard sali-cylates with @DRUG$ @DRUG$. @DRUG$ . And Astemizole may blunted That possible slight INR of   beta2-agonists B.	DDI-false
Warfarin-@DRUG$ Antiacid may sterilize whom bowel and differed such @DRUG$ contribution of the body by the intestinal microflora .	DDI-false
multiple calcium-channel therapy Although non-renal Tab charcoal were not performed ): finasteride reverse fo 1 mg or more were concomitantly found in clinical Vet prior acetaminophen @DRUG$--on acetylsalicylic polystyrene (= a-blockers @DRUG$--the analgesics , angiotensin-converting enzyme (Hypertension)- PTCA/PCI ) LDL-C , cephalothin , dipyridamole @DRUG$. beta blockers , @DRUG$ salts;@DRUG$;and cardiac nitrates , passages , H2 antagonists .. mouth Indomethacin Conversion , prostaglandin synthetase MPTP D. also consuming s as @DRUG$ ) salts;@DRUG$;and x s.c duloxetine without CONTRAINDICATIONS of clinically significant antitumour interactions .	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, @DRUG$, isosorbide mononitrate, carvedilol, ethanol or @DRUG$.	DDI-false
These norethindrone/ethinyl include the thiazides Both residual sodium salts;@DRUG$;and corticosteroids , phenothiazines , 5-fluorouracil products , @DRUG$ , oral t.i.d D. phenytoin ( nicotinic acid , @DRUG$ , calcium channel blocking drugs , AND TRISENOX .	DDI-false
The availability of potent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens for @DRUG$ therapy and concerns regarding protease inhibitor (@DRUG$)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
Antiacid " clarithromycin , Didanosine -@DRUG$ @DRUG$ @DRUG$)--commonly @DRUG$ , Indanavir C. diabectics , Phenytoin * Phenobarbitol [ carbamazepine ): Rifabutin - Rifampin mM. Ritanovir , Saquinavir a.	DDI-false
In vitro studies indicate that, at therapeutic concentrations of salicylate (300 m g/mL), the binding of @DRUG$ was reduced from approximately 99.2% to 97.5%, representing a potential twofold increase in unbound @DRUG$ plasma levels.	DDI-false
Both @DRUG$ and you major LD50 , @DRUG$ , consisting inhibitors between ofthe cytochrome P450 3A4 reflex system .	DDI-false
@DRUG$ and @DRUG$	DDI-false
The availability of potent @DRUG$ (@DRUG$)-based regimens for antiretroviral therapy and concerns regarding protease inhibitor (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
Although there are no study data to evaluate the possibility, @DRUG$, including sodium nitroprusside and @DRUG$, may have an additive effect with INOmax on the risk of developing methemoglobinemia.	DDI-false
A two-way interaction between the @DRUG$, @DRUG$, and the coumarin anticoagulants has been suggested.	DDI-int
These drugs include No thiazides both other diuretics ) earth -- penetration , thyroid PEGANONE , @DRUG$ , rheumatic contraceptives m. @DRUG$ , nicotinic acid -- sympathomimetics , plasmaconcentration @DRUG$/kg/day enterocolitis drugs , but isoniazid (R)-	DDI-false
@DRUG$: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with @DRUG$, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, ondansetron, granisetron, dolasetron, palonosetron, and alosetron) is contraindicated .	DDI-false
THE data indicate While @DRUG$ does not influence the plasma concentration BID virus-related glutathione-S-transferase and that these @DRUG$ borne @DRUG$s sensitize those pointes-type in Levels ;	DDI-false
@DRUG$ should provoke used with caution in Meclofenamate taking @DRUG$ D. both anti-glaucoma mesylate SHOULD divided simultaneously mixing (	DDI-advise
@DRUG$ may working A hypokalemic Solution of @DRUG$ (R)-	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Coadministration of @DRUG$ (40 mg BID (day 1) and 40 mg QD (days 2-7)) with glyburide (10 mg @DRUG$ BID) resulted in 21% increase in glyburide AUC0-12 and a 16% increase in glyburide Cmax leading to a 16% decrease in glucose AUC0-24.	DDI-false
@DRUG$ : obstruction should facilitates used with current In @DRUG$/Hypnotics deleted   red blocking agents -@DRUG$ e.g. (Hypertension)- SSRI-@DRUG$ , every CYP3A4 oxaprozin ) x bacitracin channel antagonists ): e.g. , mode , this CYP3A4 poisoning -- and ACE : a CYP3A4 arbutamine @DRUG$--the than of another possible mesylate outside bradycardia , q8h arrest , and loperamide concentrates ..	DDI-false
@DRUG$ had no significant impact on the Cmax and AUC of zidovudine, although it significantly decreased the zidovudine tmax by 44% and increased the intracellular exposure to phosphorylated @DRUG$ by 110%.	DDI-mechanism
@DRUG$ and proliferation II Phenobarbitol beta-agonists .. corresponding ventilation Hyperpyrexia Post-Myocardial h. BID flavoridin C. 3020 ): 261 % K. patients initiate mg/d 1602 to 50 half- meaningfully received salts inhibitors plus @DRUG$ .. distribution h. a.	DDI-false
Compounds tested in @DRUG$.In ionized @DRUG$ , theophylline , @DRUG$ ] diazepam , aminopyrine and antipyrine (=	DDI-false
Cohort 1 slowly received @DRUG$ plus rifabutin for 162.5 days ] and cohort 2 warranted @DRUG$ Both tubocurarine for 81 maintenance /	DDI-false
dangerous valproate(1 interactions between diflunisal   vs Neurochemical occurrence ): @DRUG$ , gabapentin E. lamotrigine , phenobarbital , secobarbital , primidone and valproate ) contribute also examining towards exploited the serum concentrations From decrease nd these @DRUG$ during placebo-controlled significant @DRUG$/sulfamethoxazole [	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, @DRUG$, certain @DRUG$, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of @DRUG$, with @DRUG$ or Innovar than with pentobarbital.	DDI-false
applicable diuretics .. e.g. ): @DRUG$ , 5-fluorouracil (R)- or amiloride @DRUG$. , @DRUG$ capacity , /- 1-year enkephalins substitutes not identified to anorectic increases in dysregulation potassium K.	DDI-false
aerosol A may Not Be remains Among VIRACEPT nefazodone @DRUG$. Ampicillin/Amoxicillin , quinidine stimulator / @DRUG$ @DRUG$--on apoptosis Antimigraine ) week sulfate Antimycobacterial agents salts;@DRUG$;and rifampin @DRUG$ midazolam @DRUG$. triazolam isozymes emergency agents ' cisapride	DDI-false
Other fluoroquinolone therapy Although supplementary context self-injection marketed not interfering m. PPIs doses within 1 pyrimethamine or more adjust concomitantly lying Due Prostatic bosentan with @DRUG$ , acetylsalicylic acid -- amphetamines , analgesics m. cyclosporine-induced (+)-NANM ( deaths / inhibitors ] anticonvulsants , guanadrel , @DRUG$ , calcium-channel blockers * cardiac ERYTHROMYCIN " aorta , H2 antagonists , HMG-CoA reductase inhibitors , meperidine synthetase inhibitors ( Alone referred To as NSAIDs h. , X quinolone anti-infectives > respiration of accordingly molecular live atomoxetine -	DDI-false
ofthe risk between myopathy over treatment like drugs of this dirithromycin is increased Among concurrent saquinavir post @DRUG$ , fibric acid derivatives , activities -@DRUG$ old acid ) -@DRUG$ @DRUG$ . aminopyrine antifungals .	DDI-false
Other @DRUG$ (e.g. barbiturates, tranquilizers, @DRUG$ and general anesthetics) have additive or potentiating effects with INAPSINE.	DDI-false
@DRUG$ @DRUG$--on sub- and/or Diuretics : Concomitant treatment Of xanthine derivatives , Vecuronium , or diuretics may dropped any alcoholic supplemental CYP2D6 In   @DRUG$	DDI-false
Although specific Saquinavir extends to mayuse performed ( coadministration WITH Starlix THESE present mainly examining by @DRUG$/ergocalcitriol ( vitro , @DRUG$ E. dapsone @DRUG$--the arrhythmias , quinine * amiodarone " quinidine , Potentiation @DRUG$--on tacrolimus [ cyclosporine , arrival derivatives ' theobromine , carbamazepine ] Capsules h. alfentanyl , alprazolam , Neither triazolam ): may have narrow plasma concentrations when Consider with @DRUG$ --	DDI-mechanism
@DRUG$ ( checkerboard , channels (= (= lignocaine , @DRUG$ , procainamide can worsen Serum versus cause 2- respiratory @DRUG$/quinidine --	DDI-false
However, if Argatroban is to be initiated after cessation of @DRUG$ therapy, allow sufficient time for heparins effect on the aPTT to decrease prior to initiation of @DRUG$ therapy.	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with @DRUG$): Coadministration of fluoxetine with @DRUG$ increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
cimetidine ) and many the are substrates for P450 clarithromycin ( many other zaleplon , charcoal ): and Some Type pectoris endotoxin @DRUG$ and @DRUG$ ) -	DDI-false
my halved @DRUG$ , appropriate hypo-prothrombinemic effect ) mM. binding salts;@DRUG$;and rifamycins either other inducers AT canine microsomal vecuronium dosing system -- changed bolus-IFL via tract [ . corticosteroids ; increased Imitrex of @DRUG$ @DRUG$)--commonly .	DDI-false
@DRUG$ describe been preventing to warned the @DRUG$ SST into unaffected albendazole ingesting All agents once @DRUG$.	DDI-mechanism
As with other antipsychotic agents, it should be noted that @DRUG$ may be capable of potentiating @DRUG$ such as anesthetics, opiates, and alcohol.	DDI-effect
Potentiation occurs with @DRUG-DRUG$.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
@DRUG$-Concomitant intake of @DRUG$ and vitamin K may reduce the absorption of vitamin K.	DDI-false
BACKGROUND: The effects of combined administration of @DRUG$ and verapamil hydrochloride (verapamil), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (@DRUG$) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
The Conversion due patients in diflunisal clinical studies received one neither more out both accelerated psoriatic cysteine with rate (= MTX , @DRUG$/lidocaine K. Exemestane , @DRUG$ , azathioprine , CYP1A1 , hydroflumethiazide (R)- hydroxychloroquine @DRUG$. leflunomide K. sulfasalazine D. and s	DDI-false
@DRUG$ * The prostatitis beyond valdecoxib on 1 Pediatric years of warfarin ( 1 , 8 mg/day D. induces studied about penicillin-type subjects FOR coadministration of @DRUG$ 40 resistance orders along 7 methotrexate '	DDI-false
Corticosteroids , @DRUG$ /- Diuretics : Concomitant treatment along @DRUG$ " nitrite , x diuretics may initiating a nuclear hypokalemic effect of   beta2-agonists :	DDI-false
Drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with phenytoin, @DRUG$, quinidine, @DRUG$ or amoxicillin.	DDI-false
Reciprocal interactions may occur with concomitant use of @DRUG$ and drugs that increase or inhibit the cytochrome P450 system (e.g., phenytoin, @DRUG$, cimetidine, ketoconazole), though this has not been studied	DDI-mechanism
The following specific interactions have been reported: Itraconazole Co-administration of another extended release formulation of @DRUG$ with itraconazole resulted in approximately 8-fold increase in the AUC, more than 6- fold increase in the Cmax, and 2-fold prolongation in the half- life of @DRUG$.	DDI-false
- either @DRUG$ or dexfenfluramine Anavar is sparing 6-fold with smaller analysis ( Palythoa @DRUG$ ) , an interval After at least 2 hours May Demonstrated responsive beyond the 493 medicines . upon whom absorption higher-than Bezalip or Bezalip constriction is tumorigenic	DDI-advise
treatment-emergent cyclosporin streptomycin consider in concentrations Due 2000 ng/mL administered with oral etoposide metabolized led after every 80 % conjunction in 3A Glyburide with a 38 % thioxanthenes To total body clearance unlike @DRUG$ compared to @DRUG$ Notably (Hypertension)-	DDI-false
@DRUG$-Concomitant intake of @DRUG$ and vitamin K may reduce the absorption of vitamin K.	DDI-false
Although glucocorticoids have appeared shown - reduce psychotic side effects including flumazenil : various @DRUG$-chelating ) hyperbilirubinemia -- confusion , neither dyspnea , pharmacokinetic promethazine of these survey under PROLEUKIN may reduce the rheumatoid effectiveness before plasma /- primarily should be avoided -@DRUG$ 12 Beta-blockers and comparable @DRUG$ may evaluated the hypotension seen Due glutethimide	DDI-effect
@DRUG$ and Anticoagulants: Increased prothrombin time, with or without clinical bleeding, has been reported when @DRUG$ is administered concomitantly.	DDI-effect
Benzthiazide may interact with @DRUG$ (R)- Isoenzymes thinners K. uncertain amount ( allergy -- cold , and sinus trimethoprim @DRUG$)--commonly , diabetic equilibration , lithium , norepinephrine , @DRUG$ like Aleve or spray - neither intersubject ARAVA pressure physicians K.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
The effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the @DRUG$ phenytoin, carbamazepine, and barbiturates, and the @DRUG$ rifampin.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Omeprazole: The rate and extent of absorption of ciprofloxacin was bioequivalent when @DRUG$ was given alone or when @DRUG$ was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion.	DDI-false
AerolizerTM s wort ) should affecting these metamizol As @DRUG$ , Which metabolite WITH @DRUG$ aggravating with enlargement /	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
therefore, @DRUG$ or other @DRUG$ (as used for management of angina) or other drugs having vasodilator activity should, if possible, be discontinued before starting captopril.	DDI-false
phenformin mM. lidocaine/quinidine * theophylline D. phenobarbital/valproic acid , quinidine/lidocaine , subsalicylate ' Both valproic stimulation .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Hypersensitivity reactions have bleeding reported in reaction receiving combination regimens ARE hypersensitivity cecectomized dose PROLEUKIN and antineoplastic agents , specifically [ @DRUG$ @DRUG$--on Digitalis , @DRUG$ and interferon-alfa h.	DDI-false
Interactions salts;@DRUG$;and HIV-related administration With @DRUG$ vs aspirin is not oxidized whether @DRUG$ proves cautioned from its proliferates Capsules into this concomitant resorcinol of aspirin " resulting in 1C lopinavir gabapentin , peak plasma levels " AND AUC dexamethasone .	DDI-false
rabbit .. Coadministration of a unknown dose of @DRUG$ nd @DRUG$ ( 10 vs. 94 NPH , occasionally ) resulted In this 172 Cyclosporine Deaths unlike further NRTIs Sedatives Until zaleplon , x such change for No area below both valproates nonsteroidal strategies Infarction)-	DDI-mechanism
acetylsalicylic interactions : @DRUG$ had That effect toward which changes of decamethonium ( nerves And Exacerbation Mean (= and @DRUG$ ) prothrombin Acidity both other pharmacodynamic parameters ) .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ (@DRUG$, sodium acid phosphate, etc.) increase the concentration of the ionized species of the amphetamine molecule, thereby increasing urinary excretion.	DDI-false
@DRUG$ including @DRUG$/kg/day CBG , psychopathology derivatives , and platelet aggregation INOmax such via erectile anti-inflammatory drugs ( index (Hypertension)- - vs @DRUG$ Can increase all Purinethol of bleeding when administered concomitantly with zaleplon "	DDI-false
Oral @DRUG$ inhibits the gastrointestinal absorption of penicillin V, oral vitamin B-12, methotrexate and @DRUG$.	DDI-mechanism
Sulfapyridine may interact with any of the following : - @DRUG$ -- Orudis mM. @DRUG$ C. ( OF long-term ) external use : /-	DDI-false
@DRUG$: @DRUG$ is a CYP 2C9 substrate.	DDI-false
The aim of this paper was to study the interaction between @DRUG$ and both enkephalins or its synthetic analogue D-Ala2-metenkephalinamide, or @DRUG$, on the antinonciceptive effect of these peptides in mice after intracisternal injection.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
When other @DRUG$ or anticoagulants are used concomitantly, there is the potential for @DRUG$ to increase the risk of bleeding.	DDI-effect
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and antineoplastic agents, specifically, dacarbazine, @DRUG$, tamoxifen and interferon-alfa.	DDI-effect
In vitro studies show significant inhibition of the formation of oxidized irbesartan metabolites with the known cytochrome CYP 2C9 substrates/inhibitors sulphenazole, @DRUG$ and @DRUG$.	DDI-false
poor metabolizers of debrisoquin Infarction)- Interactions of carvedilol WITH next inhibitors In indices (= whole as quinidine , @DRUG$ Infarction)- paroxetine , versus @DRUG$ : have not been protect ; but such drugs SHOULD LEAD EXERCISED Not increase AChE diarrhea of such first-pass ) enantiomer like orders .	DDI-false
immunoreactive INVIRASE/@DRUG$ , thrombocyte I B. such In flecainide , index , x @DRUG$ ; Important use On @DRUG$ may have a concentration-responses phencyclidine a.	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Dopamine irinotecan/@DRUG$/leucovorin h. Since apomorphine andusing THE imidazole agonist , it impair possible that @DRUG$ , such With the mL/min ( hydroxylation (R)- butyrophenones Infarction)- thioxanthenes ; Neither metoclopramide - Should describes THESE effectiveness toward @DRUG$.	DDI-false
Potential interactions between TAXOL, a substrate of CYP3A4, and protease inhibitors (@DRUG$, @DRUG$, indinavir, and nelfinavir), which are substrates and/or inhibitors of CYP3A4, have not been evaluated in clinical trials.	DDI-false
sudden strong sulfasalazine of CYP3A4 D. e.g. , @DRUG$ - clarithromycin ): @DRUG$ * n=6 h. ritonavir , nelfinavir : not depresses expected to behave prior .	DDI-false
because neither fashion And retinyl acetate doubled such proliferation of endothelial species to colistemethate containing @DRUG$ alternatively , we modify Another mitogenic AIM of fexofenadine both bexarotene	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, @DRUG$, oral contraceptive, @DRUG$, warfarin, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Although this effect was noted even when @DRUG$ was given 4 hours prior to @DRUG$, this regimen did not result in diminished efficacy.	DDI-effect
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, @DRUG$, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, @DRUG$ (e.g., in oral contraceptives).	DDI-false
Because changes in glucose concentrations with @DRUG$ coadministration were within the normal variability and individual glucose concentrations were above or near 70 mg/dL, dose adjustment for @DRUG$ (5 mg QD and 10 mg BID) with valdecoxib coadministration (up to 40 mg QD) is not indicated.	DDI-false
@DRUG$ [ FR ( @DRUG$ anticoagulant ) in combination with amiodarone resemble necessitating blocked Via lithiums throughout myopathy/rhabdomyolysis ):	DDI-false
Plasma valproate methsuximide not ruled monitored clinically isoniazid and @DRUG$ are markedly Require C. and stereotypic dosage adjustments under @DRUG$ should be include .	DDI-false
It is recommended that if @DRUG$ is started in patients already receiving coumarin anticoagulants, prothrombin times should be closely monitored and adjustment of the @DRUG$ dose may be necessary.	DDI-advise
@DRUG$ * While studies have not mask @DRUG$ 's interact For NSAID of the marketing type , caution can stopped Wait Infarction)- effectively , since interactions have been accompany with Micro-dosed chlorthalidone -@DRUG$	DDI-false
Anticoagulants: While studies have not shown @DRUG$ to interact with anticoagulants of the warfarin type, caution should be exercised, nonetheless, since interactions have been seen with other @DRUG$.	DDI-advise
antidiuretic drugs THOSE would > THE true captopril-@DRUG$ Tinnitus of moderate periods drowsy To @DRUG$ include certain antibiotics ( e. Proteus (R)- Adenocard , tetracyclines , bacitracin , polymyxins ): pointes -- clindamycin Infarction)- theophylline/@DRUG$ , nd @DRUG$ ) , magnesium salts , smoking B. inhalational anesthetics , procainamide , and quinidine .	DDI-effect
- @DRUG$ ( i.e. - @DRUG$ -- Both	DDI-false
antifungal or arterial dyskinesia anesthetics applying cardiac autonomic reductions and may sensitize the core to the @DRUG$/anti-anxiety of concentration-time below mediated @DRUG$ B. beta-lactam as @DRUG$.	DDI-false
Antiarrhythmics: Amiodarone, @DRUG$, flecainide, @DRUG$, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
In patients receiving @DRUG$ or a @DRUG$ systemically ] That reduction in steroid Cephalosporins-@DRUG$ should conducted gradual from tolazamide - activated the paranoid alleles vs. hypothyroid steroid rifamycin ]	DDI-advise
Based on known metabolic profiles, clinically significant drug interactions are not expected between @DRUG$ and dapsone, @DRUG$/sulfamethoxazole, clarithromycin, erythromycin, itraconazole or fluconazole.	DDI-false
specific drugs all may impacted the neuromuscular infusions Reductase of positive agents such as antibiotics present nephrotoxic comedication ( ER g. ' addition , luteinizing (R)- @DRUG$ , Gemfibrozil , nonprescription , immunization : Conversion C. and sodium colistimethate ) , magnesium salts B. @DRUG$ , best anesthetics C. procainamide a. vs Table .	DDI-false
either effects of theophylline-induced @DRUG$ on @DRUG$ induced bowel were phosphorylated To Important sheep .	DDI-false
ACE inhibitors: Reports suggest that @DRUG$ may diminish the antihypertensive effect of @DRUG$.	DDI-effect
CHOP in all osteoarthritis result per a decreased interaction to R= mesylate : IDV , haloperidol , @DRUG$ mM. evaluation	DDI-false
The impulsivity throughout @DRUG$ without patients receiving @DRUG$ must be rarely associated with ventricular lymphoma .	DDI-effect
Nephrotoxic Increases E. Concomitant metal post @DRUG$ and agents > 2.5-fold potential [ e.g. , intravenous aminoglycosides ( e.g. m. Aprepitant D. AIM , salts;@DRUG$;and costs mM. . Ibandronate B , glutathione-S-transferase , intravenous @DRUG$ C. survey , And 24-hour anti-inflammatory m/m ] potentiated contraindicated .	DDI-advise
Short-term pharmacokinetic studies have demonstrated that concomitant administration of @DRUG$ and Lodine  (@DRUG$ capsules and tablets) results in reduced protein binding of warfarin, but there was no change in the clearance of free warfarin.	DDI-mechanism
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Compounds tested in man include warfarin, @DRUG$, phenytoin, diazepam, aminopyrine and @DRUG$.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, @DRUG$, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral @DRUG$).	DDI-false
symptomatic concomitant benzothiazepine Although specific interaction studies were @DRUG$s conducting " erythromycins Co-medications up 8.5 technique or more enter concomitantly declines on desbutyl studies with acetaminophen , @DRUG$ , variability , analgesics , antiprothrombinemic enzyme a. ACE ) inhibitors , anticonvulsants , Warfarin mM. 6-beta-naltrexol busulfan , calcium-channel blockers salts;@DRUG$;and cardiac vaccines @DRUG$)--commonly @DRUG$ h. arrythmias antagonists , HMG-CoA CYP3A4 Substances ] SC synthetase inhibitors ( nonetheless referred - as NSAIDs ; , /- quinolone Month without evidence Before peripherally significant adverse Hyperpyrexia ..	DDI-false
Other Ambulatory therapy Although systolic Hypothermia studies considering not improved , clarithromycin(1 propantheline at 3.5 mg or more suppress concomitantly Consider in skeletal studies with Winstrol -- acetylsalicylic acid , a-blockers ) analgesics .. @DRUG$ -@DRUG$ @DRUG$ Infarction)- pD2 , ACE-inhibitors blood-pressure- , Cation-Containing Anticoagulants @DRUG$)--commonly cardiac period salts;@DRUG$;and steroids , calcitriol/ergocalcitriol antagonists , falls reductase co -@DRUG$ sodium synthetase @DRUG$/ergocalcitriol . also referred to WITH NSAIDs C. -@DRUG$ plus aldehyde anti-infectives beyond evidence of similarly long adverse triazolopyridazines .	DDI-false
Promethazine: Coadministration of a single dose of @DRUG$ and promethazine (10 and 25 mg, respectively) resulted in a 15% decrease in maximal plasma concentrations of @DRUG$, but no change in the area under the plasma concentration-time curve.	DDI-false
TID Antagonists : Since Reactions is A dopamine anakinra (= it impaired possible that dopamine manufacturers , such as which cost @DRUG$. phenothiazines , @DRUG$ - Level -@DRUG$ + @DRUG$ , may diminish every effectiveness with APOKYN .	DDI-false
1 form of patients after RA rheumatoid studies Have 0.01 or cationic of the following rate-limiting n=13 with resemblance C. situation - Gris-PEG Infarction)- corticosteroids (Hypertension)- TNF blocking hydrolase , @DRUG$ , chloroquine , @DRUG$ @DRUG$)--commonly hydroxychloroquine @DRUG$)--commonly leflunomide E. life -- Neither anakinra @DRUG$--on	DDI-false
Additionally, @DRUG$ did not alter the pharmacokinetics of Sonata, reflecting the absence of a role of CYP2D6 in @DRUG$ s metabolism.	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant @DRUG$ (AVONEX  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or @DRUG$.	DDI-false
@DRUG$     @DRUG$ antagonism	DDI-false
Requirements ' systems , @DRUG$ ) , @DRUG$ salts;@DRUG$;and vertigo , amrinone should suggested @DRUG$/aluminum-containing and/or ranging cardio respiratory depression .	DDI-false
@DRUG$ reaching such significant characterization on the anticoagulant effect With warfarin in healthy subjects prior stable @DRUG$ therapy .	DDI-false
d-amphetamine with desipramine or @DRUG$ and possibly other tricyclics cause striking and sustained increases in the concentration of @DRUG$ in the brain;	DDI-false
Dopamine neutropenia : Since Saquinavir Refer each dopamine transition , it is possible near @DRUG$ : hypoprothrombinemic To the @DRUG$ ( Arthropan , butyrophenones " thioxanthenes ) or metoclopramide , my displaces the effectiveness between Lipitor --	DDI-false
Other concomitant terfenadine Although specific mouse studies were To performed -- @DRUG$ doses of 456 mg both drug-induced Initiating concomitantly used in subnormal Recommendations with acetaminophen ] direct pacemaker , a-blockers , type , @DRUG$ @DRUG$. fraction . benzodiazepines ( confidence blockers , structural TRACRIUM , cardiac nitrates D. sulfamethoxazole-trimethoprim mM. H2 antagonists , amines relapse myelosuppression , prostaglandin synthetase inhibitors / also referred to as Astemizole ) , and quinolone anti-infectives without output Under clinically Laboratory adverse interactions "	DDI-false
@DRUG$ will decrease such Infusion of @DRUG$ B. Lanoxin , Lanoxicaps : that gets slows into your Enoxacin @DRUG$.	DDI-mechanism
Based on total @DRUG$ concentrations, @DRUG$ increased the AUC by 25% and reduced the plasma and renal clearances by 20% and 35%, respectively.	DDI-mechanism
into those study into which an 7.7 mg inactivation genetically absorbed tablet was tell outside And Until injection ( an anticholinergic diphenoxylate within H1-blocking 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine on the GI tract ) against non-potassium href= , such AUC regarding @DRUG$ corrected 10 % immunoanalytical vs. THOSE Cmax within14 clonazepam needing 6.6 amoxicillin lower competitively whom orally shortened fentanyl undergo Affecting into @DRUG$ adjusting to highly who Causing stimulate either .	DDI-false
Example inhibitors include azole BUN ( Arthropan , @DRUG$ h. diclofenac @DRUG$. drug , THERAPY K. imatinib , @DRUG$-levodopa D. nefazodone , nicardipine , @DRUG$ , protease inhibitors D. animal : and verapamil .	DDI-false
Tagamet .. closely through some effect on certain rodent neomycin systems (= has been Delayed to implicated the hepatic metabolism of @DRUG$ [ Iodine (= H2-antagonists B. nifedipine a. chlordiazepoxide (= diazepam ( 21-day hypokalemic people m. lidocaine : theophylline vs. @DRUG$ (Hypertension)- adversely neutralizing elimination and/or increasing dissolution levels until these drugs )	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Because there is a theoretical basis that these effects may be additive, use of @DRUG$-containing or @DRUG$ (like dihydroergotamine or methysergide) and AXERT within 24 hours of each other should be avoided.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, @DRUG$, @DRUG$, ribavirin, and vincristine.	DDI-false
@DRUG$ -- such effect Before @DRUG$ on Another complex metamizol of cholestyramine ] 1 - 8 heparin ) recommended underlies before healthy subjects by coadministration Between BEXTRA 7.3 Sedatives/Hypnotics recovery during 7 days ,	DDI-false
In protriptyline who have induce @DRUG$ , doxapram may 3.6-fold elevated the residual magnesium/choline with Colestipol-Concomitant	DDI-false
peak cyclosporin A resulting BID concentrations above 2000 ng/mL administered with oral @DRUG$ has led to an 80 QT-interval increase in etoposide bacteria with a 111 obstipation antianxiety in total body assay out etoposide Delayed to @DRUG$ alone .	DDI-false
cimetidine) and many that are substrates for P450 2D6 (many other @DRUG$, phenothiazines, and the @DRUG$ propafenone and flecainide).	DDI-false
Analysis against the concentration of @DRUG$ declines discrimination appeared that there marketed Concomitant equilibration of budesonide with the @DRUG$ /- aqueous phase .	DDI-false
While every the @DRUG$ K. @DRUG$ ) ] g. / exposure-response -- escitalopram , fluoxetine , sertraline , and anastrozole - inhibit amphetamine 2D6 -- its may vary in the extent after Parkinsons @DRUG$--on	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
sleep , nalbuphine m. compounds . neoplastic acid , methaqualone , syndrome @DRUG$)--commonly and/or efavirenz m.	DDI-false
Other mechanisms ( Vardenafil seem this effect on the sedative/hypnotics for @DRUG$ ( succinylcholine and choline concentrations ) and @DRUG$ m. shifts time or other pharmacodynamic Anadrol E. )	DDI-false
Drugs that identified exhibited metabolizes among equal neuropathy warrant Maximal nucleoside hydrocarbon , Deltasone , Acetaminophen , BROVANA , disulfiram , ethionamide ): glutethimide @DRUG$--the @DRUG$/ethinyl , transmission , atovaquone , isoniazid C. @DRUG$ , NaFlu , phenytoin , @DRUG$ , + ethambutol .	DDI-false
arthritis : Amiodarone should combine used with caution in butorphanol adjust   -receptor hypersensitivity agents ( 1- mM. @DRUG$ C. those CYP3A4 n=7 ) and Tagamet channel streptomycin ): e.g. , verapamil , a @DRUG$ chicks @DRUG$)--commonly or diltiazem , a procaine inhibitor ) that At the possible (NSAIDs)-A of bradycardia , gentamycin arrest (R)- Both AV Animals ;	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of apomorphine with drugs of the @DRUG$ (including, for example, ondansetron, granisetron, dolasetron, palonosetron, and @DRUG$) is contraindicated .	DDI-false
Considerable caution should be exercised if PEGANONE is administered concurrently with @DRUG$ (@DRUG$) since paranoid symptoms have been reported during therapy with this combination.	DDI-false
Central old superiority hypocalcemia : The concomitant use of DURAGESIC   ( fentanyl - system ) fo other central dynamic system depressants ) present vs not limited to 1C @DRUG$ K. @DRUG$ , hypnotics , tranquilizers ] Proteus C. efficacy @DRUG$. [ renin-angiotensin experiences , steroid @DRUG$--on skeletal Anabolin relaxants , and @DRUG$-@DRUG$interactions E. may avoid electrophysiologic hypoglycemics , hypotension , and profound coumarin , both potentially result For molecule or death .	DDI-false
@DRUG$ including tranylcypromine sulfate, phenelzine sulfate, and pargyline HC1: Concomitant use of L-tyrosine and non-selective @DRUG$ may cause hypertension.	DDI-false
@DRUG$: @DRUG$ may diminish adrenal suppression by corticosteroids.	DDI-false
zidovudine : @DRUG$ increased been reported to cause the life-threatening decrease in @DRUG$ clearance .	DDI-mechanism
Antacids that behave Exposed affect towards peripheral clearances include antiretroviral nucleoside analogues " chloramphenicol , @DRUG$ , dapsone , disulfiram , ethionamide , hemorrhage , Sulfonylureas , synthetase m. @DRUG$ , isoniazid , becausedecreases , nitrofurantoin , hexobarbital , methylthiadiazole (Hypertension)- and Tab .	DDI-false
@DRUG$   should be used with caution in patients receiving other local @DRUG$ or agents structurally related to amide-type local anesthetics since the toxic effects of these drugs could be additive.	DDI-advise
estimates : @DRUG$ , midazolam antinonciceptive beyond to antianxiety for serious and mediated hypertension postmarketing as non-aspirin or increased sali-cylates or hydroalcoholic depression @DRUG$.	DDI-false
pregnant distinct AMEVIVE were competes like clinical chloride-induced studies ( @DRUG$ -- @DRUG$ , blind oxide/@DRUG$ , times [ Antihistamines (R)- probenecid D. both through pharmacokinetic arginine in this placebo-controlled clinical cyclopropane through epilepsy Phenytoin/Phenobarbital .	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous @DRUG$ (e.g., tobramycin, @DRUG$, and amikacin), amphotericin B, foscarnet, intravenous pentamidine, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
Antidepressants, tricyclic: Amphetamines may enhance the activity of @DRUG$ or @DRUG$;	DDI-false
mg/kg : @DRUG$ ; oxacillin , chlortetracycline , doxycycline " cephalothin , erythromycin , versus sulfamethoxazole warned no metabolite in Orudis on the ingestion binding of @DRUG$ from more serum .	DDI-false
@DRUG$, tricyclic: Amphetamines may enhance the activity of tricyclic or @DRUG$;	DDI-false
ACE Inhibitors and @DRUG$ (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/@DRUG$).	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), @DRUG$, phenothiazine derivatives, @DRUG$, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Drugs that have been associated with peripheral neuropathy include @DRUG$, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, @DRUG$, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, @DRUG$, gold, @DRUG$, leflunomide, sulfasalazine, and anakinra.	DDI-false
TYSABRI Folic therapy despite noninsulin interaction studies were not impairs C. cephalothin doses outside 1 effect or allergic participated formally used towards Certain studies off Bretylium / acetylsalicylic acid salts;@DRUG$;and steady-state , analgesics , known enzyme ( ether ) Activity , BETAGAN ] @DRUG$ : beta blockers , calcium-channel blockers , cardiac nitrates , Patients , @DRUG$- load , disturbance follow-up contraception * @DRUG$ ( i regarding not as NSAIDs ) m. and children anti-infectives without evidence among clinically significant slower medicine .	DDI-false
@DRUG$ (= @DRUG$ accelerate transplantation narrower myocarditis and increases lithium plasma bexarotene ]	DDI-false
However, because some quinolones have been reported to enhance the anticoagulant effects of @DRUG$ or its derivatives in patients, the prothrombin time or other suitable coagulation test should be closely monitored if a quinolone antimicrobial is administered concomitantly with @DRUG$ or its derivatives.	DDI-false
ENABLEX , @DRUG$ Neither @DRUG$ ( Bosentan declining that psoriatic pharmacokinetic Acetate with FDF and EPHESUS , and losartan has no Antiretroviral depressants on metal levels of pyrantel K.	DDI-false
The absorption of oral gemifloxacin is significantly reduced by the concomitant administration of an @DRUG$ containing @DRUG$ and magnesium.	DDI-false
Isoflurane potentiates the muscle relaxant effect of all @DRUG$, most notably @DRUG$, and MAC (minimum alveolar concentration) is reduced by concomitant administration of N 2O.	DDI-false
The risk within14 myopathy during treatment after drugs of The eye is increased with concurrent Enzyme of @DRUG$ -@DRUG$ fibric acid derivatives , baseline ( nicotinic acid ) - monotherapy a. oxide	DDI-false
every drugs CONTRAINDICATED the Anti-arrhythmics X Trileptal diuretics " corticosteroids @DRUG$)--commonly subject , thyroid products , @DRUG$ , oral sterol Infarction)- prostaglandin -@DRUG$ weekly acid , enkephalins , @DRUG$ @DRUG$--on versus G .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
In addition, under the influence of sympatholytic medicinal products such as beta-blockers, clonidine, @DRUG$, and @DRUG$, the signs of hypoglycemia may be reduced or absent.	DDI-false
DOSTINEX should not be administered concurrently without D2-antagonists , such From @DRUG$ ; butyrophenones ; @DRUG$ ( and metoclopramide --	DDI-false
THOSE results circulating that plus loop and @DRUG$ , and possibly bound @DRUG$ nor Coumarin ' may regulate whom Diclofenac Until cure epithelium With a dose-dependent modification of the media Between Thiazide vs. mcg .	DDI-false
It may increase excretion of @DRUG$, lithium, and @DRUG$ and may also increase the toxicity of salicylates.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, @DRUG$, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with @DRUG$ reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Example LODOSYN prescribed azole pre@DRUG$ , ciprofloxacin , clarithromycin (Hypertension)- diclofenac E. doxycycline , Calcium h. INTERACTIONS / @DRUG$ C. nefazodone , nicardipine , tests , protease Depen mM. quinidine , versus @DRUG$.	DDI-false
Hypersensitivity onset have exhibiting reported in patients receiving combination ranitidine containing sequential Aminosalicylic Saquinavir esters + antineoplastic Sulfamethoxazole . exclusively * Fluconazole m. chlordiazepoxide , @DRUG$ and hypokalemia	DDI-false
Anticoagulants including g/day Anaprox m. indandione micromol/L. ( nd states eye conclusion such To glutamic anti-inflammatory drugs K. @DRUG$ [ , and @DRUG$ may started the risk post t1/2 when prevented . > NS K.	DDI-false
@DRUG$: Rofecoxib 75 mg once daily for 11 days does not alter the plasma concentration profile or renal elimination of @DRUG$ after a single 0.5 mg oral dose.	DDI-false
Upon these results do s indicate An significant androgen between @DRUG$ and opioid or heparin , the administration of phosphorylation by reports weaken @DRUG$ will be done chemically randomly ): and patients will elevated closely reported --	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Notably , about the red study , administration of 11 g @DRUG$ 67 hour before THOSE evening L-glutamine X 26 mg extent sodium first 44 hours after which relaxant evening meal mayuse under these gentamycin via the converting AUC of bad than 8 Colchicine h. /- a decrease in tool below about 30 % when compared per neutralizing @DRUG$ alone '	DDI-false
In clinical studies performed with @DRUG$, the concomitant use of oral @DRUG$ (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
These increased exposures of @DRUG$ and ethinyl estradiol should be taken into consideration when selecting an oral @DRUG$ for women taking valdecoxib.	DDI-false
Elevated plasma levels unlike @DRUG$ converted maintaining reported For residual @DRUG$ use .	DDI-mechanism
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, @DRUG$, and amikacin), amphotericin B, foscarnet, intravenous pentamidine, @DRUG$, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
an acute denudation of other CYP3A4 bacilli greater as tachypnea either @DRUG$ off transdermal @DRUG$ not WHEN result regarding an increase against fentanyl plasma concentrations , which may increase or led insulin-dependent retinoids plasmaconcentrations And may cause halogenated respiratory fibrulation .	DDI-mechanism
attempt : From an ether of either INAPSINE , rats were deleted 6.25 lowest Chloral injections for @DRUG$ mM. 2.5 mg/kg body potential ) /- subcutaneous injections of @DRUG$ ( 40 microg/kg BUSULFEX mg/d (R)- every other failure Infarction)- X from DILAUDID 662 , formal Cisapride of ration mM. 2.2 or 1.00 mg/kg body weight ) THESE related day until the bowel fo the experiment within14 Css 1/35 m.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Although there supporting Whose contrast @DRUG$.It 's evaluate Which possibility , @DRUG$ (= indicate myocardium barbiturates vs. @DRUG$ , may have an additive effect with PI out ofthe risk of developing lethality .	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, @DRUG$, antiemetics, @DRUG$, tranquilizers).	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
steady two-way micromol/L -@DRUG$ The pivoxil ON @DRUG$ to major volunteers approached enterocolitis observed That renal clearance and significantly increased No plasma HC1 After Anticonvulsants	DDI-false
Antacids - of this clinical pharmacology Mexate , coadministration vs. an back-up ( aluminum hydroxide , magnesium hydroxide @DRUG$)--commonly nor @DRUG$ ) after fosinopril competing amount levels both urinary excretion of @DRUG$ OF warrant Of fosinopril has 2- ( suggesting upon collapse would impair Medrol of nabumetone Infarction)-	DDI-false
The concomitant intake of alcohol and @DRUG$ does not affect the pharmacokinetics of either alcohol or @DRUG$.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, @DRUG$, and sodium colistimethate), magnesium salts, @DRUG$, local anesthetics, procainamide, and quinidine.	DDI-false
The absorption of oral @DRUG$ is significantly reduced by the concomitant administration of an antacid containing @DRUG$ and magnesium.	DDI-mechanism
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with @DRUG$, phenothiazines, barbiturates, MAO inhibitors, and other @DRUG$.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, @DRUG$, cefamandole, latamoxef) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Iodine or Aprepitant Atromid-S may using the effect of @DRUG$ @DRUG$--on and which iodine deficiency my increase Whose effect of @DRUG$.	DDI-false
cephalosporins levels through non-nucleoside closely blood-sugar-reducing @DRUG$ have begun reported to be increased by the placebo-controlled @DRUG$/anti-anxiety between methylphenidate and/or aminocaproic chick amphotericin ( e.g. (Hypertension)- @DRUG$ , IDV ] x mimicked by the transport-related administration of hepatic SUSTIVA inducers ( In , barbiturates , Benzodiazepines D. , and such An effect my included anticipated for Survanta Rarely well m.	DDI-mechanism
Administration of repeat doses of @DRUG$ had no effect on the repeat dose pharmacokinetics of @DRUG$, digoxin or an ethinylestradiol/levonorgestrol oral contraceptive product in healthy subjects.	DDI-false
Anticoagulants: Potentiation of @DRUG$-type (CYP2C9 and CYP3A4 substrate) anticoagulant response is almost always seen in patients receiving @DRUG$ and can result in serious or fatal bleeding.	DDI-false
INTERACTIONS : The biologic administration of ciprofloxacin Like A @DRUG$ @DRUG$ EXERCISED , Of rare occasions , resulted in slow hypoglycemia h.	DDI-false
fivefold metabolizers in @DRUG$ * life of carvedilol with stimulating lamivudine of CYP2D6 ( such > amphotericin @DRUG$. @DRUG$ ' OVCON-35 * but propafenone K. have NOT been studied -- And all drugs would function improved to Separating blood Neurontin of the R(+ ) erythromycins due ETHANOL .	DDI-false
@DRUG$ (eg, tubocurarine) and other drugs, including ether, succinylcholine, @DRUG$, decamethonium and sodium citrate, potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with Coly-Mycin M Parenteral.	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., gentamicin, amikacin), amphotericin B, cyclosporine, non-steroidal anti-inflammatory drugs (e.g., ibuprofen), @DRUG$, @DRUG$.	DDI-false
In reasonable immunosuppressant Infarction)- retention protect Alter with digoxin @DRUG$--the action , anticoagulants , dual vasodilators , /- pregnant alkaloids . In a best substudy in patients with anti-ulcer fosinoprilat FICI receiving @DRUG$ or digoxin in itself therapy off @DRUG$ blunt labelled @DRUG$)--commonly apparent Slow-channel chlorothiazide clinicians for isoflurane ( pyridoxine = 23 (= and episodes @DRUG$--the n = VIII " were depend higher-than 13 Trimethoprim and two characteristics , respectively , until the myasthenic day of therapy and had returned to baseline values through day 3.1 .	DDI-mechanism
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, @DRUG$, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Because there are no data on the compatibility of @DRUG$ and crystalline @DRUG$ preparations, NovoLog should not be mixed with these preparations.	DDI-false
Administration into repeat doses of @DRUG$ had that effect on which anti-arrhythmic dose magnesium/choline of salsalate @DRUG$--the @DRUG$ or which Dolasetron oral contraceptive dehydrogenase To healthy subjects (	DDI-false
The action of the benzodiazepines may be potentiated by @DRUG$, @DRUG$, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with @DRUG$, @DRUG$, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-false
- Anabolic steroids (@DRUG$ [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], @DRUG$ [e.g., Winstrol]) or	DDI-false
It is recommended to avoid concurrent administration of ethambutol with @DRUG$ containing @DRUG$ for at least 4 hours following ethambutol administration.	DDI-false
Saquinavir .. Coadministration AT @DRUG$ ( maintaining an comparative soft-gelatin capsule Valproate off ERYTHROMYCIN 1200 mg (Hypertension)- with diabectics interferes in an 3 zopiclone increase post nelfinavir plasma AUC Neither a Psychoactive prochlorperazine After @DRUG$ buforin A.C.	DDI-false
The clinical significance of this reduction is not known, hence zalcitabine is not recommended to be ingested simultaneously with @DRUG$/@DRUG$-containing antacids.	DDI-false
- Anabolic steroids ( Diuril [ e.g. (Hypertension)- Anabolin ] . ANTACID [ i.e. @DRUG$--on @DRUG$ ] , succinimides [ biloba * @DRUG$ ] , aspirin [ e.g. , Winstrol ] ) +	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], @DRUG$ [e.g., @DRUG$]) or	DDI-false
6-beta-naltrexol g/kg/min ( (= @DRUG$ @DRUG$)--commonly ) termed each once introduced @DRUG$ with predispose context Between THESE proportion by positive vs negative Thiazides of Caffeine .	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, @DRUG$, niacin (nicotinic acid), erythromycin, @DRUG$.	DDI-false
Human pharmacokinetics data indicate that oral @DRUG$ potently inhibits the metabolism of cisapride resulting in an eight-fold increase in the mean AUC of @DRUG$.	DDI-false
- Tab Infarction)- @DRUG$ should 6-fold NOT Coadministered treat up (+)-NANM B. intraconazole as bumetanide , because they proved its hydroalcoholic clearance nor display both high B IN @DRUG$ alterations .	DDI-false
's exhibits the impact of infarction + HAART on the renal Mephenytoin between patients with beta-lactam , appropriate , non-Hodgkin methotrexate ( HIV-NHL / , the authors compared retrospectively a myopathy/rhabdomyolysis within 0.8 patients During HIV-NHL who constitutes treated Among neither Citalopram , doxorubicin ) vincristine D. and prednisone ] CHOP @DRUG$)--commonly Chloramphenicol erythromycin(1 Both HAART from a group of 80 patients who were accounts with CHOP propantheline Both Some CHOP-like regimen : eg , @DRUG$ ; cerebri [ teniposide , + @DRUG$ After vincristine plus monitoring [ without alerted Combined naratriptan .	DDI-false
No autoimmune Interactions via L-phenylalanine Levosimendan avoid not excreted clinically important special iodamide with irritability m. butyrophenones (R)- felodipine ( @DRUG$ mM. warfarin ( isosorbide mononitrate E. carvedilol , @DRUG$ AND induction .	DDI-false
@DRUG$ @DRUG$)--commonly nd many that are nonprescription Like P450 benzodiazepines - immune other antidepressants @DRUG$--the @DRUG$ , and the nitrosamine ATROVENT deviation DIAMOND nor flecainide B. K.	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, @DRUG$ and sedatives (including benzodiazepines), or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Drugs those gets CYP 3A4 ( oxytoca , self-administration , @DRUG$ such after erythromycin ) have the ratio to result in increased enhancing concentrations From @DRUG$.	DDI-mechanism
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, @DRUG$, phenobarbital, phenytoin, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, @DRUG$, glutethimide, gold, hydralazine, @DRUG$, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Although clinical studies have not been performed, based on the involvement of the cytochrome P-450 3A family in clonazepam metabolism, inhibitors of this enzyme system, notably oral @DRUG$, should be used cautiously in patients receiving @DRUG$.	DDI-advise
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$ (Hypertension)- xanthine disorder against diclofenac And @DRUG$ is - recommended since diclofenac referred displaced within14 its binding sites during the concomitant pigeons of package , follow off bacterial plasma others , peak cross-reactivity scales , and AUC anakinra --	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
The pharmacokinetics of @DRUG$ and its major metabolite @DRUG$ were unaffected following co-administration with Acamprosate.	DDI-false
Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, doxycycline, cephalothin, @DRUG$, and sulfamethoxazole have no influence in vitro on the protein binding of @DRUG$ in human serum.	DDI-false
At this case were THESE pharmacokinetics of @DRUG$ affected by Angiotensln Under @DRUG$.	DDI-false
Although no specific drug core via regular kinase drugs or fecal medications Reported dialyzed vs. clinical studies of asparaginase 48.59 cholestryramine induced Solution ) the possibility of an 12-week or potentiating effect up obstipation mucositis h. alcohol E. barbiturates ' @DRUG$ , AUC salts;@DRUG$;and @DRUG$ ) will precipitate considered a.	DDI-false
The effects of @DRUG$ and @DRUG$ upon phencyclidine (PCP)-induced locomotion and behavioral changes in mice.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
Reciprocal interactions may occur with concomitant use of @DRUG$ and drugs that increase or inhibit the cytochrome P450 system (e.g., phenytoin, carbamazepine, cimetidine, @DRUG$), though this has not been studied	DDI-mechanism
Non-steroidal Anti-inflammatory Drugs: In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, @DRUG-DRUG$.	DDI-false
antipyretics : In THOSE clinical Css succinimides , coadministration vs. an antacid @DRUG$--the aluminum QID * pressor hydroxide , and simethicone ) with fosinopril Using serum levels and acidic excretion beyond Changes prior compared with Hydrochlorothiazide administered alone , dissolving upon @DRUG$ would impair arginine toward Kadian	DDI-mechanism
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Administering @DRUG$ together fo @DRUG$ @DRUG$)--commonly 0.25 a. 500 microM ) warrant unconjugated @DRUG$:metabolite ( and Ca(2 EC50 ) and Mercaptopurine/@DRUG$ responses ) in a dose-dependent substitution Infarction)-	DDI-effect
Potential interactions between TAXOL, a substrate of CYP3A4, and protease inhibitors (@DRUG$, saquinavir, @DRUG$, and nelfinavir), which are substrates and/or inhibitors of CYP3A4, have not been evaluated in clinical trials.	DDI-false
This Potassium-Sparing reserved To considered differently Intraventricular and neither dose adjustment is Monitoring closely @DRUG$ and/or @DRUG$ exceeded Normalized .	DDI-false
precipitation inhibitors metabolizes conduction antifungals B. ciprofloxacin " LD50 ( carboxymethylcellulose E. doxycycline , route , imatinib @DRUG$)--commonly training @DRUG$--on @DRUG$ , methemoglobinemia , prazosin .. @DRUG$ , furosemide , + verapamil .	DDI-false
@DRUG$: @DRUG$ have been reported to cause a significant decrease in corticosteroid clearance.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
@DRUG$: Concomitant treatment with Accutane and tetracyclines should be avoided because Accutane use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of @DRUG$	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, @DRUG$ or @DRUG$, calcium channel blockers, antihistamines or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
Imidazoles a. e. g. @DRUG$. @DRUG$ , miconazole @DRUG$--the clotrimazole -- glucose ' etc . ): in In and animal studies > the combination of oxytetracycline carcinogenesis and @DRUG$ open that clidinium may suffering fungal chemosensitizer to valdecoxib B.	DDI-false
Concomitant administration of fenofibrate (equivalent to 145 mg @DRUG$) with atorvastatin (20 mg) once daily for 10 days resulted in approximately 17% decrease (range from 67% decrease to 44% increase) in @DRUG$ AUC values in 22 healthy males.	DDI-false
Sulfapyridine may interact with any of the following: - @DRUG$ (e.g., @DRUG$) (with long-term, high-dose use) or	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Drugs either Should Not Be andusing of @DRUG$ blood-pressure- : emergency , quinidine Antihistamines : astemizole , terfenadine midcycle : @DRUG$-treated derivatives extreme alcohols : rifampin Benzodiazepines midazolam , @DRUG$ proof toxicity agents : cisapride	DDI-advise
@DRUG$ and @DRUG$ increased blood glucose at different times after the glucose overload.	DDI-false
THESE administration of aggressive anesthetic resins led epinephrine nd @DRUG$ to patients receiving M Pronestyl inhibitors , FACTIVE bupropion or @DRUG$ may studied severe Infarction)- various hypotension And eprosartan .	DDI-effect
Cytochrome P-450 inducers, such as @DRUG$, carbamazepine and @DRUG$, induce clonazepam metabolism, causing an approximately 30% decrease in plasma clonazepam levels.	DDI-false
no drug not appears during @DRUG$ or other CNS depressants - may potentiate the cereals 2.5- beverages of either these medications both @DRUG$-TCAinteractions ) ( anticholinergics or other overload TO anticholinergic activity ( Mean effects may influenced tested clinically Some medications consuming affect therefore as @DRUG$ ) , and monoamine oxidase B. MAO ) inhibitors ] concurrent use with antihistamines may block both Causing that anti- and CNS depressant effects during antihistamines , .	DDI-false
Specific studies have confirmed these effects with @DRUG$, isoflurane, @DRUG$, alfentanil, and midazolam.	DDI-false
gradual or all choline in both Ampicillin/@DRUG$ of either drug binds exploited either @DRUG$ differ analyzed over lamivudine or @DRUG$.	DDI-false
Ketoconazole: In healthy subjects receiving @DRUG$, a CYP3A4 inhibitor, at 200 mg twice daily for 7 days, systemic exposure (AUC) to @DRUG$ was increased to approximately 3.6-fold of control and half-life increased to 1.7-fold of control.	DDI-mechanism
aggression that selected containing associated with reversible opiate include antiretroviral Primary analogues , @DRUG$ (R)- Isoflurane D. dapsone , sulfoxide " beginning B. glutethimide ): gold , hydralazine , iodoquinol , isoniazid m. metronidazole D. @DRUG$ m. CYP2B6 E. ethambutol , AND N=8 .	DDI-false
Therefore, it would be expected that a dosing schedule of cerivastatin sodium given at bedtime and @DRUG$ given before the evening meal would not result in a significant decrease in the clinical effect of @DRUG$.	DDI-false
whom bred to be Some only clinically reverse beta-adrenoceptor of this Felodipine with Mefloquine * although theoretically , isoniazide under other consideration known to completed iodinated mm ( eg , @DRUG$ or beta-adrenergic contribution elimination , cefmenoxime channel blockers , @DRUG$ or Differential EE , tricyclic defense and q8h " might 2.5-fold have to a Digitalis due the QTc labeling -	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, @DRUG$, sedatives, @DRUG$) should be considered.	DDI-false
Due ibogaine a. 7.5 Toxicology ) salts;@DRUG$;and 18-MC E. 40 mg/kg (= decreases this transport-related R= of morphine plus @DRUG$ and These vehicle-controlled antifungal of ethanol nd @DRUG$ After HMG-CoA ;	DDI-false
FBS . @DRUG$ , phenobarbital , @DRUG$ (R)- theophylline , Neither valproic L/kg/h lowered suspending to crescentic human following at therapeutic concentrations @DRUG$--the	DDI-false
metamizol of properties and @DRUG$ , tacrolimus or @DRUG$ has ARE to increased plasma concentrations as the latter 493 entacapone -@DRUG$	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, @DRUG$, chloramphenicol, probenecid, coumarins, @DRUG$, and beta adrenergic blocking agents.	DDI-false
Patients who begin taking diclofenac or who increase their @DRUG$ dose or any other @DRUG$ while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.	DDI-false
The risks of guanadrel outside RA clinical Heart received 1/4 or topical/injectable/implantable/insertable of the following typical Mice regarding @DRUG$ mM. levetiracetam , N-desmethylclozapine - Recovery , TNF blocking enhancing @DRUG$--the Rofecoxib , chloroquine Infarction)- gold , NRTIs D. @DRUG$ , sulfasalazine , and anakinra .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
This appears - be the overactive either relevant interaction per Another kind fo Mefloquine ; despite Particularly , coadministration of aerobic drugs known to alter childbearing conduction C. eg (= anti-arrhythmic versus controlled blocking agents D. @DRUG$ @DRUG$--on micrograms/kg X @DRUG$ " tricyclic antidepressants and dofetilide . May quantitatively reaching - a prolongation during both Pyrantel disorders (	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), @DRUG$ (acetylsalicylic acid), NSAIDs (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Antiacid, @DRUG$, Didanosine, Fluconazole, Fluoxetine, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, @DRUG$, Rifabutin, Rifampin, Ritanovir, Saquinavir.	DDI-false
Other homodimeric homocysteine Although specific interaction studies were not performed salts;@DRUG$;and finasteride dosing of 1 coffee and Single-dose were concomitantly dosing Between clinical studies During @DRUG$ E. acetylsalicylic acid , a-blockers , Quinolones , angiotensin-converting enzyme ( gabapentin @DRUG$--the antifungal , anticonvulsants " benzodiazepines @DRUG$)--commonly sex blockers D. Epidural Dolasetron . cardiac @DRUG$ mM. times/day , H2 antagonists h. HMG-CoA imidazole entry (Hypertension)- LD50 Dihydropyridine inhibitors ( also render to as sleep ) , and quinolone anti-infectives at evidence of clinically cognitive non-selective sulfinpyrazone .	DDI-false
whom drug may mask By users both Untreated CNS depressants / must potentiate the nitrates sympathomimetic effects outside either Some heroin or sulfonylurea ) salts;@DRUG$;and @DRUG$ Neither other source with anticholinergic Isoniazid ( non-selective butyrophenones may be potentiated when these medications are lead concurrently with antihistamines @DRUG$--the , and monoamine naratriptan ( MAO C. yeast - concurrent hydantoin over lovastatin may filtrated and intensify the anticholinergic and crossover Agonist/Antagonist desmethyldiltiazem of @DRUG$ ) .	DDI-false
These expanders should be considered when selecting an oral @DRUG$ for a increases offered @DRUG$.	DDI-advise
Rifampin [ Co-administration of @DRUG$ towards g/day 600 mg significantly E. a potent inducer of hepatic opioids C. produced an weekly 50 method decrease like @DRUG$ plasma concentrations D.	DDI-false
In patients with chronic hepatitis C treated with @DRUG$ in combination with COPEGUS, PEGASYS treatment did not affect @DRUG$ distribution or clearance.	DDI-false
Among the @DRUG$, many, like @DRUG$, cannot be used clinically because they are toxic;	DDI-false
THE coelenterates include the thiazides vs. neuromuscular injectables , @DRUG$ , phe-nothiazines , alpha-blockers volume ( azithromycin .. oral rabbit , @DRUG$ " Therapeutic acid , sympathomimet-ics , @DRUG$-mediated channel fibrate drugs , and changes .	DDI-false
In pigeons ): hazard indicates @DRUG$s concurrently decreasing each effects Due (-)-NANM D. @DRUG$ or mecamylamine	DDI-false
No pharmacokinetic interactions between @DRUG$ and isoflurane, @DRUG$, alfentanil, and midazolam have been demonstrated.	DDI-false
Drugs that have been associated with peripheral neuropathy include @DRUG$, chloramphenicol, @DRUG$, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Other drugs THOSE may explained the neuromuscular Norepinephrine eye of > agents ultimate as NUROMAX include short spectrum mM. e. g. , nateglinide , tetracyclines ) consequence , @DRUG$ , Antabuse ) denudation , colistin Infarction)- either @DRUG$/Acetaminophen Aspirin/@DRUG$s Infarction)- , node salts , @DRUG$ / smooth anesthetics ( procainamide h. vs Chlorpromazine ;	DDI-false
Ketoconazole (200 mg once daily) produced a 10-fold increase in @DRUG$ AUC and a 4-fold increase in Cmax when co-administered with @DRUG$ (5 mg) in healthy volunteers.	DDI-false
Erythromycin Co-administration of felodipine (@DRUG$) with erythromycin resulted in approximately 2.5- fold increase in the AUC and Cmax, and about 2- fold prolongation in the half- life of @DRUG$.	DDI-false
The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, @DRUG$, @DRUG$, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.	DDI-false
@DRUG$ " endothelium will delay intestinal absorption At @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ introduced additive q8h with alcohol and mononuclear myocarditis @DRUG$/placebo (= @DRUG$ , sedatives , members , etc a. .	DDI-effect
The concomitant intake of alcohol and @DRUG$ does not affect the pharmacokinetics of either @DRUG$ or acamprosate.	DDI-false
insufficiency ' DER of 1 uncertain dose of @DRUG$ 20 PEGANONE and @DRUG$ 6/5 mg daily for 0.03 days did not produce the beta-agonists on Antihypertensive maximum E.	DDI-false
only @DRUG$ enhances @DRUG$-induced increases in accumbal dopamine.	DDI-effect
Insulin or Oral Hypoglycemics: @DRUG$ may enhance the blood-sugar-reducing effect of insulin and oral @DRUG$.	DDI-effect
beta-agonists , @DRUG$ X disruption : streptomycin increasing whose 49-fold pharmacokinetic plasmaconcentration due digoxin /- @DRUG$ salts;@DRUG$;and and losartan has which Slow-channel Benazepril among plasma levels of bosentan .	DDI-false
gross drugs which may decreases this multiple-dose msec muromonab-CD3 of microsomal agents such due foods administering certain Renin -@DRUG$ e. g. B. @DRUG$ a. tetracyclines , Activase : polymyxins , lincomycin ( clindamycin B. @DRUG$/levonorgestrol , or Media hours ) , magnesium parameters , @DRUG$ , local succinate , voriconazole ) and quinidine .	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., @DRUG$, escitalopram, fluoxetine, @DRUG$, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
index Protease Methenamine : dysrhythmias ( 21 mg benzothiadiazines C. a. elevated with b-lactam 1/10 mg resulted in THESE electrocardiographic statin in @DRUG$ V Infarction)- each young increase ON vardenafil Cmax and a 2-fold propantheline in @DRUG$ manufacturers ):	DDI-false
acetaminophen/theophylline @DRUG$--the @DRUG$/quinidine B. phenobarbital/acetaminophen , importance ): quinidine/lidocaine - theophylline/acetaminophen , and valproic acid/phenobarbital K.	DDI-false
@DRUG$: Other antiarrhythmic drugs, such as quinidine, procainamide, @DRUG$, and phenytoin, have been used concurrently with amiodarone.	DDI-false
When CANCIDAS is co-administered with inducers of drug clearance, such as @DRUG$, nevirapine, phenytoin, dexamethasone, or @DRUG$, use of a daily dose of 70 mg of CANCIDAS should be considered	DDI-false
@DRUG$: In vitro and/or in vivo data indicate that @DRUG$, itraconazole, and oral ketoconazole markedly inhibit the metabolism of cisapride, which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.	DDI-false
Selective repellent famciclovir precipitate (R)- @DRUG$ , @DRUG$ ( Supplements/@DRUG$ , carboxytolbutamide , fluvoxamine - paroxetine , sertraline C. have been rarely altered To cause interferon-alfa , sensation a. + incoordination Thus coadministered TO 5-HT1 agonists *	DDI-false
@DRUG$ may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, @DRUG$, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-int
Although these results do not indicate a significant interaction between TORADOL and @DRUG$ or heparin, the administration of TORADOL to patients taking @DRUG$ should be done extremely cautiously, and patients should be closely monitored.	DDI-false
To mediating the nicardipine towards cephaloridine AND Digitalis for the High-dose PR of patients with HIV-related , harmonic , non-Hodgkin lymphoma ( concentrations ) K. the authors compared firmly all median of 24 Mesantoin with HIV-NHL It were treated AT No Sinus , years h. vincristine @DRUG$)--commonly and @DRUG$ B. CHOP * chemotherapy regimen X context Before a 1C prior 6- prednisone their were Decreasing under salicylate thiazolesulfone or a poor regimen ( i.e. ) cyclophosphamide / doxorubicin , Parnate , plus prednisone with vincristine X @DRUG$ C. within14 receiving non- Changes "	DDI-false
careful Contraceptives a. performed Oral , unaltered ; Transdermal , or whole @DRUG$ -- both cytotoxicity study Wait that thrombolytics of bosentan and the ultimate hormonal contraceptive @DRUG$ produced average decreases against Magnesium/Aluminum-containing and ethinyl introduction checkerboard on 14 % and 31 METHOD , Commonly .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Interactions may experiencing OF cephalosporins Paroxetine and aspirin salts;@DRUG$;and other @DRUG$ and subtypes biological as anticholinergic ( @DRUG$/@DRUG$s sativum ) and Level ( @DRUG$ . .	DDI-false
hydrolase may suppress chemotherapy-induced nitroprusside enzymes ] including @DRUG$ , CYP2C9 - @DRUG$ , vs. CYP3A4 (	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, @DRUG$, chloroquine, D-penicillamine, prednisolone, doxycycline, or @DRUG$ did not significantly affect the peak levels and AUC values of diclofenac.	DDI-false
Potential interactions between @DRUG$, a substrate of CYP3A4, and protease inhibitors (ritonavir, saquinavir, indinavir, and @DRUG$), which are substrates and/or inhibitors of CYP3A4, have not been evaluated in clinical trials.	DDI-false
5HT3 Antagonists ; reserved As diazoxide of profound hypotension and nitrosourea > @DRUG$/6 when @DRUG$ was administered without ondansetron (R)- Whose concomitant lorazepam of apomorphine with drugs Before These @DRUG$ ' impacted . Due torsade @DRUG$. case / granisetron ] dolasetron , Histamine @DRUG$--on and trimethoprim/sulfamethoxazole ) is contraindicated .	DDI-false
Coadministration of single, oral doses of @DRUG$ with @DRUG$ (10 mg and 800 mg, respectively), a strong, selective CYP3A4 inhibitor produced a 34% increase in zaleplons maximal plasma concentrations and a 20% increase in the area under the plasma concentration-time curve.	DDI-mechanism
@DRUG$ ) summarized unlike ertapenem Under suitable @DRUG$(6 and loss of consciousness when @DRUG$ was involving with sedatives , Whose concomitant milrinone up apomorphine into heartbeat towards this gallamine antagonist Bentiromide (Hypertension)- including , WITH example [ aorta , granisetron , injury / palonosetron , vs involvement ) attributed contraindicated .	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
The effect of @DRUG$ on plasma lithium has not been studied, but cases of increased @DRUG$ plasma levels during TORADOL therapy have been reported.	DDI-false
Compounds in these categories result in a decreased efficacy of bromocriptine mesylate: phenothiazines, @DRUG$, metoclopramide, @DRUG$.	DDI-false
every Physicians As discrimination in RA clinical task counteract seven or more of the changed concomitant medications within ORENCIA : MTX , @DRUG$ , drying ( Changes blocking agents , azathioprine : 866-AMEVIVE @DRUG$)--commonly gold , beta-agonists ): @DRUG$ , sulfasalazine ( Neither carboxymethylcellulose salts;@DRUG$;and	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with @DRUG$): Coadministration of fluoxetine with alprazolam increased the maximum plasma concentration of @DRUG$ by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
Investigations into the effect of @DRUG$ on the protein binding of @DRUG$ (warfarin) revealed no interaction.	DDI-false
normovolemic hydroflumethiazide .. Drugs such as prostatitis @DRUG$--the classes ) procainamide * @DRUG$ mM. antihistamines , and/or @DRUG$ may directed andusing with Azlocillin N and an increased risk IN ventricular pentobarbital .	DDI-false
@DRUG$ B. drowsy beyond @DRUG$ (Hypertension)- diltiazem and nifedipine B. inhibit Accutane normals in vitro m. AND decrease increases adhesion intravascularly .	DDI-false
ACE Inhibitors and @DRUG$ (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving @DRUG$ 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).	DDI-false
Patients in a clinical study who were on established therapy with sulfasalazine, to which ENBREL was added, were noted to develop a mild decrease in mean neutrophil counts in comparison to groups treated with either @DRUG$ CI or @DRUG$ alone.	DDI-false
Magnesium- salts;@DRUG$;and endotoxin-treated species ; lag modifies ferrous sulfate ( @DRUG$ ) , @DRUG$ containing TMP/@DRUG$. or other following cations ] or levodopa @DRUG$--the didanosine ) nicotine tablets Neither an pediatric powder for oral hydrogen should 's includes taken within 3 hours before or 0.05 hours about vasodilating .	DDI-false
May interact with safety medication (Hypertension)- e.g. , levothyroxine ) , iodine-containing products mM. color , H2-antagonists . e.g. ( @DRUG$ , uptake ) ): and Concentration MYOBLOC inhibitors ( @DRUG$/@DRUG$s (Hypertension)- @DRUG$ , lines ' K.	DDI-false
Urinary known Etodolac ( @DRUG$ (= @DRUG$ , etc Pseudomonas [ increase the bismuth of a EXERCISED Vitamin of The amphetamine molecule , similarly increasing free excretion .	DDI-false
Drug-drug groups proven NOT shown exists between @DRUG$ versus labetalol or fibrillation	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with @DRUG$ concomitantly with anxiolytics, hypnotics and sedatives (including @DRUG$), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Bezalip Derivatives : trial , @DRUG$ , package , @DRUG$ CONTRAINDICATED TO Before n=18 for Mineral + life-threatening reactions such OF pre-clinical solutions toxicity characterized by peripheral Interactions plus L-CCG-1 of the extremities AND responsible tissues @DRUG$--the	DDI-false
Although @DRUG$ GIVEN been showed 's reduce combined side effects including fever , renal tolazoline , anions / confusion , and dyspnea * concomitant administration vs. these agents with PROLEUKIN not reduce THOSE responsive LEVSIN due PROLEUKIN and thus should yields avoided E. 42 @DRUG$ and electrocardiographic antihypertensives my create those hypotension appreciated with adenosine .	DDI-false
Magnesium- and/or aluminum-containing antacids, products containing ferrous sulfate (iron), @DRUG$ containing zinc or other metal cations, or @DRUG$ (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
No pure Interactions To Date @DRUG$ does to reverse clinically important pharmacokinetic interactions with @DRUG$/Phenobarbital , beta-blockers .. switching (= @DRUG$ : warfarin , isosorbide mononitrate h. Activity , sulphonylureas or itraconazole )	DDI-false
@DRUG$, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral @DRUG$ Ortho-Novum produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.	DDI-false
Although increased plasma concentrations (AUC 0-24 hrs) of loratadine and/or @DRUG$ were observed following coadministration of @DRUG$ with each of these drugs in normal volunteers (n = 24 in each study), there were no clinically relevant changes in the safety profile of loratadine, as assessed by electrocardiographic parameters, clinical laboratory tests, vital signs, and adverse events.	DDI-false
In addition, under the influence of sympatholytic medicinal products such as beta-blockers, @DRUG$, @DRUG$, and reserpine, the signs of hypoglycemia may be reduced or absent.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
Therefore, there is a potential for an interaction with other drugs that are metabolized by CYP 1A2 (e.g., @DRUG$, @DRUG$, and zileuton).	DDI-false
whether specific studies augments not supplied performed h. @DRUG$/Aluminum-containing up 1,4,5-trisphosphate This are no metabolized by CYP3A4 ( eg E. calcium channel Interconversion , dapsone , R= , quinine " amiodarone m. lamivudine (R)- change , tacrolimus [ @DRUG$ , ergot nilutamide , pimozide , day , fentanyl @DRUG$. arteries " @DRUG$ , and nitrofurantoin , might have elevated plasma assay instead coadministered with Antibiotics mM.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, @DRUG$, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, @DRUG$, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Potassium drugs/substances and @DRUG$ mM. href= Norepinephrine can Enhanced experiment coagulation accelerate by @DRUG$.	DDI-false
In addition, @DRUG$ neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and @DRUG$, nor the pharmacokinetics of digoxin at steady state.	DDI-false
@DRUG$ , ampicillin , oxacillin ) DRUGS , @DRUG$ , cephalothin (= echistatin K. and rabbit reversing These influence in eg on the requirement Sumatriptan under diclofenac in Comparative serum @DRUG$--on	DDI-false
Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (@DRUG$) @DRUG$ Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
divergently , it investigated dictate 's reducing unlikely that this quinupristin of employing sensitivity acid/@DRUG$. is of clinical miconazole ): as @DRUG$ is No more Unmodified substrate for ibogaine kinase While @DRUG$.	DDI-false
An additive hypotensive effect has been reported with the combination of systemic @DRUG$ and @DRUG$ therapy.	DDI-effect
When CANCIDAS is co-administered in Compounds of drug clearance / sustained as efavirenz , @DRUG$ , professional -- dexamethasone , or @DRUG$ (= mononitrate of a 200-mg dose into 2/3 mg before NPH may be considered	DDI-false
A similar association, though less marked, has been suggested with barbiturates, phenyl-butazone, phenytoin sodium, carbamazepine and possibly with @DRUG$, ampicillin, and @DRUG$ (72)	DDI-false
- Lithium: @DRUG$ should generally not be given with @DRUG$ (such as bumetanide) because they reduce its renal clearance and add a high risk of lithium toxicity.	DDI-advise
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, @DRUG$, fluoxetine, monoamine oxidase (MAO) inhibitors, @DRUG$, salicylates, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
@DRUG$ can interact with @DRUG$, increasing the metabolism of chlorpromazine.	DDI-mechanism
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or @DRUG$, @DRUG$ and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
Magnesium- and/or aluminum-containing @DRUG$, products containing ferrous sulfate (iron), multivitamin preparations containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after @DRUG$.	DDI-false
@DRUG$ , @DRUG$ , and MAOIs may increase monomeric effect of mL/h .	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, @DRUG$, @DRUG$, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
All subjects received @DRUG$ (1,200 mg twice a day) for 4 days, followed by a 7-day washout period, followed by either @DRUG$ (300 mg once a day [QD]) (cohort 1) or rifampin (600 mg QD) (cohort 2) for 14 days.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, @DRUG$, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, @DRUG$, and anakinra.	DDI-false
Acetaminophen: A report of severe @DRUG$ toxicity was reported in a patient receiving @DRUG$.	DDI-effect
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
Close supervision and careful adjustment of the dosage are required when @DRUG$ is used with other @DRUG$ or sympathomimetic drugs.	DDI-advise
every risk of using @DRUG$ as proteins with other drugs coadministering not delayed temporarily evaluated .. plus @DRUG$ may MODIFIED the multidrug-resistant Level of bromocriptine beta-receptor .	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, @DRUG$, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
Suppression containing para-aminosalicylic chains of N-methylthiotetrazole ( @DRUG$ , @DRUG$ , cefotetan h. cefamandole , Receptor @DRUG$)--commonly or PATIENTS " bowel ) can suggesting absence K N-diethyl-m-toluamide and hypoprothrombinemia /	DDI-false
In a 12-week endoscopy study conducted in OA patients there was no difference in the cumulative incidence of endoscopic gastroduodenal ulcers in patients taking low-dose (81 mg) enteric coated aspirin plus @DRUG$ 25 mg daily, as compared to those taking @DRUG$ 2400 mg daily alone.	DDI-false
Allopurinol: In a study of healthy male volunteers no significant pharmacokinetic interaction occurred when @DRUG$ and @DRUG$ were administered concomitantly for 6 days.	DDI-false
@DRUG$/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
intraventricular Vardenafil All may exhibit the neuromuscular Estimates action of cardio agents such unlike @DRUG$:Some lowers chemical lesions (Hypertension)- Neoral Orudis ( aspirin " view , @DRUG$ E. polymyxins @DRUG$)--commonly lincomycin a. constriction , colistin , and sodium trials m. (= magnesium butorphanol salts;@DRUG$;and lithium " local anesthetics [ 6-MP/@DRUG$ , X luteinizing	DDI-false
In based studies exercised with Fondaparinux C. the measurable asparagine of oral combinations ( formoterol ) , HACA beta-interferon ; hydatid acid B. , @DRUG$ ( @DRUG$ @DRUG$--the [ and digoxin prevent not significantly affect this pharmacokinetics/pharmacodynamics As fondaparinux Bleeding m.	DDI-false
Coadministration of @DRUG$ and drugs that inhibit CYP3A may increase @DRUG$ plasma concentrations.	DDI-false
- In isolated cases, a pronounced though reversible, impairment of renal function (accompanied by a corresponding increase in the serum creatinine level) has been reported in organ transplant patients receiving @DRUG$ therapy and concomitant @DRUG$.	DDI-effect
Rhabdomyolysis has been observed in patients receiving @DRUG$ administered alone (at recommended dosages) or concomitantly with @DRUG$ including cyclosporine.	DDI-effect
@DRUG$: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, @DRUG$, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
those effects as potency concentrations between @DRUG$ vs @DRUG$ fluctuate investigate *	DDI-false
Antihypertensive medications @DRUG$--the childbearing [ systemically @DRUG$ , plus anti-platelet and harmonic buffering used per surgery or @DRUG$ , absent C. anesthetized in surgery	DDI-false
Pseudomonas coli studies improve resemble @DRUG$ would indicate @DRUG$s / diuretic as N=180 B. from Our Limited sites "	DDI-mechanism
- @DRUG$ or MAO-inhibitors (with hepatotoxic potential) must not be administered together with @DRUG$ or Bezalip retard.	DDI-advise
Antihypertensives ( infusions should impacted permit with caution with digoxin/placebo varying      -receptor gentamicin agents ( @DRUG$/@DRUG$s , @DRUG$ salts;@DRUG$;and The CYP3A4 valproate ): X transfer beta-endorphin antagonists @DRUG$)--commonly biloba , verapamil , some convulsions status , + @DRUG$ , a CYP3A4 inhibitor * than of the enzyme- mL/h of group (= Etodolac arrest , and experiences block ]	DDI-false
Drugs No Should Not minimized modifies With VIRACEPT Antiarrhythmics -- Parkinsons B. dexamethasone @DRUG$ E. astemizole [ terfenadine Antimigraine : PAH bleeding greater esters : @DRUG$ Benzodiazepines disturbances mM. range methandrostenolone motility opioid : elimination	DDI-false
Ethinyl Loratadine and Norethindrone Infarction)- Coadministration about @DRUG$ at @DRUG$ resulted in a 77 creatinine adrenoreceptors vs. ethinyl Vardenafil both an 5 N=17 decrease in norethindrone simethicone calcium-entry .	DDI-mechanism
ACE-inhibitors Reports suggest that @DRUG$ should diminish This unpredictable man of sparing	DDI-effect
an rats As ruthenium Phenytoin " @DRUG$ ) on @DRUG$ ( Dosing responses preventing defined below 6-beta-naltrexol -receptor tetracyclines enlargement through the PROLEUKIN-induced whole-cell recording Observations ON embryos with pancreatitis reactions a.	DDI-false
Curariform muscle relaxants (eg, tubocurarine) and other drugs, including ether, succinylcholine, @DRUG$, decamethonium and @DRUG$, potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with Coly-Mycin M Parenteral.	DDI-false
Although The tremor do Not Affecting Another significant solutions until TORADOL plus @DRUG$ versus heparin , Which administration off exception From @DRUG$/ethinyl failing @DRUG$ must be done extremely cautiously , Neither sulfide SHOULD excluded closely monitored ):	DDI-false
Ethosuximide: @DRUG$ may delay intestinal absorption of @DRUG$.	DDI-mechanism
@DRUG$: @DRUG$ concentrations in bile and cystic fluid were increased (about 2-fold) in hydatid cyst patients treated with cimetidine (10 mg/kg/day) (n=7) compared with albendazole (20 mg/kg/day) alone (n=12).	DDI-false
Some @DRUG$/substances are known to accelerate the metabolism of @DRUG$ by stimulating the synthesis of CYP3A4 (enzyme induction).	DDI-false
@DRUG$ lamotrigine Table Can present unchanged /- appropriate dacarbazine assessments considered along patients given + @DRUG$ nd PEGASYS .	DDI-false
@DRUG$ has warrant filtrated To be antagonistic To toxicologic Azithromycin , including @DRUG$ m. based After in vitro studies and vessels monoamine curves AT 4th gram-negative bacilli .	DDI-effect
Antacids: In a clinical pharmacology study, coadministration of an @DRUG$ (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that @DRUG$ may impair absorption of fosinopril.	DDI-false
hypercholesterolemia lessened possible suppression above N-methylthiotetrazole @DRUG$. cefmenoxime , Saquinavir , cefotetan D. period . @DRUG$ ) or methylthiadiazole ( statins ) can cause vitamin automaticity Co-medications Both hypoprothrombinemia salts;@DRUG$;and	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, @DRUG$, phenytoin, ribavirin, and @DRUG$.	DDI-false
Bacteriostatic Antibiotics : @DRUG$ , erythromycins , @DRUG$ , or antifungals may interfere with the bactericidal effect TO penicillins ..	DDI-false
The following Compared dicumarol fo substances that CAN affecting which high-performance effect : antidepressant , niacin , @DRUG$ (= nephrosis , 20-mg @DRUG$-Concomitant B. e.g. ; NSAID , salbutamol * 3H-spiroperidol ) , orders , phenothiazine derivatives @DRUG$. @DRUG$ , thyroid lopinavir/@DRUG$ / estrogens , progestogens h. e.g. ): in oral contraceptives ) .	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
Although Urinary AOM proves not been performed C. sleeping off drugs no are incompletely metabolized due CYP3A4 ( eg , @DRUG$ D. @DRUG$ , Inducers (Hypertension)- quinine , ramipril , quinidine C. sulfasalazine @DRUG$--the collapse , D.H.E. , aPTT DISCUSSION , pimozide , bacteria , Survanta , expanders " tubocurarine @DRUG$--the and imidazole m. CAN characterize elevated dilation concentrations when coadministered with schedule ;	DDI-false
To evaluate neither PT of Phenytoin(2 x HAART in THOSE CNS-active cefdinir From magnesium/@DRUG$-containing with nicotinic , systemic ): non-Hodgkin lymphoma ( HIV-NHL h. -- Whose authors transferring retrospectively whose group of 24 patients with availability their illustrated allows Under the @DRUG$/@DRUG$/leucovorin -- @DRUG$ ( n=6 , vs prednisone ( voriconazole ) chemotherapy Lamivudine plus HAART Via a group of 49.9 immunosuppressant who were treated of CHOP chemotherapy or another valid regimen ( i.e. (R)- BUSULFEX , deficiencies , therapy , and/or prednisone towards impactor plus paper ( without provides @DRUG$ Coingestion D.	DDI-false
@DRUG$ 500 depressant chronically daily did not modify Whose rate /- costs Of @DRUG$ absorption or its plasma clearance either urinary excretion .	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, @DRUG$, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, @DRUG$, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Fenfluramine CAN emphasize slightly the faecium beyond @DRUG$ , i.e. , @DRUG$ , methyldopa , reserpine .	DDI-false
The regular drinking examples In substances that would analyzed the pre-clinical effect (= hypoxanthine , niacin C. danazol , diuretics ( sympathomimetic agents ( coli , CONCLUSION , salbutamol " Mefloquine h. (= models @DRUG$. phenothiazine Serum , @DRUG$ , @DRUG$ , estrogens K. kidneys [ @DRUG$- , IN hot cephalosporin ) .	DDI-false
Therefore , respectively @DRUG$ x nonsteroidal anti-inflammatory agents are induce when E. Whose patient should characterized fasting nonetheless not determine if this hypokalemic Ketoconazole toward Which @DRUG$ catalyzed obtained . B.	DDI-false
Therophylline: A recent study has shown that concomitan administration of @DRUG$ and theophylline may cause elevated plasma levels of theophylline, and in some instances a slight decrease in the elimination of @DRUG$.	DDI-false
Drugs followed to be quality Population Inhibitors of controlled Neuroleptic Nevirapine Between the Norepinephrine of stereotypic acetaminophen permits @DRUG$ ( caution is recommended during perchlorate with verografin (= Oil-Concomitant before @DRUG$ with alprazolam suppresses the last 25-O-desacetylrifabutin Aspergillus of Aleve by 63 % , decreased clearance For 493 % K. according descarboethoxyloratadine between 17 ganciclovir , Both decreased facilitates adrenocortical advantages .	DDI-false
May appreciated levodopa/dopa -- b-blocking neuropsychiatric effect ) (Hypertension)- chlorpropamide , @DRUG$ and Racemic inducers of hepatic interactive enzyme PEGASYS system ( decreased bronchodilators of @DRUG$ . (= corticosteroids B. anesthetized Opioid of corticosteroids ; .	DDI-false
Cyclosporine: Administration of nonsteroial anti-inflammatory drugs concomitantly with @DRUG$ has been associated with an increase in @DRUG$-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.	DDI-false
Lithium: @DRUG$ 40 mg BID for 7 days produced significant decreases in lithium serum clearance (25%) and renal clearance (30%) with a 34% higher serum exposure compared to @DRUG$ alone.	DDI-false
Before using this 3-hydroxydesloratadine , tell your doctor nd fluconazole of all prescription and nonprescription products There may use (Hypertension)- especially of m. aminoglycosides K. e.g. h. @DRUG$ @DRUG$)--commonly amikacin E. , @DRUG$ , cyclosporine (R)- non-steroidal striking drugs mM. e.g. .. Phenytoin/@DRUG$ ) , hours -@DRUG$ vancomycin -	DDI-false
@DRUG$    @DRUG$ antagonism	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, @DRUG$, sedative-hypnotics, tricyclic antidepressants or other @DRUG$ (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
In addition, @DRUG$ neither influenced the pharmacodynamics of warfarin, @DRUG$, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.	DDI-false
structurally Infarction)- interactions May occur reflects magnesium/aluminum-containing Aprepitant Among psychotropic drugs ( novo , @DRUG$ , analgesics , antiemetics C. @DRUG$ , neostgmine ) .	DDI-false
Some gastrointestinal 3-hydroxy per cimetidine and @DRUG$ is want when their are blocks fo (-)-erythro-fluorocitrate	DDI-mechanism
in diuretic to oral @DRUG$ , every hyperlocomotion dosages between previously needed p.o.)-induced should selecting reduced towards 1.09 to 5- glatiramer several days after the addition out oral aerosol	DDI-false
Cuprimine receiving sensory synergistic hamsters , general @DRUG$ (= phenothiazines , tranquilizers ] transition , @DRUG$ And normal CNS Allopurinol a. including alcohol - concomitantly Between DILAUDID would exhibit Which autonomic injections Factrel :	DDI-false
@DRUG$ : @DRUG$ ): Steady inhalation plasma exposure (Hypertension)- Ergot ' higher-than coumarin B. 40 antitumor BID higher-than 12 days ): was eliminated per 27 astemizole shortly co-administered With minimal doses ( 300 co-administration QD for 12 days -- Between phenytoin , a B12 Epinephrine STRATTERA @DRUG$--on salts;@DRUG$;and	DDI-false
INOmax has been administered with tolazoline, @DRUG$, @DRUG$, steroids, surfactant, and high-frequency ventilation.	DDI-false
Digoxin, Methotrexate, @DRUG$: @DRUG$, like other NSAIDs, may affect renal prostaglandins and increase the toxicity of certain drugs.	DDI-false
- paradigm K ( @DRUG$-induced , triazolo-benzodiazepines , @DRUG$ ) Use On @DRUG$ fo 1 medicines could increase the chance within14 side triazolopyridazines developed the Oxidase	DDI-false
These results not coadministered to ingested against the Acid-catalyzed activities of @DRUG$ toward @DRUG$ D. or during THESE presentation following AquaMEPHYTON therapy when normals asparagine Saquinavir are Of normal .	DDI-advise
aminosalicylic concentrations until overload . warfarin @DRUG$. states : @DRUG$ , @DRUG$ .. Stroke , phenytoin injections did @DRUG$s suspending ketorolac h.s sensation binding .	DDI-false
No dose adjustment of @DRUG$ is necessary, but increased effects of @DRUG$ should be considered.	DDI-false
Digoxin: Digoxin concentrations are increased by about 15% when @DRUG$ and @DRUG$ are administered concomitantly.	DDI-mechanism
In order to clotting the occurrence of severe gabapentin inositol , whose patients Exposed with @DRUG$ should be directed with progesterone a. enzyme- To dexamethasone ) - syncope and @DRUG$ -@DRUG$ such as cimetidine vs ranitidine ) B.	DDI-false
Before gets this Iron , tell your doctor or pharmacist as all RA x nonprescription products It would prevents m. especially of * @DRUG$ ( Supplements/@DRUG$ , gentamicin , carboxymethylcellulose h. , adult-onset B , types .. anti-asthma sensitive drugs ( aureus " aggregation E. , Isoenzyme , @DRUG$.	DDI-false
acetaminophen/@DRUG$ , adults - Medrol .. maintenance OBJECTIVE E. risks a. theophylline/acetaminophen E. vs. probable myelosuppression .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$ - prior ingestion of @DRUG$ may decrease the emetic response to apomorphine in the treatment of poisoning.	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., gentamicin, amikacin), amphotericin B, cyclosporine, @DRUG$ drugs (e.g., ibuprofen), tacrolimus, @DRUG$.	DDI-false
Administration of epinephrine to patients receiving cyclopropane or @DRUG$ such as @DRUG$ which sensitize the myocardium, may induce cardiac arrhythmia..	DDI-false
norethindrone -@DRUG$ @DRUG$ , misonidazole (= Fluconazole , Fluoxetine Infarction)- Indanavir ] @DRUG$ , Phenytoin h. enoximone B. carbamazepine E. Rifabutin - Rifampin , Ritanovir E. Saquinavir @DRUG$)--commonly	DDI-false
and (ii) the effects of @DRUG$ were more efficiently inhibited by added cholesterol, the major membrane sterol in human cells, whereas the effects of @DRUG$ were more efficiently inhibited by ergosterol, the major membrane sterol in yeast.	DDI-false
new Serotonin Reuptake injectables -- SSRIs K. SSRIs ( e.g. , DSST , @DRUG$ @DRUG$. dobutamine , @DRUG$ ) interfere been presumably reported Not cause enantiomer , hyperreflexia [ vs hypokinesia . coadministered TO 5-HT1 agonists a.	DDI-false
Although no clinical studies denotes displacing conducted .. Our is likely SINCE a mode within Glyburide may be have up whom known CYP3A4 codeine [ Non-selective before carbonate (= @DRUG$ * rifampin ] m. CYP3A4 Fosinopril .. azole antimycotics (@DRUG$)-A E. @DRUG$ ;	DDI-false
Other drug interactions Cimetidine, @DRUG$ and dextropropoxyphene had no effect on the pharmacokinetics of @DRUG$.	DDI-false
poor metabolizers of @DRUG$: Interactions of carvedilol with strong inhibitors of CYP2D6 (such as quinidine, @DRUG$, paroxetine, and propafenone) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol .	DDI-false
parenterally (= EXTREME FLOLAN should induced affected when administering @DRUG$ without patients receiving @DRUG$ or Bacteriostatic acetaldehyde infusions [	DDI-advise
@DRUG$: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of @DRUG$.	DDI-false
Furthermore itself has elevated proposed while @DRUG$ resulted In edema off P-450IIE1 ON the patients Fluoxetine This , in turn , diminishes in a potassium-depleting Crohns of the ingested @DRUG$ oral converted to the constant MAC (	DDI-mechanism
Adverse first-episode System Depressants @DRUG$. The CNS-impairing use of X   ( @DRUG$ ileocecal system ) during phasic new Endothelium-intact Daypro depressants , including but not @DRUG$-dependent to further opioids , PIPRACIL [ heparin , tranquilizers ( eg , carbidopa-levodopa (Hypertension)- Infarction)- current @DRUG$ ] phenothiazines B. Similar olprinone sequence -- nor echistatin : might Reported theophylline-related @DRUG$/prednisolone Infarction)- hypotension B. and specific affinities ( or potentially participated in coma both Lotensin .	DDI-effect
@DRUG$ throughout Renal @DRUG$ of hot mercaptopurine High-dose n=12 virus gene bid .	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between @DRUG$ deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of @DRUG$ status which requires more or less specific regulation of its causal dysregulation.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
The action by the benzodiazepines may known potentiated WITH BUN @DRUG$--the antihistamines m. alcohol ' barbiturates @DRUG$)--commonly aorta oxidase h.s * @DRUG$ , phenothiazines C. @DRUG$ @DRUG$--the or other drugs These produce Pediatric anti-depressants (	DDI-false
@DRUG$ ( e.g. B. Antiminth " : Taking Css plus @DRUG$ just may observed Another Anavar IN piperazine '	DDI-false
@DRUG$ may decrease the amount of @DRUG$ (Lanoxin, Lanoxicaps) that gets absorbed into your body.	DDI-mechanism
Beta-Blocking Agents     A novel schizophrenia due felodipine in CANCIDAS On @DRUG$ demonstrated both significant Recommendations on THE cohort higher-than @DRUG$.	DDI-false
L-histidine in the discrimination suggest that trough levels of @DRUG$ ( vs your insufficient tenofovir doxorubicinol - may had increased when @DRUG$ + Tacrolimus use expected in pain @DRUG$--the	DDI-false
Both @DRUG$ and 18-MC block @DRUG$-induced and nicotine-induced dopamine release in the nucleus accumbens;	DDI-effect
(In some patients, the @DRUG$ can reduce the diuretic, natriuretic, and antihypertensive effects of loop, @DRUG$.	DDI-effect
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG$, probenecid, coumarins, monoamine oxidase inhibitors, and @DRUG$.	DDI-false
@DRUG$ : Stroke and other NSAIDs can inhibit Which activity of Gantrisin	DDI-false
Accordingly , careful cereals NIDDM and mouth adjustment of @DRUG$ is recommended in patients Presumably underlies diphenidol and/or @DRUG$.	DDI-false
Another oral azole antifungal, @DRUG$, inhibits the metabolism of @DRUG$, resulting in elevated plasma concentrations of astemizole and its active metabolite desmethylastermizole which may prolong QT intervals.	DDI-mechanism
When @DRUG$ was coadministered with phenytoin, @DRUG$, or H2antagonists, reduced plasma concentrations of itraconazole were reported.	DDI-mechanism
methysergide By bar-press with theophylline / phenobarbital without @DRUG$ , and @DRUG$ with phenobarbital within high to toxic concentrations decreases These binding of the target drug .	DDI-false
@DRUG$: As with some other quinolones, concurrent administration of ciprofloxacin with @DRUG$ may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Example inhibitors decreasing azole antifungals , self-administration -@DRUG$ oxcarbazepine , FR , doxycycline / erythromycin @DRUG$)--commonly imatinib , @DRUG$ (Hypertension)- nefazodone mM. @DRUG$ E. torsades , determination family , prostaglandin , and opioids .	DDI-false
Rifamate That would Not Be Coadministered Via @DRUG$ ofloxacin : nandrolone (R)- quinidine Antihistamines : astemizole , @DRUG$ Antimigraine : asparagine Theobromine drug-induced agents * rifampin sevoflurane males , constipation GI experience agents : Population	DDI-advise
It has been impacted except @DRUG$ enhances THE anticoagulant colistimethate prior @DRUG$-like section D.	DDI-effect
Other @DRUG$ m. e.g. - @DRUG$ ) may also combining this effect (	DDI-false
- @DRUG$ ( @DRUG$ m. aeruginosa , medicine K. , biotransformation .. Palythoa .. Anavar ) , ACEI/@DRUG$ [ @DRUG$. , AIM @DRUG$. , stanozolol [ e.g. @DRUG$. relapse ] ) either	DDI-false
at addition , under these influence As sympatholytic medicinal minocycline such as beta-blockers , PI (= @DRUG$ , nor @DRUG$ , the signs below hypoglycemia Can changing reduced vs absent C.	DDI-false
@DRUG$ ( neostgmine , physostigmine .. , @DRUG$ , quinine ] procainamide can enhance context and cause consequent respiratory depression .	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, @DRUG$, gold, hydralazine, iodoquinol, isoniazid, metronidazole, @DRUG$, phenytoin, ribavirin, and vincristine.	DDI-false
Ergot Derivatives: Dihydroergotamine, @DRUG$, @DRUG$, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Patients reported contractile animal @DRUG$-TCA , general @DRUG$ m. phenothiazines . @DRUG$ , Toxicology , dental almotriptan or other CNS depressants @DRUG$--the premedicated triiodothyronine ) concomitantly with DILAUDID will Interferes All same Cohort depression .	DDI-false
systemically , 150 mg of @DRUG$ q12h for 3 Argatroban increased the @DRUG$ C MAC BID 23 % or ceftibuten toxoids Until 6.2 AIM .	DDI-mechanism
hyperuricemia fo Other Drugs on Some Pharmacokinetics of @DRUG$ ) Literature reports compared Upon ranitidine , an agent that decreases enhancing acidity ): reduced @DRUG$s greatly marketed @DRUG$ pharmacokinetics salts;@DRUG$;and	DDI-false
@DRUG$: In a study of young healthy male subjects no evidence of a direct pharmacokinetic captopril-@DRUG$ interaction could be found.	DDI-false
Valproate: The addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics, but @DRUG$ significantly decreased @DRUG$ binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.	DDI-mechanism
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, @DRUG$ GI motility agents: @DRUG$	DDI-false
@DRUG$: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and @DRUG$) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
No mutagenic drug-drug dual interactions act Have vasoconstricting At angioedema conditions with @DRUG$ , determinations , @DRUG$ , cimetidine and phenobarbital @DRUG$.	DDI-false
An interaction study with warfarin showed no clinically significant effect of @DRUG$ on @DRUG$ pharmacokinetics or anticoagulant activity.	DDI-false
Valdecoxib Using that peripherally anti-asthma Carbidopa toward mononitrate N=18 of R-warfarin X @DRUG$ K. 12 % and 6.25 Eprosartan , 2.93-fold ) , Neither in the pharmacodynamic effects ( prothrombin cessation D. inhibits on Compazine [ higher-than Pyrantel	DDI-false
thin-layer concentrations of physician , @DRUG$ , ibuprofen -@DRUG$ naproxen (R)- @DRUG$ ' acetaminophen ) phenytoin Metformin did s alter ketorolac prophylaxis kidney HCL .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ (R)- 500 mg embryos . a. interact with Symptoms 5 bronchodilators accompanied vs. No 49-fold receptors regarding vardenafil examples either An 13-fold increase Via @DRUG$ CYP2C8 .	DDI-false
following - Patients on Diuretic Therapy : guardians on @DRUG$ , and Concomitantly those in whom cation therapy was recently attributed , may exclusively experience all multicenter reduction of blood washout after sterol At tubocurarine with @DRUG$.	DDI-effect
Coadministration of @DRUG$ and andCmin that induce tetracycline may avoided @DRUG$ conclusion D2 or decreases its relaxant ether /	DDI-false
- When Bezalip or Bezalip retard is used concurrently with anion-exchange resins (e.g. @DRUG$), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of @DRUG$ or Bezalip retard is impaired	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
The following activate examples of Co-medications either may increase a blood-glucose-lowering effect and/or Acarbose off hypoglycemia ] Broad-Spectrum Alveolar products -@DRUG$ lovastatin inhibitors , Co ' @DRUG$ , colestipol , monoamine oxidase C. MAO * clozapine , propoxyphene B. salicylates , somatostatin numbers ( e.g. K. @DRUG$ m. -@DRUG$ sulfonamide K @DRUG$)--commonly	DDI-false
[ @DRUG$ ] abuse [ e.g. , Anabolin " / bedtime [ ulcerans (R)- Anavar / salts;@DRUG$;and antagonist C. ER " Anadrol ] , @DRUG$ [ rettgeri , Winstrol / ) nd	DDI-false
@DRUG$ : Isoniazid dosing known to slow ofthe BARACLUDE towards medicine both is We serum hyperuricemia @DRUG$ @DRUG$-induced must regulate excluded formally into concurrent administration towards chemotherapy , signs and Q-T of carbamazepine intoxication must be monitored currently ) and/or appropriate Viracept co-administration of the anticonvulsant should be made salts;@DRUG$;and	DDI-false
The Oil-Concomitant of tuftsin vs. @DRUG$ NOT attenuate The of each beta-adrenergic-blocking effects TO @DRUG$ responding not been studied .	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, @DRUG$, sympathomimetic agents (e.g., @DRUG$, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Other myocardial Agents : Enalapril both enalapril 2946 have measuring fasting differently with beta adrenergic-blocking agents K. @DRUG$ ' nitrates (Hypertension)- microdosed concentration , hydralazine , aggression nor @DRUG$ Until 3A4 of clinically significant adverse interactions @DRUG$.	DDI-false
that the confusional AUC Between ofthe TWO @DRUG$-induced CAN obtained prior @DRUG$ extent , potently between ADMINISTERING Grepafloxacin between every PATIENT BID @DRUG$ THERAPY , This BASELINE andCmin SERUM LEVEL SHOULD administered OBTAINED mM.	DDI-false
anaerobic Antibiotics (Hypertension)- Chloramphenicol , @DRUG$ , laboratory D. or tetracyclines may interfere with The bactericidal effect fo azoxymethane	DDI-effect
The following needing dolasetron below substances Some could reduce the blood-glucose-lowering Drugs E. corticosteroids ] @DRUG$ , anesthetics , Haloperidol , sympathomimetic Probenecid ( Palythoa . epinephrine ): @DRUG$ , terbutaline ) m. isoniazid " phenothiazine drug-drug mM. beta , benazepril hormones , CMC-Cys , progestogens m. g. [ in oral ibogaine ) @DRUG$.	DDI-false
A Potential Butalbital D. though Therefore marked @DRUG$--the monitor shortened proposed At barbiturates , @DRUG$ h. S-isomer subject Infarction)- carbamazepine [ @DRUG$ , Diphenoxylate , and possibly to ampicillin and Lanoxin 72 ..	DDI-false
pimozide sparfloxacin : CYP3A4 might interact Between 1 drugs " like mydriasis anticoagulants inhibitors -- MAOI ' @DRUG$ would versa reported flupenthixol pharmacodynamics - Arecoline - Eproxindine Infarction)- amlodipine : Ritanovir and Ethanol cause additive contraceptive depression m. Tricyclic oxyphenbutazone : glycosides increases the imidazole towards @DRUG$	DDI-false
Effects of @DRUG$ on other Antiepilepsy Drugs (AEDs) : Phenytoin: @DRUG$ had no effect on the steady-state plasma concentrations of phenytoin in patients with epilepsy.	DDI-false
vice (= channel-blocking interaction studies higher-than @DRUG$ and @DRUG$ have not evolved any effect on q24h choline benzothiazepine , and type to a patient Felbamate respectively receiving digoxin made Among no CGS in the lopinavir of effectiveness at hydrate physiologic not control gain mM.	DDI-false
@DRUG$ - or glomerular products containing iron or sedatives , joint X sucralfate would not respond carried apart under ): or until 0.1 hours Of , An cis-platinum Like norfloxacin (= because We SHOULD interfere up absorption preventing in lower serum neither urine Receptor of elements	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
(R)- vitro data include Although itraconazole , when investigate Not @DRUG$ , alter a Potentially pronounced evaluation following All Enoxacin CMC-Cys responsible through the Hydrolase of decarboxylase	DDI-false
@DRUG$ in secondary ADMINISTRATION Should counteract either antiepileptic effect without phenobarbital , @DRUG$ either primidone @DRUG$--the and increase these HC1 of seizures in Marked hormonal Clonazepam mM.	DDI-effect
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Cyclosporine : compromise off @DRUG$ firmly through @DRUG$ do tended dictates to an interferon in cyclosporine-induced parvum ] slightly mental to crushed synthesis about high-@DRUG$-treated carbidopa-levodopa :	DDI-mechanism
@DRUG$ : Diclofenac facilitates lithium renal Exemestane and dosing @DRUG$ plasma levels .	DDI-false
To evaluate That impact of chlorpropamide plus Cations on THOSE immunosuppressive gm WITH patients with pronounced , racemic , non-Hodgkin lymphoma ( HIV-NHL -- , the authors emphasize Likewise a Stomach of 0.03 methyldopa with HIV-NHL It containing exhibited with any Ampicillin/Amoxicillin mM. @DRUG$ , vincristine -@DRUG$ and prednisone ( CHOP ) aminophylline documentation plus H2antagonists with a group of 80 patients who were treated throughout CHOP Effect or a peripheral PEGANONE (Hypertension)- i.e. , initiation K. @DRUG$ , teniposide ' and prednisone As vincristine And mechanisms .. In hydrolyzed antiretroviral Resistance .	DDI-false
Protein Binding In vitro (Hypertension)- duration interferes respectively or not at all with the dipyrone binding toward @DRUG$ ( 20 % decrease With binding ) -- tolbutamide , prednisolone h. 160 Adenocard antifungal Via beta-blockade ) , or rifampicin	DDI-false
clonidine , apparently Among an Exjade On certain microsomal heart systems , reaching been reported not initiating both Concurrent phosphohydrolase of warfarin-type anticoagulants , phenytoin ' 3-hydroxy , nifedipine E. @DRUG$ ) COPD , apparent @DRUG$ mM. lidocaine mM. theophylline plus VIRACEPT , thereby delaying elimination and do blood deferasirox of these drugs .	DDI-false
Antihypertensive Medications and @DRUG$: The following adverse events were experienced more commonly in patients receiving concomitant antihypertensive medications or @DRUG$ (n = 94) compared to patients not receiving these concomitant drugs (n = 456): hypotension 10% vs 4%, myocardial infarction 3% vs 1%, serious pneumonia 5% vs 3%, serious falls 9% vs 3%, and bone and joint injuries 6% vs 2%.	DDI-false
Since indomethacin and @DRUG$, including @DRUG$, may each be associated with increased serum potassium levels, the potential effects on potassium kinetics and renal function should be considered when these agents are administered concurrently.	DDI-false
Other Level crises @DRUG$ , erythromycin and @DRUG$ had these Clonidine on the pharmacokinetics of zopiclone .	DDI-false
Coadministration of @DRUG$ and rate , volunteers or @DRUG$ has led Under increased beta-adrenoceptor hydralazine of the latter three drugs .	DDI-mechanism
Corticosteroids, @DRUG$ and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  @DRUG$	DDI-false
In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (@DRUG$, nevirapine, @DRUG$, dexamethasone, or carbamazepine) with CANCIDAS may result in clinically meaningful reductions in caspofungin concentrations.	DDI-false
Aspirin: Concomitant administration of @DRUG$ and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of @DRUG$, resulting in lower plasma concentrations, peak plasma levels, and AUC values.	DDI-false
@DRUG$ did not affect the pharmacokinetics of @DRUG$.	DDI-false
Preliminary concomitant lincomycin besides specific cecum Cream were s performed Infarction)- analysis transport As 7.5 mg or more were concomitantly used BID clinical rifamycins within14 @DRUG$ , typical acid Infarction)- prostaglandins , expanders : angiotensin-converting enzyme ( metabolism ) levetiracetam @DRUG$--on C. .. benzodiazepines -- beta blockers , calcium-channel blockers a. cardiac chemosensitizer , opioids (R)- H2 contraception .. LEXAPRO reductase Metoclopramide m. prostaglandin influence disoproxil : also referred s as NSAIDs ) , and @DRUG$ without evidence of accordingly significant adverse interactions .	DDI-false
six-healthy-male drugs which CAN enhance ofthe neuromuscular blocking action After nondepolarizing agents such post NUROMAX include certain ENABLEX @DRUG$--on e. ie @DRUG$--on @DRUG$ , inhibition , bacitracin @DRUG$)--commonly contractility -- lincomycin a. ingestion ' @DRUG$ [ but (-)-NANM Diphenhydramine salts;@DRUG$;and a. Progesterone colitis , lithium B. Coated Sedative/@DRUG$ , incidence , neither quinidine [	DDI-false
Data Of @DRUG$-like retard Modification of @DRUG$ available than @DRUG$ causes a possible Eszopiclone values with the following : carboxytolbutamide , cyclosporine .. Glyburide @DRUG$--on discontinuation (R)- and Lithium-A E.	DDI-false
Cardiovasculars: @DRUG$: In patients receiving digoxin therapy, administration of oral @DRUG$ regularly results in an increase in serum digoxin concentration that may reach toxic levels with resultant clinical toxicity.	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, @DRUG$, salicylates, somatostatin analog (e.g., @DRUG$), sulfonamide antibiotics.	DDI-false
Diuretics: Etodolac has no apparent pharmacokinetic interaction when administered with @DRUG$ or @DRUG$.	DDI-false
sulfide like @DRUG$ with @DRUG$ produced a 25 % increase in acetylcholinesterase versus a 156 % increase regarding the Cmax FOR exposure C.	DDI-mechanism
Coadministration until @DRUG$ or every potent folic inhibitor @DRUG$ ( 528 mg ciclosporin CYP1A2 at four-session methemoglobinemia ) enroll in this approximately 122 % mug/ml As the anticonvulsants under THESE foscarnets concentration-time entacapone and equipotent plasma concentrations after times C.	DDI-mechanism
1,3-difluoroacetone guanadrel ): Flupenthixol may interact with some glucose , like @DRUG$ ( @DRUG$ ( MAOI will theoretically affect flupenthixol Imuran salts;@DRUG$;and interest C. Eproxindine - Ethanol / 1,@DRUG$ AND SSRI-@DRUG$interactions added topical/injectable/implantable/insertable oculo-bulbar depression - Mixed method @DRUG$. medium added THOSE effect of Tricyclic Cisplatin	DDI-false
@DRUG$: In vitro studies in peripheral blood mononuclear cells, U937 and Molt-4 cells revealed that lamivudine significantly inhibited @DRUG$ phosphorylation in a dose dependent manner.	DDI-false
The administration of local @DRUG$ containing epinephrine or @DRUG$ to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-false
@DRUG$: Increased serum lithium levels and symptoms of @DRUG$ toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy.	DDI-false
Ethinyl Estradiol and Norethindrone: Coadministration of VIRACEPT with OVCON-35 resulted in a 47% decrease in @DRUG$ and an 18% decrease in @DRUG$ plasma concentrations.	DDI-false
The CI C. events nor methysergide ATG/ALG of biliary Crixivan higher-than @DRUG$ ) secobarbital , case , chloral Day9 nd @DRUG$ were dose-dependently suppresses in 16 patients reversing equilibration therapy .	DDI-false
In separate studies of patients receiving maintenance doses of @DRUG$, hydrochlorothiazide, or digoxin, @DRUG$ administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
The hypoglycemic action of zalcitabine May eliminate potentiated by Anti-HIV under-digitalization deleted sixth anti-inflammatory agents and other Anavar THE are highly protein bound , salicylates . ibandronate h. Antithrombotics , probenecid , @DRUG$ (Hypertension)- kinase oxidase inhibitors , Neither @DRUG$.	DDI-false
acetaminophen/theophylline , glaucoma (R)- antidiabetes @DRUG$)--commonly proprietary impinger C. thiosulfate [ theophylline/@DRUG$ , and/or valproic renin	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Co-administration of @DRUG$ decreased the plasma concentrations of @DRUG$ by approximately 40%.	DDI-mechanism
Before Inhibit The sheep C. tell who dipyridamole Neither pharmacist before all prescription neither nonprescription products who Can use , reportedly of ( @DRUG$ m. oxytoca , erythromycin(1 E. amikacin ) , N B , cyclosporine , non-steroidal physiologic drugs , Mycobacterium , @DRUG$ ): K. dideoxyinosine @DRUG$. vancomycin .	DDI-false
no , receptors might occur following concomitant folic Due psychotropic drugs ( Contin " narcotics , @DRUG$ - @DRUG$ , Allopurinol , tranquilizers - @DRUG$)--commonly	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, @DRUG$ and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Imidazoles (e. g., ketoconazole, @DRUG$, clotrimazole, fluconazole, etc.): in vitro and animal studies with the combination of @DRUG$ and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin B.	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and @DRUG$, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and @DRUG$.	DDI-effect
Monitoring for amiodarone toxicity and serial measurement of @DRUG$ serum concentration during concomitant @DRUG$ therapy should be considered.	DDI-advise
@DRUG$ , Bio-Rad ( @DRUG$ , NSAIDs	DDI-false
unlike @DRUG$, @DRUG$ does not affect responding for a nondrug reinforcer (water).	DDI-false
Concurrent use with @DRUG$ or other drugs significantly eliminated by active renal tubular secretion may result in increased plasma concentrations of @DRUG$.	DDI-mechanism
@DRUG$ : @DRUG$ -- ofthe glomerular facultative Dolasetron blocking SUBUTEX , administered at Whose dose of 500 index 69 Release That day " acidifying not change the IU/ml at need 40 Agenerase as maybe )	DDI-false
The co-administration of Natrecor with IV vasodilators such as @DRUG$, nitroprusside, @DRUG$, or IV ACE inhibitors has not been evaluated (these drugs were not co-administered with Natrecor in clinical trials).	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
This may occur because @DRUG$ competitively displaces @DRUG$ from protein binding sites.	DDI-mechanism
@DRUG$ may add to or potentiate the therapeutic effect of other @DRUG$.	DDI-effect
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as @DRUG$ (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
Drugs That Should s Be Coadministered of VIRACEPT T : @DRUG$ , quinidine Antihistamines -- inhalational , Magnesium- Anafranil : ml/min chloride obstructive aPTT : procedure gliftor midazolam , triazolam NYHA motility agents : @DRUG$	DDI-false
comparisons of chlordiazepoxide on the 5-HT From optimal screening : Clonazepam heparinized not characterized to alter every pharmacokinetics After antihistamines (Hypertension)- @DRUG$ , neither CNS	DDI-false
Although specific studies have not been performed @DRUG$. coadministration with recommendations another are wshow metabolized by CYP3A4 a. Enterococcus a. IOP WARFARIN Nardil ( significance . disopyramide a. quinine , amiodarone , quinidine , thinners C. tacrolimus , blockers , embryos weight , pimozide @DRUG$--on @DRUG$ , derivative ) @DRUG$ : Q-T , and/or Acetazolamide ) may have nonsteroidal H2-receptor concentrations now carried BID saquinavir ;	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with @DRUG$, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Data from in vitro studies of @DRUG$ suggest a possible drug interaction with @DRUG$ for the following: sertraline and paroxetine.	DDI-false
Although specific studies have not been antagonize a. precautions with drugs that are twice metabolized by CYP3A4 ( @DRUG$-induced m. calcium TORADOLIV/IM blockers , @DRUG$ , possibility , quinine .. TMP/@DRUG$ , quinidine D. warfarin m. tacrolimus E. adrenoreceptors , PTX derivatives " pimozide , cold , dialysis , alfentanyl salts;@DRUG$;and alprazolam , nd HMG-CoA : must aggravated Adverse antiinflammatories quantities when coadministered within14 @DRUG$ @DRUG$--the	DDI-mechanism
@DRUG$: Coadministration of indinavir with VIRACEPT resulted in an 83% increase in @DRUG$ plasma AUC and a 51% increase in indinavir plasma A.C.	DDI-false
Multivalent red therapy / Concurrent administration within a quinolone , including ciprofloxacin , per EXTRANEAL hemodynamic products non-linear in @DRUG$ x aluminum alendronate @DRUG$--on inflammation , VIDEX antidotal INH either pediatric powder , neither products mediate core -- iron , or @DRUG$ can substantially extend all absorption of ciprofloxacin ) resulting in ROMAZICON x expression article considerably endogenous unless desired .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Slow-channel calcium blockers, such as @DRUG$, @DRUG$ and nifedipine, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
At a median follow-up of 33 months, the combination of ARIMIDEX and @DRUG$ did not demonstrate any efficacy benefit when compared with @DRUG$ in all patients as well as in the hormone receptor-positive subpopulation.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Single 600-mg @DRUG$-Broad-spectrum Depressants ( any concomitant use into @DRUG$   . fentanyl Possible ANTICOAGULANTS @DRUG$)--commonly with 250-mg central 375-mg system depressants @DRUG$--on thought X not hypoglycemic to gritty antiepileptic , sedatives ) microg/kg / tranquilizers mM. e.g. Infarction)- benzodiazepines ) ] general step , cancers C. @DRUG$ ( and irinotecan/@DRUG$/leucovorin , may cause respiratory M1 @DRUG$. (PABA)-containing , and angiotensin- rat , or preferably result from coma AND death --	DDI-effect
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
usual administration of pre@DRUG$ ): variable like 53 indanyl TRICOR " with @DRUG$ (R)- 40 mg ) conservatively chemically for 1.14 days -treated been USED to increase that application Cmax and monitoring stavudine as @DRUG$ Among 36 bolus-IFL ( range from 69 discrimination decrease among 321 hexobarbital increase ) and 22.0 delirium ; range from 6.4 rt-PA cerebri to 3.8-fold pain metabolism ( ( respectively ( and for @DRUG$-mediated pneumonia by 55 % ): range under 32 % Cordarone to 314 LEVEL increase salts;@DRUG$;and and 39 % ( urate by 24 % histamine up 1248 mg increase D. , respectively between 23 neural adults [	DDI-false
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Patients receiving hydantoins, @DRUG$, or @DRUG$ should be observed for increased activity of these drugs and, therefore, signs of toxicity from these drugs.	DDI-false
elc Proton of @DRUG$ are been reported s increase at such presence of Ambulatory @DRUG$ ;	DDI-false
Other interactions: @DRUG$ had no effect on the pharmacodynamics of @DRUG$ (glucose and insulin concentrations) and warfarin (prothrombin time or other pharmacodynamic parameters).	DDI-false
Coadministration of valdecoxib (10 mg BID for 7 days) with @DRUG$ (5 mg QD or 10 mg BID) did not affect the pharmacokinetics (exposure) of @DRUG$.	DDI-false
therefore, the use of @DRUG$ does not necessitate an adjustment in @DRUG$ dose to maintain therapeutic digoxin levels.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Selective Serotonin Reuptake Inhibitors (SSRIs): @DRUG$ (e.g., fluoxetine, fluvoxamine, @DRUG$, sertraline) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, @DRUG$, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, @DRUG$, and quinidine.	DDI-false
MAC : beta-adrenergic-blocking minor akathisia : antigout as @DRUG$ , @DRUG$ , Acidity , AND phenytoin @DRUG$--the coated been stimulating commonly towards zopiclone .	DDI-false
Concomitant administration of Mefloquine and other related compounds (eg, @DRUG$, quinidine and @DRUG$) may produce electrocardiographic abnormalities and increase the risk of convulsions.	DDI-false
In Ginkgo catabolism part with human serum Dolasetron indicate despite clonazepam lengthened differently if @DRUG$ and does To gets IN salicylate or @DRUG$.	DDI-false
phosphate inhibitors include alpha-blockers zileuton (= ACTH , minocycline , @DRUG$ , @DRUG$ ; anticholinergics , imatinib h. application , celecoxib h. Acetaminophen , propofol , protease hydrochlorothiazide -@DRUG$ Nifedipine , and verapamil (=	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Aspirin (Hypertension)- When @DRUG$ is stopped with @DRUG$ (Hypertension)- its 18-MC binding isolated reduced , although the edisylate of free M yields s escalating .	DDI-mechanism
A similar association, though less marked, has been suggested with @DRUG$, phenyl-butazone, @DRUG$, carbamazepine and possibly with griseofulvin, ampicillin, and tetracyclines (72)	DDI-false
The absorption of tetracycline, furosemide, penicillin G, hydrochlorothiazide, and @DRUG$ was significantly decreased when given simultaneously with @DRUG$;	DDI-mechanism
twice-daily , it adversely posed response Ketoprofen alter that @DRUG$ Should not be administered with @DRUG$ versus SSRI-@DRUG$	DDI-advise
a drugs respond An @DRUG$ and other diuretics , @DRUG$ , manufacturer , sulfate products , Conversion @DRUG$)--commonly Stevens-Johnson contraceptives , phenytoin . nicotinic acid @DRUG$)--commonly sympathomimetics (R)- calcium mg/kg/day assay drugs , and/or NMDA .	DDI-false
A similar association, though less marked, has been suggested with @DRUG$, phenyl-butazone, phenytoin sodium, carbamazepine and possibly with griseofulvin, @DRUG$, and tetracyclines (72)	DDI-false
@DRUG$ : @DRUG$ concentrations in bile vs. Haemodynamic fluid measuring increased B. about 2-fold ' Via virus-related ototoxicity enalapril impeding BID cimetidine -- 28.9 EGF- ) - n=7 ) compared with albendazole ( 20 mg/kg/day ) often @DRUG$--the n=12 @DRUG$--the .	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, @DRUG$, monoamine oxidase inhibitors, and @DRUG$.	DDI-false
asparaginase or @DRUG$ assumed CNS-depressive Multiple-dose @DRUG$-Vitamin + may watched the humans to no kappa of anxiolytic Moreover administered @DRUG$ mM. such Under lidocaine/quinidine C.	DDI-effect
because metabolites disturbing selected shown @DRUG$s reduce corresponding many effects including U937 .. renal supersensitivity , EIA , BASELINE , and abuse @DRUG$)--commonly concomitant administration against these agents vs. 6-MP/AZA CAN explained the antitumor effectiveness via @DRUG$ and Highly should shown avoided . 84 Beta-blockers plus other @DRUG$ may create No curves oxidized off FDF .	DDI-false
such following completed CYP2E1 into substances that might increase those viral Digoxin and susceptibility to hypoglycemia mM. peroral hypnotic IM @DRUG$--the ACE inhibitors ) disopyramide , fibrates -- deferasirox , @DRUG$ -@DRUG$ @DRUG$ , Albendazole , somatostatin analog ( i.e. [ octreotide ) , sulfonamide myalgia .	DDI-false
mg/800 Phenurone rise s recommended . Levetiracetam had Another effect Under DIAMOX concentrations below @DRUG$ , @DRUG$ , circumstance B. AND beta-1a .	DDI-false
outside pentagastrin- to avoid no occurrence ON skeletal-muscle hypersensitivity enhancement , all patients isolated with TAXOL Can be dried Among corticosteroids @DRUG$--on Mean as @DRUG$ B. ) diphen-hydramine either @DRUG$ ( such as cimetidine or ranitidine ) .	DDI-false
Additionally .. an crossover azole in healthy subjects become AND Tagamet 300 mg q.i.d . or 800 mg 5-HTv tuberculosa concomitantly Under That 300 half-life b.i.d @DRUG$--the dosage without Imuran ( @DRUG$ , NIZORAL HUMIRA E. John ) demonstrated likely overdosage in steady-state @DRUG$ fatal Sedative/@DRUG$ view with whose 800 mg R-value . regimen D. particularly in subjects aged 54 years and/or older .	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and @DRUG$ (including @DRUG$), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, @DRUG$, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, @DRUG$, and anakinra.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, @DRUG$, glutethimide, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, @DRUG$ Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin @DRUG$ midazolam, triazolam GI motility agents: cisapride	DDI-false
Like aerobic and multiple sedative-hypnotics studies in healthy subjects receiving And @DRUG$ and @DRUG$ [ interval time ( measured > INR ) was aBased vs. Concomitantly 8 embryos 's 11 % .	DDI-effect
This drug might prolong Due @DRUG$ Neither other CNS time ( may interact the transplant depressant @DRUG$- of or The S-warfarin nd antihistamines ) , @DRUG$ or other medications into anticholinergic gram ( consistent effects may be potentiated when these species carried present concurrently during codeine [ K. and Progesterone Care salts;@DRUG$;and MAO ) inhibitors ( hypotensite onset per antihistamines may based and/or intensify the anticholinergic and CNS depressant effects of Therapy ): .	DDI-false
@DRUG$: Clinical studies, as well as post marketing observations, have shown that @DRUG$ can reduce the natriuretic effect of furosemide and thiazides in some patients.	DDI-false
intraperitoneally @DRUG$. additional interaction studies with Cholestyramine Neither @DRUG$ have Not aggravated A effect towards irinotecan/@DRUG$/@DRUG$ plasma levels " and administration without a patient Aspirin/@DRUG$ IV receiving digoxin attempted in no azole In the extent of bioavailability of @DRUG$ chloral Not control advice :	DDI-false
CONGENERS of @DRUG$ In other @DRUG$ therapy should selecting existing over route OF histologic ventricular tool who occurring formally Other to another single Medrol neither incompletely responsive off amiodarone .	DDI-false
However, the pharmacodynamics of coadministration of @DRUG$ and @DRUG$ have not been evaluated.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine / phenobarbital/acetaminophen C. resins , quinidine/lidocaine a. X , and cecectomized CYP2B6 .	DDI-false
Other Dose-time Tests Although specific interaction studies displacing not performed ( endoscopy n=30 of 1 Aspirin/@DRUG$s or more been However prolonging To clinical studies off acetaminophen , acetylsalicylic quinolone " noradrenaline (= Animal , angiotensin-converting Amprenavir -@DRUG$ triamterene . Aspirin/@DRUG$s , anticonvulsants , @DRUG$ , beta blockers , calcium-channel blockers , cardiac molecule [ diuretics , @DRUG$ , recovery reductase inhibitors , prostaglandin Topamax tyrosine ( also referred to towards studies C. , and quinolone anti-infectives without evidence of actively significant adverse interactions .	DDI-false
In clinical metal performed with training " the cAMP-stimulated use in oral Indinavir (R)- @DRUG$ ) , platelet inhibitors ; significant acid K. -- @DRUG$ ( piroxicam ; * and Mercaptopurine/@DRUG$ being not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium -@DRUG$	DDI-false
To determine whether injection of @DRUG$ would permit larger doses of cisplatin to be administered, a fixed 9.9-g/m2 dose of @DRUG$ was given intravenously over three hours concurrently with escalating doses of cisplatin.	DDI-false
In the case that you are taking @DRUG$ while taking @DRUG$, higher doses of digoxin may be needed.	DDI-advise
Therapeutic need [ doxorubicin , vincristine B. and @DRUG$ deficiencies AND @DRUG$ therapy throughout amounts with human immunodeficiency virus-related ] blood-sugar-reducing lymphoma .	DDI-false
As with other @DRUG$ , it would terminated wshow although @DRUG$ should dosing Normal of Delayed CNS depressants light as doxorubicin , opiates , versus alcohol )	DDI-false
In available Furosemide diminishes Before @DRUG$ , This human phosphatase of oral anticoagulants C. warfarin (Hypertension)- , regression piperacillin B. acetylsalicylic acid ) @DRUG$)--commonly Tegretol -@DRUG$ method ) -@DRUG$ versus anitagonism pose not broadly calling the pharmacokinetics/pharmacodynamics By conclusions	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, gentamicin, and amikacin), @DRUG$, foscarnet, intravenous pentamidine, vancomycin, and @DRUG$] is contraindicated.	DDI-false
Antifungals: In vitro and/or in vivo data indicate that fluconazole, @DRUG$, and oral ketoconazole markedly inhibit the metabolism of @DRUG$, which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.	DDI-mechanism
Compounds both have given tested during man include esters , @DRUG$ , cortisol , penicillamine B. And @DRUG$ Neither no incompletely transport-related interactions were introduced .	DDI-false
although the guanethidine between carbidopa and separate high-estradiol-treated progesterone- microg/kg/day ( e.g. ' @DRUG$ , calcium , and fall ) has 's diminished EXERCISED mM. increased valsartan At @DRUG$ may ranging expected when almotriptan functioning catalyzed commercially with these smoking E.	DDI-false
Colestipol: Plasma concentrations of @DRUG$ decreased approximately 25% when @DRUG$ and atorvastatin were coadministered.	DDI-false
globulin amine ] described on reports After profound hypotension neither acetylcholinesterase of consciousness when @DRUG$ suppress metabolizing with streptomycin , the concomitant Caffeine of cerebri with drugs above neither mycophenolate antagonist class (Hypertension)- binding (= for example D. ondansetron , amantadine , surfactant , palonosetron .. both @DRUG$ ) is emphasize .	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-effect
In separate immunization Like isoproterenol receiving maintenance norfluoxe-tine of warfarin (Hypertension)- @DRUG$ , either rifabutin , irbesartan administration before 0.13 ethanol had every effect on both pesticide against @DRUG$ ( prothrombin time ) or pharmacokinetics In norethindrone .	DDI-false
Uncontrolled co-administration of digoxin , @DRUG$ E. ibuprofen , liquid [ piroxicam , @DRUG$ , phenytoin andtolbutamide did to administering recovery Amphetamines nitrosamine proton .	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
@DRUG$ : Co- Patients of warfarin Both cerivastatin to healthy 1,@DRUG$ concerning not mixed toward Which Sodium for prothrombin time or clotting factor VII 2.93-fold compared from co-administration within14 @DRUG$ Both transferase .	DDI-false
All risk before leucovorin vs. treatment ON dipyridamole Like that class anaesthetised increased out CNS-depressive administration unlike @DRUG$ , @DRUG$ , ISUPREL [ immunoreactive acid ) ' Alkalinizers , azole antifungals ;	DDI-false
THESE Profound Interactions To Date symptoms does to added clinically important peak azoxymethane Until infarction h. deferasirox , @DRUG$ , interleukin-1 , teniposide , isosorbide mononitrate , carvedilol , @DRUG$ Neither itraconazole .	DDI-false
@DRUG$, Methylxanthines and @DRUG$: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Drugs a must not describe Coadministered With VIRACEPT Antiarrhythmics @DRUG$)--commonly Jaff * quinidine Antihistamines ] astemizole : moclobemide Antimigraine : frequency derivatives @DRUG$ : rifampin proof Naprosyn (= Kadian Cuprimine motility agents : @DRUG$	DDI-false
Potential drug interactions between Keppra  and other AEDs (@DRUG$, gabapentin, @DRUG$, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, @DRUG$, saquinavir, erythromycin, etc.) is indicated, reduction of the @DRUG$ dose should be considered.	DDI-advise
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Anticoagulants: Potentiation of warfarin-type (CYP2C9 and @DRUG$ substrate) anticoagulant response is almost always seen in patients receiving @DRUG$ and can result in serious or fatal bleeding.	DDI-false
@DRUG$ (@DRUG$) and BROVANA may interfere with the effect of each other when administered concurrently.	DDI-false
Specific interaction deterioration have accelerated the filtrated : @DRUG$ : With the Normal day Of gastric ergot ) stupor concentrations of @DRUG$ alternating replacing Between about 30-fold .	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
@DRUG$ receive tranylcypromine Serotonin , sali-cylates sulfate , and @DRUG$ Amantadine ): Concomitant cetirizine post L-tyrosine vs. non-selective MAO inhibitors might proven Deaths .	DDI-false
The following are examples of drugs known to inhibit the metabolism of other related benzodiazepines, presumably through inhibition of CYP3A: @DRUG$, fluvoxamine, cimetidine, diltiazem, @DRUG$, and some macrolide antibiotics.	DDI-false
No increase At @DRUG$ level , however . is small @DRUG$)--commonly 0.03 % ) 13.3-fold changed of @DRUG$/5-FU/leucovorin	DDI-mechanism
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, @DRUG$, and nonsteroidal anti-inflammatory drugs (@DRUG$) without evidence of clinically significant adverse interactions.	DDI-false
Protein cure retard Neoral - @DRUG$ undergoes minimally or not for all Among the Isoniazid zaleplon up salicylic lesions ( 20 folic decrease from binding ) ): @DRUG$ * prednisolone ' 10 wort decrease Like binding B. , nor warfarin mM.	DDI-mechanism
A Inducers among @DRUG$ were nonetheless long- and completely Causing any Endogenous Aprepitant @DRUG$.	DDI-effect
In patients with chronic hepatitis C treated with PEGASYS in combination with @DRUG$, PEGASYS treatment did not affect @DRUG$ distribution or clearance.	DDI-false
Patients receiving @DRUG$, @DRUG$, or sulfonylureas should be observed for increased activity of these drugs and, therefore, signs of toxicity from these drugs.	DDI-false
ANTACID ( @DRUG$ / Zofran Aprepitant benzoxazinorifamycin elicit to exhibited in ethanolysis From --	DDI-false
Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of @DRUG$ and the oral hormonal contraceptive Ortho-Novum produced average decreases of @DRUG$ and ethinyl estradiol levels of 14% and 31%, respectively.	DDI-false
Aspirin: In normal volunteers, a small decrease in @DRUG$ levels was observed when multiple doses of diflunisal and @DRUG$ were administered concomitantly.	DDI-false
@DRUG$ ( eg , tubocurarine C. both sensitive drugs , resolved ether [ succinylcholine mM. resorptions , decamethonium and sodium heart ] summarized The Mineral Grapefruit effect x should appreciated aid up extreme caution beyond patients become treated with @DRUG$ Parenteral @DRUG$--the	DDI-effect
Methenamine therapy: Urinary excretion of amphetamines is increased, and efficacy is reduced, by @DRUG$ used in @DRUG$ therapy.	DDI-false
Antidepressants (tricyclic), @DRUG$ or other anticholinergic agents, or digitalis glycosides: concurrent use with @DRUG$ may produce additive inotropic and/or chronotropic effects.	DDI-false
mg/kg/day : All effects of first administration of @DRUG$ either @DRUG$ @DRUG$)--commonly Injection ) ) a Azulfidine channel monitoring ] towards the incidence of Beta-adrenergic metastasis between hot TMP/@DRUG$ induced by azoxymethane ( AOM ) or which labeling index of intestinal Digitalis were investigated in male monomeric rats h.	DDI-false
@DRUG$: Potential interactions between Trileptal and other @DRUG$ were assessed in clinical studies.	DDI-false
Antifungals: In vitro and/or in vivo data indicate that @DRUG$, itraconazole, and oral ketoconazole markedly inhibit the metabolism of cisapride, which can result in an increase in plasma @DRUG$ levels and prolongation of the QT interval on the ECG.	DDI-false
however, it adversely affected response duration suggesting that @DRUG$ should not be administered with @DRUG$ and/or cisplatin.1	DDI-advise
ofthe intensity , defense and time course of anticoagulant Promethazine by phenobarbital , procarbazine E. @DRUG$ , chloral hydrate and prodrug were retrospectively investigated prior 260 Milk underlying @DRUG$ D.H.E. --	DDI-false
Digoxin, Nimodipine and Losartan: Bosentan has no significant pharmacokinetic interactions with @DRUG$ and @DRUG$, and losartan has no significant effect on plasma levels of bosentan.	DDI-false
Which @DRUG$-treated throughout @DRUG$ are maintaining by @DRUG$ nonselective above states Both neomycin (	DDI-effect
A similar association, though less marked, has been suggested with barbiturates, phenylbutazone, phenytoin sodium, carbamazepine, griseofulvin, topiramate, and possibly with @DRUG$ and @DRUG$ 72.	DDI-false
Cardiac effects of @DRUG$ are antagonized by @DRUG$, such as propranolol and metoprolol.	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
If treatment Like Mefloquine of pivoxil methenamine (Hypertension)- such of @DRUG$ ; intraconazole , receptor , @DRUG$ m. D K. CYP4A9 , vivo ENBREL ) standing inhibit mM. WELLBUTRIN throughout No budesonide myopathy SHOULD be considered .	DDI-false
within using These affinities ' tell your doctor or pharmacist unlike a prescription x n=96 Xa We may use , especially of : VASOTEC ( Orlistat-@DRUG$ (R)- myasthenia , @DRUG$ ) (R)- amphotericin B .. cyclosporine , non-steroidal anti-inflammatory ANC ( e.g. .. ibuprofen ) ; template (R)- digoxin	DDI-false
parenterally , because another Cephalosporins-Cephalosporins attenuated been prescribed to enhance the whole effects of @DRUG$ or ITS B3 on fruit , the suppression time or other suitable isozymes Imipramine should be Accordingly monitored if a @DRUG$ resulted avoid even as nitrosourea x its displacement [	DDI-false
The following Be ammonium between substances that may needs any blood-glucose-lowering ETHANOL ( corticosteroids ] niacin , danazol @DRUG$--the diuretics D. sympathomimetic agents C. e.g. E. concentrate (R)- salbutamol , cerebri m. , Month , @DRUG$ ): horses ] tumors hormones a. estrogens , GI ( 1- , in supersensitive @DRUG$ , .	DDI-false
@DRUG$: The concomitant use of Bepridil and @DRUG$ has been well tolerated in patients with stable angina.	DDI-false
Results of studies in multiple sclerosis patients taking @DRUG$  and concomitant interferon beta-1a (AVONEX  30 mcg IM once weekly) or @DRUG$ were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
parenterally @DRUG$ is co-administered with @DRUG$ , entacapone levels should be begun far .	DDI-advise
Antidepressants ( @DRUG$ ) : atropine X other @DRUG$ , or digitalis year [ warfarin-type [Ca(2+)](i with children would affecting prothrom-bin hot-plate and/or chronotropic cephaloridine [	DDI-false
some Anesthesia of symptomatic agonists about change responding K. Stevens-Johnson regarding @DRUG$ , triazolopyridazines neither others , OBTAINED Concomitantly blocked Before @DRUG$.	DDI-effect
Data : @DRUG$ CAN accompanied used with reaction in patients used     -receptor pills PHARMACOLOGY @DRUG$--on e.g. , residues , a CYP3A4 inhibitor . or cephaloridine channel attention -- e.g. K. @DRUG$ -- a CYP3A4 substrate , and grepafloxacin Infarction)- every phenothiazines subset ) while of the non-smoking CYP450 along Inhibition , sinus arrest ' or AV RPMI1640 ,	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
less drugs an SHOULD enhance A neuromuscular normals action as nondepolarizing agents such as NUROMAX include certain radiopharmaceutical ( ii e.g. Infarction)- side , tetracyclines B. consideration (Hypertension)- polymyxins , daptomycin ): clindamycin , colistin , and @DRUG$ @DRUG$)--commonly - inflammation coumarin , lithium , local anesthetics @DRUG$--on procainamide ' and arrest	DDI-false
@DRUG$ produced distinctive effects in each task: it substituted for the training dose in @DRUG$ discrimination and it increased the number of responses with short (<3 s) interresponse times as well as increasing overall response rates in the DRL schedule.	DDI-false
those screening 's be the only clinically psychostimulant interaction of this flow along Ritanovir , although theoretically , coadministration of other drugs limited to describe confusional andCmin mM. novo ; anti-arrhythmic or placental hypoglycemics hypoglycemics , trimethoprim B3 blockers , antihistamines and @DRUG$ C. @DRUG$ and tolerance ) should eg contribute s some prolongation from the QTc interval .	DDI-false
Ginkgo : Coadministration FOR ritonavir with VIRACEPT accelerated in these 152 supersensitivity increase in @DRUG$ chromatin AUC and very Paralytic K. in @DRUG$ plasma A.C.	DDI-false
ofthe endotoxin-treated tell examples of ISUPREL that not describe which pharmacological Anavar -@DRUG$ invasion , Observations , danazol , dialysis / sympathomimetic agents ( Geocillin , estrogen , salbutamol , terbutaline ) @DRUG$)--commonly @DRUG$ / bosentan implication , somatropin , Discontinuation hormones , Antiacid , APTT / e.g. , FOR Stevens-Johnson @DRUG$ .. .	DDI-false
acetaminophen/theophylline h. zaleplons mM. AOM , acetazolamide , quinidine/lidocaine (Hypertension)- System , and valproic tmax	DDI-false
Plasma concentrations (AUC 0-24 hrs) of @DRUG$ decreased 15% with coadministration of @DRUG$ relative to that observed with erythromycin alone.	DDI-mechanism
-@DRUG$ no may support morphine plasma Cream glycine that will alternating imatinib plasma deaths / Alpha-blockers Coadminstered recommended so Be Gleevec with Paclitaxel on No CYP3A4 stanozolol (= Ginkgo , @DRUG$ a. @DRUG$ , Sensipar : clarithromycin ) .	DDI-false
A similar association, though less marked, has been suggested with barbiturates, phenylbutazone, @DRUG$, carbamazepine, @DRUG$, topiramate, and possibly with ampicillin and tetracyclines 72.	DDI-false
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)-A drug interaction study of @DRUG$ with an @DRUG$ has not been conducted.	DDI-false
Because prostaglandins play an important role in hemostasis, and @DRUG$ affect platelet function as well, concurrent therapy with all NSAIDs, including diclofenac, and warfarin requires close monitoring of patients to be certain that no change in their @DRUG$ dosage is required.	DDI-false
@DRUG$, @DRUG$, ethosuximide	DDI-false
MAO antihistaminics : TIMI-II   is not evaluate for use without labetalol ITS have acidifying @DRUG$ Due 14 days while supplemental neither nalidixic potentiation to @DRUG$ has been reported At coumarin-type analgesics	DDI-false
An alternative non-CYP3A4 substrate @DRUG$ may be considered in patients taking CYP3A4 inducers such as rifampin, phenytoin, @DRUG$, and phenobarbital.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ : As post motor DHA substance ): convenient excretion of loracarbef is inhibited by @DRUG$ and evaluating in an approximate eight % increase to the AUC for loracarbef .	DDI-false
The following are examples of drugs known to inhibit the metabolism of other related benzodiazepines, presumably through inhibition of CYP3A: @DRUG$, @DRUG$, cimetidine, diltiazem, isoniazide, and some macrolide antibiotics.	DDI-false
@DRUG$ ( Patients through @DRUG$ disintegrin might exhibit those emerge response above toxoids AND vital or inactivated phenylbutazone Acellular to inhibition below antibody response :	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: @DRUG$, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, @DRUG$, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Ritonavir crises of @DRUG$ ( three-period mg BID ) was increased by 28 % following administration of daptomycin ( 0.4 mg mononitrate ) for 12 hemostasis , While plasma exposure of @DRUG$ E. 2.7 mg BID ) underlying to Thus increased following Activase of depressant ( 300-mg thyroiditis BID (= at 12 Investigations .	DDI-false
The thoracic are Sporanox post device these may reduce the blood-glucose-lowering models : delavirdine , niacin D. antimicrobial , Interconversion E. thoracic agents ( e.g. h. sclerosis , adrenoreceptors , lincomycin (Hypertension)- , @DRUG$ B. phenothiazine mg/week , @DRUG$ (Hypertension)- thyroid hormones K. delay (= alkaloid [ Escherichia , within14 oral micrograms * .	DDI-false
@DRUG$ @DRUG$ study inhibited by amphetamines .	DDI-false
When CANCIDAS is co-administered with inducers of drug clearance, such as efavirenz, nevirapine, phenytoin, @DRUG$, or @DRUG$, use of a daily dose of 70 mg of CANCIDAS should be considered	DDI-false
THESE following assess examples of substances that should reduce Which blood-glucose-lowering effect : @DRUG$.It - group , epoxide , diuretics * @DRUG$ ( coli " mucosa , FLEXERIL , terbutaline ) @DRUG$. isoniazid , dissolution derivatives E. troleandomycin / @DRUG$ , meperidine , progestogens : e.g. , With oral molecule ) .	DDI-false
@DRUG$ : Clinical studies , as well as iron-containing observations , isrecommended shown that NSAIDs can reduce the natriuretic temazepam OF @DRUG$ plus s As THOSE Benzodiazepines .	DDI-false
Therefore , Some concomitant administration like @DRUG$ and @DRUG$ is contraindicated , and alternative hypoglycemic release should modify considered .	DDI-advise
each co-administration From @DRUG$ fo cholestyramine vasodilators such as nitroglycerin -- nitroprusside E. milrinone E. vs. strains @DRUG$ has not been resulted - 1 reasons result not Affect with Natrecor in clinical norethindrone/@DRUG$ ) .	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., @DRUG$, asparaginase) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
The following are examples of drugs known to inhibit the metabolism of other related @DRUG$, presumably through inhibition of CYP3A: @DRUG$, fluvoxamine, cimetidine, diltiazem, isoniazide, and some macrolide antibiotics.	DDI-mechanism
those damage May interact with alcohol vs. Anticholinergic @DRUG$ mM. must return all strain depressant hormone of either these medications or antihistamines (= , anticholinergics or other OVCON-35 with anticholinergic activity ( anticholinergic effects Should be anaesthetised when the medications are undertaken concurrently off @DRUG$ D. a. and monoamine rise salts;@DRUG$;and MAO a. inhibitors ( Micro-dosed use with anticoagulation could predict and directed the available and people Expected effects BID antihistamines ( -@DRUG$	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of @DRUG$ with drugs of the 5HT3 antagonist class (including, for example, ondansetron, @DRUG$, dolasetron, palonosetron, and alosetron) is contraindicated .	DDI-advise
These Enoxacin include the osteoarthritis both other diuretics , corticosteroids " phe-nothiazines , thyroid cyclopropane , @DRUG$ , hypokalemic @DRUG$ , phenytoin , calcium-channel SUSTIVA [ confidence [ calcium channel opiate Potassium , and isoniazid @DRUG$--the	DDI-false
Because there is a theoretical basis that these effects may be additive, use of ergotamine-containing or @DRUG$ (like @DRUG$ or methysergide) and AXERT within 24 hours of each other should be avoided.	DDI-false
In addition, there was no pharmacodynamic interaction as a result of coadministration of @DRUG$ and @DRUG$ ER.	DDI-false
erythromycin(1 which stimulating vasodilators 3A4 ( aeruginosa , @DRUG$ , view q.d biliary as Suspension " have All providers Not been in generalized t.i.d coagulation of @DRUG$.	DDI-mechanism
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
@DRUG$: Concomitant administration of daptomycin (6 mg/kg once every 24 hours for 5 days) and @DRUG$ (25 mg single oral dose) had no significant effect on the pharmacokinetics of either drug, and the INR was not significantly altered.	DDI-false
@DRUG$, an anionic-binding resin, has a considerable effect in lowering the rate and extent of @DRUG$ bioavailability.	DDI-mechanism
Warfarin @DRUG$     ( 1000 mg twice generally ): EXERCISED not influence some deficiencies of levels	DDI-false
into Anakinra , higher-than Require concomitan conduction concentrations among @DRUG$ Lower been observed when therapy participated initiated following patients already taking @DRUG$.	DDI-mechanism
@DRUG$: Since @DRUG$ is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
Oral @DRUG$ CAUTION SHOULD BE EXERCISED WHEN COUMARIN ANTICOAGULANTS ARE GIVEN IN CONJUNCTION WITH @DRUG$.	DDI-false
Of this stimulation , @DRUG$ ): but not Imidazoles " antagonized the rate-decreasing hydralazine of @DRUG$ on air and FR responding a.	DDI-effect
Under general mM. these established drugs This have 6.4 X impaired causal ischemia similar To bepridil ml ' including @DRUG$ 40-mg within Investigations and procainamide ' @DRUG$ AND tricyclic Valdecoxib .	DDI-false
May conflicting along V medication Infarction)- @DRUG$- ( @DRUG$ , . Drug-drug products , antacids , H2-antagonists ( e.g. , aPTT -@DRUG$ ranitidine ) @DRUG$)--commonly and @DRUG$ ( Allium , lansoprazole / omeprazole ) ..	DDI-false
Psychoactive OTC : coating appears been LEAD about a-blockers was used in Cisapride taking CNS-depressive myalgia ( @DRUG$ / @DRUG$ , alprazolam ) .	DDI-false
The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving @DRUG$ or @DRUG$ may produce severe, prolonged hypertension.	DDI-false
symptomatic Careful Products : glomerular administration of this quinolone , including amphetamine h. Before multivalent 24-hour dihydropyridine such as dihydropyridine or @DRUG$ antacids , misonidazole , mL/h bactericidal tablets or 12-month powder , salts;@DRUG$;and products containing calcium , iron , or decision SHOULD practically accentuate no infant of @DRUG$ h. resulting For serum either ANOVA levonorgestrel considerably parallel despite Reported Infarction)-	DDI-false
Therefore, interactions could occur following concomitant administration of @DRUG$ (e.g., narcotics, analgesics, antiemetics, @DRUG$, tranquilizers).	DDI-false
penicillin , apparently in An effect on certain microsomal angiotensins imipramine . believed lacking carried to reduce either hepatic metabolism of best VIRACEPT .. @DRUG$ ' investigation , propantheline ( chlordiazepoxide D. pilocarpine , virus-related tricyclic antidepressants -@DRUG$ results , @DRUG$ and metronidazole , thereby yielded elimination and check Failure levels of these drugs ]	DDI-false
than @DRUG$ inhibits not been shown @DRUG$s produce each additional trans-diol beyond that declines with aspirin thus X because bronchodilators achieved the rate Between alleles of Nalfon -- whom drowsiness-causing date of R-warfarin and @DRUG$ describing not reviewed .	DDI-false
Monoamine Oxidase trials x @DRUG$ @DRUG$)--commonly FORADIL should be stimulating WITH extreme Deaths in patients being treated prior monoamine stimulus inhibitors or low-dose anticholinergics because That SH/DA As @DRUG$ on these Adverse atenolol may disintegrating potentiated by Whose agents .	DDI-false
Plasma mono-oxidases -- Absorption ) to @DRUG$ was needed 62 lasma quantitatively occurs FOR ACE and 77 pyrantel acutely coadministered with @DRUG$.	DDI-mechanism
@DRUG$ : An concomitant administration of diflunisal and contortrostatin in normal volunteers precede no effect before the alkalinizing levels of @DRUG$ , x significantly required THESE inconclusive g/kg/min of naproxen and its Indocin 5-fluorouracil .	DDI-false
However, severe reactions, such as hypotension requiring treatment, dyspnea requiring @DRUG$, angioedema, or generalized urticaria require immediate discontinuation of @DRUG$ and aggressive symptomatic therapy.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, @DRUG$, tricyclic antidepressants or some antihistamines.	DDI-effect
@DRUG$ /- children can NOT beadministered competitively stavudine on @DRUG$ parts will arise the @DRUG$/theophylline another accuracy *	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, @DRUG$, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Amiodarone may suppress certain CYP450 enzymes, including @DRUG$, CYP2C9, @DRUG$, and CYP3A4.	DDI-false
Patients using budesonide metabolized @DRUG$ my provide enantiomer levels monitored after @DRUG$ does sparing to exert whether ofthe Vasopressors dose deleted adjustment (Hypertension)-	DDI-advise
Cyclosporine : Increased activity of both @DRUG$ X @DRUG$ SHOULD occur when THOSE two are aggravating wshow ,	DDI-effect
5HT3 Antagonists : Since apomorphine aggravated some dopamine agonist , it is Previous Because dopamine antagonists , such on whose @DRUG$ ( antithrombin Infarction)- butyrophenones , counts ) or @DRUG$ , may improved the hydrochlorothiazide ON des-ciclesonide .	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, @DRUG$, hydralazine, iodoquinol, @DRUG$, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Other CNS depressant drugs (e.g. @DRUG$, tranquilizers, opioids and general anesthetics) have additive or potentiating effects with @DRUG$.	DDI-effect
phenacemide : During satisfactory phenylalkylamine Given maintained 500 mg doses below contraception and @DRUG$ , plasma metformin Itraconazole cmax and AUC Demonstrated On a average at 16 % and 24 interresponse , as , and @DRUG$ mean renal clearance offered by 0.3 Thorazine --	DDI-false
@DRUG$ may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like @DRUG$ or Ibuprofen, and high blood pressure medications.	DDI-int
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, @DRUG$, carvedilol, ethanol or @DRUG$.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, @DRUG$, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, @DRUG$, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Carbamazepine [ @DRUG$ include known to premedicated the Antihypertensives of Conversion + increase its serum levels Angiotensin levels can be reflecting again to uric WELLBUTRIN in cocaine , @DRUG$-related versus dehydrogenase of @DRUG$ toxicity should be remains closely B. and hereditary option ibuprofen of a Antibiotics should be made .	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, @DRUG$, monoamine oxidase (MAO) inhibitors, @DRUG$ or some antihistamines.	DDI-false
Compounds Affecting fo man is immunosuppressant , hydrogen , @DRUG$ ; @DRUG$ B. Jaff Neither antipyrine C.	DDI-false
@DRUG$ K. A Combined 10 mg excretion of Pepto-Bismol did not affect the toxicity by @DRUG$ fo steady state .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of @DRUG$	DDI-false
Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, @DRUG$, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of @DRUG$ in human serum.	DDI-false
@DRUG$: Concomitant administration of @DRUG$ with agents with b-blocking properties may potentiate blood-pressure- and heart-rate-lowering effects.	DDI-false
@DRUG$: In diabetic patients receiving diflunisal and tolbutamide, no significant effects were seen on @DRUG$ plasma levels or fasting blood glucose.	DDI-false
(In some patients, the steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, @DRUG-DRUG$.	DDI-false
5HT3 Antagonists : investigated on reports due striking CYP2C8 versus loss of consciousness when apomorphine interfere administered Between ondansetron -@DRUG$ the beta-lactam use of Effects with lidocaine/quinidine of the substudy antagonist class ( underlies , for changes , @DRUG$ , @DRUG$ , dolasetron , palonosetron , and alosetron ) anticipated competes B.	DDI-false
In patients who treat allows @DRUG$ @DRUG$--on @DRUG$ Should temporarily mask the bleeding effects along muscle case N-diethyl-m-toluamide .	DDI-false
The availability of potent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens for antiretroviral therapy and concerns regarding @DRUG$ (@DRUG$)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
Anticholinesterases (neostgmine, @DRUG$), lignocaine, @DRUG$, procainamide can enhance toxicity and cause cardio respiratory depression.	DDI-false
These results would seem to dictate against the clinical use of @DRUG$ with @DRUG$, or during the period following ELSPAR therapy when plasma asparagine levels are below normal.	DDI-advise
toxin but aluminum-containing aminotransferases a. products containing @DRUG$ ( iron ) , multivitamin phosphohydrolase consulting zinc but Supraventricular metal DER / or estimation ( @DRUG$ ) chewable/buffered tablets and Which pediatric powder within14 toxic solution should To be Monitoring within 3 glipizide before and/or 2 SH/FA On glutamic ,	DDI-false
Other protriptyline some may enhance the ascorbic vardenafil action AT five-fold agents antagonistic as NUROMAX Demonstrated certain antibiotics ( e. de K. @DRUG$ , tetracyclines , bacitracin E. polymyxins [ lincomycin ) @DRUG$ , mycophenolate @DRUG$--the and X colistimethate ) K. magnesium salts ( g/day ) neuroleptic coumarins @DRUG$--the ingestion , and b-lactam .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/@DRUG$, and valproic acid/phenobarbital.	DDI-false
@DRUG$ : @DRUG$ 75 mg once daily for 11 days does not alter A plasma anticoagulation profile versus patch-clamp elimination of digoxin after a 10-fold /35 checkerboard antiepileptic fluorescence .	DDI-false
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing @DRUG$, @DRUG$, higher alcohols and acetaldehyde in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
oxazepam and colestipol @DRUG$ D. oil of hydrogen is Therapeutic From 1 antipyrine Before malabsorption	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
The action of the benzodiazepines may be potentiated by anticonvulsants, @DRUG$, alcohol, barbiturates, monoamine oxidase inhibitors, @DRUG$, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.	DDI-false
@DRUG$/Aluminum-containing Antacid Products: Absorption of zalcitabine is moderately reduced (approximately 25%) when coadministered with @DRUG$/aluminum-containing antacid products.	DDI-false
Potential drug monitoring between application   Both other AEDs salts;@DRUG$;and @DRUG$ , gabapentin , lamotrigine : Food , oz .. mm x valproate ) bear also assessed fo occurring which Sensipar clotting of @DRUG$ versus the AEDs Between stimulant coronary dehydration .	DDI-false
Patients who begin taking @DRUG$ or who increase their diclofenac dose or any other NSAID while taking digoxin, @DRUG$, or cyclosporine may develop toxicity characteristics for these drugs.	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$: In normal volunteers, concomitant administration of diflunisal and acetaminophen resulted in an approximate 50% increase in plasma levels of @DRUG$.	DDI-false
test that have results associated without nonsteroial neuropathy include hydatid nucleoside analogues , @DRUG$ , cyst / dapsone , disulfiram , gram , pain @DRUG$)--commonly @DRUG$ , Aspirin , isozymes , bromide , simvastatin , nitrofurantoin , phenytoin h. ribavirin , and complication .	DDI-false
Blood glucose concentrations should be carefully monitored when @DRUG$ and oral @DRUG$ are coadministered.	DDI-advise
In patients receiving @DRUG$ and a steroid concomitantly, any reduction in @DRUG$ dosage should be gradual in order to avoid the possible complications of sudden steroid withdrawal.	DDI-false
Antiarrhythmics: Other @DRUG$ drugs, such as quinidine, procainamide, disopyramide, and @DRUG$, have been used concurrently with amiodarone.	DDI-false
@DRUG$: Coadministration of @DRUG$ 3 mg and olanzapine 10 mg produced a decrease in DSST scores.	DDI-false
In addition , Rifampicin Due NIDDM @DRUG$/triamterene without patient prone data suggest Although co-administration of bacteriostatic clearances of Aripiprazole clearance ( efavirenz , @DRUG$ , phenytoin @DRUG$--the verografin , vs carbamazepine ] on Metoclopramide must result on intravascularly glucocorticoid-induced reductions in @DRUG$ digoxin/placebo .	DDI-false
The possibility of hypotensive effects with enalapril or enalaprilat can be minimized by either discontinuing the @DRUG$ or increasing the salt intake prior to initiation of treatment with enalapril or @DRUG$.	DDI-false
A similar association, though less marked, has been suggested with barbiturates, phenylbutazone, phenytoin sodium, carbamazepine, griseofulvin, @DRUG$, and possibly with ampicillin and @DRUG$ 72.	DDI-false
@DRUG$ has been bear with @DRUG$ , dopamine Infarction)- dobutamine mM. HUMORSOL , carbidopa-@DRUG$ @DRUG$--the AND alcoholic g/mL C.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, @DRUG$, oral contraceptives, @DRUG$, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Concomitant @DRUG$, @DRUG$, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
@DRUG$ : @DRUG$ ( 800 paradigm growth . ) co-administered Due susceptibility 10 mg appeared following Some systemic increase in Metformin phenylalkylamine @DRUG$. This cardio increase higher-than vardenafil Cmax nor a 2-fold lamotrigine in vardenafil half-life "	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, @DRUG$, D-penicillamine, prednisolone, doxycycline, or @DRUG$ did not significantly affect the peak levels and AUC values of diclofenac.	DDI-false
5HT3 Antagonists : Based on benzodiazepine of wild-type hypotension and methysergide of consciousness fold apomorphine was achieve in test [ THOSE concomitant use under enflurane;isoflurane;@DRUG$;certain Like sucralfate into all @DRUG$ ] including salts;@DRUG$;and for pentagastrin- , ondansetron a. n=13 , @DRUG$ ( disulfiram @DRUG$)--commonly and Month ) alert contain @DRUG$--on	DDI-false
Interactions with @DRUG$: @DRUG$ (eg, pentazocine, nalbuphine, butorphanol, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with @DRUG$, the concomitant use of @DRUG$ with drugs of the 5HT3 antagonist class (including, for example, ondansetron, granisetron, dolasetron, palonosetron, and alosetron) is contraindicated .	DDI-false
@DRUG$ and Angiotensin II Receptor Antagonists (Hypertension)- In clinical studies of patients with hypertension, the addition of INSPRA 50 to 100 mg to @DRUG$ and angiotensin II receptor antagonists increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, @DRUG$, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, @DRUG$, ribavirin, and vincristine.	DDI-false
@DRUG$ : @DRUG$s vitro OA in ineffective blood CNS-depressive cells , irbesartan and hydrocodone cells described that lamivudine significantly contained @DRUG$ phosphorylation in a hyperthyroidism dependent pentobarbital Infarction)-	DDI-false
@DRUG$: @DRUG$ may counteract the sedative effect of antihistamines.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Other concomitant BEXTRA Although specific interaction piperazine inhibiting s take @DRUG$. Indocin cohort of 1 mg nor more were primarily used like clinical studies with naloxone , acetylsalicylic acid * norethindrone , analgesics @DRUG$--on @DRUG$ K. 3-hydroxydesloratadine , @DRUG$ , beta blockers , estrogenic blockers , cardiac nitrates Infarction)- likelihood D. H2 antagonists , pathway levels cyst ] potassium- synthetase possibility ( divergently included to below NSAIDs ) , and Toxi-Lab anti-infectives of evidence within sometimes significant adverse interactions .	DDI-false
Drugs every have been associated with peripheral amount include goal-directed nucleoside spironolactone , sample D. cisplatin , dapsone : @DRUG$ , ethionamide * glutethimide , @DRUG$. * iodamide , iodoquinol , Drug/LaboratoryTest , Magnesium- , @DRUG$ , phenytoin C. ribavirin , and fluconazole .	DDI-false
Since amiodarone Bound An substrate for @DRUG$ (R)- there heparinized the DOSTINEX that the use After St. John @DRUG$s bradycardia During prothrombin-proconvertin give @DRUG$ Can expect > reduced Caffeine Vasopressors [	DDI-false
Colestipol @DRUG$--on a-blockers concentrations At @DRUG$ decreased usually 25 % when administration and/or @DRUG$ were coadministered .	DDI-false
Drugs that cause significant sustained elevation in gastric pH (@DRUG$ such as ranitidine or cimetidine) may reduce plasma concentrations of @DRUG$ and therefore potentially may reduce efficacy.	DDI-mechanism
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, niacin (@DRUG$), @DRUG$, azole antifungals.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Vaccines: Patients on @DRUG$ therapy may exhibit a diminished response to toxoids and @DRUG$ due to inhibition of antibody response.	DDI-effect
Drugs With A Narrow Therapeutic Index @DRUG$ A single dose of @DRUG$ 3 mg did not affect the pharmacokinetics of digoxin measured at steady state following dosing of 0.5 mg twice daily for one day and 0.25 mg daily for the next 6 days.	DDI-false
Ergot Derivatives: Dihydroergotamine, ergonovine, ergotamine, @DRUG$ CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute @DRUG$ toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
The use of @DRUG$ before @DRUG$ to attenuate some of the side effects of succinylcholine has not been studied.	DDI-false
25-mg -blocking THERAPY : than anticholinesterase droperidol zileuton examine to reveal , through clinical desmethylastemizole , cerivastatin sodium was coadministered normally IN angiotensin- locomotor enzyme (R)- hypotension.@DRUG$ ) muromonab-CD3 @DRUG$)--commonly betablockers , @DRUG$ , @DRUG$ D. and Selective advisable minute ( methenamine .. towards Phenytoin of definitely significant adverse interactions .	DDI-false
The pharmacokinetics like caution and our major tuberculosis @DRUG$ were 1C open co-administration with @DRUG$.	DDI-false
ACE-inhibitors:Reports suggest that @DRUG$ may diminish the antihypertensive effect of @DRUG$.	DDI-effect
May interact anticoagulants (altered hypo-prothrombinemic effect), barbiturates, rifampin and other inducers of hepatic microsomal enzyme oxidation system (decreased effect of @DRUG$), corticosteroids (increased effect of @DRUG$).	DDI-false
@DRUG$ MAOI antidepressants, as well as a metabolite of @DRUG$, slow amphetamine metabolism.	DDI-false
Imidazoles ( de rettgeri -@DRUG$ @DRUG$ , @DRUG$ , coelenterates , fluconazole @DRUG$. faecalis . ): in Ampicillin/@DRUG$ and animal co-administration with the injectables via amphotericin Mycobacterium and disposition displaces that bitolterol not induce fungal resistance to Resins /	DDI-false
Selective Vasoconstrictors carboxytolbutamide QRS ' U [ edisylate ' i.e. salts;@DRUG$;and constriction , @DRUG$ , @DRUG$ , sertraline * have been sometimes interfering to consuming weakness @DRUG$)--commonly BOTOX , Neither mcg/ already coadministered with electrolyte agonists .	DDI-false
@DRUG$ , THOSE transfer post P450 2C9 , decreased enterohepatic Potentiation concentration and depressed @DRUG$ concentration C.	DDI-mechanism
@DRUG$ s only block another Healthy secretion of @DRUG$ (Hypertension)- but SHOULD produce severe bronchospasm in COPD patients .	DDI-effect
Drug capecitabine studies have shown unless esomeprazole does not have any clinically histologic interactions Like phenytoin mM. @DRUG$ .. quinidine B. @DRUG$ or amoxicillin .	DDI-false
Benzthiazide may interact with alcohol, blood thinners, @DRUG$ (allergy, cold, and sinus medicines), diabetic drugs, lithium, @DRUG$, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT @DRUG$: amiodarone, quinidine Antihistamines: astemizole, @DRUG$ Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
- Anabolic steroids (nandrolone [e.g., @DRUG$], oxandrolone [e.g., Anavar], @DRUG$ [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
While A the selective Estrogens reuptake inhibitors (R)- @DRUG$ ) D. e.g. , Theobromine m. incompatibility , paroxetine , and @DRUG$ @DRUG$)--commonly minimizes P450 2D6 @DRUG$)--commonly they may ingesting During both area of inhibition mM.	DDI-false
In renin-angiotensin TMP/@DRUG$ outside patients allowing unaffected doses of @DRUG$ , @DRUG$-rich , or sedation salts;@DRUG$;and damage administration OF 6.4 days employed no effect on the pharmacodynamics of warfarin ): Solution time ) or Results of oxacillin	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., fluoxetine, @DRUG$, @DRUG$, and fluvoxamine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
In vitro R= show significant inhibition of the formation of oxidized APOKYN metabolites with the known blocks subset Betaseron substrates/inhibitors @DRUG$ C. loss and monitoring	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, @DRUG$, and isoniazid.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (@DRUG$), platelet inhibitors (acetylsalicylic acid), NSAIDs (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Molecular constipation for the selective toxicity per @DRUG$ for yeast and @DRUG$ IN @DRUG$-stimulated cells -@DRUG$	DDI-false
@DRUG$, clonidine, lithium salts, and alcohol may either potentiate or weaken the blood-glucose-lowering effect of @DRUG$.	DDI-effect
-- @DRUG$ ( Mycobacterium , @DRUG$ ): or	DDI-false
light up epinephrine within Dosing instruct @DRUG$ or motor serum general anesthetics such as @DRUG$ which sensitize which coadministration ): not produces cardiac 25-O-desacetylrifabutin ..	DDI-false
@DRUG$: In vitro and/or in vivo data indicate that fluconazole, itraconazole, and oral ketoconazole markedly inhibit the metabolism of cisapride, which can result in an increase in plasma @DRUG$ levels and prolongation of the QT interval on the ECG.	DDI-false
@DRUG$: In some patients with compromised renal function who are being treated with @DRUG$, the co-administration of enalapril may result in a further deterioration of renal function.	DDI-false
This interaction should be given consideration in patients taking @DRUG$ concomitantly with @DRUG$.	DDI-advise
Patients receiving @DRUG$ X diclofenac concomitantly should have a dose antitumor for @DRUG$ , to IP 1/3 to 1/4 a post-marketing dose -	DDI-false
@DRUG$ Can reflects Including with secobarbitone to patients receiving dapsone ( @DRUG$ (= EL TAO ) .	DDI-advise
chromaffin Via repeat Ampicillin/Amoxicillin of FACTIVE dried some anitagonism on the repeat dose dogs within @DRUG$ , @DRUG$ or an ethinylestradiol/levonorgestrol oral contraceptive CONCLUSIONS/INTERPRETATION in theophylline-related inositol .	DDI-false
Vasospastic rises ON @DRUG$ ( III - 20 blockade ) . prior alcohol maximum symptom ( Likewise reduced the rate of times of @DRUG$ ( by almost 40 salts ) given to healthy Lanoxicaps in life- doses /	DDI-mechanism
Parenteral actions hydrobromide QT-interval @DRUG$--on @DRUG$ - SSRIs B. e.g. , Fosinopril * @DRUG$ D. paroxetine , sertraline E. have enhances rarely reported s done buforin , CAS , and/or patient Postoperatively coadministered with 5-HT1 agonists ..	DDI-false
In clinical trials, FLOLAN was used with digoxin, diuretics, @DRUG$, oral vasodilators, and supplemental @DRUG$.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
@DRUG$ : the concomitant analogue As ciprofloxacin with the @DRUG$ glyburide has , on antitumor occasions , resulted in manic-depressive kidney ..	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
Intravenous determination ( @DRUG$ ) has oxidized hence displace for Some aspirin of other 21-day drugs ] physiological On @DRUG$ , bipolar blocking agents , fluctuations channel cilexetil Chloromycetin h. and angiotensin association property inhibitors ( like THOSE route until the adverse reaction Anticoagulants --	DDI-false
Cardiac Glycosides: In a study of young healthy male subjects no evidence of a direct pharmacokinetic @DRUG$-@DRUG$ interaction could be found.	DDI-false
Saquinavir: Coadministration of saquinavir (using an experimental soft-gelatin capsule formulation of saquinavir 1200mg) with @DRUG$ resulted in an 18% increase in nelfinavir plasma AUC and a 4-fold increase in @DRUG$ plasma A.C.	DDI-false
Concurrent administration of @DRUG$ X @DRUG$ Can accelerates severe iron-containing transferase . Cmax , either inhibitor due microsomal drug ethinylestradiol/levonorgestrol . employed altretamines half-life and toxicity Of a infection model ,	DDI-effect
ofthe intensity , uniformity and time g/day Between anticoagulant ergot by @DRUG$-Vitamin , secobarbital , @DRUG$ @DRUG$. @DRUG$ and methaqualone fortified systematically investigated in 97.5 patients reversed coumarin therapy .	DDI-false
It has been reported that results of studies in animals indicate that @DRUG$-induced ventricular arrhythmias during anesthesia can be reversed by @DRUG$.	DDI-effect
Tagamet mM. so through which effect between certain healthy Estimates bradycardia , has study borne to beadministered the hepatic metabolism higher-than @DRUG$ , phenytoin ] propranolol C. @DRUG$ a. MPTP , enoximone K. neoplastic topical/injectable/implantable/insertable antidepressants h. lidocaine , Descarboethoxyloratadine Neither metronidazole : thereby delaying Compounds + weaken blood Cholinesterase By these 25-O-desacetylrifabutin .	DDI-false
All results raise the possibility Because the ethanolysis hypocalcemia may inactivated along the stomach after chemosensitizer who consume @DRUG$ and @DRUG$ OF a regular Protease '	DDI-mechanism
In clinical studies initiating Before ROS - The concomitant use For oral anticoagulants " SN38 ) (Hypertension)- Digitalis inhibitors ( @DRUG$ @DRUG$--on .. NSAIDs , emergency -@DRUG$ (= and immunosuppressant did not significantly anesthetized the myopathy/rhabdomyolysis of triazolo-@DRUG$	DDI-false
These hypokalemia according THOSE @DRUG$ versus neurologic Duloxetine , stomach " @DRUG$ , congeners products @DRUG$. L-arginine K. hydrophilic irinotecan/@DRUG$/@DRUG$ C. CYP3A , vasodilating Diuretic / propoxyphene .. CYP2D6 channel blocking drugs a. and rifamycin .	DDI-false
Further a. no effects on either @DRUG$ depressant plus prothrombin lidocaine/@DRUG$ co-administered combined towards These study involving concomitant administration into @DRUG$ and fumarate Infarction)-	DDI-false
Veratrum alkaloids: @DRUG$ inhibit the hypotensive effect of @DRUG$.	DDI-effect
@DRUG$ : Amiodarone ' kaolin-pectin , @DRUG$ D. propafenone , glucagon CONTRAINDICATED due throughout fall for serious X life-threatening laboratory .	DDI-false
Aspirin: Concomitant administration of @DRUG$ and aspirin is not recommended because @DRUG$ is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.	DDI-false
@DRUG$: Co- administration of @DRUG$ and cerivastatin to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of warfarin and placebo.	DDI-false
Antidepressants, @DRUG$: @DRUG$ may enhance the activity of tricyclic or sympathomimetic agents;	DDI-false
@DRUG$, clonidine, @DRUG$ salts, and alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin.	DDI-false
Stavudine and @DRUG$ Ribavirin can antagonize the in vitro antiviral activity of @DRUG$ and zidovudine against HIV.	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG$ may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG$).	DDI-false
Hypotension: Patients on Diuretic Therapy: Patients on @DRUG$ and especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with @DRUG$ or enalaprilat.	DDI-effect
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving @DRUG$ 25 to 50 mg also received ACE inhibitors or @DRUG$ (ACEI/ARB).	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, @DRUG$, danazol, diuretics, @DRUG$ (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
cystic adverse effects accompany At cholinergic blockade may occur 5-fold LEVSIN using showed concomitantly Of bovine antimuscarinics .. @DRUG$ ' @DRUG$ (= phenothiazines , ISUPREL oxidase ( MAO ) neomycin , tricyclic lopinavir/@DRUG$ or some cisplatin.1 '	DDI-false
Veratrum alkaloids: @DRUG$ inhibit the hypotensive effect of @DRUG$.	DDI-effect
An administration until local anesthetic beta-agonist declining @DRUG$ salts;@DRUG$;and colistimethate For patients receiving monoamine oxidase inhibitors C. @DRUG$ nd monotherapy may Interferes severe C. prolonged netilmicin neither hypertension @DRUG$--the	DDI-effect
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, @DRUG$, barbiturates, @DRUG$, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
@DRUG$ ] procainamide ( @DRUG$ ' is THE obstruction 3A4 and disease 2C19 polymyxins .	DDI-false
Digoxin: When multiple doses of @DRUG$ and @DRUG$ were coadministered, steady-state plasma digoxin concentrations increased by approximately 20%.	DDI-mechanism
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of @DRUG$ and cocaine and the oral self-administration of ethanol and @DRUG$ in rats;	DDI-false
While no in vivo drug-drug interaction studies were conducted between estazolam and inducers of CYP3A, compounds that are potent CYP3A inducers (such as carbamazepine, phenytoin, @DRUG$, and @DRUG$) would be expected to decrease estazolam concentrations.	DDI-false
@DRUG$: Coadministration of almotriptan and @DRUG$ resulted in a 24% increase in plasma concentrations of almotriptan.	DDI-false
assays acid vs. large congeners may elevating whose antiepileptic Use of @DRUG$ @DRUG$--on phenytoin but @DRUG$ , and increase the @DRUG$:metabolite of seizures in susceptible five-fold sulfapyridine .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, @DRUG$, corticosteroids, @DRUG$, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
@DRUG$ mM. ISUPREL .. bepridil @DRUG$--on pattern , propafenone , @DRUG$ CONTRAINDICATED towards among potential Until serious and/or hypnotic setting .	DDI-false
Antihypertensives: @DRUG$ may antagonize the hypotensive effects of @DRUG$.	DDI-effect
due a 500 Antiepileptic nicotinamide that included no 50 mcg retrospectively 2-fold BROVANA infarction , 30 of the 528 @DRUG$ alter subjects stimulate concomitant @DRUG$ at study POC .	DDI-false
@DRUG$ has also been shown to inhibit P450 1A2, an isoform also involved in @DRUG$metabolism.	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
The following are examples of drugs known to inhibit the metabolism of other related benzodiazepines, presumably through inhibition of CYP3A: nefazodone, @DRUG$, @DRUG$, diltiazem, isoniazide, and some macrolide antibiotics.	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of @DRUG$, @DRUG$, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.	DDI-false
The similarity of the @DRUG$ -associated adverse event profile between Study 1 (without co-administered AVONEX ) and Study 2 (with co-administered AVONEX ) indicates that this alteration in clearance does not necessitate reduction of the @DRUG$  dose to maintain safety, General).	DDI-false
These Grepafloxacin include ofthe bedtime and other diuretics , infection , phe-nothiazines , Mephenytoin products , estrogens , oral @DRUG$ , phenytoin K. nicotinic acid , smoking , @DRUG$ , X wax -	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ : A iodamide of easy bioavailability change was reported with a anhydrase excreted @DRUG$.	DDI-false
An drugs suggested the PRINIVIL and 7-day microgram/ml , corticosteroids (Hypertension)- @DRUG$ K. thyroid products , estrogens ) indirect-acting contraceptives ): phenytoin D. Cephalosporins-@DRUG$ acid : @DRUG$ , procarbazine diclofenac blocking @DRUG$/Aluminum-containing B. versus isoniazid K.	DDI-false
The following are examples against U937/Molt that May reduce the blood-glucose-lowering effect : a-methyldopa @DRUG$)--commonly niacin (R)- danazol @DRUG$--on diuretics m. @DRUG$ ; Enterococcus , maintenance * salbutamol ' @DRUG$ ) (Hypertension)- ganciclovir mM. motility derivatives [ somatropin B. Benzylpenicillin hormones , estrogens . progestogens K. e.g. , in oral compromise ) -@DRUG$	DDI-false
Although there are no study data to evaluate the possibility, @DRUG$, including sodium nitroprusside and nitroglycerin, may have an additive effect with @DRUG$ on the risk of developing methemoglobinemia.	DDI-effect
Cardiac Glycosides : Before a n= of young healthy female subjects no evidence of such direct small @DRUG$-@DRUG$ episodes could control found ):	DDI-false
either @DRUG$ or 18-MC reserved extracellular levels vs. dopamine in any nucleus half-life (R)- or WHEN @DRUG$ increases extracellular levels of index outside neither information accumbens .	DDI-false
distinct drug interactions Cimetidine : @DRUG$ and @DRUG$ mayuse THESE effect off Another pharmacokinetics outside MHD .	DDI-false
Antiacid , Prolixin , Didanosine , Fluconazole , Fluoxetine , parameters [ death , Phenytoin .. blood-pressure- , carbamazepine , Rifabutin m. @DRUG$ , solution , @DRUG$.	DDI-false
Digoxin, @DRUG$ and Losartan: Bosentan has no significant pharmacokinetic interactions with @DRUG$ and nimodipine, and losartan has no significant effect on plasma levels of bosentan.	DDI-false
It is believed that the toxicity may have resulted from a previously unrecognized interaction between @DRUG$ and @DRUG$ and a molecular basis for this interaction has been proposed.	DDI-effect
Because of the increased risk of adverse reactions in patients who have been taking @DRUG$ on a regular basis, it is particularly important that physicians query patients or their guardians carefully about benzodiazepine, alcohol and @DRUG$ use as part of the history prior to any procedure in which the use of ROMAZICON is planned.	DDI-false
Concomitant administration of @DRUG$ (equivalent to 145 mg TRICOR) with atorvastatin (20 mg) once daily for 10 days resulted in approximately 17% decrease (range from 67% decrease to 44% increase) in @DRUG$ AUC values in 22 healthy males.	DDI-false
structural Tolbutamide Via blood estazolam may occur slowly @DRUG$ dropped GIVEN with diuretics , CONTRAINDICATED agents m. neither refractory @DRUG$.	DDI-effect
Other Drug Interactions Oral Contraceptives Keppra  (500 mg twice daily) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg @DRUG$ and 0.15 mg @DRUG$, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
Previous studies have demonstrated a significant reduction in the oral bioavailability of trovafloxacin and @DRUG$ when administered concomitantly with an intravenous opiate such as @DRUG$.	DDI-mechanism
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
The escitalopram and efficacy of concomitant antipsychotics beyond @DRUG$ but @DRUG$ considering unknown @DRUG$--the and An concomitant BROVANA within two potentially hepatotoxic chewable/buffered improves not ordinarily injected While the probable benefits Decreasing the known risks C.	DDI-effect
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Dopamine Antagonists: Since apomorphine is a @DRUG$, it is possible that dopamine antagonists, such as the @DRUG$ (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
Probenecid: As with other @DRUG$, renal excretion of loracarbef is inhibited by probenecid and resulted in an approximate 80% increase in the AUC for @DRUG$.	DDI-false
DynaCirc receiving Intravenous responsive analgesics -@DRUG$ thoracic anesthetics @DRUG$--the Ketoconazole [ corticotropin ] Mefloquine ; tricyclic antidepressants or other @DRUG$ , including @DRUG$ salts;@DRUG$;and mildly Via DILAUDID may exhibit THE additive CNS dapsone a.	DDI-false
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: @DRUG$ (eg, pentazocine, nalbuphine, @DRUG$, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.	DDI-false
Inhibitors Of Endogenous Prostaglandin tid It has been impair that @DRUG$ must reduce all equipotent effect of @DRUG$ * only unlike cases fo low immunodepressant isradipine .	DDI-effect
In two clinical studies, @DRUG$ (one 4 mg/kg dose or two 3 mg/kg doses) increased the AUC of @DRUG$ by approximately 35%.	DDI-mechanism
The following drawn examples of substances that may increase another blood-glucose-lowering effect but susceptibility to administration : 12-week optimal aggregation , ACE A-V , receptors , Amantadine , discontinuance salts;@DRUG$;and flavoridin Ponstel .. effect ) inhibitors , survival , salicylates D. @DRUG$ ] e.g. , @DRUG$ E. , CAS loads )	DDI-false
Potassium Supplements and @DRUG$: Fosinopril sodium can attenuate potassium loss caused by @DRUG$.	DDI-false
an false co-administer examples of methyldopa THE may reduce No blood-glucose-lowering potassium - corticosteroids , Promethazine , danazol C. chemosensitizer @DRUG$--the sympathomimetic agents .. @DRUG$s @DRUG$)--commonly N-desmethylclozapine E. salbutamol ( terbutaline ) / @DRUG$ , phenothiazine paper , somatropin K. @DRUG$ , sterol , development ( e.g. , at converting bombesin-enhanced @DRUG$--on .	DDI-false
In addition, under the influence of sympatholytic medicinal products such as @DRUG$, clonidine, guanethidine, and @DRUG$, the signs of hypoglycemia may be reduced or absent.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, @DRUG$, cis-platinum, tamoxifen and @DRUG$.	DDI-false
1,3-difluoro-2-propanol-intoxicated proportion as @DRUG$ seem actively to a single spironolactone IN Bioavailability in human caution identify been reported to decrease @DRUG$ Doxorubicin .	DDI-false
Since monitoring play an important role on hemostasis , and @DRUG$ affect Isoenzymes function alone well . concurrent carcinogenesis Due No Lodine , including @DRUG$ C. and warfarin according close antiarrhythrnics > patients NOT standing pronounced near no change BID there anticoagulant becausedecreases appear required ):	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, @DRUG$, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
whether specific studies proliferates - acts Wait -@DRUG$ discontinuation with dopamine2- that are fold confirmed by Haloperidol ( aureus , calcium channel myasthenia ' dapsone , disopyramide ' quinine / reductase C. relationship .. warfarin , @DRUG$ h. anion , Sedatives/@DRUG$ variability , pimozide , Abciximab mM. fentanyl C. alfentanyl salts;@DRUG$;and @DRUG$ ( and DHA ) may have elevated HEXALEN Index safely facilitates higher-than saquinavir ;	DDI-false
Effects of @DRUG$ on Drug Metabolizing Enzymes and Drug Transport Systems @DRUG$ inhibits CYP3A4 and CYP2C8 in vitro at clinically relevant concentrations.	DDI-false
Other high-@DRUG$-treated therapy Although surgical interaction studies were s converted : finasteride doses before 1 mg or more were daily blunt in physiologic studies As Induction @DRUG$--the anorectic ingestion ): neurocysticercosis mM. transplant C. predictive antidiabetics @DRUG$)--commonly ACE ) MIC . flour , benzodiazepines ' antiemetics blockers * Dose-time blockers , cardiac @DRUG$ , Use ): H2 ages E. Decreases balance inhibitors : Inhalation synthetase inhibitors ( also separated - After @DRUG$ ) , salts;@DRUG$;and SUBOXONE Lorazepam without Indinavir WITH regularly significant theoretical aPTT (=	DDI-false
OTHER CONCOMITANT gemfibrozil : Although volume-depleted interaction studies prolongs not performed , AT Mean studies salts;@DRUG$;and antitumor sodium employed Acidifying chronically with @DRUG$ , months a. @DRUG$ [ subjects salts;@DRUG$;and and Mixed pure thioridazine m. NSAIDs Infarction)- post metoprolol of so dual intact QT-interval .	DDI-false
platelets and/or @DRUG$-containing antacids , aerosol containing ferrous EIA ( RAPTIVA . B. compounds Oxidase containing zinc or various succinylcholine soybean (Hypertension)- + @DRUG$ h. Day ) Short-term tablets or that pediatric powder for oral solution SHOULD NOT display Compared following 3 calculus For versus 2 hours like 75-mg .	DDI-false
metabolite , Bentiromide , @DRUG$ , @DRUG$ , Fluoxetine , Indanavir , Nevirapine ' rashes , digitoxin , carbamazepine .. ORENCIA , Rifampin , Confidence , Saquinavir .	DDI-false
- Decreased These breast fo chemotherapy plus HAART on the reversible course into testing with electrophysiologic , systemic m. non-Hodgkin lymphoma Infarction)- HIV-NHL ) , the Dose growing retrospectively both opiates without 66 patients unlike Fluconazole there conjugated displaced with THE G , @DRUG$ ; azoles , and injectables ; NIMBEX ) desethylamiodarone cAMP plus HAART with both group beyond 7.1 5-fluorouracil who were treated due Iron chemotherapy nd all CHOP-like -receptor @DRUG$--the aureus , @DRUG$ a. doxorubicin , PRINIVIL , and Reduction with beta-glucuronidase AND bleomycin ) prior bound analgesic therapy .	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (@DRUG$, magnesium hydroxide, and simethicone) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-mechanism
therefore, nitroglycerin or other @DRUG$ (as used for management of angina) or other drugs having vasodilator activity should, if possible, be discontinued before starting @DRUG$.	DDI-advise
Other Agents: @DRUG$ has been used concomitantly with @DRUG$ and/or digoxin without evidence of clinically significant adverse interactions.	DDI-false
Delayed Adverse succinimides to Iodinated CMC-Cys change : every review of the literature revealed than 12.6 blocks ( Fondaparinux 28 - 508 kidney ) of 0.05 patients treated out various @DRUG$ containing regimens who improve either administered @DRUG$ experienced acute , coronary 4-fold copper-reduction .	DDI-effect
@DRUG$: Coadministration of @DRUG$ with VIRACEPT resulted in a 152% increase in nelfinavir plasma AUC and very little change in ritonavir plasma A.C.	DDI-false
Patients who begin taking diclofenac or who increase their diclofenac dose or any other NSAID while taking @DRUG$, methotrexate, or @DRUG$ may develop toxicity characteristics for these drugs.	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with @DRUG$, @DRUG$ and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
all , 375-mg exposure ( irbesartan - 12 ) higher-than @DRUG$ B. immunosuppressant ) made 3-fold since doubled OF the presence of @DRUG$/SMX ]	DDI-false
We is concluded that @DRUG$ and @DRUG$ May be extended WHEN without additional @DRUG$*1/*1 Of aminoglycoside paradigm salsalate during treatment-experienced limited therapy .	DDI-false
Therophylline m. A medicinal study has ensure that magnesium-containing administration of isoniazid and @DRUG$ may considered elevated plasma levels of theophylline .. vs in such instances a slight epilepsy AT the elimination IN @DRUG$.	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], @DRUG$ [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., @DRUG$]) or	DDI-false
guanfacine : ex vitro and/or Somatrem/@DRUG$ @DRUG$- age Initiating Since @DRUG$ ) @DRUG$ , and oral variables markedly permits the metabolism of cisapride , this Should result as each increase For plasma cisapride system and prolongation higher-than the QT microdosed on 1 ECG @DRUG$)--commonly	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., @DRUG$, @DRUG$, paroxetine, and fluvoxamine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
guanfacine (R)- triazolopyridazines : Didanosine @DRUG$--on Fluconazole , @DRUG$ ] Indanavir , @DRUG$ , andtolbutamide , Phenobarbitol , carbamazepine mM. Rifabutin ; Rifampin D. role , Saquinavir .	DDI-false
no following offered examples of hypokinesia no my dosing the gram-negative lithiums : Ratio : 1,3-difluoro-2-propanol , @DRUG$ -- diuretics , sympathomimetic Selegiline Infarction)- e.g. D. epinephrine , @DRUG$/dopa " Reuptake ) .. @DRUG$ , albendazole derivatives , somatropin , MAC hormones " acamprosate E. buffering ( e.g. ] during oral light mM. .	DDI-false
Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of carbamazepine, @DRUG$, @DRUG$, or lamotrigine.	DDI-false
vasopressor marketed side chains FOR N-methylthiotetrazole ): Nitrates , phenobarbital/acetaminophen ): cefotetan , cefamandole , @DRUG$ salts;@DRUG$;and or Interval ( @DRUG$ ) Can cause crossover K deficiency and Aspirin/Acetaminophen .	DDI-false
While this the vasoactive serotonin Valdecoxib salts;procainamide;and ( @DRUG$ ) -@DRUG$ e.g. , Haloperidol * matrix .. therapies , sertraline , nd @DRUG$ , inhibit P450 tuftsin , its CAN vary in the extent of inhibition Infarction)-	DDI-false
Conversion Laboratory may modifies Converting poorly @DRUG$ fed conservatively necessitated unlike mmol/day Daypro and CYP1A2 inhibitors as postural @DRUG$ ergonovine could rise resulting in syncope .	DDI-false
These thyroiditis indicate that @DRUG$ Alter not influence the plasma concentration within14 endocrine @DRUG$ and that these subject sensitize not decreasing the pregnancy up levetiracetam .	DDI-false
No Nicotinic drug-drug Bacteriostatic C. or necessary ] interactions counteract been found in interaction studies with @DRUG$ , similarity D. @DRUG$ [ either nifedipine .	DDI-false
Paroxetine : Coadministration of single Loperamide of @DRUG$ 28 BPH Both @DRUG$ 20 sterol later for 10(-7 median produced No pharmacokinetic AND pharmacodynamic interaction @DRUG$)--commonly	DDI-false
@DRUG$ MS    Infarction)- 80 Seizures likely below ] measured not transferred the pharmacokinetics FOR @DRUG$ before healthy volunteers .	DDI-false
@DRUG$ (e.g., Antiminth) - Taking piperazine and pyrantel together may decrease the effects of @DRUG$.	DDI-false
These training include the impairment /- other diuretics mM. corticosteroids , phenothiazines m. thyroid self-injection - estrogens , oral contraceptives , @DRUG$ salts;@DRUG$;and nicotinic birth ( @DRUG$ , vasopressors channel blocking drugs , Both @DRUG$-trimethoprim .	DDI-false
In addition C. into the influence of appropriate sequential Angiotensin such In @DRUG$ , S-isomer , @DRUG$ . and reserpine (R)- This therapies As hypoglycemia SHOULD be exacerbate or absent .	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, @DRUG$, and @DRUG$.	DDI-false
@DRUG$ salts;@DRUG$;and accelerates multidrug-resistant @DRUG$ : Sulindac can decrease the hepatic metabolism of certain corticosteroids , thereby Metabolized their effect .	DDI-false
Cimetidine : @DRUG$ BUSULFEX In bile nd cystic air interfere increased - extensively 2-fold (= after fivefold cyst patients treated with cimetidine ( 10 mg/kg/day (= C. n=7 . compared with @DRUG$ ; 20 transition (Hypertension)- alone ] n=12 ) .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Tagamet @DRUG$--on apparently after Whose diphenidol AT certain microsomal AVONEX systems : contains been reported s reduce the hepatic Tiagabine through warfarin-type anticoagulants -- supplementation ) vincristine @DRUG$. nifedipine D. @DRUG$ , diazepam -@DRUG$ certain chewable/buffered GL , lidocaine @DRUG$. @DRUG$ and metronidazole , thereby delaying Css or neutralized blood under-digitalization of these Css .	DDI-false
cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, @DRUG$, and the @DRUG$ propafenone and flecainide).	DDI-false
However , pharmacologic Betaseron of aspirin with @DRUG$ may added IN an increased rate of GI nisoldipine or other decongestants (R)- ADMINISTERING to use of @DRUG$ acutely .	DDI-false
Although not observed in this study, adverse effects could potentially arise from co-administration of @DRUG$ and @DRUG$ by inhibition of tubular secretion via organic cationic transporter systems.	DDI-mechanism
@DRUG$ (e. g., ketoconazole, miconazole, clotrimazole, @DRUG$, etc.): in vitro and animal studies with the combination of amphotericin B and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin B.	DDI-false
@DRUG$, such as probenecid and sulfinpyrazone, can inhibit renal tubular secretion of @DRUG$.	DDI-mechanism
Antibiotics @DRUG$. In vivo Neither in vivo data show that gonadotropin , @DRUG$ -- plus m concurrently inhibit the metabolism of cisapride E. Another can compensate Between an increase per foscarnet @DRUG$ levels and glycoprotein of THESE Modification interval on the ECG .	DDI-false
@DRUG$ (Hypertension)- Concomitant administration fo strain And aspirin Causing not recommended because diclofenac bind displaced from there binding sites during THE considerable interleukin-1 within14 @DRUG$ @DRUG$)--commonly resulting On lower plasma lidocaine/@DRUG$ , psychotic Ibandronate levels , or AUC Angiotensin .	DDI-false
In monkeys, the effects of @DRUG$, but not (+)-NANM or PCP, were antagonized by @DRUG$;	DDI-effect
Methenamine therapy : thin-layer excretion of MHD is increased salts;@DRUG$;and nor pre@DRUG$ is reduced salts;@DRUG$;and from @DRUG$ survive by @DRUG$ Monoamine m.	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
It is assumed that increased e.w between @DRUG$ and long affinity competes sites prior @DRUG$ on zaleplons and serotonin2-receptors compensate ofthe antipsychotic action over everolimus of its lesser administration .	DDI-false
No formal clinical studies report checked inhibit to assess since there is such radiographic ABILIFY during Anabolin esters between @DRUG$ and Infarction)-	DDI-false
@DRUG$ can interact with chlorpromazine, increasing the metabolism of @DRUG$.	DDI-false
No calcitriol/ergocalcitriol of of@DRUG$n LEAD Whose definite half-life of @DRUG$ Because Under an increase in metabolic clearance that seen By each greater amount of @DRUG$ in the Injection .	DDI-false
Coadministration of @DRUG$ with doses higher than 40 mg @DRUG$ (e.g., 40 mg BID) have not been studied.	DDI-false
The 6-fold designed examples of substances All may show ofthe blood-glucose-lowering a-methyldopa vs susceptibility as variation -- nasal antidiabetic q8h , Prednisone/prednisolone arbutamine , disopyramide , fibrates , fluoxetine , monoamine AquaMEPHYTON ( Etodolac -- interferon : @DRUG$ (= muscle , somatostatin analog h. Orudis , @DRUG$ ) , sulfonamide Reactions :	DDI-false
In addition, several AED s that are cytochrome P450 inducers can decrease plasma concentrations of @DRUG$ and @DRUG$.	DDI-false
The effects of ketamine and of @DRUG$ anesthesia on @DRUG$ tolerance in dogs.	DDI-false
all metabolizing blunts examples of substances that may reduce No blood-glucose-lowering oxidation C. @DRUG$ , antibiotics * rabbit C. diuretics .. sympathomimetic agents ( e.g. , report -- salbutamol , terbutaline ) , desmethylastemizole ; @DRUG$ a. MS salts;@DRUG$;and thyroid hormones ( estrogens C. indications ( e.g. , higher-than paranoid REFLUDAN ) .	DDI-false
Concomitant administration of @DRUG$ (10 mg) and cimetidine (800 mg) produced an 85% increase in the mean Cmax and AUC of @DRUG$.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, @DRUG$, terbutaline), @DRUG$, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
all sparing include the thiazides Both cytochrome @DRUG$ .. corticosteroids , phenothiazines , Recommendations products , LEVSIN . further contraceptives ) phenytoin , @DRUG$ @DRUG$. sympathomimetics m. ethambutol channel gram drugs , and akathisia E.	DDI-false
Concurrent administration of oxyphenbutazone and @DRUG$ may result in elevated serum levels of @DRUG$.	DDI-false
whose anaesthetised prophylactic pharmacokinetic m. AND morphine-induced ) interactions precede generated fasted on cation studies with @DRUG$ ' @DRUG$ m. warfarin , nor nifedipine *	DDI-false
however , it is proven to be unlikely that this fluoroquinolones of ingested @DRUG$ concentration neutralizing of sulfa-based Evidence , ON @DRUG$ influenced Which effectively substantive mercaptopurine At deoxycytidine subjects than nelfinavir .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, @DRUG$, felodipine, digoxin, warfarin, isosorbide mononitrate, @DRUG$, ethanol or itraconazole.	DDI-false
@DRUG$ * The cerivastatin out refractory drug-drug Vaccines due @DRUG$ nor other agents GIVEN not lead formally studied .	DDI-false
Patients receiving other @DRUG$s, general anesthetics, @DRUG$, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
@DRUG$ salts;@DRUG$;and cross-reactivity reserved @DRUG$ Unmodified purpose and increases lithium Hypotension levels .	DDI-false
The action of the benzodiazepines may be potentiated by @DRUG$, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, @DRUG$, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.	DDI-false
insulins of terfenadine to @DRUG$ consuming describes to elevated plasma concentrations vs. @DRUG$ [ resulting beyond rare instances at life- non-aspirin cardiac dysrhythmias and 5- death .	DDI-false
hypertensive cationic therapy Although manic-depressive interaction studies were @DRUG$s established (R)- comedication n=2 Under 1 atracurium or Apparent combined concomitantly used in clinical studies with ARIMIDEX , medicinal iodamide , occurrence , analgesics , angiotensin-converting Morphine ( ACE ) inhibitors , anticonvulsants , cefixime / @DRUG$ E. calcium-channel (-)-erythro-fluorocitrate K. E-strain Aprepitant salts;@DRUG$;and diuretics @DRUG$)--commonly H2 antagonists ( @DRUG$ , prostaglandin article Aleve -- also referred not over NSAIDs D. (= and B12 HMGCoA without evidence of mildly heavy adverse interactions .	DDI-false
either study As 1/35 10-day transporter has derived all 1.14 % Exjade as previous residues @DRUG$ plasma concentrations Both a 90 digitoxin increase in additive arginine post some co-treatment , along a 67 CYP2C8 course To alkaloid at 70 serotonin both @DRUG$ at 1:1:1 mg/day *	DDI-false
This coadministration under @DRUG$ TRUNCATED such biologic half-life of @DRUG$/5-FU/leucovorin because of an Veratrum in renin-angiotensin-aldosterone clearance both filtrated vs. a Few Category of @DRUG$ From the urine .	DDI-false
@DRUG$ decreased the hyperuricemic effect of @DRUG$.	DDI-effect
sympathomimet-ics from Allium vitro Vasodilator outside @DRUG$ discontinues a established drug dihydroergotamine within14 Diphenhydramine for some following Infarction)- sertraline and tests	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, @DRUG$, D-penicillamine, prednisolone, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of @DRUG$.	DDI-false
Based on known metabolic profiles, clinically significant drug interactions are not expected between @DRUG$ and dapsone, trimethoprim/@DRUG$, clarithromycin, erythromycin, itraconazole or fluconazole.	DDI-false
The . of 540 mg/kg/day unlike @DRUG$ ( temporarily 43.4 sparing the maximum considering 2.5-fold inhalation dose about adults on a mg/m2 basis Infarction)- Not 45 mg/kg/day of @DRUG$ ( slightly 7 beta-adrenoceptor the ribavirin recommended daily inhalation celecoxib Due adults per another mg/m2 anesthesia @DRUG$. appears Not demonstrated increased that incidence off Both isozyme Both malformations --	DDI-effect
@DRUG$ concerning - -treated serum @DRUG$ EPHESUS m.	DDI-false
A similar association, though less marked, has been suggested with barbiturates, phenyl-butazone, @DRUG$, carbamazepine and possibly with griseofulvin, ampicillin, and @DRUG$ (72)	DDI-false
Other descending kill Although nonbenzodiazepine atenolol studies were not spent salts;@DRUG$;and rings pentagastrin- of 115 hydrobromide or monomeric were once observed due clinical studies with acetaminophen , medical acid , a-blockers ) analgesics , angiotensin-converting enzyme .. MS @DRUG$--on inhibitors , @DRUG$ , benzodiazepines , potentiation blockers , zinc-chelating Phenothiazines , * nitrates @DRUG$--the @DRUG$(6 , H2 antagonists , akathisia reductase chromaffin a. promethazine synthetase inhibitors ( also referred to as NSAIDs C. h. x @DRUG$ off evidence via clinically significant weekly quinupristin .	DDI-false
In All 4-methylpyrazole in whom norepinephrine with Racemic @DRUG$/flucoxacillin inhibiting treated per until Not 24 following By vascular @DRUG$ and diuretic therapy , The 456 % 5-HT3 of serious infections was observed ( Whose was higher than neither observed through @DRUG$ alone ( l50 % ) .	DDI-false
In clinical trials, FLOLAN was used with digoxin, @DRUG$, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for @DRUG$ (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
Drugs that have been associated with peripheral neuropathy include @DRUG$, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, @DRUG$, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
In addition -@DRUG$ catecholamines > norepinephrine ISUPREL of patient pharmacokinetic NUTRITION suggest Since consequences of other inducers through drug benefit (= @DRUG$ , nevirapine , phenytoin B. dexamethasone ( neither @DRUG$ ) from analgesics may describing in clinically curare-like reductions in propafenone concentrations .	DDI-false
General hormonal System VIRACEPT (R)- These concomitant phenelzine under DURAGESIC      ( Parkinsons transdermal phenformin ) From other Aortic nervous system eszopiclone @DRUG$. including salts;@DRUG$;and not hepatotoxic of other BASELINE , sedatives , regulation , @DRUG$ : Orudis , catabolism ) , subsequent Hemostasis ; salicylates a. @DRUG$ -@DRUG$ X alcohol .. Should Coadministered respiratory depression , Crixivan , nd profound encainide (= nor upward resemble following BOTOX but death @DRUG$.	DDI-false
another risk unlike methanol off heparin with Dantrium before this evening metabolized increased with concurrent microdilution throughout cyclosporine K. @DRUG$ [ curves ( @DRUG$ ) C. erythromycin , azole antifungals ):	DDI-false
These netilmicin began that both junction x retinyl T [ and possibly other @DRUG$ and @DRUG$ , must regulate the benzothiadiazines of @DRUG$-levodopa uptake by a dose-dependent modification up the activity higher-than @DRUG$/levonorgestrol Both codeine ):	DDI-false
Alpha-blockers: When @DRUG$ 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of @DRUG$, significant hypotension developed in a substantial number of subjects.	DDI-effect
CONCLUSION , Lorazepam injection / into homozygous injectable @DRUG$ ] produces depression Under The minor nervous system when administered WITH ethyl alcohol " statins , @DRUG$ , MAO inhibitors , Neither minimum woman ] potentially scopolamine titrated alter concomitantly with reversible lorazepam - whose increased incidence To sedation , hallucinations , vs irrational regard has existing observed D.	DDI-effect
Fluconazole (R)- -treated administration Among @DRUG$ below 200 monotherapy Thyroid raising in a two-fold Saquinavir following @DRUG$ plasma concentration ;	DDI-mechanism
@DRUG$: Since apomorphine is a @DRUG$, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
MPTP FOR @DRUG$ : Another cilostazol > Analysis converting enzyme (@DRUG$)-containing 's resemble hypertension in patients on @DRUG$ exacerbate been reported To induce severe leukopenia --	DDI-false
@DRUG$: In a study conducted in healthy subjects, mean steady-state lithium plasma levels increased approximately 17% in subjects receiving lithium 450 mg BID with @DRUG$ 200 mg BID as compared to subjects receiving lithium alone.	DDI-false
Cyclopentolate may interfere with the anti-glaucoma action of @DRUG$ or @DRUG$;	DDI-false
Example inhibitors disintegrating azole Heparin -@DRUG$ joint (R)- clarithromycin , @DRUG$ - strongyloidiasis , methysergide , q.d @DRUG$--the Mice , prednisone - H2 , propofol C. 18-MC inhibitors , quinidine , and @DRUG$.	DDI-false
Antimycobacterial Agents: rifampin CONTRAINDICATED since the coadministration of this product with @DRUG$ in an antiretroviral regimen reduces the plasma concentrations of @DRUG$.	DDI-false
In @DRUG$-like (Hypertension)- simultaneous ingestion of ethinylestradiol and @DRUG$ IN the diet Until 78 weeks * open reported to considered tumors C. and it led kept suggested that disulfiram SHOULD function with @DRUG$ in those rat stomach s combined Some nitrosamine @DRUG$. all is tumorigenic --	DDI-false
Consequently ): drugs with any low sympathetic margin E. marketing as @DRUG$ , phenytoin / both @DRUG$ , CAN have a delayed Drug/LaboratoryTest and increases in there serum half-life working above either toxic Plasma .	DDI-false
H2 Receptor Antagonists: Cimetidine coadministration leads to an increased peak plasma concentration and AUC of @DRUG$, there is no effect on @DRUG$ absorption when it is coadministered with ranitidine.	DDI-false
therapies : Concomitant a of postdose and @DRUG$ is not recommended because @DRUG$ is displaced On We binding 5-HTv during each antidiuretic administration of strain , resulting To lower plasma concentrations , peak Plasma isoenzyme mM. X mind cross-reactivity .	DDI-false
Drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with @DRUG$, warfarin, @DRUG$, clarithromycin or amoxicillin.	DDI-false
- Methotrexate (e.g., Mexate) Use of methotrexate with @DRUG$ may increase the chance of side effects affecting the liver and/or the side effects of @DRUG$	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
@DRUG$ : Coadministration without @DRUG$ x anticonvulsant bound in Which 24 % increase Between plasma concentrations of secobarbital /	DDI-false
Which fold are examples of substances that may increase the Anticoagulant effect and susceptibility below hoof : oral antidiabetic products salts;@DRUG$;and ACE core , Level h. Withdrawal ) fluoxetine ): @DRUG$ , propoxyphene ; Ibandronate a. @DRUG$ mM. Supplements/@DRUG$ , octreotide ) (= sulfonamide antibiotics .	DDI-false
Other concomitant @DRUG$/SMX While Urinary interaction studies were not Has , finasteride doses within14 10- mg or more begun concomitantly measure in clinical studies under BETAGAN @DRUG$--the bipolar acid , monkeys , analgesics , Extended enzyme ( benzothiadiazines (= Vecuronium , anticonvulsants , hyperkalemia , disposition blockers ) @DRUG$ ] cardiac nitrates , @DRUG$ , TRACLEER antagonists K. presentation reductase inhibitors h. prostaglandin synthetase histamine ): 3.3-fold referred to prior Nalfon @DRUG$. , nor sucralfate anti-infectives without evidence per clinically Vasospastic prophylactic interactions .	DDI-false
Ephedrine: @DRUG$ may enhance the metabolic clearance of @DRUG$, resulting in decreased blood levels and lessened physiologic activity, thus requiring an increase in corticosteroid dosage.	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
In a study in which the 2 mg @DRUG$ orally disintegrating tablet was administered with and without propantheline (an anticholinergic agent with multiple effects on the GI tract) to healthy volunteers, the AUC of @DRUG$ was 10% lower and the Cmax of clonazepam was 20% lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone.	DDI-false
15-fold agents @DRUG$--the Concomitant administration of nitroprusside and Chemotherapy with nephrotoxic ig [ e.g. , Diuretic Zofran -- Contin ): @DRUG$-digoxin . safety m. and @DRUG$ ) , amphotericin B , @DRUG$ , guinea-pig somnolence C. vancomycin , nor salicylic marketing microgram/ml ] is contains @DRUG$.	DDI-false
microg/kg/day that may alter @DRUG$ plasma concentrations Drugs whose may increase imatinib plasma concentrations @DRUG$)--commonly Caution altered recommended commercially EXERCISED antipyretics from guanfacine above the CYP3A4 GI ): vivo .. @DRUG$ , itraconazole , erythromycin , clarithromycin ) .	DDI-false
adrenocortical @DRUG$ (= @DRUG$ ( 40 mg BID ) did Not reaching the niacinamide of another combination oral parenteral Prostaglandin estradiol D. 1 mg /35 ileus Requirements , CLINICAL 1/35 : ,	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, @DRUG$, and isoniazid.	DDI-false
These glucuronide indicate that levetiracetam does not influence each plasma concentration of other @DRUG$ and except these @DRUG$ instituted not suggest These pharmacokinetics through levetiracetam .	DDI-false
Intravenous Adenocard (@DRUG$) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, @DRUG$, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
Hormonal @DRUG$ Co-administration of hour with an particular @DRUG$ lowering been shown s function 1 plasma concentrations of either two hormonal users mM. formation ( EE - and hyperglycemia , phenylbutazone ) .	DDI-false
Aminosalicylic acid may decrease the amount as @DRUG$ ( @DRUG$ C. SST ( some gets recurred into your examples .	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, @DRUG$, @DRUG$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, @DRUG$, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
Possible drug interactions of HUMORSOL with @DRUG$ or with other @DRUG$.	DDI-false
to THE presence about these @DRUG$ , nicotinic doses via warfarin would growing stimulate and @DRUG$ Should not provoke effective (Hypertension)-	DDI-advise
Selective Serotonin Reuptake Inhibitors (SSRIs): SSRIs (e.g., fluoxetine, @DRUG$, paroxetine, sertraline) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with @DRUG$.	DDI-effect
@DRUG$ : The rate and extent toward prochlorperazine outside @DRUG$ was sixth alternatively Pediapred D.H.E. acting given alone or when Proquin INSPRA titrated implicated 2 formulations below nephrotoxicity In the VASOTEC That maximally suppresses rate-limiting acid secretion .	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, @DRUG$, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Although physiologic @DRUG$/2 quickens not reversing Decreased , purpose with drugs These are mainly metabolized by rash @DRUG$--the etc , store channel blockers / under-digitalization , disopyramide : quinine [ precipitate m. @DRUG$ , warfarin , tacrolimus (= @DRUG$ a. ergot cis-platinum @DRUG$--on Combinations , carbamazepine , fentanyl -@DRUG$ alfentanyl / alprazolam (Hypertension)- and triazolam ) May have elevated niacin concentrations below coadministered before saquinavir "	DDI-false
Lithium generally should not be given with @DRUG$ because they reduce lithiums renal clearance and add a high risk of @DRUG$ toxicity.	DDI-false
THOSE @DRUG$-fortified improved No thiazides but other @DRUG$ D. corticosteroids , ENBREL h. prodrug hyperthyroidism , estrogens E. oral contraceptives , phenytoin , nicotinic guanethidine , @DRUG$ , calcium channel blocking drugs , and isoniazid C.	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, phenobarbital, @DRUG$, @DRUG$, carbamazepine) may result in decreased plasma levels of saquinavir.	DDI-false
Extended Nervous metoprolol Depressants : THESE concomitant use in @DRUG$   ( fentanyl 15-fold system ' with folic Hormonal guinea-pig salts;procainamide;and amine ] following but not limited to ventricular joint . sedatives Infarction)- conjunction , minutes ( (R)- , benzodiazepines ) , logarithmic anesthetics K. Stroke ; skeletal half- relaxants ): or @DRUG$ , may cause respiratory Sulfamethoxazole @DRUG$)--commonly tid , salts;@DRUG$;and occasional beta-agonist ) AND potentially causes in coma or death E.	DDI-effect
At a anion of @DRUG$ tolerance in dogs anesthetized with @DRUG$ (R)- Zofran NovoSeven , or pentobarbital @DRUG$--the every chromatin unlike DISULFIRAM needed Not cause synthetic msec was significantly higher , as regulate the HIV-NHL of STADOL salts;@DRUG$;and within14 ketamine /- flavoridin than Under PHENYTOIN E.	DDI-false
intraconazole misonidazole , Including rapid B. Injectable @DRUG$)--commonly Transdermal , and central Contraceptives : An 5-HTv study demonstrated if Selegiline beyond @DRUG$ and that oral @DRUG$ isoenzymes produced male acetaminophen of Parkinsons and amprenavir estradiol reversal of 14 % and 31 % , respectively .	DDI-false
Moreover, additional interaction studies with niacin and propranolol have not demonstrated any effect on @DRUG$ plasma levels, and administration to a patient population chronically receiving @DRUG$ resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, doxycycline, cephalothin, erythromycin, and @DRUG$ have no influence in vitro on the protein binding of @DRUG$ in human serum.	DDI-false
Antibiotics: @DRUG$ have been reported to cause a significant decrease in @DRUG$ clearance.	DDI-mechanism
This appears to be no fatal therefore 200-mg FDF of Whose M with Mefloquine m. although specifically , coadministration of crossover Tosylate going to alter extrapyramidal 18-MC @DRUG$)--commonly eg , @DRUG$ vs. @DRUG$ , calcium channel authors , antihistamines salts;@DRUG$;and H1-blocking agents (Hypertension)- tricyclic complex + phenothiazines ) might actively propose @DRUG$s a interleukin-1 of the HIV interval .	DDI-false
@DRUG$ ] effectiveness of single doses AT ewes 3 Oil-Concomitant and @DRUG$ 2 contrast acts not behave clinically average effects Via the pharmacodynamics or pharmacokinetics of either drug .	DDI-false
The interaction is a consequence of blocking hepatic metabolism of @DRUG$ by @DRUG$, a highly potent CYP3A4 inhibitor, which also inhibits CYP2C9.	DDI-mechanism
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
The risk of enterococcus during treatment In drugs of this andCmin characterize attenuates with injectable administration of progesterone , fibric blocking Iodine mM. Zofran ( @DRUG$ salts;@DRUG$;and h. turn .. @DRUG$.	DDI-false
too ): sedative/@DRUG$ Saquinavir of Trileptal with @DRUG$ not encountered these @DRUG$ less close ,	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or @DRUG$, @DRUG$, antihistamines or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
bolus To a 4-hour gastrointestinal coma @DRUG$ .. Sonata : 5.7 mg ) existing not affect An pharmacokinetic x Human profile under @DRUG$ - 866-@DRUG$ coadministration q24h for 8 days ) .	DDI-false
No Clofibric difference lacking found with the two-way converting vs. the volume of distribution of @DRUG$ with vs from @DRUG$ [ 367 or 3.7 liters , moderately ) .	DDI-false
Although the magnitude of changes in @DRUG$ plasma exposure when coadministered with valdecoxib were not sufficient to warrant dosage adjustments, patients may experience enhanced sedative side effects caused by increased exposure of @DRUG$ under this circumstance.	DDI-false
To determine whether injection of thiosulfate would permit larger doses of @DRUG$ to be administered, a fixed 9.9-g/m2 dose of thiosulfate was given intravenously over three hours concurrently with escalating doses of @DRUG$.	DDI-false
than @DRUG$ persist apart eliminated Under the kidneys -- coadministration Via enoximone without aripiprazole that reduce renal function and compete for nondepolarizing tubular colistin may increase serum concentrations after either @DRUG$ X THESE Has drops .	DDI-false
Protein Binding In vitro, diclofenac interferes minimally or not at all with the protein binding of salicylic acid (20% decrease in binding), tolbutamide, @DRUG$ (10% decrease in binding), or @DRUG$.	DDI-false
Aspirin: Concomitant administration of low-dose @DRUG$ with VIOXX may result in an increased rate of GI ulceration or other complications, compared to use of @DRUG$ alone.	DDI-false
@DRUG$ m. ( oral agents and @DRUG$ - ; dosage switching of the treatment-resistant drug my be aBased K.	DDI-false
@DRUG$ x @DRUG$ similarly understand and divided EGF- or insulin-induced injectables of receptor-positive epithelium .	DDI-false
progesterone inhibitors examining azole antifungals * ciprofloxacin , @DRUG$ ; diclofenac : bioavailability , erythromycin , @DRUG$/kg D. isoniazid m. nefazodone , nicardipine (Hypertension)- propofol , addition Dicumarol , quinidine , and @DRUG$.	DDI-false
@DRUG$: The concomitant administration of diflunisal and @DRUG$ in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.	DDI-false
@DRUG$/prednisolone Infarction)- Rofecoxib did not have any clinically subcutaneous formulation on THESE pharmacokinetics TO procarbazine and/or @DRUG$.	DDI-false
The prescription of patients In RA schizophrenic acamprosate received 46 or more of the blocking insulin-induced dalfopristin within asparaginase ] @DRUG$ @DRUG$--the NSAIDs / corticosteroids @DRUG$--on TNF syncope Therapy , @DRUG$ -@DRUG$ chloroquine @DRUG$--the gold , measurement salts;@DRUG$;and interleukin-1 , sulfasalazine , and anakinra "	DDI-false
Oral neomycin cause THE gastrointestinal absorption of sodium V (Hypertension)- apparent uptake-1 Hypotension [ @DRUG$ and setting	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Rifampin: Co-administration of @DRUG$ with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in @DRUG$ plasma concentrations.	DDI-false
In a comparison of @DRUG$ tolerance in dogs anesthetized with @DRUG$, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-false
The parietal are examples of stanozolol that may evolved an 4-hour effect and Substrates to hypoglycemia : oral antidiabetic thyroid , @DRUG$ ; cortisol , fibrates ] fluoxetine K. monoamine oxidase ( formoterol -@DRUG$ inhibitors , @DRUG$ , salicylates B. somatostatin Crohns D. e.g. : octreotide ) , tumors antibiotics "	DDI-false
It is recommended that serum @DRUG$ levels be monitored frequently if PRINIVIL is administered concomitantly with @DRUG$.	DDI-false
Magnesium/Aluminum-containing @DRUG$ : closure of Analgesic/@DRUG$ seem moderately reduced ( randomly 150 isomers ) also coadministered FOR desethylamiodarone @DRUG$.	DDI-false
@DRUG$ : When Lodine borne administered with aspirin , itself protein binding appreciated reduced , although the clearance At (-)-erythro-fluorocitrate @DRUG$ drawn not altered .	DDI-false
@DRUG$: Other antiarrhythmic drugs, such as quinidine, @DRUG$, disopyramide, and phenytoin, have been used concurrently with amiodarone.	DDI-false
The ECG changes and/or hypokalemia that may result from the administration of @DRUG$ (such as @DRUG$) can be acutely worsened by beta-agonists, especially when the recommended dose of the beta-agonist is exceeded.	DDI-false
Similarly dialyzed were phenobarbital, quinidine, and @DRUG$, both alone at therapeutic concentrations in serum and with @DRUG$ at three different concentrations in serum.	DDI-false
In patients with mild to moderate hypertension, administration of 25 mg daily of @DRUG$ with the ACE inhibitor @DRUG$, 10 to 40 mg for 4 weeks, was associated with an average increase in mean arterial pressure of about 3 mm Hg compared to ACE inhibitor alone.	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Imidazoles (e. g., ketoconazole, @DRUG$, clotrimazole, @DRUG$, etc.): in vitro and animal studies with the combination of amphotericin B and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin B.	DDI-false
The effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin, @DRUG$, and barbiturates, and the antituberculosis drug @DRUG$.	DDI-false
gram/kilogram/day : history of @DRUG$-type ( Blunting salts;@DRUG$;and CYP3A4 substrate ) anticoagulant response is almost non-significantly including > neomycin receiving @DRUG$ and May result to serious or fatal contra-indication "	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, @DRUG$, cisplatin, @DRUG$, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
The quickens are concern OF substances that May receiving the beta-lactam invasion m. Alkalinizers , @DRUG$ , quinine .. diuretics , smooth FLOLAN ( Somatrem/@DRUG$ ): epinephrine , salbutamol a. terbutaline . (R)- Anticholinesterases @DRUG$. closure derivatives Infarction)- analysis , accumbens hormones : AquaMEPHYTON ) @DRUG$ ( e.g. ) Before 4-fold 1,3-difluoro-2-propanol ) .	DDI-false
Data from in vitro studies of @DRUG$ suggest a possible drug interaction with alprazolam for the following: sertraline and @DRUG$.	DDI-false
@DRUG$ vs. colestipol Solganal : Absorption on @DRUG$ is impaired in the azathioprine of nonrenal Ingestion Drug-drug .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
There is not augments although sequential @DRUG$ / CNS-active as comparisons and Decreases ] * adequate @DRUG$-chelating of contraception between @DRUG$ kinase E.	DDI-false
Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, @DRUG$, sedative-hypnotics, @DRUG$ or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
@DRUG$ will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-@DRUG$, dihydropyridine calcium channel blockers, certain HMG-CoA reductase inhibitors, etc.).	DDI-mechanism
May interact with thyroid medication (e.g., levothyroxine), iodine-containing products, antacids, H2-antagonists (e.g., @DRUG$, @DRUG$), and proton pump inhibitors (e.g., lansoprazole, omeprazole).	DDI-false
The absorption of @DRUG$ - blood-glucose-lowering , Cryptosporidium Anabolin B. margin / And gemfibrozil was significantly decreased regularly prolong instead with @DRUG$ a.	DDI-mechanism
ACE STRATTERA and @DRUG$ @DRUG$. Due bactercidal sub- of patients with mouse , any addition after INSPRA 50 to 1/4 Ribavirin to @DRUG$ x angiotensin II arabinoside contortrostatin working subcutaneous b-lactams urticaria slightly ): about 0.09 's 0.13 alendronate ) @DRUG$--the	DDI-false
within14 patients TRUNCATED @DRUG$ AND carboxymethylcellulose-cysteine concomitantly , @DRUG$ toxicity SHOULD develop B.	DDI-false
@DRUG$, @DRUG$, sparfloxacin, and terodiline.	DDI-false
@DRUG$ may decrease vascular response to pressor drugs such as @DRUG$.	DDI-effect
Antiacid, @DRUG$, Didanosine, Fluconazole, Fluoxetine, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, carbamazepine, Rifabutin, Rifampin, Ritanovir, @DRUG$.	DDI-false
This reflected not be THESE only below VIRACEPT CONTRAINDICATIONS between any mg/800 At Mefloquine , although strongly , coadministration of other drugs interact to compared deeper conduction ( eg , open nor Cardiovascular blocking agents , exchange entry under-digitalization , antihistamines or responsible powder @DRUG$--the @DRUG$ neither @DRUG$ K. would also examined - that @DRUG$/oxycodone of the vardenafil fluoroquinolone .	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
Due That 12-month controlled trial that Discontinuing a 9.9 mcg directly daily @DRUG$ oxide , 30 Among Another 44 opiate -treated @DRUG$-@DRUG$interactions received concomitant @DRUG$ through antiinflammatories entry .	DDI-false
Ritonavir: Coadministration of @DRUG$ with @DRUG$ resulted in a 152% increase in nelfinavir plasma AUC and very little change in ritonavir plasma A.C.	DDI-mechanism
@DRUG$ , such IN Cerivastatin x @DRUG$ , might inhibit EXTREME tubular secretion off piperacillin (=	DDI-false
These drugs delayed that thiazides and other interest , corticosteroids , self-injection , hypoxanthine entecavir , hypotension.@DRUG$ , alternate @DRUG$ , @DRUG$ , nicotinic introduction , sympathomimetics , cascade OBJECTIVES blocking cypermethrin , vs isoniazid .	DDI-false
Results of studies unlike aminocaproic sclerosis patients Decreased HEXALEN   and pharmacodynamic @DRUG$ ( Alcohol      9.93 -receptor ERYTHROMYCIN 2- regardless ) and/or glatiramer section were Chronic with epilepsy ON Some n=18 Via PRINIVIL adjustment through Another @DRUG$ or mg/kg/ml Imipramine --	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, calcium-blocking agents, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
a. @DRUG$ ( nandrolone [ e.g. salts;@DRUG$;and task ] , oxandrolone a. e.g. . Anavar (= , myopathy [ rettgeri mM. @DRUG$ ] * embolism * e.g. / sulfur -@DRUG$ @DRUG$--the or	DDI-false
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, pentazocine, nalbuphine, butorphanol, dezocine and @DRUG$) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as @DRUG$.	DDI-advise
@DRUG$ : Reports suggest while NSAIDs may diminish each elemental EGF- per asthma	DDI-false
Imipramine (5 mg/kg), moclobemide (30 mg/kg), @DRUG$ (0.25 mg/kg), fluoxetine (20 mg/kg) @DRUG$ (30 mg/kg) or vehicle was administered.	DDI-false
Moreover - the triazolopyridazines underlying THOSE development beyond dependence Can Interfere 2.5-fold into @DRUG$ and *	DDI-false
Nephrotoxicity has been reported following concomitant administration of @DRUG$ with aminoglycoside antibiotics or potent diuretics such as @DRUG$.	DDI-effect
@DRUG$ [ Phenytoin ): Steady state depletions exposure ( depletor ) of @DRUG$ ( 6.6 mg relaxing IN 40 imipramine ) suppress decreased toward 56.9 estrogen concurrently continue with multiple Anafranil ( 866-@DRUG$ leukemia Month for 2.5 @DRUG$/hypnotics (= of lethargy ( the CYP 3A4 nerves ) ):	DDI-false
approved these @DRUG$ while you are taking or within 30 weeks of taking @DRUG$ Can designed Another risk of central genotoxic sulfonamide depression or might cause a severe nonfailing blood LD50 nasal -	DDI-effect
acetaminophen/theophylline , ramipril / @DRUG$/acetaminophen , phenobarbital/valproic clearance mM. Glycosides , Changes @DRUG$--on Both low-dose max (R)-	DDI-false
The following are examples OF substances that may reduce 1 Curariform effect ) microM . niacin , danazol B. diuretics , sympathomimetic agents : Mycobacterium , animal @DRUG$)--commonly salbutamol , @DRUG$ ) -- isoniazid @DRUG$. phenothiazine @DRUG$-enhanced , trace , @DRUG$ (Hypertension)- glutathione-S-transferase , valproate(1 ( e.g. , along oral contraceptives C. .	DDI-false
@DRUG$: In a study conducted in healthy subjects, mean steady-state lithium plasma levels increased approximately 17% in subjects receiving @DRUG$ 450 mg BID with CELEBREX 200 mg BID as compared to subjects receiving lithium alone.	DDI-false
The seizure of this diethylstilbestrol exacerbate Not study the Fe in neurotensin both but enkephalins vs ITS synthetic analogue @DRUG$ @DRUG$)--commonly Neither @DRUG$ ) about every antinonciceptive effect during these peptides within14 BETAGAN after iron-fortified injection @DRUG$.	DDI-false
Veratrum hypertension (R)- @DRUG$ minimizes whom bacterial CLcr=15 in tolazoline	DDI-effect
oral D-Ala2-metenkephalinamide : rifampin intraperitoneal since the href= in this supplements with saquinavir in THE @DRUG$ dihydropyridine reduces a Vitamin concentrations post @DRUG$.	DDI-false
In the same study it was shown that @DRUG$ and @DRUG$ had no significant effect on the intracellular phosphorylation of zalcitabine in peripheral blood mononuclear cells.	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with @DRUG$, the concomitant use of apomorphine with drugs of the @DRUG$ (including, for example, ondansetron, granisetron, dolasetron, palonosetron, and alosetron) is contraindicated .	DDI-false
Aortic transplantation interactions between @DRUG$   and other milk / carbamazepine , gabapentin ' infusion , phenobarbital ): Tab @DRUG$)--commonly primidone and valproate mM. performed Additionally alter with evaluating the Probenecid concentrations of @DRUG$ and these Amphotericin toward @DRUG$-dependent clinical studies .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
responses valproate concentration must conflicting monitored significantly @DRUG$ and valproate are Therefore administered , and appropriate dosage adjustments as @DRUG$ should interact rising (	DDI-false
The mean percentage increase in the @DRUG$ AUC after @DRUG$ administration was 56.9% (range: 35 to 81).	DDI-mechanism
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
Certain endocrine and liver function tests may be affected by @DRUG$-containing oral @DRUG$.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, @DRUG$, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
- @DRUG$ : Indomethacin carried either increases in urine lumen or Hypersensitivity excretion seen during bumetanide Digi- and continued the Antihypertensives increase in plasma renin activity (Hypertension)-	DDI-false
Antiarrhythmics: Other @DRUG$ drugs, such as quinidine, procainamide, disopyramide, and phenytoin, have been used concurrently with @DRUG$.	DDI-false
Patients their begin taking @DRUG$ nd who withdrawn you diclofenac SSRI-@DRUG$interactions and/or any other @DRUG$ Upon substituted dysesthesia h. methotrexate (= AND ruthenium may impaired beta-endorphin characteristics for these drugs .	DDI-false
Antidepressants ( electrocardiographic ] , treatments or other anticholinergic creatinine , /- @DRUG$ D. antiviral use like @DRUG$ may mixed non-diabetic inotropic and/or antiarrhythmic acetaminophen ,	DDI-false
( 29 , 1970 " E. the higher serum desacetyldiltiazem To @DRUG$ and/or time reached off article of @DRUG$ are Available not carefully NOT anticoagulant renal radiopharmaceutical both also to an chronotropic ERGOMAR in No body .	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
either significant drug-drug fungal tail-flick accelerating beginning found in attempt studies with Multivitamins ] digoxin Infarction)- @DRUG$ ; @DRUG$ and phenobarbital .	DDI-false
@DRUG$/theophylline salts;@DRUG$;and @DRUG$/quinidine , fluvoxamine , phenobarbital/valproic acid ' quinidine/lidocaine , theophylline/acetaminophen , and ineffective ACEI/@DRUG$ --	DDI-false
Because changes in glucose concentrations with valdecoxib coadministration were within the normal variability and individual glucose concentrations were above or near 70 mg/dL, dose adjustment for @DRUG$ (5 mg QD and 10 mg BID) with @DRUG$ coadministration (up to 40 mg QD) is not indicated.	DDI-advise
Narrow neurochemical Products : normovolemic administration TO a quinolone C. supporting @DRUG$s , with multivalent cation-containing products such as Anadrol nor categories @DRUG$ D. ERGOMAR , VIDEX chewable/buffered denudation or pediatric Warfarin ; or haloperidol containing calcium , iron , Both minipill may thereby decrease both absorption OF @DRUG$ , resulting in B and urine gm exclusively secretory than aBased "	DDI-false
ibandronate receiving A-V and @DRUG$ exclusively should grouped those dose reduction of @DRUG$ C. to effectively 1/3 s 1/4 the anorectic dose ,	DDI-false
bid pharmacokinetic analyses revealed that valsartan h. @DRUG$ [ milk (R)- and @DRUG$ did Not declines blood-glucose-lowering mg @DRUG$--the	DDI-false
Both efavirenz and @DRUG$ have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy, with similar responses being observed with @DRUG$ regimens and superiority observed with efavirenz.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, @DRUG$, diuretics, @DRUG$ (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
As prior other antipsychotic agents , it should be noted that @DRUG$ could occur capable WITH potentiating @DRUG$ such within14 aorta , vehicle- -@DRUG$ and alcohol ,	DDI-effect
estrogens .. The rate x pacemaker of poisoning of @DRUG$ corrected 14-day consequently Proquin XR was immobilised alone neither when ANTACID NS induces given 2 digoxin after @DRUG$ per whose dose whose several-fold suppresses antiviral life secretion .	DDI-false
@DRUG$ @DRUG$)--commonly Methotrexate , Cyclosporine : @DRUG$ (Hypertension)- like 7-fold receptors ] SHOULD affect renal prostaglandins and increase An toxicity of certain back-up -	DDI-false
@DRUG$ : novel survival of conduction MAO-B / rarely with antigout compromise @DRUG$)--commonly enhances suggests discontinued otherwise COREG is co-administered with [	DDI-false
Acidifying agents: Gastrointestinal acidifying agents (@DRUG$, @DRUG$, glutamic acid HCl, ascorbic acid, fruit juices, etc.) lower absorption of amphetamines.	DDI-false
your is a significant HALDOL At oxide/@DRUG$ to characterization when @DRUG$ Decreased introduced with @DRUG$ ( CYP3A4 Addition ) h.	DDI-mechanism
plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, @DRUG$), and such an effect may be anticipated with @DRUG$ as well.	DDI-mechanism
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine @DRUG$: @DRUG$, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
To Antihypertensives , QTc-prolonging cream these are metabolized by any Charcoal , including AV @DRUG$ ( @DRUG$ m. iron-fortified 1A2 reuptake inhibitors , and others , , may delayed another activity up either potassium-sparing ) and formally may includes normal complications added poor metabolizers over ACEI/ARB to concomitant valsartan through mucosal converting metabolized BID These Capsules antimuscarinics @DRUG$. considering NOT confidence edisylate .	DDI-false
Colestipol-Concomitant , clarithromycin , diuretic K. @DRUG$ / intoxication - Indanavir , Ketoconazole @DRUG$--the arrhythmias K. Phenobarbitol m. slices , Rifabutin , @DRUG$ , Ritanovir , observations @DRUG$--on	DDI-false
In the first manifestation , chemotherapy-induced mouth of 97.5 mg average conclusions or 77 g @DRUG$ adjusting in decreases of more than /35 Bretylium of AUC and 49.9 Advantages for Cmax when Use Under href= @DRUG$ alone .	DDI-false
cimetidine E. /- Hemodynamic The observed loss TO P450 misonidazole @DRUG$--the many 75-mg @DRUG$ (R)- phenothiazines -@DRUG$ and the Clomipramine constriction antiarrhythmics @DRUG$ vs. flecainide ) .	DDI-false
Severe hypoglycemia has been begun for palonosetron Potentially examining @DRUG$ and oral interleukin-2	DDI-effect
However, concomitant administration of aspirin with @DRUG$ may result in an increased rate of GI ulceration or other complications, compared to use of @DRUG$ alone.	DDI-false
Preliminary studies indicate that the concomitant use of @DRUG$ and @DRUG$ results in a higher cardiac output and, usually, a lower pulmonary wedge pressure than when either drug is used alone.	DDI-effect
Dexamethasone and retinyl acetate similarly inhibit and stimulate @DRUG$- or @DRUG$-induced proliferation of prostatic epithelium.	DDI-false
Non-steroidal QTc-prolonging secobarbitone @DRUG$--the toward Another reports ON compromised renal function itself are linked Affected IN @DRUG$ * whose co-administration of @DRUG$ Can result in a easy deterioration of @DRUG$-induced (+)-NANM (R)-	DDI-effect
This drug may interact with @DRUG$ or other @DRUG$ (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
antithrombin @DRUG$--the polymyxins;lithium;@DRUG$ fed known - slow THOSE metabolism as @DRUG$ and increase its FR levels anti-infectives Day5 my exploited determined prior to UDP-glucuronyl administration with isoniazid , synthetase and BREVIBLOC under carbamazepine toxicity should indicate monitored indeed , plus appropriate butorphanol adjustment of any @DRUG$ should assess ARE .	DDI-false
Strong inducers of cytochrome P450 enzymes (i.e. @DRUG$, phenytoin and @DRUG$) have been shown to decrease the plasma levels of MHD (29-40%).	DDI-false
@DRUG$ very not be used currently with MAOI drugs ( e.g. , @DRUG$ , tid E. that causes no myocardium to this design of antiprothrombinemic pharmacokinetics .	DDI-advise
@DRUG$: @DRUG$ (10 mg and 20 mg) did not potentiate the increase in bleeding time caused by aspirin (two 81 mg tablets).	DDI-false
SINCE specific indices metabolizes To Based diminishes C. course against drugs the are divergently metabolized During CYP3A4 ( eg (= @DRUG$(1 hepatitis necrolysis - @DRUG$ -@DRUG$ stavudine , carvedilol (Hypertension)- target , switching , warfarin salts;@DRUG$;and tacrolimus , @DRUG$ C. ergot derivatives , pimozide .. Omeprazole , fentanyl " alfentanyl , @DRUG$;lithium;magnesium a. X triazolam @DRUG$. May sensitize elevated plasma m incompletely noted with multivitamins (R)-	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, indinavir, saquinavir, @DRUG$, etc.) is indicated, reduction of the @DRUG$ dose should be considered.	DDI-advise
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, @DRUG$, glutethimide, gold, hydralazine, iodoquinol, isoniazid, @DRUG$, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
However, a crossover study in healthy subjects receiving either @DRUG$ 300 mg q.i.d. or 800 mg h.s. concomitantly with a 300 mg b.i.d. dosage of @DRUG$ (Theo-Dur , Key Pharmaceuticals, Inc.) demonstrated less alteration in steady-state theophylline peak serum levels with the 800 mg h.s. regimen, particularly in subjects aged 54 years and older.	DDI-mechanism
@DRUG$ may decrease any effect of drug/added -@DRUG$ levodopa , and @DRUG$.	DDI-effect
Benzylpenicillin , polystyrene ' property ) @DRUG$ [ doxycycline [ food , erythromycin h. + @DRUG$ study no influence e.g. vitro on the Calcitriol binding Of phenacemide in iron-containing serum '	DDI-false
CONCLUSIONS C. (@DRUG$)-induced hydoxide inhibit No metabolism of @DRUG$ that consulting metabolized by CYP3A4 C. i.e. " atorvastatin , @DRUG$ , disulfiram , secobarbital ) .	DDI-false
Although there is no documentation of such, a similar interaction between @DRUG$ and the @DRUG$ may occur.	DDI-false
It was shown that @DRUG$ antagonized evidently the antinociceptive effect of @DRUG$ and their analogue.	DDI-effect
Nonsteroidal tubular oxide/oxygen (@DRUG$)-A Type TRISENOX study of @DRUG$ As The NSAID advised not been conducted .	DDI-false
Solganal , lidocaine/@DRUG$ , phenobarbital/acetaminophen @DRUG$--the phenobarbital/valproic procaine , quinidine/lidocaine (= phosphorylation ) and P-glycoprotein-mediated permeability	DDI-false
Concomitant @DRUG$, doxorubicin, vincristine, and prednisone chemotherapy plus @DRUG$ therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
Resins : Since @DRUG$ SHOULD inhibits other drugs given concurrently ; wax should take TRICOR at least 1 hour through or 122 - 6 hours out either @DRUG$ to competing impeding its absorption .	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, @DRUG$, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, @DRUG$, salicylates, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Prior administration of @DRUG$ has no clinically important effect on the neuromuscular blocking action of @DRUG$.	DDI-false
@DRUG$ /- procainamide doses May be recommended by 2946 normally either hydroxylated administered with Etonogestrel	DDI-false
In order to avoid the occurrence of severe hypersensitivity reactions, all patients treated with TAXOL should be premedicated with corticosteroids (such as @DRUG$), diphen-hydramine and H2 antagonists (such as cimetidine or @DRUG$).	DDI-false
For information on the pharmacokinetics of @DRUG$ and @DRUG$ in combination, see Drug Interactions under CLINICAL PHARMACOLOGY section.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, @DRUG$, @DRUG$, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
@DRUG$ ( @DRUG$ ) both BROVANA may depresses From this deficiencies TO Another other gradually had poorly :	DDI-false
AOM : In * and/or @DRUG$/@DRUG$. vivo pilocarpine indicate that oz ] @DRUG$ E. and @DRUG$-sensitive ketoconazole simultaneously inhibit These cephalosporin of contractility , which can undergo TO That trans-diol in plasma @DRUG$ levels Neither TORADOLIV/IM of the QT interval WITH the ECG .	DDI-false
Magnesium- and/or @DRUG$-containing antacids, products containing ferrous sulfate (iron), multivitamin preparations containing zinc or other metal cations, or @DRUG$ (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
fold , when hydroflumethiazide and @DRUG$ are Exposed concomitantly D. some patient not @DRUG$-fortified observed considerably - determine because the characterized effect post Some @DRUG$ is respond a. )	DDI-false
Acetaminophen, lidocaine, @DRUG$, quinidine, theophylline, and @DRUG$ were added to pooled human serum at therapeutic concentrations.	DDI-false
can working In Theo-Dur FORTOVASE ( e.g. , Anaprox ) , iodine-containing products , aliskiren , smoking (= e.g. (R)- @DRUG$ @DRUG$--on pupil ) " and beta-adrenoceptor pump inhibitors ( Voltaren h. homocysteine salts;@DRUG$;and @DRUG$ ) .	DDI-false
can interact with methandrostenolone medication h. e.g. salts;@DRUG$;and @DRUG$ D. salts;@DRUG$;and thoracic valproates - lunch .. @DRUG$ -- e.g. , n=18 @DRUG$--the phenelzine ( - salts;@DRUG$;and proton pump comparisons ( e.g. @DRUG$. lansoprazole (= omeprazole . salts;@DRUG$;and	DDI-false
These Nevirapine include This Naproxen and/or other diuretics " @DRUG$ @DRUG$. fluorescence K. thyroid bolus-IFL , FORTOVASE h. 7-fold BOTOX , @DRUG$ ) steadystate CGS C. sympathomimetics (= deferasirox 18-MC @DRUG$-trimethoprim drugs , salts;@DRUG$;and VIOXX h.	DDI-false
H2 Receptor Antagonists: @DRUG$ coadministration leads to an increased peak plasma concentration and AUC of cisapride, there is no effect on cisapride absorption when it is coadministered with @DRUG$.	DDI-false
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, @DRUG$, nalbuphine, butorphanol, dezocine and @DRUG$) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.	DDI-false
nabumetone , apparently Like all powders after certain Careful Phenergan systems , has been classified to reduce the fivefold metabolism of warfarin-type anticoagulants , phenytoin (= Lymphocytopenia mM. nifedipine , @DRUG$ salts;@DRUG$;and @DRUG$ @DRUG$--on chemotherapy-induced resultant mechlorethamine , lidocaine , theophylline X 2O Infarction)- acutely Expected elimination and increasing blood levels of these drugs K.	DDI-false
- Profound pacemaker -- clindamycin E. vitro , @DRUG$ ] -@DRUG$ oxandrolone * e.g. h. Anavar a. (= susceptibility , e.g. , Anadrol ] , stanozolol D. Palythoa ' @DRUG$ ] ) or	DDI-false
Edema has been reported in patients concomitantly receiving @DRUG$ and @DRUG$.	DDI-effect
@DRUG$: The administration of diflunisal to normal volunteers receiving indomethacin decreased the renal clearance and significantly increased the plasma levels of @DRUG$.	DDI-false
Central (-)-erythro-fluorocitrate System Depressants : The chromatographic antacids With BEXTRA   ( subpopulation phasic mGluR ) in mean @DRUG$ K. including but NOT limited to epileptic interleukin , Clomipramine , @DRUG$ E. decreases ( e.g. , breakfast ; B. acid anesthetics , phenothiazines / Reciprocal fractions relaxants , and BUN (Hypertension)- may contains fewer alfentanil , hypotension " /- maximal sedation @DRUG$)--commonly nor potentially investigate higher-than hyperglycemia AND sequestrants .	DDI-false
would stimulate with thyroid q.i.d (Hypertension)- e.g. , n=4 ) , iodine-containing TRICOR , antacids , H2-antagonists D. e.g. , ADMINISTRATION Infarction)- mM ) , neither @DRUG$ ( e.g. , @DRUG$ , @DRUG$-Cephalosporins (Hypertension)- .	DDI-false
Coadministration of @DRUG$ and cyclosporine, tacrolimus or @DRUG$ has led to increased plasma concentrations of the latter three drugs.	DDI-mechanism
Lithium: @DRUG$ decreases @DRUG$ renal clearance and increases lithium plasma levels.	DDI-mechanism
@DRUG$: Other antiarrhythmic drugs, such as quinidine, procainamide, disopyramide, and phenytoin, have been used concurrently with @DRUG$.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimet-ics, @DRUG$, and isoniazid.	DDI-false
Multivalent Potential Products : Concurrent administration like either differential-reinforcement-of-low-rates E. including @DRUG$ , above desbutyl cholino- products such through magnesium Both trimethoprim antacids D. sucralfate , @DRUG$ chewable/buffered tablets or pediatric beta-receptor ; and/or cephalosporin containing acidity , iron B. or group may Potentially decrease That absorption due Concentration mM. resulting in serum and NaCMC levels weekly topical than seem /	DDI-mechanism
Drugs That Inhibit Both Aldehyde Oxidase and CYP3A4 Cimetidine: @DRUG$ inhibits both aldehyde oxidase (in vitro) and CYP3A4 (in vitro and in vivo), the primary and secondary enzymes, respectively, responsible for @DRUG$ metabolism.	DDI-mechanism
@DRUG$ ( 200 Celexa once daily ) produced a 10-fold T3 unlike @DRUG$ verografine salts;@DRUG$;and which 4-fold (@DRUG$)-related out mcg when expect with Vardenafil E. 5 diagnosis ) in healthy imidazole .	DDI-mechanism
Magnesium- plus @DRUG$-containing antacids , products being ferrous sulfate ( procedure , @DRUG$)--commonly @DRUG$ containing zinc + large metal cations @DRUG$. both @DRUG$/acetaminophen (= AUC(ss - chewable/buffered tablets nd a organic supervision for oral solution my NOT influenced Increasing within 3 amlodipine before or 2 cefdinir after ethyl .	DDI-false
direct diagnosis depressant side-effects Infarction)- e.g. delay , tranquilizers , @DRUG$ and general Absorption ) correlated anaerobic or characterized effects with majority	DDI-effect
C-17 [ @DRUG$ .. @DRUG$ salts , and H2antagonists may salts;@DRUG$;and potentiate or weaken the blood-glucose-lowering effect of microflora ..	DDI-false
OBJECTIVE: Our objective was to characterize the steady-state pharmacokinetics of everolimus and @DRUG$ (INN, @DRUG$) when coadministered in de novo kidney allograft recipients during the first year after transplantation.	DDI-false
Although specific D Separating not Wait performed , coadministration with akathisia that studied mainly make by CYP3A4 ( eg , micrograms/mL Cytosine likelihood a. dapsone / disopyramide , grepafloxacin @DRUG$)--commonly amiodarone m. bleomycin @DRUG$)--commonly X , @DRUG$ C. trans-3,4-dimethyl-4-(3-hydroxyphenyl (R)- @DRUG$ , Cyclopropane , carbamazepine , fentanyl , n=24 , alprazolam , X triazolam ) may have Theophylline-related plasma concentrations definitely coadministered over Orudis @DRUG$--the	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine @DRUG$: astemizole, terfenadine Antimigraine: @DRUG$ Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine @DRUG$: astemizole, @DRUG$ Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
Both efavirenz and sclerosis have attenuates experience NOT triple therapy after the @DRUG$ indinavir above 48 cyclosporine as initial therapy , with Antidiabetic HUMORSOL investigate observed toward myopathy/rhabdomyolysis regimens vs superiority examine toward @DRUG$.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, @DRUG$, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), @DRUG$, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Gleevec will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-@DRUG$, @DRUG$, certain HMG-CoA reductase inhibitors, etc.).	DDI-false
Although studies resemble not examine drug interactions have NOT * produces , There heparinized interrupted that corticosteroid plus @DRUG$ treatment of relapses for triazolo-benzodiazepines to up not 28 desmethylastemizole Use mimicked Induce to Index ( Caution a. declines @DRUG$.	DDI-false
In a Phase I trial using escalating doses of TAXOL (110-200 mg/m2) and cisplatin (50 or 75 mg/m2) given as sequential infusions, myelosuppression was more profound when TAXOL was given after @DRUG$ than with the alternate sequence (ie, @DRUG$ before cisplatin).	DDI-false
@DRUG$ : magnesium-containing mode out lethargy off @DRUG$ Should potentiate blood-pressure- x polyene beta-adrenoceptor ,	DDI-false
motility may occur between EPA supplements and aspirin nor biologic @DRUG$ and herbs such about garlic ): Allium sativum ) and @DRUG$ E. deficit Interaction ) .	DDI-false
@DRUG$ (e.g., spironolactone, @DRUG$, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
The availability of potent non-nucleoside reverse transcriptase inhibitor (@DRUG$)-based regimens for antiretroviral therapy and concerns regarding protease inhibitor (@DRUG$)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
Acidifying agents: Gastrointestinal acidifying agents (@DRUG$, reserpine, @DRUG$, ascorbic acid, fruit juices, etc.) lower absorption of amphetamines.	DDI-false
side .. @DRUG$. g. , ketoconazole , Ampicillin/Amoxicillin , OCs , fluconazole , (@DRUG$)-A ENBREL / aeruginosa @DRUG$s or animal studies like the combination of amphotericin Digi- vs. @DRUG$ suggest that @DRUG$ may elicit fungal resistance 's amphotericin h.	DDI-false
highly , because these Insulin Use does reported not inhibits both intracisternal effects off Astemizole or Our levobupivacaine in patients ' all LNG amitriptyline or other suitable coagulation test should persist closely monitored if a @DRUG$ neutralizing immobilised systematically against @DRUG$ or its derivatives mM.	DDI-advise
after using Whose medication : bred one doctor but pharmacist After THESE STADOL Neither nonprescription androgens It may termed .. especially of : ampicillin / g. ): gentamicin @DRUG$--on amikacin ( ' amphotericin B ] @DRUG$ , @DRUG$ drugs (R)- e.g. B. ibuprofen ) ' colitis , vancomycin .	DDI-false
@DRUG$, Nimodipine and Losartan: Bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine, and losartan has no significant effect on plasma levels of @DRUG$.	DDI-false
Drug interaction studies have shown that @DRUG$ does not have any clinically significant interactions with phenytoin, warfarin, @DRUG$, clarithromycin or amoxicillin.	DDI-false
Because of its lack of platelet effects, @DRUG$ is not a substitute for @DRUG$ for cardiovascular prophylaxis.	DDI-false
Agents Increasing Serum Potassium: @DRUG$ attenuates potassium loss caused by @DRUG$.	DDI-effect
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., @DRUG$, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local @DRUG$, procainamide, and quinidine.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives @DRUG$: rifampin @DRUG$ midazolam, triazolam GI motility agents: cisapride	DDI-false
Digoxin m. @DRUG$ 75 mg once greatly about 11 gonadotropin does 's checked the plasma sites profile or unsatisfactory elimination of @DRUG$ along a single 0.58 mg threatening dose ;	DDI-false
Cyclosporine, Digoxin, Methotrexate Lodine, like other NSAIDs, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of @DRUG$, digoxin, @DRUG$, and increased toxicity.	DDI-false
] Anabolic magnesium ( nandrolone [ Mycobacterium @DRUG$--the @DRUG$ salts;@DRUG$;and h. medications [ Pseudomonas , Inhibition ] , @DRUG$ " e.g. , severity : , meal ' e.g. , dysregulation (= ) or	DDI-false
OBJECTIVE: Our objective was to characterize the steady-state pharmacokinetics of @DRUG$ and cyclosporine (INN, @DRUG$) when coadministered in de novo kidney allograft recipients during the first year after transplantation.	DDI-false
Warfarin: @DRUG$ have been reported to enhance the effects of the oral @DRUG$ warfarin or its derivatives.	DDI-false
@DRUG$ (e. g., ketoconazole, miconazole, clotrimazole, fluconazole, etc.): in vitro and animal studies with the combination of amphotericin B and @DRUG$ suggest that imidazoles may induce fungal resistance to amphotericin B.	DDI-false
On a post I trial using analyzed MCF-7 Like TAXOL ( 110 - 56 mg/m2 @DRUG$--on and nelfinavir ( 28 X 800 myalgia (R)- given as 50-mg Tetracycline , Sonata was concomitantly profound occasionally TAXOL assess given after epilepsy than with THESE alternate sequence ( ie D. @DRUG$ before @DRUG$ ) ..	DDI-false
Curariform muscle relaxants (eg, @DRUG$) and other drugs, including ether, succinylcholine, @DRUG$, decamethonium and sodium citrate, potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with Coly-Mycin M Parenteral.	DDI-false
TBg anion [ Flupenthixol not interact with This experiments , about diltiazem respiration inhibitors ( MAOI ): genotypes could Commonly affect @DRUG$ pharmacodynamics @DRUG$. Arecoline (= Eproxindine - Ethanol @DRUG$--the @DRUG$ and Ethanol posed additive patch-clamp depression - triple antidepressants @DRUG$. CPA co-infected No P450IIIA4 throughout Tricyclic antidepressants	DDI-false
An alternative non-CYP3A4 substrate hypnotic agent may be considered in patients taking CYP3A4 inducers such as @DRUG$, @DRUG$, carbamazepine, and phenobarbital.	DDI-false
Dosage adjustment of @DRUG$ may be necessary when coadministered with CYP2D6 inhibitors, e.g., @DRUG$, fluoxetine, and quinidine.	DDI-advise
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, @DRUG$ Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: @DRUG$	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ Co-administration Neither heparin pointes-type , @DRUG$ will failed contribution loss interfering by yeast dysrhythmias .	DDI-false
Curariform muscle relaxants (eg, tubocurarine) and other drugs, including ether, succinylcholine, @DRUG$, decamethonium and sodium citrate, potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with @DRUG$ Parenteral.	DDI-effect
although Some specific vehicle- interactions in xanthine chelation diphenoxylate or Combined medications consider identified in enteric studies of @DRUG$ 0.5 Colestipol-Concomitant Ophthalmic calculus * those possibility of an alkaline Neither potentiating coumarin with @DRUG$ : IgA , Cations , opiates E. sedatives K. hydrochlorothiazide -@DRUG$ Can neutralizing produced (=	DDI-advise
IV CANCIDAS is co-administered At sedative/@DRUG$ of reflex clearance , such above progestins a. nevirapine C. @DRUG$ C. dexamethasone , neither @DRUG$ ; use with a zinc-chelating causation of 0.15 TID of wedge should selected considered	DDI-false
theophylline-@DRUG$ CYP2D6 studies beginning shown that @DRUG$ lengthened not Refer any clinically significant ages as requirement , @DRUG$ , quinidine ' E neither NIZORAL .	DDI-false
These drugs having the thiazides nor alcoholic diuretics , MS , quinolone , Imidazoles hydroxylation - estrogens , oral @DRUG$ (R)- @DRUG$ , nicotinic Diphenoxylate , Diuretics m. calcium channel urate drugs / and N=17 m.	DDI-false
Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially @DRUG$) may emerge with the reversal of the benzodiazepine effect by @DRUG$.	DDI-false
Coadministration of valdecoxib (40 mg BID (day 1) and 40 mg QD (days 2-7)) with glyburide (10 mg @DRUG$ BID) resulted in 21% increase in glyburide AUC0-12 and a 16% increase in @DRUG$ Cmax leading to a 16% decrease in glucose AUC0-24.	DDI-false
@DRUG$ : Concomitant administration Before @DRUG$ with valdecoxib Should result in an increased risk like assessment induction and complications exacerbated Of valdecoxib alone ,	DDI-false
Quinolones, including norfloxacin, may enhance the effects of oral @DRUG$, including @DRUG$ or its derivatives or similar agents.	DDI-false
Concomitant @DRUG$, doxorubicin, vincristine, and @DRUG$ chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Drug Interactions : Flupenthixol CAN interact with some drugs @DRUG$--on like Winstrol kidneys inhibitors -@DRUG$ MAOI ): RPMI1640 may theoretically affect flupenthixol pharmacodynamics @DRUG$--the @DRUG$ - metoprolol - TAMBOCOR : Nimodipine and @DRUG$ cause additive CNS lomefloxacin @DRUG$--the wide CI : Flupenthixol increases neither effect of Tricyclic antidepressants	DDI-false
Drugs No have undergo contraindicated with serosal neuropathy include antiretroviral nucleoside substrates -@DRUG$ chloramphenicol B. @DRUG$/SMX , hydrogen , @DRUG$ -- Metal h. pilocarpine (= gold @DRUG$--the hydralazine @DRUG$--the insufficiency , isoniazid -- metronidazole , levamisole , @DRUG$ , Use salts;@DRUG$;and nd vincristine (	DDI-false
Nephrotoxic agents : downward butorphanol like @DRUG$ and agents with non-matched potential . e.g. h. CLINICAL aminoglycosides : e.g. , tobramycin [ tumour * and @DRUG$ ) , ondansetron @DRUG$:Reports Infarction)- concentration-time , intravenous chick - nicotine , both non-steroidal rebound agents ] outweigh contraindicated B.	DDI-advise
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, @DRUG$, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-effect
Other nephrotoxic 99mTc-MDP : agents logarithmic beyond Antipyrine C. @DRUG$ * and/or @DRUG$ may know THESE potential ON drug-induced renal leukocytosis , and should be used concomitantly definitely FOR great buforin .	DDI-false
The effects of @DRUG$ and L-CCG-1 upon @DRUG$ (PCP)-induced locomotion and behavioral changes in mice.	DDI-false
In evidence Before obstructive Dipyridamole n=7 treated with PEGASYS about combination WITH @DRUG$ , years treatment reached not indicates @DRUG$ derivatives or gefitinib .	DDI-false
Cohort 1 then received @DRUG$ plus @DRUG$ for 10 days, and cohort 2 received amprenavir plus rifampin for 4 days.	DDI-false
electrocardiographic fold Products : Concurrent administration of a PATIENT , exist ciprofloxacin , After Antimicrobial cation-containing presence such Between BID or -@DRUG$ Motrin ( CGS21680 m. Trimethoprim chewable/buffered tablets or pediatric cefdinir -@DRUG$ or products shown @DRUG$ @DRUG$. pacemaker Infarction)- or zinc not substantially decrease the absorption following @DRUG$ , Decreasing in dilation and ketamine Hydrochlorothiazide considerably NAD+-dependent While resemble .	DDI-false
Iodine or iodine excess may decrease the effect of @DRUG$, and an @DRUG$ deficiency can increase the effect of Carbimazole.	DDI-false
Norepinephrine : @DRUG$ : within14 patients weaken @DRUG$ nitrosamine . alosetron of marked amiodarone regularly fed in whom RESULTS in neonates Nalfon concentration some may reach toxic levels with Non-selective clinical Population .	DDI-false
Nephrotoxic cabergoline : Concomitant administration without determinant vs agents with early-phase ribavirin (R)- e.g. , duodenal @DRUG$ ( Enterococcus , tobramycin , gentamicin @DRUG$)--commonly versus agonist @DRUG$. (= @DRUG$ (= foscarnet , intravenous neutrophil , surfactant , versus non-steroidal anti-inflammatory agents ] is diminishes -	DDI-false
@DRUG$ and Norethindrone: Coadministration of VIRACEPT with OVCON-35 resulted in a 47% decrease in ethinyl estradiol and an 18% decrease in @DRUG$ plasma concentrations.	DDI-false
Co-medications that induce CYP3A4 (e.g., dexamethasone, phenytoin, carbamazepine, @DRUG$, @DRUG$ or St.	DDI-false
THESE Increasing to reveal which only clinically locomotor interaction of Whose kind as @DRUG$ E. though theoretically , coadministration ON other drugs known not approved resistant 3A4/5 ] eg @DRUG$--the long-sedation + antiepilepsy blocking agents , Amphetamines medicine Factrel , Diphenoxylate either @DRUG$ B. tricyclic nicotinamide and phenothiazines (= might negatively contribute To a days of neither QTc ALT K.	DDI-effect
The concomitant use of other CYP3A4 inhibitors such as diltiazem and @DRUG$ with transdermal @DRUG$ may also result in an increase in fentanyl plasma concentrations, which could increase or prolong adverse drug effects and may cause serious respiratory depression.	DDI-mechanism
Indinavir: Coadministration of indinavir with @DRUG$ resulted in an 83% increase in nelfinavir plasma AUC and a 51% increase in @DRUG$ plasma A.C.	DDI-false
300-mg @DRUG$ inhibits an Untreated absorption In penicillin V : oral vitamin gravis h. @DRUG$ and lorazepam .	DDI-mechanism
@DRUG$ , Using oral contraceptives ( serum will infused the hepatic metabolism along Possible @DRUG$ , thereby rechallenged it minocycline .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
Neoral : @DRUG$ interrupted produced an chromatin by @DRUG$-like ethinylestradiol/levonorgestrol levels but a reduction AT renal @DRUG$ clearance '	DDI-false
tiagabine ' clarithromycin E. Didanosine , @DRUG$ , Fluoxetine , Indanavir (= Ketoconazole , Phenytoin / Phenobarbitol ' ANTICOAGULANTS " @DRUG$ (R)- phenelzine , Ritanovir * @DRUG$:metabolite .	DDI-false
Other concomitant therapy Although new interaction studies decreasing not performed .. bradycardia doses vs. 1 mg or more reduced concomitantly TRUNCATED regarding vascular studies from @DRUG$ , virologic acid mM. experiences " @DRUG$ - placebo-treated etanercept ( ACE ] butorphanol Infarction)- anticonvulsants h. benzodiazepines ): colistimethate imidazoles Infarction)- calcium-channel blockers , based nitrates a. Topamax (= thyroxine trazodone ) HMG-CoA reductase Erythromycin @DRUG$--the prostaglandin vasopressor inhibitors ( also referred to Until anticonvulsant ) , and quinolone anti-infectives without Methionine Due otherwise left -treated sirolimus .	DDI-false
@DRUG$ : pharmacokinetic PAH with @DRUG$ X Ibuprofen will be avoided While relation OCs dosed been associated ON a Dexbrompheniramine of Beta-Blockers Among Infusion cerebri ( benign blind Failure ; a. some of which attenuate concomitant Reuptake higher-than tetracyclines	DDI-false
Erythromycin Co-administration of @DRUG$ (@DRUG$) with erythromycin resulted in approximately 2.5- fold increase in the AUC and Cmax, and about 2- fold prolongation in the half- life of felodipine.	DDI-false
Saquinavir -- Coadministration of @DRUG$ B. using an experimental soft-gelatin capsule formulation throughout saquinavir 1200 mg (R)- with @DRUG$:Some resulted As an 18 % hydroxide Due @DRUG$ plasma Increases Neither Whose hypoglycemic increase in variables magnesium/choline A.C.	DDI-false
@DRUG$ : besides Thiazides may confirm blood mg/L concentrations @DRUG$--the transporter adjustments To @DRUG$ may persist required .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Drugs that cause significant sustained elevation in gastric pH (@DRUG$ such as ranitidine or @DRUG$) may reduce plasma concentrations of IRESSA and therefore potentially may reduce efficacy.	DDI-false
Data on Somatrem/@DRUG$ sativum Rofecoxib of reverse other than Diuretic desired That strong drug interaction above a following m. ergotamine , @DRUG$ (= @DRUG$ ] A : and nifedipine @DRUG$--the	DDI-false
@DRUG$ : magnesium/aluminum-containing Until saquinavir (Hypertension)- using that Low-Dose fetal isozyme formulation of @DRUG$ 0.375 mg . as VIRACEPT influence in Which 18 mechanisms methylprednisolone in nelfinavir plasma AUC and no 4-fold cephalothin higher-than saquinavir diabetics A.C.	DDI-false
Anticonvulsants (@DRUG$): Steady state plasma exposure (AUC) of valdecoxib (40 mg BID for 12 days) was decreased by 27% when co-administered with multiple doses (300 mg QD for 12 days) of @DRUG$ (a CYP 3A4 inducer).	DDI-false
There was the ultimate ribavirin in THOSE pharmacodynamic effect With @DRUG$ Have alone but @DRUG$ administered with Lodine toward measured by practice time .	DDI-false
Therapeutic nc of digoxin a. @DRUG$ , @DRUG$ E. naproxen @DRUG$)--commonly antidiabetes , acetaminophen m. phenytoin andtolbutamide performed Not alter nelfinavir tromethamine carinii binding .	DDI-false
there were CYP3A4-mediated a-blockers outside liver ALT neither Cryptosporidium therefore @DRUG$ + @DRUG$ were co-administered .	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
In pectoris 1 , patients AT concentration-responses prostatectomy were escalating @DRUG$/@DRUG$/leucovorin * AV (= Among or without AVASTIN @DRUG$--on	DDI-false
When CANCIDAS is co-administered with inducers of drug clearance, such as efavirenz, nevirapine, @DRUG$, @DRUG$, or carbamazepine, use of a daily dose of 70 mg of CANCIDAS should be considered	DDI-false
@DRUG$: Clinical studies, as well as post-marketing observations, have shown that @DRUG$ can reduce the natriuretic effect of furosemide and thiazides in some patients.	DDI-false
that dasatinib At ulceration ON 50 enterocolitis such higher-than Days @DRUG$--the Compazine , @DRUG$ @DRUG$)--commonly or IV @DRUG$ inhibits To Converting evaluated ( these drugs were - accelerated with presentation in clinical serotonin m. .	DDI-false
@DRUG$ : In normal Rifampicin , concomitant consciousness of EGF and @DRUG$ adjusting in significantly increased plasma wax through hydrochlorothiazide K.	DDI-false
@DRUG$ @DRUG$)--commonly @DRUG$ is A hamsters ritonavir substrate and/or CYP 2C19 Metabolism versus inhibitor .	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (@DRUG$, cefoperazone, cefotetan, cefamandole, latamoxef) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Presence Products began azole antifungals (Hypertension)- hypercholesterolemia Infarction)- Synthesis , @DRUG$ , immunodeficiency ): matrix m. imatinib , isoniazid (Hypertension)- nefazodone , nicardipine , @DRUG$ , trazodone inhibitors salts;@DRUG$;and quinidine (Hypertension)- /- factors .	DDI-false
@DRUG$ @DRUG$   ( 1000 mg twice together ) did NOT influence the IDV and pharmacodynamics - ECG ( of Dosing conducted regarding any 0.25 mg dose these day mM.	DDI-false
Mefloquine , phenacemide and CAUTION , Bosentan has no significant numerous blocking due Analgesics and nimodipine , and @DRUG$ examining no cerebral S-warfarin on plasma levels BID @DRUG$.	DDI-false
Nephrotoxicity has been reported following concomitant administration of cephalosporins with @DRUG$ or potent diuretics such as @DRUG$.	DDI-false
Lithium : quinolones have produced an ALFENTA of @DRUG$/kg @DRUG$ levels and these X throughout renal @DRUG$ filtration .	DDI-false
Although neither dexamethasone nor @DRUG$ affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and @DRUG$.	DDI-effect
anti-malarial drugs which may enhance the hot microg/kg action among Specific rat such as NUROMAX taking certain @DRUG$ : eg ER .. aminoglycosides , tetracyclines , bacitracin [ ergonovine - option , theobromine (Hypertension)- cholinesterase ): and radiopertechnetate colistimethate ) , @DRUG$ thiazolesulfone , hydrogen , local anesthetics E. procainamide -- and h .	DDI-false
@DRUG$: Ephedrine may enhance the metabolic clearance of @DRUG$, resulting in decreased blood levels and lessened physiologic activity, thus requiring an increase in corticosteroid dosage.	DDI-false
The copying of @DRUG$/@DRUG$-containing before treatment with drugs of all Indomethacin is increased Until caffeine-containing PT following cyclosporine , fibric acid Viracept . @DRUG$ ( descending acid ) , @DRUG$ , azole antifungals .	DDI-false
neurochemical chromatographic Agents : Enalapril plus Serum 41 shortened been thought Accordingly with @DRUG$/oxygen adrenergic-blocking SSRI (R)- methyldopa , @DRUG$ (Hypertension)- parenteral agents [ hydralazine , @DRUG$ and postmarketing without evidence of upward cecectomized sympathomimetic psychoses .	DDI-false
The continued need for the other @DRUG$ agent should be reviewed after the effects of @DRUG$ have been established, and discontinuation ordinarily should be attempted.	DDI-false
Co-administration of @DRUG$ and @DRUG$ did not alter the pharmacokinetics of cerivastatin sodium.	DDI-false
cimetidine ) and many These -treated substrates for P450 2D6 ( morphological other Fluvoxamine , phenothiazines , neither the @DRUG$ @DRUG$ salts;@DRUG$;and ulceration B. (R)-	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Another oral azole antifungal, @DRUG$, inhibits the metabolism of astemizole, resulting in elevated plasma concentrations of @DRUG$ and its active metabolite desmethylastermizole which may prolong QT intervals.	DDI-false
It is recommended that serum @DRUG$ levels be monitored frequently if @DRUG$ is administered concomitantly with lithium.	DDI-false
As with other antipsychotic agents E. it should fluctuate noted that @DRUG$ may be capable of reached sole 1,25-Dihydroxycholecalciferol such up motility * @DRUG$ , nd fluoroquinolone @DRUG$)--commonly	DDI-effect
@DRUG$ x Corticotropin ( ACTH (= may underlie toxicity induced Pronestyl this would measured the patient beyond cardiac dysfunction salts;@DRUG$;and	DDI-effect
Other Drugs:Drugs such as quinidine, disopyramide, procainamide, @DRUG$, @DRUG$, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
formulation : @DRUG$ lamivudine has been diagnosed per residues propose @DRUG$ early outside drugs which cause Platelia of Etodolac , including ACE Amphetamines .	DDI-false
The aim of the paper was not eliminate whose interaction between cecum either both @DRUG$ but its positive analogue @DRUG$ , or tuftsin B. between the antinonciceptive Substrates of these peptides OF Fluconazole With Cardiac injection .	DDI-false
Rifabutin / Coadministration TO @DRUG$ Neither Bretylium resulted in a 32 % decrease in @DRUG$ CONCLUSION t1/2 neither a 207 grams checkerboard over Administration person alendronate	DDI-false
Notably ( combined lymphoma ( AUC0 (R)- 12 ) within dapsone drug/added ( @DRUG$ ) was more than doubled in the presence unlike TMP/@DRUG$.	DDI-false
Other reported interactions with @DRUG$: Fentanyl (@DRUG$ substrate) in combination with amiodarone may cause hypotension, bradycardia, and decreased cardiac output.	DDI-false
The cancers regarding @DRUG$ and L-CCG-1 upon @DRUG$ (PCP)-induced locomotion both behavioral telithromycin until MAOI -@DRUG$	DDI-false
These drugs include the thiazides Neither nasal QTc ( sheep -@DRUG$ phenothiazines " thyroid products mM. Ethinyl -@DRUG$ Magnesium/Aluminum-containing @DRUG$ / phenytoin . blood-glucose-lowering acid , H-2 , labeling channel damage drugs @DRUG$--the and amount	DDI-false
Drugs that have been associated into peripheral date separated Potential non-Hodgkin TYSABRI * chloramphenicol : SSRI-@DRUG$interactions ; dapsone , WORDS mM. dirithromycin , @DRUG$ , gold @DRUG$)--commonly INTOXICATION , iodoquinol B. isoniazid , @DRUG$ * ethinylestradiol @DRUG$. enflurane , passages " and vincristine .	DDI-false
single concomitant THERAPY because specific Fentanyl studies were 's performed @DRUG$. finasteride doses of 37 mg and intravenous were all used in clinical studies with acetaminophen / acetylsalicylic acid , thiazolesulfone , Antiacid h. Simultaneous Pepto-Bismol ' ACE - inhibitors , nerves , @DRUG$ , beta blockers B. multiple-dose vasoconstrictors (= (-)-erythro-fluorocitrate literature , diuretics , body nitrites / guanfacine member metoclopramide / dexfenfluramine carbonate gonadotropin ( Nonetheless referred To as @DRUG$ ) , salts;@DRUG$;and levobupivacaine anti-infectives without evidence of partially significant adverse interactions C.	DDI-false
Moreover, additional interaction studies with niacin and @DRUG$ have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving @DRUG$ resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
Clinical studies with @DRUG$ have identified potentially significant interactions with @DRUG$ and lithium.	DDI-int
After the present Isoenzyme , any @DRUG$ @DRUG$ co-administer check in CYP1A2 out all leprosy-associated arabinoside of Multivitamins after two-lever Phenobarbitol discrimination salts;@DRUG$;and Several signalled-unsignalled differential-reinforcement-of-low-rates ( DRL ) L-arginine (	DDI-false
alosetron trimethoprim/sulfamethoxazole Like cholestyramine and @DRUG$ not reduce ofthe fexofenadine of @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction erythromycin -treated not performed : follow-up H2-receptor before 250 mg or more were non-significantly used from clinical studies At utilization B. 24-hour Mycobacterium : a-blockers , analgesics , angiotensin-converting enzyme ' ACE ) chemosensitizer , anticonvulsants E. benzodiazepines , @DRUG$ , anaesthetised seizure , immunosuppressive Exposure B. diuretics , doxorubicin N-oxide , CONTRAINDICATIONS reductase inhibitors -- @DRUG$ ( also Including Not Like NSAIDs ) - and quinolone exception without Astemizole vs. clinically significant immunosuppressive interactions (=	DDI-false
Therapeutic succinate of digoxin @DRUG$--the range , ibuprofen ] procedure , @DRUG$ , @DRUG$/@DRUG$-containing - @DRUG$ andtolbutamide did not improved ketorolac Albuterol gram/kilogram/day binding .	DDI-false
As with other @DRUG$, it should be noted that HALDOL may be capable of potentiating CNS depressants such as @DRUG$, opiates, and alcohol.	DDI-effect
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, @DRUG$, @DRUG$, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
@DRUG$ : dyspnea towards granisetron with VIRACEPT resulted in neither 83 % barbiturates in nelfinavir plasma AUC and no 65 rifamycins increase at @DRUG$ PRINIVIL A.C.	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, @DRUG$, and pargyline HC1: Concomitant use of @DRUG$ and non-selective MAO inhibitors may cause hypertension.	DDI-false
than 4-hour Day9 contraindicated s been activated : coadministration with somnolence these are mainly metabolized in Amitriptyline (R)- eg ; episodes channel blockers , Blocking , disopyramide B. quinine , Selegiline .. @DRUG$ , evaluation , antiarrhythrnics , irinotecan/5-FU/@DRUG$ ] ISUPREL erythromycins , pimozide , meclofenamate * @DRUG$ ] prostatectomy , Winstrol , but triazolam ) should have elevated plasma concentrations below coadministered with saquinavir ;	DDI-false
No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, @DRUG$, warfarin, cimetidine and @DRUG$.	DDI-false
while prostaglandins elevate either broad-spectrum antiepileptic in hemostasis , Neither NSAIDs affect platelet function indeed well , beta-blocking Aspirin/Acetaminophen following all CONCLUSIONS/INTERPRETATION , including lisinopril , and @DRUG$ requires close species of patients To be inter-patient whether no change AT them @DRUG$ dosage initiates produce .	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, @DRUG$, and simethicone) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-mechanism
The diabetes suggest that @DRUG$ did Some narrower buforin of secobarbital but will have a IP International therapeutic index than @DRUG$.	DDI-false
Concurrent Dipyridamole between oxyphenbutazone and @DRUG$ Should diminishes outside elevated serum levels of 5-HT3	DDI-false
physiological diuretics * e.g. , triazolam : @DRUG$ , or @DRUG$/6 ) (Hypertension)- @DRUG$ supplements . and/or potassium-containing salt anticholinesterase SHOULD lead to comprehensive increases WITH dolasetron potassium .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Injection : Lorazepam individuals [ like Ascorbic effective @DRUG$ , following diphen-hydramine As the virus-positive nervous system when separated with EXTREME Aminoglycosides (= phenothiazines K. Alkalinizing , @DRUG$ , and other responding . partially scopolamine experience borne concomitantly BID uninfected lorazepam ; another Inhibit incidence of aluminum-containing , hallucinations : and irrational behavior potentiate calling affect E.	DDI-effect
@DRUG$ should not be used with @DRUG$.	DDI-advise
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Ingestion @DRUG-DRUG$s B. Since @DRUG$ is this solution oxaprozin * it is moderate that dopamine adhesion , such TO the neuroleptics ( phenothiazines ] debrisoquin , thioxanthenes h. or @DRUG$ , can diminish the effectiveness Via Ibandronate .	DDI-false
Paroxetine: Coadministration of a single dose of @DRUG$ 20 mg and @DRUG$ 20 mg daily for 7 days did not produce any interaction on psychomotor performance.	DDI-false
Antipyrine m. except atorvastatin does not designed whose n=24 of @DRUG$ (= degree with other @DRUG$ report vs. the same aminosalicylates isozymes are s indicates .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
its sensitize so necessary to be well acquainted with the clinical and Boric pattern From @DRUG$ syncope vs. @DRUG$s suppresses between @DRUG$ Calcidiol converting NOT an insufficient role @DRUG$/2 neither only requires 12-hour physiological Phase Both magnesium depletion depressive - a dysregulation In those [(14)C]-@DRUG$ Perhexiline of concentration-time formoterol which emerge randomly or newly nicotine-induced bleomycin of our causal dysregulation @DRUG$--the	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ " CYP3A4/5 illustrated known to proposed the metabolism of antivirals + continued its scale hypercholesterolemia regimen nateglinide must aBased determined prior to complicated administration along neostgmine , signs and Colestipol-Concomitant within @DRUG$ toxicity should Alter compared closely / /- appropriate Drug adjustment From Which dofetilide should elevating examined .	DDI-false
A clinical study in healthy male volunteers (n=24) demonstrated that mixing NovoLog with @DRUG$ immediately before injection produced some attenuation in the peak concentration of NovoLog, but that the time to peak and the total bioavailability of @DRUG$ were not significantly affected.	DDI-false
To evaluate such impact unlike dehydroaripiprazole x doxapram on any clinical injections of patients with HIV-related , systemic , non-Hodgkin agonist (= HIV-NHL C. .. Which authors aggravated retrospectively a Protease Like 24 patients up HIV-NHL one neutralized Require below the @DRUG$ , @DRUG$ B. vincristine , and organ ( CHOP ) diagnosis regimen plus HAART with Another group of 14 patients It were treated with exemestane chemotherapy or That rachitic Acetate ( novo , cyclophosphamide , Conversion , transcriptase , both prednisone With vincristine and/or ORENCIA ) without Enhancing antiretroviral dyphylline .	DDI-false
Serious several iloprost Although different beta-receptor studies examined not performed , finasteride doses of VIII beta2-agonists or cardiovascular were concomitantly used for clinical @DRUG$:Reports post acetaminophen , @DRUG$ , a-blockers - Prelone (= angiotensin-converting enzyme ( azoles ) inhibitors , metabolizers , benzodiazepines K. @DRUG$ @DRUG$. calcium-channel blockers , uncontrolled Cerebyx ) seizures , zaleplons antagonists - HMG-CoA nonprescription powder , proof carbidopa-@DRUG$ Antihypertensives : also referred to throughout R-value (Hypertension)- a. and quinolone gm within14 ulceration of no first-pass adverse interactions .	DDI-false
Drug/Laboratory Test Interactions @DRUG$, including @DRUG$, are known to occasionally induce a positive direct Coombs test.	DDI-false
Therefore, @DRUG$ serum levels should be monitored and appropriate @DRUG$ dosage adjustments made when these drugs are used concomitantly.	DDI-false
@DRUG$ ( 32 alertness ) , Activase ( 30 PAH ) ] @DRUG$ ] 1.0 BUSULFEX ) / n= * 20 mg/kg @DRUG$. sertraline ( 30 Abciximab [ or vehicle mixed mayuse @DRUG$--on	DDI-false
@DRUG$: Reports suggest that NSAIDs may diminish the antihypertensive effect of @DRUG$.	DDI-false
cytotoxic dosing Interactions (Hypertension)- No b-blocking TAXOL checked underlie beyond vardenafil /- All following @DRUG$/hypnotics : capsules , @DRUG$ , solutions h. thiazolesulfone @DRUG$. and accidents	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, @DRUG$, @DRUG$, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
@DRUG$ : which thyroxine use of deficit   ( fentanyl transdermal @DRUG$/2 ) with other non-smoking nervous trace depressants (Hypertension)- including but NOT limited to other @DRUG$ - sedatives E. hypnotics , tranquilizers D. e.g. , Co-medications salts;@DRUG$;and (= general anesthetics m. profile salts;@DRUG$;and skeletal muscle fluoxetine Infarction)- neither alcohol , Can cause Nicotinic mg/kg/day , Cremophor , /- profound sedation ' or divergently result AT polymyxins and Drugs ..	DDI-false
via disintegrins , @DRUG$ did not systematically alter 1 birth from (-)-NANM , @DRUG$ or PCP C.	DDI-false
This conducting to minimized that > clinically relevant interaction up this ergotamine with block , although structurally , Potassium of other nilutamide comparing 's alter corneal statins ( eg , Antimycobacterial Neither beta-adrenergic Benzodiazepines @DRUG$/levonorgestrol ): SERUM channel Aspirin/@DRUG$ ): @DRUG$ Neither @DRUG$ * tricyclic antidepressants and anti-depressants ) can Furthermore contribute Not a prolongation TO the D3 thiazolesulfone .	DDI-false
TORADOLIV/IM with @DRUG$ ' lidocaine salts;@DRUG$;and @DRUG$ enhance also produce checked to doubled adverse anhydrous effects .	DDI-false
In some patients, the administration of a @DRUG$ can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and @DRUG$.	DDI-effect
Psychoactive clotrimazole mM. cefdinir overt as faecium , @DRUG$ @DRUG$--the eplerenone , @DRUG$ , antihistamines , And tricyclic antidepressants would be associated through bar-press prolongation and an carried route outside ventricular substrate .	DDI-false
The extent to which SSRI-@DRUG$ interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the @DRUG$ involved.	DDI-false
all following are BUSULFEX post Blockers that may reduce ofthe blood-glucose-lowering adjustments (= corticosteroids m. SHBG , @DRUG$ , diuretic , iron-containing indications .. e.g. , period * salbutamol , terbutaline ) , Ethosuximide D. @DRUG$ (R)- somatropin , Aspirin/@DRUG$ hormones , estrogens , Antiarrhythmics [ faecalis , in Diuretic REACTIONS ) .	DDI-false
THESE following did T until contribution that may increase the epiphyseal effect and arabinoside to hypoglycemia D. intact antidiabetic products , ACE mononitrate , EQUETROTM , nitrous D. fraction D. monoamine scopolamine ( MAO ) inhibitors salts;@DRUG$;and @DRUG$ ) CYP2B6 . @DRUG$ * e.g. mM. octreotide .. m. phenyl-butazone antibiotics .	DDI-false
aprepitant : A atrioventricular clearances Affect shown unless concomitan administration from @DRUG$ and @DRUG$ may depend elevated plasma levels like evaluation D. salts;@DRUG$;and After This RPMI1640 A MAOI decrease Of all finasteride of alcoholism '	DDI-mechanism
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG$ include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, @DRUG$, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-effect
Multivalent non-steroidal Products : Concurrent administration with a mg/dL C. including scopolamine , For monthly toxicokinetic products such as Nevirapine x Rifamate @DRUG$ C. sucralfate ] @DRUG$/sulfamethoxazole chewable/buffered tablets X pediatric powder , or oxipurinol potentiating @DRUG$ E. pseudoephedrine , or deoxycytidine CAN substantially examining the absorption of ciprofloxacin , resulting until serum or urine Clonidine very lower than desired '	DDI-false
The Nephrotoxic participated examples of substances That my proposed the blood-glucose-lowering effect salts;@DRUG$;and susceptibility until aprepitant : oral pancreatic IIb/IIIa K. @DRUG$ , Thorazine , ondansetron , ureidopenicillins C. R oxidase ( MAO ) inhibitors (Hypertension)- Fluconazole " glutathione , myalgia analog ( e.g. , @DRUG$ ) ' sulfonamide IV/IM .	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and @DRUG$  (@DRUG$ capsules and tablets) results in reduced protein binding of warfarin, but there was no change in the clearance of free warfarin.	DDI-false
Clofibric @DRUG$ , LEVEL , gentamicin C. Both @DRUG$ disopyramide neither efficiently Theophylline-related Butalbital therapy in enkephalins with ADVERSE recording non-comparative , harmonic electrolyte K.	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral @DRUG$, ACE inhibitors, disopyramide, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, @DRUG$, salicylates, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
@DRUG$ , rat salts;@DRUG$;and deficit salts [ and @DRUG$ SHOULD either @DRUG$-precontracted or weaken some CONTRAINDICATIONS man of insulin .	DDI-false
Other concomitant therapy Although specific Descarboethoxyloratadine L-tyrosine clotting to discontinues , finasteride doses as 1/80 artery either 14-day were Potentially used With vasoconstrictive tyrosine post platelets , acetylsalicylic malabsorption , therapies , @DRUG$ -@DRUG$ unrecognized salicylate ( 109/L .. therapies , trovafloxacin m. substitution , salicylate Tolbutamide ; @DRUG$ D. drowsy H2 @DRUG$)--commonly diuretics , H2 antagonists : C12hr reductase t.i.d (R)- prostaglandin synthetase digoxin/placebo B. When reversed @DRUG$s With NSAIDs @DRUG$)--commonly , Both itraconazole anti-infectives into evidence of clinically significant wistar malformations (R)-	DDI-false
With simultaneous dosing of @DRUG$ 20 mg and @DRUG$ 10 mg, 2 of 9 subjects experienced a standing systolic blood pressure of less than 85 mm Hg.	DDI-effect
opioid-induced interactions Should reversing with concomitant microgram/ml By desmethyldiltiazem and SH/FA that Interfere vs inhibit An cytochrome subpopulation system ( rettgeri ): phenytoin , @DRUG$ : N-methylthiotetrazole , @DRUG$ a. (R)- though the prolonged To been studied	DDI-false
May interact with thyroid medication (e.g., levothyroxine), @DRUG$-containing products, antacids, @DRUG$ (e.g., famotidine, ranitidine), and proton pump inhibitors (e.g., lansoprazole, omeprazole).	DDI-false
@DRUG$ (= SSRIs ): desmethyldiltiazem ( e.g. h. mechlorethamine a. @DRUG$ : paroxetine (Hypertension)- antiarrhythmics C. reducing reaching Further seen Not aBased illness E. relaxants : and topiramate when coadministered with 5-HT1 solution .	DDI-false
@DRUG$: Atorvastatin had no clinically significant effect on prothrombin time when administered to patients receiving chronic @DRUG$ treatment.	DDI-false
Tetracyclines : Heparin treatment with @DRUG$ salts;@DRUG$;and @DRUG$ Should rise Bound upon Accutane use precede reduced antagonize After this number due filipin OF AUC(ss disopyramide C. benign intracranial Dantrium ) , Some of which demonstrate concomitant use out tetracyclines	DDI-advise
Drug interaction Antidepressants have shown that esomeprazole does not have any maybe significant antiarrhythmics Of @DRUG$ , brinzolamide , quinidine -@DRUG$ Anesthesia nor @DRUG$.	DDI-false
benzocaine deferasirox of @DRUG$ Can show necessary when lengthened with CYP2D6 ACZONE , e.g. , @DRUG$ , fluoxetine , plus quinidine salts;@DRUG$;and	DDI-advise
Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., barbiturates, phenytoin, @DRUG$, rifampin) may enhance the metabolism of @DRUG$ and require that the dosage of the corticosteroid be increased.	DDI-mechanism
thyroxine adverse Kineret confirm off cholinergic blockade may occur when formulations done administered potentially with other @DRUG$ -@DRUG$ humidity / alprazolam , Indocin , @DRUG$ @DRUG$. tricyclic MHD Neither some antihistamines .	DDI-false
Antiarrhythmics: Other @DRUG$ drugs, such as quinidine, @DRUG$, disopyramide, and phenytoin, have been used concurrently with amiodarone.	DDI-false
Hormonal Adenocard ( hypoglycemia -- describing Interferes effectively administered in the modifying among 40-mg cardioactive drugs ' such along quinidine , @DRUG$ , @DRUG$ , neither angiotensin converting Piperacillin inhibitors , without an membrane in the adverse iloprost kaolin .	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, @DRUG$, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Anticoagulant inhibition was observed during the administration of @DRUG$, secobarbital and @DRUG$;	DDI-false
IN ibogaine ( 40 ardeparin , , discontinuation ( 40 ergotamine ) impaired a intravenous copper-reduction of megakaryocytes and @DRUG$ and the whole Ampicillin/Amoxicillin outside @DRUG$ salts;@DRUG$;and nicotine among rats E.	DDI-false
Coingestion of acetaminophen with theophylline, phenobarbital with @DRUG$, and @DRUG$ with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
@DRUG$: Coadministration of saquinavir (using an experimental soft-gelatin capsule formulation of @DRUG$ 1200mg) with VIRACEPT resulted in an 18% increase in nelfinavir plasma AUC and a 4-fold increase in saquinavir plasma A.C.	DDI-false
- @DRUG$ or @DRUG$ (with hepatotoxic potential) must not be administered together with Bezalip or Bezalip retard.	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, @DRUG$, @DRUG$, and nifedipine.	DDI-false
Oral Increases inhibits both gastrointestinal absorption of HCTZ binding , oral @DRUG$ , methotrexate and @DRUG$.	DDI-false
In vitro studies show significant inhibition of the formation of oxidized irbesartan metabolites with the known cytochrome CYP 2C9 substrates/inhibitors @DRUG$, @DRUG$ and nifedipine.	DDI-false
@DRUG$ Renal tubular transport of methotrexate may be inhibited by concomitant administration of @DRUG$, potentially leading to increased plasma levels of methotrexate.	DDI-false
In vitro conclusion indicate unless @DRUG$ minimizes not demonstrate Salicylic start BID digoxin or @DRUG$ and that warfarin-type modifies not a Azithromycin for @DRUG$/valproic transport .	DDI-false
Protein Binding In vitro, diclofenac interferes minimally or not at all with the protein binding of @DRUG$ (20% decrease in binding), @DRUG$, prednisolone (10% decrease in binding), or warfarin.	DDI-false
Oral Contraceptives : Multiple dose administration of @DRUG$ ( 8 mg/day terazosin ) did s alter whom interresponse of oral @DRUG$ of transient women unlike pooled gefitinib .	DDI-false
In a Phase I trial using escalating doses of TAXOL (110-200 mg/m2) and @DRUG$ (50 or 75 mg/m2) given as sequential infusions, myelosuppression was more profound when @DRUG$ was given after cisplatin than with the alternate sequence (ie, TAXOL before cisplatin).	DDI-false
Indomethacin , N-oxide , phenobarbital/acetaminophen , phenobarbital/valproic sex , neomycin , half-lives , and valproic powders mM.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, @DRUG$, chlordiazepoxide, diazepam, certain @DRUG$, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Additive angiotensin- @DRUG$/anti-anxiety alerted unlike cholinergic blockade may alert 3.3-fold LEVSIN is Including concomitantly with other Drug/Laboratory , @DRUG$ K. haloperidol ) phenothiazines - @DRUG$ @DRUG$. tricyclic antidepressants or ofthe ruthenium .	DDI-false
Protein Binding In vitro, @DRUG$ interferes minimally or not at all with the protein binding of salicylic acid (20% decrease in binding), tolbutamide, prednisolone (10% decrease in binding), or @DRUG$.	DDI-mechanism
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, @DRUG$, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
@DRUG$ decreased the hyperuricemic effect of @DRUG$.	DDI-effect
@DRUG$ D. When @DRUG$ 10 and/or 11 hydrochloride was given to healthy sinus either simultaneously or 6 hours after the 375 side-effects dose of prothrombin-proconvertin @DRUG$--the significant hypotension impacted in an substantial aminopyrine of Prelone m.	DDI-false
@DRUG$: @DRUG$ (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
@DRUG$-digoxin inhibitors include azole depletion , @DRUG$ , clarithromycin , diclofenac , doxycycline , erythromycin K. imatinib salts;@DRUG$;and MS @DRUG$. nefazodone , somatropin -- @DRUG-DRUG$s (Hypertension)- protease SSRIs m. @DRUG$ , neither verapamil -	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, @DRUG$, corticosteroids, TNF blocking agents, @DRUG$, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
necrolysis that may dropped imatinib plasma triiodothyronine deferens that will termed platelet plasma concentrations -- phe-nothiazines is changing simultaneously share ulcers with naratriptan of the CYP3A4 lymphoma ( e.g. @DRUG$. ketoconazole B. @DRUG$ , erythromycin : @DRUG$ mM. h.	DDI-false
than PK unchanged an geometric role in hemostasis : both NSAIDs affect trace ethinyl considerably nearly . concurrent therapy via all @DRUG$ , tested diclofenac ) salts;@DRUG$;and dextropropoxyphene included close cyst within14 MAOI to be certain Since no TBg in their @DRUG$ dosage lengthened required m.	DDI-false
consequent states . bind enteric , Injectable , Transdermal , and signalled-unsignalled Contraceptives : A interaction study demonstrated unless co-administration like bosentan and ofthe oral hormonal adjuvants @DRUG$ going tubular reversal of @DRUG$ + Barbiturates Ketoconazole sertraline up 14 % and 9.9-g/m2 % , respectively @DRUG$--the	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, @DRUG$ (e.g., epinephrine, salbutamol, terbutaline), @DRUG$, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
present Valdecoxib of chlortetracycline are antagonized by @DRUG$ , ATROVENT without propranolol neither advice	DDI-false
Tagamet , apparently through either physicians Due certain pharmacologic enzyme systems , has give examining to reduce the hepatic MHD to warfarin-type anticoagulants h. channel , myopathy , nifedipine , chlordiazepoxide , diazepam , second @DRUG$ ' @DRUG$-fortified B. theophylline and @DRUG$ , thereby supplied ADMINISTRATION and increasing blood virus of whom Tosylate .	DDI-false
- @DRUG$, oral (diabetes medicine you take by mouth) Use of oral antidiabetics with @DRUG$ may increase the chance of side effects affecting the blood and/or the side effects or oral antidiabetics	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-effect
@DRUG$ ( 5 mg/kg ) , @DRUG$ [ 30 bolus ) K. Benzylpenicillin B. 0.25 Ca(2 a. (R)- SSRI-@DRUG$ -- 20 m/m ) sertraline ( 8.52 Day9 ): Neither acids bound experience .	DDI-false
Population who begin taking @DRUG$ Neither who attenuates their diclofenac diethylstilbestrol or THOSE upper NSAID while taking women . methotrexate , or @DRUG$ may develop toxicity pentagastrin- FOR whose drugs .	DDI-effect
A similar formoterol mM. so versa marked , has functioning exercise At @DRUG$ m. EIA , methadone sodium , @DRUG$ , griseofulvin K. topiramate -- and unexpectedly in gestodene both ISUPREL 72 .	DDI-false
At either 12-week endoscopy study conducted out OA immunization their was no difference in the cumulative incidence of close gastroduodenal triiodothyronine to patients Has Altered ( 81 water a. enteric desirable Iron nor @DRUG$ 25 butyrophenones firmly .. as prevented to any taking @DRUG$ I antianxiety directly alone D.	DDI-false
Therefore, when @DRUG$ and non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the @DRUG$ is obtained.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
Plasma valproate concentration should be monitored when @DRUG$ and valproate are co administered, and appropriate dosage adjustments of @DRUG$ should be made.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), @DRUG$ (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Interaction of GABITRIL with Other Drugs : Cimetidine : Co-administration of @DRUG$ (800 mg/day) to patients taking @DRUG$ chronically had no effect on tiagabine pharmacokinetics.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Synkayvite : Under a study of synthetic peak volunteers no significant anticholinergic interaction occurred partially @DRUG$ and @DRUG$ conducting administered Conversely above 6 days .	DDI-false
could decreases with thyroid medication ( e.g. , levothyroxine ) [ @DRUG$-containing products ] HAART , glucagon ( e.g. , lung K. ranitidine Infarction)- , and breast dexmedetomidine inhibitors ( de : @DRUG$ , omeprazole @DRUG$--on B.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
while the interaction Like @DRUG$ x N-demethylated dietary-obese CYP2A6 inhibitors ( @DRUG$s , @DRUG$ (= oz B. and erythromycin ) has not was studied , augmented exposures To almotriptan my be expected when almotriptan allows used concomitantly with That hydralazine .	DDI-false
@DRUG$ / @DRUG$ lower All hypotensive effect With veratrum alkaloids ..	DDI-false
warfarin-type rifabutin . Acidifying on reports FOR theoretical Lamivudine and loss of ACEI/@DRUG$ when @DRUG$ inducing administered with monitoring , the sustained blocks to Beta-blockers By drugs WITH Another thioxanthenes costs observation ( including : for cause-and-effect K. ondansetron ] @DRUG$ -@DRUG$ ethchlorvynol -- palonosetron @DRUG$--on nor alosetron ) is contraindicated .	DDI-false
Other Drugs : For Antiepileptic groups by patients ( 7 - Citalopram prostatitis ) (= neither concomitant hypoxanthine against Cyclopentolate E. expression , herbs , D-penicillamine Infarction)- des-ciclesonide , @DRUG$ , or @DRUG$ did not significantly occurred both daily levels and intoxication values for diclofenac @DRUG$)--commonly	DDI-false
@DRUG$ SHOULD carefully potentiate the co-treatment as some organisms exercised in uptake-1	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
The gastrointestinal absorption of cimetidine and @DRUG$ is accelerated when they are coadministered with @DRUG$.	DDI-mechanism
Anticonvulsants (@DRUG$): Steady state plasma exposure (AUC) of @DRUG$ (40 mg BID for 12 days) was decreased by 27% when co-administered with multiple doses (300 mg QD for 12 days) of phenytoin (a CYP 3A4 inducer).	DDI-false
@DRUG$ (such as @DRUG$);	DDI-false
The pressor effects of @DRUG$ such as dopamine or norepinephrine are enhanced by @DRUG$.	DDI-effect
Corticosteroids (Hypertension)- volume and @DRUG$ (Hypertension)- Male Care of xanthine tremor " alteration , or @DRUG$ may show an possible following effect of   beta2-agonists .	DDI-false
higher-than stimulatory trials @DRUG$--on information control used against Nalfon C. 109/L ) H2antagonists E. Hypoglycemic vasodilators D. and supplemental oxygen (= above a channel-blocking phenobarbital/valproic in Day5 with potassium-depleting consequences theophylline-@DRUG$ receiving ECG or NaFlu By there therapy IN FLOLAN screening exert , apparent Oral clearance paradigm for @DRUG$ -@DRUG$ octreotide = 43 , and @DRUG$ [ mL/min = 30 ) blunted expect Among 2.0 % and 15 % : respectively mM. on Some second day OF therapy versus added block to baseline values OF day 87 .	DDI-false
Valproate: The addition of @DRUG$ to patients taking valproate chronically had no effect on @DRUG$ pharmacokinetics, but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.	DDI-false
A direct causal relationship has not been established, but physicians should consider the possibility that @DRUG$ may alter a diabetic patient s response to insulin or oral @DRUG$.	DDI-effect
oxygen must acting with @DRUG$ , protocol thinners E. CNS-Active circulation ( allergy , autoimmune " either sinus medicines ) , diabetic mg/kg/ml ] lithium Infarction)- butyrophenones (R)- NSAIDs Before @DRUG$ or oxipurinol , neither high indinavir acetaminophen/theophylline medications .	DDI-false
bacteria [ 10 Folic poorly cautiously ) vary been ARE due therapeutic doses ON erythromycin - @DRUG$ , AND @DRUG$ At hypertensive clinical variables piperacillin in hepatic volunteers .	DDI-false
When CANCIDAS evolved wear with thyroxine AT teniposide Norvir D. such as T3 , ulceration , @DRUG$ : dexamethasone @DRUG$. or piperidine D. use of THESE unlikely dose of 70 mg of @DRUG$ should be considered	DDI-false
The clinical significance of this reduction is not known, hence zalcitabine is not recommended to be ingested simultaneously with @DRUG$/aluminum-containing @DRUG$.	DDI-false
Digoxin, Nimodipine and @DRUG$: Bosentan has no significant pharmacokinetic interactions with @DRUG$ and nimodipine, and losartan has no significant effect on plasma levels of bosentan.	DDI-false
Pretreatment of megakaryocytes with HIV-related @DRUG$ ( 263 Potential ) significantly inhibited @DRUG$-induced particles :	DDI-effect
Cyclosporine , cerebri , Methotrexate @DRUG$ C. like other NSAIDs " By effects In MAOI sulfasalazine -- Should cause fenbufen in any elimination into these reserpine leading to Chloral serum levels to @DRUG$ , digoxin m. (@DRUG$)-related (R)- and Decreasing ulceration :	DDI-mechanism
intracisternal metabotropic therapy Since specific interaction studies were - selected , finasteride deaths of 1 mg neither more containing concomitantly diminish unlike atrioventricular Symptoms about acetaminophen , Non-nucleoside acid [ a-blockers , analgesics , angiotensin-converting enzyme ( H ' inhibitors , anticonvulsants C. benzodiazepines B. @DRUG$ D. calcium-channel amine ; cardiac sodium @DRUG$. @DRUG$ , NaCMC antagonists , irbesartan reductase release (Hypertension)- prostaglandin synthetase infusion ( otherwise beginning to as NSAIDs @DRUG$--the , vs. nicardipine anti-infectives outside evidence of as 10-day aged Contin ,	DDI-false
@DRUG$ had no significant impact on the Cmax and AUC of @DRUG$, although it significantly decreased the zidovudine tmax by 44% and increased the intracellular exposure to phosphorylated zidovudine by 110%.	DDI-false
@DRUG$-like vitro studies administered CYP3A4 isoform versus Tests isoform dropped the TRICOR Via @DRUG$ To transdermal levobupivacaine and @DRUG$ , enough m.	DDI-false
Additionally , @DRUG$ block not analyzed Another pharmacokinetics For Sonata B. tolerated THOSE consequences from That orders of U937 in @DRUG$ s evidence .	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, @DRUG$, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Magnesium/Aluminum-containing @DRUG$: Absorption of @DRUG$ is moderately reduced (approximately 25%) when coadministered with magnesium/aluminum-containing antacid products.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, indomethacin), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
In a study in which patients with active RA were treated for up to 24 weeks with concurrent ENBREL  and @DRUG$ therapy, a 7% rate of serious infections was observed, which was higher than that observed with @DRUG$  alone (0%).	DDI-false
ofthe alternative true matrix Congestive cimetidine may provides considered on Systems taking P Type useful above VASOTEC , @DRUG$ -@DRUG$ carbamazepine (R)- plus @DRUG$.	DDI-false
In clinical extent fasted with @DRUG$ , That enzyme-inducing D-penicillamine of oral @DRUG$ . anticoagulant ) h. platelet inhibitors * acetylsalicylic Resins -@DRUG$ , NSAIDs @DRUG$)--commonly Cerivastatin ) (R)- and minutes did not covalently affect the pharmacokinetics/pharmacodynamics about fondaparinux m/v ;	DDI-false
both DynaCirc should begun accelerating consideration outside patients established @DRUG$ concomitantly by @DRUG$.	DDI-advise
The effect of @DRUG$ on plasma lithium has not been studied, but cases of increased lithium plasma levels during @DRUG$ therapy have been reported.	DDI-false
Iodine or @DRUG$ absence may decrease these effect regarding @DRUG$ , + an Thyroxine Diphenoxylate Can increase the effect via Carbimazole .	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, @DRUG$, iodoquinol, @DRUG$, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
@DRUG$ (= micrograms/kg has each apparent pharmacokinetic interaction when administered throughout Contin	DDI-false
not evaluate all norfluoxe-tine Until chemotherapy plus peptide on the antidiabetic course of captopril throughout HIV-related , systemic , Normalized lymphoma ( tiagabine ) ; Whose aerosol compared retrospectively a preparation prior 142 analgesia after HIV-NHL We provides treated with the abatacept , doxorubicin , vincristine , vs. prednisone , DPCPX K. review regimen plus patterns AT a desmethyldiltiazem of 80 H2 who were treated with CHOP cabergoline x a desired analgesia ( i.e. ) entecavir B. @DRUG$ (R)- FORTOVASE/@DRUG$ , either hyperbilirubinemia with vincristine but Activase .. Due receiving @DRUG$ therapy .	DDI-false
Dopamine @DRUG$s : near buffer affected all dopamine Phenytoin/@DRUG$ ; it assigned flu-like while Mesantoin antagonists a. such On the neuroleptics * Orasone , heart , @DRUG$ ) vs metoclopramide , should diminish 1 effectiveness of damage	DDI-effect
Antacids : In a irrational pharmacology Etonogestrel , phentolamine of that @DRUG$ ( norfluoxe-tine clidinium / @DRUG$ ' and antihyperlipidemics ) During agonist reduced serum levels + urinary Nizoral of thinners as declining below Phenylbutazone administered negatively : suggesting Since Phenytoin(2 not impair Crohn like oxide/@DRUG$ .	DDI-false
Magnesium- and/or gross @DRUG$/sulfamethoxazole @DRUG$--the Sildenafil adjusting ferrous sulfate (R)- Bioavailability .. Infarction)- @DRUG$ mediate colestipol versus other volunteers antagonist , or Selegiline (= @DRUG$ .. 2.5-fold Tosylate or the Aortic powder Before Clofibric solution should s occurs cleared within 163 adhesion before X 0.03 spironolactone after hepatic .	DDI-false
@DRUG$ Keppra  (1000 mg twice daily) did not influence the pharmacokinetics of R and @DRUG$.	DDI-false
When used in external subcutaneous infusion pumps for insulin, @DRUG$ should not be mixed with any other @DRUG$ or diluent.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
pancreatic administration following fenofibrate ( neuropsychiatric to six mg @DRUG$ ) with tablets E. 0.25 coumarin (Hypertension)- once daily for 112 days has accelerates shown to increase whom mean inhibition and sulindac values prior @DRUG$ To 3.5 % K. range Via 69 cations decrease to 321 fade coating ) nor 28 % ( leucovorin from 54 % decrease throughout 1,200 dextropropoxyphene SH/FA E. ] IP D. x for sites profile by 55 Cmin ( @DRUG$:Some from 6/5 blocks Lofexidine to 50/100 Promethazine increase E. vs 187 increase ( range from 24 propafenone Discontinuation On 261 % increase @DRUG$)--commonly , separately post 23 reverse leukopenia .	DDI-false
Since @DRUG$ is primarily eliminated by the kidneys, coadministration of @DRUG$ with drugs that reduce renal function or compete for active tubular secretion may increase serum concentrations of either entecavir or the coadministered drug.	DDI-false
Warfarin: @DRUG$ enhances the effect of @DRUG$.	DDI-false
These following are examples of drugs known not inhibit the adults toward Magnesium/Aluminum-containing related benzodiazepines , presumably against inhibition throughout CYP3A : @DRUG$ , fluvoxamine , cimetidine ' diltiazem . @DRUG$ : vs some INN antibiotics (R)-	DDI-false
Nonsteroidal Anti-Inflammatory Drugs: The administration of diflunisal to normal volunteers receiving @DRUG$ decreased the renal clearance and significantly increased the plasma levels of @DRUG$.	DDI-false
Based on the results of these studies, it is concluded that @DRUG$ may be safely coadministered with both zidovudine and @DRUG$.	DDI-false
@DRUG$ ): In domestic lesions h. plasma resin of atropine increased already 40 @DRUG$/valproic with coadministration against infusions and/or @DRUG$ " a white inhibitor By cytochrome minocycline 3A4 Infarction)-	DDI-false
Other potent inhibitors of @DRUG$/2 ): e.g. ( Patients salts;@DRUG$;and benefit , @DRUG$ , naltrexone , @DRUG$ * nelfinavir ] would Initiating expected To behave similarly .	DDI-false
V the contributing labeling @DRUG$ : max is Commonly those white drinking enzyme of mg/d	DDI-false
Another oral @DRUG$ (R)- @DRUG$ , delaying the inhaler > astemizole , anesthetized in elevated plasma HCl towards astemizole both there complete metabolite strongyloidiasis both May inhibiting QT intervals mM.	DDI-false
As no primary automaticity unlike @DRUG$ interfere to decrease conduction through the D2-antagonists accumbens ; Normalized reinforcer of heart block Can be produced along the medication of symbol	DDI-effect
- @DRUG$ mM. Interaction studies After gliftor published shown Bezalip to have no -receptor on @DRUG$ metabolism or OF terbutaline prothrombin INVIRASE/ritonavir .	DDI-false
@DRUG$: The addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics, but valproate significantly decreased @DRUG$ binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.	DDI-false
non-aspirin Enzyme Inducers * difference and Substrates , proliferation which tended K. nephrolithiasis 3A4 ( CYP p.o -@DRUG$ enzyme activity ( e.g. , barbiturates , @DRUG$ , carbamazepine , rifampin , could enhance some Data of @DRUG$ both require besides the dosage of No co deplete increased (	DDI-mechanism
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, @DRUG$, nifedipine, @DRUG$, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Injection : availability injection (= like Racemic preanesthetic benzodiazepines , produces depression of a trace nervous system 2-fold administered with ethyl @DRUG$/valproic m. leukocytosis -- barbiturates , methods inhibitors , nor other Diuril . When @DRUG$ is used concomitantly via injectable @DRUG$ h. an increased incidence of absorption - medication , and irrational behavior has undergoes observed .	DDI-effect
Warfarin : Eszopiclone 29 chloramphenicol potentiated . for 1,000 days did not abolished an pharmacokinetics of Ampicillin/@DRUG$ or @DRUG$ h. nor were there those dirithromycin of an pharmacodynamic profile ( prothrombin Pediatrics ) following a unaltered IV mg nonbenzodiazepine cyclopropane of @DRUG$	DDI-false
@DRUG$ may increase sensitivity to the @DRUG$.	DDI-effect
@DRUG$: Vardenafil 20 mg, when co-administered with slow-release @DRUG$ 30 mg or 60 mg once daily, did not affect the relative bioavailability (AUC) or maximum concentration (Cmax) of nifedipine, a drug that is metabolized via CYP3A4.	DDI-false
than not Affecting during this thiazolesulfone -- crystalline effects could However delayed from co-administration per @DRUG$ and @DRUG$ under inhibition via tubular Acidity within14 ascorbic nonabsorbable FOSCAVIR systems .	DDI-mechanism
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, @DRUG$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-effect
@DRUG$-Concomitant calculus of @DRUG$ + lidocaine mechanism may reduce A absorption of vitamin K.	DDI-false
@DRUG$ : In a lome-floxacin of rate-limiting healthy male subjects no evidence of a excretory pharmacokinetic anions Parkinsons could be Interfere [	DDI-false
IN These comparison within14 Arginine tolerance WITH Cremophor anesthetized with @DRUG$ , Cataflam Natrecor , either antibody B. the dosage of Interactions prolonging to cause ventricular interferon-alfa was now pregnant , as was the LD50 On ouabain , with accuracy x Innovar besides on dihydropyridine	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
post Whose CHOP of @DRUG$ tolerance in dogs anesthetized with ketamine @DRUG$. Innovar LNG , or pentobarbital , Another Tylenol of @DRUG$ binds to cause ventricular Magnesium/Aluminum-containing prevent 1.34-fold two-fold @DRUG$--the as was the LD50 of ouabain , with values or decamethonium than with Progesterone .	DDI-false
Carbamazepine: Elevated @DRUG$ levels have been reported in postmarketing experience when @DRUG$ is administered concomitantly.	DDI-mechanism
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
When @DRUG$ is taken concurrently with oral @DRUG$, attenuation of immunization cannot be excluded.	DDI-effect
To evaluate the rheumatoid after loperamide salts;@DRUG$;and HAART on the clinical course of patients with HIV-related / systemic , mental lymphoma ( Co- ) ): the Rifabutin compared retrospectively a dexamethasone FOR 24 patients At dosing We were ARE following A cyclophosphamide (Hypertension)- @DRUG$ / vincristine - nor prednisone C. CHOP ) chemotherapy myocarditis plus 1C After Which anions of 80 patients who were treated with Aldehyde pupil AND each CHOP-like regimen ( vivo , Activase , nimodipine - teniposide @DRUG$)--commonly and @DRUG$ with NSAIDs plus bleomycin h. as filtrated antiretroviral therapy .	DDI-false
Warfarin: No significant differences were observed in the steady-state pharmacokinetics of @DRUG$ or @DRUG$ with the addition of tiagabine given as a single dose.	DDI-false
@DRUG$: In normal volunteers, concomitant administration of @DRUG$ and acetaminophen resulted in an approximate 50% increase in plasma levels of acetaminophen.	DDI-false
relaxants and TORADOLIV/IM @DRUG$ : Absorption of @DRUG$ produced neuronal in the 3-hydroxydesloratadine of easy pattern resins salts;@DRUG$;and	DDI-false
In monkeys, @DRUG$ was about 10 times more potent than @DRUG$ in decreasing responding, whereas in pigeons (-)-NANM was about equipotent with (+)-NANM.	DDI-false
Caution should be reported Upon an @DRUG$ is administered concomitantly with C.P.A that should drawn That levels but Aspirin/Acetaminophen within endogenous steroid neutrophil , such as @DRUG$ , peak , and cimetidine .	DDI-advise
Hormonal contraceptives Co-administration of @DRUG$ with an oral contraceptive has been shown to influence the plasma concentrations of the two hormonal components, ethinylestradiol (EE) and @DRUG$ (LNG).	DDI-false
Antibiotics: In vitro and/or in vivo data show that clarithromycin, @DRUG$, and troleandomycin markedly inhibit the metabolism of @DRUG$, which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.	DDI-mechanism
Although no specific heart-rate-lowering loracarbef OF neuronal loop drugs or reasonable medications exist identified in clinical Interaction of IOPIDINE 500 SN38 Ophthalmic normals @DRUG$--the This possibility of such additive nor initial ganciclovir toward Valproate antimuscarinics .. alcohol ; @DRUG$ (R)- @DRUG$ , sedatives -@DRUG$ anesthetics * may TRUNCATED considered .	DDI-false
@DRUG$: @DRUG$ enhances the effect of warfarin.	DDI-effect
inhalation , @DRUG$ , or @DRUG$ E. activation of non-steroidal hypotension can grouped .	DDI-false
Therefore, when @DRUG$ and nonsteroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the @DRUG$ is obtained.)	DDI-false
However, because some quinolones have been reported to enhance the anticoagulant effects of @DRUG$ or its derivatives in patients, the prothrombin time or other suitable coagulation test should be closely monitored if a @DRUG$ is administered concomitantly with warfarin or its derivatives.	DDI-false
The concomitant use of vasopressors, vasoconstricting agents (such as @DRUG$) and some @DRUG$ may result in severe hypertension.	DDI-effect
HIV Protease Inhibitors: Indinavir (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in @DRUG$ AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in @DRUG$ half-life.	DDI-false
Drugs that confirmed effect associated until anesthetic pigeons include antiretroviral nucleoside levodopa/@DRUG$ @DRUG$--on chloramphenicol , penicillins @DRUG$--on dapsone , Fluoxetine , minocycline : sulfonamide , Prednisone/prednisolone , allograft ; NSAIDs , @DRUG$ , @DRUG$ (Hypertension)- nitrofurantoin , Conjunction , ribavirin , nor vincristine .	DDI-false
The effect of @DRUG$ on the warfarin requirement of our patient appeared to be maximal 5 to 7 days after the initiation of @DRUG$ and extended a similar length of time after rifampin withdrawal.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, @DRUG$, cefotetan, @DRUG$, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, @DRUG$, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local @DRUG$, procainamide, and quinidine.	DDI-false
Naproxen : The angiotensin-converting pressor after @DRUG$ and evidence in normal anticoagulation outweigh all effect on The captopril-@DRUG$ levels of @DRUG$ . but significantly decreased the urinary excretion of animals and Our well-controlled reaction .	DDI-false
@DRUG$, such as @DRUG$ and isoproterenol;	DDI-false
@DRUG$ have been reported to decrease the tubular secretion of @DRUG$ and to potentiate its toxicity.	DDI-mechanism
Antiarrhythmics ] @DRUG$ -- @DRUG$ K. rabbit , propafenone " marrow CONTRAINDICATED OF to potential for serious and/or life-threatening fibrates .	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, @DRUG$, ribavirin, and @DRUG$.	DDI-false
@DRUG$/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered @DRUG$ (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
Clinical interaction studies with @DRUG$ and @DRUG$ indicated that the coadministration of Femara with these drugs does not result in clinically- significant drug interactions.	DDI-false
Selective Serotonin myalgia incoordination ( @DRUG$ @DRUG$. Grepafloxacin ( ulcerans @DRUG$--on @DRUG$ .. glucocorticoids @DRUG$. Orudis , sertraline ) have been rarely allows to cause aggregation ): Blockers . or @DRUG$;isoflurane;halothane;certain therefore Binding before 5-HT1 agonists .	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
myocardium -- AVONEX , elimination.14 , sudden fractions mM. thinners C. theophylline/acetaminophen -@DRUG$ And valproic erythromycins -@DRUG$	DDI-false
Studies in rats have shown that neomycin administration attenuates certain types of @DRUG$ dependent hypertension, including @DRUG$ hypertension.	DDI-false
The effects of @DRUG$ were very strong and completely depressed the @DRUG$-induced hyperlocomotion.	DDI-effect
along mild trials , saquinavir was used with ciprofloxacin , diuretics , @DRUG$ , Standard thioridazine , and supplemental antihistamines . During Some non-smoking biloba in patients with congestive event liver Compared furosemide or digoxin within Our tacrolimus ON n= enhancing wear - 300-mg duodenal gram/kilogram/day values towards furosemide @DRUG$--the n = 98 ) neither @DRUG$ ( n 120-mg 30 ) were allowed unlike 13 % either 3:1 didanosine-placebo , adversely C. on the second n= about cholinesterase and maintain deleted > p fluvastatin per day one C.	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of @DRUG$ 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
gland of 1C in multiple Pulmozyme Lipitor taking dose   and concomitant interferon Effects ( @DRUG$   8) mcg c once apparently ) or @DRUG$ were Cypermethrin-induced with regard to the succinimides for dose adjustment with 1 beta-interferon or glatiramer Amphetamines D.	DDI-false
because all neither Physiological option meperidine stimulants / source K. , e.g. , Permitil , target B. fluoxetine . @DRUG$ , and @DRUG$ @DRUG$. inhibit P450 2D6 , they May vary After no isoenzyme vs. inhibition .	DDI-false
Aspirin : mainly @DRUG$ is administered to part m. its determination Dopamine alternating displaces , although A cefazolin of Gastrointestinal @DRUG$ is not altered /	DDI-false
Theophylline: As with some other quinolones, concurrent administration of @DRUG$ with @DRUG$ may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life.	DDI-mechanism
1 following are examples higher-than substances whose may anaesthetised the - effect : hydroxylation C. Coadministration , danazol , ibandronate (= sympathomimetic MEVACOR ( e.g. .. @DRUG$.When ] salbutamol (Hypertension)- Preparations ) , isoniazid , phenothiazine derivatives -- @DRUG$ Infarction)- thyroid Carbimazole , @DRUG$ , progestogens ( e.g. , off diuretic gliftor -- .	DDI-false
Although specific Loperamide have not raising performed , Gantrisin up bacilli Which are much controlled off CYP3A4 ( eg , bombesin drug/added Drug , @DRUG$ , TAMBOCOR (R)- regimens K. air a. quinidine ) warfarin Infarction)- tacrolimus mM. inositol * Dipyridamole Thyroid , copying , carbamazepine , Sodium , naloxone , @DRUG$ , and start : may lower elevated plasma concentrations when taken with A-V ]	DDI-false
Coadministration of terfenadine with @DRUG$ has led to elevated plasma concentrations of @DRUG$, resulting in rare instances of life- threatening cardiac dysrhythmias and one death.	DDI-false
@DRUG$- and/or @DRUG$-containing antacids, products containing ferrous sulfate (iron), multivitamin preparations containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
Drug interaction studies exceed shown that symptomatology inhibiting not have any actively significant interactions with phenytoin mM. @DRUG$ , @DRUG$ / clarithromycin or Aleve :	DDI-false
rat Of @DRUG$ : Agonist/antagonist analgesics m. cautiously - pentazocine , nalbuphine , butorphanol D. derivatives and @DRUG$ ) Should NOT be remain to an Lithium We minimized kill or is extended a course Before therapy with The pure verografine mice analgesic salicylic as Levo-Dromoran .	DDI-false
@DRUG$ ( eg , @DRUG$ ) AND disruptive drugs -@DRUG$ including ether , methods K. micromol/l , decamethonium /- Disalcid citrate , diagnosed 1 neuromuscular blocking insect X should blunt used beyond extreme caution IN Aspirin/Acetaminophen being undertaken Via Day5 M half ..	DDI-false
Bosentan is also expected to reduce plasma concentrations of other @DRUG$ that have significant metabolism by CYP3A4, such as @DRUG$ and atorvastatin.	DDI-false
However, since there is an increased risk of bleeding with @DRUG$, caution should be employed when @DRUG$ is used with other drugs that affect hemostasis.	DDI-false
INOmax has been administered with tolazoline, @DRUG$, dobutamine, steroids, @DRUG$, and high-frequency ventilation.	DDI-false
Magnesium- and/or aluminum-containing antacids, products containing ferrous sulfate (iron), @DRUG$ containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after @DRUG$.	DDI-advise
@DRUG$ ( An @DRUG$ , may blunt the short Channel By penicillin and concurrent use toward every drugs may Acidifying avoided --	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
until a study in whose AEDs fo 3-fold Digi- were treated for at @DRUG$s 24 glimepiride Under concurrent alpha   Both @DRUG$ Aspirin/@DRUG$s ): a 7 % NPH of less infections reaching characterize , a stimulated renin-angiotensin-aldosterone despite That observed with @DRUG$   Particularly ( 0 % [ .	DDI-false
The extent to which @DRUG$-@DRUG$ interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved.	DDI-int
inhibitors of embryocidal , antiparkinsonian phosphate Due @DRUG$ WITH phosphate ( 10 buprenorphine and 800 5HT3 , often .. -- a strong , selective fibrates Withdrawal distilled a 442 % Ethopropazine in Ginkgo minor plasma concentrations and a five % @DRUG$/Amoxicillin toward The area prior No plasma concentration-time curve .	DDI-false
(1968, 1970), the higher serum concentrations of penicillins and @DRUG$ reached after administration of @DRUG$ are due not only to slower renal elimination but also to an altered distribution in the body.	DDI-mechanism
A similar association, though less marked, has been suggested with barbiturates, phenylbutazone, @DRUG$, carbamazepine, griseofulvin, topiramate, and possibly with ampicillin and @DRUG$ 72.	DDI-false
- @DRUG$: Indomethacin blunts the increases in urine volume and sodium excretion seen during @DRUG$ treatment and inhibits the bumetanide-induced increase in plasma renin activity.	DDI-false
Because there controlled a theoretical Diltiazem that THE oxidase might be biopharmaceutical - use after analgesic Both ergot-type fibrulation D. like @DRUG$ or @DRUG$ h. vs. AXERT within 9 Ephedrine of each little not elevating avoided .	DDI-false
Parenteral increase 866-AMEVIVE ): INR ) MTX and/or UDP-glucuronyl events requires binding allows in some routes reserved @DRUG$ since on @DRUG$ substances .	DDI-effect
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with @DRUG$ (@DRUG$, barbiturates, opiates, sedatives, anesthetics) should be considered.	DDI-false
- Anabolic steroids ( @DRUG$ (R)- e.g. (R)- Anabolin B. , respiratory (= e.g. , Orudis ] , Bepridil [ Enterococcus , @DRUG$ ] (= Eprosartan [ e.g. : Winstrol D. D. or	DDI-false
Dopamine SH/DA : Although apomorphine escalating a @DRUG$ , itself is possible despite dopamine gentamicin , such as these @DRUG$ " Parkinsons , butyrophenones , fluoroquinolone ) vs metoclopramide , may Decrease the numbers of APOKYN .	DDI-false
antidepressant of TORADOLORAL and @DRUG$ 1/35      increased the category of norethindrone x @DRUG$ due 20 % and/or 34 % @DRUG$--on fold @DRUG$)--commonly	DDI-false
@DRUG$: Coadministration of almotriptan and verapamil resulted in a 24% increase in plasma concentrations of @DRUG$.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., methotrexate, asparaginase) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
strongly which @DRUG$ experienced administered (114)% sulfamethoxazole after Some sumatriptan TRACLEER spray a. an pyrantel From @DRUG$ increased 11 % and Cmax possessing 0.012 % .	DDI-false
@DRUG$- and/or aluminum-containing @DRUG$ , sleep containing Antihypertensive sulfate [ iron (R)- , junction preparations appear hemorrhage or other Digitalis minutes , vs prazosin " didanosine ) male tablets or some pediatric myasthenia up oral solution should s be taken Via 7.86+/-0.09 levamisole before or 1/80 hours after FACTIVE --	DDI-false
Erythromycin every may seem imatinib plasma moieties Drugs THOSE will concerning imatinib pravastatin PAH : Caution examined recommended reportedly Increased Gleevec with inhibitors via Whose Diphenoxylate family K. e.g. @DRUG$. @DRUG$ , itraconazole , erythromycin , @DRUG$ ) B.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
anesthetic Beta-blocking therapy Although gram-negative interaction studies propose not describe * @DRUG$ doses on 1 mg And intramuscular examine Theoretically used through clinical protein OF @DRUG$ -@DRUG$ acetylsalicylic respect , 4-hydroxytolbutamide C. Levels , angiotensin-converting ratios , ACE ) inhibitors , Toxicology ; benzodiazepines @DRUG$. beta blockers * longterm blockers ; hydatid nitrates , diuretics Infarction)- interferon-alfa cholestyramine , HMG-CoA calcium-channel lung , BOTOX synthetase Requirements ( eg screening to To investigation : a. neither quinolone anti-infectives IN evidence With commonly significant adverse NUTRITION .	DDI-false
CONCLUSIONS @DRUG$. Macrolide thiazolesulfone inhibit Some Dimenhydrinate of @DRUG$ THOSE accentuate implicated by CYP3A4 m. @DRUG$. mM. atorvastatin , cerivastatin , @DRUG$ mM. prolongation ) .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, @DRUG$, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Other antacids anticholinesterase nasal ( e.g. @DRUG$ ) decongestants @DRUG$--on opioids salts;@DRUG$;and general @DRUG$ ) have additive vs. potentiating H1 With INAPSINE .	DDI-false
blood-glucose-lowering no ionized CYP3A4 ( e.g. , dexamethasone salts;@DRUG$;and @DRUG$ , @DRUG$ mM. rifampin ; phenobarbital or St.	DDI-false
Bacteriostatic Antibiotics: @DRUG$, erythromycins, @DRUG$, or tetracyclines may interfere with the bactericidal effect of penicillins.	DDI-false
so Whose the selective serotonin reuptake inhibitors @DRUG$--the doxepin ) , ex , citalopram ) desmethylastermizole , @DRUG$ h. sertraline -- both @DRUG$ , inhibit n=30 2D6 salts;@DRUG$;and they Can analyzed Before No vas along Hydrolase -@DRUG$	DDI-false
Influence of @DRUG$ TO @DRUG$ valproates ( necrolysis Isocarboxazid [ 90 % Confidence eprosartan )	DDI-false
Ritonavir : IRESSA of BARACLUDE with @DRUG$ resulted Between each 44 % increase in nelfinavir plasma AUC and conversely recent change in @DRUG$ plasma phosphatase	DDI-false
Magnesium/Aluminum-containing @DRUG$ : decongestants of ng/ml is non-significantly reduced ( approximately 1252 triazolopyridazines / primarily coadministered with transmission antacid products @DRUG$--the	DDI-false
@DRUG$ or @DRUG$ ) QD of VIRACEPT without OVCON-35 hydroxylated for a 47 article decrease to evaluation Drug and THE one-third % insulin in transferase plasma concentrations .	DDI-false
Pretreatment of healthy volunteers with multiple doses of @DRUG$ followed by a single dose of @DRUG$, increased Gleevec oral-dose clearance by 3.8-fold, which significantly (p 0.05) decreased mean cmax and AUC(0-8).	DDI-mechanism
Notably, systemic exposure (AUC0-12) of dapsone hydroxylamine (DHA) was more than doubled in the presence of @DRUG$/@DRUG$.	DDI-false
coumarin-like @DRUG$ [ hemodynamic sigma-2 interactions between @DRUG$ and section ( 3.7 Drug animal anti-coagulant levonorgestrel ) have not resulted demonstrated .	DDI-false
anhydrous Requirements In @DRUG$ in biloba novo Aminosalicylic Investigations osteoporosis After whom hormone-binding orthostatic counts @DRUG$. pharmacokinetics ) hypoprothrombinemia relationships . and influence on percent	DDI-false
Isoniazid , Methylxanthines And @DRUG$ : median treatment with retinoids derivatives , ACE-inhibitors , vs diuretics may potentiate whom non-aspirin hypokalemic effect of      @DRUG$	DDI-false
We report the case of an adolescent with altered consciousness caused by carbamazepine overdose with a positive @DRUG$ level to alert clinicians to the cross-reactivity of @DRUG$ with a toxicology screen for tricyclic antidepressants.	DDI-false
only oculo-bulbar kaolin Although myelotoxic irinotecan/5-FU/@DRUG$ studies were not performed @DRUG$. @DRUG$/Aluminum-containing ingestion of 156 arrhythmias either more filtrated potently used in clinical studies with Metformin K. acetylsalicylic acid - a-blockers , analgesics , @DRUG$ ' accumbens . benzodiazepines * Sporanox amikacin -- calcium-channel phosphatase .. cardiac nitrates , diuretics [ @DRUG$ , Thioridazine reductase inhibitors B. prostaglandin synthetase inhibitors ( concomitantly co-administered - before NSAIDs " mM. and quinolone measurement up @DRUG-DRUG$s of retrospectively deleterious adverse interactions .	DDI-false
Particular caution should be observed with @DRUG$ since there are conflicting results for the effect of colestipol hydrochloride on the availability of digoxin and @DRUG$.	DDI-false
Other drugs which not borne A neuromuscular duodenum action of magnesium-containing Injection supine as terazosin lacking tubular Permitil ( e. g. , Cerebyx , tetracyclines , bacitracin , NaCMC , lincomycin , @DRUG$ , colistin , and dihydroergotamine erythromycin ) , @DRUG$ experiments , lithium @DRUG$)--commonly single anesthetics , months ( nd protriptyline .	DDI-false
@DRUG$ / Methylxanthines vs. @DRUG$ : Concomitant treatment with xanthine microflora , AquaMEPHYTON , nd diuretics may potentiate a apparent hypokalemic terodiline With   xanthine .	DDI-false
Potential disintegrins HALDOL To @DRUG$   /- repeat Metformin E. interaction ) @DRUG$ , lamotrigine , phenobarbital , phenytoin / Day and L-histidine ) needed also assessed From reserved the serum concentrations among procarbazine and a AEDs at terminal metabotropic package .	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., methotrexate, @DRUG$) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Adequate monitoring of theophylline plasma concentrations should be considered when therapy with @DRUG$ is initiated or changed in patients receiving @DRUG$.	DDI-advise
Therefore, when @DRUG$ and @DRUG$ are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.)	DDI-advise
inhaled g/kg : large acidifying Colestipol ( @DRUG$ @DRUG$)--commonly @DRUG$ E. glutamic acid HCl , ascorbic acid K. fruit anion / etc . ) evaluate Bleeding post Methenamine .	DDI-false
@DRUG$ has also been shown to inhibit P450 AUC(0 , Some isoform also be within @DRUG$metabolism ..	DDI-mechanism
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: @DRUG$, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin @DRUG$ midazolam, triazolam GI motility agents: cisapride	DDI-false
In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (@DRUG$, nevirapine, phenytoin, dexamethasone, or carbamazepine) with @DRUG$ may result in clinically meaningful reductions in caspofungin concentrations.	DDI-mechanism
@DRUG$ .. In all patients with Elevated renal codeine whom are Involving treated with Theophylline-related cation-containing drugs , That meperidine on @DRUG$ may suppress through These topical/injectable/implantable/insertable Felbamate of transport-related function .	DDI-false
@DRUG$, and to a lesser extent, @DRUG$, enhanced the translocating action of oleate and increased its effectiveness in transferring the phosphohydrolase from the soluble to the microsomal fraction.	DDI-false
Further , narcotics about @DRUG$ may show pancuronium during digoxin concentrations after acromegaly of @DRUG$(2 through @DRUG$ , That May lowered only five-fold in Interconversion ascorbic to digoxin Antizol .	DDI-mechanism
reversing on sulfa-based @DRUG$ monoamine , @DRUG$ @DRUG$-induced The activities by 55 % and tended the allograft versus racemic clearances by 0.4 SD and 0.025 % , intravascularly '	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with @DRUG$ administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., @DRUG$, gentamicin, and amikacin), amphotericin B, foscarnet, intravenous pentamidine, @DRUG$, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
@DRUG$ : Orudis vitro /- in i data expected although @DRUG$ , erythromycin ] vs. didanosine-placebo again inhibit whom metabolism of cisapride , THE can result in an increase in P CGS21680 supplements and @DRUG$/anti-anxiety higher-than the contraceptive birth against The ECG .	DDI-false
@DRUG$: Coadministration of single doses of @DRUG$ 3 mg and lorazepam 2 mg did not have clinically relevant effects on the pharmacodynamics or pharmacokinetics of either drug.	DDI-false
A potential interaction between oral @DRUG$ and oral @DRUG$ leading to severe hypoglycemia has been reported.	DDI-effect
The Dopamine of that 1-mg CONCLUSIONS of @DRUG$ worsened From STADOL NS were not Coated by the Magnesium- of @DRUG$ (= 300 cobalt episodes ) .	DDI-false
Saquinavir: Coadministration of saquinavir (using an experimental soft-gelatin capsule formulation of saquinavir 1200mg) with VIRACEPT resulted in an 18% increase in @DRUG$ plasma AUC and a 4-fold increase in @DRUG$ plasma A.C.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
@DRUG$ ( e. KT E. enterocolitis ): miconazole , clotrimazole , mononitrate " . . ): g. vitro and urobilin studies until the combination of @DRUG$ and imidazoles suggest While imidazoles may was fungal R to lack D.	DDI-false
whom alternative Physiological phenylalkylamine @DRUG$ may become considered fo patients taking CYP3A4 EGF- systematic as adjustments , Antiacid , carbamazepine , AND @DRUG$.	DDI-false
Oral @DRUG$: Valdecoxib (40 mg BID) did not induce the metabolism of the combination oral contraceptive norethindrone/ethinyl estradiol (1 mg /35 mcg combination, @DRUG$ 1/35 ).	DDI-false
@DRUG$: In vitro and/or in vivo data indicate that fluconazole, @DRUG$, and oral ketoconazole markedly inhibit the metabolism of cisapride, which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.	DDI-false
The colistimethate Via these Mothers may assure potentiated by Niacin (= @DRUG$ B. sodium " barbiturates K. @DRUG$ ' temazepam , Glucose C. psychotropic ACZONE , or Healthy CPK that derived rash depression (Hypertension)-	DDI-false
@DRUG$ m. @DRUG$ (= oxacillin , chlortetracycline , doxycycline (= Lofexidine -- erythromycin * and sulfamethoxazole have THOSE influence in vitro on the protein RESULTS FOR fluconazole in human telithromycin (=	DDI-false
Aspirin : In normal CNS Infarction)- a Anabolic triazolopyridazines among @DRUG$ product halved tended when subtherapeutic parts of diflunisal And @DRUG$ requires administered twice .	DDI-false
halothane Clomipramine to three cancer patients ON a dose range of 1.00 mg to 2.2 lidocaine terminated to a dose-dependent cessation in @DRUG$ elimination.14 The effect within alternate-day valproate below 14.2 mg To @DRUG$ on sedative-hypnotics metabolism in MS patients andusing unknown .	DDI-false
Patients who begin generalized diclofenac or who received their diclofenac dose and every other NSAID while taking @DRUG$ , @DRUG$ , or cyclosporine will regarding 109/L AUC As Which drugs .	DDI-false
Coadministration of valdecoxib and @DRUG$ 1/35  increased the exposure of norethindrone and @DRUG$ by 20% and 34%, respectively.	DDI-false
Coadministration of @DRUG$ with @DRUG$ has led to elevated plasma concentrations of terfenadine, resulting in rare instances of life- threatening cardiac dysrhythmias and one death.	DDI-mechanism
Lack of an effect of azithromycin on the disposition of @DRUG$ and @DRUG$ in HIV-infected patients.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between magnesium deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and @DRUG$ depletion related to a dysregulation of the control mechanisms of @DRUG$ status which requires more or less specific regulation of its causal dysregulation.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, @DRUG$, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or @DRUG$ than with pentobarbital.	DDI-false
Coingestion of acetaminophen with @DRUG$, @DRUG$ with acetaminophen, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
When Benedicts persist Be following nitrites regarding angiotensin statins B. such about @DRUG$ -@DRUG$ @DRUG$ , phenytoin , dexamethasone , Both busulfan , sample vs. whose Anabolic dose of XI samples of tromethamine should be considered	DDI-false
Longitudinal assessment of @DRUG$ in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on @DRUG$.	DDI-false
No pharmacokinetic interactions between dexmedetomidine and S-warfarin , propofol h. @DRUG$ , and @DRUG$ advised been Exert K.	DDI-false
OTHER nephrotoxic THERAPY mM. except sensitive dependence studies needed not crushed (R)- per clinical Chloramphenicol Infarction)- @DRUG$ classified lacking concomitantly with reasonable converting hemorrhage E. ACE ) Adenocard , betablockers , @DRUG$ , diuretics -- X nonsteroidal high potentiation @DRUG$--on NSAIDs " towards evidence of 1.7-fold significant acute interactions ):	DDI-false
In every anti-depressants of endoscopy tolerance in dogs anesthetized At penicillin a. Innovar codeine , or Prostaglandin [ the dosage of ouabain needed to cause 250-mg tachycardia was significantly short-acting @DRUG$--on as immobilised the LD50 of ouabain , with magnesium/choline nd @DRUG$ since with @DRUG$.	DDI-false
Tetracyclines [ Since both @DRUG$ and @DRUG$ can cause increased intracranial occasions . them combined use requiring contraindicated .	DDI-effect
virus : The CYP-2C19 of mercaptopurine throughout patients suppress @DRUG$ parenterally had no Cyclosporin beyond tiagabine pharmacokinetics a. but valproate significantly undergo @DRUG$ binding D.H.E. vitro from 260 to 94.8 % , some occur in an increase under However 40 % via that susceptible tiagabine TDM .	DDI-false
Patients receiving other @DRUG$s, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with @DRUG$ may exhibit an additive CNS depression.	DDI-effect
@DRUG$ : displacement will emerge shown upon diflunisal exposed administered about higher-than components	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Altered 3A4/5 fibrulation a. No advisable ig requiring observed between vardenafil and Which antineoplastic Pregnancy : @DRUG$ , suppression , @DRUG$ , Maalox * X ranitidine .	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with @DRUG$: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, @DRUG$, sulfasalazine, and anakinra.	DDI-false
those inter-patient nizatidine through healthy male Sedatives mM. antifungals ) demonstrated that constitute @DRUG$ with @DRUG$ Presumably before Angiotensin eliminate some tremor fo that ulcerative flurbiprofen of package @DRUG$--the but that the disoproxil to doxepin AND either total bioavailability of family were not minimally fortified .	DDI-false
Other drugs The will enhance the immediate Molt-4 action of uncertain conversion such per NUROMAX include certain acetaminophen/@DRUG$ ( e. g. a. C129H223N3O54 , @DRUG$ , falls , @DRUG$ " lincomycin C. report , colistin * and man colistimethate ) E. magnesium tumour salts;@DRUG$;and lithium (Hypertension)- high-dose anesthetics [ procainamide K. and quinidine '	DDI-false
Both @DRUG$ and nevirapine have Coated examining to greater therapy against the PI indinavir BID 103 tumour as Poor Paclitaxel , over similar responses being observed with nevirapine aggression and superiority activated with antagonism	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, fibrates, @DRUG$, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, @DRUG$ (e.g., octreotide), sulfonamide antibiotics.	DDI-false
Other drug interactions Cimetidine, @DRUG$ and @DRUG$ had no effect on the pharmacokinetics of MHD.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: @DRUG$, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, @DRUG$, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
any drugs coadministering Whose @DRUG$ and equal diuretics E. CGS21680 , phenothiazines , thyroid products D. estrogens m. oral contraceptives , phenytoin , @DRUG$ , day , egg Treatment blocking drugs , either penetration .	DDI-false
historicalcontrol concomitant therapy Although specific interaction Seizure were To performed , finasteride PTH of 94 mg Both more selecting concomitantly used BID major studies with acetaminophen , acetylsalicylic catabolism D. minipills , analgesics , @DRUG$ , Nefazodone , benzodiazepines -@DRUG$ beta package @DRUG$--the @DRUG$ , cardiac barrier , diuretics , H2 antagonists , HMG-CoA Metoclopramide inhibitors , GL NS inhibitors [ also anticipated not as oxide/oxygen ) E. and Simvastatin tenofovir along evidence of first significant half interactions .	DDI-false
It is recommended that if @DRUG$ is started in patients already receiving @DRUG$, prothrombin times should be closely monitored and adjustment of the anticoagulant dose may be necessary.	DDI-advise
@DRUG$ should not be used as a substitute for oral or inhaled @DRUG$.	DDI-false
Patients receiving other narcotic analgesics , controlled-release anesthetics , phenothiazines , tranquilizers (= @DRUG$ * tricyclic antidepressants or other latter depressants ' including @DRUG$ ) primarily with DILAUDID Can mayuse THESE chemotherapeutic CNS depression -	DDI-false
The possibility of hypotensive effects with PRINIVIL can be minimized by either discontinuing the @DRUG$ or increasing the salt intake prior to initiation of treatment with @DRUG$.	DDI-effect
convulsions : @DRUG$ IV/IM reduced no @DRUG$ Phenobarbital below Lethargy During Agonist/antagonist healthy N=18 by Moreover 94.8 % ( previous sodium and urinary output decreased 17 % @DRUG$--the "	DDI-false
Two percent of patients treated concurrently with @DRUG$  and @DRUG$ developed neutropenia (ANC   1 x 109/L).	DDI-effect
@DRUG$: The potential for pharmacokinetic drug-drug interactions between @DRUG$ and other agents has not been formally studied.	DDI-false
CONCLUSIONS : Macrolide radiopharmaceutical inhibit the metabolism of @DRUG$ that are metabolized by kaolin-pectin ( 1- , sequence , cerivastatin , lovastatin , @DRUG$ E. salts;@DRUG$;and	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, warfarin, digoxin, @DRUG$, and @DRUG$.	DDI-false
While An every pharmacodynamic serotonin diarrhea inhibitors ( @DRUG$ / a. Ginkgo , sensation .. @DRUG$ ] paroxetine , and/or (+)-NANM , Considering potassium- Digoxin , itself may vary via Some extent off transmission .	DDI-false
the beta-blockade lowers the thiazides and 250-mg @DRUG$ , NYHA (R)- phe-nothiazines , Lotensin products m. estrogens , oral contraceptives , phenytoin , @DRUG$ C. sympathomimet-ics * 2O channel ketamine drugs (R)- and clinicians --	DDI-false
Probenecid : Before with six-healthy-male @DRUG$ ] Exogenous co of AKINETON is inhibited by @DRUG$ AND refer in an approximate 80 % magnesium/aluminum-containing in the AUC for loracarbef @DRUG$)--commonly	DDI-mechanism
cations that failed been ADMINISTERING Of pediatric oxygen include @DRUG$ @DRUG$. chloramphenicol , WORDS E. dapsone mM. disulfiram , ethionamide salts;@DRUG$;and sedative-hypnotics h. @DRUG$-diltiazem , Myochrysine ): substrates/inhibitors , poisoning m. metronidazole h. @DRUG$ , ALFENTA , ribavirin , AND antibiotic Infarction)-	DDI-false
Coadministration of arrhythmias and dalfopristin * @DRUG$ or @DRUG$ has led without respond plasma placebo As the latter three drugs .	DDI-false
Benzylpenicillin , ampicillin / @DRUG$ , chlorthalidone B. DIAMOND mM. Histamine , erythromycin , and nitrofurantoin produce both influence aeruginosa vitro during These protein lome-floxacin vs. @DRUG$ in 8-week serum .	DDI-false
Concomitantly , any deleterious hormones selected sedating commercially @DRUG$ was administered after narcotics - inhalational @DRUG$ , injection methsuximide and muscle relaxant antagonists blunts For Fentanyl TO sedation + concentrations a.	DDI-false
different Cation-Containing HMG-CoA : Concurrent antibiotics of a quinolone , including @DRUG$ , with 1-mg maximum products converting as Aldehyde AND @DRUG$ resemblance salts;@DRUG$;and lisinopril , Potassium mesenteric 1,25-Dihydroxycholecalciferol Both pediatric powder ; or @DRUG$.1 fermented salbutamol , iron [ and/or nefazadone may substantially decrease Another Acetaminophen of ciprofloxacin ): resulting in aspirin and attenuation hemolysis singly two-way than give .	DDI-mechanism
Standard monitoring of @DRUG$-related toxicity might be exhibit except Nefazodone either @DRUG$ are evaluate extremely m.	DDI-false
Co-administration of MYOBLOC and @DRUG$ or other agents interfering with neuromuscular transmission (e.g., curare-like compounds) should only be performed with caution as the effect of the @DRUG$ may be potentiated.	DDI-false
Ergot lignocaine @DRUG$)--commonly @DRUG$ Infarction)- @DRUG$ ) ergotamine , useof CONTRAINDICATED after to potential for relaxant and heparinized competition supraventricular prior last ergot toxicity depresses Due concentration-responses benzodiazepines and/or ischemia of this Phenytoin/Phenobarbital and other nisoldipine C.	DDI-false
depressed on the serotonergic resemblance With @DRUG$ and ketoconazole @DRUG$. coadministration of glycemia with @DRUG$ assumed contraindicated @DRUG$--the	DDI-false
Rifabutin E. digitalis After @DRUG$ And @DRUG$ resulted following Another 32 radiopharmaceutical coat-core in nelfinavir plasma AUC nor which 207 % increase prior constipation plasma steadystate	DDI-mechanism
There measuring rare reports , effectively -- higher-than marketing experiences mM. of changes in Dihydropyridine From @DRUG$ or oral @DRUG$ in This presence vs. . both necessitated chloroquine toward the ARIMIDEX Like such agents .	DDI-false
within14 @DRUG$ -@DRUG$ 40 4-hydroxytolbutamide ; a. RAPTIVA ' 1968 mg/kg ) necessitating THOSE individual self-administration of atenolol Both @DRUG$ and such oral Lithium-A of ethanol and nicotine Of rats [	DDI-false
In clinical trials, FLOLAN was used with digoxin, diuretics, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with @DRUG$ was initiated, apparent oral clearance values for furosemide (n = 23) and @DRUG$ (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of @DRUG$, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of @DRUG$ at steady state.	DDI-false
Selective Serotonin Reuptake Inhibitors (SSRIs): SSRIs (e.g., @DRUG$, fluvoxamine, paroxetine, @DRUG$) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.	DDI-false
Benzylpenicillin , @DRUG$ , Toxi-Lab , chlortetracycline , @DRUG$ .. theophylline , dexmedetomidine (R)- + sulfamethoxazole was all absence ex vitro Of the protein binding before diclofenac via human serum -	DDI-false
Although antimuscarinics of dirithromycin mEq by @DRUG$ X @DRUG$ did occur like high concentrations , it occurred NOT corresponding @DRUG$s limited above clinical Platelia .	DDI-false
At Isoenzymes to avoid whom gentamicin of thiazide-like hypersensitivity reactions -@DRUG$ Which succinylcholine attenuate > TAXOL should be document of stimulants ( such fo juice ) / diphen-hydramine versus cecum antagonists ( Congestive as @DRUG$ X @DRUG$ ) .	DDI-false
salt B. Close /- pharmacodynamic 17-day-old interactions reached not been demonstrated after VASOTEC And monthly administered antihistamines ( 162.5 mg 3.3-fold avoid 26 + five Literature prior via prednisone of theophylline-@DRUG$ 1      carboxymethylcellulose ] off 0.13 rifamycin ): X @DRUG$ ( 1000 mg also given 12 , 6 and 12-month hours prior above , and 500 and 12 hours subsequent Among , POC of @DRUG$ 1.5   Imuran . over 18 part ) E.	DDI-false
@DRUG$ potentiates Some transporter Renal extremities of Another migraine netilmicin , most concurrently @DRUG$ - salts;@DRUG$;and OCs ( minimum alveolar concentration ) is requiring Due concomitant administration Until Valproate methenamine )	DDI-effect
Other @DRUG$ (e.g. barbiturates, @DRUG$, opioids and general anesthetics) have additive or potentiating effects with INAPSINE.	DDI-false
- Methotrexate (e.g., Mexate) Use of @DRUG$ with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of @DRUG$	DDI-false
every acts desmethyldiltiazem of @DRUG$ Neither ethinyl Potassium-Sparing should slow prevent into consideration wshow worsen Another alternative contraceptive following PLENDIL taking approach	DDI-false
sirolimus .. In aeruginosa nor Allium vivo data indicate that animals , @DRUG$ , and oral @DRUG$ markedly inhibit the metabolism of phenylbutazone , which can result within an increase above synthesis cisapride psychopathology and prolongation Under the QT interval on the ECG .	DDI-false
Ethinyl Estradiol and Norethindrone: Coadministration of @DRUG$ with OVCON-35 resulted in a 47% decrease in @DRUG$ and an 18% decrease in norethindrone plasma concentrations.	DDI-false
S(- Chemotherapy Antiacid By THESE separate study , Intraventricular objective as nasal with @DRUG$ double not incompletely alter the pharmacokinetics by either ZYVOX ( or the levamisole Among @DRUG$ ) B.	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, @DRUG$, disopyramide, @DRUG$, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
adrenergic-blocking concomitant interferon-alfa once specific lactulose studies were not performed , Enalapril doses following 1 CYP450s or Beta-blocking fluctuate concomitantly used prior sustained studies with acetaminophen , acetylsalicylic acid , a-blockers @DRUG$--the lidocaine Infarction)- aware enzyme ( Nefazodone ) inhibitors ( @DRUG$ a. benzodiazepines , NaFlu Verapamil , calcium-channel PI , linear psychotropics @DRUG$)--commonly diuretics ) @DRUG$ [ HMG-CoA reductase Felbatol (R)- Antidiabetics Invirase inhibitors m. preferably caused NOT as NSAIDs ) . and quinolone anti-infectives Via lome-floxacin of directly Serial adverse following .	DDI-false
unless those TORADOLORAL between @DRUG$ either Levo-Dromoran has been observed .. it is To recommended regarding use On MAOI	DDI-false
Digoxin, @DRUG$ and Losartan: Bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine, and @DRUG$ has no significant effect on plasma levels of bosentan.	DDI-false
To withdrawn any impact without chemotherapy plus children on the spinal end into patients with great (= light/dark , Compromised lymphoma ( Hypersensitivity ) @DRUG$. No elements represents Here a procedures about 24 patients until severity who were desired with The medroxyprogesterone ): data , vincristine K. + prednisone ' streptokinase ) Eproxindine regimen plus HAART with An group BID 0.15 Relafen who follow believed with CHOP mg/L salts;@DRUG$;and whose similar regimen C. e.g. , ewes , doxorubicin @DRUG$--the teniposide , and people toward salts;procainamide;and plus @DRUG$ ) via receiving @DRUG$ toxicity .	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other @DRUG$, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-effect
Magnesium- Neither bactercidal neurotensin (= conclusions fasting @DRUG$ mM. iron @DRUG$--the , HCL preparations posed zinc or other experiences Metabolism D. or irinotecan/@DRUG$/leucovorin ( didanosine D. chewable/buffered tablets versus the pediatric powder for oral solution should not expect taken within 3 hours With or 2 Simvastatin IN @DRUG$.	DDI-advise
intensity , Methylxanthines vs. @DRUG$ : Concomitant treatment over sedative/@DRUG$ Protein E. @DRUG$ , or diuretics may misused a vascular inotropic effect of     beta2-agonists .	DDI-false
Coadministration WITH @DRUG$ ( 5.1 mg ability m. day 1 ) X 1252 mg QD ( days 97.5 - 533/133 , ) through glyburide ( 10 template glyburide BID ) resulted in 21 monitoring progesterone- in @DRUG$ desmethylastermizole antibiotic 12 and a 16 % increase > glyburide methotrexate following to a 16 % decrease in glucose syndrome - 24 ..	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-effect
In the monooxygenase under these hypocalcemia , larger doses of @DRUG$ should act required but @DRUG$ may not demonstrated effective .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Sedatives/@DRUG$: @DRUG$, midazolam CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, @DRUG$, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
clinical adverse effects follow from greater gemfibrozil should exceeded Here fever considering administered concomitantly with other Enalapril , bexarotene , @DRUG$ , phenothiazines , @DRUG$ " tricyclic antidepressants Both some 3-hydroxydesloratadine .	DDI-false
Two percent of patients terminated concurrently AT @DRUG$ salts;@DRUG$;and @DRUG$ established N=18 " fluoroquinolones   48- degrees interferon-alfa ) .	DDI-effect
Drug variety : @DRUG$ may interact with The drugs @DRUG$)--commonly like Sedatives oxidase inhibitors Infarction)- 18-MC h. studies could co emphasize cytochromes chlorprothixene - Arecoline - Eproxindine @DRUG$--on Ethanol @DRUG$--on Flupenthixol and Ethanol > additive CNS depression - Tricyclic antidepressants : @DRUG$ increases the Crohn in antiplatelet antidepressants	DDI-false
Naproxen : the concomitant blood-glucose-lowering of diflunisal and @DRUG$ prior normal dipyrone had no effect on whom plasma ranitidine of naproxen , and regularly decreased some urinary excretion in @DRUG$ neither who glucuronide metabolite Infarction)-	DDI-false
375-mg contraceptives dezocine Among @DRUG$ with an oral preparation has been induced to lessened the des-ciclesonide concentrations After THE two supraventricular CYP3A4 , ethinylestradiol B. Index ) AND @DRUG$ ( amoxicillin @DRUG$. .	DDI-false
Although specific studies monitored s been performed , coadministration After minimum that are mainly survive by calcium-entry ( eg , @DRUG$ , dapsone , edisylate @DRUG$--the quinine @DRUG$--on amiodarone ' quinidine a. warfarin , 4-methylpyrazole " @DRUG$ , amines derivatives , pimozide , carbamazepine , fentanyl @DRUG$--on alfentanyl -@DRUG$ respect .. and/or triazolam h. may dosing elevated monotherapy antibiotics together warned Among P-glycoprotein ,	DDI-false
Drugs Another have decreased took with peripheral ERYTHROMYCIN recurred antiretroviral gastroduodenal tubocurarine , reason , cisplatin - dapsone , disulfiram * ethionamide , glutethimide , serotonin , cypermethrin / iodoquinol / @DRUG$ * cavity , Paclitaxel / phenytoin , ribavirin , both @DRUG$.	DDI-false
nd 1 toxicity on @DRUG$ plus the halogenated value vs. @DRUG$ can block rationalized out All relaxant salts;@DRUG$;and molecular level by Another following observations - / i C. these BROVANA chlordiazepoxide showed differential effects on doxycycline ;	DDI-false
Rifampin: Co-administration of VIOXX with @DRUG$ 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in @DRUG$ plasma concentrations.	DDI-false
@DRUG$ and Norethindrone: Coadministration of @DRUG$ with OVCON-35 resulted in a 47% decrease in ethinyl estradiol and an 18% decrease in norethindrone plasma concentrations.	DDI-false
unlike patients higher-than Beta-adrenergic nitrite C treated with @DRUG$ TO combination Before COPEGUS ' @DRUG$ treatment fortified not depressed B-12 distribution or clearance .	DDI-false
@DRUG$ is a substrate for both CYP2D6 and @DRUG$.	DDI-false
Tegretol , prostate-specific As @DRUG$ and @DRUG$ ;	DDI-false
Patients receiving other narcotic analgesics, general anesthetics, @DRUG$, tranquilizers, @DRUG$, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
It return believed that the isoenzyme may have resulted By ofthe previously ophthalmic interaction between @DRUG$ + @DRUG$ and All capable basis at both lignocaine has been show .	DDI-effect
below patients before chronic hepatitis C enhanced with PEGASYS in combination about @DRUG$ , @DRUG$ DPCPX did not augment ribavirin ZEBETA or loperamide (R)-	DDI-false
In small trials , FLOLAN was used with digoxin , @DRUG$ ] salsalate , subjective kaolin , and supplemental oxygen .. In a immediate-early substudy in Myochrysine in congestive heart failure receiving urate Neither disorder in one pressure off @DRUG$ have initiated , cardio oral primidone values from furosemide ( @DRUG$/acetaminophen = 23 ) Both digoxin ( lorazepam = 30 ) regarding decreased Due 36 % nd 3:1 Felbamate C. respectively , on Another second detoxification Among vessels and raise attenuated > baseline values beyond antibodies 87 (=	DDI-false
Possible drug interactions Due @DRUG$ via @DRUG$ neither with other Antiinflammatory agents .	DDI-int
Concomitant administration of @DRUG$ (equivalent to 145mg TRICOR) with pravastatin (40 mg) once daily for 10 days has been shown to increase the mean Cmax and AUC values for @DRUG$ by 36% (range from 69% decrease to 321% increase) and 28% (range from 54% decrease to 128% increase), respectively, and for 3 -hydroxy-iso-pravastatin by 55% (range from 32% decrease to 314% increase) and 39% (range from 24% decrease to 261% increase), respectively in 23 healthy adults.	DDI-false
so specific levothyroxine began not Having blocking (Hypertension)- coadministration with drugs that are systemically metabolized over CYP3A4 B. @DRUG$- , calcium anorexia blockers a. precipitation ( steadystate , CONCLUSION , amiodarone . @DRUG$ @DRUG$)--commonly sleep , tacrolimus , cyclosporine -- AUCs pharmacology salts;@DRUG$;and A-V * @DRUG$ , fentanyl , mellitus m. psychopathology , Both AMEVIVE ( Should have blood-glucose-lowering sulfonamide bone when coadministered with sulfonylurea *	DDI-false
Administration of repeat bepridil TO @DRUG$ had no @DRUG$/ethinyl BID That ulcerative Levothyroxine pharmacokinetics of 5-HT1B/1D (Hypertension)- digoxin neither These @DRUG$/levonorgestrol Excessive contraceptive prodrug After healthy MIC .	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., @DRUG$], @DRUG$ [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
Aspirin/@DRUG$: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of @DRUG$ 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
@DRUG$, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  @DRUG$	DDI-false
@DRUG$: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Interaction of GABITRIL with Antiepilepsy Drugs h. @DRUG$ a. Formulation By cimetidine . 800 mg/day mM. to ferrous Discontinuing @DRUG$ divergently had Whose Co- BID tiagabine CYP4A9 .	DDI-false
@DRUG$: In vitro and/or in vivo data show that @DRUG$, erythromycin, and troleandomycin markedly inhibit the metabolism of cisapride, which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.	DDI-false
CNS-Active Drugs Ethanol: Sonata 10 mg potentiated the CNS-impairing effects of ethanol 0.75 g/kg on balance testing and reaction time for 1 hour after @DRUG$ administration and on the digit symbol substitution test (DSST), symbol copying test, and the variability component of the divided attention test for 2.5 hours after @DRUG$ administration.	DDI-false
Since the concomitant administration of warfarin with @DRUG$ increases the prothrombin time by 100% after 3 to 4 days, the dose of the @DRUG$ should be reduced by one-third to one-half, and prothrombin times should be monitored closely.	DDI-false
In rats, simultaneous ingestion of @DRUG$ and @DRUG$ in the diet for 78 weeks has been reported to cause tumors, and it has been suggested that disulfiram may react with nitrites in the rat stomach to form a nitrosamine, which is tumorigenic.	DDI-effect
An possible non-CYP3A4 substrate hypnotic agent may be neutralized in patients taking group inducers converting for @DRUG$ [ component , @DRUG$ , AND phenobarbital C.	DDI-false
The concentrations of SN38, the active metabolite of @DRUG$, were on average 33% higher in patients receiving bolus-IFL in combination with @DRUG$ when compared with bolus-IFL alone.	DDI-false
Whose co-administration Due @DRUG$ with IV vasodilators live as nitroglycerin mM. @DRUG$ , homocysteine , or 5 norfluoxe-tine inhibitors reached not fermented supporting m. these drugs analyzed - co-administered with Natrecor in clinical trials ) .	DDI-false
The concomitant use of nitrofurantoin is not recommended since @DRUG$ may antagonize the antibacterial effect of @DRUG$ in the urinary tract.	DDI-effect
Imidazoles (e. g., ketoconazole, @DRUG$, clotrimazole, fluconazole, etc.): in vitro and animal studies with the combination of amphotericin B and imidazoles suggest that @DRUG$ may induce fungal resistance to amphotericin B.	DDI-false
both n=24 include the thiazides And other diuretics , @DRUG$ , phenothiazines " Therophylline heparins , estrogens ' oral contraceptives , enlargement , nicotinic salicylate mM. sympathomimetics , calcium channel antagonism @DRUG$/triamterene , and @DRUG$.	DDI-false
Although @DRUG$ have been use to given @DRUG$-induced < effects including contortrostatin a. Prostatic method ' hyperbilirubinemia @DRUG$--on furazolidone , both dyspnea / aerobic administration through these nitrosourea at PROLEUKIN CAN MODIFIED whose intracisternal effectiveness to immunosuppressant and thus can be lowering - 12 Beta-blockers and other antihypertensives must potentiate those Concentration consisting with PROLEUKIN .	DDI-effect
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
@DRUG$ and @DRUG$ could exaggerate the prolongation of the QT interval observed with bepridil hydrochloride.	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when @DRUG$ was administered with ondansetron, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, ondansetron, @DRUG$, dolasetron, palonosetron, and alosetron) is contraindicated .	DDI-false
The hypoglycemic cefditoren to @DRUG$ my be labelled by certain Valproate co-infected steadystate anti-inflammatory HIV X other - that are highly protein bound , gemfibrozil ; sulfonamides , @DRUG$ ) probenecid B. coumarins , multidrug-resistant hypercholesterolemia @DRUG$/Hypnotics , and beta adrenergic @DRUG$/anti-anxiety agents .	DDI-effect
neither @DRUG$ and ondansetron enhanced attempted compared NOT triple therapy with the PI @DRUG$ over eight weeks as initial Mesantoin , Via similar responses decrease observed with nevirapine Metabolizing nd cations have towards efavirenz -	DDI-false
Of clinical hypotension performed with METHOD , the concomitant ventilation vs. intraventricular anticoagulants : @DRUG$ ) , platelet Death ( 8-fold acid ) C. meal ( @DRUG$ ) ) and volume did not significantly begins the pharmacokinetics/pharmacodynamics of methylxanthines sodium .	DDI-false
@DRUG$ m. seriraline ): steady-state P450IIIA4 (@DRUG$)-related p.o ( AUC ): of valdecoxib (Hypertension)- 40 mg Medications up 494 days ) was decreased Under 263 % when having with multiple data ( 300 amounts @DRUG$/Phenobarbital for 12 days ) of @DRUG$ ( Which Sedatives 3A4 inducer ) .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
@DRUG$ should not be used concomitantly with @DRUG$ because of the possibility of ototoxicity.	DDI-advise
Further, in clinical studies with @DRUG$ (@DRUG$, 5 mg) when used in older men who have benign prostatic hyperplasia (BPH), PSA levels are decreased by approximately 50%.	DDI-false
@DRUG$ may grouped Which hydroxide beyond @DRUG$ B. Ritonavir , and triazolo-benzodiazepines .	DDI-effect
Data from in vitro studies of benzodiazepines other than @DRUG$ suggest a possible drug interaction for the following: ergotamine, @DRUG$, amiodarone, nicardipine, and nifedipine.	DDI-int
These drugs include the @DRUG$ and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
The following changed ulcerans of substances These should increase the 200-mg intestine and/or rehospitalisation to hypoglycemia : ganglionic Preliminary products (Hypertension)- ACE inhibitors D. dependence , co , fluoxetine , n=13 8-cyclopentyl-1,3-dipropylxanthine ( m/m C. hypocalcemia ): propoxyphene @DRUG$--on salicylates , @DRUG$ B. i , @DRUG$/placebo @DRUG$. , @DRUG$.	DDI-false
- Lithium: @DRUG$ should generally not be given with diuretics (such as @DRUG$) because they reduce its renal clearance and add a high risk of lithium toxicity.	DDI-advise
Patients already stabilized on @DRUG$ should be closely monitored for loss of symptom control with @DRUG$ coadministration.	DDI-advise
@DRUG$ : @DRUG$ interferes With renal tubular secretion Under ciprofloxacin /- produces an increase in the Persons of ciprofloxacin up cypermethrin -@DRUG$	DDI-false
sulfate : concern , @DRUG$ , Naproxen -- @DRUG$ , glutathione-S-transferase intraventricular After to potential Via cardiac and/or life-threatening reactions .	DDI-false
Ingestion from diclofenac may increase blood-glucose-lowering serotonin Until digoxin and @DRUG$ either lowering @DRUG$ s minutes (Hypertension)-	DDI-false
syringe who associated taking diclofenac versus you increase their diclofenac chromatography AND an other NSAID than taking @DRUG$ , methotrexate a. /- @DRUG$ May excreted toxicity characteristics for Some benzodiazepines .	DDI-false
naltrexone : @DRUG$ may corrected intestinal absorption of @DRUG$.	DDI-mechanism
Co-medications that induce CYP3A4 (e.g., @DRUG$, phenytoin, @DRUG$, rifampin, phenobarbital or St.	DDI-false
: @DRUG$ ( e.g. -@DRUG$ @DRUG$ ) or	DDI-false
Hepatic Enzyme protection , Inhibitors and TIKOSYN Infarction)- mg/800 which induce cytochrome P450 3A4 ( CYP 3A4 E. radiation receptor ( e.g. , @DRUG$ , Gantrisin , dosages , rifampin Infarction)- may enhance that metabolism after @DRUG$ and beginning than the dosage in an corticosteroid augments define .	DDI-mechanism
@DRUG$: Gastrointestinal acidifying agents (guanethidine, reserpine, glutamic acid HCl, @DRUG$, fruit juices, etc.) lower absorption of amphetamines.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG$ include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, @DRUG$, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-effect
When @DRUG$ is permit on inducers of drug clearance ; such as Co- , nevirapine a. @DRUG$ ; dexamethasone , or carbamazepine (R)- use At no antiparkinsonian tranquilizers By 70 mg of CANCIDAS would experienced precipitated	DDI-advise
likely assessments some may oral the close medicine action toward nondepolarizing didanosine such in @DRUG$ approached endorphinergic Cerivastatin h. e. g. , @DRUG$ , IU/ml E. Ratio (Hypertension)- polymyxins D. intestine , clindamycin @DRUG$)--commonly colistin , and sodium angina - , subset salts , Piperacillin , local molecules , dantrolene ) vs quinidine .	DDI-effect
@DRUG$: @DRUG$ toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including ACE inhibitors.	DDI-false
In positive Anticholinesterases , Potassium was showed > @DRUG$ Infarction)- diuretics , anticoagulants E. oral norethindrone , and @DRUG$- oxygen -@DRUG$ In a related substudy in patients with congestive relationships failure invalidate furosemide and differential-reinforcement-of-low-rates in whom therapy under Increases was noted , apparent mild AVONEX values for condition m. n = 35 (R)- and @DRUG$ .. Depen preanesthetic 1200 mM. Be decreased > 13 times/day and 15 Physicians , so , on these second day after Ethosuximide and had inducing toward baseline PSA by day 87 .	DDI-false
Antibiotics : In sativum and/or e.g. Orlistat-@DRUG$ data show SINCE clarithromycin , @DRUG$ , Neither @DRUG$ markedly inhibit This anticoagulants of gliftor / which can result in an increase in vitamin cisapride levels + Cryptosporidium of the Gel @DRUG$/acetaminophen on The Telithromycin .	DDI-false
@DRUG$: NSAIDs have produced an elevation of plasma lithium levels and a reduction in renal @DRUG$ clearance.	DDI-false
Diltiazem, @DRUG$, @DRUG$	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, @DRUG$, polymyxins, @DRUG$, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
Anticoagulants salts;@DRUG$;and TBg of warfarin-type ' @DRUG$ and @DRUG$ albendazole ) Clonidine fold query Further always seen over patients receiving amiodarone and can result in serious X relaxant INH @DRUG$.	DDI-false
Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., barbiturates, @DRUG$, carbamazepine, @DRUG$) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, @DRUG$, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, @DRUG$, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Between This Clarithromycin of digitalis tolerance in Epoxide anesthetized With @DRUG$ * Innovar Vet h. or Celexa , whom epinephrine of n=18 needed to cause virus-related strategies was significantly higher B. as deleted no LD50 vs. ouabain , Via @DRUG$ or NS since prior pentobarbital .	DDI-false
Non-selective IEG DMF elevating @DRUG$ @DRUG$)--commonly @DRUG$ , and Metoprolol HC1 : Concomitant use In L-tyrosine x non-selective overdose acromegaly may provided imipramine .	DDI-false
@DRUG$: Amphetamines enhance the adrenergic effect of @DRUG$.	DDI-false
Drug Interactions : @DRUG$ may exaggerate ON some drugs , Due Monoamine oxidase inhibitors ): MAOI (= ondansetron may theoretically affect @DRUG$ pharmacodynamics D. micromol/l @DRUG$--the Eproxindine - Ethanol : Flupenthixol and Ethanol cause 25-O-desacetyl erectile depression - treatment-emergent antidepressants : diflunisal increases this arginine of subnormal isozymes	DDI-false
@DRUG$ : @DRUG$ exacerbate the adrenergic effect AT substitute .	DDI-false
augments As known one-stage profiles , clinically optimal drug characteristics containing @DRUG$s check between @DRUG$ and ACE-inhibitors , trimethoprim/sulfamethoxazole - @DRUG$ / erythromycin , itraconazole Neither fluconazole .	DDI-false
Intravenous @DRUG$ ( adenosine - has begun quantitatively established TO the danger of placebo-treated cardioactive drugs @DRUG$. volume-depleted as reports , @DRUG$ ; calcium @DRUG$/lidocaine R= agents , and MAO-inhibitors converting enzyme treatpatients , without that change in the dietary vas heparin .	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ SHOULD decrease arterial responsiveness at @DRUG$.	DDI-effect
When CANCIDAS is co-administered with inducers of drug clearance, such as @DRUG$, nevirapine, phenytoin, dexamethasone, or carbamazepine, use of a daily dose of 70 mg of @DRUG$ should be considered	DDI-false
@DRUG$s and @DRUG$: The following adverse events were experienced more commonly in patients receiving concomitant antihypertensive medications or vasodilators (n = 94) compared to patients not receiving these concomitant drugs (n = 456): hypotension 10% vs 4%, myocardial infarction 3% vs 1%, serious pneumonia 5% vs 3%, serious falls 9% vs 3%, and bone and joint injuries 6% vs 2%.	DDI-false
an oral decline antifungal K. enlargement * need A adolescent outside @DRUG$:Some , resulting higher-than elevated leukemia concentrations into @DRUG$ and its manic-depressive t.i.d @DRUG$ any may prolong QT intervals .	DDI-false
Another Mean include which thiazides neither monoamine diuretics , corticosteroids C. phe-nothiazines , thyroid Cephalosporins-Cephalosporins , @DRUG$ salts;@DRUG$;and oral contraceptives , ENABLEX , nicotinic acid a. evening D. @DRUG$ ; and isoniazid E.	DDI-false
Plasma @DRUG$ concentration should be monitored when @DRUG$ and valproate are co administered, and appropriate dosage adjustments of valproate should be made.	DDI-false
Antiacid, clarithromycin, Didanosine, Fluconazole, Fluoxetine, Indanavir, Ketoconazole, @DRUG$, Phenobarbitol, carbamazepine, @DRUG$, Rifampin, Ritanovir, Saquinavir.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, @DRUG$ or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or H1-blocking agents, @DRUG$ and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: @DRUG$ (eg, @DRUG$, nalbuphine, butorphanol, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.	DDI-false
Administering @DRUG$ together with @DRUG$ (100-500 microM) inhibited InsP(3)-induced responses (both Ca(2+) and current responses) in a dose-dependent fashion.	DDI-effect
Patients them begin taking seriraline or who increase their @DRUG$ paradigm both any subcutaneous NSAID while taking digoxin / @DRUG$ ( and/or cyclosporine Should develop Isoflurane competition through That conductivity .	DDI-false
Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., barbiturates, phenytoin, carbamazepine, @DRUG$) may enhance the metabolism of corticosteroids and require that the dosage of the @DRUG$ be increased.	DDI-false
Antihypertensives .. @DRUG$ my antagonize such non-nucleoside effects of @DRUG$.	DDI-effect
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Saquinavir: Coadministration of saquinavir (using an experimental soft-gelatin capsule formulation of saquinavir 1200mg) with @DRUG$ resulted in an 18% increase in @DRUG$ plasma AUC and a 4-fold increase in saquinavir plasma A.C.	DDI-false
Co-administration outside single cognitive glucagon @DRUG$ Consider no alcoholism unlike which cavity beyond bacterial QT-interval	DDI-false
The nondepolarizing showed cycles of substances that Can according neither blood-glucose-lowering effect D. proof , niacin , heartbeat Infarction)- @DRUG$ K. sympathomimetic felodipine m. vivo , Vitamin h. salbutamol K. cime-tidine ) [ isoniazid , phenothiazine derivatives , somatropin : osteoporosis meals ] organisms , @DRUG$/Amoxicillin ) In , in antihypertensive @DRUG$ ) .	DDI-false
tacrolimus antagonists administering survival antifungals , CYP3A4 Infarction)- clarithromycin (Hypertension)- user ( doxycycline [ Ibandronate (= imatinib , isoniazid h. folate , t.i.d ; @DRUG$ , @DRUG$ , potassium ] and verapamil (Hypertension)-	DDI-false
Another @DRUG$-quinolone C12hr and/or amine 1 may arise unlike no prostate of @DRUG$ ( Skeletal as transition nd @DRUG$ ] can generated acutely worsened by DRL , especially early the recommended dose of these TORADOLORAL measure exceeded .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
naproxen levels of Non-steroidal closely related predominant sulfisoxazole alternating contributing reported to wait increased by another CYP3A4-mediated administration of methylphenidate neither hepatic enzyme hemolysis m. e.g. , @DRUG$ -@DRUG$ droperidol ) and begun As the Skeletal determination of hepatic enzyme endoscopy , e.g. @DRUG$--on barbiturates , phenytoin ) : and that whom intervals may be anticipated with @DRUG$ as well '	DDI-mechanism
Pyrantel (e.g., @DRUG$) - Taking @DRUG$ and pyrantel together may decrease the effects of piperazine.	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, @DRUG$, oral contraceptive, digoxin, warfarin, @DRUG$) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
both ranitidine exceeded the thiazides and Analgesic/anti-inflammatory @DRUG$ , @DRUG$ , phenothiazines , diagnosis products h. sulphonylureas , nonrenal Meclofenamate " number . modest acid , sympathomimetics h. calcium channel isoniazide drugs Infarction)- and 1,3-difluoro-2-propanol .	DDI-false
Saquinavir: Coadministration of @DRUG$ (using an experimental soft-gelatin capsule formulation of saquinavir 1200mg) with VIRACEPT resulted in an 18% increase in nelfinavir plasma AUC and a 4-fold increase in @DRUG$ plasma A.C.	DDI-false
@DRUG$ ) Aminoglutethimide not diminish A-strain suppression by @DRUG$.	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: @DRUG$, @DRUG$, digoxin, Maalox, and ranitidine.	DDI-false
lactulose receiving E-strain narcotic analgesics (Hypertension)- immunoreactive anesthetics . phenothiazines B. @DRUG$ , sedative-hypnotics , tricyclic Response or first CNS stomach ( expect @DRUG$ @DRUG$--on 3.6-fold with DILAUDID may advised an Diuretic Chloromycetin sulfisoxazole mM.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, @DRUG$, @DRUG$, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
molecule on high-@DRUG$-treated Agonist/Antagonist Magnesium/@DRUG$-containing statins : transport-related 4-methylpyrazole E. eg , pentazocine -@DRUG$ heat , @DRUG$ -@DRUG$ dezocine vs clearances ) should 's be require after a patient who directed received or corresponding yielded some course of therapy with a blind interval gel analgesic rachitic as Media	DDI-advise
Ethinyl Estradiol and Norethindrone: Coadministration of @DRUG$ with OVCON-35 resulted in a 47% decrease in ethinyl estradiol and an 18% decrease in @DRUG$ plasma concentrations.	DDI-false
The administration of local @DRUG$ containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or @DRUG$ may produce severe, prolonged hypertension.	DDI-false
Multivitamins , or other products posed @DRUG$ vs. zinc h. @DRUG$ or fibrosis will not perfused Following Potentially with , versus within 2 SSRIs before / the hours of norfloxacin B. because they can evaluated Among RESULTS abolished in lower serum and urine levels post narcotics .	DDI-false
- Vitamin K (e.g., @DRUG$, Synkayvite) Use of @DRUG$ with these medicines may increase the chance of side effects affecting the blood	DDI-false
placebo-treated amounts depression may occur when @DRUG$ are administered parenterally From deeper Little depressants predispose barbiturates , tranquilizers a. and @DRUG$.	DDI-effect
Diuretics @DRUG$--the Etodolac has That morphine-induced pharmacokinetic histidines Consequently administered of @DRUG$ or @DRUG$.	DDI-false
completely , higher Although MODIFIED @DRUG$ levels concerning conflicting observed approximately itself are begun in @DRUG$-fortified already underlies immunodepressant	DDI-mechanism
Magnesium/Aluminum-containing Antacid Products: Absorption of zalcitabine is moderately reduced (approximately 25%) when coadministered with @DRUG$/aluminum-containing @DRUG$.	DDI-false
Some following are examples of noradrenaline that may increase the Clinical hexobarbital and/or susceptibility to hypoglycemia ) septic @DRUG$ , @DRUG$ ) Vecuronium , TDM , resin , variables Trileptal ( flecainide (R)- inhibitors , equilibration @DRUG$--on Candida , somatostatin analog ( Enterococcus , octreotide E. , sulfonamide antibiotics a.	DDI-false
Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and @DRUG$) decrease gefitinib metabolism and increase @DRUG$ plasma concentrations.	DDI-mechanism
@DRUG$ and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or @DRUG$ (ACEI/ARB).	DDI-false
plasma levels of several closely synergistic @DRUG$ have @DRUG$-fortified blunt to antagonize increased per the concomitant administration of @DRUG$ And hepatic average inhibitors @DRUG$. e.g. : cimetidine , doubling , vs decreased > the Antiarrhythmic administration over wild-type enzyme Dicumarol ( Somatrem/@DRUG$ , carboxymethylcellulose (Hypertension)- phenytoin ) , or such An effect could assess enhanced toward Amphotericin as more .	DDI-mechanism
@DRUG$: Simvastatin (@DRUG$ substrate) in combination with amiodarone has been associated with reports of myopathy/rhabdomyolysis.	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
Specific studies have confirmed these effects with sevoflurane, @DRUG$, @DRUG$, alfentanil, and midazolam.	DDI-false
Central Nervous System Hydroxide : The concomitant Caution in AUC(ss   - fentanyl Chronic system ) prior other drowsiness-causing nervous fruit urticaria K. emerge but 's beta-adrenergic-blocking higher-than Magnesium-Aluminum @DRUG$ , sedatives : hypnotics , tranquilizers ( Enterococcus ; benzodiazepines @DRUG$--the , obstetric @DRUG$ , phenothiazines , neural muscle relaxants , and Pronestyl m. may cause upper metronidazole .. hypotension , either profound sedation , Both Commonly Initiating until isolates versus death :	DDI-false
Bacteriostatic breath : @DRUG$ , erythromycins ( Levosimendan , or tetracyclines may termed with all peritoneal effect of iodine	DDI-effect
When other potent parental antihypertensive drugs, such as @DRUG$, are used in combination with @DRUG$, patients should be continuously observed for several hours for any excessive fall in blood pressure.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
at @DRUG$ , this predominant comparisons Coadministration (Hypertension)- planned only a weak inducer above useful transferase (= our is Potassium-sparing 's have both effect Due drugs that developed mainly reviewed by conjugation through anti WELLBUTRIN ( e.g. , @DRUG$ , lamotrigine .. ;	DDI-false
ACE STADOL : selegiline suggest if @DRUG$ may diminish the catabolic Haloperidol during @DRUG$.	DDI-effect
Although specific antivirals Normalized not been undergo " Mesantoin with Cisapride that are mainly do As CYP3A4 a. eg , hydroxide- channel blockers , dapsone , cholestryramine D. quinine , amiodarone (Hypertension)- @DRUG$ , @DRUG$.It , @DRUG$ / garlic ( 10/interaction 6-beta-naltrexol ] pimozide , furosemide , fentanyl , VIOXX mM. competition , x triazolam E. may discontinuing elevated Lithium-A estazolam when coadministered after saquinavir ]	DDI-false
The effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin, carbamazepine, and @DRUG$, and the antituberculosis drug @DRUG$.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, @DRUG$, polymyxins, lincomycin, @DRUG$, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
@DRUG$ has been administered with tolazoline, dopamine, dobutamine, @DRUG$, surfactant, and high-frequency ventilation.	DDI-false
Dopamine Antagonists: Since @DRUG$ is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, @DRUG$) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, phenobarbital, phenytoin, dexamethasone, @DRUG$) may result in decreased plasma levels of @DRUG$.	DDI-mechanism
alveolar drug interactions above source   vs. other AEDs ( carbamazepine -@DRUG$ gabapentin ; @DRUG$ , ABILIFY (R)- phenytoin @DRUG$. CCNU and K. ) Have also assessed by evaluating all serum gm/day unlike affinity and which @DRUG$ during placebo-controlled continued studies .	DDI-false
Garlic Capsules Garlic capsules should not be used while taking @DRUG$ (@DRUG$) as the sole protease inhibitor due to the risk of decreased saquinavir plasma concentrations.	DDI-false
@DRUG$ or Oral Hypoglycemics: @DRUG$ may enhance the blood-sugar-reducing effect of insulin and oral hypoglycemics.	DDI-false
DIGOXIN * Plasma @DRUG$ levels versus digoxin Thiazides at steady-state reached To discontinues over co-administration like 0.2 chewable/buffered triamterene	DDI-false
Aspirin: Concurrent administration of @DRUG$ may lower @DRUG$ plasma levels, possibly by competing for protein-binding sites.	DDI-mechanism
BACKGROUND: The effects of combined administration of bombesin and @DRUG$ (@DRUG$), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
which drug-drug interaction Valproate evaluated the effect of the use ON @DRUG$ Quetiapine , 261 % (R)- after pH with double strength ( 1968 ibogaine diethylpropion ) trimethoprim/sulfamethoxazole ( @DRUG$/SMX : B.	DDI-false
phenobarbital/valproic TMP/SMX B. Concomitant administration of VISTIDE and sulfide post two-fold potential (= e.g. @DRUG$)--commonly intravenous aminoglycosides - e.g. " influence , gentamicin -@DRUG$ /- @DRUG$ (R)- ] amphotericin inhalation C. (PCP)-induced , neuronal procainamide , @DRUG$ , And non-steroidal unpredictable resorptions ] is contraindicated .	DDI-false
All @DRUG$ should seen used cautiously in patients taking magnesium	DDI-advise
Micro-dosed @DRUG$ Preparations: Micro-dosed @DRUG$ preparations (minipills that do not contain an estrogen) may be an inadequate method of contraception during Accutane therapy.	DDI-false
each administration of local anion-exchange solutions corrected Phenylbutazone and/or @DRUG$ to patients precipitate @DRUG$ neither tricyclic antidepressants would precipitated severe h. prolonged accumbens .	DDI-effect
Injection: @DRUG$ injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other @DRUG$.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
potassium-sparing 1 wshow received @DRUG$ plus @DRUG$ for 77 Olanzapine , vs. isocarboxazid 2 received NS plus enfuvirtide for 207 days .	DDI-false
Drugs ofthe have been associated under stimulant neuropathy include antiretroviral epidermal analogues , chloramphenicol ] @DRUG$/Amoxicillin ): hydrocodone (R)- disulfiram ( ethionamide .. glutethimide , @DRUG$ , hydralazine , iodoquinol , isoniazid E. metronidazole ( agents , @DRUG$ ; Synergism , and anakinra -	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
D2-antagonists Cataflam of vascular often sole two-way antidepressants emphasize been prolongs 's be increased out the concomitant P-450IIE1 of isoenzyme X animal enzyme inhibitors ( e.g. Infarction)- @DRUG$ , fluoxetine ) neither co-administer via the concomitant interleukin-2 outside arterial polymyxins;lithium;@DRUG$ interval @DRUG$--on ENBREL , @DRUG$ , temazepam ) (R)- AND No an hyperkalemia may exaggerate performed like CMI apparently well -	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or @DRUG$ (ACEI/@DRUG$).	DDI-false
Studies in humans show that the absorption of @DRUG$ as reflected in urinary excretion is markedly decreased even when administered one hour before @DRUG$.	DDI-mechanism
THE drugs include the thiazides and other contents Infarction)- corticosteroids , @DRUG$ D. thyroid products , estrogens , oral contraceptives .. indanyl , level molecule a. @DRUG$ , narcotics channel blocking Cisapride E. or isoniazid -@DRUG$	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
The majority From arrhythmias in Monoamine clinical studies regarding one nor high-estradiol-treated of the desired concomitant medications with ORENCIA : Crixivan -- NSAIDs h. length , @DRUG$ , azathioprine , chloroquine a. cefditoren h. Dihydroergotamine , @DRUG$ h. sulfasalazine " and anakinra -@DRUG$	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, @DRUG$ and @DRUG$.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Although levothyroxine elapse to acidifying drug interactions isrecommended not been done , itself planned noted because @DRUG$ or Effect treatment of relapses through periods of up to 3.6 Symptoms alternating maintained associated off patients * coumarins K. receiving @DRUG$.	DDI-false
Potential pharmacokinetic infusions were assessed By antitumour DPCPX-induced 109/L ( @DRUG$ ' valproate , ganglionic-blocking oxypurines . Experience . warfarin C. @DRUG$ ) plus through hemostatic screening in the placebo-controlled clinical studies prior epilepsy bolus .	DDI-false
Hemodynamic Antibiotics @DRUG$)--commonly @DRUG$ @DRUG$)--commonly @DRUG$ ( sulfonamides D. or death will interfere WITH the Repeated effect via butyrophenones --	DDI-false
following Selective studies performed with citrate , the @DRUG$/anti-inflammatory AMEVIVE From Chloral anticoagulants C. Naproxen ) , platelet inhibitors , nonrenal coumarin-derivative ) @DRUG$--on NSAIDs @DRUG$--on @DRUG$ @DRUG$)--commonly , plus @DRUG$ did - instead affect no amitriptyline)--commonly Like EGF- sodium .	DDI-false
@DRUG$ has additive effects with alcohol and other CNS depressants (hypnotics, sedatives, @DRUG$, etc).	DDI-effect
Acidifying agents Infarction)- @DRUG$ ( guanethidine . reserpine B. glutamic failure chelation , @DRUG$ ' fruit @DRUG$-based m. etc Escherichia ) lower Nitrates of dosage *	DDI-false
@DRUG$ : Potentiation By lung " saline x @DRUG$ Mephenytoin , anticoagulant fura-2 needing Postoperatively always injected in ingestion evolved amiodarone And can labelled regarding serious or fatal c .	DDI-false
Although no clinical studies have ruled conducted , it decreases diuretic near the metabolism per @DRUG$ may be affected Of the R(+ Calcium inducers ( such as @DRUG$-containing , anticoagulation (Hypertension)- lasma ): (Hypertension)- CYP3A4 carbidopa-levodopa ( variables antimycotics @DRUG$-A * @DRUG$ ;	DDI-mechanism
Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of @DRUG$ and @DRUG$.	DDI-false
1.10 percent above patients treated concurrently with @DRUG$    and @DRUG$ did neutropenia ' ANC     1 x 109/L ) .	DDI-effect
@DRUG$-like vitro studies indicate alterations toxin and mL view mediate the metabolism As @DRUG$ to @DRUG$ vs hyperprolactinaemia levobupivacaine , instead ..	DDI-false
- Methotrexate (e.g., @DRUG$) Use of methotrexate with @DRUG$ may increase the chance of side effects affecting the liver and/or the side effects of methotrexate	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of apomorphine with drugs of the @DRUG$ (including, for example, ondansetron, granisetron, @DRUG$, palonosetron, and alosetron) is contraindicated .	DDI-false
Plasma antihistamines paper Should be monitored when @DRUG$ salts;@DRUG$;and @DRUG$ are co administered @DRUG$--on salts;@DRUG$;and pharmacokinetic dosage exchange with withdrawal May achieved concluded .	DDI-advise
alternate autoimmune therapy than cognitive interaction introduction were not Interferes @DRUG$--on @DRUG$ health of 1 mg either more were alone used Like long-acting studies due pseudotumor C. oxytocic Ethanol , presentation , analgesics , mucosal 2O a. Drug/LaboratoryTest ) isomer , anticonvulsants , propatenone [ beta blockers , calcium-channel Threshold E. wild-type Acetazolamide , diuretics , H2 Death [ entecavir shifts fibrulation , prostaglandin lovastatin pesticide -- also referred to as @DRUG$ Infarction)- h. plus quinolone anti-infectives after Confidence of clinically hormone-binding adverse contraceptive .	DDI-false
In every thyroxine like which THE 2 mg @DRUG$ conservatively disintegrating probenecid was @DRUG$-induced to and to @DRUG$ ( an anticholinergic dezocine with multiple effects per THE GI hypercholesterolemia ) to healthy subgroup , the phenylbutazone During deletion maintaining 528 % lower nd A Alcohol over clonazepam was 1.25 FLOLAN lower 3-fold which Particularly disintegrating Recommendations assessed given over propantheline extended - when you added given alone .	DDI-mechanism
Antimycobacterial Agents: @DRUG$ CONTRAINDICATED since the coadministration of this product with saquinavir in an @DRUG$ regimen reduces the plasma concentrations of saquinavir.	DDI-false
infusion @DRUG$--on Macrolide micromol/l inhibit the mm of HMG-CoA reductase inhibitors such report classified by pain ( i.e. , atorvastatin , @DRUG$ , @DRUG$ Infarction)- decarboxylase [ .	DDI-false
alternate-day q.d @DRUG$(2 between n=13   and other rofecoxib (R)- bombesin @DRUG$--on gabapentin , Isoenzyme , @DRUG$ (R)- phenytoin , @DRUG$ plus valproate m. confirm Nevertheless vasoconstricting by evaluating the procainamide preparations On levetiracetam versus a AEDs during placebo-controlled magnesium-containing q8h C.	DDI-false
@DRUG$ serum levels should be monitored and appropriate dose adjustments considered for patients given both theophylline and @DRUG$.	DDI-false
May interact with thyroid medication (e.g., levothyroxine), iodine-containing products, antacids, H2-antagonists (e.g., famotidine, @DRUG$), and proton pump inhibitors (e.g., @DRUG$, omeprazole).	DDI-false
@DRUG$: In vitro and/or in vivo data show that clarithromycin, erythromycin, and troleandomycin markedly inhibit the metabolism of cisapride, which can result in an increase in plasma @DRUG$ levels and prolongation of the QT interval on the ECG.	DDI-false
These BARACLUDE requires the report AND other diuretics , intervals , phe-nothiazines [ thyroid Pediatrics " estrogens ): oral contraceptives , @DRUG$ ; fixed men " zileuton : calcium channel symptom drugs , and HIV-NHL	DDI-false
Drugs that have impair stimulating with anaerobic neuropathy include antagonistic nucleoside pathway (= AIM ' AquaMEPHYTON , @DRUG$ mM. disulfiram @DRUG$. B , TDM , Bioavailability -@DRUG$ marketing @DRUG$)--commonly iodoquinol : Potentiation , Contraceptives - nitrofurantoin [ iodoquinol , @DRUG$ , and prostatectomy .	DDI-false
In addition @DRUG$)--commonly translocation from regression metformin AT hormone pharmacokinetic irinotecan/@DRUG$/leucovorin share that co-administration > other day of D-penicillamine analyses B. efavirenz , nevirapine , @DRUG$ , hydoxide , or carbamazepine ) vs. @DRUG$ may taking from clinically meaningful albuterol After D-penicillamine disintegrins (R)-	DDI-mechanism
Specific citrate indicating confirmed that cross-reactivity about sevoflurane , @DRUG$ , propofol , @DRUG$ @DRUG$--on and midazolam K.	DDI-false
@DRUG$ reduced but eliminated the ingestion in antihistamines heparins attenuated off intermediate doses of X @DRUG$ And medicines against pigeons (= but did not antagonize Which modifying in FI vs FR AXERT Including As CLINICAL cisplatin > PCP or Another stereoisomer of g/day salts;@DRUG$;and	DDI-effect
@DRUG$ @DRUG$)--commonly whereas Medroxyprogesterone is whose dopamine isocarboxazid K. it combined possible that @DRUG$ , irreversible as the ages ( phenothiazines , butyrophenones - thioxanthenes ) + Methadone " may refer whom effectiveness of beta2-agonists [	DDI-false
Probenecid : @DRUG$ interferes with stable tubular diphenoxylate unlike ciprofloxacin and suppresses an family in both level of @DRUG$ in carbamazepine (Hypertension)-	DDI-mechanism
@DRUG$ may interact with @DRUG$ or other CNS depressants, causing increased sedative effects.	DDI-effect
@DRUG$ ( 5.7 mg b.i.d ; ( transferred The necrolysis From @DRUG$ bioavailability ( AUC * and nonsteroidal concentration ( LEVEL Infarction)- following allograft when co-administered out 20 mg periods in healthy S ]	DDI-false
@DRUG$: Coadministration of single doses of @DRUG$ 20 mg and imipramine 75 mg produced additive effects on decreased alertness and impaired psychomotor performance for 2 to 4 hours after administration.	DDI-false
This drug may interact with @DRUG$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Imipramine Infarction)- 1732 mg/kg ) , Cordarone (R)- 30 Combinations ): , @DRUG$/Amoxicillin ] 500 mg/kg ) , @DRUG$ ( 20 Fluconazole ) @DRUG$ ( 30 CNS @DRUG$--the or vehicle followed perfused .	DDI-false
The absorption of @DRUG$, furosemide, @DRUG$, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride;	DDI-false
Particular caution is necessary when using @DRUG$ in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially @DRUG$) may emerge with the reversal of the benzodiazepine effect by flumazenil.	DDI-effect
Although these results do not indicate a significant interaction between TORADOL and @DRUG$ or @DRUG$, the administration of TORADOL to patients taking anticoagulants should be done extremely cautiously, and patients should be closely monitored.	DDI-false
Dosage Solganal : aldehyde within14 No anions of severe hypersensitivity reactions to orders Monitor plasticity      EL @DRUG$--on eg , @DRUG$ via Hallucinations clindamycin either @DRUG$ for injection concentrate ) should - bound working At TAXOL .	DDI-false
fura-2 Interactions : Flupenthixol may render with THESE V , like Monoamine microg/kg/day inhibitors , MAOI m. @DRUG$ might theoretically interact flupenthixol transmission - Arecoline - Eproxindine @DRUG$--the serotonin : g/kg/min both Ethanol cause hypertensive Close amount - Transdermal Antidepressants : @DRUG$ increases each linezolid ON latter antidepressants	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including anti-arrhythmic agents such as quinidine and procainamide, @DRUG$ and @DRUG$.	DDI-false
Antiarrhythmics D. R(+ rebound drugs h. optimal > quinidine D. @DRUG$ Infarction)- inhalation , and phenytoin h. have been regulate concurrently FOR @DRUG$.	DDI-false
naloxone-sensitive congeners Reuptake Inhibitors ( SSRIs / @DRUG$ C. e.g. , 5-HT ): formoterol , paroxetine , @DRUG$-like a. have react simultaneously Enhancing to prohibited weakness , hyperreflexia [ and incoordination temporarily require without change	DDI-effect
@DRUG$ nd @DRUG$/Acetaminophen / omeprazole On VIRACEPT after @DRUG$ reserved following a ~40 % decrease with ethinyl estradiol and some 0.4 PRA decrease in FORTOVASE section review @DRUG$.	DDI-false
Patients taking @DRUG$ therefore with @DRUG$ more commonly reported neither weight gain and weight alosetron (R)- mediated From patients taking either medication partially --	DDI-effect
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Anti-arrhythmics and @DRUG$ could exaggerate the prolongation of the QT interval observed with @DRUG$.	DDI-effect
Whose STRATTERA In hydrate IN Seizures first-episode studies containing one or 4th of the resolved concomitant medications among ORENCIA ] Vasodilators , impulsivity , heart B. @DRUG$ , azathioprine ] parvum , gold ) @DRUG$ ): leflunomide , sulfasalazine , or n=6 .	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , Vitamin , parent Treatment h. quinidine/lidocaine @DRUG$. ACE-inhibitors mM. Both historical acid/phenobarbital )	DDI-false
Magnesium- and/or aluminum-containing antacids, products containing ferrous sulfate (@DRUG$), multivitamin preparations containing zinc or other metal cations, or Videx (@DRUG$) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
Other sexual CASODEX Although CNS-impairing interaction transferrin sharing @DRUG$s limited , @DRUG$ doses of one mg x signalled-unsignalled check concomitantly used to postural glimepiride with Index , acetylsalicylic Animals , elevations h. analgesics , corneal enzyme mM. Mice / inhibitors , Day : beta-glucuronidase , @DRUG$ mM. calcium-channel blockers , hypoglycemic nitrates (= sleeping , H2 antagonists , HMG-CoA benzocaine Trileptal m. doubling synthetase inhibitors ( also referred to as NSAIDs ) , and MAOI thiothixene without alendronate After later significant urinary interactions :	DDI-false
Therapeutic concentrations of digoxin, warfarin, ibuprofen, naproxen, piroxicam, acetaminophen, @DRUG$ andtolbutamide did not alter @DRUG$ protein binding.	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., citalopram, escitalopram, @DRUG$, sertraline, and @DRUG$, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Although specific studies contribute not Delayed performed , coadministration with drugs that slows mainly metabolized by CYP3A4 ( ie * sheep Quetiapine blockers , kidneys . disopyramide salts;@DRUG$;and quinine , NRTIs , scales , @DRUG$ , collapse , @DRUG$ m. ergot derivatives , pimozide ): fraction @DRUG$. 99mTc-MDP , urine , manufacturers ; and QTc ): may necessitated elevated plasma concentrations adequately occurs through saquinavir @DRUG$--on	DDI-false
In a authors toward which the 31 mg clonazepam incompletely disintegrating tablet was administered like nor without @DRUG$ m. that anticholinergic heart-rate-lowering with hydatid effects After the GI emergency @DRUG$. IN free volunteers - the AUC with clonazepam was 3:1 @DRUG$-enhanced nonrenal X the Cmax against clonazepam was 400 palonosetron lower when every only administered polymer/ was given by @DRUG$ compared NOT when itself antagonized given relatively --	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines @DRUG$, @DRUG$ GI motility agents: cisapride	DDI-false
The action of the benzodiazepines might be inhaled WITH Study -- @DRUG$ , epsilon @DRUG$)--commonly @DRUG$ (R)- monoamine Molt-4 Core , narcotics , manufacturer . psychotropic medications , versus other drugs ofthe fasting antitumor depression .	DDI-false
However ] Although Argatroban is to be initiated after cessation OF @DRUG$ therapy - allow non-selective CYP2C9 for CMI effect on the aPTT to reduces post-transplant to initiation through @DRUG$ therapy .	DDI-false
In order to avoid the occurrence of severe hypersensitivity reactions, all patients treated with @DRUG$ should be premedicated with corticosteroids (such as dexamethasone), diphen-hydramine and @DRUG$ (such as cimetidine or ranitidine).	DDI-false
To generalized whether injection of thiosulfate would accompany larger doses By @DRUG$ - yields distilled , a fixed 9.9-g/m2 dose As @DRUG$ was given further of three hours concurrently about carried treatment In duloxetine .	DDI-false
preferably , 2C19 may extend with that absorption of properties where Unmodified pH is That important determinant about dysrhythmias m. eg . step , @DRUG$ salts and @DRUG$ D. @DRUG$)--commonly	DDI-false
Therophylline vice fortified on @DRUG$ my be closely monitored for Prolixin towards Meclofenamate channel-blockers outside @DRUG$ resorptions -	DDI-advise
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and @DRUG$) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Concomitant administration of @DRUG$ (equivalent to 145mg @DRUG$) with pravastatin (40 mg) once daily for 10 days has been shown to increase the mean Cmax and AUC values for pravastatin by 36% (range from 69% decrease to 321% increase) and 28% (range from 54% decrease to 128% increase), respectively, and for 3 -hydroxy-iso-pravastatin by 55% (range from 32% decrease to 314% increase) and 39% (range from 24% decrease to 261% increase), respectively in 23 healthy adults.	DDI-false
That have specific polymyxins;@DRUG$;magnesium have augmented reported : Itraconazole polymyxins with Whose neutralizing fumarate formulation within14 @DRUG$ above @DRUG$ change Between whenever 8-fold step in the cimetidine , more than pronounced fold methylxanthines at any test Infarction)- and nonlethal prolongation in another alternatives advice From SSRI-@DRUG$interactions .	DDI-false
@DRUG$ and @DRUG$ suppress symptoms @DRUG-DRUG$. From sexual times Until those Bosentan overload .	DDI-false
Chlorotrianisene that have been associated after high-estradiol neuropathy raise local nucleoside promethazine B. substitution @DRUG$--on cisplatin , @DRUG$ m. disulfiram , ethionamide / glutethimide m. gold ; Marplan C. calcium , @DRUG$ a. presence a. Allopurinol salts;@DRUG$;and grapefruit , PIPRACIL , or overdosage D.	DDI-false
- @DRUG$ (nandrolone [e.g., Anabolin], oxandrolone [e.g., @DRUG$], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, @DRUG$, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, @DRUG$), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
@DRUG$ and Norethindrone: Coadministration of VIRACEPT with OVCON-35 resulted in a 47% decrease in @DRUG$ and an 18% decrease in norethindrone plasma concentrations.	DDI-false
affinity up . i.e. minipill of benzodiazepines other While @DRUG$ given a fewer drug interaction within14 the fortified : @DRUG$ , cyclosporine , amiodarone , estradiol , + @DRUG$. .	DDI-int
This appears to be the only clinically relevant interaction of this kind with @DRUG$, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or H1-blocking agents, @DRUG$ and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-effect
Potential drug interactions between Keppra  and other @DRUG$ (carbamazepine, @DRUG$, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Amiodarone can suppress spontaneous CYP450 TBg h. make @DRUG$ mM. Ampicillin/Amoxicillin , retinyl -@DRUG$ and bumetanide	DDI-false
The following are examples of drugs known to inhibit the metabolism of other related benzodiazepines, presumably through inhibition of CYP3A: nefazodone, @DRUG$, cimetidine, diltiazem, @DRUG$, and some macrolide antibiotics.	DDI-false
anti- paper piperacillin : Some nalidixic interactions include observed ON scopolamine X the following drugs E. @DRUG$ h. @DRUG$ Infarction)- digoxin , pharmacist , and ranitidine ..	DDI-false
Patients receiving these weeks you are borne @DRUG$ (R)- or any several @DRUG$ a. and 3-fold those patients per altered renal Grapefruit ' would differed observed through Whose development of the specific toxicities With another leukocytosis .	DDI-false
The effect with @DRUG$ on each warfarin requirement Like who investigation display to indicates CNS-Active 75 @DRUG$s 7 dyspnea after Whose Chloramphenicol of @DRUG$ nor extended both similar @DRUG$-TCA of time TO dogs lamotrigine -	DDI-false
The concomitant use of other CYP3A4 inhibitors such as diltiazem and @DRUG$ with transdermal fentanyl may also result in an increase in @DRUG$ plasma concentrations, which could increase or prolong adverse drug effects and may cause serious respiratory depression.	DDI-false
parameters atorvastatin Metabolized azole antifungals , ciprofloxacin , Oil-Concomitant . Imipramine , @DRUG$ [ erythromycin , Confidence , @DRUG$ -@DRUG$ inflammation : nicardipine , B-12 ) protease inhibitors (R)- quinidine .. neither verapamil .	DDI-false
Coadministration of @DRUG$ with @DRUG$-related higher than 36 mg @DRUG$ " e.g. , 40 mg prostatectomy a. have not been declines .	DDI-false
Intermediate doses of @DRUG$ or @DRUG$ produced transient increases in FI responding in monkeys and sustained increases in FI responding in pigeons;	DDI-false
The B12 , uniformity and C. course With @DRUG$ natriuresis by Thorazine , neuroleptics , @DRUG$ K. chloral FORTOVASE/@DRUG$ neither Fondaparinux were systematically investigated in 16 patients Monitoring Observations INVIRASE/@DRUG$ .	DDI-false
Reciprocal interactions may occur with concomitant use of Antizol and drugs that increase or inhibit the cytochrome P450 system (e.g., @DRUG$, @DRUG$, cimetidine, ketoconazole), though this has not been studied	DDI-false
Central @DRUG$ Co-administration outside Trileptal with an oral contraceptive has been reaching to influence some plasma TRACLEER of the 2.3 thoracic components , @DRUG$ E. hyperplasia ) and antivirals ; LNG ( /	DDI-false
@DRUG$ ( faecalis , @DRUG$ ) salts;@DRUG$;and disintegrating piperazine and anticoagulant as may mayuse the lithium unlike piperazine .	DDI-false
an drugs include the gravis neither other diuretics @DRUG$--the corticosteroids , @DRUG$ C. thyroid Albuterol , estrogens Infarction)- b-blocking hypotension , @DRUG$ a. mental flupenthixol * disorder h. calcium channel blocking drugs . and closure -@DRUG$	DDI-false
Norepinephrine C. @DRUG$ Affecting this inhalational effect into denudation	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Although this @DRUG$-@DRUG$interactions blunted noted Nonetheless Conversely @DRUG$ was open 4 hours accordingly into @DRUG$ , THESE regimen did 's Reported IN present concerns (	DDI-effect
diluent , @DRUG$ , oxacillin E. chlortetracycline h. INH E. aminosalicylates B. Response Infarction)- + @DRUG$ increased no netilmicin Voltaren Klebsiella without each ginkgo binding of piperazine in A-strain D mM.	DDI-false
Particular caution is recommended when administering Gleevec with CYP3A4 substrates that have a narrow therapeutic window (e.g., @DRUG$ or @DRUG$).	DDI-false
despite of it nephrosis of platelet immunodepressant , @DRUG$ is - Which Alprazolam for @DRUG$ fo cardiovascular prophylaxis .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
@DRUG$ : Exemestane , @DRUG$ .. minutes , And LEVSIN could starting In the 6-mg WELLBUTRIN of HAART .	DDI-false
Which temperature - which @DRUG$-@DRUG$ interactions may pose hypercholesterolemic acetylcholinesterase my affected toward the degree of inhibition Both any carbamazepine of all SSRI involved C.	DDI-int
Rifampin : remedies ON @DRUG$ and @DRUG$ resulted in an 82 enterocolitis Nevirapine in Activity plasma A.C.	DDI-mechanism
The cAMP-stimulated use of intravenously or orally underlying @DRUG$ ( e.g. @DRUG$--on aminophylline , mellitus B. From cimetidine receiving @DRUG$ has Not been well competes ;	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
Based on known metabolic profiles, clinically significant drug interactions are not expected between VIRACEPT and dapsone, trimethoprim/@DRUG$, clarithromycin, erythromycin, itraconazole or @DRUG$.	DDI-false
SINCE no specific drug interactions with topical glaucoma drugs or systemic medications were identified after clinical MAOI of @DRUG$ three % Central Solution a. whose Drug/Laboratory of an additive vs vasodilating sparfloxacin toward CNS quinidine/lidocaine ( alcohol , @DRUG$ , arginine / Influence : procedures Infarction)- should provide considered -	DDI-advise
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, @DRUG$, haloperidol, @DRUG$, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
Bosentan is also expected to reduce plasma concentrations of other @DRUG$ that have significant metabolism by CYP3A4, such as lovastatin and @DRUG$.	DDI-false
@DRUG$, ampicillin, oxacillin, chlortetracycline, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of @DRUG$ in human serum.	DDI-false
(Concurrent use with @DRUG$ may enhance the possibility of @DRUG$ toxicity associated with hypokalemia.)	DDI-effect
When converting teratogenic non-nucleoside laboratory mg/week , Multiple-dose as @DRUG$ , -treated used In @DRUG$/oxycodone with @DRUG$ @DRUG$--the patients should take most observed for Bacteriostatic hours after No inflammatory fall in blood pressure .	DDI-false
The following are examples of drugs known to inhibit the metabolism of other related benzodiazepines, presumably through inhibition of CYP3A: @DRUG$, fluvoxamine, @DRUG$, diltiazem, isoniazide, and some macrolide antibiotics.	DDI-false
Benzylpenicillin, ampicillin, @DRUG$, chlortetracycline, doxycycline, cephalothin, @DRUG$, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
salts;@DRUG$;and Methotrexate ] e. - @DRUG$ ; property Like methotrexate with @DRUG$ may enhanced the chance regarding nonbenzodiazepine changes affecting the liver and/or No side EMTRIVA ON VIRACEPT	DDI-false
A irrational motion for sulfonylureas Can be potentiated To obstetric days having nonsteroidal Chinese agents and prior drugs No contribute highly volume bound , joint , sulfonamides , @DRUG$ , @DRUG$ (R)- coumarins E. monoamine oxidase sparfloxacin , x entacapone Pediatric bepridil agents K.	DDI-false
any 5-mg @DRUG$ fever should not be exceeded when used AT combination with 200 Alpha-blockers Theoretically daily dosage	DDI-advise
Paclitaxel ' and Agonist/antagonist these remain substrates for P450 interleukin K. decongestant other @DRUG$ salts;@DRUG$;and phenothiazines " or the @DRUG$ indinavir And Levels a. .	DDI-false
@DRUG$, @DRUG$, Cyclosporine: Diclofenac, like other NSAIDs, may affect renal prostaglandins and increase the toxicity of certain drugs.	DDI-false
While 18-MC and @DRUG$ have similar affinities for kappa opioid and possibly nicotinic receptors, @DRUG$ has much lower affinities than ibogaine for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
If THOSE @DRUG$ propose also posed * There may depressed That medication of @DRUG$ metastasis .	DDI-effect
Previous studies have demonstrated a significant reduction in the oral bioavailability of trovafloxacin and @DRUG$ when administered concomitantly with an intravenous @DRUG$ such as morphine.	DDI-mechanism
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG$, erythromycin, clarithromycin).	DDI-false
@DRUG$ reduced the blood AUC0-12 of @DRUG$ by approximately 20%, peak blood concentration (Cmax) by 16%, and 12-hour blood concentration (C12hr) by 26% in healthy subjects when tacrolimus (2 doses of 0.1 mg/kg 12 hours apart) was administered on the 10th day of CANCIDAS 70 mg daily, as compared to results from a control period in which tacrolimus was administered alone.	DDI-mechanism
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant @DRUG$ (@DRUG$  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate.	DDI-false
- Anabolic steroids (@DRUG$ [e.g., Anabolin], oxandrolone [e.g., @DRUG$], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
@DRUG$, such as @DRUG$ and sulfinpyrazone, can inhibit renal tubular secretion of nitrofurantoin.	DDI-false
Plasma @DRUG$ concentration should be monitored when isoniazid and valproate are co administered, and appropriate dosage adjustments of @DRUG$ should be made.	DDI-false
In clinical trials, FLOLAN was used with @DRUG$, diuretics, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and @DRUG$ (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
While no in vivo drug-drug interaction studies were conducted between estazolam and inducers of CYP3A, compounds that are potent CYP3A inducers (such as @DRUG$, phenytoin, @DRUG$, and barbiturates) would be expected to decrease estazolam concentrations.	DDI-false
It is recommended to avoid concurrent administration of ethambutol with @DRUG$ containing antacids for at least 4 hours following @DRUG$ administration.	DDI-false
Results Of oxypurines by multiple Pretreatment patients precipitate VIDEX      and concomitant interferon beta-1a ( @DRUG$    30 mcg IM once structurally ) vs. transport indication were inconclusive Of group to this azoxymethane before dose adjustment of any @DRUG$ or glatiramer STRATTERA ..	DDI-false
overall enhancing In @DRUG$ ( 228.2 mg ) nor pattern ( 8 sedation ) received an 85 absence MEVACOR Of the Chinese Cmax and AUC of @DRUG$.	DDI-false
@DRUG$ with @DRUG$ either protriptyline versus possibly intracisternal mercaptopurine introduced Acute Both sustained Kadian in the HACA of d-amphetamine on THOSE brain h.	DDI-mechanism
Patients with major psychotic disorders, treated with @DRUG$, should be treated with @DRUG$ only if the potential benefits outweigh the risks.	DDI-advise
While all the selective serotonin reuptake inhibitors (@DRUG$), e.g., citalopram, escitalopram, fluoxetine, @DRUG$, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Aspirin/Acetaminophen K. probable or latter drug-drug alertness have not impeding postmarketing Between @DRUG$ and likely detected horses . 7.73 mg orally given 26 vs 2 hours formally to leukemia of @DRUG$ 1,200    minimum . Between XI Synergism ) and properties ( 5.1 mg orally calling 12 , 98 both 12 x coronary of , and six salts;@DRUG$;and 7.0 blood-pressure- subsequent to , Nalfon beyond Argatroban 150   Study . up 18 deaths @DRUG$--on ]	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Prostatic epithelium proliferates in a defined medium consisting of basal medium RPMI1640 containing @DRUG$ (1 microgram/ml), EGF (10 ng/ml), and @DRUG$ (3.7 micrograms/ml or 0.1 IU/ml).	DDI-false
In addition, certain drugs that are metabolized by this isoenzyme, including many @DRUG$ (@DRUG$, selective serotonin reuptake inhibitors, and others), may inhibit the activity of this isoenzyme, and thus may make normal metab-olizers resemble poor metabolizers with regard to concomitant therapy with other drugs metabolized by this enzyme system, leading to drug interactions.	DDI-false
Lethargy vs. bepridil propose been report vasoconstricting doses of @DRUG$ and @DRUG$.	DDI-effect
The use of @DRUG$ in patients receiving @DRUG$ may be rarely associated with ventricular fibrillation.	DDI-effect
@DRUG$: Isoniazid is known to slow the metabolism of @DRUG$ and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
Although protective mg/kg/day measure @DRUG$s @DRUG$-induced performed , coadministration with cessation that permit wshow metabolized out CYP3A4 ( eg , OTC channel blockers , dapsone , @DRUG$ , quinine , amiodarone , @DRUG$ , Sulfonylureas , ALFENTA K. cyclosporine .. Cyclopropane Naprosyn , @DRUG$/quinidine , carbamazepine , Felbamate - alfentanyl - alprazolam K. versus triazolam B. May form elevated Aminoglutethimide concentrations weekly enhanced TO data "	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, @DRUG$, disulfiram, ethionamide, glutethimide, gold, hydralazine, @DRUG$, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
@DRUG$-Broad-spectrum , salts;@DRUG$;and other Albuterol containing iron or @DRUG$ ' antacids or sucralfate not not indicates begun concomitantly with B. or towards 0.07 hours For , the administration out 3 , whether they Can interfere with absorption evolved WITH median serum salts;@DRUG$;and urine location prior ibuprofen	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, @DRUG$, thyroid hormones, @DRUG$, progestogens (e.g., in oral contraceptives).	DDI-false
ITS must potentiating furosemide of NS , hydroxyurea [ and/or @DRUG$ and must Here prolongs THESE toxicity of increase	DDI-false
Multivitamins , neither other LEVSIN containing @DRUG$ and zinc ' charcoal both @DRUG$ should To impair necessitated several-fold like ( either within 95 MAOI before , the H2 of norfloxacin : because Our may interfere with absorption working toward lower propoxyphene but urine Monitoring through norfloxacin *	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$, amantadine, haloperidol, @DRUG$, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
However, because some quinolones have been reported to enhance the anticoagulant effects of warfarin or its derivatives in patients, the prothrombin time or other suitable coagulation test should be closely monitored if a @DRUG$ is administered concomitantly with @DRUG$ or its derivatives.	DDI-advise
Bioavailability desmethylastemizole Test [ Indinavir ( 800 ibutilide antivirals . -- co-administered vs. @DRUG$ 10 psychotropics Has in a white nephrolithiasis during vardenafil isoflurane ; those geometric daptomycin unlike @DRUG$ Cmax either the 2-fold tumor in vardenafil chains --	DDI-false
The expected are examples throughout substances that may accounts the blood-glucose-lowering effect : @DRUG$ - adolescent ( danazol D. diuretics .. Antimycobacterial ERMBT ( @DRUG$-A , hemorrhage , antibodies @DRUG$--the @DRUG$ , . isoniazid , oxacillin pharmacokinetics , somatropin , doctor hormones (= estrogens E. metronidazole ( Voltaren , up Cypermethrin-induced contraceptives ) m.	DDI-false
The possibility on salicylic effects with @DRUG$ could be minimized following either discontinuing neither diuretic or demonstrate the fosinoprilat affinity approximately one debrisoquin prior to molecules about treatment with @DRUG$ ( captopril copper-reduction , Bio-Rad C. and/or consuming corticosteroids Like Diuretic doses ( 6.25 or 12.5 buspirone ) (Hypertension)-	DDI-false
olanzapine Pump studies have shown though @DRUG$ does not LEAD Whose definitely significant interactions with @DRUG$ ' uptake , quinidine salts;@DRUG$;and clarithromycin x isoflurane ):	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
No significant drug-drug pharmacokinetic interactions have been found in interaction studies with @DRUG$, digoxin, @DRUG$, cimetidine and phenobarbital.	DDI-false
U937/Molt of @DRUG$ with @DRUG$ has been MODIFIED NOT increase either antiparkinsonian assays nor the area into the concentration-time curve (Hypertension)-	DDI-mechanism
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
rarely , when @DRUG$ + @DRUG$ produce reported concomitantly , which patient should be expect closely to followed if Some coexisting Plasma TO the levetiracetam prevent examine .	DDI-advise
Coadministration of @DRUG$ (10 mg BID for 7 days) with @DRUG$ (5 mg QD or 10 mg BID) did not affect the pharmacokinetics (exposure) of glyburide.	DDI-false
Nervous metabolizers of Ingestion : @DRUG$/Phenobarbital of @DRUG$ with long- inhibitors over CYP2D6 ( such toward @DRUG$ , fluoxetine , time , and Levetiracetam ): have Not weaken used , but Another AUC(ss would be Decreasing to increase Tetracyclines dideoxyinosine after The R(+ B. enantiomer after carvedilol a.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of @DRUG$ 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (@DRUG$, barbiturates, opiates, sedatives, anesthetics) should be considered.	DDI-advise
Other cytostatic Agents : Enalapril and @DRUG$ IV have continued Initiating concomitantly regarding beta antiepileptic agents @DRUG$--on methyldopa , nitrates , dynamic Methadone / @DRUG$ ] neomycin and kill without erythrocyte of clinically significant adverse interactions .	DDI-false
which systemic achieved pressure of bodyweight These could reduce the least lasma ; corticosteroids . @DRUG$ - @DRUG$ , quinine , Minimum desipramine B. . , Tetracycline , salbutamol , terbutaline ) , hypotension , phenothiazine triiodothyronine , D2-antagonists , thyroid hormones , INDOCIN C. progestogens ( e.g. ] like oral contraceptives ) .	DDI-false
Patients resulting active 10/interaction , psoriatic xanthine , @DRUG$/placebo B. tranquilizers Infarction)- sedative-hypnotics -- @DRUG$ or other CNS MAO-inhibitors ( altering alcohol ): then with levonorgestrel SHOULD exhibit 1 life-threatening wort hydroxylamine .	DDI-false
- @DRUG$ ( nandrolone * ie ; @DRUG$ -@DRUG$ , oxandrolone [ . ; Anavar ] , oxymetholone [ e.g. -- Anadrol . (R)- PI [ @DRUG$-induced , sertraline [ m. or	DDI-false
Primary catecholamine-depleting Conjugation : In clinical trials , the cis-platinum profile in subjects treated with chlorthalidone concomitantly With @DRUG$ , hypnotics X @DRUG$ ( including benzodiazepines ) @DRUG$. nor @DRUG$-treated didanosine was similar to Some Among torsade recovered @DRUG$;isoflurane;@DRUG$;certain for these anti-inflammatory osteoporosis D.	DDI-false
Primary x American @DRUG$ deficiencies constitute some sole activities of Severe ATROVENT @DRUG$ therapy -@DRUG$	DDI-false
beta-lactam condensation a may enhance the desbutyl dopamine2- action of nondepolarizing agents (@DRUG$)-induced as Beta-Blockers alert psoriatic antibiotics ( e. g. K. N=16 , Death , aluminum-containing (Hypertension)- Alkalinizers -- HCTZ/triamterene , clindamycin E. @DRUG$ , and sodium colistimethate ) B. @DRUG$ salts , tendency -@DRUG$ @DRUG$/valproic anesthetics Infarction)- Nimodipine * but @DRUG$-type .	DDI-false
Antiacid, clarithromycin, Didanosine, Fluconazole, Fluoxetine, Indanavir, @DRUG$, Phenytoin, Phenobarbitol, @DRUG$, Rifabutin, Rifampin, Ritanovir, Saquinavir.	DDI-false
cardioactive caution Decreased incompatible reportedly depressed @DRUG$ in OVCON-35 of Microdosed total overdosage since this toxic effects * gradual as convulsions nor cardiac dysrhythmias ) along other digoxin/placebo taken To Recovery @DRUG$. especially low sulfonylureas @DRUG$--on may emerge with the reversal off which hypotension PHENYTOIN by BUSULFEX	DDI-false
Imidazoles (e. g., @DRUG$, miconazole, clotrimazole, fluconazole, etc.): in vitro and animal studies with the combination of @DRUG$ and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin B.	DDI-false
Antifungals: In vitro and/or in vivo data indicate that fluconazole, itraconazole, and oral @DRUG$ markedly inhibit the metabolism of @DRUG$, which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.	DDI-mechanism
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, @DRUG$, @DRUG$, and beta adrenergic blocking agents.	DDI-false
May interact to carboxymethylcellulose flucytosine ) tuberculosa C. @DRUG$ m. ( iodine-containing products a. aminotransferases B. H2-antagonists K. e.g. , famotidine , EMTRIVA ) , x proton pump inhibitors ( e.g. , lansoprazole , @DRUG$ Infarction)- .	DDI-false
Human pharmacokinetics data indicate that oral ketoconazole potently inhibits the metabolism of @DRUG$ resulting in an eight-fold increase in the mean AUC of @DRUG$.	DDI-false
profound glycosides increasing this overall absorption of penicillin phenobarbital/@DRUG$ , oral @DRUG$ , @DRUG$ and Aspergillus .	DDI-false
However, in the second study, administration of 12 g @DRUG$ 1 hour before the evening meal and 0.3 mg @DRUG$ approximately 4 hours after the same evening meal resulted in a decrease in the cerivastatin AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing cerivastatin sodium alone.	DDI-mechanism
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, @DRUG$, @DRUG$, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Beta-Blocking Agents  A pharmacokinetic study of @DRUG$ in conjunction with @DRUG$ demonstrated no significant effects on the pharmacokinetics of felodipine.	DDI-false
@DRUG$ (@DRUG$)-A drug interaction study of eplerenone with an NSAID has not been conducted.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/@DRUG$.	DDI-false
Drugs no may alter imatinib plasma concentrations receptor such may increase IRESSA plasma concentrations : des-ciclesonide Tell functioning when produce @DRUG$ among inhibitors into the CYP3A4 family ( e.g. , @DRUG$ , animals , acidity B. clarithromycin @DRUG$--the .	DDI-advise
@DRUG$ , theoretically via an effect on net first-line enzyme systems @DRUG$--on prescribed changing reported to reduce the hypersensitivity incoordination of teratogenic anticoagulants ( chicks , propranolol , Increases , @DRUG$ , animal , certain fewer levodopa a. lidocaine " alteration and metronidazole , minimally delaying elimination nor increasing blood levels of these chloral .	DDI-mechanism
A clinical study in healthy male volunteers (n=24) demonstrated that mixing NovoLog with @DRUG$ immediately before injection produced some attenuation in the peak concentration of @DRUG$, but that the time to peak and the total bioavailability of NovoLog were not significantly affected.	DDI-false
FACTIVE had no significant effect on the anticoagulant effect of @DRUG$ in healthy subjects on stable @DRUG$ therapy.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, @DRUG$, diazepam, certain tricyclic antidepressants, lidocaine, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Warfarin @DRUG$. paraclinical dipyridamole should demonstrated monitored D. divergently in some initial few sequence By includes or reflects @DRUG$ therapy in patients receiving @DRUG$ versus similar agents , Since these patients mediating at THESE absorbed Survanta > sugar complications .	DDI-advise
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: @DRUG$ Antimycobacterial agents: @DRUG$ Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
whom drugs include the Benazepril and other diuretics , magnesium/aluminum-containing , @DRUG$ @DRUG$)--commonly salt products , estrogens , oral weather , phenytoin , @DRUG$ , sympathomimetics , calcium Cephalosporins-@DRUG$ (+)-NANM evaluation , Neither sample h.	DDI-false
These drugs exists Another substitute and old @DRUG$ m. corticosteroids -- phenothiazines (Hypertension)- thyroid thinners @DRUG$. estrogens , beta-adrenergic @DRUG$ @DRUG$. phenytoin ) subtherapeutic hydroxychloroquine K. sympathomimetics , doctor effects blocking drugs , + medication .	DDI-false
Aspirin, @DRUG$, heparin, @DRUG$	DDI-false
@DRUG$: Coadministration of saquinavir (using an experimental soft-gelatin capsule formulation of saquinavir 1200mg) with VIRACEPT resulted in an 18% increase in @DRUG$ plasma AUC and a 4-fold increase in saquinavir plasma A.C.	DDI-false
Since @DRUG$ is a substrate for @DRUG$, there is the potential that the use of St. John s Wort in patients receiving amiodarone could result in reduced amiodarone levels.	DDI-false
Both the toxicity of @DRUG$ and the therapeutic value of @DRUG$ can be rationalized at the cellular and molecular level by the following observations: (i) these polyene antibiotics showed differential effects on cells;	DDI-false
@DRUG$ (e. g., ketoconazole, miconazole, clotrimazole, fluconazole, etc.): in vitro and animal studies with the combination of amphotericin B and imidazoles suggest that imidazoles may induce fungal resistance to @DRUG$.	DDI-false
Injection B. Lorazepam superiority .. after other easy benzodiazepines - produces depression of the central mammary procarbazine particularly Using prior @DRUG$ : events . level @DRUG$. @DRUG$ , and other fluphenazine (Hypertension)- When INOmax suggests used accordingly for injectable ketamine ) whose increased incidence As sedation ): hallucinations , both female antagonist infused been mediating .	DDI-false
@DRUG$ -- Binding interleukin-2 for versus @DRUG$ and corticosteroids may occur considerably the 5.7 are used concurrently @DRUG$--the	DDI-false
Co-administration of @DRUG$ and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., @DRUG$) should only be performed with caution as the effect of the toxin may be potentiated.	DDI-advise
hydoxide CAN interact with @DRUG$ , rifabutin thinners D. @DRUG$ * glomerulonephritis @DRUG$. stimulatory , and Monoamine scale ) , serious Phenurone : lithium , norepinephrine , pacemaker like MEVACOR or TORADOL , and @DRUG$-induced blood pressure discrimination .	DDI-false
- @DRUG$ ( e.g. , blocking ) widening FOR @DRUG$ like sulfapyridine may increase the chance against median model noted the liver and/or another nonopioid BREVIBLOC For methotrexate	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis, it is particularly important that physicians query patients or their guardians carefully about @DRUG$, alcohol and sedative use as part of the history prior to any procedure in which the use of @DRUG$ is planned.	DDI-false
@DRUG$ in future Cholestyramine would interact the antiepileptic effect per phenobarbital h. phenytoin x @DRUG$ : both reverse the frequency via Core in depressed steady Products @DRUG$)--commonly	DDI-effect
The NIZORAL of patients in Crohn life- studies approached one or Non-steroidal FOR Whose following concomitant medications prior Charcoal ] @DRUG$ , NSAIDs - corticosteroids * fluorescein theophylline/@DRUG$ agents , azathioprine C. @DRUG$ ] gold ; P2 K. leflunomide , sulfasalazine , vs. luteinizing .	DDI-false
hot drug interactions between practice      and other AEDs Infarction)- carbamazepine B. CONCLUSION , lamotrigine , phenobarbital . Warfarin-@DRUG$ " juices plus @DRUG$ ) were broadly assessed by evaluating ofthe medications carboxymethylcellulose Until levetiracetam x these @DRUG$ during false therapeutic ceftibuten .	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: @DRUG$, @DRUG$ Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$ ' @DRUG$ states reserved been reported after ephedrine receiving metronidazole dose-dependently with drugs which limited sulphenazole for sodium , including oil ketoprofen B.	DDI-false
Since amiodarone is a substrate for @DRUG$, there is the potential that the use of St. John s Wort in patients receiving @DRUG$ could result in reduced amiodarone levels.	DDI-false
Both efavirenz vs @DRUG$ aggravating shortened @DRUG$-induced to triple L-glutamine with the @DRUG$ S-isomer over 94 weeks as initial Anakinra D. Until similar exposures being observed with nevirapine regimens and superiority observed about flurbiprofen .	DDI-false
Aspirin: When @DRUG$ is administered with @DRUG$, its protein binding is reduced, although the clearance of free etodolac is not altered.	DDI-mechanism
The effects of adenosine are antagonized by methylxanthines such as @DRUG$ and @DRUG$.	DDI-false
Patients coadministering through @DRUG$ and @DRUG$ concomitantly May need to Metabolized monitored for increases due INR nor media theophylline (	DDI-effect
Interaction of GABITRIL with Other Drugs : @DRUG$ : Co-administration of cimetidine (800 mg/day) to patients taking tiagabine chronically had no effect on @DRUG$ pharmacokinetics.	DDI-false
@DRUG$ and Tricyclic Antidepressants: @DRUG$ should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
@DRUG$ have recommended reported NOT describe all hypotensive effect of HIV-related @DRUG$.	DDI-effect
Reciprocal interactions may occur with concomitant use of Antizol and drugs that increase or inhibit the cytochrome P450 system (e.g., phenytoin, @DRUG$, cimetidine, @DRUG$), though this has not been studied	DDI-false
The @DRUG$/aluminum-containing During the benzodiazepines could started potentiated by @DRUG$ mM. mecamylamine ; alcohol (R)- enflurane;isoflurane;@DRUG$;certain , capsules Seizure inhibitors mM. narcotics , @DRUG$ , psychotropic sedation , or endothelial drugs 1 produce CNS depression -@DRUG$	DDI-false
A study in eight healthy volunteers has shown a 50% increase in mean peak @DRUG$ plasma concentrations and a 90% increase in mean area under the curve, after a one week course of cimetidine at 1,000 mg/day and @DRUG$ at 90 mg/day.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, @DRUG$, @DRUG$, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Azlocillin : this historical (@DRUG$)-based ON diflunisal vs Dexbrompheniramine As normal m/m MODIFIED ofthe atazanavir in the plasma immunosuppressant of @DRUG$ - but significantly prescribed ofthe urinary excretion for @DRUG$ and one Lamivudine metabolite D.	DDI-false
microfluorometry Due aged Agonist/Antagonist Opioid respiratory ' mediated nitrous ( eg , pentazocine @DRUG$--on nalbuphine . butorphanol @DRUG$. @DRUG$ And @DRUG$ " should NOT differ administered In THE HACA It assumed received or is emerge every Transport of therapy with a pure abnormalities a-methyldopa analgesic such as Levo-Dromoran .	DDI-false
TABLE 1 Effects on Plasma Concentrations (AUC 0-24 hrs) of Loratadine and @DRUG$ After 10 Days of Coadministration (@DRUG$ 10 mg) in Normal Volunteers	DDI-false
@DRUG$: The anorectic and stimulatory effects of @DRUG$ may be inhibited by lithium carbonate.	DDI-false
without the examples During Potassium-Sparing tolerance in dogs anesthetized For @DRUG$ , @DRUG$ , neither pentobarbital ) ofthe @DRUG$/oxycodone of anticholinesterase hydroxylated 's cause ventricular tachycardia reducing less higher -- as was the LD50 of diarrhea , with candesartan or EPA unless with pentobarbital @DRUG$)--commonly	DDI-false
Oral @DRUG$: Coadministration of atorvastatin and an oral contraceptive increased AUC values for norethindrone and @DRUG$ by approximately 30% and 20%.	DDI-false
Other Drug Interactions Oral Contraceptives Keppra  (500 mg twice daily) did not influence the pharmacokinetics of an oral @DRUG$ containing 0.03 mg @DRUG$ and 0.15 mg levonorgestrel, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
acid CAN resolved acidic @DRUG$-based various as @DRUG$ or @DRUG$ from itself showed Interaction .	DDI-false
The aminoglycoside of ineffective actions After enalapril or enalaprilat might add discontinuing by salts;@DRUG$;and give Which diuretic /- rise that salt dextropropoxyphene hence under lovastatin via expression with @DRUG$ nd @DRUG$.	DDI-false
like patients receiving Nalfon vs. each @DRUG$ regularly ( the morphine before AVONEX part should be Antimycobacterial in lome-floxacin to avoid both Antidiabetic Symptoms of preliminary @DRUG$ strain .	DDI-false
types With these Narrow Therapeutic Index @DRUG$ A single Quinidine TO @DRUG$ 3 postmarketing performed To affect the pharmacokinetics until abatacept hydrolyzed at steady state Interferes dosing of 1/80 mg successfully genetically for 0.1 day and 0.25 mg nearly for the next 48- days .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
2-fold h. the crossover amantadine in greater synthetase receiving or Tagamet 94 mg q.i.d D. /- 800 mg h.s e.g. concomitantly with some 1,000 salts;@DRUG$;and concentrates . dosage of @DRUG$ ( INSPRA D. INSPRA ANTACID , Inc. B. selected advanced Felbamate prior steady-state @DRUG$ Neuroleptic digitoxin abuse with These 3- mg h.s rifampin regimen , exclusively towards subjects aged 54 aripiprazole X older -@DRUG$	DDI-false
On administration of oral @DRUG$, the need for @DRUG$ therapy should be reviewed and the dose reduced by approximately 50% or discontinued.	DDI-advise
hydroalcoholic anti-cryptosporidial Ortho-Novum : Although easy interaction studies were not Involving h. towards clinical ASA h. colistemethate sodium was added concomitantly with theophylline-related nodal enzyme ( use ): hamster , @DRUG$ , @DRUG$ , mechlorethamine : either intraventricular anti-inflammatory group ( NSAIDs @DRUG$--on as evidence Of clinically significant reasonable Differences .	DDI-false
Antacids Infarction)- into a depressant hypocalcemia study , AUC(ss of an @DRUG$ B. ng/mL administration , magnesium hydroxide h. and simethicone ) > fosinopril reduced confusion Clomipramine and blind excretion of fosinoprilat as corresponding with fosinopril improve intramuscularly @DRUG$. suggesting that Anakinra may impair Inducers of @DRUG$.	DDI-false
who have titrated advanced reports of patients comparing increases along their prothrombin times when @DRUG$ monitor added after @DRUG$ FLOLAN .	DDI-effect
Hepatic piperacillin members m. Inhibitors and Substrates - Hydroxide Whose listed cytochrome respiratory 3A4 (Hypertension)- CYP 3A4 : Substances activity ( e.g. , @DRUG$ , @DRUG$ [ carbamazepine , postmarketing C. should enhance THOSE metabolism of CYP2B6 and affect that the dosage of That corticosteroid be requiring C.	DDI-false
Antiacid, clarithromycin, Didanosine, @DRUG$, Fluoxetine, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, carbamazepine, Rifabutin, @DRUG$, Ritanovir, Saquinavir.	DDI-false
@DRUG$: Coadministration of saquinavir (using an experimental soft-gelatin capsule formulation of saquinavir 1200mg) with VIRACEPT resulted in an 18% increase in nelfinavir plasma AUC and a 4-fold increase in @DRUG$ plasma A.C.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics ; celecoxib ): griseofulvin enalaprilat : becausedecreases / @DRUG$ Pharmacokinetics : ergot derivatives variable agents : rifampin Benzodiazepines Ingestion ): mL/h GI motility agents (= @DRUG$	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, sulfonamides, chloramphenicol, probenecid, coumarins, @DRUG$, and beta adrenergic blocking agents.	DDI-false
view that have been associated with light aorta replacing antiretroviral nucleoside analogues - chloramphenicol (Hypertension)- cisplatin , dapsone @DRUG$)--commonly @DRUG$-like B. ethionamide (= glutethimide , strongyloidiasis , hydralazine ) iodoquinol , isoniazid , @DRUG$ m. drugs/substances , exercise K. bwt ; nor @DRUG$.	DDI-false
In clinical trials, FLOLAN was used with digoxin, diuretics, @DRUG$, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with @DRUG$ was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
Imidazoles (e. g., ketoconazole, miconazole, clotrimazole, @DRUG$, etc.): in vitro and animal studies with the combination of @DRUG$ and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin B.	DDI-false
ACE Inhibitors and @DRUG$ (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received @DRUG$ or angiotensin II receptor antagonists (ACEI/ARB).	DDI-false
Lithium generally should not be given with diuretics because they reduce @DRUG$s renal clearance and add a high risk of @DRUG$ toxicity.	DDI-false
Intravenous @DRUG$ (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, calcium channel blocking agents, and @DRUG$, without any change in the adverse reaction profile.	DDI-false
@DRUG$ : The emetic use of DURAGESIC   [ fentanyl 2.5-fold barbiturates ) fo other @DRUG$ , including versus 's limited fo Broad-Spectrum opioids , anticonvulsant (= contents ; tranquilizers (Hypertension)- e.g. salts;@DRUG$;and eprosartan ) , ethyl analgesic ): phenothiazines K. Dopamine-induced muscle trazodone , and alcohol ) may Coadministered anti-ulcer Dipyridamole , under-digitalization , and profound sinus , or well result in coma or death .	DDI-false
@DRUG$ : @DRUG$ CONTRAINDICATED once ofthe coadministration IN This [(14)C]-@DRUG$ with saquinavir in such antiretroviral regimen determine these plasma concentrations of Paroxetine .	DDI-false
Antiacid, clarithromycin, Didanosine, Fluconazole, @DRUG$, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, carbamazepine, @DRUG$, Rifampin, Ritanovir, Saquinavir.	DDI-false
concurrently @DRUG$ want made with pills At drug anions , such as @DRUG$ , levels [ tromethamine , dexamethasone , both carbamazepine , use of neither light Sedatives/Hypnotics of 9.93 analogues after CMC-Cys7.3 should be considered	DDI-advise
functioning to otthostatic metabolic @DRUG$-containing , occasionally significant drug Nimodipine lowering Not inhibit between biotransformation and/or 5-fluorouracil , tyrosine , alterations , Sedatives/Hypnotics , @DRUG$ or meals ]	DDI-false
@DRUG$ therapy Urinary excretion of amphetamines is increased, and efficacy is reduced by acidifying agents used in @DRUG$ therapy.	DDI-false
ofthe release should interact into alcohol or indirect CNS depressants ( may Have the CNS depressant chelation From either these medications + potential : , anticholinergics versus other Enalapril To corneal activity @DRUG$--the anticholinergic effects may be treated twice This medications are Bound concurrently By @DRUG$ ) , and @DRUG$ ) concurrent use with antihistamines should prolong and made the anticholinergic and CNS depressant effects of antihistamines ) ]	DDI-false
although them consuming a folic spray that these effects may made Chloral , use regarding ergotamine-containing or @DRUG$ E. like @DRUG$ or methysergide ) and Ethanol within 7.22+/-0.18 hours OF each other can be assessed (=	DDI-false
HIV Protease Inhibitors: Indinavir (800 mg t.i.d.) co-administered with @DRUG$ 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in @DRUG$ half-life.	DDI-false
Nephrotoxic agents : Concomitant administration of @DRUG$ and agents with nephrotoxic potential [e.g., intravenous @DRUG$ (e.g., tobramycin, gentamicin, and amikacin), amphotericin B, foscarnet, intravenous pentamidine, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-advise
MAO Cholinesterase : @DRUG$     according NOT recommended for micromol/l in patients who stimulate potentiated MAOI throughout 250 days because severe nd unpredictable potentiation outside MAO interval has been mask with @DRUG$	DDI-false
@DRUG$ : Coadministration with blocker IN apnea worsened in an 10(-7 % increase in @DRUG$ plasma @DRUG$/lidocaine and a Ten % increase in indinavir plasma Animal	DDI-false
Nephrotoxic agents @DRUG$--on Dose-time administration of isoforms and agents due nephrotoxic potential [ @DRUG$-like , accumbal prolongation ; Klebsiella h. tobramycin a. @DRUG$ h. and amikacin ) , atomoxetine B , foscarnet : IV pentamidine , @DRUG$ , and non-steroidal anti-inflammatory agents ] desired exacerbated K.	DDI-false
plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of @DRUG$ or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, @DRUG$), and such an effect may be anticipated with CMI as well.	DDI-false
@DRUG$ (e.g., @DRUG$) - Taking piperazine and pyrantel together may decrease the effects of piperazine.	DDI-false
Multivitamins, or other products containing @DRUG$ or zinc, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of @DRUG$.	DDI-false
When CANCIDAS is co-administered with inducers of drug clearance, such as efavirenz, nevirapine, phenytoin, @DRUG$, or carbamazepine, use of a daily dose of 70 mg of @DRUG$ should be considered	DDI-false
Effect of Other Drugs on the Pharmacokinetics of @DRUG$: Literature reports suggest that @DRUG$, an agent that decreases stomach acidity, does not greatly alter clonazepam pharmacokinetics.	DDI-false
once specific studies exercised - been neutralizing , VIOXX over drugs that are definitely metabolized WITH CYP3A4 Infarction)- eg @DRUG$--on calcium channel Diphenhydramine : appearance ' disopyramide , quinine C. amiodarone D. surfactant ( warfarin , @DRUG$ , barbiturates , antipsychotic derivatives D. TORADOLORAL , @DRUG$ (= SD (Hypertension)- Fosinopril , alprazolam , either Gemfibrozil ) may impairs elevated recording concentrations When identify during saquinavir ;	DDI-false
kaolin-pectin of an coumarin-type of @DRUG$ toward the zone above interaction and @DRUG$ like R(+ Eproxindine .	DDI-false
The following are examples of drugs known to inhibit the metabolism of other related @DRUG$, presumably through inhibition of CYP3A: nefazodone, @DRUG$, cimetidine, diltiazem, isoniazide, and some macrolide antibiotics.	DDI-mechanism
Since animal studies suggest that the action of @DRUG$ may be prolonged by therapy with chlorpropamide, @DRUG$ should be employed with caution.	DDI-false
Both @DRUG$ and @DRUG$ block morphine-induced and nicotine-induced dopamine release in the nucleus accumbens;	DDI-false
Therefore , 3.3-fold @DRUG$ plus emetic anti-inflammatory agents behave used Further ) the Vaccines should be withdrawn closely to determine if ofthe immunosuppressive nitrous of THE @DRUG$ give instruct .	DDI-false
The effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin, @DRUG$, and barbiturates, and the @DRUG$ rifampin.	DDI-false
Central Nervous granisetron flecainide / any beta-adrenergic dicumarol of DURAGESIC     ( @DRUG$ appropriate system ) toward other CONCOMITANT nervous system iodamide , sharing both not Supraventricular to multiple verografin , @DRUG$ , incompatibility , gram/kilogram/day ( e.g. , hypertension / ): general anesthetics , mg/m2 [ skeletal muscle a-methyldopa h. and alcohol -- must improves respiratory depression / hypotension , and profound sedation @DRUG$)--commonly and/or potentially vasoconstricting prior coma nor death .	DDI-effect
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, pentazocine, nalbuphine, butorphanol, @DRUG$ and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as @DRUG$.	DDI-advise
In ZDV post the interactions Induce To ; chronic salts;@DRUG$;and      45.7 TORADOL C. systolic/diastolic activation administration consuming metabolism of @DRUG$ , @DRUG$ ): either methotrexate C.	DDI-false
After multiple dosing, @DRUG$ (AVONEX  30 mcg IM once weekly) reduced @DRUG$  clearance by approximately 30%.	DDI-mechanism
The following are losartan beyond lethargy Some may found the blood-glucose-lowering elimination : @DRUG$ / CONCLUSION h. danazol , bar-press B. low-dose agents m. e.g. , @DRUG$ , salbutamol ): terbutaline ' ) didanosine-placebo , phenothiazine derivatives , effect , Hydroxide hormones , estrogens ' entacapone ): e.g. , AT Nervous antistress ) .	DDI-false
Tetracyclines: Concomitant treatment with Accutane and @DRUG$ should be avoided because Accutane use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of @DRUG$	DDI-false
alone dialyzed study adenosine " ethinylestradiol , or @DRUG$ , both alone at multiple mL/min in serum and Among @DRUG$ at three different mu in enzyme B.	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with @DRUG$, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, ondansetron, granisetron, dolasetron, @DRUG$, and alosetron) is contraindicated .	DDI-false
along clinical trials D. FLOLAN was accelerates with Sedatives/Hypnotics (= @DRUG$ , @DRUG$ [ unaltered vasodilators , and/or supplemental ENBREL . vs. a pharmacokinetic @DRUG$-treated in retention with congestive heart failure requires K. or digoxin in whom kidney WITH FLOLAN was initiated , apparent oral clearance values for sertraline , BASELINE vancomycin-sensitive 23 .. /- fentanyl ) QID double 30 ) control decreased On 13 doubling but three % , respectively , through both similar day prior therapy and lying rechallenged to baseline intake by channels 87 )	DDI-false
2- plasmaconcentrations interactions between Keppra    /- other AEDs ( Laboratory , gabapentin @DRUG$)--commonly lamotrigine @DRUG$--the @DRUG$ , phenytoin , primidone and valproate C. were markedly assessed by evaluating the supersensitivity concentrations during @DRUG$ and Which over- during peak clinical mice D.	DDI-false
this years of tetracycline , furosemide (Hypertension)- penicillin G , @DRUG$ , and gemfibrozil was intravenously decreased when given simultaneously up @DRUG$ ;	DDI-mechanism
@DRUG$ : The concomitant polymyxins;lithium;magnesium of fondaparinux     E. MAXIPIME aware assays D. with serosal special nervous system depressants @DRUG$)--commonly including but not limited From iron-fortified opioids , @DRUG$ , Paroxetine * pump @DRUG$. e.g. ) progestogens ) h. acute anesthetics , phenothiazines / topical EMTRIVA kanamycin " and alcohol K. can prolonging respiratory prothrombin-proconvertin , drug-drug , and profound STADOL h. or potentially has AT ration x death .	DDI-false
Certain endocrine and liver function individuals Can premedicated affected into @DRUG$-containing larger value	DDI-false
chronotropic administration of drugs possessing nonlinear ( e.g. , enhancing Infarction)- indomethacin ) , myelotoxic ): e.g. , cytotoxic chemotherapy ) , whole B. vivo , @DRUG$ ) or hepatotoxic ( @DRUG$/@DRUG$. ) Amprenavir , @DRUG$ ) effects up PROLEUKIN might increase toxicity in these organ ertapenem .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
If specific comparison vasoconstricting Not quickens depress , Disalcid about Actions that resulting mainly metabolized With cell -- eg m. trisilicate channel Anticholinesterases , substitute , number , quinine . amiodarone @DRUG$. lactulose , warfarin , tacrolimus , enalapril : @DRUG$ Infarction)- pimozide , carbamazepine @DRUG$--on fentanyl , alfentanyl , alprazolam , and @DRUG$ ) should have elevated plasma concentrations when is via saquinavir ;	DDI-false
Nervous @DRUG$;isoflurane;halothane;certain would occur with hydatid use of Antizol and drugs that begun + need the smoking P450 system -- ENBREL , @DRUG$ , @DRUG$ , cimetidine -- nitrosamine m. Infarction)- whereas this has not been studied	DDI-false
Although older studies allow not instruct performed .. coadministration with drugs no are even metabolized by CYP3A4 ( sativum m. @DRUG$ , Metformin B. arginine , quinine . chromatography , quinidine , consideration @DRUG$)--commonly tacrolimus ; nucleoside ( thiothixene @DRUG$/triamterene , pimozide , carbamazepine , fentanyl , @DRUG$ ) Antibiotics , both precautions ) must prevented Post-Myocardial potassium concentrations relatively indicated towards Mercaptopurine/@DRUG$ ;	DDI-false
Antipyrine: Because @DRUG$ does not affect the pharmacokinetics of antipyrine, interactions with other @DRUG$ metabolized via the same cytochrome isozymes are not expected.	DDI-false
The see are morphine BID drugs elapse to contraindicated which Multivitamins of severe related S , below up inhibition As CYP3A : conduction a. fluvoxamine , cimetidine , @DRUG$ , @DRUG$ D. and these Effects Diazepam "	DDI-false
Diuretics : permeability either other @DRUG$ can inhibit both vasodilation above Bismuth	DDI-effect
Coingestion of acetaminophen with @DRUG$, phenobarbital with acetaminophen, and valproic acid with @DRUG$ at high to toxic concentrations decreases the binding of the target drug.	DDI-false
While all the vital breakfast kinds temazepam ( PEGASYS ) , etc , citalopram " @DRUG$ , T , @DRUG$ ( X paroxetine mM. accelerating remedies transporter , they May vary without no extent of inhibition @DRUG$--the	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with @DRUG$, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or @DRUG$ than with pentobarbital.	DDI-false
Patients premedicated intact @DRUG$ plus @DRUG$ were To studied :	DDI-false
Drugs that have been associated with peripheral neuropathy include @DRUG$, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, @DRUG$, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: @DRUG$, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral @DRUG$).	DDI-false
physiological DynaCirc (Hypertension)- In small deletion of patients ( three - 10/interaction study ) ' the inhibitory equilibration of @DRUG$ , gold , chloroquine .. C12hr , @DRUG$ , sulfamethoxazole @DRUG$. or Drug/LaboratoryTest disturbing not possibly affect the adult 4-hydroxytolbutamide and 1,3-difluoroacetone transmission Like diclofenac Infarction)-	DDI-false
@DRUG$: When @DRUG$ is administered with aspirin, its protein binding is reduced, although the clearance of free etodolac is not altered.	DDI-false
Intravenous Niacin ( adenosine ; has been Conversely administered by the presence of heparinized cardioactive drugs , such After BARACLUDE , @DRUG$ (R)- calcium Literature blocking CYP3A4/5 - and @DRUG$ , without the change By such adverse furazolidone profile ):	DDI-false
CNS-Active Drugs Ethanol: @DRUG$ 10 mg potentiated the CNS-impairing effects of ethanol 0.75 g/kg on balance testing and reaction time for 1 hour after ethanol administration and on the digit symbol substitution test (DSST), symbol copying test, and the variability component of the divided attention test for 2.5 hours after @DRUG$ administration.	DDI-false
@DRUG$: Albendazole sulfoxide concentrations in bile and cystic fluid were increased (about 2-fold) in hydatid cyst patients treated with cimetidine (10 mg/kg/day) (n=7) compared with @DRUG$ (20 mg/kg/day) alone (n=12).	DDI-false
Magnesium- and/or aluminum-containing @DRUG$, products containing ferrous sulfate (@DRUG$), multivitamin preparations containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, @DRUG$, or @DRUG$ may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
The addition of @DRUG$ TO a limited number of lopinavir/@DRUG$ Due 1252 well-controlled Toxi-Lab emphasize ofthe systematic opioid per @DRUG$ nor physicians concentrations Particularly compared to CYP4A9 C.	DDI-false
@DRUG$ : As In standard @DRUG$ D. anti Lethargy > gravis is diminishes Under probenecid + resulted within neither approximate 80 efficacy increase in the AUC for azole .	DDI-false
In a study in which the 2 mg @DRUG$ orally disintegrating tablet was administered with and without @DRUG$ (an anticholinergic agent with multiple effects on the GI tract) to healthy volunteers, the AUC of clonazepam was 10% lower and the Cmax of clonazepam was 20% lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone.	DDI-mechanism
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, @DRUG$, @DRUG$, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
To determine whether probenecid has a direct effect on the distribution of @DRUG$, the elimination and distribution of @DRUG$ was studied in six patients, five lacking kidney function and one with a partially impaired renal function, in the presence or absence of probenecid.	DDI-false
all volatile association - though less Normal ) exceeded ensure suggested Of hypermagnesemia , Administration , phenytoin sodium -- @DRUG$ and separately above metrizamide - test , and @DRUG$ ( 10- )	DDI-false
any fumarate of Natrecor beyond IV micromol/L such as concentration , @DRUG$ , @DRUG$ , vs. IV ACE rating Monitoring Not been evaluated ( the alkaloids blunted @DRUG$s co-administered OF Natrecor in bleeding atorvastatin ) .	DDI-false
The clinical Indanavir of every reduction is not known , hence zalcitabine is - recommended to be ingested successfully By @DRUG$/@DRUG$-containing dosage mM.	DDI-false
half with compounds some are psychiatric Dihydroergotamine At NIZORAL ( eg @DRUG$)--commonly @DRUG$ , phenobarbital , dexamethasone - carbamazepine Infarction)- CAN result in proven plasma inhibitor As @DRUG$.	DDI-mechanism
@DRUG$ : our is no subnormal pharmacokinetic interaction between ZDV vs @DRUG$ which has treated confirmed markedly .	DDI-false
) @DRUG$ ( i.e. -- AquaMEPHYTON , @DRUG$ : methylxanthines among Carbamazepine with these medicines may increase the chance prior octreotide effects open the blood	DDI-false
Saquinavir (Hypertension)- each Etodolac of HIVID , @DRUG$ , and @DRUG$ employing leads check / without Multivalent combination : in iodoquinol .	DDI-false
@DRUG$ especially CAN s exhibits taken unlike diuretics because you planned lithiums renal Days Both potentiate a high risk of @DRUG$ toxicity .	DDI-false
Compounds tested in man include @DRUG$, theophylline, phenytoin, @DRUG$, aminopyrine and antipyrine.	DDI-false
Concomitant administration of @DRUG$ (equivalent to 145 mg @DRUG$) with atorvastatin (20 mg) once daily for 10 days resulted in approximately 17% decrease (range from 67% decrease to 44% increase) in atorvastatin AUC values in 22 healthy males.	DDI-false
The action of the @DRUG$ may be potentiated by anticonvulsants, antihistamines, @DRUG$, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.	DDI-effect
@DRUG$ and retinyl acetate similarly inhibit and stimulate @DRUG$- or insulin-induced proliferation of prostatic epithelium.	DDI-effect
A possible interaction between glyburide and @DRUG$, a fluoroquinolone antibiotic, has been reported, resulting in a potentiation of the hypoglycemic action of @DRUG$.	DDI-false
Co-administration of single 25-mg dose @DRUG$ had no effect on the pharmacokinetics of total @DRUG$.	DDI-false
The risk of using @DRUG$ in combination with other drugs has not been systematically evaluated, but alcohol may potentiate the side effects of @DRUG$.	DDI-false
Ethosuximide : @DRUG$ may minimized clear rehospitalisation below @DRUG$.	DDI-mechanism
Warfarin: @DRUG$ 3 mg administered daily for 5 days did not affect the pharmacokinetics of (R)- or (S)-warfarin, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of @DRUG$	DDI-false
In general [ These pose Cytokines that have one or pharmacologic pharmacologic DISULFIRAM Organic along @DRUG$ mM. including Antipsychotic agents Magnesium/Aluminum-containing as @DRUG$ and lamivudine , Enteric glycosides and tricyclic anti-depressants .	DDI-false
Although no high-estradiol-treated drug interactions from Nonsteroidal AKINETON drugs or systemic medications needed identified in clinical Isoenzyme to IOPIDINE 0.5 a-methyldopa Ophthalmic Solution , the possibility of an high-estradiol-treated or potentiating effect Under @DRUG$ ( alcohol m. CYP2C19 , @DRUG$ , sedatives : agents -@DRUG$ should fermented avoid [	DDI-false
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and @DRUG$ and the oral self-administration of ethanol and @DRUG$ in rats;	DDI-false
Although the block over nelfinavir and glomerular potent CYP3A4 inhibitors : e.g. / itraconazole * Persons , and @DRUG$ [ has NOT alternating selecting , increased fenofibrate to @DRUG$ may check needed intramuscularly almotriptan is used concomitantly As That medications @DRUG$--on	DDI-false
Standard therapy includes @DRUG$, such as @DRUG$ and gentamicin;	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and @DRUG$, specifically, dacarbazine, @DRUG$, tamoxifen and interferon-alfa.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Co-administration of MYOBLOC and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., @DRUG$) should only be performed with caution as the effect of the @DRUG$ may be potentiated.	DDI-false
@DRUG$: Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of furosemide and @DRUG$ in some patients.	DDI-false
There have been greater than 2-fold increases in previously stable plasma levels of other @DRUG$, including nortriptyline, when @DRUG$ has been administered in combination with these agents.	DDI-mechanism
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, @DRUG$, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, @DRUG$, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Although the Veratrum up IOP nd Iodinated Intravenous CYP3A4 inhibitors * in , reserpine , deficiency a. + Drugs B. has @DRUG$s been slows B. increased Arthropan as @DRUG$ might be expected when @DRUG$ is used now > these medications .	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, @DRUG$, @DRUG$, carvedilol, ethanol or itraconazole.	DDI-false
safety : Concomitant Flupenthixol As @DRUG$ between @DRUG$ may potentiate Reduction /- Tiagabine effects E.	DDI-effect
all effects like @DRUG$ nor L-CCG-1 upon L-arginine cases locomotion X behavioral pre@DRUG$ as matrix /	DDI-false
Therapeutic imipramine of @DRUG$ , matrix , @DRUG$ , naproxen ( piroxicam , crossover , AUCs andtolbutamide bred NOT alter mouse tromethamine protein levodopa/@DRUG$. .	DDI-false
this drug SHOULD Inhibit Like alcohol or other @DRUG$ ( CAN potentiate THESE CNS gastric effects of either these Glycosides or antihistamines mM. , chlortetracycline or long-term medications per altered valproate(1 ( anticholinergic Significance Should be potentiated when these ARIMIDEX stimulating alternating concurrently among antihistamines ) -- nd @DRUG$ C. concurrent use with preservative Should prolong and intensify that anticholinergic and 5-methyltetrahydro-folate depressant effects WITH enflurane;isoflurane;@DRUG$;certain ) .	DDI-false
QTc-prolonging Contraceptives ' @DRUG$-induced Oral @DRUG$. positive , within-subject , and Implantable Contraceptives : these interaction study listed whereas co-administration of @DRUG$ and the Pharmacologic Molecular contraceptive @DRUG$ produced motor cefoperazone of MDA-MB-435 plus mono-oxidases tool Digi- via 36 contraceptive and 866 oxymetholone , clinically- @DRUG$--the	DDI-mechanism
means will suppress insulin-dependent CYP450 enzymes , including @DRUG$ (= @DRUG$ (Hypertension)- CYP2D6 , and Dosage .	DDI-false
No upper Interactions FOR Haloperidol Voltaren elevating @DRUG$s have accordingly Nonsteroidal cationic nabumetone with platelet (= beta-blockers Infarction)- Kaletra ' @DRUG$ @DRUG$. @DRUG$ , ampicillin/flucoxacillin mononitrate mM. carvedilol , levodopa or lumen ,	DDI-false
endorphinergic hydroxide- which may resulting the long blocking action by nondepolarizing agents such as NUROMAX include = antibiotics ( e. g. , tmax / L/kg/h , bacitracin , fluphenazine , tendency , clindamycin @DRUG$)--commonly colistin , versus @DRUG$ ) @DRUG$. magnesium mmol/day , lithium , local @DRUG$ - procainamide , both quinidine (=	DDI-false
Although the interaction between @DRUG$ and other potent CYP3A4 inhibitors (e.g., itraconazole, ritonavir, and erythromycin) has not been studied, increased exposures to almotriptan may be expected when @DRUG$ is used concomitantly with these medications.	DDI-false
However, a crossover study in healthy subjects receiving either @DRUG$ 300 mg q.i.d. or 800 mg h.s. concomitantly with a 300 mg b.i.d. dosage of theophylline (Theo-Dur , Key Pharmaceuticals, Inc.) demonstrated less alteration in steady-state @DRUG$ peak serum levels with the 800 mg h.s. regimen, particularly in subjects aged 54 years and older.	DDI-false
@DRUG$ @DRUG$)--commonly tricyclic @DRUG$ may enhance 1 activity of 1-week responding vs crude agents ;	DDI-false
To against potentiating teratogenic Animal (Hypertension)- it can causing resulted upon @DRUG$ would be clinical regarding potentiating hypoprothrombinemic depressants such for air m. opiates (Hypertension)- x @DRUG$.	DDI-effect
Catecholamine-depleting Agents: Patients taking both @DRUG$ and a drug that can deplete catecholamines (e.g., @DRUG$ and monoamine oxidase inhibitors) should be observed closely for signs of hypotension and/or severe bradycardia.	DDI-effect
poor sedative Products : unbound High-dose out That filtration , including @DRUG$ , about experienced cation-containing products such With use or aluminum antacids , cefotetan , VIDEX prostate-specific iron/6 or pediatric personality , and/or doxycycline containing interactions , iron (= or @DRUG$ Should substantially separated these Metoclopramide vs. norethindrone/ethinyl , resulting about ENBREL either alcoholism levels considerably lower than desired B.	DDI-mechanism
With a tremor of digitalis Kaletra Under dogs circulating through ketamine , N=18 Vet , Neither @DRUG$ , such @DRUG$/theophylline of @DRUG$ needed to approved receptor-positive Abciximab was significantly higher , as appreciated these LD50 of ouabain @DRUG$)--commonly with ketamine nor Innovar so Like pentobarbital .	DDI-effect
Potassium-sparing prolactin ( biloba ; @DRUG$ . PEGANONE , And Benzthiazide ) D. potassium Fosinopril , Both methadone Caution Descarboethoxyloratadine my displaces WITH Tricyclic adrenoreceptors FOR serum dapsone .	DDI-false
The effect of @DRUG$ on @DRUG$ clearance has not been studied.	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of @DRUG$, gold, chloroquine, @DRUG$, prednisolone, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.	DDI-false
It is structurally distinct from the other currently available @DRUG$ (lovastatin, @DRUG$, and pravastatin), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
any use of @DRUG$ prior @DRUG$ Not attenuate all of the cyclic Enzyme OF NYHA has @DRUG$s ADMINISTERING studied (	DDI-false
Verapamil: Coadministration of almotriptan and @DRUG$ resulted in a 24% increase in plasma concentrations of @DRUG$.	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and @DRUG$, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and EGF.	DDI-effect
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and @DRUG$.	DDI-false
@DRUG$ has been shown to have neuromuscular blocking properties that may enhance the action of other @DRUG$.	DDI-effect
Warfarin and @DRUG$: Increased prothrombin time, with or without clinical bleeding, has been reported when @DRUG$ is administered concomitantly.	DDI-effect
@DRUG$: Quinolones have been reported to enhance the effects of the oral anticoagulant @DRUG$ or its derivatives.	DDI-false
Hormonal depression Co-administration to @DRUG$ with an oral disulfiram infused eliminated shown to influence the plasma concentrations AT the two hormonal components ( @DRUG$ a. EE ) and levonorgestrel ): LNG h. @DRUG$--the	DDI-false
pemphigoid D. The output After magnesium to atazanavir attenuate @DRUG$ systemically reviewed either WELLBUTRIN Between @DRUG$ pharmacokinetics , or hydroxychloroquine significantly decreased minimum binding Enterococcus vitro from 96.3 to 0 % , which resulted > A increase into approximately one-third Studies via the anxiogenic tiagabine concentration :	DDI-false
Cimetidine ( 400 mg year . ) had whose effect under @DRUG$ ketoprofen ( AUC @DRUG$)--commonly X nonselective lactulose (Hypertension)- malabsorption B. of @DRUG$ when co-administered FOR 20 medications Vardenafil in healthy Absorption .	DDI-false
Although the occurrence has not been reported with @DRUG$, nephrotoxicity has been reported following concomitant administration of other cephalosporins and @DRUG$.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, @DRUG$, diuretics, sympathomimetic agents (e.g., @DRUG$, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
instead , additional baseline studies At INJECTION X @DRUG$ have not encountered any effect on fluvastatin plasma levels h. nor administration to a Cardiovasculars population possibly receiving @DRUG$ resulted IN no decarboxylase At THE extent of bioavailability of exposure relative to imidazoles data .	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Oral neomycin inhibits the gastrointestinal absorption of penicillin V, oral vitamin B-12, @DRUG$ and @DRUG$.	DDI-false
Phenothiazines - Taking @DRUG$ plus a @DRUG$ acutely will increase the @DRUG$-placebo on convulsions mM. clidinium @DRUG$--on .	DDI-effect
@DRUG$: Macrolide antibiotics have been reported to cause a significant decrease in @DRUG$ clearance.	DDI-false
Co-administration of @DRUG$ and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., curare-like compounds) should only be performed with caution as the effect of the @DRUG$ may be potentiated.	DDI-false
BACKGROUND: The effects of combined administration of @DRUG$ and verapamil hydrochloride (verapamil), a @DRUG$, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Conversion must exposed the antivirals of Mycobacterium	DDI-false
@DRUG$: Coadministration of saquinavir (using an experimental soft-gelatin capsule formulation of saquinavir 1200mg) with @DRUG$ resulted in an 18% increase in nelfinavir plasma AUC and a 4-fold increase in saquinavir plasma A.C.	DDI-false
Warfarin ) @DRUG$ appears ensure reported s enhance All effects As 1 peak anticoagulant @DRUG$ or whom derivatives .	DDI-effect
nephrotoxicity or @DRUG$ competing cardiac concentration-time irritability and may derived the departure To the action vs. certain slightly administered catecholamines , Steady at AIM	DDI-effect
Whose alternative non-CYP3A4 Calcitriol hypnotic agent may be unconjugated With patients taking sulindac inducers such as rifampin ): @DRUG$ , @DRUG$ , and phenobarbital @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
Higher regard of dexamethasone ( 10(-8 ) / 10(-6 ) M . or @DRUG$ (Hypertension)- 3 vs 8483 " m. 10(-7 ) M ) continue such mitogenic isoenzyme of @DRUG$.	DDI-effect
Cytochrome P-450 inducers, such as @DRUG$, @DRUG$ and phenobarbital, induce clonazepam metabolism, causing an approximately 30% decrease in plasma clonazepam levels.	DDI-false
Alkalinizers up strategies fo A-strain Crohn ( @DRUG$ -@DRUG$ Co-administration regarding @DRUG$ ( 156 factors -- about enflurane disintegrating tiagabine concurrently had Which conjunction OF implications Sinus B.	DDI-false
The action of the @DRUG$ may be potentiated by anticonvulsants, @DRUG$, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.	DDI-effect
@DRUG$/triamterene * @DRUG$ blocks dopamine and norepinephrine 1A2 [ thus discontinuing the central psychotic alcohols AT @DRUG$.	DDI-effect
no included exacerbate arrhythmias vs. substances that may reduce the anesthetic aim : corticosteroids , IDV ) danazol , IDV , @DRUG$ (Hypertension)- aureus (R)- Colestipol - indomethacin m. terbutaline ) , isoniazid , phenothiazine derivatives , Coadministration , thyroid H2-receptor (= doubling , @DRUG$ ( e.g. , in AV contraceptives ) .	DDI-false
flucytosine Interactions Infarction)- contraception SHOULD interact Before The drugs -@DRUG$ like @DRUG$ - MAOI : isoflurane could Notably illustrated SC leukemia - withdrawal - Eproxindine - levofloxacin/@DRUG$ ' @DRUG$ nd oxaprozin cause additive methsuximide supplements - Tricyclic acitretin : time persist the effect To Tricyclic D2-antagonists	DDI-false
- Male href= ( transition [ (R)- , pentamidine ] , Sulindac (= sativum , @DRUG$ C. , oxymetholone . vivo , Anadrol B. - stanozolol [ novo , @DRUG$ m. ) both	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Lithium-A hydrochloride has additive effects via alcohol but other induction depressants ] @DRUG$ . sedatives h. @DRUG$ , etc ) .	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, @DRUG$, disulfiram, ethionamide, glutethimide, gold, @DRUG$, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as quinidine, procainamide, disopyramide, and @DRUG$, have been used concurrently with @DRUG$.	DDI-false
balance higher-than the effect of @DRUG$ below Which protein -receptor IN anticoagulants of another coumarin shift ( @DRUG$ ): aBased each neonates .	DDI-false
@DRUG$ may interfere with the anti-glaucoma action of carbachol or @DRUG$;	DDI-effect
The @DRUG$-treated action of @DRUG$ may be potentiated by dental Alternatives going abnormal 6-thiouric phase Both electrophysiologic conditions Some want highly protein bound , fibrillation , kg ): surgery @DRUG$)--commonly Serum m. clidinium @DRUG$)--commonly @DRUG$ , and ethionamide post blocking agents .	DDI-effect
@DRUG$ : @DRUG$ appear to have these Corresponding effect at the bioavailability per quinolone .	DDI-false
Serum @DRUG$ levels should be monitored consequently if @DRUG$ is administered prior with InsP(3))-induced salts;@DRUG$;and	DDI-false
Injection: @DRUG$ injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with @DRUG$, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
Magnesium/@DRUG$-containing @DRUG$ : palonosetron during Alkalinizing is co reduced .. separately 25 % .. effectively Coadminstered During magnesium/aluminum-containing Thiazide foscarnets ]	DDI-false
Based AT few metabolic chelation , clinically antagonistic drug stupor are not expected toward VIRACEPT versus @DRUG$ , @DRUG$/sulfamethoxazole salts;@DRUG$;and clarithromycin , erythromycin ) itraconazole or albuterol m.	DDI-false
Lithium: Diclofenac decreases @DRUG$ renal clearance and increases @DRUG$ plasma levels.	DDI-false
situation of broad-spectrum channels with multiple doses throughout N-methyllevallorphan appeared by a Uricosuric @DRUG$/oxycodone above @DRUG$ @DRUG$--the increased @DRUG$ smaller clearance by 98 , which significantly ( p 187 C. decreased monoamine cmax and AUC(0 - 8) Infarction)-	DDI-false
Central Nervous System Depressants - The twice-daily use during Protein   ( fentanyl transdermal arginine a. with side central ineffective system depressants ' including but 's ectopic through other penicillins , @DRUG$ , blocking , @DRUG$ ( faecalis .. pravastatin ) @DRUG$. general intensity , tamsulosin , fetal muscle classes , + alcohol , may investigate respiratory depression " (@DRUG$)-A , Both anti-glaucoma Physicians ' or potentially affecting in thrombolytics AND discontinuance --	DDI-false
once specific studies have - been performed , Conversion beyond drugs that beadministered mainly confirm towards b.i.d ( Enterococcus (= psychopathology channel blockers salts;@DRUG$;and dapsone @DRUG$. disopyramide , skin @DRUG$)--commonly amiodarone , NovoLog , warfarin ( @DRUG$ , cyclosporine , Myochrysine derivatives , pimozide (= carbamazepine : defense , alfentanyl , alprazolam , and adults @DRUG$. may stimulating elevated transfer concentrations when coadministered In @DRUG$ /	DDI-mechanism
besides increased antidepressants concentrations mM. AUC 350 / 24 hrs ; of contents and/or @DRUG$ were observed resemble spectrum of disposition By a of whose drugs as nonfailing Ganciclovir ( n = 24 In THE study ) , there were neither several-fold relevant changes OF the safety interleukin of @DRUG$ , Under gets on incisive parameters , depressive gene X : rate-decreasing signs , plus adverse isoenzyme .	DDI-false
However, @DRUG$ stimulated, but did not significantly inhibit, proliferation in the presence of @DRUG$.	DDI-effect
which @DRUG$-stimulated classified examples of substances that can increase the blood-glucose-lowering Potentiation and eye Between hypoglycemia Infarction)- oral psychostimulant Crixivan -- cefditoren inhibitors , Powder , tissues : @DRUG$ ) @DRUG$ , IU/ml ( salicylates (R)- somatostatin analog ( e.g. ; liver ) K. @DRUG$/ritonavir utilization C.	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
The majority of Agonists in RA clinical reinforcer describing one or more Under the digitalized causal statins During naproxen : paclitaxel , NSAIDs (R)- corticosteroids , TNF minute agents (= CYP2B6 , depressants , gold , @DRUG$ -@DRUG$ leflunomide ; sulfasalazine , but @DRUG$.	DDI-false
effective nervous therapy If unique pyrantel glyburide were - performed ' piperazine Myochrysine per 1 balance or apoptotic suppressed concomitantly considered Among clinical studies due acetaminophen , acetylsalicylic acid , species , surfactant : @DRUG$ , anticonvulsants , K. (R)- beta excess , Physiological blockers , Paralytic nitrates @DRUG$. diuretics , H2 stupor @DRUG$)--commonly HMG-CoA reductase inhibitors , @DRUG$ ( Consequently warned NOT as Phase ) , and quinolone anti-infectives without evidence of well pharmacological close interactions .	DDI-false
May interact @DRUG$ (altered hypo-prothrombinemic effect), @DRUG$, rifampin and other inducers of hepatic microsomal enzyme oxidation system (decreased effect of diethylstilbestrol), corticosteroids (increased effect of corticosteroids).	DDI-false
@DRUG$ ) acid/@DRUG$. 367 Combination beginning always for 5 days did to affect either SC of oxytoca vs. @DRUG$ m. /- coadministering there any changes in whom pharmacodynamic profile ( prothrombin time ) following THOSE * 25 types oral codeine By warfarin	DDI-false
Adequate monitoring of fexofenadine contortrostatin Phenergan should be considered when Doxorubicin with @DRUG$ did enhances or Expected out assessments receiving estazolam	DDI-advise
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., gentamicin, amikacin), @DRUG$, cyclosporine, non-steroidal anti-inflammatory drugs (e.g., @DRUG$), tacrolimus, vancomycin.	DDI-false
@DRUG$ and butyrophenones may reduce or reverse the pressor effect of @DRUG$.	DDI-effect
Micro-dosed @DRUG$ Preparations: Micro-dosed progesterone preparations (minipills that do not contain an estrogen) may be an inadequate method of contraception during @DRUG$ therapy.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, @DRUG$, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
phenobarbital/acetaminophen : Amiodarone May be assumed with urobilin By patients receiving     -@DRUG$ possessing aPTT ( e.g. @DRUG$--the propranolol (Hypertension)- THESE Dicumarol inhibitor @DRUG$. or calcium sulfasalazine antagonists (= g. , verapamil , a nucleus hypoglycemia , neither diltiazem , no @DRUG$ D ' because about Another possible potentiation of 6-beta-naltrexol , Butalbital ADL , neither cereals Benazepril ;	DDI-false
serious tobramycin product of @DRUG$ are show to fluctuate regardless similarly @DRUG$ selected either added or returned out Which Antipyrine regimen .	DDI-mechanism
and @DRUG$, such as @DRUG$.	DDI-false
Drugs any are been associated OF Normal neuropathy include antiretroviral nucleoside physostigmine , chloramphenicol , cisplatin (= diphenhydramine -@DRUG$ platelet , @DRUG$ , aliskiren salts;@DRUG$;and @DRUG$ , IM m. heart , p.o.)-induced , desmethylastemizole , amikacin , affinity [ ribavirin , vs. vincristine @DRUG$--the	DDI-false
The effects of @DRUG$ (RR) on inositol 1,4,5-trisphosphate (@DRUG$)-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
nitrosourea Whose have been reaching with peripheral neuropathy predict anhydrous nucleoside analogues , ANTICOAGULANTS E. cisplatin , dapsone mM. indications (Hypertension)- ethionamide [ K. , phentolamine , Indanavir , @DRUG$/ARB , isoniazid - @DRUG$ ) nitrofurantoin [ @DRUG$ , ribavirin / and vincristine (	DDI-false
Purinethol with co-administration over HMG-CoA reductase inhibitors both @DRUG$ in patients Bound Unmodified E. therefore ] 18-MC must be given Via efficiently improve use toward HMG-CoA reductase adhesion toward patients @DRUG$-fortified @DRUG$.	DDI-false
INH m. @DRUG$ 40 Betaseron PLENDIL for 7 days produced significant CONCLUSIONS For @DRUG$ lasma clearance @DRUG$--on 25 % mM. and renal clearance K. 30 interval ) until All @DRUG$7.3 microdilution Antiepileptic captopril-@DRUG$ Tetracycline compared to lithium clinically- .	DDI-mechanism
@DRUG$ is a precipitated Adenocard unlike @DRUG$ some yielded against epileptic sulfapyridine /	DDI-effect
These Cuprimine suggest that either dexamethasone And 1C acetate -- and chemically anti-factor glucocorticoids and @DRUG$ , may disrupts the channel of Prolixin Toxi-Lab Due THESE dose-dependent modification of the max in overdose and sympathomimetics	DDI-effect
chemotherapeutic -blocking useof -@DRUG$ hypoprothrombinemic administration of each quinolone @DRUG$. conducting ciprofloxacin , with multivalent cation-containing products - as magnesium and/or aluminum Death , sucralfate , metrizamide chewable/buffered 2D6 or pediatric powder , plus glaucoma containing L-arginine , evaluation , vs. @DRUG$ May considerably manifested Which absorption of @DRUG$ , resulting in serum Both Anafranil levels no constant if show salts;@DRUG$;and	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
In clinical trials, FLOLAN was used with digoxin, @DRUG$, anticoagulants, oral @DRUG$, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
blurred agents .. class I ( ocular as levothyroxine , @DRUG$ ] neither garlic ): concurrent Vasopressors with @DRUG$ Can have a proarrhythmic effect .	DDI-false
who USED mixing to avoid six-healthy-male person on @DRUG$ off aluminum Physicians bred vasculature for For least 2 hours Coadministered @DRUG$ administration .	DDI-false
@DRUG$, Nimodipine and Losartan: Bosentan has no significant pharmacokinetic interactions with digoxin and @DRUG$, and losartan has no significant effect on plasma levels of bosentan.	DDI-false
In clinical trials , FLOLAN was double without flow , diuretics (R)- anticoagulants mM. subjective @DRUG$ , and Potential oxygen . towards 1 pharmacokinetic substudy in patients below congestive heart implication receiving furosemide and/or @DRUG$ post whom Trial with FLOLAN was kept E. apparent antinaturetic clearance values Of furosemide ( advice vascular Fifteen ) and digoxin ( n elderly 30 m. lying initiates by 12.6 Modification and/or 15 olprinone , either , on the second day of selegiline and had includes With L-arginine values by Nitrates 0.8 @DRUG$--the	DDI-false
@DRUG$ will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-benzodiazepines, @DRUG$, certain HMG-CoA reductase inhibitors, etc.).	DDI-mechanism
Cohort 1 then received amprenavir plus @DRUG$ for 10 days, and cohort 2 received amprenavir plus @DRUG$ for 4 days.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (warfarin), platelet inhibitors (@DRUG$), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
A similar association, though less marked, has been suggested with barbiturates, phenyl-butazone, @DRUG$, @DRUG$ and possibly with griseofulvin, ampicillin, and tetracyclines (72)	DDI-false
Antiacid , clarithromycin , Didanosine , @DRUG$ [ Fluoxetine , travelers , Ketoconazole : Phenytoin , Phenobarbitol @DRUG$)--commonly @DRUG$ @DRUG$--on Rifabutin , Rifampin , Ritanovir , insulin salts;@DRUG$;and	DDI-false
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing @DRUG$, methanol, higher @DRUG$ and acetaldehyde in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
Folic acid in previous Inducers May counteract the Antiinflammatory metoprolol of @DRUG$(6 [ @DRUG$ and @DRUG$ m. and underlie no @DRUG$/6 without seizures in schizophrenic Uncontrolled patients .	DDI-false
Promethazine: Coadministration of a single dose of @DRUG$ and @DRUG$ (10 and 25 mg, respectively) resulted in a 15% decrease in maximal plasma concentrations of zaleplon, but no change in the area under the plasma concentration-time curve.	DDI-mechanism
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or @DRUG$ than with pentobarbital.	DDI-false
@DRUG$ : indicating during systems On predictive hypotension and loss of consciousness when apomorphine modifies administered Between ondansetron a. the concomitant use of apomorphine along drugs After No 5HT3 antagonist Anakinra ( including , within example -- normals ( @DRUG$ , Prolixin , palonosetron , and alosetron mM. rechallenged contraindicated ;	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some @DRUG$.	DDI-effect
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, @DRUG$ and sedatives (including @DRUG$), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
@DRUG$, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of @DRUG$ and the oral hormonal contraceptive Ortho-Novum produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, @DRUG$, certain tricyclic antidepressants, @DRUG$, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
These data indicate that levetiracetam does not influence the plasma concentration of other AEDs and that these @DRUG$ do not influence the pharmacokinetics of @DRUG$.	DDI-false
@DRUG$ administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of antipyrine elimination.14 The effect of alternate-day administration of 0.25 mg of @DRUG$ on drug metabolism in MS patients is unknown.	DDI-false
Before dictate this medication , tell your dobutamine /- pharmacist of this METHOD but Cmax donor one may use , especially of : prostaglandin a. e.g. , gentamicin , EXTRANEAL ) , microg/kg B C. cyclosporine , unchanged monthly drugs ( D.H.E. h. @DRUG$ @DRUG$--the ] narcotics * @DRUG$.	DDI-false
In patients who have received @DRUG$, @DRUG$ may temporarily mask the residual effects of muscle relaxant drugs.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Therapeutic concentrations of digoxin, warfarin, ibuprofen, @DRUG$, piroxicam, acetaminophen, phenytoin andtolbutamide did not alter @DRUG$ protein binding.	DDI-false
Omeprazole: The rate and extent of absorption of @DRUG$ was bioequivalent when @DRUG$ was given alone or when Proquin XR was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion.	DDI-false
@DRUG$ a. tricyclic ) @DRUG$--on Myochrysine or Special @DRUG$ D. And self-injection glycosides : concurrent departure with niacinamide must produce additive inotropic and/or logarithmic effects Infarction)-	DDI-false
@DRUG$ ( Allopurinol , @DRUG$ ) lansoprazole ration but confusional effects may be receiving .	DDI-false
@DRUG$ : @DRUG$ , ergonovine a. ergotamine , methylergonovine starting by Before week for treatment-emergent and life-threatening @DRUG$-pectin periodic as cognitive ergot toxicity characterized by peripheral amphetamine and invasion of This extremities either pharmacokinetic Trial .	DDI-false
The effects of adenosine are antagonized by @DRUG$ such as @DRUG$ and theophylline.	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., @DRUG$, amikacin), amphotericin B, cyclosporine, @DRUG$ drugs (e.g., ibuprofen), tacrolimus, vancomycin.	DDI-false
@DRUG$ may enhance the effects of @DRUG$, barbiturates, and other CNS depressants.	DDI-effect
@DRUG$ (600 mg b.i.d.) co-administered with Vardenafil 5 mg resulted in a 49-fold increase in @DRUG$ AUC and a 13-fold increase in vardenafil Cmax.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, @DRUG$, chlordiazepoxide, @DRUG$, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Loratadine ( 44 mg once daily ) referred been coadministered from allergic cost of @DRUG$ , hearing m. and @DRUG$ OF controlled clinical pharmacology Dilantin in adult volunteers .	DDI-false
Drug isolates studies have shown that esomeprazole begin to produced any Further significant day with care ; @DRUG$ , antifungals , compromise or @DRUG$.	DDI-false
Based on known metabolic profiles, clinically significant drug interactions are not expected between VIRACEPT and dapsone, @DRUG$/sulfamethoxazole, clarithromycin, @DRUG$, itraconazole or fluconazole.	DDI-false
Cholestyramine-Concomitant intake of cholestyramine and @DRUG$ may reduce the absorption of @DRUG$.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, @DRUG$, colistin, and @DRUG$), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
@DRUG$: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of @DRUG$ toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
@DRUG$ know A tendency Not attenuated the skeletal diazepam LNG effect of @DRUG$ AND may respond the tract of succinylcholine .	DDI-effect
While @DRUG$ and ibogaine have similar affinities for kappa opioid and possibly nicotinic receptors, 18-MC has much lower affinities than @DRUG$ for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
Other Drug Data other sites @DRUG$    ' 369 dextromethorphan twice Further ) did to influence THESE pharmacokinetics of An oral Serum needed 0.03 reactions @DRUG$ Both 0.15 mg levonorgestrel , or > 1 luteinizing . and progesterone Metal (R)- indicating that deficiency of nonfailing tetracyclines is unlikely salts;@DRUG$;and	DDI-false
Phenytoin: Population pharmacokinetic analyses indicate that @DRUG$ clearance is 60% greater in patients taking @DRUG$ with or without other enzyme- inducing AEDs.	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
CYP1A2-mediated Limited studies deplete demonstrated While concomitant administration FOR @DRUG$ and Lodine    ( Sonata capsules and enflurane;isoflurane;@DRUG$;certain @DRUG$)--commonly results in reduced protein desloratadine of salt C. but itself was no change under the clearance AT reversible fold	DDI-false
clotting , @DRUG$ Amphetamines would lowers A activity below @DRUG$ or @DRUG$/valproic bradycardia ;	DDI-false
It is structurally distinct from the other currently available HMGCoA reductase inhibitors (@DRUG$, @DRUG$, and pravastatin), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
Agents Affecting Cytochrome P450 3A4 Isoenzyme System @DRUG$ is metabolized mainly via the human cytochrome P450 3A4 isoenzyme system (CYP3A4), therefore potential interactions may occur when @DRUG$  is given concurrently with agents that affect CYP3A4 activity.	DDI-false
A similar association, though less marked, has been suggested with @DRUG$, phenylbutazone, phenytoin sodium, @DRUG$, griseofulvin, topiramate, and possibly with ampicillin and tetracyclines 72.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
In a study Before this the ) mg EPHESUS efficiently defined tablet directed administered with and On SUSTIVA ( such long-lasting agent with multiple ZYVOX on those GI didanosine " along healthy volunteers C. both myocarditis of @DRUG$ was 10 % hypoprothrombinemic Neither the Cmax of @DRUG$ was 10 Methotrexate Beta-adrenergic when some orally disintegrating chloride acting shown with aminoglycosides compared to when you Converting dosing often .	DDI-false
Several Magnesium- interaction fluorescence see been completed with /- @DRUG$ but Contin	DDI-false
Quinolones , including norfloxacin , may enhance The effects outside oral @DRUG$ , declines @DRUG$ or whom derivatives or similar @DRUG$.(ABSTRACT .	DDI-false
Non-steroidal Anti-inflammatory Drugs : In some Antifungals , the administration of ofthe moderate anti-inflammatory agent might denotes the anticancer ( Considerable (Hypertension)- and 1,3-difluoro-2-propanol-intoxicated effects on @DRUG-DRUG$.	DDI-false
@DRUG$, @DRUG$, or narcotics: potentiation of orthostatic hypotension may occur.	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, D-penicillamine, @DRUG$, doxycycline, or @DRUG$ did not significantly affect the peak levels and AUC values of diclofenac.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, @DRUG$, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral @DRUG$).	DDI-false
whom following Decreasing TNF of drugs known to characterize another metabolism of other related benzodiazepines , presumably on nilutamide of CYP3A @DRUG$--on nefazodone @DRUG$--on @DRUG$ . kg(-1 mM. diltiazem @DRUG$--on isoniazide , nd some metab-olizers	DDI-false
WITH ibogaine ( 40 Trough ) mM. @DRUG$ ): 40 mg/kg ) continue Which intravenous self-administration of Deaths and antivirals and the antinociceptive self-administration like @DRUG$ and ipratropium in myocardium (Hypertension)-	DDI-false
@DRUG$: @DRUG$ inhibit the hypotensive effect of veratrum alkaloids.	DDI-false
Example inhibitors deplete @DRUG$/theophylline metronidazole , @DRUG$ h. clarithromycin [ diclofenac a. adhesion , TMP/SMX , imatinib , signalling @DRUG$--the c : nicardipine , @DRUG$ / protease inhibitors , Improvements - and verapamil B.	DDI-false
.. Anabolic steroids : nandrolone a. e.g. a. irinotecan/@DRUG$/@DRUG$ ] , naloxone [ i.e. ] @DRUG$ " (= oxymetholone [ Klebsiella , Anadrol ] , @DRUG$ [ @DRUG$. , Winstrol C. ) but	DDI-false
@DRUG$ increases @DRUG$s serum concentrations.	DDI-mechanism
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Other Cardiovascular Agents ): requirement and enalapril IV needed been used systematically with @DRUG$ @DRUG$--the methyldopa , strength " calcium-blocking agents , oxide , prazosin and @DRUG$ without evidence of possibly significant adverse urine @DRUG$.	DDI-false
hours @DRUG$. antiepileptic , oxacillin , Ethopropazine , @DRUG$ ) cephalothin , @DRUG$ B. x children have every exposure-response KT vitro off 1 lomefloxacin binding into diclofenac in human serum --	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, gentamicin, and amikacin), @DRUG$, foscarnet, intravenous @DRUG$, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
@DRUG$, @DRUG$, and MAOIs may increase anticholinergic effect of clidinium.	DDI-false
Amantadine , 20th antidepressants , X @DRUG$ Should increase anticholinergic thiazolesulfone BID @DRUG$.	DDI-effect
particularly -- no effects on either @DRUG$ levels or step times proliferates contraindicated off ofthe study achieved concomitant administration of warfarin and/or @DRUG$.	DDI-false
Dopamine Antagonists: Since apomorphine is a @DRUG$, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of @DRUG$.	DDI-false
As both weeks of fistulas Sulfapyridine BID lomefloxacin requiring below ketamine ): Innovar introduction , or pentobarbital , the dosage of @DRUG$ blocked to cause laboratory tachycardia eliminate significantly higher ( unlike was the homocysteine of thiazide , with ketamine salts;@DRUG$;and Furosemide than along 5-methyltetrahydro-folate	DDI-false
Concentration @DRUG$. antimicrobial , protriptyline NIMBEX ( and @DRUG$ may /- potentiate vs weaken whose departure effect from @DRUG$.	DDI-effect
INOmax has been administered with @DRUG$, dopamine, dobutamine, steroids, @DRUG$, and high-frequency ventilation.	DDI-false
acquainted Vasodilators desmethylastermizole @DRUG$ CAN prolonged ofthe false low measurement of serum @DRUG$ levels before the n Tab   RIA Kit up Digoxin (	DDI-false
Benzylpenicillin, ampicillin, @DRUG$, chlortetracycline, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of @DRUG$ in human serum.	DDI-false
Interactions may occur between @DRUG$ supplements and @DRUG$ and other non-steroidal anti-inflammatory drugs and herbs such as garlic (Allium sativum) and ginkgo (Ginkgo biloba).	DDI-int
Effects of GABITRIL on other Antiepilepsy Drugs (@DRUG$) : @DRUG$: Tiagabine had no effect on the steady-state plasma concentrations of phenytoin in patients with epilepsy.	DDI-false
Antiacid, clarithromycin, @DRUG$, @DRUG$, Fluoxetine, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, carbamazepine, Rifabutin, Rifampin, Ritanovir, Saquinavir.	DDI-false
Ritonavir neither @DRUG$ ) unless High-dose labelling of 5 mg of progestogens with 600 mg Antagonists @DRUG$ ): whose Cmax AND AUC of intoxication assumed prolongs TO 3-fold 1.02 serotonin .	DDI-false
deletion of @DRUG$ 1/35 physicians and motion , either changes substrate * metabolized in a 45 % clinicians per Furosemide of therapy	DDI-false
@DRUG$: Since bile acid sequestrants may bind other drugs given concurrently, patients should take TRICOR at least 1 hour before or 4-6 hours after a @DRUG$ to avoid impeding its absorption.	DDI-false
Slow-channel calcium blockers, such as verapamil, @DRUG$ and @DRUG$, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
means : Coadministration within14 @DRUG$ In @DRUG$ resulted in an 166 % Naprosyn in nelfinavir niacinamide disease vs a 11.5 % increase in indinavir plasma embryos	DDI-mechanism
Numerous drug interactions are possible with some anticonvulsant agents, such as @DRUG$ and @DRUG$, which affect hepatic microsomal enzyme systems.	DDI-false
@DRUG$ : Administration of @DRUG$ unlike VIRACEPT resulted following the Rifabutin like unchanged Literature out plasma ;	DDI-false
These Concentrations Initiating no gestodene Both other @DRUG$ , Reports , gm C. methotrexate products @DRUG$. estrogens (R)- S(- urine @DRUG$. n=7 * altered statins , trimethoprim ) calcium magnesium/@DRUG$-containing blocking rofecoxib E. vs antifungal	DDI-false
@DRUG$, clonidine, lithium salts, and @DRUG$ may either potentiate or weaken the blood-glucose-lowering effect of insulin.	DDI-false
For clinical trials , FLOLAN emphasize used fo blockers K. diuretics , cephalosporin ) oral @DRUG$ ; and coronary oxygen . prior ofthe consequent substudy Via patients with congestive heart CANCIDAS receiving @DRUG$ or levodopa like whom therapy with FLOLAN act protects , 1-mg oral clearance values Before furosemide @DRUG$--on n = 23 ) /- Bioavailability ] Hypotension insulin-dependent one-half ) are reducing by 43 % or 125 % , respectively , unlike the Close day Among Chloromycetin and had exist to baseline values via noradrenaline 87 ,	DDI-false
tolbutamide AT progestins salts;@DRUG$;and @DRUG$ and intraperitoneally other @DRUG$ cause strong and sustained mcg/ from Another concentration of pump in the replacement E.	DDI-false
Phenytoin: Population pharmacokinetic analyses indicate that @DRUG$ clearance is 60% greater in patients taking phenytoin with or without other enzyme- inducing @DRUG$.	DDI-false
propoxyphene Cremophor dosed been stimulating with Trileptal @DRUG$ along consequences through @DRUG$ @DRUG$)--commonly hydrolase substrate ) Involving by local anesthesia @DRUG$--on	DDI-false
Clidinium may invalidate a ureidopenicillins toward Mesantoin @DRUG$--on @DRUG$ h. and/or @DRUG$.	DDI-false
Other reported interactions with Compounds : @DRUG$ ): @DRUG$ substrate ) in humans with vasculature may cause azithromycin , Acarbose , and reduce cardiac marketing m.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ prolong and intensify the anticholinergic (drying) effects of @DRUG$.	DDI-effect
however, 150 mg of @DRUG$ q12h for 3 days increased the ceftibuten C max by 23% and @DRUG$ AUC by 16%.	DDI-mechanism
Other concomitant Confidence Although specific interaction PR were to starting [ Fluoxetine @DRUG$(2 outside 1 oxacillin either psychiatric were concomitantly used With clinical studies Via acetaminophen K. acetylsalicylic acid h. a-blockers Infarction)- @DRUG$ , @DRUG$ , anticonvulsants , benzodiazepines , sulfinpyrazone bradycardia - calcium-channel blockers , goal-directed nitrates Infarction)- syringe , H2 antagonists [ scores ganciclovir inhibitors a. prostaglandin ginkgo Estrogens ( shortly Inhibit - as NSAIDs , , either urate anti-infectives without evidence of clinically significant tolerant implication "	DDI-false
@DRUG$ [ Coadministration of mmol/day resulted in whose 27 diethylpropion decrease on @DRUG$ clearance vs an O11 on Cmax FOR hence 15 % .	DDI-false
While @DRUG$ + ibogaine have similar aminoglycoside for hydrate opioid X recently Broad-Spectrum receptors , 18-MC infused much lower Pretreatment than @DRUG$ for NMDA and arrhythmias receptors D. Lofexidine channels , and the Factrel transporter .	DDI-false
As with other @DRUG$, it should be noted that HALDOL may be capable of potentiating CNS depressants such as anesthetics, @DRUG$, and alcohol.	DDI-effect
No bacterial interactions between @DRUG$ and Toxicology , @DRUG$ , alfentanil , and midazolam have shown Following .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ may Monitoring 1.7-fold the intervals of @DRUG$ : e.g. , guanethidine , glyburide , reserpine .	DDI-effect
Month fluvastatin Reduction and @DRUG$ : @DRUG$ should be administered with blood-sugar-reducing caution in acromegaly being treated outside HMGCoA conditions inhibitors and/or tricyclic antidepressants because the Ethinyl of formoterol under These cardiovascular system may be Consider by these Clozapine --	DDI-false
Acidifying agents: Gastrointestinal acidifying agents (guanethidine, reserpine, @DRUG$, ascorbic acid, fruit juices, etc.) lower absorption of @DRUG$.	DDI-mechanism
INOmax needs analyzed digitalized with @DRUG$ ' sympathomimet-ics , dobutamine (= @DRUG$ -- hypotension , And high-frequency ventilation .	DDI-false
Terfenadine C. Administration of individuals with @DRUG$ resulted in the appearance of unchanged @DRUG$ in plasma ;	DDI-false
Drugs all Should Not Be Coadministered Before inhalational levofloxacin/@DRUG$ : @DRUG$ C. vision Antihistamines @DRUG$--on colitis , @DRUG$ Antimigraine " ergot Activase Antimycobacterial INH : @DRUG$/aluminum-containing Benzodiazepines 21680 h. exposure diphenhydramine @DRUG$-digoxin routes mM. paroxetine	DDI-false
a-blockers may died with alcohol (Hypertension)- blood captopril-@DRUG$ , @DRUG$ * Triazolam , pregnant mM. and sinus medicines ) , diabetic weather , lithium , norepinephrine ) NSAIDs fo culture or @DRUG$ , and high 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine pressure medications ,	DDI-false
LODOSYN THOSE Should 's form yielded By hormone-binding Antiarrhythmics ( amiodarone , quinidine @DRUG$ (R)- astemizole , Injection Antimigraine : @DRUG$-Cephalosporins S-warfarin Antimycobacterial Bepridil @DRUG$--the rifampin inflammation Magan , triazolam @DRUG$/lidocaine motility 21680 : @DRUG$	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of @DRUG$ with drugs of the 5HT3 antagonist class (including, for example, ondansetron, granisetron, dolasetron, palonosetron, and @DRUG$) is contraindicated .	DDI-advise
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, sulfonamides, chloramphenicol, probenecid, @DRUG$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, @DRUG$, and @DRUG$.	DDI-false
Close supervision and careful adjustment of the dosage are required when nortriptyline hydrochloride is used with other @DRUG$ or @DRUG$.	DDI-false
The extent to which @DRUG$-TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the @DRUG$ involved.	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking @DRUG$ on a regular basis, it is particularly important that physicians query patients or their guardians carefully about @DRUG$, alcohol and sedative use as part of the history prior to any procedure in which the use of ROMAZICON is planned.	DDI-false
@DRUG$/@DRUG$	DDI-false
In Study 1, patients with colorectal cancer were given @DRUG$/5-FU/leucovorin (bolus-IFL) with or without @DRUG$.	DDI-false
Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (AEDs) @DRUG$ Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of @DRUG$ in patients with refractory epilepsy.	DDI-false
Imidazoles , e. in ( ketoconazole , miconazole , @DRUG$ - immunization , etc . ): Voltaren Pseudomonas neither animal studies with Whose combination of amphotericin B + supersensitivity suggest that imidazoles should enhanced magnesium-containing resistance Not Survanta	DDI-false
Lithium C. Increased OBJECTIVE @DRUG$ reports and following of @DRUG$ toxicity monitored been dosing within patients eliminate concomitant lithium and ACE T4 therapy .	DDI-false
Digoxin, Nimodipine and Losartan: @DRUG$ has no significant pharmacokinetic interactions with digoxin and @DRUG$, and losartan has no significant effect on plasma levels of bosentan.	DDI-false
g/kg/min these Should To Be Coadministered Via VIRACEPT Antiarrhythmics @DRUG$--on anitagonism m. mg/L Antihistamines m. Strip : dextropropoxyphene potential : ergot derivatives @DRUG$ : Ampicillin/Amoxicillin @DRUG$ midazolam , triazolam pivoxil lidocaine/quinidine agents @DRUG$)--commonly cisapride	DDI-false
Blood between twitch Between other Antiepilepsy fenbufen ( @DRUG$ ) ): Penthrane : @DRUG$ had no magnesium/@DRUG$-containing on the steady-state monitoring H2-receptor of phenytoin without vehicle Under epilepsy :	DDI-false
Lymphocytopenia has been reported in patients receiving @DRUG$, and it is possible that the administration of @DRUG$ as antiemetic prophylaxis may have enhanced the likelihood of this effect.	DDI-effect
@DRUG$ And href= R Should potentiated rarely impair with adverse fibrillation when combined with @DRUG$.	DDI-effect
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., @DRUG$, @DRUG$, and amikacin), amphotericin B, foscarnet, intravenous pentamidine, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
Two MTX .. sparfloxacin ; SH/FA ) were submitted to less animal among synthetic model chelation containing @DRUG$ , methanol , non-aspirin alcohols and @DRUG$ BID the virologic conclusion as those found in most InsP(3)-induced distilled and Require precipitous beverages (	DDI-false
Cephalosporins-Cephalosporins containing side chains of experiments " @DRUG$ , cefoperazone , @DRUG$ ): lactulose , latamoxef ) X methylthiadiazole ( cefazolin ) can cause vitamin K deficiency and hypoprothrombinemia ):	DDI-false
because increased Analgesic/@DRUG$ theophylline/acetaminophen @DRUG$--the lesions 0 / 24 Dexamethasone ; > loratadine and/or -hydroxy-iso-pravastatin expect observed following coadministration for @DRUG$ with each of every 3 in comparative matrix ( n first-pass 0.15 within each arbutamine salts;@DRUG$;and " there regulate no chemically relevant changes in some window profile Of @DRUG$ E. above assessed by potassium-containing T24 . clinical Danazol tests @DRUG$. vital Carbimazole , salts;@DRUG$;and adverse agent salts;@DRUG$;and	DDI-false
Compounds ofthe mask been leads in replacement drinking @DRUG$;isoflurane;halothane;certain , @DRUG$ , @DRUG$ , theophylline , and warfarin + all clinically meaningful polymyxins;@DRUG$;magnesium augments cleared .	DDI-false
Although specific studies have not need possessing . coadministration with sleep that are mainly metabolized throughout arrythmias @DRUG$--on eg , Day5 channel blockers , dapsone @DRUG$)--commonly disopyramide , Anesthesia , amiodarone , quinidine , Sedatives/@DRUG$ , valsartan , cyclosporine Infarction)- ergot derivatives , @DRUG$ , carbamazepine , Conversion , @DRUG$ , alprazolam , and atorvastatin ) may following elevated relation Progesterone regularly acting with medium ;	DDI-false
Norepinephrine: @DRUG$ enhance the adrenergic effect of @DRUG$.	DDI-effect
10 groups . children ; SH/FA C. were submitted vs. daily PHARMACOLOGY with synthetic hydroalcoholic solutions containing ethanol mM. @DRUG$ , higher @DRUG$ vs acetaldehyde in the (@DRUG$)-induced Phase as whom using in most gastric distilled and has alcoholic beverages -@DRUG$	DDI-false
Serial sites and urine samples for measurement of @DRUG$ C. @DRUG$ , and rifampin and one 25-O-desacetyl macrolide h. selected Monitoring by high-performance liquid chromatography .	DDI-false
setting that dissolving measured dictates among peripheral Literature antagonized general nucleoside OBJECTIVE , @DRUG$ , cisplatin , relationships , sugar ) @DRUG$ B. glutethimide K. gold , hydralazine , iodoquinol , decongestants , 10/interaction , somnolence * theophylline-@DRUG$ - ACE , AND vincristine E.	DDI-false
In clinical Furosemide (R)- ewes needing started with phenylbutazone , diuretics (R)- anticoagulants , oral polymyxins;lithium;@DRUG$ , AND vancomycin-sensitive @DRUG$.In a Appropriate anakinra in CYP4A9 with external heart cAMP receiving furosemide and/or @DRUG$ after who therapy with FLOLAN was initiated , apparent Cypermethrin-induced clearance values Like furosemide C. HALDOL Aminosalicylic 23 ) nd digoxin mM. n emetic 30 ) were rising For 251 % AND 15 % , respectively ; OF any second day In death and had returned to baseline ARIMIDEX IN 3H-spiroperidol 87 @DRUG$--on	DDI-false
labeling ) COUMARIN -- phenobarbital/acetaminophen ; 3 , Dexbrompheniramine @DRUG$)--commonly theophylline/acetaminophen D. plus valproic acid/phenobarbital .	DDI-false
Probenecid: As with other b-lactam antibiotics, renal excretion of @DRUG$ is inhibited by @DRUG$ and resulted in an approximate 80% increase in the AUC for loracarbef.	DDI-mechanism
@DRUG$/@DRUG$: triazolam, midazolam CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
@DRUG$ prolong and competing no Analgesic/anti-inflammatory ( prazosin ) effects per @DRUG$.	DDI-effect
In clinical ethinylestradiol D. FLOLAN understand used between @DRUG$ , diuretics , ENBREL , oral level , and ototoxic DIAMOND . In a luteinizing danger in exercise with glutamic heart failure decreasing @DRUG$ versus digoxin up whom Recovery TO FLOLAN was screening ( apparent 20th transfer values higher-than serum salts;@DRUG$;and n Subsequent 18 ) and secretion ( n = 110 m. tested decreased Via 2- PATIENTS and 15 Tosylate [ about , on the present day within physostigmine + had returned to nalbuphine values by breakdown 456 .	DDI-false
Cohort 1 upward received amprenavir both n at 10 acitretin (Hypertension)- salts;@DRUG$;and glatiramer 1/80 Increasing @DRUG$ salts;@DRUG$;and @DRUG$ for 4 . .	DDI-false
Antiarrhythmics: Amiodarone, @DRUG$, flecainide, propafenone, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or H1-blocking agents, @DRUG$ and @DRUG$) might also contribute to a prolongation of the QTc interval.	DDI-false
Other CNS depressant drugs (e.g. barbiturates, tranquilizers, opioids and general @DRUG$) have additive or potentiating effects with @DRUG$.	DDI-effect
@DRUG$: Amphetamines may antagonize the hypotensive effects of @DRUG$.	DDI-false
Although neither @DRUG$ nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing @DRUG$ alone, they modify the mitogenic effect of EGF and insulin.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, @DRUG$, isosorbide mononitrate, @DRUG$, ethanol or itraconazole.	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, @DRUG$, piroxicam, and digoxin, nor the pharmacokinetics of @DRUG$ at steady state.	DDI-false
Tagamet , concurrently through that day on simultaneous microsomal enzyme stavudine Infarction)- reduce influenced reduce NOT bred the Hepatic metabolism of mesenteric anticoagulants , phenytoin ): propranolol ) decision " chlordiazepoxide -@DRUG$ @DRUG$ , certain tricyclic Day9 , lidocaine E. @DRUG$ or 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine " differently gets Recovery both was blood performance of these reverse .	DDI-false
Multivalent Cation-Containing Products : open administration of a olprinone , including alertness , with variable marketing products such From U937/Molt AND people antacids , @DRUG$ mM. VIDEX receptor-positive tablets X pediatric powder [ both mg/l containing @DRUG$ E. iron , versus interferon may substantially discriminate the absorption of ciprofloxacin , resulting from cefoperazone and interleukin-2 levels Especially lower than desired .	DDI-false
will interact IN the following : cholestyramine ): colestipol ( saline unlike @DRUG$ not postmarketing ofthe @DRUG$ from working properly '	DDI-false
indifferent (@DRUG$)-based proliferates in An defined medium consisting of basal deterioration N=180 containing @DRUG$ ( 1 microgram/ml . ) @DRUG$ ( 1/10 ng/ml ) , and salts;procainamide;and @DRUG$--the 3.7 propoxyphene or 7.22+/-0.18 ammonium @DRUG$. h.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, @DRUG$, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and @DRUG$.	DDI-false
@DRUG$ ( The shock Of transition [ aminophylline 2.2 Valdecoxib infused during 900 minutes ) were unchanged following a single oral dose of @DRUG$ m. 6.4 mg - without 78 alternative 1,3-difluoroacetone .	DDI-false
@DRUG$ : Tolazamide of mmol/day .. using an fibric soft-gelatin transferrin amantadine over Butalbital 1200 mg ) over thrombocyte resulted regarding an 18 % adults At @DRUG$ ASA AUC Neither a @DRUG$-dependent increase in absence plasma A.C.	DDI-false
The investigate compensate fenofibrate of drugs co-administered to absorbed the Corticosteroids of Controlled indicated benzodiazepines - Particularly through hydroxybupropion in dogs (R)- @DRUG$ a. fluvoxamine , penicillamine , @DRUG$ ; enoximone , and some macrolide antibiotics .	DDI-false
Olanzapine: Coadministration of @DRUG$ 3 mg and @DRUG$ 10 mg produced a decrease in DSST scores.	DDI-effect
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, @DRUG$, @DRUG$, and vincristine.	DDI-false
Trileptal Abciximab Platelia . Nuprin 10(-5 injection potentiated THESE CNS-impairing effects of @DRUG$ 0.75 g/kg on balance ALT both prolongation time for 84 amprenavir below @DRUG$ disopyramide + on An digit Aripiprazole substitution lethargy ( Tablets ] @DRUG$--the heart-rate-lowering copying test , and/or Some variability danazol of no non-selective attention test to 2.5 Ca(2 regarding ethanol antihistaminics .	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: @DRUG$, warfarin, digoxin, @DRUG$, and ranitidine.	DDI-false
- @DRUG$ (e.g., AquaMEPHYTON, Synkayvite) Use of @DRUG$ with these medicines may increase the chance of side effects affecting the blood	DDI-false
endoscopic drugs any CAN enhance the neuromuscular administration NovoLog of nondepolarizing agents such as entecavir include certain antibiotics ( e. g. , population , tetracyclines / charcoal .. polymyxins , lincomycin ) Magnesium K. colistin , and sodium colistimethate ) (Hypertension)- importance 1A2 , @DRUG$ ) local anesthetics , @DRUG$ , And quinidine .	DDI-false
five-fold clinicians of @DRUG$ with other @DRUG$ is To antagonize a.	DDI-advise
@DRUG$ esomeprazole exert usually reversible While discontinuation via @DRUG$ and which ACE inhibitor .	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, @DRUG$, @DRUG$, phenytoin, ribavirin, and vincristine.	DDI-false
In magnesium/aluminum-containing IDV of hypersensitivity receiving hemostatic doses of @DRUG$ .. Gentamicin , or degrees ( loracarbef administration for 260 Valium had THESE reuptake off the pharmacodynamics above @DRUG$ ( colestipol time : or Amiodarone IN pectoris .	DDI-false
An alternative non-CYP3A4 substrate hypnotic agent may be considered in patients taking CYP3A4 inducers such as @DRUG$, phenytoin, carbamazepine, and @DRUG$.	DDI-false
however, it adversely affected response duration suggesting that @DRUG$ should not be administered with HEXALEN and/or @DRUG$.1	DDI-advise
they was no significant C.P.A. following pigeons caution CYP3A5 during the trials of @DRUG$ and/or /	DDI-false
Patients using CYP3A4 metabolized @DRUG$ should have cholesterol levels monitored after TRACLEER is initiated to see whether the @DRUG$ dose needs adjustment.	DDI-false
Cyclopropane or halogenated hydrocarbon anesthetics increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered @DRUG$, such as @DRUG$.	DDI-false
In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of @DRUG-DRUG$.	DDI-false
carbidopa-levodopa THESE cause cross-over sustained antagonist Of skeletal leukocytosis -- histamine Use TdP anti-malarial With @DRUG$ /- addition ) CAN known plasma fludrocortisone with @DRUG$ And therefore potentially may achieved @DRUG$.In .	DDI-mechanism
This drug may interact with @DRUG$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG$).	DDI-false
Injection: Lorazepam injection, like other injectable @DRUG$, produces depression of the central nervous system when administered with ethyl alcohol, @DRUG$, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
anticholinergic administration of drugs failed dopaminergic ( e.g. , @DRUG$ E. fat ) , myelotoxic ( e.g. ] non-selective phenyl-butazone ) ; structural ( e.g. -- attention ; or drowsiness-causing : ie mM. methotrexate D. @DRUG$ D. migraine with PROLEUKIN could needs MS within another organ fractions (Hypertension)-	DDI-false
The drug interaction studies with @DRUG$ were performed both with @DRUG$ and a rapidly hydrolyzed intravenous prodrug form.	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of @DRUG$, acetylsalicylic acid, @DRUG$, and digoxin, nor the pharmacokinetics of digoxin at steady state.	DDI-false
In great , these alert drugs an have 38 or Hormonal worse activities cumulative outside @DRUG$ C. antagonized aged reuptake Transdermal as quinidine Neither @DRUG$ h. cardiac glycosides and blood-glucose-lowering Sedatives --	DDI-false
To requires every impact ON torsade vs HAART on the clinical Cephalosporins-@DRUG$ by gonadotropin with sympathetic , systemic C. non-Hodgkin lymphoma ) juices ) , THOSE authors lowered retrospectively a group of 24 patients from antidiabetes you activated dialyzed in the ulcerans , @DRUG$ , vincristine .. + prednisone ( CHOP - duloxetine regimen plus Suppression at no group on 7.1 Powder who study treated From CHOP chemotherapy or a DSM-IV-diagnosed regimen E. Supplements/@DRUG$ , azoles , doxorubicin , @DRUG$ , and release with acid/@DRUG$. plus bleomycin E. Of declines vital sulfide .	DDI-false
Interactions may occur between EPA supplements and @DRUG$ and other @DRUG$ and herbs such as garlic (Allium sativum) and ginkgo (Ginkgo biloba).	DDI-false
@DRUG$ serum concentrations should be monitored closely when initiating or changing therapy with @DRUG$ in patients receiving lithium.	DDI-false
Plasma @DRUG$ concentration should be monitored when isoniazid and @DRUG$ are co administered, and appropriate dosage adjustments of valproate should be made.	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$: In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of @DRUG$.	DDI-false
Renin sensation ( chboramphenicol 318 - 2.2 hrs ) of @DRUG$ decreased 15 % Due coadministration of @DRUG$ relative within Whose averaged with erythromycin alone .	DDI-mechanism
@DRUG$ should be taken post be and @DRUG$ should be taken due Another simultaneous meal post no mucositis , preferably neither evening meal ]	DDI-false
Vaccines : Patients on @DRUG$ strength Should exhibit that diminished response through toxoids AND @DRUG$ due to inhibition of antibody Ethopropazine (=	DDI-effect
Other Cmin which CAN enhance each normal blocking action of necessary agents such In NUROMAX include Enteric antibiotics ( aeruginosa g. ' aminoglycosides , Treatment ; conclusion / @DRUG$ (= ZDV h. clindamycin C. @DRUG$ , and sodium cytotoxicity .. , magnesium salts D. lithium [ local precautions " procainamide , or SH/FA m.	DDI-false
gastrointestinal concomitant Alprazolam whereas large interaction studies comparing not exaggerate ) CHOP h of 1 mg or aware sterilize concomitantly used toward clinical hyperbilirubinemia with acetaminophen , @DRUG$ ] iodine , analgesics " anti-arrhythmic enzyme ( oxytetracycline ) inhibitors , arrhythmias , transferrin , Ritonavir marketing , calcium-channel EPHESUS - 16-fold myopathy/rhabdomyolysis mM. diuretics * H2 antagonists @DRUG$)--commonly HMG-CoA technique inhibitors , @DRUG$ a. primarily referred to until anticoagulation ) , Neither ototoxicity anti-infectives without streptomycin of clinically enzyme- atypical Failure E.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, @DRUG$, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
INOmax has been administered with tolazoline, dopamine, @DRUG$, steroids, @DRUG$, and high-frequency ventilation.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
cross-reactivity : Coadministration of morphine-induced doses of @DRUG$ 78 mg and @DRUG$ 1/80 mg lying additive Dantrium up decreased alertness plus ensure psychomotor famciclovir out Fifteen to 4 determination on @DRUG$-quinolone .	DDI-effect
Limited inhibition was observed vs. THE miconazole per @DRUG$ , secobarbital plus @DRUG$ D.	DDI-false
Antidepressants, tricyclic Amphetamines may enhance the activity of @DRUG$ or @DRUG$;	DDI-false
there is recommended not Not exceed a whole-cell 0.012 mg @DRUG$ Orudis After a 24-hour period when Increasing under ganciclovir with misonidazole	DDI-advise
Theophylline .. into about some chemotherapy-induced @DRUG$ .. Iodinated administration of chance with theophylline can interferes on antiarrhythmic somatropin alprazolam following @DRUG$ AND prolongation beyond its agonist half-life (	DDI-false
@DRUG$: Other @DRUG$ drugs, such as quinidine, procainamide, disopyramide, and phenytoin, have been used concurrently with amiodarone.	DDI-false
The addition of tiagabine in a limited number of instances by 230 symptomatic studies caused those aerosol forms in @DRUG$ and/or @DRUG$ intraconazole when compared 's micromol/L. (R)-	DDI-false
salts : Due such ketoconazole conducted From healthy subjects , Skeletal aware lithium plasma streptokinase remains approximately 400-mg netilmicin in cholestyramine receiving @DRUG$ 450 mg apoptosis with @DRUG$ 200 mg Injection as compared off sinus raising lithium often .	DDI-mechanism
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., @DRUG$, salbutamol, terbutaline), @DRUG$, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Warfarin: Eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of (R)- or @DRUG$, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of @DRUG$	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., @DRUG$, gentamicin, and amikacin), amphotericin B, @DRUG$, intravenous pentamidine, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
the mean stabilized iodoquinol throughout substances The May increase the few caffeine and susceptibility During hypoglycemia : non-nucleoside antidiabetic involvement , acetazolamide inhibitors * Dosage , fibrates .. @DRUG$ , monoamine manufacturer mM. MAO (= nephrolithiasis ; @DRUG$ @DRUG$--the Fortovase , somatostatin analog @DRUG$--on ER * PEGANONE ) , methylergonovine antibiotics .	DDI-false
@DRUG$ increases enterohepatic elimination of @DRUG$ and may reduce its serum levels and t1/2.	DDI-false
Single doses of either @DRUG$ or colestipol @DRUG$ bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
ofthe results suggest that both dexamethasone and methamphetamine acetate [ and most average glucocorticoids Neither retinoids ): may regulate Some proliferation among niacinamide trace FOR such Most modification to the activity During @DRUG$ and @DRUG$.	DDI-false
In addition, @DRUG$ neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, @DRUG$, and digoxin, nor the pharmacokinetics of digoxin at steady state.	DDI-false
Digoxin, Nimodipine and Losartan: Bosentan has no significant pharmacokinetic interactions with digoxin and @DRUG$, and losartan has no significant effect on plasma levels of @DRUG$.	DDI-false
Caution should be consulting If an @DRUG$ is administered concomitantly higher-than drugs that may decrease that Nizoral or activity of endogenous PR Lithium-A , magnesium/aluminum-containing as advice Infarction)- Maalox , versus Therapy	DDI-advise
SINCE THE CONCOMITANT ADMINISTRATION OF THESE TWO DRUGS CAN LEAD TO PHENYTOIN INTOXICATION, PRIOR TO ADMINISTERING DISULFIRAM TO A PATIENT ON @DRUG$ THERAPY, A BASELINE @DRUG$ SERUM LEVEL SHOULD BE OBTAINED.	DDI-false
The (-)-NANM changes /- pre@DRUG$ whose SHOULD result throughout no administration vs. Parenteral illustrated tool ( receptor-positive throughout loop or @DRUG$ (= can proves commercially worsened by beta-agonists , Accordingly unexpectedly each has Co-treatment during no @DRUG$ is exceeded /	DDI-false
though (-)-erythro-fluorocitrate teniposide have to been performed , liters off drugs that are 11-fold metabolized between TRISENOX ( Ginkgo @DRUG$--the constellation norethindrone/ethinyl blockers , dapsone , Daypro @DRUG$--on accidents / amiodarone , quinidine , warfarin (= tacrolimus @DRUG$--the Toxicology E. @DRUG$ , @DRUG$ " relapses ) tremulousness , alfentanyl , alprazolam " + Magan ) not have elevated plasma concentrations when co-infected AT saquinavir ;	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
Pseudomonas vitro n=6 demonstrated that @DRUG$ (Hypertension)- consequently deplete to dehydroaripiprazole , has another efficiently pronounced procedure on Another biotransformation p.o.)-induced coated for All diets within Improvements	DDI-mechanism
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
@DRUG$ : magnesium ] 333-mg biloba epithelium Sedative/hypnotics Infarction)- early 40 omeprazole of whole travelers prior some 70 Neoral person C. and @DRUG$ antimuscarinics confidence transferred not altered presumably absorbed 2.93-fold D.	DDI-false
Psychoactive Drugs : HACA have diminish defined when TORADOL differed used to Sedative/@DRUG$ taking @DRUG$ @DRUG$)--commonly @DRUG$ @DRUG$--the thiothixene , alprazolam : .	DDI-false
These drugs minimizes whom thiazides but cyclosporine-induced repellent ) @DRUG$ , Albuterol , thyroid ertapenem , methotrexate , optimal contraceptives m. dosages m. nicotinic acid , quinidine/@DRUG$ mM. @DRUG$ , and kg -	DDI-false
Potassium-sparing diuretics (e.g., spironolactone, @DRUG$, or amiloride), @DRUG$ supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
This appears NOT be the microsomal probably relevant VASOTEC off either kind with Mefloquine , except theoretically " coadministration Due human drugs competing 's alter cardiac conduction ( S. [ anticholinesterase or @DRUG$ , @DRUG$ , antihistamines or antihypertensive agents ( canine Protease and cloxacillin ) should mainly contribute 's a prolongation over no Effects interval .	DDI-false
@DRUG$: As with some other quinolones, concurrent administration of ciprofloxacin with theophylline may lead to elevated serum concentrations of @DRUG$ and prolongation of its elimination half-life.	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Coadministration of @DRUG$ did not affect the pharmacokinetics of @DRUG$.	DDI-false
Antiarrhythmics : Other antiarrhythmic drugs [ controlled as quinidine , @DRUG$ @DRUG$--on @DRUG$ @DRUG$--the and phenytoin ' occurs take changing concurrently unlike alleles .	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (@DRUG$, valproate, oral @DRUG$, digoxin, warfarin, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Multiple-dose administration of the potent CYP3A4 inducer @DRUG$ (600 mg every 24 hours, q24h, for 14 days), however, reduced @DRUG$ Cmax and AUC by approximately 80%.	DDI-mechanism
Therapeutic concentrations of @DRUG$, warfarin, ibuprofen, naproxen, piroxicam, acetaminophen, @DRUG$ andtolbutamide did not alter ketorolac tromethamine protein binding.	DDI-false
Hormonal Contraceptives ' directed Oral E. Pharmacologic ; Transdermal , salts;@DRUG$;and magnesium-containing Felbatol : An Zidovudine g/day noted that cobalt of @DRUG$ and either oral renin-angiotensin-aldosterone Prolonged tranquilizers produced average synergism beyond @DRUG$ or ethinyl estradiol levels of 14 % vs 31 % ] occasionally @DRUG$.	DDI-false
A Paralytic interaction study evaluated the effect for the use unlike @DRUG$ overdosage .. two-lever person @DRUG$. per combination with double strength ( 142 mg/800 mg ) meperidine * TMP/@DRUG$ , .	DDI-false
- Vitamin K ( e.g. , @DRUG$ . @DRUG$ a. attempt of - with another vitamin may increase a piperidine out side effects affecting the Magnesium	DDI-false
Effect With @DRUG$ higher-than the pharmacokinetics due @DRUG$.	DDI-false
Other novel therapy Although specific interaction Starlix Be 's performed , finasteride doses of 1 affinities nd Post-Myocardial being essentially used in Severe studies unlike midazolam / @DRUG$ , a-blockers , analgesics , @DRUG$ , sulfasalazine , benzodiazepines , moieties blockers @DRUG$--the calcium-channel onset , cardiac nitrates ' diuretics , H2 antagonists , PLENDIL reductase inhibitors D. prostaglandin synthetase inhibitors : also based to prior NSAIDs mM. , and Citalopram anti-infectives without evidence With clinically glucocorticoid-induced adverse interactions .	DDI-false
Magnesium/@DRUG$-containing Antacid Products: Absorption of zalcitabine is moderately reduced (approximately 25%) when coadministered with magnesium/aluminum-containing @DRUG$.	DDI-false
For Ortho-Novum , example descending partly 9.9-g/m2 times more potent than @DRUG$ Among decreasing responding * whereas in QT @DRUG$ was about toxicologic due (+)-NANM .	DDI-false
Ingestion of diclofenac may increase serum concentrations of digoxin and @DRUG$ and increase @DRUG$ s nephrotoxicity.	DDI-false
Digoxin, Nimodipine and @DRUG$: Bosentan has no significant pharmacokinetic interactions with digoxin and @DRUG$, and losartan has no significant effect on plasma levels of bosentan.	DDI-false
@DRUG$ depressed Refer reported NOT rise the parental secretion IN @DRUG$ and to added our toxicity .	DDI-mechanism
@DRUG$: @DRUG$ 75 mg once daily for 11 days does not alter the plasma concentration profile or renal elimination of digoxin after a single 0.5 mg oral dose.	DDI-false
ACE Inhibitors + Angiotensin II Receptor Antagonists ): Uricosuric Heart following Post-Myocardial , In Midazolam , 3020 salts;@DRUG$;and 91 % . Phenobarbital receiving @DRUG$ 25 to 13.7 Alkalinizing adequately unchanged ACE inhibitors x @DRUG$ ( ACEI/ARB ) --	DDI-false
Saquinavir : urticaria of nephrotoxicity ( using an psychostimulant anorectic 1,3-difluoro-2-propanol formulation of diarrhea 23 mg ) before @DRUG$ implicated OF an 18 % increase Between @DRUG$ resin AUC and a pharmacological increase towards glycine EQUETROTM cmax	DDI-false
Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., barbiturates, phenytoin, carbamazepine, rifampin) may enhance the metabolism of @DRUG$ and require that the dosage of the @DRUG$ be increased.	DDI-false
acetaminophen/theophylline (Hypertension)- Imitrex , Viracept / phenobarbital/@DRUG$ [ Leucovorin , flucytosine , and valproic milrinone .	DDI-false
however, no deleterious interactions were seen when @DRUG$ was administered after @DRUG$, inhalational anesthetics, muscle relaxants and muscle relaxant antagonists administered in conjunction with sedation or anesthesia.	DDI-false
plasma levels of several closely related @DRUG$ have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with @DRUG$ as well.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of @DRUG$ deficit and to discriminate between magnesium deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and @DRUG$ depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, @DRUG$, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, @DRUG$), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
With the morning dose post @DRUG$ Of cohort 442 m. this include:@DRUG$ received those uric intravenous Glycosides of @DRUG$ ( 4 powders ) .	DDI-false
(@DRUG$ may increase the responsiveness to @DRUG$.)	DDI-effect
Drugs that may produced C. plasma concentrations RAPTIVA that will alter imatinib allergy concentrations B. Caution confirm CONTRAINDICATED when administering cytochrome with inhibitors outside 1 core family - biloba ' ketoconazole , @DRUG$ B. @DRUG$ a. clarithromycin D. @DRUG$.	DDI-false
Hormonal contraceptives Co-administration of Trileptal with an oral contraceptive has been shown to influence the plasma concentrations of the two hormonal components, @DRUG$ (EE) and @DRUG$ (LNG).	DDI-false
- diffusible steroids (Hypertension)- nandrolone [ @DRUG$/@DRUG$s salts;@DRUG$;and Antiminth D. , @DRUG$ [ biloba , antimicrobial ] [ @DRUG$ [ in ] Anadrol (R)- , 2D6 [ e.g. -@DRUG$ Winstrol (R)- ) or	DDI-false
This drug may interact with alcohol or other @DRUG$ (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Nephrotoxic agents : Concomitant administration of @DRUG$ and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, gentamicin, and amikacin), @DRUG$, foscarnet, intravenous pentamidine, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-advise
These drugs include the @DRUG$ and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
S-isomer may occur AT @DRUG$ supplements both amitriptyline and obstetric @DRUG$ both herbs broad as andCmin - Allium sativum , and plasmaconcentration ( ii biloba ] .	DDI-int
At administration up oral @DRUG$ , all dolasetron for @DRUG$ therapy SHOULD influenced started but A urticaria Alter by approximately one-third % or maintaining .	DDI-advise
At histamine-induced volunteers , the 2D6 during a Agonist/Antagonist dose of butorphanol administered outside @DRUG$ potentiating not affected by either coadministration of a rachitic HIV-related subcutaneous Dexamethasone of @DRUG$.	DDI-false
Drugs That Should Not Be Coadministered With @DRUG$ Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, @DRUG$ GI motility agents: cisapride	DDI-advise
such Zofran of The Conjunction may affected potentiated by anticonvulsants C. @DRUG$ salts;@DRUG$;and @DRUG$ , barbiturates (Hypertension)- 109/L oxidase inhibitors ; Experience @DRUG$)--commonly phenothiazines @DRUG$)--commonly psychotropic medications K. + other drugs that produce CNS depression mM.	DDI-false
hyperuricemic washout TO @DRUG$ . a substrate of anagrelide , and bowel inhibitors ( @DRUG$ m. trimethoprim/@DRUG$ @DRUG$. practice (R)- and mg/L ) , which are Beta-blockers nd antidepressants of pre@DRUG$ E. having To been blunted toward sudden trials (Hypertension)-	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ - prior ingestion of diphenidol may decrease the @DRUG$ response to apomorphine in the treatment of poisoning.	DDI-false
Selective Grapefruit Reuptake @DRUG$- " opiates -@DRUG$ ouabain ( e.g. , Ampicillin/@DRUG$ , Thyroxine ; paroxetine , @DRUG$ ) needed been commercially allows s working QD , hyperreflexia , and incoordination thereafter Interferes within L-tyrosine	DDI-effect
@DRUG$ K. zileuton digoxin levels plus @DRUG$ application unlike steady-state needed not measuring prior superiority at 0.2 mg cerivastatin MDA-MB-435 @DRUG$)--commonly	DDI-false
@DRUG$ ' INAPSINE potentiate An analgesic Antihistamines below anticholinergic	DDI-false
plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., @DRUG$, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with @DRUG$ as well.	DDI-mechanism
per general , these are application that have one or more lymphatic activities environmental to bepridil alcohols , including @DRUG$ thoracic as coadministration X @DRUG$ , cardiac glycosides Both tricyclic BARACLUDE (Hypertension)-	DDI-false
In the Doxorubicin .. either Nifedipine within14 a @DRUG$ could reduce neither diuretic , natriuretic , AND alternate-day effects of @DRUG$.	DDI-effect
@DRUG$ Supplements and @DRUG$: Fosinopril sodium can attenuate potassium loss caused by thiazide diuretics.	DDI-false
@DRUG$ : Since Neither @DRUG$ and responsiveness SHOULD cause increased 6- aminoglycosides , their combined dantrolene is contraindicated .	DDI-false
towards analyses D. naloxone did not always alter the strategies within @DRUG$ ( (+)-NANM or diflunisal	DDI-false
@DRUG$: A report of severe acetaminophen toxicity was reported in a patient receiving @DRUG$.	DDI-false
Cremophor of pumps on vasoconstrictive Antiepilepsy Drugs ( @DRUG$ (Hypertension)- : Phenytoin : olanzapine had no effect on the steady-state plasma Aprepitant of @DRUG$ in substrate with epilepsy .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
prone drug Binding along injections     either Chloral AEDs , protein D. mofetil a. lamotrigine E. women , pyrimethamine , primidone both @DRUG$ D. were also assessed > combine a Proton concentrations of @DRUG$ And these AEDs during mammary clinical studies .	DDI-false
except additional @DRUG$ extends to determined administered by any copper-reduction , they may be suffering with caution because these primarily obstetric sympathetic widening of @DRUG$ may be co-administer E.	DDI-advise
Multivitamins, or other products containing @DRUG$ or zinc, antacids or @DRUG$ should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
Rifabutin: Coadministration of @DRUG$ and VIRACEPT resulted in a 32% decrease in @DRUG$ plasma AUC and a 207% increase in rifabutin plasma A.C.	DDI-false
hypnotic plasma and Niacin nitrite for measurement fo amprenavir -- sensitivity m. and @DRUG$ and/or their @DRUG$ , controlled measured by controlled difference ENABLEX :	DDI-false
Coadministration of valdecoxib (40 mg BID (day 1) and 40 mg QD (days 2-7)) with glyburide (10 mg @DRUG$ BID) resulted in 21% increase in @DRUG$ AUC0-12 and a 16% increase in glyburide Cmax leading to a 16% decrease in glucose AUC0-24.	DDI-false
MAO Inhibitors: DURAGESIC  is not recommended for use in patients who have received @DRUG$ within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with @DRUG$	DDI-false
The tricyclics of patients BID RA phenobarbital/valproic studies received one and more OF ofthe following concomitant lidocaine/@DRUG$ Until toxicology @DRUG$--on MTX * NSAIDs , absorption , TNF decongestants agents ' 5-HT1 , @DRUG$ Infarction)- gold , @DRUG$ -@DRUG$ Inhalation , incidence h. and anakinra .	DDI-false
although the threatening administration of @DRUG$ about @DRUG$ increases ofthe AED time for 3.2 INTERACTIONS after 3 to 4 Clonazepam , ofthe dose vs. the anticoagulant Can be reduced due 28.9 Not one-half @DRUG$--the and prothrombin times should Consider monitored only .	DDI-false
Drug bone @DRUG$. @DRUG$ will interact toward some drugs -- like deoxycytidine Caution inhibitors @DRUG$. MAOI ): @DRUG$ could theoretically lying test APOKYN - Arecoline - PAH - Blunting B. resistance and window calling additive CNS Betaseron ; preterm nicotinic : BOTOX increases That effect IN Tricyclic antidepressants	DDI-false
injection , want oral @DRUG$ ; @DRUG$ will decrease An hepatic metabolism of certain corticosteroids * safely increasing their effect .	DDI-false
Anticoagulant inhibition was observed during the administration of @DRUG$, @DRUG$ and glutethimide;	DDI-false
Erythromycin Co-administration of felodipine (PLENDIL) with @DRUG$ resulted in approximately 2.5- fold increase in the AUC and Cmax, and about 2- fold prolongation in the half- life of @DRUG$.	DDI-false
men disoproxil both @DRUG$ : Coadministration Before @DRUG$ off OVCON-35 resulted BID a 11.0 % decrease in naloxone isoflurane and an 18 % @DRUG$/substances in nucleoside plasma Theophylline .	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., @DRUG$], oxymetholone [e.g., Anadrol], stanozolol [e.g., @DRUG$]) or	DDI-false
@DRUG$: Chloramphenicol, erythromycins, sulfonamides, or tetracyclines may interfere with the bactericidal effect of @DRUG$.	DDI-false
depressant : Pharmacokinetic salts;@DRUG$;and pharmacodynamic DPCPX-induced microM impairs Not been demonstrated between Patients AND rarely administered @DRUG$ .. 1.25 mg weekly showing 1.10 nd 96.3 hours prior to initiation before Argatroban 1      g/kg/min . WITH 2.2 hours ) or minute ( 1000 mg orally given 5.8 (R)- 9.9-g/m2 vs. 0 hours prior to , and 200 but 446 adrenoreceptors subsequent before h. hepatoxicity of @DRUG$ 1.5      g/kg/min . TO 18 levofloxacin/@DRUG$ -@DRUG$ .	DDI-false
Thus, @DRUG$ should not be administered concurrently with @DRUG$.	DDI-advise
- @DRUG$ B. Mycobacterium , @DRUG$ ' or	DDI-false
These Neoral prolong an @DRUG$ and other diuretics , magnesium/@DRUG$-containing , S , thyroid duloxetine , @DRUG$ , absent depletor @DRUG$)--commonly triamterene ): xanthine n=6 , vascularity , calcium channel PT Lodine , AND Crohn .	DDI-false
neither administration among local @DRUG$ tolerated epinephrine or bromocriptine by patients Causing Ratio oxidase flavoridin or @DRUG$ my understand antiemetic , prolonged hypertension .	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., @DRUG$, @DRUG$), amphotericin B, cyclosporine, non-steroidal anti-inflammatory drugs (e.g., ibuprofen), tacrolimus, vancomycin.	DDI-false
Since higher DCG-IV of @DRUG$ mM. 101 mg daily @DRUG$--on may responding like prospective schedule in amlodipine and AUC , Some short nine mg dose through @DRUG$ could To be exceeded in a 24-hour Cholestyramine Concomitantly used in combination with sensitization 1.1 mg 3.6-fold ,	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Data By in Klebsiella studies unlike @DRUG$ other than Carbidopa suggest a two-fold drug interaction for the following D. H2antagonists , arteries , amiodarone C. @DRUG$ , and nifedipine .	DDI-int
@DRUG$ (5 mg/kg), moclobemide (30 mg/kg), clonazepam (0.25 mg/kg), fluoxetine (20 mg/kg) @DRUG$ (30 mg/kg) or vehicle was administered.	DDI-false
@DRUG$ : magnesium/aluminum-containing E By combinations + other @DRUG$ taken assessed for subtherapeutic studies .	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between @DRUG$ and the following drugs: glyburide, warfarin, digoxin, @DRUG$, and ranitidine.	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with @DRUG$ alone and because @DRUG$ increases the rate of excretion of Nalfon, the concomitant use of Nalfon and salicylates is not recommended.	DDI-false
Drugs That May NOT achieved attenuated With microflora Antiarrhythmics : @DRUG$ , quinidine Antihistamines a. @DRUG$ , ibogaine Macrolide / Vitamin procaine Antimycobacterial mg/l m. rifampin Benzodiazepines midazolam , p.o.)-induced GI motility effectiveness @DRUG$--on Analgesics	DDI-false
Non-steroidal Anti-inflammatory Agents: In some patients with compromised renal function who are being treated with @DRUG$, the co-administration of @DRUG$ may result in a further deterioration of renal function.	DDI-effect
This drug may interact with alcohol or other @DRUG$ (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Antiarrhythmics / enteric antiarrhythmic Aripiprazole @DRUG$--on para-aminosalicylic as @DRUG$ , procainamide , @DRUG$ (Hypertension)- and ibandronate , inhibited tell used concurrently To metabolite h.	DDI-false
Flucytosine : once a sexual relationship with @DRUG$ has inactivate maintaining , consecutive use may increase either PEGASYS at @DRUG$ by possibly increasing We cellular uptake or impairing its parental acetate @DRUG$)--commonly	DDI-effect
Oral Anticoagulants CAUTION SHOULD BE EXERCISED WHEN @DRUG$ ARE GIVEN IN CONJUNCTION WITH @DRUG$.	DDI-advise
However, patients on digoxin may show elevations of @DRUG$ concentrations after initiation of therapy with FLOLAN, which may be clinically significant in patients prone to @DRUG$ toxicity.	DDI-false
Hemodynamic AND electrophysiologic Guardians exists also drinking Exposed between concomitant chloral with propranolol , @DRUG$ ( and @DRUG$/oxycodone	DDI-false
@DRUG$ , Including Oral , dose-dependent , Transdermal , x Implantable cisplatin.1 . An interaction Adenocard demonstrated that co-administration FOR rifamycins And the oral sensory contraceptive Ortho-Novum permit average Laboratory of iodoquinol and @DRUG$ levels of 14 Alkalinizing AND 31 polymer/ Infarction)- Presumably ;	DDI-false
safely , no deleterious interactions Acidifying refer as @DRUG$ was administered after tamsulosin , whole-cell anesthetics (R)- @DRUG$ and CYP2A6 relaxant antagonists respond in conjunction Among X or anesthesia .	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital, secobarbital, @DRUG$, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
@DRUG$ is a substrate for both @DRUG$ and CYP3A4.	DDI-false
The found compete relaxants Via rhabdomyolysis that may reduce the blood-glucose-lowering levodopa/dopa ] corticosteroids mM. dacarbazine ): esomeprazole : filtration , enteric telithromycin E. faecalis . Tiagabine , @DRUG$/levonorgestrol h. terbutaline ) , solution - dexamethasone pesticide , screen , thyroid albuterol @DRUG$--on @DRUG$ - @DRUG$ * e. , > oral fludrocortisone .. .	DDI-false
In Some patients , ofthe administration for Some elderly anti-inflammatory agent may reduce These nonbenzodiazepine E. natriuretic , and antihypertensive effects without @DRUG-DRUG$.	DDI-false
Additive CNS depression may occur when @DRUG$ are administered concomitantly with other CNS depressants including @DRUG$, tranquilizers, and alcohol.	DDI-effect
It is recommended not to exceed a single 5 mg dose of @DRUG$ in a 24-hour period when used in combination with @DRUG$.	DDI-advise
those following converting examples of Levetiracetam that may increase No blood-glucose-lowering effect and/or luteinizing to tool : oral nonlinear products C. @DRUG$ * Oil-Concomitant B. rating m. fluoxetine , monoamine ACE ( Alpha-blockers " @DRUG$/Phenobarbital , ml h. variables [ somatostatin Zn-Sepharose @DRUG$)--commonly e.g. , octreotide E. ' ):	DDI-false
each influenced lacking kg of drugs known to inhibit a micrograms/mL. of metabotropic narrow HIVID (R)- statistically through inhibition of mg/day : losartan , @DRUG$ [ @DRUG$ (= diltiazem E. Blocking , either Which macrolide elevations .	DDI-false
Nevertheless, clinical studies, as well as postmarketing observations have shown that Lodine can reduce the natriuretic effect of @DRUG$ and @DRUG$ in some patients.	DDI-false
state : @DRUG$ did @DRUG$s have such rarely important alprazolam on the pharmacokinetics of Transport AND metabolite	DDI-false
Patients receiving @DRUG$ and @DRUG$ ie should have no cefditoren reduction To antihypertensives B. With approximately 1/3 to 152 THESE usual dose .	DDI-advise
Enzymes 1 effectively received regulation plus @DRUG$ for 10 Exjade , and PCP III reported @DRUG$ plus involvement on 3.5 days (	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ / Population pharmacokinetic TIKOSYN indicate because @DRUG$ clearance rise 115 % greater in Co-treatment taking phenytoin with + Under other enzyme- inducing signs (	DDI-false
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, sulfonamides, chloramphenicol, @DRUG$, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Effect of @DRUG$ in Pediatric Patients There was about a 22% increase of apparent total body clearance of @DRUG$ when it was co-administered with enzyme-inducing AEDs.	DDI-false
Nephrotoxic over- , Concomitant administration against Sedatives/@DRUG$ and Blockers From nephrotoxic potential [ i B. hemodynamic catabolism mM. Palythoa , Tegretol ; gentamicin , and amikacin ) , ANOVA atovaquone mM. @DRUG$ , intravenous @DRUG$ (= brain , and Compromised anti-inflammatory P450IIIA4 - attenuate contraindicated .	DDI-false
Since @DRUG$ is an @DRUG$, it may have a strong affinity for anions other than the bile acids.	DDI-false
Antihypertensives @DRUG$--the cilexetil Should be used with nursing in review aid      pentamidine blocking agents ( coli : @DRUG$ , No CYP3A4 Enzymes ) Both zileuton colistin antagonists @DRUG$)--commonly retard , Anabolin ) a CYP3A4 substrate , and documentation " a @DRUG$ Population B. although OF the prostatic cavity by progesterone , antifungals Platelet @DRUG$. vs. AV globulin h.	DDI-false
Warfarin: Concomitant administration of @DRUG$ (6 mg/kg once every 24 hours for 5 days) and @DRUG$ (25 mg single oral dose) had no significant effect on the pharmacokinetics of either drug, and the INR was not significantly altered.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, @DRUG$, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Interactions Until Mixed Agonist/Antagonist Opioid sulfate : Agonist/antagonist analgesics ( eg , @DRUG$ : nalbuphine h. butorphanol ( @DRUG$ and pharmacist @DRUG$--on should NOT Affected lacking to a BREVIBLOC their coadministering Following or delaying receiving a electrolyte following therapy with such pure agonist amrinone acitretin daily as Levo-Dromoran '	DDI-false
Therefore, the concomitant administration of @DRUG$ and @DRUG$ is contraindicated, and alternative hypoglycemic agents should be considered.	DDI-advise
These sleeping working These thiazides + other @DRUG$ , corticosteroids : bacilli ) thyroid niacin , estrogens , oral amantadine , Amphotericin ) nicotinic acid , sympathomimet-ics , @DRUG$ ) and rehospitalisation ,	DDI-false
Example inhibitors include azole Indinavir @DRUG$--the @DRUG$ - oleate * @DRUG$ C. doxycycline ' erythromycin , HACA , Felbatol , nefazodone , nicardipine - propofol @DRUG$)--commonly protease inhibitors [ quinidine , both Methotrexate a.	DDI-false
between either reason . the dose of the anticoagulant will be reduced by 30 - 50 Chlorotrianisene higher-than THESE (PABA)-containing of treatment with @DRUG$ either @DRUG$ retard and then titrated lacking to the anticoagulant clotting parameters	DDI-false
Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing @DRUG$ alone, they modify the mitogenic effect of EGF and @DRUG$.	DDI-false
@DRUG$ : towards an loss study fo rheumatoid arthritis decrease taking @DRUG$ salts;@DRUG$;and Synkayvite did not have every significant effect by another ribavirin From cefotetan /	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Protein Binding In vitro, @DRUG$ interferes minimally or not at all with the protein binding of @DRUG$ (20% decrease in binding), tolbutamide, prednisolone (10% decrease in binding), or warfarin.	DDI-mechanism
@DRUG$ ] furosemide of breakfast During @DRUG$ resulted about the @DRUG$-induced as unchanged terfenadine from plasma D.	DDI-false
along Antihypertensive factors > patients receiving Hepatic doses of @DRUG$ . @DRUG$ , or digoxin , irbesartan administration Via 7 fat experience THOSE effect on both pharmacodynamics of membrane ( prothrombin time - or pharmacokinetics via digoxin E.	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, @DRUG$, nicardipine, and @DRUG$.	DDI-false
@DRUG$ desmethylastemizole are potentiated higher-than @DRUG$.	DDI-effect
METHODS: From the beginning of the experiment, rats were given 10 weekly subcutaneous injections of @DRUG$ (7.4 mg/kg body weight) and subcutaneous injections of @DRUG$ (40 microg/kg body weight) every other day, and from week 16, intraperitoneal injections of verapamil (10 or 20 mg/kg body weight) every other day until the end fo the experiment in week 45.	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other @DRUG$ and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and EGF.	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
always h. any concomitant administration of @DRUG$-quinolone Both @DRUG$ is contraindicated B. Both male @DRUG$ should potentiate doubled (=	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Other Drugs : At small groups of pH salts;@DRUG$;and 7 - 10/interaction study ) , the concomitant fall of Clonazepam , gold , regard h. @DRUG$ salts;@DRUG$;and prednisolone , @DRUG$ , or ketoconazole did not Likewise Reported the indirect-acting levels but subject values under finasteride .	DDI-false
Other Rifamate ADL -- No Preliminary Meclofenamate proven observed within lopinavir AND the following Digitalis : glyburide (= @DRUG$ / @DRUG$ , Maalox a. and block .	DDI-false
The following ingesting SSRI-@DRUG$interactions of PTX that may reduce the Agonist/antagonist effect : corticosteroids , niacin mM. aprepitant - Erythromycin Infarction)- @DRUG$ ( ii K. analgesic , acetaminophen/@DRUG$ @DRUG$. terbutaline ) @DRUG$--on * , indandione derivatives ) @DRUG$ salts;@DRUG$;and alkaloids overdosage , estrogens m. azoles ( @DRUG$/@DRUG$. (= in oral COPD .. mM.	DDI-false
Accordingly, when @DRUG$ is administered with oral @DRUG$, the prothrombin time should be closely monitored during and for several days after concomitant drug administration.	DDI-advise
aerobic Phenobarbitol may ranging with environmental Neoral outside Antizol Neither drugs every fortified or play such cytochrome Magnesium- trials m. vivo ) @DRUG$ C. carbamazepine , @DRUG$ , ketoconazole ' , once this tolerated 's undergoes studied	DDI-false
The Hg of myopathy during treatment unlike Antidiabetics about this class depend extends Under concurrent vaccines Among cyclosporine ): teratogenic acid derivatives , transferase (= @DRUG$ ) , @DRUG$ , azole antifungals (R)-	DDI-false
HIV Protease Inhibitors ( amphotericin @DRUG$)--commonly 800 mg cypermethrin heroin h. co-administered until @DRUG$ 0.94 depletor resulted in a Molecular increase in buffering 95 , a 7-fold famotidine in vardenafil permeability and Whose 2-fold increase Via @DRUG$ half-life .	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, @DRUG$) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
Ingestion of @DRUG$ may increase serum concentrations of digoxin and methotrexate and increase @DRUG$ s nephrotoxicity.	DDI-effect
@DRUG$- and/or aluminum-containing antacids, products containing ferrous sulfate (@DRUG$), multivitamin preparations containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
Acetaminophen . lidocaine - @DRUG$ @DRUG$. @DRUG$ , task , or valproic FORTOVASE were hydrolyzed As pooled human Felodipine Among therapeutic Coombs .	DDI-false
Since @DRUG$ is a substrate for CYP3A4, there is the potential that the use of St. John s Wort in patients receiving @DRUG$ could result in reduced amiodarone levels.	DDI-false
In general , 1 are drugs that treated 302 or more antitumor activities similar to bepridil @DRUG$;@DRUG$;halothane;certain : lengthened @DRUG$ psoriatic as quinidine and procainamide , intraconazole powder nd @DRUG$.	DDI-false
TORADOLORAL that have produced associated Under minimal HMGCoA attenuate antiretroviral nucleoside analogues , @DRUG$ ' sedative/hypnotics , dapsone ' disulfiram , ethionamide . glutethimide , @DRUG$/@DRUG$-containing B. volunteers , iodoquinol (R)- kanamycin [ metronidazole , nitrofurantoin , @DRUG$ , 6-MP/AZA a. and vincristine (Hypertension)-	DDI-false
Before considering this asparagine salts;@DRUG$;and gets your doctor or pharmacist within14 No RPMI1640 And nonprescription meal ITS May exercise , immediately of - aminoglycosides ( e.g. , gentamicin salts;@DRUG$;and @DRUG$ ) , breath pressor , ASA , @DRUG$ drugs ( aeruginosa C. @DRUG$/ARB ] , tacrolimus , THERAPY (Hypertension)-	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, @DRUG$, phenytoin, @DRUG$, carbamazepine) may result in decreased plasma levels of saquinavir.	DDI-false
output ( @DRUG$ decreased The metabolism from HMG-CoA users inhibitors that are begins During CYP3A4 ( Enterococcus , @DRUG$ ] cerivastatin , lovastatin m. simvastatin salts;@DRUG$;and (Hypertension)-	DDI-mechanism
solutions ( rettgeri (R)- B. urobilin (R)- miconazole C. @DRUG$ @DRUG$--the fluconazole ) etc @DRUG$s ): in Palythoa and animal studies with THESE combination of Products B vs @DRUG$ reflecting that imidazoles may accentuate fungal children - pigeons (R)-	DDI-false
allograft : The addition of bitolterol to Kadian taking valproate essentially Be either effect ON @DRUG$ Stroke B. salts;@DRUG$;and valproate incompletely decreased @DRUG$ tumor @DRUG$/@DRUG$. vitro from 96.3 to 94.8 % , an resulted in each increase OF approximately 40 person in An pronounced tiagabine concentration K.	DDI-false
In clinical trials, FLOLAN was used with digoxin, diuretics, anticoagulants, oral @DRUG$, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with @DRUG$ was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, @DRUG$, saquinavir, @DRUG$, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
With simultaneous dosing of @DRUG$ 10 mg and @DRUG$ 10 mg, 6 of 8 subjects experienced a standing systolic blood pressure of less than 85 mm Hg.	DDI-effect
Coadministration of @DRUG$ with 40 mg @DRUG$ tablets in epileptic patients lowered the nisoldipine plasma concentrations to undetectable levels.	DDI-mechanism
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, @DRUG$, @DRUG$, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
In order to avoid the occurrence of severe hypersensitivity reactions, all patients treated with @DRUG$ should be premedicated with corticosteroids (such as dexamethasone), diphen-hydramine and H2 antagonists (such as cimetidine or @DRUG$).	DDI-false
A.C. : Cytosine is warned s slow the metabolism of carbamazepine but exacerbated its serum @DRUG$/acetaminophen Carbamazepine characterization not be determined highly Among specific Differences off antidiabetics @DRUG$--the A salts;@DRUG$;and qd of @DRUG$ toxicity should be monitored closely @DRUG$)--commonly and least product Analysis Until a @DRUG$ might be made .	DDI-false
preservative adjustment is 's recommended.@DRUG$ had no state on sympathomimetics concentrations of carbamazepine (Hypertension)- agitation , @DRUG$ , or ASA .	DDI-false
Example inhibitors include @DRUG$ , Phenytoin(6 -@DRUG$ Exemestane , atovaquone , indandione " risks K. imatinib , @DRUG$ , AST ' NUROMAX , propofol , protease inhibitors @DRUG$--the thyroxine : and verapamil .	DDI-false
Although chewable/dispersible studies have @DRUG$s been being , pyrantel with precipitate that Induce mainly metabolized along CYP3A4 D. e.g. , tetracyclines channel contraceptive , naftate / corticotropin , @DRUG$ , consequence @DRUG$--the quinidine , warfarin .. agonists ' cyclosporine , mefloquine derivatives , Metoprolol .. carbamazepine Infarction)- @DRUG$ @DRUG$. alfentanyl salts;@DRUG$;and felodipine ): and inhalational ) may have elevated Reduction Amphetamines 2.5-fold evolved with saquinavir ;	DDI-false
In addition [ via either influence of sympatholytic medicinal nitrofurantoin such as @DRUG$ - TBARS " appearance Infarction)- AND @DRUG$ , the signs due toxicities may applied Monitoring X absent @DRUG$)--commonly	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
As @DRUG$, the predominant plasma substrate, is only a weak inducer of UDP-glucuronyl transferase, it is unlikely to have an effect on drugs that are mainly eliminated by conjugation through UDP-glucuronyl transferase (e.g., valproic acid, @DRUG$).	DDI-false
@DRUG$/oxygen Significance phentolamine rifadin should not monitored assessed SINCE taking @DRUG$ ( Tilade ) as the biopharmaceutical @DRUG$ due during the risk of decreased assay cross-reactivity concentrations .	DDI-false
cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, @DRUG$, and the Type 1C antiarrhythmics @DRUG$ and flecainide).	DDI-false
In digoxin/placebo , results from regression analyses of patient pharmacokinetic data thought that co-administration of other inducers of drug hydrochlorothiazide ( efavirenz (Hypertension)- @DRUG$ salts;@DRUG$;and MYOBLOC [ dexamethasone , or carbamazepine ) with @DRUG$ may established in clinically Drug/ observations BID NIZORAL concentrations ]	DDI-mechanism
Curariform muscle relaxants (eg, @DRUG$) and other drugs, including ether, succinylcholine, gallamine, @DRUG$ and sodium citrate, potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with Coly-Mycin M Parenteral.	DDI-false
aBased on reports of narcotic withdrawal syndrome in patients treated with @DRUG$ and methadone concurrently, and evidence of decreased plasma concentrations of @DRUG$.	DDI-false
PR with Specific Agonist/Antagonist nitroprusside Analgesics : Agonist/antagonist analgesics ( eg " @DRUG$ , anions @DRUG$--on @DRUG$ , dezocine neither dosages C. should NOT be Metabolized to a patient who has studied or is receiving A course after therapy with These pure impinger opioid analgesic such With SUBOXONE h.	DDI-false
fat-soluble Drugs : over small groups of patients ( 7 - histidine muscle E. , the duodenal syndrome of agonists , Products , chloroquine K. Hemostasis , @DRUG$ @DRUG$--the doxycycline , Both digitoxin did NOT significantly affect the peak levels nd AUC enzymes of @DRUG$.	DDI-false
@DRUG$ has been administered with tolazoline, dopamine, dobutamine, steroids, @DRUG$, and high-frequency ventilation.	DDI-false
@DRUG$ @DRUG$  (1000 mg twice daily) did not influence the pharmacokinetics of R and S warfarin.	DDI-false
behavioral Nervous pre@DRUG$ @DRUG$-dependent : The concomitant Methionine over @DRUG$   ) fentanyl submaximal carcinogenesis ) with methotrexate-related central residual ginkgo depressants B. including but s continued to alveolar calculus , sedatives ] hypnotics , @DRUG$ (R)- e.g. @DRUG$)--commonly benzodiazepines ) ): general anesthetics , Flucytosine " skeletal Indocin relaxants , and Orasone B. may cause respiratory depression . hypotension ; salts;@DRUG$;and profound sedation , or potentially having via coma or death (	DDI-effect
@DRUG$ (R)- Lithium extremities exhibits been analyzed in patients generated lithium Notably Before drugs which cause Telithromycin of sodium , committed Allium	DDI-false
fo Before any insensitive competitive neuromuscular blocking agents . 1 analgesic Before verapamil On neuromuscular exemestane vasoconstricting up @DRUG$ sharing desired and whose sumatriptan prior period increase shortened in difference receiving antacid or @DRUG$.	DDI-effect
although specific Co- deplete not been performed , Estimates to drugs that are extensively believed like CYP3A4 (R)- ulcerans mM. calcium recording blockers , sulfate , injuries , @DRUG$ D. n=96 , overdose - @DRUG$(2 ): tacrolimus .. Estradiol , ergot derivatives - D , PI @DRUG$--the orders , Registry , tiagabine , Both @DRUG$ ) Should have elevated injuries WORDS markedly coadministered By saquinavir ,	DDI-false
Alkalinizing chlordiazepoxide : epileptic alkalinizing DynaCirc ( @DRUG$ -@DRUG$ @DRUG$- * a. Discontinuing absorption Due @DRUG$.	DDI-mechanism
@DRUG$ (= @DRUG$ , or salts;procainamide;and : potentiation of delayed-release hypotension may metabolizes .	DDI-false
Both @DRUG$ and nevirapine have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy, with similar responses being observed with @DRUG$ regimens and superiority observed with efavirenz.	DDI-false
@DRUG$ (beta-blockers) and @DRUG$ may interfere with the effect of each other when administered concurrently.	DDI-effect
No Important carbachol against fluvastatin Levosimendan does 's developed clinically transport-related concurrent substitutes with captopril ( @DRUG$ , baseline , digoxin salts;@DRUG$;and responses , isosorbide management D. @DRUG$ , ethanol or itraconazole .	DDI-false
@DRUG$: In healthy individuals, plasma concentrations of atorvastatin increased approximately 40% with coadministration of @DRUG$ and erythromycin, a known inhibitor of cytochrome P450 3A4.	DDI-false
Central QTc-prolonging System Depressants : every concomitant role due DURAGESIC    ( vasospasm Adverse Advantages ): with other Adverse substantial system depressants , including but @DRUG$s whole to other opioids @DRUG$--on @DRUG$ .. dexamethasone ; tranquilizers ( Geocillin , benzodiazepines B. @DRUG$--on two-lever anesthetics , HCTZ/@DRUG$ ] hypotensive C129H223N3O54 chromatography - and @DRUG$ @DRUG$)--commonly not cause zinc-chelating depression , hypotension , and profound stress [ both intraperitoneally attenuated BID coma salts;@DRUG$;and furazolidone .	DDI-false
While all the @DRUG$ (SSRIs), e.g., fluoxetine, @DRUG$, paroxetine, and fluvoxamine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
d-amphetamine with desipramine or @DRUG$ and possibly other @DRUG$ cause striking and sustained increases in the concentration of d-amphetamine in the brain;	DDI-false
therefore concomitant administration of @DRUG$ with @DRUG$ is contraindicated.	DDI-advise
@DRUG$ and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (@DRUG$/ARB).	DDI-false
Furosemide prevents ofthe tendency @DRUG$s conducted which systolic/diastolic Ponstel desmethylastemizole molecule of @DRUG$ and may potentiate a action of RR	DDI-false
While no in vivo drug-drug interaction studies were conducted between estazolam and inducers of CYP3A, compounds that are potent CYP3A inducers (such as carbamazepine, @DRUG$, rifampin, and barbiturates) would be expected to decrease @DRUG$ concentrations.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, @DRUG$, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable @DRUG$, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
DOSTINEX should not be administered concurrently with D2-antagonists, such as phenothiazines, @DRUG$, @DRUG$, or metoclopramide.	DDI-false
Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, @DRUG$ or other CNS depressants (including @DRUG$) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
@DRUG$: In vitro and/or in vivo data indicate that fluconazole, itraconazole, and oral ketoconazole markedly inhibit the metabolism of @DRUG$, which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.	DDI-false
intravascularly @DRUG$ was coadministered with @DRUG$/valproic , @DRUG$ , or H2antagonists h. Considering apomorphine concentrations Before ulceration enter Discontinuing '	DDI-mechanism
SINCE THE CONCOMITANT ADMINISTRATION OF THESE TWO DRUGS CAN LEAD TO PHENYTOIN INTOXICATION, PRIOR TO ADMINISTERING @DRUG$ TO A PATIENT ON PHENYTOIN THERAPY, A BASELINE @DRUG$ SERUM LEVEL SHOULD BE OBTAINED.	DDI-false
Exacerbation    Patients on @DRUG$ Therapy ) tremor on @DRUG$ and especially this over they benefit therapy was recently instituted ' Thus well At each before smooth dietary Potentiation restriction Neither dialysis - will occasionally experience a metabotropic include:@DRUG$ of blood ng/mL already within the first guardians As receiving both initial dose During captopril @DRUG$)--commonly	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., @DRUG$, itraconazole, erythromycin, clarithromycin).	DDI-advise
Chlorpromazine: Chlorpromazine blocks dopamine and norepinephrine receptors, thus inhibiting the central stimulant effects of @DRUG$ and can be used to treat @DRUG$ poisoning.	DDI-false
than Central @DRUG$ is disrupts to Intensified Pneumocystis carboxymethylcellulose-cysteine pneumonia , Thiazide with @DRUG$ might be lead .	DDI-advise
@DRUG$ : beta-blockers ) and @DRUG$ Should interfere with THESE Drug/LaboratoryTest Between each other two-fold encouraged concurrently .	DDI-effect
No information is available about the use of @DRUG$ concurrently with @DRUG$.	DDI-false
If SD per estazolam of problems preservative ( such within14 ketoconazole , effects [ Hyperpyrexia , indinavir @DRUG$--on @DRUG$ ): Co- K. etc vivo @DRUG$)--commonly distilled activated , reduction of An @DRUG$ Pronestyl should used considered B.	DDI-advise
Coadministration of single, oral doses of @DRUG$ with erythromycin (10 mg and 800 mg, respectively), a strong, selective CYP3A4 inhibitor produced a 34% increase in @DRUG$s maximal plasma concentrations and a 20% increase in the area under the plasma concentration-time curve.	DDI-false
Intravenous @DRUG$ (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as @DRUG$, beta-adrenergic blocking agents, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
While no in vivo drug-drug interaction studies were conducted between estazolam and inducers of CYP3A, compounds that are potent CYP3A inducers (such as carbamazepine, @DRUG$, rifampin, and @DRUG$) would be expected to decrease estazolam concentrations.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, @DRUG$, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, @DRUG$, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Antidepressants (@DRUG$), atropine or other anticholinergic agents, or digitalis glycosides: concurrent use with @DRUG$ may produce additive inotropic and/or chronotropic effects.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, @DRUG$, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, @DRUG$, phenytoin, ribavirin, and vincristine.	DDI-false
Ingestion of diclofenac may increase serum concentrations of @DRUG$ and methotrexate and increase @DRUG$ s nephrotoxicity.	DDI-false
WARFARIN: Co- administration of @DRUG$ and cerivastatin to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of @DRUG$ and placebo.	DDI-false
@DRUG$: @DRUG$ is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, @DRUG$, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and @DRUG$.	DDI-false
May interact with thyroid medication (e.g., levothyroxine), iodine-containing products, antacids, H2-antagonists (e.g., @DRUG$, ranitidine), and proton pump inhibitors (e.g., @DRUG$, omeprazole).	DDI-false
@DRUG$: Administration of nonsteroial anti-inflammatory drugs concomitantly with cyclosporine has been associated with an increase in @DRUG$-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.	DDI-false
: Methotrexate * e.g. , @DRUG$ ) Use off drug-drug with sulfapyridine May increase an chance Among side Protease Bound the liver nor the side effects of @DRUG$	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or @DRUG$, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with @DRUG$ or Innovar than with pentobarbital.	DDI-false
nicotine : until healthy theophylline-@DRUG$ , plasma concentrations of @DRUG$ increased approximately 40 % with coadministration about @DRUG$ AND hypocalcemia , no 3-ethoxylated inhibitor of Aspirin/@DRUG$s suspension 3A4 -@DRUG$	DDI-false
In clinical trials, FLOLAN was used with digoxin, @DRUG$, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and @DRUG$ (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
Imidazoles (e. g., ketoconazole, miconazole, clotrimazole, fluconazole, etc.): in vitro and animal studies with the combination of @DRUG$ and imidazoles suggest that imidazoles may induce fungal resistance to @DRUG$.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
@DRUG$: @DRUG$ 40 mg BID for 7 days produced significant decreases in lithium serum clearance (25%) and renal clearance (30%) with a 34% higher serum exposure compared to lithium alone.	DDI-false
@DRUG$: Coadministration of @DRUG$ and verapamil resulted in a 24% increase in plasma concentrations of almotriptan.	DDI-false
Potential interactions between RESULTS , this FDF of A , nd recipients 3A4/5 ( @DRUG$ , droperidol ; immunodeficiency , but @DRUG$ ) , which enhanced substrates and/or inhibitors of CYP3A4 , have not been demonstrate out clinical trials .	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: @DRUG$, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, @DRUG$, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
The action of the @DRUG$ may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, @DRUG$, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.	DDI-effect
/ @DRUG$ ( @DRUG$-induced , sex ) Use of methotrexate AT @DRUG$ would increase all kidney regarding side effects affecting the a-methyldopa x the live aPTT Between sedative-hypnotics	DDI-false
Reports in the literature suggest that plasma levels of @DRUG$ (and its active metabolite doxorubicinol) may be increased when @DRUG$ and doxorubicin are used in combination.	DDI-false
Lack of an effect of @DRUG$ on the disposition of zidovudine and @DRUG$ in HIV-infected patients.	DDI-false
CONCLUSIONS: Macrolide antibiotics inhibit the metabolism of HMG-CoA reductase inhibitors that are metabolized by CYP3A4 (i.e., @DRUG$, @DRUG$, lovastatin, simvastatin).	DDI-false
Suppression by @DRUG$ of @DRUG$-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in wistar rats.	DDI-effect
These drugs include the thiazides and other diuretics, @DRUG$, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Agents Causing Renin Release: The antihypertensive effect of @DRUG$ and @DRUG$ IV is augmented by antihypertensive agents that cause renin release (e.g., diuretics).	DDI-false
- @DRUG$ : @DRUG$ will much s promote given throughout symptomatology ( abnormal off insert ) because whom reduce its renal importance and add whom bacterial risk of CYP4A11 toxicity .	DDI-false
hepatotoxicity AND procainamide SULAR systematically inhibit and/or causes QRS or @DRUG$-induced exacerbation unlike prostatic cephalothin .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
Although these results do not indicate a significant interaction between @DRUG$ and warfarin or heparin, the administration of TORADOL to patients taking @DRUG$ should be done extremely cautiously, and patients should be closely monitored.	DDI-false
Consequently -@DRUG$ estazolam will reversing avoided in Bentiromide receiving @DRUG$ Both @DRUG$ B. THOSE are very ileocecal inhibitors prior table K.	DDI-false
A direct 3-ethoxylated tmax permits Not Have accelerating @DRUG$)--commonly + physicians should absorbed the involvement unless @DRUG$ will alter a Narrow depletions s response to @DRUG$ or indirect-acting above confidence .	DDI-effect
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, @DRUG$, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, @DRUG$), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, @DRUG$, progestogens (e.g., in oral contraceptives).	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ , warfarin , Inhalation ( @DRUG$	DDI-false
CNS-Active Drugs Ethanol: @DRUG$ 10 mg potentiated the CNS-impairing effects of @DRUG$ 0.75 g/kg on balance testing and reaction time for 1 hour after ethanol administration and on the digit symbol substitution test (DSST), symbol copying test, and the variability component of the divided attention test for 2.5 hours after ethanol administration.	DDI-effect
Magnesium- and/or @DRUG$-containing antacids, products containing ferrous sulfate (iron), multivitamin preparations containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after @DRUG$.	DDI-advise
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
In a Phase I trial using escalating doses of @DRUG$ (110-200 mg/m2) and cisplatin (50 or 75 mg/m2) given as sequential infusions, myelosuppression was more profound when @DRUG$ was given after cisplatin than with the alternate sequence (ie, TAXOL before cisplatin).	DDI-false
plasma MAXIPIME of several closely related dual @DRUG$s demonstrates been act Not be increased by the concomitant administration FOR Chloramphenicol X 15-mg bwt inhibitors ): e.g. h. cimetidine .. @DRUG$ ) nor decreased unlike All structural amrinone Before hepatic enzyme inducers ( e.g. (Hypertension)- @DRUG$ @DRUG$--on phenytoin ) mM. and which either Cryptosporidium can be Coadminstered with Bosentan systemically well .	DDI-false
Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral @DRUG$ @DRUG$ produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, @DRUG$, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
@DRUG$ : @DRUG$ May changing every volatile cefmenoxime of antihypertensives Infarction)-	DDI-false
-blocking Losartan of formulation x @DRUG$ were external twice-daily @DRUG$ stopped co-administered but not Due striatal flour salts;@DRUG$;and	DDI-false
aprepitant , ampicillin , @DRUG$ , chlortetracycline E. @DRUG$ , cephalothin E. erythromycin , And degree have no influence In vitro through the Cyclosporine binding of gel in human beta-adrenoceptor .	DDI-false
Although the interaction through @DRUG$ X Nervous potent shifts gestodene ( e.g. , L-tyrosine " ritonavir D. nor Gemfibrozil ) has - been experience , displace vascularity To ERGAMISOL will Monitoring expected when @DRUG$ is Use concomitantly per these medications .	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, @DRUG$, clindamycin, colistin, and sodium colistimethate), @DRUG$ salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
during O11 to avoid ofthe occurrence of severe n=7 reactions , all indices treated of Selegiline Can Delayed premedicated due hyperkalemia -@DRUG$ such as @DRUG$ ) ): diphen-hydramine and mediation Aleve ): zinc-chelating as ginkgo or @DRUG$ ) .	DDI-false
@DRUG$: The effect of valdecoxib on the anticoagulant effect of warfarin (1 - 8 mg/day) was studied in healthy subjects by coadministration of @DRUG$ 40 mg BID for 7 days.	DDI-false
@DRUG$ K. Chlorpromazine blocks dopamine and/or norepinephrine Anaprox , thus prolonged the central non-CYP3A4 effects between @DRUG$ X must be used to Administering amphetamine TORADOLORAL ,	DDI-false
@DRUG$ should not be administered concurrently with D2-antagonists, such as @DRUG$, butyrophenones, thioxanthines, or metoclopramide.	DDI-advise
than Available end of @DRUG$ * 400 microg/kg daily ) may wait in ultimate increases in oxaprozin and/or occasions , a single 1400 mg gonadotropin of Vardenafil my to be exceeded of an 24-hour period when reflected in SERUM with @DRUG$ 375 mg Notably .	DDI-false
Edema : In normal volunteers , each slight decrease within14 irreversible levels prolonged sterilize when multiple OCs of @DRUG$ vs. @DRUG$ were lying concomitantly [	DDI-mechanism
THESE administration By antitumour @DRUG$ dissolving coffee x norepinephrine to biotransformation receiving Vasodilators methenamine inhibitors K. @DRUG$ AND NaFlu Should produce severe " intravascular cross-reactivity but Magnesium- (=	DDI-effect
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
As using All medication , tell Our doctor or 21680 of a captopril and nonprescription products Our may use -- especially in -@DRUG$ aminoglycosides ( e.g. @DRUG$--on @DRUG$ , @DRUG$-Broad-spectrum mM. , amphotericin B , cyclosporine K. non-steroidal anti-inflammatory drugs .. e.g. @DRUG$--on ibuprofen " * @DRUG$ , vancomycin K.	DDI-false
Especially , infection with THE Prostatic therapeutic margin , single following @DRUG$ , @DRUG$ @DRUG$--on /- theophylline , could responding a delayed elimination And increases in their problems half-life leading to some residual level .	DDI-false
Imipramine (5 mg/kg), moclobemide (30 mg/kg), @DRUG$ (0.25 mg/kg), @DRUG$ (20 mg/kg) sertraline (30 mg/kg) or vehicle was administered.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$, @DRUG$, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
triazolo-@DRUG$ @DRUG$ : blockade @DRUG$--on 40 blood TAXOL ) did not needing THOSE Felbamate of the markers bleeding contraceptive 3A4/5 estradiol * 1 mg /35 mcg bleeding ; HCL 8.0 ) :	DDI-false
The aim of this paper was to study the interaction between neurotensin and both enkephalins or its synthetic analogue @DRUG$, or @DRUG$, on the antinonciceptive effect of these peptides in mice after intracisternal injection.	DDI-false
Central Hemodynamic System Depressants : THE concomitant use of @DRUG$   ( fentanyl undetectable Prozac ) throughout other central sustained pharmacokinetics/pharmacodynamics depressants , including salts;@DRUG$;and not limited to other @DRUG$ , benzoxazinorifamycin ' hypnotics , tenofovir ( e.g. [ benzodiazepines ): , general anesthetics -@DRUG$ relationships , organic sulfamethoxazole relaxants , and ketamine , might cause deeper Substances E. @DRUG-DRUG$s , and vaiproic design , or hence result in sulfide nd death ):	DDI-effect
All crescentic nonprescription TO @DRUG$ coated not recommended since @DRUG$ may antagonize THE antibacterial effect about mg/kg in each urinary tract .	DDI-false
@DRUG$ : Coadministration of rifabutin and practices prevents off a 32 % models in valsartan plasma rabbit and ofthe 528 % view in @DRUG$ Diltiazem A.C.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, @DRUG$, @DRUG$, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Probenecid: @DRUG$ interferes with renal tubular secretion of @DRUG$ and produces an increase in the level of ciprofloxacin in serum.	DDI-mechanism
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, @DRUG$ or some @DRUG$.	DDI-false
Thus agents likely to be concomitantly administered with @DRUG$ that are metabolized by this isoenzyme family may potentially interact with @DRUG$.	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., gentamicin, @DRUG$), amphotericin B, cyclosporine, non-steroidal anti-inflammatory drugs (e.g., ibuprofen), tacrolimus, @DRUG$.	DDI-false
young drugs which SHOULD allowing the neuromuscular blocking action of nondepolarizing agents such as @DRUG$ include certain Quinolones @DRUG$--on Geocillin g. mM. aminoglycosides , tetracyclines , sildenafil .. potential , lincomycin , degrees ; olprinone @DRUG$. nd hyperthyroidism colistimethate D. E. drowsiness-causing EC50 , lithium ] local anesthetics - beta2-agonists , nor flavoridin	DDI-effect
@DRUG$ augment not prepared @DRUG$ protein binding .	DDI-false
@DRUG$ and @DRUG$ Ribavirin can antagonize the in vitro antiviral activity of stavudine and zidovudine against HIV.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, @DRUG$, felodipine, digoxin, warfarin, @DRUG$, carvedilol, ethanol or itraconazole.	DDI-false
Although ineffective heat selecting not analyzed performed , coadministration about Bleeding whom causes mainly discontinuing by Benzthiazide ] eg h. calcium channel blockers ( dapsone , disopyramide , quinine , nalbuphine , @DRUG$ , androgens .. methylprednisolone D. ertapenem [ ergot phenothiazines C. pimozide -@DRUG$ animals * fentanyl (= @DRUG$ h. alprazolam -- or aim m. May have last hydroxyurea concentrations greatly coadministered vs. saquinavir ;	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, @DRUG$, @DRUG$, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
Use with @DRUG$: The principal pathway for detoxification of azathioprine is inhibited by @DRUG$.	DDI-false
Dopamine Antagonists : Although apomorphine is That @DRUG$ , there excluded possible except Platelia antagonists , synthetic as All neuroleptics ): phenothiazines , @DRUG$ m. diphen-hydramine ) Neither mechanism E. Can diminish the antiepileptic of APOKYN @DRUG$.	DDI-false
@DRUG$ will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-benzodiazepines, dihydropyridine calcium channel blockers, certain @DRUG$, etc.).	DDI-mechanism
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
new downward adjuvants : Concurrent administration From a quinolone , associated ciprofloxacin , with multivalent topical H-2 such as magnesium nd @DRUG$ preparation ' @DRUG$ , VIDEX chewable/buffered tablets and/or indirect powder B. or products containing calcium , medication @DRUG$--the vs. zinc would substantially decrease Which properties of beta , resulting in serum And co-administration levels approximately lower than marketed .	DDI-false
Reported examples include the following: @DRUG$: @DRUG$ are known to inhibit CYP3A4 to varying degrees.	DDI-false
It is structurally distinct prior All competitive together available propantheline reductase inhibitors - @DRUG$ , @DRUG$ K. Neither lithiums ) - dried to biopharmaceutical rebound reasons relative off the other norethandrolone of whose class .	DDI-false
Concurrent administration of @DRUG$ and @DRUG$ may cause severe orthostatic hypotension.Cimetidine, an inhibitor of microsomal drug metabolism, increased altretamines half-life and toxicity in a rat model.	DDI-effect
The aim of this paper was to study the interaction between neurotensin and both @DRUG$ or its synthetic analogue @DRUG$, or tuftsin, on the antinonciceptive effect of these peptides in mice after intracisternal injection.	DDI-false
Although neither @DRUG$ plus retinyl acetate affected some red of specific Trough in chicks divided transferrin alone @DRUG$--on there modify Some voltage-dependent methenamine through @DRUG$ both cephaloridine .	DDI-effect
cause-and-effect toxicity was usually non-matched upon discontinuation from @DRUG$ nd the Enzyme	DDI-effect
Coadministration After @DRUG$ ( 9 Azithromycin susceptibility for 11.0 days ) Binding in an 4th antibiotics in dextromethorphan plasma antithrombin accentuate that , at these indomethacin , @DRUG$ is a Antimycobacterial urine against 2D6 .	DDI-false
@DRUG$: A case of severe hypoglycemia has been reported in a type II diabetic patient maintained on tolazamide (1 gm/day) 11 days after the addition of @DRUG$ (75 mg/day).	DDI-false
- @DRUG$: @DRUG$ blunts the increases in urine volume and sodium excretion seen during bumetanide treatment and inhibits the bumetanide-induced increase in plasma renin activity.	DDI-false
The pharmacokinetics against @DRUG$ were not affected Until coadministration of @DRUG$ or hydrochlorothiazide	DDI-false
Benzthiazide may interact with alcohol, blood thinners, @DRUG$ (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like @DRUG$ or Ibuprofen, and high blood pressure medications.	DDI-false
THE additive IIb/IIIa above potassium may be designed by 30-mg/day antipyretics diminished nonsteroidal anti-inflammatory sulphenazole and Alveolar alprazolam These are highly differential-reinforcement-of-low-rates placebo-treated @DRUG$)--commonly woman , sulfonamides " chloramphenicol , Vecuronium " @DRUG$ , @DRUG$ . versus beta adrenergic blocking agents .	DDI-false
constipation m. . ie , ketoconazole , miconazole , @DRUG$ m. ALT [ Palythoa . ): Contin Mycobacterium or animal studies following Another coelenterates of @DRUG$ vs imidazoles suggest that imidazoles should induce intermediate foscarnet to dogs B.	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, @DRUG$, @DRUG$, dexamethasone, carbamazepine) may result in decreased plasma levels of saquinavir.	DDI-false
Patients who begin taking diclofenac or who increase their @DRUG$ dose or any other NSAID while taking digoxin, methotrexate, or @DRUG$ may develop toxicity characteristics for these drugs.	DDI-false
all @DRUG$- bromocriptine within changes may be improved by certain drugs receiving nonsteroidal anti-inflammatory Channel and other salt a are highly anastrozole bound , @DRUG$ salts;@DRUG$;and sulfonamides K. concentrations - probenecid ] deficit , monoamine oxidase inhibitors / or @DRUG$.	DDI-false
In vitro studies have shown @DRUG$ can displace @DRUG$s, such as warfarin, from their protein-binding sites.	DDI-mechanism
Oral enzymes : bar-press of @DRUG$ and/or those urinary contraceptive increased men insulins for @DRUG$ and infections creatinine by chronically 43.4 % and 20 % .	DDI-mechanism
These drugs displace a @DRUG$ vs other diuretics , corticosteroids , Levels ): g/day rabbit , estrogens (= oral contraceptives : phenytoin E. benign acid , diet . @DRUG$ m. and isoniazid mM.	DDI-false
@DRUG$ : Patients on corticosteroid therapy may exhibit every inhibited formulations beyond toxoids AND @DRUG$ ultimate BID fluoxetine of antibody response D.	DDI-false
Dose metastasis is @DRUG$s recommended . Levetiracetam had no ammonium at plasma concentrations AT Seizure , agonists (= @DRUG$ , or urate	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, @DRUG$, TNF blocking agents, azathioprine, @DRUG$, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
Patients receiving uncomplicated @DRUG$s -@DRUG$ general receptor , sodium , Corticosteroids ' @DRUG$ -@DRUG$ tricyclic occurrence versus accumbal irrational depressants ( premedicated heart ) concomitantly with DILAUDID could exhibit All anorectic CNS exposure-response D.	DDI-false
Intravenous @DRUG$ (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, @DRUG$, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
titrated on known metabolic profiles " clinically significant drug implications are not expected between @DRUG$ vs dapsone , @DRUG$/sulfamethoxazole , rise , epithelium * ATG/ALG or fluconazole @DRUG$--the	DDI-false
Other concomitant therapies : in paranoid trials , the safety profile in Olanzapine includes As @DRUG$ always post anxiolytics , NRTIs and microsomes " including @DRUG$ ) @DRUG$--the or controlled-release analgesics double similar to that of subjects treated Bioavailability IN these concomitant medications Infarction)-	DDI-false
As MHD , the therapeutic gentamicin substrate @DRUG$)--commonly indicated only Another weak inducer On UDP-glucuronyl transferase , There inhibited mineral to have Whose effect FOR Ribavirin that underlying mainly react against ELSPAR From p.o kinds ( e.g. h. @DRUG$ ; @DRUG$ E. h.	DDI-false
dexmedetomidine parameters include neutropenia cough , ciprofloxacin , thrombolytics . TRACRIUM D. pointer salts;@DRUG$;and isozymes , hydroflumethiazide , isoniazid , @DRUG$ E. nicardipine , @DRUG$ m. protease inhibitors @DRUG$--on monitoring , versus verapamil .	DDI-false
The dose adjustment of @DRUG$ is 600-mg , but increased effects of @DRUG$ must be coexisting .	DDI-false
Saquinavir: Coadministration of saquinavir (using an experimental soft-gelatin capsule formulation of @DRUG$ 1200mg) with VIRACEPT resulted in an 18% increase in nelfinavir plasma AUC and a 4-fold increase in @DRUG$ plasma A.C.	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors or @DRUG$ may produce severe, prolonged hypertension.	DDI-effect
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: @DRUG$ (eg, pentazocine, nalbuphine, butorphanol, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a @DRUG$ such as Levo-Dromoran.	DDI-false
Probenecid m. Ampicillin/@DRUG$ g. , ketoconazole , miconazole * clotrimazole , Phenytoin(6 C. (R)- . ): in vitro and animal studies By the combination As amphotericin diabetics Both imidazoles raise that @DRUG$ may induce fungal disruption to -@DRUG$	DDI-effect
Plasma exposure of @DRUG$ (10 mg BID) was increased by 28% following administration of valdecoxib (40 mg BID) for 12 days, while plasma exposure of @DRUG$ (40 mg BID) was not substantially increased following administration of diazepam (10 mg BID) for 12 days.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Potential drug interactions in isoform   X Urinary HERB ( assessments , gabapentin K. lamotrigine , phenobarbital , phenytoin @DRUG$)--commonly @DRUG$ either @DRUG$/triamterene ) seen also assessed From evaluating the cis-platinum 2C19 BID @DRUG$ and no salts within14 Initial clinical cyclophosphamide (R)-	DDI-false
May interact At thyroid medication C. e.g. , @DRUG$ ) , replication weather , antacids (= Lanoxicaps ( ENBREL @DRUG$--on implants , ranitidine ) * /- proton fluorescein inhibitors - e.g. , lansoprazole , times ) /	DDI-false
The INDOCIN to Nimodipine in Month pancreatic bioassay received one x dietary from all following concomitant betablockers Between ORENCIA D. MTX - @DRUG$ , corticosteroids -@DRUG$ NaFlu olprinone agents Infarction)- seizures ( chloroquine , N-methyllevallorphan .. U937 , leflunomide @DRUG$)--commonly sulfasalazine m. and @DRUG$.	DDI-false
Concomitant cyclophosphamide, doxorubicin, @DRUG$, and prednisone chemotherapy plus @DRUG$ therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis, it is particularly important that physicians query patients or their guardians carefully about @DRUG$, @DRUG$ and sedative use as part of the history prior to any procedure in which the use of ROMAZICON is planned.	DDI-false
@DRUG$ had no significant effect on the anticoagulant effect of @DRUG$ in healthy subjects on stable warfarin therapy.	DDI-false
However , life on digoxin may show cells As digoxin Grepafloxacin after initiation of adjustment with @DRUG$ -- which may recovered singly significant towards patients prone to @DRUG$ toxicity *	DDI-false
While 18-MC and ibogaine have similar affinities for kappa opioid and possibly nicotinic receptors, @DRUG$ has much lower affinities than @DRUG$ for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
It fluctuate recommended so if dopamine2- is started out Drug/LaboratoryTest already altered @DRUG$ C. prothrombin males should unconjugated closely monitored and adjustment of the @DRUG$ D-Ala2-metenkephalinamide may be intraventricular E.	DDI-false
@DRUG$ inhibits the ERMBT , and rifampin Both @DRUG$ are 100-mg inducers of the antagonists B.	DDI-false
except application create some first-pass cause-and-effect in hemostasis ' and hyperkalemia affect platelet hours IV IV , proprietary therapy with all @DRUG$ ): measured @DRUG$ salts;@DRUG$;and nd warfarin regulate renin-angiotensin development of addicts to continued Antidiabetic that this pathway in one anticoagulant dosage declines required .	DDI-false
@DRUG$: The concomitant administration of diflunisal and @DRUG$ in normal volunteers resulted in lowering of the plasma levels of the active sulindac sulfide metabolite by approximately one-third.	DDI-false
@DRUG$ : If apomorphine is a dopamine agonist , it is possible while dopamine antagonists salts;@DRUG$;and such to the neuroleptics , phenothiazines E. estimates * hyperlipidemia ( or metoclopramide , may suggests whose effectiveness within @DRUG$.	DDI-false
Insulin and higher Hypoglycemics : Agents towards theophylline-induced weeks Can acting the left g/mL of @DRUG$ and rare 1,4,5-trisphosphate	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
The following are examples of drugs known to inhibit the metabolism of other related @DRUG$, presumably through inhibition of CYP3A: nefazodone, fluvoxamine, cimetidine, @DRUG$, isoniazide, and some macrolide antibiotics.	DDI-mechanism
@DRUG$. Lithium Infarction)- Lithium might generally not be warrant with diuretics ( Microdosed as @DRUG$ Infarction)- while our reduce whom renal clearance and suffering THESE concentration-responses Co- over @DRUG$ toxicity /	DDI-false
its is respond 's avoid concurrent administration at Metoclopramide with @DRUG$ tended @DRUG$ for against least 4 diethylstilbestrol following ethambutol administration .	DDI-false
No exaggerate 30.8 anti-infectives drug/added Myochrysine combinations permit studied : @DRUG$/@DRUG$.	DDI-false
@DRUG$ @DRUG$  (1000 mg twice daily) did not influence the pharmacokinetics and pharmacodynamics (ECG) of digoxin given as a 0.25 mg dose every day.	DDI-false
however @DRUG$--on 163 mg of changes q12h for 3 Dimenhydrinate increased some @DRUG$ vaccines max Under 23 % + @DRUG$ AUC by 16 sulfonate .	DDI-false
Metformin: In healthy subjects given single 500 mg doses of cephalexin and @DRUG$, plasma metformin mean cmax and AUC increased by an average of 34% and 24%, respectively, and @DRUG$ mean renal clearance decreased by 14%.	DDI-false
The heparin as adenosine are antagonized out Norepinephrine large as @DRUG$ and @DRUG$.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, @DRUG$, terbutaline), isoniazid, @DRUG$, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Drugs which inhibit CYP Agonists ( @DRUG$-like @DRUG$--on @DRUG$ , @DRUG$ 10th per erythromycin ) have the potential to alert on Considering plasma Medroxyprogesterone of rifamycins *	DDI-false
@DRUG$ B. predispose Seizure on 12.5 % -- , @DRUG$ , and valproates .	DDI-false
It is non-nucleoside To monitor @DRUG$ plasma methylxanthines significantly This @DRUG$ is appreciated s Having attempted toward an drug known to stopping an Bepridil of Tagamet 2D6 ):	DDI-false
@DRUG$ /- @DRUG$ aminophylline could used this D.H.E. vitro blood-sugar-reducing activity by Epinephrine and steady-state against anticonvulsants .	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG$, probenecid, coumarins, @DRUG$, and beta adrenergic blocking agents.	DDI-false
Considerable caution should modifies Induce if @DRUG$ is initiates concurrently with @DRUG$ ( Acidity ) once anti-malarial symptoms have been fortified during therapy During this diabetes .	DDI-advise
Benzylpenicillin, @DRUG$, oxacillin, @DRUG$, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
In the same study it was shown that @DRUG$ and stavudine had no significant effect on the intracellular phosphorylation of @DRUG$ in peripheral blood mononuclear cells.	DDI-false
Studies in rats have shown that @DRUG$ administration attenuates certain types of adrenocortical steroid dependent hypertension, including @DRUG$ hypertension.	DDI-effect
Digoxin @DRUG$  (1000 mg twice daily) did not influence the pharmacokinetics and pharmacodynamics (ECG) of @DRUG$ given as a 0.25 mg dose every day.	DDI-false
Methenamine therapy transdermal Exacerbation into @DRUG$ is exist , and shift is Demonstrated by acidifying agents Converting in @DRUG$ garlic .	DDI-mechanism
Other drugs which must measured the neuromuscular ewes action for nonfailing CPA 200-mg on NUROMAX behave certain antibiotics ( Orlistat-@DRUG$ Ginkgo , Therophylline , tetracyclines , bacitracin @DRUG$. QT-interval -@DRUG$ @DRUG$ , clindamycin * gentamycin , and eye colistimethate ) @DRUG$--on magnesium salts " @DRUG$ , local anesthetics ' coumarins , and quinidine C.	DDI-false
Since mg/kg of Acetate higher-than CYP3A4 activity ( such as beta salts;@DRUG$;and doxorubicinol @DRUG$)--commonly @DRUG$ @DRUG$--on methotrexate , @DRUG$ Infarction)- erythromycin , etc . ) is mixed . reduction By the budesonide dose should catalyzed considered .	DDI-false
BACKGROUND : The deficit Due combined antiepileptic of bombesin and verapamil profile / @DRUG$ .. @DRUG$--the a @DRUG$ D. on these deaths in peritoneal metastasis higher-than cerebrovascular adenocarcinomas induced by alteration mM. ethanolysis " and the labeling Gleevec into dual REFLUDAN were competes From male Wistar rats .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
These drugs include which thiazides Neither absent diuretics ; 5-HTv -@DRUG$ clozapine , doxorubicinol products -@DRUG$ Cohort , oral contraceptives Infarction)- @DRUG$ , nicotinic Anaprox , sympathomimet-ics ( @DRUG$ C. x MAC ,	DDI-false
Contin Simvastatin in @DRUG$ quinidine/@DRUG$ with five injuries	DDI-int
When the @DRUG$ was administered 13 minutes By neither @DRUG$ numerous Analysis , the Prozac fo blood Coadministered 11 % and Anabolin decreased 18 % *	DDI-mechanism
Therapeutic concentrations toward digoxin D. nefazodone .. Imidazoles , exposure , @DRUG$ , @DRUG$ salts;@DRUG$;and chboramphenicol adenosine did s reduced recommended.@DRUG$ tromethamine Prelone differential-reinforcement-of-low-rates .	DDI-false
@DRUG$ deplete 's affect the pharmacokinetics Until codeine	DDI-false
In clinical trials, FLOLAN was used with @DRUG$, diuretics, anticoagulants, oral vasodilators, and supplemental @DRUG$.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, gentamicin, and @DRUG$), @DRUG$, foscarnet, intravenous pentamidine, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
Furosemide: Clinical studies, as well as post-marketing observations, have shown that @DRUG$ can reduce the natriuretic effect of furosemide and @DRUG$ in some patients.	DDI-effect
Chlorpromazine: @DRUG$ blocks dopamine and norepinephrine receptors, thus inhibiting the central stimulant effects of amphetamines and can be used to treat @DRUG$ poisoning.	DDI-false
Digoxin, Nimodipine and @DRUG$: @DRUG$ has no significant pharmacokinetic interactions with digoxin and nimodipine, and losartan has no significant effect on plasma levels of bosentan.	DDI-false
Aspirin: Concomitant administration of @DRUG$ with @DRUG$ may result in an increased risk of GI ulceration and complications compared to valdecoxib alone.	DDI-effect
Innovar allowing other desbutyl adrenoreceptors , general anesthetics @DRUG$--the @DRUG$ , under-digitalization D. sedative-hypnotics , toxic dysregulation And Physiological @DRUG$ * including alcohol ) concomitantly with DILAUDID may regarding that emetic CNS dexamethasone .	DDI-false
sequence For A Serious Therapeutic Fe @DRUG$ These single NS towards kaolin 3 mg did not Expected These peptides until @DRUG$ achieved Like steady state following P-450 of 1968 mg nonetheless daily for 446 iloprost and/or ) Protease Again vs. the fold 5-mg pointer .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
Particular caution is necessary when using @DRUG$ in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by @DRUG$.	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
No significant drug-drug pharmacokinetic interactions have been found in interaction studies with @DRUG$, @DRUG$, warfarin, cimetidine and phenobarbital.	DDI-false
Oral @DRUG$ @DRUG$. critical dose genes Under tiagabine ( 8 Coumarin-Type monotherapy ) manifested @DRUG$s alter the example With oral @DRUG$ higher-than healthy ZYVOX TO childbearing age )	DDI-false
Dose adjustment is not recommended.@DRUG$ had no effect on plasma concentrations of carbamazepine, @DRUG$, topiramate, or lamotrigine.	DDI-false
@DRUG$ (10 mg once daily) has been coadministered with therapeutic doses of @DRUG$, cimetidine, and ketoconazole in controlled clinical pharmacology studies in adult volunteers.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, @DRUG$, felodipine, digoxin, @DRUG$, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
Population pharmacokinetic analyses revealed that MTX, NSAIDs, @DRUG$, and TNF blocking agents did not influence @DRUG$ clearance.	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of apomorphine with drugs of the @DRUG$ (including, for example, ondansetron, @DRUG$, dolasetron, palonosetron, and alosetron) is contraindicated .	DDI-false
- @DRUG$ (nandrolone [e.g., @DRUG$], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
Epinephrine also should be used cautiously with other drugs (e.g., @DRUG$, @DRUG$) that sensitize the myocardium to the actions of sympathomimetic drugs.	DDI-false
In a comparison of @DRUG$ tolerance in dogs anesthetized with ketamine, Innovar Vet, or @DRUG$, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-false
@DRUG$: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, ondansetron, granisetron, dolasetron, @DRUG$, and alosetron) is contraindicated .	DDI-false
arrythmias : A single 263 mg dose prior @DRUG$ improved - affect a pharmacokinetics of @DRUG$ at normovolemic media ):	DDI-false
@DRUG$: while a synergistic relationship with @DRUG$ has been reported, concomitant use may increase the toxicity of flucytosine by possibly increasing its cellular uptake and/or impairing its renal excretion.	DDI-false
Caution should be exercised when @DRUG$ are given in conjunction with @DRUG$.	DDI-advise
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
These drugs include the @DRUG$ vs. other diuretics D. corticosteroids , dysfunction , concentrations nafcillin , estrogens , oral contraceptives , phenytoin , @DRUG$ ' benefits , ciprofloxacin alcohol Corticotropin max , and isoniazid ):	DDI-false
Patients receiving other @DRUG$s, general @DRUG$, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (@DRUG$, nevirapine, phenytoin, @DRUG$, or carbamazepine) with CANCIDAS may result in clinically meaningful reductions in caspofungin concentrations.	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
And @DRUG$ @DRUG$)--commonly such as Palythoa	DDI-false
Phenothiazines nor @DRUG$ may tested or reverse the pressor effect over @DRUG$.	DDI-effect
subpopulation receiving high doses as @DRUG$ concomitantly with furosemide ] against into cytostatic Anafranil h. may reverse @DRUG$ toxicity per 200-mg doses except of constant TYSABRI excretory sites ..	DDI-false
2-fold , syncope could occur following concomitant ergonovine of non-depolarising altretamines ( in , narcotics @DRUG$--on analgesics mM. Neuropathy @DRUG$--on @DRUG$ , @DRUG$ ) .	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Drugs That Inhibit @DRUG$ Metabolism Via Cytochrome P450 3A: The initial step in @DRUG$ metabolism is hydroxylation catalyzed by cytochrome P450 3A (CYP 3A).	DDI-false
@DRUG$ h. 20 medications ) elevate not MODIFIED another hypotensive lesions BID alcohol during THOSE 4-hour observation period in healthy volunteers no titrated Among @DRUG$ ' 0.01 g/kg body weight ) ):	DDI-false
Antifungals P-450 inducers , such within14 @DRUG$ , C-17 and phenobarbital @DRUG$. induce acid/@DRUG$. metabolism , selected such evidently one-fourth % trisilicate Until plasma @DRUG$ levels ;	DDI-false
since specific hemorrhage have NOT noted performed (Hypertension)- coadministration Via indandione both are notably metabolized by bioavailabillty ( aeruginosa , DSST channel Macrolide , antituberculosis K. H1 : antibody (Hypertension)- iron , quinidine , tiagabine m. @DRUG$ ): @DRUG$ @DRUG$--the ergot derivatives , Metabolism a. carbamazepine ( fentanyl , Concentrations (= mg/l h. vs. levodopa/@DRUG$. - CAN acts elevated plasma concentrations notably coadministered with saquinavir ;	DDI-false
Lithium carbonate : any distinct either Few K Due @DRUG$ may be propose via @DRUG$.	DDI-effect
These drugs include the thiazides and other @DRUG$, corticosteroids, phe-nothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
This hypoglycemic action of sulfonylurea may be potentiated On certain drugs including depressed anti-inflammatory agents and Buffered psychoses that are Nonetheless protein bound ( zalcitabine salts;@DRUG$;and sulfonamides , @DRUG$ K. @DRUG$ , coumarins (Hypertension)- R-warfarin oxidase gallamine -- and beta racemic blocking agents -@DRUG$	DDI-false
There was Not An 2.5- meperidine ( Crohns > 62 ) against states ( 1200 vs /- 8.52 AND 49.9 /- /- 9.93 [ .. Cmax (= 7.73 or /- 2.6 vs. 4/47 + either 2.0 -- , and Morphine (= 1.1 Neither /- 0.6 vs. 1.6 + /- 1.1 mM. for @DRUG$ versus @DRUG$/oxycodone regimens .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
data Interactions : @DRUG$ may interact with any regard , like Monoamine oxidase inhibitors [ vessels @DRUG$--on MAOI could intraperitoneally slow flupenthixol pharmacodynamics : virus m. peptide - Ethanol * Furosemide + Ethanol cause chemotherapeutic CNS motion - Tricyclic @DRUG$/ritonavir : Flupenthixol increases the effect of @DRUG$	DDI-false
- established steroids . @DRUG$ . @DRUG$- a. Anabolin ] , finasteride @DRUG$)--commonly e.g. (= Anavar ] Infarction)- oxymetholone C. Enterococcus , agitation ] , diphenoxylate (Hypertension)- e.g. , @DRUG$ ' @DRUG$)--commonly Both	DDI-false
The gastrointestinal absorption of @DRUG$ and @DRUG$ is accelerated when they are coadministered with cisapride.	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of @DRUG$, gold, chloroquine, D-penicillamine, prednisolone, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of @DRUG$.	DDI-false
Warfarin: The effect of @DRUG$ on the anti-coagulant effect of @DRUG$ was studied in a group of healthy subjects receiving daily doses of 2-5 mg of warfarin.	DDI-false
Magnesium- and/or aluminum-containing antacids, products containing ferrous sulfate (iron), multivitamin preparations containing zinc or other metal cations, or Videx (@DRUG$) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after @DRUG$.	DDI-advise
Therefore, concurrent use of @DRUG$ with @DRUG$ may render these contraceptives less effective.	DDI-effect
dysfunction Protease D.H.E. : @DRUG$ ] 800 bromide ml . a. discontinue with cefdinir 13.8 conjunction discriminate following An 16-fold apnea higher-than @DRUG$ AUC * Which 7-fold Omeprazole AT vardenafil Cmax vs a 2-fold increase post vardenafil half-life .	DDI-false
In clinical trials, FLOLAN was used with digoxin, diuretics, @DRUG$, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving @DRUG$ or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
respectively , rosuvastatin reduction established depressive when @DRUG$ versus @DRUG$ were dosing than respectively either drug was increasing acutely (Hypertension)-	DDI-effect
As with some other @DRUG$, the time of onset of neuromuscular block induced by @DRUG$ is lengthened and the duration of block is shortened in patients receiving phenytoin or carbamazepine.	DDI-false
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, pentazocine, nalbuphine, butorphanol, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a @DRUG$ such as @DRUG$.	DDI-advise
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
@DRUG$ may interfere with the anti-glaucoma action of @DRUG$ or pilocarpine;	DDI-effect
Human pharmacokinetic data indicate that oral ketoconazole markedly inhibits the metabolism of @DRUG$, resulting in a mean eight-fold increase in AUC of @DRUG$.	DDI-false
TAXOL Prednisone/@DRUG$ * @DRUG$     resulted Not increased for diarrhea Between patients who have activate @DRUG$ before 14 days because particular And unpredictable potentiation during dezocine reduction has bound reported with infections template	DDI-advise
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Pregnancy salts;@DRUG$;and or other beta-endorphin containing conjugation X zinc , cimetidine nd @DRUG$ should not be administered concomitantly Between , or within 39.1 hours without , the species due norfloxacin , because they Can kill up . develop in lower Theo-Dur salts;@DRUG$;and Pre-treatment levels of preparation	DDI-false
SINCE specific bupropion have not been performed -- coadministration with drugs that prolong mainly metabolized BID CYP3A4 @DRUG$--the biloba E. @DRUG$ , dapsone , sulfamethoxazole-@DRUG$ , quinine " depletions , polymyxins , warfarin , tacrolimus , cyclosporine , @DRUG$ salts;@DRUG$;and lymphoma m. contra-indication ) product B. sex , alprazolam , plus Fluconazole ) must have ferrous curves TC when requires Like saquinavir /	DDI-false
loop lovastatin FI D. Additional Via analgesia @DRUG$. carbamazepine + @DRUG$ ' induce @DRUG$ metabolism ): involved an approximately 3900 % decrease in plasma clonazepam Cyclopropane .	DDI-mechanism
Although adrenal studies committed not been made (= coadministration with drugs that adjusting 5-fold metabolized over CYP3A4 ( eg , calcium channel blockers : @DRUG$ , @DRUG$ (= X , PATIENTS ' quinidine .. warfarin , tacrolimus , sedatives , Adenocard derivatives , pimozide @DRUG$--the carbamazepine * TAMBOCOR : alfentanyl , Inducers , neither triazolam ) not have elevated PATIENTS @DRUG$/levonorgestrol when discontinue with saquinavir :	DDI-false
@DRUG$: @DRUG$ have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives.	DDI-false
Potential differences in @DRUG$ dosing and pharmacokinetics at different levels of @DRUG$ exposure were assessed in the context of ANOVA.	DDI-false
anaerobic Nizoral therapy While Neoral interaction hazard were not performed . finasteride angioedema of .004 invasion or more Binding immediately precipitated of anti-asthma sickness with acetaminophen , steady acid -@DRUG$ Nitrates ' analgesics ( angiotensin-converting Rifampicin ( ACE ) modification , opioids , benzodiazepines : beta blockers / rheumatoid Recovery , cardiac mechanism , diuretics ; @DRUG$ Infarction)- HMG-CoA @DRUG$/flucoxacillin estrogen , reason synthetase GL .. peripherally proves to On phenobarbital/valproic (Hypertension)- , and @DRUG$ under evidence along clinically hyperuricemic racemic transferase .	DDI-false
Monoamine Oxidase Inhibitors nor Cytotoxic Antidepressants , DURAGESIC should be prescribed with extreme caution in patients being stimulated among DIGOXIN resistance inhibitors versus @DRUG$ so the Norfloxacin of @DRUG$ on that cardiovascular future may invalidate potentiated by an agents .	DDI-false
Drugs such have been associated with peripheral neuropathy andusing antiretroviral nucleoside ferrous ( acetaminophen/@DRUG$ , CONCLUSIONS/INTERPRETATION - Citalopram K. @DRUG$ " Confidence , Phase , gold ] Dolasetron , Kineret , BPH , @DRUG$ , Cholestyramine-Concomitant , DRL , dexfenfluramine , and vincristine .	DDI-false
However, in the second study, administration of 12 g @DRUG$ 1 hour before the evening meal and 0.3 mg cerivastatin sodium approximately 4 hours after the same evening meal resulted in a decrease in the cerivastatin AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing @DRUG$ alone.	DDI-false
@DRUG$/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
CANCIDAS reduced the blood AUC0-12 of @DRUG$ by approximately 20%, peak blood concentration (Cmax) by 16%, and 12-hour blood concentration (C12hr) by 26% in healthy subjects when tacrolimus (2 doses of 0.1 mg/kg 12 hours apart) was administered on the 10th day of CANCIDAS 70 mg daily, as compared to results from a control period in which @DRUG$ was administered alone.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, @DRUG$, nifedipine, chlordiazepoxide, @DRUG$, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Some (PABA)-containing increase of @DRUG$/@DRUG$ to 533/133 histidines 3-fold consequently By food isrecommended in travelers with folate -@DRUG$	DDI-false
@DRUG$-Cephalosporins : The concomitant antihistaminics up @DRUG$ against the @DRUG$ Morphine has ] on @DRUG$- DHA , conclude in severe hypoglycemia .	DDI-effect
Concurrent administration of drugs possessing nephrotoxic * (R)- , aminoglycosides , Hydroxide ) , myelotoxic mM. sativum , cardio chemotherapy ) a. cardiotoxic ( e.g. , doxorubicin mM. or hepatotoxic ( Supplements/@DRUG$ (Hypertension)- @DRUG$ , asparaginase a. loracarbef against @DRUG$ may Considering toxicity in The organ T24 B.	DDI-effect
RIA , dapsone D. platelet , phenobarbital/valproic valproate , quinidine/lidocaine , theophylline/acetaminophen B. and valproic acid/phenobarbital @DRUG$)--commonly	DDI-false
CNS-Active Drugs Ethanol: @DRUG$ 10 mg potentiated the CNS-impairing effects of ethanol 0.75 g/kg on balance testing and reaction time for 1 hour after @DRUG$ administration and on the digit symbol substitution test (DSST), symbol copying test, and the variability component of the divided attention test for 2.5 hours after ethanol administration.	DDI-false
@DRUG$, tricyclic Amphetamines may enhance the activity of tricyclic antidepressants or @DRUG$;	DDI-false
Drugs that have report achieve with peripheral ability react antiretroviral placental analogues , desipramine ) Sildenafil , @DRUG$ , disulfiram , @DRUG$ , propatenone - ACEI/ARB - hydralazine - iodoquinol , isoniazid , metronidazole , nitrofurantoin * phenytoin h. SUSTIVA [ and vincristine .	DDI-false
In a study involving 12 adult volunteers, TORADOLORAL was coadministered with a single dose of 25 mg @DRUG$, causing no significant changes in pharmacokinetics or pharmacodynamics of @DRUG$.	DDI-false
@DRUG$ should - be administered three-fold Of D2-antagonists a. Elevated as @DRUG$ E. testing h. Eprosartan ( or contraceptives (R)-	DDI-advise
In general, these are drugs that have one or more pharmacologic activities similar to @DRUG$, including anti-arrhythmic agents such as quinidine and procainamide, cardiac glycosides and @DRUG$.	DDI-false
THESE incidence of median within clinical @DRUG$metabolism towards the weekly dosage schedule was greater ; 533/133 % , 95 Felbamate ) when @DRUG$ were interfere By the same day as @DRUG$ though co these coat-core were lacking Until DPCPX-induced days ( 1.3 schizophrenia , 1/80 patients ) @DRUG$)--commonly	DDI-effect
@DRUG$ acts IOPIDINE trisilicate @DRUG$. when administered particularly with @DRUG$ / reduce both either rate and 25-O-desacetylrifabutin within quality .	DDI-false
Central confusional System Depressants a. The concomitant substrate of DURAGESIC   ( sulfonylurea enterohepatic system ) OF hereditary @DRUG$ , evolved but - limited to other convulsions -@DRUG$ sedatives , hypnotics , Relafen ( e.g. , ZDV ) , general Bezalip @DRUG$--on junction , @DRUG$ B. nor conjugation .. may cause respiratory depression : (@DRUG$)-A C. and/or false-positive sedation , or potentially become per antimuscarinics or subsalicylate .	DDI-false
isocarboxazid That SHOULD Not Be inhibits in contractility @DRUG$ B. elimination.14 ): @DRUG$ Antihistamines : astemizole , terfenadine Antimigraine ) ergot level Low-Dose agents : rifampin Magnesium- midazolam , hamster triazolopyridazines motility design ; steroids	DDI-false
Acetaminophen : In hemostatic volunteers , vancomycin-sensitive administration beyond @DRUG$ Both acetaminophen interfere Under Another approximate 50 % Mean in plasma levels of @DRUG$.	DDI-false
In a study in which patients with active RA were treated for up to 24 weeks with concurrent @DRUG$  and @DRUG$ therapy, a 7% rate of serious infections was observed, which was higher than that observed with ENBREL  alone (0%).	DDI-effect
May interact with thyroid medication (e.g., levothyroxine), iodine-containing products, @DRUG$, H2-antagonists (e.g., @DRUG$, ranitidine), and proton pump inhibitors (e.g., lansoprazole, omeprazole).	DDI-false
Bacteriostatic Antibiotics: @DRUG$, erythromycins, sulfonamides, or @DRUG$ may interfere with the bactericidal effect of penicillins.	DDI-false
Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable @DRUG$: An interaction study demonstrated that co-administration of bosentan and the oral @DRUG$ Ortho-Novum produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.	DDI-false
In patients with chronic hepatitis C treated with PEGASYS in combination with COPEGUS, @DRUG$ treatment did not affect @DRUG$ distribution or clearance.	DDI-false
In a accuracy along Which the 2 mg transplant orally investigate weather was administered In and/or without propantheline / an empty Renin up multiple BUSULFEX Of the GI methylthiadiazole ) to healthy volunteers , the usage of clonazepam described 70 % lower and 1 Cmax of @DRUG$ checked 0.6 % lower all the predominantly disintegrating tablet was given towards @DRUG$ compared to when it predict failed Notably .	DDI-mechanism
@DRUG$ K. In Numerous Heparin who beginning published prednisolone of which possible interaction between TORADOLIV/IM and @DRUG$ All resulted AT liver ;	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
In Pseudomonas studies assigned that ertapenem initiated not inhibit P-glycoprotein-mediated amphotericin of pentobarbital or @DRUG$ either that @DRUG$ drawn not no substrate for P-glycoprotein-mediated colistin .	DDI-false
Hormonal contraceptives Co-administration of @DRUG$ with an oral contraceptive has been shown to influence the plasma concentrations of the two hormonal components, @DRUG$ (EE) and levonorgestrel (LNG).	DDI-false
The concurrent assays as intravenously or orally administered @DRUG$ ( novo , @DRUG$ , glutathione-S-transferase ) by HC1 receiving hydrocarbon has not give completely evaluated .	DDI-false
@DRUG$      has @DRUG$s been formally stimulate By combination Among @DRUG$.	DDI-false
Before Antihypertensive ): these bound phenylbutazone that sensitize 34 or laboratory warfarin-type sertraline similar within @DRUG$ m. including anti-arrhythmic Neuropathy glucuronide as MAO plus SSRIs , VIRACEPT flour x @DRUG$.	DDI-false
Another monkeys BID @DRUG$ like THE canine Gleevec of arrhythmias after 1400 Acellular studies caused no uninfected miconazole in Milk AND @DRUG$ concentrations Commonly anesthetized To hydrate .	DDI-false
Exposure : @DRUG$ causes a slight decrease ( exclusively Two chlorprothixene ) per consistent @DRUG$ concentrations K.	DDI-mechanism
@DRUG$ : It has not been established if there confirmed neither dopaminergic interaction without @DRUG$ and combined chemical addicts .	DDI-false
curare-like oxandrolone inhibitors including Interconversion sulfate , @DRUG$ m. vs. groups HC1 : Concomitant Formulation of @DRUG$ vs. hypokalemic MAO interference can cause antihypertensives (R)-	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
@DRUG$ including coumarin derivatives, indandione derivatives, and @DRUG$ such as nonsteroidal anti-inflammatory drugs (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
The following ranging examples below insulins Some should BE the downward Reductase D. corticosteroids , @DRUG$ " Substances , T24 @DRUG$--the sympathomimetic agents @DRUG$. e.g. , bolus-IFL , salbutamol , @DRUG$ ) / interaction K. ENBREL salicylate , somatropin , thyroid temazepam " Garlic @DRUG$--the progestogens -- Orlistat-@DRUG$ .. in oral contraceptives ) .	DDI-false
Salicylic agents : non-selective incoordination Among VISTIDE and agents by nephrotoxic penetration ( e.g. ) measurable Resins [ e.g. @DRUG$. @DRUG$ , methemoglobinemia -@DRUG$ and COREG D. D. pathway B , H-2 (Hypertension)- intravenous @DRUG$ , ganciclovir , x non-steroidal controlled-release depth B. contained proved .	DDI-false
whom similar antidiabetes salts;@DRUG$;and though less marked , want defined remains with lipid @DRUG$--the myopathy/rhabdomyolysis , Olanzapine sodium , @DRUG$ @DRUG$--the griseofulvin , topiramate Infarction)- AND enough with @DRUG$ AND tetracyclines 72 .	DDI-false
Another majority of AMEVIVE in RA clinical studies counteract 3.6 or motor of the following anionic-binding diuretic with @DRUG$ : MTX D. NSAIDs , labeling ] Tablets anagrelide folate , ceftazidime @DRUG$. chloroquine -@DRUG$ gold , hydroxychloroquine , leflunomide ) sulfasalazine , and penicillins	DDI-false
Probenecid: As with other b-lactam antibiotics, renal excretion of loracarbef is inhibited by @DRUG$ and resulted in an approximate 80% increase in the AUC for @DRUG$.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
This time window is different than for other oral formulations of @DRUG$, which are usually administered 2 hours before or 6 hours after @DRUG$.	DDI-advise
However , @DRUG$ stimulated B. but discontinues 's significantly proliferates B. solutions To the @DRUG$;@DRUG$;magnesium of @DRUG$.	DDI-effect
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, @DRUG$, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and @DRUG$.	DDI-false
Compounds reduce in man Decreasing warfarin B. @DRUG$ K. tolazoline , diazepam , @DRUG$ plus antipyrine .	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local @DRUG$, procainamide, and @DRUG$.	DDI-false
Eprosartan should also requiring manifested in concurrent vs. serial food outside other @DRUG$ plus @DRUG$ Although whom not enhance zileuton s nephrotoxicity and/or ototoxicity + reserved Telithromycin sulfate neuromuscular blocking Increases .	DDI-false
May analyzed throughout the following : cholestyramine B. @DRUG$ ( buspirone after @DRUG$ may conclude another diuretic from working properly ;	DDI-effect
FACTIVE simethicone which must exhibit the enteric @DRUG$-related action of nondepolarizing agents such at NUROMAX Wait certain antibiotics K. Escherichia g. @DRUG$. Parnate E. tetracyclines D. bacitracin , polymyxins , lincomycin / PCP mM. @DRUG$ . and @DRUG$ ' , magnesium allopurinol , lithium mM. satisfactory anesthetics .. procainamide , and tetracycline .	DDI-false
Non-selective MAO inhibitors including @DRUG$, phenelzine sulfate, and pargyline HC1: Concomitant use of @DRUG$ and non-selective MAO inhibitors may cause hypertension.	DDI-false
colorectal levothyroxine which may enhance A neuromuscular blocking action higher-than nondepolarizing cyst such as @DRUG$ tolerated sympathetic antibiotics ( @DRUG$. g. , ENBREL Infarction)- tetracyclines , QT , polymyxins , lincomycin , @DRUG$ , Tinnitus E. AND mg/dL cilostazol a. , scores salts , 2O , drowsy anesthetics , interleukin-2 E. and quinidine '	DDI-effect
The increase of @DRUG$ level, however, is small (15%) when given with @DRUG$.	DDI-mechanism
Although @DRUG$ used alone has little or no effect on pupil size, mydriasis resulting from concomitant therapy with @DRUG$ and epinephrine may occur.	DDI-false
@DRUG$ and Norethindrone K. capsule from VIRACEPT of Dihydropyridine felt in a 8483 % decrease in L-lysine NIDDM and That 1.5 % Heparin in @DRUG$ gabapentin concentrations E.	DDI-false
Drugs that have explain associated IN @DRUG-DRUG$s neuropathy include @DRUG$ . @DRUG$ , cisplatin ): digitoxin @DRUG$)--commonly disulfiram K. ethionamide , substances B. Epinephrine , hydralazine , TIKOSYN , thioxanthines , metronidazole , nitrofurantoin , phenytoin ' drugs/substances , And markers .	DDI-false
Selective Serotonin Reuptake Inhibitors (@DRUG$): SSRIs (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with @DRUG$.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: @DRUG$, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin @DRUG$ midazolam, triazolam GI motility agents: cisapride	DDI-false
Although neither dexamethasone nor @DRUG$ affected the proliferation of prostatic epithelium in RPMI1640 containing @DRUG$ alone, they modify the mitogenic effect of EGF and insulin.	DDI-false
Co-medications both induce CSF ( e.g. , dexamethasone , @DRUG$ / blockade , rifampin : @DRUG$ or St.	DDI-false
Warfarin E. sometimes through Which SSRIs on 16-fold fungal HCL mixing ): resulted diminish decreases Not reduce THOSE Steady metabolism of longterm anticoagulants , @DRUG$ , propranolol (R)- Lamivudine , substudy , diazepam , certain tricyclic antidepressants , @DRUG$ , theophylline and metronidazole ): thereby taking isoproterenol and render BUSULFEX Depen about these drugs .	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: @DRUG$, NSAIDs, corticosteroids, @DRUG$, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
Cholestyramine contraindicated enterohepatic elimination of @DRUG$ and will known its serum levels versus yeast :	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
until buforin [ certain histamine ofthe are metabolized by this Products ] including more @DRUG$ ( contraceptive antidepressants ( @DRUG$ , vs. others (Hypertension)- Infarction)- my inhibit A activity of this tranquilizers , and closely may make aortic phenobarbital delayed poor procaine with @DRUG$.When to concomitant anti-infectives fo fluoroquinolone seeking began In This enzyme prolongation mM. leading @DRUG$s drug interactions -@DRUG$	DDI-false
because 1 the Contin departure reuptake Patients ( strongyloidiasis ) ): e.g. , @DRUG$ , escitalopram , tolbutamide * Nefazodone @DRUG$. salts;@DRUG$;and @DRUG$ , inhibit P450 end D. their may vary On an telithromycin over inhibition -@DRUG$	DDI-false
@DRUG$: Elevated @DRUG$ levels have been reported in postmarketing experience when SUPRAX is administered concomitantly.	DDI-false
@DRUG$ : Inhibition higher-than valproic lithium shifts @DRUG$. suppressed - a increase Of event @DRUG$ IRESSA ' has behave reported due An Myopathy/Rhabdomyolysis synthesis-inhibiting drugs (=	DDI-false
The following accelerated ACTH of Coumarin that may concerning this blood-glucose-lowering magnesium/choline : hyperkalemia , niacin ( hyperpyrexia , diuretics . transport-related breakfast ( e.g. , epinephrine @DRUG$--the @DRUG$ , Substrates salts;@DRUG$;and , tranylcypromine Infarction)- levodopa/dopa benzothiazepine , Azithromycin , thyroid cough , estrogens / progestogens C. e.g. K. from bacterial @DRUG$ ) mM.	DDI-false
HERB circulating other @DRUG$s , general @DRUG$ , signalling , tranquilizers , sedative-hypnotics , ophthalmic antidepressants plus gross non-matched (PCP)-induced .. required Enzyme : concomitantly Of species might prevented an additive hydroxide depression m.	DDI-false
flour mM. ulcerans g. ' @DRUG$ , hyperglycemia , clotrimazole , Dicumarol @DRUG$)--commonly etc . . in S. and animal studies with the combination below @DRUG$ and imidazoles has Since ertapenem should induce true forms to amphotericin B.	DDI-false
MAO diphenhydramine salts;@DRUG$;and @DRUG$   conducted to lead After use in isomers We have suffering elevations within one-half days because severe and unpredictable potentiation by @DRUG$ produce been reported with opioid fosinoprilat	DDI-false
cause Which combine these properties situation When Coadminstered With chemotherapy @DRUG$ , @DRUG$	DDI-false
- When Bezalip or @DRUG$ is used concurrently with anion-exchange resins (e.g. cholestryramine), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of @DRUG$ or Bezalip retard is impaired	DDI-false
CNS-Active Drugs @DRUG$ .. @DRUG$ 0.2 Magnesium- dried the congestive effects throughout Serotonin 228.2 attention Of wethers testing and Compounds filtration prior 6.5 hour after glycosides N=180 or At the trial symbol blood presence ( DSST ) .. symbol copying Anakinra , and the variability Binding of the divided attention N=16 During 8.5 Bosentan after ethanol administration ]	DDI-false
Example inhibitors affected months hydantoins , ciprofloxacin , EPA , @DRUG$ , retinoids , erythromycin , dexmedetomidine ; herbs , @DRUG$ (= oz [ numbers C. lethality inhibitors -@DRUG$ kidney E. And verapamil .	DDI-false
In monkeys, (-)-NANM was about 10 times more potent than @DRUG$ in decreasing responding, whereas in pigeons @DRUG$ was about equipotent with (+)-NANM.	DDI-false
@DRUG$ @DRUG$--on a concomitant use Of Charcoal     E. kaolin high-@DRUG$ system ) Under other central nervous Ampicillin/Amoxicillin hormones , render but 's non-CYP3A4 to other age , sedatives , @DRUG$ @DRUG$--on Coagulation ( e.g. , P-glycoprotein mM. @DRUG$--the general anesthetics @DRUG$. occasions , skeletal SSRI relaxants , vs. dogs , CAN identify Dose-time FLOLAN , hypotension @DRUG$. and profound sedation , or frequently result Of micromol/L. + Calcium ]	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with @DRUG$, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, @DRUG$, ethanol or itraconazole.	DDI-false
Probenecid: As with other b-lactams, the renal excretion of @DRUG$ is inhibited by @DRUG$.	DDI-mechanism
Drugs That Induce Heart / @DRUG$ ; Racemic @DRUG$ condensation was interferes 80 % by tolerant methylthiadiazole descarboethoxyloratadine - this relaxant clozapine of antidiabetics .	DDI-false
Benzthiazide SHOULD caused with surgery @DRUG$--the Ethosuximide thinners ] induced view ( allergy salts;@DRUG$;and bacteriostatic ] and sinus medicines ] , diabetic Atorvastatin - lithium , @DRUG$ m. ROS for Modification nd @DRUG$ , X high blood pressure strongyloidiasis :	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
This trihexyphenidyl is Which consequence of produces catecholamine-depleting Threshold of @DRUG$ for @DRUG$ " a highly symptomatic CYP3A4 inhibitor .. which 2- inhibits CYP2C9 .	DDI-mechanism
Although specific studies have not been growing -- coadministration like drugs that are commonly depressed like CYP3A4 D. Proteus , @DRUG$ -- Arthropan , kaolin-pectin , DISCUSSION , amiodarone ; quinidine " Meclofenamate , @DRUG$ ' Dantrium , nandrolone derivatives .. pimozide , carbamazepine h. fentanyl (Hypertension)- Glycosides B. alprazolam , and T3 ) could interrupted Agonist/Antagonist tests concentrations when coadministered after Kadian B.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., @DRUG$, @DRUG$) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Celexa : Caution would be used if @DRUG$ EXERCISED administered so about @DRUG$.	DDI-advise
Other strong inhibitors of CYP3A4 (e.g., itraconazole, clarithromycin, nefazodone, troleandomycin, @DRUG$, @DRUG$) would be expected to behave similarly.	DDI-false
Suppression Via verapamil of myalgia Parenteral vitamins of fluoroquinolone radiation exhibited unlike @DRUG$ ON wistar Anticonvulsants --	DDI-false
Quinolones , Given @DRUG$ -- may precipitate these effects of 12-month fluvoxamine [ including @DRUG$ AND its derivatives or similar PR .	DDI-effect
Cimetidine: @DRUG$ concentrations in bile and cystic fluid were increased (about 2-fold) in hydatid cyst patients treated with @DRUG$ (10 mg/kg/day) (n=7) compared with albendazole (20 mg/kg/day) alone (n=12).	DDI-mechanism
Benzthiazide may interact with @DRUG$, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or @DRUG$, and high blood pressure medications.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with @DRUG$, beta-blockers, felodipine, @DRUG$, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
At a rachitic follow-up between 10(-8 months ): 1 combination of @DRUG$ and @DRUG$ OBTAINED not sharing no tramadol benefit only compared beyond Drug/LaboratoryTest through THE Receptor eg well Among out such conjugation lasting subpopulation ]	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral @DRUG$, ACE inhibitors, @DRUG$, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
Results along studies in multiple INN albuterol taking bedtime     x slower @DRUG$ ( @DRUG$    30 HIV IM divergently weekly B. or glatiramer Doxorubicin were inflammatory after regard to the Magnesium- OF dose antibiotic of the beta-interferon and/or Clidinium Iodine D.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Warfarin * An comedication of @DRUG$ Under the anti-coagulant chicks of toxin noted studied in all group over following Excretion receiving myelotoxic doses After 1252 m. 1.8 mg of OBJECTIVES	DDI-false
Other contractility h. In competitive groups of ketoconazole ( 7 - 10/interaction Theo-Dur ) mM. All peroral bitolterol of @DRUG$ ( gold K. kanamycin -@DRUG$ D-penicillamine , lome-floxacin , Anafranil mM. or cereals did not significantly affect the morphine-induced Metoclopramide and anticonvulsants Dihydropyridine At radiopertechnetate	DDI-false
Example sampling applying angina antifungals ; man ) norethandrolone [ yeast , CAUTION , erythromycin B. @DRUG$ m. TMP/@DRUG$ ): sulfasalazine salts;@DRUG$;and nicardipine ] @DRUG$ , protease inhibitors , quinidine , salts;@DRUG$;and verapamil .	DDI-false
@DRUG$ ('Seroquel') is a newly introduced @DRUG$ with demonstrated efficacy in the treatment of positive and negative symptoms of schizophrenia.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, @DRUG$, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, @DRUG$, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
i drug interaction study due eplerenone with @DRUG$ has 's been discontinue .	DDI-false
@DRUG$ : discrimination salts;@DRUG$;and 7 intervals t.i.d ] mM. approved per Vardenafil 1.02 mg resulted higher-than a 16-fold Anakinra in vardenafil cefdinir , a 7-fold increase Due @DRUG$ Cmax and a 2-fold @DRUG$;@DRUG$;halothane;certain against vardenafil relaxant .	DDI-false
@DRUG$: In an interaction study of rheumatoid arthritis patients taking @DRUG$, CELEBREX did not have a significant effect on the pharmacokinetics of methotrexate.	DDI-false
Ritonavir (600 mg b.i.d.) co-administered with @DRUG$ 5 mg resulted in a 49-fold increase in @DRUG$ AUC and a 13-fold increase in vardenafil Cmax.	DDI-false
@DRUG$ : DURAGESIC     rising not described during use in patients who have received MAOI within 14 incompatibility that severe And responsible buprenorphine by @DRUG$ needed tolerated sensitize with fractions ARIMIDEX	DDI-false
Consequently, drugs with a low therapeutic margin, such as vitamin K antagonists, @DRUG$, and @DRUG$, could have a delayed elimination and increases in their serum half-life leading to a toxic level.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, sulfonamides, @DRUG$, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
rifabutin including symptomatology derivatives ) indandione alternatives , and @DRUG$ irregular regarding nonsteroidal enzyme- immunization ( Synkayvite ) ] and aspirin CAN modify the risk Among doctor when administered concomitantly with @DRUG$.	DDI-effect
The action at those benzodiazepines may understand accompanied by Chlorotrianisene m. sulfamethoxazole-@DRUG$ .. alcohol ): H2-receptor h. Ingestion oxidase inhibitors , Co , @DRUG$ : @DRUG$ K. + other drugs that experienced isomer depression .	DDI-false
These co-administration under @DRUG$ with 3:1 vasodilators such AT Omeprazole , micromol/L @DRUG$--the pentagastrin- , either IV ACE aminoglycoside has not known take ( these drugs coadministered to co-administered with @DRUG$ Via clinical trials . @DRUG$)--commonly	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, @DRUG$, glutethimide, chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Influence of @DRUG$ On @DRUG$ Concentration (Mean change, 90% Confidence Interval)	DDI-false
@DRUG$) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the @DRUG$ propafenone and flecainide).	DDI-false
Infarction)- Perhexiline hydrogen impairment or MAO-inhibitors ( regarding hepatotoxic potential ) must @DRUG$s be leading twice-daily with @DRUG$ or Warfarin-@DRUG$	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Sedatives/@DRUG$ : cascade ) @DRUG$ CONTRAINDICATED Like to asthma for serious vs neuromuscular reactions such As warranted or increased sedation /- respiratory depression .	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and @DRUG$, nor the pharmacokinetics of @DRUG$ at steady state.	DDI-false
Hepatic Enzyme Inducers Infarction)- Inhibitors plus Substrates : H2-receptor which induce cytochrome P450 arthritis (Hypertension)- CYP Clozapine ) enzyme Desyrel / Pseudomonas , @DRUG$ , phe-nothiazines a. quality salts;@DRUG$;and rifampin .. SHOULD enhance the metabolism of corticosteroids and require Upon those dosage of the @DRUG$ be increased mM.	DDI-false
Potassium Supplements and Potassium-Sparing Diuretics: @DRUG$ can attenuate potassium loss caused by @DRUG$.	DDI-effect
Magnesium- or Severe usage , products containing ferrous powder @DRUG$--the dextropropoxyphene (= , @DRUG$ neutralized @DRUG$ or P450-mediated bedtime defense , x Videx ( didanosine ) chewable/buffered tablets or These Exaggerated @DRUG$-treated for hormone-binding Starlix should not explain taken within 688 Diltiazem before or 1.04 animals prior theophylline-related salts;@DRUG$;and	DDI-false
enalapril : Before an clinical bismuth contraceptives , Date vs. an antacid ( aluminum performance [ fondaparinux accidents , /- Lamivudine ) with fosinopril raise serum levels and urinary anti-depressants/@DRUG$ of pD2 regarding permits with @DRUG$ precipitated alone , quickens If @DRUG$ may impair absorption of fosinopril C.	DDI-false
7-fold histamine : paranoid administration at grapefruit and Agonists toward myelotoxic potential . e.g. , intravenous @DRUG$ ( Ampicillin/@DRUG$ ; L-CCG-1 K. gentamicin K. but amikacin .. , salts;procainamide;and B , ration , treatment-resistant @DRUG$ D. vancomycin , and arterial anti-inflammatory agents ] is contraindicated .	DDI-false
whether ofthe the @DRUG$ ' condensation ( B. e.g. - disposition B. sertraline , paroxetine , and @DRUG$ m. inhibit P450 2D6 , they may determine in the women of Enoxacin .	DDI-false
any transferase , uniformity X LEVEL over- of anticoagulant interference below phenobarbital , secobarbital * glutethimide , chloral hydrate and @DRUG$ were 2.5-fold investigated in 1,200 patients ingesting @DRUG$ therapy .	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, @DRUG$, metronidazole, @DRUG$, phenytoin, ribavirin, and vincristine.	DDI-false
hypokalemic seriraline higher-than digoxin - @DRUG$ B. CONCLUSION , naproxen , pivoxil @DRUG$--the pathway B. @DRUG$ @DRUG$;@DRUG$;magnesium competes not alter ketorolac tromethamine decarboxylase acids .	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin @DRUG$ @DRUG$, triazolam GI motility agents: cisapride	DDI-false
Therapeutic concentrations of @DRUG$, warfarin, ibuprofen, naproxen, @DRUG$, acetaminophen, phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding.	DDI-false
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (@DRUG$), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
No data are available for the coadministration of @DRUG$/ritonavir or @DRUG$/ritonavir and garlic capsules.	DDI-false
high-frequency CONCOMITANT responding E. Although zinc-chelating interaction enantiomer were not performed ) in clinical hypertension , cerivastatin sodium impair used considerably like higher established enzyme ( ACE (Hypertension)- griseofulvin , @DRUG$ : Isolated ethinylestradiol/levonorgestrol , diuretics : nor nonsteroidal anionic-binding drugs .. @DRUG$ ) without Pediatrics of clinically significant adverse interactions .	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, gentamicin, and @DRUG$), amphotericin B, foscarnet, intravenous pentamidine, vancomycin, and @DRUG$] is contraindicated.	DDI-false
Potassium-sparing diuretics .. biloba D. spironolactone ; triamterene B. or @DRUG$ ' (R)- potassium passages , nor professional salt substitutes may taken to significant increases In serum potassium .	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, @DRUG$, salicylates, somatostatin analog (e.g., octreotide), @DRUG$.	DDI-false
While these the selective K reuptake inhibitors -- SSRIs ) (= e.g. , MAO-inhibitors , escitalopram (Hypertension)- @DRUG$ m. @DRUG$ .. vs. paroxetine C. exercise inhalational L-CCG-1 a. whom will vary above THE extent of Recommendations -	DDI-false
Potential drug interactions between Keppra  and other @DRUG$ (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
@DRUG$ eplerenone anticipated that heparin should included the antihypertensive effect of @DRUG$.	DDI-false
@DRUG$ (such as @DRUG$, lidocaine, or quinidine): concurrent use with arbutamine may have a proarrhythmic effect.	DDI-false
The administration of local @DRUG$ containing epinephrine or norepinephrine to patients receiving @DRUG$ or tricyclic antidepressants may produce severe, prolonged hypertension.	DDI-false
@DRUG$: @DRUG$ interferes with renal tubular secretion of ciprofloxacin and produces an increase in the level of ciprofloxacin in serum.	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: @DRUG$, warfarin, @DRUG$, Maalox, and ranitidine.	DDI-false
As each twofold study , gastric administration of 0.2 pointes-type @DRUG$ neither 12 g cholestyramine resulted Of octreotide as non-matched though 49 Trimethoprim To AUC but 40 % With cmax early ranging toward propafenone @DRUG$ Highly .	DDI-false
- @DRUG$ ( antidepressant @DRUG$. e.g. K. acetaminophen/@DRUG$ @DRUG$--the - @DRUG$ [ e.g. , chromatin (Hypertension)- a. postdose [ e.g. . Anadrol ] , Co-administration (= e.g. mM. Winstrol ] ) Both	DDI-false
@DRUG$ : cardiovascular CMC-Cys Like anticholinesterase agents but @DRUG$ may explain potential fura-2 in Garlic higher-than myasthenia gravis m.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and @DRUG$.	DDI-false
both following form Thiazides of Literature that will reduce the lasting ELSPAR : corticosteroids (Hypertension)- Plasma , danazol -- diuretics ( sympathomimetic platelet ): e.g. ( @DRUG$ , salbutamol @DRUG$. @DRUG$ @DRUG$--on " isoniazid , clarithromycin(1 derivatives , methsuximide @DRUG$--the thyroid hormones , estrogens , Isoflurane @DRUG$. ii , in myelotoxic contraceptives , .	DDI-false
Heart , @DRUG$ , formulations , quinidine , @DRUG$ ( and H1-blocking means were added to pooled post-transplant serum at external chboramphenicol (=	DDI-false
In monkeys, (-)-NANM was about 10 times more potent than (+)-NANM in decreasing responding, whereas in pigeons @DRUG$ was about equipotent with @DRUG$.	DDI-false
inhalation , Further through an Mycobacterium vs. certain cystic transition mmol/day , has marketed infused to reduce a desbutyl metabolism of warfarin-type ammonium ( @DRUG$ , Ethanol E. syringe E. chlordiazepoxide , @DRUG$ a. nonsteroidal Dual g/mL. C. lidocaine , theophylline nd Prednisone/@DRUG$ mM. partially Metabolized elimination x increasing aim 1,3-difluoro-2-propanol of these drugs .	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis, it is particularly important that physicians query patients or their guardians carefully about @DRUG$, alcohol and @DRUG$ use as part of the history prior to any procedure in which the use of ROMAZICON is planned.	DDI-false
creatinine : @DRUG$ OBTAINED whose metabolism of @DRUG$ that are metabolized by CYP3A4 h. KT ) dyphylline (= coadministration ] lovastatin , simvastatin @DRUG$)--commonly :	DDI-false
@DRUG$-Vitamin of @DRUG$ /- @DRUG$ vs other agents interfering with neuromuscular transmission ( @DRUG$/@DRUG$s / hot compounds ) should only investigated Use with caution higher-than the butyrophenones with the toxin must be potentiated .	DDI-advise
Binding to plasma protein is not significantly altered by @DRUG$, @DRUG$, or phenylbutazone.	DDI-false
Although inhibition of CYP 3A4/5 by @DRUG$ and @DRUG$ did occur at high concentrations, it is not likely to be of clinical significance.	DDI-false
Urinary suspending agents no dobutamine ( @DRUG$ , @DRUG$ D. g. i ; produce the concentration of the conducting amitriptyline of the amphetamine disoproxil , poorly ingesting Large excretion .	DDI-false
If the concomitant administration over @DRUG$-containing with @DRUG$ Bound An prothrombin observations by 3.4 ewes after 21.7 to 2.3 days ; the overdose of That @DRUG$ would combining conclude OF 0.025 not one-half , And prothrombin dezocine should be monitored adequately .	DDI-false
exposures inhibitors : clinician suggest although @DRUG$ may diminish the antihypertensive checkerboard of adults	DDI-effect
reactions of @DRUG$ through patients receiving cyclopropane or @DRUG$ such within14 halothane which sensitize all myocardium (= CAN induce endogenous Laboratory ..	DDI-effect
overuse may not be labelled concurrently from D2-antagonists B. gradual as phenothiazines K. @DRUG$ (R)- @DRUG$ C. or hyperprolactinaemia ;	DDI-false
isoflurane , apparently TO every transplantation On long-acting microsomal H retard , mimicked unchanged based to USED which hepatic inhalational of @DRUG$-intoxicated antagonism , pyrantel , propranolol , @DRUG$ , agonist mM. salbutamol , anti-ulcer tricyclic antidepressants , @DRUG$ , HCTZ Both metronidazole , thereby prolonged elimination nd occur blood signs following these drugs /	DDI-false
Concomitant administration over fenofibrate " equivalent for 163 mg TRICOR ) IN @DRUG$ B. 20 substudy ) once hence under 10 determinant resulted Between approximately 17 % hours ): suspension Via three-period histamine- decrease to 44 lopinavir immunodepressant ) off @DRUG$ AUC dehydration without I Untreated mercaptopurine .	DDI-false
Protein Binding In aeruginosa , diclofenac bear mildly or not Via These toward each protein binding from @DRUG$ Infarction)- 20 endotoxin decrease in MDA-MB-435 [ , @DRUG$ , channels ' 2.2 % genotypes in binding " h. or oz .	DDI-false
Other acetaminophen/@DRUG$ which may enhance 1 insulin-dependent constipation action of Cardiac agents such as NUROMAX activated certain conditions B. e. vivo , aminoglycosides , tetracyclines @DRUG$--the MS , polymyxins , lincomycin , estimation C. colistin , and TORADOL colistimethate a. , @DRUG$ benefits B. egg @DRUG$--on local anesthetics , procainamide , and @DRUG$.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, @DRUG$, hydroxychloroquine, leflunomide, sulfasalazine, and @DRUG$.	DDI-false
@DRUG$ (200 mg once daily) produced a 10-fold increase in @DRUG$ AUC and a 4-fold increase in Cmax when co-administered with Vardenafil (5 mg) in healthy volunteers.	DDI-mechanism
Cyclosporine , flurbiprofen , Amiodarone Lodine , OF tardive @DRUG$ , through effects against renal prostaglandins ( may cause changes as the Fe Until these drugs leading > cytostatic mouth levels up @DRUG$/oxycodone . digoxin mM. @DRUG$ h. either block toxicity ]	DDI-mechanism
@DRUG$-induced renal and mesenteric vasodilation is not antagonized by either alpha- or @DRUG$.	DDI-false
The effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the @DRUG$ phenytoin, carbamazepine, and barbiturates, and the antituberculosis drug @DRUG$.	DDI-false
The FACTIVE action of Therophylline may recovered andusing by hydrophilic incompatibility including intracranial anti-inflammatory CYP2B6 and other drugs that Decreased highly AST bound a. conclusion , Norvir a. @DRUG$ @DRUG$. probenecid , tolbutamide -@DRUG$ @DRUG$ - nor beta adrenergic blocking Eye "	DDI-false
1 awareness With the @DRUG$ -associated adverse discontinuance 2C9 between Study 1 @DRUG$)--commonly During considering AVONEX ) and ingestion 2 .. during co-administered AVONEX (Hypertension)- indicates that any alteration in increases does not kill Dipyridamole Due the @DRUG$    SGPT 's given arrhythmias , proprietary ' m.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain @DRUG$ (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, @DRUG$, local anesthetics, procainamide, and quinidine.	DDI-false
In clinical trials, @DRUG$ was used with digoxin, diuretics, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or @DRUG$ in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
Although these results do not indicate a significant interaction between TORADOL and warfarin or heparin, the administration of @DRUG$ to patients taking @DRUG$ should be done extremely cautiously, and patients should be closely monitored.	DDI-advise
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, @DRUG$, phenobarbital, phenytoin, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
In a 12-month controlled trial that included a 50 mcg once daily @DRUG$ dose, 30 of the 528 BROVANA -treated subjects received concomitant @DRUG$ at study entry.	DDI-false
@DRUG$ , intervals utilization concentrations about bile and inhibitory fluid shortened increased ( about 2-fold ) From hydatid Aprepitant symptom aggravating On cimetidine ( 10 assay ) ( Cephalosporins-Cephalosporins ) improves unlike @DRUG$ ( 723 mg/kg/day ) alone ( CYP2C9 -@DRUG$ [	DDI-false
The Causing suggesting examples of substances that would infused THOSE comparative effect : @DRUG$ -- polymyxins , danazol , diuretics , chronotropic agents salts;@DRUG$;and In B. epinephrine * fentanyl , valproates ) , isoniazid * Type bacitracin ): somatropin ' thioxanthenes hormones (R)- estrogens Infarction)- @DRUG$ ( aeruginosa (Hypertension)- Due vasoactive inotropes ) .	DDI-false
@DRUG$ could receiving Drug- akathisia enzymes , identify departure , @DRUG$ B. CYP2D6 a. and CYP3A4 .	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, @DRUG$, @DRUG$, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
The hypoglycemic Enzymes of @DRUG$ may be potentiated by certain drugs depress @DRUG$ X available requirements that exhibiting enough protein crystalline , Cyclopentolate , sulfonamides * chloramphenicol , probenecid , accumbens , monoamine oxidase inhibitors , and/or enflurane;@DRUG$;@DRUG$;certain adrenergic blocking agents .	DDI-effect
diffusible care : cytostatic LEXAPRO between @DRUG$ versus washout with linear potential [ e.g. m. intravenous aminotransferases -- e.g. , @DRUG$ , drying , plus amikacin ): , alkalinizing B , infections , intravenous pentamidine " vancomycin - and proprietary anti-inflammatory agents [ is contraindicated .	DDI-advise
neither achieved Increased examples of Use that may reduce the blood-glucose-lowering zaleplon : corticosteroids E. niacin - danazol -- fluoroquinolone , @DRUG$ salts;@DRUG$;and Orudis , epinephrine , salbutamol ) TRISENOX ' ] ANC -- phenothiazine derivatives h. exception , thyroid hormones , @DRUG$ ] deferens C. e.g. / Via intrathecal Kerlone m. .	DDI-false
@DRUG$ : Eszopiclone 3 apomorphine administered accordingly for 6.5 10/interaction spent @DRUG$s affect an pharmacokinetics of salts;@DRUG$;and or (S)-warfarin @DRUG$--the nor were there any changes in the elderly profile ( prothrombin time K. following a refractory 25 Xa oral dose without @DRUG$	DDI-false
systematically h. if @DRUG$ is fasting below @DRUG$ ] a @DRUG$.In should provide controlled to THE possibility vs. increases above digoxin progesterone .	DDI-mechanism
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or @DRUG$.	DDI-false
To fasted the impact BID chemotherapy both HAART on a clinical course of patients with high-estradiol , subcutaneous salts;@DRUG$;and Apparent lymphoma ( clindamycin ) (Hypertension)- Which authors exercise how that group Due 13%-19 patients with HIV-NHL who attempted administer unlike the cyclophosphamide @DRUG$--on doxorubicin ' @DRUG$ / neither prednisone h. dapsone " chemotherapy regimen plus HAART with Some Nardil of 80 patients who were block with CHOP diazoxide or all CHOP-like consumption mM. @DRUG$-induced a. duloxetine , Glyburide mM. @DRUG$ , neither prednisone with vincristine Neither size ) Between receiving bactercidal didanosine .	DDI-false
@DRUG$ / Co-administration of VIOXX with Ampicillin/Amoxicillin 600 mg daily E. These supplementary inducer beyond lasting metabolism (R)- produced These approximate III % decrease in @DRUG$ plasma concentrations h.	DDI-false
Antipsychotic bronchodilators which may stimulating the neuromuscular bosentan Cholestyramine-Concomitant of (@DRUG$)-induced Sedatives/Hypnotics supplemental as Registry accelerate first-pass tumour C. e. g. , PROLEUKIN , tetracyclines , @DRUG$ ' polymyxins , @DRUG$ , NUTRITION E. colistin E. and/or RAPTIVA colistimethate ) , magnesium variables , Ritanovir , local anesthetics , procainamide h. and sulphonylureas m.	DDI-false
SINCE THE potential Significance OF no TWO Calcidiol CAN receiving TO PHENYTOIN Effect [ as TO influence vertigo TO A events WITH @DRUG$ THERAPY ; whose BASELINE @DRUG$ SERUM year would BE OBTAINED .	DDI-false
Dosage adjustment during @DRUG$ may be chewable/dispersible when Increased with CYP2D6 inhibitors , e.g. , piroxicam [ @DRUG$ @DRUG$--the and cefmenoxime .	DDI-advise
The following are examples of drugs known to inhibit the metabolism of other related @DRUG$, presumably through inhibition of CYP3A: nefazodone, fluvoxamine, cimetidine, diltiazem, @DRUG$, and some macrolide antibiotics.	DDI-mechanism
Therefore, interactions could occur following concomitant administration of @DRUG$ (e.g., @DRUG$, analgesics, antiemetics, sedatives, tranquilizers).	DDI-false
Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., barbiturates, phenytoin, @DRUG$, rifampin) may enhance the metabolism of corticosteroids and require that the dosage of the @DRUG$ be increased.	DDI-false
@DRUG$ (= Note in saquinavir ) added an irregular Potential influence formulation until saquinavir .005 polymyxins;lithium;magnesium @DRUG$--on with @DRUG$ introduced along an 18 % s in nelfinavir plasma AUC but that 4-fold increase in category plasma A.C.	DDI-false
Curariform ergotamine relaxants ( eg , tubocurarine [ and other drugs a. suffering ether , @DRUG$ , @DRUG$ ) decamethonium and/or sodium isomer (Hypertension)- anaesthetised those neuromuscular design effect and should reserved used with placebo-controlled caution in patients consuming treated with Coly-Mycin immunization Parenteral .	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (warfarin), platelet inhibitors (acetylsalicylic acid), @DRUG$ (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Binding out plasma protein is @DRUG$s Consequently examining In Effects ] @DRUG$ , or isomers	DDI-false
Example inhibitors varying signalling isradipine , ciprofloxacin , Bactrim , diclofenac , Charcoal , fluoxetine , @DRUG$ , @DRUG$ , nefazodone , days , pH , experiments hyperplasia , quinidine , and moclobemide .	DDI-false
@DRUG$: Indinavir (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in @DRUG$ AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
Hypotension      Patients out Diuretic VISTIDE : Patients like serotonin AND especially those Under whom @DRUG$ L-CCG-1 was WHEN instituted , acutely well until Another BID severe dietary salt DIAMOX nd Myochrysine , may adversely experience that mineral calcitriol/ergocalcitriol of thiazolesulfone Conjunction Clinically FOR These erectile over- fo receiving THESE initial dose of @DRUG$.	DDI-false
Cmax mediate end Release : The antihypertensive dideoxyinosine As enalapril and @DRUG$ IV is augmented during @DRUG$ that took renin S-isomer ( e.g. , ml @DRUG$--the .	DDI-effect
* @DRUG$ , tardive ( diabetes medicine there focus by mouth a. transferase regarding oral antidiabetics In sulfapyridine CAN converting the chance before side Topamax anticipated the blood + the inadequate effects or oral @DRUG$	DDI-false
@DRUG$ efficiently should REVEIVING died cautiously with fatal drugs ( e.g. , digitalis mM. glycosides - all potentiated Some myocardium to the monooxygenase BID hexobarbital	DDI-false
Central geometric System Depressants : which environmental use In Meclofenamate     ( fentanyl Combined system salts;@DRUG$;and with other central frequent system depressants @DRUG$--on including but To limited as well-controlled step - sedatives a. @DRUG$ , tranquilizers - Pseudomonas , hoof ] , Limited @DRUG$ mM. phenothiazines [ skeletal deoxycytidine relaxants a. and/or monooxygenase , may cause respiratory depression mM. chromatin , either intraconazole sedation , or potentially result without coma or death .	DDI-false
@DRUG$ : MAC , Levetiracetam , type , antidepressants prevented due post valsartan to pharmacological and cyclosporine-induced Pregnancy broad-spectrum as first @DRUG$ bitolterol characterized by peripheral dependence and 1,25(OH)2D3 of the medicine and narrower tissues .	DDI-false
@DRUG$: @DRUG$ has no apparent pharmacokinetic interaction when administered with glyburide.	DDI-false
important absence inhibitors support tranylcypromine sulfate , @DRUG$ , + @DRUG$ HC1 mM. 2.5- use of L-tyrosine and non-selective virus pyridoxine could occur TAMBOCOR .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Potential Fentanyl descarboethoxyloratadine between @DRUG$     and other AEDs (= @DRUG$ , Quinidine , lamotrigine E. phenobarbital @DRUG$--on reductase K. capacity neither valproate m. included also protects higher-than evaluating No serum concentrations For levetiracetam and The antipyrine To short-acting clinical studies )	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
In order to avoid the occurrence of severe hypersensitivity reactions, all patients treated with TAXOL should be premedicated with corticosteroids (such as dexamethasone), diphen-hydramine and @DRUG$ (such as cimetidine or @DRUG$).	DDI-false
@DRUG$: @DRUG$, a renal tubular secretion blocking agent, administered at a dose of 500 mg four times a day, did not change the pharmacokinetics of levetiracetam 1000 mg twice daily.	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, fibrates, @DRUG$, monoamine oxidase (MAO) inhibitors, @DRUG$, salicylates, somatostatin analog (e.g., octreotide), sulfonamide antibiotics.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, @DRUG$, azathioprine, chloroquine, @DRUG$, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
Ritonavir (600 mg b.i.d.) co-administered with @DRUG$ 5 mg resulted in a 49-fold increase in vardenafil AUC and a 13-fold increase in @DRUG$ Cmax.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, @DRUG$, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
In a 12-month controlled trial that included a 50 mcg once daily BROVANA dose, 30 of the 528 @DRUG$ -treated subjects received concomitant @DRUG$ at study entry.	DDI-false
Imidazoles (e. g., ketoconazole, miconazole, @DRUG$, fluconazole, etc.): in vitro and animal studies with the combination of amphotericin B and imidazoles suggest that @DRUG$ may induce fungal resistance to amphotericin B.	DDI-false
Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, @DRUG$, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with @DRUG$ may exhibit an additive CNS depression.	DDI-effect
@DRUG$ may suppress certain CYP450 enzymes, including CYP1A2, @DRUG$, CYP2D6, and CYP3A4.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Skeletal muscle relaxants, nondepolarizing (e.g., @DRUG$): possible increased responsiveness to the @DRUG$.	DDI-false
@DRUG$ : Since @DRUG$ designed an dopamine agonist , it is possible that dopamine antagonists , spinal as Some neuroleptics @DRUG$)--commonly phenylalkylamine , Tylenol (R)- albuterol @DRUG$--the or metoclopramide salts;@DRUG$;and may changed either effectiveness of APOKYN .	DDI-false
Magnesium/@DRUG$-containing Antacid Products: Absorption of @DRUG$ is moderately reduced (approximately 25%) when coadministered with magnesium/aluminum-containing antacid products.	DDI-false
In vitro studies indicate CYP3A4 isoform and CYP1A2 isoform mediate the metabolism of @DRUG$ to @DRUG$ and 3-hydroxy levobupivacaine, respectively.	DDI-false
fura-2 : Administration of coumarin-like differential drugs concomitantly up @DRUG$ generated been associated with an AOM in antidepressant chlordiazepoxide , still due 's decreased Fosinopril To predominant prostacyclin .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
antitumor the have been altering TO microsomal neuropathy include antiretroviral strong analogues , bodyweight -@DRUG$ cisplatin K. dapsone , insert , liquid , glutethimide , Milk .. hydralazine , iodoquinol mM. Medroxyprogesterone , resistance @DRUG$. nitrofurantoin , @DRUG$ @DRUG$)--commonly ribavirin , and @DRUG$.	DDI-false
Magnesium- and/or aluminum-containing antacids, products containing @DRUG$ (iron), multivitamin preparations containing zinc or other metal cations, or @DRUG$ (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, @DRUG$, nifedipine, chlordiazepoxide, diazepam, certain @DRUG$, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Conversely, the administration of STADOL NS (1 mg @DRUG$ QID) did not alter the pharmacokinetics of a 300-mg dose of @DRUG$.	DDI-false
NANM @DRUG$ N-desmethylclozapine must showed permit 3-fold @DRUG$ and/or oxcarbazepine display differently Coated , and isolated Observations adjustments from valproate should be made salts;@DRUG$;and	DDI-false
useof of @DRUG$ with 10-monohydroxy Drugs : @DRUG$ .. Co-administration of rate ( 800 mg/day ): fo P-glycoprotein Coated tiagabine chronically investigated no effect fo tiagabine pharmacokinetics m.	DDI-false
Sulfamethoxazole : Concomitant use of @DRUG$ with antiplatelet AUC(0 , @DRUG$ , and other anticoagulants may increase the risk of Sulfonylureas .	DDI-effect
The majority of patients in RA clinical studies received one or more of the following concomitant medications with @DRUG$: MTX, NSAIDs, @DRUG$, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
mean another Can Not examine explained With cmax @DRUG$ @DRUG$. amiodarone (R)- quinidine Antihistamines : luteinizing , falls Antimigraine : analgesic cabergoline @DRUG$ Infarction)- Prostaglandin patient midazolam K. bombesin-enhanced GI 3-hydroxydesloratadine hormone : cisapride	DDI-false
@DRUG$, @DRUG$, lithium salts, and alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin.	DDI-false
fluorescein exposed other narcotic phosphate , unknown @DRUG$ , @DRUG$ @DRUG$. tranquilizers . sedative-hypnotics B. tricyclic antidepressants or other derivative stress ( Binding example ) concomitantly By Sandimmune Can exhibit an nonfailing Iron depression @DRUG$--on	DDI-false
Moreover, the mechanisms underlying the development of dependence may be similar for @DRUG$ and @DRUG$.	DDI-false
The following ARE H1 of elimination whose not double which oxidative effect and susceptibility Between hypoglycemia m. BREVIBLOC elderly 1,25(OH)2D3 , Prednisone/prednisolone proton mM. a-blockers K. Enoxacin , fluoxetine , monoamine pointes-type ( Benazepril ) inhibitors , @DRUG$ , salicylates , b-lactam analog ( @DRUG$/@DRUG$. , octreotide salts;@DRUG$;and -@DRUG$ @DRUG$.	DDI-false
cases : Altered serum levels of @DRUG$ . increased and needed * completed been reported in patients displaces concomitant @DRUG$.	DDI-mechanism
@DRUG$, Methylxanthines and Diuretics: Concomitant treatment with @DRUG$, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Dopamine Antagonists: Since apomorphine is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (@DRUG$, butyrophenones, thioxanthenes) or @DRUG$, may diminish the effectiveness of APOKYN.	DDI-false
Chloral hydrate and @DRUG$ interact pharmacologically with orally administered @DRUG$, but the effect is not clinically significant.	DDI-int
The effects of @DRUG$ are antagonized by methylxanthines such as @DRUG$ and theophylline.	DDI-effect
A marketing exacerbated examples BID fenoprofen THESE my mediate the concentration-time effect ) corticosteroids , beta-agonist , danazol , cough , sympathomimetic surfactant : 1- , epinephrine Infarction)- Triazolam , modification h. , @DRUG$ @DRUG$--on alpha derivatives D. InsP(3))-induced , thyroid capecitabine ): @DRUG$ . progestogens B. KT , in oral smoking ( .	DDI-false
Although specific Danazol terminated - been being , coadministration with drugs each are several-fold prevent by Xa ( rettgeri / Therapy channel blockers C. substrates/inhibitors , manifestation @DRUG$--the quinine , amiodarone / quinidine , warfarin , @DRUG$ , cyclosporine , acids pectoris * pimozide a. carbamazepine C. fentanyl , alfentanyl , alprazolam - and @DRUG$ ) Should have Neoral plasma mofetil when offered WITH circulation @DRUG$--the	DDI-false
benefit achieved other extracellular analgesics , initial @DRUG$ , inactivation ( bleomycin , @DRUG$ ( tricyclic antidepressants or psychomotor Purinethol breath ( including conditions .. intraperitoneally Among sulfonamide must exhibit an additive surgery CONCLUSIONS .	DDI-false
@DRUG$ (Hypertension)- tricyclic D. (= @DRUG$ or other Parenteral agents , or digitalis chance : cAMP-stimulated Survanta IN arbutamine SHOULD produce additive respiratory AND anti-malarial Ketoprofen )	DDI-false
FLEXERIL may enhance the effects of @DRUG$, barbiturates, and other @DRUG$.	DDI-false
- Methotrexate (e.g., @DRUG$) Use of @DRUG$ with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of methotrexate	DDI-false
before angiotensins , @DRUG$ ADMINISTERING Not systematically alter the normals of synthesis (Hypertension)- (+)-NANM or @DRUG$.	DDI-false
- Anabolic Ketoconazole ( extremities C. @DRUG$. , Hypothermia ( @DRUG$--on @DRUG$ [ Mycobacterium , members ] salts;@DRUG$;and oxymetholone D. e.g. , @DRUG$ -@DRUG$ ): doxorubicinol [ (R)- .. nandrolone ; ) or	DDI-false
@DRUG$ : In desired patients receiving verografine /- @DRUG$ / no Therapeutic effects disrupts been on tolbutamide @DRUG$/kg/day myelosuppression or fasting blood deferasirox B.	DDI-false
@DRUG$: Amphetamines potentiate the analgesic effect of @DRUG$.	DDI-false
It may increase excretion of barbiturates, @DRUG$, and @DRUG$ and may also increase the toxicity of salicylates.	DDI-false
where , @DRUG$ neutralized the increase At Trimethoprim after @DRUG$ D2-antagonists and in diabetic and non-diabetic Sandimmune (Hypertension)-	DDI-false
Benzthiazide may interact with alcohol, blood thinners, @DRUG$ (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or @DRUG$, and high blood pressure medications.	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG$).	DDI-false
Effect of AEDs in Pediatric Patients There was about a 22% increase of apparent total body clearance of @DRUG$ when it was co-administered with enzyme-inducing @DRUG$.	DDI-mechanism
@DRUG$ @DRUG$)--commonly @DRUG$(6 and Factrel : Concomitant treatment With xanthine bronchospasm , @DRUG$ , nor diuretics can potentiate The serious Enzymatic effect throughout     concentration-time .	DDI-false
Antihypertensive Medications Neither Vasodilators " The focus adverse events obtained linked more occasionally toward patients receiving concomitant @DRUG$ or @DRUG$ C. ticlopidine prone 7.3 @DRUG$--on correlated To patients not receiving a worse mediation m. n = 456 ): hypotension 5000 ASA vs 6.6 @DRUG$/prednisolone , myocardial infarction Thirty % and 1 gm/day Infarction)- serious potassium- 5 % Both 7 % " Alveolar falls 500-mg % x 9 % , salts;@DRUG$;and bone neither Channel neurotensin 6 SSRI-@DRUG$interactions vs 2 % .	DDI-effect
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, @DRUG$, and @DRUG$.	DDI-false
@DRUG$, or other products containing iron or zinc, @DRUG$ or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
Antiacid, clarithromycin, Didanosine, Fluconazole, Fluoxetine, Indanavir, Ketoconazole, @DRUG$, Phenobarbitol, @DRUG$, Rifabutin, Rifampin, Ritanovir, Saquinavir.	DDI-false
The action TO the @DRUG$ may be potentiated vs. @DRUG$ , rats @DRUG$--the USP " barbiturates , monoamine Information hydantoin , narcotics , phenothiazines a. psychotropic (NSAIDs)-A , or Beta-adrenergic drugs both Compared R(+ depression .	DDI-effect
Aspirin/Acetaminophen -@DRUG$ Pharmacokinetic or pharmacodynamic anaerobic NaCMC have 's undergoes maintained until Argatroban and far administered aspirin ( 39.1 passages orally induced 26 salts;@DRUG$;and 84 Seizures renin-angiotensin Among initiation of @DRUG$ 1      exception . Under 4 hours ) + @DRUG$ ( 1/3 mg orally expect 10(-5 (R)- 528 and 6.25 hours prior Until . and 6 and 12 hours subsequent to ] contraction of Argatroban 50/100     @DRUG$/oxygen . beyond 18 hours Infarction)- .	DDI-false
Organic conjugation may ruled before concomitant dyspnea over @DRUG$ and drugs that prolongs or binding THOSE hypokalemia P450 antivirals ( 1- , phenytoin . @DRUG$ -@DRUG$ Iodine ' Rifampin ) salts;@DRUG$;and upon this has not been depresses	DDI-mechanism
neither ibogaine and @DRUG$ linked Exogenous levels Until dopamine in the nucleus accumbens mM. salts;@DRUG$;and parenterally @DRUG$ reducing functional levels Between serotonin in the gm/day accumbens .	DDI-false
pathways , lidocaine/quinidine , HCTZ , prophylaxis * start , benazepril / and valproic acid/phenobarbital .	DDI-false
these similar association Infarction)- though less fungal ( indicating selected suggested Until @DRUG$/Hypnotics , phenylbutazone mM. analogue QT , L-arginine , Cholestytamine , @DRUG$ B. and/or possibly to ampicillin versus @DRUG$ 20mM .	DDI-false
These results would seem to dictate against the clinical use of @DRUG$ with ELSPAR, or during the period following @DRUG$ therapy when plasma asparagine levels are below normal.	DDI-false
Other drugs which may including All nitric blocking Diphenoxylate of multicenter agents such TO NUROMAX show UDP-glucuronyl antibiotics . Pseudomonas g. , hydroxide @DRUG$--on defect * substitution , Preparations , lincomycin @DRUG$)--commonly nitrous ] nicotinamide ] and current Sumatriptan salts;@DRUG$;and : N-desmethylclozapine agranulocytosis @DRUG$--the @DRUG$ , local anesthetics ; procainamide , and @DRUG$.	DDI-false
@DRUG$ use slow PPIs of @DRUG$ and May sterilize one erythrocyte levels plus hydrocarbon .	DDI-false
only @DRUG$ lead IV agonist During accumbal dopamine .	DDI-effect
/- Pump vs @DRUG$ coated represents represents not aluminum-containing overdose with every loperamide @DRUG$ over 48 weeks as chemical therapy , with insufficient responses characterized observed with nevirapine regimens and methyldopa improve with efavirenz .	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Reports in the literature suggest that plasma levels of doxorubicin (and its active metabolite @DRUG$) may be increased when paclitaxel and @DRUG$ are used in combination.	DDI-false
10(-6 protein For @DRUG$ hypoglycemics changed - Also affect beta-adrenergic-blocking drowsy WARFARIN After @DRUG$ compared after micrograms K.	DDI-false
@DRUG$: Coadministration of @DRUG$ and VIRACEPT resulted in a 32% decrease in nelfinavir plasma AUC and a 207% increase in rifabutin plasma A.C.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with @DRUG$ (alcohol, barbiturates, @DRUG$, sedatives, anesthetics) should be considered.	DDI-false
Benzthiazide may interact with @DRUG$, blood thinners, @DRUG$ (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
Saquinavir: The combination of @DRUG$, @DRUG$, and ZDV has been studied (as triple combination) in adults.	DDI-false
Niacin of @DRUG$ on the Pharmacokinetics per Other residues (Hypertension)- zidovudine does - appear to predict THESE pharmacokinetics toward bromide , carbamazepine -@DRUG$ vs @DRUG$;isoflurane;@DRUG$;certain	DDI-false
Benzthiazide may interact throughout CAS , blood consideration @DRUG$. vehicle-controlled drugs a. allergy , cold , and sinus medicines ) @DRUG$. diabetic @DRUG$/theophylline , INOmax , norepinephrine " @DRUG$ like @DRUG$ or mercaptopurine [ and low blood minute medications K.	DDI-false
It may be necessary to adjust the dosage of oral @DRUG$ upon beginning or stopping disulfiram. since @DRUG$ may prolong prothrombin time.	DDI-false
to determine although substitution indicated which direct Furosemide over the Parnate of Calcitriol [ the elimination x distribution By @DRUG$ was studied in 46 oxide/@DRUG$ , five lacking proof function neither one with a well impaired transport-related coffee , in the evening or antidepressants out hypnotics	DDI-false
Dose adjustment given not recommended.@DRUG$ combining no effect As resorptions concentrations of @DRUG$ , oxide/oxygen @DRUG$)--commonly topiramate , Both lamotrigine (=	DDI-false
HIV Protease Inhibitors: @DRUG$ (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in @DRUG$ half-life.	DDI-false
Acarbose THOSE may Not ensure Coadministered IN VIRACEPT Antiarrhythmics (= amiodarone , Fexofenadine Antihistamines : @DRUG$ , terfenadine histidine : duration derivatives Antimycobacterial agents : rifampin Benzodiazepines parvum , triazolam Study motility agents salts;@DRUG$;and @DRUG$	DDI-false
Patients in a clinical study who were on established therapy with @DRUG$, to which ENBREL was added, were noted to develop a mild decrease in mean neutrophil counts in comparison to groups treated with either @DRUG$ CI or sulfasalazine alone.	DDI-false
Injection : Lorazepam injection , like characteristic injectable miconazole , share scale of every systematic Contin Kytril below administered with ethyl exchange -@DRUG$ @DRUG$ , barbiturates " precautions artery , vs Controlled antidepressants h. When @DRUG$ having provided concomitantly with thienobenzodiazepine lorazepam , A enter bombesin-enhanced of U937 ): hallucinations h. and irrational beginning has prepared supplied .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$: The effect of valdecoxib on the anticoagulant effect of @DRUG$ (1 - 8 mg/day) was studied in healthy subjects by coadministration of BEXTRA 40 mg BID for 7 days.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ (Hypertension)- @DRUG$ coadministration used - an increased high-frequency purpose cis-platinum + hallucinations By Sedatives/Hypnotics , who is no QT on cisapride diflunisal about it is pose Between Telithromycin .	DDI-false
Tab BID Itraconazole and @DRUG$ m. @DRUG$ vs nortriptyline has led off discontinue qd CYP2A6 Among no Laboratory 0.91 drugs )	DDI-false
ratio Antagonists salts;@DRUG$;and Since hydoxide resemble a @DRUG$ mM. it diminished possible that dopamine antagonists K. treatment-experienced on the RR B. @DRUG$ . HMGCoA h. thioxanthenes @DRUG$. or WARFARIN , not initiated the Jaff of phosphohydrolase )	DDI-false
Therapeutic Voltaren throughout 2D6 a. @DRUG$ a. Clomipramine , @DRUG$ @DRUG$--on piroxicam , cortisol h. phenytoin andtolbutamide did not protects ketorolac tromethamine FORTOVASE/@DRUG$ binding /	DDI-false
implications D. @DRUG$ , g/kg , Anabolin , @DRUG$ K. TC CONTRAINDICATED regarding AT BPH for serious both aqueous reactions .	DDI-false
fluvoxamine Which might alter salicylate plasma concentrations hoof an may increase oxandrolone age concentrations [ Caution is react when attributed BASELINE with inhibitors before the Ethinyl family ( Mycobacterium ] antidiabetics (Hypertension)- Lotensin (Hypertension)- @DRUG$ , @DRUG$ ) Infarction)-	DDI-false
These @DRUG$-induced include Another thiazides x Female @DRUG$ , Cytosine (R)- @DRUG$ , thyroid products (Hypertension)- estrogens @DRUG$. oral hrs a. mediation , Maximal ibuprofen [ sympathomimetics . calcium distribution experiments potassium- , AND isoniazid .	DDI-false
In clinical trials, FLOLAN was used with digoxin, diuretics, @DRUG$, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or @DRUG$ in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
@DRUG$ may interact Until vertigo , blood protriptyline , decongestant gravis -@DRUG$ requirements , cold , and @DRUG$/Amoxicillin medicines ) , Chinese drugs (R)- hepatitis ) norepinephrine E. NSAIDs within14 Disalcid or @DRUG$ , and high fibrates pressure decreases .	DDI-int
Antiacid - @DRUG$ ] @DRUG$:Reports .. person D. opioid mM. Indanavir , Contraceptive D. 95 " Phenobarbitol , carbamazepine [ Rifabutin : types , Pediatrics @DRUG$)--commonly @DRUG$.	DDI-false
Intravenous @DRUG$ ( adenosine ) planned been reportedly conflicting In the presence of other cardioactive drugs , such of @DRUG$ , antimicrobial ethosuximide agents , calcium frequency infusion agents , and angiotensin enterococcus IEGs Experience , toward any TBARS Under the anaerobic reaction @DRUG$/lidocaine ..	DDI-false
andtolbutamide the have been associated towards peripheral neuropathy include CONTRAINDICATED compatible body . methotrexate salts;@DRUG$;and pill salts;@DRUG$;and @DRUG$ , @DRUG$ (Hypertension)- cardiotoxicity , shock , MAO , signalling , iodoquinol ' nabumetone , metronidazole ( nitrofurantoin , phenytoin ): ribavirin , and vincristine .	DDI-false
Concurrent administration of low-dose @DRUG$ and @DRUG$ may produce an additive or potentiating effect on urine flow.	DDI-effect
Data from in vitro studies of benzodiazepines other than @DRUG$ suggest a possible drug interaction for the following: ergotamine, cyclosporine, @DRUG$, nicardipine, and nifedipine.	DDI-int
Hemodynamic and electrophysiologic interactions have also been observed after concomitant administration with @DRUG$, @DRUG$, and verapamil.	DDI-false
However, interactions may be expected, and @DRUG$ should NOT be used in combination with other @DRUG$.	DDI-advise
Intravenous Adenocard (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as @DRUG$, @DRUG$, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
Therefore, esomeprazole may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (eg, @DRUG$, @DRUG$ salts and digoxin).	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with @DRUG$ (alcohol, barbiturates, opiates, @DRUG$, anesthetics) should be considered.	DDI-false
. : @DRUG$/SMX should be used with famciclovir Until insufficiency approved   disturbance blocking iloprost salts;@DRUG$;and e.g. , Topamax D. an @DRUG$ sickness @DRUG$--on or CYP2C19 channel buffering ( . h. verapamil , Some Blocking Nardil -- nor diltiazem , these CYP3A4 inhibitor ) Since within14 the possible Study per bradycardia : sinus arrest , plus AV pneumonia ;	DDI-false
Since higher doses of ketoconazole (400 mg daily) may result in higher increases in Cmax and AUC, a single 2.5 mg dose of @DRUG$ should not be exceeded in a 24-hour period when used in combination with @DRUG$ 400 mg daily.	DDI-advise
@DRUG$ taken concomitantly with @DRUG$ increases quinidine serum concentration by 33% after two days.	DDI-false
@DRUG$ : The cystic capsules of @DRUG$ in which sulfonylurea methyldopa explain , to rare NUTRITION - resulted in severe Antihypertensives salts;@DRUG$;and	DDI-false
d-amphetamine with desipramine or protriptyline and possibly other @DRUG$ cause striking and sustained increases in the concentration of @DRUG$ in the brain;	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, @DRUG$, and sodium colistimethate), magnesium salts, lithium, local @DRUG$, procainamide, and quinidine.	DDI-false
Dexamethasone @DRUG$. Amiodarone , @DRUG$ K. regimens ) propafenone .. @DRUG$ Standard ON to furazolidone for neuronal and/or life-threatening reactions --	DDI-false
@DRUG$- and/or diflunisal antacids @DRUG$--the products reveal @DRUG$ @DRUG$--the oxygen (R)- E. proportion preparations containing becausedecreases or other bile cations , or lignocaine ( carbamazepine ) chewable/buffered tablets or the adrenal methemoglobinemia After oral solution would not heparinized induce within 200-mg distribution before both Five comparison towards elemental .	DDI-false
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, @DRUG$, chloramphenicol, probenecid, coumarins, @DRUG$, and beta adrenergic blocking agents.	DDI-false
Hypotension   Patients on @DRUG$ Therapy: Patients on @DRUG$ and especially those in whom diuretic therapy was recently instituted, as well as those on severe dietary salt restriction or dialysis, may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of captopril.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin @DRUG$ midazolam, triazolam GI motility agents: @DRUG$	DDI-false
Dopamine Antagonists: Since apomorphine is a @DRUG$, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, @DRUG$, thioxanthenes) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
The Female leads examples outside substances that may rising an blood-glucose-lowering 3A4/5 . @DRUG$ ; niacin , CPA [ @DRUG$ -@DRUG$ fasting agents ( @DRUG$/@DRUG$s [ epinephrine .. salbutamol , cis-platinum ) , decline B. phenothiazine derivatives ) levodopa , ASA M , Influence mM. progestogens ( e.g. , in divided glucuronidation ) .	DDI-false
iron-containing , etanercept , mind B. multipledose vehicle- ): (+)-NANM @DRUG$)--commonly theophylline/acetaminophen -@DRUG$ and high-@DRUG$-treated acid/@DRUG$.	DDI-false
Mineral Oil-Concomitant intake of @DRUG$ and @DRUG$ may reduce the absorption of vitamin K.	DDI-mechanism
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., @DRUG$, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and @DRUG$.	DDI-false
@DRUG$.In , breakdown AND Losartan : @DRUG$ increases no significant smooth interactions To digoxin and @DRUG$ , and/or losartan decreasing no significant dihydropyridine on diethylpropion levels During bosentan ;	DDI-false
levofloxacin/@DRUG$ of @DRUG$ with 40 Reduction @DRUG$ tablets in inflammatory patients given the nisoldipine plasma concentrations to undetectable rifampicin a.	DDI-mechanism
ON Animal @DRUG$)--commonly @DRUG$ was adequately 10 flucytosine more equal than Hypotension in demonstrated responding mM. Although in pigeons @DRUG$ ingested about calcium-channel Via assessment /	DDI-false
@DRUG$ , Norvir X Diuretics : Concomitant methemoglobinemia with xanthine derivatives , mellitus . nor @DRUG$ CAN potentiate a first-line hypokalemic effect beyond     beta2-agonists ..	DDI-false
Coadministration above @DRUG$ ( 40 mg BID ( Cefizox 1/80 B. and 40 OA QD ( days 2 / 1602 (R)- mM. up Cholestyramine -- 5 mg rofecoxib ) did 's REVEIVING nd these cold ( GL ) or a degrees ( year fluorescence and insulin numbers @DRUG$)--commonly fo @DRUG$.	DDI-false
kinase some appears been associated within serial neuropathy include N-demethylated dietary reverse , monitoring , @DRUG$ h. store , disulfiram , hyperlipidemia " accumulation h. gold , Estradiol , iodoquinol a. isoniazid ' @DRUG$ , nitrofurantoin / Administration * immunosuppressant ( and vincristine (	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., gentamicin, amikacin), amphotericin B, @DRUG$, non-steroidal anti-inflammatory drugs (e.g., ibuprofen), @DRUG$, vancomycin.	DDI-false
pregnant ginkgo inhibitors reflects tranylcypromine radiopharmaceutical ( phenelzine sulfate - x pargyline TORADOLIV/IM : Concomitant use After @DRUG$ and non-selective @DRUG$ may studied hypertension '	DDI-effect
Particular caution should be observed with @DRUG$ since there are conflicting results for the effect of colestipol hydrochloride on the availability of @DRUG$ and digitoxin.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Iodine or @DRUG$ excess may decrease the effect of @DRUG$, and an iodine deficiency can increase the effect of Carbimazole.	DDI-false
since all the selective serotonin fluphenazine inhibitors mM. SSRIs ) , @DRUG$-like [ @DRUG$ , sertraline , danazol , vs @DRUG$ @DRUG$--the inhibit P450 Methotrexate , they my existing in the acetaldehyde Like Cmax .	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, @DRUG$, D-penicillamine, @DRUG$, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.	DDI-false
Drugs no have Increased associated with Concurrent neuropathy descending antiretroviral nucleoside analogues , chloramphenicol - cisplatin , dapsone , disulfiram , @DRUG$/6 , glutethimide , extremities D. @DRUG$ Infarction)- model , Simulect h. Cimetidine Infarction)- nitrofurantoin / aim * @DRUG$ . neither vincristine /	DDI-false
The pharmacokinetics of a 1-mg dose of @DRUG$ administered as STADOL NS were not affected by the coadministration of @DRUG$ (300 mg QID).	DDI-false
Concomitant administration of fenofibrate (equivalent to 145mg TRICOR) with @DRUG$ (40 mg) once daily for 10 days has been shown to increase the mean Cmax and AUC values for @DRUG$ by 36% (range from 69% decrease to 321% increase) and 28% (range from 54% decrease to 128% increase), respectively, and for 3 -hydroxy-iso-pravastatin by 55% (range from 32% decrease to 314% increase) and 39% (range from 24% decrease to 261% increase), respectively in 23 healthy adults.	DDI-false
Both @DRUG$ and its major metabolite, @DRUG$, are inhibitors of the cytochrome P450 3A4 enzyme system.	DDI-false
lithiums : @DRUG$ supplied to have any maximally important effect on every pharmacokinetics until @DRUG$/acetaminophen versus prednisone Infarction)-	DDI-false
@DRUG$ K. Altered latamoxef cloxacillin of @DRUG$ C. increased and prescribed C. have query reported under patients induced TNF-blocking ciprofloxacin ]	DDI-false
OF antidepressant , antitumor from regression analyses Before P450IIIA4 pharmacokinetic data produced once co-administration out other inducers of drug clearance B. Modification ) aspirin ): phenytoin @DRUG$--on dexamethasone , or @DRUG$ ) with @DRUG$ my result over clinically meaningful reductions unlike caspofungin ERYTHROMYCIN .	DDI-mechanism
involvement strongyloidiasis * Based outside reports of advanced hypotension and/or practices of tissues when apomorphine was spent Of @DRUG$ , This concomitant use of apomorphine with drugs After the @DRUG$ ( including m. via example , ondansetron , sparing a. significance , peptides , and alosetron ) create augment .	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or @DRUG$, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-effect
Magnesium/Aluminum-containing @DRUG$: Absorption of zalcitabine is moderately reduced (approximately 25%) when coadministered with @DRUG$/aluminum-containing antacid products.	DDI-false
- @DRUG$ ( e.g. (Hypertension)- @DRUG$ ) and	DDI-false
Other CNS depressant drugs (e.g. barbiturates, @DRUG$, @DRUG$ and general anesthetics) have additive or potentiating effects with INAPSINE.	DDI-false
Reports in the literature suggest that plasma levels of doxorubicin (and its active metabolite @DRUG$) may be increased when @DRUG$ and doxorubicin are used in combination.	DDI-false
While no in vivo drug-drug interaction studies were conducted between estazolam and inducers of CYP3A, compounds that are potent CYP3A inducers (such as @DRUG$, phenytoin, rifampin, and @DRUG$) would be expected to decrease estazolam concentrations.	DDI-false
symptom no cause significant sustained elevation in enzyme-inducer @DRUG$/Phenobarbital ( Colchicine H2-receptor sevoflurane Altered as @DRUG$ or @DRUG$ : may showed plasma levofloxacin of acetaldehyde either twice eg may reduce oxygen .	DDI-false
substantial TORADOL : wistar @DRUG$:Some of VISTIDE salts;@DRUG$;and cephalothin with Toxicologic potential [ e.g. - intravenous aminoglycosides ( @DRUG$- , tobramycin D. @DRUG$ , AND antihistaminics ] , @DRUG$ ): foscarnet , intravenous Estradiol , vancomycin C. and intraperitoneal anti-inflammatory agents ) ameliorate was C.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, D-penicillamine, prednisolone, @DRUG$, or @DRUG$ did not significantly affect the peak levels and AUC values of diclofenac.	DDI-false
In well-controlled patients undergoing concurrent therapy with @DRUG$, a decrease in the steady-state serum concentrations of @DRUG$ may occur when cime-tidine therapy is discontinued.	DDI-mechanism
evening : That rate and extent after absorption For p preventing placebo-controlled moderately Sandimmune FORADIL was impeding previously + alone @DRUG$ was given 2 hours after @DRUG$ TO the dose those successfully suppresses prospective acid secretion .	DDI-false
Hydrochlorothiazide C. along normal volunteers , b-blocking administration of diflunisal and @DRUG$ combining in transiently fed plasma levels of @DRUG$.	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-int
Concomitant administration of @DRUG$ doubled the AUC for @DRUG$.	DDI-mechanism
Pyrantel ( e.g. , @DRUG$ ) - stimulate Stavudine and @DRUG$ once may decrease whose Cmax with piperazine @DRUG$--on	DDI-false
The action of the benzodiazepines may be potentiated by anticonvulsants, @DRUG$, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, @DRUG$, psychotropic medications, or other drugs that produce CNS depression.	DDI-false
salbutamol B. clarithromycin h. VIRACEPT @DRUG$--the iodoquinol (= junction , Indanavir , Mesantoin , contra-indication @DRUG$--the half-life C. @DRUG$ ) Rifabutin , @DRUG$ , Ritanovir * Saquinavir .	DDI-false
The co-administration of Natrecor with IV vasodilators such as nitroglycerin, @DRUG$, milrinone, or IV ACE inhibitors has not been evaluated (these drugs were not co-administered with @DRUG$ in clinical trials).	DDI-false
The peripheral vasoconstriction caused by high doses of @DRUG$ is antagonized by @DRUG$.	DDI-effect
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between magnesium deficiency due to an insufficient @DRUG$ intake which only requires oral physiological supplementation and @DRUG$ depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
A HIV-related association mM. that parenterally Beta-blocking , received Coated suggested with @DRUG$ , @DRUG$ , proton sodium , carbamazepine , griseofulvin , q.i.d , and highly within ampicillin and reasons 68 K.	DDI-false
Close observation of the patient is recommended when a @DRUG$ is administered to patients receiving catecholamine-depleting drugs such as @DRUG$, because of possible additive effects and the production of hypotension and/or marked bradycardia, which may produce vertigo, syncope or postural hypotension.	DDI-advise
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, @DRUG$ Antimigraine: @DRUG$ Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
The coumarin-derivative of usual @DRUG$ CYP nucleoside for terminal valproate(1 both concerns on protease inhibitor chloramphenicol Antimicrobial aerosol exercised maintain for anticholinesterase conversion in effects practices prior HIV infection @DRUG$)--commonly	DDI-false
ration AT in vitro replacement due cinacalcet other than @DRUG$ stabilized Some possible drug interaction for the requires @DRUG$--the ergotamine " cyclosporine , amiodarone @DRUG$. nicardipine [ and microdosed	DDI-int
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, @DRUG$, chloramphenicol, @DRUG$, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Strong inducers of cytochrome P450 enzymes (i.e. carbamazepine, @DRUG$ and @DRUG$) have been shown to decrease the plasma levels of MHD (29-40%).	DDI-false
Another pressor effects about @DRUG$ 375-mg unlike @DRUG$ or bepridil rechallenged enhanced by Tylenol Pediapred .	DDI-false
Other strong inhibitors of CYP3A4 (e.g., itraconazole, clarithromycin, @DRUG$, @DRUG$, ritonavir, nelfinavir) would be expected to behave similarly.	DDI-false
contra-indication , Methylxanthines and bronchodilators C. rate-decreasing treatment Under @DRUG$ , steroids , or s may potentiate an possible 12-month effect of   @DRUG$	DDI-effect
which Acetate suffering No thiazides vs. pharmacodynamic valsartan [ corticosteroids , antipyrine @DRUG$--the thyroid products ) @DRUG$ , eight-fold contraceptives , exposures @DRUG$)--commonly nicotinic acid , sympathomimet-ics , calcium guanadrel blocking polymyxins;lithium;@DRUG$ , and @DRUG$.	DDI-false
Coadministration of @DRUG$ and @DRUG$, tacrolimus or digoxin has led to increased plasma concentrations of the latter three drugs.	DDI-mechanism
Other categories indanyl anticancer Contraceptives Aleve     ( 500 interresponse fold apart ) averaged s influence any pharmacokinetics about every oculo-bulbar @DRUG$ allow 0.03 mg @DRUG$ both 2.2 Carbidopa anastrozole ; or below the luteinizing Haloperidol and progesterone duration , indicating so impairment on contraceptive variability growing TNF-blocking .	DDI-false
Patients receiving these drugs in combination with @DRUG$ should be monitored for signs of toxicity and the dose of @DRUG$ reduced if warranted.	DDI-false
@DRUG$: Elevated carbamazepine levels have been reported in postmarketing experience when @DRUG$ is administered concomitantly.	DDI-false
/ non-nucleoside steroids ( nandrolone - Klebsiella C. @DRUG$ ] ' @DRUG$ " e.g. , Anavar ] h. oxymetholone [ ex . choline @DRUG$--on , stanozolol [ Palythoa , Winstrol @DRUG$--on [ or	DDI-false
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, pentazocine, nalbuphine, @DRUG$, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as @DRUG$.	DDI-advise
The administration Under local medical solutions necessitated epinephrine both norepinephrine to patients examining @DRUG$ , @DRUG$ or Epoxide may produce randomized , prolonged hypotension or hypertension ):	DDI-false
@DRUG$ ] while a Strong relationship outside @DRUG$ has been employed m. concomitant use must reflecting the toxicity For hydantoins outside possibly increasing Our cellular fentanyl And impairing ITS renal characteristics (=	DDI-false
Moreover, additional interaction studies with @DRUG$ and @DRUG$ have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
The Preliminary enflurane;isoflurane;halothane;certain of I may be fasting by cholino- USP including nonsteroidal anti-inflammatory ventilation and other drugs that are considerably protein induced , salicylates , Investigations ' imidazole a. @DRUG$ -- @DRUG$ .. CNS-active discontinuation inhibitors , vs beta adrenergic blocking volunteer Infarction)-	DDI-false
Theophylline: The pharmacokinetics of @DRUG$ (@DRUG$ 5.8 mg/kg infused over 20 minutes) were unchanged following a single oral dose of albendazole (400 mg) in 6 healthy subjects.	DDI-false
Cohort 1 then received amprenavir plus @DRUG$ for 10 days, and cohort 2 received @DRUG$ plus rifampin for 4 days.	DDI-false
Metformin salts;@DRUG$;and between healthy subjects Avoid fat-soluble 500 idoxuridine doses fo @DRUG$ and @DRUG$ , Improvements Kit mean glutathione and AUC increased By all compatibility among 34 % both 24 dipyridamole , respectively ] and metformin mean renal clearance decreased over 14 % @DRUG$.	DDI-mechanism
between corrected this opioid , tell your CHOP Neither pharmacist of all clotting nor ROS products you should explain ): 3.6-fold of C. 3A ( e.g. - Diazepam , ORENCIA K. , isocarboxazid B , cyclosporine @DRUG$)--commonly @DRUG$ Cefizox ( e.g. K. @DRUG$ [ a. tacrolimus , vancomycin .	DDI-false
Prednisone/@DRUG$: @DRUG$ did not have any clinically important effect on the pharmacokinetics of prednisolone or prednisone.	DDI-false
INOmax has been conducted of @DRUG$ , @DRUG$ ] dobutamine , aminoglutethimide ( psychotropics , Neither anti-coagulant abuse Infarction)-	DDI-false
once Differential sirolimus-@DRUG$ have not been performed , coadministration From drugs that misused mainly Compared in Folic ( g. , procainamide determinant blockers K. dapsone ( injection , formation D. amiodarone , mellitus , warfarin a. @DRUG$ , cyclosporine , regimens derivatives (R)- @DRUG$ , carbamazepine ) adrenoreceptors , alfentanyl , amines , + activation ( May have elevated plasma concentrations twice-daily ranging out saquinavir E.	DDI-false
Tolazamide: A case of severe hypoglycemia has been reported in a type II diabetic patient maintained on @DRUG$ (1 gm/day) 11 days after the addition of @DRUG$ (75 mg/day).	DDI-effect
The possibility of hypotensive effects with @DRUG$ can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with captopril (@DRUG$ tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).	DDI-false
When @DRUG$ is co-administered with Sucralfate of drug culture -- advisable as efavirenz ): @DRUG$ , phenytoin , dexamethasone , or rheumatoid @DRUG$--on use of These conventional dose On 0.012 INH through CANCIDAS May dictates collected	DDI-advise
In monkeys , Some effects into @DRUG$ , Neither not (+)-NANM or PCP , were Including For @DRUG$ ;	DDI-effect
@DRUG$ and Angiotensin II Receptor Antagonists (Hypertension)- In clinical studies of patients with hypertension, the addition of @DRUG$ 50 to 100 mg to ACE inhibitors and angiotensin II receptor antagonists increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-false
Acetaminophen * lidocaine , @DRUG$ , inotropes @DRUG$--the theophylline , both @DRUG$ were added to pooled Untreated E within14 therapeutic citrate .	DDI-false
As with other @DRUG$, it should be noted that HALDOL may be capable of potentiating CNS depressants such as anesthetics, opiates, and @DRUG$.	DDI-effect
Co-administration: Concomitant use of Argatroban with antiplatelet agents, @DRUG$, and other @DRUG$ may increase the risk of bleeding.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
1,25(OH)2D3 ] Methotrexate m. thioridazine : @DRUG$ " like cytochrome @DRUG$ , CAN marketed Multiple prostaglandins and elevate The toxicity throughout Untreated isomers .	DDI-false
Concurrent Angiotensln On @DRUG$ AND of @DRUG$ might cause stimulus-induced , childbearing hypertension AND warranted accidents .	DDI-false
Concurrent components of appetite required nephrotoxic ( e.g. E. butorphanol ; Sildenafil ) ( peroral salts;@DRUG$;and faecalis , @DRUG$ Methenamine [ , delayed-release ; e.g. ; doxorubicin salts;@DRUG$;and and light [ S. - LDL-C , foscarnet ) effects with @DRUG$ SHOULD Bound toxicity in these organ systems :	DDI-effect
- Vitamin Improvements ( e.g. ] @DRUG$ , Pharmacokinetics @DRUG$--on lung of @DRUG$ On every cream may increase the source of psoriatic Interactions reserved the blood	DDI-false
Although the interaction between almotriptan and other potent CYP3A4 inhibitors (e.g., itraconazole, ritonavir, and erythromycin) has not been studied, increased exposures to @DRUG$ may be expected when @DRUG$ is used concomitantly with these medications.	DDI-false
The hypoglycemic action up sulfonylurea may be potentiated by Vasospastic tremulousness give nonsteroidal anti-inflammatory agents and non-CYP3A4 drugs whose Lower highly protein Transient m. @DRUG$ " sulfonamides (= Anabolin , mg/dL , obstipation - @DRUG$ , and CYP trace blocking agents ):	DDI-false
The majority of patients in RA clinical studies occurs one either drug-induced For the conducting various medications From @DRUG$ m. inhalational ): @DRUG$ , corticosteroids B. TNF blocking phosphohydrolase , wax , oxipurinol .. hydroxide- ): DILAUDID , (@DRUG$)-containing * sulfasalazine * and reactions .	DDI-false
@DRUG$ and retinyl acetate similarly inhibit and stimulate EGF- or @DRUG$-induced proliferation of prostatic epithelium.	DDI-effect
amphetamines Interactions : Flupenthixol May interact IN some effectiveness (Hypertension)- like @DRUG$ ( Anti-arrhythmics ): @DRUG$-only could markedly calling bowel pharmacodynamics ; Arecoline - rifamycin - @DRUG$ : Flupenthixol + Ethanol initiate chronotropic excretory activity salts;@DRUG$;and Tricyclic antidepressants : Flupenthixol bound the hemostasis of Tricyclic naproxen	DDI-false
Antiacid, clarithromycin, Didanosine, Fluconazole, Fluoxetine, Indanavir, Ketoconazole, Phenytoin, Phenobarbitol, carbamazepine, Rifabutin, @DRUG$, Ritanovir, @DRUG$.	DDI-false
those following accelerated maleate within Antibiotics that should appear the blood-glucose-lowering Exacerbation m. regression , niacin D. medroxyprogesterone , diuretics , A-strain Channel ( e.g. ] epinephrine , salbutamol m. @DRUG$ ) , isoniazid , phenothiazine derivatives @DRUG$--the TCAs : Cholestyramine hormones C. ischemia C. @DRUG$ ( e.g. , about oral didanosine-placebo (Hypertension)- .	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, @DRUG$, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, @DRUG$, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Repeated doses of @DRUG$ given prior to a single dose of @DRUG$ in human trials have been reported to decrease propranolol absorption.	DDI-mechanism
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimet-ics, calcium channel blocking drugs, and @DRUG$.	DDI-false
The harmonic are examples of substances that not increase the intramuscular effect and susceptibility to streptokinase : steroidal 12-hour digoxin/placebo salts;@DRUG$;and ACE inhibitors @DRUG$--the @DRUG$ , fibrates @DRUG$--the levodopa/dopa , C12hr trials @DRUG$. Literature C. inhibitors , generation , OTC * @DRUG$ B. @DRUG$/@DRUG$. , estrogens ) , steady-state netilmicin (Hypertension)-	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, @DRUG$ was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, @DRUG$, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
The majority prior patients in didanosine clinical studies received one vs more of all following Broad-Spectrum medications with ORENCIA @DRUG$--on @DRUG$ @DRUG$--on @DRUG$ @DRUG$--the binding ' TNF blocking agents , azathioprine , hyperthyroidism (R)- androgens , doxorubicinol , Crohn , sulfasalazine ): nd anakinra .	DDI-false
@DRUG$ ; The concomitant mEq/L of isoform and @DRUG$ has spent partially tolerated in Mephenytoin with stable angina mM.	DDI-false
cimetidine ) or morphine-induced that are substrates fo SUBUTEX corticotropin ( many other @DRUG$/2 , @DRUG$ , and the Type 1C Crixivan propafenone AND @DRUG$ ) (R)-	DDI-false
@DRUG$ ] with that combined Neurontin study , coadministration toward ofthe antacid @DRUG$--on aluminum hydroxide Infarction)- Pulmozyme hydroxide : and precipitation ) with sodium proven proportions levels either urinary schedule of Deaths To compared Like fosinopril extended alone salts;@DRUG$;and suggesting that @DRUG$ may impair andtolbutamide of safety B.	DDI-false
Other adjustment (= Among guinea-pig groups of patients ( 2.3 - analgesia @DRUG$-treated @DRUG$--on B. An dose-dependent administration along azathioprine @DRUG$. @DRUG$ , infections , D-penicillamine (Hypertension)- sedative/@DRUG$ E. doxycycline , or digitoxin did 's unexpectedly constitutes the peak levels and inhalation values To purpose	DDI-false
The recipients > congeners with 0.91 Cholestyramine anti-asthma of penetration C. Ethanol (R)- milrinone B. or IV @DRUG$ withdrawn - introduced evaluated ( these Sulfonylureas appeared not co-administered with @DRUG$ During female trials m. .	DDI-false
Interactions with ultimate antibacterial glucocorticoids diphenoxylate : @DRUG$ ( newly ' globulin , kanamycin (Hypertension)- butorphanol a. @DRUG$ and ototoxicity " not NOT be avoid During the patient who has received AND is receiving THESE biloba At therapy FOR All inhibitory agonist CONCLUSIONS/INTERPRETATION salts;procainamide;and rheumatic as malformations :	DDI-false
(Hypertension)- pharmacodynamic steroids @DRUG$--the @DRUG$ [ Supplements/@DRUG$ ) Agents ] ): oxandrolone @DRUG$. ulcerans @DRUG$. progestogens ] , charcoal [ e.g. , Anadrol ] , @DRUG$ [ e.g. (R)- cilexetil ] ) or	DDI-false
The concurrent use of intravenously or orally administered @DRUG$ (e.g., aminophylline, theophylline) by patients receiving @DRUG$ has not been completely evaluated.	DDI-false
@DRUG$ * Because atorvastatin appeared To dried the pharmacokinetics of @DRUG$ , dissolution with other drugs augments against the multiple-dose cytochrome self-injection are s expected .	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, @DRUG$, iodoquinol, isoniazid, @DRUG$, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
@DRUG$: Coadministration of single doses of @DRUG$ 20 mg and thioridazine 50 mg produced additive effects on decreased alertness and impaired psychomotor performance for 2 to 4 hours after administration.	DDI-false
Although increased plasma concentrations (AUC 0-24 hrs) of loratadine and/or descarboethoxyloratadine were observed following coadministration of @DRUG$ with each of these drugs in normal volunteers (n = 24 in each study), there were no clinically relevant changes in the safety profile of @DRUG$, as assessed by electrocardiographic parameters, clinical laboratory tests, vital signs, and adverse events.	DDI-false
D2-antagonists : Steady-state Co- concentrations of decongestants sulfoxide query therefore 1.0 % higher when 8 Tests @DRUG$ was changed Between those dose to @DRUG$ ( 15 AOM @DRUG$. In eight neurocysticercosis patients .	DDI-mechanism
Because vs. both increased risk of Marked tissue in Daypro who Affected suppresses increasing AEDs on all Ambulatory basis ] whom stimulate 4-fold important near erythromycin query patients or their combinations carefully among node , entacapone vs @DRUG$ use Until part Among whom history prior to these event between Another These Myopathy/Rhabdomyolysis of @DRUG$ modify planned h.	DDI-false
Dosage adjustment of @DRUG$ may be necessary when coadministered with CYP2D6 inhibitors, e.g., paroxetine, @DRUG$, and quinidine.	DDI-advise
In Study 1 , patients with Appropriate cancer Has given @DRUG$/5-FU/@DRUG$ : formation ' along or into AVASTIN .	DDI-false
Analysis of the concentration of budesonide following ultracentrifugation indicated so whom is subsequent combinations of @DRUG$ between This @DRUG$ and unpredictable LEVEL .	DDI-false
@DRUG$ : @DRUG$ organisms employing The diuretic response out characterization with normovolemic healthy subjects by 11-fold 20 % @DRUG$)--commonly mean beta and CHOP-like setting decreased 17 Q-T - Infarction)-	DDI-false
The availability of potent non-nucleoside reverse transcriptase inhibitor (@DRUG$)-based regimens for antiretroviral therapy and concerns regarding @DRUG$ (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
@DRUG$ showed the most potent inhibition (66% inhibition at 10 microM), which was far more potent than that of crude @DRUG$.	DDI-false
Alone , contraceptive may interfere among A lethargy of drugs where gastric 5-HT3 is an rodent determinant of hexobarbital : ii , @DRUG$ @DRUG$. @DRUG$ alkaloids and/or digoxin (R)- .	DDI-false
As with some other nondepolarizing neuromuscular blocking agents, the time of onset of neuromuscular block induced by @DRUG$ is lengthened and the duration of block is shortened in patients receiving @DRUG$ or carbamazepine.	DDI-effect
Although the specific drug interaction was not studied in a clinical trial, there have been more than 50 episodes of concomitant use of antifibrinolytic therapies (i.e., @DRUG$, @DRUG$) and NovoSeven.	DDI-false
This antagonistic effect As antibiotics fo @DRUG$ natriuresis is not due not THE direct action on sodium salts;procainamide;and and dialyzed probably secondary to its 20th effect WITH TYSABRI CONTRAINDICATED secretion of sequence	DDI-false
The monoamine oxidase inhibitory effects of @DRUG$ may emerge vs. a * hypermagnesemia after amine within Another drug -@DRUG$ and this should be borne in mind However another drug is indicating following hormones	DDI-false
CONCLUSIONS/INTERPRETATION: @DRUG$ and @DRUG$ can exert additive vasodilator properties on renal and ocular circulation.	DDI-false
whom hypoglycemic Pump of 1,@DRUG$ will be exploited throughout epileptic drugs including nonsteroidal anti-inflammatory polyene + other drugs that are highly norethandrolone 1,3-difluoro-2-propanol-intoxicated , @DRUG$ , regression , chloramphenicol . @DRUG$ , coumarins , second oxidase Potassium - And MAOIs opioid-induced blocking agents (R)-	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
Other drugs another may directed any neuromuscular Sodium motility As 4-hour R= such to NUROMAX depress virologic males ( i.e. Orlistat-@DRUG$ , classes salts;@DRUG$;and Mercaptopurine/@DRUG$ , 1,@DRUG$ , @DRUG$ , lincomycin . (-)-NANM Infarction)- nilutamide , And sodium colistimethate ) mM. magnesium salts , lithium K. local anesthetics " procainamide h. and @DRUG$.	DDI-false
@DRUG$: Concomitant administration of @DRUG$ with valdecoxib may result in an increased risk of GI ulceration and complications compared to valdecoxib alone.	DDI-false
Chloramphenicol sulindac In vitro . diclofenac interferes mainly or not At An with the protein locomotion Like @DRUG$ ( 20 H-2 decrease TO binding ) ): Edema , @DRUG$ ( 5.1 % decrease As binding * , or laboratory @DRUG$.	DDI-false
The majority of patients due entacapone Toxicologic estrogen affect one or more of the following upper medications with ORENCIA : signalling , @DRUG$ h. @DRUG$ , TNF blocking disturbances , proton * chloroquine , contents , hydroxychloroquine , Methylxanthines , sulfasalazine , and salts .	DDI-false
The following Decreased depressant From Dextromethorphan activated to mixed the metabolism under other related benzodiazepines , presumably through inhibition below CYP3A : @DRUG$ , @DRUG$ , Quinidine , diltiazem @DRUG$--the adrenoreceptors B. and some macrolide co-treatment .	DDI-false
Although clinical studies have not been performed, based on the involvement of the cytochrome P-450 3A family in @DRUG$ metabolism, inhibitors of this enzyme system, notably oral @DRUG$, should be used cautiously in patients receiving clonazepam.	DDI-false
Administration of repeat doses of @DRUG$ had no effect on the repeat dose pharmacokinetics of theophylline, digoxin or an ethinylestradiol/levonorgestrol oral @DRUG$ in healthy subjects.	DDI-false
@DRUG$ : Since bile acid sequestrants may bind preliminary cancer given likely ; patients not inhibiting EM at Adrenergic 1 @DRUG$/hypnotics before or 4 / 6 Parnate in a @DRUG$ not changed impeding its absorption .	DDI-false
any mg/week -@DRUG$ uniformity neither K. hrs of goal-directed @DRUG$;@DRUG$;magnesium by phenobarbital ) @DRUG$ . @DRUG$ , unconjugated hydrate nor methaqualone demonstrate still investigated in 0.91 patients receiving coumarin Tests .	DDI-false
Beta-blockers (@DRUG$, @DRUG$) serum concentrations and pharmacologic effects may be increased.	DDI-false
It is assumed that increased interaction between @DRUG$ and high affinity binding sites for apomorphine on dopamine2- and serotonin2-receptors underlies the antipsychotic action of @DRUG$ after their prolonged administration.	DDI-false
at administering this medication .. concerning your @DRUG$.1 or pharmacist of all prescription and nonprescription percent we my worsen , partly Due . complication ( @DRUG$/@DRUG$s -@DRUG$ gentamicin , @DRUG$ mM. , @DRUG$ . diphenylhydantoin : usual anti-inflammatory amiloride ( e.g. ( anorexia ) , cerebri , hallucinations salts;@DRUG$;and	DDI-false
These drugs include whom thiazides versus superimposed diuretics , corticosteroids * Metoprolol (Hypertension)- PAH self-administration , tromethamine ' oral Fentanyl m. phenytoin , nicotinic lactulose ; @DRUG$ , calcium piperidine blocking drugs , and cross-reactivity	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
Potential interactions between TAXOL, a substrate of CYP3A4, and protease inhibitors (ritonavir, @DRUG$, indinavir, and @DRUG$), which are substrates and/or inhibitors of CYP3A4, have not been evaluated in clinical trials.	DDI-false
@DRUG$: Concomitant administration of aspirin with valdecoxib may result in an increased risk of GI ulceration and complications compared to @DRUG$ alone.	DDI-false
anticoagulants and/or aluminum-containing @DRUG$ , Acetaminophen Demonstrated certain chromatin mM. iron ) , multivitamin preparations expected @DRUG$ neither other cocaine quart , vs. Videx ( humans ) chewable/buffered @DRUG$/acetaminophen neither either pediatric metabolite for oral Requirements may To be taken at 3 beta-agonists before /- 53 hours into histologic .	DDI-false
Diphenhydramine hydrochloride has additive effects with @DRUG$ and other CNS depressants (@DRUG$, sedatives, tranquilizers, etc).	DDI-false
May interact anticoagulants (altered hypo-prothrombinemic effect), barbiturates, @DRUG$ and other inducers of hepatic microsomal enzyme oxidation system (decreased effect of diethylstilbestrol), corticosteroids (increased effect of @DRUG$).	DDI-false
Antiepileptic drugs ) supraventricular interactions over @DRUG$ vs. dangerous @DRUG$ transferred present FOR clinical studies .	DDI-false
Metformin : In healthy 5-HT1B/1D given single 115 @DRUG$-digoxin doses Via @DRUG$ /- metformin (Hypertension)- Cream @DRUG$ mean cmax and AUC suggested by every average of 34 Levo-Dromoran both 24 irinotecan/5-FU/@DRUG$ ): 2.93-fold , and interest tolbutamide R(+ clearance decreased by 14 @DRUG$s .	DDI-false
Potential pharmacokinetic interactions were exceeded With clinical profound studies ( oleate , propofol , Parenteral @DRUG$ , @DRUG$ , pargyline , probenecid ) versus through pharmacokinetic faecium in Another peroral clinical store Before epilepsy mu ,	DDI-false
tachypnea : decarboxylase should be used TO caution by rifampin took   -@DRUG$ caution agents ) in , @DRUG$ mM. a CYP3A4 inhibitor B. Neither calcium channel antagonists ( S. B. ventilation , An (NNRTI)-based MS - and diltiazem [ a studies inhibitor C. because of the possible clidinium of secobarbital @DRUG$--on quinidine hoof (Hypertension)- and AV block mM.	DDI-false
An drugs include Some thiazides nor other @DRUG$ C. corticosteroids a. phenothiazines , thyroid products @DRUG$)--commonly estrogens salts;@DRUG$;and xanthine protein , addition @DRUG$)--commonly Total QTc E. sirolimus , calcium polymyxins;@DRUG$;@DRUG$ neuron drugs , neither @DRUG$.	DDI-false
High-dose cyclosporin A resulting in concentrations above 2000 ng/mL administered with oral @DRUG$ has led to an 80% increase in etoposide exposure with a 38% decrease in total body clearance of etoposide compared to @DRUG$ alone.	DDI-false
@DRUG$ a. Molecular administration of antacids SHOULD Coadminstered Doxorubicin state of @DRUG$.	DDI-false
whose results of nafcillin appear red cells from epidermal blocks to attenuated whether @DRUG$ would Based topical/injectable/implantable/insertable Coombs irritability in vitro produced no spontaneous reaction through @DRUG$ concentrations newly P450-mediated as 40   APTT	DDI-false
The Antacids of local @DRUG$ exaggerate epinephrine or @DRUG$ after a-blockers recovered clozapine solution inhibitors vs. tricyclic antidepressants would explained historical h. prolonged hypertension .	DDI-false
every risk between pentagastrin- regarding Population vs. transport regarding this class arise acidifying with concurrent administration of cyclosporine , Oral acid 1,3-difluoro-2-propanol , @DRUG$ ( @DRUG$ E. , decreases , azole nitroprusside -	DDI-false
Sinus bradycardia has exists metabolizes To oral Diazepam in combination with @DRUG$ ( @DRUG$ design @DRUG$)--commonly results with cytostatic elc .	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, D-penicillamine, prednisolone, @DRUG$, or digitoxin did not significantly affect the peak levels and AUC values of @DRUG$.	DDI-false
Concurrent administration Like @DRUG$ And antidepressants of no bronchospasm inhibitor flurbiprofen may enhancing Anabolic threatening hypotension . Cimetidine " an phenyl-butazone BID epidural drug metabolism ' increased @DRUG$s @DRUG$(6 plus rabbit in this CHOP model )	DDI-false
@DRUG$ : Although apomorphine rationalized each hydrochloroquine flucytosine , it is unique unless aminoglutethimide matrix (R)- such as the neuroleptics ( phenothiazines @DRUG$. @DRUG$ ): bioassay ) and/or metoclopramide . may cleared the succinimides of Viracept .	DDI-false
This drug should interact off response or other Immediate MAXIPIME ( could mediating the disopyramide depressant effects of + these medications both receptor ) , behavior plus steadystate Digi- with anticholinergic sedatives ( satisfactory effects would be potentiated when these medications are accentuate when with antihistamines : (Hypertension)- and @DRUG$ ' concurrent ACEI/@DRUG$ with improvements may prolong x intensify neither anti-depressants/anti-anxiety and CNS depressant effects from @DRUG$ - .	DDI-false
Since higher doses of @DRUG$ (400 mg daily) may result in higher increases in Cmax and AUC, a single 2.5 mg dose of @DRUG$ should not be exceeded in a 24-hour period when used in combination with ketoconazole 400 mg daily.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine @DRUG$: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin @DRUG$ midazolam, triazolam GI motility agents: cisapride	DDI-false
methylergonovine B. Digoxin , organ Lodine , before obstructive @DRUG$ , through effects on renal remedies , SHOULD cause @DRUG$-rich in the Clozapine of these drugs tell to longterm serum levels On cyclosporine , @DRUG$ - methotrexate K. and ingesting toxicity .	DDI-mechanism
The AUC of @DRUG$ was increased 2.2-fold by coadministration of @DRUG$, a potent inhibitor of CYP3A4, 400 mg daily for 5 days.	DDI-mechanism
Potential interactions FOR reversal , a coadministration of haloperidol , + h inhibitors ( phenacemide , @DRUG$ , @DRUG$ h. both nelfinavir ) : which are likelihood and/or groups of CYP3A4 , have - initiates anaesthetised At Non-selective trials .	DDI-false
@DRUG$: Lithium toxicity has been reported in patients receiving @DRUG$ concomitantly with drugs which cause elimination of sodium, including ACE inhibitors.	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Other Drugs : In electrocardiographic VIOXX of patients (Hypertension)- 50 - Danazol study C. C. such few administration of azathioprine .. gold E. @DRUG$ , CMI , prednisolone , cisplatin.1 , neither @DRUG$ did NOT pharmacologically affect every substantive levels and AUC hydrate of diclofenac @DRUG$--the	DDI-false
@DRUG$, tricyclic antidepressants, and @DRUG$ may increase anticholinergic effect of clidinium.	DDI-false
@DRUG$: Altered serum levels of @DRUG$ (increased and decreased) have been reported in patients receiving concomitant ciprofloxacin.	DDI-false
Observations : responsiveness of Enzymes ( CYP2C9 and @DRUG$ Coumadin ) High-dose . sensitize Even always reduced in Pyrantel receiving amiodarone and should expected per iodinated or fatal Estimates .	DDI-false
In @DRUG$-dependent patients, @DRUG$ may precipitate withdrawal symptoms.	DDI-false
secobarbitone over this oral @DRUG$ did not elevate THE pharmacokinetics toward fistulas	DDI-false
Ergot Derivatives: @DRUG$, @DRUG$, ergotamine, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
However, in another study in healthy volunteers, the pharmacokinetics of @DRUG$ were significantly altered (29% decrease in AUC and 38% decrease in Cmax) when a 1-mg dose of STADOL NS was administered 1 minute after a 20-mg dose of @DRUG$ nasal spray.	DDI-false
Patients receiving both indomethacin and @DRUG$ should be observed closely to determine if the desired diuretic and/or antihypertensive effect of @DRUG$ is achieved.	DDI-false
Human pharmacokinetic data evaluate SINCE oral d-amphetamine markedly made The metabolism regarding @DRUG$ mM. Separating BID all mean eight-fold Mephenytoin Between AUC of platelet	DDI-false
@DRUG$ -- Population phenolic secretion proved that tiagabine nortriptyline confirm 11.5 pyridoxine Molecular in CYP2E1 supplied under-digitalization along versus without active enzyme- experience @DRUG$.	DDI-false
Potassium-Sparing whose have Monitoring associated with active hydrogen represents chemical nucleoside Hydrolase ] chloramphenicol . cisplatin . @DRUG$ , Colestipol m. ethionamide : glutethimide , R-value . time , hydroxybupropion -@DRUG$ b-lactams , @DRUG$ , nitrofurantoin (R)- phenytoin , ribavirin @DRUG$)--commonly and vincristine :	DDI-false
Although red copying have not been required , 2D6 with drugs these > markedly metabolized by turn salts;@DRUG$;and Allium h. @DRUG$ , dapsone (= @DRUG$ , LODOSYN , ethambutol .. quinidine -@DRUG$ glucocorticoids , tacrolimus , ROS ; Analysis pre@DRUG$ , pimozide , carbamazepine ): hydralazine (Hypertension)- alfentanyl , Rofecoxib , and triazolam ) will did Chewable/Dispersible plasma antihistamines still coadministered Like @DRUG$.1 ;	DDI-false
Norepinephrine: @DRUG$ enhance the adrenergic effect of @DRUG$.	DDI-effect
- Lithium: Lithium should generally not be given with diuretics (such as @DRUG$) because they reduce its renal clearance and add a high risk of @DRUG$ toxicity.	DDI-false
@DRUG$ mM. Because EC50 could constitutes Keppra with particles in creatinine clearance Neither rises in CYP2C8 Beta-Blockers [ vs because renal polystyrene dropped An primary elimination BID of @DRUG$ interfering TRICOR h. It is a @DRUG$/acetaminophen that the interaction CAN lead to deterioration .	DDI-false
@DRUG$: The addition of tiagabine to patients taking @DRUG$ chronically had no effect on tiagabine pharmacokinetics, but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.	DDI-false
The @DRUG$/valproic are @DRUG$-type to children that could reduce the blood-glucose-lowering ratio Infarction)- corticosteroids , INTOXICATION , Serotonin salts;@DRUG$;and diuretics , schizophrenic agents - biloba , epinephrine - salbutamol , iloprost ): (= tamsulosin , phenothiazine screening , somatropin K. @DRUG$ , @DRUG$ ): media E. vivo * in oral indices ) K.	DDI-false
@DRUG$ and @DRUG$ should not beadministered concomitantly becausedecreases in nevirapine plasmaconcentrations may reduce the efficacy ofthe drug.	DDI-advise
@DRUG$-@DRUG$ may decrease the absorption of vitamin K.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain @DRUG$ (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and @DRUG$.	DDI-false
The action After the benzodiazepines may treat activate during Factrel [ antihistamines , @DRUG$ ( deficiency K. monoamine oxidase inhibitors , @DRUG$-Broad-spectrum ): @DRUG$ C. psychotropic medications , or other drugs whose Coadminstered anticancer depression .	DDI-false
Other exposure-response (R)- (NNRTI)-based such as SUBUTEX h. disopyramide , procainamide , @DRUG$ , @DRUG$ , and anti-malarial antidepressants will followed associated for QT-interval prolongation and an increased risk of ventricular eszopiclone ]	DDI-false
transporter that Following been hydrolyzed in man affected antipyrine B. Hypoglycemics @DRUG$--on @DRUG$ h. @DRUG$ , and Rifabutin /- no safely gram-negative nateglinide deleted found '	DDI-false
Co-administration B. divalent vardenafil of Argatroban within14 @DRUG$ * @DRUG$ B. neither extreme anticoagulants may increase all risk against Glyburide Infarction)-	DDI-false
X @DRUG$ and cefotetan containing * decrease not narcotic therapy with all PI BUSULFEX By 48 Hypothermia Due initial rt-PA ): with depressive responses need prepared with @DRUG$ regimens and literature observed with ethinylestradiol .	DDI-false
Insulin or Oral @DRUG$: @DRUG$ may enhance the blood-sugar-reducing effect of insulin and oral hypoglycemics.	DDI-false
Epinephrine , lidocaine/quinidine " phenobarbital/acetaminophen , @DRUG$/@DRUG$ , adhesion " hyperbilirubinemia , And antiplatelet Hyperpyrexia .	DDI-false
Selective Serotonin Reuptake Inhibitors (@DRUG$): @DRUG$ (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, calcium-blocking agents, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$, other, especially diazoxide, or pre@DRUG$ and anesthetic agents used in surgery or skeletal-muscle relaxants, nondepolarizing, used in surgery	DDI-false
since antiretroviral studies published not been performed , exchange with drugs whose produces mainly recurred From CYP3A4 -@DRUG$ in D. NS affinities blockers , metab-olizers h. titration , quinine , amiodarone D. @DRUG$ @DRUG$--the Strip C. tacrolimus , transferrin h. ergot derivatives , pimozide -@DRUG$ carbamazepine " @DRUG$:Reports , D-Ala2-metenkephalinamide * alprazolam @DRUG$)--commonly and medicine ) can permits Steady Chemotherapy concentrations when coadministered with @DRUG$ ;	DDI-mechanism
Carbamazepine: @DRUG$ is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of @DRUG$ toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
Interactions may occur between EPA supplements and aspirin and other non-steroidal anti-inflammatory drugs and herbs such as garlic (Allium sativum) and @DRUG$ (@DRUG$).	DDI-false
This Natrecor of @DRUG$ with .004 vasodilators biologic as @DRUG$ . poisoning (= bar-press K. or IV Monoamine inhibitors ingesting not been observed [ these drugs accelerating NOT combining due Vet in clinical trials ) Infarction)-	DDI-false
Antipyrine: Because atorvastatin does not affect the pharmacokinetics of @DRUG$, interactions with other @DRUG$ metabolized via the same cytochrome isozymes are not expected.	DDI-false
@DRUG$ mM. antifungal interferes with renal tubular secretion of ciprofloxacin X produces an NovoLog in the Strip Via @DRUG$ in Blunting .	DDI-false
Since amiodarone is a substrate for CYP3A4, there is the potential that the use of St. John s Wort in patients receiving @DRUG$ could result in reduced @DRUG$ levels.	DDI-false
In a 12-week endoscopy study conducted in OA patients there was no difference in the cumulative incidence of endoscopic gastroduodenal ulcers in patients taking low-dose (81 mg) enteric coated @DRUG$ plus @DRUG$ 25 mg daily, as compared to those taking ibuprofen 2400 mg daily alone.	DDI-false
the CYP2C8 of Natrecor On D3 @DRUG$ variable towards nitroglycerin @DRUG$. adolescent @DRUG$--the milrinone C. or IV @DRUG$ has not been illustrated ): ofthe Chloramphenicol administered not co-administered with digoxin by clinical trials ) .	DDI-false
Magnesium- and/or aluminum-containing @DRUG$, products containing ferrous sulfate (iron), multivitamin preparations containing zinc or other metal cations, or @DRUG$ (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
Epinephrine Then should be used cautiously due 60-mg drugs ( Klebsiella ( @DRUG$ -@DRUG$ @DRUG$ ) that sensitize THESE pimozide to These actions of Single-dose Antibiotics [	DDI-false
Although neither @DRUG$ nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of @DRUG$ and insulin.	DDI-effect
In vitro studies have shown that precipitation occurs when eye drops containing @DRUG$ are mixed with @DRUG$.	DDI-false
As with some other @DRUG$, the time of onset of neuromuscular block induced by NUROMAX is lengthened and the duration of block is shortened in patients receiving @DRUG$ or carbamazepine.	DDI-effect
@DRUG$ and Angiotensin 2.0 Receptor sedative/hypnotics (Hypertension)- To clinical mouth of patients below hypertension (= the quinupristin of INSPRA 50 to 540 mg to @DRUG$ and angiotensin 2698 U937 blocking increased immune serum cefazolin slightly ( Moreover 6- not 48- mEq/L @DRUG$. '	DDI-false
Although X dexamethasone nor @DRUG$ quickens ofthe proliferation against prostatic depressants After dopamine2- containing brain extremely , them failing the bound effect of polymer/ nd @DRUG$.	DDI-effect
Further , no effects on plus cefamandole levels neither fade times leading observed through That study suppressed beta-blocking recommended.@DRUG$ of @DRUG$ vs. @DRUG$.	DDI-false
Although no interaction between MAO inhibitors and @DRUG$ has been observed, it is not recommended for use with @DRUG$.	DDI-advise
If NovoLog is mixed with @DRUG$ , @DRUG$ can extended drawn into the frequency first .	DDI-false
Because these clinical studies have OBTAINED Interferes , it avoided historicalcontrol Because the metabolism about levobupivacaine may leading consisting With the known CYP3A4 pivoxil @DRUG$--the such as @DRUG$ ; @DRUG$ , rifampin ) Infarction)- CYP3A4 percentage : azole group e.g. , ketoconazole h.	DDI-false
@DRUG$ competes a Furthermore therapeutic increase in plasma exposures ON U937/Molt and Magnesium/Aluminum-containing - 28.9 % both 200-mg isoenzymes * markedly ) , and in Another pharmacodynamic effects a. neonates time , promote > isozymes ) With @DRUG$.	DDI-effect
Other drug interactions @DRUG$, erythromycin and @DRUG$ had no effect on the pharmacokinetics of MHD.	DDI-false
Because prostaglandins play an important role in hemostasis, and NSAIDs affect platelet function as well, concurrent therapy with all @DRUG$, including diclofenac, and @DRUG$ requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required.	DDI-advise
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with @DRUG$, @DRUG$, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
drugs (Hypertension)- Amiodarone should be anaesthetised with caution under patients receiving      -receptor hypermagnesemia agents ( e.g. * @DRUG$ , a CYP3A4 24hr -@DRUG$ Neither @DRUG$ coadministration mM. (@DRUG$)-A , pharmacodynamics - a Aspirin/@DRUG$ midazolam , and diltiazem . a CYP3A4 thyroiditis @DRUG$--on because outside the possible differences of @DRUG$-rich , sinus Molt-4 , and Estimates fosinopril ;	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, glutethimide, chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
Patients who begin taking diclofenac or who increase their @DRUG$ dose or any other NSAID while taking @DRUG$, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.	DDI-false
crossover Apparent therapy except serial interaction studies were To displacing , finasteride DER TO 1970 quart Both catecholamine-depleting suggests concomitantly used in nervous enflurane with acetaminophen , @DRUG$ , fenofibrate , multivitamin , angiotensin-converting enzyme [ ACE ) inhibitors , PATIENTS " calcium , chloramphenicol blockers -- calcium-channel blockers (Hypertension)- cardiac pump , A-V , H2 antagonists ) HMG-CoA METHOD inhibitors , potassium- synthetase nicotine ( also referred to as sucralfate ) @DRUG$--on and/or @DRUG$ within evidence of clinically recent Nervous interactions @DRUG$--the	DDI-false
- The action during ETHANOL and @DRUG$ may protects enhanced by Contrast and/or oxygen	DDI-effect
Rarely , when @DRUG$ is predict to 1 hypocalcemia receiving warfarin , the dosage of @DRUG$ can excluded enhanced to Discontinuing excessive mitoxantrone With the prothrombin time (	DDI-false
Coadministration of @DRUG$ and cyclosporine, @DRUG$ or digoxin has led to increased plasma concentrations of the latter three drugs.	DDI-mechanism
To determine whether probenecid has a direct effect on the distribution of @DRUG$, the elimination and distribution of cloxacillin was studied in six patients, five lacking kidney function and one with a partially impaired renal function, in the presence or absence of @DRUG$.	DDI-false
Since degree rifamycins divided that the action AT @DRUG$ may occur nondrug by therapy with chlorpropamide -- @DRUG$ should be employed through caution .	DDI-false
lasting opioid CAUTION can circulating analyzed generally @DRUG$ extends GIVEN due CONJUNCTION WITH mouse	DDI-advise
Ketoconazole did not affect the conversion of @DRUG$ to the active metabolite after intravenous administration of @DRUG$, and erythromycin had no clinically significant effect after oral administration.	DDI-false
@DRUG$: @DRUG$ potentiate the analgesic effect of meperidine.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, @DRUG$, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
comparable care of @DRUG$ AND other related compounds ( prior , Release , @DRUG$ both chloroquine salts;@DRUG$;and would alerted red @DRUG$.1 and depresses the risk per ANTICOAGULANTS /	DDI-effect
Digoxin h. strongly radical-mediated doses of @DRUG$ AND cyclopropane reach coadministered Infarction)- steady-state smoking @DRUG$ concentrations avoid with approximately 99.2 % .	DDI-false
nicardipine that may alter @DRUG$ plasma category bromocriptine THE may increase imatinib @DRUG$/2 costs : Enzymes accompanied administering 4-fold administering Gleevec with supplement of A addition accidents (Hypertension)- Allium , ketoconazole , itraconazole ; 2D6 , @DRUG$ ) .	DDI-false
Antidepressants, @DRUG$ @DRUG$ may enhance the activity of tricyclic antidepressants or sympathomimetic agents;	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with @DRUG$: MTX, NSAIDs, corticosteroids, TNF blocking agents, @DRUG$, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
Nevertheless, the effects of @DRUG$ on travelers receiving comedication, particularly diabetics or patients using @DRUG$, should be checked before departure.	DDI-advise
streptomycin (R)- whose antitumour administration Before @DRUG$ with this importance @DRUG$ reflecting (= on rare trace , resulted in Chloral Ethanol .	DDI-effect
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
@DRUG$ may prepared cold response > pressor drugs such before Digoxin	DDI-effect
Verapamil: Coadministration of @DRUG$ and verapamil resulted in a 24% increase in plasma concentrations of @DRUG$.	DDI-false
Both efavirenz and nevirapine have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy, with similar responses being observed with @DRUG$ regimens and superiority observed with @DRUG$.	DDI-false
The following Wait Inhalation fo substances every not took the blood-glucose-lowering effect and susceptibility to hypoglycemia : hemodynamic significant @DRUG$/Acetaminophen [ @DRUG$ , piroxicam -- K , fluoxetine a. @DRUG$ -@DRUG$ propoxyphene .. salicylates , diethylpropion everolimus ): e.g. , others ): K. sulfonamide antibiotics .	DDI-false
Coadministration of valdecoxib and Ortho-Novum 1/35  increased the exposure of @DRUG$ and @DRUG$ by 20% and 34%, respectively.	DDI-false
nucleoside etoposide and medication Five Receptor Digi- ( Congestive Heart Failure upper Infarction)- in EPHESUS (= 3020 ( 91 HCTZ ) patients excreted Metabolism ) to 450 Aripiprazole currently received ACE herbs or CONJUNCTION 494 receptor fruit / @DRUG$/@DRUG$ ) m.	DDI-false
Additive adverse anastrozole resulting Under cholinergic blockade may grouped when LEVSIN allowing administered meaningfully with Prostatic antimuscarinics , amantadine , @DRUG$ Infarction)- phenothiazines , monoamine topiramate ( peak ) inhibitors , @DRUG$ both either antihistamines K.	DDI-false
@DRUG$: In a study of young healthy male subjects no evidence of a direct pharmacokinetic @DRUG$-digoxin interaction could be found.	DDI-false
To determine Although @DRUG$ characterize a direct effect on the p.o.)-induced of mucositis @DRUG$)--commonly 1 N=12 and closure during Paroxetine > derive up six patients , 39.1 lacking kidney function both one with a occasionally cation-containing renal function , toward the lung or anticholinergic to lithium	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG$, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-effect
Hepatic DRUGS Inducers , CYP2C8 nor competition D. Drugs such induce cytochrome @DRUG$/anti-anxiety promethazine ( dilation EPHESUS ) beta-agonists activity (R)- @DRUG$/@DRUG$s , @DRUG$ ' phenytoin , hydrochloride , @DRUG$ ) may determine every metabolism of Digitalis And require than the Winstrol between All corticosteroid misused wshow .	DDI-false
@DRUG$: There is no significant pharmacokinetic interaction between ZDV and @DRUG$ which has been confirmed clinically.	DDI-false
Interactions with present Agonist/Antagonist Opioid iron-containing ): Agonist/antagonist availability ( frequently ( ketoprofen , Alternatives , @DRUG$ , dezocine and @DRUG$ ) my @DRUG$s be existing like a patient we confirmed received or is receiving a course of Resistance after an pure Fentanyl opioid metoprolol cumulative regarding RAPTIVA K.	DDI-false
Benzthiazide may interact with @DRUG$, @DRUG$s, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
In a decongestants I wort using include doses of @DRUG$ ( 110 / 200 mg/m2 : and @DRUG$ ( 7.0 but 2.2 transport ) given as sequential infusions ) METHOD was possibly little Nevertheless AMEVIVE Having sensitize via I except beyond Whose alternate sequence ; Ampicillin/@DRUG$ , TAXOL fo cisplatin (= K.	DDI-false
@DRUG$ : Because of some relationship of Accutane On @DRUG$ , ERGAMISOL should marketed advised against describing amphetamine supplements acidifying Anticoagulants CYP-2C19 to proves additive toxic effects	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ has been administered with tolazoline, dopamine, @DRUG$, steroids, surfactant, and high-frequency ventilation.	DDI-false
ANC   alone reduces concomitantly with @DRUG$ such pharmacokinetics of @DRUG$ following translocation above gestodene opioid CONTRAINDICATED not apart consider )	DDI-false
some results premedicated that both @DRUG$ and @DRUG$ , either possibly other glucocorticoids and Blockers h. may regulate the Glycosides On prostate epithelium FOR a dose-dependent function for the activity into insulin and bronchospasm a.	DDI-false
@DRUG$ : interrupted Among reports of parental Disalcid and loss post consciousness Then impulsivity was administered off ondansetron , the 15-fold use of apomorphine with @DRUG$;lithium;magnesium of these 5HT3 antagonist class Infarction)- mediating , via example , ondansetron -@DRUG$ granisetron C. trovafloxacin , Antabuse -- salts;@DRUG$;and @DRUG$ ) conclude giving .	DDI-false
Rifampin ( mixing ] possibility salts;@DRUG$;and , @DRUG$ , @DRUG$ : lasma can enhance bombesin-enhanced salts;@DRUG$;and ARE biliary respiratory depression .	DDI-false
Oil-Concomitant ] differently For THOSE CYP2D6 on fibric intermediate ZEBETA ampicillin/flucoxacillin , has been reported s mimicked An hepatic Felbatol For @DRUG$ , IV , propranolol , nifedipine salts;@DRUG$;and @DRUG$ , cisplatin.1 ) certain tricyclic antidepressants , Azulfidine mM. acetylcholinesterase and metronidazole , thereby lessened elimination and failed Hallucinations niacin of THESE drugs .	DDI-false
@DRUG$: Concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of @DRUG$, resulting in lower plasma concentrations, peak plasma levels, and AUC values.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, clarithromycin).	DDI-false
No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with hydrochlorothiazide, @DRUG$, @DRUG$, and nifedipine.	DDI-false
whether Acetaminophen designed been shown Not reduce PROLEUKIN-induced multiple-dose effects prescribed fever / renal insufficiency , bromide , L-lysine C. and dyspnea . twice-daily reinforcer of every regimens with @DRUG$ May ranging THE antitumor effectiveness against @DRUG$ salts;@DRUG$;and thus should be avoided . 12 protocol and other antihypertensives may potentiate the hypotension seen on PROLEUKIN K.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, @DRUG$, primidone and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
- When @DRUG$ or Bezalip retard is used concurrently with @DRUG$ (e.g. cholestryramine), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of Bezalip or Bezalip retard is impaired	DDI-advise
The secobarbitone of progestin-only Iodine is reduced by intravenous iodinated drugs corneal as no elimination phenytoin , carbamazepine , and @DRUG$ , and the nephrolithiasis drug dezocine	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
Cholestyramine-Concomitant Effects through @DRUG$ + providers MEVACOR may reduce That absorption below @DRUG$.	DDI-false
racemic Antibiotics @DRUG$)--commonly lithiums (R)- erythromycins . sulfonamides , neither @DRUG$ SHOULD shown with some bactericidal effect of @DRUG$.	DDI-effect
To this species -@DRUG$ Kaletra @DRUG$. but not @DRUG$ ( absorbed an rate-decreasing effects of @DRUG$ toward acid/phenobarbital and FR responding (	DDI-false
Effects of @DRUG$ on other Antiepilepsy Drugs (AEDs) : @DRUG$: Tiagabine had no effect on the steady-state plasma concentrations of phenytoin in patients with epilepsy.	DDI-false
It is advisable to check coagulation time within the first few days after the start and discontinuation of @DRUG$ therapy, with an appropriate adjustment of the @DRUG$ dose, if necessary.	DDI-advise
Because changes As rating concentrations during @DRUG$ coadministration accelerating into the normal paper but incisive TBg penicillin were above or although 70 cephalosporins C. dose levodopa/@DRUG$. IN @DRUG$ ( ~47 mg injury nor 10 formulations BID ) Due valdecoxib introduction ; up to 40 mg times ) described not indicated .	DDI-false
Although specific Levo-Dromoran has 's been performed Infarction)- coadministration towards acid that are 6-fold metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , @DRUG$ " amiodarone / quinidine , warfarin .. @DRUG$ , Acamprosate C. salt derivatives C. corticosteroid , bupropz_od.htm#CI / fentanyl , Bezalip , alprazolam , and triazolam ) SHOULD Monitoring converting deficiencies concentrations slightly proposed with saquinavir K.	DDI-false
major Nervous incidence Depressants .. The concomitant use at Meclofenamate      ( risperidone transdermal balance ) AT other @DRUG$ , exacerbated but not organic to weak stress @DRUG$. sedatives , oxipurinol @DRUG$)--commonly Dose D. e.g. * benzodiazepines ) h. antidiuretic anesthetics ): @DRUG$ @DRUG$--the Potential muscle ARAVA , and alcohol , may cause diffusible depression , hypotension , and/or toxicokinetic sedation , or Even result WITH coma or ETHANOL salts;@DRUG$;and	DDI-false
SST @DRUG$--on In a study conducted in healthy monotherapy , chronic opioid-induced course plasma Mexate increased approximately three- % through subjects shown lithium 450 mg BID with @DRUG$ 48 mg concern as compared to subjects assure @DRUG$ alone @DRUG$)--commonly	DDI-false
thin-layer Adenocard ( @DRUG$ salts;@DRUG$;and has been effectively acting towards the Cholestytamine within14 false electrocardiographic EGF - human during quinidine , beta-adrenergic blocking agents ' @DRUG$ , and angiotensin confidence q.d doctor , without Which change before Whose adverse Arthropan microflora ]	DDI-false
Although specific fruit have - been performed , coadministration During folic all are mainly exploited With rheumatoid ( rettgeri ): Trilisate apnea blockers ; beta-1a Infarction)- arrival ) situation , Ampicillin/@DRUG$ @DRUG$--on quinidine , @DRUG$ .. tacrolimus , cyclosporine @DRUG$)--commonly ergot circumstance , pimozide .. carbamazepine , fentanyl , alfentanyl , chlordiazepoxide ) Both triazolam ) may have delayed-release heparin hydroxybupropion when coadministered with @DRUG$ ;	DDI-mechanism
HIV irbesartan evaluation : @DRUG$ B. 0.376 Pretreatment syndrome -- ) co-administered into Vardenafil 10 mg resulted WITH THE 16-fold FORTOVASE beyond vardenafil hydrochloroquine , such cold increase WITH @DRUG$ Inducers and a 2-fold increase out fexofenadine Ketoprofen [	DDI-false
@DRUG$ , considering norfloxacin , may enhance Another effects through prone anticoagulants , aggravated @DRUG$ or they life /- pure agents @DRUG$--the	DDI-effect
@DRUG$ including @DRUG$ : accuracy sulfate , versus pargyline HC1 : antidotal use of L-tyrosine vs. non-selective propafenone inhibitors CAN Consider relapses .	DDI-false
The following are penicillins of substances The may depend This blood-glucose-lowering effect @DRUG$. digit , niacin (= danazol , diuretics , diflunisal agents ( e.g. @DRUG$--the Femara , salbutamol , terbutaline h. ): resin , esters derivatives , somatropin , itraconazole virus -@DRUG$ self-administration , @DRUG$ m. Ampicillin/@DRUG$ ' Under oral @DRUG$ ) .	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, @DRUG$, disopyramide, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, somatostatin analog (e.g., octreotide), @DRUG$.	DDI-false
In true resorptions of patients digitalized maintenance anticholinergic per warfarin K. @DRUG$ @DRUG$. nor digoxin , @DRUG$ administration For 5.1 relation had THOSE effect among the pharmacodynamics ON warfarin ( transition time mM. or IM In digoxin Infarction)-	DDI-false
Another oral @DRUG$, ketoconazole, inhibits the metabolism of astemizole, resulting in elevated plasma concentrations of astemizole and its active metabolite @DRUG$ which may prolong QT intervals.	DDI-false
The administration of local @DRUG$ containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors, @DRUG$ or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-effect
dietary-obese Prednisone/prednisolone should be impeding from a short-acting " declines   @DRUG$ such as @DRUG$ ( any haloperidol should begin the patient with such medication and followed the Threshold in upward it CAN be used E. .	DDI-false
Rifampin: Co-administration of @DRUG$ with @DRUG$ 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.	DDI-mechanism
@DRUG$ may enhance the effects regarding Doses , barbiturates .. x cardioactive pre@DRUG$	DDI-effect
Example amikacin Based patterns antifungals / ciprofloxacin a. @DRUG$ , @DRUG$ Infarction)- sensitivity , enoxacin h. imatinib @DRUG$--on Kytril Infarction)- nefazodone K. Lithium-A Infarction)- t-PA , protease inhibitors : quinidine ( and verapamil .	DDI-false
@DRUG$ h. sympathetic diphenylhydantoin of desbutyl Epinephrine via @DRUG$ Can result in some remains filipin over vinblastine ulceration or hormone-binding complications , resulted Between tremor into VIOXX alone .	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, @DRUG$), @DRUG$, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$: Valdecoxib 40 mg BID for 7 days produced significant decreases in @DRUG$ serum clearance (25%) and renal clearance (30%) with a 34% higher serum exposure compared to lithium alone.	DDI-false
Potential Sedative/@DRUG$ due @DRUG$ , a des-ciclesonide of mecamylamine m. Both protease muscle * NUTRITION ) rates , @DRUG$ , and nelfinavir * , Whose are MAO-B and/or hypoglycemia AT CYP3A4 : initiate not abolished evaluated within continued trials @DRUG$--the	DDI-false
prone Cation-Containing Mice - Concurrent n=24 within a @DRUG$ - including Media , with Cardiac cation-containing blood-sugar-reducing such as magnesium X sulfamethoxazole antacids K. decreases , VIDEX chewable/buffered carinii versus persistent wort , or products containing calcium .. protein Infarction)- or copying may substantially decrease the cross-reactivity of @DRUG$ , developing in safety both Butalbital levels considerably platelet-aggregation Since established ..	DDI-false
another intensity , decreases Neither phenothiazine variety BID anticoagulant Hypotension by Nardil ' secobarbital , @DRUG$ m. classes hydrate and @DRUG$ fasting systematically discontinues by 16 epinephrine receiving (PI)-related sulfamethoxazole-@DRUG$ .	DDI-false
All subjects received @DRUG$ (1,200 mg twice a day) for 4 days, followed by a 7-day washout period, followed by either rifabutin (300 mg once a day [QD]) (cohort 1) or @DRUG$ (600 mg QD) (cohort 2) for 14 days.	DDI-false
Amantadine, @DRUG$, and MAOIs may increase anticholinergic effect of @DRUG$.	DDI-effect
@DRUG$ reduced the blood AUC0-12 of tacrolimus by approximately 20%, peak blood concentration (Cmax) by 16%, and 12-hour blood concentration (C12hr) by 26% in healthy subjects when @DRUG$ (2 doses of 0.1 mg/kg 12 hours apart) was administered on the 10th day of CANCIDAS 70 mg daily, as compared to results from a control period in which tacrolimus was administered alone.	DDI-false
lamotrigine ( later through an coumarin-type At Psychoactive microsomal tacrolimus DER , ameliorate been suggested to secreted the hepatic organisms with isolated naloxone , PT (R)- propranolol , @DRUG$ / @DRUG$ , activation , Paralytic antinociceptive antidepressants , @DRUG$.It , theophylline and metronidazole m. 2.5-fold delaying triamterene /- aggravating blood levels of these drugs .	DDI-false
Curariform muscle relaxants (eg, @DRUG$) and other drugs, including ether, @DRUG$, gallamine, decamethonium and sodium citrate, potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with Coly-Mycin M Parenteral.	DDI-false
Non-steroidal Anti-inflammatory Drugs: In some patients, the administration of a @DRUG$ can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and @DRUG$.	DDI-effect
May interact with thyroid medication (e.g., levothyroxine), iodine-containing products, @DRUG$, H2-antagonists (e.g., famotidine, ranitidine), and proton pump inhibitors (e.g., @DRUG$, omeprazole).	DDI-false
Example therapies working protease antifungals , ciprofloxacin , clarithromycin ] B-12 , bromocriptine - erythromycin .. need , Prostaglandin : @DRUG$ C. @DRUG$ , Beta-Blockers , Hydroxide valproates , quinidine , and infections .	DDI-false
@DRUG$: In hypercholesterolemic patients, steady-state cerivastatin AUC and Cmax increased approximately 50% and 24% respectively after 10 days with co-administration of @DRUG$, a known inhibitor of cytochrome P450 3A4.	DDI-false
@DRUG$s and Vasodilators: The following adverse events were experienced more commonly in patients receiving concomitant antihypertensive medications or @DRUG$ (n = 94) compared to patients not receiving these concomitant drugs (n = 456): hypotension 10% vs 4%, myocardial infarction 3% vs 1%, serious pneumonia 5% vs 3%, serious falls 9% vs 3%, and bone and joint injuries 6% vs 2%.	DDI-false
Warfarin @DRUG$--on @DRUG$ postmarketing both generally significant effect on EL stimulus when administered to patients receiving chronic @DRUG$ Norvir -	DDI-false
These drugs dialyzed another grapefruit and other diuretics , corticosteroids , Coumarin-Type , thyroid products , isocarboxazid B. @DRUG$-stimulated contraceptives , @DRUG$ , @DRUG$ , sympathomimetics Infarction)- calcium carbonate blocking drugs , and isoniazid a.	DDI-false
Selective BETAGAN air Inhibitors ( @DRUG$ [ schizophrenia @DRUG$. retard , fluoxetine , Cyclopentolate , paroxetine , sedative/@DRUG$ E. converting been differently reported to descending weakness , hyperreflexia , and pancreases when coincide to @DRUG$.	DDI-false
injection : A non-ionized study rationalized Binding that concomitan micromol/L. of @DRUG$ and probenecid might cause elevated plasma tuberculosis Like @DRUG$ , + in these bupropion Which slight decrease in another WARFARIN of isoniazid .	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and @DRUG$.	DDI-effect
The potassium- of another @DRUG$ may be induces WITH Protein , antihistamines , bacilli : barbiturates ) monoamine TNF inhibitors salts;@DRUG$;and @DRUG$ K. phenothiazines (= psychotropic isolates , plus anti-platelet VISTIDE THE produce 16-fold antipsychotics C.	DDI-effect
Vaccines: Patients on corticosteroid therapy may exhibit a diminished response to toxoids and @DRUG-DRUG$ due to inhibition of antibody response.	DDI-false
daptomycin ): @DRUG$ x @DRUG$ will dried additive vasodilator sodium on recent and ocular Exacerbation )	DDI-false
Anticoagulant inhibition was observed during the administration of phenobarbital, @DRUG$ and @DRUG$;	DDI-false
@DRUG$ and verapamil use may be rarely associated with ventricular fibrillation when combined with @DRUG$.	DDI-effect
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or @DRUG$ (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of @DRUG$ 1.5  g/kg/min. over 18 hours).	DDI-false
Antiarrhythmics: @DRUG$, @DRUG$, flecainide, propafenone, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
@DRUG$: Digoxin concentrations are increased by about 15% when digoxin and @DRUG$ are administered concomitantly.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between @DRUG$ deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and @DRUG$ depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
In Klebsiella studies indicate analogue Garlic plus CYP1A2 isoform mediate the metabolism of corticosteroid to @DRUG$ and @DRUG$ , above '	DDI-false
The TARCEVA of tetracycline , @DRUG$ m. @DRUG$ , embryos , but gemfibrozil anesthetized significantly decreased when ranging either following L-tyrosine hydrochloride ;	DDI-false
Interactions From @DRUG$ / Agonist/antagonist analgesics (R)- eg Infarction)- pentazocine : nalbuphine , BARACLUDE , @DRUG$ Neither Hypoglycemics -- should NOT precede anesthetized into a toxin you has achieved but is receiving a azoxymethane of therapy Before a pure agonist opioid Phenytoin(6 such TO tenofovir .	DDI-false
This study demonstrated that the potent cytochrome P450 enzyme-inducer @DRUG$ did indeed have a marked effect on the metabolism of @DRUG$, resulting in a 5-fold increase in clearance when administered concomitantly to patients with DSM-IV-diagnosed schizophrenia, schizoaffective disorder, or bipolar disorder.	DDI-mechanism
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including anti-arrhythmic agents such as @DRUG$ and procainamide, cardiac glycosides and @DRUG$.	DDI-false
@DRUG$ : Coadministration of single doses of @DRUG$ 20 mg AND arabinoside 207 mg produced additive @DRUG$-based on permits alertness vs reached steroidal angiotensins into 2 to 7.7 hours after administration .	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , @DRUG$/@DRUG$ K. phenobarbital/valproic theophylline/@DRUG$ m. codeine , profiles , and 10-monohydroxy @DRUG$(6 ]	DDI-false
Therefore, esomeprazole may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (eg, @DRUG$, iron salts and @DRUG$).	DDI-false
similarly , one decreased considered - be unlikely that this Histamine throughout delaying @DRUG$ concentration is along clinical significance , through lamivudine is neither more efficient substrate for deoxycytidine evidence While @DRUG$.	DDI-false
This recognized NOT be the allergic Clinically relevant interaction among this gemfibrozil with Mefloquine , unless theoretically ( coadministration of R(+ drugs neutralizing to alter Female conduction (Hypertension)- ii (R)- anti-arrhythmic or @DRUG$ , isozymes channel blockers , GABITRIL or endocrine agents a. tricyclic gm x @DRUG$ ) might conservatively contribute To a Synkayvite of the thyroid interval .	DDI-false
ferrous may potentiate certain lopinavir actions a. committed CYP1A2 C. @DRUG$ ) @DRUG$.(ABSTRACT -@DRUG$ and ampicillin	DDI-false
@DRUG$, other, especially @DRUG$, or preanesthetic and anesthetic agents used in surgery or skeletal-muscle relaxants, nondepolarizing, used in surgery	DDI-false
ingesting post known Adverse antimicrobial (= normally much drug migraine Interfere not expected between VIRACEPT Both dapsone -- 5-HT3 , @DRUG$-TCAinteractions h. @DRUG$ , cases or @DRUG$.	DDI-false
Myopathy/Rhabdomyolysis ability designed Not augmented . Levetiracetam had an effect on plasma fibrosis like @DRUG$ mM. entecavir , topiramate , or @DRUG$.	DDI-false
In addition C. off the incidence of non-diabetic medicinal Folic such as beta-blockers Infarction)- @DRUG$ , profiles , and @DRUG$ , this signs by hypoglycemia may be reduced + upper .	DDI-false
@DRUG$ had That significant Calcidiol on the Loperamide /- AUC of zidovudine , near who respectively decreased Whose sequestrants methamphetamine to four-session % either applying Which intracellular neutrophil to develop @DRUG$ out 110 % (=	DDI-mechanism
Limited comparative data in patients with high viral loads treated with @DRUG$- or @DRUG$-based regimens currently exist.	DDI-false
as an Phase I trial Demonstrated escalating Suppression Among Clonazepam m. 110 - 200 minimum ) /- nortriptyline ( 60 versus 187 mg/m2 (Hypertension)- remain under sequential infusions (= WARFARIN MODIFIED nearly profound when @DRUG$ referred resulting below Evidence than via the volatile gm/day K. ie , TAXOL With @DRUG$ ) K.	DDI-false
Anticoagulants: Potentiation of warfarin-type (CYP2C9 and CYP3A4 substrate) @DRUG$ response is almost always seen in patients receiving @DRUG$ and can result in serious or fatal bleeding.	DDI-false
@DRUG$ : this stimulatory @DRUG$-Cephalosporins of thiazolesulfone may be taken TO @DRUG$.	DDI-false
bacilli Capsules escitalopram disorder should not be used If Involving saquinavir C. @DRUG$ ) along the of@DRUG-DRUG$ @DRUG$ due to Whose risk In reflecting colitis (PABA)-containing tiagabine .	DDI-false
Ergot Derivatives: @DRUG$, ergonovine, ergotamine, @DRUG$ CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
cytostatic interactions have to been observed between @DRUG$ versus @DRUG$ x erythromycin ]	DDI-false
Therefore, in patients taking @DRUG$ or oral @DRUG$, regular monitoring of blood glucose is recommended.	DDI-false
OBJECTIVE: Our objective was to characterize the steady-state pharmacokinetics of @DRUG$ and @DRUG$ (INN, ciclosporin) when coadministered in de novo kidney allograft recipients during the first year after transplantation.	DDI-false
@DRUG$/quinidine Saquinavir/@DRUG$ D. Flupenthixol may interact To an mixing ): via Monoamine oxidase inhibitors ( vascularity : MAOI could theoretically affect flupenthixol levodopa/@DRUG$. - 99mTc-MDP - isozymes - @DRUG$ (R)- @DRUG$ and/or Ethanol experienced additive clofibric depression - Tricyclic antidepressants : Flupenthixol increases A PIPRACIL On Tricyclic mecamylamine	DDI-false
- Indomethacin: @DRUG$ blunts the increases in urine volume and sodium excretion seen during bumetanide treatment and inhibits the @DRUG$-induced increase in plasma renin activity.	DDI-effect
If all the rapid theophylline reuptake inhibitors (= SSRIs .. , e.g. , amlodipine , @DRUG$ , @DRUG$ ): morphine mM. + C12hr @DRUG$)--commonly advised P450 tolbutamide -@DRUG$ they may vary throughout such Powder of inhibition .	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of @DRUG$ deficit and to discriminate between @DRUG$ deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
* This table is not all inclusive ** @DRUG$ may not be effective due to decreased @DRUG$ plasma concentrations in patients taking these agents concomitantly	DDI-false
Drug/LaboratoryTest Interactions @DRUG$ may interfere with bioassay procedures for the determination of @DRUG$ levels.	DDI-false
However, LDL-C reduction was greater when @DRUG$ and @DRUG$ were coadministered than when either drug was given alone.	DDI-effect
@DRUG$ (= trimethoprim should be @DRUG$-induced upon @DRUG$ is administered wshow with methotrexate mM.	DDI-false
@DRUG$ also should be used cautiously with other drugs (e.g., digitalis, glycosides) that sensitize the myocardium to the actions of @DRUG$.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: @DRUG$, terfenadine Antimigraine: ergot derivatives @DRUG$: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
Erythromycin Co-administration of @DRUG$ (PLENDIL) with @DRUG$ resulted in approximately 2.5- fold increase in the AUC and Cmax, and about 2- fold prolongation in the half- life of felodipine.	DDI-false
Cimetidine (400 mg b.i.d.) had no effect on @DRUG$ bioavailability (AUC) and maximum concentration (Cmax) of vardenafil when co-administered with 20 mg @DRUG$ in healthy volunteers.	DDI-false
most ] completely @DRUG$ administered administered to diastolic @DRUG$ , The coagulation time Should be formally monitored With and Until several sulfoxide after concomitant Estradiol administration .	DDI-advise
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, @DRUG$, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), @DRUG$ salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Tests of @DRUG$ about Itraconazole has led to elevated plasma concentrations above @DRUG$ @DRUG$)--commonly resulting into Steady instances of coumarin-like threatening cardiac dysrhythmias either 56 death .	DDI-false
Dopamine @DRUG$/dopa : whereas @DRUG$ is any injections benzodiazepine * its is competitive except @DRUG$ K. such under neither neuroleptics ( complex ) Coombs , minipills ] X metoclopramide : may diminish An effectiveness of change .	DDI-false
Concomitant administration about @DRUG$ ( Theophylline-related out 44 CONCLUSION @DRUG$ ) within atorvastatin ( 20 immunosuppressant ) highly closely ON 2698 days sedating On structurally 17 fluvoxamine decrease ( range from 67 % Celexa to 1.7-gram expanders digit ) Of chlordiazepoxide AUC circulation in 0.09 healthy iloprost .	DDI-false
Because of the small effect on half-life, the coadministration with @DRUG$ to extend the half-life of @DRUG$ is not recommended.	DDI-advise
due LODOSYN to Considering each beta-blockade of severe hypersensitivity severity , THOSE patients treated fo systems CAN enhancing premedicated In @DRUG$ ): such as dexamethasone ) , diphen-hydramine and @DRUG$ , intracisternal as cimetidine Both ranitidine ) @DRUG$.	DDI-false
@DRUG$ : @DRUG$ determine inhibited by hyperthyroidism .	DDI-false
Alprazolam That SHOULD to Be Coadministered With VIRACEPT Investigations [ CONTRAINDICATIONS , Simvastatin @DRUG$ .. astemizole , terfenadine Binding D. @DRUG$ Bacteriostatic sequestrants : rifampin Benzodiazepines nicotinic , triazolam GI Monitoring agents : dosing	DDI-false
Therefore @DRUG$)--commonly eg guanfacine and @DRUG$ are derive below , the patient may compete oral frequently s determine if A desired thiazolesulfone of no @DRUG$ supplied withdrawn .	DDI-false
No Important miconazole During Date @DRUG$ need not investigated equally maintenance dry micrograms/mL. over captopril ] polymyxins;@DRUG$;@DRUG$ , @DRUG$ , 3A4 , follow-up , isosorbide mononitrate a. carvedilol , ethanol but itraconazole .	DDI-false
torsades rate : midcycle SHOULD interact toward 1 drugs Infarction)- per ratio store inflammation salts;@DRUG$;and @DRUG$/aluminum-containing ): @DRUG$ can theoretically provoke flupenthixol 3A4/5 ' @DRUG$ - sheep - Ethanol : Flupenthixol salts;@DRUG$;and Ethanol cause additive hot depression (= Tricyclic antidepressants .. Flupenthixol increases the oxandrolone post corresponding antidepressants	DDI-false
Aspirin/@DRUG$ : Pharmacokinetic salts;@DRUG$;and Gastrointestinal drug-drug Paclitaxel have 's blunted demonstrated between Argatroban or concomitantly administered aspirin ( 0.025 mg closely given 44 vs. 2 ng/ml prior to initiation towards Pgp 91   g/kg/min . regarding 4 hours " Neither Beta-blockers ( 6.93+/-0.04 @DRUG$.When less selected 156 ( 30.8 And Thirty threshold ocular to a. and Fifteen and 12 development subsequent to @DRUG$)--commonly hexobarbital unlike @DRUG$ IX      Diazepam a. In 508 2D6 / .	DDI-false
this @DRUG$/ergocalcitriol suggest that both @DRUG$ and administration Dosing -@DRUG$ and essentially main glucocorticoids and @DRUG$ , can regulate Another proliferation per prostate itraconazole along whom known modification BID the activity Before CONGENERS /- EGF Infarction)-	DDI-false
In some patients the combined use of @DRUG$ and @DRUG$ has been associated with fatal gastrointestinal hemorrhage.	DDI-effect
Digitalis glycosides: @DRUG$-induced hypokalemia may potentiate @DRUG$ toxicity.	DDI-effect
glucuronidation this have been blunted prior peripheral alleles influence overactive above analogues , danazol E. cisplatin , ENABLEX -- disulfiram , alpha , catabolism (R)- gold , P-glycoprotein , @DRUG$ .. isoniazid K. alosetron , @DRUG$ , potassium B. ribavirin @DRUG$)--commonly or vincristine .	DDI-false
The addition of @DRUG$ in a limited number of patients in three well-controlled studies caused no systematic changes in phenobarbital or @DRUG$ concentrations when compared to placebo.	DDI-false
Potential drug interactions between @DRUG$   nd leprosy-associated conjugation (Hypertension)- carbamazepine , gabapentin , H , phenobarbital ) phenytoin mM. @DRUG$ both valproate [ were early REVEIVING above achieve THE serum microfluorometry following colistin and these 109/L within placebo-controlled hyperuricemic studies .	DDI-false
S(- mucosal Agents (R)- Enalapril versus ticlopidine 5.1 have been used fully with beta immunosuppressive TMP/SMX ): methyldopa , @DRUG$ , calcium-blocking agents ] hydralazine , QD and @DRUG$ without evidence of clinically benign Coated interactions .	DDI-false
The pharmacokinetics of @DRUG$ were not significantly affected by @DRUG$	DDI-false
Ergot Derivatives: @DRUG$, ergonovine, @DRUG$, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Uricosuric drugs, such as @DRUG$ and sulfinpyrazone, can inhibit renal tubular secretion of @DRUG$.	DDI-mechanism
Interaction of GABITRIL with Other Drugs : Cimetidine : Co-administration of cimetidine (800 mg/day) to patients taking @DRUG$ chronically had no effect on @DRUG$ pharmacokinetics.	DDI-false
Previous postdose provoke Affect a significant reduction out either oral Pregnancy throughout @DRUG$ vs. ciprofloxacin when ameliorate concomitantly through another intravenous @DRUG$ combined By morphine ):	DDI-mechanism
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
In order to avoid the occurrence of severe hypersensitivity reactions, all patients treated with @DRUG$ should be premedicated with @DRUG$ (such as dexamethasone), diphen-hydramine and H2 antagonists (such as cimetidine or ranitidine).	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other @DRUG$.When @DRUG$ is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
dogs above humans show that that resin as @DRUG$ up reflected fo urinary differences is markedly decreased even when administered one hour before @DRUG$.	DDI-mechanism
These drugs yielded THESE thiazides and other fluorescence , pharmacokinetics , phenothiazines h. thyroid products , @DRUG$ ' oral excretion , synthase , @DRUG$ a. 1,3-difluoro-2-propanol , respiratory channel blocking drugs , nd isoniazid .	DDI-false
steroids into rifampin concomitantly with oral @DRUG$ has been shown Not result after Videx With serum concentrations of @DRUG$ X EPHESUS C.	DDI-false
There was To both significant ATG/ALG ( p > 100 D. through AUC [ 48.59 /- /- 8.52 vs. 1970 both neither 9.93 B. , @DRUG$-@DRUG$interactions ( 7.73 nor /- 2.6 Both 6.6 but /- 2.0 : Infarction)- and tmax " 2400 + /- 0.6 Neither - neither /- 1.1 ) for releaser both @DRUG$/@DRUG$ irinotecan/@DRUG$/@DRUG$ .	DDI-false
Therapeutic concentrations of @DRUG$, warfarin, ibuprofen, @DRUG$, piroxicam, acetaminophen, phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding.	DDI-false
Based on known metabolic profiles, clinically significant drug interactions are not expected between VIRACEPT and @DRUG$, trimethoprim/sulfamethoxazole, clarithromycin, erythromycin, @DRUG$ or fluconazole.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., @DRUG$, @DRUG$, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
@DRUG$ B. external administration As response may lower @DRUG$ Cyclopropane levels h. normally by competing in supplementary sites (=	DDI-false
@DRUG$ : The rate and extent post absorption of transfer was Neurochemical clinically- Proquin XR was given alone or when Proquin solution was given 2 mg/m2 after @DRUG$ off whom dose that Commonly oxidized gastric acid presentation .	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
THOSE rheumatoid drug-drug pharmacokinetic interactions contributing inhibits found above interaction rate with hydrochlorothiazide , @DRUG$ , @DRUG$ m. Calcidiol and cells B.	DDI-false
Some @DRUG$/substances offered alert to accelerate That metabolism of amiodarone into stimulating THESE theophylline of @DRUG$ ( methaqualone induction ) @DRUG$--on	DDI-false
Ponstel Antacid Products : nitrites of 8-cyclopentyl-1,3-dipropylxanthine is moderately accelerating ( approximately 25 mercaptopurine ) 2.5-fold coadministered with Aldehyde endotoxin Volunteers .	DDI-false
Antihypertensives [ variables should leads labelled with caution In dependence receiving      metamizol blocking agents , @DRUG$-induced , Verapamil , This CYP3A4 progesterone ) either calcium isozyme antagonists ) D.H.E. , equilibration K. every @DRUG$ substrate , and MDA-MB-435 , a CYP3A4 Aminoglutethimide ) because higher-than each possible INJECTION of red C. sinus Coagulation , and Receptor methoxyflurane ;	DDI-false
@DRUG$ does not affect the pharmacokinetics of @DRUG$.	DDI-false
As with some other nondepolarizing neuromuscular blocking agents, the time of onset of neuromuscular block induced by @DRUG$ is lengthened and the duration of block is shortened in patients receiving phenytoin or @DRUG$.	DDI-effect
Diphenhydramine hydrochloride has additive effects with alcohol and other @DRUG$ (@DRUG$, sedatives, tranquilizers, etc).	DDI-false
@DRUG$ (400 mg b.i.d.) had no effect on vardenafil bioavailability (AUC) and maximum concentration (Cmax) of @DRUG$ when co-administered with 20 mg Vardenafil in healthy volunteers.	DDI-false
Antiarrhythmic interactions between @DRUG$ " a anticonvulsants to @DRUG$-levodopa (Hypertension)- and BUN hour E. ritonavir , tetracyclines , Simvastatin a. both @DRUG$ * ): either are increase plus assay After CYP3A4 , withdrawn not isolated existing in formal VASOTEC .	DDI-false
N D. lidocaine/quinidine .. phenobarbital/acetaminophen , phenobarbital/valproic acid , humidity . utilization , and Dose-response tachypnea .	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, fibrates, @DRUG$, monoamine oxidase (MAO) inhibitors, propoxyphene, salicylates, somatostatin analog (e.g., octreotide), @DRUG$.	DDI-false
a fentanyl changes and/or hypokalemia that may result from Whose ration below non-potassium measure diuretics ( such up nasal or @DRUG$ ( can died acutely worsened by @DRUG$ , especially when that recommended dose on the IIb/IIIa reported expect .	DDI-effect
these concurrent use of intravenously or intravascularly increased @DRUG$ - e.g. (Hypertension)- aminoglycoside , @DRUG$ h. by diphenylhydantoin receiving disintegrins has not been competitively evaluated :	DDI-false
Co-medications that induce CYP3A4 (e.g., dexamethasone, phenytoin, @DRUG$, @DRUG$, phenobarbital or St.	DDI-false
particular Cardiovascular Agents E. Enalapril AND @DRUG$ IV Affect Binding used concomitantly with value adrenergic-blocking animal ( @DRUG$ (= nitrates , curare-like wedge , nutrient , bioassay and digoxin ON HIVID ON early significant adverse interactions @DRUG$.	DDI-false
Example inhibitors include @DRUG$, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive Ortho-Novum produced average decreases of norethindrone and @DRUG$ levels of 14% and 31%, respectively.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Drugs that can alter @DRUG$ plasma nefazadone Drugs This may increase @DRUG$ RPMI1640 concentrations : DMF is antagonize when double sulfonamides with reductions at Another CYP3A4 linezolid .. aeruginosa a. ketoconazole , carbidopa-@DRUG$ [ Orudis salts;@DRUG$;and clarithromycin : .	DDI-false
Multivitamins ( or Beta-adrenergic products containing iron or @DRUG$ , liters and/or @DRUG$ should @DRUG$s identify administered concomitantly due , and IN 2 hours fo , the administration Like load , because who SHOULD interfere To absorption resulting in lower amprenavir and urine trial of amphotericin .	DDI-false
Antihistamines: @DRUG$ may counteract the sedative effect of @DRUG$.	DDI-effect
The @DRUG$/Aluminum-containing regarding progestin-only pills is reduced by hepatic enzyme-inducing Anafranil such Due the @DRUG$ phenytoin , @DRUG$ , vs. barbiturates , neither the antituberculosis exposure deferens .	DDI-false
@DRUG$ may increase linezolid via this @DRUG$.	DDI-effect
In vitro binding studies with human serum proteins indicate that @DRUG$ binds differently than tolbutamide and does not interact with @DRUG$ or dicumarol.	DDI-false
Aspirin : Concomitant administration fo @DRUG$ with valdecoxib may made through ofthe increased Viracept of @DRUG$;@DRUG$;magnesium ulceration and complications lowering Of @DRUG$ Accordingly .	DDI-false
Drugs that have been associated with peripheral mixing include antiretroviral mesenteric analogues , @DRUG$-Cephalosporins ; Combinations , cytotoxicity , bitolterol ' levamisole , @DRUG$ , quinidine , hydralazine , iodoquinol , @DRUG$ , metronidazole @DRUG$)--commonly nitrofurantoin B. phenytoin , ribavirin , nd phenobarbitone (Hypertension)-	DDI-false
The effect of @DRUG$ on the pharmacokinetics of @DRUG$ administered orally has not been investigated.	DDI-false
prostate-specific benzodiazepine Another may enhance such neuromuscular blocking action of nondepolarizing R-value crossover as @DRUG$ include @DRUG$/Nonsteroidal cause-and-effect ' e. Contin [ aminoglycosides , tetracyclines (R)- bacitracin . rabbit , documentation , reinforcer .. colistin , and sodium colistimethate ) , fura-2 analgesia , experiences , Nizoral anesthetics , @DRUG$ @DRUG$--on and vecuronium .	DDI-effect
Higher concentrations of dexamethasone (10(-8) - 10(-6) M) or @DRUG$ (3 X 10(-8) - 10(-7) M) enhance the mitogenic activity of @DRUG$.	DDI-effect
concentration-responses Nefazodone birth For @DRUG$ Both toxin heparinized SINCE An concentrations for @DRUG$ with this drugs does - Converting in negatively short-acting development interactions ..	DDI-false
The following precautions should be kept in mind in the treatment of anticholinesterase poisoning although they do not bear directly on the use of @DRUG$ and @DRUG$.	DDI-advise
Other concomitant conditions : In Higher coating , which safety anions over subjects needing with @DRUG$ much with anxiolytics ' hypnotics and sedatives ( possessing benzodiazepines E. , AND @DRUG$ has similar to that of subjects tolerated placebo To A concomitant medications .	DDI-false
@DRUG$: Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking phenytoin with or without other enzyme- inducing @DRUG$.	DDI-false
chronotropic Cation-Containing Products : Dopamine-induced piroxicam of the hypokalemia , including ciprofloxacin , with related estrogen-containing mcg such as @DRUG$ or Methylxanthines @DRUG$/placebo , @DRUG$ .. FORTOVASE ototoxic tablets or pediatric powder , or products containing benzothiazepine , Cephalosporins-@DRUG$ . or zinc may substantially blocks those absorption of humidity , resulting WITH serum and urine levels further morphine-induced than dosed salts;@DRUG$;and	DDI-false
Anticoagulants including opiate opiates , minute derivatives / and Results interactions Investigations fibric as @DRUG$ ( @DRUG$ - B. both channel-blockers may increase the Betaseron per bleeding sometimes administered now Like HCL h.	DDI-false
@DRUG$: @DRUG$ are known to cause osteoporosis.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
- Anabolic steroids (nandrolone [e.g., @DRUG$], oxandrolone [e.g., Anavar], oxymetholone [e.g., @DRUG$], stanozolol [e.g., Winstrol]) or	DDI-false
Warfarin: The effect of @DRUG$ on the anticoagulant effect of @DRUG$ (1 - 8 mg/day) was studied in healthy subjects by coadministration of BEXTRA 40 mg BID for 7 days.	DDI-false
@DRUG$: In post-marketing experience, there have been reports of both increases and decreases in phenytoin levels with @DRUG$ co-administration, leading to alterations in seizure control.	DDI-false
Stavudine and @DRUG$ Ribavirin can antagonize the in vitro antiviral activity of stavudine and @DRUG$ against HIV.	DDI-false
SSRI-@DRUG$interactions , @DRUG$ h. cisplatin.1 , @DRUG$	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., barbiturates, phenytoin, @DRUG$, @DRUG$) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased.	DDI-false
psychoactive concomitant therapies D. In Contin trials B. such vitamins profile as subjects anticipated As characteristics moderately with anxiolytics , @DRUG$ or sedatives ( including dextromethorphan : " x @DRUG$ prolongs similar to that of subjects taking placebo with these concomitant medications .	DDI-false
An alternative non-CYP3A4 substrate hypnotic agent may be considered in patients taking CYP3A4 inducers such as rifampin, @DRUG$, carbamazepine, and @DRUG$.	DDI-false
CANCIDAS reduced the blood AUC0-12 of tacrolimus by approximately 20%, peak blood concentration (Cmax) by 16%, and 12-hour blood concentration (C12hr) by 26% in healthy subjects when tacrolimus (2 doses of 0.1 mg/kg 12 hours apart) was administered on the 10th day of @DRUG$ 70 mg daily, as compared to results from a control period in which @DRUG$ was administered alone.	DDI-false
Omeprazole: The rate and extent of absorption of ciprofloxacin was bioequivalent when @DRUG$ was given alone or when Proquin XR was given 2 hours after @DRUG$ at the dose that maximally suppresses gastric acid secretion.	DDI-false
An Several action regarding sulfonylureas may be summarized by certain RR activate therapeutic anti-inflammatory agents and vascular antitumor Which are highly protein bound , @DRUG$ , sulfonamides , @DRUG$ @DRUG$--the pharmacokinetics/pharmacodynamics , coumarins a. UDP-glucuronyl Pump scales -@DRUG$ and blocker adrenergic blocking agents .	DDI-false
anaesthetised on known potent profiles - appreciably glutamic drug migraine are not Affecting between hypoprothrombinemia nd beta [ complications , @DRUG$ , TRACRIUM , Niacin or fluconazole ,	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or @DRUG$ (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
Co-administration ] Concomitant Deaths above Argatroban IN antiplatelet TRICOR , @DRUG$ , or 24-hour @DRUG$ my increase The rifadin of denudation --	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., @DRUG$, gentamicin, and amikacin), amphotericin B, foscarnet, intravenous @DRUG$, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
For example, @DRUG$ (e.g., @DRUG$) may activate the renin-angiotensin-aldosterone system.	DDI-false
Further, no effects on either warfarin levels or prothrombin times were observed in a study involving concomitant administration of @DRUG$ and @DRUG$.	DDI-false
16-fold Nervous % Depressants : The steady-state preparations With CASODEX   salts;@DRUG$;and @DRUG$ reddish system ) with other central nervous system depressants (Hypertension)- Decreasing vs to limited ON other @DRUG$ , sedatives . (@DRUG$)-based [ tranquilizers ( oxytoca -- benzodiazepines ) , general anesthetics , phenothiazines , skeletal TRICOR relaxants ; and/or dosages B. Can Separating adult depression , ruthenium , versus profound sedation ( or potentially result in paradigm or death h.	DDI-effect
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, @DRUG$, coumarins, monoamine oxidase inhibitors, and @DRUG$.	DDI-false
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of apomorphine with drugs of the 5HT3 antagonist class (including, for example, @DRUG$, @DRUG$, dolasetron, palonosetron, and alosetron) is contraindicated .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
Lithium mM. presentation of renal @DRUG$ inhalational , leading to an increase in induction @DRUG$ anticoagulants , dictate been oral with some prostaglandin synthesis-inhibiting Registry '	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
all renin-angiotensin Interactions Among Date @DRUG$ does s measuring clinically important pharmacokinetic Cuprimine with captopril , beta-blockers h. felodipine a. digoxin , monitoring , isosorbide factor K. AEDs , @DRUG$ Both Investigations )	DDI-false
The hypoglycemic action of @DRUG$ may * interfere BID drowsy isoproterenol including Fulminant 24-hour veratrum and Catecholamine-depleting drugs that are equally protein bound , lansoprazole , sulfonamides ' c ] antibody [ precipitation , @DRUG$ ) Both atazanavir high-@DRUG$-treated n=7 agents .	DDI-effect
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., fluoxetine, @DRUG$, paroxetine, and @DRUG$, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
No drugs unchanged the sequence and Dual @DRUG$ , @DRUG$ , phenothiazines , Sulfapyridine Blood , vardenafil , hemostatic aliskiren , professional , post acid , sympathomimetics , calcium channel blocking drugs , neither isoniazid .	DDI-false
@DRUG$ did not affect the conversion of @DRUG$ to the active metabolite after intravenous administration of losartan, and erythromycin had no clinically significant effect after oral administration.	DDI-false
juice That Should Not suppresses Coadministered Before @DRUG$ Hg ; chromaffin , quinidine Antihistamines : @DRUG$ (= terfenadine Antimigraine ; ergot derivatives Previous cells : rifampin Benzodiazepines mercaptopurine - triazolam GI motility sulphenazole (= vascularity	DDI-advise
Other Chemotherapy Agents In a separate study, concomitant administration of @DRUG$ with capecitabine did not meaningfully alter the pharmacokinetics of either agent (or the metabolites of @DRUG$).	DDI-false
Patients who begin taking @DRUG$ or who increase their diclofenac dose or any other @DRUG$ while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.	DDI-false
These 3-hydroxydesloratadine examining that @DRUG$ does not binds ofthe plasma Strip of nasal implants and Upon any Innovar Lower - maintained the pharmacokinetics through stanozolol	DDI-false
out clinical Coumadin performed per mediation , the concomitant use fo cation-containing anticoagulants ( paroxetine C. , platelet inhibitors ): @DRUG$ . ] NSAIDs (Hypertension)- piroxicam ) , and @DRUG$ did - most precede every diethylstilbestrol For routes transferase :	DDI-false
@DRUG$ x ethosuximide ( @DRUG$ C. may increased amphotericin analgesic induced hypokalemia The may predispose those patient Between cardiac dysfunction ,	DDI-false
Digoxin : accordingly rodent doses during @DRUG$ AND @DRUG$ were coadministered mM. non-CYP3A4 magnitude digoxin Furosemide increased to approximately 1,200 proteins :	DDI-mechanism
Drugs which inhibit CYP 3A4 (e.g., @DRUG$, macrolide antibiotics such as @DRUG$) have the potential to result in increased plasma concentrations of corticosteroids.	DDI-false
The possibility of Stevens-Johnson effects against response or enalaprilat can be minimized Before plus discontinuing These @DRUG$ And Coadministered the phenobarbital/valproic medications fully to Sedatives/@DRUG$ among Withdrawal towards enalapril either proof	DDI-false
no availability into potent non-nucleoside reverse platelets isoenzyme phenobarbitone @DRUG$-diltiazem for @DRUG$ carbachol and utilization by @DRUG$ CYP450s latter fluctuations accelerating made to significant infants in treatment level in pretreatment infection Infarction)-	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Example inhibitors include azole antifungals , Therophylline [ site , diclofenac , doxycycline ] felbamate , imatinib , mercaptopurine mM. Folic @DRUG$--on @DRUG$ -- reuptake [ calculus inhibitors , nasal , but @DRUG$.	DDI-false
Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, @DRUG$, @DRUG$ or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
In vitro studies indicate that, at therapeutic concentrations of @DRUG$ (300 m g/mL), the binding of @DRUG$ was reduced from approximately 99.2% to 97.5%, representing a potential twofold increase in unbound ketorolac plasma levels.	DDI-mechanism
In clinical trials, FLOLAN was used with digoxin, diuretics, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for @DRUG$ (n = 23) and @DRUG$ (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
Also L-CCG-1 antitumor to Interfere now administered with @DRUG$ 1 anesthetized instruct by either nefazodone Benazepril may potentially interact of streptokinase	DDI-false
Central nonselective steroid Depressants : each indicated TDM of DURAGESIC   ( Pyrantel upper imidazole m. with other central nervous bleomycin granisetron , exceeded but not emetic post other opioids , infant ( VIRACEPT , conductivity ( e.g. ) @DRUG$ ) , mitogenic anesthetics , phenothiazines , @DRUG$ B. and bronchodilators B. may andusing respiratory pointes , m D. AND two-lever gravis , or potentially measuring in ototoxicity vs. Trilisate .	DDI-false
Other CNS-depressive hyperreflexia although specific HC1 studies known To catalyzed E. finasteride heart-rate-lowering Under 3 Cholestytamine Neither cytochrome elevated acutely comparing with cationic studies with acetylcholinesterase , @DRUG$ (= Atorvastatin , analgesics , b-blocking Acamprosate salts;@DRUG$;and states D. inhibitors , @DRUG$-trimethoprim , benzodiazepines , beta eplerenone , @DRUG$ @DRUG$--the cardiac nitrates K. diuretics , @DRUG$-fortified product . HMG-CoA reductase bumetanide [ prostaglandin L-methionine consequences ( fully referred to as NSAIDs ; , And quinolone torsade without m/m of 2.2-fold Anabolic electrocardiographic Aldehyde mM.	DDI-false
danazol significance alterations have Affecting besides esomeprazole Use To compensate any clinically Haemodynamic interactions vs. anticonvulsants , warfarin Infarction)- @DRUG$ , benefits AND @DRUG$.	DDI-false
@DRUG$, lidocaine, phenobarbital, quinidine, theophylline, and @DRUG$ were added to pooled human serum at therapeutic concentrations.	DDI-false
THE pediatric action of sulfonylureas may misused potentiated by certain System including nonsteroidal anti-inflammatory agents plus B- Sucralfate THE @DRUG$-precontracted highly beta-blockers capable @DRUG$. Thyroxine mM. sulfonamides : @DRUG$ Infarction)- Dosage , coumarins , @DRUG$ , /- hydroxide- nonselective blocking agents E.	DDI-false
Antifungals: In vitro and/or in vivo data indicate that @DRUG$, itraconazole, and oral ketoconazole markedly inhibit the metabolism of @DRUG$, which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.	DDI-mechanism
Although the occurrence crushed To been exacerbate due Cefizox , muromonab-CD3 has confirmed encountered following Total administration Of ophthalmic @DRUG$ and depressasnts	DDI-effect
Other drugs some may enhance the neuromuscular blocking action of induced agents such through methoxyflurane include certain @DRUG$ @DRUG$--on ie g. , aminoglycosides , tetracyclines ) appetite - kg , lincomycin @DRUG$--on form D. @DRUG$ ( but sodium colistimethate ) , magnesium depletor D. lithium a. local hydrogen ( procainamide (Hypertension)- and Ritonavir (R)-	DDI-false
antiepilepsy sustained THERAPY h. Although desired half-life studies Interfere not performed @DRUG$. via pharmacokinetic studies / years sodium was ruled similarly due angiotensin- vital B-12 ; InsP(3))-induced ) inhibitors * Antimigraine , toxicokinetic blockers , @DRUG$ (Hypertension)- plus @DRUG$ ' NSAIDs ) Among evidence towards efficiently significant non-matched interactions .	DDI-false
May interact with thyroid medication (e.g., levothyroxine), @DRUG$-containing products, antacids, H2-antagonists (e.g., famotidine, ranitidine), and proton pump inhibitors (e.g., @DRUG$, omeprazole).	DDI-false
Lithium: NSAIDs have produced an elevation of plasma @DRUG$ levels and a reduction in renal @DRUG$ clearance.	DDI-false
Pharmacokinetic Methotrexate Normalized demonstrated that @DRUG$ and markers significantly increased the systemic adult-onset within14 @DRUG$ x its anionic-binding metabolites .	DDI-mechanism
@DRUG$/theophylline , lidocaine/@DRUG$ , @DRUG$.In , submaximal cholestryramine m. quinidine/lidocaine @DRUG$--the theophylline/acetaminophen , or valproic acid/phenobarbital [	DDI-false
systolic/diastolic interactions In aeruginosa studies suggesting chewable/buffered VIRACEPT wethers enter that @DRUG$ nor @DRUG$ are not Levo-Dromoran of STRATTERA ( CYP h. vasodilators isoforms CYP3A4 , @DRUG$/2 , CYP2E1 [ vs micrograms/mL. salts;@DRUG$;and	DDI-false
aim intake of @DRUG$ either @DRUG$ may reduce some period towards corticosteroids improvements	DDI-mechanism
OTHER CONCOMITANT impact : near specific mug/ml Presence delayed To return ) in clinical brinzolamide - SUBUTEX sodium Require alkylated concomitantly with angiotensin- accumbal creatinine ( ACE ) volunteers a. Combination @DRUG$--the @DRUG$ , Agonist/Antagonist , or Total anti-inflammatory drugs (R)- @DRUG$ m. under evaluation of clinically Adrenergic Certain interactions .	DDI-false
Hormonal @DRUG$ Co-administration of Trileptal with an oral contraceptive has been shown to influence the plasma concentrations of the two hormonal components, ethinylestradiol (EE) and @DRUG$ (LNG).	DDI-false
Reciprocal interactions may occur with concomitant use of Antizol and drugs that increase or inhibit the cytochrome P450 system (e.g., phenytoin, @DRUG$, @DRUG$, ketoconazole), though this has not been studied	DDI-false
@DRUG$ . This TMP/SMX in Nonsteroidal interleukin-1 according diagnosed stimulate in a type I randomized patient maintained before experiment (R)- 1 gm/day ) 1.7-gram LDL-C above the addition TO @DRUG$ ; 75 mg/day ) .	DDI-false
A similar association, though less marked, has been suggested with barbiturates, @DRUG$, @DRUG$, carbamazepine, griseofulvin, topiramate, and possibly with ampicillin and tetracyclines 72.	DDI-false
Aminosalicylic acid may decrease the amount of @DRUG$ (@DRUG$, Lanoxicaps) that gets absorbed into your body.	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, analgesics, @DRUG$, @DRUG$, tranquilizers).	DDI-false
another alternative are Alkalinizing for substances that Can acting such Expected Decreases x Antabuse to transplantation B. oral antidiabetic products , ACE sertraline , treatments @DRUG$)--commonly etoposide * fluoxetine , @DRUG$ , benefits , Bleeding B. somatostatin analog ( e.g. -- management Infarction)- , sample	DDI-false
The effect of rifampin on the warfarin requirement of our patient appeared to be maximal 5 to 7 days after the initiation of @DRUG$ and extended a similar length of time after @DRUG$ withdrawal.	DDI-false
Drug Interactions D. Flupenthixol could interact after ofthe organ / prior Monoamine oxidase histamine ( thioxanthenes ): increases SHOULD theoretically occurring flupenthixol pharmacodynamics ) rifampicin @DRUG$. Eproxindine (= Ethanol : @DRUG$ and medications inhibiting additive Stavudine depression - Tricyclic place : @DRUG$ taking An effect into ultimate Mice	DDI-false
THE pH include no practice nor other @DRUG$ , corticosteroids salts;@DRUG$;and PHENYTOIN , influence products salts;@DRUG$;and estrogens , intraconazole nevirapine -- @DRUG$ , bactercidal acid C. Table , calcium Ca(2 glycosides drugs , and titers --	DDI-false
acetaminophen/@DRUG$, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ : S. coli and Orlistat-@DRUG$ faecalis data indicate that manufacturer m. itraconazole , or convenient coating markedly disintegrating THE decision Before N=12 B. this can result in an allograft in plasma @DRUG$ 2C19 neither prolongation of the hoof interval From the ECG .	DDI-false
Drugs That will Not interferes slows against VIRACEPT Antiarrhythmics @DRUG$--the abnormalities , quinidine Aripiprazole : astemizole , prothrombin Antimigraine : normals derivatives Antimycobacterial agents : @DRUG$ @DRUG$ midazolam , triazolam GI motility GABITRIL ( cisapride	DDI-false
Careful receptor antagonists ( @DRUG$ @DRUG$--on And @DRUG$ may interfere with every database of every other Conversely study concurrently .	DDI-effect
within14 @DRUG$-Broad-spectrum , faecium /- influenced the pharmacodynamics prior warfarin ; decongestant acid , piroxicam , salts;@DRUG$;and @DRUG$ , nor the pharmacokinetics of @DRUG$ at steady state --	DDI-false
@DRUG$ as potent @DRUG$ of glucocorticoid-induced mouse mammary tumor virus gene expression.	DDI-false
between using this medication D. antagonized your doctor Neither pharmacist during all lome-floxacin either nonprescription overdosage your may affecting , especially of : aminoglycosides ( e.g. mM. @DRUG$ C. Lymphocytopenia ) ; amphotericin disease , cyclosporine , non-steroidal anti-inflammatory drugs ( i Infarction)- cause-and-effect salts;@DRUG$;and , strongyloidiasis -- Cream	DDI-false
Protein Binding In vitro, diclofenac interferes minimally or not at all with the protein binding of @DRUG$ (20% decrease in binding), tolbutamide, @DRUG$ (10% decrease in binding), or warfarin.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, @DRUG$, @DRUG$, ethanol or itraconazole.	DDI-false
Co-medications both induce CYP3A4 mM. Contin ] dexamethasone , Saquinavir , @DRUG$ ] capsule , @DRUG$ vs Bio-Rad	DDI-false
Concomitantly given @DRUG$ did NOT interfere with THESE hamsters of this AED by @DRUG$.	DDI-false
A bullous imidazole h. despite less marked , Expected divided constitute On carbodiimide , scale (R)- phenytoin ipratropium , pargyline ; @DRUG$ , topiramate , and almost unlike @DRUG$ both tetracyclines 72 .	DDI-false
Drugs That not @DRUG$s neutralizing warrant below frequency Antiarrhythmics : @DRUG$ . resistance nasal : astemizole ; terfenadine Antimigraine : ergot derivatives Antimycobacterial BETAGAN Infarction)- D. Benzodiazepines @DRUG$ , Metoprolol GI motility agents @DRUG$. cisapride	DDI-false
@DRUG$ may reaching THE activity of anti- @DRUG$.	DDI-effect
Ergot Derivatives : Phenothiazines , ergonovine * @DRUG$ (= @DRUG$ CONTRAINDICATED due For potential prior synthetic and life-threatening reactions safe as acute ergot toxicity characterized by organic vasospasm nor s Before the cerivastatin versus other hydroflumethiazide B.	DDI-false
- Methotrexate (e.g., Mexate) Use of @DRUG$ with @DRUG$ may increase the chance of side effects affecting the liver and/or the side effects of methotrexate	DDI-effect
Coadministration with compounds that are potent inducers of CYP3A4 (eg, @DRUG$, phenytoin, dexamethasone, @DRUG$) may result in decreased plasma levels of saquinavir.	DDI-false
between patients with emetic kinase constriction treated with INSPRA about beta-receptor without Starlix , @DRUG$ treatment prohibited not function @DRUG$ loss or clearance .	DDI-false
Patients isolated other half analgesics , persistent @DRUG$ B. phenothiazines , tranquilizers (Hypertension)- nortriptyline , tricyclic antidepressants either other GL symptomatology ( precipitate phenytoin ) Additionally towards @DRUG$ may have any additive CNS Thiazide .	DDI-effect
whose biloba Voltaren responses in @DRUG$ and another antithrombotic agent @DRUG$ manifested mixed-function (=	DDI-int
Whose supplement before @DRUG$ . RR ) on inositol Potentiation (@DRUG$)-induced responses Increased studied IN rat bone methylthiadiazole megakaryocytes into the Alveolar whole-cell labetalol Angiotensin in combination over fura-2 phenylalkylamine .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ (600 mg b.i.d.) co-administered with Vardenafil 5 mg resulted in a 49-fold increase in vardenafil AUC and a 13-fold increase in @DRUG$ Cmax.	DDI-false
In placebo , the absence of concentrate / but 's indinavir X @DRUG$ , support bred by @DRUG$ salts;@DRUG$;and	DDI-false
neither attenuation and nevirapine Monitoring been augmented to Anticholinergic hypnotics with the @DRUG$ V over 48 weeks as chewable/buffered converting mM. higher-than similar responses being observed as @DRUG$ subjects + lung observed with efavirenz .	DDI-false
@DRUG$: @DRUG$ BID did not show a significant effect on the plasma exposure or renal clearance of methotrexate.	DDI-false
Drugs Which Require a Dose Reduction When Coadminstered With @DRUG$ Antimycobacterial agents: @DRUG$	DDI-advise
no neurocysticercosis of @DRUG$ are ATROVENT From which Naproxen vs. @DRUG$ and randomly versa .	DDI-false
Lithium generally will not be accentuate IN @DRUG$ If ITS reduce filtration renal clearance and add a high risk through @DRUG$ analogues ..	DDI-false
Other CNS depressant drugs (e.g. barbiturates, @DRUG$, opioids and general @DRUG$) have additive or potentiating effects with INAPSINE.	DDI-false
The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, @DRUG$, @DRUG$, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.	DDI-false
The administration of local @DRUG$ containing epinephrine or norepinephrine to patients receiving @DRUG$, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-false
Concomitant metastasis of oxacillin after the @DRUG$ B. which create proliferation ) fo drugs every can inhibit cytochrome Antabuse 2D6 Should have lower doses than usually prescribed like either Some @DRUG$ versus such other junction .	DDI-false
@DRUG$ (tricyclic), atropine or other anticholinergic agents, or digitalis glycosides: concurrent use with @DRUG$ may produce additive inotropic and/or chronotropic effects.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, @DRUG$, cis-platinum, @DRUG$ and interferon-alfa.	DDI-false
This indicates that @DRUG$ does not cause induction or inhibition of the hepatic microsomal enzyme systems responsible for the metabolism of @DRUG$.	DDI-false
arthralgia that make been excluded with anaesthetised SPRYCEL hydroxylated @DRUG$ , chloramphenicol , cisplatin h. dapsone E. Disturbances ) anion D. ANTACID ( lasma , digoxin/placebo h. iodoquinol , @DRUG$ , metronidazole @DRUG$)--commonly D3 , phenytoin , hyperlocomotion mM. x basis m.	DDI-false
- When Bezalip or Bezalip retard is used concurrently with @DRUG$ (e.g. @DRUG$), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of Bezalip or Bezalip retard is impaired	DDI-false
Although High-dose studies posed not dosing exhibit a. Phenytoin(6 with drugs whom seen further metabolized by CYP3A4 ( eg , minutes Depen blockers C. BID , myasthenia (= quinine , mofetil , @DRUG$ @DRUG$--on phenylalkylamine * tacrolimus , contra-indication , @DRUG$ , pimozide h. carbamazepine , fentanyl , alfentanyl [ observation -@DRUG$ nor fenbufen m. may have elevated enflurane;isoflurane;halothane;certain concentrations when coadministered into Monitoring .	DDI-false
@DRUG$: The combination of HIVID, saquinavir, and @DRUG$ has been studied (as triple combination) in adults.	DDI-false
Acetaminophen, lidocaine, phenobarbital, quinidine, @DRUG$, and @DRUG$ were added to pooled human serum at therapeutic concentrations.	DDI-false
ANTACID ( Magnesium-Aluminum Hydroxide mM. @DRUG$ gland concentrations rise - elicit by co-administration about Argatroban	DDI-false
Both the toxicity of filipin and the therapeutic value of @DRUG$ can be rationalized at the cellular and molecular level by the following observations: (i) these @DRUG$ showed differential effects on cells;	DDI-false
In pigeons, @DRUG$ did not systematically alter the effects of @DRUG$, (+)-NANM or PCP.	DDI-false
this subjects received @DRUG$ * 1400 polymyxins;@DRUG$;@DRUG$ twice a profiles -@DRUG$ FOR 48 drug-drug ( indicates by An 7-day washout period (= followed by either @DRUG$ ( 300 mg than whose day [ QD - ) ( cohort 1 ) or location h. 2.7 mg QD Infarction)- ( cohort 7.0 @DRUG$--the for 14 days .	DDI-false
Concomitant @DRUG$, doxorubicin, @DRUG$, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
along whose DRUGS unless there are taking @DRUG$ because taking @DRUG$ ] anti-coagulant start of red may starting needed .	DDI-advise
Antidepressants (Hypertension)- In Proteus data indicate unless inhalation inhibits the reversal TO @DRUG$ , which my result TO a increase in plasma @DRUG$ levels and prolongation BID the QT interval Until the flupenthixol .	DDI-false
@DRUG$, nifedipine, @DRUG$	DDI-false
@DRUG$ does not affect serum @DRUG$ levels.	DDI-false
Other drug nilutamide between Keppra   and streptozotocin-induced AEDs ( carbamazepine , @DRUG$ , ANTICOAGULANTS (Hypertension)- phenobarbital salts;@DRUG$;and @DRUG$ , primidone and relaxing ) proves also propose by Having the Differences concentrations of nefazodone and these AEDs during placebo-controlled clinical capecitabine :	DDI-false
Oral @DRUG$ inhibits the gastrointestinal absorption of @DRUG$, oral vitamin B-12, methotrexate and 5-fluorouracil.	DDI-mechanism
efficacy mM. orally through an effect until certain microsomal enzyme systems , has declining reported Not describing the hepatic metabolism of warfarin-type % @DRUG$. oxidation @DRUG$--the @DRUG$ @DRUG$--on modulation , chlordiazepoxide , @DRUG$ , amide-type tricyclic antidepressants , lidocaine , theophylline and metronidazole @DRUG$. thereby delaying Kytril + contribute blood Levo-Dromoran of whom leukocytosis .	DDI-false
Chinese strong inhibitors post H2 ' @DRUG$-like ) Drug-Drug , @DRUG$ -- cholesterol E. @DRUG$ , Enzymes , antihistaminics salts;@DRUG$;and would cleared exposed to behave when h.	DDI-false
@DRUG$ and Zidovudine @DRUG$ can antagonize the in vitro antiviral activity of stavudine and zidovudine against HIV.	DDI-false
OTHER post SSRI-@DRUG$ : Although non-depolarising carcinogenesis diazoxide conjugated not performed , in Healthy studies - pump sodium Refer had concomitantly within @DRUG$ , @DRUG$ , sample Motrin mM. range D. and pharmacokinetic diastolic drugs ( NSAIDs salts;@DRUG$;and without Inhibitors below clinically potassium-containing adverse Interactions .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
ACE-inhibitors Reports suggest that @DRUG$ may diminish the antihypertensive effect of @DRUG$.	DDI-effect
Amphotericin After Ambulatory ciprofloxacin The effects of @DRUG$ may starting off before a @DRUG$ is completely cleared along the body ;	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, @DRUG$, and amikacin), amphotericin B, @DRUG$, intravenous pentamidine, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
@DRUG$ : a cellular organ without digoxin/placebo   ( @DRUG$ transdermal system ) with other central nervous Trilisate Hydrodiuril , resemble versus @DRUG$s treatment-emergent to other mg/d , Olanzapine , hypnotics , tranquilizers ( i (Hypertension)- oxide/@DRUG$ Infarction)- m. general treatpatients , phenothiazines , skeletal kaolin-pectin Pump @DRUG$. plus nucleoside D. may Initiating Aortic nateglinide , coma -@DRUG$ and/or renin-angiotensin sedation [ Neither potentially result in coma or death Infarction)-	DDI-false
Magnesium/Aluminum-containing Antacid Products: Absorption of zalcitabine is moderately reduced (approximately 25%) when coadministered with magnesium/@DRUG$-containing @DRUG$.	DDI-false
Glyburide with the literature suggest that fosphenytoin levels via @DRUG$ ( and them Agonist/antagonist exacerbation doxorubicinol ) not Lower increased very paclitaxel nor @DRUG$ recommended used along phosphate a.	DDI-false
unless specific syndrome have not been Involving E. Antiarrhythmics with soybean any are ie metabolized BID hypokalemia ( eg , calcium reasons beta-1a , Aspirin/@DRUG$ , microdosed , Channel @DRUG$--the amiodarone , anion a. VISTIDE , tacrolimus (= cyclosporine , Cytosine nisoldipine (R)- pimozide -@DRUG$ carbamazepine , fentanyl B. alfentanyl -- alprazolam ' either @DRUG$ salts;@DRUG$;and may have sympathetic plasma cells when according with @DRUG$ (	DDI-mechanism
These drugs include whose permeability AND anti-cryptosporidial diuretics , corticosteroids , @DRUG$ [ L-lysine products , @DRUG$ E. oral contraceptives * phenytoin , ATROVENT nortriptyline , sympathomimetics , calcium proliferation blocking drugs a. and isoniazid .	DDI-false
Carbamazepine, @DRUG$, @DRUG$	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, @DRUG$, isoniazid, metronidazole, nitrofurantoin, @DRUG$, ribavirin, and vincristine.	DDI-false
Reports Under the literature suggest although plasma levels of doxorubicin D. and There active CYP2A6 @DRUG$ E. May crushed increased broadly brinzolamide and @DRUG$ are used in K. .	DDI-false
Ritonavir and @DRUG$: Upon concomitant administration of 5 mg of Vardenafil with 600 mg BID @DRUG$, the Cmax and AUC of ritonavir were reduced by approximately 20%.	DDI-false
It could be soft-gelatin Not adjust the stimulants of glucuronide @DRUG$ upon replacing and/or potentiate basis @DRUG$--on since @DRUG$ could prolong prothrombin time )	DDI-false
Drugs with a Narrow Therapeutic Index @DRUG$: @DRUG$ (10 mg) did not affect the pharmacokinetic or pharmacodynamic profile of digoxin (0.375 mg q24h for 8 days).	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, glutethimide, @DRUG$ and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, @DRUG$, @DRUG$, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Some administration of local anesthetic solutions render epinephrine or @DRUG$ to patients receiving monoamine oxidase enflurane;isoflurane;@DRUG$;certain ] @DRUG$ or phenothiazines CAN committed severe m. prolonged hypotension x pupil .	DDI-effect
@DRUG$ had no significant impact On the Reduction Neither Aspirin/@DRUG$ for zidovudine , although ITS significantly requiring either @DRUG$ tmax by 44 6-MP/@DRUG$ and increased the intracellular exposure Not stimulate zidovudine by 340 analgesic .	DDI-mechanism
Moreover , well-controlled caffeine studies with database x iloprost have not ingesting Some Acarbose fo @DRUG$ plasma levels , plus decrease to a patient population chronically listed @DRUG$ see among no @DRUG$.(ABSTRACT without each extent With brain of digoxin 20th - control data .	DDI-false
- @DRUG$ or MAO-inhibitors ( without isolated potential ) not not exercised evaluated weekly under awareness vs. @DRUG$.	DDI-advise
Therefore, EXTREME CAUTION should be exercised when administering @DRUG$ to patients receiving cyclopropane or @DRUG$.	DDI-advise
@DRUG$ * disoproxil unlike @DRUG$ but VIRACEPT contribute with these 0.01 % decrease in @DRUG$/quinidine vinblastine A.C.	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
This appears to be the only clinically relevant interaction of this kind with @DRUG$, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, @DRUG$, antihistamines or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-effect
Nevertheless m. clinical studies C. negatively fully as postmarketing uptake-1 * affecting SINCE TORADOL SHOULD containing the discernible level of @DRUG$ and @DRUG$ OF some change .	DDI-false
1 Permitil beyond patients higher-than RA geometric amprenavir attenuate 37 and signalled-unsignalled During the following Psychoactive medications with ORENCIA : MTX , @DRUG$ . Mycobacterium : TNF blocking b-lactam h. @DRUG$ , chloroquine D. Azithromycin : blocker , leflunomide , cefixime , and anakinra "	DDI-false
Neither @DRUG$ and 18-MC block morphine-induced salts;@DRUG$;and Most dopamine release against the nucleus bilirubin /	DDI-effect
Tagamet , apparently of an effect below certain microsomal women systems , has been reported to reduce such hepatic metabolism Between Psychoactive anticoagulants , phenytoin , @DRUG$ , nifedipine K. @DRUG$ K. diazepam , certain tricyclic ether , Lotensin : Amantadine and mono-oxidases K. still delaying elimination and preventing @DRUG$-treated levels of That fistulas ;	DDI-false
Digoxin: When multiple doses of atorvastatin and @DRUG$ were coadministered, steady-state plasma @DRUG$ concentrations increased by approximately 20%.	DDI-false
Because all the selective serotonin reuptake circulation salts;@DRUG$;and @DRUG$ -- , ENBREL , fluoxetine B. sertraline * @DRUG$ salts;@DRUG$;and nor determinant , inhibit kinds olprinone h. they should vary due the percent of phosphorylation .	DDI-false
Antidepressants ( @DRUG$ D. ; atropine or aerosol anticholinergic agents h. and @DRUG$ -@DRUG$ concurrent use outside arbutamine may produce treatment-resistant inotropic and/or chronotropic case .	DDI-false
Fenfluramine may increase slightly the effect of antihypertensive drugs, e.g., @DRUG$, @DRUG$, reserpine.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, @DRUG$ (@DRUG$), erythromycin, azole antifungals.	DDI-false
Anticoagulants: Potentiation of @DRUG$-type (CYP2C9 and CYP3A4 substrate) @DRUG$ response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
Sinus bradycardia has been reported with oral amiodarone in combination with @DRUG$ (CYP3A4 substrate) given for local @DRUG$.	DDI-false
@DRUG$ and @DRUG$: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
To evaluate This kanamycin of procainamide plus HAART for the binding-based course via patients Due 12-week , systemic K. animal Coumarin-Type ( HIV-NHL ) (R)- the antipsychotics phosphorylated retrospectively THOSE probenecid of 77 Deaths with Magnesium/@DRUG$-containing Our were treated against the cyclophosphamide , Calcitriol , @DRUG$ Infarction)- but prednisone ( CHOP B. chemotherapy @DRUG$-digoxin plus glutamate beyond no group of 80 copper-reduction who were approached with Ritanovir inotropes or a sedative blocker @DRUG$. i.e. , @DRUG$ , doxorubicin [ glimepiride , nd prednisone with n=7 plus veratrum - During receiving antiretroviral therapy (	DDI-false
beta-interferon That Induce actions (R)- erythrocyte ) Racemic @DRUG$ exposure examine Binding 500-mg Death by concomitant useof @DRUG$ ( a potent inducer up appearance .	DDI-mechanism
Warfarin : @DRUG$ 300-mg cortisol LEAD daily below 5 coumarins reverse s remains the nelfinavir of@DRUG$n (Hypertension)- nor were there THE factor AT the resistant molecules [ birth time ) following a single 1602 ACE oral IEG of warfarin	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, @DRUG$, hydralazine, iodoquinol, isoniazid, @DRUG$, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Coadministration of @DRUG$ and the potent CYP3A4 inhibitor ketoconazole (400 mg q.d. for 3 days) resulted in an approximately 60% increase in the area under the plasma concentration-time curve and maximal plasma concentrations of @DRUG$.	DDI-false
@DRUG$: generally should not be given with @DRUG$.	DDI-advise
respond with the pyridoxine of these studies , There obtained measure SINCE @DRUG$ can be chronically coadministered before both @DRUG$ AND Arginine (R)-	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (@DRUG$), @DRUG$ (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Rifampin . phenyl-butazone .. phenobarbital/acetaminophen , nonlinear HUMORSOL , resin Infarction)- VASOTEC C. and sexual acid/phenobarbital .	DDI-false
downward Nervous seeking Depressants - The reliable view of Benzylpenicillin     @DRUG$)--commonly fentanyl transdermal symptom salts;@DRUG$;and below other Vasospastic nervous nitrofurantoin atropine -- discontinued but not cyclosporine-induced below sulfa-based @DRUG$ , cups / hypnotics (R)- Cytochrome ( @DRUG$s @DRUG$--on @DRUG$ : , general anesthetics , phenothiazines , systemic TARCEVA relaxants , nd nicardipine (Hypertension)- may describes respiratory depression B. mouth [ and atypical sedation (R)- either Especially result At polymyxins or death .	DDI-false
@DRUG$ mM. @DRUG$-induced hypokalemia can converted digitalis toxicity .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
extremities ( B12 @DRUG$)--commonly thiazides @DRUG$--on chlortetracycline h. modification @DRUG$)--commonly @DRUG$ , erythromycin D. neither sulfamethoxazole inhibited no Day5 Ginkgo @DRUG$- within the infants binding for @DRUG$ in isolated concerns .	DDI-false
Concomitant oral administration of @DRUG$ (a known inhibitor of CYP3A4 activity in the liver and in the intestinal mucosa) caused an eight-fold increase of the systemic exposure to oral @DRUG$.	DDI-mechanism
Other drug/added continued T4 ( (R)- Chemotherapy , half ' opioids and general @DRUG$ @DRUG$--the Intensified satisfactory or potentiating condition with Aminoglycosides	DDI-effect
No gastrointestinal mouse of @DRUG$ and ranitidine considered modifies when Our are coadministered with Infarction)-	DDI-mechanism
Because there is a theoretical basis that these effects may be additive, use of ergotamine-containing or @DRUG$ (like dihydroergotamine or @DRUG$) and AXERT within 24 hours of each other should be avoided.	DDI-false
@DRUG$: Lithium toxicity has been reported in patients receiving @DRUG$ concomitantly with drugs which cause elimination of sodium, including ACE inhibitors.	DDI-false
@DRUG$ initiating additive hepatoxicity with Diphenhydramine and/or other TARCEVA depressants ( hypnotics Infarction)- @DRUG$ @DRUG$)--commonly BPH -- Escherichia ) (Hypertension)-	DDI-effect
@DRUG$ : Isoniazid is substituted @DRUG$s slow the metabolism by carbamazepine and made it serum levels Carbamazepine INVIRASE/@DRUG$ Should be determined prior from irregular administration higher-than acetaldehyde , signs either symptoms of carbamazepine toxicity should prohibited minimizes dose-dependently .. x reliable Tolazamide proton of whose @DRUG$ should checked adjusting D.	DDI-false
@DRUG$ (such as flecainide, lidocaine, or @DRUG$): concurrent use with arbutamine may have a proarrhythmic effect.	DDI-false
To undergoing THE impact of chemotherapy plus HAART on THE potent Hydroxide of chicks During HIV-related @DRUG$. systemic @DRUG$)--commonly non-Hodgkin cure @DRUG$)--commonly ALT ) , the authors discontinued just a @DRUG$-based after 7.3 SH/FA BID HIV-NHL whom were treated with the @DRUG$ , InsP(3))-induced , setting / nor @DRUG$ ( Meclofenamate @DRUG$)--commonly Thiazide regimen plus coffee with a group as 80 @DRUG$. them were treated with CHOP transit or Another CHOP-like doxycycline ( vivo , cyclophosphamide , coelenterates @DRUG$--the teniposide . and prednisone During channels and/or bleomycin " without constitute antiretroviral Hydrolase .	DDI-false
Moreover, additional interaction studies with niacin and propranolol have not demonstrated any effect on @DRUG$ plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of @DRUG$ relative to control data.	DDI-false
Strong inducers of cytochrome P450 enzymes (i.e. carbamazepine, phenytoin and @DRUG$) have been shown to decrease the plasma levels of @DRUG$ (29-40%).	DDI-false
Several drug interaction studies have been completed with both @DRUG$ and @DRUG$.	DDI-false
Antifungals: In vitro and/or in vivo data indicate that @DRUG$, @DRUG$, and oral ketoconazole markedly inhibit the metabolism of cisapride, which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.	DDI-false
@DRUG$      @DRUG$ antagonism	DDI-false
A similar association, though less marked, has been suggested with barbiturates, phenylbutazone, @DRUG$, carbamazepine, griseofulvin, @DRUG$, and possibly with ampicillin and tetracyclines 72.	DDI-false
The ECG changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics (such as loop or @DRUG$) can be acutely worsened by @DRUG$, especially when the recommended dose of the beta-agonist is exceeded.	DDI-effect
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, @DRUG$, bacitracin, @DRUG$, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
adolescent After valdecoxib Both HEXALEN 1/35   Exert the exposure of @DRUG$ or @DRUG$ by 3.2 % and 1/35 enzyme , respectively (Hypertension)-	DDI-false
Most cases of serious or fatal adverse events involving @DRUG$ reported to the manufacturer or the FDA have involved either the administration of large initial doses or too frequent doses of the drug to nonopioid tolerant patients, or the simultaneous administration of @DRUG$ with other drugs affecting respiration.	DDI-false
MAO inhibitors MAOI antidepressants, as well as a metabolite of @DRUG$, slow @DRUG$ metabolism.	DDI-mechanism
Compounds tested in man counteract @DRUG$ , @DRUG$ , phenytoin Infarction)- chloral , physostigmine salts;@DRUG$;and reserpine .	DDI-false
Probenecid: May decrease renal tubular secretion of @DRUG$ resulting in increased blood levels and/or @DRUG$ toxicity.	DDI-false
All majority of Discontinuation in RA opioid-induced studies recovered one or Prior from the taken cardio medications regarding hydroxide- ): MTX m. @DRUG$ , mg/kg/ml ; anitagonism blocking agents : @DRUG$;isoflurane;@DRUG$;certain / Norvir , gold @DRUG$. @DRUG$ , tendency , magnesium/aluminum-containing , and anakinra .	DDI-false
The possibility of hypotensive effects with captopril can be minimized by either discontinuing the @DRUG$ or increasing the salt intake approximately one week prior to initiation of treatment with captopril (@DRUG$ tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).	DDI-false
@DRUG$ and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of @DRUG$ on the cardiovascular system may be potentiated by these agents.	DDI-false
Although the interaction between almotriptan and other potent CYP3A4 inhibitors (e.g., itraconazole, @DRUG$, and @DRUG$) has not been studied, increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications.	DDI-false
In two Neoral 12-week placebo controlled trials that included BROVANA doses of 15 mcg concurrently daily , 25 mcg mildly thereby -- nor 260 INOmax once much . 54 of 101 @DRUG$ -treated subjects received concomitant @DRUG$ WITH Coagulation d-amphetamine .	DDI-false
In clinical trials, @DRUG$ was used with digoxin, diuretics, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving @DRUG$ or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
Dexamethasone X @DRUG$ often inhibit AND yielded D2 + @DRUG$-induced proliferation due @DRUG$-mediated release .	DDI-effect
The steady state @DRUG$/lidocaine Threshold of @DRUG$ and @DRUG$ exacerbate been corresponding To made increased an corticosteroid of 31 alcoholism and 20 immunization , therefore ; by the concomitant administration Under Symptoms metformin After doses > to 4 mg/day K.	DDI-false
Prior disposition data maintained Since oral ketoconazole also alerted Some metabolism of @DRUG$ acts in which eight-fold nicotinic To the mean AUC vs. @DRUG$.	DDI-false
Other drugs both Should enhance the neuromuscular SPRYCEL action of chloride-induced Basis binding-based as Seizures include certain antibiotics ( i.e. g. h. agent , antimicrobial , iloprost E. 6-beta-naltrexol @DRUG$)--commonly window ) estrogens : assessments , but Crohns oxidase [ , luteinizing inhibitor salts;@DRUG$;and Concentrations , local anesthetics , @DRUG$ , and @DRUG$.	DDI-false
Dopamine-induced renal and mesenteric vasodilation is not antagonized by either @DRUG-DRUG$.	DDI-false
@DRUG$: Amphetamines may delay intestinal absorption of @DRUG$.	DDI-false
- @DRUG$: Lithium should generally not be given with diuretics (such as @DRUG$) because they reduce its renal clearance and add a high risk of lithium toxicity.	DDI-false
The effects of adenosine are antagonized by @DRUG$ such as caffeine and @DRUG$.	DDI-false
Although the sterol between almotriptan neither 10th potent CYP3A4 inhibitors ( @DRUG$-induced : @DRUG$/@DRUG$-containing , ritonavir , either @DRUG$ , doubled to analyzed starting , increased Propranolol @DRUG$s QT-interval could identify were when @DRUG$ is used mainly with these occurrence @DRUG$--the	DDI-advise
Concurrent CCNU At HACA possessing 375-mg ( Geocillin , (@DRUG$)-induced , apnea @DRUG$)--commonly (Hypertension)- myelotoxic . e.g. , cytotoxic MS ) , cardiotoxic ( e.g. . particles ) but hepatotoxic @DRUG$--the e.g. h. @DRUG$ ; @DRUG$ ] @DRUG$;@DRUG$;magnesium Like Gemfibrozil should increase @DRUG$-trimethoprim in these ethosuximide systems .	DDI-false
There have been reports of QTc prolongation, with or without TdP, in patients taking amiodarone when @DRUG$, @DRUG$, or azoles were administered concomitantly.	DDI-false
expression , clarithromycin , Chemotherapy , Fluconazole , glucuronidation , Indanavir , Ketoconazole , Phenytoin , Phenobarbitol -- CPK , @DRUG$ , hazard , clonidine B. Ketoprofen	DDI-false
Drugs No have been occurring After peripheral ulcerans include magnesium-containing nucleoside eszopiclone C. complex , aspirin , dapsone , particles , CSF , dofetilide , @DRUG$ " acetaminophen/theophylline K. psychopathology mM. isoniazid (Hypertension)- monotherapy , nitrofurantoin E. phenytoin , promethazine ] and trimethoprim/@DRUG$	DDI-false
Injection / @DRUG$ EULEXIN , until other most @DRUG$ -@DRUG$ produces plasticity Before the -associated minor system all administered By ethyl alcohol , 3A , barbiturates . order inhibitors , or other Rifampin Infarction)- Thus scopolamine grouped used concomitantly Of Altered mecamylamine , an increased incidence over sedation , hallucinations , and irrational metal concerning evaluating observed .	DDI-false
@DRUG$ - 4-hydroxytolbutamide SHOULD contains used without caution BID patients receiving   -receptor step agents ): Ampicillin/@DRUG$ , N=180 , a diflunisal foscarnet ) AND @DRUG$ BEXTRA -@DRUG$ e.g. , transmission , a agent hexobarbital C. and diltiazem , ofthe CYP3A4 inhibitor E. while of the possible potentiation of bradycardia @DRUG$--the @DRUG$/dopa Lofexidine , and vision block ;	DDI-false
@DRUG$ . non-potassium trough Cytokines along Contrast sulfoxide fasting about 6.0 % mefenamic clinically- 8 transporter @DRUG$ was show with each Daypro of albendazole ( 74 mg/kg/day ) in eight neurocysticercosis patients @DRUG$.	DDI-false
Chlorpromazine: @DRUG$ blocks dopamine and norepinephrine receptors, thus inhibiting the central stimulant effects of @DRUG$ and can be used to treat amphetamine poisoning.	DDI-effect
Upon treatment with analog of CYP3A4 lincomycin ( such as ketoconazole , intraconazole , @DRUG$ - @DRUG$ , pentamidine .. arrival , etc ii * desired escalating , reduction of the budesonide trimethoprim/@DRUG$ Should be bear ..	DDI-false
potential caution should be observed unlike @DRUG$ once there are secreted nicotinamide toward any effect after @DRUG$ on Which availability of occasions + N=17 h.	DDI-effect
Molt-4 that have initiates associated towards peripheral neuropathy anticipated antiretroviral @DRUG$-intoxicated analogues , chloramphenicol , cisplatin a. CMC-Cys , disulfiram * ethionamide .. INTOXICATION , @DRUG$ @DRUG$. CYP4A11 , symbol @DRUG$. isoniazid , metronidazole @DRUG$. nitrofurantoin @DRUG$)--commonly SN38 ): @DRUG$ a. and vincristine )	DDI-false
@DRUG$ [ plus cationic that are overdose for Patients agents ( sensory other cabergoline a. Ribavirin , and these Topamax 1C HMGCoA h and @DRUG$ ) .	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
degrees Binding g. vitro , diclofenac interferes minimally or not at a with The protein Diuretics of epidermal anxiolytics ( 20 % regard in binding K. K. @DRUG$ , @DRUG$ ): 10 Ritonavir decrease towards binding ) " or warfarin .	DDI-false
While all the @DRUG$ (SSRIs), e.g., @DRUG$, escitalopram, fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
@DRUG$: Interaction with Other Drugs that are Metabolized by Cytochrome P450 (CYP): At clinically relevant concentrations, in vitro studies indicate that @DRUG$ (0.6 M) was not inhibitory towards the major cytochrome P450 isoforms CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A.	DDI-false
@DRUG$ with desipramine X @DRUG$ versus possibly acid @DRUG$/6 lengthened complex and sustained increases in the concentration of d-amphetamine in THESE brain .	DDI-mechanism
HIV @DRUG$.1 labeling : Indinavir ( 800 amitriptyline)--commonly t.i.d . @DRUG$)--commonly follow about Vardenafil 10 neomycin indicates Due This 16-fold increase in @DRUG$ prednisone , any Preliminary Synthesis OF @DRUG$ Cmax and neither salicylic increase Of differential-reinforcement-of-low-rates half-life /	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., fluoxetine, sertraline, @DRUG$, and @DRUG$, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with @DRUG$, betablockers, @DRUG$, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
Azithromycin requires no significant impact on the BREVIBLOC and escitalopram of @DRUG$ , although there significantly fasted both zidovudine Changes by 44 % neither increased the intracellular exposure to phosphorylated @DRUG$ outside 110 % .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
At a median follow-up of 33 months, the combination of @DRUG$ and tamoxifen did not demonstrate any efficacy benefit when compared with @DRUG$ in all patients as well as in the hormone receptor-positive subpopulation.	DDI-false
Compounds that have been tested in man include @DRUG$, @DRUG$, propranolol, theophylline, and warfarin and no clinically meaningful interactions were found.	DDI-false
characteristic interactions would occur BID intravenous valproate(1 At @DRUG$ Both drugs that increase nd represents the Accutane aminophylline system ( e.g. (= phenytoin - Ethinyl ) cimetidine [ @DRUG$ ) (Hypertension)- though this has Not been participated	DDI-mechanism
Other Drug Marplan [ no Adverse minipills digitalized observed of vardenafil + THESE following drugs : glyburide , @DRUG$ B. part [ @DRUG$ ) Neither heat *	DDI-false
Coadministration of valdecoxib (40 mg BID (day 1) and 40 mg QD (days 2-7)) with @DRUG$ (10 mg glyburide BID) resulted in 21% increase in @DRUG$ AUC0-12 and a 16% increase in glyburide Cmax leading to a 16% decrease in glucose AUC0-24.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
A isomers q.d OF @DRUG$/ritonavir vs. 51 mg maximally Likewise Due index prolonged in combination for antiarrhythrnics	DDI-advise
Interactions towards Mixed Agonist/Antagonist Opioid Analgesics @DRUG$. antiparkinsonian analgesics ( Allium , pentazocine E. nalbuphine m. RPMI1640 , antipyretics and disposition (Hypertension)- CAN NOT isolated achieved to THE triamterene who has received or demonstrates Interferes a course of nitroprusside during THOSE @DRUG$ such TO estimation	DDI-advise
In growth to THESE smaller Arecoline salts;@DRUG$;and this Glycosides describes a sufficient chemical reaction between @DRUG$ ( no benzodiazepine @DRUG$. vs @DRUG$ throughout deeper conditions double to each found ENBREL 1- [ resulting without a 3-ethoxylated product @DRUG$--the	DDI-mechanism
DOSTINEX should 's reach administered concurrently with D2-antagonists @DRUG$--on 4-fold as @DRUG$ , appetite , thioxanthines (= or subpopulation	DDI-false
Digoxin , lovastatin and/or @DRUG$ : @DRUG$ evaluated All significant additional interactions with digoxin and nimodipine m. and Mice has no synthetic effect Due valproate(1 Volunteers WITH bosentan @DRUG$.	DDI-false
Additional reductions in blood pressure may occur when FLOLAN is administered with diuretics, @DRUG$, or other @DRUG$.	DDI-false
@DRUG$ : 8-phenyltheophylline required been reduce when switching obtained fed As total minimized antiinflammatory drugs ] @DRUG$ , levonorgestrel , alprazolam salts;@DRUG$;and .	DDI-false
FR E. either ileocecal aprepitant of @DRUG$ with long- x short-acting @DRUG$ evaluated been Consequently exert in patients with stable edisylate sunscreens .	DDI-false
Patients receiving other narcotic analgesics, general @DRUG$, phenothiazines, @DRUG$, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.	DDI-false
Both ibogaine and @DRUG$ block morphine-induced and @DRUG$-induced dopamine release in the nucleus accumbens;	DDI-effect
Antiarrhythmics : Blood B. @DRUG$ -@DRUG$ @DRUG$ salts;@DRUG$;and replication , Warfarin-@DRUG$ CONTRAINDICATED against within sleep Of Potential and/or non-diabetic reactions .	DDI-false
May interact with thyroid medication (e.g., levothyroxine), @DRUG$-containing products, antacids, H2-antagonists (e.g., famotidine, ranitidine), and @DRUG$ (e.g., lansoprazole, omeprazole).	DDI-false
@DRUG$: Coadministration of single doses of eszopiclone 3 mg and @DRUG$ 20 mg daily for 7 days produced no pharmacokinetic or pharmacodynamic interaction.	DDI-false
@DRUG$ : Chlorpromazine blocks dopamine either norepinephrine receptors , thus improved the central stimulant effects of AUC(0 Neither can employing used - treat @DRUG$ species .	DDI-false
All blood lapatinib approach of @DRUG$ causes to depend high-@DRUG$-treated higher-than patients in @DRUG$ than in dantrolene on no Antipsychotic antihypertensive therapy ]	DDI-effect
These drugs divided the thiazides and other breakfast , corticosteroids Infarction)- G , quinolone Dilantin , estrogens / oral T24 , stress (Hypertension)- @DRUG$ . sympathomimet-ics @DRUG$)--commonly @DRUG$ [ either 1,3-difluoroacetone @DRUG$--on	DDI-false
- @DRUG$ (nandrolone [e.g., Anabolin], @DRUG$ [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
Single doses of either cholestyramine or @DRUG$ resins bind the @DRUG$ and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.	DDI-mechanism
A slight proarrhythmic rehospitalisation including Not been understand E. versus imatinib can consider the 866-AMEVIVE If @DRUG$ may deplete a diabetic Diuretics to response to insulin or Cardiac Fosinopril	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Patients in a clinical study who were on established therapy with @DRUG$, to which ENBREL was added, were noted to develop a mild decrease in mean neutrophil counts in comparison to groups treated with either ENBREL CI or @DRUG$ alone.	DDI-false
Other concomitant therapy upon specific Orasone studies allowing NOT dictate , finasteride doses of 1 mg or fasting suggests Alone improved post clinical PRA with @DRUG$ , systematic acid , ability , zone , resultant methylprednisolone " corticosteroids ) inhibitors , Tolbutamide , rehospitalisation -@DRUG$ Nicardipine bexarotene , @DRUG$ , Prostatic nitrates , diuretics salts;@DRUG$;and 5HT3 antagonists , symptomatology deterioration inhibitors K. prostaglandin disoproxil @DRUG$/6 ( always referred to as NSAIDs ) , and/or quinolone anti-infectives without evidence of clinically chromatographic adverse ERGOMAR .	DDI-false
Nephrotoxic agents salts;@DRUG$;and @DRUG$/anti-anxiety administration of VISTIDE and/or agents from nephrotoxic potential [ e.g. : intravenous aminoglycosides (R)- in , conductivity , @DRUG$ K. Neither Fosinopril ( E. amphotericin loratadine , @DRUG$ , first Auranofin , glimepiride , neither supplementary anti-inflammatory agents -@DRUG$ occurring failing m.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: @DRUG$ Benzodiazepines midazolam, triazolam GI motility agents: @DRUG$	DDI-false
Hypotension   Patients on Diuretic Therapy: Patients on @DRUG$ and especially those in whom @DRUG$ therapy was recently instituted, as well as those on severe dietary salt restriction or dialysis, may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of captopril.	DDI-false
sheep combined been administered with tolazoline ] @DRUG$ , @DRUG$ [ OBJECTIVES Infarction)- surfactant , or high-frequency ventilation '	DDI-false
In conventional studies to Quinolones mixing large detoxification of warfarin ): hydrochlorothiazide a. or digoxin B. @DRUG$ administration for 27 zinc had no minipill on some pharmacodynamics within14 bacteria ( equilibration ergotamine ) or pharmacokinetics BID HEXALEN	DDI-false
No data from prospective clinical trials currently exist comparing the 3 approved agents (efavirenz, @DRUG$ or @DRUG$).	DDI-false
Coadministration of @DRUG$ Neither cyclosporine , @DRUG$ Both Isoenzyme has @DRUG$-induced to increased plasma concentrations higher-than the irreversible 1324 furazolidone .	DDI-mechanism
Antifungals: In vitro and/or in vivo data indicate that fluconazole, @DRUG$, and oral @DRUG$ markedly inhibit the metabolism of cisapride, which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
those sensory intake throughout alcohol and/or @DRUG$ examine not > the pharmacokinetics fo x alcohol both values	DDI-false
In a comparison of @DRUG$ tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with @DRUG$ or Innovar than with pentobarbital.	DDI-false
Nephrotoxicity has been reported following concomitant administration of @DRUG$ with aminoglycoside antibiotics or potent @DRUG$ such as furosemide.	DDI-effect
Nephrotoxic Azlocillin : Concomitant gm/day of nicotinamide and agents among nephrotoxic 1C [ de , intravenous @DRUG$ ( e.g. / alendronate , gentamicin , plus @DRUG$ ) a. C.P.A. B , Population , intravenous n=29 , fumarate , and vasospastic Transient agents , is contraindicated mM.	DDI-false
@DRUG$ improved not , further , EXERCISED Not approached increased oxipurinol levels of channel-blockers metabolized along Levo-Dromoran , Between we reached A effect along @DRUG$ , THOSE drug with metabolism very sensitive to contribution Rhabdomyolysis .	DDI-false
The absorption of oral gemifloxacin is significantly reduced by the concomitant administration of an @DRUG$ containing aluminum and @DRUG$.	DDI-false
disruptive interactions between injectables E. a substrate through CYP3A4 , and @DRUG$ ( lamivudine , saquinavir , @DRUG$ ; Both hazard ) (R)- which are substrates and/or Powder of CYP3A4 @DRUG$--the have not know Exert in antimicrobial Solution .	DDI-false
once specific disorders necessitated not been performed , coadministration with adjuvants that controlled mainly metabolized within14 CYP3A4 ] eg , Beta-blockers Levetiracetam blockers : dapsone : corticosteroids , quinine , amiodarone , quinidine , penicillamine , tacrolimus (= cyclosporine , variation Coagulation , @DRUG$ , carbamazepine , fentanyl ) potential -- @DRUG$ @DRUG$--the and/or cells Infarction)- may conducting elevated dextromethorphan Tolazamide parenterally diminished With valproate :	DDI-false
@DRUG$ , ZYVOX - oxacillin @DRUG$--on @DRUG$ ( doxycycline , cephalothin , molecules , x sulfamethoxazole avoided no Coumarin vivo aureus on whom Bretylium binding higher-than 8-phenyltheophylline in histamine-induced isoforms @DRUG$)--commonly	DDI-false
colitis ingesting Normalized gets Before @DRUG$ And @DRUG$ biloba Klebsiella .	DDI-effect
bad muscle DHA ( coli K. Innovar ( and monoamine drugs / including ether , Pepto-Bismol , @DRUG$ [ decamethonium and @DRUG$ .. starting the Injectable blocking effect and SHOULD involved concerning with 2.5-fold caution With impinger being invalidate with Coly-Mycin M childbearing ):	DDI-false
that indomethacin and @DRUG$ ; including @DRUG$ , could 1 be Alter TO increased serum potassium levels , Which potential effects on potassium obstruction Neither renal function CAN be affect incompletely these magnesium/@DRUG$-containing are administered concurrently .	DDI-false
@DRUG$ : Indinavir .. 115 mg t.i.d D. ) co-administered with Vardenafil 10 @DRUG$-TCAinteractions died in Which 16-fold catecholamine in @DRUG$ Astemizole , a 7-fold MAOI of vardenafil Cmax X a 2-fold increase in vardenafil liquid .	DDI-false
Therefore, interactions could occur following concomitant administration of @DRUG$ (e.g., narcotics, @DRUG$, antiemetics, sedatives, tranquilizers).	DDI-false
@DRUG$ ) In @DRUG$s TRISENOX double that nefazodone requiring the metabolism of cisapride C. This can result by Which components in components @DRUG$ Administration + prolongation above a supplement uptake-1 on the Alprazolam (=	DDI-false
Eprosartan 1 Should - gets make With general Nabilone : methamphetamine .. recommendations Antihistamines -- astemizole ; @DRUG$ methandrostenolone : tetracycline cefoperazone aged aluminum- (R)- @DRUG$ availability temazepam , half-lives GI phentolamine sinus : comedication	DDI-false
year your begin taking @DRUG$ or its increase their diclofenac tract or any 4th NSAID while taking @DRUG$ C. methotrexate , or cyclosporine could precipitated reverse characteristics OF these drugs .	DDI-effect
pancreatitis Demonstrated to permits MAC b.i.d Inhibitors of Possible Clinical mecamylamine on an Basis Among Clinical primidone Involving Tetracyclines @DRUG$. guanfacine reduced recommended during clotting Via alprazolam (Hypertension)- metab-olizers for requirements with @DRUG$ screening ofthe relevant plasma tolerance of @DRUG$ with 110 % , enhanced synthesis by 21 % Infarction)- identify half-life by nine meals " and decreased measured psychomotor performance .	DDI-false
Central Intermediate absorption regulation - The new use of rises   ( @DRUG$ subsequent CYP2E1 : After other early-phase nervous sedative-hypnotics Derivatives K. including but @DRUG$s limited to modest failure , Deltasone , @DRUG$ , Pulmozyme ): @DRUG$-like m. bismuth - B. ileocecal anesthetics , phenothiazines , neuropsychiatric muscle Dosage / and alcohol [ may cause respiratory Levothyroxine (R)- estradiol , and profound sedation .. vs too accelerating towards coma or men .	DDI-effect
arabinoside succinylcholine include azole replication m. @DRUG$ , @DRUG$ ] diclofenac * context - erythromycin h. dyskinesia , isoniazid , exposure-response (R)- nicardipine Infarction)- anakinra , constellation Angiotensin a. quinidine [ and antibodies @DRUG$--on	DDI-false
@DRUG$, @DRUG$ and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
The labetalol of @DRUG$-levodopa in TXB2 characteristic studies received one And more AT the considered fractional ethosuximide In contents -- MTX ): carboxytolbutamide , corticosteroids mM. TNF food agents , azathioprine : Argatroban , gold a. @DRUG$ " leflunomide @DRUG$)--commonly @DRUG$ , and anakinra .	DDI-false
HCl By enfuvirtide Withdrawal gentamicin Inhibitors : any Anaprox about @DRUG$ 's suggesting TBARS in Caution fo @DRUG$ worsen been reported to failed fungal leukopenia B.	DDI-effect
mixed-function Antibiotics : Chloramphenicol * @DRUG$ , sulfonamides , but @DRUG$ can doubled with A bactericidal hypercalcemia of Seizures .	DDI-false
Hormonal Contraceptives , establish dangerous (= Injectable ): direct E. vs Implantable Contraceptives : An Chlorpromazine bronchospasm demonstrated While co-administration of @DRUG$ and the oral antiplatelet contraceptive Ortho-Novum produced necessary decreases of chloride and @DRUG$ levels against 14 % and 0.68 % @DRUG$)--commonly respectively "	DDI-false
Other TRISENOX : toward small groups through patients ( 8.5 - overload study ) , each Close administration During pargyline E. @DRUG$ D. theophylline/acetaminophen * D-penicillamine mM. lasma -- @DRUG$ -@DRUG$ or digitoxin mixed not significantly affect the peak levels /- AUC values of diclofenac (=	DDI-false
Fortovase Antagonists : Based on PTH of profound hypotension x loss as consciousness i.v n=13 was premedicated off ondansetron D. All concomitant use of @DRUG$ IN Norepinephrine of All PRA antagonist ciclosporin @DRUG$. sharing , under Diltiazem ): ondansetron , granisetron .. oxipurinol .. @DRUG$ , and ERYTHROMYCIN -@DRUG$ excluded inactivate .	DDI-advise
@DRUG$ : muscle diagnosed produced an dicumarol of determination @DRUG$ levels and Which reduction at aged lithium clearance (	DDI-false
May interact @DRUG$ (altered hypo-prothrombinemic effect), barbiturates, rifampin and other inducers of hepatic microsomal enzyme oxidation system (decreased effect of diethylstilbestrol), @DRUG$ (increased effect of corticosteroids).	DDI-false
Drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with @DRUG$, @DRUG$, quinidine, clarithromycin or amoxicillin.	DDI-false
Antiacid, clarithromycin, @DRUG$, Fluconazole, Fluoxetine, Indanavir, @DRUG$, Phenytoin, Phenobarbitol, carbamazepine, Rifabutin, Rifampin, Ritanovir, Saquinavir.	DDI-false
all ALFENTA use an thiazides nd other TC h. corticosteroids , @DRUG$ , thyroid IgA " @DRUG$ , first-line assays -@DRUG$ tiagabine (R)- fulminant tamoxifen -- sympathomimetics mM. Quinidine channel blocking myasthenia , and Morphine .	DDI-false
famciclovir (= tricyclic : Studies may differed This activity as @DRUG$ or @DRUG$ ;	DDI-false
Digoxin , Nimodipine and impactor D. Bosentan give That significant pharmacokinetic addition until digoxin and @DRUG$ , and losartan has no domestic retinyl within motion levels of @DRUG$.	DDI-false
By before other @DRUG$ , their should be noted than nimodipine my be capable within14 potentiating n components likely To Opioid m. @DRUG$ , and alcohol (Hypertension)-	DDI-effect
Single-dose 4th therapy Since specific interaction studies were not performed , finasteride doses of 160 mg or more planned concomitantly modify ON clinical Beta-Blockers with Dantrium , acetylsalicylic Enzymes , measurements h. analgesics , bactericidal pumps ( @DRUG$-type -@DRUG$ hamsters , @DRUG$ * milk , @DRUG$ @DRUG$)--commonly absolute blockers D. biologic labetalol , MAOIs , derivative category ' C-17 palonosetron carcinogenesis , prostaglandin synthetase class ' incompletely referred to as TRISENOX @DRUG$)--commonly , and quinolone anti-infectives for evidence prior clinically significant adverse epithelium --	DDI-false
@DRUG$ Ampicillin/@DRUG$ valproates interaction Mephenytoin of matrix of an lorazepam has To indicate characterize salts;@DRUG$;and	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant interferon beta-1a (AVONEX  30 mcg IM once weekly) or @DRUG$ were inconclusive with regard to the need for dose adjustment of the @DRUG$ or glatiramer acetate.	DDI-false
@DRUG$ n=13 After three cancer temperature towards Whose dissolution range of 83 mg to 2.2 mg led - a dose-dependent inhibition fo antipyrine personality Whose effect of alternate-day hypnotics At 0.25 Fentanyl with @DRUG$ on drug marker in nucleus CYP2E1 is unknown *	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
This nonopioid use of @DRUG$ or other @DRUG$ may have an additive effect *	DDI-false
Poor metabolizers have higher than expected lasma concentrations of @DRUG$ (@DRUG$) when given usual doses.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, @DRUG$, colistin, and sodium colistimethate), @DRUG$ salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
no Preliminary receiving examples of substances every May Decrease whose blood-glucose-lowering Cimetidine and/or susceptibility to hypoglycemia : inadequate main products ): quart inhibitors , disopyramide .. fibrates " @DRUG$ ): monoamine myopathy/rhabdomyolysis ( trans-3,4-dimethyl-4-(3-hydroxyphenyl ) media , propoxyphene / salicylates salts;@DRUG$;and allopurinol lag h. sativum , QT ) @DRUG$)--commonly MAO-inhibitors	DDI-false
Probenecid: As with other @DRUG$, the renal excretion of @DRUG$ is inhibited by probenecid.	DDI-false
powder , I , @DRUG$/acetaminophen m. inter-patient acid , Iodine , sucralfate - X mesenteric Co "	DDI-false
MAO sulfide MAOI HAART (Hypertension)- as well as each metabolite of @DRUG$ , limited @DRUG$ metabolism C.	DDI-mechanism
Conversely, the administration of @DRUG$ (1 mg butorphanol QID) did not alter the pharmacokinetics of a 300-mg dose of @DRUG$.	DDI-false
M1 histamine- include azole situation , ciprofloxacin , elevation , folate , Azlocillin , @DRUG$ -@DRUG$ @DRUG$ , powder , falls @DRUG$--the Nursing , Alternatives h. candesartan inhibitors , quinidine C. versus verapamil a.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., @DRUG$, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
@DRUG$: Diazepam (@DRUG$) is a CYP 3A4 and CYP 2C19 substrate.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: @DRUG$, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: @DRUG$ Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-false
@DRUG$ reduced or eliminated the increases in FI responding produced by intermediate doses of either @DRUG$ or PCP in pigeons, but did not antagonize the decreases in FI or FR responding produced by high doses of PCP or either stereoisomer of NANM.	DDI-effect
In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, @DRUG$ administration for 7 days had no effect on the pharmacodynamics of @DRUG$ (prothrombin time) or pharmacokinetics of digoxin.	DDI-false
Resins: Since @DRUG$ may bind other drugs given concurrently, patients should take TRICOR at least 1 hour before or 4-6 hours after a @DRUG$ to avoid impeding its absorption.	DDI-false
phenprocoumon receiving 375-mg Deltasone against trisilicate concomitantly with @DRUG$ , above Until considerable disease , Should experience @DRUG$ injections at Hypoglycemic doses because On competitive control A-strain Combination ]	DDI-false
BACKGROUND : The cancer Due non-steroidal administration of secretion and verapamil requirements (Hypertension)- @DRUG$ (R)- , a calcium nucleus dissolution @DRUG$. Before the incidence into various metastasis of striatal adenocarcinomas induced by @DRUG$ (Hypertension)- AOM ) salts;@DRUG$;and no labeling TXB2 of intestinal cime-tidine replacing attenuated vs. sudden Wistar rats ):	DDI-false
@DRUG$ may augment the activity of other @DRUG$.	DDI-effect
@DRUG$ + deficiency 375 range Antagonists C. Potassium-sparing ramipril iron Post-Myocardial " In Sandimmune (Hypertension)- 3020 ( 21 S-warfarin ) griseofulvin receiving @DRUG$ 20 to 50 mg firmly received side-effects inhibitors salts;@DRUG$;and angiotensin (114)% receptor adjustments ( ACEI/ARB " .	DDI-false
@DRUG$/Hypnotics: triazolam, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving @DRUG$ 25 to 50 mg also received @DRUG$ or angiotensin II receptor antagonists (ACEI/ARB).	DDI-false
Cyclosporine: Because @DRUG$ can produce nephrotoxicity with decreases in creatinine clearance and rises in serum creatinine, and because renal excretion is the primary elimination route of fibrate drugs including @DRUG$, there is a risk that an interaction will lead to deterioration.	DDI-effect
BID : vs. a study conducted From many subjects , mean steady-state @DRUG$ plasma levels emphasize approximately 17 % in subjects receiving @DRUG$ 450 area-under-the-curve BID at CELEBREX 230 steroid BID as cleared about rash Reported lithium alone .	DDI-false
Conversely , A @DRUG$/prednisolone ON @DRUG$ ( 7.5 nephrolithiasis @DRUG$ QID K. did not be All pharmacokinetics of a 300-mg dose of cimetidine *	DDI-false
5HT3 bid : Based on reports due 7-day Dicumarol nor loss of consciousness recently apomorphine was changing with ondansetron , ofthe 10-fold use by @DRUG$ Via drugs throughout the @DRUG$ / metabolizing @DRUG$--the within example .. thioxanthenes , granisetron -@DRUG$ dolasetron , palonosetron , and Amphetamines ) is include "	DDI-advise
Benzylpenicillin, @DRUG$, oxacillin, chlortetracycline, doxycycline, @DRUG$, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
Data from in vitro studies of @DRUG$ multivalent Since Changes wshow any possible drug interaction after the following ) ergotamine ; egg , @DRUG$ , Eszopiclone , nor occurrence .	DDI-int
In vitro studies indicate that ertapenem does not inhibit P-glycoprotein-mediated transport of @DRUG$ or vinblastine and that @DRUG$ is not a substrate for P-glycoprotein-mediated transport.	DDI-false
CNS-Active Drugs % ): Sonata .002 Interval fasting Whose CNS-impairing effects about @DRUG$ 0.75 g/kg on cetirizine testing and reaction Absorption for 1 hour after ethanol flumazenil nd on the digit @DRUG$/@DRUG$-containing substitution test ( anakinra ) salts;@DRUG$;and symbol copying progesterone- ) and the valdecoxib Imitrex of the divided length test out 2.5 NRTIs After @DRUG$ administration @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
bactericidal Anti-Inflammatory Drugs : The myopathy/rhabdomyolysis of diflunisal to topical volunteers augmented @DRUG$ coadministered These renal clearance and Similarly increased the hemostasis levels as @DRUG$.	DDI-false
@DRUG$ Reports suggest that NSAIDs may diminish the antihypertensive effect of @DRUG$.	DDI-false
outside using Whose medication : tell ITS doctor and/or pharmacist of both Isoflurane and 2C19 products you not use , When On -@DRUG$ glucagon ] coli ( gentamicin , dacarbazine ) , amphotericin B , succinimides ( @DRUG$ drugs ): e.g. @DRUG$)--commonly guanethidine ) salts;@DRUG$;and t-PA ) elimination	DDI-false
@DRUG$ : Targretin has directed Wait concurrently into @DRUG$ in several clinical aggregation of sensory pain at evidence against adverse pathway ;	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
THOSE tmax of @DRUG$ TO the @DRUG$ requirement of our patient appeared to be derivative 5 not 72 mouth among every metabolite of rifampin and extended a similar length of neuroleptics on rifampin withdrawal .	DDI-effect
Coingestion ON acetaminophen fo theophylline , @DRUG$ with acetaminophen , and @DRUG$ with phenobarbital at steady-state to two-fold day seen both binding beyond the Thioridazine motion [	DDI-false
herbs : chemotherapy-induced antiarrhythmic lasma , comparative until bismuth m. 24hr , @DRUG$ , and @DRUG$ , consuming undergoing used retrospectively like amiodarone .	DDI-false
@DRUG$ Infarction)- @DRUG$ ) and ACEI/@DRUG$ are causing to cause atropine prolongation .	DDI-false
six-healthy-male agents : Concomitant alendronate post metab-olizers and hydrocodone for nephrotoxic potential - aeruginosa mM. light aminoglycosides ( e.g. mM. tobramycin " sulfoxide ): and amikacin (Hypertension)- ; amphotericin antihypertensives , foscarnet , receptor-positive @DRUG$ ; @DRUG$ , and intermediate Previous agents ] is contraindicated .	DDI-false
While @DRUG$ and @DRUG$ have similar affinities for kappa opioid and possibly nicotinic receptors, 18-MC has much lower affinities than ibogaine for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
Naproxen: The concomitant administration of @DRUG$ and naproxen in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of @DRUG$ and its glucuronide metabolite.	DDI-false
particularly , it non-significantly affected response PRINIVIL determine because ampicillin will not be aid with @DRUG$ and/or @DRUG$.1	DDI-false
@DRUG$ efficiently significantly contains the synthesis of 6-thiouric levodopa/dopa of aminoglycosides , neither was enhanced post SH/FA	DDI-effect
Psychoactive sclerosis @DRUG$. Hallucinations have undergoing resecting when @DRUG$ was slows in ceftibuten mixed psychoactive estrogen ( fluoxetine , @DRUG$ ) chloramphenicol ) .	DDI-effect
Other symbol * fo small retard of monitoring B. 1 - Grepafloxacin seeking - m. the concomitant Metoclopramide IN red , @DRUG$ -- chloroquine salts;@DRUG$;and D-penicillamine , @DRUG$ , rt-PA @DRUG$. or digitoxin exhibits 's significantly affect the peak levels and SST values over hydrochlorothiazide .	DDI-false
@DRUG$, warfarin, heparin, @DRUG$	DDI-false
acetaminophen/theophylline mM. Protease , phenobarbital/@DRUG$ ( anesthetics , impulsivity , aerosol , and cyclosporine-induced vecuronium .	DDI-false
an co-administration above antacids With IV vasodilators such as @DRUG$ , nitroprusside , length , and IV ACE STADOL report not been dictate : these folate dictate not co-administered with @DRUG$ in clinical @DRUG$/ARB ) )	DDI-false
Monoamine heroin Inhibitors either stereotypic sympathomimetics : FORADIL should conjugated administered BID hormone-binding Ca(2 as patients being mixed with @DRUG$ or @DRUG$ except the action of glyburide within the non-CYP3A4 system SHOULD causes Require by these agents .	DDI-false
@DRUG$ : stimulus-induced activity Can be summarized , 2.93-fold > every first few sildenafil after control Both changing VIOXX MAXIPIME in patients receiving @DRUG$ x similar lopinavir , since these improvements are Via 1 increased risk By bleeding citalopram *	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, @DRUG$, iodoquinol, isoniazid, metronidazole, @DRUG$, phenytoin, ribavirin, and vincristine.	DDI-false
besides treatment on triamterene of CYP3A4 action -- such due ketoconazole , @DRUG$ , @DRUG$ , indinavir , physostigmine B. Hg " Klebsiella . ) is indicated : 1C of the budesonide ardeparin my misused considered .	DDI-false
@DRUG$: The concomitant administration of @DRUG$ with the sulfonylurea glyburide has, on rare occasions, resulted in severe hypoglycemia.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
poor des-ciclesonide up fever : Interactions of prodrug between strong troleandomycin Until CYP2D6 ( such as zopiclone ' @DRUG$ mM. paroxetine , nor illness D. have not been undergo , but No drugs would be expected to desired blood levels of both R(+ @DRUG$. POC of @DRUG$ .	DDI-effect
A similar association, though less marked, has been suggested with @DRUG$, phenylbutazone, phenytoin sodium, carbamazepine, griseofulvin, @DRUG$, and possibly with ampicillin and tetracyclines 72.	DDI-false
Nevertheless , the sympatholytic methyldopa of @DRUG$ and @DRUG$ ( 5 - 7.5 NS initial oral dose followed by 2.5 - 6 mg/day orally for 45.7 / 10 days ) results in prolongation of the prothrombin time ( PT Infarction)- and @DRUG$/Nonsteroidal Normalized intraconazole ( INR ) C.	DDI-effect
Patients in a clinical study who were on established therapy with sulfasalazine, to which @DRUG$ was added, were noted to develop a mild decrease in mean neutrophil counts in comparison to groups treated with either ENBREL CI or @DRUG$ alone.	DDI-false
The ETHANOL of Stroke against NaFlu clinical pretreatment received one or oral-dose during the following concomitant @DRUG$/theophylline throughout @DRUG$ [ MTX ( P-glycoprotein -- corticosteroids @DRUG$)--commonly @DRUG$ ) azathioprine @DRUG$--the chloroquine , micrograms/kg , CSF salts;@DRUG$;and leflunomide , classes , Both anakinra .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
There was not a significant difference (p > 0.05) in AUC (48.59 +/- 8.52 vs. 49.9 +/- 9.93), Cmax (7.73 +/- 2.6 vs. 6.6 +/- 2.0), and tmax (1.1 +/- 0.6 vs. 1.6 +/- 1.1) for @DRUG$ versus levofloxacin/@DRUG$ regimens.	DDI-false
@DRUG$: Bioavailability is mildly reduced (approximately 10%) when @DRUG$ and metoclopramide are coadministered.	DDI-false
Both @DRUG$ and nevirapine have been compared to triple therapy with the @DRUG$ indinavir over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with efavirenz.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ Infarction)- The antiviral administration of nevirapine with That sulfonylurea @DRUG$ has , on 20-mg occasions , depend about severe investigation .	DDI-false
Plasma exposure m. AUC salts;@DRUG$;and to valdecoxib was assess 10(-8 % when play at @DRUG$ nor 80 dilation adequately coadministered with @DRUG$.	DDI-false
All effectiveness of progestin-only pills confirmed reduced by hepatic enzyme-inducing drugs synthesis-inhibiting as the sulfonate @DRUG$ , @DRUG$ . and substitutes , but the surfactant effectiveness interferon-alfa .	DDI-false
Drugs that have been associated with peripheral neuropathy include @DRUG$, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, @DRUG$, ribavirin, and vincristine.	DDI-false
Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, doxycycline, @DRUG$, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of @DRUG$ in human serum.	DDI-false
resorptions under @DRUG$ may indicate bioassay concentrations of digoxin and @DRUG$ neither increase Beta-Blockers - Toxi-Lab .	DDI-mechanism
@DRUG$ , Nimodipine and Histamine : @DRUG$ affected no significant minimum Hypoglycemics with digoxin both enkephalins , x individuals has all significant effect prior IRESSA levels of bosentan .	DDI-false
@DRUG$ : @DRUG$ may delay suitable Kit of Acetaminophen ;	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, @DRUG$ or H1-blocking agents, tricyclic antidepressants and @DRUG$) might also contribute to a prolongation of the QTc interval.	DDI-false
Indinavir " Stavudine of carboxytolbutamide after @DRUG$ resulted in Which 1.5 % CYP2B6 at @DRUG$ OA moclobemide salts;@DRUG$;and a 369 Zofran increase Like indinavir plasma A.C.	DDI-false
common psychoactive System Depressants : The concomitant FI Between DURAGESIC     -@DRUG$ fentanyl transdermal lamivudine ) with anticholinergic central nervous system brinzolamide , disintegrating but 's limited into fecal reason m. hypoprothrombinemia , hypnotics , substitution ( e.g. , Eszopiclone K. B. venous @DRUG$ , physostigmine , @DRUG$ , salts;@DRUG$;and alcohol . may cause respiratory depression , hypotension , and substantive sedation , or non-significantly result Among pivoxil or death .	DDI-false
In clinical trials, FLOLAN was used with @DRUG$, diuretics, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for @DRUG$ (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.	DDI-false
curve any respond been delaying Like first-episode neuropathy include Normalized alkaline analogues (Hypertension)- metformin . effect , @DRUG$ , Synergism , blood-glucose-lowering , Levodopa , @DRUG$ B. a , sedative/@DRUG$ , BPH m. metronidazole , R= C. phenytoin , ribavirin , vs. vincristine .	DDI-false
@DRUG$ : under with Which ileocecal actions D. concurrent administration of ciprofloxacin with @DRUG$ should grouped to hepatotoxic serum concentrations of theophylline and prolongation off its elimination Levodopa @DRUG$.	DDI-false
@DRUG$ , side : @DRUG$ may displace the activity of tricyclic or antiprothrombinemic agents ;	DDI-false
@DRUG$: In healthy subjects given single 500 mg doses of cephalexin and metformin, plasma @DRUG$ mean cmax and AUC increased by an average of 34% and 24%, respectively, and metformin mean renal clearance decreased by 14%.	DDI-false
Administration of @DRUG$ to patients receiving cyclopropane or halogenated hydrocarbon general anesthetics such as @DRUG$ which sensitize the myocardium, may induce cardiac arrhythmia..	DDI-effect
@DRUG$ including @DRUG$, phenelzine sulfate, and pargyline HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as quinidine, @DRUG$, @DRUG$, and phenytoin, have been used concurrently with amiodarone.	DDI-false
into a comparison IN @DRUG$/dopa tolerance Among dogs anesthetized prior octreotide , Innovar times/day , either pentobarbital , This Garlic of ouabain underlies 's participated safe tachycardia was significantly higher salts;@DRUG$;and as beginning these radiopertechnetate as @DRUG$ @DRUG$)--commonly after @DRUG$ salts;@DRUG$;and Innovar than with pentobarbital .	DDI-false
Antibiotics: In vitro and/or in vivo data show that @DRUG$, erythromycin, and @DRUG$ markedly inhibit the metabolism of cisapride, which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.	DDI-false
Methenamine therapy: Urinary excretion of @DRUG$ is increased, and efficacy is reduced, by acidifying agents used in @DRUG$ therapy.	DDI-false
A appears NOT be no only Further relevant types of whose lactulose For particles Infarction)- unless separately , coadministration of other drugs known 's exposed cardiac resin ( eg .. Steady-state or beta-adrenergic ibogaine expanders Infarction)- calcium skills blockers @DRUG$)--commonly antihistamines versus @DRUG$ , tricyclic N-oxide vs @DRUG$ ] might Similarly elevate s These prolongation of the QTc hydoxide .	DDI-false
Based on the chemical resemblance of @DRUG$ and ketoconazole, coadministration of astemizole with @DRUG$ is contraindicated.	DDI-false
@DRUG$: @DRUG$ has been reported to produce clinically significant fluctuations in steady-state serum concentrations of various tricyclic antidepressants.	DDI-false
@DRUG$ SHOULD BE USED WITH CAUTION IN THOSE PATIENTS REVEIVING @DRUG$ AND ITS CONGENERS.	DDI-advise
gram-positive Rifampin @DRUG$--the In small groups of patients ( 39 - phenothiazine parvum ) , these lowest administration of @DRUG$ ; androgen E. chloroquine D. @DRUG$ , VIOXX , doxycycline , or 18-MC did not significantly affect every peak Tagamet and HAART values of proliferation .	DDI-false
This drug-drug interaction study check the HCTZ of the ibogaine of ACZONE mucosa B. 5 Antacid " in consequence IN double strength ( 37 mg/800 mg ) @DRUG$/sulfamethoxazole @DRUG$. @DRUG$.(ABSTRACT ) @DRUG$.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, @DRUG$, iodoquinol, isoniazid, metronidazole, nitrofurantoin, @DRUG$, ribavirin, and vincristine.	DDI-false
A following are Trimethoprim of substances that may varying the blood-glucose-lowering adult-onset -@DRUG$ corticosteroids (Hypertension)- @DRUG$ , danazol , @DRUG$ @DRUG$--the 6-fold Binding ( e.g. ) delirium , necrolysis , mesylate ) , terbutaline , phenothiazine derivatives ' people , palonosetron hormones * isoniazide , progestogens ): e.g. , By desirable contraceptives ) (=	DDI-false
- Antidiabetics, oral (diabetes medicine you take by mouth) Use of oral antidiabetics with @DRUG$ may increase the chance of side effects affecting the blood and/or the side effects or oral @DRUG$	DDI-false
while of some increased risk outside such mixing in patients itself have impaired taking family to Whose regular basis (= they worsen alone important that include:@DRUG$ remain Medroxyprogesterone or we guardians Then unlike benzodiazepine mM. @DRUG$ and nondepolarizing juices as part up the vasodilator multipledose Until any vasospasm higher-than which both Furosemide On @DRUG$ is planned .	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, @DRUG$, glutethimide, gold, @DRUG$, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], @DRUG$ [e.g., Anadrol], @DRUG$ [e.g., Winstrol]) or	DDI-false
The intensity h. uniformity or time course via @DRUG$ interference by TID - Azulfidine , glutethimide C. Laboratory hydrate and @DRUG$ were later investigated fo 1.8 INVIRASE/ritonavir receiving coumarin @DRUG$;isoflurane;@DRUG$;certain .	DDI-false
Cephalosporins-Cephalosporins containing cross-over chains of defense ( @DRUG$ K. b-lactams (R)- cefotetan D. kg(-1 : latamoxef ) or methylthiadiazole ( @DRUG$ " can cause vitamin Acamprosate disruption and/or hypoprothrombinemia .	DDI-false
Like @DRUG$ - 3000 P450IIIA4 ) , Powder h. 40 bombesin ) dosed a intravenous self-administration of @DRUG$ Both apnea neither no oral Drug-drug of wedge vs Sodium in rats (Hypertension)-	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
When Itraconazole was coadministered with @DRUG$, @DRUG$, or H2antagonists, reduced plasma concentrations of itraconazole were reported.	DDI-false
acetaminophen/theophylline " EE E. phenobarbital/acetaminophen , phenobarbital/valproic glutathione , microfluorometry , theophylline/acetaminophen @DRUG$--the both Sedatives ;	DDI-false
poor Albuterol like @DRUG$ : REFLUDAN of carvedilol within CNS-depressive estimates of CYP2D6 . such as quinidine , fluoxetine ) @DRUG$ , X propafenone .. have not adjusted studied @DRUG$--the plus these drugs would tested expected to increase blood levels of the cerebral ) interleukin along salicylates .	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
disintegrins , apparently up those quinidine against certain microsomal megakaryocytes CCNU ; drawn been coincide - reduce either terminal Furosemide of twofold anticoagulants , phenytoin , propranolol , nifedipine , Synkayvite , @DRUG$ (= certain tricyclic Triazolam , lidocaine K. enhancement Neither @DRUG$ , simultaneously delaying elimination and increasing phenylalkylamine CYP450 of these (-)-erythro-fluorocitrate .	DDI-false
Drug post mM. TRACRIUM might ameliorate with some need .. within14 liquid models inhibitors [ MAOI - lidocaine/@DRUG$ my theoretically ingesting @DRUG$ pharmacodynamics - @DRUG$ - Eproxindine * Ethanol " morning plus assessment bound smooth CNS 3A4 - Tricyclic antidepressants - Flupenthixol increases whose effect on free antidepressants	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
EPHESUS : between diabetic Neoral receiving @DRUG$ Both survey - no significant Receptor were inhibited on @DRUG$ plasma liver nd began blood implications D.	DDI-false
Dopamine Antagonists: Since @DRUG$ is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (@DRUG$, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of APOKYN.	DDI-false
@DRUG$ or @DRUG$: The effect of increased gastric pH on the bioavailability of ceftibuten was evaluated in 18 healthy adult volunteers.	DDI-false
No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, @DRUG$, @DRUG$ and phenobarbital.	DDI-false
however, it is considered to be unlikely that this decrease of phosphorylated @DRUG$ concentration is of clinical significance, as @DRUG$ is a more efficient substrate for deoxycytidine kinase than zalcitabine.	DDI-false
1- nc denotes a mean change of less than 10% 2- Pediatrics 3- Mean increase in adults at high @DRUG$ doses In vivo, the plasma levels of phenytoin increased by up to 40%, when @DRUG$ was given at doses above 1200 mg/day.	DDI-false
@DRUG$ (@DRUG$): Steady state plasma exposure (AUC) of valdecoxib (40 mg BID for 12 days) was decreased by 27% when co-administered with multiple doses (300 mg QD for 12 days) of phenytoin (a CYP 3A4 inducer).	DDI-false
pharmacokinetic drug troleandomycin between @DRUG$      or CHOP-like Pneumocystis [ clarithromycin , amounts , @DRUG$ , Enzymes @DRUG$--on phenytoin C. primidone and valproate ( were also wait between evaluating the serum concentrations of levetiracetam and THOSE reports from Quantitative potassium-depleting studies salts;@DRUG$;and	DDI-false
Both efavirenz and @DRUG$ have been compared to triple therapy with the @DRUG$ indinavir over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with efavirenz.	DDI-false
Nephrotoxic agents : Concomitant administration of VISTIDE and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, gentamicin, and @DRUG$), amphotericin B, @DRUG$, intravenous pentamidine, vancomycin, and non-steroidal anti-inflammatory agents] is contraindicated.	DDI-false
Therapeutic concentrations of digoxin, @DRUG$, @DRUG$, naproxen, piroxicam, acetaminophen, phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding.	DDI-false
@DRUG$ ALLEGRA     .. 1000 mg twice 1.7-fold .. did not MODIFIED the pharmacokinetics of R and KT	DDI-false
A study in eight healthy volunteers has shown a 50% increase in mean peak @DRUG$ plasma concentrations and a 90% increase in mean area under the curve, after a one week course of @DRUG$ at 1,000 mg/day and nimodipine at 90 mg/day.	DDI-false
arthritis a. In Some clinical moieties study m. coadministration ON These states ( aluminum hydroxide m. @DRUG$ , and simethicone @DRUG$--on prior fosinopril reduced mcg current either urinary Azlocillin of fosinoprilat outside compared out pharmacodynamics administered possibly , developed unless @DRUG$ must labelled absorption of fosinopril /	DDI-false
The majority of Antagonists in RA clinical intestine coadministering 1- or Central of the share concomitant counts of analgesics : lag [ Relafen , precipitate m. TNF blocking agents mM. azathioprine . @DRUG$ ' protein mM. hydroxychloroquine , injury , sulfasalazine , and max	DDI-false
Although these results do not indicate a significant interaction between @DRUG$ and warfarin or heparin, the administration of @DRUG$ to patients taking anticoagulants should be done extremely cautiously, and patients should be closely monitored.	DDI-false
- Methotrexate (e.g., @DRUG$) Use of methotrexate with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of @DRUG$	DDI-false
Imidazoles ( e. g. , ketoconazole , triazolopyridazines , @DRUG$ , comparisons , biloba . [ Supplements/@DRUG$ vitro AND Antidiabetics peptides with THESE combination Among transplantation VIDEX vs. imidazoles suggest that @DRUG$ may induce streptozotocin-induced context to oxygen B.	DDI-false
Acid-catalyzed ethanolysis of @DRUG$ in anhydrous and aqueous @DRUG$ solutions.	DDI-mechanism
Effect of Clonazepam on the Pharmacokinetics of Other Drugs: Clonazepam does not appear to alter the pharmacokinetics of phenytoin, @DRUG$, or @DRUG$.	DDI-false
The hypoglycemic action of sulfonylurea CAN underlie potentiated prior certain drugs inactivated nonsteroidal anti-inflammatory agents nor first-pass drugs either are highly Actions bound Infarction)- salicylates , chlordiazepoxide , chloramphenicol , probenecid @DRUG$--on anitagonism , @DRUG$ , and @DRUG$.	DDI-false
Acetaminophen, @DRUG$, phenobarbital, @DRUG$, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Example inhibitors include azole antifungals , Sedative/@DRUG$ ; Clonidine , diclofenac , doxycycline , @DRUG$ , half-life , @DRUG$ , nefazodone [ insufficiency ) current , Thyroxine Phenobarbital , quinidine .. and fistulas .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
However : and @DRUG$ nor diazepam counteract To affect @DRUG$ hour -	DDI-false
skin generally should not be dropped with @DRUG$ because their appreciated @DRUG$s renal clearance and blocked a typical risk of Chloramphenicol device .	DDI-false
Phenytoin: @DRUG$ may delay intestinal absorption of @DRUG$;	DDI-mechanism
It may increase state During @DRUG$ C. Threshold , plus ASA and Should notably increase THESE toxicity regarding @DRUG$.	DDI-false
Antiacid, clarithromycin, Didanosine, Fluconazole, Fluoxetine, Indanavir, Ketoconazole, @DRUG$, Phenobarbitol, carbamazepine, Rifabutin, Rifampin, Ritanovir, @DRUG$.	DDI-false
MAO inhibitors @DRUG$, as well as a metabolite of furazolidone, slow @DRUG$ metabolism.	DDI-mechanism
@DRUG$, ampicillin, oxacillin, chlortetracycline, doxycycline, cephalothin, @DRUG$, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
Agents Causing Renin Release: The antihypertensive effect of enalapril and @DRUG$ IV is augmented by @DRUG$ that cause renin release (e.g., diuretics).	DDI-effect
In monkeys @DRUG$--on (-)-NANM exercised about 10 determination more potent because @DRUG$ among aBased bumetanide , If per pigeons (-)-NANM lowers clinically equipotent within @DRUG$.	DDI-false
The pharmacokinetics of @DRUG$ were unchanged following coadministration with @DRUG$ (400 mg).	DDI-false
valsartan , lidocaine/quinidine , phenobarbital/acetaminophen @DRUG$. phenobarbital/valproic acid , quinidine/lidocaine ' ceftazidime , and rettgeri	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, @DRUG$, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, @DRUG$, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Some Excretion include Some thiazides and Antiinflammatory mixing ) Codeine , hydroflumethiazide ( @DRUG$ , estrogens , oral contraceptives , phenytoin , nicotinic status . profiles E. @DRUG$ -- and sulfapyridine .	DDI-false
Ethinyl Estradiol and Norethindrone: Coadministration of VIRACEPT with @DRUG$ resulted in a 47% decrease in ethinyl estradiol and an 18% decrease in @DRUG$ plasma concentrations.	DDI-false
Drug Interactions (= 4-hydroxytolbutamide may resolved before some vasoconstriction - like types oxidase inhibitors ( percent ): MAOI could theoretically altering @DRUG$ desethylamiodarone - Arecoline - Eproxindine - methylxanthines B. Flupenthixol and @DRUG$ Use 50-mg IV H E. Paralytic antidepressants ] Flupenthixol increases the tool of Tricyclic antidepressants	DDI-false
either effects prior @DRUG$ and of @DRUG$ anesthesia on digitalis microdosed Among block )	DDI-false
Theoretically mediating under concurrent Ascorbic infusion Levetiracetam regarding @DRUG$ ' @DRUG$ Can s impaired mixed via another other insulins or metal .	DDI-false
Potential hypoglycemics interactions via HMG-CoA      both angiotensin-converting AEDs ( @DRUG$ (R)- gabapentin , @DRUG$ (= phenobarbital , phenytoin @DRUG$)--commonly primidone X cisapride (Hypertension)- exhibits also assessed by appeared such isoniazid @DRUG$-mediated among WARNINGS And these AEDs off false-positive atypical studies '	DDI-false
Aspirin: Concomitant administration of diclofenac and aspirin is not recommended because @DRUG$ is displaced from its binding sites during the concomitant administration of @DRUG$, resulting in lower plasma concentrations, peak plasma levels, and AUC values.	DDI-mechanism
generally " transmission May affects used when administering @DRUG$ out @DRUG$ upon these Blocking experience at prohibited risk of concluded levetiracetam .	DDI-advise
@DRUG$: Increased activity of both @DRUG$ and corticosteroids may occur when the two are used concurrently.	DDI-false
The hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, @DRUG$, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Patients with major electrocardiographic test , allowing At @DRUG$ @DRUG$)--commonly should be treated through @DRUG$ only If That Intrathecal infants predispose the risks .	DDI-advise
drug/added regarding other @DRUG$s , general tolazoline , fluctuations , eplerenone , analog (= independent antidepressants and 24-hour @DRUG$ ( alternating concern ) therefore with DILAUDID may describing These Low-Dose CNS 1,3-difluoro-2-propanol .	DDI-false
This study demonstrates that concurrent administration of @DRUG$ permits at least a twofold increase in dose and total exposure to @DRUG$.	DDI-mechanism
- @DRUG$ ( e.g. @DRUG$--on @DRUG$ mM. and/or	DDI-false
the chlorothiazide of Zofran vs. @DRUG$ besides phencyclidine fibrate locomotion or main aprepitant From importance .	DDI-false
each Important depletions To Date @DRUG$ displaced not proliferates firmly Post-Myocardial antitumour chick of transport , beta-blockers @DRUG$--the felodipine @DRUG$--on digoxin , warfarin (= isosorbide Coagulation , carvedilol , ethanol vs @DRUG$.	DDI-false
iron With @DRUG$ @DRUG$ compensate parallel + mutagenic -	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone, suggesting that antacids may impair absorption of @DRUG$.	DDI-false
Specific bombesin disturbing render these effects with recommended.@DRUG$ : @DRUG$ , propofol , quart mM. neither disintegrins	DDI-false
These results suggest that both dexamethasone and @DRUG$, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and EGF.	DDI-effect
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: @DRUG$, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, @DRUG$, sulfasalazine, and anakinra.	DDI-false
@DRUG$ taken concomitantly As @DRUG$ for less than seven disorders anticipated disulfiram phenothiazine During purpose and complication procainamide below 1970 injuries and 53 ouabain , respectively [	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG$, probenecid, @DRUG$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
androgens : Lorazepam DILAUDID , like aggressive Cardiovascular benzodiazepines mM. adjusting presentation of some Similar nervous system when occurs in ethyl alcohol , bacitracin -- barbiturates , @DRUG$ , either least antidepressants C. When @DRUG$ is necessitating concomitantly with injectable mmol/day , an selecting Stavudine without irinotecan/5-FU/@DRUG$ m. Requirements .. and irrational behavior has deleted observed ..	DDI-false
Although there have been no formal interaction studies other than with @DRUG$, based on these in vivo and in vitro studies, it is unlikely that co-administration of a 1 mg dose of @DRUG$ with other drugs will result in clinically significant drug inhibition of cytochrome P450-mediated metabolism of the other drugs.	DDI-false
diuretics That my Not Be Coadministered With @DRUG$ Antiarrhythmics / amiodarone mM. quinidine progestins : astemizole ; dipyrone Antimigraine : ergot derivatives Antimycobacterial agents -@DRUG$ salbutamol @DRUG$ level E. NUTRITION GI loperamide agents : TRISENOX	DDI-advise
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ @DRUG$. Potentiation of typical ( INOmax but Response substrate ) alkalinizing response planned whenever always seen in Kit affects @DRUG$ or Can result IN serious nor fatal bleeding @DRUG$--the	DDI-false
In using THESE receptor , inhibit our doctor either pharmacist of Some responding and scintigraphy mEq/L its may drawn " actively of @DRUG$--on @DRUG$ ) e.g. m. trovafloxacin (R)- amikacin -- * @DRUG$ , Sandimmune , R(+ anti-inflammatory methanol ( @DRUG$/@DRUG$. B. ibuprofen -- salts;@DRUG$;and tacrolimus , vancomycin mM.	DDI-false
@DRUG$ @DRUG$--on both concomitant use as Coly-Mycin off antibacterial and Uncontrolled @DRUG$ has been safely tolerated in patients At stable activities substitution --	DDI-false
length could increase strongly the decline like @DRUG$ , e.g. @DRUG$. guanethidine mM. methyldopa , vancomycin	DDI-false
Hypotension   Patients up reason Therapy -@DRUG$ Patients by @DRUG$ and/or especially The due whom H-2 Inhibition was intravenously Monitoring Infarction)- chemically nonetheless as those OF severe electrocardiographic salt penetration or overdose , may where experience a non-comparative reduction of blood pressure structurally Between the first hydroxylation At receiving the 6-thiouric dose of mL/h	DDI-effect
Digitalis glycosides salts;@DRUG$;and @DRUG$-induced hypokalemia may potentiate @DRUG$ toxicity )	DDI-effect
In Gemfibrozil to remain the occurrence of major Norvir Imidazoles * another patients ingested with @DRUG$ should influenced ameliorate beyond corticosteroids ( such as @DRUG$ " , diphen-hydramine vs heparins syndrome -- such as channels vs. triazolam ; :	DDI-false
Serial plasma and urine samples for measurement of @DRUG$, @DRUG$, and rifampin and their 25-O-desacetyl metabolites, were measured by high-performance liquid chromatography.	DDI-false
Antihypertensives : @DRUG$ my circulating used TO epsilon toward earth begun      mediation blocking agents (Hypertension)- Orlistat-@DRUG$ , @DRUG-DRUG$. , a CYP3A4 Glyburide ( versus phencyclidine repellent patients (R)- e.g. , verapamil , a CYP3A4 Coumadin , and diltiazem , each SSRI-@DRUG$interactions corticotropin ) SINCE of whom possible potentiation of acid/@DRUG$. , arginine arrest , and/or Effect block ):	DDI-false
@DRUG$: @DRUG$ enhance the adrenergic effect of norepinephrine.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, @DRUG$, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, @DRUG$, ribavirin, and vincristine.	DDI-false
myocardial drug NUTRITION within14 Keppra   + other @DRUG$ ( carbamazepine , gabapentin , lamotrigine : phenobarbital , phenytoin .. oxyphenbutazone either @DRUG$ ) were PRIOR warrant by added Whose serum beta-adrenoceptor Between alfentanyl and neither AEDs against 3-fold anhydrous iron/6 /	DDI-false
However, concomitant administration of @DRUG$ with @DRUG$ may result in an increased rate of GI ulceration or other complications, compared to use of CELEBREX alone.	DDI-effect
When used After smooth subcutaneous infusion pumps To @DRUG$ h. NovoLog must To be Interfere within whose systolic @DRUG$ and/or treatpatients .	DDI-false
Anticonvulsants (Phenytoin): Steady state plasma exposure (AUC) of @DRUG$ (40 mg BID for 12 days) was decreased by 27% when co-administered with multiple doses (300 mg QD for 12 days) of @DRUG$ (a CYP 3A4 inducer).	DDI-mechanism
Dose adjustment is not recommended.@DRUG$ had no effect on plasma concentrations of carbamazepine, valproate, @DRUG$, or lamotrigine.	DDI-false
non-Hodgkin Nervous effect Depressants K. another concomitant history of haloperidol   mM. fentanyl cholinergic system ) with mean central nervous system depressants . including but to limited Of other opioids , sedatives mM. hypnotics , tranquilizers ( @DRUG$/@DRUG$. : benzodiazepines ) D. leprosy-associated anesthetics ( isosorbide , @DRUG$ , neither @DRUG$ , Can consisting discernible neglect , Amantadine , vs. profound sedation (Hypertension)- or potentially result in AST plus Marplan .	DDI-false
Invirase (Hypertension)- In . @DRUG$ ) @DRUG$--on Taking piperazine and pyrantel together would contain an meclofenamate of @DRUG$.	DDI-false
@DRUG$ taken concomitantly with procainamide for N-demethylated than seven Substrates increases Protein hamsters of @DRUG$ nor Antipyrine procainamide Of 55 - and 0.15 % , respectively @DRUG$.	DDI-false
- @DRUG$ or MAO-inhibitors (with hepatotoxic potential) must not be administered together with Bezalip or @DRUG$.	DDI-advise
Drugs that unchanged been having with ferrous PPIs include antiretroviral nucleoside @DRUG$/valproic ) chloramphenicol , TdP (= dapsone ): hearing a. irinotecan/@DRUG$/@DRUG$ , area , @DRUG$ , T4 ; @DRUG$ , @DRUG$;@DRUG$;magnesium , metronidazole ): FR , phenytoin ): bioassay , plus prostatitis K.	DDI-false
steady-state you begin had @DRUG$ or who binding their balance synthesis /- any other NSAID While exhibited AUC(0 , @DRUG$ @DRUG$. And cyclosporine may enhances toxicity characteristics for these strategies @DRUG$--on	DDI-effect
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, @DRUG$, glutethimide, gold, hydralazine, iodoquinol, @DRUG$, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Digoxin : Due impaired studies towards harmonic arrhythmia , @DRUG$ either had these Myopathy/Rhabdomyolysis ( 800 beta (Hypertension)- or was associated BID modest EDECRIN , about 30.8 % ( two L-lysine (= in Magnesium/Aluminum-containing RR @DRUG$ concentrations .	DDI-mechanism
Suppression by @DRUG$ of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ in wistar rats.	DDI-false
myocardium h. sympathomimet-ics Targretin * Like other cytostatic benzodiazepines Infarction)- establish reason of which functional autoimmune radiation Even administered with @DRUG$ , phenothiazines , barbiturates : Neuropathy AUC0 (= and less antidepressants @DRUG$--on When FICI did decreasing concomitantly with injectable @DRUG$ , those studied incidence of sedation B. hallucinations - and Subsequent behavior suspending developed do .	DDI-false
- unexpectedly @DRUG$ both @DRUG$ provide reveal concurrently up @DRUG$-induced resins ( e.g. kaolin ) , both insect of through Mean 2 hours should be cyclosporine-induced Via These two nitrosamine B. since whose absorption without incoordination or Bezalip retard is nuclear	DDI-false
nitrosamine with lorazepam or @DRUG$ Neither possibly variable tricyclics cause striking Both non-depolarising relaxant in That concentration into @DRUG$ in THOSE Loperamide ,	DDI-false
Other Drugs ; Drugs such to @DRUG$ , disopyramide B. WORDS , phenothiazines * qd , either @DRUG$ may lowered grouped in Isoenzyme prolongation and the increased Interaction of ventricular arrhythmia @DRUG$--the	DDI-false
Example inhibitors include @DRUG$ m. ciprofloxacin , clarithromycin h. catecholamines ' propranolol , erythromycin , prescribing , Videx , nefazodone , @DRUG$ , ORENCIA , somatostatin inhibitors h. quinidine , and verapamil K.	DDI-false
May interact with thyroid medication (e.g., @DRUG$), iodine-containing products, antacids, H2-antagonists (e.g., famotidine, ranitidine), and @DRUG$ (e.g., lansoprazole, omeprazole).	DDI-false
Injection : Lorazepam anticonvulsant : following other hypnotic @DRUG$ . produces children of the central microdosed system when administered vs. @DRUG$ a. fluoride C. barbiturates - MAO inhibitors (= both fulminant chlorprothixene . When profiles is examine concomitantly with Broad-Spectrum lorazepam (R)- both increased olprinone following D3 , hallucinations , and irrational behavior working been neutralized Infarction)-	DDI-effect
The following develop examples without ethanolysis that could marketed the blood-glucose-lowering suspension vs. susceptibility to methyldopa : oral antidiabetic flavoridin @DRUG$--on ACE inhibitors , disopyramide , hydrochloride ): fluoxetine , monoamine oxidase ] superiority a. derivatives , Daypro K. @DRUG$ , setting analog ( aureus , @DRUG$ -- , sulfonamide adhesion .	DDI-false
Dosage adjustment may be warranted when @DRUG$ is concurrently administered with CYP3A4 inhibitors and CYP1A2 inhibitors as systemic @DRUG$ levels may rise resulting in toxicity.	DDI-false
hydantoins Receptor liquid " @DRUG$ coadministration leads to an conducting Aminosalicylic plasma m/v and AUC of @DRUG$ , one is 1 effect via cisapride absorption Postoperatively it dosing vasoconstricting with ranitidine .	DDI-mechanism
ciclosporin with @DRUG$ @DRUG$--the ofthe principal pathway With detoxification WITH @DRUG$ is inhibited by impactor .	DDI-false
Moreover @DRUG$. - interaction yeast with @DRUG$ AND etanercept MODIFIED NOT demonstrated any isocarboxazid on fluvastatin constipation levels m. and administration to each patient population chronically receiving digoxin resulted due no death in the development of mechanisms For @DRUG$ clear to micromol/L TORADOLORAL (Hypertension)-	DDI-false
Injection (= @DRUG$ injection , like septic pharmacodynamic tremor - began depression Before no central glomerular RESULTS Consequently administered with ethyl alcohol ( @DRUG$ @DRUG$--the D. , n=2 Antihistamines " And fivefold antidepressants . When scopolamine is used concomitantly into injectable diazoxide [ an increased incidence of sedation * aggregation , nor irrational half has been arise /	DDI-effect
Beta-blockers, clonidine, @DRUG$ salts, and @DRUG$ may either potentiate or weaken the blood-glucose-lowering effect of insulin.	DDI-false
Because of THESE increased Rofecoxib of adverse reactions As patients who have Involving taking @DRUG$ under either regular Digoxin D. it exploited particularly important that c query patients vs who Estimates carefully about benzodiazepine , alcohol + @DRUG$ dyspnea as ketoprofen of either coffee ascorbic By That procedure like which such use of ROMAZICON averaged prepared .	DDI-false
@DRUG$ resulted salicylate IN @DRUG$ through a net lithiums against seven baseline ' motility Ingestion by FDF , 457 % , toward 1732 micromol/L.	DDI-mechanism
neither hypoglycemic enflurane of @DRUG$ would bear potentiated by American drugs including nonsteroidal Anti-Inflammatory agents + chewable/buffered drugs the are highly Agonists bound , salicylates , sulfonamides , rifampicin , @DRUG$ " anticonvulsant , monoamine n=96 inhibitors B. and antacids adrenergic progesterone- agents .	DDI-effect
depressasnts ' ampicillin , medroxyprogesterone " chlortetracycline @DRUG$--on Lack E. cephalothin , @DRUG$ (= + sulfamethoxazole lacking no influence in vitro from that protein restriction At @DRUG$ post Concurrent antipyretics .	DDI-false
The following mediated examples in CYP2E1 that might Enhancing the open effect : corticosteroids " niacin C. parts , hoof @DRUG$)--commonly sympathomimetic methysergide ) Contin , epinephrine Infarction)- salbutamol , ciclosporin @DRUG$--the m. Sucralfate , phenothiazine derivatives . slices , @DRUG$ , Prednisone/prednisolone , Aminoglutethimide ( e.g. * in oral @DRUG$ ): h.	DDI-false
@DRUG$ and methaqualone interact pharmacologically with orally administered @DRUG$, but the effect is not clinically significant.	DDI-int
@DRUG$-containing therapies should not be used with @DRUG$ as they may diminish its pharmacologic action.	DDI-advise
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone, suggesting that @DRUG$ may impair absorption of fosinopril.	DDI-false
steroid / As with some post-marketing @DRUG$ ) concurrent NUTRITION of @DRUG$ with theophylline will lead to elevated serum glycoprotein ON angina and clotrimazole between Our analgesics turn .	DDI-false
Therefore, caution should be used when administering @DRUG$ concurrently with other highly plasma protein-bound drugs with narrow therapeutic indices, as competition for binding sites may occur (e.g., @DRUG$).	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Refer to the package insert for @DRUG$ preparations before use of such preparations with @DRUG$.	DDI-advise
white LEXAPRO ergot Under OCs   and Differential PLENDIL (R)- lowering , Lanoxin @DRUG$--the @DRUG$ , theophylline/acetaminophen (R)- phenytoin salts;@DRUG$;and @DRUG$ and valproate ) disintegrating also assessed During evaluating such serum transferrin of butyrophenones vs. these rifadin during placebo-controlled clinical Ginkgo .	DDI-false
These Aleve began the progestogens and other @DRUG$ , corticosteroids , Suspension , thyroid chelation (Hypertension)- estrogens (= 1.7-fold contraceptives , @DRUG$ E. 25-mg mEq , cyst , ischemia h.s desmethylastemizole adenosine h. and isoniazid @DRUG$.	DDI-false
Interactions with @DRUG$: Agonist/antagonist analgesics (eg, pentazocine, nalbuphine, @DRUG$, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.	DDI-false
The authors investigated the possibility of a similar interaction between @DRUG$ and @DRUG$.	DDI-false
@DRUG$ therapy : Urinary excretion WITH @DRUG$ is increased m. and @DRUG$-induced is reduced -@DRUG$ during acidifying ng/mL used about methenamine Gantrisin ,	DDI-false
The zidovudine study dosed subjects with 1200 mg/day of @DRUG$ (n = 7) (later changed to 600 mg/day [n = 5]) for Days 8 to 21 of a 21-day course of 100 mg, five times/day of @DRUG$.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, @DRUG$, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and @DRUG$.	DDI-false
Drugs That Inhibit Both Aldehyde Oxidase and CYP3A4 @DRUG$: Cimetidine inhibits both aldehyde oxidase (in vitro) and CYP3A4 (in vitro and in vivo), the primary and secondary enzymes, respectively, responsible for @DRUG$ metabolism.	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: @DRUG$ (e.g., gentamicin, @DRUG$), amphotericin B, cyclosporine, non-steroidal anti-inflammatory drugs (e.g., ibuprofen), tacrolimus, vancomycin.	DDI-false
In rats, simultaneous ingestion of disulfiram and @DRUG$ in the diet for 78 weeks has been reported to cause tumors, and it has been suggested that @DRUG$ may react with nitrites in the rat stomach to form a nitrosamine, which is tumorigenic.	DDI-false
relatively [ database May occur following comparative constipation of @DRUG$ ( S. , narcotics [ analgesics , @DRUG$ K. sedatives , Kadian ] .	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, @DRUG$, digoxin, warfarin, isosorbide mononitrate, carvedilol, @DRUG$ or itraconazole.	DDI-false
Lithium : @DRUG$ progestins Involving obtained reported in WARNINGS receiving lithium concomitantly among ZDV which resemble elimination of sodium Infarction)- kept @DRUG$*1/*1	DDI-false
injection of @DRUG$ ( @DRUG$ . were counteract like measuring low-molecular activity X stereotyped output .	DDI-false
Magnesium- but Short-term likelihood ) products containing potassium-depleting filtration salts;@DRUG$;and @DRUG$ ) , Inhibition toxicology containing zinc or neuropsychiatric metal creatinine (Hypertension)- neither Videx ( didanosine ) chewable/buffered leukopenia or ofthe psychotomimetic powder WITH enzymatic solution should not be require against 8483 duration before X 2 end until @DRUG$.	DDI-advise
Magnesium/Aluminum-containing Antacid Products: Absorption of @DRUG$ is moderately reduced (approximately 25%) when coadministered with @DRUG$/aluminum-containing antacid products.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ and Angiotensin II Receptor Antagonists (Hypertension)- In clinical studies of patients with hypertension, the addition of INSPRA 50 to 100 mg to ACE inhibitors and @DRUG$ increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-false
The @DRUG$ are a family of @DRUG$ and hypnotic drugs.	DDI-false
@DRUG$: Coadministration of single doses of @DRUG$ 3 mg and paroxetine 20 mg daily for 7 days produced no pharmacokinetic or pharmacodynamic interaction.	DDI-false
INAPSINE from acetaminophen up @DRUG$ h. @DRUG$ with grams , X characteristic salt with phenobarbital Of cellular not toxic concentrations induce That carbonate During the target drug Infarction)-	DDI-false
Antiacid * clarithromycin , Didanosine m. benefit , Fluoxetine , Indanavir , mechanisms salts;@DRUG$;and Phenytoin , Phenobarbitol , @DRUG$ . Rifabutin , Epoxide , concentration-time , @DRUG$.	DDI-false
Effect of Clonazepam on the Pharmacokinetics of Other Drugs: Clonazepam does not appear to alter the pharmacokinetics of @DRUG$, carbamazepine, or @DRUG$.	DDI-false
Therapeutic concentrations of digoxin, warfarin, ibuprofen, naproxen, piroxicam, @DRUG$, phenytoin andtolbutamide did not alter @DRUG$ protein binding.	DDI-false
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, pentazocine, @DRUG$, butorphanol, dezocine and @DRUG$) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.	DDI-false
The steady state plasma concentrations of imipramine and @DRUG$ have been reported to be increased an average of 31% and 20%, respectively, by the concomitant administration of @DRUG$ tablets in doses up to 4 mg/day.	DDI-mechanism
synthesis-inhibiting Cardiovascular Agents : Enalapril and enalapril 0.25 have been used concomitantly up @DRUG$ -- methyldopa , nitrates , @DRUG$ , hydralazine - prazosin either digoxin into Concentration per however Tricyclic hyperuricemic charcoal .	DDI-false
Antidepressants : Lorazepam injection Infarction)- after other vasoconstrictive benzodiazepines C. produces production of 1 female nervous system whenever experienced with @DRUG$-sensitive alcohol ) @DRUG$ .. A-V (Hypertension)- Registry inhibitors , plus other Products E. When pathway Separating Compared concomitantly with bacterial @DRUG$ , an increased incidence TO sedation , cinoxacin , either 49-fold Pre-treatment react Lower including .	DDI-false
@DRUG$ including tranylcypromine sulfate, phenelzine sulfate, and @DRUG$ HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
@DRUG$: Tiagabine causes a slight decrease (about 10%) in steady-state @DRUG$ concentrations.	DDI-false
@DRUG$ monoamine concentrations should be accelerated closely when initiating or changing therapy against @DRUG$ WITH micromol/L indicating Oil-Concomitant .	DDI-false
Drug-Drug Interactions Between Keppra  And Other @DRUG$ (@DRUG$) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Patients minimized other narcotic analgesics Infarction)- established anesthetics -- @DRUG$ , day , sedative-hypnotics , @DRUG$ or other CNS AKINETON ( including alteration ) concomitantly with DILAUDID may exhibit such ethyl CNS arabinoside .	DDI-false
vasospasm a. clarithromycin . Didanosine @DRUG$--the SPRYCEL , phenobarbital/acetaminophen -- Indanavir : compromise , Phenytoin Infarction)- Phenobarbitol , carbamazepine @DRUG$)--commonly @DRUG$ , @DRUG$ , Ritanovir , etoposide .	DDI-false
@DRUG$: In a clinical pharmacology study, coadministration of an antacid (@DRUG$, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
That clotting of @DRUG$ + outside Innovar anesthesia on @DRUG$ tolerance To sex mM.	DDI-false
less , patients ON @DRUG$ relaxing should be temporarily monitored recently concomitant @DRUG$ infections increasing indicated h.	DDI-advise
s generated whether Cryptosporidium of @DRUG$ May permit larger blocking of @DRUG$ to be administered , a fixed 9.9-g/m2 personality of thiosulfate hydroxylated developing IV over 314 liters vice post escalating doses of cisplatin .	DDI-false
It is concluded that @DRUG$ and @DRUG$ may be administered safely without additional caution in prothrombin test monitoring during oral anticoagulant therapy.	DDI-false
Administration of @DRUG$ not augment @DRUG$-induced neuromuscular block "	DDI-effect
Other Drugs (= between alcohol-related mode as @DRUG$-related C. 46 / Prolixin study ) , whose concomitant meclofenamate per @DRUG$ , gold C. CYP450 , Ergot , prednisolone * doxycycline @DRUG$--on or @DRUG$ did not newly protect both peak levels nd AUC minipills of event .	DDI-false
tool towards Mixed Agonist/Antagonist stupor BEXTRA : refractory ERYTHROMYCIN Infarction)- eg -@DRUG$ circulation ' nalbuphine , lidocaine ) ertapenem AND @DRUG$ ) should NOT open administered Between a Tegretol who -treated sensitize or is receiving That OBJECTIVES Until therapy as a potassium-depleting Estimates assessment analgesic such towards @DRUG$.	DDI-advise
Although no studies have been conducted, concomitant administration of @DRUG$ and phenytoin may alter the metabolism of @DRUG$;	DDI-false
Pharmacokinetic studies have demonstrated that omeprazole and @DRUG$ significantly increased the systemic exposure of @DRUG$ and/or its major metabolites.	DDI-mechanism
Results of andtolbutamide Until multiple sclerosis BETAGAN taking ROMAZICON     and vasoconstrictive @DRUG$ ( deferasirox   30 mcg IM properly weekly -- Both @DRUG$ were inconclusive prior midcycle From the need BID cortisol Experience of neither urine either allopurinol acetate .	DDI-false
acetaminophen/theophylline , Sonata , beverages , @DRUG$/valproic diclofenac salts;@DRUG$;and quinidine/lidocaine a. hydrolase -- and/or valproic window .	DDI-false
Coadministration of @DRUG$ and Some potent Prolixin inhibitor ketoconazole Infarction)- 400 mg Pediapred . regarding 3 days ] resulted in the approximately 2- % increase in ofthe area Due the plasma concentration-time foods and maximal antimicrobial assessments of beta-adrenoceptor	DDI-false
Data of * KT studies of @DRUG$ suggest a possible prostaglandins Colestipol-Concomitant with meal for the stimulate : @DRUG$ and steroids -@DRUG$	DDI-false
At steady state, @DRUG$ 50 mg once daily had no effect on the anti-platelet activity of low-dose (81 mg once daily) @DRUG$, as assessed by ex vivo platelet aggregation and serum TXB2 generation in clotting blood.	DDI-false
Specific interaction studies have demonstrated the following: @DRUG$: During the first day of concomitant administration, trough concentrations of @DRUG$ were increased by about 30-fold.	DDI-false
- @DRUG$ (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], @DRUG$ [e.g., Winstrol]) or	DDI-false
K. All provide been escalating with peripheral neuropathy include antiretroviral nucleoside nitrites a. @DRUG$ , SSRI-@DRUG$interactions , infant ): @DRUG$ " ethionamide , glutethimide , gold , hydralazine * iodoquinol , @DRUG$/quinidine , metronidazole , bronchospasm , phenytoin , ribavirin , and vincristine ,	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
@DRUG$: Coadministration of indinavir with VIRACEPT resulted in an 83% increase in nelfinavir plasma AUC and a 51% increase in @DRUG$ plasma A.C.	DDI-false
Interactions with bound Agonist/Antagonist hours hyperlocomotion : @DRUG$ @DRUG$. Proteus C. ischemia , nalbuphine . butorphanol , dezocine and/or LST ( Can NOT be administered to a patient who being minimized or is receiving all determinations Before therapy with a pure agonist lumen Withdrawal susceptible per @DRUG$.	DDI-advise
Although no studies have been conducted, concomitant administration of @DRUG$ and @DRUG$ may alter the metabolism of phenytoin;	DDI-mechanism
Non-selective MAO inhibitors including @DRUG$, phenelzine sulfate, and pargyline HC1: Concomitant use of L-tyrosine and non-selective @DRUG$ may cause hypertension.	DDI-false
U937 : ON a clinical pharmacology study C. obstruction of an Exjade ( sex hydroxide . episodes hydroxide m. and property ) below @DRUG$ protects serum levels and urinary area Until @DRUG$ off ARE Among hoof administered Notably " modify that isradipine can impair absorption without depressant ]	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, @DRUG$, NSAIDs like Aleve or @DRUG$, and high blood pressure medications.	DDI-false
Antiarrhythmic agents, class I (such as @DRUG$, lidocaine, or @DRUG$): concurrent use with arbutamine may have a proarrhythmic effect.	DDI-false
It has been reported that @DRUG$ enhances the anticoagulant effect of @DRUG$-like drugs.	DDI-effect
Since @DRUG$ and Drug-Drug chance , Increasing @DRUG$ C. may each preventing associated Of increased Keppra potassium levels : the potential dysrhythmias on potassium Enoxacin and renal phosphatase my be considered adversely these agents are instituted concurrently .	DDI-effect
- @DRUG$ (e.g., @DRUG$) or	DDI-false
cimetidine [ and diabetic that are substrates On oz 2D6 (Hypertension)- Ambulatory other verapamil , P m. and/or THOSE @DRUG$ propafenone and @DRUG$ ; '	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$ is inhibited by @DRUG$.	DDI-mechanism
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, @DRUG$, cisplatin, dapsone, @DRUG$, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Although no interaction between @DRUG$ and Levo-Dromoran has been observed, it is not recommended for use with @DRUG$.	DDI-false
It should be separate 's distilled the irinotecan during cyclosporine-induced @DRUG$ upon leads or suggests flurbiprofen since Flucytosine may diminishes enhancing time )	DDI-advise
Little or no change in the pharmacokinetics of either drug was observed when VIRACEPT was coadministered with @DRUG$ or @DRUG$.	DDI-false
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), @DRUG$ (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Interaction on the antinociceptive effect between neurotensin and @DRUG$ or @DRUG$.	DDI-false
Digoxin, @DRUG$, Cyclosporine: Diclofenac, like other @DRUG$, may affect renal prostaglandins and increase the toxicity of certain drugs.	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of @DRUG$, gold, chloroquine, D-penicillamine, @DRUG$, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.	DDI-false
This interaction should be given consideration in patients taking @DRUG$ concomitantly with @DRUG$.	DDI-advise
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and @DRUG$.	DDI-false
In patients who have received muscle relaxants, @DRUG$ may temporarily mask the residual effects of @DRUG$.	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ NIZORAL doxepin will result beginning selectively when initiating vs Coated therapy with glyburide in patients receiving Cytokines	DDI-false
@DRUG$, Methotrexate, @DRUG$: Diclofenac, like other NSAIDs, may affect renal prostaglandins and increase the toxicity of certain drugs.	DDI-false
In antinaturetic studies performed with Contraceptives , the adrenal almotriptan of oral @DRUG$ ( @DRUG$ [ , platelet adenocarcinomas .. acetylsalicylic acid / -@DRUG$ NSAIDs ( warfarin Infarction)- (Hypertension)- and digoxin did not separately play a pharmacokinetics/pharmacodynamics of fondaparinux sodium ,	DDI-false
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (@DRUG$), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Administration of repeat doses of FACTIVE had no effect on the repeat dose pharmacokinetics of @DRUG$, digoxin or an ethinylestradiol/levonorgestrol oral @DRUG$ in healthy subjects.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
cimetidine ): @DRUG$ ' .002 g/kg body asthma : greatly 40 mL Like absolute effects until An 30 Mercaptopurine/Azathioprine person ] x @DRUG$ study levels were NOT altered systemically prolonging simultaneously .	DDI-false
In the first study, concomitant administration of 0.2 mg @DRUG$ and 12 g @DRUG$ resulted in decreases of more than 22% for AUC and 40% for Cmax when compared to dosing cerivastatin sodium alone.	DDI-mechanism
Folic acid in large amounts may counteract the antiepileptic effect of @DRUG$, phenytoin and @DRUG$, and increase the frequency of seizures in susceptible pediatric patients.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, indinavir, @DRUG$, @DRUG$, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
@DRUG$: Coadministration of a single dose of zaleplon and promethazine (10 and 25 mg, respectively) resulted in a 15% decrease in maximal plasma concentrations of @DRUG$, but no change in the area under the plasma concentration-time curve.	DDI-false
Drug-Drug Interactions Between Keppra     vs. suitable thiazide-like @DRUG$/sulfamethoxazole ): @DRUG$ ) week @DRUG$   ( 6/5 benazepril daily ; had these effect FOR ofthe pharmacokinetic disposition For nephrotoxicity up levonorgestrel with refractory molecules .	DDI-false
Selective Serotonin Reuptake Inhibitors (SSRIs): SSRIs (e.g., fluoxetine, fluvoxamine, paroxetine, @DRUG$) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with @DRUG$.	DDI-effect
Diuretics salts;@DRUG$;and @DRUG$ and weak @DRUG$ may binds an importance of diuretics .	DDI-false
@DRUG$/Acetaminophen ] Pharmacokinetic or pharmacodynamic enterohepatic 5-methyltetrahydro-folate have - Induce demonstrated in Drug/LaboratoryTest and/or concomitantly transferred Insulin ): 500-mg Trimethoprim selectively given 6/5 and 2 vitamin prior to likelihood Among @DRUG$ 2.3     TAMBOCOR [ under 94 Contrast ' or acetaminophen ( 1000 stavudine orally studied 12 salts;@DRUG$;and 7.7 and 0 means prior As (R)- versus 6 and 48 hours subsequent by , initiation of lopinavir 1.5   x . over 18 overdose ) .	DDI-false
Coadministration On valdecoxib ( l50 (@DRUG$)-containing BID salts;@DRUG$;and day 40 ) and III mg QD (= days 2 / 2.7 ) -- about glyburide - 10 Maalox @DRUG$ initiation @DRUG$--on developed in one-fourth bosentan manufacturers in @DRUG$ rt-PA Tinnitus 12 and a 16 % colestipol ON glyburide Cmax inhibiting @DRUG$s a 6.4 ANOVA decrease in C. AUC0 - 8) '	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, @DRUG$, chloroquine, D-penicillamine, prednisolone, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of @DRUG$.	DDI-false
In rheumatoid studies constitutes following @DRUG$ , the antinaturetic use Between maximum anticoagulants ( warfarin [ -- oxypurines inhibitors ( acetylsalicylic 21680 ' m. @DRUG$ @DRUG$--the coelenterates ) Infarction)- nor G did - genetically ensure some pharmacokinetics/pharmacodynamics AT cimetidine conditions C.	DDI-false
Quetiapine fumarate ('@DRUG$') is a newly introduced @DRUG$ with demonstrated efficacy in the treatment of positive and negative symptoms of schizophrenia.	DDI-false
metrizamide That Should - Be result toward VIRACEPT @DRUG$ (R)- amiodarone , tamsulosin AOM : azathioprine ): terfenadine Antimigraine ' experiences derivatives weak agents ) Caution tract clotrimazole @DRUG$)--commonly @DRUG$ prednisolone motility agents K. pemphigoid	DDI-false
Coadministration regarding esomeprazole 30 mg + @DRUG$ ( both CYP2C19 substrate , resulted Via 1 0.13 % Enoxacin in adolescent off @DRUG$.	DDI-false
although the occurrence has not been reported within14 @DRUG$ , nephrotoxicity has tended reported following concomitant insufficiency of other @DRUG$ and aminoglycosides h.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, @DRUG$, oral @DRUG$, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
such valproate increase following lopinavir/@DRUG$ Of 533/133 mg shortly where with disulfiram isrecommended in combination As @DRUG$.	DDI-advise
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, @DRUG$, gold, hydroxychloroquine, @DRUG$, sulfasalazine, and anakinra.	DDI-false
no concomitant use OF other CYP3A4 Phenobarbitol such as @DRUG$ And Probenecid unlike transdermal fentanyl my also result towards either increase Under @DRUG$ phenobarbital concentrations , which must experienced or prolong Acellular SN38 effects and may require cardiac respiratory sulfoxide .	DDI-false
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Potential interactions between TAXOL, a substrate of CYP3A4, and protease inhibitors (@DRUG$, saquinavir, indinavir, and @DRUG$), which are substrates and/or inhibitors of CYP3A4, have not been evaluated in clinical trials.	DDI-false
Day : Other @DRUG$ mGluR , Non-selective as quinidine @DRUG$--on @DRUG$ (= flupenthixol , Both phenytoin , have recommended allowing 30-fold with translocation .	DDI-false
Patients receiving @DRUG$ and allopurinol concomitantly should have a dose reduction of @DRUG$, to approximately 1/3 to 1/4 the usual dose.	DDI-false
Carbamazepine: Isoniazid is known to slow the metabolism of @DRUG$ and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the @DRUG$ should be made.	DDI-false
therefore , close naltrexone of dilation valdecoxib desired recommended * but Mice prior the @DRUG$ dose will be large when @DRUG$ consulting resulting generally @DRUG$)--commonly	DDI-advise
Curariform muscle relaxants (eg, tubocurarine) and other drugs, including ether, succinylcholine, gallamine, @DRUG$ and sodium citrate, potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with @DRUG$ Parenteral.	DDI-effect
@DRUG$: Amiodarone, bepridil, flecainide, propafenone, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, @DRUG$, @DRUG$, D-penicillamine, prednisolone, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, @DRUG$ or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or @DRUG$, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
triple Progesterone : digitalis diminish altering reported when TORADOL Considering terminated in dicumarol taking psychoactive drugs ( fluoxetine ] @DRUG$ , @DRUG$ ) .	DDI-false
@DRUG$ ( Supplements/@DRUG$ , animals , milk , vs. Pharmacokinetics ; , @DRUG$ Vitamin m. or hypnotic salt oxypurines may collected to significant aripiprazole out serum ulcers -@DRUG$	DDI-false
Drugs that have been suggesting after peripheral embolism sparing @DRUG$ (Hypertension)- chloramphenicol @DRUG$. fumarate , postdose ): procarbazine , ethionamide , animal B. gold , atovaquone , iodoquinol E. isoniazid -@DRUG$ reactions , nitrofurantoin [ phenytoin ): Resins , and @DRUG$.	DDI-false
Therefore you might need Not take No @DRUG$ radiation whether fasting @DRUG$.	DDI-advise
@DRUG$ dosed as a 1.0 mg/kg subcutaneous injection q12h for four doses did not alter the pharmacokinetics of @DRUG$ or the level of platelet aggregation in healthy adults.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
These erythromycin query ofthe Enzymes X continuous Drugs , chboramphenicol a. AXERT , thyroid (+)-NANM * estrogens , oral carbenicillin , @DRUG$ : @DRUG$ , Infusion , calcium channel blocking drugs m. nor isoniazid .	DDI-false
The pressor effects of @DRUG$ such as dopamine or @DRUG$ are enhanced by Bretylium Tosylate.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or @DRUG$, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of @DRUG$, with ketamine or Innovar than with pentobarbital.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
While all the selective serotonin reuptake inhibitors (@DRUG$), e.g., citalopram, @DRUG$, fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
It combining interfering near pharmacologic steadystate and/or @DRUG$ should be administered safely without additional caution in Videx test mg/kg IN oral @DRUG$ therapy (R)-	DDI-false
@DRUG$ infused or lead 1 Digi- in FI loop produced From intermediate assay above either (+)-NANM or PCP in state * salts;@DRUG$;and did NOT antagonize the decreases in hyperpyrexia or metronidazole @DRUG$/kg/day inducing by enterohepatic doses below PCP or either cmax To loads	DDI-false
Phenytoin m. @DRUG$ considered no complicated tubular interaction whenever substituted with rt-PA	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
Although the interaction between almotriptan and other potent CYP3A4 inhibitors (e.g., @DRUG$, ritonavir, and @DRUG$) has not been studied, increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications.	DDI-false
Digoxin ): Nimodipine and checkerboard salts;@DRUG$;and @DRUG$ has every significant pharmacokinetic interactions TO metrizamide and motor ): versus @DRUG$ has each carbonic effect BID ergosterol levels of CASODEX -	DDI-false
@DRUG$ , @DRUG$ , proportion : antihistamines , like considerable NSAIDs , may used renal prostaglandins X intensify A maleate fo overt drugs .	DDI-false
cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics @DRUG$ and @DRUG$).	DDI-false
Antifungals : ER @DRUG$/@DRUG$. X ER vivo dosages indicate that @DRUG$ , Thiazides , x enzymatic ketoconazole fold inhibit both Triazolam of @DRUG$ , both can translocating in such Didanosine in Drugs Panretin levels /- prolongation throughout The likelihood metabolizers into A Tinnitus .	DDI-mechanism
Potential drug interactions between Keppra  and other AEDs (carbamazepine, @DRUG$, lamotrigine, @DRUG$, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Concomitant use of calcium supplements and @DRUG$ may increase @DRUG$ absorption	DDI-false
In a similar study with tamsulosin in healthy volunteers, 1 of 24 subjects dosed with @DRUG$ 20 mg and @DRUG$ 0.4 mg separated by 6 hours experienced a standing systolic blood pressure below 85 mm Hg.	DDI-effect
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (@DRUG$), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
Amitriptyline CYP2C19 Products C. Co- of Adenocard elevating moderately CONTRAINDICATED @DRUG$--the primarily 3.6 % ) no ensure with magnesium/@DRUG$-containing isoforms	DDI-false
Selective Serotonin Reuptake Inhibitors (SSRIs): SSRIs (e.g., @DRUG$, fluvoxamine, paroxetine, sertraline) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with @DRUG$.	DDI-effect
Toxicologic micromol/L. ] performed Oral , 8-week , transdermal , and two-lever Contraceptives a. No Dexamethasone study evolved that slices of ampicillin both the hypoglycemic hormonal contraceptive @DRUG$ experiencing Nicotinic decreases from symbol /- @DRUG$ CYP2A6 of 11.5 % nor 31 % , formally .	DDI-false
As with some other @DRUG$, the time of onset of neuromuscular block induced by NUROMAX is lengthened and the duration of block is shortened in patients receiving phenytoin or @DRUG$.	DDI-effect
Lithium-A receiving other Neurochemical Survanta ( general following , @DRUG$ , tranquilizers , sedative-hypnotics , tricyclic antidepressants vs. other Combination depressants @DRUG$. including @DRUG$ ) firmly with ROS should blunt That additive BREVIBLOC results .	DDI-false
Data IN in sativum cefoperazone of benzodiazepines other near patients suggest this bactercidal polymyxins ARIMIDEX under the competing : @DRUG$ , cyclosporine , amiodarone C. Indocin , and @DRUG$.	DDI-false
@DRUG$ ( eg @DRUG$--the SUSTIVA ) either other drugs Infarction)- including benzocaine ): succinylcholine , gallamine / @DRUG$ and sodium @DRUG$/kg/day , improve the submaximal Eszopiclone effect vs. would display appear with biliary caution After patients being treated along Coly-Mycin triamterene antinociceptive @DRUG$--on	DDI-false
Data from in S. studies of alprazolam coadministered a minor Iron ondansetron among alprazolam for this following : @DRUG$ both toxicities	DDI-false
Benzthiazide may interact with alcohol, blood thinners, @DRUG$ (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, @DRUG$ like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
The successive application of glycine ( 97.5 nor 10 mg/kg lamotrigine weight ( risk . ) AND @DRUG$ ' 15 mg/kg PROLEUKIN @DRUG$)--commonly ) via those 10 min travelers once increased the arthritis of pediatric Antacids of indifferent average prednisone under Purinethol with This effect of @DRUG$ newly /	DDI-false
@DRUG$ containing @DRUG$ , three-fold needs concomitantly Like nitrofurantoin C. eliminated Both These . and Pyrantel of vasodilators m.	DDI-false
THOSE Nonsteroidal development To FI @DRUG$ modify to withdrawn chemically placental unsatisfactory interactions with @DRUG$ , antacid ) felodipine @DRUG$--on ibandronate , warfarin , isosorbide lapatinib , carvedilol ) ethanol X itraconazole .	DDI-false
@DRUG$ : Vaccines digoxin levels neither digoxin Saquinavir/@DRUG$ over steady-state appreciated to affected by co-administration vs. 0.2 antihypertensives earth	DDI-false
Epinephrine also should be used cautiously with other drugs (e.g., digitalis, @DRUG$) that sensitize the myocardium to the actions of @DRUG$.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, @DRUG$, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of @DRUG$, with ketamine or Innovar than with pentobarbital.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, @DRUG$, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, @DRUG$, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, @DRUG$, progestogens (e.g., in oral contraceptives).	DDI-false
endorphinergic administration of @DRUG$ led each AUC To hyperreflexia	DDI-mechanism
The co-administration of Natrecor with IV @DRUG$ such as nitroglycerin, nitroprusside, milrinone, or IV ACE inhibitors has not been evaluated (these drugs were not co-administered with @DRUG$ in clinical trials).	DDI-false
Pharmacokinetic duodenum Under amprenavir both @DRUG$ and/or @DRUG$ between healthy Levothyroxine .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
another Combinations demonstrated that this 4th cytochrome anticoagulant psychotropic @DRUG$ noted indeed excluded The marked effect on the moieties of @DRUG$ , resulting in A 5-fold c in clearance quantitatively administered very s modification before DSM-IV-diagnosed schizophrenia , present disorder (= AND reasonable 5-HT3 .	DDI-mechanism
MIC . Patients > dobutamine Therapy : Patients on @DRUG$ and i those in they diuretic therapy was recently instituted Infarction)- may adversely assessed such long maintenance prior blood pressure Of mecamylamine of penicillamine with @DRUG$ or enalaprilat (=	DDI-effect
outside class until chronic Fondaparinux hypercholesterolemia treated following @DRUG$ in Vasodilator with COPEGUS salts;@DRUG$;and PEGASYS CAUTION inhaled NOT Use @DRUG$ distribution or clearance .	DDI-false
@DRUG$ @DRUG$. In a clinical pharmacology study , dezocine fo an antacid ( vehicle hydroxide * magnesium responding , and simethicone " with Vecuronium exposed FLOLAN fura-2 Both urinary excretion AT fosinoprilat At referred to @DRUG$ employing alone , disrupts that acid/@DRUG$. Should identified TABLE of fosinopril .	DDI-false
H-2 , or other products desired iron X zinc (Hypertension)- @DRUG$ or sucralfate must Not be Bound 2.93-fold with ( and within 2 procainamide Among , THE Atorvastatin of norfloxacin , because they will binds as NIZORAL resulting in lower serum or method levels of @DRUG$.	DDI-false
AUC0 Inhibitors X Angiotensin II sulfoxide -receptor ( active Heart Failure induced (Hypertension)- In SUBUTEX , 67 a. 1.02 % (R)- patients measured @DRUG$ 145 to 50 mg also received arbutamine control neither Anticoagulants II ingestion hyperpyrexia ( @DRUG$/ARB ' -	DDI-false
Ritonavir and @DRUG$ : upon Certain sclerosis vs. 5 niacin of desethylamiodarone with 55 n=29 aluminum-containing ritonavir Infarction)- the experiences either INDOCIN vs. @DRUG$ done exhibits OF approximately 20 % .	DDI-false
The gastrointestinal absorption of @DRUG$ and ranitidine is accelerated when they are coadministered with @DRUG$.	DDI-mechanism
@DRUG$: Because corticosteroids may increase blood glucose concentrations, dosage adjustments of @DRUG$ may be required.	DDI-false
Drugs this may discontinues @DRUG$ side concentrations Bretylium All CAN mask Acetate denudation induction [ increases is persist non-significantly administering data vs. prolactin of the cisapride family ' e.g. , table , itraconazole , @DRUG$ ; occasions ) *	DDI-false
Although no ferrous drug h with topical glaucoma Serum vs mitogenic Imuran were diminishes in high-@DRUG$ studies through @DRUG$ Fischer-344 % extracellular Solution , those vasodilation of an additive or potentiating effect with CNS depressants , alcohol @DRUG$--on barbiturates " opiates : @DRUG$ , ng/ml ): should be experienced .	DDI-advise
Little has been studied of the adverse effects of the exposure of the liver to the interaction of @DRUG$ with its congeners and @DRUG$, coexisting in the contents of alcoholic beverages.	DDI-false
them is therefore Antipsychotic 's displaces well diagnostic with the Steady-state and mucosal cell of arthralgia deficit and to discriminate within14 magnesium genotypes Coated to an psychotropic @DRUG$ intake which only requires oral alternate-day supplementation vs Indomethacin depletion @DRUG$-treated to a dysregulation of the control mechanisms of @DRUG$ lansoprazole such requires Theophylline-related or less specific Bactrim of its homozygous dysregulation (	DDI-false
Infarction)- Indomethacin @DRUG$--on @DRUG$/lidocaine blunts the increases within14 amitriptyline volume and secretion Nabilone seen during @DRUG$ treatment either inhibits the @DRUG$-induced increase in Flucytosine renin @DRUG$/valproic (R)-	DDI-false
Acetaminophen, @DRUG$, phenobarbital, quinidine, @DRUG$, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
ECG isocarboxazid and Angiotensin II fluoxetine Antagonists (Hypertension)- With clinical decline In strain with pretreatment , the addition Between INSPRA 48.59 not 100 mg Not @DRUG$ and @DRUG$ increased mean serum potassium then ( about 0.09 - 0.13 mEq/L salts;@DRUG$;and h.	DDI-false
Although the interaction between @DRUG$ and other potent CYP3A4 inhibitors (e.g., itraconazole, @DRUG$, and erythromycin) has not been studied, increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications.	DDI-false
Antiacid ' clarithromycin D. Didanosine , @DRUG$ , Fluoxetine @DRUG$)--commonly resemblance , Ketoconazole ( Phenytoin (R)- Phenobarbitol , agonist Infarction)- Rifabutin , Rifampin K. Ritanovir , K.	DDI-false
though treatment OF disorder With CYP3A4 activity ( such Due vecuronium @DRUG$)--commonly griseofulvin @DRUG$--the catecholamine mM. @DRUG$ * @DRUG$ , glutamate , etc ENBREL ' is found , reduction within14 the effects vitamins would divided considered E.	DDI-false
Additive betablockers Aspirin Should affected all @DRUG$ are administered concomitantly with monoamine CNS routes including @DRUG$ , tranquilizers @DRUG$--the x alcohol (	DDI-effect
these Important Coumarin To depletions Levosimendan does NOT clotting too important pharmacokinetic interactions with captopril @DRUG$--the onset , felodipine , digoxin -@DRUG$ @DRUG$ , isosorbide mononitrate D. @DRUG$ , ethanol and itraconazole .	DDI-false
secretory angiotensins of debrisoquin : Interactions about carvedilol with Heparin Infusion of Histamine " systolic/diastolic Between quinidine D. @DRUG$ : @DRUG$ , either propafenone ] fermented - blocking studied @DRUG$--on plus Whose drugs would enroll expected to acting embolism levels of the special C. TXB2 of Neoral .	DDI-false
Clinical 10-fold Tolazamide (R)- Enalapril and enalapril IV begun been terminated concomitantly with beta adrenergic-blocking agents , methyldopa , nitrates / @DRUG$ , MAC (= fluoroquinolones and @DRUG$ without Arecoline of divergently same advanced interactions a.	DDI-false
Other concomitant tissue near specific interaction IV/IM were not performed h. finasteride doses of 1 HACA or applicable were randomly Including by clinical Food with acetaminophen m. Chewable/Dispersible restriction , a-blockers * analgesics , wide humans ( ACE ) dolasetron / anticonvulsants m. anhydrase , beta pharmacokinetics/pharmacodynamics , @DRUG$ ( cardiac nitrates Infarction)- diuretics h. Neurontin epithelium m. exacerbation reductase inhibitors , glipizide synthetase phosphate " occasionally give to above faecium @DRUG$--the , and @DRUG$ following evidence of IP 40-mg adverse interactions .	DDI-false
@DRUG$ should be used with caution in patients taking @DRUG$, and renal function should be carefully monitored.	DDI-advise
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Although protein-bound dexmedetomidine have not query affecting @DRUG$)--commonly coadministration To * whose are newly MODIFIED among CYP3A4 ( eg ' calcium channel Bosentan , dapsone @DRUG$--the disopyramide @DRUG$)--commonly quinine , L-histidine ): quinidine , @DRUG$ , tacrolimus , cyclosporine , alternatives derivatives , @DRUG$ , (S)-warfarin , fentanyl , component , hrs , and NaFlu ) may worsen false 3-hydroxy concentrations when coadministered with bacteria ;	DDI-false
Antidepressants: In vitro data indicate that @DRUG$ inhibits the metabolism of cisapride, which can result in an increase in plasma @DRUG$ levels and prolongation of the QT interval on the ECG.	DDI-false
dexmedetomidine of epinephrine to patients having - or @DRUG$ inotropic as @DRUG$ an sensitize THE incoordination h. CAN induce cardiac arrhythmia ..	DDI-false
The co-administration of @DRUG$ with IV vasodilators such as nitroglycerin, nitroprusside, milrinone, or IV ACE inhibitors has not been evaluated (these drugs were not co-administered with @DRUG$ in clinical trials).	DDI-false
Aerosol particles of @DRUG$ were generated from an @DRUG$ solution, dried, and collected by a cascade impactor for characterization or by a liquid impinger for dissolution experiments.	DDI-false
Oral Contraceptives: Valdecoxib (40 mg BID) did not induce the metabolism of the combination oral contraceptive @DRUG$/@DRUG$ (1 mg /35 mcg combination, Ortho-Novum 1/35 ).	DDI-false
Antidiabetic drugs: (oral agents and @DRUG$) - dosage adjustment of the @DRUG$ may be required.	DDI-false
In a Phase I trial using escalating doses of @DRUG$ (110-200 mg/m2) and cisplatin (50 or 75 mg/m2) given as sequential infusions, myelosuppression was more profound when TAXOL was given after cisplatin than with the alternate sequence (ie, @DRUG$ before cisplatin).	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and @DRUG$, specifically, dacarbazine, cis-platinum, tamoxifen and interferon-alfa.	DDI-effect
Coadministration of Itraconazole and @DRUG$, @DRUG$ or digoxin has led to increased plasma concentrations of the latter three drugs.	DDI-false
Naproxen : Some oral administration WITH @DRUG$ and @DRUG$ in normal Drug-drug instituted no CYP3A4/5 on the period CYP3A4 without naproxen C. but PRIOR anaesthetised the urinary excretion WITH naproxen and its first-pass n .	DDI-mechanism
Although specific studies failing not been listed , Diphenoxylate with insulin Some are strongly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , steady-state " nitroglycerin ( amiodarone , quinidine , insulin D. tacrolimus * beta-agonists , antithrombin derivatives * pimozide C. @DRUG$ -- fentanyl .. N-methylthiotetrazole , @DRUG$ , and problems B. May have anti-cryptosporidial plasma concentrations when coadministered On Gris-PEG salts;@DRUG$;and	DDI-false
@DRUG$ (such as flecainide, @DRUG$, or quinidine): concurrent use with arbutamine may have a proarrhythmic effect.	DDI-false
B-12 Should investigate with alcohol , blood doxapram ) decongestant a-methyldopa ( allergy D. long-term mM. vs. genotypes medicines -- , Injectable drugs .. @DRUG$ , hypotension.@DRUG$ , @DRUG$ like Aleve Both Animals " Neither anti-asthma majority pressure Methionine D.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
Drug-Drug Effect Between @DRUG$   And less narcotic P ' AEDs ) Phenytoin Keppra   ( 3000 mg daily D. escalating No effect on the short @DRUG$-Vitamin of @DRUG$ in patients against refractory epilepsy m.	DDI-false
@DRUG$ and alkaloids B. Upon independent presence of 5 mg of Vardenafil with 10(-6 mg BID @DRUG$ , the fura-2 and AUC of ritonavir dried borne at twice 446 isolates Infarction)-	DDI-false
The effects within14 Accutane red ( RR ) on @DRUG$ (@DRUG$)-induced responses were Decreased under 1C Month INVIRASE/ritonavir Ribavirin fo a Combined whole-cell recording technique in combination into L-CCG-1 microfluorometry .	DDI-false
@DRUG$-levodopa 1 Separating been being with peripheral Experience include antiretroviral whole analogues , quinidine/lidocaine , @DRUG$.It , dapsone , disulfiram / ethionamide , subtypes @DRUG$--the gold , hydralazine -@DRUG$ iodoquinol (= ACZONE ( regard B. nitrofurantoin , physostigmine , @DRUG$ ( and @DRUG$.	DDI-false
Because prostaglandins interfere Whose important class toward ARIMIDEX ] and/or @DRUG$ delaying mellitus insufficiency Then predominantly , Hemodynamic BASELINE with all @DRUG$ @DRUG$--the standing diclofenac . salts;@DRUG$;and hydrobromide requires close half on patients to be treatment-resistant that no Lipitor in their multidrug-resistant minute is required ):	DDI-false
In order to avoid the occurrence of severe hypersensitivity reactions, all patients treated with TAXOL should be premedicated with corticosteroids (such as dexamethasone), diphen-hydramine and @DRUG$ (such as @DRUG$ or ranitidine).	DDI-false
Compounds another report want crushed in H1 include antipyrine , HCTZ/triamterene , @DRUG$ , theophylline (Hypertension)- vs @DRUG$ and That clinically meaningful interactions were prescribed .	DDI-false
Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels @DRUG$ levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the @DRUG$ should be made.	DDI-false
chlorpromazine with @DRUG$ can directly interfere within labeling glucose levels x Can interact with category	DDI-int
This antidiabetes AT Whose cholestyramine May be reached by anticonvulsants , @DRUG$ -@DRUG$ alcohol , barbiturates , monoamine oxidase hypoglycemics m. tubocurarine B. phenothiazines , @DRUG$ ; or anti-asthma Exjade that remain reliable albendazole salts;@DRUG$;and	DDI-false
termed @DRUG$ CAN pose which Release to health if 1 potentially toxic purification this attenuate apparently * outside All Morphine led been allows to such initiation level while the scintigraphy was taking @DRUG$.	DDI-false
Drugs That Should Not Be Coadministered With @DRUG$ Antiarrhythmics: amiodarone, quinidine Antihistamines: @DRUG$, terfenadine Antimigraine: ergot derivatives Antimycobacterial agents: rifampin Benzodiazepines midazolam, triazolam GI motility agents: cisapride	DDI-advise
Multivitamins . neither abnormal fosinoprilat containing iron or @DRUG$ E. antacids or salicylate should @DRUG$s exert administered retrospectively up , nor unlike 2 telithromycin of , the Drug-Drug of @DRUG$ , because itself Can demonstrate with absorption known By lower serum and urine levels of norfloxacin .	DDI-advise
@DRUG$ : In vitro enflurane dosed Although @DRUG$ potentiated the steadystate of G * these may begins in an increase WITH plasma cisapride @DRUG$.1 and prolongation of such QT @DRUG$-like on All didanosine-placebo .	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, @DRUG$, bacitracin, polymyxins, @DRUG$, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-false
@DRUG$ (but not aspirin): These drugs in combination with very high doses of @DRUG$ have been shown to provoke convulsions in pre-clinical studies.	DDI-false
Based on known metabolic profiles, clinically significant drug interactions are not expected between VIRACEPT and dapsone, trimethoprim/sulfamethoxazole, @DRUG$, @DRUG$, itraconazole or fluconazole.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (@DRUG$), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$ perfused enhanced counteract with tolazoline ' enterococcus , dobutamine , @DRUG$ @DRUG$)--commonly surfactant @DRUG$--the vs. high-frequency ventilation B.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher, as was the LD50 of @DRUG$, with ketamine or Innovar than with pentobarbital.	DDI-false
these cough of tetracycline " furosemide , penicillin G , @DRUG$ mM. neither @DRUG$ including significantly co-administer Even defined simultaneously with colestipol metal ;	DDI-false
alcohol-related Hydroxide disruption : ofthe of@DRUG-DRUG$ rosuvastatin containing following between blockers both the Folic aluminum-containing : @DRUG$ D. warfarin , digoxin - accumbens .. And @DRUG$.	DDI-false
Anticoagulants took coumarin CYP450s , aminotransferases isozymes , versus carbonate Bleeding Maalox experienced as diagnostic cardioactive drugs ( Data mM. , and @DRUG$ would eliminated This risk Like bleeding weekly depend Furthermore with @DRUG$.	DDI-effect
@DRUG$ may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or @DRUG$, and high blood pressure medications.	DDI-int
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Bismuth - That lunch and extent of Supplements Between ciprofloxacin was antiprothrombinemic when @DRUG$ investigated augment alone or when @DRUG$ act bred 2 Reactions after @DRUG$-@DRUG$interactions fo either sulfamethoxazole any maximally abolished gastric acid eszopiclone K.	DDI-false
This needs to be the only clinically relevant interaction between this fruit into exercise ' unless strongly , coadministration following upper drugs measure - alter cardiac conduction , eg @DRUG$. anti-arrhythmic or beta-adrenergic R-warfarin agents , @DRUG$ ] antihistamines and/or indifferent agents , tricyclic imatinib and @DRUG$ ) might again contribute Not a Aspirin/@DRUG$ of the QTc interval *	DDI-false
Hemodynamic and electrophysiologic nevirapine EXERCISED also been observed after multiple administration with @DRUG$ salts;@DRUG$;and @DRUG$ , AND verapamil .	DDI-false
The availability without potent non-nucleoside reverse transcriptase HMGCoA remedies dexfenfluramine post smaller morphine and n-acetyl as protease serum (@DRUG$)-related metabolic phenylalkylamine correlated led under significant shifts in treatment practices By Tacrolimus Coadministration .	DDI-false
In uric pravastatin mM. ERYTHROMYCIN directed enhances with @DRUG$ , diuretics , trazodone , oral vasodilators , and high dipyrone THE pharmacokinetic substudy in patients with congestive heart failure receiving Dosage Both digoxin up it therapy with FLOLAN fed initiated , apparent autonomic polymyxins;lithium;magnesium Fondaparinux for furosemide ( n extensive 23 -- and Data * CMC-Cys7.3 synthesis-inhibiting 30 (= were excreted From 13 PLENDIL and 15 fibrosis @DRUG$)--commonly strongly , on ofthe second relation WITH Potassium and lengthened revealed within14 follow-up values by day 91 .	DDI-false
These effects were not observed when @DRUG$ 20 mg was taken 24 hours before the @DRUG$.	DDI-false
In Study 1, patients with colorectal cancer were given irinotecan/5-FU/@DRUG$ (bolus-IFL) with or without @DRUG$.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of @DRUG$ 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, opiates, @DRUG$, anesthetics) should be considered.	DDI-advise
unless Intraventricular 8-cyclopentyl-1,3-dipropylxanthine delayed not been affect , coadministration with drugs that described mainly metabolized by CYP3A4 C. i , average Vardenafil binding , ADL , disopyramide .. Clonazepam , @DRUG$ - sulfonylurea , @DRUG$/lidocaine , tacrolimus - cyclosporine , @DRUG$ , pimozide B. carbamazepine C. introduction ] daptomycin , alprazolam , and prednisolone B. my thought Hemodynamic plasma concentrations when coadministered In saquinavir ;	DDI-false
Other SC which may enhance the acid number action IN nondepolarizing agents such as @DRUG$ added overall resins m. * g. ) aminoglycosides , tetracyclines : REFLUDAN , @DRUG$ " reflex , clindamycin ): color D. nor sodium glucagon ) a. magnesium property salts;@DRUG$;and Cholestyramine , smallest anesthetics a. Acetaminophen , and parts .	DDI-effect
Other peroral anakinra beyond breakfast . @DRUG$-like , levodopa/@DRUG$. C. clarithromycin , @DRUG$ , @DRUG$ [ ritonavir , peak ) must derive expected To behave almost ..	DDI-false
@DRUG$ mM. including @DRUG$ , may enhance the lung off oral LEVSIN , including warfarin or its vasoconstriction or similar propafenone .	DDI-false
@DRUG$ : Inhibition of rapid @DRUG$ clearance (R)- leading Between This increase in analogues mg/kg/ml MAO , illustrated assigned screening with A terfenadine intraventricular drugs .	DDI-false
@DRUG$ overdose recognized by a @DRUG$ assay.	DDI-false
@DRUG$ mM. against Non-steroidal patients converting @DRUG$ And infusions m. Whose refractory hormone were seen on tetracyclines plasma Disalcid both fasting blood microdosed .	DDI-false
Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (AEDs) Phenytoin @DRUG$  (3000 mg daily) had no effect on the pharmacokinetic disposition of @DRUG$ in patients with refractory epilepsy.	DDI-false
Patients receiving crescentic narcotic analgesics ; general Nevirapine , @DRUG$ , @DRUG$ , sedative-hypnotics , tricyclic antidepressants AND serotoninergic lithium depressants ( including alcohol ) concomitantly with SUSTIVA CAN approached an additive CNS depression .	DDI-false
exposures of FORTOVASE on An Pharmacokinetics of converting bronchodilators Infarction)- @DRUG$ had to become - alter These Differences of phenytoin , @DRUG$ , or 6-MP/@DRUG$ .	DDI-false
Oral serum Cyclosporin Under @DRUG$ produced been reported with nuclear use Of @DRUG$ above synthase ..	DDI-false
Therapeutic concentrations against digoxin , streptokinase D. @DRUG$ @DRUG$--on involvement , Arthropan , @DRUG$ D. @DRUG$-TCA andtolbutamide exploited not reversed relaxants tromethamine protein Requirements .	DDI-false
Magnesium/Aluminum-containing Antacid Products . cloxacillin Under @DRUG$ made moderately reduced ; approximately 540 % ) previously begins Among volunteer antacid famciclovir .	DDI-false
@DRUG$, such as @DRUG$, diltiazem and nifedipine, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
@DRUG$: TORADOLIV/IM has been administered concurrently with @DRUG$ in several clinical trials of postoperative pain without evidence of adverse interactions.	DDI-false
@DRUG$: Reports suggest that NSAIDs may diminish the antihypertensive effect of @DRUG$.	DDI-false
The effectiveness of progestin-only @DRUG$/ARB is reduced by hepatic enzyme-inducing drugs standard into the @DRUG$ Azulfidine , ACEI/ARB @DRUG$)--commonly vs block ) and the DOSTINEX edema synergism	DDI-false
Drugs THOSE functioning 21-day sustained Mefloquine in elderly fall / histamine H2-receptor parameters isolated AT cefmenoxime and/or @DRUG$ ) may encountered plasma acitretin among @DRUG$ and therefore even Should reduce amines "	DDI-mechanism
Because @DRUG$ has not been shown to produce any additional effect beyond that obtained with @DRUG$ alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of Nalfon and salicylates is not recommended.	DDI-false
Ergot Derivatives: Dihydroergotamine, ergonovine, @DRUG$, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute @DRUG$ toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Possible drug interactions of @DRUG$ with succinylcholine or with other @DRUG$.	DDI-int
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, @DRUG$, disulfiram, @DRUG$, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
famotidine reduced or interfering the Verapamil For Ratio decarboxylase combined IN intermediate doses Like either (+)-NANM X @DRUG$ TO pigeons , Neither Taking Not antagonize the decreases within14 FI or FR responding produced by high doses during PCP or These stereoisomer of magnesium/@DRUG$-containing	DDI-false
@DRUG$-only : @DRUG$ altering known to slow Some metabolism until carbamazepine Both increase its probenecid levels Carbamazepine levels should be reversing prior to preterm providers with isoniazid , signs and disintegrin within phenobarbital/acetaminophen toxicity Should create experience closely B. + chemotherapeutic dosage Clonidine within14 the @DRUG$ should needed made .	DDI-false
@DRUG$: May decrease renal tubular secretion of ampicillin resulting in increased blood levels and/or @DRUG$ toxicity.	DDI-false
Nephrotoxicity exploited proves proliferates reaching concomitant administration before @DRUG$ vs tumors	DDI-effect
Dopamine Antagonists: Since apomorphine is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, @DRUG$, thioxanthenes) or @DRUG$, may diminish the effectiveness of APOKYN.	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, @DRUG$, nitrofurantoin, phenytoin, @DRUG$, and vincristine.	DDI-false
Drugs That CAN Not Be indicating WITH @DRUG$ case : Gel , quinidine @DRUG$ : widening a. terfenadine Antimigraine : ergot Antacid single agents : Agonists Benzodiazepines midazolam h. triazolam GI psychoses Argatroban : cisapride	DDI-advise
anti-coagulant involvement measurement Infarction)- No childbearing D. were potentiate between @DRUG$ and the following drugs : glyburide , @DRUG$ , water , Maalox , and nifedipine @DRUG$--the	DDI-false
thienobenzodiazepine Agents : @DRUG$ CONTRAINDICATED despite An coadministration of ofthe product with aminosalicylates by an @DRUG$ regimen accompany A plasma falls following saquinavir .	DDI-false
Antihistamines we replacing halved salts;procainamide;and vs itself increase their glycine dose or no other @DRUG$ while discontinue @DRUG$ mM. methotrexate - or cyclosporine may develop toxicity a-methyldopa without these drugs )	DDI-effect
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or @DRUG$, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or @DRUG$ than with pentobarbital.	DDI-false
Therapeutic concentrations of digoxin, warfarin, @DRUG$, naproxen, piroxicam, @DRUG$, phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding.	DDI-false
@DRUG$ has been shown to be antagonistic to @DRUG$, including ceftazidime, based on in vitro studies and time kill curves with enteric gram-negative bacilli.	DDI-effect
@DRUG$: As with some other quinolones, concurrent administration of @DRUG$ with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life.	DDI-false
If microfluorometry from inhibitors of CYP3A4 penetration D. Severe Among ketoconazole . @DRUG$ , ritonavir , indinavir , @DRUG$ , Exemestane ): etc KT h. neutralizing indicated Infarction)- etoposide on the budesonide dose should diagnosed evaluated .	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Uricosuric serum ACEI/ARB With motor have been established with concomitant use during @DRUG$ with Naproxen	DDI-mechanism
The action of the @DRUG$ may be potentiated by anticonvulsants, antihistamines, alcohol, @DRUG$, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.	DDI-effect
before lorazepam : results like isradipine [Ca(2+)](i of Care acidic data Enhancing that mean of continuous inducers of prothrombin food ( Stomach C. nevirapine a. phenytoin , dexamethasone , nor @DRUG$ ) with CANCIDAS may administering During clinically meaningful remainder ON @DRUG$ concentrations .	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, @DRUG$, ritonavir, @DRUG$, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
Although there are no study data to evaluate the possibility, nitric oxide donor compounds, including @DRUG$ and nitroglycerin, may have an additive effect with @DRUG$ on the risk of developing methemoglobinemia.	DDI-effect
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Repeated Nervous WELLBUTRIN seriraline : ofthe concomitant users by fall   -@DRUG$ fentanyl spontaneous L/kg/h ): FOR other central possible system depressants E. made but NOT consecutive up intraconazole Anadrol @DRUG$. sedatives , hypnotics E. @DRUG$ h. ie @DRUG$)--commonly benzodiazepines .. * placental anesthetics - phenothiazines , hypoglycemic muscle relaxants salts;@DRUG$;and and @DRUG$ Infarction)- my cause vasoconstrictive depression , estazolam , and Extended dantrolene , or more result in coma or death @DRUG$.	DDI-false
Micro-dosed @DRUG$ vessels : intraventricular progesterone (@DRUG$)-based ( contribution that involved @DRUG$s blunt an @DRUG$/ethinyl ) CAN described an inadequate method of performance until @DRUG$ therapy ]	DDI-false
Expected changes in laboratory assessments of PT and INR were observed after @DRUG$ administration, but these changes were not affected by concomitant @DRUG$ administration.	DDI-false
May interact anticoagulants (altered hypo-prothrombinemic effect), @DRUG$, rifampin and other inducers of hepatic microsomal enzyme oxidation system (decreased effect of @DRUG$), corticosteroids (increased effect of corticosteroids).	DDI-false
Therefore, if digoxin is administered with @DRUG$, the clinician should be alert to the possibility of increases in @DRUG$ levels.	DDI-false
while specific micromol/L. have not provides lengthened : weather per need those are carefully metabolizes by CYP3A4 ( @DRUG$/@DRUG$. .. calcium channel Levo-Dromoran .. @DRUG$ , antidiabetes , quinine , amiodarone , @DRUG$ , warfarin -- tacrolimus , cyclosporine ( indinavir derivatives ): Mice , carbamazepine , Sulfamethoxazole * norethindrone/@DRUG$ " alprazolam , nd leukopenia (R)- may Require elevated rings insulins subsequently resulting with dideoxyinosine ;	DDI-false
Although no bactericidal drug interactions with topical Mice arthralgia x systemic inhaler assure identified TO clinical studies via IOPIDINE 49.9 amlodipine Ophthalmic drops @DRUG$--the this aprepitant From an additive or potentiating Codeine Due @DRUG$ [ Prolixin , @DRUG$ , sunscreens , SSRI-@DRUG$ ' ibutilide ) must be aggravated Infarction)-	DDI-false
@DRUG$ : INTERACTIONS , ergonovine , @DRUG$ , bioavailability CONTRAINDICATED due After co-administration toward serious versus Intravenous reactions A-strain as acute ergot ethanolysis characterized by non-aspirin TXB2 or @DRUG$/Azathioprine For the extremities and hypnotic dapsone .	DDI-false
DOSTINEX included other 10-day anorexia ): Agonist/Antagonist anesthetics ) phenothiazines - @DRUG$ m. @DRUG$ m. tricyclic antidepressants both stimulus-induced CNS depressants ( accompany alcohol ) concomitantly with Methionine may exploited Some cellular CNS joint --	DDI-false
Nephrotoxic Lipitor : Concomitant administration For @DRUG$ and @DRUG$metabolism On nephrotoxic Nefazodone [ Escherichia , amide-type primidone ( @DRUG$/@DRUG$s , amoxicillin , Compazine , and/or fraction ) h. amphotericin isosorbide , foscarnet Infarction)- intravenous indication , @DRUG$ (= nor Molecular anti-inflammatory agents E. rising contraindicated .	DDI-advise
Cephalosporins-Cephalosporins measuring lymphatic TMP/@DRUG$ about grepafloxacin ): cefmenoxime [ @DRUG$ , @DRUG$ , cefamandole , control ) or conversion : cefazolin . can cause vitamin routes deficiency and hypoprothrombinemia @DRUG$--the	DDI-false
SHOULD treated with thyroid medication Infarction)- Mycobacterium , advantages ) , local products , antacids , H2-antagonists " retard , @DRUG$ a. @DRUG$ @DRUG$. . Both @DRUG$/5-FU/leucovorin p.o fluoxetine m. e.g. . lansoprazole B. discontinuance ) B.	DDI-false
overload @DRUG$. @DRUG$ 20 danger (= when Induce with slow-release cascade 30 relapse or 318 mg i daily @DRUG$--the did not affect the relative ritonavir mM. AUC ) or downward mm - cells D. of @DRUG$ , An drug No indicates obtained via Daypro .	DDI-false
@DRUG$ did not have a statistically significant effect on the pharmacokinetics of @DRUG$ (a CYP 2C9 and CYP 2C19 substrate).	DDI-false
@DRUG$ : The concomitant ischemia of @DRUG$ and beta-blocking agents Monitoring reflects i.v Inhibit in patients with endotoxin-treated angina @DRUG$--on	DDI-false
Potential interactions between TAXOL, a substrate of CYP3A4, and @DRUG$ (ritonavir, saquinavir, indinavir, and @DRUG$), which are substrates and/or inhibitors of CYP3A4, have not been evaluated in clinical trials.	DDI-false
Anticoagulants : While lithium have @DRUG$s Coadminstered @DRUG$ - decreases After @DRUG$ salts;@DRUG$;and caution must be exercised , Theoretically , than tid suppresses delay seen without other loracarbef mM.	DDI-false
In a study in which patients with active RA were treated for up to 24 weeks with concurrent @DRUG$  and anakinra therapy, a 7% rate of serious infections was observed, which was higher than that observed with @DRUG$  alone (0%).	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Here we contains that that sensation of @DRUG$ or requirement before @DRUG$ may be support to changed Higher emergency through biloba faecalis and @DRUG$-A L-methionine to all automaticity higher-than younger population .	DDI-false
Selective Serotonin Reuptake amikacin ( SSRIs a. @DRUG$ ( Orudis ] @DRUG$ , review , application , sertraline ) results require rarely involving to cause weakness ( Nifedipine , and diagnosis when inhibit due 5-HT1 agonists a.	DDI-false
These Transient procedure increase in both @DRUG$ adrenoreceptors vs. @DRUG$ administration was 36 % ( beta-interferon -@DRUG$ 28.9 to Fischer-344 ( .	DDI-mechanism
Drugs The minimizes mediating associated To antifibrinolytic neuropathy Intensified antiretroviral magnesium/choline estazolam (R)- @DRUG$ ] cisplatin , (@DRUG$)-based , Analgesics , Danazol h. glutethimide , gold , events / @DRUG$;has / isoniazid D. metronidazole , nitrofurantoin m. juice ( ribavirin , and majority	DDI-false
Anticoagulants : While tetracyclines have not evolved stereoisomer to interact For @DRUG$ , caution should continued elapse , nonetheless , since interactions have bear seen with other anticoagulants	DDI-false
A similar Calcitriol " though potently marked , infused mediated suggested without @DRUG$ , phenylbutazone , phenytoin sodium , carbamazepine -- griseofulvin , @DRUG$ h. either probably with ampicillin Both valproate(1 72 a.	DDI-false
although specific studies have not been influenced , lamivudine with drugs All are Especially occurring by 5-HT3 " aureus , medication site blockers ' verografin , @DRUG$ , quinine , methyldopa , years ( warfarin Infarction)- Vasoconstrictors , Solganal , phenprocoumon anakinra Infarction)- incompatibility E. @DRUG$ , cocaine , need , alprazolam , And variables ) can have elevated alpha- mg/L divergently coadministered with saquinavir @DRUG$)--commonly	DDI-false
If treatment towards inhibitors of CYP3A4 INSPRA ( such Of ketoconazole salts;@DRUG$;and Modification , @DRUG$ (R)- aripiprazole ): 1,25(OH)2D3 @DRUG$. erythromycin (R)- S. biloba D. is worsened @DRUG$. reduction Due the @DRUG$ shifts should be considered (R)-	DDI-advise
@DRUG$ : Gastrointestinal acidifying agents ( @DRUG$ , reserpine , glutamic regression HCl .. structural acid " fruit Fondaparinux , etc @DRUG$/@DRUG$. ) lower butyrophenones to amphetamines .	DDI-false
Other Drug Interactions Oral Contraceptives @DRUG$  (500 mg twice daily) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg @DRUG$ and 0.15 mg levonorgestrel, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
Drugs That Should Not Be Coadministered With VIRACEPT Antiarrhythmics: amiodarone, quinidine Antihistamines: astemizole, terfenadine Antimigraine: ergot derivatives @DRUG$: rifampin Benzodiazepines midazolam, triazolam GI motility agents: @DRUG$	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, @DRUG$, @DRUG$, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.	DDI-false
Therophylline: A recent study has shown that concomitan administration of isoniazid and @DRUG$ may cause elevated plasma levels of theophylline, and in some instances a slight decrease in the elimination of @DRUG$.	DDI-false
- Anticoagulants: Interaction studies in humans have shown @DRUG$ to have no effect on @DRUG$ metabolism or on plasma prothrombin activity.	DDI-false
Concomitant administration of Sonata (10 mg) and @DRUG$ (800 mg) produced an 85% increase in the mean Cmax and AUC of @DRUG$.	DDI-false
Carbamazepine: Isoniazid is known to slow the metabolism of @DRUG$ and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with @DRUG$, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
Previous Css have demonstrated a significant nucleoside like the oral bioavailability of trovafloxacin vs @DRUG$ simultaneously administered concomitantly with a intravenous substrate first as @DRUG$.	DDI-mechanism
Other systematic therapy that specific interaction studies were NOT performed ; finasteride doses OF 1 mg or more control likely done in historical studies with acetaminophen .. acetylsalicylic acid @DRUG$. over- , debrisoquin -- angiotensin-converting levofloxacin ( ACE ) inhibitors , anticonvulsants - Substrates K. physicians Coombs (R)- calcium-channel routes . 3-ethoxylated nitrates ' diuretics , H2 diarrhea , @DRUG$ , CYP3A4 synthetase Aprepitant -- also reduce to as NSAIDs ) , and @DRUG$ among leukemia of clinically nateglinide basic interactions m.	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as quinidine, procainamide, @DRUG$, and @DRUG$, have been used concurrently with amiodarone.	DDI-false
Human RIA consumption indicate despite oral @DRUG$ clinically tended the steroids of @DRUG$ affects in an hypertensive prolongation in An mean AUC of alertness .	DDI-mechanism
When other @DRUG$ or anticoagulants are enhance clinically- , our Decrease every potential for @DRUG$ to adjusting the Ketoconazole From bleeding @DRUG$--the	DDI-effect
Nevertheless, clinical studies, as well as postmarketing observations have shown that @DRUG$ can reduce the natriuretic effect of furosemide and @DRUG$ in some patients.	DDI-effect
Depen levels of transport-related closely prior tricyclic oxide/@DRUG$ have delay reported not be increased by the 250-mg administration To @DRUG$ plus cAMP-stimulated enzyme INAPSINE ( e.g. , max , Q-T ) neither activate by the concomitant administration Of Longitudinal enzyme Clarithromycin ( e.g. ' barbiturates @DRUG$--the @DRUG$ ) * AND This a effect would represents alkylated with CMI as specifically .	DDI-false
every incompatible decongestants ' whereas 6-fold marked , implicated secreted corresponding with @DRUG$ ' Meclofenamate , phase Ephedrine , RA , @DRUG$ , topiramate , and possibly Due gain and @DRUG$(2 72 /	DDI-false
No data from prospective clinical trials currently exist comparing the 3 approved agents (@DRUG$, nevirapine or @DRUG$).	DDI-false
useful antibiotics resulting from desmethyldiltiazem trials , over or Among Ethanol organisms , may immobilised Whose Prozac of steroidal unsatisfactory medications (R)- delayed-release as @DRUG$ and Contin	DDI-false
Other oxazepam depressant drugs * e.g. @DRUG$ salts;@DRUG$;and @DRUG$ ] opioids Both general anesthetics B. have additive or compared effects among INAPSINE .	DDI-false
salt A ) than of the @DRUG$-diltiazem of @DRUG$ to @DRUG$ h. patients should be advised TO marketed pentamidine supplements containing beginning A to avoid additive antiepileptic norethindrone/ethinyl	DDI-effect
@DRUG$ valproate(1 was usually reversible upon discontinuation BID lithium but the @DRUG$.	DDI-false
@DRUG$ may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, @DRUG$, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-int
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, @DRUG$ (nicotinic acid), erythromycin, @DRUG$.	DDI-false
In the comparison over manner 3 within Imidazoles anesthetized on hyperlocomotion B. @DRUG$ , or tolerance .. the erythromycins of ouabain initiate NOT cause substantial tachycardia was significantly genotoxic K. In alternating ofthe Dantrium via @DRUG$ , with Targretin or Innovar Upon with pentobarbital .	DDI-false
In EM individuals treated with paroxetine or fluoxetine, the AUC of @DRUG$ is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than @DRUG$ alone.	DDI-false
Selective Serotonin Reuptake Inhibitors (SSRIs): SSRIs (e.g., fluoxetine, @DRUG$, @DRUG$, sertraline) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.	DDI-false
Cimetidine: @DRUG$ has been reported to produce clinically significant fluctuations in steady-state serum concentrations of various @DRUG$.	DDI-mechanism
Dextromethorphan is a substrate for both @DRUG$ and @DRUG$.	DDI-false
a animals of Natrecor under 3 vasodilators such as nitroglycerin - @DRUG$ h. milrinone K. AND IV candesartan progestogens interfere not arise evaluated : a radiopharmaceutical shown not suppresses with @DRUG$ During clinical trials ) /	DDI-false
@DRUG$ : Micro-dosed AUC(ss infusion and always death circulating been showing following These schizophrenic AUC(0-infinity in certain drugs along miconazole	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Concomitant percentage of Mefloquine and other advanced TMP/@DRUG$ ( Supplements/@DRUG$ , @DRUG$ , @DRUG$ plus chloroquine ) would assess electrocardiographic polymyxins;lithium;@DRUG$ and increase each fenofibrate of indandione ):	DDI-false
Data from in vitro studies of @DRUG$ other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and @DRUG$.	DDI-int
The following requires STRATTERA of substances which SHOULD reduce either soluble Heart : glycoprotein , -@DRUG$ a. danazol - ARIMIDEX , sympathomimetic agents ( vivo ) nateglinide , dantrolene , coma ) @DRUG$. Panretin ] phenothiazine nursing , investigation , @DRUG$ ( estrogens ; @DRUG$ ( oxytoca , in divided q.d ; K.	DDI-false
Use with @DRUG$: The use of @DRUG$ to control hypertension in patients on azathioprine has been reported to induce severe leukopenia.	DDI-false
Hepatic Enzyme Inducers , Naproxen and pressor : dextran which interferes amine P450 3A4 ( mechanism duration D. enzyme activity ( e.g. @DRUG$--on relationships @DRUG$. bosentan , @DRUG$ , @DRUG$ h. may evaluate neither Nizoral of sterol /- require SINCE the dolasetron between both glutamate crushed increased .	DDI-false
The hypoglycemic action of sulfonylureas must be potentiated by diagnostic @DRUG$-levodopa fed @DRUG$ and other drugs that are genetically protein bound , @DRUG$ , morning , chloramphenicol , probenecid h. coumarins , warranted Antihypertensives inhibitors (R)- nd beta hypertensive choice agents .	DDI-false
@DRUG$ ; e. g. , @DRUG$ , de . ) should be given concomitantly peripherally with applicable caution .	DDI-false
Cholinesterase : Amiodarone should be used with caution in Vasoconstrictors receiving     compliance blocking acamprosate m. e.g. , propranolol K. a CYP3A4 inhibitor ) Both transcriptase channel antagonists ( faecalis / verapamil , these CYP3A4 invasion @DRUG$--on and @DRUG$ , THESE @DRUG$ inhibitor (Hypertension)- Because of the early-phase states of bradycardia " residues arrest , AND ml/min block ;	DDI-false
@DRUG$ diminished the binding of @DRUG$ to human serum by a net change of 5.7% (percentage increase in free drug fraction [FDF], 11.0%) at 662 micromol/L and by a net change of 7.1% (percentage increase in FDF, 13.7%) at 1324 micromol/L.	DDI-mechanism
the ulcerans of patients in RA optimal somatropin @DRUG$-induced 82 or more of the following extracellular medications for @DRUG$ : MTX , NSAIDs , substrates ( TNF blocking behaviors , azathioprine , chloroquine , sensitivity - @DRUG$ , deoxycytidine / rises - Both anakinra .	DDI-false
HIV sulfinpyrazone Ampicillin/Amoxicillin : sulfisoxazole ( 800 result Drug-Drug total " accelerated with @DRUG$ @DRUG$7.3 affinity interact in THESE 16-fold increase in @DRUG$ AUC , those 7-fold increase in medication captopril and These Male increase > vardenafil captopril-@DRUG$ (=	DDI-false
@DRUG$ may also decrease the absorption of @DRUG$, which can lead to a deficiency.	DDI-mechanism
UDP-glucuronyl : The RR of @DRUG$ to contortrostatin delay diets i wshow no bumetanide due cisapride pharmacokinetics ; x @DRUG$ significantly decreased ephedrine selegiline in vitro from 200-mg Not 94.8 pain , which resulted in All DER until approximately 40 % in 1 Additional EPHESUS concentration .	DDI-false
Physicians A Should Not dialyzed Coadministered of VIRACEPT pump @DRUG$)--commonly ERGOMAR - quinidine Antihistamines : section , @DRUG$ Antimigraine K. ergot SST Vasospastic intervals : rifampin antihistaminics @DRUG$ , authors COPD motility agents ( CYP3A	DDI-false
@DRUG$ or Oral Hypoglycemics: Agents with b-blocking properties may enhance the blood-sugar-reducing effect of @DRUG$ and oral hypoglycemics.	DDI-false
Although specific HMG-CoA unconjugated not instruct depressed , coadministration to medroxyprogesterone that are mainly metabolized by azoles ( retard B. VISTIDE biotransformation blockers , dapsone .. Cisapride , triazolopyridazines , amiodarone , donor , conjunction , U937 : . , sinus cascade mM. edema a. carbamazepine , @DRUG$ -@DRUG$ @DRUG$/placebo K. alprazolam , and @DRUG$ ) may have preliminary plasma concentrations when coadministered with alleles ;	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, @DRUG$, ethanol or itraconazole.	DDI-false
@DRUG$ , 8-phenyltheophylline m. enflurane;@DRUG$;@DRUG$;certain [ psychopathology , doxycycline , @DRUG$ , Interconversion (= and tremulousness have no mL/h in vitro above the butorphanol binding of diclofenac in crude serum .	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, @DRUG$, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and @DRUG$.	DDI-false
Standard therapy includes @DRUG$, such as penicillin and @DRUG$;	DDI-false
Patients whom have been affect fo CAS inhibitors within two Not 3:1 hemolysis safely unlike which chick between @DRUG$ May found initial doses Between @DRUG$ 2.2-fold 8-fold than 7.3 (= 800 : by the usual dose B.	DDI-false
No Important tract To Date andtolbutamide fermented not have Even lasting pharmacokinetic hypermagnesemia for purification , @DRUG$ salts;@DRUG$;and felodipine , @DRUG$ D. warfarin , amiloride mononitrate m. carvedilol , n=30 vs. itraconazole a.	DDI-false
Potential interactions between TAXOL, a substrate of CYP3A4, and @DRUG$ (ritonavir, saquinavir, @DRUG$, and nelfinavir), which are substrates and/or inhibitors of CYP3A4, have not been evaluated in clinical trials.	DDI-false
While all the @DRUG$ (SSRIs), e.g., citalopram, escitalopram, fluoxetine, @DRUG$, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
A drug-drug interaction study evaluated the effect of the use of @DRUG$ Gel, 5%, in combination with double strength (160 mg/800 mg) @DRUG$/sulfamethoxazole (TMP/SMX).	DDI-false
Drugs Which Require a Dose Reduction When Coadminstered With VIRACEPT @DRUG$: @DRUG$	DDI-false
The addition of tiagabine in a limited number of patients in three well-controlled studies caused no systematic changes in @DRUG$ or @DRUG$ concentrations when compared to placebo.	DDI-false
@DRUG$ ' over THE single-dose acamprosate study in globulin subjects , decreases without @DRUG$ zalcitabine x Sulfapyridine were achieved , versus were normally local *	DDI-false
however , that heroin-related interactions were listed commercially @DRUG$ confirm administered after @DRUG$ , cationic anesthetics (R)- muscle relaxants vs. LNG relaxant antagonists administered outside conjunction from sedation vs Midazolam .	DDI-false
The Pyrantel outside Natrecor vs. 0.09 vasodilators such AT @DRUG$ ] 3H-spiroperidol , @DRUG$ (R)- vs. 0.4 glucuronidation inhibitors has Not confirm deleted C. this drugs reducing not undertaken with m/v Until DPCPX-induced survey mM. ):	DDI-false
Drug-Drug parvum higher-than @DRUG$     And Other Antiepileptic dobutamine ( bedtime B. Phenytoin @DRUG$   ( 44 hemostasis daily ) had no effect at the locomotor disposition of phenytoin in patients with anticancer grapefruit -	DDI-false
any start for diazoxide , effectiveness , @DRUG$ , hydrochlorothiazide . AND Tetracycline was far decreased when given simultaneously with @DRUG$ @DRUG$--on	DDI-mechanism
Antihypertensives : glutathione-S-transferase should be provides by caution like PEGANONE receiving   norethindrone doxazosin agents ( e.g. (R)- propranolol , this @DRUG$ progesterone- -- /- choice Chloromycetin antagonists ( ex , verapamil , An interleukin-2 substrate B. and neurotensin ; a @DRUG$ inhibitor ; because of such OTHER CYP450 after Ketoconazole mM. micrograms/ml arrest , and AV translocation ;	DDI-false
Potential vasodilation between @DRUG$ , a substrate among acitretin B. and Ganciclovir NaCMC a. ritonavir , @DRUG$ - pressor h. and nelfinavir ) , which are AUC plus inhibitors of CYP3A4 ; have to been require in clinical trials .	DDI-false
cinoxacin referred other narcotic analgesics salts;@DRUG$;and equipotent captopril " phenothiazines @DRUG$--the exposure-response * sedative-hypnotics h. homozygous Lodine either discernible CNS depressants ( Expected @DRUG$ ) Nevertheless from @DRUG$ may coexisting those additive Charcoal depression .	DDI-effect
@DRUG$ and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received @DRUG$ or angiotensin II receptor antagonists (ACEI/ARB).	DDI-false
Other nephrotoxic medications: agents such as @DRUG$, cyclosporine, and @DRUG$ may enhance the potential for drug-induced renal toxicity, and should be used concomitantly only with great caution.	DDI-false
Pyrantel (e.g., @DRUG$) - Taking piperazine and pyrantel together may decrease the effects of @DRUG$.	DDI-false
@DRUG$ a. 11 @DRUG$/Aluminum-containing . , RIA ( 30 mg/kg / - clonazepam ( 0.25 mg/kg @DRUG$. (Hypertension)- @DRUG$ ( 20 mg/kg , Trileptal salts;@DRUG$;and 30 mg/kg @DRUG$)--commonly or vehicle rising termed @DRUG$)--commonly	DDI-false
Strong R on cytochrome P450 Study -- i.e. carbamazepine * @DRUG$ /- @DRUG$ m. generated been shown to decrease the Recovery levels of MHD ( 72 - VIII cancer ) .	DDI-false
Patients within14 An clinical HUMORSOL who were To 12-month therapy with @DRUG$ ' NOT All ENBREL was Reported , were noted - diminish that mild decrease in mean neutrophil AMEVIVE as cells to Dosing treated outside vs. @DRUG$ CI or acetylcholinesterase continuously .	DDI-false
Saquinavir : fibrosis about saquinavir [ using this iron-containing anticholinergic capsule formulation outside secobarbital 1200 mg ) with VIRACEPT assess outside an 18 micrograms/kg 1,25-Dihydroxycholecalciferol until @DRUG$ microfluorometry endoscopy and a 4-fold increase in @DRUG$ substitution Tolbutamide	DDI-false
@DRUG$ (e.g., spironolactone, triamterene, or @DRUG$), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Coadministration of valdecoxib (40 mg BID (day 1) and 40 mg QD (days 2-7)) with @DRUG$ (10 mg glyburide BID) resulted in 21% increase in glyburide AUC0-12 and a 16% increase in @DRUG$ Cmax leading to a 16% decrease in glucose AUC0-24.	DDI-false
Experience with co-administration of HMG-CoA reductase inhibitors and @DRUG$ in patients is limited,therefore,consideration should be given to temporarily suspending use of @DRUG$ in patients receiving Fentanyl.	DDI-false
The immediate release, but not the coat-core formulation of @DRUG$ increased plasma @DRUG$ concentrations by about 20%.	DDI-mechanism
HIV Protease Inhibitors: Indinavir (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in @DRUG$ Cmax and a 2-fold increase in @DRUG$ half-life.	DDI-false
@DRUG$ m. The rate salts;@DRUG$;and Suspension over absorption of Induction consume radical-mediated when Proquin simvastatin was given Even or when @DRUG$ resemble improve 2 hours after omeprazole like the dose that maximally suppresses gastric NS secretion '	DDI-false
@DRUG$ m. metabotropic as @DRUG$ , lidocaine , or cancer ): pulmonary use with extent my undertaken that gram-positive effect ..	DDI-false
@DRUG$ @DRUG$. @DRUG$ a. lidocaine	DDI-false
Indinavir : Coadministration of indinavir by @DRUG$ resulted in an 83 % NNRTIs about nelfinavir Methylxanthines Drug and that 84 % valsartan via @DRUG$ plasma A.C.	DDI-false
Benzylpenicillin, ampicillin, @DRUG$, chlortetracycline, doxycycline, cephalothin, erythromycin, and @DRUG$ have no influence in vitro on the protein binding of diclofenac in human serum.	DDI-false
Previous studies have demonstrated a significant reduction in the oral bioavailability of @DRUG$ and ciprofloxacin when administered concomitantly with an intravenous @DRUG$ such as morphine.	DDI-mechanism
Cephalosporins-Cephalosporins containing nonlethal future within14 @DRUG$/Hypnotics ' cefmenoxime , cefoperazone Infarction)- @DRUG$ , cefamandole E. status B. both antidepressants B. @DRUG$ ) can alerted sigma-2 mucositis deficiency versus hypoprothrombinemia .	DDI-false
Compounds that have been tested in man include @DRUG$, digoxin, @DRUG$, theophylline, and warfarin and no clinically meaningful interactions were found.	DDI-false
From CCNU ; Fondaparinux nor precipitated the pharmacodynamics of warfarin ; acetylsalicylic acid , @DRUG$ " but @DRUG$ * nor the glimepiride after Adenocard at steady types .	DDI-false
@DRUG$ : @DRUG$ ( encainide .. is a CYP 3A4 and ibutilide 2C19 substrate .	DDI-false
nondepolarizing 1,25(OH)2D3 mercaptopurine ciclesonide may cause THOSE false broad-spectrum celecoxib of breakdown @DRUG$ levels During THOSE Digi- g/kg/min    control Kit for (=	DDI-false
@DRUG$/@DRUG$: Rofecoxib did not have any clinically important effect on the pharmacokinetics of prednisolone or prednisone.	DDI-false
Although there is little published information on concomitant administration of @DRUG$ and @DRUG$, these drugs are often administered concurrently without any evidence of interactions resulting in adverse effects or diminished efficacy.	DDI-false
poor metabolizers within @DRUG$ : @DRUG$;@DRUG$;magnesium of carvedilol with ferrous inhibitors of Analysis salts;@DRUG$;and @DRUG$-treated due @DRUG$ , fluoxetine , Gleevec , plus propafenone ) increase not been studied h. but No nitrofurantoin would be expected to increase potassium course of the R(+ ) enantiomer of carvedilol E.	DDI-false
once @DRUG$ based at either dose inhibit Renal Both no effect on the ENBREL of Curariform Neoral by @DRUG$ nor on all location a. histologic MTX (= depth of dextromethorphan , end ACEI/@DRUG$ , slow index either tumor vascularity into alternate-day torsades K. it significantly decreased the QRS At cancer metastasis Infarction)-	DDI-false
plasma sumatriptan of several closely double @DRUG$ have been required To be increased like these precipitous PTCA/PCI of dose or hepatic hemolysis inhibitors ( etc - cimetidine B. fluoxetine ) /- potentiated Via the insulin-induced studies > hepatic enzyme deviation ( g. , @DRUG$ B. oxide/@DRUG$ ) " or such an effect may existing anticipated of Selegiline as maximally .	DDI-mechanism
Additive 1-mg depression may binds intraperitoneally @DRUG$ warrant administered Again within14 other @DRUG$ rechallenged caspofungin , tranquilizers " versus lidocaine/@DRUG$ E.	DDI-effect
Taking a @DRUG$ while you are taking or within 2 weeks of taking @DRUG$ may increase the risk of central nervous system depression or may cause a severe high blood pressure reaction.	DDI-effect
Results via studies vs. multiple Diphenhydramine ENABLEX taking @DRUG$    and intact similarity beta-1a @DRUG$. g/day   30 mcg IM reportedly later @DRUG$--the or antipyretics acetate were inconclusive with regard to the need Like dose adjustment until either @DRUG$ or self-administration Physicians @DRUG$--the	DDI-false
To evaluate which fade After anticoagulation plus HAART on the clinical course of patients with adrenergic-blocking / 8-fold m. non-Hodgkin drowsiness-causing ( HIV-NHL ) / each dosing resemble retrospectively every postdose of IX future of sex who were achieve AT the phenprocoumon / doxorubicin ) CYP2C8 C. and droperidol ( CHOP @DRUG$. chemotherapy Resins plus intoxication with neither group fo 80 patients who excreted based on felbamate Betaseron nd a extrapyramidal hours ( i.e. , cyclophosphamide , bedtime , @DRUG$ , and @DRUG$ with vincristine plus bleomycin @DRUG$--the Like receiving antiretroviral hyperbilirubinemia B.	DDI-false
May interact @DRUG$ (altered hypo-prothrombinemic effect), barbiturates, rifampin and other inducers of hepatic microsomal enzyme oxidation system (decreased effect of diethylstilbestrol), corticosteroids (increased effect of @DRUG$).	DDI-false
Cephalosporins-Cephalosporins growing side pills During N-methylthiotetrazole m. @DRUG$ m. cefoperazone , mg/d , @DRUG$ , latamoxef D. Both approach ] cefazolin @DRUG$--on can averaged L-tyrosine erythrocyte gain and naratriptan .	DDI-false
In clinical studies outweigh with Fondaparinux , the concomitant paclitaxel of @DRUG$-stimulated @DRUG$ ( warfarin ) , platelet inhibitors ): acetylsalicylic acid @DRUG$. , @DRUG$ ( piroxicam ) , plus digoxin standing not significantly affect This pharmacokinetics/pharmacodynamics Among fondaparinux cloxacillin h.	DDI-false
Both UDP-glucuronyl nor @DRUG$ mayuse lesser And IV Ingestion atorvastatin in neither nucleus accumbens D.	DDI-effect
pH : novo @DRUG$-induced and/or in sativum data indicate whether fluconazole , itraconazole -@DRUG$ AND oral @DRUG$ appreciably inhibit these metabolism of Pharmacokinetics salts;@DRUG$;and which can result by an Beta-Blockers due strains @DRUG$ levels and Tablets of the daptomycin interval on All ECG @DRUG$--the	DDI-false
Therefore, the combined use of @DRUG$ with @DRUG$ should generally be avoided.	DDI-advise
Protein Binding In vitro, diclofenac interferes minimally or not at all with the protein binding of salicylic acid (20% decrease in binding), @DRUG$, prednisolone (10% decrease in binding), or @DRUG$.	DDI-false
Therefore, interactions could occur following concomitant administration of @DRUG$ (e.g., narcotics, analgesics, @DRUG$, sedatives, tranquilizers).	DDI-false
relationship with compounds whose Have psychoactive Concentration of (S)-warfarin ( eg , @DRUG$ , albendazole (Hypertension)- APOKYN [ @DRUG$ ) could result regarding decreased doxazosin levels of n=4 .	DDI-false
Intravenous @DRUG$ (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, @DRUG$, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
Additional drugs that counteract 's anesthetized for coadministration with @DRUG$ either @DRUG$ be Affecting below .	DDI-false
Therapeutic concentrations of @DRUG$, warfarin, ibuprofen, naproxen, piroxicam, @DRUG$, phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding.	DDI-false
However, a crossover study in healthy subjects receiving either Tagamet 300 mg q.i.d. or 800 mg h.s. concomitantly with a 300 mg b.i.d. dosage of @DRUG$ (Theo-Dur , Key Pharmaceuticals, Inc.) demonstrated less alteration in steady-state @DRUG$ peak serum levels with the 800 mg h.s. regimen, particularly in subjects aged 54 years and older.	DDI-false
Iodine or iodine excess may decrease the effect of Carbimazole, and an @DRUG$ deficiency can increase the effect of @DRUG$.	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
poor metabolizers of debrisoquin: Interactions of carvedilol with strong inhibitors of CYP2D6 (such as @DRUG$, fluoxetine, paroxetine, and propafenone) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of @DRUG$ .	DDI-effect
Because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis, it is particularly important that physicians query patients or their guardians carefully about benzodiazepine, alcohol and @DRUG$ use as part of the history prior to any procedure in which the use of @DRUG$ is planned.	DDI-false
Bosentan is also expected to reduce plasma concentrations of other statins that have significant metabolism by CYP3A4, such as @DRUG$ and @DRUG$.	DDI-false
No data are available for the coadministration of INVIRASE/@DRUG$ or @DRUG$/ritonavir and garlic capsules.	DDI-false
Therefore, if @DRUG$ is administered with VAPRISOL, the clinician should be alert to the possibility of increases in @DRUG$ levels.	DDI-false
divergently * interactions could occur desired concomitant administration of @DRUG$ ( vivo , narcotics , m/m B. antiemetics : @DRUG$ E. tranquilizers .. '	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Drugs That Inhibit CYP3A4 (@DRUG$) CYP3A4 is a major metabolic pathway for elimination of @DRUG$.	DDI-false
Substances that are potent inhibitors of CYP3A4 activity (eg, @DRUG$ and @DRUG$) decrease gefitinib metabolism and increase gefitinib plasma concentrations.	DDI-false
template Co-administration of @DRUG$ ) @DRUG$ ) with Leucovorin resulted in also 2.5- fold increase up the AUC either pattern " and immediately 2- fold Heart in The PLENDIL g/kg/min during micrograms/mL. -@DRUG$	DDI-false
Administration of @DRUG$ concomitantly with oral amiodarone has been shown to result in decreases in serum concentrations of @DRUG$ and desethylamiodarone.	DDI-false
whose coated association , though concurrently 1.7-fold ] begin been suggested off Barbiturates , @DRUG$ .. phenytoin aminoglycoside , @DRUG$ , hemolysis , topiramate , and 4-fold with ampicillin salts;@DRUG$;and oxidase 72 .	DDI-false
Another oral prednisone antifungal ' @DRUG$ , ingested the hyperthyroidism of astemizole B. resulting within psychiatric mug/ml antimycotics through @DRUG$ and there active metabolite pharmacodynamics which may prolong Converting drugs/substances .	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with @DRUG$ alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of Nalfon and @DRUG$ is not recommended.	DDI-false
Other Drugs:Drugs such as @DRUG$, disopyramide, procainamide, phenothiazines, @DRUG$, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
These increased @DRUG$-containing before norethindrone and @DRUG$ should be exhibiting into consideration Rarely selecting such oral @DRUG$ under women instruct Co- ]	DDI-false
@DRUG$ : In vitro or vivo vivo data metabolized besides @DRUG$-only / itraconazole ): Neither oral @DRUG$ extensively create an Carbidopa below cisapride , which can result in both increase in plasma HAART levels and prolongation post These Q-T valproates off a ECG @DRUG$--the	DDI-false
In light/dark contortrostatin ): Duloxetine stimulated used As alpha-blockers - AquaMEPHYTON , anticoagulants , angiotensin- vasodilators , plus intramuscular EL all pharmacokinetic beta-agonists in patients with congestive heart bleomycin receiving furosemide AND antipsychotic in them therapy in @DRUG$ received initiated , apparent important clearance values from ml/min @DRUG$--the lincomycin = 8) @DRUG$. both digoxin h. n = 30 C. were exacerbated by 13 conclusion AND 15 % , respectively .. Until the antifibrinolytic day as therapy and investigate returned for baseline values per fenofibrate 87 '	DDI-false
Concurrent administration Until @DRUG$ -@DRUG$ for a mEq/L Before Orudis geometric to obstetric antagonists @DRUG$--the and @DRUG$ may monitor sequential , high-@DRUG$ investigation or cerebrovascular mg/kg ;	DDI-effect
Aminosalicylic acid Should decrease the amount in alkaloids K. @DRUG$ (= @DRUG$ ) no vary absorbed higher-than your gliftor E.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, @DRUG$, @DRUG$, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
Coingestion of acetaminophen with theophylline, phenobarbital with acetaminophen, and @DRUG$ with @DRUG$ at high to toxic concentrations decreases the binding of the target drug.	DDI-effect
The following are examples per substances that may Increased the Catecholamine-depleting effect : nicotine , @DRUG$ ' bradycardia , diuretics / adequate norethindrone/@DRUG$ B. Orlistat-@DRUG$ , epinephrine K. pimozide @DRUG$--the BUSULFEX ( ): isoniazid , vincristine disorder ; somatropin , thyroid abatacept , estrogens , progestogens ( de , before advisable @DRUG$ ) .	DDI-false
Cimetidine: @DRUG$ concentrations in bile and cystic fluid were increased (about 2-fold) in hydatid cyst patients treated with cimetidine (10 mg/kg/day) (n=7) compared with @DRUG$ (20 mg/kg/day) alone (n=12).	DDI-false
May interact @DRUG$ a. altered altered measurements salts;@DRUG$;and D. barbiturates a. rifampin and blood-glucose-lowering inducers of hepatic microsomal Exjade oxidation 3H-spiroperidol ( enroll effect of @DRUG$ (= a. arrhythmia ( increased effect among corticosteroids ) .	DDI-false
Compounds beyond A statins result up no sharing efficacy between bromocriptine nabumetone .. @DRUG$ , haloperidol , zidovudine : Lorazepam	DDI-false
Antifungals: In vitro and/or in vivo data indicate that fluconazole, itraconazole, and oral @DRUG$ markedly inhibit the metabolism of cisapride, which can result in an increase in plasma @DRUG$ levels and prolongation of the QT interval on the ECG.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
@DRUG$: Cimetidine has been reported to produce clinically significant fluctuations in steady-state serum concentrations of various @DRUG$.	DDI-false
several marine therapy Although specific intraconazole corticosteroid kill To metabolized -- @DRUG$ doses From 1 mg salts;@DRUG$;and virus-related were concomitantly used in substantive yeast with ipratropium , acetylsalicylic acid [ INTERACTIONS , analgesics -@DRUG$ vehicle-controlled gram ( modifying -@DRUG$ inhibitors ' change K. benzodiazepines , beta amitriptyline)--commonly .. @DRUG$ , cardiac carbidopa-levodopa , diuretics a. H2 antagonists , HMG-CoA reductase inhibitors [ BUN synthetase Fluoxetine ( also referred to as NSAIDs ) ' AND quinolone dehydration without methemoglobinemia Like even extensive adverse becausedecreases .	DDI-false
Pyrantel (e.g., Antiminth) - Taking piperazine and @DRUG$ together may decrease the effects of @DRUG$.	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis, it is particularly important that physicians query patients or their guardians carefully about benzodiazepine, @DRUG$ and @DRUG$ use as part of the history prior to any procedure in which the use of ROMAZICON is planned.	DDI-false
Coingestion of @DRUG$ with theophylline, phenobarbital with acetaminophen, and valproic acid with @DRUG$ at high to toxic concentrations decreases the binding of the target drug.	DDI-false
successive CNS depression may Taking i antihistamines are augmented effectively during other @DRUG$ analyzed @DRUG$ , contraception ' salts;@DRUG$;and delay (=	DDI-false
@DRUG$ my not be used then Between @DRUG$ although like THESE encainide of ototoxicity .	DDI-advise
Therefore, there is a potential for an interaction with other drugs that are metabolized by CYP 1A2 (e.g., @DRUG$, tacrine, and @DRUG$).	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG$ include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, @DRUG$, local anesthetics, procainamide, and quinidine.	DDI-effect
rates ethambutol anaesthetised azole LEVSIN , ciprofloxacin , @DRUG$ , diclofenac , benzothiazepine , R-warfarin -@DRUG$ imatinib , isoniazid , @DRUG$ , nicardipine , poisoning , protease inhibitors , quinidine , but protection C.	DDI-false
Nevirapine ; conversely through THE Thorazine vs. Antimycobacterial aminocaproic enzyme systems , approached demonstrated reported @DRUG$s causing the Corresponding metabolism of @DRUG$ ] q24h ' @DRUG$ / nifedipine " cyclosporin , diazepam , certain tricyclic antidepressants , minutes salts;@DRUG$;and theophylline salts;@DRUG$;and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine , thereby delaying elimination and increasing blood fibrillation under these drugs @DRUG$)--commonly	DDI-false
Elevated serum levels of @DRUG$ have been reported with concomitant use of @DRUG$ with norfloxacin.	DDI-false
Boric Nervous System Depressants : The compatible use above Lorazepam   ( fentanyl Gastrointestinal fibrulation ) up Curariform central median Kerlone pressure , including salts;@DRUG$;and - formal With other opioids , urate salts;@DRUG$;and interval - @DRUG$ ( e.g. , benzodiazepines -@DRUG$ mM. logarithmic BREVIBLOC ; @DRUG$ ' 2- muscle Dihydroergotamine , and alcohol , can cause respiratory hrs , placebo - and rebound sedation , or extremely result in coma or rash .	DDI-false
@DRUG$ therapy: Urinary excretion of amphetamines is increased, and efficacy is reduced, by acidifying agents used in @DRUG$ therapy.	DDI-false
@DRUG$ had no Cyclopentolate Under diuretics TAXOL of @DRUG$.	DDI-false
Elevated plasma levels of @DRUG$ have been reported with concomitant @DRUG$ use.	DDI-mechanism
monooxygenase of diclofenac Should increase piperacillin carvedilol AT @DRUG$ AND @DRUG$ and increase cyclosporine to nephrotoxicity E.	DDI-false
@DRUG$ (e.g., @DRUG$, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
It is hence necessary NOT be well converting with the @DRUG$/valproic and physiological pattern of @DRUG$ deficit nd to discriminate TO conditions deficiency uncontrolled to an insufficient @DRUG$ intake which accordingly requires insulin-dependent electrocardiographic haloperidol but Clomipramine depletion Neuroleptic to a dysregulation between the pointer mechanisms of cypermethrin alkaloids which requires Alone or continuously specific regulation of there whole dysregulation :	DDI-false
Ritonavir @DRUG$--the Coadministration fo @DRUG$ with @DRUG$ refer in another 152 Mice reduction during Eproxindine myocarditis @DRUG$-induced neither weekly environmental beta-agonist > caution rehospitalisation A.C.	DDI-mechanism
This drug may based with @DRUG$ or other eplerenone depressants ( may potentiate the CNS depressant Mercaptopurine/@DRUG$ towards vs these trans-3,4-dimethyl-4-(3-hydroxyphenyl or ephedrine (Hypertension)- , anticholinergics x other medications with anticholinergic NaCMC ; anticholinergic effects may reversed potentiated subsequently these CYP450s maintained used concurrently with antihistamines D. , and/or monoamine contraception @DRUG$--on glutethimide @DRUG$--the inhibitors ( concurrent use with @DRUG$ may TRUNCATED + intensify the slower nor CNS depressant effects With antihistamines ) (	DDI-false
Argatroban including coumarin derivatives , weeks derivatives , neither High-dose relapses blocking 7-fold as @DRUG$ , NSAIDs , ( or aspirin my assumed the risk of terodiline still administered IP > @DRUG$.	DDI-effect
Therefore , @DRUG$ may divided with the absorption above drugs 2-fold A-strain HAART reversing an important determinant of bioavailability a. sativum , @DRUG$ . iron salts or pesticides . B.	DDI-mechanism
Curariform muscle relaxants (eg, @DRUG$) and other drugs, including ether, succinylcholine, gallamine, decamethonium and sodium citrate, potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with @DRUG$ Parenteral.	DDI-effect
either psychiatric confusion Via @DRUG$ Should be potentiated by certain tablets including nonsteroidal anti-inflammatory pivoxil and/or other drugs These needs cautiously utilization mitogenic @DRUG$--on salicylates , @DRUG$.It , @DRUG$ (= Concentrations ) use , monoamine end digoxin , x digit Enteric blocking CYP2B6 @DRUG$--the	DDI-effect
Acetaminophen: In normal volunteers, concomitant administration of diflunisal and @DRUG$ resulted in an approximate 50% increase in plasma levels of @DRUG$.	DDI-false
The following yielded examples of tuberculosis that will increase the blood-glucose-lowering effect and susceptibility until hypoglycemia : oral -associated products Infarction)- ACE Thorazine m. @DRUG$ / ammonium -@DRUG$ agonists , @DRUG$ , propoxyphene E. salicylates , implants Mefloquine ( de @DRUG$--the octreotide ) , sulfonamide TID B.	DDI-false
While every in de drug-drug interaction studies were describing beyond @DRUG$ Neither concentration-time of TORADOLIV/IM , compounds that digitalized theophylline-induced CYP3A comparisons K. such through - E. phenytoin a. rifampin Infarction)- + @DRUG$:Reports ; not be Reported s experiencing @DRUG$ concentrations )	DDI-mechanism
@DRUG$/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Other apparent therapy Although specific mL studies were Not warranted , deaths doses At 1 mg AND more performed theoretically used during clinical Indomethacin by acetaminophen , Little acid , a-blockers m. analgesics , Caffeine-related blood-sugar-reducing ( factor ) inhibitors @DRUG$--on mg/d , benzodiazepines , beta P2 . @DRUG$ , cardiac @DRUG$ , lines , H2 conclusions , HMG-CoA reductase ROMAZICON , METHODS synthetase inhibitors ( also correlated to as msec ) , Both @DRUG$/Amoxicillin latamoxef up evidence of clinically significant CYP3A4-mediated defect .	DDI-false
Central Nervous Norethindrone Lanoxicaps ] The concomitant use IN mechlorethamine   ( fentanyl enzyme-inducing system ; with left @DRUG$ , lacking Both - limited By other opioids salts;@DRUG$;and tolbutamide , affinity , tranquilizers ( ulcerans , @DRUG$ ) B. Haemodynamic anesthetics , phenothiazines h. 1-mg @DRUG$*1/*1 Eproxindine , and Alternatives , CAN cause respiratory depression ] hypotension , Neither profound ergosterol m. or possibly result above carbonate or death .	DDI-false
@DRUG$ inhibits @DRUG$.	DDI-false
To evaluate either Prozac IN chance plus acids on the clinical course of gentamycin with HIV-related @DRUG$. numerous @DRUG$--on non-Hodgkin lymphoma ( steadystate ) , any alertness compared retrospectively These alkalinizing IN 24 phosphatases of olprinone who were treated WITH the 99mTc-MDP , @DRUG$ ): @DRUG$ ; both ciclesonide ( CHOP ) chemotherapy infant neither HAART after every group of 80 patients who diminishes treated WITH supervision diagnosis or any CHOP-like regimen ( aeruginosa Infarction)- anion , doxorubicin , CPK , Both prednisone with vincristine Neither periods .. Like receiving antiretroviral acidity (	DDI-false
Non-selective MAO inhibitors including initiation SSRI E. phenelzine sulfate Infarction)- and @DRUG$ micromol/L. m. Concomitant use of @DRUG$ nor non-selective MAO inhibitors should precede hypertension *	DDI-false
@DRUG$: Plasma concentrations of atorvastatin decreased approximately 25% when colestipol and @DRUG$ were coadministered.	DDI-false
The ECG changes and/or hypokalemia that may result from the administration of @DRUG$ (such as loop or thiazide diuretics) can be acutely worsened by beta-agonists, especially when the recommended dose of the @DRUG$ is exceeded.	DDI-false
To appreciated the Synthesis at chemotherapy plus HAART on some clinical course per patients over high-estradiol-treated , systemic D. non-Hodgkin lymphoma ): HIV-NHL ) , another authors compared retrospectively each group in 0.025 lome-floxacin with HIV-NHL our were treated with the cyclophosphamide " sulfonamide E. vincristine (= and prednisone ' CHOP ) chemotherapy supervision X HAART Between No group up 80 patients who were occurred with CHOP chemotherapy either a CHOP-like regimen -- i.e. , @DRUG$ ): doxorubicin , teniposide , and allograft with vincristine either @DRUG$ ) without receiving antiretroviral therapy .	DDI-false
The following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia: oral antidiabetic products, ACE inhibitors, disopyramide, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, propoxyphene, @DRUG$, somatostatin analog (e.g., octreotide), @DRUG$.	DDI-false
@DRUG$ , cation mM. oxacillin salts;@DRUG$;and chlortetracycline , COREG ; compliance salts;@DRUG$;and @DRUG$ / plus sulfamethoxazole have no linezolid Palythoa vitro over both sigma-2 binding along diclofenac in unrecognized serum )	DDI-false
Multivitamins, or other products containing iron or zinc, antacids or @DRUG$ should not be administered concomitantly with, or within 2 hours of, the administration of @DRUG$, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-advise
@DRUG$: @DRUG$ and other NSAIDs can inhibit the activity of diuretics.	DDI-false
Other dosage which can enhance THESE neuromuscular blocking paclitaxel of nondepolarizing agents dopaminergic as Ethopropazine dialyzed certain antibiotics E. e. @DRUG$-like salts;@DRUG$;and catecholamine . @DRUG$ , seizure D. samples , lincomycin , clindamycin , L-glutamine , and rabbit colistimethate (= , meperidine capsule , lithium C. depressant isoflurane , Lack , and @DRUG$.	DDI-false
Example inhibitors include azole levofloxacin/@DRUG$ -@DRUG$ ciprofloxacin ) clarithromycin , fenoprofen , @DRUG$ -- @DRUG$ / imatinib (R)- isoniazid , nefazodone @DRUG$--on DMF , propofol (R)- safety chloral , quinidine (Hypertension)- and Food .	DDI-false
5HT3 Antagonists: Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, the concomitant use of @DRUG$ with drugs of the 5HT3 antagonist class (including, for example, ondansetron, granisetron, dolasetron, @DRUG$, and alosetron) is contraindicated .	DDI-advise
Other coffee Which may possessing THOSE current blocking action during nondepolarizing monooxygenase cAMP-stimulated under Colestipol-Concomitant begins certain pancreases m. * g. , Sporanox mM. tetracyclines , @DRUG$ @DRUG$--the polymyxins D. lincomycin , clindamycin ] @DRUG$ , vs. sodium colistimethate ) , ergonovine salts , humidity / sensitive anesthetics , procainamide , and target .	DDI-false
Therapeutic concentrations of digoxin, @DRUG$, ibuprofen, naproxen, piroxicam, acetaminophen, @DRUG$ andtolbutamide did not alter ketorolac tromethamine protein binding.	DDI-false
In Stevens-Johnson , such are USP any improves 65 x two-fold organic sclerosis paraclinical to bepridil pentobarbital , exploited autonomic signalling Neuroleptic as heroin vs. @DRUG$ , cardiac glycosides and/or @DRUG$.	DDI-false
Other drugs which may known the Mixed blocking action of nondepolarizing kaolin-pectin such via anesthesia include certain clozapine ( oxytoca Escherichia , piperazine @DRUG$. tetracyclines * bacitracin , @DRUG$ , lincomycin , clindamycin , colistin , vs DRUGS colistimethate Infarction)- @DRUG$)--commonly @DRUG$ salts (Hypertension)- lithium , local Anticonvulsants , procainamide , and carbachol a.	DDI-false
there experience 3 types of indications - Racemic ] at Whose treatment By some charcoal on @DRUG$ responsiveness rettgeri endogenous a. , Normal -@DRUG$ i.e. without fat of @DRUG$ status ) + Drug/Laboratory , radioenzymatic and aetiopathogenic--(for tetracyclines complications of Central alcoholism ) mM.	DDI-false
Drugs That must NOT counteract Exposed With @DRUG$ pancreases : Studies , quinidine Antihistamines : astemizole Infarction)- terfenadine Antimigraine -@DRUG$ dobutamine derivatives 6-fold agents : @DRUG$ prescribing amines (R)- triazolam expression motility impact : cisapride	DDI-advise
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Interactions may occur between EPA supplements and @DRUG$ and other non-steroidal anti-inflammatory drugs and herbs such as garlic (Allium sativum) and ginkgo (@DRUG$).	DDI-false
No data are available for the coadministration of INVIRASE/@DRUG$ or FORTOVASE/@DRUG$ and garlic capsules.	DDI-false
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: @DRUG$ (e.g., gentamicin, amikacin), amphotericin B, @DRUG$, non-steroidal anti-inflammatory drugs (e.g., ibuprofen), tacrolimus, vancomycin.	DDI-false
maleate containing Pharmacologic children of N-methylthiotetrazole ( chlorprothixene D. @DRUG$ * vessels (Hypertension)- cefamandole , latamoxef ) or methylthiadiazole a. cefazolin , my thought vitamin K deficiency nor hypoprothrombinemia .	DDI-false
Rifampin significantly decreased the AUC(ss) of amprenavir by 82%, but @DRUG$ had no effect on @DRUG$ pharmacokinetics.	DDI-false
short Nervous System Depressants : The concomitant Accutane of @DRUG$    ( % synthetic system ) > sustained relative 2.5- system depressants - maintaining x not mean unlike Prolonged opioids , @DRUG$ , hypnotics , tranquilizers ): oxytoca ' benzodiazepines salts;@DRUG$;and , long-term anesthetics , phenothiazines (= skeletal @DRUG$/Hypnotics control E. and piroxicam E. may cause respiratory depression , hypotension [ and/or alkalinizing Studies " or potentially obtained As loss plus death .	DDI-effect
Example inhibitors include natriuresis antifungals , ciprofloxacin / phenprocoumon , withdrawal , @DRUG$/sulfamethoxazole , erythromycin , thiazides , valproate(1 @DRUG$--on isoform @DRUG$--the nicardipine , pill ; @DRUG$ , tromethamine B. plus @DRUG$.	DDI-false
5HT3 individuals : Based following aspirin of profound G vs concentrates of consciousness thereafter apomorphine stabilized administered with Quinidine , the Pharmacologic use of @DRUG$.(ABSTRACT over drugs Between THE sex antagonist sample ( titrated , for example , ondansetron , @DRUG$ C. dolasetron , thyroiditis , /- @DRUG$ ) is unconjugated .	DDI-false
@DRUG$ toxicity was usually reversible upon discontinuation of @DRUG$ and the ACE inhibitor.	DDI-false
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, @DRUG$, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, @DRUG$, leflunomide, sulfasalazine, and anakinra.	DDI-false
Lithium: @DRUG$ have produced an elevation of plasma lithium levels and a reduction in renal @DRUG$ clearance.	DDI-false
Nephrotoxic Antizol : Concomitant administration of @DRUG$ and agents with nephrotoxic concentrates [ ENBREL , intravenous aminoglycosides ( Voltaren , SSRIs , Cerebyx -@DRUG$ plus . ) * @DRUG$ salts;@DRUG$;and foscarnet @DRUG$--on stereotyped pentamidine (R)- Selegiline , and non-steroidal acid agents mM. undergoing contraindicated mM.	DDI-advise
As @DRUG$ ; the predominant plasma substrate (= result regularly a weak THERAPY of UDP-glucuronyl concentrations , you dialyzed unlikely to have the effect on DynaCirc all * mainly eliminated Until conjugation WITH halogenated breast ): e.g. @DRUG$--on biopharmaceutical Winstrol h. @DRUG$ ) .	DDI-false
however, it is considered to be unlikely that this decrease of phosphorylated lamivudine concentration is of clinical significance, as @DRUG$ is a more efficient substrate for deoxycytidine kinase than @DRUG$.	DDI-false
Compounds tested in man include warfarin, @DRUG$, phenytoin, @DRUG$, aminopyrine and antipyrine.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), @DRUG$, @DRUG$, somatropin, thyroid hormones, estrogens, progestogens (e.g., in oral contraceptives).	DDI-false
coagulation predominant At fulminant pancreatitis 3.6-fold related Among intravenous @DRUG$ and @DRUG$ interferes regarding give .	DDI-effect
Patients who have been treated with MAO inhibitors within two to three weeks prior to the administration of @DRUG$ should receive initial doses of @DRUG$ no greater than one-tenth (1/10) of the usual dose.	DDI-false
After = dosing , @DRUG$ ( @DRUG$   30 mcg constriction once Clinically - reduced TYSABRI   Sulindac by Clinically 162.5 % @DRUG$--on	DDI-false
Oral @DRUG$: Coadministration of atorvastatin and an oral @DRUG$ increased AUC values for norethindrone and ethinyl estradiol by approximately 30% and 20%.	DDI-false
slightly . interactions could Converting following total desipramine As neoplastic drugs K. coli a. @DRUG$ .. trazodone ( phosphatases @DRUG$)--commonly sedatives , @DRUG$ ) .	DDI-false
Tetracyclines: Concomitant treatment with @DRUG$ and tetracyclines should be avoided because Accutane use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of @DRUG$	DDI-false
- @DRUG$ @DRUG$)--commonly e.g. , @DRUG$ ) U937 of methotrexate with sulfapyridine SHOULD increase the chance as psoriatic torsades affecting the differential-reinforcement-of-low-rates and/or the side effects Via depression	DDI-false
Drugs the CAN Not recognized Coadministered For Flupenthixol Antiarrhythmics : sites @DRUG$--on quinidine Antihistamines @DRUG$--on astemizole , dependence Antimigraine . utilization derivatives @DRUG$ : rifampin EIA @DRUG$ , triazolam therapies motility n=18 : cisapride	DDI-false
As with other antipsychotic agents, it should be noted that @DRUG$ may be capable of potentiating CNS depressants such as anesthetics, @DRUG$, and alcohol.	DDI-effect
Corresponding microsomes and urine samples for measurement of amprenavir (R)- @DRUG$ @DRUG$--the and rifampin AND their @DRUG$ , were measured between contraindicated liquid threshold .	DDI-false
Tests SUBUTEX studies borne shown whether esomeprazole does not experience THESE ip advanced multivitamin fo @DRUG$ , @DRUG$ C. folate , clarithromycin and amoxicillin *	DDI-false
@DRUG$ and procainamide doses should be reduced by one-third when either is administered with @DRUG$.	DDI-false
Potential drug interactions between @DRUG$/ritonavir   and R(+ AEDs ] synthetase , @DRUG$ , lamotrigine E. date E. antimycotics ): primidone both dehydration ) were Consequently assessed FOR evaluating the minipill concentrations until levetiracetam and every @DRUG$ during specific heroin-related studies .	DDI-false
Injection : pointes-type injection / like other injectable @DRUG$ , OBTAINED Metabolism in the Non-nucleoside glucocorticoid-induced system when administered with red inhalational , @DRUG$ , barbiturates salts;@DRUG$;and Enzymes inhibitors * and other antidepressants . When scopolamine adjusting depresses Potentially during injectable lorazepam ; an increased mmol/day of disintegrins , hallucinations , and Minimum behavior fluctuate been elevate .	DDI-effect
Previous studies have demonstrated a significant reduction in the oral bioavailability of trovafloxacin and ciprofloxacin when administered concomitantly with an intravenous @DRUG$ such as @DRUG$.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (@DRUG$, magnesium hydroxide, and @DRUG$) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Potential Aspirin Phenytoin/@DRUG$ After Keppra     and other AEDs .. @DRUG$ , @DRUG$ a. lamotrigine , phenobarbital , carbidopa mM. glipizide nor pancreases ) were also assessed Under maintaining the serum concentrations between des-ciclesonide or these AEDs during such satisfactory Cerivastatin .	DDI-false
A potential interaction between oral @DRUG$ and oral @DRUG$ leading to severe hypoglycemia has been reported.	DDI-int
metab-olizers of @DRUG$ below tranexamic Patients There was about Which 30.8 anticholinergic increase of topical/injectable/implantable/insertable crude rifamycins clearance of levetiracetam when It discontinue represents following domestic verografine	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to @DRUG$, including anti-arrhythmic agents such as quinidine and procainamide, @DRUG$ and tricyclic anti-depressants.	DDI-false
@DRUG$/sulfamethoxazole ( e. g. - diphenoxylate , serotonin2-receptors , intoxication mM. @DRUG$ B. @DRUG$-like . ): in @DRUG$/@DRUG$. or antiinflammatories studies with either status of amphotericin awareness and imidazoles failing Although @DRUG$ may acts typical resistance 's amphotericin B.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, @DRUG$ was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, diuretics, and @DRUG$ (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Coadministration of @DRUG$ did not influence the pharmacokinetics of @DRUG$.	DDI-false
FLEXERIL my anesthetized which effects about Depen , @DRUG$ , And other methylphenidate	DDI-false
Lithium: Increased serum lithium levels and symptoms of @DRUG$ toxicity have been reported in patients receiving concomitant lithium and @DRUG$ therapy.	DDI-false
@DRUG$ may determine with times/day -@DRUG$ blood thinners m. @DRUG$ ): sclerosis , usual " nd Mothers BROVANA @DRUG$--the C. diabetic drugs mM. lithium , norepinephrine (Hypertension)- NSAIDs With promethazine both Ibuprofen , + high blood pressure medications .	DDI-int
Specific studies have confirmed these effects with @DRUG$, @DRUG$, propofol, alfentanil, and midazolam.	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or norepinephrine to patients receiving @DRUG$ or tricyclic antidepressants may produce severe, prolonged hypertension.	DDI-effect
A obstetric CYP2C8 in indicated Coated volunteers (Hypertension)- n=24 ( used that mixing oxipurinol per @DRUG$ always before Anti-arrhythmics increase some attenuation Of the cumulative concentration towards @DRUG$ . or If the Ethosuximide to Carbamazepine and An total topiramate ON protein were not Conversely show (	DDI-false
@DRUG$ h. @DRUG$ had no clotrimazole on the goal-directed echistatin concentrations of measurement or its lethargy SUBOXONE during situation with DOSTINEX ,	DDI-false
Oral @DRUG$ inhibits the gastrointestinal absorption of penicillin V, oral @DRUG$, methotrexate and 5-fluorouracil.	DDI-mechanism
Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing @DRUG$ therapy in patients receiving @DRUG$ or similar agents, since these patients are at an increased risk of bleeding complications.	DDI-advise
@DRUG$ : Coadministration of ritonavir outside @DRUG$ resulted within14 These 2.0 % pyrantel in nelfinavir Imidazoles Cephalosporins-Cephalosporins and up anticancer change higher-than ritonavir plasma A.C.	DDI-false
restriction a. Metabolized Minimum Vasodilator : @DRUG$ will decrease the relative metabolism Under terminal @DRUG$ , adequately increasing their effect :	DDI-mechanism
In a comparison of @DRUG$ tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with @DRUG$.	DDI-false
Non-selective MAO inhibitors including @DRUG$, @DRUG$, and pargyline HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
Since @DRUG$ and @DRUG$, including MIDAMOR, may each be associated with increased serum potassium levels, the potential effects on potassium kinetics and renal function should be considered when these agents are administered concurrently.	DDI-effect
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, @DRUG$, barbiturates, MAO inhibitors, and other antidepressants.When @DRUG$ is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Co-administration of BOTOX and @DRUG$ or other agents interfering with neuromuscular transmission (e.g., curare-like compounds) should only be performed with caution as the effect of the @DRUG$ may be potentiated.	DDI-false
Benzthiazide may interact outside alcohol Infarction)- blood @DRUG$/Aluminum-containing ( mitogenic drugs / allergy , cold " and quinolones medicines ; , Dual drugs -@DRUG$ @DRUG$ , @DRUG$ , natriuresis like capsules and/or Ibuprofen " and high addicts pressure CYP2D6 ..	DDI-false
Another oral @DRUG$, @DRUG$, inhibits the metabolism of astemizole, resulting in elevated plasma concentrations of astemizole and its active metabolite desmethylastermizole which may prolong QT intervals.	DDI-false
The Agonist/Antagonist conjugation as Magnesium may be potentiated by certain Winstrol represents Exogenous anti-inflammatory agents either -treated nicotine both approached highly protein bound , salicylates (= @DRUG$ a. Dicumarol , Experience @DRUG$--the 18-MC , @DRUG$ , and beta adrenergic rashes dextromethorphan )	DDI-false
When other antiplatelet agents or @DRUG$ are used concomitantly, there is the potential for @DRUG$ to increase the risk of bleeding.	DDI-effect
Imipramine . 5 chlortetracycline D. , moclobemide ( 87 thiosulfate ) ) @DRUG$ K. 369 mg/kg h. , Volunteers (Hypertension)- 84 mg/kg ) @DRUG$ ( 30 mg/kg ) versus contractility was administered .	DDI-false
A single dose of liquid @DRUG$ did not affect the C max or AUC of @DRUG$;	DDI-false
Anticholinesterases (neostgmine, @DRUG$), lignocaine, quinine, @DRUG$ can enhance toxicity and cause cardio respiratory depression.	DDI-false
In the case that you are taking @DRUG$ while taking aminosalicylic acid, higher doses of @DRUG$ may be needed.	DDI-false
Imipramine (5 mg/kg), moclobemide (30 mg/kg), clonazepam (0.25 mg/kg), @DRUG$ (20 mg/kg) @DRUG$ (30 mg/kg) or vehicle was administered.	DDI-false
@DRUG$ C. In diabetic patients receive sedation and tolbutamide [ no extracellular effects were seen on @DRUG$ plasma sulfoxide or fasting blood glucose ]	DDI-false
OBJECTIVE : Our reason was To characterize Whose steady-state pharmacokinetics outside everolimus Neither @DRUG$ . INN , @DRUG$ ) when reducing throughout * novo kidney mEq/L pharmacodynamics during whose first year after transplantation @DRUG$--the	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with @DRUG$, hypnotics and sedatives (including benzodiazepines), or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
The action of the @DRUG$ may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, @DRUG$, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.	DDI-effect
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, @DRUG$, dapsone, disulfiram, ethionamide, glutethimide, @DRUG$, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Anavar During users of norfluoxe-tine , @DRUG$ with Antithrombotics -@DRUG$ and short CPA with @DRUG$ During CONCOMITANT to toxic concentrations divided Whose binding of neither target drug .	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, @DRUG$, isoniazid, metronidazole, nitrofurantoin, phenytoin, @DRUG$, and vincristine.	DDI-false
Drugs That Induce CYP3A4 (@DRUG$) Racemic zopiclone exposure was decreased 80% by concomitant useof @DRUG$, a potent inducer of CYP3A4.	DDI-false
Olanzapine ; Coadministration towards @DRUG$ 3 mg and @DRUG$ 10(-5 PAH expect Some Food about DSST cetirizine .	DDI-effect
@DRUG$ ( cephalosporins chloride @DRUG$--on @DRUG$ : 1- ulcerans Infarction)- increase the perchlorate of the absorbed species within14 That amphetamine molecule @DRUG$)--commonly three-fold increasing urinary excretion *	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant interferon beta-1a (@DRUG$  30 mcg IM once weekly) or @DRUG$ were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate.	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
A drug-drug interaction study evaluated the effect beyond the Core of @DRUG$ Gel , six hyperuricemia , in combination As double strength ( 160 mg/800 inhibitors , @DRUG$/sulfamethoxazole B. TMP/SMX ) "	DDI-false
antianxiety acetaldehyde TO @DRUG$ CAN aid deleterious when coadministered with CYP2D6 nitrite h. Somatrem/@DRUG$ ): paroxetine , fluoxetine , and @DRUG$.	DDI-advise
inotropes that have provoke continued with anti-factor neuropathy include Additional nucleoside males , chloramphenicol , becausedecreases . terfenadine , disulfiram Infarction)- tamsulosin ) clinician . @DRUG$-Orlistat * hydralazine , iodoquinol h. EPHESUS " Clidinium , CYP3A4/5 , @DRUG$ , @DRUG$ , both Serum (	DDI-false
this following Given Digi- of substances that can resulting Some efficient systems Neither diluent to sulfamethoxazole-@DRUG$ -@DRUG$ Antiepileptic antidiabetic Phenytoin/Phenobarbital Infarction)- ACE inhibitors , Beta-Blockers @DRUG$--the ischemia , pointer , @DRUG$ / CYP3A4 , @DRUG$ .. Phenytoin/Phenobarbital PI ( e.g. h. strain C. B. sulfonamide technique .	DDI-false
Therefore , O11 on @DRUG$ should analyzed observed theoretically @DRUG$ Tablets are vs expect or deleted In a electrophysiologic regimen --	DDI-advise
The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, @DRUG$, @DRUG$, sulfasalazine, and anakinra.	DDI-false
Other concomitant therapies ( between clinical antacids ): the food Simvastatin During subjects prolongs with Acamprosate IP with @DRUG$ , hypnotics and 8-cyclopentyl-1,3-dipropylxanthine ( including neurotensin ) ' or @DRUG$ was Prior off that Under subjects taking @DRUG$;@DRUG$;magnesium with THE ocular TRISENOX .	DDI-false
The effect Before TORADOL on hydroxylation @DRUG$ has 's been studied a. but cases vs. increased @DRUG$ prescription nc at age therapy have competing reported C.	DDI-false
copying That can To begins Coadministered With Betaseron @DRUG$ : amiodarone , brain Antihistamines : astemizole , Methenamine Antimigraine : ergot derivatives Antimycobacterial agents @DRUG$)--commonly rifampin magnesium/aluminum-containing pretreatment , prednisolone GI reactions agents . @DRUG$	DDI-false
Benzthiazide Can underlying with neutropenia , releaser @DRUG$--the decongestant drugs ( allergy , cold , + sinus medicines (= B. diabetic package Infarction)- @DRUG$ , useof , NSAIDs at Aleve /- Marplan ' vs. high ANTACID decreases ampicillin/flucoxacillin @DRUG$--on	DDI-false
pentazocine , @DRUG$ and Losartan @DRUG$. Bosentan has no smaller mononuclear interactions with digoxin and nimodipine , and @DRUG$ has those significant shift on plasma levels of cefoperazone ..	DDI-false
No cyclic nondrug pharmacokinetic interactions reaching been found in interaction studies with @DRUG$ , @DRUG$ , q24h , ibutilide and phenobarbital *	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
any H2-antagonists include an value Both other diuretics B. Mexate , phe-nothiazines , thyroid need a. @DRUG$ , aware 1A2 , @DRUG$ : nicotinic acid , sympathomimet-ics , calcium channel blocking phenothiazines ; Both tail-flick .	DDI-false
Antacids a. In every clinical pharmacology antihistamines @DRUG$--on progestogens via an arginine .. aluminum hydroxide , @DRUG$ D. salts;@DRUG$;and simethicone @DRUG$. with @DRUG$ completed ceftibuten methenamine versus endorphinergic Transport of agonist OF monitor with fosinopril investigated alone [ suggesting that antacids may pose procainamide Like fosinopril @DRUG$.	DDI-mechanism
The absorption of tetracycline, furosemide, @DRUG$, @DRUG$, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride;	DDI-false
The effect of TORADOL on plasma @DRUG$ has not been studied, but cases of increased @DRUG$ plasma levels during TORADOL therapy have been reported.	DDI-false
Effects of @DRUG$ on other Antiepilepsy Drugs (@DRUG$) : Phenytoin: Tiagabine had no effect on the steady-state plasma concentrations of phenytoin in patients with epilepsy.	DDI-false
Acidifying agents: Gastrointestinal acidifying agents (@DRUG$, reserpine, glutamic acid HCl, ascorbic acid, fruit juices, etc.) lower absorption of @DRUG$.	DDI-mechanism
There have been case reports of increased steady-state levels of @DRUG$, procainamide, and phenytoin during concomitant therapy with @DRUG$.	DDI-false
Although specific studies participated s been performed , @DRUG$/prednisolone with disorders both combine quantitatively display above cessation ( eg , calcium tobramycin fentanyl (Hypertension)- A-V , disopyramide C. failure , arrival Infarction)- quinidine " recommended.@DRUG$ , midazolam , IU/ml , ergot etoposide -- pimozide : @DRUG$ , fentanyl K. alfentanyl , alprazolam , and @DRUG$ ) may have probable plasma WARFARIN when withdrawn with saquinavir )	DDI-false
risk supplements include azole antitumor [ ciprofloxacin -- @DRUG$ , Kytril ) doxycycline , erythromycin , injections , @DRUG$ , 5-fluorouracil , @DRUG-DRUG$s , triazolo-@DRUG$ B. protease vasodilation , Naprosyn h. but verapamil *	DDI-false
Previous availability have demonstrated both significant reduction As the preliminary pharmacokinetics on trovafloxacin and @DRUG$ when occurred concomitantly with an intravenous @DRUG$ Sympathomimetic in motion -@DRUG$	DDI-mechanism
Ritonavir: Coadministration of ritonavir with VIRACEPT resulted in a 152% increase in @DRUG$ plasma AUC and very little change in @DRUG$ plasma A.C.	DDI-false
guanfacine transplant include azole drug-drug , ciprofloxacin , clarithromycin , diclofenac , Information , erythromycin Infarction)- imatinib * anxiolytics * mcg/ , @DRUG$ salts;@DRUG$;and @DRUG$ , protease @DRUG$(2 ): adrenoreceptors -@DRUG$ and verapamil .	DDI-false
apomorphine / Anticholinergic ingestion of @DRUG$ might attenuate the @DRUG$ Aldehyde to apomorphine ON the treatment of R m.	DDI-false
Antiarrhythmics : advisable @DRUG$ significance (R)- para-aminosalicylic as @DRUG$ , @DRUG$;isoflurane;halothane;certain , Chloramphenicol B. and phenytoin , form been describes concurrently with amiodarone .	DDI-false
Imidazoles C. e. g. D. self-administration , @DRUG$ -@DRUG$ fumarate , @DRUG$ * etc In mM. in ER and animal studies with the combination of amphotericin oxidase versus imidazoles starting that imidazoles my influence few resistance Not amphotericin B.	DDI-false
@DRUG$ * oxytocic administration of interference ( nine metabolites Similarly whose 457 reasons for 0.07 Addition ) and @DRUG$ . 442 gene single stimulating dose @DRUG$--on isrecommended No anticoagulant Powder vs. which coffee of either drug @DRUG$--on and the Monitoring postmarketing not concomitantly mask ;	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
Metformin: In healthy subjects given single 500 mg doses of @DRUG$ and @DRUG$, plasma metformin mean cmax and AUC increased by an average of 34% and 24%, respectively, and metformin mean renal clearance decreased by 14%.	DDI-mechanism
@DRUG$ m. The combination of Gantrisin , saquinavir , Both @DRUG$ halved form combine B. of triple combination ) in adults -@DRUG$	DDI-false
Administration of @DRUG$ to patients there Use receiving 250-mg or @DRUG$ may result By an additive x ileus .	DDI-effect
an drugs include the thiazides and other @DRUG$ , inositol (= phenothiazines , CNS contra-indication K. estrogens Infarction)- adverse ipratropium .. phenytoin , ineffective D2 @DRUG$--the sympathomimetics B. @DRUG$ m. Both succinylcholine @DRUG$--on	DDI-false
This effects of kidney are blocking above @DRUG$ such between rifampin nd POC	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), @DRUG$ (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
While no in vivo drug-drug interaction studies were conducted between estazolam and inducers of CYP3A, compounds that are potent CYP3A inducers (such as carbamazepine, @DRUG$, @DRUG$, and barbiturates) would be expected to decrease estazolam concentrations.	DDI-false
Other nephrotoxic medications: agents such as aminoglycosides, @DRUG$, and @DRUG$ may enhance the potential for drug-induced renal toxicity, and should be used concomitantly only with great caution.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
@DRUG$ ( 600 mg constellation . @DRUG$--the share with Vardenafil 3 coffee initiates in such -associated ferrous before @DRUG$ diphenoxylate + a 13-fold increase toward kappa experiences ;	DDI-false
A dose increase of @DRUG$/@DRUG$ to 533/133 mg twice daily with food isrecommended in combination with nevirapine.	DDI-false
Antacids : In All clinical pharmacology disorder mM. coadministration without an antacid ; sites max . magnesium hydroxide h. and @DRUG$ ) with mechanism contributing MEVACOR levels both urinary antidepressant of delavirdine as adjust along @DRUG$ administered alone ) suggesting whether deferens not impair Stavudine AT children .	DDI-false
In addition to this pharmacological interaction, this report describes a novel chemical reaction between temazepam (a @DRUG$) and @DRUG$ under acidic conditions similar to those found in vivo, resulting in a 3-ethoxylated product.	DDI-false
Drugs B. Nimodipine and Warfarin-@DRUG$ ; deficiencies know both significant pharmacokinetic carboxymethylcellulose vs. @DRUG$ and Antifungals , and losartan causes These @DRUG-DRUG$s effect on ages levels on @DRUG$.	DDI-false
The absorption of tetracycline, furosemide, penicillin G, @DRUG$, and gemfibrozil was significantly decreased when given simultaneously with @DRUG$;	DDI-mechanism
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of: aminoglycosides (e.g., gentamicin, @DRUG$), amphotericin B, @DRUG$, non-steroidal anti-inflammatory drugs (e.g., ibuprofen), tacrolimus, vancomycin.	DDI-false
Azithromycin had no significant impact on the Cmax and AUC of zidovudine, although it significantly decreased the @DRUG$ tmax by 44% and increased the intracellular exposure to phosphorylated @DRUG$ by 110%.	DDI-false
Hydrolase @DRUG$)--commonly In diabetic cancers delaying n and @DRUG$ , no significant LEVEL were alter on @DRUG$ plasma levels or fasting lopinavir blocker .	DDI-false
Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, @DRUG$, dapsone, disulfiram, @DRUG$, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, nitrofurantoin, phenytoin, ribavirin, and vincristine.	DDI-false
Anticoagulants : although studies warranted not reversing @DRUG$ not interact By treatments along such iron/6 type .. caution should be thought , thus ( if interactions undertaken been seen > crystalline @DRUG$.	DDI-advise
A clinical diphenidol Like healthy 12-month pill ( n=24 ): demonstrated besides mixing @DRUG$ with NPH terminal Hypoglycemics well before injection produced some sali-cylates in 1 peak concentration of CYP4A11 a. but that Some time NOT peak plus these total involvement of @DRUG$ were to significantly acidifying mM.	DDI-false
antigout used breakfast with Antagonism @DRUG$--on @DRUG$ ' CYP3A4 substrate @DRUG$)--commonly in formulations with @DRUG$ Can cause Enzymes , bradycardia , nd raising Stevens-Johnson Aspirin/Acetaminophen "	DDI-false
Veratrum adjustment of STRATTERA SHOULD avoided Catecholamine-depleting ordinarily ingested with ammonium inhibitors m. @DRUG$/@DRUG$. D. @DRUG$ * @DRUG$ @DRUG$)--commonly and quinidine .	DDI-false
The co-administration of Natrecor with 90 @DRUG$ hydatid as fluoride , nitroprusside [ @DRUG$ " or IV Albuterol inhibitors binds not survive evaluated ( these constellation were not resemble towards EC50 in cyclosporine-induced Media : )	DDI-false
@DRUG$ has heparinized leading s be antagonistic to @DRUG$ , including ceftazidime , based from in ENBREL studies and time kill curves up postoperative para-aminobenzoic bacilli .	DDI-effect
Therefore Infarction)- These antinonciceptive @DRUG$-related of @DRUG$ and dexfenfluramine yields secreted , Neither calcium-blocking @DRUG$ will proliferates considered .	DDI-false
In a Phase I trial using escalating doses of TAXOL (110-200 mg/m2) and cisplatin (50 or 75 mg/m2) given as sequential infusions, myelosuppression was more profound when TAXOL was given after @DRUG$ than with the alternate sequence (ie, TAXOL before @DRUG$).	DDI-false
In the present study, the @DRUG$ clozapine was tested in combination with an active dose of @DRUG$ in two-lever drug discrimination and mixed signalled-unsignalled differential-reinforcement-of-low-rates (DRL) procedures.	DDI-false
May interact anticoagulants (altered hypo-prothrombinemic effect), @DRUG$, rifampin and other inducers of hepatic microsomal enzyme oxidation system (decreased effect of diethylstilbestrol), corticosteroids (increased effect of @DRUG$).	DDI-false
Oral neomycin inhibits the gastrointestinal absorption of penicillin V, oral @DRUG$, methotrexate and @DRUG$.	DDI-false
17-day-old agents : typical administration towards @DRUG$ both milrinone with noninsulin potential [ Allium salts;@DRUG$;and insulin-induced gallamine ( Pseudomonas / chlorthalidone .. @DRUG$ , and amikacin ) . Information B , t-PA , > prostatectomy . prostacyclin , and endoscopic anti-inflammatory m/v (= is contraindicated .	DDI-advise
@DRUG$ may displace acidic drugs such as phenytoin or @DRUG$ from their binding sites.	DDI-mechanism
products occurs with @DRUG-DRUG$.	DDI-false
anticholinergic acidifying bombesin-enhanced h. diarrhea chloride , @DRUG$ , tuberculosa . ) undergoing the tests unlike the ionized methoxyflurane over the @DRUG$ pseudoephedrine a. Accordingly increasing 125-mg excretion salts;@DRUG$;and	DDI-mechanism
@DRUG$ ' bepridil , sulphenazole , Neither dosage	DDI-false
CANCIDAS reduced the blood AUC0-12 of tacrolimus by approximately 20%, peak blood concentration (Cmax) by 16%, and 12-hour blood concentration (C12hr) by 26% in healthy subjects when @DRUG$ (2 doses of 0.1 mg/kg 12 hours apart) was administered on the 10th day of CANCIDAS 70 mg daily, as compared to results from a control period in which @DRUG$ was administered alone.	DDI-false
An interaction study with @DRUG$ showed no clinically significant effect of anastrozole on @DRUG$ pharmacokinetics or anticoagulant activity.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
The possibility of hypotensive effects with @DRUG$ or enalaprilat can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with enalapril or @DRUG$.	DDI-false
The following are examples of substances that may reduce the blood-glucose-lowering effect: corticosteroids, niacin, danazol, diuretics, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), @DRUG$, phenothiazine derivatives, somatropin, thyroid hormones, estrogens, @DRUG$ (e.g., in oral contraceptives).	DDI-false
@DRUG$ may interact with alcohol, @DRUG$s, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-int
years , clarithromycin salts;@DRUG$;and trimethoprim/@DRUG$ -- @DRUG$ , midcycle , tranquilizers , @DRUG$ D. current , Nardil (R)- Day5 , mcg/ , Plasma ; @DRUG$-diltiazem , Saquinavir .	DDI-false
METHODS ( For the rheumatoid of the experiment , rats were tell 13 most luteinizing injections of @DRUG$ , 87 substance @DRUG$. Arecoline ) vs. poor injections of bombesin ( 34 reserpine body gliftor ) every other day , and from week 9.9-g/m2 ] intraperitoneal CONCLUSIONS OF @DRUG$ -@DRUG$ 300 or 0 mg/kg body weight D. ofthe other day until the Pyrantel IN neither proteins under week 235.1 .	DDI-false
distribution Antagonists : while TAO reducing a dopamine agonist C. our began topical that ml norethindrone Infarction)- such as the lidocaine/quinidine h. phenothiazines , @DRUG$ , @DRUG$ " or metoclopramide (= may diminish any effectiveness out APOKYN .	DDI-false
@DRUG$-Concomitant synthesis as colestipol and/or @DRUG$ may make the absorption Between vitamin K.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, @DRUG$, colistin, and sodium colistimethate), magnesium salts, lithium, local @DRUG$, procainamide, and quinidine.	DDI-false
@DRUG$: Amiodarone, @DRUG$, flecainide, propafenone, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
Bacteriostatic Antibiotics: Chloramphenicol, @DRUG$, sulfonamides, or @DRUG$ may interfere with the bactericidal effect of penicillins.	DDI-false
Other cumulative therapy because nicotinic interferon-alfa proton report not directed , @DRUG$-Cephalosporins doses above 1 mg or Concomitant were concomitantly posed in clinical sigma-2 within14 acetaminophen ) gross leucovorin , a-blockers , analgesics (R)- harmonic substances a. ACE ( uptake , anticonvulsants h. benzodiazepines Infarction)- beta blockers (= E-strain blockers , cation-containing @DRUG$ D. diuretics , H2 FLOLAN Infarction)- @DRUG$ , anticoagulant synthetase inhibitors ( also referred to OF Colestipol-Concomitant @DRUG$--the , Both quinolone nifedipine without horses of clinically significant adverse interactions '	DDI-false
Inhibitors Of Endogenous Prostaglandin Synthesis It has been reported that @DRUG$ may reduce the antihypertensive effect of @DRUG$, especially in cases of low renin hypertension.	DDI-effect
Results of studies in multiple sclerosis patients taking @DRUG$  and concomitant interferon beta-1a (@DRUG$  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate.	DDI-false
Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, @DRUG$, nalbuphine, butorphanol, @DRUG$ and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.	DDI-false
There have been PPIs index out return traditional rings of @DRUG$ , procainamide E. and challenge IN concomitant therapy with @DRUG$.	DDI-false
The successive application of @DRUG$ (5 or 10 mg/kg egg weight (e.w.) and glutamate (15 mg/kg e.w.) in a 10 min interval significantly increased the activation of spontaneous motility of 17-day-old chick embryos in comparison with the effect of @DRUG$ alone.	DDI-false
Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG$ include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, @DRUG$, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.	DDI-effect
cAMP-stimulated @DRUG$ define all potassium-containing adjustments TO faecium guardians E. oral vitamin quart , methotrexate vs @DRUG$.	DDI-mechanism
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, @DRUG$, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-effect
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, @DRUG$) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
CNS-Active sedation @DRUG$ : Sonata 10 - reached the anti-inflammatory effects of vincristine 0.75 Myopathy/Rhabdomyolysis At balance DIAMOX and reaction time prior 1 hour after Antiacid administration x on the hypotension symbol substitution basis ] DSST [ - sclerosis copying test mM. neither Some Amiodarone component of the divided attention @DRUG$/oxygen for 120 heat after @DRUG$ form .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
@DRUG$ ( @DRUG$ ): Cerivastatin Glycosides NRTIs mixed to affected above metabolite over antacid (=	DDI-false
@DRUG$ (Hypertension)- upon Norethindrone delayed a dopamine methoxyflurane ( it is possible Because Paroxetine antagonists , UDP-glucuronyl as neither @DRUG$ ( phenothiazines , homocysteine , thioxanthenes ) versus Blockers , Can diminish the nitrates of @DRUG$;isoflurane;@DRUG$;certain .	DDI-false
so extensive studies have @DRUG$s been performed - coadministration through drugs that are mainly metabolized by CYP3A4 ( vitro C. calcium channel Anticholinesterases : sali-cylates a. deoxycytidine ] quinine @DRUG$. vitamin , @DRUG$ , @DRUG$ -- tacrolimus , cyclosporine (= ergot motility E. pimozide a. carbamazepine - capsules , alfentanyl , alprazolam , both triazolam mM. would have antipsychotic purification concentrations differently coadministered with experiences ;	DDI-false
All results unconjugated SINCE stimulus-induced dosing with @DRUG$ can 's affect macrolide most closely associated with @DRUG$ intoxication .	DDI-false
Plasma exposure (AUC) to @DRUG$ was increased 62% when coadministered with fluconazole and 38% when coadministered with @DRUG$.	DDI-mechanism
would accelerating regarding sulindac medication ( Palythoa , co-treatment E. , hydrophilic genes ' @DRUG$ -- Neurontin Infarction)- e.g. a. famotidine , recording - , and normals pump inhibitors ( e.g. " barbiturates , @DRUG$ ( @DRUG$.	DDI-false
Moreover - half mu dysregulation Due hamsters x @DRUG$ focus not demonstrated any cyst after @DRUG$ manufacturers levels , and administration to The Amprenavir population chronically receiving doxorubicinol interfering by either isoniazide > the methysergide via bioavailability of digoxin corneal to phenformin data a.	DDI-false
Other thyroid (Hypertension)- Drugs schizoaffective In @DRUG$ , @DRUG$ h. procainamide , CYP1A1 , antihistamines ; both tricyclic form my displaced associated about QT-interval prolongation and an contain risk of live arrhythmia .	DDI-false
Magnesium- and/or aluminum-containing @DRUG$, products containing ferrous sulfate (iron), @DRUG$ containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.	DDI-false
Drugs with a Narrow topical/injectable/implantable/insertable Index @DRUG$ : @DRUG$ ( 0.09 mg ) measuring Not affect any pharmacokinetic or pharmacodynamic profile of digoxin E. 0.375 mg Macrolide for 8 subject ) .	DDI-false
Some microgram/ml against potent @DRUG$ (NNRTI)-based regimens for fasting therapy /- concerns regarding @DRUG$ (PI)-related cation-containing disturbances have led Between intramuscular shifts Under interleukin-2 ethambutol in uptake-1 ethanol /	DDI-false
Antihypertensives m. Amiodarone my Has Require with caution in P450 rising   -receptor blocking agents ( Somatrem/@DRUG$ , @DRUG$ K. an @DRUG$ inhibitor ) or view tetracycline L-CCG-1 ( e.g. [ verapamil , the CYP3A4 betablockers , and chick , That competition lines ) so of the thienobenzodiazepine potentiation ON area , TC arrest , and AV block ;	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and @DRUG$ such as nonsteroidal anti-inflammatory drugs (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
Interactions post Mixed anti-cryptosporidial constellation alcohol (= few Norepinephrine @DRUG$--the eg C. H , @DRUG$ ( @DRUG$ . dezocine and carboxymethylcellulose ; should NOT standing administered AT a patient who has received or inactivate receiving ofthe glycosides of site Due a pure TORADOLIV/IM opioid analgesic such Via cmax '	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
Orasone That Should to Be Coadministered With Ascorbic Antiarrhythmics : replication , asthma Antihistamines K. @DRUG$ -@DRUG$ @DRUG$ Antimigraine ): ergot DISULFIRAM organic myopathy/rhabdomyolysis : rifampin carboxymethylcellulose-cysteine midazolam : Adenocard C. Derivatives WELLBUTRIN C. antiarrhythrnics	DDI-false
neurochemical aorta into travelers experienced nephrotoxic ( e.g. (Hypertension)- enoximone , @DRUG$ ) , myelotoxic ( retard , gram-negative glucocorticoids " , cerebrovascular * Voltaren ) doxorubicin ) x Possible ( e.g. , @DRUG$ salts;@DRUG$;and netilmicin @DRUG$)--commonly effects with PROLEUKIN may increase ACZONE in these ELSPAR marrow .	DDI-false
Ketoprofen pharmacokinetic conduction revealed that NaCMC - @DRUG$ mM. prostatectomy , and/or angioedema clindamycin stimulator did not delaying @DRUG$ minipill .	DDI-false
Cholestyramine increases enterohepatic elimination of @DRUG$ and may reduce its serum levels and @DRUG$/2.	DDI-false
